data_2a5m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2a5m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.742 0 N-CA-C 107.084 -2.406 . . . . 0.81000000000000005 107.084 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.66 148.9 32.65 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 120.216 -0.992 . . . . 0.01 110.866 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -151.18 136.81 17.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.951 . . . . 0.02 108.839 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 7' ' ' ILE . 6.3 tt -130.25 140.58 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -120.85 129.28 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.455 -0.778 . . . . 0.39000000000000001 109.897 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.6 m-85 -109.42 139.51 44.3 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.839 -0.801 . . . . 0.02 108.839 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -124.18 139.69 53.68 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.184 -0.948 . . . . 0.02 110.126 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.32 -27.3 66.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.029999999999999999 111.826 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.42 169.97 8.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.838 -1.164 . . . . 0.029999999999999999 110.466 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 59.3 mtt180 -74.93 158.49 33.22 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 109.816 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.4 m-20 65.91 34.71 7.01 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.813 0.816 . . . . 0.73999999999999999 110.842 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.2 p90 49.41 44.29 23.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.72 0.771 . . . . 0.02 111.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -111.74 165.95 11.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.43 -167.61 35.73 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.593 -1.289 . . . . 0.029999999999999999 110.487 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -68.6 143.1 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 2.7599999999999998 109.024 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 21' ' ' ASP . 3.0 tmm_? -121.51 149.96 42.32 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.752 0.787 . . . . 1.8899999999999999 110.163 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -133.52 128.17 34.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.444 -0.947 . . . . 0.02 108.444 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' CZ ' ' A' ' 19' ' ' ARG . 45.5 m-20 -111.43 136.9 49.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.494 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.3 t -130.79 137.62 49.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.535 0.684 . . . . 0.02 109.412 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 p-10 -117.0 10.47 14.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.706 -0.621 . . . . 0.20000000000000001 109.535 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -158.32 174.51 15.04 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.158 -1.053 . . . . 1.23 108.158 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.1 p30 -62.08 144.3 55.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.61 -1.306 . . . . 0.02 110.253 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 t -131.33 117.45 18.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.569 -0.9 . . . . 0.02 108.569 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.79 -25.19 53.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.087 -1.008 . . . . 0.23999999999999999 110.613 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.29 101.52 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.966 -1.083 . . . . 1.1399999999999999 108.742 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -104.61 8.35 35.28 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.541 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -59.0 -24.08 62.46 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.556 -0.715 . . . . 3.1099999999999999 110.787 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -74.29 -16.5 60.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.716 -1.24 . . . . 0.88 110.047 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -103.59 -22.16 13.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.02 109.228 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -150.27 128.92 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 3.3199999999999998 109.086 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 p -85.64 -9.98 56.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.735 -0.603 . . . . 0.02 111.086 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -170.78 161.66 7.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 t -142.41 114.37 8.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.718 -1.239 . . . . 0.02 108.573 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -108.71 0.82 20.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.895 -1.128 . . . . 0.029999999999999999 110.609 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 3.2 p -156.55 153.39 28.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -145.38 148.47 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.08 -1.013 . . . . 0.02 109.74 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -124.09 124.87 43.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.387 -1.338 . . . . 0.02 107.387 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -105.69 113.29 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.601 -1.629 . . . . 0.02 106.601 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -83.63 -34.14 25.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.049 -0.66 . . . . 3.8100000000000001 109.744 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.75 150.7 19.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.525 -1.798 . . . . 0.02 110.532 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.92 174.18 50.13 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.513 -1.327 . . . . 0.01 110.095 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 53.9 m -109.62 160.73 16.03 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.996 -1.483 . . . . 1.48 106.996 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 74.6 m95 -148.15 146.89 28.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.324 -1.485 . . . . 0.02 111.443 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.05 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.263 -2.125 . . . . 0.23999999999999999 105.263 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.78 143.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.586 -0.696 . . . . 0.65000000000000002 109.65 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.78 144.85 48.08 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.245 1.021 . . . . 0.02 109.903 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.59 -34.74 78.56 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.829 -0.623 . . . . 0.02 111.541 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -124.25 157.5 64.2 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.104 -0.997 . . . . 0.02 109.326 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.28 165.53 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.491 1.461 . . . . 0.02 113.152 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 64.18 37.31 8.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.221 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 45.24 51.32 9.32 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.655 0.741 . . . . 3.3900000000000001 110.483 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -125.81 163.27 23.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 2.3300000000000001 109.714 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.02 -161.42 31.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.642 -1.383 . . . . 0.02 109.642 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -65.15 138.24 58.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.04 -1.271 . . . . 0.02 110.161 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.6 ptm -118.61 135.79 54.24 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.067 -0.716 . . . . 5.0099999999999998 109.067 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.583 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.7 m-85 -134.82 139.94 45.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.8 0.809 . . . . 0.02 109.856 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -95.52 132.49 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.561 -0.903 . . . . 1.72 108.561 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -118.59 111.78 37.63 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.569 -0.707 . . . . 0.02 110.357 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.89 168.1 22.71 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.127 1.081 . . . . 1.47 109.897 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 7.9 tm0? -53.37 140.81 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.796 -1.19 . . . . 4.25 110.36 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.04 -176.9 32.56 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.689 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.1 tp10 -118.13 129.31 55.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -1.146 . . . . 0.95999999999999996 108.929 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.528 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 47.3 m-85 -120.4 96.8 49.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 107.548 -1.278 . . . . 0.02 107.548 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -68.74 -3.9 12.18 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 120.541 0.827 . . . . 0.02 113.818 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -156.91 154.34 29.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.453 -1.405 . . . . 2.02 107.962 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 52.0 p90 -60.51 -37.62 81.72 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.59 -0.694 . . . . 0.02 111.537 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.39 -23.97 64.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.014 -1.053 . . . . 0.02 110.454 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.52 -18.48 62.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.433 -0.951 . . . . 3.4199999999999999 108.433 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.583 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.75 10.98 30.71 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.188 -1.412 . . . . 0.02 107.188 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.4 OUTLIER 59.61 21.76 10.4 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.598 0.713 . . . . 0.02 110.27 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.7 145.1 45.73 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.871 -1.692 . . . . 0.02 108.871 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.27 -30.48 48.55 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.536 -1.283 . . . . 0.97999999999999998 107.536 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 16.0 t-20 -156.77 -172.36 4.02 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.514 -1.662 . . . . 0.02 106.514 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.537 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 32.6 p30 -97.52 27.29 4.38 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.709 -1.245 . . . . 0.02 110.087 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -96.04 122.86 39.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.055 -1.028 . . . . 3.2000000000000002 110.493 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.9 mt -144.31 120.55 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.469 -1.308 . . . . 2.6099999999999999 107.469 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 -16.52 13.06 Favored Glycine 0 N--CA 1.504 3.172 0 O-C-N 121.317 -0.864 . . . . 0.02 112.507 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 35.3 m -156.06 156.06 33.72 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.372 -1.663 . . . . 0.02 110.239 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.7 p -144.12 146.91 33.09 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.372 0.606 . . . . 0.02 109.447 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -135.03 140.18 45.4 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.01 108.857 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.82 130.57 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.36 -0.978 . . . . 0.42999999999999999 108.36 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.1 125.2 44.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.389 -0.967 . . . . 1.25 108.389 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -90.51 135.8 33.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 1.77 108.94 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.76 138.2 37.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.986 -0.746 . . . . 1.6299999999999999 108.986 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -113.29 126.11 55.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.863 -0.792 . . . . 1.0800000000000001 108.863 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -102.51 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.209 -1.774 . . . . 1.26 106.209 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.56 -48.31 0.9 Allowed Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.376 -1.452 . . . . 0.01 112.529 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.16 -99.63 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 118.259 -1.924 . . . . 0.01 112.388 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -121.58 119.63 32.48 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.285 -1.127 . . . . 4.4299999999999997 110.756 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -77.75 131.08 37.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.105 -0.702 . . . . 2.9900000000000002 109.105 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.3 ttpm? -131.13 140.35 49.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.461 -0.774 . . . . 6.3600000000000003 108.931 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -128.9 143.66 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.386 -0.821 . . . . 1.0900000000000001 110.109 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.23 133.73 54.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.905 -1.146 . . . . 2.0499999999999998 107.905 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.03 147.17 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.876 -1.14 . . . . 1.1000000000000001 109.691 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 29.5 m-85 -118.56 140.87 49.21 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.129 0.966 . . . . 0.72999999999999998 110.835 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -66.26 -29.42 69.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.772 -0.649 . . . . 0.02 111.721 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -116.91 170.25 8.77 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 120.984 -1.072 . . . . 3.1800000000000002 110.573 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 165.32 50.12 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.831 -0.907 . . . . 0.01 110.831 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 56.5 38.41 29.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.834 -0.803 . . . . 0.01 111.461 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE1' ' OG ' ' A' ' 128' ' ' SER . 11.3 m-85 52.57 54.5 10.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.01 111.509 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.638 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 6.3 t-20 -129.25 166.31 19.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.196 -1.038 . . . . 3.1499999999999999 108.196 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.638 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 92.52 -164.46 28.03 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.514 -1.434 . . . . 0.01 109.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 65.8 tt0 -75.16 144.54 42.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.1 -1.235 . . . . 0.01 108.493 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 48.2 ttp -116.65 142.11 47.32 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.654 0.74 . . . . 0.01 109.88 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 30.2 m-85 -131.24 135.33 47.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.912 -1.144 . . . . 2.48 107.912 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -120.43 135.09 55.15 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.623 -0.673 . . . . 0.01 110.041 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.53 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 7.1 t -149.63 151.62 34.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.295 1.045 . . . . 1.6899999999999999 110.934 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.525 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 5.3 p -110.06 10.3 24.07 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.503 -0.771 . . . . 0.01 109.787 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.53 ' H ' ' HG1' ' A' ' 110' ' ' THR . 41.7 mt-10 -121.11 162.92 19.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 3.21 111.156 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -66.78 155.79 37.25 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.151 -1.055 . . . . 0.01 108.151 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.0 t -123.98 110.12 29.47 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.528 -0.916 . . . . 0.01 108.528 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.71 -32.82 3.33 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 120.002 1.036 . . . . 0.01 111.697 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -139.64 106.78 5.47 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.33 -39.91 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.869 -0.519 . . . . 1.8300000000000001 111.065 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 36.1 ttp -66.59 -38.0 86.09 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.996 -1.082 . . . . 1.3400000000000001 109.957 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -70.25 -38.96 75.26 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.522 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 45.7 tt0 -80.16 -48.2 13.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 2.0800000000000001 112.507 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.522 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 81.3 m-85 -111.41 -1.29 15.99 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.353 -0.842 . . . . 0.02 112.611 -175.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 61.79 33.77 17.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.792 -1.193 . . . . 0.02 109.668 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.52 136.05 53.45 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.487 -0.758 . . . . 0.02 109.293 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -90.21 -21.46 22.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.986 . . . . 5.3200000000000003 110.87 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -148.73 164.14 35.24 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.02 110.124 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.433 HG23 HD12 ' A' ' 126' ' ' ILE . 37.2 mm -129.29 126.57 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.503 -1.295 . . . . 2.1699999999999999 107.503 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.54 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 m80 -109.92 -13.22 14.47 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.251 -0.906 . . . . 0.02 112.618 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.534 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 47.5 t -161.39 154.34 20.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.786 -1.196 . . . . 0.01 109.0 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -170.64 147.28 2.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.22 109.684 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -119.86 109.9 16.11 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.986 -1.071 . . . . 1.4099999999999999 109.237 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 106.273 -1.751 . . . . 0.01 106.273 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 42.9 m95 . . . . . 0 N--CA 1.503 2.198 0 N-CA-C 107.461 -1.311 . . . . 0.01 107.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.409 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 36.3 mt -118.51 133.14 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.565 -1.335 . . . . 1.6899999999999999 109.502 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.09 141.62 44.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.334 -1.728 . . . . 2.4900000000000002 106.334 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 21.4 m-85 -123.45 143.07 50.38 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.197 -0.94 . . . . 0.02 109.731 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -74.25 -30.36 62.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.675 -0.641 . . . . 0.02 111.882 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.49 155.12 47.6 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.62 -1.3 . . . . 1.48 108.951 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -56.51 167.27 2.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.098 1.199 . . . . 0.02 112.615 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.25 31.21 21.01 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.413 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.48 50.68 10.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 0.02 111.082 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.36 165.13 18.25 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.656 -0.652 . . . . 0.02 109.766 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.7 33.98 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.549 -1.021 . . . . 0.02 110.549 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.57 142.15 53.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.542 -0.975 . . . . 0.02 108.788 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.5 mt-30 -113.14 148.45 35.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.351 0.596 . . . . 0.02 110.083 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -124.3 134.19 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.687 -0.856 . . . . 0.01 108.687 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.0 tp -96.0 120.55 36.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.156 . . . . 0.01 109.654 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.95 149.36 23.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.856 -0.794 . . . . 0.01 108.856 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.3 m-20 -109.58 -177.32 3.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 2.27 109.374 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -72.83 35.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.8400000000000001 109.469 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.6 mttp -111.55 176.2 5.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.078 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.92 127.03 52.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.424 -0.797 . . . . 0.01 109.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -98.31 112.26 24.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.01 108.847 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -88.7 -27.85 20.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.762 -0.586 . . . . 0.01 111.298 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -122.53 153.43 62.59 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 107.907 -1.146 . . . . 2.54 107.907 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.0 Cg_endo -62.24 -41.44 34.61 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.315 0.791 . . . . 0.69999999999999996 110.805 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.57 -18.26 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.862 -1.149 . . . . 0.85999999999999999 109.457 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.5 -18.22 65.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.891 -1.13 . . . . 0.02 111.948 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.31 15.83 27.51 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.737 -1.227 . . . . 0.02 110.207 178.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.72 10.14 76.79 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.12 -0.987 . . . . 0.02 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.41 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.06 140.61 34.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.862 -1.375 . . . . 0.02 110.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.27 -7.05 59.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.621 -0.675 . . . . 0.58999999999999997 109.521 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.5 p -140.46 150.38 60.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.239 -0.913 . . . . 0.87 109.06 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.66 16.14 0.64 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 120.566 0.844 . . . . 0.38 111.776 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.19 119.9 24.66 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.307 1.051 . . . . 0.17999999999999999 110.817 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.43 123.64 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.57 -2.011 . . . . 3.9900000000000002 105.57 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -111.9 -13.16 13.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.369 -0.832 . . . . 5.1699999999999999 113.16 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.1 p -157.03 160.1 38.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 119.276 -2.14 . . . . 0.02 109.965 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.1 153.9 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 2.02 110.202 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -144.18 149.26 36.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.342 -0.849 . . . . 0.01 110.068 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 93' ' ' ALA . 4.6 ptp180 -87.02 141.48 28.64 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.603 -0.888 . . . . 0.01 108.603 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 41.7 mt -93.88 129.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 3.04 109.482 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.78 149.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.407 -0.808 . . . . 1.8899999999999999 109.771 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 4.8899999999999997 109.536 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 105.593 -3.003 . . . . 0.81000000000000005 105.593 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 146.61 31.53 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.383 -0.913 . . . . 0.01 111.179 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.23 137.4 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.76 -0.847 . . . . 0.02 108.82 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 tt -129.89 140.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.937 -0.764 . . . . 0.02 108.937 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -120.9 130.14 53.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.721 . . . . 0.39000000000000001 109.654 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 25.7 m-85 -108.96 138.73 44.84 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.88 -0.785 . . . . 0.02 108.88 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.34 138.28 54.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.302 -0.874 . . . . 0.02 109.398 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -68.21 -27.75 66.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 0.029999999999999999 111.605 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -114.93 170.13 8.57 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.976 -1.077 . . . . 0.029999999999999999 110.422 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -74.73 161.66 29.42 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.708 0.766 . . . . 0.029999999999999999 110.063 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.2 t-20 62.58 34.91 14.74 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.894 0.854 . . . . 0.73999999999999999 110.559 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.0 p90 49.45 42.9 23.23 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.473 -0.785 . . . . 0.02 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -109.35 165.89 11.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.806 -1.183 . . . . 0.02 107.806 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -167.98 35.01 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.681 -1.262 . . . . 0.029999999999999999 110.837 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.9 143.96 54.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.955 . . . . 2.7599999999999998 109.035 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -122.16 150.05 42.76 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.727 0.775 . . . . 1.8899999999999999 110.207 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.24 128.59 36.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.158 -1.053 . . . . 0.02 108.158 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -110.98 135.92 50.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.549 -0.719 . . . . 1.1200000000000001 109.465 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -129.99 137.81 50.49 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.486 0.66 . . . . 0.02 109.682 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 10.89 14.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.248 -0.649 . . . . 0.20000000000000001 109.248 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.1 t -158.83 174.17 15.4 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.06 -1.089 . . . . 1.23 108.06 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 15.8 p-10 -61.66 144.74 54.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.756 -1.215 . . . . 0.02 110.216 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 t -131.49 117.5 18.88 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.5 -0.926 . . . . 0.02 108.5 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.01 44.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.23999999999999999 111.292 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -153.21 102.49 2.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.149 . . . . 1.1399999999999999 108.946 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' C ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -101.68 8.49 41.62 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.962 0.887 . . . . 6.3700000000000001 109.689 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -59.14 -26.74 65.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.731 -0.606 . . . . 3.1099999999999999 111.657 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.28 -17.32 60.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.591 -1.318 . . . . 0.88 110.36 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.14 -22.22 13.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.02 109.799 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 tp -150.1 128.26 11.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.052 -1.03 . . . . 3.3199999999999998 109.019 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -84.77 -9.21 58.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.781 -0.575 . . . . 0.02 111.016 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -171.03 164.11 7.46 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -142.24 114.15 8.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.726 -1.234 . . . . 0.02 108.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.2 m-80 -109.14 -0.93 19.11 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.942 -1.099 . . . . 0.029999999999999999 111.343 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 1.3 t -154.02 153.8 32.59 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.457 ' N ' ' HG ' ' A' ' 38' ' ' SER . 16.3 mt -145.74 146.73 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.136 -0.978 . . . . 0.02 110.552 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' NE ' ' OH ' ' A' ' 10' ' ' TYR . 25.3 ttp180 -124.56 125.22 43.82 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.476 -1.305 . . . . 0.02 107.476 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.544 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 43.8 t -104.07 113.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 106.565 -1.643 . . . . 0.02 106.565 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' C ' ' NE2' ' A' ' 63' ' ' GLN . 11.1 tp10 -83.01 -34.47 26.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 3.8100000000000001 109.389 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.59 18.02 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.726 -1.702 . . . . 0.02 110.302 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.81 173.56 49.82 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.711 -1.233 . . . . 0.01 110.243 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -119.02 135.48 54.61 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.473 -1.306 . . . . 1.48 107.473 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.41 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.2 m95 -123.91 153.65 40.85 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.835 -1.166 . . . . 0.02 112.259 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.29 53.08 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.14 -2.17 . . . . 0.23999999999999999 105.14 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.63 142.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.129 -0.693 . . . . 0.65000000000000002 109.129 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.04 146.33 46.83 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.295 1.045 . . . . 0.02 109.617 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.53 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -66.0 -35.66 81.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.55 -0.75 . . . . 0.02 111.121 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -123.46 158.52 58.56 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 121.2 -0.937 . . . . 0.02 109.067 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.83 168.38 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.65 1.567 . . . . 0.02 112.8 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 62.75 37.42 12.57 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.421 -0.809 . . . . 0.02 111.197 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.73 52.11 8.01 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.573 0.701 . . . . 3.3900000000000001 110.793 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.605 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 28.8 t -126.61 164.16 21.84 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.193 0.52 . . . . 2.3300000000000001 109.838 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.605 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.35 -161.55 32.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.517 -1.433 . . . . 0.02 109.517 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -66.44 137.55 56.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.927 -1.337 . . . . 0.02 109.61 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.49 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.8 ptm -119.24 137.52 53.6 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.305 -0.628 . . . . 5.0099999999999998 109.305 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.1 m-85 -132.3 138.9 47.99 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.02 109.466 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.4 mm -96.23 132.1 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.764 -0.828 . . . . 1.72 108.764 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.45 110.13 34.23 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.255 -0.903 . . . . 0.02 110.751 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.2 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.793 0.962 . . . . 1.47 109.981 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 -50.56 138.71 17.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 4.25 110.254 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.04 -179.17 32.15 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.035 -1.555 . . . . 0.02 110.884 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.0 130.83 55.89 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.547 -0.972 . . . . 0.95999999999999996 109.462 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -120.87 94.33 48.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.664 -1.236 . . . . 0.02 107.664 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.08 -4.47 11.6 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.781 0.988 . . . . 0.02 113.738 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -155.01 154.43 32.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.723 -1.236 . . . . 2.02 108.008 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CE2' ' CD ' ' A' ' 70' ' ' GLN . 33.3 p90 -61.12 -38.74 87.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.514 -0.741 . . . . 0.02 111.396 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.447 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 12.8 mm100 -60.38 -24.39 65.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.102 -0.999 . . . . 0.02 110.058 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.541 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.06 -18.09 63.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.293 -1.003 . . . . 3.4199999999999999 108.293 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.7 10.13 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.221 -1.4 . . . . 0.02 107.221 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.1 mpp? 59.2 21.9 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.664 0.745 . . . . 0.02 110.138 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 144.47 46.48 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.321 -1.512 . . . . 0.02 109.321 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 -30.03 48.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.623 -1.251 . . . . 0.97999999999999998 107.623 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.53 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -157.96 -171.17 3.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.533 -1.654 . . . . 0.02 106.533 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.9 p-10 -98.21 28.3 4.13 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.682 -1.262 . . . . 0.02 110.403 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.508 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -97.57 122.83 41.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.814 -1.179 . . . . 3.2000000000000002 111.056 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -142.33 122.01 13.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.286 -1.376 . . . . 2.6099999999999999 107.286 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -18.12 10.6 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.985 -1.072 . . . . 0.02 112.302 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.546 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 28.4 t -156.14 155.86 33.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.463 -1.61 . . . . 0.02 110.277 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.546 ' N ' ' HG ' ' A' ' 81' ' ' SER . 70.4 m -144.33 147.63 33.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.02 109.791 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -135.02 140.22 45.47 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.28 -0.888 . . . . 0.01 109.111 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 134.92 37.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 0.42999999999999999 108.753 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 123.09 45.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.554 -0.906 . . . . 1.25 108.554 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -90.48 136.18 33.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.183 -1.043 . . . . 1.77 108.183 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.51 137.29 38.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 1.6299999999999999 109.6 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.8 m -112.1 126.32 55.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.58 -0.896 . . . . 1.0800000000000001 108.58 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -102.99 -155.47 0.53 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.262 -1.755 . . . . 1.26 106.262 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.16 -48.96 0.86 Allowed Glycine 0 N--CA 1.498 2.83 0 O-C-N 120.438 -1.414 . . . . 0.01 112.384 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.88 -99.58 0.13 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.444 -1.836 . . . . 0.01 112.166 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -120.84 119.6 33.14 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.246 -1.149 . . . . 4.4299999999999997 110.751 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.3 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.187 -0.671 . . . . 2.9900000000000002 109.187 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -130.91 141.16 50.27 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.557 -0.714 . . . . 6.3600000000000003 109.085 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.78 144.84 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.319 -0.863 . . . . 1.0900000000000001 109.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.4 pm0 -121.76 134.37 54.93 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.404 -1.332 . . . . 2.0499999999999998 107.404 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 146.58 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.914 -1.116 . . . . 1.1000000000000001 109.371 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 36.0 m-85 -120.23 141.64 49.75 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.158 0.98 . . . . 0.72999999999999998 111.108 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -66.43 -30.05 70.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.699 -0.682 . . . . 0.02 111.816 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -116.29 168.09 10.44 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.956 -1.09 . . . . 3.1800000000000002 110.54 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.94 164.14 43.77 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 111.153 -0.779 . . . . 0.01 111.153 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 56.54 39.23 29.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.675 0.75 . . . . 0.01 110.941 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 51.45 56.31 8.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.625 -0.672 . . . . 0.01 111.115 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -128.55 165.64 20.36 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.008 -1.108 . . . . 3.1499999999999999 108.008 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.61 -164.08 27.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.151 -1.579 . . . . 0.01 109.151 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.66 144.32 43.87 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.983 -1.304 . . . . 0.01 108.411 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.8 ttt -116.5 141.74 47.79 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.619 0.723 . . . . 0.01 109.521 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -131.65 135.72 47.14 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.069 -1.085 . . . . 2.48 108.069 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -118.93 135.12 54.75 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.668 -0.645 . . . . 0.01 109.928 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -149.64 151.55 33.94 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.392 1.091 . . . . 1.6899999999999999 110.95 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.401 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 18.6 p -111.05 9.68 22.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.396 -0.82 . . . . 0.01 109.923 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 30.5 mp0 -121.28 163.85 17.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.324 -0.86 . . . . 3.21 111.556 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -67.73 156.03 37.88 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.443 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 12.3 m -124.83 111.67 27.3 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.753 -0.832 . . . . 0.01 108.753 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.0 Cg_endo -76.21 -31.78 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 CA-C-N 119.958 1.021 . . . . 0.01 111.439 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -141.3 107.03 5.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.573 -0.899 . . . . 0.02 108.573 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.85 -39.28 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.81 -0.557 . . . . 1.8300000000000001 111.139 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.5 tmt? -67.19 -38.2 84.98 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.97 -1.092 . . . . 1.3400000000000001 109.892 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.14 -38.44 78.82 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.484 -1.385 . . . . 2.1099999999999999 109.826 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -79.63 -47.4 15.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 2.0800000000000001 112.38 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.12 -0.48 15.59 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.469 -0.769 . . . . 0.02 112.75 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m80 61.54 33.77 18.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.687 -1.258 . . . . 0.02 109.719 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.8 136.21 53.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.371 -0.831 . . . . 0.02 109.256 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -89.46 -21.73 22.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 5.3200000000000003 110.473 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -150.38 165.67 32.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.958 -1.088 . . . . 0.02 110.256 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.7 mm -129.87 126.57 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.219 -1.4 . . . . 2.1699999999999999 107.219 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -108.97 -12.94 14.81 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.14 -0.975 . . . . 0.02 112.598 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 21.1 m -158.16 152.34 24.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.764 -1.21 . . . . 0.01 108.753 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.8 t -166.51 142.81 4.75 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.099 -1.001 . . . . 1.22 109.152 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.531 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 31.4 ttpt -123.21 105.34 9.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.57 1.176 . . . . 1.4099999999999999 109.504 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 107.5 -1.296 . . . . 0.01 107.5 179.127 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 107.549 -1.278 . . . . 0.01 107.549 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.3 mt -118.98 135.75 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.581 -1.324 . . . . 1.6899999999999999 109.566 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.34 142.16 43.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.341 -1.725 . . . . 2.4900000000000002 106.341 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 31.9 m-85 -122.23 143.53 49.53 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.113 -0.992 . . . . 0.02 109.364 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 47.4 tt0 -76.68 -30.03 56.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.747 -0.596 . . . . 0.02 111.833 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.1 mt -114.33 152.57 46.13 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.562 -1.336 . . . . 1.48 109.064 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.72 165.64 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.65 0.9 . . . . 0.02 112.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 59.71 31.67 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.307 -0.86 . . . . 0.75 111.549 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 57.88 52.13 8.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.514 -0.742 . . . . 0.02 111.412 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.439 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.0 165.51 19.3 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.473 -0.767 . . . . 0.02 110.059 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.86 -165.54 33.36 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.962 -1.255 . . . . 0.02 109.962 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -69.83 143.59 52.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.02 108.94 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 58' ' ' MET . 16.6 mt-30 -113.08 149.5 33.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.02 110.085 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.87 133.61 53.01 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.92 121.58 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.944 -1.098 . . . . 0.01 109.785 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -98.31 142.32 30.1 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.72 -0.845 . . . . 0.01 108.72 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 154' ' ' LYS . 95.1 m-20 -110.26 -172.55 2.06 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.445 -0.784 . . . . 2.27 109.739 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -71.64 37.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.636 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 152' ' ' ASP . 30.6 mmtp -112.31 168.74 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.413 -0.804 . . . . 2.2799999999999998 109.3 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -104.34 127.0 51.92 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.039 -1.097 . . . . 0.01 108.039 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 54.8 m-85 -99.58 112.47 24.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.928 . . . . 0.01 110.258 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.444 ' O ' ' OG ' ' A' ' 128' ' ' SER . 78.7 mtt180 -89.31 -27.39 20.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.632 -0.667 . . . . 0.01 110.845 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -124.43 152.82 68.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 108.134 -1.062 . . . . 2.54 108.134 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 7.8 Cg_endo -60.83 -40.25 55.37 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 CA-C-N 119.437 0.835 . . . . 0.69999999999999996 111.005 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.49 -18.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 120.724 -1.235 . . . . 0.85999999999999999 109.67 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 156' ' ' TYR . 39.2 t70 -65.4 -17.6 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.91 -1.119 . . . . 0.02 112.062 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.17 16.7 24.59 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 120.733 -1.23 . . . . 0.02 110.229 178.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.02 77.68 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.174 -0.954 . . . . 0.02 112.874 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.11 139.81 34.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.85 -1.382 . . . . 0.02 110.146 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.67 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.58999999999999997 109.342 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 p -138.92 151.77 68.91 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.87 109.261 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.77 13.58 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.756 0.971 . . . . 0.38 111.892 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.55 119.62 24.0 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.603 1.192 . . . . 0.17999999999999999 111.039 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.508 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 0.9 OUTLIER -150.55 121.93 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.013 -1.847 . . . . 3.9900000000000002 106.013 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.507 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 11.0 mp0 -113.69 -11.57 12.93 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 113.253 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 18.1 m -156.46 159.01 38.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.119 -2.238 . . . . 0.02 110.45 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.443 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 25.3 p90 -152.79 154.34 34.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.029 -1.044 . . . . 2.02 110.3 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -144.21 149.88 37.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 0.01 110.125 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -87.05 141.97 28.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.311 -0.996 . . . . 0.01 108.311 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.6 mt -93.71 129.54 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.325 -0.859 . . . . 3.04 109.411 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 m -138.28 149.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.351 -0.843 . . . . 1.8899999999999999 109.756 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 4.8899999999999997 109.56 179.474 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.601 0 N-CA-C 107.16 -2.376 . . . . 0.81000000000000005 107.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 149.31 33.31 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.162 -1.018 . . . . 0.01 110.683 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -150.88 136.84 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.496 -1.002 . . . . 0.02 109.493 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.9 140.42 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 109.2 -0.666 . . . . 0.02 109.2 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.525 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -122.03 130.23 53.11 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.571 -0.705 . . . . 0.39000000000000001 109.642 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 24.6 m-85 -110.31 140.13 44.8 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.007 -0.738 . . . . 0.02 109.007 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.525 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 9.0 m-85 -121.98 138.45 54.42 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.339 -0.851 . . . . 0.02 109.546 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 66.2 mt-10 -68.14 -27.82 66.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -0.989 . . . . 0.029999999999999999 111.706 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -114.26 170.03 8.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.867 -1.146 . . . . 0.029999999999999999 110.468 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -75.22 158.26 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.498 0.666 . . . . 0.029999999999999999 110.058 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.9 m-80 66.2 34.65 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.826 0.822 . . . . 0.73999999999999999 110.767 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.95 45.22 25.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.668 0.746 . . . . 0.02 111.428 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.24 165.88 11.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.66 -167.71 35.43 Favored Glycine 0 N--CA 1.496 2.674 0 O-C-N 120.793 -1.192 . . . . 0.029999999999999999 110.912 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -68.61 142.74 55.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.45 -1.03 . . . . 2.7599999999999998 109.279 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -120.02 148.65 43.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.597 -0.69 . . . . 1.8899999999999999 110.23 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -132.33 127.06 34.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.257 -1.016 . . . . 0.02 108.257 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -111.81 136.51 50.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.483 -0.761 . . . . 1.1200000000000001 109.762 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -130.91 138.02 49.58 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.573 0.701 . . . . 0.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -116.47 11.29 14.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.623 -0.673 . . . . 0.20000000000000001 109.477 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 19.9 p -157.79 174.15 15.73 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.195 -1.039 . . . . 1.23 108.195 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 19.3 p30 -61.11 144.66 53.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.72 -1.238 . . . . 0.02 109.955 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 t -131.76 116.53 17.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.415 -0.957 . . . . 0.02 108.415 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.59 52.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.23999999999999999 110.733 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -156.58 100.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.676 -0.861 . . . . 1.1399999999999999 108.676 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -104.89 10.46 34.33 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 122.175 0.988 . . . . 6.3700000000000001 109.799 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.4 mmp_? -59.27 -23.44 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.68 -0.638 . . . . 3.1099999999999999 111.018 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 p -75.5 -17.0 60.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.685 -1.259 . . . . 0.88 110.185 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 26.2 m-85 -104.26 -21.74 13.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.495 -0.753 . . . . 0.02 109.132 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.6 tp -148.53 126.42 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 3.3199999999999998 109.41 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 m -86.29 -11.54 51.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.463 -0.773 . . . . 0.02 111.405 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.2 tpp180 -170.65 160.39 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.697 -1.223 . . . . 0.02 107.697 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -140.89 114.61 8.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.897 -1.127 . . . . 0.02 109.455 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 11' ' ' GLU . 2.7 m120 -108.2 -0.96 20.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.535 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.6 m -155.7 153.59 30.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.1 mt -145.14 146.91 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 0.02 110.063 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -123.11 123.92 41.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.78 -1.193 . . . . 0.02 107.78 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 38.3 t -106.52 114.17 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -84.0 -33.74 24.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.234 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.46 18.0 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.109 -1.519 . . . . 0.02 110.048 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 173.41 49.72 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.487 -1.34 . . . . 0.01 110.04 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.2 m -120.39 138.03 53.98 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.107 -1.072 . . . . 1.48 108.107 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -126.99 154.43 44.62 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.559 1.171 . . . . 0.02 112.057 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.54 133.57 51.81 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 104.938 -2.245 . . . . 0.23999999999999999 104.938 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 141.42 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.178 -0.675 . . . . 0.65000000000000002 109.178 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.06 144.18 48.68 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.184 0.992 . . . . 0.02 109.706 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.36 -34.51 78.32 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.339 -0.846 . . . . 0.02 111.459 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -124.09 157.81 62.68 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.238 -0.914 . . . . 0.02 109.328 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.67 167.52 0.97 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.762 1.641 . . . . 0.02 112.563 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 2.0 t30 63.27 37.12 11.31 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.457 -0.792 . . . . 0.02 111.211 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 1.8 m-85 45.35 51.26 9.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.613 -0.679 . . . . 3.3900000000000001 110.819 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -125.75 163.91 21.82 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.153 0.501 . . . . 2.3300000000000001 109.994 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -162.01 31.53 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.715 -1.354 . . . . 0.02 109.715 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -65.57 137.25 57.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.332 . . . . 0.02 109.806 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.468 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.4 ptm -117.66 136.35 53.38 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.487 0.66 . . . . 5.0099999999999998 109.692 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -133.62 139.87 46.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.484 -0.76 . . . . 0.02 109.49 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -95.7 132.03 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 mt -122.25 109.42 33.28 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.57 -0.706 . . . . 0.02 110.206 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -75.49 170.64 19.83 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.893 0.998 . . . . 1.47 110.352 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 41' ' ' VAL . 1.1 tm0? -51.83 140.26 19.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 4.25 109.862 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 155.53 -177.79 32.49 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.486 -1.34 . . . . 0.02 110.565 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -120.63 131.3 54.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.516 -0.991 . . . . 0.95999999999999996 109.305 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 64.8 m-85 -122.42 93.56 48.4 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.866 -1.161 . . . . 0.02 107.866 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.06 -3.68 7.61 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.034 1.156 . . . . 0.02 113.92 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -156.87 152.95 27.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.379 -1.451 . . . . 2.02 107.91 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -60.07 -38.7 83.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.612 -0.68 . . . . 0.02 111.977 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.5 -24.85 65.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.972 . . . . 0.02 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -17.98 63.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 3.4199999999999999 108.999 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.89 12.06 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.277 -1.379 . . . . 0.02 107.277 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.2 mtp 60.2 21.85 11.2 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.528 0.68 . . . . 0.02 110.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.92 144.65 46.44 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.386 -1.486 . . . . 0.02 109.386 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.24 -30.45 43.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.549 -1.278 . . . . 0.97999999999999998 107.549 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 51.6 t30 -156.98 -171.92 3.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.397 -1.705 . . . . 0.02 106.397 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 30.6 p-10 -98.58 27.93 4.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.66 -1.275 . . . . 0.02 110.208 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -96.0 122.55 38.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.848 -1.157 . . . . 3.2000000000000002 110.638 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.427 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 51.3 mt -143.48 121.48 12.08 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.808 -1.182 . . . . 2.6099999999999999 107.808 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.11 -17.71 9.31 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 121.26 -0.9 . . . . 0.02 112.641 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.451 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 5.1 t -155.53 155.77 33.99 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.043 -1.857 . . . . 0.02 110.867 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.451 ' N ' ' HG ' ' A' ' 81' ' ' SER . 10.9 p -145.5 147.72 32.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.02 110.653 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 13.8 mtp180 -136.67 141.83 43.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.01 109.288 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 130.35 36.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.451 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 t -90.18 123.55 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.608 -0.886 . . . . 1.25 108.608 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -90.3 135.41 33.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 1.77 108.703 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -99.65 138.66 36.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.729 -0.841 . . . . 1.6299999999999999 108.729 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 p -113.2 125.67 54.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.942 -0.762 . . . . 1.0800000000000001 108.942 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.0 t -102.79 -155.4 0.52 Allowed 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 105.992 -1.855 . . . . 1.26 105.992 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.74 -47.35 0.95 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 120.356 -1.465 . . . . 0.01 112.345 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.53 -98.86 0.12 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.433 -1.841 . . . . 0.01 112.181 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 16.7 tm0? -119.56 117.97 29.78 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.222 -1.163 . . . . 4.4299999999999997 110.317 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.0 132.1 39.96 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.304 -0.628 . . . . 2.9900000000000002 109.304 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -131.01 137.42 49.19 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.028 -0.73 . . . . 6.3600000000000003 109.028 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 tt -125.22 142.61 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.874 0.845 . . . . 1.0900000000000001 109.139 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.502 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 11.0 pt20 -124.77 132.26 53.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.744 -1.206 . . . . 2.0499999999999998 107.744 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.06 148.15 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 120.919 -1.113 . . . . 1.1000000000000001 109.659 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -117.97 140.96 48.99 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.042 0.925 . . . . 0.72999999999999998 110.849 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.59 -30.12 70.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.938 -0.574 . . . . 0.02 111.765 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 128' ' ' SER . 83.3 mttt -116.57 168.4 10.21 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.983 -1.073 . . . . 3.1800000000000002 110.49 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.21 164.59 44.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 56.71 39.18 29.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.635 0.731 . . . . 0.01 111.117 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.477 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.5 m-85 52.53 55.68 8.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.583 -0.698 . . . . 0.01 111.076 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -129.65 166.32 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.515 -0.92 . . . . 3.1499999999999999 108.515 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.79 -164.71 27.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.277 -1.529 . . . . 0.01 109.277 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.26 145.11 42.17 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.009 -1.289 . . . . 0.01 108.619 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.484 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 9.9 tmm? -116.51 141.72 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.633 0.73 . . . . 0.01 109.772 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.484 ' N ' ' SD ' ' A' ' 107' ' ' MET . 59.8 m-85 -130.32 135.17 47.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.888 -1.153 . . . . 2.48 107.888 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -121.32 135.01 55.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.727 -0.608 . . . . 0.01 109.809 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -149.55 153.63 37.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.242 1.02 . . . . 1.6899999999999999 110.786 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.489 ' CG2' ' NE2' ' A' ' 92' ' ' GLN . 34.9 p -110.43 9.41 23.38 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.646 -0.706 . . . . 0.01 109.933 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -121.39 163.07 19.3 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.381 -0.824 . . . . 3.21 111.384 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.32 155.0 38.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.193 -1.04 . . . . 0.01 108.193 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 29.4 t -124.15 111.42 28.63 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.77 -31.86 4.97 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 CA-C-N 120.134 1.084 . . . . 0.01 111.554 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -141.6 108.33 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.22 -0.925 . . . . 0.02 108.959 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.8 mt -62.97 -38.75 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.853 -0.529 . . . . 1.8300000000000001 110.408 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 30.9 ttm -66.5 -37.26 84.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.12 -1.032 . . . . 1.3400000000000001 109.831 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -70.91 -39.34 72.78 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.44 -1.412 . . . . 2.1099999999999999 109.69 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 6.6 tt0 -80.85 -48.2 12.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 2.0800000000000001 112.679 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.54 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 62.5 m-85 -111.95 -1.79 15.33 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.376 -0.828 . . . . 0.02 112.491 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 61.23 33.84 18.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.873 -1.142 . . . . 0.02 109.589 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.6 mt -114.02 135.44 54.0 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.413 -0.804 . . . . 0.02 109.195 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -90.68 -21.7 21.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.126 -0.984 . . . . 5.3200000000000003 111.276 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.41 164.97 33.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.721 -1.237 . . . . 0.02 110.668 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -127.66 123.81 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.726 -1.213 . . . . 2.1699999999999999 107.726 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -109.11 -14.78 14.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.11 -0.994 . . . . 0.02 112.642 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.477 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 23.6 p -160.91 153.71 21.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.572 -1.33 . . . . 0.01 108.941 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 1.8 t -167.0 141.02 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.628 -0.878 . . . . 1.22 108.628 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.538 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -121.26 97.4 5.5 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.133 -1.062 . . . . 1.4099999999999999 108.133 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.396 -0.965 . . . . 0.01 108.396 179.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 81.9 m95 . . . . . 0 N--CA 1.509 2.508 0 CA-C-O 121.127 0.489 . . . . 0.01 110.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.72 136.21 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.304 -0.998 . . . . 1.6899999999999999 108.304 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -112.58 142.36 45.25 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.67 -1.604 . . . . 2.4900000000000002 106.67 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.56 ' HH ' ' NH2' ' A' ' 173' ' ' ARG . 20.3 m-85 -123.42 145.99 48.36 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.161 -0.962 . . . . 0.02 110.081 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.04 -31.19 61.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.02 111.465 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.7 mt -115.6 155.75 46.99 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.68 -1.263 . . . . 1.48 108.985 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -57.44 167.53 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.101 1.201 . . . . 0.02 112.741 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 9.9 t30 59.4 31.44 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.192 -0.913 . . . . 0.75 111.325 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.88 51.77 8.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.5 -0.75 . . . . 0.02 110.952 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.36 164.82 20.23 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.51 -0.744 . . . . 0.02 109.791 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.416 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.55 -165.62 33.9 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.279 -1.129 . . . . 0.02 110.279 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.58 142.36 53.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.499 -1.001 . . . . 0.02 108.825 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.3 mt-30 -113.06 148.14 35.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.34 0.591 . . . . 0.02 109.826 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -122.86 132.66 54.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.436 -0.95 . . . . 0.01 108.436 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.36 121.56 37.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.933 -1.105 . . . . 0.01 109.702 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.03 161.22 13.92 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.796 -1.187 . . . . 0.01 107.796 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.704 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 4.0 m-20 -111.38 -110.46 0.34 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.413 -0.805 . . . . 2.27 109.801 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -151.16 31.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 1.8400000000000001 109.03 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -109.73 -165.42 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.974 -0.75 . . . . 2.2799999999999998 108.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 2.7 mm-40 -106.26 118.37 36.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.517 -0.739 . . . . 0.01 109.419 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.704 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 79.8 m-85 -97.4 113.13 24.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -90.09 -27.4 19.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.487 -0.758 . . . . 0.01 111.625 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -127.0 156.26 74.52 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.738 -1.226 . . . . 2.54 108.064 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.14 -38.84 53.11 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.51 0.807 . . . . 0.69999999999999996 111.282 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.48 -19.39 18.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.856 -1.152 . . . . 0.85999999999999999 109.914 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.76 -18.32 65.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.823 -1.173 . . . . 0.02 112.111 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.36 16.28 26.1 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.722 -1.236 . . . . 0.02 110.191 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.25 10.69 77.25 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.104 -0.998 . . . . 0.02 112.806 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.52 140.57 34.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.861 -1.376 . . . . 0.02 110.303 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.6 -7.95 58.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.696 -0.628 . . . . 0.58999999999999997 109.715 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 p -140.67 150.85 61.59 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.227 -0.92 . . . . 0.87 109.33 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.59 14.48 1.21 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.903 1.068 . . . . 0.38 112.304 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 121.28 26.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.891 -1.13 . . . . 0.17999999999999999 111.231 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.5 mp -153.1 124.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.469 -1.678 . . . . 3.9900000000000002 106.469 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -114.15 -8.72 12.97 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.425 -0.797 . . . . 5.1699999999999999 113.143 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 p -157.22 158.69 36.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.359 -2.088 . . . . 0.02 109.448 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -152.82 154.21 34.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -0.886 . . . . 2.02 110.147 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.56 ' NH2' ' HH ' ' A' ' 139' ' ' TYR . 81.5 mtm180 -144.48 150.34 37.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.265 -0.897 . . . . 0.01 110.296 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.52 142.71 27.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.703 -0.851 . . . . 0.01 108.703 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.46 128.61 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.311 -0.868 . . . . 3.04 109.329 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.11 148.47 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.127 -0.983 . . . . 1.8899999999999999 110.009 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.45 -0.781 . . . . 4.8899999999999997 109.435 179.569 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.593 0 N-CA-C 107.095 -2.402 . . . . 0.81000000000000005 107.095 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.06 148.88 33.59 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.174 -1.012 . . . . 0.01 110.625 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HZ2' ' CB ' ' A' ' 6' ' ' LYS . 7.7 ttpm? -150.72 136.72 18.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.979 . . . . 0.02 109.077 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.71 140.42 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.897 -0.779 . . . . 0.02 108.897 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.539 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.88 129.97 52.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.483 -0.76 . . . . 0.39000000000000001 109.644 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 7.7 m-85 -109.68 139.96 44.1 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.572 -0.899 . . . . 0.02 108.572 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 5.9 m-85 -122.05 138.67 54.35 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.229 -0.92 . . . . 0.02 109.646 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -68.23 -27.67 66.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.919 -1.113 . . . . 0.029999999999999999 111.736 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.63 170.4 8.34 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.869 -1.144 . . . . 0.029999999999999999 110.11 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -75.39 161.34 29.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.738 0.78 . . . . 0.029999999999999999 110.217 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 m120 63.04 34.95 13.43 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.933 0.873 . . . . 0.73999999999999999 110.433 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p90 49.51 42.52 22.89 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.39 -0.823 . . . . 0.02 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -109.11 166.07 11.12 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.34 -168.14 34.76 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 120.739 -1.225 . . . . 0.029999999999999999 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -70.05 145.3 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.474 -1.016 . . . . 2.7599999999999998 109.098 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -120.4 149.24 42.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.594 -0.692 . . . . 1.8899999999999999 110.272 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -132.07 126.99 35.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.942 -1.133 . . . . 0.02 107.942 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.33 136.7 51.46 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 110.02 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -131.14 137.96 49.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.56 0.695 . . . . 0.02 109.471 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -116.59 10.7 14.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.672 -0.643 . . . . 0.20000000000000001 109.503 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.8 t -157.71 173.84 16.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.134 -1.061 . . . . 1.23 108.134 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -60.85 144.29 53.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.683 -1.261 . . . . 0.02 110.087 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.52 116.9 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.438 -0.949 . . . . 0.02 108.438 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.89 52.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.192 -0.942 . . . . 0.23999999999999999 110.537 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -153.48 100.61 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 1.1399999999999999 108.701 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -104.21 9.21 36.21 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.285 1.04 . . . . 6.3700000000000001 109.39 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -58.68 -24.03 60.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.741 . . . . 3.1099999999999999 110.571 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 m -74.39 -16.84 60.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.16 . . . . 0.88 110.057 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.66 -22.14 13.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.357 -0.84 . . . . 0.02 109.272 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.06 128.47 12.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 3.3199999999999998 109.014 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.1 p -85.33 -9.87 57.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.689 -0.632 . . . . 0.02 110.964 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.91 163.01 6.17 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -142.7 115.51 8.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.873 -1.142 . . . . 0.02 108.709 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.64 0.91 20.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.854 -1.154 . . . . 0.029999999999999999 110.601 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 13.1 t -156.67 153.45 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.538 ' N ' ' HG ' ' A' ' 38' ' ' SER . 79.6 mt -145.12 148.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.013 -1.054 . . . . 0.02 109.969 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -124.7 124.69 42.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.348 -1.353 . . . . 0.02 107.348 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.46 114.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.099 -1.445 . . . . 0.02 107.099 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.61 -34.47 25.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 3.8100000000000001 109.855 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.28 17.53 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 118.698 -1.715 . . . . 0.02 110.433 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.96 173.26 49.66 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.547 -1.311 . . . . 0.01 110.23 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -120.01 136.13 54.67 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.806 -1.183 . . . . 1.48 107.806 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.5 m95 -125.17 154.5 41.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.518 1.152 . . . . 0.02 112.159 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.12 133.44 52.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 104.964 -2.235 . . . . 0.23999999999999999 104.964 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.23 141.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.704 ' HH ' HH21 ' A' ' 83' ' ' ARG . 69.6 m-85 -120.58 143.56 48.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.261 1.029 . . . . 0.02 109.224 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 8.1 tp10 -66.1 -35.23 79.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.359 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -122.75 158.05 58.02 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 121.114 -0.991 . . . . 0.02 109.402 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -54.51 166.7 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.46 1.44 . . . . 0.02 112.567 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 63.12 37.36 11.5 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.382 -0.827 . . . . 0.02 111.173 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 44.67 52.57 7.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.674 0.749 . . . . 3.3900000000000001 110.773 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -126.4 163.75 22.61 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.114 0.483 . . . . 2.3300000000000001 109.705 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.4 -161.62 32.73 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.719 -1.352 . . . . 0.02 109.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -66.22 137.54 57.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.313 . . . . 0.02 110.139 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.2 ptm -121.27 136.53 54.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.664 -0.648 . . . . 5.0099999999999998 109.482 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.62 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.4 m-85 -133.32 142.03 48.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.717 . . . . 0.02 109.418 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 mm -96.14 132.56 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.127 -0.694 . . . . 1.72 109.127 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -121.73 109.69 34.04 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.481 -0.762 . . . . 0.02 110.391 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -75.81 169.78 21.51 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.033 1.048 . . . . 1.47 110.403 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -53.06 140.18 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.908 -1.12 . . . . 4.25 110.572 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.18 -177.23 32.52 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.614 -1.279 . . . . 0.02 110.386 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -118.98 129.94 55.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.471 -1.017 . . . . 0.95999999999999996 109.413 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 46.0 m-85 -120.82 95.48 48.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.32 -3.9 10.81 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 120.682 0.921 . . . . 0.02 113.666 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -156.82 154.28 29.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 2.02 108.254 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.37 -38.57 84.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.582 -0.699 . . . . 0.02 111.654 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.63 -24.54 65.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.028 -1.045 . . . . 0.02 110.336 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.68 -18.23 64.23 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.956 0.884 . . . . 3.4199999999999999 108.831 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.62 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.64 11.86 28.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.333 -1.358 . . . . 0.02 107.333 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.5 mpt? 59.49 22.78 11.35 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.504 0.669 . . . . 0.02 110.243 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 146.35 46.62 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.253 -1.539 . . . . 0.02 109.253 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.8 tp -79.63 -30.63 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.97999999999999998 108.013 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.541 HD21 ' H ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -157.65 -170.89 3.36 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.64 27.85 4.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.776 -1.203 . . . . 0.02 110.436 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.541 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -96.31 122.5 39.25 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.081 -1.012 . . . . 3.2000000000000002 110.0 -178.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.5 mt -143.5 122.66 12.93 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.957 -1.127 . . . . 2.6099999999999999 107.957 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.98 -17.82 9.3 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.168 -0.957 . . . . 0.02 112.732 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 t -156.1 156.1 33.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 119.978 -1.896 . . . . 0.02 110.857 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.2 t -145.47 147.54 32.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.02 110.254 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.704 HH21 ' HH ' ' A' ' 49' ' ' TYR . 61.8 mtm180 -135.64 140.8 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.921 -0.77 . . . . 0.01 108.921 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.96 132.29 37.8 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.092 -1.005 . . . . 0.42999999999999999 108.679 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.29 124.14 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.438 -0.949 . . . . 1.25 108.438 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.41 134.66 34.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.104 -0.998 . . . . 1.77 108.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.6 137.97 35.72 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.456 -0.942 . . . . 1.6299999999999999 108.456 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -110.9 125.65 53.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.483 -0.932 . . . . 1.0800000000000001 108.483 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -103.28 -155.0 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.59 -48.53 0.92 Allowed Glycine 0 N--CA 1.498 2.809 0 O-C-N 120.458 -1.401 . . . . 0.01 112.055 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.38 -99.33 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.592 -1.766 . . . . 0.01 112.187 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -122.29 120.12 33.14 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.402 -1.057 . . . . 4.4299999999999997 110.653 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.37 129.83 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.914 -0.714 . . . . 2.9900000000000002 109.142 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -131.48 139.53 49.35 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 6.3600000000000003 109.334 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.83 145.58 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.389 -0.819 . . . . 1.0900000000000001 109.85 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.02 133.63 55.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.284 -1.376 . . . . 2.0499999999999998 107.284 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.68 147.11 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.852 -1.155 . . . . 1.1000000000000001 109.419 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.3 m-85 -119.3 141.61 48.84 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.055 0.931 . . . . 0.72999999999999998 111.07 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -66.27 -29.85 70.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.919 -0.582 . . . . 0.02 111.589 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.54 168.08 10.49 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.933 -1.105 . . . . 3.1800000000000002 110.696 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.07 42.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.989 -0.844 . . . . 0.01 110.989 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t0 56.56 39.47 29.85 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.65 0.738 . . . . 0.01 110.951 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.432 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.2 m-85 52.49 55.36 9.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.688 -0.633 . . . . 0.01 111.038 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -128.63 165.81 20.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.468 -0.938 . . . . 3.1499999999999999 108.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.11 -164.94 27.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.23 -1.548 . . . . 0.01 109.23 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.499 ' CD ' ' HH ' ' A' ' 108' ' ' TYR . 46.7 tt0 -74.53 144.57 44.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.951 -1.323 . . . . 0.01 108.3 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 24.2 ttp -116.53 142.27 47.1 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.554 0.692 . . . . 0.01 109.804 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.499 ' HH ' ' CD ' ' A' ' 106' ' ' GLN . 58.1 m-85 -131.56 136.0 47.48 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.05 -1.093 . . . . 2.48 108.05 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.8 tm-20 -120.25 135.35 55.02 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.446 -0.784 . . . . 0.01 110.145 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.597 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 3.9 t -149.2 151.64 34.64 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.277 1.037 . . . . 1.6899999999999999 111.0 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.3 p -110.73 9.39 22.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.606 -0.725 . . . . 0.01 110.009 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.597 ' H ' ' HG1' ' A' ' 110' ' ' THR . 49.9 mt-10 -121.1 163.32 18.58 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.291 -0.881 . . . . 3.21 111.366 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.02 155.29 39.02 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 34.9 t -125.44 113.67 25.56 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.752 -0.832 . . . . 0.01 108.752 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.33 -29.08 8.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.388 1.174 . . . . 0.01 111.278 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.402 ' HG ' ' H ' ' A' ' 119' ' ' GLU . 13.1 t -142.53 109.88 5.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 0.02 109.359 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.99 -39.62 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 122.003 -0.435 . . . . 1.8300000000000001 110.149 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.44 -37.37 80.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.425 -0.91 . . . . 1.3400000000000001 110.447 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.402 ' H ' ' HG ' ' A' ' 116' ' ' SER . 37.0 tt0 -70.44 -39.37 74.38 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.908 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 8.6 tt0 -79.46 -47.67 15.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.0800000000000001 112.428 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.458 ' CZ ' ' CD ' ' A' ' 120' ' ' GLN . 28.2 m-85 -110.8 0.52 17.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.434 -0.791 . . . . 0.02 112.628 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.1 m80 60.63 33.19 20.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.682 -1.261 . . . . 0.02 109.507 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -113.51 135.23 54.12 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.749 -0.834 . . . . 0.02 108.749 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.62 -21.56 22.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.378 -0.826 . . . . 5.3200000000000003 110.276 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -150.76 165.87 32.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.135 -0.978 . . . . 0.02 109.992 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.73 128.63 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.212 -1.403 . . . . 2.1699999999999999 107.212 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.2 m-70 -108.89 -12.44 14.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.539 -0.726 . . . . 0.02 112.256 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.432 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 10.1 t -159.51 152.72 22.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.01 108.555 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.8 p -163.41 145.87 9.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 1.22 109.665 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -116.61 102.93 9.89 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.701 -1.249 . . . . 1.4099999999999999 108.591 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.299 -1.595 0 N-CA-C 107.604 -1.258 . . . . 0.01 107.604 179.032 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.511 2.616 0 CA-C-O 121.638 0.732 . . . . 0.01 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -120.13 137.45 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.322 -0.992 . . . . 1.6899999999999999 108.322 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.3 142.03 44.06 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 106.827 -1.546 . . . . 2.4900000000000002 106.827 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.7 m-85 -123.37 143.76 49.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.044 -1.035 . . . . 0.02 109.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.0 -31.24 62.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.796 -0.565 . . . . 0.02 111.854 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.28 155.36 47.01 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.67 -1.269 . . . . 1.48 108.899 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -57.22 166.66 4.11 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.186 1.257 . . . . 0.02 112.832 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.77 31.26 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.2 -0.909 . . . . 0.75 111.386 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.1 m-85 58.11 52.23 7.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.629 -0.669 . . . . 0.02 111.327 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.49 165.15 19.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.529 -0.732 . . . . 0.02 109.954 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.96 -165.34 34.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -69.06 141.55 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.531 -0.982 . . . . 0.02 108.723 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.499 ' O ' ' CG ' ' A' ' 58' ' ' MET . 2.2 mt-30 -113.86 150.12 34.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.543 -0.539 . . . . 0.02 109.543 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.76 132.91 53.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.567 -0.901 . . . . 0.01 108.567 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.93 120.24 34.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.21 . . . . 0.01 108.892 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.4 mt -102.48 140.22 37.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 154' ' ' LYS . 27.8 m-20 -108.5 -163.27 0.87 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.53 -0.731 . . . . 2.27 109.474 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -75.12 40.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 1.8400000000000001 109.588 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 152' ' ' ASP . 18.6 ttmt -113.55 162.25 16.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.622 -0.674 . . . . 2.2799999999999998 109.413 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 3.3 mp0 -103.32 130.43 50.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.899 -1.148 . . . . 0.01 107.899 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 49.1 m-85 -102.5 112.11 24.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.01 110.515 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -90.06 -27.13 19.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.01 110.432 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -123.77 153.91 66.98 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 107.63 -1.248 . . . . 2.54 107.63 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.05 -41.47 35.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 CA-C-N 119.202 0.751 . . . . 0.69999999999999996 111.047 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.35 -18.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 120.812 -1.18 . . . . 0.85999999999999999 109.389 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.55 -18.87 65.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.808 -1.182 . . . . 0.02 112.029 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.08 15.92 27.12 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 120.705 -1.247 . . . . 0.02 110.311 178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.82 75.82 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.192 -0.942 . . . . 0.02 112.91 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.427 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.87 140.35 35.28 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.862 -1.375 . . . . 0.02 110.124 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -6.94 59.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.58999999999999997 109.574 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.2 m -139.43 151.18 66.28 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.19 -0.944 . . . . 0.87 109.548 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.34 14.72 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.934 1.089 . . . . 0.38 112.173 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.9 122.1 28.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.17999999999999999 111.794 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mp -147.6 127.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.112 -1.81 . . . . 3.9900000000000002 106.112 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -110.68 -14.26 14.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.308 -0.87 . . . . 5.1699999999999999 112.675 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 11.6 t -156.59 158.7 37.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.389 -2.07 . . . . 0.02 110.068 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -150.38 151.9 33.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.192 -0.942 . . . . 2.02 109.889 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.511 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.5 mtp180 -143.87 150.3 38.23 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.173 -0.955 . . . . 0.01 110.543 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.75 143.32 27.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.423 -0.954 . . . . 0.01 108.423 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.68 129.97 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.404 -0.81 . . . . 3.04 109.563 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 177' ' ' GLU . 57.5 t -137.24 148.26 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 1.8899999999999999 109.336 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 176' ' ' VAL . 1.4 pp20? . . . . . 0 N--CA 1.505 2.282 0 CA-C-O 121.244 0.545 . . . . 4.8899999999999997 111.327 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 107.003 -2.439 . . . . 0.81000000000000005 107.003 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.36 148.14 32.25 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.595 -1.002 . . . . 0.01 110.595 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -153.77 138.33 16.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.557 -0.967 . . . . 0.02 108.72 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.18 141.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.163 -0.68 . . . . 0.02 109.163 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -121.9 130.22 53.18 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 0.39000000000000001 109.559 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 13.8 m-85 -109.44 139.08 44.87 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.742 -0.836 . . . . 0.02 108.742 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -122.42 138.79 54.42 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.187 -0.946 . . . . 0.02 109.625 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -68.36 -27.2 66.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.029999999999999999 111.839 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.48 169.47 9.02 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.847 -1.158 . . . . 0.029999999999999999 110.138 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.57 158.67 32.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.611 0.72 . . . . 0.029999999999999999 110.064 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.4 35.04 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.858 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 20.5 p90 50.0 43.88 25.52 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.602 -0.726 . . . . 0.02 111.312 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -112.09 166.39 11.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.031 -1.1 . . . . 0.02 108.031 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -168.06 36.24 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.728 -1.225 . . . . 0.029999999999999999 110.82 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -69.15 143.62 54.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.423 -1.045 . . . . 2.7599999999999998 108.978 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -119.95 149.09 42.7 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.586 0.707 . . . . 1.8899999999999999 110.035 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -132.19 127.16 35.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.991 -1.115 . . . . 0.02 107.991 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 11.4 p30 -111.59 135.84 51.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.603 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.3 t -129.99 137.53 50.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.472 0.653 . . . . 0.02 109.474 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.69 11.47 14.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.722 -0.612 . . . . 0.20000000000000001 109.535 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -157.88 174.07 15.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -61.71 145.4 52.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.709 -1.244 . . . . 0.02 109.984 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.3 t -131.72 116.59 17.5 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.635 -0.876 . . . . 0.02 108.635 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.6 -24.15 53.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.23999999999999999 110.675 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.76 100.84 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.54 -0.911 . . . . 1.1399999999999999 108.54 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -104.32 9.66 35.8 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.165 0.983 . . . . 6.3700000000000001 109.867 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.565 ' NH2' ' CZ ' ' A' ' 51' ' ' ARG . 90.1 mtt180 -59.25 -22.84 61.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.585 -0.697 . . . . 3.1099999999999999 110.857 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -75.9 -16.85 59.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.88 110.227 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.63 -22.12 13.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.445 -0.784 . . . . 0.02 109.307 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -150.55 128.94 12.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.331 -0.856 . . . . 3.3199999999999998 108.813 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.5 p -86.53 -10.86 53.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.796 -0.565 . . . . 0.02 111.286 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.623 ' HE ' HD22 ' A' ' 37' ' ' ASN . 54.9 ttt180 -171.14 161.67 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.02 108.021 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.31 115.27 8.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.938 -1.101 . . . . 0.02 109.378 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.623 HD22 ' HE ' ' A' ' 35' ' ' ARG . 3.3 m120 -106.73 -0.67 23.37 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.224 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -157.05 154.58 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.747 -1.205 . . . . 0.02 107.747 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -144.77 148.54 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -0.999 . . . . 0.02 109.2 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -123.65 123.9 41.58 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.154 -1.424 . . . . 0.02 107.154 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -105.33 114.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.845 -1.539 . . . . 0.02 106.845 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -84.21 -33.96 24.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.462 -0.773 . . . . 3.8100000000000001 109.569 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.79 18.54 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.649 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.4 173.69 49.95 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.726 -1.226 . . . . 0.01 110.407 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.2 m -118.9 136.13 54.22 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.822 -1.177 . . . . 1.48 107.822 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -124.6 152.67 43.27 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.851 -1.156 . . . . 0.02 112.103 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.45 133.6 52.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.007 -2.22 . . . . 0.23999999999999999 105.007 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.46 141.7 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.026 -0.731 . . . . 0.65000000000000002 109.026 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.5 m-85 -119.69 142.85 48.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.223 1.011 . . . . 0.02 109.386 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -64.78 -35.85 82.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.334 -0.848 . . . . 0.02 111.303 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.688 HH12 ' NH2' ' A' ' 78' ' ' ARG . 3.7 mmp_? -121.36 153.83 58.86 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.096 -1.002 . . . . 0.02 109.578 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -52.76 167.45 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.371 1.38 . . . . 0.02 112.457 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 64.68 37.24 7.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.746 0.784 . . . . 0.02 111.26 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 46.37 51.02 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.422 0.629 . . . . 3.3900000000000001 111.156 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -127.47 164.62 21.51 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.289 0.566 . . . . 2.3300000000000001 110.306 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.29 -162.68 30.98 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.216 -1.153 . . . . 0.02 110.216 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.627 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 4.9 t60 -63.37 143.04 58.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.11 -1.229 . . . . 0.02 110.347 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.8 mtp -116.49 135.22 54.02 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.291 0.567 . . . . 5.0099999999999998 109.755 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' HIS . 32.9 m-85 -134.84 133.35 39.66 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.405 -0.809 . . . . 0.02 108.958 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -95.42 131.84 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.578 -0.897 . . . . 1.72 108.578 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -121.21 109.72 34.97 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.517 -0.739 . . . . 0.02 110.21 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.64 169.54 21.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 119.969 1.025 . . . . 1.47 110.369 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.9 140.71 29.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.76 -1.212 . . . . 4.25 110.667 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.83 -175.11 32.25 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.32 . . . . 0.02 110.255 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -116.17 128.12 55.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -1.054 . . . . 0.95999999999999996 108.804 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 37.7 m-85 -119.28 97.99 50.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.101 -1.074 . . . . 0.02 108.101 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 6.5 Cg_endo -69.88 -6.56 18.96 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 120.553 0.835 . . . . 0.02 114.179 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 76.1 mt-10 -157.53 155.47 30.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.215 -1.553 . . . . 2.02 108.417 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 38.8 p90 -60.24 -36.93 78.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.47 -0.769 . . . . 0.02 112.665 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.63 -21.37 60.37 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.182 -0.949 . . . . 0.02 110.061 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -67.51 -19.96 65.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 3.4199999999999999 110.348 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.45 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.8 p90 -110.04 16.04 22.13 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.305 -0.872 . . . . 0.02 108.828 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.6 OUTLIER 65.32 24.98 12.14 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.234 0.54 . . . . 0.02 110.739 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 145.56 49.33 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.731 -1.347 . . . . 0.02 109.731 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.51 -30.27 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.646 -1.242 . . . . 0.97999999999999998 107.646 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -155.82 -171.53 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.702 -1.592 . . . . 0.02 106.702 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' CG ' ' A' ' 69' ' ' TYR . 95.8 m-20 -97.89 27.45 4.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.832 -1.168 . . . . 0.02 110.298 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' NH2' HH12 ' A' ' 51' ' ' ARG . 38.2 mtp180 -95.51 122.42 38.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.962 -1.086 . . . . 3.2000000000000002 110.591 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.9 mt -142.52 120.53 12.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.536 -1.283 . . . . 2.6099999999999999 107.536 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.37 -17.17 10.21 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 121.358 -0.838 . . . . 0.02 112.485 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.581 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 11.3 t -156.23 156.42 34.09 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.331 -1.687 . . . . 0.02 110.648 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.581 ' N ' ' HG ' ' A' ' 81' ' ' SER . 6.1 p -145.05 147.75 32.93 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.691 0.758 . . . . 0.02 110.247 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 15.9 mtp180 -135.63 140.47 44.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.621 -0.881 . . . . 0.01 108.621 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.11 131.26 38.25 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.204 -0.935 . . . . 0.42999999999999999 108.539 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.92 122.88 40.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.41 -0.959 . . . . 1.25 108.41 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -91.03 134.92 34.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.798 -1.189 . . . . 1.77 108.505 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 136.93 38.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.305 -0.998 . . . . 1.6299999999999999 108.305 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -110.96 126.31 54.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.32 -0.863 . . . . 1.0800000000000001 108.673 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.4 m -103.77 -154.65 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.275 -1.75 . . . . 1.26 106.275 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.16 -48.15 0.93 Allowed Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.567 -1.333 . . . . 0.01 112.103 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.63 -99.57 0.13 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.729 -1.701 . . . . 0.01 111.934 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -120.74 118.91 31.26 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.096 -1.238 . . . . 4.4299999999999997 110.352 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' A' ' 92' ' ' GLN . . . -74.72 130.55 39.69 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.112 -0.699 . . . . 2.9900000000000002 109.112 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -129.28 136.18 49.73 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.882 -0.784 . . . . 6.3600000000000003 108.882 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -127.64 144.07 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.471 -0.768 . . . . 1.0900000000000001 109.326 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.53 133.06 54.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.922 -1.14 . . . . 2.0499999999999998 107.922 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.06 145.89 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.77 -1.206 . . . . 1.1000000000000001 109.384 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.66 140.91 49.16 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.999 0.904 . . . . 0.72999999999999998 110.816 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.1 tm-20 -65.85 -30.38 70.98 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.911 -0.586 . . . . 0.02 111.775 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -117.12 169.77 9.18 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.216 1.007 . . . . 3.1800000000000002 110.663 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.34 36.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.723 -0.951 . . . . 0.01 110.723 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.81 38.12 22.38 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.539 0.685 . . . . 0.01 110.739 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.45 53.73 11.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.705 -0.622 . . . . 0.01 110.974 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -125.91 165.89 17.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.53 28.08 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.27 145.05 42.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.983 -1.304 . . . . 0.01 108.482 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.83 142.53 46.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.558 0.694 . . . . 0.01 109.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.414 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.8 m-85 -130.69 135.87 48.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.947 -1.131 . . . . 2.48 107.947 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -119.34 134.42 55.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.01 109.731 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -149.92 151.17 32.97 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.268 1.033 . . . . 1.6899999999999999 110.798 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.4 p -110.35 10.18 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.536 -0.756 . . . . 0.01 109.676 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -121.36 163.05 19.28 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -0.827 . . . . 3.21 111.393 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.76 154.34 39.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.386 -0.968 . . . . 0.01 108.386 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 14.3 t -123.58 110.25 30.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.527 -0.916 . . . . 0.01 108.527 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -77.85 -32.69 2.53 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 119.932 1.012 . . . . 0.01 112.032 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -140.33 108.43 5.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.108 -0.995 . . . . 0.02 109.189 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 117' ' ' ILE . 19.1 mt -63.49 -40.99 91.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.825 -0.547 . . . . 1.8300000000000001 110.656 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.32 -38.48 87.79 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.134 -1.026 . . . . 1.3400000000000001 110.415 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -70.55 -38.82 74.21 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.145 -1.597 . . . . 2.1099999999999999 109.35 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.482 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 49.6 tt0 -80.54 -48.14 13.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 2.0800000000000001 112.45 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.482 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 70.4 m-85 -111.8 -1.83 15.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.261 -0.899 . . . . 0.02 112.661 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.93 35.01 19.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.851 -1.156 . . . . 0.02 109.506 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 mt -114.57 136.42 53.05 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.53 -0.731 . . . . 0.02 109.381 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.521 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.2 -21.11 23.44 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.217 -0.927 . . . . 5.3200000000000003 110.465 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -149.33 165.48 31.85 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.7 -1.25 . . . . 0.02 110.367 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mm -127.42 123.7 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.206 -1.405 . . . . 2.1699999999999999 107.206 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.7 m-70 -109.23 -14.09 14.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.158 -0.964 . . . . 0.02 112.467 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.8 t -159.57 151.49 20.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.01 108.763 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 30.0 p -168.6 146.14 3.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.925 . . . . 1.22 108.906 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -122.17 109.12 14.11 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.353 1.073 . . . . 1.4099999999999999 109.228 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 106.868 -1.53 . . . . 0.01 106.868 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.3 m95 . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 107.062 -1.459 . . . . 0.01 107.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 32.0 mt -118.81 132.43 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.335 -1.478 . . . . 1.6899999999999999 109.782 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -111.54 141.99 44.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.221 -1.77 . . . . 2.4900000000000002 106.221 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.5 m-85 -123.06 143.34 50.02 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 0.02 109.755 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.84 -30.86 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.754 -0.591 . . . . 0.02 111.563 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.84 154.93 48.24 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.729 -1.232 . . . . 1.48 108.929 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.49 167.09 2.97 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.349 1.366 . . . . 0.02 113.038 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 44.4 t-20 60.0 31.53 20.69 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.116 -0.947 . . . . 0.75 111.363 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.97 51.48 10.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.498 -0.751 . . . . 0.02 111.01 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -126.65 165.29 19.49 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.601 -0.687 . . . . 0.02 109.937 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.47 -165.3 33.79 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.205 -1.158 . . . . 0.02 110.205 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.39 141.5 54.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.509 -0.995 . . . . 0.02 108.837 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -114.59 148.77 37.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.541 -0.541 . . . . 0.02 109.541 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 4.7 m-85 -123.26 134.25 54.11 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.905 -0.776 . . . . 0.01 108.905 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.2 tp -95.93 120.76 36.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.895 -1.128 . . . . 0.01 109.046 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' LEU . 9.5 mp -97.69 140.6 31.85 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.74 -0.837 . . . . 0.01 108.74 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 60.1 m-20 -105.01 -170.39 1.75 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.46 -0.775 . . . . 2.27 109.627 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.53 41.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.8400000000000001 109.881 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -113.34 172.56 6.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.482 -0.761 . . . . 2.2799999999999998 109.43 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.6 126.29 51.55 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.509 -0.923 . . . . 0.01 108.509 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 3.2 m-85 -100.68 111.96 24.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.199 -0.938 . . . . 0.01 110.145 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -92.79 -26.75 17.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.01 110.644 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -123.28 153.62 65.21 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.902 -1.147 . . . . 2.54 107.902 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -60.96 -40.52 51.88 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.33 0.797 . . . . 0.69999999999999996 110.962 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.12 -18.62 18.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.046 -1.033 . . . . 0.85999999999999999 109.332 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 52.9 t0 -65.76 -19.0 65.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.11 . . . . 0.02 112.164 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.53 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.12 15.69 27.88 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 120.655 -1.278 . . . . 0.02 110.143 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 9.7 76.77 Favored Glycine 0 N--CA 1.5 2.903 0 O-C-N 121.177 -0.952 . . . . 0.02 113.149 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.443 ' HB1' ' HE1' ' A' ' 162' ' ' TRP . . . -100.55 141.18 33.77 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.812 -1.405 . . . . 0.02 110.274 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.11 -7.22 59.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.688 -0.633 . . . . 0.58999999999999997 109.598 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.6 p -142.42 150.77 55.88 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.87 109.107 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -75.81 17.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.698 0.932 . . . . 0.38 112.052 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.1 121.63 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.304 1.05 . . . . 0.17999999999999999 111.154 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mp -151.07 125.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.499 -1.667 . . . . 3.9900000000000002 106.499 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -110.84 -13.34 14.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.746 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.16 158.3 37.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 119.378 -2.076 . . . . 0.02 109.91 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.55 153.06 33.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.28 -0.888 . . . . 2.02 109.905 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -142.92 148.75 37.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.835 0.826 . . . . 0.01 110.081 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -86.01 142.17 28.96 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.868 -1.16 . . . . 0.01 107.868 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.5 mt -95.17 128.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 3.04 109.41 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.57 148.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.36 -0.838 . . . . 1.8899999999999999 109.837 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 4.8899999999999997 109.435 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.679 0 N-CA-C 106.871 -2.492 . . . . 0.81000000000000005 106.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.06 32.24 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.315 -0.945 . . . . 0.01 110.904 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -151.86 137.33 17.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.693 -0.886 . . . . 0.02 108.653 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 7' ' ' ILE . 8.7 tt -130.19 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.368 -0.604 . . . . 0.02 109.368 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -120.71 128.77 53.26 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.793 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.79 137.94 44.91 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.241 -1.022 . . . . 0.02 108.241 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.6 m-85 -122.13 138.25 54.53 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.125 -0.984 . . . . 0.02 109.96 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.06 -28.26 67.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 0.029999999999999999 111.292 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.02 170.51 8.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.023 -1.048 . . . . 0.029999999999999999 110.305 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.588 ' NE ' HD22 ' A' ' 37' ' ' ASN . 96.8 mtt180 -75.59 161.85 28.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.795 0.807 . . . . 0.029999999999999999 110.604 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 41.3 t-20 62.59 33.6 15.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.03 0.919 . . . . 0.73999999999999999 110.89 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 65' ' ' GLU . 0.3 OUTLIER 55.31 40.31 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.861 -0.609 . . . . 0.02 110.67 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -110.12 165.21 11.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.219 -1.03 . . . . 0.02 108.219 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.21 -167.74 36.25 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 120.794 -1.191 . . . . 0.029999999999999999 110.759 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -69.21 143.35 54.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -1.003 . . . . 2.7599999999999998 109.541 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.36 149.74 41.87 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.728 0.775 . . . . 1.8899999999999999 109.713 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 32.5 t80 -132.97 126.84 32.88 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.598 -1.26 . . . . 0.02 107.598 178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -111.78 137.61 49.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.46 -0.775 . . . . 1.1200000000000001 109.666 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -131.32 138.17 49.1 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.609 0.718 . . . . 0.02 109.387 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -116.98 10.44 14.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.745 -0.597 . . . . 0.20000000000000001 109.47 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -158.09 174.45 15.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.213 -1.032 . . . . 1.23 108.213 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 29.4 t0 -60.99 143.34 55.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.762 -1.212 . . . . 0.02 110.153 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 58.1 m -131.31 116.94 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.02 108.435 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -26.29 51.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.23999999999999999 110.882 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -152.96 101.14 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 108.641 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -104.86 8.75 34.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.143 0.973 . . . . 6.3700000000000001 109.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -58.29 -23.32 55.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.601 -0.687 . . . . 3.1099999999999999 110.626 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 p -74.56 -17.01 60.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.816 -1.178 . . . . 0.88 110.266 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -103.72 -22.42 13.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.467 -0.771 . . . . 0.02 109.333 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -149.71 128.0 12.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 3.3199999999999998 108.811 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m -86.47 -9.9 55.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.02 110.96 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 77' ' ' ASP . 40.6 ttt180 -171.04 161.41 6.84 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.681 -1.229 . . . . 0.02 107.681 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.9 t -143.28 115.71 8.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.794 -1.191 . . . . 0.02 108.822 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.588 HD22 ' NE ' ' A' ' 13' ' ' ARG . 33.4 t-20 -108.16 1.42 22.18 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.318 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 3.2 t -156.43 153.52 29.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.509 -1.293 . . . . 0.02 107.509 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' HG ' ' A' ' 38' ' ' SER . 84.9 mt -145.44 148.01 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.095 . . . . 0.02 109.895 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -124.54 125.25 43.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.565 -1.272 . . . . 0.02 107.565 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 t -105.48 114.0 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.98 -1.489 . . . . 0.02 106.98 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 4.8 tm-20 -83.63 -34.29 25.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 109.689 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.06 148.99 16.89 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.611 -1.757 . . . . 0.02 110.569 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.83 173.89 50.02 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.985 -1.246 . . . . 0.01 109.985 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -119.6 135.89 54.61 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.3 m95 -123.41 153.49 40.34 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.537 1.16 . . . . 0.02 112.155 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.6 132.47 53.25 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.02 -2.215 . . . . 0.23999999999999999 105.02 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.26 142.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.931 -0.766 . . . . 0.65000000000000002 108.931 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.433 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 31.8 m-85 -121.56 145.98 47.42 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.272 1.034 . . . . 0.02 109.801 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.29 -34.85 78.25 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.732 -0.667 . . . . 0.02 111.134 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.64 153.52 66.45 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.113 -0.992 . . . . 0.02 109.309 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -51.54 167.68 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.546 1.497 . . . . 0.02 113.249 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 63.79 37.06 10.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.049 -0.978 . . . . 0.02 111.127 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 45.19 50.77 9.47 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.62 0.724 . . . . 3.3900000000000001 110.379 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.57 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 47.7 t -125.2 163.59 22.14 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.746 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.57 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.34 -161.85 32.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.488 -1.445 . . . . 0.02 109.488 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -67.59 137.9 56.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.812 -1.405 . . . . 0.02 109.89 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 21.2 ptm -119.14 137.82 53.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.473 0.654 . . . . 5.0099999999999998 109.541 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -132.9 140.07 47.69 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.476 -0.765 . . . . 0.02 109.666 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -95.47 132.34 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.355 -0.98 . . . . 1.72 108.355 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.56 108.35 39.6 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.508 -0.745 . . . . 0.02 110.329 -178.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -75.2 168.27 25.06 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.044 1.051 . . . . 1.47 110.267 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 42' ' ' GLU . 7.9 tt0 -53.43 140.03 28.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.834 -1.166 . . . . 4.25 110.487 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.99 -176.75 32.57 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.508 -1.33 . . . . 0.02 110.301 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 15' ' ' PHE . 62.3 tt0 -118.64 130.06 55.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.389 -1.065 . . . . 0.95999999999999996 109.369 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 25.5 m-85 -120.75 92.83 48.36 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.826 -1.176 . . . . 0.02 107.826 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -65.7 -4.87 10.57 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.035 1.157 . . . . 0.02 113.746 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -157.03 153.57 28.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.579 -1.326 . . . . 2.02 107.889 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.526 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 8.8 p90 -60.59 -37.62 81.97 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.468 -0.77 . . . . 0.02 112.162 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 22.1 mm100 -60.32 -23.68 64.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.942 -1.099 . . . . 0.02 110.661 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.7 62.39 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.898 0.856 . . . . 3.4199999999999999 108.854 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.571 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -107.74 9.91 28.97 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.393 -1.336 . . . . 0.02 107.393 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.7 mtt 61.34 21.89 12.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.652 . . . . 0.02 110.641 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.27 144.47 45.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.182 -1.567 . . . . 0.02 109.182 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.4 tp -79.06 -30.71 44.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.619 -1.252 . . . . 0.97999999999999998 107.619 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 49.6 t30 -157.69 -173.25 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.476 -1.676 . . . . 0.02 106.476 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -98.16 27.41 4.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.843 -1.161 . . . . 0.02 110.215 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.05 122.24 38.67 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.267 -0.896 . . . . 3.2000000000000002 109.954 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.3 mt -144.5 119.52 10.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.586 -1.264 . . . . 2.6099999999999999 107.586 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.96 -16.02 14.86 Favored Glycine 0 N--CA 1.503 3.136 0 C-N-CA 120.525 -0.845 . . . . 0.02 112.395 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -156.47 155.91 32.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.405 -1.644 . . . . 0.02 110.03 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 30.3 p -144.28 147.59 33.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.02 109.491 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -134.53 140.04 45.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.323 -0.861 . . . . 0.01 108.797 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.03 130.96 37.11 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.205 -0.934 . . . . 0.42999999999999999 108.651 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.62 123.34 42.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.96 133.49 35.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.015 . . . . 1.77 108.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.06 139.67 32.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.766 . . . . 1.6299999999999999 109.049 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 t -111.48 125.59 54.06 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.465 -0.939 . . . . 1.0800000000000001 108.465 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 t -102.75 -155.68 0.53 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.282 -1.747 . . . . 1.26 106.282 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.21 -47.88 0.95 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.545 -1.347 . . . . 0.01 112.051 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.34 -98.6 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 118.587 -1.768 . . . . 0.01 112.267 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -122.48 120.89 35.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.394 -1.062 . . . . 4.4299999999999997 110.762 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.82 132.01 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.171 -0.677 . . . . 2.9900000000000002 109.171 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.32 139.24 49.5 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 6.3600000000000003 109.236 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tt -126.54 143.68 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.743 0.783 . . . . 1.0900000000000001 109.645 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -123.74 131.23 53.56 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.649 -1.241 . . . . 2.0499999999999998 107.649 177.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 m -124.31 148.34 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 120.871 -1.143 . . . . 1.1000000000000001 109.671 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -118.68 141.38 48.66 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.041 0.924 . . . . 0.72999999999999998 111.022 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.52 -29.47 69.57 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.747 -0.66 . . . . 0.02 111.446 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 60.4 mttp -116.39 169.86 8.99 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.092 -1.005 . . . . 3.1800000000000002 110.353 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.8 165.79 50.13 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.073 -0.811 . . . . 0.01 111.073 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 56.38 39.25 30.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.99 -0.712 . . . . 0.01 111.426 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 51.78 54.57 10.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.599 -0.688 . . . . 0.01 111.2 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -129.62 166.4 19.82 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.154 -1.054 . . . . 3.1499999999999999 108.154 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.97 -164.42 28.68 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' OH ' ' A' ' 108' ' ' TYR . 8.9 tt0 -75.55 144.94 41.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.938 -1.331 . . . . 0.01 108.714 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.5 tmm? -116.87 142.3 47.1 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.688 0.756 . . . . 0.01 109.972 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.44 ' N ' ' SD ' ' A' ' 107' ' ' MET . 41.8 m-85 -130.39 134.66 47.31 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.7 -1.222 . . . . 2.48 107.7 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -121.42 135.63 55.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.725 -0.609 . . . . 0.01 109.83 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.499 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 9.5 t -150.34 153.1 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.223 1.011 . . . . 1.6899999999999999 110.738 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 30.5 p -109.35 10.0 25.58 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.829 -0.623 . . . . 0.01 109.864 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.5 mp0 -121.0 163.3 18.49 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.426 -0.796 . . . . 3.21 111.046 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 155.16 38.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.283 -1.006 . . . . 0.01 108.283 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.86 111.43 29.17 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.64 -0.874 . . . . 0.01 108.64 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.54 -32.86 3.48 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 CA-C-N 120.032 1.047 . . . . 0.01 111.605 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -141.23 107.81 5.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.285 -0.884 . . . . 0.02 108.855 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.53 -38.77 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.838 -0.539 . . . . 1.8300000000000001 110.361 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.5 ttt -66.4 -37.76 85.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.868 -1.133 . . . . 1.3400000000000001 109.873 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -70.27 -39.06 75.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.408 -1.432 . . . . 2.1099999999999999 109.53 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 8.8 tt0 -80.44 -47.05 14.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -0.975 . . . . 2.0800000000000001 112.316 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.556 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 m-85 -110.51 -1.68 16.85 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.375 -0.828 . . . . 0.02 112.752 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m170 61.16 33.48 19.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.677 -1.264 . . . . 0.02 109.343 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 mt -114.34 135.39 54.13 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.517 -0.74 . . . . 0.02 109.161 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -89.41 -21.1 23.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.181 -0.949 . . . . 5.3200000000000003 110.763 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -148.32 163.69 36.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.949 -1.095 . . . . 0.02 110.105 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.33 126.05 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.202 -1.407 . . . . 2.1699999999999999 107.202 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -109.55 -13.04 14.62 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.353 -0.842 . . . . 0.02 112.682 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 21.3 p -160.82 153.5 20.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.269 . . . . 0.01 109.111 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 20.4 p -170.28 144.33 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.925 -1.139 . . . . 1.22 107.925 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.3 pttt -127.92 101.84 6.5 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.903 -1.123 . . . . 1.4099999999999999 109.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 107.83 -1.174 . . . . 0.01 107.83 178.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.6 m95 . . . . . 0 N--CA 1.505 2.319 0 N-CA-C 107.863 -1.162 . . . . 0.01 107.863 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.3 mt -119.18 134.96 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 120.562 -1.336 . . . . 1.6899999999999999 109.846 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.46 141.7 44.68 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.193 -1.78 . . . . 2.4900000000000002 106.193 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 m-85 -123.51 143.63 50.06 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.206 -0.934 . . . . 0.02 109.88 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.45 -30.96 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.976 -0.452 . . . . 0.02 111.721 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.51 155.14 47.62 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.759 -1.213 . . . . 1.48 108.809 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -56.86 166.79 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.05 1.167 . . . . 0.02 112.927 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 42.8 t-20 59.66 31.89 21.17 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.173 -0.921 . . . . 0.75 111.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.9 m-85 57.45 51.95 9.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.527 -0.733 . . . . 0.02 111.523 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -126.75 165.32 19.5 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.463 -0.773 . . . . 0.02 110.057 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.13 -165.24 34.28 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.286 -1.126 . . . . 0.02 110.286 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -69.39 141.72 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.946 . . . . 0.02 108.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' MET . 18.4 mt-30 -114.12 148.59 36.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.778 -0.576 . . . . 0.02 110.109 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -123.75 133.86 53.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -95.34 121.12 36.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.868 -1.145 . . . . 0.01 109.461 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.83 145.49 26.92 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.761 -0.829 . . . . 0.01 108.761 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.542 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 13.1 m-20 -110.0 -179.31 3.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.534 -0.729 . . . . 2.27 109.645 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -71.52 38.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.87 . . . . 1.8400000000000001 109.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.1 mttm -112.04 177.18 4.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 109.208 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 26.4 mp0 -105.96 122.31 45.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.505 -0.747 . . . . 0.01 109.018 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.542 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 91.7 m-85 -97.7 113.82 25.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.837 . . . . 0.01 109.242 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.41 -27.59 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.01 111.268 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -124.59 155.57 69.15 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.803 -1.184 . . . . 2.54 107.803 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.3 Cg_endo -61.5 -40.97 43.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.065 0.702 . . . . 0.69999999999999996 111.116 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.11 -18.87 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.8 -1.187 . . . . 0.85999999999999999 109.495 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.89 -18.15 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.02 111.899 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.63 15.42 28.98 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.674 -1.266 . . . . 0.02 110.147 178.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.92 74.3 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 121.088 -1.008 . . . . 0.02 112.939 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.436 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.96 140.48 35.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.912 -1.346 . . . . 0.02 109.995 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.04 -6.67 59.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.664 -0.647 . . . . 0.58999999999999997 109.703 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -139.76 150.34 62.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.245 -0.91 . . . . 0.87 109.603 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.08 13.73 0.8 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.746 0.964 . . . . 0.38 111.838 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.04 24.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.312 1.053 . . . . 0.17999999999999999 110.655 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.517 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.1 mt -150.03 123.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.569 -2.011 . . . . 3.9900000000000002 105.569 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -111.84 -12.67 13.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.454 -0.779 . . . . 5.1699999999999999 113.011 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 p -157.08 159.66 38.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.295 -2.128 . . . . 0.02 109.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.13 152.64 33.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.208 -0.932 . . . . 2.02 110.055 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.491 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 15.8 mtp180 -142.42 148.81 38.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.057 -1.027 . . . . 0.01 110.244 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -86.78 140.24 29.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.141 -1.059 . . . . 0.01 108.141 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 21.0 mt -94.7 130.59 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.2 -0.937 . . . . 3.04 109.585 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.91 147.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 1.8899999999999999 109.541 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 4.8899999999999997 109.403 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 107.205 -2.358 . . . . 0.81000000000000005 107.205 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.36 150.65 33.67 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 120.184 -1.008 . . . . 0.01 110.779 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -151.48 136.75 17.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.46 -1.023 . . . . 0.02 108.916 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 7.2 tt -130.77 142.16 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.39 -0.596 . . . . 0.02 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.526 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.5 t -122.87 130.48 52.91 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.475 -0.765 . . . . 0.39000000000000001 109.379 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.9 m-85 -109.71 139.94 44.16 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.947 -0.761 . . . . 0.02 108.947 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 12.7 m-85 -122.79 139.1 54.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.433 -0.792 . . . . 0.02 109.64 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.91 -26.66 64.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.029999999999999999 111.985 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.0 m-20 -114.17 170.01 8.6 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.029999999999999999 110.571 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -74.23 157.19 36.31 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.734 0.778 . . . . 0.029999999999999999 110.149 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.27 35.72 5.79 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.821 0.819 . . . . 0.73999999999999999 111.101 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.0 p90 49.66 44.61 24.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.679 0.752 . . . . 0.02 111.105 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -112.3 166.1 11.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.988 -1.115 . . . . 0.02 107.988 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.52 -167.9 34.28 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 120.735 -1.228 . . . . 0.029999999999999999 110.532 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.565 HH21 ' H ' ' A' ' 34' ' ' SER . 36.7 ttp180 -70.01 144.29 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -1.005 . . . . 2.7599999999999998 108.841 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.65 150.22 41.27 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.726 0.774 . . . . 1.8899999999999999 110.412 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -132.7 127.63 35.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.138 -1.06 . . . . 0.02 108.138 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -113.32 137.46 51.47 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 110.119 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.91 139.48 48.76 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.681 0.753 . . . . 0.02 109.351 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 m-20 -117.08 11.28 14.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.271 -0.64 . . . . 0.20000000000000001 109.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -158.57 174.49 14.99 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.119 -1.067 . . . . 1.23 108.119 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.21 144.34 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.601 -1.312 . . . . 0.02 110.249 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.0 m -131.41 116.86 18.08 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.372 -0.973 . . . . 0.02 108.372 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.2 -26.03 52.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.67 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -154.2 100.46 2.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 1.1399999999999999 108.7 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -104.96 9.65 34.47 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.538 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -58.3 -23.76 57.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.618 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -74.38 -16.89 60.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.169 . . . . 0.88 110.002 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -105.11 -21.9 13.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.516 -0.74 . . . . 0.02 109.395 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.47 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.1 tp -148.37 125.68 11.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 3.3199999999999998 109.166 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.565 ' H ' HH21 ' A' ' 18' ' ' ARG . 83.2 p -86.3 -11.05 53.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.02 111.263 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.47 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.9 tpp180 -170.68 161.58 7.54 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.746 -1.205 . . . . 0.02 107.746 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.6 p -140.51 113.35 8.22 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.848 -1.157 . . . . 0.02 108.752 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 19.2 t-20 -106.35 -2.31 22.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.866 -1.146 . . . . 0.029999999999999999 110.259 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 8.4 m -154.43 154.15 32.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.304 -0.999 . . . . 0.02 108.304 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.2 mt -144.66 146.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.02 109.599 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -124.44 124.8 43.11 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.046 -1.464 . . . . 0.02 107.046 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 24.9 t -105.6 113.65 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.822 -1.547 . . . . 0.02 106.822 177.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.08 -34.61 26.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 110.015 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.09 150.15 19.17 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.48 -1.819 . . . . 0.02 110.468 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.86 175.36 50.91 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.457 -1.354 . . . . 0.01 109.929 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.408 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 34.3 m -110.29 161.93 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.823 -1.547 . . . . 1.48 106.823 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CZ3' ' SG ' ' A' ' 22' ' ' CYS . 64.5 m95 -147.65 147.01 29.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.286 -1.509 . . . . 0.02 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.31 54.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.158 -2.164 . . . . 0.23999999999999999 105.158 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.02 142.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.679 . . . . 0.65000000000000002 109.466 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 19.7 m-85 -119.72 144.79 47.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.295 1.045 . . . . 0.02 109.46 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.19 -34.88 79.04 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.748 -0.66 . . . . 0.02 111.183 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -125.66 158.36 65.28 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.112 -0.992 . . . . 0.02 109.496 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.41 167.11 1.46 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.739 1.626 . . . . 0.02 113.145 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.97 36.78 9.8 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.097 -0.956 . . . . 0.02 111.208 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.16 51.91 10.74 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.476 0.655 . . . . 3.3900000000000001 110.915 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.9 t -127.37 164.55 21.57 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 2.3300000000000001 110.118 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.16 -162.55 32.4 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.017 -1.233 . . . . 0.02 110.017 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.491 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 85.9 m-70 -62.8 142.03 58.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.02 110.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.2 mtp -115.89 135.09 54.32 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.955 -0.757 . . . . 5.0099999999999998 108.955 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -136.16 133.31 37.04 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.362 -0.836 . . . . 0.02 109.469 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -96.13 131.78 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.245 -1.02 . . . . 1.72 108.245 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.8 mt -120.48 110.45 35.65 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.673 -0.642 . . . . 0.02 110.344 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.61 169.61 21.49 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 CA-C-N 119.923 1.008 . . . . 1.47 110.079 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 12.7 tm0? -53.13 140.83 24.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.827 -1.171 . . . . 4.25 110.355 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.31 -176.28 32.2 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.02 110.522 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.13 128.75 55.44 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -1.011 . . . . 0.95999999999999996 108.738 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 30.1 m-85 -118.64 98.08 51.04 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' OG ' ' A' ' 38' ' ' SER . 1.8 Cg_endo -67.75 -6.64 17.3 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.645 0.897 . . . . 0.02 114.401 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 31.1 mt-10 -158.64 155.9 29.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.366 -1.459 . . . . 2.02 108.382 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.666 ' HH ' HE21 ' A' ' 70' ' ' GLN . 20.8 p90 -59.99 -37.39 79.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.02 112.374 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.666 HE21 ' HH ' ' A' ' 69' ' ' TYR . 53.5 mt-30 -59.97 -21.83 61.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.02 109.988 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.38 -20.37 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.703 . . . . 3.4199999999999999 110.294 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -109.49 15.87 22.66 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.232 -0.917 . . . . 0.02 108.669 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt 64.66 23.86 12.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.331 0.586 . . . . 0.02 110.769 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.53 146.54 50.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.35 -1.5 . . . . 0.02 109.35 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 14.2 mt -80.59 -28.69 37.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.97999999999999998 108.261 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.71 -170.66 3.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.012 -1.477 . . . . 0.02 107.012 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 35.2 p30 -98.28 28.28 4.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.753 -1.217 . . . . 0.02 110.274 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -97.08 123.52 40.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.324 -0.86 . . . . 3.2000000000000002 111.246 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -143.88 120.27 10.95 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.022 -1.473 . . . . 2.6099999999999999 107.022 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.8 -16.4 14.1 Favored Glycine 0 N--CA 1.503 3.101 0 O-C-N 121.312 -0.867 . . . . 0.02 112.166 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.8 t -156.11 155.72 33.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.51 -1.582 . . . . 0.02 109.686 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.0 m -144.91 148.13 33.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.735 . . . . 0.02 109.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.481 ' CZ ' ' OH ' ' A' ' 49' ' ' TYR . 39.5 mtm180 -134.1 139.63 46.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.352 -0.842 . . . . 0.01 108.854 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 131.3 38.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.961 -1.126 . . . . 0.42999999999999999 107.961 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -90.96 124.08 43.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.378 -0.971 . . . . 1.25 108.378 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.12 135.12 33.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 1.77 108.457 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.17 137.81 36.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.957 -0.757 . . . . 1.6299999999999999 108.957 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -111.54 125.88 54.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 m -102.74 -155.41 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.222 -1.77 . . . . 1.26 106.222 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.73 -48.64 0.9 Allowed Glycine 0 N--CA 1.498 2.797 0 O-C-N 120.463 -1.398 . . . . 0.01 112.305 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.38 -99.47 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.502 -1.809 . . . . 0.01 112.208 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.25 120.38 33.96 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.231 -1.158 . . . . 4.4299999999999997 110.82 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.74 132.32 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.126 -0.694 . . . . 2.9900000000000002 109.126 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -129.95 140.38 50.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.525 -0.734 . . . . 6.3600000000000003 109.121 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -125.5 141.89 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.867 0.842 . . . . 1.0900000000000001 109.528 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -124.59 131.41 53.48 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.514 -1.291 . . . . 2.0499999999999998 107.514 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -123.84 146.39 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.983 -1.073 . . . . 1.1000000000000001 109.819 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -117.43 140.72 49.22 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.991 0.901 . . . . 0.72999999999999998 110.77 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -66.14 -29.84 70.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.001 -0.545 . . . . 0.02 111.663 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -116.84 167.97 10.64 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.062 -1.024 . . . . 3.1800000000000002 110.586 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.01 43.39 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.08 -0.808 . . . . 0.01 111.08 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 56.55 38.58 29.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.868 -0.783 . . . . 0.01 110.801 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 52.55 55.31 9.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.753 -0.592 . . . . 0.01 110.959 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -128.58 165.96 19.78 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.497 -0.927 . . . . 3.1499999999999999 108.497 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.57 -164.85 26.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.36 -1.496 . . . . 0.01 109.36 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 107' ' ' MET . 36.7 tp60 -74.85 144.82 43.25 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.039 -1.271 . . . . 0.01 108.255 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 5.1 tmm? -116.29 142.44 46.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.669 0.747 . . . . 0.01 109.653 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.552 ' N ' ' SD ' ' A' ' 107' ' ' MET . 80.8 m-85 -131.19 135.58 47.53 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.014 -1.106 . . . . 2.48 108.014 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.8 tm-20 -120.37 134.08 55.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.74 -0.6 . . . . 0.01 109.709 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 112' ' ' GLU . 2.8 t -149.63 152.11 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 1.6899999999999999 110.558 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.433 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 40.6 p -109.35 10.42 25.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.828 -0.624 . . . . 0.01 109.964 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.2 mp0 -120.58 163.06 18.58 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.41 -0.806 . . . . 3.21 111.317 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.08 155.23 37.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.007 -1.108 . . . . 0.01 108.007 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 49.2 t -122.54 110.66 31.95 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.938 -0.764 . . . . 0.01 108.938 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.82 -34.35 2.43 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 CA-C-N 119.976 1.027 . . . . 0.01 111.685 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.9 m -140.41 107.54 5.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.02 108.685 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.97 -39.42 85.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.865 -0.522 . . . . 1.8300000000000001 110.553 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttp -66.52 -37.67 85.53 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.967 -1.093 . . . . 1.3400000000000001 109.944 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.39 -39.12 74.73 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.388 -1.445 . . . . 2.1099999999999999 109.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 tt0 -80.29 -47.52 14.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 2.0800000000000001 112.425 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.424 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 66.7 m-85 -111.38 -1.25 16.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.8 . . . . 0.02 112.615 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 61.77 34.29 17.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.71 -1.244 . . . . 0.02 109.742 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.87 135.42 54.22 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.497 -0.752 . . . . 0.02 109.231 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.52 -21.19 23.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 5.3200000000000003 110.768 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.42 164.42 34.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.02 109.968 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 126' ' ' ILE . 51.0 mm -128.61 124.92 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.154 -1.424 . . . . 2.1699999999999999 107.154 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.1 m-70 -109.27 -13.17 14.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 0.02 112.32 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 t -159.91 152.34 20.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.843 -1.16 . . . . 0.01 109.059 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.7 p -167.42 145.14 4.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.154 -1.054 . . . . 1.22 108.154 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -121.67 104.73 9.82 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.229 1.014 . . . . 1.4099999999999999 109.621 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.685 -1.228 . . . . 0.01 107.685 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 55.3 m95 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 107.349 -1.352 . . . . 0.01 107.349 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mt -118.36 133.38 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.41 -1.432 . . . . 1.6899999999999999 109.775 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.72 141.28 44.22 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.378 -1.712 . . . . 2.4900000000000002 106.378 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -122.86 142.73 50.45 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.019 -1.051 . . . . 0.02 109.556 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.18 -30.68 62.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.02 111.718 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.84 154.87 48.23 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 120.749 -1.22 . . . . 1.48 108.896 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.31 167.24 2.74 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.28 1.32 . . . . 0.02 112.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.02 30.91 20.85 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.154 -0.93 . . . . 0.75 111.479 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.79 51.85 8.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.5 -0.75 . . . . 0.02 111.289 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.73 165.14 19.81 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.513 -0.742 . . . . 0.02 109.703 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.422 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.16 -165.51 34.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.124 -1.19 . . . . 0.02 110.124 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.46 142.02 53.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.981 . . . . 0.02 108.863 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -113.93 148.92 36.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 12.2 m-85 -123.36 133.9 54.06 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.773 -0.825 . . . . 0.01 108.773 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.3 120.47 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.148 . . . . 0.01 109.197 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 mp -98.73 138.6 35.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.299 -1.0 . . . . 0.01 108.299 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.752 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 3.1 m-20 -108.08 -173.76 2.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 2.27 109.628 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.67 40.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 1.8400000000000001 109.578 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.2 mttp -112.13 167.74 10.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.441 -0.787 . . . . 2.2799999999999998 109.358 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -105.06 124.11 48.96 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.752 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 71.4 m-85 -99.54 114.12 26.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.279 -0.888 . . . . 0.01 110.456 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -92.9 -26.22 17.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.01 110.636 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -123.63 154.45 66.66 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.993 -1.114 . . . . 2.54 107.993 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.557 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -61.64 -41.12 41.43 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 CA-C-N 119.245 0.766 . . . . 0.69999999999999996 110.802 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.74 -18.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.727 -1.233 . . . . 0.85999999999999999 109.311 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 50.7 t0 -65.29 -18.39 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.101 . . . . 0.02 111.927 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.75 15.42 29.02 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.8 -1.187 . . . . 0.02 110.164 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.4 76.3 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.163 -0.961 . . . . 0.02 113.113 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -101.15 141.41 34.08 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.836 -1.39 . . . . 0.02 110.227 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.433 ' C ' ' HG ' ' A' ' 166' ' ' SER . . . -84.51 -6.34 59.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.721 -0.612 . . . . 0.58999999999999997 109.641 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 165' ' ' ALA . 3.4 m -142.1 150.55 56.12 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.106 -0.996 . . . . 0.87 109.298 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.09 16.49 0.67 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 120.801 1.0 . . . . 0.38 112.018 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 120.79 25.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.17999999999999999 110.78 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.7 mt -149.08 124.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.719 -1.956 . . . . 3.9900000000000002 105.719 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -111.91 -13.72 13.6 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.174 -0.954 . . . . 5.1699999999999999 113.027 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 47.0 t -157.13 159.84 38.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.332 -2.105 . . . . 0.02 109.919 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 20.5 p90 -152.27 153.53 33.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.374 -0.829 . . . . 2.02 110.324 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -143.85 150.03 37.86 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.275 -0.89 . . . . 0.01 110.202 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.09 141.29 28.77 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.416 -0.957 . . . . 0.01 108.416 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 mt -94.84 129.61 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 3.04 109.373 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.46 147.67 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.423 -0.798 . . . . 1.8899999999999999 109.561 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 4.8899999999999997 109.431 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.573 0 N-CA-C 105.986 -2.846 . . . . 0.81000000000000005 105.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.41 147.71 31.68 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.419 -0.896 . . . . 0.01 111.007 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.65 138.66 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.02 108.421 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -130.29 140.83 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.354 0.597 . . . . 0.02 109.693 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -121.8 129.73 52.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.478 -0.764 . . . . 0.39000000000000001 109.778 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 29.1 m-85 -109.14 139.27 44.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.838 -0.801 . . . . 0.02 108.838 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.1 m-85 -122.68 138.56 54.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.297 -0.877 . . . . 0.02 109.742 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.14 -27.58 65.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.029999999999999999 111.671 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.83 170.33 8.42 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.872 -1.142 . . . . 0.029999999999999999 110.58 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -74.51 157.45 35.5 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.755 0.788 . . . . 0.029999999999999999 110.181 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.9 OUTLIER 65.77 35.33 6.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.891 0.853 . . . . 0.73999999999999999 110.943 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.5 p90 49.82 45.28 24.94 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.679 0.752 . . . . 0.02 111.266 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -112.51 166.78 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.08 -1.081 . . . . 0.02 108.08 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.4 -167.88 36.04 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.737 -1.221 . . . . 0.029999999999999999 110.624 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -69.89 143.76 52.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -1.073 . . . . 2.7599999999999998 109.134 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -120.35 149.07 42.92 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.71 0.767 . . . . 1.8899999999999999 110.582 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -132.24 126.75 34.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.064 -1.087 . . . . 0.02 108.064 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -112.04 136.83 50.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.414 -0.804 . . . . 1.1200000000000001 109.814 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.62 137.78 49.78 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.478 0.656 . . . . 0.02 109.538 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.89 10.59 14.15 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.303 0.573 . . . . 0.20000000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 43.1 t -158.15 173.86 16.07 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 1.23 108.129 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.659 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 2.9 m-20 -61.77 144.77 54.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.615 -1.303 . . . . 0.02 110.541 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 t -132.2 116.45 16.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.585 -0.895 . . . . 0.02 108.585 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.9 -23.5 55.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.486 -0.758 . . . . 0.23999999999999999 110.634 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -155.61 101.88 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.48 -0.933 . . . . 1.1399999999999999 108.48 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.67 10.22 34.88 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.344 1.069 . . . . 6.3700000000000001 109.816 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -59.88 -23.43 63.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.505 -0.747 . . . . 3.1099999999999999 110.713 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 m -75.35 -16.55 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.688 -1.258 . . . . 0.88 110.373 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -103.15 -21.4 13.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.402 -0.811 . . . . 0.02 109.017 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -149.88 128.58 12.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 3.3199999999999998 108.848 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 p -84.73 -10.12 57.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.71 -0.619 . . . . 0.02 110.376 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -171.61 163.3 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.704 -1.221 . . . . 0.02 107.704 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -141.73 114.77 8.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.853 -1.154 . . . . 0.02 108.663 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.646 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -107.81 -2.18 20.18 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.953 -1.092 . . . . 0.029999999999999999 110.614 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 t -154.36 153.42 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.99 -1.115 . . . . 0.02 107.99 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.0 mt -144.63 146.65 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.89 -1.131 . . . . 0.02 109.9 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' A' ' 42' ' ' GLU . 38.9 ttp180 -123.77 123.76 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.25 -1.389 . . . . 0.02 107.25 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.54 114.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 106.879 -1.526 . . . . 0.02 106.879 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 30.9 mt-10 -83.7 -33.92 25.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.98 -0.688 . . . . 3.8100000000000001 109.721 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.16 150.4 19.64 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 118.475 -1.822 . . . . 0.02 110.369 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 173.57 49.77 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.671 -1.252 . . . . 0.01 110.077 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -119.45 135.86 54.57 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.482 -1.303 . . . . 1.48 107.482 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -124.12 154.45 39.98 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.523 1.154 . . . . 0.02 111.936 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.31 132.93 53.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.032 -2.21 . . . . 0.23999999999999999 105.032 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.99 140.25 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.063 -0.717 . . . . 0.65000000000000002 109.063 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 53.7 m-85 -121.46 144.02 48.92 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 122.22 1.009 . . . . 0.02 109.54 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.452 ' CG ' HH11 ' A' ' 51' ' ' ARG . 1.8 tp10 -66.2 -35.82 81.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.196 -0.911 . . . . 0.02 111.75 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.452 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -122.09 158.6 54.78 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.944 -1.098 . . . . 0.02 109.212 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.66 167.25 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.517 1.478 . . . . 0.02 112.591 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.09 37.26 11.67 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.683 0.754 . . . . 0.02 111.265 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 4.1 m-85 44.87 52.33 8.12 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.935 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -125.8 163.44 22.89 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.846 -0.534 . . . . 2.3300000000000001 109.943 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.21 31.7 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.653 -1.379 . . . . 0.02 109.653 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -65.99 137.15 56.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.324 . . . . 0.02 110.045 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 15.8 ptm -119.37 135.98 54.48 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.447 0.641 . . . . 5.0099999999999998 109.398 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.605 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 47.1 m-85 -133.14 141.01 47.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.566 -0.709 . . . . 0.02 109.267 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.37 132.09 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.571 -0.706 . . . . 1.72 109.431 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.17 109.55 35.18 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.552 -0.718 . . . . 0.02 110.332 -178.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.04 169.39 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.061 1.058 . . . . 1.47 110.229 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -52.82 140.59 23.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.901 -1.124 . . . . 4.25 110.706 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.46 -176.26 32.33 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.432 -1.365 . . . . 0.02 110.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -118.39 129.97 55.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.375 -1.073 . . . . 0.95999999999999996 109.405 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 59.9 m-85 -121.07 97.66 47.79 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.773 -1.195 . . . . 0.02 107.773 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.55 -3.7 13.06 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.648 0.898 . . . . 0.02 113.952 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -155.68 154.07 30.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.454 -1.404 . . . . 2.02 108.044 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -60.59 -38.44 84.64 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.563 -0.711 . . . . 0.02 111.708 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.02 110.152 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.12 -18.75 63.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.009 0.909 . . . . 3.4199999999999999 108.694 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -107.24 10.86 29.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.251 -1.389 . . . . 0.02 107.251 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 32.9 mtm 61.18 22.47 12.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.02 110.521 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.48 145.06 47.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tp -78.86 -29.97 44.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -1.205 . . . . 0.97999999999999998 107.75 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.419 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 43.9 p30 -156.86 -171.45 3.66 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.57 27.49 4.29 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.731 -1.23 . . . . 0.02 109.987 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -95.92 122.48 38.77 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.032 -1.042 . . . . 3.2000000000000002 110.358 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 mt -144.72 121.66 11.34 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.922 -1.14 . . . . 2.6099999999999999 107.922 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.77 -16.84 9.57 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 121.33 -0.856 . . . . 0.02 112.847 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.7 t -155.15 155.63 34.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 120.023 1.912 . . . . 0.02 111.084 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.0 m -145.5 148.2 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.542 0.687 . . . . 0.02 110.306 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 12.7 mtp180 -134.6 139.25 45.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.01 108.935 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 132.74 37.24 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.623 -0.88 . . . . 0.42999999999999999 108.623 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.72 123.49 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.508 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -89.4 135.81 33.38 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.027 -1.101 . . . . 1.77 108.027 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' CD1' ' OE1' ' A' ' 177' ' ' GLU . 1.5 mt -99.2 137.71 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.752 -0.833 . . . . 1.6299999999999999 108.752 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.6 p -112.64 126.06 54.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.811 -0.811 . . . . 1.0800000000000001 108.811 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 p -102.96 -155.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.162 -1.792 . . . . 1.26 106.162 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -48.99 0.86 Allowed Glycine 0 N--CA 1.501 2.979 0 O-C-N 120.413 -1.429 . . . . 0.01 112.506 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.69 -100.0 0.14 Allowed Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.632 -1.746 . . . . 0.01 112.019 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -120.18 119.28 32.79 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.111 -1.229 . . . . 4.4299999999999997 110.753 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.84 129.93 36.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.016 -0.674 . . . . 2.9900000000000002 109.406 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -132.12 139.89 48.62 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.495 -0.753 . . . . 6.3600000000000003 109.287 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.89 145.77 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.404 -0.81 . . . . 1.0900000000000001 109.857 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -122.7 132.74 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.25 -1.389 . . . . 2.0499999999999998 107.25 177.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.51 149.24 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.107 . . . . 1.1000000000000001 109.585 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.2 141.45 48.87 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.034 0.921 . . . . 0.72999999999999998 110.998 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.36 -29.27 69.42 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.823 -0.626 . . . . 0.02 111.514 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -116.31 169.46 9.28 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.311 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.3 164.79 50.18 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.801 -0.92 . . . . 0.01 110.801 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.6 m-20 56.74 38.16 29.31 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.875 -0.779 . . . . 0.01 111.3 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.51 ' H ' ' CB ' ' A' ' 128' ' ' SER . 10.7 m-85 53.07 54.69 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.586 -0.696 . . . . 0.01 111.475 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -129.01 165.1 21.81 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.331 -0.989 . . . . 3.1499999999999999 108.331 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.88 -163.9 27.24 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.424 -1.471 . . . . 0.01 109.424 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -75.37 144.07 42.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.108 -1.231 . . . . 0.01 108.577 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.2 tmm? -116.71 142.82 46.41 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.576 0.703 . . . . 0.01 109.836 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.76 135.56 46.9 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.311 -0.996 . . . . 2.48 108.311 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -121.21 135.54 55.12 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.58 -0.7 . . . . 0.01 109.93 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -149.88 152.49 35.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.189 0.995 . . . . 1.6899999999999999 110.799 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -109.41 9.87 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.01 109.97 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -120.77 163.2 18.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.817 . . . . 3.21 111.388 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.8 155.72 37.47 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.083 -1.081 . . . . 0.01 108.083 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.1 m -124.66 112.41 27.43 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.423 -0.798 . . . . 0.01 108.94 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.43 ' C ' ' HG ' ' A' ' 171' ' ' SER . 17.8 Cg_endo -76.44 -32.66 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 120.135 1.084 . . . . 0.01 111.551 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.6 t -140.76 107.9 5.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.876 . . . . 0.02 108.989 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -64.15 -39.98 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 1.8300000000000001 110.593 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 118' ' ' MET . 2.0 tmt? -66.17 -37.8 86.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.134 -1.027 . . . . 1.3400000000000001 109.849 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.52 -38.85 74.32 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.448 -1.407 . . . . 2.1099999999999999 109.729 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.31 -47.57 14.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.354 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.46 -0.86 16.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.424 -0.798 . . . . 0.02 112.663 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m170 61.19 33.75 19.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.139 . . . . 0.02 109.662 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.5 mt -114.22 135.93 53.51 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.476 -0.765 . . . . 0.02 109.235 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.66 -22.0 21.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 5.3200000000000003 110.9 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -148.54 163.84 35.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.884 -1.135 . . . . 0.02 110.065 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 126' ' ' ILE . 40.0 mm -128.43 125.28 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.456 -1.313 . . . . 2.1699999999999999 107.456 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -111.56 -14.04 13.73 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.285 -0.885 . . . . 0.02 112.698 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.51 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 18.7 m -160.16 152.06 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.77 -1.206 . . . . 0.01 109.044 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 31.9 p -168.87 150.13 4.59 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.504 -0.924 . . . . 1.22 108.504 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 35.4 mttm -113.28 100.71 8.77 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.327 1.06 . . . . 1.4099999999999999 108.406 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.429 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 1.2 p . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 108.697 -0.853 . . . . 0.01 108.697 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.429 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 85.6 m95 . . . . . 0 N--CA 1.508 2.474 0 CA-C-O 121.193 0.52 . . . . 0.01 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.6 mt -120.1 136.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.254 -1.017 . . . . 1.6899999999999999 108.254 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.43 141.43 43.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.109 -1.441 . . . . 2.4900000000000002 107.109 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -122.72 142.77 50.34 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.173 -0.954 . . . . 0.02 109.894 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.03 -30.31 61.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.02 112.319 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.4 154.83 48.99 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.587 -1.321 . . . . 1.48 108.619 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.28 167.06 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.068 1.179 . . . . 0.02 113.04 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.1 m120 58.66 30.75 20.32 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.263 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 57.47 51.21 10.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.665 . . . . 0.02 111.066 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' NH1' ' SD ' ' A' ' 73' ' ' MET . 23.3 mmm180 -125.0 164.8 19.37 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.45 -0.781 . . . . 0.02 109.549 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.34 -165.93 34.47 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.338 -1.105 . . . . 0.02 110.338 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -69.7 142.9 53.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.458 -1.025 . . . . 0.02 109.022 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.483 ' O ' ' CG ' ' A' ' 58' ' ' MET . 6.1 mt-30 -113.41 149.76 33.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.72 -0.613 . . . . 0.02 109.558 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.13 132.51 54.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.904 -1.147 . . . . 0.01 107.904 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.8 tp -95.48 121.2 36.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.633 -1.292 . . . . 0.01 109.347 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.2 mt -93.49 162.42 13.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.811 -1.181 . . . . 0.01 107.811 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.91 -116.94 0.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.357 -0.839 . . . . 2.27 109.283 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -141.29 26.31 2.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 1.8400000000000001 109.006 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -110.35 -166.81 1.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.849 -0.797 . . . . 2.2799999999999998 108.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.29 131.9 53.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.532 -0.73 . . . . 0.01 109.496 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.06 110.78 23.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.354 -0.841 . . . . 0.01 108.911 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.449 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.0 ptm180 -88.1 -27.79 21.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.01 111.309 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -124.08 154.22 68.13 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.696 -1.224 . . . . 2.54 107.696 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.66 -39.27 44.69 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 CA-C-N 119.382 0.815 . . . . 0.69999999999999996 110.903 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.09 -18.41 17.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.478 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.46 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.039 -1.038 . . . . 0.02 112.272 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.12 15.63 28.07 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.799 -1.188 . . . . 0.02 109.887 178.377 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.22 75.33 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.164 -0.96 . . . . 0.02 112.948 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.416 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.22 140.45 35.49 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.847 -1.384 . . . . 0.02 110.233 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -6.85 59.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.642 -0.661 . . . . 0.58999999999999997 109.711 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.7 p -140.34 150.83 62.51 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.176 -0.952 . . . . 0.87 109.297 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.88 15.23 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.667 0.911 . . . . 0.38 111.865 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.64 24.19 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.33 1.062 . . . . 0.17999999999999999 110.682 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.463 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.01 123.5 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.577 -2.009 . . . . 3.9900000000000002 105.577 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.62 -12.77 12.8 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.21 -0.932 . . . . 5.1699999999999999 113.271 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 9.2 t -157.23 158.93 37.09 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 119.134 -2.229 . . . . 0.02 109.945 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.528 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 18.1 p90 -152.77 154.75 35.82 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.092 -1.005 . . . . 2.02 110.148 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -144.67 150.56 37.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.01 110.395 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -87.89 143.04 27.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.01 108.613 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.65 129.39 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.311 -0.868 . . . . 3.04 109.266 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.08 147.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -0.926 . . . . 1.8899999999999999 109.783 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.473 ' OE1' ' CD1' ' A' ' 87' ' ' LEU . 51.5 tp10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 4.8899999999999997 109.413 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.729 0 N-CA-C 106.785 -2.526 . . . . 0.81000000000000005 106.785 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 149.09 33.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.745 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -150.45 136.34 18.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -1.053 . . . . 0.02 109.367 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -128.96 139.25 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.012 -0.736 . . . . 0.02 109.012 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.534 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.3 t -121.77 130.35 53.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.605 -0.684 . . . . 0.39000000000000001 109.438 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -108.67 138.38 45.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.041 -0.726 . . . . 0.02 109.041 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 7.0 m-85 -122.65 138.53 54.57 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.215 -0.928 . . . . 0.02 109.734 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 70.6 mt-10 -71.33 -28.2 63.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.029999999999999999 111.635 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.535 ' C ' HD22 ' A' ' 37' ' ' ASN . 24.0 t0 -113.57 168.04 10.09 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.851 -1.156 . . . . 0.029999999999999999 110.171 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 96.0 mtt180 -73.73 157.19 36.96 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.629 0.728 . . . . 0.029999999999999999 110.051 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.629 ' ND2' ' CE2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER 66.35 35.23 5.9 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.83 0.824 . . . . 0.73999999999999999 110.928 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.629 ' CE2' ' ND2' ' A' ' 14' ' ' ASN . 13.5 p90 50.06 45.49 25.38 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.815 0.817 . . . . 0.02 111.162 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -112.9 166.09 11.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.81 -1.182 . . . . 0.02 107.81 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -166.79 35.86 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.617 -1.278 . . . . 0.029999999999999999 110.825 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -69.42 140.8 54.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.928 . . . . 2.7599999999999998 109.268 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -120.94 149.09 43.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.259 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -132.81 127.09 33.79 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.945 -1.131 . . . . 0.02 107.945 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.81 136.86 50.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.528 -0.732 . . . . 1.1200000000000001 109.706 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.22 138.2 49.26 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.422 0.629 . . . . 0.02 109.449 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -116.81 10.89 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.46 -0.57 . . . . 0.20000000000000001 109.46 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.476 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.2 p -157.88 174.43 15.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.61 144.91 55.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.551 -1.343 . . . . 0.02 110.435 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.2 t -132.48 116.65 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.547 -0.909 . . . . 0.02 108.547 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -24.55 52.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.23999999999999999 110.751 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.76 100.41 2.37 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.445 -0.946 . . . . 1.1399999999999999 108.445 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 20.5 p90 -106.06 9.88 32.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.199 1.0 . . . . 6.3700000000000001 110.058 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -58.89 -22.68 59.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.633 -0.667 . . . . 3.1099999999999999 110.595 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -74.7 -16.61 60.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.676 -1.265 . . . . 0.88 110.324 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.37 -22.0 14.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.376 -0.827 . . . . 0.02 109.053 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -150.3 129.44 12.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.453 -0.944 . . . . 3.3199999999999998 108.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 p -85.26 -9.66 57.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.79 -0.569 . . . . 0.02 110.804 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -169.54 161.43 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 m -141.83 112.68 7.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.796 -1.19 . . . . 0.02 109.125 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.716 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.1 OUTLIER -110.66 -0.6 17.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.054 -1.029 . . . . 0.029999999999999999 110.981 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.31 152.24 30.9 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.736 -1.209 . . . . 0.02 107.736 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -146.4 148.37 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.89 -1.131 . . . . 0.02 110.555 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -125.92 125.88 43.49 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.973 -1.121 . . . . 0.02 107.973 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.8 115.42 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.587 -1.634 . . . . 0.02 106.587 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.68 -33.8 25.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.63 -0.669 . . . . 3.8100000000000001 110.404 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.65 21.22 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.064 -1.541 . . . . 0.02 109.996 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.58 174.76 50.33 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.547 -1.311 . . . . 0.01 109.999 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 14.8 m -109.79 160.65 16.15 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.646 -1.613 . . . . 1.48 106.646 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CD1' ' O ' ' A' ' 45' ' ' THR . 62.5 m95 -147.97 147.81 30.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.285 . . . . 0.02 111.432 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.59 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.157 -2.164 . . . . 0.23999999999999999 105.157 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.9 143.29 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.664 -0.647 . . . . 0.65000000000000002 109.436 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.92 145.46 47.67 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.299 1.047 . . . . 0.02 109.997 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -65.9 -33.56 76.12 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.501 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -124.31 157.4 64.73 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.995 -1.066 . . . . 0.02 109.578 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.11 166.42 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.603 1.535 . . . . 0.02 112.778 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.11 36.39 9.72 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.442 -0.799 . . . . 0.02 111.114 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.03 50.88 9.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.602 0.715 . . . . 3.3900000000000001 110.61 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -125.72 163.58 22.52 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.252 0.548 . . . . 2.3300000000000001 109.914 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.62 -161.93 31.33 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.477 -1.449 . . . . 0.02 109.477 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 16.0 t-80 -66.53 138.29 57.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.948 -1.325 . . . . 0.02 109.897 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.531 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 21.8 ptm -119.1 137.21 53.73 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.557 0.694 . . . . 5.0099999999999998 109.605 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.624 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 13.2 m-85 -132.19 140.31 48.67 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.759 0.79 . . . . 0.02 109.174 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.5 mm -96.5 131.71 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.47 -0.937 . . . . 1.72 108.47 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -122.76 113.58 30.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.373 -0.829 . . . . 0.02 110.741 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.11 169.96 20.54 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 CA-C-N 120.062 1.058 . . . . 1.47 110.238 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 1.8 pm0 -51.9 141.33 17.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 4.25 110.153 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.34 -177.48 32.51 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.341 -1.409 . . . . 0.02 110.707 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -119.08 130.0 55.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.529 -0.983 . . . . 0.95999999999999996 109.62 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 52.3 m-85 -120.71 95.78 48.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 107.765 -1.198 . . . . 0.02 107.765 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -68.37 -3.66 11.35 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 120.699 0.933 . . . . 0.02 113.835 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 82.6 mt-10 -157.6 154.81 29.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.544 -1.348 . . . . 2.02 108.252 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -60.5 -39.36 87.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.492 -0.755 . . . . 0.02 111.937 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -59.49 -23.86 63.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.02 110.132 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.57 62.4 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.443 -0.947 . . . . 3.4199999999999999 108.443 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.592 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.39 9.05 31.9 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.354 -1.35 . . . . 0.02 107.354 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.6 mtm 60.6 21.64 11.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.606 -0.684 . . . . 0.02 110.527 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.87 143.88 44.93 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.195 -1.562 . . . . 0.02 109.195 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -30.14 50.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.084 -1.45 . . . . 0.97999999999999998 107.084 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -156.57 -172.04 3.92 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.27 -1.752 . . . . 0.02 106.27 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -97.78 27.79 4.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.728 -1.232 . . . . 0.02 110.464 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 78' ' ' ARG . 8.5 mtt-85 -96.4 122.84 39.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.12 -0.988 . . . . 3.2000000000000002 110.752 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.459 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 29.9 mt -144.87 120.15 10.21 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.517 -1.29 . . . . 2.6099999999999999 107.517 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.0 -15.87 11.3 Favored Glycine 0 N--CA 1.507 3.378 0 O-C-N 121.271 -0.893 . . . . 0.02 112.869 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.4 p -155.51 156.14 34.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.217 -1.755 . . . . 0.02 110.276 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.5 p -145.03 148.35 33.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.02 109.484 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -133.71 138.63 45.93 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.751 -0.833 . . . . 0.01 108.751 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.62 131.77 36.84 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.473 -0.936 . . . . 0.42999999999999999 108.473 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.27 123.82 43.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.74 -0.837 . . . . 1.25 108.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -92.18 135.08 34.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.984 -1.073 . . . . 1.77 108.281 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.01 137.84 36.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.471 -0.768 . . . . 1.6299999999999999 109.386 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.8 m -111.03 127.09 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.548 -0.908 . . . . 1.0800000000000001 108.548 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 p -104.02 -154.73 0.51 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 106.464 -1.68 . . . . 1.26 106.464 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.81 -49.02 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.454 -1.403 . . . . 0.01 112.275 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.0 -100.2 0.14 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 118.331 -1.89 . . . . 0.01 112.122 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -119.99 118.58 31.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.27 -1.135 . . . . 4.4299999999999997 110.714 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 130.92 38.22 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.095 -0.705 . . . . 2.9900000000000002 109.095 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -130.48 138.54 50.32 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.834 -0.802 . . . . 6.3600000000000003 108.834 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.15 143.86 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.358 -0.839 . . . . 1.0900000000000001 109.402 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -122.14 133.71 54.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.596 -1.261 . . . . 2.0499999999999998 107.596 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.81 146.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.992 -1.068 . . . . 1.1000000000000001 109.038 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -120.59 141.75 50.02 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 122.127 0.965 . . . . 0.72999999999999998 111.277 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -66.16 -30.01 70.4 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.807 -0.633 . . . . 0.02 111.821 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -116.61 168.05 10.53 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.636 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.75 163.57 43.8 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 111.016 -0.833 . . . . 0.01 111.016 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 57.03 38.86 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 122.011 -0.699 . . . . 0.01 110.979 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.3 m-85 52.23 56.71 7.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.597 -0.69 . . . . 0.01 111.083 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -128.84 165.46 20.96 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.17 -1.048 . . . . 3.1499999999999999 108.17 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.2 -164.43 28.41 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.016 -1.634 . . . . 0.01 109.016 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.22 143.68 45.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.988 -1.301 . . . . 0.01 108.479 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 3.8 tmm? -116.49 142.41 46.91 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.696 0.76 . . . . 0.01 109.683 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -131.58 135.36 46.94 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.978 -1.119 . . . . 2.48 107.978 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.77 135.17 55.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.592 -0.692 . . . . 0.01 109.764 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 111' ' ' THR . 5.1 t -150.26 154.33 37.74 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.486 1.136 . . . . 1.6899999999999999 111.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.523 ' N ' ' HG1' ' A' ' 110' ' ' THR . 10.9 p -111.39 9.86 21.48 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.347 -0.842 . . . . 0.01 109.988 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -122.18 163.52 19.42 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.252 -0.905 . . . . 3.21 111.632 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.94 155.98 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.529 -0.915 . . . . 0.01 108.529 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.34 112.42 27.98 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.965 -0.754 . . . . 0.01 108.965 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.71 -33.44 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.188 1.103 . . . . 0.01 111.548 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.453 ' HG ' ' CB ' ' A' ' 119' ' ' GLU . 4.6 t -140.29 107.53 5.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.02 108.743 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.54 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.819 -0.55 . . . . 1.8300000000000001 111.222 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.1 OUTLIER -66.48 -37.65 85.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.819 -1.152 . . . . 1.3400000000000001 109.578 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.453 ' CB ' ' HG ' ' A' ' 116' ' ' SER . 7.4 tm-20 -70.42 -38.85 74.65 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.464 -1.398 . . . . 2.1099999999999999 109.589 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -80.68 -48.17 12.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 112.485 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.02 -2.13 15.16 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.711 . . . . 0.02 112.705 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.9 33.86 17.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.814 -1.179 . . . . 0.02 109.942 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -114.2 135.49 53.99 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.491 -0.755 . . . . 0.02 109.1 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -90.98 -21.45 21.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 5.3200000000000003 111.273 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.12 163.98 35.28 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.228 . . . . 0.02 110.093 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.38 124.3 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.58 -1.267 . . . . 2.1699999999999999 107.58 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -108.44 -13.94 14.76 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.098 -1.001 . . . . 0.02 112.52 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 129' ' ' CYS . 13.5 t -160.57 152.38 19.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.746 -1.221 . . . . 0.01 108.82 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.528 ' N ' ' HG ' ' A' ' 128' ' ' SER . 10.3 t -167.28 145.09 4.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 1.22 109.164 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -123.65 106.09 10.26 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.398 1.094 . . . . 1.4099999999999999 109.385 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.334 -1.358 . . . . 0.01 107.334 179.053 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.4 m95 . . . . . 0 N--CA 1.505 2.283 0 N-CA-C 107.819 -1.178 . . . . 0.01 107.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.06 134.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.634 -1.291 . . . . 1.6899999999999999 109.94 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -110.24 141.38 43.28 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.541 -2.022 . . . . 2.4900000000000002 105.541 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.536 ' HH ' ' HE ' ' A' ' 173' ' ' ARG . 39.3 m-85 -123.19 143.24 50.15 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.111 -0.993 . . . . 0.02 110.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 35.4 tt0 -72.97 -31.97 64.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.791 -0.568 . . . . 0.02 111.67 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.97 154.76 48.4 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.738 -1.226 . . . . 1.48 108.819 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -56.45 167.44 2.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.069 1.179 . . . . 0.02 112.849 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 59.06 31.63 21.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.159 -0.928 . . . . 0.75 111.51 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.03 51.91 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.765 . . . . 0.02 111.361 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -127.12 165.47 19.47 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.569 -0.707 . . . . 0.02 110.097 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.71 -164.99 34.71 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.211 -1.156 . . . . 0.02 110.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -69.17 141.34 54.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -1.065 . . . . 0.02 108.817 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 5.6 mt-30 -113.69 148.79 35.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.439 -0.578 . . . . 0.02 109.439 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -124.55 134.42 52.99 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.758 -0.83 . . . . 0.01 108.758 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -95.99 121.02 37.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.871 -1.143 . . . . 0.01 109.477 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.38 146.18 26.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.493 -0.929 . . . . 0.01 108.493 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.3 m-20 -110.6 178.46 4.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.599 -0.688 . . . . 2.27 109.532 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -71.65 39.79 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 1.8400000000000001 109.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.6 mttm -110.31 -178.71 3.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.135 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -106.09 120.0 40.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.323 -0.861 . . . . 0.01 108.898 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.07 110.05 22.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.924 . . . . 0.01 108.986 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -28.13 16.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.506 -0.746 . . . . 0.01 111.176 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -123.5 152.27 64.63 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 107.722 -1.214 . . . . 2.54 107.722 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.8 Cg_endo -60.61 -39.65 62.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 CA-C-N 119.866 0.988 . . . . 0.69999999999999996 110.987 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.97 -18.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.779 -1.201 . . . . 0.85999999999999999 109.665 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.95 -18.63 65.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.02 112.38 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.66 16.0 27.17 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.828 -1.17 . . . . 0.02 109.912 178.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.1 11.2 76.69 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.227 -0.921 . . . . 0.02 112.849 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.404 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 140.63 34.95 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.42 . . . . 0.02 110.11 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.64 -7.48 58.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.628 -0.67 . . . . 0.58999999999999997 110.092 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.0 p -139.97 150.72 63.27 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.198 -0.939 . . . . 0.87 109.463 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.93 14.27 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 120.812 1.008 . . . . 0.38 112.094 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.15 27.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.919 -1.113 . . . . 0.17999999999999999 111.15 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 mp -151.65 125.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.513 -1.662 . . . . 3.9900000000000002 106.513 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.0 mp0 -112.2 -12.03 13.68 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.357 -0.84 . . . . 5.1699999999999999 112.533 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.9 t -156.88 158.99 37.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.197 -2.189 . . . . 0.02 110.045 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -152.26 154.15 35.16 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.147 -0.97 . . . . 2.02 110.057 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.536 ' HE ' ' HH ' ' A' ' 139' ' ' TYR . 61.0 mtm180 -143.08 148.39 36.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.01 109.804 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -86.37 141.14 29.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.184 -1.043 . . . . 0.01 108.184 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 25.8 mt -95.1 129.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.212 -0.93 . . . . 3.04 109.516 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.46 147.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 1.8899999999999999 109.618 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 4.8899999999999997 109.718 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.407 0 N-CA-C 105.653 -2.979 . . . . 0.81000000000000005 105.653 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 147.6 31.86 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.338 -0.934 . . . . 0.01 111.231 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -152.84 138.05 17.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.586 -0.949 . . . . 0.02 109.184 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.22 140.0 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.259 -0.645 . . . . 0.02 109.259 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -122.56 130.66 53.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.633 -0.667 . . . . 0.39000000000000001 109.877 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 10.9 m-85 -110.6 140.2 45.14 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.85 -0.796 . . . . 0.02 108.85 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.0 m-85 -122.43 139.03 54.32 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.289 -0.882 . . . . 0.02 109.856 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -68.58 -28.47 66.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.063 . . . . 0.029999999999999999 111.88 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.98 170.42 8.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.796 -1.19 . . . . 0.029999999999999999 110.351 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 31.9 mtp180 -74.81 157.58 34.91 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.698 0.761 . . . . 0.029999999999999999 110.354 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t30 66.29 33.85 6.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 111.374 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.23 42.43 28.01 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.287 0.565 . . . . 0.02 111.424 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -113.64 166.35 11.62 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.611 -0.885 . . . . 0.02 108.611 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.4 -167.53 37.44 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.954 -1.117 . . . . 0.029999999999999999 111.094 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.423 HH21 ' H ' ' A' ' 34' ' ' SER . 37.7 ttp180 -69.11 142.13 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.578 -0.954 . . . . 2.7599999999999998 109.265 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -121.51 149.46 43.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.738 0.78 . . . . 1.8899999999999999 110.324 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -131.99 127.39 36.17 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.968 -1.123 . . . . 0.02 107.968 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.26 137.4 50.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.564 -0.71 . . . . 1.1200000000000001 109.564 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.9 t -131.24 138.35 49.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.51 0.671 . . . . 0.02 109.673 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.44 10.52 14.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.608 -0.683 . . . . 0.20000000000000001 109.529 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.1 p -157.37 174.28 15.66 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.216 -1.031 . . . . 1.23 108.216 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.34 144.32 54.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.662 -1.274 . . . . 0.02 110.189 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.13 116.7 17.35 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.468 -0.938 . . . . 0.02 108.468 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.89 -24.29 52.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 110.663 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -153.82 100.72 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 108.509 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -106.7 8.38 30.99 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.182 0.991 . . . . 6.3700000000000001 110.168 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.674 ' NH2' HH12 ' A' ' 78' ' ' ARG . 86.7 mtt180 -59.79 -21.29 60.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 3.1099999999999999 110.495 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.3 m -74.89 -16.48 60.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.905 -1.122 . . . . 0.88 109.871 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -102.37 -21.65 14.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.02 109.086 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -150.26 129.66 12.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.913 -0.773 . . . . 3.3199999999999998 108.913 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 29.8 t -86.76 -12.22 48.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.854 -0.529 . . . . 0.02 111.098 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' SER . 10.5 mtm180 -167.1 161.09 14.49 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.153 -1.425 . . . . 0.02 107.153 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 16.8 p -143.34 115.31 8.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.831 -1.168 . . . . 0.02 108.643 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.5 m-20 -107.3 0.73 23.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.733 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 p -157.08 155.2 30.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.757 -1.201 . . . . 0.02 107.757 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.66 147.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.02 110.27 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -123.25 124.36 42.83 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -106.26 114.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.78 -34.08 27.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 3.8100000000000001 110.265 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.78 151.29 21.02 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.116 -1.516 . . . . 0.02 110.125 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.38 49.64 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.495 -1.336 . . . . 0.01 110.082 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.82 137.41 54.0 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.802 -1.184 . . . . 1.48 107.802 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -125.66 153.62 43.56 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.498 1.142 . . . . 0.02 111.983 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.62 52.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 104.869 -2.271 . . . . 0.23999999999999999 104.869 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.41 142.28 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.526 -0.733 . . . . 0.65000000000000002 109.089 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 13.8 m-85 -119.5 144.04 47.22 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.378 1.085 . . . . 0.02 109.723 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 5.6 tp10 -65.95 -35.02 79.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.669 -0.696 . . . . 0.02 110.882 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -125.17 157.19 68.14 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.093 -1.004 . . . . 0.02 109.702 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 167.43 1.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.806 1.67 . . . . 0.02 113.056 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.06 37.25 9.27 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.144 -0.934 . . . . 0.02 111.017 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 45.21 52.22 8.74 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.598 0.713 . . . . 3.3900000000000001 110.71 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.2 p -127.56 164.32 22.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.297 0.57 . . . . 2.3300000000000001 109.911 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -162.3 31.81 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.922 -1.271 . . . . 0.02 109.922 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.682 ' HD1' ' N ' ' A' ' 58' ' ' MET . 14.9 t-80 -63.29 142.61 58.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.268 . . . . 0.02 110.507 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.682 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 31.4 mtp -116.78 134.56 54.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.266 0.555 . . . . 5.0099999999999998 109.519 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 17.0 m-85 -135.27 134.35 39.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.393 -0.817 . . . . 0.02 109.124 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -96.86 131.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.986 -0.746 . . . . 1.72 108.986 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.0 mt -122.92 111.48 30.89 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.394 -0.816 . . . . 0.02 110.668 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.1 171.29 18.4 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 CA-C-N 119.856 0.984 . . . . 1.47 110.286 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 1.3 tm0? -51.78 140.42 19.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 4.25 109.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 155.95 -178.15 32.65 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.325 -1.417 . . . . 0.02 110.71 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.84 131.24 55.23 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.581 -0.952 . . . . 0.95999999999999996 109.587 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 62.4 m-85 -121.08 99.42 46.53 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.116 -1.068 . . . . 0.02 108.116 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.36 -4.21 13.96 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.64 0.893 . . . . 0.02 113.99 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 37.7 mt-10 -157.44 155.23 30.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.453 -1.405 . . . . 2.02 108.238 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 70' ' ' GLN . 27.7 p90 -60.36 -38.19 83.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.634 -0.666 . . . . 0.02 111.749 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 69' ' ' TYR . 13.3 mm-40 -59.83 -23.89 63.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.915 -1.115 . . . . 0.02 110.211 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.5 -18.6 62.28 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.176 0.989 . . . . 3.4199999999999999 108.588 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.603 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -105.67 9.25 33.25 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.937 -1.505 . . . . 0.02 106.937 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt 59.87 21.56 10.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.606 -0.684 . . . . 0.02 110.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.81 144.09 46.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.02 109.497 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.78 -29.68 51.01 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.324 -1.362 . . . . 0.97999999999999998 107.324 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -156.85 -170.85 3.44 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.405 -1.702 . . . . 0.02 106.405 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -97.82 29.25 3.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.612 -1.305 . . . . 0.02 110.172 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.674 HH12 ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -98.19 122.4 41.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.206 -0.934 . . . . 3.2000000000000002 110.988 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 mt -144.59 122.03 11.68 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.362 -1.347 . . . . 2.6099999999999999 107.362 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.19 -16.46 12.31 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 120.448 -0.882 . . . . 0.02 112.405 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.8 p -156.31 157.32 35.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.309 -1.7 . . . . 0.02 110.405 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.3 m -144.85 148.37 33.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.767 -0.583 . . . . 0.02 109.559 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -136.44 140.69 43.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.233 -0.917 . . . . 0.01 109.136 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.48 132.77 36.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.224 -0.922 . . . . 0.42999999999999999 109.323 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.28 123.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.511 -0.922 . . . . 1.25 108.511 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -88.93 135.51 33.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.097 -1.075 . . . . 1.77 108.097 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.29 139.0 37.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.445 -0.576 . . . . 1.6299999999999999 109.445 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 p -111.98 122.39 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.685 -1.228 . . . . 1.0800000000000001 107.685 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.8 p -114.22 133.84 55.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.752 -1.218 . . . . 1.26 107.865 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.5 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.501 3.033 0 C-N-CA 117.459 -2.305 . . . . 0.01 113.652 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.12 -103.03 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 120.308 2.054 . . . . 0.01 111.202 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.45 ' NE2' ' CG2' ' A' ' 111' ' ' THR . 0.3 OUTLIER -119.93 119.2 32.79 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.359 -1.083 . . . . 4.4299999999999997 110.174 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.1 129.98 38.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.191 -0.67 . . . . 2.9900000000000002 109.191 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -132.14 138.19 47.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.717 . . . . 6.3600000000000003 109.319 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -127.36 145.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.478 -0.764 . . . . 1.0900000000000001 109.457 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.445 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.3 pt20 -122.02 131.65 54.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.603 -1.258 . . . . 2.0499999999999998 107.603 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.6 146.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 120.811 -1.18 . . . . 1.1000000000000001 109.386 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.25 140.86 49.17 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.022 0.915 . . . . 0.72999999999999998 110.812 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -65.66 -29.96 70.59 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.959 -0.564 . . . . 0.02 111.395 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -116.94 168.36 10.31 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.571 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.61 168.92 30.6 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.959 -0.857 . . . . 0.01 110.959 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 52.21 40.09 28.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.671 0.748 . . . . 0.01 111.168 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 13.7 m-85 51.77 51.92 15.62 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.563 -0.711 . . . . 0.01 110.804 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -124.83 165.33 18.22 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.568 -0.901 . . . . 3.1499999999999999 108.568 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -165.37 26.84 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.34 -1.504 . . . . 0.01 109.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -75.18 145.38 42.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.124 -1.221 . . . . 0.01 108.264 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.464 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.7 tmm? -116.47 142.31 47.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.678 0.752 . . . . 0.01 110.131 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.453 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.6 m-85 -130.85 135.31 47.6 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.844 -1.169 . . . . 2.48 107.844 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.25 135.77 54.8 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.596 -0.69 . . . . 0.01 109.751 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.15 154.46 39.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.039 -1.038 . . . . 1.6899999999999999 110.674 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.45 ' CG2' ' NE2' ' A' ' 92' ' ' GLN . 58.8 p -111.34 8.35 21.32 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.818 -0.628 . . . . 0.01 110.009 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.2 163.5 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.337 -0.852 . . . . 3.21 111.383 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.77 155.92 38.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.124 -1.065 . . . . 0.01 108.124 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.496 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 44.5 t -126.0 112.41 24.33 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.687 -0.857 . . . . 0.01 108.687 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -74.81 -28.69 9.31 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.245 1.123 . . . . 0.01 111.094 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -142.52 108.65 5.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -0.843 . . . . 0.02 108.953 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.62 -38.27 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.879 -0.513 . . . . 1.8300000000000001 110.414 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.78 -37.38 79.27 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.224 -0.99 . . . . 1.3400000000000001 110.451 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.87 -39.25 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.462 -1.399 . . . . 2.1099999999999999 109.963 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.3 tt0 -79.38 -47.27 16.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 2.0800000000000001 112.409 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.71 -0.1 16.11 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.431 -0.793 . . . . 0.02 112.808 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 m80 61.3 34.08 18.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.812 -1.18 . . . . 0.02 109.639 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.25 134.15 54.73 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -21.61 21.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 5.3200000000000003 109.984 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -149.83 164.56 35.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.149 -0.97 . . . . 0.02 109.859 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.96 128.52 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.294 -1.373 . . . . 2.1699999999999999 107.294 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -107.23 -12.85 15.28 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.518 -0.739 . . . . 0.02 111.974 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.2 t -161.33 155.14 22.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.01 108.905 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.2 t -166.66 144.46 5.11 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.957 -1.127 . . . . 1.22 107.957 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -119.39 101.89 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.176 0.988 . . . . 1.4099999999999999 109.004 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.487 -0.931 . . . . 0.01 108.487 179.752 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.0 m95 . . . . . 0 N--CA 1.51 2.551 0 CA-C-O 121.524 0.678 . . . . 0.01 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -121.14 138.86 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.929 -0.767 . . . . 1.6899999999999999 108.929 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -111.92 142.01 44.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.089 -1.448 . . . . 2.4900000000000002 107.089 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 22.0 m-85 -123.17 144.04 49.62 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.214 -0.929 . . . . 0.02 109.448 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.2 -30.22 60.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.02 111.552 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 155.46 46.76 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.68 -1.262 . . . . 1.48 108.954 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -57.09 167.27 3.38 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.183 1.255 . . . . 0.02 112.721 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.7 t30 59.01 31.63 21.54 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.144 -0.935 . . . . 0.75 111.341 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.52 51.19 10.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.02 111.157 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.34 165.1 18.97 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.614 -0.679 . . . . 0.02 109.914 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.67 -165.38 33.55 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.174 -1.17 . . . . 0.02 110.174 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -69.94 143.02 52.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -1.035 . . . . 0.02 108.915 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -112.03 147.75 35.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.383 0.611 . . . . 0.02 109.816 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.42 133.76 53.29 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.841 -0.8 . . . . 0.01 108.841 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -97.95 122.64 41.31 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.827 -1.17 . . . . 0.01 109.923 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.8 mt -91.75 143.46 26.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.01 108.61 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 154' ' ' LYS . 20.1 m-20 -108.23 -179.01 3.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.438 -0.789 . . . . 2.27 109.725 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.522 ' CB ' ' HZ2' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -75.28 36.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 1.8400000000000001 109.526 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 152' ' ' ASP . 89.3 mttt -111.9 177.57 4.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.789 . . . . 2.2799999999999998 109.271 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -106.07 121.87 45.01 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.843 -0.799 . . . . 0.01 108.843 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.97 113.04 25.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.349 -0.844 . . . . 0.01 110.346 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -94.18 -25.58 17.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.127 -0.983 . . . . 0.01 110.934 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -124.75 154.31 70.43 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.922 -1.111 . . . . 2.54 108.119 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.55 -40.69 45.31 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.186 0.745 . . . . 0.69999999999999996 110.555 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.8 -19.72 21.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.991 -1.068 . . . . 0.85999999999999999 109.055 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.14 -18.59 65.44 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.962 -1.086 . . . . 0.02 111.388 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -102.74 14.27 32.37 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.037 -1.04 . . . . 0.02 109.859 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.15 9.77 69.84 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.393 -0.817 . . . . 0.02 113.734 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.581 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.86 140.89 34.51 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.533 -1.569 . . . . 0.02 110.619 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.14 -7.1 59.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.58999999999999997 109.333 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.8 m -142.53 150.71 55.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.126 -0.984 . . . . 0.87 109.293 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.43 17.7 0.63 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.729 0.953 . . . . 0.38 112.28 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.6 29.07 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.476 1.132 . . . . 0.17999999999999999 111.429 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.5 mt -148.77 127.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.84 -1.541 . . . . 3.9900000000000002 106.84 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -113.34 -16.31 12.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.231 -0.918 . . . . 5.1699999999999999 112.726 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 23.0 t -157.18 159.49 37.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 119.287 -2.133 . . . . 0.02 110.176 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.04 152.85 34.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.868 . . . . 2.02 109.917 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -144.71 151.06 38.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.244 -0.91 . . . . 0.01 110.498 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -87.95 143.52 27.06 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.722 -0.844 . . . . 0.01 108.722 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.2 mt -94.91 128.7 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 3.04 109.119 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.66 146.64 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.19 -0.944 . . . . 1.8899999999999999 109.418 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 4.8899999999999997 109.099 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 106.984 -2.447 . . . . 0.81000000000000005 106.984 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 148.15 32.5 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.309 -0.948 . . . . 0.01 110.84 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -152.19 137.05 17.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.944 . . . . 0.02 108.984 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 7' ' ' ILE . 6.5 tt -130.22 140.91 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -121.03 129.21 53.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.774 . . . . 0.39000000000000001 109.833 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 17.1 m-85 -109.42 139.68 44.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.898 -0.778 . . . . 0.02 108.898 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 16.6 m-85 -123.05 138.33 54.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.265 -0.897 . . . . 0.02 109.915 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 34' ' ' SER . 16.6 mm-40 -67.1 -27.68 67.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.029999999999999999 111.258 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 10.2 t70 -114.18 169.78 8.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 110.136 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 16.1 mtp180 -75.61 162.3 28.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 110.276 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.7 m120 62.94 34.49 14.1 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.955 0.883 . . . . 0.73999999999999999 110.397 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.6 42.64 23.38 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.391 -0.822 . . . . 0.02 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.6 166.21 11.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.88 36.07 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 110.522 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -68.32 143.72 55.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -1.02 . . . . 2.7599999999999998 109.153 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -121.33 149.2 43.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.5 -0.75 . . . . 1.8899999999999999 110.179 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -133.36 128.56 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.644 -0.873 . . . . 0.02 108.644 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.72 136.46 50.93 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.457 -0.777 . . . . 1.1200000000000001 109.538 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.39 137.61 49.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.282 -0.636 . . . . 0.02 109.282 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -117.05 11.11 14.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.605 -0.684 . . . . 0.20000000000000001 109.741 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 48.5 t -158.36 174.45 15.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 35.0 t0 -60.58 143.21 54.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.692 -1.255 . . . . 0.02 109.893 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 9.7 t -130.46 116.63 18.49 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.449 -0.945 . . . . 0.02 108.449 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.06 -23.79 51.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.076 -1.015 . . . . 0.23999999999999999 110.678 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -156.0 100.91 2.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.896 -1.127 . . . . 1.1399999999999999 108.576 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -105.32 8.77 33.9 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.177 0.989 . . . . 6.3700000000000001 109.613 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.31 -24.39 63.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.602 -0.686 . . . . 3.1099999999999999 110.94 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.6 p -74.5 -16.62 60.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 109.876 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -105.04 -21.7 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.737 . . . . 0.02 109.259 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 1.7 tp -148.14 125.56 11.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 3.3199999999999998 109.247 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.519 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 4.6 m -85.87 -11.35 53.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.833 . . . . 0.02 111.313 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.51 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 7.2 mtm180 -171.56 161.7 6.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.364 -1.347 . . . . 0.02 107.364 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 39' ' ' ILE . 34.8 t -141.47 113.93 8.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.223 -0.923 . . . . 0.02 109.205 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.456 ' ND2' ' CG ' ' A' ' 77' ' ' ASP . 3.3 m120 -108.13 -0.17 21.23 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.01 -1.056 . . . . 0.029999999999999999 110.589 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.422 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 3.3 t -156.21 152.46 27.83 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.524 -1.288 . . . . 0.02 107.524 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.422 ' N ' ' HG ' ' A' ' 38' ' ' SER . 84.2 mt -144.79 147.44 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.35 1.072 . . . . 0.02 110.198 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 22.1 ttp180 -122.5 123.14 40.57 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.412 -1.329 . . . . 0.02 107.412 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.95 113.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 106.723 -1.584 . . . . 0.02 106.723 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 47.8 mm-40 -83.52 -34.09 25.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.968 -0.693 . . . . 3.8100000000000001 109.639 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 150.6 19.94 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 118.7 -1.714 . . . . 0.02 110.463 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.09 173.48 49.7 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.881 -1.152 . . . . 0.01 110.404 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.3 m -119.83 136.73 54.36 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.19 -1.041 . . . . 1.48 108.19 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -125.88 153.83 43.59 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.613 1.197 . . . . 0.02 112.158 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.27 133.8 51.99 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 104.942 -2.244 . . . . 0.23999999999999999 104.942 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.98 142.39 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.65000000000000002 109.329 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 40.8 m-85 -121.63 144.44 48.75 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.058 0.932 . . . . 0.02 109.754 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.33 -35.57 80.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.521 -0.763 . . . . 0.02 111.833 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.401 HH22 ' CZ ' ' A' ' 78' ' ' ARG . 3.6 mmp_? -124.05 153.89 67.96 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.147 -0.97 . . . . 0.02 109.554 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -50.61 166.39 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.306 1.338 . . . . 0.02 113.378 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.81 37.52 9.7 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.123 -0.944 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 44.1 51.82 7.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.779 0.8 . . . . 3.3900000000000001 110.663 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.52 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 42.7 t -124.97 163.17 22.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.572 -0.529 . . . . 2.3300000000000001 109.572 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.73 -161.34 32.07 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.647 -1.381 . . . . 0.02 109.647 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -67.57 139.35 56.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.983 -1.304 . . . . 0.02 110.413 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 22.3 ptm -118.73 137.41 53.37 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.637 -0.664 . . . . 5.0099999999999998 109.719 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 52.6 m-85 -132.92 138.42 46.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.472 -0.767 . . . . 0.02 109.65 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -95.29 132.17 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.737 -0.838 . . . . 1.72 108.737 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -119.85 109.67 37.5 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 121.416 -0.802 . . . . 0.02 110.451 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -76.48 168.67 23.34 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.136 1.084 . . . . 1.47 109.997 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -52.23 140.31 21.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.673 -1.267 . . . . 4.25 110.18 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.88 -177.52 32.11 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.476 -1.345 . . . . 0.02 110.742 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.05 130.94 54.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.43 -1.041 . . . . 0.95999999999999996 109.305 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 27.9 m-85 -121.97 90.6 48.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.43 -4.46 8.16 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 121.006 1.138 . . . . 0.02 113.389 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -154.45 150.62 28.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 2.02 107.527 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 19.6 p90 -60.29 -37.8 81.64 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.02 112.22 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -61.02 -23.51 65.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.02 111.216 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.493 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.7 OUTLIER -72.66 -16.53 61.7 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.116 -1.034 . . . . 3.4199999999999999 109.053 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.545 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.93 10.41 30.52 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.087 -1.449 . . . . 0.02 107.087 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm 61.84 21.75 12.49 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.357 0.599 . . . . 0.02 110.764 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.06 144.66 46.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.02 109.237 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 30.8 tp -79.5 -30.68 42.05 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.837 -1.172 . . . . 0.97999999999999998 107.837 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.67 -172.4 3.94 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.619 -1.622 . . . . 0.02 106.619 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 22.3 m-20 -97.89 27.2 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.687 -1.258 . . . . 0.02 110.382 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.49 122.82 39.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.142 -0.974 . . . . 3.2000000000000002 110.777 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.8 mt -143.63 121.67 12.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.865 -1.161 . . . . 2.6099999999999999 107.865 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.95 -17.75 9.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.345 -0.847 . . . . 0.02 112.54 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 36.5 m -155.28 155.38 33.66 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.757 1.778 . . . . 0.02 110.843 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 12.7 m -145.06 146.98 32.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.567 0.698 . . . . 0.02 110.414 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 71.5 mtm180 -135.64 141.4 45.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.741 -0.837 . . . . 0.01 108.741 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 130.95 37.27 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.136 -0.978 . . . . 0.42999999999999999 108.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -88.82 123.47 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -91.02 133.89 34.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 1.77 108.208 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 139.38 35.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.997 -0.742 . . . . 1.6299999999999999 108.997 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 p -112.02 125.71 54.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.671 -0.862 . . . . 1.0800000000000001 108.671 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -102.11 -155.97 0.54 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 106.0 -1.852 . . . . 1.26 106.0 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.4 -47.36 0.97 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 120.561 -1.337 . . . . 0.01 112.279 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.76 -98.61 0.12 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.479 -1.82 . . . . 0.01 112.348 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.53 121.41 36.47 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.218 -1.166 . . . . 4.4299999999999997 111.034 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 132.23 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.166 -0.679 . . . . 2.9900000000000002 109.166 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.424 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.5 ttpm? -132.11 139.46 48.47 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.022 -0.733 . . . . 6.3600000000000003 109.022 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.1 tt -127.48 143.92 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 121.975 0.893 . . . . 1.0900000000000001 109.591 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -124.81 133.54 53.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.743 -1.206 . . . . 2.0499999999999998 107.743 177.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -124.77 147.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.946 -1.096 . . . . 1.1000000000000001 109.546 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -117.57 140.72 49.25 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.987 0.899 . . . . 0.72999999999999998 110.948 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.96 -29.68 70.12 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.987 -0.551 . . . . 0.02 111.444 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 128' ' ' SER . 54.2 mttm -117.35 171.23 8.11 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.289 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.16 170.16 41.91 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.072 -0.811 . . . . 0.01 111.072 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.3 t0 52.51 39.56 28.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.564 0.697 . . . . 0.01 111.646 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 51.92 49.47 20.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.699 -0.626 . . . . 0.01 110.796 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.76 166.2 15.97 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.369 -0.974 . . . . 3.1499999999999999 108.369 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.78 -165.48 28.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.618 -1.393 . . . . 0.01 109.618 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.419 ' OE1' ' OH ' ' A' ' 108' ' ' TYR . 6.9 tt0 -75.62 144.7 41.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.009 -1.289 . . . . 0.01 108.594 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.6 tmm? -116.9 142.98 46.24 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.684 0.754 . . . . 0.01 110.171 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.423 ' N ' ' SD ' ' A' ' 107' ' ' MET . 42.7 m-85 -130.88 135.68 47.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.891 -1.152 . . . . 2.48 107.891 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.95 135.0 54.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.548 -0.72 . . . . 0.01 110.115 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -149.76 153.15 36.39 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.109 0.957 . . . . 1.6899999999999999 110.572 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.9 p -109.38 10.37 25.47 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.812 -0.631 . . . . 0.01 109.901 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.37 163.53 18.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.409 -0.807 . . . . 3.21 111.379 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.18 154.65 39.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.346 -0.983 . . . . 0.01 108.346 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.21 111.6 30.32 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.47 -0.769 . . . . 0.01 108.928 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -77.33 -33.63 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 119.885 0.994 . . . . 0.01 111.988 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.7 m -140.94 108.44 5.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.21 -0.931 . . . . 0.02 109.188 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 26.8 mt -63.43 -39.66 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.759 -0.588 . . . . 1.8300000000000001 110.791 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttp -66.4 -37.81 86.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.002 -1.079 . . . . 1.3400000000000001 110.033 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.34 -39.19 74.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.678 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.467 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 52.6 tt0 -81.19 -47.9 12.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 2.0800000000000001 112.506 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 63.6 m-85 -111.77 -2.53 15.25 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.427 -0.796 . . . . 0.02 112.76 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 61.99 34.02 16.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.719 -1.238 . . . . 0.02 109.323 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 mt -114.7 135.71 53.86 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.333 -0.854 . . . . 0.02 109.291 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -90.0 -20.91 22.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.026 -1.046 . . . . 5.3200000000000003 111.17 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -149.23 164.9 33.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.692 -1.255 . . . . 0.02 110.709 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 126' ' ' ILE . 27.8 mm -127.54 124.37 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.553 -1.277 . . . . 2.1699999999999999 107.553 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.1 m80 -110.75 -14.66 13.98 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.107 -0.996 . . . . 0.02 113.113 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.3 p -163.36 155.47 17.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.625 -1.297 . . . . 0.01 109.204 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.5 p -171.0 143.31 1.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.22 108.964 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 24.1 pttt -119.5 99.0 6.4 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.6 1.19 . . . . 1.4099999999999999 109.289 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.306 -0.998 . . . . 0.01 108.306 179.677 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 41.3 m95 . . . . . 0 N--CA 1.506 2.335 0 N-CA-C 107.629 -1.249 . . . . 0.01 107.629 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 43.7 mt -118.7 133.57 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.455 -1.403 . . . . 1.6899999999999999 109.574 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -111.59 141.96 44.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.149 -1.797 . . . . 2.4900000000000002 106.149 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 23.1 m-85 -123.83 144.38 49.76 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.92 -1.113 . . . . 0.02 109.793 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.04 -31.43 62.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.809 -0.557 . . . . 0.02 111.799 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.21 155.14 47.2 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.816 -1.178 . . . . 1.48 108.903 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -56.81 166.75 3.54 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.128 1.219 . . . . 0.02 112.799 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.01 31.1 20.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.206 -0.906 . . . . 0.75 111.375 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 58.26 52.03 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.727 . . . . 0.02 111.285 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -126.94 165.47 19.34 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.599 -0.688 . . . . 0.02 110.021 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.48 -165.53 33.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -69.45 142.56 53.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.578 -0.954 . . . . 0.02 108.843 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -112.89 147.22 37.48 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.294 0.569 . . . . 0.02 109.687 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.57 134.14 53.87 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.676 -0.861 . . . . 0.01 108.676 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.56 120.95 37.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.922 -1.111 . . . . 0.01 109.526 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.47 144.68 27.55 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.315 -0.995 . . . . 0.01 108.315 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 154' ' ' LYS . 6.2 m-20 -108.64 -175.28 2.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 2.27 109.859 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -73.01 32.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 152' ' ' ASP . 17.6 ttmt -110.4 173.57 6.27 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.694 -0.854 . . . . 2.2799999999999998 108.694 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -105.56 129.35 53.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.01 109.364 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -100.35 111.61 23.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.359 -0.838 . . . . 0.01 109.446 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.442 ' CD ' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -89.71 -26.84 20.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.01 110.816 -177.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -123.78 155.26 66.9 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.552 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.3 Cg_endo -63.07 -39.46 39.49 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 CA-C-N 119.349 0.803 . . . . 0.69999999999999996 111.057 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.89 -18.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.773 -1.204 . . . . 0.85999999999999999 109.945 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.48 -18.41 65.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.945 -1.097 . . . . 0.02 112.38 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.552 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.13 15.62 28.11 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 120.737 -1.227 . . . . 0.02 109.917 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.92 76.6 Favored Glycine 0 N--CA 1.5 2.926 0 O-C-N 121.172 -0.955 . . . . 0.02 112.847 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 140.74 34.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.726 -1.455 . . . . 0.02 110.278 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -7.11 59.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 109.739 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.0 m -141.96 149.7 53.62 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.186 -0.947 . . . . 0.87 109.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.76 16.89 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.736 0.957 . . . . 0.38 112.06 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.64 120.71 25.42 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.362 1.077 . . . . 0.17999999999999999 110.786 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mp -150.66 124.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 106.194 -1.78 . . . . 3.9900000000000002 106.194 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.33 -12.29 14.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.83 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.9 p -156.97 160.13 38.75 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.231 -2.168 . . . . 0.02 109.925 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.99 153.4 33.98 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.312 -0.867 . . . . 2.02 110.047 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.68 149.26 36.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.01 110.24 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -86.25 142.26 28.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.183 -1.043 . . . . 0.01 108.183 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.35 128.63 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.451 -0.9 . . . . 3.04 109.327 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.73 148.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 1.8899999999999999 109.918 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.712 . . . . 4.8899999999999997 109.562 179.339 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 106.987 -2.445 . . . . 0.81000000000000005 106.987 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.29 148.72 33.04 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.607 -0.997 . . . . 0.01 110.607 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -150.77 136.26 17.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -1.005 . . . . 0.02 108.862 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.37 140.52 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.909 -0.774 . . . . 0.02 108.909 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.697 ' HG ' ' HE ' ' A' ' 19' ' ' ARG . 11.0 t -122.25 129.98 52.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.769 . . . . 0.39000000000000001 109.76 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 26.3 m-85 -108.39 138.55 44.49 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.87 -0.789 . . . . 0.02 108.87 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HH ' ' CZ ' ' A' ' 19' ' ' ARG . 26.9 m-85 -122.65 138.72 54.51 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.194 -0.941 . . . . 0.02 109.788 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.496 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 91.8 mt-10 -69.55 -27.49 65.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.675 . . . . 0.029999999999999999 112.041 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.33 170.75 8.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.569 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.669 ' NH1' HD21 ' A' ' 37' ' ' ASN . 10.9 mpt_? -73.72 157.15 37.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.757 0.789 . . . . 0.029999999999999999 109.897 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.27 35.41 5.94 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.875 0.845 . . . . 0.73999999999999999 111.117 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 7.6 p90 49.6 45.19 24.44 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.699 0.761 . . . . 0.02 111.01 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -112.0 166.29 11.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.01 -1.108 . . . . 0.02 108.01 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -167.16 35.42 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.029999999999999999 110.71 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -68.97 143.03 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.414 -1.05 . . . . 2.7599999999999998 109.204 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.697 ' HE ' ' HG ' ' A' ' 8' ' ' SER . 56.8 ttt180 -119.04 147.8 43.72 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.544 0.688 . . . . 1.8899999999999999 109.587 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -132.45 126.48 33.15 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.728 -1.212 . . . . 0.02 107.728 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -111.92 136.29 51.43 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.708 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.48 137.56 49.83 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.482 0.658 . . . . 0.02 109.48 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -116.52 10.89 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.703 -0.623 . . . . 0.20000000000000001 109.514 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 49.0 t -157.94 174.35 15.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.151 -1.055 . . . . 1.23 108.151 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 p30 -62.15 144.87 54.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.69 -1.256 . . . . 0.02 110.152 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -132.37 116.56 16.99 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.422 -0.955 . . . . 0.02 108.422 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.13 53.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.877 . . . . 0.23999999999999999 110.732 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.23 100.98 2.35 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -105.2 10.1 33.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.005 0.907 . . . . 6.3700000000000001 110.063 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.664 HH22 ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.49 -22.27 61.34 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.672 -0.642 . . . . 3.1099999999999999 110.701 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -75.54 -16.97 60.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.702 -1.249 . . . . 0.88 110.29 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -102.97 -22.03 13.87 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 0.02 109.221 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 tp -150.67 129.49 12.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.822 0.82 . . . . 3.3199999999999998 108.825 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -85.63 -10.12 56.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.656 -0.652 . . . . 0.02 111.142 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -171.65 163.91 6.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 m -141.26 113.69 8.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.823 -1.173 . . . . 0.02 109.133 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.669 HD21 ' NH1' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -107.22 -3.7 19.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.029999999999999999 110.285 -179.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.36 152.39 31.03 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.002 -1.11 . . . . 0.02 108.002 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.4 147.76 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.02 109.973 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -125.08 126.11 44.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.876 -1.157 . . . . 0.02 107.876 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.45 114.76 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.883 -1.525 . . . . 0.02 106.883 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.15 -34.07 24.11 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.783 -0.767 . . . . 3.8100000000000001 109.865 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.3 150.11 18.99 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.572 -1.775 . . . . 0.02 110.507 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.638 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 84.11 173.39 49.75 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.623 -1.275 . . . . 0.01 110.062 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.1 m -118.61 136.06 54.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.76 -1.2 . . . . 1.48 107.76 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -126.0 153.52 44.23 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.821 -1.174 . . . . 0.02 112.159 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.11 133.08 52.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.108 -2.182 . . . . 0.23999999999999999 105.108 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.94 142.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.092 -0.707 . . . . 0.65000000000000002 109.092 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -121.17 145.78 47.47 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.22 1.01 . . . . 0.02 109.77 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 10.4 tt0 -66.68 -34.09 77.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.752 -0.658 . . . . 0.02 111.663 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' NH1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 mpt_? -122.87 159.04 55.39 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 121.002 -1.061 . . . . 0.02 109.287 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.39 166.2 1.89 Allowed 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.528 1.485 . . . . 0.02 112.31 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.4 36.33 11.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.643 0.735 . . . . 0.02 111.167 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 45.52 52.42 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.462 0.648 . . . . 3.3900000000000001 111.08 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.656 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 6.7 t -125.92 163.47 22.88 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.162 0.506 . . . . 2.3300000000000001 109.752 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.656 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.91 -161.2 31.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.592 -1.403 . . . . 0.02 109.592 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.628 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 2.1 m80 -65.72 137.86 57.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.98 -1.306 . . . . 0.02 109.883 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.478 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.7 ptm -119.69 137.04 54.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.604 -0.685 . . . . 5.0099999999999998 109.392 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 49.8 m-85 -134.08 141.01 47.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.499 -0.751 . . . . 0.02 109.714 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -95.17 132.1 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.555 -0.906 . . . . 1.72 108.555 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -119.96 109.75 37.23 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.476 -0.765 . . . . 0.02 110.323 -178.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -76.49 168.68 23.32 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.007 1.038 . . . . 1.47 110.327 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 73.9 mt-30 -53.41 140.68 26.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.869 -1.144 . . . . 4.25 110.504 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -176.97 32.36 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.627 -1.273 . . . . 0.02 110.452 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.16 130.16 55.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.489 -1.006 . . . . 0.95999999999999996 109.216 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.49 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 30.5 m-85 -121.48 95.24 48.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.22 -3.71 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.767 0.978 . . . . 0.02 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -157.36 154.89 29.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.352 -1.467 . . . . 2.02 108.311 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -60.85 -39.05 87.63 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.677 . . . . 0.02 111.651 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -60.16 -23.62 64.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.02 110.34 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -18.56 62.95 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.063 0.935 . . . . 3.4199999999999999 108.578 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -107.4 10.49 29.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.337 -1.357 . . . . 0.02 107.337 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 27.6 mtm 61.55 21.98 12.53 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.473 0.654 . . . . 0.02 110.738 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.58 144.36 45.97 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.328 -1.509 . . . . 0.02 109.328 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 tp -78.72 -30.83 46.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.493 -1.299 . . . . 0.97999999999999998 107.493 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -156.37 -171.53 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.255 -1.757 . . . . 0.02 106.255 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -97.73 27.7 4.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.646 -1.284 . . . . 0.02 110.194 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.664 ' NH2' HH22 ' A' ' 30' ' ' ARG . 19.7 mmm180 -96.08 122.06 38.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.893 -1.129 . . . . 3.2000000000000002 110.631 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.1 mt -144.98 119.95 10.01 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.511 -1.292 . . . . 2.6099999999999999 107.511 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.32 -16.07 11.66 Favored Glycine 0 N--CA 1.505 3.267 0 O-C-N 121.264 -0.898 . . . . 0.02 112.879 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.8 p -155.52 155.88 34.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.204 -1.763 . . . . 0.02 110.343 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.2 t -144.94 148.21 33.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.334 0.588 . . . . 0.02 109.71 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -135.55 140.24 44.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.332 -0.855 . . . . 0.01 108.89 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 130.12 36.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.205 -0.935 . . . . 0.42999999999999999 108.72 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.55 122.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 1.25 107.993 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.0 133.94 35.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.94 -1.1 . . . . 1.77 108.576 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -98.18 137.96 36.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.242 -1.022 . . . . 1.6299999999999999 108.242 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -110.3 126.9 54.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 1.0800000000000001 108.743 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 p -104.29 -154.86 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.28 -1.748 . . . . 1.26 106.28 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.11 -47.5 0.97 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.509 -1.369 . . . . 0.01 112.237 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.53 -100.18 0.14 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.676 -1.726 . . . . 0.01 111.779 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.31 118.74 31.2 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.293 -1.122 . . . . 4.4299999999999997 110.221 -179.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.55 130.38 37.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.102 -0.703 . . . . 2.9900000000000002 109.102 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -131.28 139.19 49.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.464 -0.773 . . . . 6.3600000000000003 109.323 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 tt -129.19 144.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.462 -0.774 . . . . 1.0900000000000001 109.742 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.33 134.01 54.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.424 -1.324 . . . . 2.0499999999999998 107.424 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.44 147.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.902 -1.124 . . . . 1.1000000000000001 109.232 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 95.2 m-85 -118.77 141.34 48.71 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.097 0.951 . . . . 0.72999999999999998 111.088 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.78 -30.01 70.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.791 -0.64 . . . . 0.02 111.57 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -117.03 168.77 9.96 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.947 -1.096 . . . . 3.1800000000000002 110.553 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.07 43.31 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.013 -0.835 . . . . 0.01 111.013 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.2 m-20 56.48 39.09 30.1 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.664 0.745 . . . . 0.01 110.86 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 6.7 m-85 52.29 55.58 8.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.69 -0.631 . . . . 0.01 110.952 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -128.85 166.1 19.73 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.496 -0.927 . . . . 3.1499999999999999 108.496 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 -165.38 27.85 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.523 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.3 tt0 -74.52 145.31 43.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.093 -1.239 . . . . 0.01 108.237 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.3 ttp -117.54 142.75 46.81 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.753 0.787 . . . . 0.01 110.179 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 60.7 m-85 -130.94 135.29 47.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.963 -1.125 . . . . 2.48 107.963 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -119.79 135.56 54.81 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.608 -0.683 . . . . 0.01 109.957 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.524 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.1 t -150.09 152.13 34.29 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.33 1.062 . . . . 1.6899999999999999 111.074 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.7 p -110.28 9.55 23.68 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.622 -0.717 . . . . 0.01 109.808 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -121.08 163.32 18.56 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.311 -0.868 . . . . 3.21 111.398 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -66.51 155.28 38.07 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 27.5 t -124.53 111.6 27.86 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.737 -0.838 . . . . 0.01 108.737 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.86 -32.5 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.128 1.081 . . . . 0.01 111.732 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 m -140.82 107.61 5.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.02 108.855 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.7 mt -63.3 -39.04 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.779 -0.576 . . . . 1.8300000000000001 110.375 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 5.9 tpt -66.1 -37.89 86.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.868 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -70.73 -39.3 73.45 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.374 -1.454 . . . . 2.1099999999999999 109.532 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 42.1 tt0 -80.53 -48.01 13.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 2.0800000000000001 112.458 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 66.0 m-85 -111.23 -1.78 15.98 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.02 112.623 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 61.12 34.33 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.745 -1.222 . . . . 0.02 109.603 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' C ' ' SD ' ' A' ' 118' ' ' MET . 52.5 mt -114.33 136.21 53.23 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.517 -0.74 . . . . 0.02 109.432 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -90.25 -21.96 21.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.323 -0.861 . . . . 5.3200000000000003 110.737 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -148.91 164.3 34.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.966 -1.084 . . . . 0.02 109.939 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 126' ' ' ILE . 34.6 mm -129.49 126.7 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.453 -1.314 . . . . 2.1699999999999999 107.453 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -110.07 -12.93 14.47 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.267 -0.896 . . . . 0.02 112.658 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.5 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.8 t -160.42 153.13 21.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.691 -1.256 . . . . 0.01 109.002 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -167.08 146.32 5.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 1.22 109.349 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -125.22 106.4 9.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.45 1.119 . . . . 1.4099999999999999 109.381 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 107.328 -1.36 . . . . 0.01 107.328 179.231 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.5 m95 . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 106.789 -1.56 . . . . 0.01 106.789 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.08 134.3 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.446 -1.409 . . . . 1.6899999999999999 109.266 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.51 141.69 44.76 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.344 -1.724 . . . . 2.4900000000000002 106.344 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.643 ' HH ' ' HE ' ' A' ' 173' ' ' ARG . 11.3 m-85 -123.19 143.46 50.0 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.22 -0.925 . . . . 0.02 109.64 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.98 -30.69 62.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.739 -0.601 . . . . 0.02 111.668 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.79 154.31 49.42 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.48 108.874 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.82 169.68 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.156 1.238 . . . . 0.02 113.174 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.51 32.29 21.59 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.99 -1.004 . . . . 0.75 111.462 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 55.57 48.34 18.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.534 -0.729 . . . . 0.02 110.382 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.427 ' CA ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -122.08 163.9 18.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.659 -0.651 . . . . 0.02 109.613 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.13 -165.51 32.95 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.16 -1.176 . . . . 0.02 110.16 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.71 143.18 53.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.499 -1.001 . . . . 0.02 109.15 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.478 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.4 mt-30 -112.95 148.24 35.43 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.281 0.562 . . . . 0.02 109.763 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -123.31 133.28 54.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.435 -0.95 . . . . 0.01 108.435 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.23 120.72 37.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.794 -1.191 . . . . 0.01 109.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.66 139.71 33.15 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.174 -1.047 . . . . 0.01 108.174 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 154' ' ' LYS . 0.7 OUTLIER -107.39 -171.82 1.95 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.345 -0.847 . . . . 2.27 109.905 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.01 40.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 1.8400000000000001 109.568 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 152' ' ' ASP . 75.3 tttt -113.57 168.49 9.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.619 -0.675 . . . . 2.2799999999999998 109.28 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -103.48 127.54 50.85 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.18 -1.044 . . . . 0.01 108.18 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.477 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 92.8 m-85 -100.85 110.62 22.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.019 -1.051 . . . . 0.01 110.598 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -93.8 -26.66 16.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.314 -0.867 . . . . 0.01 110.736 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -123.24 154.09 65.23 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 107.897 -1.149 . . . . 2.54 107.897 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -62.14 -42.37 29.82 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.237 0.763 . . . . 0.69999999999999996 111.097 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 -18.68 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 120.68 -1.262 . . . . 0.85999999999999999 109.428 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 60.2 t0 -65.53 -18.18 65.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.841 -1.162 . . . . 0.02 111.964 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.77 15.84 27.7 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 120.737 -1.227 . . . . 0.02 110.037 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.89 74.35 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 121.053 -1.029 . . . . 0.02 112.869 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.415 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.56 140.59 34.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.717 -1.46 . . . . 0.02 110.13 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.83 -6.92 59.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.687 -0.633 . . . . 0.58999999999999997 109.553 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 m -140.84 150.06 58.44 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.223 -0.923 . . . . 0.87 109.088 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.47 16.15 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.672 0.915 . . . . 0.38 111.902 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.48 120.5 25.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.039 . . . . 0.17999999999999999 110.727 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.471 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -150.2 124.92 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.554 -2.017 . . . . 3.9900000000000002 105.554 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -112.41 -13.4 13.4 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.354 0.872 . . . . 5.1699999999999999 113.354 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.5 p -156.73 159.51 38.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.205 -2.184 . . . . 0.02 109.919 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -152.27 154.18 35.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.197 -0.939 . . . . 2.02 110.512 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.643 ' HE ' ' HH ' ' A' ' 139' ' ' TYR . 63.8 mtm180 -142.95 148.99 37.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.307 -0.871 . . . . 0.01 110.142 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -86.43 141.7 28.95 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.103 -1.073 . . . . 0.01 108.103 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.1 mt -94.98 128.95 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.084 -1.01 . . . . 3.04 109.766 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.2 m -137.39 149.31 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.485 -0.759 . . . . 1.8899999999999999 109.69 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 2.7 mp0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 4.8899999999999997 109.638 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 N-CA-C 106.677 -2.569 . . . . 0.81000000000000005 106.677 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.09 147.53 31.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.632 -0.987 . . . . 0.01 110.632 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -154.14 138.61 16.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.587 -0.949 . . . . 0.02 108.757 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 141.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.266 -0.642 . . . . 0.02 109.266 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.484 ' HG ' HH21 ' A' ' 19' ' ' ARG . 1.4 m -121.79 130.1 53.15 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.507 -0.746 . . . . 0.39000000000000001 109.661 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 16.8 m-85 -110.05 139.19 45.44 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.855 -0.794 . . . . 0.02 108.855 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-85 -123.04 139.39 54.13 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.156 -0.965 . . . . 0.02 110.218 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.62 -28.44 65.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.981 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.87 170.72 8.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 0.029999999999999999 110.54 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -73.39 156.3 38.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.763 0.792 . . . . 0.029999999999999999 110.371 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.98 34.71 8.72 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.811 0.815 . . . . 0.73999999999999999 111.533 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.58 42.37 29.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.02 111.333 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -112.7 165.38 12.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.202 -1.036 . . . . 0.02 108.202 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.74 -166.76 36.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.752 -1.213 . . . . 0.029999999999999999 110.496 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -69.25 142.38 54.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -1.056 . . . . 2.7599999999999998 109.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.484 HH21 ' HG ' ' A' ' 8' ' ' SER . 58.5 ttt180 -119.18 148.22 43.34 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 1.8899999999999999 109.745 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.99 126.68 32.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.209 -1.034 . . . . 0.02 108.209 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.96 136.44 51.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.429 -0.795 . . . . 1.1200000000000001 109.651 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.0 t -130.59 137.8 49.83 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.465 0.65 . . . . 0.02 109.645 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 13.7 t70 -116.98 11.32 14.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.665 -0.647 . . . . 0.20000000000000001 109.713 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.7 m -158.11 173.97 15.92 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.85 144.77 54.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.661 -1.274 . . . . 0.02 110.214 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.3 p -132.02 116.71 17.44 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.82 -25.68 53.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.23999999999999999 110.657 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.72 100.77 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 108.444 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -104.82 9.36 34.88 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.207 1.004 . . . . 6.3700000000000001 109.755 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.572 ' CZ ' ' NH2' ' A' ' 78' ' ' ARG . 57.8 mtp180 -58.93 -23.28 61.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.678 -0.639 . . . . 3.1099999999999999 110.705 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 69.2 p -75.34 -16.69 60.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.691 -1.256 . . . . 0.88 110.162 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.4 m-85 -103.21 -21.65 13.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.02 109.178 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.62 129.2 12.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 3.3199999999999998 108.816 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -86.1 -10.0 55.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.808 -0.558 . . . . 0.02 110.984 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 25.3 ttt180 -171.1 162.04 6.95 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.4 -1.333 . . . . 0.02 107.4 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 35' ' ' ARG . 3.5 m -141.36 114.33 8.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.111 . . . . 0.02 108.842 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -107.54 -0.15 22.29 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.711 -1.243 . . . . 0.029999999999999999 110.583 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 t -156.72 154.08 29.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.545 -1.28 . . . . 0.02 107.545 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.35 148.39 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.117 -0.989 . . . . 0.02 110.218 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -124.68 125.1 43.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.67 113.61 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.756 -1.572 . . . . 0.02 106.756 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -83.69 -34.14 25.03 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.127 -0.629 . . . . 3.8100000000000001 109.531 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.48 150.23 19.13 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.713 -1.708 . . . . 0.02 110.605 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.07 173.44 49.66 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.472 -1.347 . . . . 0.01 109.782 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 m -119.99 137.38 54.11 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 44.6 m95 -126.6 152.98 45.91 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.524 1.154 . . . . 0.02 111.922 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.42 133.79 51.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 104.841 -2.281 . . . . 0.23999999999999999 104.841 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.73 142.94 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.65000000000000002 109.228 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.6 m-85 -119.81 143.68 47.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.34 1.067 . . . . 0.02 109.703 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.08 -34.31 77.77 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.759 -0.655 . . . . 0.02 110.764 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -125.36 157.43 67.78 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.144 -0.972 . . . . 0.02 109.897 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.01 166.82 1.36 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.706 1.604 . . . . 0.02 113.16 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 64.43 36.37 8.93 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.054 -0.976 . . . . 0.02 111.195 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.77 51.79 10.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.534 0.683 . . . . 3.3900000000000001 110.782 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 p -127.25 164.22 22.19 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.286 0.565 . . . . 2.3300000000000001 109.824 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.47 -162.26 31.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.664 ' HD1' ' N ' ' A' ' 58' ' ' MET . 9.3 t-80 -63.05 142.78 58.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -1.204 . . . . 0.02 110.457 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.664 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 29.6 mtp -117.9 134.69 54.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.346 -0.613 . . . . 5.0099999999999998 109.346 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 31.5 m-85 -135.27 135.22 40.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.34 -0.85 . . . . 0.02 109.2 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -96.52 132.31 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.941 -0.763 . . . . 1.72 108.941 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.2 110.22 31.01 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.376 -0.828 . . . . 0.02 110.657 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -75.83 171.45 18.16 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.83 0.975 . . . . 1.47 109.91 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 1.9 pm0 -52.36 139.71 23.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.118 . . . . 4.25 110.237 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -178.02 33.04 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.435 -1.364 . . . . 0.02 110.446 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -119.11 130.06 55.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -1.084 . . . . 0.95999999999999996 109.423 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -120.87 96.54 48.65 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.75 -5.14 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.603 0.868 . . . . 0.02 114.055 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 67' ' ' PRO . 49.3 mm-40 -151.8 152.53 32.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.628 -1.249 . . . . 2.02 107.628 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -60.77 -37.89 83.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.406 -0.809 . . . . 0.02 111.075 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -59.93 -23.65 63.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.051 -1.031 . . . . 0.02 110.28 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.56 -18.75 62.23 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.283 1.039 . . . . 3.4199999999999999 108.243 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.596 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -105.66 8.42 33.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.212 -1.403 . . . . 0.02 107.212 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.3 mpt? 59.95 21.75 10.79 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.477 0.656 . . . . 0.02 110.35 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.31 143.98 45.74 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.26 -1.536 . . . . 0.02 109.26 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.4 tp -78.42 -30.78 47.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -156.22 -172.19 4.0 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.245 -1.761 . . . . 0.02 106.245 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 38.6 m-20 -97.57 27.46 4.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.781 -1.199 . . . . 0.02 110.346 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -96.1 122.09 38.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.071 -1.018 . . . . 3.2000000000000002 110.704 -179.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 mt -144.71 120.39 10.48 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.91 -16.05 12.1 Favored Glycine 0 N--CA 1.506 3.312 0 C-N-CA 120.491 -0.862 . . . . 0.02 112.64 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.3 p -156.3 156.89 34.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.393 -1.651 . . . . 0.02 110.238 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.2 m -144.84 148.66 34.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.698 -0.626 . . . . 0.02 109.415 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -136.38 140.83 43.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.332 -0.855 . . . . 0.01 109.136 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.93 36.47 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.305 -0.872 . . . . 0.42999999999999999 109.001 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.71 124.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.247 -1.02 . . . . 1.25 108.247 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -89.47 134.04 34.28 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.925 -1.139 . . . . 1.77 107.925 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.63 139.31 36.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 1.6299999999999999 109.15 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 p -111.22 122.68 48.49 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.669 -1.234 . . . . 1.0800000000000001 107.669 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 m -114.01 133.19 55.66 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.699 -1.223 . . . . 1.26 107.699 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.4 -46.31 0.02 OUTLIER Glycine 0 N--CA 1.501 3.0 0 C-N-CA 117.59 -2.243 . . . . 0.01 113.573 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.83 -103.13 0.17 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 120.17 1.985 . . . . 0.01 111.006 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -120.4 118.66 30.91 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.249 -1.148 . . . . 4.4299999999999997 110.204 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 131.21 41.34 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.141 -0.624 . . . . 2.9900000000000002 109.369 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.28 136.36 46.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.598 -0.689 . . . . 6.3600000000000003 109.67 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.93 145.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.472 -0.767 . . . . 1.0900000000000001 109.262 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -121.65 133.12 54.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 m -124.32 147.24 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 120.887 -1.133 . . . . 1.1000000000000001 109.09 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -119.26 141.11 49.24 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.081 0.943 . . . . 0.72999999999999998 111.086 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -66.66 -29.56 69.61 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.758 -0.655 . . . . 0.02 111.465 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.439 ' O ' ' OG ' ' A' ' 128' ' ' SER . 27.3 mmtp -115.6 169.02 9.5 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.148 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.83 164.82 51.2 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.056 -0.818 . . . . 0.01 111.056 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 57.14 39.46 28.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.854 -0.792 . . . . 0.01 111.411 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.582 ' H ' ' HG ' ' A' ' 128' ' ' SER . 3.6 m-85 52.04 54.13 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.618 -0.677 . . . . 0.01 111.142 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -129.65 165.49 21.68 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.052 -1.092 . . . . 3.1499999999999999 108.052 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.76 -164.63 27.84 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.171 -1.571 . . . . 0.01 109.171 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.07 144.18 43.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.829 -1.394 . . . . 0.01 108.661 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 13.0 tmm? -116.62 142.56 46.73 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.555 0.693 . . . . 0.01 109.885 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -131.42 136.31 47.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.537 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.7 tm-20 -120.41 135.72 54.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.642 -0.661 . . . . 0.01 109.806 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.537 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 5.0 t -149.37 152.48 35.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.253 1.025 . . . . 1.6899999999999999 110.881 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 p -112.01 8.76 20.3 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.729 -0.669 . . . . 0.01 109.941 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -121.48 163.46 18.76 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.331 -0.856 . . . . 3.21 111.353 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -67.94 156.74 36.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.327 -0.99 . . . . 0.01 108.327 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.08 113.08 26.51 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.511 -0.743 . . . . 0.01 109.016 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.9 -28.06 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 120.234 1.119 . . . . 0.01 111.055 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . 2.6 p -144.82 108.57 4.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 0.02 109.004 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.68 -39.52 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.873 -0.517 . . . . 1.8300000000000001 110.444 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.9 ttt -68.0 -37.25 81.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.114 -1.034 . . . . 1.3400000000000001 110.225 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 116' ' ' SER . 39.6 mt-10 -70.43 -38.78 74.63 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.636 -1.29 . . . . 2.1099999999999999 109.958 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -80.25 -47.9 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.932 . . . . 2.0800000000000001 112.417 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -110.7 -0.72 17.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.389 -0.819 . . . . 0.02 112.677 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 m170 60.39 33.52 20.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.696 -1.252 . . . . 0.02 109.434 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.83 134.52 54.31 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.733 -0.84 . . . . 0.02 108.733 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -22.3 20.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 5.3200000000000003 110.163 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -149.29 163.81 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.238 -0.914 . . . . 0.02 109.843 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mt -133.18 129.37 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.272 -1.381 . . . . 2.1699999999999999 107.272 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -108.68 -12.12 14.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.455 -0.778 . . . . 0.02 112.461 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.582 ' HG ' ' H ' ' A' ' 103' ' ' PHE . 17.8 p -160.15 154.45 23.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.01 108.749 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.8 t -166.0 143.13 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 1.22 108.897 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -120.34 103.93 9.61 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.681 1.229 . . . . 1.4099999999999999 109.153 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 p . . . . . 0 C--N 1.302 -1.482 0 N-CA-C 107.706 -1.22 . . . . 0.01 107.706 179.34 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.8 m95 . . . . . 0 N--CA 1.51 2.55 0 CA-C-O 121.625 0.726 . . . . 0.01 110.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.72 139.71 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.022 -0.733 . . . . 1.6899999999999999 109.022 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.07 141.77 45.33 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 106.799 -1.556 . . . . 2.4900000000000002 106.799 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 23.7 m-85 -122.6 143.15 49.94 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.091 -1.006 . . . . 0.02 109.228 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -74.57 -31.17 61.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.606 -0.684 . . . . 0.02 111.613 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -115.06 155.86 46.06 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.68 -1.262 . . . . 1.48 108.752 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -57.88 166.71 4.99 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.095 1.197 . . . . 0.02 112.735 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 15.8 t30 60.09 31.29 20.52 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.142 -0.935 . . . . 0.75 111.456 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 58.72 51.17 7.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.717 . . . . 0.02 110.863 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -126.09 165.61 18.53 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.611 -0.681 . . . . 0.02 110.02 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.75 -165.35 34.94 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.279 -1.128 . . . . 0.02 110.279 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.18 141.78 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.947 . . . . 0.02 108.848 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 15.2 mt-30 -112.63 147.75 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.517 -0.549 . . . . 0.02 109.517 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.18 133.23 53.61 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.764 -0.828 . . . . 0.01 108.764 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.74 121.83 39.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.941 -1.099 . . . . 0.01 109.341 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.0 mt -92.78 146.83 23.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.01 109.123 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 154' ' ' LYS . 24.2 m-20 -108.55 -171.43 1.85 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.576 -0.702 . . . . 2.27 109.442 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -75.46 29.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 1.8400000000000001 109.622 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 152' ' ' ASP . 54.8 mttp -113.21 170.94 7.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.5 -0.75 . . . . 2.2799999999999998 109.549 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.91 135.36 47.5 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -100.28 114.01 27.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.37 -0.831 . . . . 0.01 109.96 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -88.59 -28.18 20.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.01 110.988 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -124.63 155.21 69.81 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 107.4 -1.333 . . . . 2.54 107.4 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.1 Cg_endo -61.99 -39.39 50.82 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.395 0.73 . . . . 0.69999999999999996 111.457 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.79 -18.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.817 -1.177 . . . . 0.85999999999999999 109.829 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.15 -19.24 65.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.891 -1.131 . . . . 0.02 112.569 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -101.79 16.23 26.5 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 120.696 -1.252 . . . . 0.02 109.881 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.66 10.52 79.19 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.369 -0.919 . . . . 0.02 112.771 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.91 141.03 34.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.898 -1.354 . . . . 0.02 110.069 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.7 59.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.658 -0.651 . . . . 0.58999999999999997 109.848 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -142.17 150.0 53.97 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.033 -1.042 . . . . 0.87 109.119 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -75.33 18.15 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.654 0.902 . . . . 0.38 112.144 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.98 122.76 28.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.545 1.164 . . . . 0.17999999999999999 110.922 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.9 mt -148.02 125.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.433 -1.692 . . . . 3.9900000000000002 106.433 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -113.67 -16.12 12.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 5.1699999999999999 112.65 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.8 p -157.06 158.98 37.47 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 119.247 -2.158 . . . . 0.02 110.196 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.77 154.57 35.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.053 -1.029 . . . . 2.02 110.114 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.442 HH11 ' HG3' ' A' ' 173' ' ' ARG . 5.4 mtm-85 -144.12 150.54 38.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.153 -0.967 . . . . 0.01 110.612 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -86.93 143.39 27.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.69 127.96 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.171 -0.956 . . . . 3.04 109.418 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.06 147.19 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.243 -0.911 . . . . 1.8899999999999999 109.54 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.401 ' OE1' ' OE1' ' A' ' 63' ' ' GLN . 24.5 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.415 -0.803 . . . . 4.8899999999999997 109.412 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.664 0 N-CA-C 106.957 -2.457 . . . . 0.81000000000000005 106.957 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.95 149.59 33.04 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.117 -1.04 . . . . 0.01 110.725 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -151.49 136.97 17.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.493 -1.004 . . . . 0.02 109.367 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -129.46 140.06 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.881 -0.785 . . . . 0.02 108.881 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -121.39 129.84 53.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.562 -0.711 . . . . 0.39000000000000001 109.242 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -108.94 138.95 44.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.542 -0.91 . . . . 0.02 108.542 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.55 138.82 54.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.265 -0.897 . . . . 0.02 109.416 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.87 -27.75 65.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.767 . . . . 0.029999999999999999 111.705 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.71 169.85 8.76 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.893 -1.129 . . . . 0.029999999999999999 110.656 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 94.2 mtt180 -73.48 157.32 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.702 0.763 . . . . 0.029999999999999999 110.216 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 t-20 65.16 35.7 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.756 0.788 . . . . 0.73999999999999999 111.086 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.1 p90 49.97 45.05 25.52 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.685 0.755 . . . . 0.02 111.122 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -112.63 165.94 11.8 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.41 -167.13 35.28 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 120.761 -1.212 . . . . 0.029999999999999999 110.725 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -69.3 142.48 54.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 2.7599999999999998 109.125 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -121.1 149.51 42.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 1.8899999999999999 110.034 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -132.93 127.42 34.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.1 135.69 50.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 1.1200000000000001 109.22 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -130.13 136.92 49.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 -178.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.84 9.09 11.9 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.534 -0.729 . . . . 0.20000000000000001 110.343 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 44.9 t -157.69 173.69 16.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.018 -1.051 . . . . 1.23 108.469 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 64.4 t0 -60.45 142.23 55.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.074 -1.641 . . . . 0.02 110.834 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.2 m -132.36 116.47 16.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.408 -0.96 . . . . 0.02 108.408 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.1 54.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.795 . . . . 0.23999999999999999 110.873 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -155.67 101.76 2.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 108.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.1 p90 -105.85 9.6 32.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.418 1.104 . . . . 6.3700000000000001 109.908 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -60.21 -22.17 62.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.292 -0.88 . . . . 3.1099999999999999 110.801 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 18.0 p -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.785 -1.197 . . . . 0.88 109.945 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.5 m-85 -102.67 -21.3 14.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.453 -0.779 . . . . 0.02 109.083 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -149.81 128.85 12.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.846 -0.798 . . . . 3.3199999999999998 108.846 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t -84.25 -9.67 58.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.02 110.567 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -171.4 163.79 6.94 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.474 -1.306 . . . . 0.02 107.474 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -141.83 113.75 7.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.697 -1.252 . . . . 0.02 108.538 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 1.3 t30 -108.96 -1.58 18.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 111.42 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -153.86 153.53 32.27 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.179 -1.045 . . . . 0.02 108.179 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.77 146.88 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.061 -1.024 . . . . 0.02 110.672 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' NE ' ' HH ' ' A' ' 10' ' ' TYR . 19.8 ttp180 -125.5 125.68 43.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.397 -1.335 . . . . 0.02 107.397 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.56 114.32 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.949 -1.5 . . . . 0.02 106.949 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.8 -34.3 27.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.586 -0.696 . . . . 3.8100000000000001 110.485 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 152.01 21.74 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 118.974 -1.584 . . . . 0.02 110.138 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.83 174.43 49.46 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.255 -1.45 . . . . 0.01 110.026 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.441 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 31.6 m -110.77 161.24 15.98 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' C ' ' A' ' 45' ' ' THR . 70.0 m95 -148.26 148.63 30.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.618 -1.301 . . . . 0.02 111.609 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.81 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 105.452 -2.055 . . . . 0.23999999999999999 105.452 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.11 141.98 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.551 -0.718 . . . . 0.65000000000000002 109.628 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.519 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 -120.34 143.15 48.54 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.062 0.934 . . . . 0.02 109.434 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -64.69 -33.96 77.17 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.589 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -124.59 157.84 64.09 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.131 -0.981 . . . . 0.02 109.575 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.37 166.56 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.663 1.576 . . . . 0.02 112.944 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.4 t30 63.68 37.17 10.27 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.275 -0.875 . . . . 0.02 111.279 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.28 50.92 9.63 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.568 0.699 . . . . 3.3900000000000001 110.56 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.8 m -125.72 163.8 22.03 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.268 0.556 . . . . 2.3300000000000001 109.876 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.59 -162.07 31.47 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.553 -1.419 . . . . 0.02 109.553 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -67.03 138.23 57.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.98 -1.306 . . . . 0.02 110.137 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 17.7 ptm -119.21 137.46 53.62 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.417 0.627 . . . . 5.0099999999999998 109.68 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.0 m-85 -132.92 140.56 47.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.175 -0.676 . . . . 0.02 109.175 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -96.58 132.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.379 -0.971 . . . . 1.72 108.379 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -120.78 113.76 32.97 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.524 -0.735 . . . . 0.02 110.768 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.16 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 CA-C-N 119.915 1.005 . . . . 1.47 110.046 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -53.52 140.82 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.758 -1.214 . . . . 4.25 110.409 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.87 -177.78 32.78 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.512 -1.328 . . . . 0.02 110.55 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.85 130.26 55.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -1.02 . . . . 0.95999999999999996 109.438 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 23.1 m-85 -121.42 92.99 48.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 107.972 -1.121 . . . . 0.02 107.972 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.59 -3.91 8.7 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.877 1.051 . . . . 0.02 113.589 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -156.92 153.37 28.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.535 -1.353 . . . . 2.02 107.969 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -59.89 -38.07 81.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.02 111.888 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -59.9 -24.14 64.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.02 110.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.521 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.03 -18.29 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.088 0.947 . . . . 3.4199999999999999 108.495 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.574 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.5 OUTLIER -106.98 10.59 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.184 -1.413 . . . . 0.02 107.184 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.38 22.73 11.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.677 . . . . 0.02 110.417 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 145.53 46.49 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.161 -1.575 . . . . 0.02 109.161 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.43 -30.26 42.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.296 . . . . 0.97999999999999998 107.942 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 54.2 t30 -157.24 -172.08 3.87 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.477 -1.675 . . . . 0.02 106.477 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.523 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.1 p30 -97.72 27.6 4.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.705 -1.247 . . . . 0.02 110.482 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -95.8 121.78 37.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.922 -1.112 . . . . 3.2000000000000002 110.324 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.449 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 37.1 mt -144.33 119.4 10.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 2.6099999999999999 107.69 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.24 11.15 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 121.381 -0.824 . . . . 0.02 112.938 -177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 29.6 t -155.6 156.43 35.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.203 -1.763 . . . . 0.02 110.897 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.532 ' N ' ' HG ' ' A' ' 81' ' ' SER . 83.9 m -145.77 148.32 32.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.626 0.727 . . . . 0.02 110.525 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 48.5 mtm180 -134.73 139.42 45.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.677 -0.861 . . . . 0.01 108.677 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.89 130.45 36.62 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.187 -1.042 . . . . 0.42999999999999999 108.187 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.66 124.8 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.395 -0.965 . . . . 1.25 108.395 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -90.74 134.17 34.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.925 -1.109 . . . . 1.77 108.335 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.67 139.35 34.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.938 -0.764 . . . . 1.6299999999999999 108.938 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 p -112.29 125.1 53.8 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.487 -0.931 . . . . 1.0800000000000001 108.487 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -102.28 -156.06 0.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 106.163 -1.791 . . . . 1.26 106.163 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.01 -46.45 1.01 Allowed Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.57 -1.331 . . . . 0.01 112.14 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.36 -97.89 0.11 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 118.352 -1.88 . . . . 0.01 112.382 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -121.51 119.91 33.36 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.336 -1.096 . . . . 4.4299999999999997 110.966 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.81 130.23 38.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.162 -0.681 . . . . 2.9900000000000002 109.162 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -132.1 139.17 48.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.475 -0.766 . . . . 6.3600000000000003 109.319 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -127.46 144.87 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.385 -0.822 . . . . 1.0900000000000001 109.72 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 0.1 OUTLIER -123.45 132.94 54.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.938 -1.134 . . . . 2.0499999999999998 107.938 177.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.26 147.64 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.881 -1.137 . . . . 1.1000000000000001 109.586 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.9 141.49 48.61 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.019 0.914 . . . . 0.72999999999999998 111.061 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.36 -30.3 70.07 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.898 -0.592 . . . . 0.02 111.83 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 92.0 mttt -116.26 167.63 10.84 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.273 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.77 163.93 43.42 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 57.17 38.44 28.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.828 -0.807 . . . . 0.01 111.088 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 52.46 55.5 9.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.61 -0.682 . . . . 0.01 111.007 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.76 165.34 21.13 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.501 -0.926 . . . . 3.1499999999999999 108.501 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.3 -163.72 27.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.25 -1.54 . . . . 0.01 109.25 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.77 143.5 44.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.006 -1.291 . . . . 0.01 108.653 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.6 142.42 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.465 0.65 . . . . 0.01 109.427 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -131.75 135.51 46.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.239 -1.022 . . . . 2.48 108.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -121.61 135.28 54.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.648 -0.657 . . . . 0.01 110.008 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.544 ' HG1' ' N ' ' A' ' 111' ' ' THR . 3.2 t -149.64 153.4 36.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.222 1.011 . . . . 1.6899999999999999 110.587 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.544 ' N ' ' HG1' ' A' ' 110' ' ' THR . 40.8 p -109.55 10.04 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.844 -0.616 . . . . 0.01 109.712 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 20.6 mp0 -120.53 163.13 18.43 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.315 -0.866 . . . . 3.21 111.175 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.51 154.55 38.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 11.6 t -123.19 110.26 31.01 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.673 -0.862 . . . . 0.01 108.673 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.9 -32.6 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.873 0.99 . . . . 0.01 111.662 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.5 m -140.43 107.79 5.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.322 -0.861 . . . . 0.02 108.819 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.0 mt -63.82 -39.76 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.67 -0.644 . . . . 1.8300000000000001 110.794 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.26 -37.63 83.8 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.053 -1.059 . . . . 1.3400000000000001 110.073 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.24 -39.15 75.2 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.416 -1.427 . . . . 2.1099999999999999 109.763 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.9 tt0 -80.39 -47.24 14.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 2.0800000000000001 112.476 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.5 m-85 -111.27 -1.05 16.21 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.451 -0.781 . . . . 0.02 112.681 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.2 m80 61.77 33.4 17.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.839 -1.163 . . . . 0.02 109.802 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.3 mt -114.18 135.41 54.07 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.563 -0.711 . . . . 0.02 109.248 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -90.25 -22.13 21.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 5.3200000000000003 110.987 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -148.6 164.05 35.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.983 -1.073 . . . . 0.02 109.74 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.411 HG23 HD12 ' A' ' 126' ' ' ILE . 41.8 mm -128.59 125.24 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 107.21 -1.404 . . . . 2.1699999999999999 107.21 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -108.72 -14.1 14.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.305 -0.872 . . . . 0.02 112.573 -177.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 13.0 p -160.59 153.71 21.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.661 -1.274 . . . . 0.01 109.069 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -166.39 140.3 4.16 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.115 -1.069 . . . . 1.22 108.115 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.418 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 ptpt -119.53 98.85 6.33 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.4 1.095 . . . . 1.4099999999999999 108.635 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.518 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 73.7 m95 . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.38 0.61 . . . . 0.01 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mt -119.34 137.84 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.058 -1.09 . . . . 1.6899999999999999 108.058 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -111.23 141.29 44.94 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.959 -1.497 . . . . 2.4900000000000002 106.959 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 31.3 m-85 -123.24 143.56 49.97 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.1 -1.0 . . . . 0.02 109.594 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.88 -30.33 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.6 -0.687 . . . . 0.02 111.497 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.4 152.97 47.54 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.788 -1.195 . . . . 1.48 109.003 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.77 167.81 2.02 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.086 1.19 . . . . 0.02 113.05 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.31 30.86 20.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.874 -1.057 . . . . 0.75 111.278 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 58.43 51.88 7.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.528 -0.732 . . . . 0.02 111.065 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -127.16 165.54 19.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.564 -0.71 . . . . 0.02 110.141 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.95 -165.42 34.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.218 -1.153 . . . . 0.02 110.218 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -69.22 141.69 54.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.536 -0.979 . . . . 0.02 108.893 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 58' ' ' MET . 10.0 mt-30 -113.38 148.71 35.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.502 -0.555 . . . . 0.02 109.502 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -123.72 133.51 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.551 -0.907 . . . . 0.01 108.551 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.426 ' H ' ' CE ' ' A' ' 58' ' ' MET . 10.1 tp -95.51 122.28 38.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.884 -1.135 . . . . 0.01 109.266 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.1 mp -91.58 149.82 21.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.724 -0.843 . . . . 0.01 108.724 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.656 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 1.9 m-20 -108.85 -177.15 3.23 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.471 -0.768 . . . . 2.27 109.498 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -74.38 29.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.85 . . . . 1.8400000000000001 109.698 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 152' ' ' ASP . 49.6 mttm -112.94 176.12 5.15 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.476 -0.765 . . . . 2.2799999999999998 109.498 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 2.2 mp0 -105.91 134.8 48.46 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.838 -0.801 . . . . 0.01 108.838 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.656 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 97.1 m-85 -100.0 112.46 24.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.01 110.302 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -88.39 -29.5 20.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.01 111.133 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -122.72 154.35 63.57 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.056 -1.09 . . . . 2.54 108.056 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.3 Cg_endo -61.79 -42.95 28.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 CA-C-N 119.373 0.812 . . . . 0.69999999999999996 110.55 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.61 -18.81 17.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 109.454 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.59 -17.86 64.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.809 -1.182 . . . . 0.02 111.737 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.38 15.52 28.55 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 120.725 -1.234 . . . . 0.02 110.193 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.86 10.55 75.51 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 121.206 -0.934 . . . . 0.02 112.967 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.432 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.68 140.79 34.46 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.855 -1.38 . . . . 0.02 110.009 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.55 -6.83 59.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.669 -0.644 . . . . 0.58999999999999997 109.612 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -140.49 149.94 59.05 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.109 -0.994 . . . . 0.87 109.169 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.81 16.13 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.571 0.847 . . . . 0.38 111.909 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.26 120.76 25.79 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.323 1.059 . . . . 0.17999999999999999 110.841 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.427 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -150.35 123.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.416 -2.068 . . . . 3.9900000000000002 105.416 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -114.79 -11.01 12.32 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 113.365 0.876 . . . . 5.1699999999999999 113.365 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 30.9 t -156.64 158.48 37.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.276 -2.14 . . . . 0.02 110.106 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.423 ' N ' ' HG ' ' A' ' 171' ' ' SER . 24.6 p90 -151.7 153.56 34.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.198 -0.939 . . . . 2.02 110.287 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -143.19 149.34 37.87 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.816 0.817 . . . . 0.01 110.206 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.82 143.59 27.05 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.337 -0.986 . . . . 0.01 108.337 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.36 128.5 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.252 -0.905 . . . . 3.04 109.742 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.24 146.61 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.185 -0.947 . . . . 1.8899999999999999 109.839 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.105 -0.702 . . . . 4.8899999999999997 109.105 179.288 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.594 0 N-CA-C 106.943 -2.463 . . . . 0.81000000000000005 106.943 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.96 149.48 32.89 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.275 -0.964 . . . . 0.01 110.851 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -151.43 137.88 18.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.395 -1.062 . . . . 0.02 109.614 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -130.15 139.84 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.326 -0.62 . . . . 0.02 109.326 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.88 129.74 53.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.39000000000000001 109.836 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -109.59 139.41 44.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -122.89 138.36 54.68 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.266 -0.896 . . . . 0.02 109.576 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.61 -27.7 67.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.029999999999999999 111.904 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -114.97 170.92 7.98 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HE ' ' H ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -74.98 157.95 34.09 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.607 0.718 . . . . 0.029999999999999999 110.092 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.5 t-20 66.26 34.97 6.2 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.91 0.862 . . . . 0.73999999999999999 110.873 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.8 p90 50.11 44.94 25.94 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.807 0.813 . . . . 0.02 111.139 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.1 166.49 11.37 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.084 -1.08 . . . . 0.02 108.084 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.22 -167.81 36.3 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.731 -1.231 . . . . 0.029999999999999999 110.788 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -68.24 142.6 55.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 2.7599999999999998 108.939 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -121.18 149.74 42.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.686 0.755 . . . . 1.8899999999999999 110.093 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -133.05 127.62 34.45 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.012 -1.106 . . . . 0.02 108.012 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -110.78 136.15 50.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.609 -0.682 . . . . 1.1200000000000001 109.177 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -130.23 137.02 49.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.02 109.338 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.39 9.19 12.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.628 -0.67 . . . . 0.20000000000000001 110.141 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.5 p -157.8 173.82 16.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 1.23 108.318 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 16.5 t0 -59.65 141.7 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.283 -1.51 . . . . 0.02 110.568 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.5 m -131.68 116.42 17.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.281 -1.007 . . . . 0.02 108.281 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.94 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.048 -1.033 . . . . 0.23999999999999999 110.948 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -153.3 101.04 2.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.99 . . . . 1.1399999999999999 108.806 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -105.59 9.04 33.46 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.637 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.5 mmp_? -57.88 -23.66 54.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.654 -0.654 . . . . 3.1099999999999999 110.565 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -74.05 -16.91 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.154 . . . . 0.88 109.971 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -105.41 -22.06 13.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.481 -0.762 . . . . 0.02 109.498 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.2 tp -148.18 125.34 11.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 3.3199999999999998 109.082 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 58.3 m -87.58 -13.15 43.65 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.74 . . . . 0.02 111.78 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 34' ' ' SER . 51.3 mtm180 -166.27 160.43 15.92 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.2 -1.407 . . . . 0.02 107.2 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 16.3 p -140.76 113.32 8.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.847 -1.158 . . . . 0.02 108.956 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -106.71 -0.49 23.56 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.82 -1.175 . . . . 0.029999999999999999 110.379 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -156.41 154.26 30.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.42 147.71 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.043 -1.036 . . . . 0.02 110.45 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -123.8 125.29 44.44 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.41 -0.959 . . . . 0.02 108.41 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.23 113.7 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.735 -1.58 . . . . 0.02 106.735 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -82.82 -34.19 26.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.366 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 151.77 21.37 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.135 -1.507 . . . . 0.02 110.397 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.42 174.43 50.37 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.696 -1.24 . . . . 0.01 110.175 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 95.4 m -109.49 160.49 16.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.889 -1.523 . . . . 1.48 106.889 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' THR . 50.4 m95 -148.02 146.97 29.12 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.208 -1.557 . . . . 0.02 111.506 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.66 132.37 54.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.519 -2.03 . . . . 0.23999999999999999 105.519 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.42 143.12 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.523 -0.735 . . . . 0.65000000000000002 109.625 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 12.1 m-85 -119.05 142.87 47.47 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.207 1.003 . . . . 0.02 109.803 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.28 -34.68 77.92 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.873 -0.603 . . . . 0.02 111.075 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -124.33 154.21 68.98 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.04 -1.038 . . . . 0.02 109.457 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.71 168.02 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.596 1.531 . . . . 0.02 113.33 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.09 36.45 7.31 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.151 -0.931 . . . . 0.02 111.035 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 45.58 50.54 10.44 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.784 0.802 . . . . 3.3900000000000001 110.527 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -127.21 164.46 21.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.246 0.546 . . . . 2.3300000000000001 109.971 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -162.39 31.68 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.156 -1.178 . . . . 0.02 110.156 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.506 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -62.31 141.23 58.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.089 -1.242 . . . . 0.02 110.568 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 49.4 mtp -117.94 133.12 56.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.529 -0.545 . . . . 5.0099999999999998 109.529 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.55 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.3 m-85 -136.08 137.08 40.71 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.766 0.793 . . . . 0.02 109.703 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.8 mp -97.21 133.28 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.324 -0.991 . . . . 1.72 108.324 178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.9 mt -120.25 113.57 33.84 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.663 -0.648 . . . . 0.02 110.405 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -77.79 169.54 20.55 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 CA-C-N 119.987 1.031 . . . . 1.47 109.951 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -52.62 140.92 21.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 4.25 110.151 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -177.38 32.54 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.331 -1.414 . . . . 0.02 110.748 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.66 131.18 55.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.552 -0.969 . . . . 0.95999999999999996 109.349 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -120.72 97.13 48.63 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.81 -1.181 . . . . 0.02 107.81 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.03 -4.39 12.42 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.738 0.959 . . . . 0.02 113.837 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -157.39 154.68 29.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.419 -1.426 . . . . 2.02 108.254 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -60.7 -37.95 83.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.616 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -23.85 64.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.02 110.213 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.53 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.67 -18.51 62.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.128 0.966 . . . . 3.4199999999999999 108.655 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.55 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -106.73 10.07 30.98 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.17 -1.419 . . . . 0.02 107.17 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.0 mtt 60.49 21.05 10.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.51 0.672 . . . . 0.02 110.231 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 144.59 47.06 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.095 -1.602 . . . . 0.02 109.095 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.1 tp -78.14 -29.38 48.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.597 -1.26 . . . . 0.97999999999999998 107.597 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' C ' HD21 ' A' ' 76' ' ' ASN . 0.1 OUTLIER -156.75 -170.76 3.42 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 97.9 m-20 -98.1 29.05 3.67 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.62 -1.3 . . . . 0.02 110.204 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.1 123.08 41.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.262 -0.899 . . . . 3.2000000000000002 111.329 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.476 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 28.1 mt -143.18 120.48 11.57 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.733 -1.58 . . . . 2.6099999999999999 106.733 177.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.93 -16.65 13.24 Favored Glycine 0 N--CA 1.503 3.158 0 O-C-N 121.248 -0.908 . . . . 0.02 112.329 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.8 p -156.07 156.0 33.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.465 -1.609 . . . . 0.02 109.656 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.55 147.66 33.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.521 0.677 . . . . 0.02 109.547 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -134.08 139.39 45.93 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.542 -0.911 . . . . 0.01 108.542 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.86 130.12 37.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.11 -1.07 . . . . 0.42999999999999999 108.11 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.05 123.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -90.06 137.92 31.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 1.77 109.165 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.95 136.83 40.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.422 -0.955 . . . . 1.6299999999999999 108.422 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -113.34 126.85 55.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.819 . . . . 1.0800000000000001 108.968 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.9 m -103.25 -155.02 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.197 -1.779 . . . . 1.26 106.197 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.34 -48.89 0.88 Allowed Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.391 -1.443 . . . . 0.01 112.593 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.85 -100.37 0.14 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.495 -1.812 . . . . 0.01 112.136 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.76 119.05 31.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.311 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.77 129.92 36.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.909 -0.716 . . . . 2.9900000000000002 109.24 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.558 ' CB ' ' HZ2' ' A' ' 94' ' ' LYS . 7.8 ttpm? -130.52 139.42 50.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 6.3600000000000003 109.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.58 145.14 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.311 -0.868 . . . . 1.0900000000000001 109.949 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -122.67 133.16 54.52 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.251 -1.388 . . . . 2.0499999999999998 107.251 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.73 148.01 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.041 -1.037 . . . . 1.1000000000000001 109.486 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 45.3 m-85 -119.33 140.99 49.42 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.248 1.023 . . . . 0.72999999999999998 110.824 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -65.86 -29.05 69.44 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.659 -0.7 . . . . 0.02 111.33 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -116.59 169.47 9.32 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.151 -0.968 . . . . 3.1800000000000002 110.443 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.37 52.02 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.938 -0.865 . . . . 0.01 110.938 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 t0 57.36 38.37 28.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 0.01 111.252 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 51.84 54.81 10.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.01 111.296 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -129.61 165.97 20.68 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.07 -164.77 27.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.309 -1.517 . . . . 0.01 109.309 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.05 145.12 40.39 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.023 -1.28 . . . . 0.01 108.473 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 44.3 ttp -116.69 142.45 46.89 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.764 0.792 . . . . 0.01 110.093 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.36 135.0 47.59 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.777 -1.194 . . . . 2.48 107.777 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -120.68 135.54 55.09 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.632 -0.668 . . . . 0.01 110.217 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 1.5 t -149.69 151.32 33.48 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.178 0.989 . . . . 1.6899999999999999 110.84 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.7 p -109.08 9.9 26.17 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 115.641 -0.708 . . . . 0.01 109.756 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.66 163.57 17.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.369 -0.832 . . . . 3.21 111.29 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.32 155.23 37.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.181 -1.044 . . . . 0.01 108.181 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.4 t -122.42 109.25 33.06 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.619 -0.882 . . . . 0.01 108.619 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.81 -34.11 2.55 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 CA-C-N 119.878 0.992 . . . . 0.01 111.44 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 p -139.07 106.79 5.62 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.459 -0.941 . . . . 0.02 108.459 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.51 -40.12 87.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.907 -0.496 . . . . 1.8300000000000001 111.148 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.0 ttp -66.87 -37.6 84.73 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.921 -1.112 . . . . 1.3400000000000001 110.039 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.31 -38.85 75.04 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.867 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.41 ' CD ' ' CE2' ' A' ' 121' ' ' PHE . 65.2 tt0 -80.74 -47.57 13.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.228 -0.92 . . . . 2.0800000000000001 112.471 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.41 ' CE2' ' CD ' ' A' ' 120' ' ' GLN . 75.3 m-85 -111.69 -1.87 15.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.4 -0.812 . . . . 0.02 112.69 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.6 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.35 33.77 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.887 -1.133 . . . . 0.02 109.765 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.02 135.69 53.74 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.478 -0.763 . . . . 0.02 109.099 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -21.77 22.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.908 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -148.45 163.99 35.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.874 -1.141 . . . . 0.02 110.035 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 126' ' ' ILE . 35.6 mm -129.57 126.68 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.548 -1.279 . . . . 2.1699999999999999 107.548 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -110.36 -12.99 14.37 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.267 -0.896 . . . . 0.02 112.873 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 p -160.69 153.48 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.658 -1.276 . . . . 0.01 109.255 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.6 p -165.25 143.73 6.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.22 109.26 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -123.87 101.78 7.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.081 -1.012 . . . . 1.4099999999999999 109.631 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 107.984 -1.117 . . . . 0.01 107.984 179.136 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.0 m95 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 106.247 -1.76 . . . . 0.01 106.247 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.51 133.98 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.483 -1.386 . . . . 1.6899999999999999 109.408 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.51 141.4 45.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.56 -1.645 . . . . 2.4900000000000002 106.56 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.457 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 33.4 m-85 -121.52 142.61 49.9 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.258 -0.901 . . . . 0.02 109.091 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 168' ' ' ALA . 9.9 tp10 -73.87 -30.17 62.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.547 -0.72 . . . . 0.02 110.975 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.9 154.81 48.31 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.851 -1.155 . . . . 1.48 108.932 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -57.08 167.96 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.174 1.25 . . . . 0.02 113.024 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 60.09 31.5 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.284 178.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.6 51.48 9.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.74 . . . . 0.02 111.038 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -126.91 164.89 20.44 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.521 -0.737 . . . . 0.02 110.241 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.61 -165.69 32.44 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.251 -1.14 . . . . 0.02 110.251 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.41 142.85 53.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.977 . . . . 0.02 108.712 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.43 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 5.4 mt-30 -112.32 147.77 35.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.657 -0.652 . . . . 0.02 110.074 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -123.83 133.43 53.79 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.731 -0.841 . . . . 0.01 108.731 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.19 121.53 39.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.926 -1.108 . . . . 0.01 109.913 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 9.7 mp -96.48 140.78 30.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.371 -0.974 . . . . 0.01 108.371 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 154' ' ' LYS . 93.5 m-20 -104.29 -174.48 2.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.376 -0.828 . . . . 2.27 109.754 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -70.72 35.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.983 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.528 ' H ' ' C ' ' A' ' 152' ' ' ASP . 50.6 mttp -113.85 173.18 6.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 2.2799999999999998 109.22 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.67 130.67 52.66 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.391 -0.966 . . . . 0.01 108.391 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.05 111.54 23.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.11 -0.994 . . . . 0.01 109.817 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.479 ' H ' ' CD ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -92.75 -27.22 17.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.01 111.073 -177.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -123.12 153.71 64.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.813 -1.18 . . . . 2.54 107.813 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.16 -42.72 27.58 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 CA-C-N 119.246 0.766 . . . . 0.69999999999999996 111.102 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -60.6 -18.98 17.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.725 -1.234 . . . . 0.85999999999999999 109.439 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 57.4 t0 -65.72 -18.01 65.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.02 112.087 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.67 15.8 27.78 Favored 'General case' 0 N--CA 1.514 2.735 0 O-C-N 120.66 -1.275 . . . . 0.02 110.086 178.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.46 75.28 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.129 -0.982 . . . . 0.02 112.963 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.413 ' HB1' ' HE1' ' A' ' 162' ' ' TRP . . . -100.47 140.43 34.73 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.834 -1.392 . . . . 0.02 110.062 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.48 -7.1 59.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.706 . . . . 0.58999999999999997 109.427 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -140.8 150.37 59.6 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.87 108.992 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -74.36 16.52 0.58 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.632 0.888 . . . . 0.38 111.915 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.36 120.31 25.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.026 -1.046 . . . . 0.17999999999999999 110.759 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.3 mt -149.37 123.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.601 -2.0 . . . . 3.9900000000000002 105.601 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -111.9 -14.05 13.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.233 -0.917 . . . . 5.1699999999999999 113.251 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.1 t -156.24 158.68 37.96 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.257 -2.152 . . . . 0.02 109.965 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -152.9 154.49 35.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.164 -0.96 . . . . 2.02 110.569 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.457 ' NH2' ' OH ' ' A' ' 139' ' ' TYR . 87.1 mtm180 -143.3 148.35 36.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.01 109.946 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -85.96 142.78 28.56 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.388 -0.967 . . . . 0.01 108.388 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.96 126.57 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.967 -1.083 . . . . 3.04 109.764 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 177' ' ' GLU . 31.2 m -137.47 147.08 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 1.8899999999999999 109.199 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' A' ' 176' ' ' VAL . 10.2 tt0 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 108.356 -0.979 . . . . 4.8899999999999997 108.356 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 105.981 -2.848 . . . . 0.81000000000000005 105.981 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.81 146.29 30.92 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.312 -0.947 . . . . 0.01 111.196 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -152.86 138.08 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.759 -0.848 . . . . 0.02 108.756 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.05 141.06 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.354 -0.61 . . . . 0.02 109.354 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -122.06 130.26 53.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.499 -0.751 . . . . 0.39000000000000001 109.722 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -109.26 138.93 44.86 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.61 -0.885 . . . . 0.02 108.61 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.6 m-85 -122.36 139.0 54.33 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.353 -0.842 . . . . 0.02 109.802 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 10.1 mm-40 -69.19 -28.6 66.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.029999999999999999 111.79 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -114.34 169.83 8.74 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.471 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 94.7 mtt180 -74.27 157.54 35.63 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.695 0.759 . . . . 0.029999999999999999 110.02 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.5 m-80 65.97 35.56 6.39 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.995 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.8 p90 49.78 45.69 24.53 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.736 0.779 . . . . 0.02 111.414 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -113.01 166.49 11.36 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.132 -1.062 . . . . 0.02 108.132 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.08 -167.58 36.32 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 120.78 -1.2 . . . . 0.029999999999999999 110.8 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' NH2' ' H ' ' A' ' 34' ' ' SER . 30.1 ttp180 -68.94 142.73 54.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.976 . . . . 2.7599999999999998 109.196 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -120.78 148.68 43.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.649 0.737 . . . . 1.8899999999999999 110.29 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -131.73 126.68 35.1 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.915 -1.143 . . . . 0.02 107.915 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -112.09 136.81 51.0 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 1.1200000000000001 109.655 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.4 t -130.67 138.19 49.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.461 0.648 . . . . 0.02 109.565 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.2 m-20 -117.14 10.16 13.78 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.383 0.611 . . . . 0.20000000000000001 109.398 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 46.1 m -158.42 174.56 14.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.02 -1.104 . . . . 1.23 108.02 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.3 p-10 -62.11 144.41 55.36 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.581 -1.324 . . . . 0.02 110.49 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -131.59 117.25 18.46 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.99 53.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.23999999999999999 110.567 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 27.8 p-10 -154.11 100.86 2.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 1.1399999999999999 108.682 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.41 9.27 35.77 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.226 1.012 . . . . 6.3700000000000001 109.522 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.604 ' NH2' ' H ' ' A' ' 79' ' ' LEU . 10.7 mmt180 -59.25 -22.93 61.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 3.1099999999999999 110.81 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -74.83 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.699 -1.25 . . . . 0.88 110.257 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -104.06 -21.87 13.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.02 109.387 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.7 tp -149.89 128.65 12.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.301 -0.875 . . . . 3.3199999999999998 109.008 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.583 ' H ' ' NH2' ' A' ' 18' ' ' ARG . 82.9 p -85.85 -10.77 54.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.655 -0.653 . . . . 0.02 111.422 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.527 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 5.5 mtp180 -171.57 163.49 6.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.259 -1.385 . . . . 0.02 107.259 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 36' ' ' CYS . 12.5 p -142.23 113.83 7.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.771 -1.205 . . . . 0.02 108.792 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.3 m-20 -105.53 -0.95 25.38 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.537 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.48 ' HG ' ' C ' ' A' ' 67' ' ' PRO . 2.7 m -153.62 154.3 33.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 0.02 107.718 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.27 146.74 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.033 -1.042 . . . . 0.02 110.148 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 38.4 ttm180 -125.18 125.33 43.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.783 -1.192 . . . . 0.02 107.783 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.53 113.86 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.505 -1.665 . . . . 0.02 106.505 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.8 mp0 -83.54 -33.97 25.34 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.088 -0.645 . . . . 3.8100000000000001 109.853 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 150.79 20.15 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.46 -1.829 . . . . 0.02 110.607 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 174.8 50.57 Favored Glycine 0 N--CA 1.486 1.997 0 C-N-CA 119.668 -1.253 . . . . 0.01 110.337 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 23.0 m -109.94 161.98 14.96 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.736 -1.579 . . . . 1.48 106.736 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 72.7 m95 -148.48 147.79 29.51 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.223 -1.548 . . . . 0.02 111.742 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.15 55.33 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.197 -2.149 . . . . 0.23999999999999999 105.197 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.5 144.43 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.679 -0.638 . . . . 0.65000000000000002 109.403 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -121.22 145.75 47.51 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.359 1.076 . . . . 0.02 110.047 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 3.1 tp10 -65.33 -34.35 78.13 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.613 -0.722 . . . . 0.02 110.909 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -123.0 158.52 57.27 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.232 -0.918 . . . . 0.02 109.462 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.6 166.93 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.521 1.481 . . . . 0.02 112.529 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 64.05 36.79 9.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.313 -0.858 . . . . 0.02 111.136 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 44.83 51.68 8.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.587 0.708 . . . . 3.3900000000000001 110.586 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -126.78 164.23 21.81 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.889 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.34 31.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.53 -1.428 . . . . 0.02 109.53 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.418 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 11.1 m80 -66.47 138.7 57.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.312 . . . . 0.02 109.985 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.5 ptm -118.66 137.29 53.4 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.34 0.59 . . . . 5.0099999999999998 109.593 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.2 m-85 -132.06 138.06 48.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.524 -0.735 . . . . 0.02 109.459 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mm -94.74 131.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.742 -0.836 . . . . 1.72 108.742 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.8 mt -120.11 112.6 34.62 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.753 . . . . 0.02 110.857 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -78.31 169.04 20.75 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.006 1.038 . . . . 1.47 109.943 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.53 141.31 25.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.717 -1.239 . . . . 4.25 110.359 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.08 32.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.385 -1.388 . . . . 0.02 110.635 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -119.02 130.7 55.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.431 -1.041 . . . . 0.95999999999999996 109.653 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -120.24 95.64 49.1 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 108.034 -1.098 . . . . 0.02 108.034 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.48 ' C ' ' HG ' ' A' ' 38' ' ' SER . 3.4 Cg_exo -66.24 -4.93 11.38 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.716 0.944 . . . . 0.02 113.416 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -157.31 154.05 28.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.65 -1.281 . . . . 2.02 107.925 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 23.1 p90 -60.46 -37.77 82.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.895 -0.722 . . . . 0.02 111.722 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 14.9 mm100 -60.78 -24.34 65.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.02 110.444 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -69.47 -18.34 63.7 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.444 -0.947 . . . . 3.4199999999999999 108.444 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.561 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -107.62 10.83 29.01 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.363 -1.347 . . . . 0.02 107.363 -179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 59.39 21.68 10.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.639 0.733 . . . . 0.02 110.341 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.2 145.69 46.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.909 -1.677 . . . . 0.02 108.909 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 -30.98 45.78 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.639 -1.245 . . . . 0.97999999999999998 107.639 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -157.38 -171.26 3.53 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.67 -1.604 . . . . 0.02 106.67 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 6.7 p30 -97.99 28.15 4.12 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.769 -1.207 . . . . 0.02 110.311 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.8 mtt-85 -97.86 123.01 41.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.226 -0.921 . . . . 3.2000000000000002 111.122 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.604 ' H ' ' NH2' ' A' ' 30' ' ' ARG . 36.0 mt -144.04 120.83 11.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.918 -1.512 . . . . 2.6099999999999999 106.918 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.42 -16.56 14.24 Favored Glycine 0 N--CA 1.502 3.047 0 O-C-N 121.264 -0.897 . . . . 0.02 112.079 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 44.4 t -156.38 155.64 32.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.402 -1.646 . . . . 0.02 109.978 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.466 ' N ' ' HG ' ' A' ' 81' ' ' SER . 29.3 t -145.04 148.23 33.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.02 109.781 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 44.3 mtm180 -134.17 139.28 45.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.843 . . . . 0.01 109.123 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.51 131.9 38.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.207 -1.034 . . . . 0.42999999999999999 108.207 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.52 124.55 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.917 -0.771 . . . . 1.25 108.917 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -91.88 135.68 33.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.167 -0.958 . . . . 1.77 108.967 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -97.63 138.46 34.99 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.17 -0.678 . . . . 1.6299999999999999 109.17 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 p -112.23 126.42 55.21 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.828 -0.804 . . . . 1.0800000000000001 108.828 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 p -102.86 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.233 -1.766 . . . . 1.26 106.233 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.21 -49.79 0.83 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.387 -1.445 . . . . 0.01 112.527 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.7 -99.93 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 118.31 -1.9 . . . . 0.01 112.238 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.33 119.98 33.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.802 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.29 130.1 36.74 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.918 -0.713 . . . . 2.9900000000000002 109.104 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 13.7 ttmm -129.75 138.77 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.817 -0.809 . . . . 6.3600000000000003 108.817 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.53 144.47 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.294 -0.879 . . . . 1.0900000000000001 109.891 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.618 ' N ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -121.77 133.64 54.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.348 -1.352 . . . . 2.0499999999999998 107.348 176.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -122.85 145.62 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.736 -1.228 . . . . 1.1000000000000001 109.141 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 41.2 m-85 -119.57 141.1 49.56 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.125 0.964 . . . . 0.72999999999999998 111.127 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.77 -29.28 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.697 -0.683 . . . . 0.02 111.485 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 29.3 mmtm -116.36 170.16 8.75 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.125 -0.984 . . . . 3.1800000000000002 110.492 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.0 165.49 53.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.0 t0 57.16 38.27 28.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.01 111.354 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.08 54.26 11.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.62 -0.675 . . . . 0.01 111.282 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -129.51 166.38 19.77 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.165 -1.05 . . . . 3.1499999999999999 108.165 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.31 -164.98 28.6 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.122 -1.591 . . . . 0.01 109.122 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.09 143.94 43.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.999 -1.295 . . . . 0.01 108.373 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.8 tmm? -117.15 142.76 46.61 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.669 0.747 . . . . 0.01 110.147 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.438 ' N ' ' SD ' ' A' ' 107' ' ' MET . 38.7 m-85 -130.63 135.12 47.55 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.56 -1.274 . . . . 2.48 107.56 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 30.7 tt0 -119.67 135.47 54.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.558 -0.714 . . . . 0.01 110.12 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 t -150.51 153.0 35.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.461 1.124 . . . . 1.6899999999999999 111.322 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 p -110.72 9.38 22.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.27 -0.877 . . . . 0.01 109.592 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -121.25 163.74 18.08 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.445 -0.785 . . . . 3.21 111.331 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.86 155.06 39.36 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.01 108.324 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 34.5 t -124.77 111.67 27.4 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.7 -0.852 . . . . 0.01 108.7 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.67 -31.99 3.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.998 1.035 . . . . 0.01 111.876 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -140.29 108.37 5.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.02 109.074 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.04 -40.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.894 -0.504 . . . . 1.8300000000000001 110.57 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.6 tmm? -66.72 -37.81 85.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.001 -1.08 . . . . 1.3400000000000001 110.052 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -69.98 -38.57 76.08 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.479 -1.388 . . . . 2.1099999999999999 109.403 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 52.7 tt0 -80.79 -47.48 13.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.0800000000000001 112.424 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.487 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.0 m-85 -110.83 -1.92 16.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.366 -0.834 . . . . 0.02 112.574 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.33 34.14 18.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.713 -1.242 . . . . 0.02 109.436 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.4 135.92 53.57 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.426 -0.796 . . . . 0.02 109.373 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -88.66 -21.35 24.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.26 -0.9 . . . . 5.3200000000000003 110.589 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.11 165.04 32.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.932 -1.105 . . . . 0.02 110.198 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mm -127.39 123.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.494 -1.299 . . . . 2.1699999999999999 107.494 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -108.34 -13.29 14.91 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.133 -0.979 . . . . 0.02 112.132 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.2 p -160.45 152.5 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.983 -1.073 . . . . 0.01 108.927 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.3 t -167.66 144.04 4.16 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.545 -0.909 . . . . 1.22 108.545 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 41.5 tttm -122.45 110.23 15.35 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.38 1.086 . . . . 1.4099999999999999 109.473 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.442 -1.318 . . . . 0.01 107.442 179.454 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.5 m95 . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 107.614 -1.254 . . . . 0.01 107.614 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.9 mt -119.82 135.75 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.636 -1.29 . . . . 1.6899999999999999 110.089 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -111.06 142.39 43.28 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.819 -1.919 . . . . 2.4900000000000002 105.819 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.532 ' HH ' HH21 ' A' ' 173' ' ' ARG . 18.1 m-85 -123.17 144.17 49.53 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.091 -1.006 . . . . 0.02 109.842 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 25.8 tt0 -74.2 -30.88 62.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.727 -0.608 . . . . 0.02 111.68 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.73 154.54 48.06 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.698 -1.251 . . . . 1.48 108.995 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.04 167.54 2.37 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.257 1.304 . . . . 0.02 112.747 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.8 t30 59.33 31.25 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.457 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.53 51.52 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.02 111.07 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.421 ' CA ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.4 164.72 20.49 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.513 -0.742 . . . . 0.02 109.848 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.67 33.65 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.063 -1.215 . . . . 0.02 110.063 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -69.68 142.31 53.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.595 -0.944 . . . . 0.02 108.892 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.418 ' O ' ' CG ' ' A' ' 58' ' ' MET . 13.1 mt-30 -113.77 149.22 35.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.344 0.593 . . . . 0.02 109.78 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -123.62 133.99 53.85 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.41 123.37 40.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.857 -1.152 . . . . 0.01 109.916 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.9 mp -95.35 135.38 37.04 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.971 -1.122 . . . . 0.01 107.971 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -106.19 -167.67 1.33 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.731 -0.606 . . . . 2.27 110.312 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -79.6 34.46 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.576 -0.702 . . . . 1.8400000000000001 109.921 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -111.92 172.17 7.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.445 -0.785 . . . . 2.2799999999999998 109.373 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -104.38 121.28 43.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.273 -1.01 . . . . 0.01 108.273 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.03 113.48 25.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.272 -0.892 . . . . 0.01 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.39 17.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.129 -0.982 . . . . 0.01 110.706 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -123.94 155.66 66.85 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.066 -1.086 . . . . 2.54 108.066 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.5 Cg_endo -61.41 -40.83 45.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.032 0.69 . . . . 0.69999999999999996 110.764 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.76 -18.82 19.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 120.905 -1.122 . . . . 0.85999999999999999 109.295 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 49.1 t0 -65.92 -18.56 65.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.872 -1.143 . . . . 0.02 111.902 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -102.27 15.09 30.18 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 120.886 -1.134 . . . . 0.02 109.979 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.43 10.62 73.5 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.301 -0.874 . . . . 0.02 113.119 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.443 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.25 140.76 35.11 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.744 -1.445 . . . . 0.02 110.18 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.54 -7.1 59.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 0.58999999999999997 110.168 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.3 p -141.41 150.36 57.66 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.87 109.768 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -75.29 14.94 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 120.913 1.075 . . . . 0.38 111.817 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 122.64 27.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.306 1.051 . . . . 0.17999999999999999 111.014 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mp -152.56 123.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.189 -1.782 . . . . 3.9900000000000002 106.189 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 140' ' ' GLU . 3.6 mp0 -111.39 -11.56 14.12 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.524 -0.735 . . . . 5.1699999999999999 112.312 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 22.8 t -156.4 158.74 37.87 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 119.311 -2.118 . . . . 0.02 109.755 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.86 153.38 34.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.274 -0.891 . . . . 2.02 110.219 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.532 HH21 ' HH ' ' A' ' 139' ' ' TYR . 55.7 mtm180 -144.0 149.32 36.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.32 -0.862 . . . . 0.01 109.942 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.02 140.56 29.44 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.363 -0.976 . . . . 0.01 108.363 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 45.8 mt -93.89 129.99 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.2 -0.937 . . . . 3.04 109.222 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.46 148.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.475 -0.765 . . . . 1.8899999999999999 109.62 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.564 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 106.982 -2.447 . . . . 0.81000000000000005 106.982 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 148.96 32.71 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.524 -1.03 . . . . 0.01 110.524 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -153.29 138.1 17.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.442 -1.034 . . . . 0.02 108.621 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 8.1 tt -130.59 142.42 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.356 -0.609 . . . . 0.02 109.356 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -122.29 129.81 52.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.424 -0.797 . . . . 0.39000000000000001 109.512 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.29 138.47 44.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.565 -0.902 . . . . 0.02 108.565 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 80.3 m-85 -121.6 138.84 54.15 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.212 -0.93 . . . . 0.02 109.769 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.65 -28.28 66.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.489 -0.757 . . . . 0.029999999999999999 111.61 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -114.66 169.96 8.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.962 -1.086 . . . . 0.029999999999999999 110.394 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.44 158.67 32.32 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.687 0.756 . . . . 0.029999999999999999 109.995 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' ND2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER 66.47 34.61 6.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.845 0.831 . . . . 0.73999999999999999 110.776 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CZ ' ' ND2' ' A' ' 14' ' ' ASN . 16.4 p90 50.07 44.9 25.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.301 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -113.01 165.7 12.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.107 -1.071 . . . . 0.02 108.107 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.57 -168.14 34.42 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.706 -1.235 . . . . 0.029999999999999999 110.927 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.04 143.43 54.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.505 -0.997 . . . . 2.7599999999999998 109.152 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' ' OD1' ' A' ' 21' ' ' ASP . 34.0 ttp180 -119.55 148.7 43.0 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.646 0.736 . . . . 1.8899999999999999 110.392 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -132.09 126.23 33.26 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.887 -1.153 . . . . 0.02 107.887 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' OD1' ' NE ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.7 137.64 51.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.607 -0.683 . . . . 1.1200000000000001 109.751 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.08 139.67 48.59 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.591 0.71 . . . . 0.02 109.47 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 3.4 m-20 -116.09 11.93 15.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.394 -0.595 . . . . 0.20000000000000001 109.394 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 p -158.29 174.47 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.127 -1.064 . . . . 1.23 108.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.99 144.65 54.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.729 -1.232 . . . . 0.02 110.27 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -131.47 116.41 17.44 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.522 -0.918 . . . . 0.02 108.522 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.54 -21.63 55.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.23999999999999999 110.767 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -157.34 101.57 1.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.075 -1.016 . . . . 1.1399999999999999 108.577 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.8 p90 -105.13 9.95 34.05 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.254 1.026 . . . . 6.3700000000000001 110.002 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -59.91 -23.45 63.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.563 -0.711 . . . . 3.1099999999999999 110.954 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.418 ' H ' ' HG ' ' A' ' 31' ' ' SER . 11.4 p -76.05 -16.68 59.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.647 -1.283 . . . . 0.88 110.31 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -102.55 -21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.399 -0.813 . . . . 0.02 108.901 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -150.49 129.23 12.38 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.683 -0.858 . . . . 3.3199999999999998 108.683 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -86.32 -9.81 55.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.847 -0.533 . . . . 0.02 110.846 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -170.49 161.61 7.9 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.16 113.52 8.08 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.643 -1.285 . . . . 0.02 109.094 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -107.45 -3.35 19.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.029999999999999999 110.647 -178.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -154.24 153.49 31.81 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.301 -1.0 . . . . 0.02 108.301 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.35 147.71 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.951 -1.093 . . . . 0.02 110.244 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -125.02 125.68 44.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.953 -1.128 . . . . 0.02 107.953 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.16 114.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.948 -1.501 . . . . 0.02 106.948 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -84.16 -34.52 24.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.484 -0.76 . . . . 3.8100000000000001 109.812 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.57 18.22 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.674 -1.727 . . . . 0.02 110.402 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.88 173.74 49.94 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.528 -1.32 . . . . 0.01 109.893 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.4 m -120.66 138.05 54.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.803 -1.184 . . . . 1.48 107.803 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -127.25 154.36 44.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.691 1.234 . . . . 0.02 111.907 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.59 51.58 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.619 -2.363 . . . . 0.23999999999999999 104.619 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.54 142.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 18.2 m-85 -119.42 141.35 49.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.021 0.915 . . . . 0.02 109.351 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 10.0 tp10 -64.3 -34.16 77.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.571 -0.74 . . . . 0.02 111.671 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -124.08 156.59 65.94 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.025 -1.047 . . . . 0.02 109.707 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.45 165.7 0.97 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.634 1.556 . . . . 0.02 112.984 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.608 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 64.97 37.49 6.86 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.72 0.771 . . . . 0.02 111.261 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 45.21 50.89 9.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.457 0.646 . . . . 3.3900000000000001 110.785 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.5 p -126.97 164.55 21.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 110.134 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.25 -162.34 30.8 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.997 -1.241 . . . . 0.02 109.997 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.68 ' HD1' ' N ' ' A' ' 58' ' ' MET . 13.9 t-80 -62.34 143.25 57.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.03 -1.276 . . . . 0.02 110.635 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.68 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 36.5 mtp -116.32 134.58 54.73 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.514 -0.55 . . . . 5.0099999999999998 109.514 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 33.7 m-85 -136.02 134.89 38.98 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.289 -0.882 . . . . 0.02 109.205 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -96.97 131.96 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.527 -0.733 . . . . 1.72 109.114 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -122.8 111.37 31.14 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.414 -0.804 . . . . 0.02 110.784 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.19 171.2 18.55 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 119.924 1.009 . . . . 1.47 110.181 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.04 140.46 20.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 4.25 110.114 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.65 32.83 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.452 -1.356 . . . . 0.02 110.626 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.5 tp10 -119.14 130.32 55.49 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.294 -1.121 . . . . 0.95999999999999996 109.278 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 84.5 m-85 -120.7 97.76 48.34 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.796 -1.187 . . . . 0.02 107.796 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.63 -5.47 17.12 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 120.582 0.855 . . . . 0.02 113.929 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -154.03 154.09 33.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.503 -1.373 . . . . 2.02 107.864 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -60.67 -38.23 84.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.737 . . . . 0.02 111.719 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.74 -23.94 63.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.983 -1.073 . . . . 0.02 109.9 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.82 -18.54 62.73 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.112 0.958 . . . . 3.4199999999999999 108.432 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.38 9.7 31.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.245 -1.391 . . . . 0.02 107.245 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.4 mpp? 58.93 22.16 10.0 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.568 0.699 . . . . 0.02 110.304 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.26 143.61 45.94 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.258 -1.537 . . . . 0.02 109.258 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -77.75 -29.55 51.12 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.179 -1.415 . . . . 0.97999999999999998 107.179 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.2 p-10 -156.43 -171.33 3.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.118 -1.808 . . . . 0.02 106.118 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -98.47 28.62 4.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.667 -1.271 . . . . 0.02 110.381 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -96.49 122.4 39.36 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.806 -1.184 . . . . 3.2000000000000002 110.709 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 29.6 mt -144.35 120.58 10.85 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.869 -1.16 . . . . 2.6099999999999999 107.869 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.7 10.55 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 121.295 -0.878 . . . . 0.02 112.756 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 66.1 m -154.58 155.82 35.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 119.99 -1.888 . . . . 0.02 111.209 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -144.4 146.76 32.68 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.453 0.644 . . . . 0.02 109.914 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -135.94 140.04 43.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -0.77 . . . . 0.01 108.981 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.03 132.83 36.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 109.286 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.84 123.38 42.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.445 -0.946 . . . . 1.25 108.445 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -89.56 134.73 33.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.832 -1.173 . . . . 1.77 107.832 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.21 139.51 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.739 -0.601 . . . . 1.6299999999999999 109.631 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -111.61 123.35 50.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -115.05 133.88 55.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.749 -1.219 . . . . 1.26 107.971 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.88 -45.86 0.02 OUTLIER Glycine 0 N--CA 1.502 3.079 0 C-N-CA 117.669 -2.205 . . . . 0.01 113.777 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.74 -102.98 0.17 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.432 2.116 . . . . 0.01 111.129 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -119.54 118.23 30.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.284 -1.127 . . . . 4.4299999999999997 110.159 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.07 130.45 39.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.97 -0.692 . . . . 2.9900000000000002 109.258 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -131.31 136.87 48.5 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.055 -0.72 . . . . 6.3600000000000003 109.055 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 tt -128.28 145.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.528 -0.733 . . . . 1.0900000000000001 109.333 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 16.1 pt20 -121.51 132.88 54.96 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.812 -1.181 . . . . 2.0499999999999998 107.812 177.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.1 m -122.89 145.42 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.785 -1.197 . . . . 1.1000000000000001 109.229 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.95 140.58 49.52 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.059 0.933 . . . . 0.72999999999999998 110.878 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.81 -29.37 69.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.83 -0.623 . . . . 0.02 111.654 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -117.78 168.65 10.27 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.101 -0.999 . . . . 3.1800000000000002 110.453 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.32 169.31 28.68 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.935 -0.866 . . . . 0.01 110.935 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 51.91 39.36 25.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.743 0.782 . . . . 0.01 111.218 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 51.88 51.63 16.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.558 -0.714 . . . . 0.01 110.853 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -124.86 165.98 17.08 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.462 -0.94 . . . . 3.1499999999999999 108.462 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.28 -165.31 27.6 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -74.29 144.65 44.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.081 -1.246 . . . . 0.01 108.239 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 19.0 tmm? -116.01 142.89 46.2 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.642 0.734 . . . . 0.01 109.773 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.422 ' N ' ' SD ' ' A' ' 107' ' ' MET . 63.5 m-85 -131.87 136.13 47.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.068 -1.086 . . . . 2.48 108.068 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -120.13 135.2 55.04 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.589 -0.694 . . . . 0.01 110.052 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 3.1 t -149.49 151.86 34.65 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.249 1.023 . . . . 1.6899999999999999 111.016 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -111.32 9.21 21.59 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.606 -0.724 . . . . 0.01 110.006 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 5.3 mp0 -120.52 162.87 18.84 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.29 -0.881 . . . . 3.21 111.282 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 173' ' ' ARG . 5.4 p-10 -67.9 156.89 36.2 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.239 -1.023 . . . . 0.01 108.239 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . 0.456 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 43.0 t -125.84 112.08 24.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.745 -0.835 . . . . 0.01 108.745 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.3 -31.42 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.1 1.071 . . . . 0.01 111.197 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 t -140.34 106.97 5.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.583 -0.895 . . . . 0.02 108.583 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.23 -39.47 85.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.765 -0.584 . . . . 1.8300000000000001 110.808 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 ttm -66.53 -37.42 84.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.881 -1.127 . . . . 1.3400000000000001 109.98 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.15 -39.17 75.53 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.525 -1.36 . . . . 2.1099999999999999 109.798 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.456 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 9.4 tt0 -80.62 -47.0 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 2.0800000000000001 112.473 -177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -111.25 -1.24 16.16 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.37 -0.831 . . . . 0.02 112.695 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m170 61.44 34.09 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.747 -1.221 . . . . 0.02 109.775 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -114.09 135.92 53.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.478 -0.764 . . . . 0.02 109.305 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.626 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.33 -22.08 21.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.175 -0.953 . . . . 5.3200000000000003 110.743 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.58 164.52 34.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.94 -1.1 . . . . 0.02 109.932 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 mm -129.12 124.72 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.629 -1.249 . . . . 2.1699999999999999 107.629 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.6 m80 -110.04 -14.43 14.23 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.02 112.633 -177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.9 m -159.36 151.48 20.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.808 -1.183 . . . . 0.01 108.806 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.7 t -171.42 147.38 2.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.337 -0.852 . . . . 1.22 108.766 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -117.31 108.05 15.13 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.498 1.142 . . . . 1.4099999999999999 108.724 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 11.9 p . . . . . 0 C--N 1.3 -1.572 0 N-CA-C 107.396 -1.335 . . . . 0.01 107.396 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 74.4 m95 . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 121.485 0.66 . . . . 0.01 109.985 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.12 137.7 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.305 -0.998 . . . . 1.6899999999999999 108.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.42 141.45 43.48 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.137 -1.431 . . . . 2.4900000000000002 107.137 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.486 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 25.9 m-85 -121.92 142.43 50.28 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.26 -0.9 . . . . 0.02 109.337 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.85 -30.08 62.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.02 111.551 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -116.17 154.96 48.7 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.801 -1.187 . . . . 1.48 108.858 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.02 166.91 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.146 1.231 . . . . 0.02 113.031 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.09 31.62 20.65 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.096 -0.956 . . . . 0.75 111.36 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.31 51.5 9.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.02 111.045 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.42 165.7 19.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.515 -0.741 . . . . 0.02 109.996 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.17 -165.93 34.74 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.248 -1.141 . . . . 0.02 110.248 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -68.67 141.65 55.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.989 . . . . 0.02 108.917 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.486 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 17.7 mt-30 -113.97 149.41 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.02 109.969 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.19 133.42 53.55 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.707 -0.849 . . . . 0.01 108.707 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.99 121.57 36.75 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.01 109.292 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.76 139.72 32.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.64 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 21.7 m-20 -108.93 -168.48 1.35 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 2.27 109.514 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -80.33 40.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.8400000000000001 109.403 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -113.56 168.02 10.11 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 2.2799999999999998 109.42 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -102.57 120.59 40.81 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.451 -0.944 . . . . 0.01 108.451 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.64 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 68.6 m-85 -98.01 114.38 26.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.347 -0.846 . . . . 0.01 110.308 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -92.72 -25.66 18.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.01 110.854 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -124.66 153.48 70.02 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 107.953 -1.129 . . . . 2.54 107.953 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.5 Cg_endo -60.55 -39.84 61.56 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.623 0.901 . . . . 0.69999999999999996 110.661 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.39 -19.08 17.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 120.78 -1.2 . . . . 0.85999999999999999 109.39 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.75 -18.32 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.868 -1.145 . . . . 0.02 112.039 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -102.5 15.48 29.12 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.859 -1.151 . . . . 0.02 110.079 178.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.05 10.98 74.02 Favored Glycine 0 N--CA 1.497 2.757 0 O-C-N 121.185 -0.947 . . . . 0.02 113.027 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB1' ' HE1' ' A' ' 162' ' ' TRP . . . -101.24 140.45 35.52 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.727 -1.455 . . . . 0.02 110.276 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.54 -6.98 59.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.546 -0.721 . . . . 0.58999999999999997 110.062 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.0 m -140.25 150.07 60.19 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.061 -1.025 . . . . 0.87 109.747 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.94 14.63 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.815 1.01 . . . . 0.38 111.947 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 121.18 26.22 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.329 1.061 . . . . 0.17999999999999999 110.847 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 mt -149.27 123.92 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.677 -1.972 . . . . 3.9900000000000002 105.677 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.82 -13.62 13.17 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.167 -0.958 . . . . 5.1699999999999999 113.138 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.5 t -157.6 160.76 38.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.153 -2.217 . . . . 0.02 110.192 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.13 152.95 32.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.529 -0.732 . . . . 2.02 109.807 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 144' ' ' TYR . 7.5 mmt180 -144.4 150.4 37.65 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.808 0.813 . . . . 0.01 110.194 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -88.23 143.87 26.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.471 -0.768 . . . . 0.01 109.04 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.89 129.42 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.438 -0.789 . . . . 3.04 109.205 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.5 t -136.01 146.61 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.209 -0.932 . . . . 1.8899999999999999 109.57 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 4.8899999999999997 109.209 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.778 0 N-CA-C 106.926 -2.47 . . . . 0.81000000000000005 106.926 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 149.36 33.55 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.721 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.513 ' NZ ' ' OD1' ' A' ' 23' ' ' ASP . 56.0 tttp -149.19 136.36 19.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.994 . . . . 0.02 109.633 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.38 138.92 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.151 -0.685 . . . . 0.02 109.151 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -121.49 130.32 53.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.524 -0.735 . . . . 0.39000000000000001 109.985 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 22.7 m-85 -109.91 139.75 44.65 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.148 -0.686 . . . . 0.02 109.148 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.7 m-85 -122.42 138.44 54.54 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.249 -0.907 . . . . 0.02 109.563 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -70.19 -27.5 64.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.029999999999999999 111.949 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.538 ' C ' HD22 ' A' ' 37' ' ' ASN . 1.3 m-20 -114.16 169.27 9.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.729 -1.232 . . . . 0.029999999999999999 110.14 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.43 157.19 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.639 0.733 . . . . 0.029999999999999999 110.419 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.5 m-20 66.75 34.26 5.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.045 0.926 . . . . 0.73999999999999999 111.441 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.7 m-85 55.53 42.59 29.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.293 0.568 . . . . 0.02 111.323 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -113.56 166.51 11.45 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.467 -0.938 . . . . 0.02 108.467 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.24 -167.72 36.17 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.89 -1.148 . . . . 0.029999999999999999 110.901 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.428 HH21 ' H ' ' A' ' 34' ' ' SER . 39.8 ttp180 -70.33 142.9 52.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.972 . . . . 2.7599999999999998 108.984 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -120.23 148.99 42.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.574 -0.704 . . . . 1.8899999999999999 110.294 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -131.23 126.3 35.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.729 -1.211 . . . . 0.02 107.729 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.43 137.15 51.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.701 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.43 138.03 48.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.5 0.667 . . . . 0.02 109.621 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD1' ' NZ ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -117.18 10.34 13.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.20000000000000001 109.447 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.9 p -158.19 174.45 15.16 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.41 143.13 56.36 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.682 -1.261 . . . . 0.02 110.456 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.1 t -131.43 117.25 18.59 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.67 -25.68 49.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.23999999999999999 110.857 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -154.5 100.77 2.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.874 -1.141 . . . . 1.1399999999999999 108.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -105.4 9.84 33.57 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.05 0.929 . . . . 6.3700000000000001 109.641 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -57.89 -24.06 55.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.612 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 p -73.93 -16.92 61.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.805 -1.185 . . . . 0.88 109.905 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.51 -22.29 13.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.02 109.5 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.0 tp -148.56 125.99 11.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.042 -1.036 . . . . 3.3199999999999998 109.52 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.428 ' H ' HH21 ' A' ' 18' ' ' ARG . 71.0 m -86.26 -10.77 53.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.625 -0.672 . . . . 0.02 111.461 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 30.7 ttt180 -170.5 160.45 7.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.816 -1.179 . . . . 0.02 107.816 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.1 p -141.94 113.09 7.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.86 -1.15 . . . . 0.02 108.728 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -109.09 2.91 21.45 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.189 -179.398 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -155.52 152.59 29.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.66 -1.237 . . . . 0.02 107.66 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.49 147.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.02 110.119 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -124.71 125.5 44.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.78 114.22 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.779 -1.563 . . . . 0.02 106.779 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.75 -34.08 27.24 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.2 -0.6 . . . . 3.8100000000000001 110.408 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.33 151.47 21.07 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 119.081 -1.533 . . . . 0.02 110.33 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 174.46 50.01 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.543 -1.313 . . . . 0.01 110.085 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.435 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m -110.04 161.18 15.78 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.021 -1.474 . . . . 1.48 107.021 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.435 ' CD1' ' C ' ' A' ' 45' ' ' THR . 67.3 m95 -148.0 147.71 29.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.198 -1.564 . . . . 0.02 111.505 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.07 54.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 105.43 -2.063 . . . . 0.23999999999999999 105.43 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.83 142.29 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.503 -0.748 . . . . 0.65000000000000002 109.406 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 42.4 m-85 -121.56 144.64 48.61 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.952 0.882 . . . . 0.02 109.676 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.66 -34.99 79.07 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.501 -0.772 . . . . 0.02 111.722 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.06 163.59 42.78 Favored Pre-proline 0 N--CA 1.509 2.516 0 O-C-N 120.91 -1.119 . . . . 0.02 109.105 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.14 168.06 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.42 1.414 . . . . 0.02 113.359 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 63.22 36.89 11.6 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.082 -0.963 . . . . 0.02 112.121 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 44.78 52.0 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.675 0.75 . . . . 3.3900000000000001 111.017 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 m -126.58 163.98 22.23 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.239 0.542 . . . . 2.3300000000000001 109.704 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.24 -161.31 32.69 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.538 -1.425 . . . . 0.02 109.538 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.647 ' HD1' ' N ' ' A' ' 58' ' ' MET . 9.1 t-80 -69.72 137.98 52.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.993 -1.298 . . . . 0.02 109.946 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.647 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 19.0 ptm -119.16 136.47 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.333 -0.617 . . . . 5.0099999999999998 109.333 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 93.7 m-85 -128.28 139.51 52.38 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.914 -0.773 . . . . 0.02 108.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.95 131.83 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.2 mt -120.81 112.79 33.47 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.407 -0.808 . . . . 0.02 110.696 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.17 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.047 1.052 . . . . 1.47 110.096 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.542 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.2 pm0 -53.25 140.48 26.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.778 -1.201 . . . . 4.25 110.221 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.19 33.08 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.377 . . . . 0.02 110.438 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -119.25 130.18 55.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.325 -1.103 . . . . 0.95999999999999996 109.635 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -120.82 96.8 48.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.96 -4.1 11.8 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 120.74 0.96 . . . . 0.02 113.756 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -157.68 155.02 29.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.671 -1.268 . . . . 2.02 108.256 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -60.29 -38.95 85.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.02 111.851 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.02 110.544 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.91 -18.6 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.187 0.994 . . . . 3.4199999999999999 108.581 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -106.87 9.94 30.75 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.386 -1.339 . . . . 0.02 107.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.0 mtt 60.55 21.32 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.475 0.655 . . . . 0.02 110.401 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.05 45.92 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.112 -1.595 . . . . 0.02 109.112 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.13 -29.52 48.86 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.438 -1.319 . . . . 0.97999999999999998 107.438 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -157.17 -171.71 3.73 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.523 -1.658 . . . . 0.02 106.523 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 87.4 m-20 -97.66 27.91 4.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.673 -1.267 . . . . 0.02 110.289 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -98.52 123.49 42.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.882 . . . . 3.2000000000000002 111.655 -178.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.5 mt -143.25 121.05 11.92 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.912 -1.514 . . . . 2.6099999999999999 106.912 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.25 -16.99 13.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.185 -0.947 . . . . 0.02 111.981 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -155.02 154.82 33.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.397 -1.649 . . . . 0.02 110.372 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.32 147.04 32.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.02 109.953 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -134.57 140.03 45.82 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 0.01 108.814 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.07 131.77 38.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.998 -1.112 . . . . 0.42999999999999999 107.998 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.0 t -91.71 123.98 44.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -91.66 136.23 33.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.981 -1.075 . . . . 1.77 108.744 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.64 137.0 38.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.378 -0.971 . . . . 1.6299999999999999 108.378 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -110.8 126.29 54.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.437 -0.949 . . . . 1.0800000000000001 108.437 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -103.71 -154.96 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.348 -1.723 . . . . 1.26 106.348 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.38 -48.1 0.93 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.506 -1.371 . . . . 0.01 112.178 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.78 -99.85 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.484 -1.817 . . . . 0.01 111.936 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -121.54 119.24 31.37 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.342 -1.093 . . . . 4.4299999999999997 110.504 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 129.28 35.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.988 -0.745 . . . . 2.9900000000000002 108.988 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 7.8 ttpm? -130.08 140.37 50.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.421 -0.799 . . . . 6.3600000000000003 109.15 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 tt -129.97 145.17 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.831 . . . . 1.0900000000000001 109.859 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.67 134.76 54.97 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.431 -1.322 . . . . 2.0499999999999998 107.431 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.91 147.25 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.831 -1.168 . . . . 1.1000000000000001 109.531 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.0 m-85 -119.64 141.66 49.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.123 0.963 . . . . 0.72999999999999998 111.032 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -66.24 -29.2 69.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.694 -0.685 . . . . 0.02 111.369 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -116.41 169.59 9.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.162 -0.961 . . . . 3.1800000000000002 110.459 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.97 165.07 51.28 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.898 -0.881 . . . . 0.01 110.898 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.95 38.03 29.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.833 -0.804 . . . . 0.01 111.349 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 51.83 54.99 9.96 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.632 -0.667 . . . . 0.01 111.494 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -128.77 165.61 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.955 -1.128 . . . . 3.1499999999999999 107.955 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.91 -164.36 28.72 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.214 -1.554 . . . . 0.01 109.214 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 39.8 tt0 -75.35 144.12 42.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.012 -1.287 . . . . 0.01 108.748 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.75 143.17 45.98 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.601 0.715 . . . . 0.01 109.96 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 24.1 m-85 -131.39 135.71 47.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.937 -1.135 . . . . 2.48 107.937 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.2 tm-20 -118.36 134.59 54.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.809 -0.557 . . . . 0.01 109.757 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 3.7 t -149.48 150.29 32.1 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 1.6899999999999999 110.911 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.465 ' N ' ' HG1' ' A' ' 110' ' ' THR . 46.7 p -109.6 9.95 25.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.51 -0.768 . . . . 0.01 109.863 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.598 ' H ' ' HG1' ' A' ' 110' ' ' THR . 65.1 mm-40 -121.43 163.64 18.41 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.429 -0.794 . . . . 3.21 111.438 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.46 155.37 37.75 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.199 -1.037 . . . . 0.01 108.199 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.8 t -122.17 110.79 32.51 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.8 Cg_endo -77.28 -32.9 2.8 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.846 0.981 . . . . 0.01 111.584 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.1 t -141.69 107.04 5.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.011 -1.056 . . . . 0.02 108.732 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -64.35 -39.76 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.896 -0.503 . . . . 1.8300000000000001 111.087 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.38 -37.66 85.77 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.936 -1.105 . . . . 1.3400000000000001 109.888 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -70.16 -39.02 75.56 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.549 -1.344 . . . . 2.1099999999999999 109.684 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.31 -48.21 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -0.961 . . . . 2.0800000000000001 112.612 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.99 -1.09 15.52 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.367 -0.833 . . . . 0.02 112.612 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 5.8 m80 62.04 34.36 16.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.816 -1.178 . . . . 0.02 109.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 mt -114.86 135.83 53.76 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.505 -0.747 . . . . 0.02 109.514 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.642 ' N ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.45 -21.28 23.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.123 -0.985 . . . . 5.3200000000000003 110.86 -179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -148.99 164.3 34.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.943 -1.098 . . . . 0.02 110.015 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 126' ' ' ILE . 38.7 mm -129.44 126.16 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.403 -1.332 . . . . 2.1699999999999999 107.403 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -109.2 -12.72 14.77 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.267 -0.896 . . . . 0.02 112.693 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -159.52 153.13 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.679 -1.263 . . . . 0.01 108.829 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 21.8 p -167.4 142.97 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 1.22 109.399 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -124.44 106.92 10.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.464 1.126 . . . . 1.4099999999999999 109.834 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 107.575 -1.268 . . . . 0.01 107.575 178.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.7 m95 . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 106.574 -1.639 . . . . 0.01 106.574 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.74 134.24 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.577 -1.327 . . . . 1.6899999999999999 109.713 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -111.33 142.45 43.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.307 -1.738 . . . . 2.4900000000000002 106.307 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.475 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 30.9 m-85 -122.37 142.51 50.44 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.133 -0.979 . . . . 0.02 109.431 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 9.9 tp10 -75.04 -30.27 61.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.673 -0.642 . . . . 0.02 111.709 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.9 mt -114.47 152.77 46.44 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 120.66 -1.275 . . . . 1.48 109.054 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.49 165.98 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 120.81 1.007 . . . . 0.02 112.757 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 31.6 20.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.395 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 58.05 51.87 8.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.495 -0.753 . . . . 0.02 111.52 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.427 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.36 166.1 18.49 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.393 -0.817 . . . . 0.02 110.097 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.29 -165.42 34.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.064 -1.214 . . . . 0.02 110.064 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -69.66 142.91 53.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.976 . . . . 0.02 108.927 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 20.9 mt-30 -113.85 148.97 35.74 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.255 0.55 . . . . 0.02 109.727 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -123.69 133.21 53.92 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.14 122.01 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.819 -1.176 . . . . 0.01 109.255 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.8 mp -96.25 146.48 24.68 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.01 108.677 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.666 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 9.0 m-20 -105.58 -169.18 1.55 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.453 -0.78 . . . . 2.27 109.684 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.16 31.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 1.8400000000000001 109.583 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 152' ' ' ASP . 19.5 mtpp -111.7 171.31 7.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.335 -0.853 . . . . 2.2799999999999998 109.153 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.05 133.62 48.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.196 -1.039 . . . . 0.01 108.196 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.666 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 92.6 m-85 -100.22 115.01 28.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.01 110.239 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -90.57 -28.38 18.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.736 -0.602 . . . . 0.01 110.958 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -123.38 154.31 65.75 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.739 -1.208 . . . . 2.54 107.739 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -62.01 -41.84 33.97 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 119.207 0.752 . . . . 0.69999999999999996 111.209 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.87 -19.41 19.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.79 -1.193 . . . . 0.85999999999999999 109.707 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 56.2 t0 -65.92 -18.5 65.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.802 -1.187 . . . . 0.02 112.034 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.26 15.9 27.29 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.725 -1.235 . . . . 0.02 110.171 178.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.89 10.16 76.2 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.115 -0.99 . . . . 0.02 113.035 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.421 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.53 140.83 34.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.819 -1.401 . . . . 0.02 110.185 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.06 -7.05 59.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.58999999999999997 109.735 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -140.55 151.09 62.72 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.196 -0.94 . . . . 0.87 109.309 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.26 15.46 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.703 0.935 . . . . 0.38 111.952 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.66 120.52 25.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 110.741 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.43 122.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.579 -2.008 . . . . 3.9900000000000002 105.579 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 170' ' ' GLN . 5.2 mp0 -112.17 -13.13 13.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.244 -0.91 . . . . 5.1699999999999999 112.936 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 66.0 m -157.04 158.69 36.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.13 -2.231 . . . . 0.02 110.085 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -153.16 154.81 35.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 2.02 110.188 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -144.19 149.5 36.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.276 -0.89 . . . . 0.01 110.162 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -86.62 143.14 27.78 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.524 -0.917 . . . . 0.01 108.524 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.16 128.38 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.141 -0.975 . . . . 3.04 109.79 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 177' ' ' GLU . 60.6 t -137.06 147.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.229 -0.919 . . . . 1.8899999999999999 109.663 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 176' ' ' VAL . 7.8 tm-20 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 4.8899999999999997 109.297 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.684 0 N-CA-C 107.096 -2.402 . . . . 0.81000000000000005 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.82 149.82 33.54 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.112 -1.042 . . . . 0.01 110.749 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.05 136.29 18.84 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.981 . . . . 0.02 109.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 7' ' ' ILE . 8.7 tt -130.23 139.44 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.793 -0.567 . . . . 0.02 109.543 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 t -122.16 130.46 53.23 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.553 -0.717 . . . . 0.39000000000000001 109.916 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 m-85 -110.08 139.99 44.62 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.032 -0.729 . . . . 0.02 109.032 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.51 139.14 54.22 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.292 -0.88 . . . . 0.02 109.813 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -68.39 -28.03 66.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.938 -1.101 . . . . 0.029999999999999999 111.804 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -114.14 169.07 9.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.888 -1.132 . . . . 0.029999999999999999 110.201 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -74.96 158.15 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.666 0.746 . . . . 0.029999999999999999 109.895 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.47 34.94 5.84 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.729 0.776 . . . . 0.73999999999999999 110.8 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.1 p90 49.72 44.39 24.73 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.742 0.782 . . . . 0.02 111.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.73 166.72 11.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.87 -1.159 . . . . 0.02 107.87 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.1 -167.75 36.44 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.669 -1.253 . . . . 0.029999999999999999 110.673 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.19 142.73 54.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.977 . . . . 2.7599999999999998 108.943 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' NH1' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tmm_? -121.57 150.67 41.32 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.71 0.766 . . . . 1.8899999999999999 110.42 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -132.82 127.55 34.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 0.02 108.045 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' NH1' ' A' ' 19' ' ' ARG . 3.3 p-10 -111.83 136.46 51.09 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 109.711 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -130.91 137.69 49.43 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.494 0.664 . . . . 0.02 109.467 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -116.83 10.1 14.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.20000000000000001 109.375 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.3 p -158.59 174.3 15.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 13.0 t0 -60.8 142.31 56.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.782 -1.199 . . . . 0.02 110.327 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 43.2 t -131.57 116.58 17.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.316 -0.994 . . . . 0.02 108.316 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.59 -24.33 53.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.23999999999999999 110.995 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -154.65 102.4 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.006 -1.059 . . . . 1.1399999999999999 108.86 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CZ ' ' NH2' ' A' ' 30' ' ' ARG . 17.9 p90 -104.38 8.38 35.8 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.192 0.996 . . . . 6.3700000000000001 109.487 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.428 HH11 ' NH2' ' A' ' 78' ' ' ARG . 3.3 mmp_? -58.3 -24.22 58.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 3.1099999999999999 110.715 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -74.69 -17.1 60.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.768 -1.208 . . . . 0.88 109.933 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -104.13 -22.41 13.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.421 -0.799 . . . . 0.02 109.416 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.01 128.51 12.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.113 -0.992 . . . . 3.3199999999999998 109.138 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -85.54 -10.03 56.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.723 -0.611 . . . . 0.02 111.288 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -171.86 163.1 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.759 -1.2 . . . . 0.02 107.759 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 p -143.98 115.71 8.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.199 . . . . 0.02 108.736 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -107.06 1.83 24.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.957 -1.089 . . . . 0.029999999999999999 110.548 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.6 p -156.88 154.72 30.25 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.507 -1.294 . . . . 0.02 107.507 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mt -146.17 148.16 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 0.02 109.777 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -125.04 125.43 43.83 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.47 114.94 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.714 -1.587 . . . . 0.02 106.714 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.87 -34.33 26.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.796 -0.565 . . . . 3.8100000000000001 110.42 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.36 151.5 21.1 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.142 -1.504 . . . . 0.02 110.167 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 175.09 50.68 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.582 -1.294 . . . . 0.01 110.264 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.407 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 84.0 m -109.46 161.3 15.45 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.901 -1.518 . . . . 1.48 106.901 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.407 ' CD1' ' C ' ' A' ' 45' ' ' THR . 65.6 m95 -147.38 146.64 29.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.347 -1.47 . . . . 0.02 111.402 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.79 54.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 105.466 -2.05 . . . . 0.23999999999999999 105.466 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.73 141.98 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.607 -0.683 . . . . 0.65000000000000002 109.493 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 8.5 m-85 -122.0 143.36 49.53 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.511 1.148 . . . . 0.02 109.652 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 6.0 tp10 -65.37 -36.25 83.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.729 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.1 153.51 64.56 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.97 -1.081 . . . . 0.02 109.305 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.13 167.74 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.31 1.34 . . . . 0.02 112.772 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 63.26 37.05 11.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.175 -0.921 . . . . 0.02 110.998 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER 45.12 52.83 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.683 0.754 . . . . 3.3900000000000001 110.896 178.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -126.58 163.85 22.52 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.866 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.84 32.27 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.13 -1.188 . . . . 0.02 110.13 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 5.6 m170 -63.93 138.52 58.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.976 -1.308 . . . . 0.02 110.117 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.7 mtm -120.55 134.47 55.27 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.606 0.717 . . . . 5.0099999999999998 109.679 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.503 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.3 m-85 -134.25 139.02 45.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.02 109.561 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.638 ' H ' ' NE2' ' A' ' 148' ' ' GLN . 1.6 mp -97.25 133.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.85 113.68 32.91 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.561 -0.712 . . . . 0.02 110.56 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.4 168.72 22.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.154 1.091 . . . . 1.47 110.155 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.17 141.39 23.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.746 -1.221 . . . . 4.25 110.151 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.03 -176.51 32.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.412 -1.375 . . . . 0.02 110.567 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -119.4 130.6 55.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -1.082 . . . . 0.95999999999999996 109.403 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 49.3 m-85 -121.1 98.71 47.01 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 107.671 -1.233 . . . . 0.02 107.671 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -70.54 -3.39 12.42 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.629 0.886 . . . . 0.02 113.806 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -157.26 155.01 30.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.592 -1.317 . . . . 2.02 108.206 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -60.65 -39.14 87.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.577 -0.702 . . . . 0.02 111.814 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.81 -23.8 63.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.02 110.181 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.73 -18.54 62.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.96 0.886 . . . . 3.4199999999999999 108.626 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -106.82 10.31 30.74 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.171 -1.418 . . . . 0.02 107.171 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.35 22.62 11.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.557 0.694 . . . . 0.02 110.18 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.98 47.36 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.8 tp -78.76 -29.68 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.649 -1.241 . . . . 0.97999999999999998 107.649 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.626 ' ND2' ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.67 -171.03 3.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.619 -1.623 . . . . 0.02 106.619 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -98.17 28.29 4.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.633 -1.292 . . . . 0.02 110.238 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 17.7 mmm180 -98.05 123.01 41.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.285 -0.884 . . . . 3.2000000000000002 111.38 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.0 mt -144.65 121.59 11.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.048 -1.464 . . . . 2.6099999999999999 107.048 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 -16.39 14.48 Favored Glycine 0 N--CA 1.5 2.905 0 O-C-N 121.303 -0.873 . . . . 0.02 112.171 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.01 154.65 32.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.247 -1.737 . . . . 0.02 110.401 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.6 p -144.69 147.36 32.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.02 109.688 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -133.86 140.13 46.66 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.664 -0.865 . . . . 0.01 108.664 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.11 129.22 36.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 0.42999999999999999 107.935 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.0 t -91.96 123.69 44.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.893 -0.78 . . . . 1.25 108.893 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -90.66 136.65 32.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.276 -0.89 . . . . 1.77 109.006 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.25 137.48 37.7 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.94 -1.133 . . . . 1.6299999999999999 107.94 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 t -112.25 126.5 55.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -0.876 . . . . 1.0800000000000001 109.14 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -103.61 -154.94 0.51 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.221 -1.77 . . . . 1.26 106.221 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.02 -49.58 0.86 Allowed Glycine 0 N--CA 1.498 2.79 0 O-C-N 120.418 -1.426 . . . . 0.01 112.232 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.04 -100.05 0.14 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 118.397 -1.859 . . . . 0.01 111.889 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.95 118.62 30.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.292 -1.122 . . . . 4.4299999999999997 110.394 -179.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.86 129.66 36.53 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 2.9900000000000002 109.287 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -129.97 139.46 51.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.576 -0.703 . . . . 6.3600000000000003 109.436 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tt -129.35 145.78 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.414 -0.804 . . . . 1.0900000000000001 109.71 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -121.18 133.22 55.18 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.29 -1.374 . . . . 2.0499999999999998 107.29 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.4 146.61 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.954 -1.091 . . . . 1.1000000000000001 109.351 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 33.2 m-85 -119.72 141.39 49.46 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.194 0.997 . . . . 0.72999999999999998 110.922 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.31 -29.25 69.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.711 -0.677 . . . . 0.02 111.587 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -116.61 169.8 9.07 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.075 -1.016 . . . . 3.1800000000000002 110.444 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.95 165.33 50.97 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.843 -0.903 . . . . 0.01 110.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' OD1' ' NH1' ' A' ' 157' ' ' ARG . 9.6 t0 56.8 38.37 29.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.956 -0.732 . . . . 0.01 111.307 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 51.65 54.44 10.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.01 111.368 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 166.14 19.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.062 -1.088 . . . . 3.1499999999999999 108.062 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -164.19 28.63 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.014 -1.635 . . . . 0.01 109.014 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.34 143.86 42.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.285 . . . . 0.01 108.518 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.3 ttp -116.79 142.84 46.4 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.59 0.71 . . . . 0.01 109.838 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -131.65 136.38 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.073 -1.084 . . . . 2.48 108.073 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.57 134.8 54.82 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.684 -0.635 . . . . 0.01 110.093 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.514 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -149.14 150.49 32.77 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.237 1.018 . . . . 1.6899999999999999 111.031 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.502 ' N ' ' HG1' ' A' ' 110' ' ' THR . 73.6 p -110.11 10.02 24.01 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.674 -0.694 . . . . 0.01 109.811 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.403 ' H ' ' HG1' ' A' ' 110' ' ' THR . 46.4 mm-40 -120.77 163.23 18.44 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.282 -0.887 . . . . 3.21 111.272 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.1 155.18 37.57 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.021 -1.103 . . . . 0.01 108.021 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.2 t -123.18 109.77 31.3 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.67 -31.91 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 CA-C-N 119.997 1.035 . . . . 0.01 111.696 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -140.96 107.42 5.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.37 -0.832 . . . . 0.02 108.774 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 117' ' ' ILE . 23.6 mt -63.52 -39.44 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.56 . . . . 1.8300000000000001 110.668 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 40.7 ttp -66.32 -37.52 85.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.966 -1.094 . . . . 1.3400000000000001 109.959 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.18 -39.27 71.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.399 -1.438 . . . . 2.1099999999999999 109.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.72 -47.86 13.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 2.0800000000000001 112.447 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.19 -1.96 15.95 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.352 -0.843 . . . . 0.02 112.517 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.0 m80 61.87 33.96 17.29 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.659 -1.276 . . . . 0.02 109.403 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.1 mt -114.63 135.54 54.03 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.487 -0.758 . . . . 0.02 109.264 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.418 ' O ' ' OE2' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -89.13 -21.19 23.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.159 -0.963 . . . . 5.3200000000000003 110.761 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 124' ' ' ARG . 10.9 mp0 -147.32 163.95 34.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.912 -1.117 . . . . 0.02 109.504 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.0 mm -126.97 124.23 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.339 -1.356 . . . . 2.1699999999999999 107.339 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -110.3 -13.48 14.31 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.238 -0.914 . . . . 0.02 112.516 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 t -160.79 151.65 18.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.835 -1.165 . . . . 0.01 109.24 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.2 p -168.78 143.93 3.33 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.674 -0.861 . . . . 1.22 108.674 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.46 109.6 13.48 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.448 1.118 . . . . 1.4099999999999999 109.669 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.619 -1.252 . . . . 0.01 107.619 179.119 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.4 m95 . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 106.557 -1.646 . . . . 0.01 106.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.3 mt -117.18 133.62 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.507 -1.371 . . . . 1.6899999999999999 109.162 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.47 141.14 45.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.29 -1.745 . . . . 2.4900000000000002 106.29 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.8 m-85 -123.05 142.98 50.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.918 . . . . 0.02 109.605 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.66 -30.49 62.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.79 -0.569 . . . . 0.02 111.725 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.9 154.9 48.31 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.655 -1.278 . . . . 1.48 108.975 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.5 167.08 2.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.091 1.194 . . . . 0.02 112.926 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.79 31.38 20.77 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.05 -0.977 . . . . 0.75 111.363 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 57.31 51.89 9.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.42 -0.8 . . . . 0.02 111.361 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -126.57 164.84 20.33 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.504 -0.748 . . . . 0.02 110.114 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.2 33.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.227 -1.149 . . . . 0.02 110.227 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.02 108.61 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 60' ' ' ILE . 2.9 mt-30 -113.4 148.13 36.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.734 -0.604 . . . . 0.02 109.533 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.31 133.99 54.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.912 -0.773 . . . . 0.01 108.912 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 48.0 tp -96.63 121.66 38.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.01 109.378 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.3 mp -95.75 139.08 32.49 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.557 -0.905 . . . . 0.01 108.557 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 3.0 p30 -105.55 -168.32 1.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.498 -0.751 . . . . 2.27 109.499 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -82.57 38.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 1.8400000000000001 110.005 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.28 175.28 5.54 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.379 -0.826 . . . . 2.2799999999999998 109.45 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -105.31 125.51 51.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.723 -0.843 . . . . 0.01 108.723 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 1.5 m-85 -100.35 112.73 25.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.243 -0.911 . . . . 0.01 109.817 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.526 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 12.8 mmm180 -88.35 -28.09 21.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.957 -1.089 . . . . 0.01 110.549 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -126.88 156.04 74.57 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 107.045 -1.465 . . . . 2.54 107.045 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.56 -34.26 96.81 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 CA-C-N 119.721 0.936 . . . . 0.69999999999999996 110.335 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.1 t -62.88 -21.16 27.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.873 -1.142 . . . . 0.85999999999999999 109.564 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.07 -20.51 65.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.672 -1.268 . . . . 0.02 111.439 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.444 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p90 -103.03 13.32 34.53 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.979 -1.075 . . . . 0.02 109.243 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.75 11.98 64.95 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.771 -0.728 . . . . 0.02 113.549 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.444 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.78 138.06 38.33 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 119.627 1.713 . . . . 0.02 110.411 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.79 -7.85 58.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.692 -0.63 . . . . 0.58999999999999997 109.796 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 87.0 p -139.98 150.16 61.3 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.312 -0.868 . . . . 0.87 109.551 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.5 13.5 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.688 0.925 . . . . 0.38 112.031 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.95 120.2 24.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.17999999999999999 110.921 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.15 124.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.79 -1.929 . . . . 3.9900000000000002 105.79 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -112.25 -12.95 13.54 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.311 -0.868 . . . . 5.1699999999999999 113.171 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 33.3 t -156.76 159.0 37.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 119.354 -2.091 . . . . 0.02 110.076 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.01 154.14 34.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.303 -0.873 . . . . 2.02 110.7 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -143.51 149.29 37.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.385 -0.822 . . . . 0.01 110.237 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -86.41 142.83 28.15 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.53 -0.915 . . . . 0.01 108.53 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 mt -94.38 128.45 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.12 -0.987 . . . . 3.04 109.851 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.59 147.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.764 . . . . 1.8899999999999999 109.458 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 4.8899999999999997 109.102 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 107.088 -2.405 . . . . 0.81000000000000005 107.088 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.37 149.59 34.01 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 120.026 -1.083 . . . . 0.01 110.692 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -150.04 135.98 18.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.978 . . . . 0.02 109.509 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.25 140.83 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.669 ' HG ' ' HE ' ' A' ' 19' ' ' ARG . 4.3 m -121.32 130.06 53.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.625 -0.672 . . . . 0.39000000000000001 109.575 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -109.69 139.24 44.96 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.76 -0.83 . . . . 0.02 108.76 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m-85 -123.18 139.28 54.23 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.266 -0.896 . . . . 0.02 109.765 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 86.2 mt-10 -69.15 -28.1 66.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.989 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.69 170.22 8.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.426 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.495 ' NH2' ' OE1' ' A' ' 70' ' ' GLN . 73.0 mtt180 -74.07 157.71 35.59 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.638 0.732 . . . . 0.029999999999999999 109.929 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.3 t-20 65.76 35.03 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.931 0.872 . . . . 0.73999999999999999 111.037 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.1 p90 50.29 45.61 25.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.839 0.828 . . . . 0.02 111.197 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.39 165.85 11.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.989 -1.115 . . . . 0.02 107.989 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.2 35.91 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.702 -1.237 . . . . 0.029999999999999999 110.853 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' ' OE2' ' A' ' 11' ' ' GLU . 22.3 ttp180 -68.64 142.78 55.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -1.048 . . . . 2.7599999999999998 109.414 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.669 ' HE ' ' HG ' ' A' ' 8' ' ' SER . 54.9 ttt180 -119.79 147.65 44.38 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.593 0.711 . . . . 1.8899999999999999 109.893 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -132.61 126.68 33.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.833 -1.173 . . . . 0.02 107.833 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.39 137.78 50.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.756 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.7 t -131.08 138.55 49.61 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.648 0.737 . . . . 0.02 109.807 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.28 10.81 14.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.687 -0.633 . . . . 0.20000000000000001 109.542 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.8 t -157.08 174.47 15.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 40.3 t0 -60.84 144.46 52.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.733 -1.229 . . . . 0.02 109.969 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 20.9 t -131.95 116.11 16.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.49 -0.93 . . . . 0.02 108.49 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.18 51.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.23999999999999999 110.891 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.6 p-10 -154.4 101.56 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 1.1399999999999999 108.84 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.9 p90 -105.43 10.36 33.34 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.331 1.063 . . . . 6.3700000000000001 110.159 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.418 ' NH2' ' O ' ' A' ' 34' ' ' SER . 21.6 mmm180 -60.22 -23.03 63.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 3.1099999999999999 110.924 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -76.3 -16.94 59.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.619 -1.301 . . . . 0.88 110.222 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.23 -20.97 14.46 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.79 -0.818 . . . . 0.02 108.79 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -150.15 129.37 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.78 0.8 . . . . 3.3199999999999998 109.002 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 90.4 p -85.16 -10.78 56.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.762 -0.586 . . . . 0.02 110.717 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HE ' HD22 ' A' ' 37' ' ' ASN . 12.5 ptm180 -170.26 162.13 8.51 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.639 -1.245 . . . . 0.02 107.639 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 t -143.6 115.34 8.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.02 108.978 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.657 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.33 1.2 18.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.739 -1.226 . . . . 0.029999999999999999 111.422 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 t -156.96 154.78 30.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.131 -1.062 . . . . 0.02 108.131 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -146.49 146.88 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 122.185 0.993 . . . . 0.02 111.105 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -122.8 124.11 42.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.616 -1.253 . . . . 0.02 107.616 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.48 114.83 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 106.598 -1.63 . . . . 0.02 106.598 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.7 mp0 -83.83 -33.73 24.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.269 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.32 149.8 18.34 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.104 -1.522 . . . . 0.02 110.133 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.07 173.87 50.03 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.648 -1.263 . . . . 0.01 110.153 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.6 m -119.64 137.28 53.98 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -126.09 153.93 43.8 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.712 1.244 . . . . 0.02 112.361 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.99 133.39 52.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.051 -2.203 . . . . 0.23999999999999999 105.051 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.87 142.03 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.658 -0.651 . . . . 0.65000000000000002 109.337 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -120.97 143.01 49.24 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.169 0.985 . . . . 0.02 109.655 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.58 -34.3 77.93 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.376 -0.829 . . . . 0.02 111.778 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -124.82 157.84 64.75 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.942 -1.099 . . . . 0.02 109.549 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.91 166.31 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.739 1.626 . . . . 0.02 112.741 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.77 37.31 9.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.314 -0.857 . . . . 0.02 111.058 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.85 52.23 8.13 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.551 0.691 . . . . 3.3900000000000001 110.598 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -126.21 163.87 22.23 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.181 0.515 . . . . 2.3300000000000001 110.016 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -162.02 31.29 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.871 -1.292 . . . . 0.02 109.871 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.65 136.38 57.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.275 . . . . 0.02 110.035 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 19.1 ptm -118.58 135.66 54.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.62 . . . . 5.0099999999999998 109.435 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 25.6 m-85 -135.52 141.09 45.21 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.509 -0.744 . . . . 0.02 109.34 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -96.51 133.04 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.59 -0.892 . . . . 1.72 108.59 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.74 111.79 29.27 Favored Pre-proline 0 N--CA 1.502 2.159 0 O-C-N 121.371 -0.831 . . . . 0.02 110.4 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.96 171.37 18.29 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.839 0.978 . . . . 1.47 110.237 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -51.42 140.79 16.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.002 -1.061 . . . . 4.25 109.863 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -178.56 31.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.403 -1.38 . . . . 0.02 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.3 tp10 -120.36 131.21 54.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.44 -1.035 . . . . 0.95999999999999996 109.461 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 93.3 m-85 -122.21 95.29 47.36 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.2 Cg_exo -65.65 -3.45 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.892 1.061 . . . . 0.02 114.179 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 36.1 mt-10 -157.78 154.99 29.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.415 -1.428 . . . . 2.02 108.087 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 7.3 p90 -60.8 -38.57 85.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.523 -0.735 . . . . 0.02 111.995 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 24.7 mt-30 -59.58 -24.21 63.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.02 110.367 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -70.84 -18.18 62.72 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.404 -0.961 . . . . 3.4199999999999999 108.404 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.89 9.87 30.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.258 -1.386 . . . . 0.02 107.258 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 60.86 21.48 11.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.587 -0.696 . . . . 0.02 110.41 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.05 145.01 46.56 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.392 -1.483 . . . . 0.02 109.392 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 8.1 mp -78.6 -29.95 46.31 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.459 -1.682 . . . . 0.02 106.459 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 5.5 p30 -97.21 28.56 3.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.669 -1.27 . . . . 0.02 110.21 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -96.31 121.42 38.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.914 -1.116 . . . . 3.2000000000000002 110.33 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 35.1 mt -144.3 119.72 10.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.794 -1.187 . . . . 2.6099999999999999 107.794 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.22 -15.94 10.12 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.338 -0.851 . . . . 0.02 112.975 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 47.3 t -155.55 155.59 33.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.97 -1.9 . . . . 0.02 110.943 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.43 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 23.9 p -145.86 148.7 33.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.487 -0.758 . . . . 0.02 110.397 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -135.53 140.53 44.8 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.394 -0.816 . . . . 0.01 108.888 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.33 130.97 36.8 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.081 -1.012 . . . . 0.42999999999999999 109.197 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.33 123.31 41.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.334 -0.987 . . . . 1.25 108.334 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 9.6 m-70 -90.65 135.08 33.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.876 -1.14 . . . . 1.77 108.166 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.85 138.49 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.735 -0.839 . . . . 1.6299999999999999 108.735 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -111.56 125.4 53.88 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.495 -0.928 . . . . 1.0800000000000001 108.495 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -102.58 -156.13 0.55 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.93 -45.86 1.05 Allowed Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.339 -1.476 . . . . 0.01 112.068 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.33 -97.85 0.11 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.463 -1.827 . . . . 0.01 112.159 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -121.48 120.42 34.87 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.389 -1.065 . . . . 4.4299999999999997 110.707 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -74.92 131.49 40.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 2.9900000000000002 109.201 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.512 ' NZ ' HE22 ' A' ' 96' ' ' GLN . 0.5 OUTLIER -131.19 137.71 49.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.574 -0.704 . . . . 6.3600000000000003 109.523 -179.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 6.6 tt -127.78 142.75 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.861 0.838 . . . . 1.0900000000000001 109.456 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.512 HE22 ' NZ ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -125.21 134.59 52.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.177 -1.045 . . . . 2.0499999999999998 108.177 178.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.72 148.48 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.88 -1.137 . . . . 1.1000000000000001 109.961 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 51.7 m-85 -118.32 141.16 48.81 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.925 0.869 . . . . 0.72999999999999998 110.777 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.9 -29.8 69.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 116.013 -0.54 . . . . 0.02 111.813 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -116.69 167.96 10.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.087 -1.008 . . . . 3.1800000000000002 110.573 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.29 164.03 41.5 Favored Glycine 0 N--CA 1.492 2.398 0 CA-C-O 121.936 0.742 . . . . 0.01 111.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.8 m-20 56.39 39.49 30.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.955 -0.733 . . . . 0.01 110.928 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.504 ' H ' ' CB ' ' A' ' 128' ' ' SER . 4.7 m-85 52.27 55.51 9.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.732 -0.605 . . . . 0.01 110.826 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -128.82 165.84 20.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.399 -0.963 . . . . 3.1499999999999999 108.399 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.85 -164.3 27.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.204 -1.558 . . . . 0.01 109.204 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . 0.527 HE21 ' H ' ' A' ' 107' ' ' MET . 38.9 tp60 -74.51 144.5 44.08 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.263 . . . . 0.01 108.167 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.71 142.28 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.647 0.737 . . . . 0.01 109.454 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.18 136.63 48.45 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.191 -1.04 . . . . 2.48 108.191 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 110' ' ' THR . 8.8 tp10 -119.09 133.67 55.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.714 -0.616 . . . . 0.01 109.741 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.533 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -148.99 149.39 31.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 1.6899999999999999 110.593 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 24.3 p -108.7 10.25 26.88 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.763 -0.653 . . . . 0.01 109.724 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 37.3 mp0 -120.81 163.12 18.65 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.383 -0.823 . . . . 3.21 111.234 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.1 p30 -65.75 154.73 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.052 -1.092 . . . . 0.01 108.052 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.7 t -122.5 110.16 32.33 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 108.512 -0.921 . . . . 0.01 108.512 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 171' ' ' SER . 21.0 Cg_endo -76.91 -31.63 3.79 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 119.969 1.025 . . . . 0.01 111.833 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 119' ' ' GLU . 26.2 t -142.02 107.92 5.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.088 -1.008 . . . . 0.02 108.792 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.4 mt -63.52 -39.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.913 -0.492 . . . . 1.8300000000000001 110.576 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.49 -37.28 84.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.003 -1.079 . . . . 1.3400000000000001 109.945 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.441 ' H ' ' HG ' ' A' ' 116' ' ' SER . 22.3 tp10 -70.82 -39.12 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.842 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.5 tt0 -80.78 -48.22 12.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 2.0800000000000001 112.564 -176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PHE . . . . . 0.442 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 58.6 m-85 -111.82 -1.49 15.54 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.424 -0.797 . . . . 0.02 112.707 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 61.1 34.4 19.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.095 . . . . 0.02 109.769 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.19 135.49 53.98 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.534 -0.729 . . . . 0.02 109.152 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -90.32 -21.51 22.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 111.006 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.42 163.57 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.045 -1.034 . . . . 0.02 110.06 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.404 HG22 HD13 ' A' ' 126' ' ' ILE . 39.4 mm -128.48 125.6 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -109.82 -13.9 14.39 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.145 -0.972 . . . . 0.02 113.118 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 102' ' ' ASP . 8.4 m -161.81 154.16 19.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.573 -1.33 . . . . 0.01 109.627 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.7 p -166.23 142.47 4.92 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.751 -0.833 . . . . 1.22 108.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.504 ' HZ3' ' CB ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -118.72 96.88 5.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 108.221 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-N 115.281 -0.872 . . . . 0.01 108.794 -179.765 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 87.6 m95 . . . . . 0 N--CA 1.508 2.451 0 CA-C-O 121.347 0.594 . . . . 0.01 110.658 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.7 mt -119.8 137.71 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.393 -0.966 . . . . 1.6899999999999999 108.393 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.82 141.26 44.41 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.168 -1.419 . . . . 2.4900000000000002 107.168 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -122.5 142.31 50.72 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.234 -0.916 . . . . 0.02 109.646 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -31.2 61.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.714 -0.616 . . . . 0.02 112.187 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.69 155.03 48.0 Favored Pre-proline 0 N--CA 1.506 2.355 0 O-C-N 120.736 -1.228 . . . . 1.48 109.135 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.3 Cg_endo -54.92 166.43 2.09 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.022 1.148 . . . . 0.02 112.913 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 142' ' ' PRO . 5.6 p30 57.05 31.9 20.74 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.056 -0.975 . . . . 0.75 111.822 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.445 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 59.35 51.85 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.02 111.397 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.652 ' HE ' ' H ' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -127.05 166.29 17.88 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.479 -0.763 . . . . 0.02 109.793 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.652 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 87.57 -165.58 35.41 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.307 -1.117 . . . . 0.02 110.307 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.11 141.88 54.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -1.001 . . . . 0.02 108.873 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.475 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.2 mt-30 -114.8 149.15 37.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.267 0.556 . . . . 0.02 109.519 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -123.54 133.77 53.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.507 -0.923 . . . . 0.01 108.507 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.9 tp -94.69 122.3 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.792 -1.193 . . . . 0.01 109.342 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 151' ' ' LEU . 10.5 mp -93.23 149.0 21.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.01 108.875 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.6 m-20 -108.53 -175.88 2.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.51 -0.743 . . . . 2.27 109.222 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -74.4 27.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 1.8400000000000001 109.501 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 152' ' ' ASP . 55.1 mttm -112.76 174.69 5.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.354 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -106.57 138.02 43.51 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.936 -0.764 . . . . 0.01 108.936 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.465 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 92.2 m-85 -101.82 114.31 28.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.304 -0.872 . . . . 0.01 110.273 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' A' ' 128' ' ' SER . 11.2 mtp180 -86.52 -28.55 23.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.01 111.268 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -123.2 153.68 64.94 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.831 -1.174 . . . . 2.54 107.831 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.6 Cg_endo -61.83 -41.93 34.67 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 CA-C-N 119.323 0.794 . . . . 0.69999999999999996 110.455 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.8 -18.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.808 -1.182 . . . . 0.85999999999999999 109.279 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -65.88 -18.31 65.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.02 111.87 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.76 14.82 30.84 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 120.891 -1.13 . . . . 0.02 110.099 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.36 10.72 73.52 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.219 -0.926 . . . . 0.02 113.047 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.425 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.18 140.54 35.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.79 -1.417 . . . . 0.02 109.994 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.03 -6.81 59.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 109.544 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 97.2 p -140.97 150.2 58.53 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.213 -0.929 . . . . 0.87 109.192 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.33 16.64 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.585 0.857 . . . . 0.38 111.942 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.18 120.19 25.03 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.177 0.989 . . . . 0.17999999999999999 110.904 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.59 124.28 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 105.609 -1.997 . . . . 3.9900000000000002 105.609 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.09 -12.77 13.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.241 -0.912 . . . . 5.1699999999999999 113.246 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 16.9 m -157.7 160.76 38.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.146 -2.221 . . . . 0.02 110.388 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -151.59 153.14 33.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.373 -0.83 . . . . 2.02 109.875 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.445 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.2 mtp180 -143.55 150.0 38.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.217 -0.927 . . . . 0.01 110.121 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.519 ' NH2' ' O ' ' A' ' 111' ' ' THR . 3.4 ptp180 -87.4 143.1 27.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.581 -0.896 . . . . 0.01 108.581 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.79 128.51 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.207 -0.933 . . . . 3.04 109.25 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.9 t -137.52 147.81 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.199 -0.938 . . . . 1.8899999999999999 109.653 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.43 -0.794 . . . . 4.8899999999999997 109.412 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.469 -0.567 . . . . 5.2800000000000002 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -65.99 98.91 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 5.96 109.3 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 p -104.33 -140.47 0.36 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.208 -1.034 . . . . 2.2200000000000002 108.208 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.65 88.06 0.07 OUTLIER Glycine 0 N--CA 1.497 2.742 0 N-CA-C 107.084 -2.406 . . . . 0.81000000000000005 107.084 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.66 148.9 32.65 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 120.216 -0.992 . . . . 0.01 110.866 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -151.18 136.81 17.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.951 . . . . 0.02 108.839 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 7' ' ' ILE . 6.3 tt -130.25 140.58 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -120.85 129.28 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.455 -0.778 . . . . 0.39000000000000001 109.897 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.6 m-85 -109.42 139.51 44.3 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.839 -0.801 . . . . 0.02 108.839 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -124.18 139.69 53.68 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.184 -0.948 . . . . 0.02 110.126 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -68.32 -27.3 66.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.029999999999999999 111.826 -178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.42 169.97 8.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.838 -1.164 . . . . 0.029999999999999999 110.466 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 59.3 mtt180 -74.93 158.49 33.22 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 109.816 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.4 m-20 65.91 34.71 7.01 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.813 0.816 . . . . 0.73999999999999999 110.842 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.2 p90 49.41 44.29 23.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.72 0.771 . . . . 0.02 111.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -111.74 165.95 11.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.43 -167.61 35.73 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.593 -1.289 . . . . 0.029999999999999999 110.487 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -68.6 143.1 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 2.7599999999999998 109.024 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 21' ' ' ASP . 3.0 tmm_? -121.51 149.96 42.32 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.752 0.787 . . . . 1.8899999999999999 110.163 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -133.52 128.17 34.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.444 -0.947 . . . . 0.02 108.444 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' CZ ' ' A' ' 19' ' ' ARG . 45.5 m-20 -111.43 136.9 49.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.494 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.3 t -130.79 137.62 49.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.535 0.684 . . . . 0.02 109.412 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 p-10 -117.0 10.47 14.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.706 -0.621 . . . . 0.20000000000000001 109.535 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.483 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -158.32 174.51 15.04 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.158 -1.053 . . . . 1.23 108.158 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.1 p30 -62.08 144.3 55.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.61 -1.306 . . . . 0.02 110.253 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 t -131.33 117.45 18.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.569 -0.9 . . . . 0.02 108.569 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.467 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.79 -25.19 53.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.087 -1.008 . . . . 0.23999999999999999 110.613 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.29 101.52 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.966 -1.083 . . . . 1.1399999999999999 108.742 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -104.61 8.35 35.28 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.541 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -59.0 -24.08 62.46 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.556 -0.715 . . . . 3.1099999999999999 110.787 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -74.29 -16.5 60.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.716 -1.24 . . . . 0.88 110.047 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -103.59 -22.16 13.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.02 109.228 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -150.27 128.92 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 3.3199999999999998 109.086 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 p -85.64 -9.98 56.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.735 -0.603 . . . . 0.02 111.086 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -170.78 161.66 7.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 t -142.41 114.37 8.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.718 -1.239 . . . . 0.02 108.573 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -108.71 0.82 20.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.895 -1.128 . . . . 0.029999999999999999 110.609 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 3.2 p -156.55 153.39 28.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -145.38 148.47 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.08 -1.013 . . . . 0.02 109.74 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -124.09 124.87 43.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.387 -1.338 . . . . 0.02 107.387 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -105.69 113.29 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.601 -1.629 . . . . 0.02 106.601 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -83.63 -34.14 25.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.049 -0.66 . . . . 3.8100000000000001 109.744 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.75 150.7 19.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.525 -1.798 . . . . 0.02 110.532 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.92 174.18 50.13 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.513 -1.327 . . . . 0.01 110.095 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 53.9 m -109.62 160.73 16.03 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.996 -1.483 . . . . 1.48 106.996 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 74.6 m95 -148.15 146.89 28.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.324 -1.485 . . . . 0.02 111.443 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.05 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.263 -2.125 . . . . 0.23999999999999999 105.263 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.1 m -119.78 143.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.586 -0.696 . . . . 0.65000000000000002 109.65 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.78 144.85 48.08 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.245 1.021 . . . . 0.02 109.903 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.59 -34.74 78.56 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.829 -0.623 . . . . 0.02 111.541 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -124.25 157.5 64.2 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.104 -0.997 . . . . 0.02 109.326 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.28 165.53 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.491 1.461 . . . . 0.02 113.152 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 64.18 37.31 8.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.221 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 45.24 51.32 9.32 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.655 0.741 . . . . 3.3900000000000001 110.483 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -125.81 163.27 23.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 2.3300000000000001 109.714 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.02 -161.42 31.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.642 -1.383 . . . . 0.02 109.642 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -65.15 138.24 58.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.04 -1.271 . . . . 0.02 110.161 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.6 ptm -118.61 135.79 54.24 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.067 -0.716 . . . . 5.0099999999999998 109.067 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.583 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.7 m-85 -134.82 139.94 45.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.8 0.809 . . . . 0.02 109.856 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -95.52 132.49 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.561 -0.903 . . . . 1.72 108.561 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -118.59 111.78 37.63 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.569 -0.707 . . . . 0.02 110.357 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.89 168.1 22.71 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.127 1.081 . . . . 1.47 109.897 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 7.9 tm0? -53.37 140.81 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.796 -1.19 . . . . 4.25 110.36 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.04 -176.9 32.56 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.689 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.1 tp10 -118.13 129.31 55.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -1.146 . . . . 0.95999999999999996 108.929 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.528 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 47.3 m-85 -120.4 96.8 49.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 107.548 -1.278 . . . . 0.02 107.548 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -68.74 -3.9 12.18 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 120.541 0.827 . . . . 0.02 113.818 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -156.91 154.34 29.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.453 -1.405 . . . . 2.02 107.962 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 52.0 p90 -60.51 -37.62 81.72 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.59 -0.694 . . . . 0.02 111.537 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.39 -23.97 64.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.014 -1.053 . . . . 0.02 110.454 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.52 -18.48 62.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.433 -0.951 . . . . 3.4199999999999999 108.433 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.583 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.75 10.98 30.71 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.188 -1.412 . . . . 0.02 107.188 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.4 OUTLIER 59.61 21.76 10.4 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.598 0.713 . . . . 0.02 110.27 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.7 145.1 45.73 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.871 -1.692 . . . . 0.02 108.871 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.3 tt -78.27 -30.48 48.55 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.536 -1.283 . . . . 0.97999999999999998 107.536 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 16.0 t-20 -156.77 -172.36 4.02 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.514 -1.662 . . . . 0.02 106.514 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.537 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 32.6 p30 -97.52 27.29 4.38 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.709 -1.245 . . . . 0.02 110.087 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -96.04 122.86 39.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.055 -1.028 . . . . 3.2000000000000002 110.493 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.9 mt -144.31 120.55 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.469 -1.308 . . . . 2.6099999999999999 107.469 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 -16.52 13.06 Favored Glycine 0 N--CA 1.504 3.172 0 O-C-N 121.317 -0.864 . . . . 0.02 112.507 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 35.3 m -156.06 156.06 33.72 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.372 -1.663 . . . . 0.02 110.239 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.7 p -144.12 146.91 33.09 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.372 0.606 . . . . 0.02 109.447 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -135.03 140.18 45.4 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.01 108.857 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.82 130.57 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.36 -0.978 . . . . 0.42999999999999999 108.36 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.1 125.2 44.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.389 -0.967 . . . . 1.25 108.389 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' O ' ' CG2' ' A' ' 135' ' ' THR . 45.3 m-70 -90.51 135.8 33.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 1.77 108.94 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.76 138.2 37.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.986 -0.746 . . . . 1.6299999999999999 108.986 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -113.29 126.11 55.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.863 -0.792 . . . . 1.0800000000000001 108.863 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -102.51 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.209 -1.774 . . . . 1.26 106.209 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.56 -48.31 0.9 Allowed Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.376 -1.452 . . . . 0.01 112.529 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.16 -99.63 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 118.259 -1.924 . . . . 0.01 112.388 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -121.58 119.63 32.48 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.285 -1.127 . . . . 4.4299999999999997 110.756 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -77.75 131.08 37.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.105 -0.702 . . . . 2.9900000000000002 109.105 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.3 ttpm? -131.13 140.35 49.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.461 -0.774 . . . . 6.3600000000000003 108.931 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -128.9 143.66 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.386 -0.821 . . . . 1.0900000000000001 110.109 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.23 133.73 54.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.905 -1.146 . . . . 2.0499999999999998 107.905 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.03 147.17 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.876 -1.14 . . . . 1.1000000000000001 109.691 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 29.5 m-85 -118.56 140.87 49.21 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.129 0.966 . . . . 0.72999999999999998 110.835 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -66.26 -29.42 69.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.772 -0.649 . . . . 0.02 111.721 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -116.91 170.25 8.77 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 120.984 -1.072 . . . . 3.1800000000000002 110.573 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 165.32 50.12 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.831 -0.907 . . . . 0.01 110.831 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 56.5 38.41 29.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.834 -0.803 . . . . 0.01 111.461 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE1' ' OG ' ' A' ' 128' ' ' SER . 11.3 m-85 52.57 54.5 10.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.01 111.509 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.638 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 6.3 t-20 -129.25 166.31 19.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.196 -1.038 . . . . 3.1499999999999999 108.196 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.638 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 92.52 -164.46 28.03 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.514 -1.434 . . . . 0.01 109.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 65.8 tt0 -75.16 144.54 42.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.1 -1.235 . . . . 0.01 108.493 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 48.2 ttp -116.65 142.11 47.32 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.654 0.74 . . . . 0.01 109.88 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 30.2 m-85 -131.24 135.33 47.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.912 -1.144 . . . . 2.48 107.912 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -120.43 135.09 55.15 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.623 -0.673 . . . . 0.01 110.041 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.53 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 7.1 t -149.63 151.62 34.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.295 1.045 . . . . 1.6899999999999999 110.934 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.525 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 5.3 p -110.06 10.3 24.07 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.503 -0.771 . . . . 0.01 109.787 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.53 ' H ' ' HG1' ' A' ' 110' ' ' THR . 41.7 mt-10 -121.11 162.92 19.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 3.21 111.156 -178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -66.78 155.79 37.25 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.151 -1.055 . . . . 0.01 108.151 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.0 t -123.98 110.12 29.47 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.528 -0.916 . . . . 0.01 108.528 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.71 -32.82 3.33 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 120.002 1.036 . . . . 0.01 111.697 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -139.64 106.78 5.47 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.33 -39.91 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.869 -0.519 . . . . 1.8300000000000001 111.065 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 36.1 ttp -66.59 -38.0 86.09 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.996 -1.082 . . . . 1.3400000000000001 109.957 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -70.25 -38.96 75.26 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.522 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 45.7 tt0 -80.16 -48.2 13.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 2.0800000000000001 112.507 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.522 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 81.3 m-85 -111.41 -1.29 15.99 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.353 -0.842 . . . . 0.02 112.611 -175.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 61.79 33.77 17.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.792 -1.193 . . . . 0.02 109.668 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.52 136.05 53.45 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.487 -0.758 . . . . 0.02 109.293 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -90.21 -21.46 22.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.986 . . . . 5.3200000000000003 110.87 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -148.73 164.14 35.24 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.02 110.124 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.433 HG23 HD12 ' A' ' 126' ' ' ILE . 37.2 mm -129.29 126.57 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.503 -1.295 . . . . 2.1699999999999999 107.503 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.54 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 m80 -109.92 -13.22 14.47 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.251 -0.906 . . . . 0.02 112.618 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.534 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 47.5 t -161.39 154.34 20.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.786 -1.196 . . . . 0.01 109.0 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -170.64 147.28 2.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.22 109.684 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -119.86 109.9 16.11 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.986 -1.071 . . . . 1.4099999999999999 109.237 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.65 131.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.273 -1.751 . . . . 0.01 106.273 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.76 92.06 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 106.793 -1.558 . . . . 1.98 106.793 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.475 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 1.1 tm-20 -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.575 -2.009 . . . . 0.01 105.575 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.74 -43.36 1.04 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.765 -1.734 . . . . 0.01 108.765 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.472 ' H ' ' CD ' ' A' ' 133' ' ' GLU . 75.5 p -129.12 104.93 7.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.518 -0.989 . . . . 2.2999999999999998 111.794 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 42.9 m95 -129.54 144.03 51.09 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.461 -1.311 . . . . 0.01 107.461 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.409 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 36.3 mt -118.51 133.14 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.565 -1.335 . . . . 1.6899999999999999 109.502 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.09 141.62 44.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.334 -1.728 . . . . 2.4900000000000002 106.334 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 21.4 m-85 -123.45 143.07 50.38 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.197 -0.94 . . . . 0.02 109.731 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -74.25 -30.36 62.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.675 -0.641 . . . . 0.02 111.882 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.49 155.12 47.6 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.62 -1.3 . . . . 1.48 108.951 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -56.51 167.27 2.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.098 1.199 . . . . 0.02 112.615 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.25 31.21 21.01 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.413 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 57.48 50.68 10.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 0.02 111.082 177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.36 165.13 18.25 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.656 -0.652 . . . . 0.02 109.766 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.7 33.98 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.549 -1.021 . . . . 0.02 110.549 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.57 142.15 53.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.542 -0.975 . . . . 0.02 108.788 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.5 mt-30 -113.14 148.45 35.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.351 0.596 . . . . 0.02 110.083 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -124.3 134.19 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.687 -0.856 . . . . 0.01 108.687 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.0 tp -96.0 120.55 36.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.156 . . . . 0.01 109.654 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.95 149.36 23.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.856 -0.794 . . . . 0.01 108.856 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.3 m-20 -109.58 -177.32 3.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 2.27 109.374 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -72.83 35.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.8400000000000001 109.469 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.526 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.6 mttp -111.55 176.2 5.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.078 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.92 127.03 52.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.424 -0.797 . . . . 0.01 109.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -98.31 112.26 24.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.01 108.847 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -88.7 -27.85 20.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.762 -0.586 . . . . 0.01 111.298 -177.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -122.53 153.43 62.59 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 107.907 -1.146 . . . . 2.54 107.907 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.0 Cg_endo -62.24 -41.44 34.61 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.315 0.791 . . . . 0.69999999999999996 110.805 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.57 -18.26 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.862 -1.149 . . . . 0.85999999999999999 109.457 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.5 -18.22 65.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.891 -1.13 . . . . 0.02 111.948 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.31 15.83 27.51 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.737 -1.227 . . . . 0.02 110.207 178.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.72 10.14 76.79 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.12 -0.987 . . . . 0.02 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.41 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.06 140.61 34.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.862 -1.375 . . . . 0.02 110.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.27 -7.05 59.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.621 -0.675 . . . . 0.58999999999999997 109.521 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.5 p -140.46 150.38 60.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.239 -0.913 . . . . 0.87 109.06 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.66 16.14 0.64 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 120.566 0.844 . . . . 0.38 111.776 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.19 119.9 24.66 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.307 1.051 . . . . 0.17999999999999999 110.817 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.43 123.64 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.57 -2.011 . . . . 3.9900000000000002 105.57 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -111.9 -13.16 13.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.369 -0.832 . . . . 5.1699999999999999 113.16 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.1 p -157.03 160.1 38.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 119.276 -2.14 . . . . 0.02 109.965 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.1 153.9 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 2.02 110.202 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -144.18 149.26 36.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.342 -0.849 . . . . 0.01 110.068 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 93' ' ' ALA . 4.6 ptp180 -87.02 141.48 28.64 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.603 -0.888 . . . . 0.01 108.603 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 41.7 mt -93.88 129.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 3.04 109.482 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.78 149.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.407 -0.808 . . . . 1.8899999999999999 109.771 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 4.8899999999999997 109.536 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.444 -0.576 . . . . 5.2800000000000002 109.444 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -82.13 135.37 35.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 5.96 109.588 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -138.58 -129.03 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.241 -0.912 . . . . 2.2200000000000002 111.431 -178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.33 94.73 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.593 -3.003 . . . . 0.81000000000000005 105.593 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 146.61 31.53 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.383 -0.913 . . . . 0.01 111.179 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.23 137.4 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.76 -0.847 . . . . 0.02 108.82 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 tt -129.89 140.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.937 -0.764 . . . . 0.02 108.937 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -120.9 130.14 53.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.721 . . . . 0.39000000000000001 109.654 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 25.7 m-85 -108.96 138.73 44.84 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.88 -0.785 . . . . 0.02 108.88 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.34 138.28 54.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.302 -0.874 . . . . 0.02 109.398 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -68.21 -27.75 66.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 0.029999999999999999 111.605 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -114.93 170.13 8.57 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.976 -1.077 . . . . 0.029999999999999999 110.422 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -74.73 161.66 29.42 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.708 0.766 . . . . 0.029999999999999999 110.063 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.2 t-20 62.58 34.91 14.74 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.894 0.854 . . . . 0.73999999999999999 110.559 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.0 p90 49.45 42.9 23.23 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.473 -0.785 . . . . 0.02 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -109.35 165.89 11.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.806 -1.183 . . . . 0.02 107.806 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -167.98 35.01 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.681 -1.262 . . . . 0.029999999999999999 110.837 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.9 143.96 54.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.955 . . . . 2.7599999999999998 109.035 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -122.16 150.05 42.76 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.727 0.775 . . . . 1.8899999999999999 110.207 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.24 128.59 36.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.158 -1.053 . . . . 0.02 108.158 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -110.98 135.92 50.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.549 -0.719 . . . . 1.1200000000000001 109.465 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -129.99 137.81 50.49 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.486 0.66 . . . . 0.02 109.682 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 10.89 14.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.248 -0.649 . . . . 0.20000000000000001 109.248 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' SG ' ' OD1' ' A' ' 25' ' ' ASP . 14.1 t -158.83 174.17 15.4 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.06 -1.089 . . . . 1.23 108.06 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 15.8 p-10 -61.66 144.74 54.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.756 -1.215 . . . . 0.02 110.216 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 t -131.49 117.5 18.88 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.5 -0.926 . . . . 0.02 108.5 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.01 44.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.23999999999999999 111.292 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -153.21 102.49 2.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.149 . . . . 1.1399999999999999 108.946 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' C ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -101.68 8.49 41.62 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.962 0.887 . . . . 6.3700000000000001 109.689 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -59.14 -26.74 65.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.731 -0.606 . . . . 3.1099999999999999 111.657 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.28 -17.32 60.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.591 -1.318 . . . . 0.88 110.36 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.14 -22.22 13.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.02 109.799 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 tp -150.1 128.26 11.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.052 -1.03 . . . . 3.3199999999999998 109.019 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -84.77 -9.21 58.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.781 -0.575 . . . . 0.02 111.016 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -171.03 164.11 7.46 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -142.24 114.15 8.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.726 -1.234 . . . . 0.02 108.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 37' ' ' ASN . 1.2 m-80 -109.14 -0.93 19.11 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.942 -1.099 . . . . 0.029999999999999999 111.343 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 1.3 t -154.02 153.8 32.59 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.457 ' N ' ' HG ' ' A' ' 38' ' ' SER . 16.3 mt -145.74 146.73 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.136 -0.978 . . . . 0.02 110.552 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' NE ' ' OH ' ' A' ' 10' ' ' TYR . 25.3 ttp180 -124.56 125.22 43.82 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.476 -1.305 . . . . 0.02 107.476 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.544 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 43.8 t -104.07 113.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 106.565 -1.643 . . . . 0.02 106.565 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' C ' ' NE2' ' A' ' 63' ' ' GLN . 11.1 tp10 -83.01 -34.47 26.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 3.8100000000000001 109.389 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.59 18.02 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.726 -1.702 . . . . 0.02 110.302 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.81 173.56 49.82 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.711 -1.233 . . . . 0.01 110.243 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -119.02 135.48 54.61 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.473 -1.306 . . . . 1.48 107.473 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.41 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.2 m95 -123.91 153.65 40.85 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.835 -1.166 . . . . 0.02 112.259 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.29 53.08 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.14 -2.17 . . . . 0.23999999999999999 105.14 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -118.63 142.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.129 -0.693 . . . . 0.65000000000000002 109.129 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.04 146.33 46.83 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.295 1.045 . . . . 0.02 109.617 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.53 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 0.6 OUTLIER -66.0 -35.66 81.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.55 -0.75 . . . . 0.02 111.121 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -123.46 158.52 58.56 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 121.2 -0.937 . . . . 0.02 109.067 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.83 168.38 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.65 1.567 . . . . 0.02 112.8 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 62.75 37.42 12.57 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.421 -0.809 . . . . 0.02 111.197 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.73 52.11 8.01 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.573 0.701 . . . . 3.3900000000000001 110.793 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.605 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 28.8 t -126.61 164.16 21.84 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.193 0.52 . . . . 2.3300000000000001 109.838 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.605 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.35 -161.55 32.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.517 -1.433 . . . . 0.02 109.517 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -66.44 137.55 56.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.927 -1.337 . . . . 0.02 109.61 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.49 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.8 ptm -119.24 137.52 53.6 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.305 -0.628 . . . . 5.0099999999999998 109.305 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.1 m-85 -132.3 138.9 47.99 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.02 109.466 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.4 mm -96.23 132.1 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.764 -0.828 . . . . 1.72 108.764 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.45 110.13 34.23 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.255 -0.903 . . . . 0.02 110.751 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.2 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.793 0.962 . . . . 1.47 109.981 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 3.1 tp-100 -50.56 138.71 17.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 4.25 110.254 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.04 -179.17 32.15 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.035 -1.555 . . . . 0.02 110.884 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.0 130.83 55.89 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.547 -0.972 . . . . 0.95999999999999996 109.462 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -120.87 94.33 48.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.664 -1.236 . . . . 0.02 107.664 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.08 -4.47 11.6 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.781 0.988 . . . . 0.02 113.738 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -155.01 154.43 32.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.723 -1.236 . . . . 2.02 108.008 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CE2' ' CD ' ' A' ' 70' ' ' GLN . 33.3 p90 -61.12 -38.74 87.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.514 -0.741 . . . . 0.02 111.396 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.447 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 12.8 mm100 -60.38 -24.39 65.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.102 -0.999 . . . . 0.02 110.058 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.541 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.06 -18.09 63.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.293 -1.003 . . . . 3.4199999999999999 108.293 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.7 10.13 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.221 -1.4 . . . . 0.02 107.221 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.1 mpp? 59.2 21.9 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.664 0.745 . . . . 0.02 110.138 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 144.47 46.48 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.321 -1.512 . . . . 0.02 109.321 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 -30.03 48.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.623 -1.251 . . . . 0.97999999999999998 107.623 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.53 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -157.96 -171.17 3.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.533 -1.654 . . . . 0.02 106.533 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.9 p-10 -98.21 28.3 4.13 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.682 -1.262 . . . . 0.02 110.403 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.508 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -97.57 122.83 41.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.814 -1.179 . . . . 3.2000000000000002 111.056 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -142.33 122.01 13.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.286 -1.376 . . . . 2.6099999999999999 107.286 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -18.12 10.6 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.985 -1.072 . . . . 0.02 112.302 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.546 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 28.4 t -156.14 155.86 33.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.463 -1.61 . . . . 0.02 110.277 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.546 ' N ' ' HG ' ' A' ' 81' ' ' SER . 70.4 m -144.33 147.63 33.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.02 109.791 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -135.02 140.22 45.47 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.28 -0.888 . . . . 0.01 109.111 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 134.92 37.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 0.42999999999999999 108.753 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 123.09 45.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.554 -0.906 . . . . 1.25 108.554 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 135' ' ' THR . 50.1 m-70 -90.48 136.18 33.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.183 -1.043 . . . . 1.77 108.183 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.51 137.29 38.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 1.6299999999999999 109.6 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.8 m -112.1 126.32 55.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.58 -0.896 . . . . 1.0800000000000001 108.58 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -102.99 -155.47 0.53 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.262 -1.755 . . . . 1.26 106.262 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.16 -48.96 0.86 Allowed Glycine 0 N--CA 1.498 2.83 0 O-C-N 120.438 -1.414 . . . . 0.01 112.384 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.88 -99.58 0.13 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.444 -1.836 . . . . 0.01 112.166 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -120.84 119.6 33.14 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.246 -1.149 . . . . 4.4299999999999997 110.751 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.3 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.187 -0.671 . . . . 2.9900000000000002 109.187 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -130.91 141.16 50.27 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.557 -0.714 . . . . 6.3600000000000003 109.085 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.78 144.84 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.319 -0.863 . . . . 1.0900000000000001 109.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.4 pm0 -121.76 134.37 54.93 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.404 -1.332 . . . . 2.0499999999999998 107.404 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 146.58 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.914 -1.116 . . . . 1.1000000000000001 109.371 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 36.0 m-85 -120.23 141.64 49.75 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.158 0.98 . . . . 0.72999999999999998 111.108 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -66.43 -30.05 70.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.699 -0.682 . . . . 0.02 111.816 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -116.29 168.09 10.44 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.956 -1.09 . . . . 3.1800000000000002 110.54 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.94 164.14 43.77 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 111.153 -0.779 . . . . 0.01 111.153 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 56.54 39.23 29.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.675 0.75 . . . . 0.01 110.941 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 51.45 56.31 8.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.625 -0.672 . . . . 0.01 111.115 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -128.55 165.64 20.36 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.008 -1.108 . . . . 3.1499999999999999 108.008 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.61 -164.08 27.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.151 -1.579 . . . . 0.01 109.151 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.66 144.32 43.87 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.983 -1.304 . . . . 0.01 108.411 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.8 ttt -116.5 141.74 47.79 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.619 0.723 . . . . 0.01 109.521 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -131.65 135.72 47.14 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.069 -1.085 . . . . 2.48 108.069 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -118.93 135.12 54.75 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.668 -0.645 . . . . 0.01 109.928 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -149.64 151.55 33.94 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.392 1.091 . . . . 1.6899999999999999 110.95 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.401 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 18.6 p -111.05 9.68 22.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.396 -0.82 . . . . 0.01 109.923 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 30.5 mp0 -121.28 163.85 17.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.324 -0.86 . . . . 3.21 111.556 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -67.73 156.03 37.88 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.443 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 12.3 m -124.83 111.67 27.3 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.753 -0.832 . . . . 0.01 108.753 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.447 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.0 Cg_endo -76.21 -31.78 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 CA-C-N 119.958 1.021 . . . . 0.01 111.439 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -141.3 107.03 5.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.573 -0.899 . . . . 0.02 108.573 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.85 -39.28 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.81 -0.557 . . . . 1.8300000000000001 111.139 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.5 tmt? -67.19 -38.2 84.98 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.97 -1.092 . . . . 1.3400000000000001 109.892 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.14 -38.44 78.82 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.484 -1.385 . . . . 2.1099999999999999 109.826 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -79.63 -47.4 15.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 2.0800000000000001 112.38 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.12 -0.48 15.59 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.469 -0.769 . . . . 0.02 112.75 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m80 61.54 33.77 18.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.687 -1.258 . . . . 0.02 109.719 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.8 136.21 53.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.371 -0.831 . . . . 0.02 109.256 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -89.46 -21.73 22.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 5.3200000000000003 110.473 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -150.38 165.67 32.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.958 -1.088 . . . . 0.02 110.256 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.7 mm -129.87 126.57 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.219 -1.4 . . . . 2.1699999999999999 107.219 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -108.97 -12.94 14.81 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.14 -0.975 . . . . 0.02 112.598 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 21.1 m -158.16 152.34 24.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.764 -1.21 . . . . 0.01 108.753 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.8 t -166.51 142.81 4.75 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.099 -1.001 . . . . 1.22 109.152 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.531 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 31.4 ttpt -123.21 105.34 9.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.57 1.176 . . . . 1.4099999999999999 109.504 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 p -109.57 135.7 47.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.5 -1.296 . . . . 0.01 107.5 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -126.15 92.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.347 -1.723 . . . . 1.98 106.347 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.539 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 24.3 tt0 -146.42 -67.39 0.28 Allowed 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 105.355 -2.091 . . . . 0.01 105.355 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 145.55 -44.48 0.87 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.342 -1.503 . . . . 0.01 109.342 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 86' ' ' HIS . 61.8 p -129.13 106.55 8.93 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.331 -1.099 . . . . 2.2999999999999998 112.205 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.539 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 14.3 m95 -132.95 145.54 50.99 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.549 -1.278 . . . . 0.01 107.549 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.3 mt -118.98 135.75 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.581 -1.324 . . . . 1.6899999999999999 109.566 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.34 142.16 43.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.341 -1.725 . . . . 2.4900000000000002 106.341 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 31.9 m-85 -122.23 143.53 49.53 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.113 -0.992 . . . . 0.02 109.364 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 47.4 tt0 -76.68 -30.03 56.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.747 -0.596 . . . . 0.02 111.833 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.1 mt -114.33 152.57 46.13 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.562 -1.336 . . . . 1.48 109.064 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.72 165.64 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.65 0.9 . . . . 0.02 112.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 59.71 31.67 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.307 -0.86 . . . . 0.75 111.549 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 57.88 52.13 8.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.514 -0.742 . . . . 0.02 111.412 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.439 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.0 165.51 19.3 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.473 -0.767 . . . . 0.02 110.059 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.86 -165.54 33.36 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.962 -1.255 . . . . 0.02 109.962 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -69.83 143.59 52.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.02 108.94 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 58' ' ' MET . 16.6 mt-30 -113.08 149.5 33.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.02 110.085 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.87 133.61 53.01 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.92 121.58 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.944 -1.098 . . . . 0.01 109.785 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.7 mp -98.31 142.32 30.1 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.72 -0.845 . . . . 0.01 108.72 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 154' ' ' LYS . 95.1 m-20 -110.26 -172.55 2.06 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.445 -0.784 . . . . 2.27 109.739 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -71.64 37.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.636 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 152' ' ' ASP . 30.6 mmtp -112.31 168.74 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.413 -0.804 . . . . 2.2799999999999998 109.3 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -104.34 127.0 51.92 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.039 -1.097 . . . . 0.01 108.039 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 54.8 m-85 -99.58 112.47 24.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.928 . . . . 0.01 110.258 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.444 ' O ' ' OG ' ' A' ' 128' ' ' SER . 78.7 mtt180 -89.31 -27.39 20.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.632 -0.667 . . . . 0.01 110.845 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -124.43 152.82 68.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 108.134 -1.062 . . . . 2.54 108.134 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 7.8 Cg_endo -60.83 -40.25 55.37 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 CA-C-N 119.437 0.835 . . . . 0.69999999999999996 111.005 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.49 -18.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 120.724 -1.235 . . . . 0.85999999999999999 109.67 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 156' ' ' TYR . 39.2 t70 -65.4 -17.6 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.91 -1.119 . . . . 0.02 112.062 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.17 16.7 24.59 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 120.733 -1.23 . . . . 0.02 110.229 178.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.02 77.68 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.174 -0.954 . . . . 0.02 112.874 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.11 139.81 34.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.85 -1.382 . . . . 0.02 110.146 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.67 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.58999999999999997 109.342 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 p -138.92 151.77 68.91 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.87 109.261 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.77 13.58 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.756 0.971 . . . . 0.38 111.892 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.55 119.62 24.0 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.603 1.192 . . . . 0.17999999999999999 111.039 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.508 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 0.9 OUTLIER -150.55 121.93 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.013 -1.847 . . . . 3.9900000000000002 106.013 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.507 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 11.0 mp0 -113.69 -11.57 12.93 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 113.253 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 18.1 m -156.46 159.01 38.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.119 -2.238 . . . . 0.02 110.45 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.443 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 25.3 p90 -152.79 154.34 34.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.029 -1.044 . . . . 2.02 110.3 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -144.21 149.88 37.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 0.01 110.125 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -87.05 141.97 28.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.311 -0.996 . . . . 0.01 108.311 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 24.6 mt -93.71 129.54 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.325 -0.859 . . . . 3.04 109.411 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 m -138.28 149.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.351 -0.843 . . . . 1.8899999999999999 109.756 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 4.8899999999999997 109.56 179.474 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.357 -0.609 . . . . 5.2800000000000002 109.357 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -74.35 93.52 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 5.96 109.437 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -101.3 -141.28 0.34 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.677 -1.231 . . . . 2.2200000000000002 107.677 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.21 87.36 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 107.16 -2.376 . . . . 0.81000000000000005 107.16 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 149.31 33.31 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.162 -1.018 . . . . 0.01 110.683 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -150.88 136.84 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.496 -1.002 . . . . 0.02 109.493 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.9 140.42 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 109.2 -0.666 . . . . 0.02 109.2 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.525 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -122.03 130.23 53.11 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.571 -0.705 . . . . 0.39000000000000001 109.642 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 24.6 m-85 -110.31 140.13 44.8 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.007 -0.738 . . . . 0.02 109.007 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.525 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 9.0 m-85 -121.98 138.45 54.42 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.339 -0.851 . . . . 0.02 109.546 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 66.2 mt-10 -68.14 -27.82 66.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -0.989 . . . . 0.029999999999999999 111.706 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -114.26 170.03 8.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.867 -1.146 . . . . 0.029999999999999999 110.468 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -75.22 158.26 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.498 0.666 . . . . 0.029999999999999999 110.058 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.9 m-80 66.2 34.65 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.826 0.822 . . . . 0.73999999999999999 110.767 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.95 45.22 25.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.668 0.746 . . . . 0.02 111.428 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.24 165.88 11.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.66 -167.71 35.43 Favored Glycine 0 N--CA 1.496 2.674 0 O-C-N 120.793 -1.192 . . . . 0.029999999999999999 110.912 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -68.61 142.74 55.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.45 -1.03 . . . . 2.7599999999999998 109.279 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -120.02 148.65 43.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.597 -0.69 . . . . 1.8899999999999999 110.23 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -132.33 127.06 34.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.257 -1.016 . . . . 0.02 108.257 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -111.81 136.51 50.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.483 -0.761 . . . . 1.1200000000000001 109.762 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -130.91 138.02 49.58 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.573 0.701 . . . . 0.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -116.47 11.29 14.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.623 -0.673 . . . . 0.20000000000000001 109.477 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 19.9 p -157.79 174.15 15.73 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.195 -1.039 . . . . 1.23 108.195 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 19.3 p30 -61.11 144.66 53.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.72 -1.238 . . . . 0.02 109.955 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 t -131.76 116.53 17.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.415 -0.957 . . . . 0.02 108.415 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.59 52.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.23999999999999999 110.733 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -156.58 100.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.676 -0.861 . . . . 1.1399999999999999 108.676 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -104.89 10.46 34.33 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 122.175 0.988 . . . . 6.3700000000000001 109.799 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.4 mmp_? -59.27 -23.44 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.68 -0.638 . . . . 3.1099999999999999 111.018 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 p -75.5 -17.0 60.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.685 -1.259 . . . . 0.88 110.185 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 26.2 m-85 -104.26 -21.74 13.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.495 -0.753 . . . . 0.02 109.132 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.6 tp -148.53 126.42 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 3.3199999999999998 109.41 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 m -86.29 -11.54 51.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.463 -0.773 . . . . 0.02 111.405 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.2 tpp180 -170.65 160.39 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.697 -1.223 . . . . 0.02 107.697 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -140.89 114.61 8.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.897 -1.127 . . . . 0.02 109.455 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 11' ' ' GLU . 2.7 m120 -108.2 -0.96 20.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.535 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.6 m -155.7 153.59 30.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.1 mt -145.14 146.91 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 0.02 110.063 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -123.11 123.92 41.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.78 -1.193 . . . . 0.02 107.78 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 38.3 t -106.52 114.17 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -84.0 -33.74 24.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.234 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.46 18.0 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.109 -1.519 . . . . 0.02 110.048 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 173.41 49.72 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.487 -1.34 . . . . 0.01 110.04 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.2 m -120.39 138.03 53.98 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.107 -1.072 . . . . 1.48 108.107 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -126.99 154.43 44.62 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.559 1.171 . . . . 0.02 112.057 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.54 133.57 51.81 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 104.938 -2.245 . . . . 0.23999999999999999 104.938 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.7 141.42 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.178 -0.675 . . . . 0.65000000000000002 109.178 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.06 144.18 48.68 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.184 0.992 . . . . 0.02 109.706 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.36 -34.51 78.32 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.339 -0.846 . . . . 0.02 111.459 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -124.09 157.81 62.68 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.238 -0.914 . . . . 0.02 109.328 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.67 167.52 0.97 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.762 1.641 . . . . 0.02 112.563 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 2.0 t30 63.27 37.12 11.31 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.457 -0.792 . . . . 0.02 111.211 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 1.8 m-85 45.35 51.26 9.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.613 -0.679 . . . . 3.3900000000000001 110.819 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -125.75 163.91 21.82 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.153 0.501 . . . . 2.3300000000000001 109.994 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -162.01 31.53 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.715 -1.354 . . . . 0.02 109.715 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -65.57 137.25 57.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.332 . . . . 0.02 109.806 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.468 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.4 ptm -117.66 136.35 53.38 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.487 0.66 . . . . 5.0099999999999998 109.692 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -133.62 139.87 46.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.484 -0.76 . . . . 0.02 109.49 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -95.7 132.03 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.5 mt -122.25 109.42 33.28 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.57 -0.706 . . . . 0.02 110.206 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -75.49 170.64 19.83 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.893 0.998 . . . . 1.47 110.352 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 41' ' ' VAL . 1.1 tm0? -51.83 140.26 19.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 4.25 109.862 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 155.53 -177.79 32.49 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.486 -1.34 . . . . 0.02 110.565 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -120.63 131.3 54.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.516 -0.991 . . . . 0.95999999999999996 109.305 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 64.8 m-85 -122.42 93.56 48.4 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.866 -1.161 . . . . 0.02 107.866 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.06 -3.68 7.61 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.034 1.156 . . . . 0.02 113.92 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -156.87 152.95 27.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.379 -1.451 . . . . 2.02 107.91 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -60.07 -38.7 83.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.612 -0.68 . . . . 0.02 111.977 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.5 -24.85 65.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.972 . . . . 0.02 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -17.98 63.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 3.4199999999999999 108.999 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.572 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.89 12.06 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.277 -1.379 . . . . 0.02 107.277 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.2 mtp 60.2 21.85 11.2 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.528 0.68 . . . . 0.02 110.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.92 144.65 46.44 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.386 -1.486 . . . . 0.02 109.386 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.24 -30.45 43.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.549 -1.278 . . . . 0.97999999999999998 107.549 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.533 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 51.6 t30 -156.98 -171.92 3.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.397 -1.705 . . . . 0.02 106.397 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.533 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 30.6 p-10 -98.58 27.93 4.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.66 -1.275 . . . . 0.02 110.208 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -96.0 122.55 38.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.848 -1.157 . . . . 3.2000000000000002 110.638 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.427 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 51.3 mt -143.48 121.48 12.08 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.808 -1.182 . . . . 2.6099999999999999 107.808 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.11 -17.71 9.31 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 121.26 -0.9 . . . . 0.02 112.641 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.451 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 5.1 t -155.53 155.77 33.99 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.043 -1.857 . . . . 0.02 110.867 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.451 ' N ' ' HG ' ' A' ' 81' ' ' SER . 10.9 p -145.5 147.72 32.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.02 110.653 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 13.8 mtp180 -136.67 141.83 43.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.01 109.288 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 130.35 36.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.451 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 t -90.18 123.55 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.608 -0.886 . . . . 1.25 108.608 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -90.3 135.41 33.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 1.77 108.703 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -99.65 138.66 36.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.729 -0.841 . . . . 1.6299999999999999 108.729 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 133' ' ' GLU . 58.6 p -113.2 125.67 54.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.942 -0.762 . . . . 1.0800000000000001 108.942 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.0 t -102.79 -155.4 0.52 Allowed 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 105.992 -1.855 . . . . 1.26 105.992 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.74 -47.35 0.95 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 120.356 -1.465 . . . . 0.01 112.345 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.53 -98.86 0.12 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.433 -1.841 . . . . 0.01 112.181 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.516 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 16.7 tm0? -119.56 117.97 29.78 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.222 -1.163 . . . . 4.4299999999999997 110.317 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.0 132.1 39.96 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.304 -0.628 . . . . 2.9900000000000002 109.304 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -131.01 137.42 49.19 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.028 -0.73 . . . . 6.3600000000000003 109.028 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 5.6 tt -125.22 142.61 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.874 0.845 . . . . 1.0900000000000001 109.139 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.502 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 11.0 pt20 -124.77 132.26 53.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.744 -1.206 . . . . 2.0499999999999998 107.744 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.06 148.15 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 120.919 -1.113 . . . . 1.1000000000000001 109.659 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -117.97 140.96 48.99 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.042 0.925 . . . . 0.72999999999999998 110.849 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.59 -30.12 70.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.938 -0.574 . . . . 0.02 111.765 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 128' ' ' SER . 83.3 mttt -116.57 168.4 10.21 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.983 -1.073 . . . . 3.1800000000000002 110.49 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.21 164.59 44.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 56.71 39.18 29.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.635 0.731 . . . . 0.01 111.117 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.477 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.5 m-85 52.53 55.68 8.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.583 -0.698 . . . . 0.01 111.076 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -129.65 166.32 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.515 -0.92 . . . . 3.1499999999999999 108.515 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.79 -164.71 27.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.277 -1.529 . . . . 0.01 109.277 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.26 145.11 42.17 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.009 -1.289 . . . . 0.01 108.619 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.484 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 9.9 tmm? -116.51 141.72 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.633 0.73 . . . . 0.01 109.772 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.484 ' N ' ' SD ' ' A' ' 107' ' ' MET . 59.8 m-85 -130.32 135.17 47.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.888 -1.153 . . . . 2.48 107.888 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -121.32 135.01 55.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.727 -0.608 . . . . 0.01 109.809 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.5 t -149.55 153.63 37.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.242 1.02 . . . . 1.6899999999999999 110.786 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.489 ' CG2' ' NE2' ' A' ' 92' ' ' GLN . 34.9 p -110.43 9.41 23.38 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.646 -0.706 . . . . 0.01 109.933 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -121.39 163.07 19.3 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.381 -0.824 . . . . 3.21 111.384 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.32 155.0 38.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.193 -1.04 . . . . 0.01 108.193 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 29.4 t -124.15 111.42 28.63 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.77 -31.86 4.97 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 CA-C-N 120.134 1.084 . . . . 0.01 111.554 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -141.6 108.33 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.22 -0.925 . . . . 0.02 108.959 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.8 mt -62.97 -38.75 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.853 -0.529 . . . . 1.8300000000000001 110.408 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 30.9 ttm -66.5 -37.26 84.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.12 -1.032 . . . . 1.3400000000000001 109.831 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -70.91 -39.34 72.78 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.44 -1.412 . . . . 2.1099999999999999 109.69 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 6.6 tt0 -80.85 -48.2 12.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 2.0800000000000001 112.679 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.54 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 62.5 m-85 -111.95 -1.79 15.33 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.376 -0.828 . . . . 0.02 112.491 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 61.23 33.84 18.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.873 -1.142 . . . . 0.02 109.589 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.6 mt -114.02 135.44 54.0 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.413 -0.804 . . . . 0.02 109.195 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -90.68 -21.7 21.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.126 -0.984 . . . . 5.3200000000000003 111.276 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -149.41 164.97 33.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.721 -1.237 . . . . 0.02 110.668 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.8 mm -127.66 123.81 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.726 -1.213 . . . . 2.1699999999999999 107.726 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -109.11 -14.78 14.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.11 -0.994 . . . . 0.02 112.642 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.477 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 23.6 p -160.91 153.71 21.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.572 -1.33 . . . . 0.01 108.941 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.502 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 1.8 t -167.0 141.02 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.628 -0.878 . . . . 1.22 108.628 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.538 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -121.26 97.4 5.5 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.133 -1.062 . . . . 1.4099999999999999 108.133 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.9 p -109.83 142.59 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.396 -0.965 . . . . 0.01 108.396 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.77 92.29 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.192 -1.781 . . . . 1.98 106.192 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 26.2 tt0 -147.21 -68.24 0.25 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.377 -1.342 . . . . 0.01 107.377 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.14 -14.19 13.78 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.633 -2.187 . . . . 0.01 107.633 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.7 p -122.55 66.93 0.95 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.789 -0.83 . . . . 2.2999999999999998 111.283 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.529 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 81.9 m95 -131.18 133.1 45.21 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.86 -1.15 . . . . 0.01 110.318 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.72 136.21 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.304 -0.998 . . . . 1.6899999999999999 108.304 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -112.58 142.36 45.25 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.67 -1.604 . . . . 2.4900000000000002 106.67 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.56 ' HH ' ' NH2' ' A' ' 173' ' ' ARG . 20.3 m-85 -123.42 145.99 48.36 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.161 -0.962 . . . . 0.02 110.081 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.04 -31.19 61.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.02 111.465 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.7 mt -115.6 155.75 46.99 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.68 -1.263 . . . . 1.48 108.985 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -57.44 167.53 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.101 1.201 . . . . 0.02 112.741 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 9.9 t30 59.4 31.44 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.192 -0.913 . . . . 0.75 111.325 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.88 51.77 8.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.5 -0.75 . . . . 0.02 110.952 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.36 164.82 20.23 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.51 -0.744 . . . . 0.02 109.791 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.416 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.55 -165.62 33.9 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.279 -1.129 . . . . 0.02 110.279 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.58 142.36 53.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.499 -1.001 . . . . 0.02 108.825 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.3 mt-30 -113.06 148.14 35.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.34 0.591 . . . . 0.02 109.826 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -122.86 132.66 54.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.436 -0.95 . . . . 0.01 108.436 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.36 121.56 37.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.933 -1.105 . . . . 0.01 109.702 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.03 161.22 13.92 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.796 -1.187 . . . . 0.01 107.796 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.704 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 4.0 m-20 -111.38 -110.46 0.34 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.413 -0.805 . . . . 2.27 109.801 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -151.16 31.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 1.8400000000000001 109.03 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -109.73 -165.42 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.974 -0.75 . . . . 2.2799999999999998 108.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 2.7 mm-40 -106.26 118.37 36.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.517 -0.739 . . . . 0.01 109.419 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.704 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 79.8 m-85 -97.4 113.13 24.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -90.09 -27.4 19.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.487 -0.758 . . . . 0.01 111.625 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -127.0 156.26 74.52 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.738 -1.226 . . . . 2.54 108.064 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.14 -38.84 53.11 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.51 0.807 . . . . 0.69999999999999996 111.282 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.48 -19.39 18.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.856 -1.152 . . . . 0.85999999999999999 109.914 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.76 -18.32 65.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.823 -1.173 . . . . 0.02 112.111 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.36 16.28 26.1 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.722 -1.236 . . . . 0.02 110.191 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.25 10.69 77.25 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.104 -0.998 . . . . 0.02 112.806 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.52 140.57 34.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.861 -1.376 . . . . 0.02 110.303 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.6 -7.95 58.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.696 -0.628 . . . . 0.58999999999999997 109.715 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 p -140.67 150.85 61.59 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.227 -0.92 . . . . 0.87 109.33 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.59 14.48 1.21 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.903 1.068 . . . . 0.38 112.304 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.7 121.28 26.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.891 -1.13 . . . . 0.17999999999999999 111.231 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.5 mp -153.1 124.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.469 -1.678 . . . . 3.9900000000000002 106.469 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -114.15 -8.72 12.97 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.425 -0.797 . . . . 5.1699999999999999 113.143 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 p -157.22 158.69 36.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.359 -2.088 . . . . 0.02 109.448 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -152.82 154.21 34.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -0.886 . . . . 2.02 110.147 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.56 ' NH2' ' HH ' ' A' ' 139' ' ' TYR . 81.5 mtm180 -144.48 150.34 37.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.265 -0.897 . . . . 0.01 110.296 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.52 142.71 27.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.703 -0.851 . . . . 0.01 108.703 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.46 128.61 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.311 -0.868 . . . . 3.04 109.329 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.11 148.47 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.127 -0.983 . . . . 1.8899999999999999 110.009 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.45 -0.781 . . . . 4.8899999999999997 109.435 179.569 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.431 -0.581 . . . . 5.2800000000000002 109.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -76.72 92.58 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.396 -0.815 . . . . 5.96 109.538 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.2 p -101.1 -141.69 0.34 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.537 -1.283 . . . . 2.2200000000000002 107.537 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.35 86.51 0.06 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 107.095 -2.402 . . . . 0.81000000000000005 107.095 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.06 148.88 33.59 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.174 -1.012 . . . . 0.01 110.625 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HZ2' ' CB ' ' A' ' 6' ' ' LYS . 7.7 ttpm? -150.72 136.72 18.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.979 . . . . 0.02 109.077 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.71 140.42 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.897 -0.779 . . . . 0.02 108.897 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.539 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.88 129.97 52.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.483 -0.76 . . . . 0.39000000000000001 109.644 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 7.7 m-85 -109.68 139.96 44.1 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.572 -0.899 . . . . 0.02 108.572 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.539 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 5.9 m-85 -122.05 138.67 54.35 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.229 -0.92 . . . . 0.02 109.646 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -68.23 -27.67 66.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.919 -1.113 . . . . 0.029999999999999999 111.736 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.63 170.4 8.34 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.869 -1.144 . . . . 0.029999999999999999 110.11 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -75.39 161.34 29.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.738 0.78 . . . . 0.029999999999999999 110.217 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 m120 63.04 34.95 13.43 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.933 0.873 . . . . 0.73999999999999999 110.433 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p90 49.51 42.52 22.89 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.39 -0.823 . . . . 0.02 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -109.11 166.07 11.12 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.34 -168.14 34.76 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 120.739 -1.225 . . . . 0.029999999999999999 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -70.05 145.3 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.474 -1.016 . . . . 2.7599999999999998 109.098 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -120.4 149.24 42.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.594 -0.692 . . . . 1.8899999999999999 110.272 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -132.07 126.99 35.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.942 -1.133 . . . . 0.02 107.942 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.33 136.7 51.46 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 110.02 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.475 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -131.14 137.96 49.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.56 0.695 . . . . 0.02 109.471 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -116.59 10.7 14.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.672 -0.643 . . . . 0.20000000000000001 109.503 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.8 t -157.71 173.84 16.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.134 -1.061 . . . . 1.23 108.134 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -60.85 144.29 53.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.683 -1.261 . . . . 0.02 110.087 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.52 116.9 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.438 -0.949 . . . . 0.02 108.438 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.89 52.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.192 -0.942 . . . . 0.23999999999999999 110.537 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -153.48 100.61 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 1.1399999999999999 108.701 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -104.21 9.21 36.21 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.285 1.04 . . . . 6.3700000000000001 109.39 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -58.68 -24.03 60.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.741 . . . . 3.1099999999999999 110.571 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 m -74.39 -16.84 60.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.16 . . . . 0.88 110.057 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.66 -22.14 13.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.357 -0.84 . . . . 0.02 109.272 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.9 tp -150.06 128.47 12.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 3.3199999999999998 109.014 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.1 p -85.33 -9.87 57.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.689 -0.632 . . . . 0.02 110.964 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.91 163.01 6.17 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -142.7 115.51 8.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.873 -1.142 . . . . 0.02 108.709 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.64 0.91 20.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.854 -1.154 . . . . 0.029999999999999999 110.601 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.538 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 13.1 t -156.67 153.45 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.538 ' N ' ' HG ' ' A' ' 38' ' ' SER . 79.6 mt -145.12 148.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.013 -1.054 . . . . 0.02 109.969 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -124.7 124.69 42.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.348 -1.353 . . . . 0.02 107.348 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.46 114.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.099 -1.445 . . . . 0.02 107.099 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.61 -34.47 25.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 3.8100000000000001 109.855 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.28 17.53 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 118.698 -1.715 . . . . 0.02 110.433 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.96 173.26 49.66 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.547 -1.311 . . . . 0.01 110.23 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -120.01 136.13 54.67 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.806 -1.183 . . . . 1.48 107.806 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.5 m95 -125.17 154.5 41.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.518 1.152 . . . . 0.02 112.159 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.12 133.44 52.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 104.964 -2.235 . . . . 0.23999999999999999 104.964 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.23 141.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.704 ' HH ' HH21 ' A' ' 83' ' ' ARG . 69.6 m-85 -120.58 143.56 48.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.261 1.029 . . . . 0.02 109.224 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 8.1 tp10 -66.1 -35.23 79.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.359 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.4 mpt_? -122.75 158.05 58.02 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 121.114 -0.991 . . . . 0.02 109.402 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -54.51 166.7 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.46 1.44 . . . . 0.02 112.567 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 63.12 37.36 11.5 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.382 -0.827 . . . . 0.02 111.173 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 44.67 52.57 7.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.674 0.749 . . . . 3.3900000000000001 110.773 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -126.4 163.75 22.61 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.114 0.483 . . . . 2.3300000000000001 109.705 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.4 -161.62 32.73 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.719 -1.352 . . . . 0.02 109.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -66.22 137.54 57.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.313 . . . . 0.02 110.139 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.2 ptm -121.27 136.53 54.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.664 -0.648 . . . . 5.0099999999999998 109.482 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.62 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.4 m-85 -133.32 142.03 48.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.717 . . . . 0.02 109.418 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 mm -96.14 132.56 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.127 -0.694 . . . . 1.72 109.127 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -121.73 109.69 34.04 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.481 -0.762 . . . . 0.02 110.391 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -75.81 169.78 21.51 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.033 1.048 . . . . 1.47 110.403 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -53.06 140.18 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.908 -1.12 . . . . 4.25 110.572 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.18 -177.23 32.52 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.614 -1.279 . . . . 0.02 110.386 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -118.98 129.94 55.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.471 -1.017 . . . . 0.95999999999999996 109.413 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 46.0 m-85 -120.82 95.48 48.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.32 -3.9 10.81 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 120.682 0.921 . . . . 0.02 113.666 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -156.82 154.28 29.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 2.02 108.254 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.37 -38.57 84.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.582 -0.699 . . . . 0.02 111.654 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.63 -24.54 65.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.028 -1.045 . . . . 0.02 110.336 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.68 -18.23 64.23 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.956 0.884 . . . . 3.4199999999999999 108.831 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.62 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.64 11.86 28.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.333 -1.358 . . . . 0.02 107.333 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.5 mpt? 59.49 22.78 11.35 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.504 0.669 . . . . 0.02 110.243 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 146.35 46.62 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.253 -1.539 . . . . 0.02 109.253 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.8 tp -79.63 -30.63 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.97999999999999998 108.013 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.541 HD21 ' H ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -157.65 -170.89 3.36 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.64 27.85 4.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.776 -1.203 . . . . 0.02 110.436 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.541 ' H ' HD21 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -96.31 122.5 39.25 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.081 -1.012 . . . . 3.2000000000000002 110.0 -178.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.5 mt -143.5 122.66 12.93 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.957 -1.127 . . . . 2.6099999999999999 107.957 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.98 -17.82 9.3 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.168 -0.957 . . . . 0.02 112.732 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 t -156.1 156.1 33.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 119.978 -1.896 . . . . 0.02 110.857 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.2 t -145.47 147.54 32.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.02 110.254 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.704 HH21 ' HH ' ' A' ' 49' ' ' TYR . 61.8 mtm180 -135.64 140.8 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.921 -0.77 . . . . 0.01 108.921 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.96 132.29 37.8 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.092 -1.005 . . . . 0.42999999999999999 108.679 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.29 124.14 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.438 -0.949 . . . . 1.25 108.438 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.41 134.66 34.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.104 -0.998 . . . . 1.77 108.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.6 137.97 35.72 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.456 -0.942 . . . . 1.6299999999999999 108.456 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -110.9 125.65 53.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.483 -0.932 . . . . 1.0800000000000001 108.483 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -103.28 -155.0 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.59 -48.53 0.92 Allowed Glycine 0 N--CA 1.498 2.809 0 O-C-N 120.458 -1.401 . . . . 0.01 112.055 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.38 -99.33 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.592 -1.766 . . . . 0.01 112.187 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -122.29 120.12 33.14 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.402 -1.057 . . . . 4.4299999999999997 110.653 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.37 129.83 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.914 -0.714 . . . . 2.9900000000000002 109.142 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -131.48 139.53 49.35 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 6.3600000000000003 109.334 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.83 145.58 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.389 -0.819 . . . . 1.0900000000000001 109.85 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.02 133.63 55.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.284 -1.376 . . . . 2.0499999999999998 107.284 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.68 147.11 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.852 -1.155 . . . . 1.1000000000000001 109.419 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.3 m-85 -119.3 141.61 48.84 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.055 0.931 . . . . 0.72999999999999998 111.07 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -66.27 -29.85 70.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.919 -0.582 . . . . 0.02 111.589 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.54 168.08 10.49 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.933 -1.105 . . . . 3.1800000000000002 110.696 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.07 42.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.989 -0.844 . . . . 0.01 110.989 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t0 56.56 39.47 29.85 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.65 0.738 . . . . 0.01 110.951 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.432 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.2 m-85 52.49 55.36 9.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.688 -0.633 . . . . 0.01 111.038 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -128.63 165.81 20.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.468 -0.938 . . . . 3.1499999999999999 108.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.11 -164.94 27.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.23 -1.548 . . . . 0.01 109.23 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.499 ' CD ' ' HH ' ' A' ' 108' ' ' TYR . 46.7 tt0 -74.53 144.57 44.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.951 -1.323 . . . . 0.01 108.3 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 24.2 ttp -116.53 142.27 47.1 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.554 0.692 . . . . 0.01 109.804 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.499 ' HH ' ' CD ' ' A' ' 106' ' ' GLN . 58.1 m-85 -131.56 136.0 47.48 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.05 -1.093 . . . . 2.48 108.05 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.8 tm-20 -120.25 135.35 55.02 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.446 -0.784 . . . . 0.01 110.145 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.597 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 3.9 t -149.2 151.64 34.64 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.277 1.037 . . . . 1.6899999999999999 111.0 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.3 p -110.73 9.39 22.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.606 -0.725 . . . . 0.01 110.009 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.597 ' H ' ' HG1' ' A' ' 110' ' ' THR . 49.9 mt-10 -121.1 163.32 18.58 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.291 -0.881 . . . . 3.21 111.366 -178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.02 155.29 39.02 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 34.9 t -125.44 113.67 25.56 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.752 -0.832 . . . . 0.01 108.752 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.33 -29.08 8.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.388 1.174 . . . . 0.01 111.278 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.402 ' HG ' ' H ' ' A' ' 119' ' ' GLU . 13.1 t -142.53 109.88 5.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 0.02 109.359 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.0 mt -61.99 -39.62 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 122.003 -0.435 . . . . 1.8300000000000001 110.149 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.44 -37.37 80.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.425 -0.91 . . . . 1.3400000000000001 110.447 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.402 ' H ' ' HG ' ' A' ' 116' ' ' SER . 37.0 tt0 -70.44 -39.37 74.38 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.908 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 8.6 tt0 -79.46 -47.67 15.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.0800000000000001 112.428 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.458 ' CZ ' ' CD ' ' A' ' 120' ' ' GLN . 28.2 m-85 -110.8 0.52 17.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.434 -0.791 . . . . 0.02 112.628 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.1 m80 60.63 33.19 20.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.682 -1.261 . . . . 0.02 109.507 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -113.51 135.23 54.12 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.749 -0.834 . . . . 0.02 108.749 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.62 -21.56 22.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.378 -0.826 . . . . 5.3200000000000003 110.276 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -150.76 165.87 32.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.135 -0.978 . . . . 0.02 109.992 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.73 128.63 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.212 -1.403 . . . . 2.1699999999999999 107.212 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.2 m-70 -108.89 -12.44 14.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.539 -0.726 . . . . 0.02 112.256 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.432 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 10.1 t -159.51 152.72 22.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.01 108.555 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.8 p -163.41 145.87 9.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 1.22 109.665 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -116.61 102.93 9.89 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.701 -1.249 . . . . 1.4099999999999999 108.591 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.54 128.3 70.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.604 -1.258 . . . . 0.01 107.604 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.02 89.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 106.563 -1.643 . . . . 1.98 106.563 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.436 ' OE1' ' OG1' ' A' ' 135' ' ' THR . 1.8 tm-20 -150.82 -64.88 0.19 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 105.88 -1.896 . . . . 0.01 105.88 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.73 -10.08 10.49 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.742 -2.143 . . . . 0.01 107.742 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.436 ' OG1' ' OE1' ' A' ' 133' ' ' GLU . 1.7 p -125.89 70.86 1.22 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.713 -0.874 . . . . 2.2999999999999998 111.911 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -134.87 135.89 42.0 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 120.337 -1.477 . . . . 0.01 110.274 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -120.13 137.45 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.322 -0.992 . . . . 1.6899999999999999 108.322 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -111.3 142.03 44.06 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 106.827 -1.546 . . . . 2.4900000000000002 106.827 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.7 m-85 -123.37 143.76 49.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.044 -1.035 . . . . 0.02 109.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.0 -31.24 62.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.796 -0.565 . . . . 0.02 111.854 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.28 155.36 47.01 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.67 -1.269 . . . . 1.48 108.899 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -57.22 166.66 4.11 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.186 1.257 . . . . 0.02 112.832 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.77 31.26 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.2 -0.909 . . . . 0.75 111.386 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.1 m-85 58.11 52.23 7.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.629 -0.669 . . . . 0.02 111.327 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.49 165.15 19.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.529 -0.732 . . . . 0.02 109.954 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.96 -165.34 34.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -69.06 141.55 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.531 -0.982 . . . . 0.02 108.723 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.499 ' O ' ' CG ' ' A' ' 58' ' ' MET . 2.2 mt-30 -113.86 150.12 34.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.543 -0.539 . . . . 0.02 109.543 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.76 132.91 53.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.567 -0.901 . . . . 0.01 108.567 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.93 120.24 34.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.21 . . . . 0.01 108.892 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.4 mt -102.48 140.22 37.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 154' ' ' LYS . 27.8 m-20 -108.5 -163.27 0.87 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.53 -0.731 . . . . 2.27 109.474 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -75.12 40.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 1.8400000000000001 109.588 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.459 ' H ' ' C ' ' A' ' 152' ' ' ASP . 18.6 ttmt -113.55 162.25 16.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.622 -0.674 . . . . 2.2799999999999998 109.413 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 3.3 mp0 -103.32 130.43 50.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.899 -1.148 . . . . 0.01 107.899 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 49.1 m-85 -102.5 112.11 24.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.01 110.515 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -90.06 -27.13 19.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.01 110.432 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -123.77 153.91 66.98 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 107.63 -1.248 . . . . 2.54 107.63 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.05 -41.47 35.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 CA-C-N 119.202 0.751 . . . . 0.69999999999999996 111.047 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.35 -18.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 120.812 -1.18 . . . . 0.85999999999999999 109.389 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.55 -18.87 65.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.808 -1.182 . . . . 0.02 112.029 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.08 15.92 27.12 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 120.705 -1.247 . . . . 0.02 110.311 178.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.82 75.82 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.192 -0.942 . . . . 0.02 112.91 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.427 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.87 140.35 35.28 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.862 -1.375 . . . . 0.02 110.124 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -6.94 59.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.58999999999999997 109.574 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.2 m -139.43 151.18 66.28 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.19 -0.944 . . . . 0.87 109.548 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -75.34 14.72 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.934 1.089 . . . . 0.38 112.173 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.9 122.1 28.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.17999999999999999 111.794 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.1 mp -147.6 127.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.112 -1.81 . . . . 3.9900000000000002 106.112 176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -110.68 -14.26 14.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.308 -0.87 . . . . 5.1699999999999999 112.675 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 11.6 t -156.59 158.7 37.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.389 -2.07 . . . . 0.02 110.068 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -150.38 151.9 33.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.192 -0.942 . . . . 2.02 109.889 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.511 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.5 mtp180 -143.87 150.3 38.23 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.173 -0.955 . . . . 0.01 110.543 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.75 143.32 27.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.423 -0.954 . . . . 0.01 108.423 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.68 129.97 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.404 -0.81 . . . . 3.04 109.563 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 177' ' ' GLU . 57.5 t -137.24 148.26 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 1.8899999999999999 109.336 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 176' ' ' VAL . 1.4 pp20? . . . . . 0 N--CA 1.505 2.282 0 CA-C-O 121.244 0.545 . . . . 4.8899999999999997 111.327 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.343 0.592 . . . . 5.2800000000000002 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -74.19 100.26 3.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 5.96 109.187 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.3 p -107.04 -140.06 0.37 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.485 -0.932 . . . . 2.2200000000000002 108.485 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.6 88.78 0.07 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 107.003 -2.439 . . . . 0.81000000000000005 107.003 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.36 148.14 32.25 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.595 -1.002 . . . . 0.01 110.595 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -153.77 138.33 16.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.557 -0.967 . . . . 0.02 108.72 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.18 141.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.163 -0.68 . . . . 0.02 109.163 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -121.9 130.22 53.18 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 0.39000000000000001 109.559 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 13.8 m-85 -109.44 139.08 44.87 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.742 -0.836 . . . . 0.02 108.742 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -122.42 138.79 54.42 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.187 -0.946 . . . . 0.02 109.625 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -68.36 -27.2 66.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.029999999999999999 111.839 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.48 169.47 9.02 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.847 -1.158 . . . . 0.029999999999999999 110.138 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.57 158.67 32.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.611 0.72 . . . . 0.029999999999999999 110.064 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.4 35.04 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.858 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 20.5 p90 50.0 43.88 25.52 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.602 -0.726 . . . . 0.02 111.312 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -112.09 166.39 11.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.031 -1.1 . . . . 0.02 108.031 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -168.06 36.24 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.728 -1.225 . . . . 0.029999999999999999 110.82 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -69.15 143.62 54.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.423 -1.045 . . . . 2.7599999999999998 108.978 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -119.95 149.09 42.7 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.586 0.707 . . . . 1.8899999999999999 110.035 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -132.19 127.16 35.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.991 -1.115 . . . . 0.02 107.991 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 11.4 p30 -111.59 135.84 51.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.603 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.3 t -129.99 137.53 50.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.472 0.653 . . . . 0.02 109.474 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.69 11.47 14.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.722 -0.612 . . . . 0.20000000000000001 109.535 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -157.88 174.07 15.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -61.71 145.4 52.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.709 -1.244 . . . . 0.02 109.984 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.3 t -131.72 116.59 17.5 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.635 -0.876 . . . . 0.02 108.635 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.6 -24.15 53.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.23999999999999999 110.675 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.76 100.84 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.54 -0.911 . . . . 1.1399999999999999 108.54 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -104.32 9.66 35.8 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.165 0.983 . . . . 6.3700000000000001 109.867 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' NH2' ' CZ ' ' A' ' 51' ' ' ARG . 90.1 mtt180 -59.25 -22.84 61.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.585 -0.697 . . . . 3.1099999999999999 110.857 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -75.9 -16.85 59.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.88 110.227 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.63 -22.12 13.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.445 -0.784 . . . . 0.02 109.307 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.0 tp -150.55 128.94 12.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.331 -0.856 . . . . 3.3199999999999998 108.813 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.5 p -86.53 -10.86 53.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.796 -0.565 . . . . 0.02 111.286 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.623 ' HE ' HD22 ' A' ' 37' ' ' ASN . 54.9 ttt180 -171.14 161.67 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.02 108.021 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.9 m -142.31 115.27 8.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.938 -1.101 . . . . 0.02 109.378 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.623 HD22 ' HE ' ' A' ' 35' ' ' ARG . 3.3 m120 -106.73 -0.67 23.37 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.224 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -157.05 154.58 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.747 -1.205 . . . . 0.02 107.747 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -144.77 148.54 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -0.999 . . . . 0.02 109.2 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -123.65 123.9 41.58 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.154 -1.424 . . . . 0.02 107.154 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -105.33 114.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.845 -1.539 . . . . 0.02 106.845 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -84.21 -33.96 24.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.462 -0.773 . . . . 3.8100000000000001 109.569 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.79 18.54 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.649 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.4 173.69 49.95 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.726 -1.226 . . . . 0.01 110.407 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.2 m -118.9 136.13 54.22 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.822 -1.177 . . . . 1.48 107.822 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -124.6 152.67 43.27 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.851 -1.156 . . . . 0.02 112.103 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.45 133.6 52.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.007 -2.22 . . . . 0.23999999999999999 105.007 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.5 m -116.46 141.7 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.026 -0.731 . . . . 0.65000000000000002 109.026 178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.5 m-85 -119.69 142.85 48.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.223 1.011 . . . . 0.02 109.386 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -64.78 -35.85 82.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.334 -0.848 . . . . 0.02 111.303 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.688 HH12 ' NH2' ' A' ' 78' ' ' ARG . 3.7 mmp_? -121.36 153.83 58.86 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.096 -1.002 . . . . 0.02 109.578 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -52.76 167.45 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.371 1.38 . . . . 0.02 112.457 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 64.68 37.24 7.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.746 0.784 . . . . 0.02 111.26 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 46.37 51.02 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.422 0.629 . . . . 3.3900000000000001 111.156 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -127.47 164.62 21.51 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.289 0.566 . . . . 2.3300000000000001 110.306 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.29 -162.68 30.98 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.216 -1.153 . . . . 0.02 110.216 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.627 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 4.9 t60 -63.37 143.04 58.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.11 -1.229 . . . . 0.02 110.347 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.8 mtp -116.49 135.22 54.02 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.291 0.567 . . . . 5.0099999999999998 109.755 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' HIS . 32.9 m-85 -134.84 133.35 39.66 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.405 -0.809 . . . . 0.02 108.958 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -95.42 131.84 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.578 -0.897 . . . . 1.72 108.578 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -121.21 109.72 34.97 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.517 -0.739 . . . . 0.02 110.21 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.64 169.54 21.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 119.969 1.025 . . . . 1.47 110.369 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.9 140.71 29.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.76 -1.212 . . . . 4.25 110.667 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.83 -175.11 32.25 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.32 . . . . 0.02 110.255 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -116.17 128.12 55.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -1.054 . . . . 0.95999999999999996 108.804 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 37.7 m-85 -119.28 97.99 50.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.101 -1.074 . . . . 0.02 108.101 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 6.5 Cg_endo -69.88 -6.56 18.96 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 120.553 0.835 . . . . 0.02 114.179 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 76.1 mt-10 -157.53 155.47 30.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.215 -1.553 . . . . 2.02 108.417 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 38.8 p90 -60.24 -36.93 78.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.47 -0.769 . . . . 0.02 112.665 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.63 -21.37 60.37 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.182 -0.949 . . . . 0.02 110.061 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.538 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -67.51 -19.96 65.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 3.4199999999999999 110.348 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.45 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.8 p90 -110.04 16.04 22.13 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.305 -0.872 . . . . 0.02 108.828 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.6 OUTLIER 65.32 24.98 12.14 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.234 0.54 . . . . 0.02 110.739 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.14 145.56 49.33 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.731 -1.347 . . . . 0.02 109.731 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 tt -80.51 -30.27 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.646 -1.242 . . . . 0.97999999999999998 107.646 177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -155.82 -171.53 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.702 -1.592 . . . . 0.02 106.702 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' CG ' ' A' ' 69' ' ' TYR . 95.8 m-20 -97.89 27.45 4.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.832 -1.168 . . . . 0.02 110.298 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' NH2' HH12 ' A' ' 51' ' ' ARG . 38.2 mtp180 -95.51 122.42 38.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.962 -1.086 . . . . 3.2000000000000002 110.591 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.9 mt -142.52 120.53 12.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.536 -1.283 . . . . 2.6099999999999999 107.536 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.37 -17.17 10.21 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 121.358 -0.838 . . . . 0.02 112.485 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.581 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 11.3 t -156.23 156.42 34.09 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.331 -1.687 . . . . 0.02 110.648 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.581 ' N ' ' HG ' ' A' ' 81' ' ' SER . 6.1 p -145.05 147.75 32.93 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.691 0.758 . . . . 0.02 110.247 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 15.9 mtp180 -135.63 140.47 44.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.621 -0.881 . . . . 0.01 108.621 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.11 131.26 38.25 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.204 -0.935 . . . . 0.42999999999999999 108.539 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.92 122.88 40.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.41 -0.959 . . . . 1.25 108.41 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -91.03 134.92 34.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.798 -1.189 . . . . 1.77 108.505 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 136.93 38.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.305 -0.998 . . . . 1.6299999999999999 108.305 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -110.96 126.31 54.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.32 -0.863 . . . . 1.0800000000000001 108.673 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.4 m -103.77 -154.65 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.275 -1.75 . . . . 1.26 106.275 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.16 -48.15 0.93 Allowed Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.567 -1.333 . . . . 0.01 112.103 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.63 -99.57 0.13 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.729 -1.701 . . . . 0.01 111.934 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -120.74 118.91 31.26 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.096 -1.238 . . . . 4.4299999999999997 110.352 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' A' ' 92' ' ' GLN . . . -74.72 130.55 39.69 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.112 -0.699 . . . . 2.9900000000000002 109.112 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -129.28 136.18 49.73 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.882 -0.784 . . . . 6.3600000000000003 108.882 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -127.64 144.07 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.471 -0.768 . . . . 1.0900000000000001 109.326 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.53 133.06 54.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.922 -1.14 . . . . 2.0499999999999998 107.922 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.06 145.89 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.77 -1.206 . . . . 1.1000000000000001 109.384 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.66 140.91 49.16 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.999 0.904 . . . . 0.72999999999999998 110.816 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 99' ' ' GLU . 4.1 tm-20 -65.85 -30.38 70.98 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.911 -0.586 . . . . 0.02 111.775 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -117.12 169.77 9.18 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.216 1.007 . . . . 3.1800000000000002 110.663 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.34 36.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.723 -0.951 . . . . 0.01 110.723 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.81 38.12 22.38 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.539 0.685 . . . . 0.01 110.739 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.45 53.73 11.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.705 -0.622 . . . . 0.01 110.974 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -125.91 165.89 17.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.53 28.08 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.27 145.05 42.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.983 -1.304 . . . . 0.01 108.482 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.83 142.53 46.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.558 0.694 . . . . 0.01 109.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.414 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.8 m-85 -130.69 135.87 48.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.947 -1.131 . . . . 2.48 107.947 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -119.34 134.42 55.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.01 109.731 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -149.92 151.17 32.97 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.268 1.033 . . . . 1.6899999999999999 110.798 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.4 p -110.35 10.18 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.536 -0.756 . . . . 0.01 109.676 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -121.36 163.05 19.28 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -0.827 . . . . 3.21 111.393 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.76 154.34 39.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.386 -0.968 . . . . 0.01 108.386 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 14.3 t -123.58 110.25 30.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.527 -0.916 . . . . 0.01 108.527 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -77.85 -32.69 2.53 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 119.932 1.012 . . . . 0.01 112.032 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -140.33 108.43 5.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.108 -0.995 . . . . 0.02 109.189 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 117' ' ' ILE . 19.1 mt -63.49 -40.99 91.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.825 -0.547 . . . . 1.8300000000000001 110.656 -178.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.32 -38.48 87.79 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.134 -1.026 . . . . 1.3400000000000001 110.415 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -70.55 -38.82 74.21 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.145 -1.597 . . . . 2.1099999999999999 109.35 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.482 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 49.6 tt0 -80.54 -48.14 13.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 2.0800000000000001 112.45 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.482 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 70.4 m-85 -111.8 -1.83 15.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.261 -0.899 . . . . 0.02 112.661 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.93 35.01 19.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.851 -1.156 . . . . 0.02 109.506 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 mt -114.57 136.42 53.05 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.53 -0.731 . . . . 0.02 109.381 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.521 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.2 -21.11 23.44 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.217 -0.927 . . . . 5.3200000000000003 110.465 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -149.33 165.48 31.85 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.7 -1.25 . . . . 0.02 110.367 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mm -127.42 123.7 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.206 -1.405 . . . . 2.1699999999999999 107.206 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.7 m-70 -109.23 -14.09 14.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.158 -0.964 . . . . 0.02 112.467 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.8 t -159.57 151.49 20.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.01 108.763 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 30.0 p -168.6 146.14 3.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.925 . . . . 1.22 108.906 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -122.17 109.12 14.11 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.353 1.073 . . . . 1.4099999999999999 109.228 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.87 132.97 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.868 -1.53 . . . . 0.01 106.868 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.11 93.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.001 -1.481 . . . . 1.98 107.001 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.473 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 60.5 tt0 -147.65 -63.0 0.27 Allowed 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 105.383 -2.08 . . . . 0.01 105.383 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 166.42 -73.36 0.16 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.097 -2.001 . . . . 0.01 108.097 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 82.5 p -123.95 125.34 44.43 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.604 -0.939 . . . . 2.2999999999999998 110.483 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 15.3 m95 -125.9 150.71 47.73 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.062 -1.459 . . . . 0.01 107.062 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.428 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 32.0 mt -118.81 132.43 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.335 -1.478 . . . . 1.6899999999999999 109.782 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -111.54 141.99 44.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.221 -1.77 . . . . 2.4900000000000002 106.221 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.5 m-85 -123.06 143.34 50.02 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 0.02 109.755 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.84 -30.86 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.754 -0.591 . . . . 0.02 111.563 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.84 154.93 48.24 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.729 -1.232 . . . . 1.48 108.929 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.49 167.09 2.97 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.349 1.366 . . . . 0.02 113.038 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 44.4 t-20 60.0 31.53 20.69 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.116 -0.947 . . . . 0.75 111.363 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.97 51.48 10.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.498 -0.751 . . . . 0.02 111.01 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -126.65 165.29 19.49 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.601 -0.687 . . . . 0.02 109.937 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.47 -165.3 33.79 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.205 -1.158 . . . . 0.02 110.205 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.39 141.5 54.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.509 -0.995 . . . . 0.02 108.837 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -114.59 148.77 37.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.541 -0.541 . . . . 0.02 109.541 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 4.7 m-85 -123.26 134.25 54.11 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.905 -0.776 . . . . 0.01 108.905 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.2 tp -95.93 120.76 36.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.895 -1.128 . . . . 0.01 109.046 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' LEU . 9.5 mp -97.69 140.6 31.85 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.74 -0.837 . . . . 0.01 108.74 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 60.1 m-20 -105.01 -170.39 1.75 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.46 -0.775 . . . . 2.27 109.627 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.53 41.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.8400000000000001 109.881 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -113.34 172.56 6.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.482 -0.761 . . . . 2.2799999999999998 109.43 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.6 126.29 51.55 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.509 -0.923 . . . . 0.01 108.509 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 3.2 m-85 -100.68 111.96 24.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.199 -0.938 . . . . 0.01 110.145 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -92.79 -26.75 17.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.01 110.644 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -123.28 153.62 65.21 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.902 -1.147 . . . . 2.54 107.902 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -60.96 -40.52 51.88 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.33 0.797 . . . . 0.69999999999999996 110.962 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.12 -18.62 18.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.046 -1.033 . . . . 0.85999999999999999 109.332 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 52.9 t0 -65.76 -19.0 65.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.11 . . . . 0.02 112.164 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.53 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.12 15.69 27.88 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 120.655 -1.278 . . . . 0.02 110.143 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 9.7 76.77 Favored Glycine 0 N--CA 1.5 2.903 0 O-C-N 121.177 -0.952 . . . . 0.02 113.149 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.443 ' HB1' ' HE1' ' A' ' 162' ' ' TRP . . . -100.55 141.18 33.77 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.812 -1.405 . . . . 0.02 110.274 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.11 -7.22 59.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.688 -0.633 . . . . 0.58999999999999997 109.598 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.6 p -142.42 150.77 55.88 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.87 109.107 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -75.81 17.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.698 0.932 . . . . 0.38 112.052 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.1 121.63 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.304 1.05 . . . . 0.17999999999999999 111.154 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.8 mp -151.07 125.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.499 -1.667 . . . . 3.9900000000000002 106.499 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -110.84 -13.34 14.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.746 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.16 158.3 37.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 119.378 -2.076 . . . . 0.02 109.91 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.55 153.06 33.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.28 -0.888 . . . . 2.02 109.905 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -142.92 148.75 37.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.835 0.826 . . . . 0.01 110.081 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -86.01 142.17 28.96 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.868 -1.16 . . . . 0.01 107.868 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.5 mt -95.17 128.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 3.04 109.41 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.57 148.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.36 -0.838 . . . . 1.8899999999999999 109.837 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 4.8899999999999997 109.435 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.7 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.315 0.579 . . . . 5.2800000000000002 109.568 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -49.83 101.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 5.96 109.369 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -106.42 -139.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.294 -1.002 . . . . 2.2200000000000002 108.294 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.28 88.83 0.07 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 106.871 -2.492 . . . . 0.81000000000000005 106.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.06 32.24 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.315 -0.945 . . . . 0.01 110.904 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -151.86 137.33 17.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.693 -0.886 . . . . 0.02 108.653 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 7' ' ' ILE . 8.7 tt -130.19 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.368 -0.604 . . . . 0.02 109.368 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -120.71 128.77 53.26 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.793 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.79 137.94 44.91 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.241 -1.022 . . . . 0.02 108.241 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.6 m-85 -122.13 138.25 54.53 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.125 -0.984 . . . . 0.02 109.96 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -68.06 -28.26 67.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 0.029999999999999999 111.292 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.02 170.51 8.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.023 -1.048 . . . . 0.029999999999999999 110.305 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.588 ' NE ' HD22 ' A' ' 37' ' ' ASN . 96.8 mtt180 -75.59 161.85 28.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.795 0.807 . . . . 0.029999999999999999 110.604 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 41.3 t-20 62.59 33.6 15.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.03 0.919 . . . . 0.73999999999999999 110.89 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 65' ' ' GLU . 0.3 OUTLIER 55.31 40.31 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.861 -0.609 . . . . 0.02 110.67 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -110.12 165.21 11.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.219 -1.03 . . . . 0.02 108.219 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.21 -167.74 36.25 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 120.794 -1.191 . . . . 0.029999999999999999 110.759 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -69.21 143.35 54.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -1.003 . . . . 2.7599999999999998 109.541 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.36 149.74 41.87 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.728 0.775 . . . . 1.8899999999999999 109.713 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.574 ' CE2' ' SG ' ' A' ' 22' ' ' CYS . 32.5 t80 -132.97 126.84 32.88 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.598 -1.26 . . . . 0.02 107.598 178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -111.78 137.61 49.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.46 -0.775 . . . . 1.1200000000000001 109.666 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -131.32 138.17 49.1 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.609 0.718 . . . . 0.02 109.387 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -116.98 10.44 14.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.745 -0.597 . . . . 0.20000000000000001 109.47 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -158.09 174.45 15.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.213 -1.032 . . . . 1.23 108.213 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 29.4 t0 -60.99 143.34 55.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.762 -1.212 . . . . 0.02 110.153 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 58.1 m -131.31 116.94 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.02 108.435 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -26.29 51.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.23999999999999999 110.882 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -152.96 101.14 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 108.641 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -104.86 8.75 34.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.143 0.973 . . . . 6.3700000000000001 109.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -58.29 -23.32 55.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.601 -0.687 . . . . 3.1099999999999999 110.626 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 p -74.56 -17.01 60.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.816 -1.178 . . . . 0.88 110.266 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -103.72 -22.42 13.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.467 -0.771 . . . . 0.02 109.333 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.9 tp -149.71 128.0 12.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 3.3199999999999998 108.811 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m -86.47 -9.9 55.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.02 110.96 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 77' ' ' ASP . 40.6 ttt180 -171.04 161.41 6.84 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.681 -1.229 . . . . 0.02 107.681 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.9 t -143.28 115.71 8.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.794 -1.191 . . . . 0.02 108.822 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.588 HD22 ' NE ' ' A' ' 13' ' ' ARG . 33.4 t-20 -108.16 1.42 22.18 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.318 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 3.2 t -156.43 153.52 29.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.509 -1.293 . . . . 0.02 107.509 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.417 ' N ' ' HG ' ' A' ' 38' ' ' SER . 84.9 mt -145.44 148.01 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.095 . . . . 0.02 109.895 -178.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -124.54 125.25 43.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.565 -1.272 . . . . 0.02 107.565 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 t -105.48 114.0 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.98 -1.489 . . . . 0.02 106.98 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 4.8 tm-20 -83.63 -34.29 25.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 109.689 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.06 148.99 16.89 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.611 -1.757 . . . . 0.02 110.569 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.83 173.89 50.02 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.985 -1.246 . . . . 0.01 109.985 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -119.6 135.89 54.61 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.3 m95 -123.41 153.49 40.34 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.537 1.16 . . . . 0.02 112.155 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.6 132.47 53.25 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.02 -2.215 . . . . 0.23999999999999999 105.02 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.26 142.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.931 -0.766 . . . . 0.65000000000000002 108.931 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 31.8 m-85 -121.56 145.98 47.42 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.272 1.034 . . . . 0.02 109.801 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.29 -34.85 78.25 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.732 -0.667 . . . . 0.02 111.134 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.64 153.52 66.45 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.113 -0.992 . . . . 0.02 109.309 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -51.54 167.68 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.546 1.497 . . . . 0.02 113.249 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 63.79 37.06 10.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.049 -0.978 . . . . 0.02 111.127 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 45.19 50.77 9.47 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.62 0.724 . . . . 3.3900000000000001 110.379 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.57 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 47.7 t -125.2 163.59 22.14 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.746 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.57 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.34 -161.85 32.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.488 -1.445 . . . . 0.02 109.488 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -67.59 137.9 56.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.812 -1.405 . . . . 0.02 109.89 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 21.2 ptm -119.14 137.82 53.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.473 0.654 . . . . 5.0099999999999998 109.541 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -132.9 140.07 47.69 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.476 -0.765 . . . . 0.02 109.666 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -95.47 132.34 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.355 -0.98 . . . . 1.72 108.355 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.56 108.35 39.6 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.508 -0.745 . . . . 0.02 110.329 -178.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -75.2 168.27 25.06 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.044 1.051 . . . . 1.47 110.267 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 42' ' ' GLU . 7.9 tt0 -53.43 140.03 28.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.834 -1.166 . . . . 4.25 110.487 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.99 -176.75 32.57 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.508 -1.33 . . . . 0.02 110.301 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 15' ' ' PHE . 62.3 tt0 -118.64 130.06 55.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.389 -1.065 . . . . 0.95999999999999996 109.369 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 25.5 m-85 -120.75 92.83 48.36 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.826 -1.176 . . . . 0.02 107.826 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -65.7 -4.87 10.57 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.035 1.157 . . . . 0.02 113.746 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -157.03 153.57 28.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.579 -1.326 . . . . 2.02 107.889 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.526 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 8.8 p90 -60.59 -37.62 81.97 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.468 -0.77 . . . . 0.02 112.162 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 22.1 mm100 -60.32 -23.68 64.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.942 -1.099 . . . . 0.02 110.661 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.7 62.39 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.898 0.856 . . . . 3.4199999999999999 108.854 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.571 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.3 OUTLIER -107.74 9.91 28.97 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.393 -1.336 . . . . 0.02 107.393 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.7 mtt 61.34 21.89 12.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.652 . . . . 0.02 110.641 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.27 144.47 45.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.182 -1.567 . . . . 0.02 109.182 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.4 tp -79.06 -30.71 44.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.619 -1.252 . . . . 0.97999999999999998 107.619 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 49.6 t30 -157.69 -173.25 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.476 -1.676 . . . . 0.02 106.476 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -98.16 27.41 4.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.843 -1.161 . . . . 0.02 110.215 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.05 122.24 38.67 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.267 -0.896 . . . . 3.2000000000000002 109.954 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.3 mt -144.5 119.52 10.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.586 -1.264 . . . . 2.6099999999999999 107.586 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.96 -16.02 14.86 Favored Glycine 0 N--CA 1.503 3.136 0 C-N-CA 120.525 -0.845 . . . . 0.02 112.395 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -156.47 155.91 32.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.405 -1.644 . . . . 0.02 110.03 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 30.3 p -144.28 147.59 33.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.02 109.491 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -134.53 140.04 45.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.323 -0.861 . . . . 0.01 108.797 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.03 130.96 37.11 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.205 -0.934 . . . . 0.42999999999999999 108.651 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.62 123.34 42.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' O ' ' CG2' ' A' ' 135' ' ' THR . 14.8 m-70 -91.96 133.49 35.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.015 . . . . 1.77 108.386 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.06 139.67 32.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.766 . . . . 1.6299999999999999 109.049 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 t -111.48 125.59 54.06 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.465 -0.939 . . . . 1.0800000000000001 108.465 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 t -102.75 -155.68 0.53 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.282 -1.747 . . . . 1.26 106.282 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.21 -47.88 0.95 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.545 -1.347 . . . . 0.01 112.051 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.34 -98.6 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 118.587 -1.768 . . . . 0.01 112.267 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -122.48 120.89 35.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.394 -1.062 . . . . 4.4299999999999997 110.762 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.82 132.01 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.171 -0.677 . . . . 2.9900000000000002 109.171 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.32 139.24 49.5 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 6.3600000000000003 109.236 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tt -126.54 143.68 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.743 0.783 . . . . 1.0900000000000001 109.645 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -123.74 131.23 53.56 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.649 -1.241 . . . . 2.0499999999999998 107.649 177.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 m -124.31 148.34 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 120.871 -1.143 . . . . 1.1000000000000001 109.671 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -118.68 141.38 48.66 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.041 0.924 . . . . 0.72999999999999998 111.022 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.52 -29.47 69.57 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.747 -0.66 . . . . 0.02 111.446 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 60.4 mttp -116.39 169.86 8.99 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.092 -1.005 . . . . 3.1800000000000002 110.353 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.8 165.79 50.13 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.073 -0.811 . . . . 0.01 111.073 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 56.38 39.25 30.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.99 -0.712 . . . . 0.01 111.426 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 51.78 54.57 10.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.599 -0.688 . . . . 0.01 111.2 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -129.62 166.4 19.82 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.154 -1.054 . . . . 3.1499999999999999 108.154 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.97 -164.42 28.68 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.43 ' OE1' ' OH ' ' A' ' 108' ' ' TYR . 8.9 tt0 -75.55 144.94 41.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.938 -1.331 . . . . 0.01 108.714 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.5 tmm? -116.87 142.3 47.1 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.688 0.756 . . . . 0.01 109.972 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.44 ' N ' ' SD ' ' A' ' 107' ' ' MET . 41.8 m-85 -130.39 134.66 47.31 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.7 -1.222 . . . . 2.48 107.7 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -121.42 135.63 55.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.725 -0.609 . . . . 0.01 109.83 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.499 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 9.5 t -150.34 153.1 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.223 1.011 . . . . 1.6899999999999999 110.738 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 112' ' ' GLU . 30.5 p -109.35 10.0 25.58 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.829 -0.623 . . . . 0.01 109.864 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.5 mp0 -121.0 163.3 18.49 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.426 -0.796 . . . . 3.21 111.046 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 155.16 38.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.283 -1.006 . . . . 0.01 108.283 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.86 111.43 29.17 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.64 -0.874 . . . . 0.01 108.64 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.54 -32.86 3.48 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 CA-C-N 120.032 1.047 . . . . 0.01 111.605 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -141.23 107.81 5.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.285 -0.884 . . . . 0.02 108.855 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.53 -38.77 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.838 -0.539 . . . . 1.8300000000000001 110.361 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.5 ttt -66.4 -37.76 85.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.868 -1.133 . . . . 1.3400000000000001 109.873 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -70.27 -39.06 75.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.408 -1.432 . . . . 2.1099999999999999 109.53 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 8.8 tt0 -80.44 -47.05 14.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -0.975 . . . . 2.0800000000000001 112.316 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.556 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 m-85 -110.51 -1.68 16.85 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.375 -0.828 . . . . 0.02 112.752 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m170 61.16 33.48 19.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.677 -1.264 . . . . 0.02 109.343 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 mt -114.34 135.39 54.13 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.517 -0.74 . . . . 0.02 109.161 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -89.41 -21.1 23.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.181 -0.949 . . . . 5.3200000000000003 110.763 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -148.32 163.69 36.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.949 -1.095 . . . . 0.02 110.105 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 mm -129.33 126.05 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.202 -1.407 . . . . 2.1699999999999999 107.202 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -109.55 -13.04 14.62 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.353 -0.842 . . . . 0.02 112.682 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 21.3 p -160.82 153.5 20.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.269 . . . . 0.01 109.111 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 20.4 p -170.28 144.33 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.925 -1.139 . . . . 1.22 107.925 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.3 pttt -127.92 101.84 6.5 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.903 -1.123 . . . . 1.4099999999999999 109.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.24 140.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.83 -1.174 . . . . 0.01 107.83 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.69 91.1 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 106.25 -1.759 . . . . 1.98 106.25 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 136' ' ' TRP . 24.7 tt0 -146.83 -70.04 0.24 Allowed 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.455 -2.054 . . . . 0.01 105.455 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.53 -40.63 1.03 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.177 -1.569 . . . . 0.01 109.177 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 86' ' ' HIS . 70.5 p -129.38 103.07 6.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.407 -1.055 . . . . 2.2999999999999998 112.375 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 133' ' ' GLU . 17.6 m95 -132.88 144.75 50.39 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 107.863 -1.162 . . . . 0.01 107.863 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.3 mt -119.18 134.96 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 120.562 -1.336 . . . . 1.6899999999999999 109.846 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.46 141.7 44.68 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.193 -1.78 . . . . 2.4900000000000002 106.193 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 m-85 -123.51 143.63 50.06 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.206 -0.934 . . . . 0.02 109.88 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.45 -30.96 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.976 -0.452 . . . . 0.02 111.721 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.51 155.14 47.62 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.759 -1.213 . . . . 1.48 108.809 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -56.86 166.79 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.05 1.167 . . . . 0.02 112.927 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 42.8 t-20 59.66 31.89 21.17 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.173 -0.921 . . . . 0.75 111.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.9 m-85 57.45 51.95 9.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.527 -0.733 . . . . 0.02 111.523 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -126.75 165.32 19.5 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.463 -0.773 . . . . 0.02 110.057 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.13 -165.24 34.28 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.286 -1.126 . . . . 0.02 110.286 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -69.39 141.72 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.946 . . . . 0.02 108.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' MET . 18.4 mt-30 -114.12 148.59 36.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.778 -0.576 . . . . 0.02 110.109 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -123.75 133.86 53.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -95.34 121.12 36.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.868 -1.145 . . . . 0.01 109.461 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.83 145.49 26.92 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.761 -0.829 . . . . 0.01 108.761 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.542 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 13.1 m-20 -110.0 -179.31 3.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.534 -0.729 . . . . 2.27 109.645 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -71.52 38.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.87 . . . . 1.8400000000000001 109.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.1 mttm -112.04 177.18 4.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 109.208 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 26.4 mp0 -105.96 122.31 45.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.505 -0.747 . . . . 0.01 109.018 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.542 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 91.7 m-85 -97.7 113.82 25.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.837 . . . . 0.01 109.242 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.41 -27.59 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.01 111.268 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -124.59 155.57 69.15 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.803 -1.184 . . . . 2.54 107.803 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.3 Cg_endo -61.5 -40.97 43.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.065 0.702 . . . . 0.69999999999999996 111.116 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.11 -18.87 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.8 -1.187 . . . . 0.85999999999999999 109.495 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.89 -18.15 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.02 111.899 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.63 15.42 28.98 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.674 -1.266 . . . . 0.02 110.147 178.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.92 74.3 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 121.088 -1.008 . . . . 0.02 112.939 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.436 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.96 140.48 35.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.912 -1.346 . . . . 0.02 109.995 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.04 -6.67 59.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.664 -0.647 . . . . 0.58999999999999997 109.703 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -139.76 150.34 62.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.245 -0.91 . . . . 0.87 109.603 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.08 13.73 0.8 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.746 0.964 . . . . 0.38 111.838 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.04 24.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.312 1.053 . . . . 0.17999999999999999 110.655 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.517 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.1 mt -150.03 123.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.569 -2.011 . . . . 3.9900000000000002 105.569 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -111.84 -12.67 13.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.454 -0.779 . . . . 5.1699999999999999 113.011 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 p -157.08 159.66 38.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.295 -2.128 . . . . 0.02 109.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.13 152.64 33.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.208 -0.932 . . . . 2.02 110.055 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.491 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 15.8 mtp180 -142.42 148.81 38.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.057 -1.027 . . . . 0.01 110.244 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -86.78 140.24 29.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.141 -1.059 . . . . 0.01 108.141 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 21.0 mt -94.7 130.59 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.2 -0.937 . . . . 3.04 109.585 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.91 147.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 1.8899999999999999 109.541 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 4.8899999999999997 109.403 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.493 -0.558 . . . . 5.2800000000000002 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -73.95 97.64 2.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 5.96 109.313 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.0 p -102.78 -140.7 0.35 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.1 -1.074 . . . . 2.2200000000000002 108.1 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.77 87.89 0.07 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 107.205 -2.358 . . . . 0.81000000000000005 107.205 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.36 150.65 33.67 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 120.184 -1.008 . . . . 0.01 110.779 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -151.48 136.75 17.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.46 -1.023 . . . . 0.02 108.916 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 7.2 tt -130.77 142.16 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.39 -0.596 . . . . 0.02 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.526 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.5 t -122.87 130.48 52.91 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.475 -0.765 . . . . 0.39000000000000001 109.379 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.9 m-85 -109.71 139.94 44.16 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.947 -0.761 . . . . 0.02 108.947 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 12.7 m-85 -122.79 139.1 54.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.433 -0.792 . . . . 0.02 109.64 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.91 -26.66 64.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.029999999999999999 111.985 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.0 m-20 -114.17 170.01 8.6 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.029999999999999999 110.571 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -74.23 157.19 36.31 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.734 0.778 . . . . 0.029999999999999999 110.149 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.27 35.72 5.79 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.821 0.819 . . . . 0.73999999999999999 111.101 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.0 p90 49.66 44.61 24.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.679 0.752 . . . . 0.02 111.105 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -112.3 166.1 11.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.988 -1.115 . . . . 0.02 107.988 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.52 -167.9 34.28 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 120.735 -1.228 . . . . 0.029999999999999999 110.532 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.565 HH21 ' H ' ' A' ' 34' ' ' SER . 36.7 ttp180 -70.01 144.29 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -1.005 . . . . 2.7599999999999998 108.841 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.65 150.22 41.27 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.726 0.774 . . . . 1.8899999999999999 110.412 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -132.7 127.63 35.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.138 -1.06 . . . . 0.02 108.138 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -113.32 137.46 51.47 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 110.119 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.91 139.48 48.76 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.681 0.753 . . . . 0.02 109.351 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 m-20 -117.08 11.28 14.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.271 -0.64 . . . . 0.20000000000000001 109.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -158.57 174.49 14.99 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.119 -1.067 . . . . 1.23 108.119 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.21 144.34 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.601 -1.312 . . . . 0.02 110.249 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.0 m -131.41 116.86 18.08 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.372 -0.973 . . . . 0.02 108.372 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.2 -26.03 52.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.67 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -154.2 100.46 2.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 1.1399999999999999 108.7 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -104.96 9.65 34.47 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.538 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -58.3 -23.76 57.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.618 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -74.38 -16.89 60.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.169 . . . . 0.88 110.002 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -105.11 -21.9 13.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.516 -0.74 . . . . 0.02 109.395 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.47 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.1 tp -148.37 125.68 11.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 3.3199999999999998 109.166 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.565 ' H ' HH21 ' A' ' 18' ' ' ARG . 83.2 p -86.3 -11.05 53.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.02 111.263 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.47 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.9 tpp180 -170.68 161.58 7.54 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.746 -1.205 . . . . 0.02 107.746 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.495 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 23.6 p -140.51 113.35 8.22 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.848 -1.157 . . . . 0.02 108.752 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 19.2 t-20 -106.35 -2.31 22.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.866 -1.146 . . . . 0.029999999999999999 110.259 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 8.4 m -154.43 154.15 32.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.304 -0.999 . . . . 0.02 108.304 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.2 mt -144.66 146.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.02 109.599 -178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -124.44 124.8 43.11 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.046 -1.464 . . . . 0.02 107.046 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 24.9 t -105.6 113.65 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.822 -1.547 . . . . 0.02 106.822 177.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.08 -34.61 26.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 110.015 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.09 150.15 19.17 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.48 -1.819 . . . . 0.02 110.468 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.86 175.36 50.91 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.457 -1.354 . . . . 0.01 109.929 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.408 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 34.3 m -110.29 161.93 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.823 -1.547 . . . . 1.48 106.823 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CZ3' ' SG ' ' A' ' 22' ' ' CYS . 64.5 m95 -147.65 147.01 29.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.286 -1.509 . . . . 0.02 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.31 54.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.158 -2.164 . . . . 0.23999999999999999 105.158 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.02 142.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.679 . . . . 0.65000000000000002 109.466 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 19.7 m-85 -119.72 144.79 47.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.295 1.045 . . . . 0.02 109.46 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.19 -34.88 79.04 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.748 -0.66 . . . . 0.02 111.183 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -125.66 158.36 65.28 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.112 -0.992 . . . . 0.02 109.496 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.41 167.11 1.46 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.739 1.626 . . . . 0.02 113.145 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.97 36.78 9.8 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.097 -0.956 . . . . 0.02 111.208 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.16 51.91 10.74 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.476 0.655 . . . . 3.3900000000000001 110.915 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.9 t -127.37 164.55 21.57 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 2.3300000000000001 110.118 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.16 -162.55 32.4 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.017 -1.233 . . . . 0.02 110.017 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.491 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 85.9 m-70 -62.8 142.03 58.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.02 110.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.2 mtp -115.89 135.09 54.32 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.955 -0.757 . . . . 5.0099999999999998 108.955 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -136.16 133.31 37.04 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.362 -0.836 . . . . 0.02 109.469 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.497 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -96.13 131.78 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.245 -1.02 . . . . 1.72 108.245 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.8 mt -120.48 110.45 35.65 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.673 -0.642 . . . . 0.02 110.344 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.61 169.61 21.49 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 CA-C-N 119.923 1.008 . . . . 1.47 110.079 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 12.7 tm0? -53.13 140.83 24.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.827 -1.171 . . . . 4.25 110.355 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.31 -176.28 32.2 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.02 110.522 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.13 128.75 55.44 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -1.011 . . . . 0.95999999999999996 108.738 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 30.1 m-85 -118.64 98.08 51.04 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' OG ' ' A' ' 38' ' ' SER . 1.8 Cg_endo -67.75 -6.64 17.3 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.645 0.897 . . . . 0.02 114.401 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 31.1 mt-10 -158.64 155.9 29.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.366 -1.459 . . . . 2.02 108.382 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.666 ' HH ' HE21 ' A' ' 70' ' ' GLN . 20.8 p90 -59.99 -37.39 79.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.02 112.374 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.666 HE21 ' HH ' ' A' ' 69' ' ' TYR . 53.5 mt-30 -59.97 -21.83 61.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.02 109.988 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.587 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.38 -20.37 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.703 . . . . 3.4199999999999999 110.294 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . . . . . . . . . 2.9 p90 -109.49 15.87 22.66 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.232 -0.917 . . . . 0.02 108.669 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt 64.66 23.86 12.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.331 0.586 . . . . 0.02 110.769 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.53 146.54 50.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.35 -1.5 . . . . 0.02 109.35 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 14.2 mt -80.59 -28.69 37.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.97999999999999998 108.261 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.71 -170.66 3.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.012 -1.477 . . . . 0.02 107.012 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 35.2 p30 -98.28 28.28 4.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.753 -1.217 . . . . 0.02 110.274 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -97.08 123.52 40.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.324 -0.86 . . . . 3.2000000000000002 111.246 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 mt -143.88 120.27 10.95 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.022 -1.473 . . . . 2.6099999999999999 107.022 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.8 -16.4 14.1 Favored Glycine 0 N--CA 1.503 3.101 0 O-C-N 121.312 -0.867 . . . . 0.02 112.166 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.8 t -156.11 155.72 33.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.51 -1.582 . . . . 0.02 109.686 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.0 m -144.91 148.13 33.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.735 . . . . 0.02 109.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.481 ' CZ ' ' OH ' ' A' ' 49' ' ' TYR . 39.5 mtm180 -134.1 139.63 46.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.352 -0.842 . . . . 0.01 108.854 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 131.3 38.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.961 -1.126 . . . . 0.42999999999999999 107.961 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -90.96 124.08 43.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.378 -0.971 . . . . 1.25 108.378 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 135' ' ' THR . 13.7 m-70 -91.12 135.12 33.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 1.77 108.457 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.17 137.81 36.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.957 -0.757 . . . . 1.6299999999999999 108.957 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -111.54 125.88 54.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 m -102.74 -155.41 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.222 -1.77 . . . . 1.26 106.222 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.73 -48.64 0.9 Allowed Glycine 0 N--CA 1.498 2.797 0 O-C-N 120.463 -1.398 . . . . 0.01 112.305 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.38 -99.47 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.502 -1.809 . . . . 0.01 112.208 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.25 120.38 33.96 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.231 -1.158 . . . . 4.4299999999999997 110.82 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.74 132.32 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.126 -0.694 . . . . 2.9900000000000002 109.126 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -129.95 140.38 50.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.525 -0.734 . . . . 6.3600000000000003 109.121 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -125.5 141.89 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.867 0.842 . . . . 1.0900000000000001 109.528 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -124.59 131.41 53.48 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.514 -1.291 . . . . 2.0499999999999998 107.514 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -123.84 146.39 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.983 -1.073 . . . . 1.1000000000000001 109.819 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -117.43 140.72 49.22 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.991 0.901 . . . . 0.72999999999999998 110.77 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -66.14 -29.84 70.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.001 -0.545 . . . . 0.02 111.663 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -116.84 167.97 10.64 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.062 -1.024 . . . . 3.1800000000000002 110.586 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.01 43.39 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.08 -0.808 . . . . 0.01 111.08 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 56.55 38.58 29.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.868 -0.783 . . . . 0.01 110.801 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 52.55 55.31 9.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.753 -0.592 . . . . 0.01 110.959 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -128.58 165.96 19.78 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.497 -0.927 . . . . 3.1499999999999999 108.497 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.57 -164.85 26.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.36 -1.496 . . . . 0.01 109.36 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.497 HE21 ' H ' ' A' ' 107' ' ' MET . 36.7 tp60 -74.85 144.82 43.25 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.039 -1.271 . . . . 0.01 108.255 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 5.1 tmm? -116.29 142.44 46.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.669 0.747 . . . . 0.01 109.653 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.552 ' N ' ' SD ' ' A' ' 107' ' ' MET . 80.8 m-85 -131.19 135.58 47.53 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.014 -1.106 . . . . 2.48 108.014 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.8 tm-20 -120.37 134.08 55.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.74 -0.6 . . . . 0.01 109.709 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 112' ' ' GLU . 2.8 t -149.63 152.11 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 1.6899999999999999 110.558 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.433 ' N ' ' OE2' ' A' ' 112' ' ' GLU . 40.6 p -109.35 10.42 25.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.828 -0.624 . . . . 0.01 109.964 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.2 mp0 -120.58 163.06 18.58 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.41 -0.806 . . . . 3.21 111.317 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.08 155.23 37.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.007 -1.108 . . . . 0.01 108.007 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 49.2 t -122.54 110.66 31.95 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.938 -0.764 . . . . 0.01 108.938 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.82 -34.35 2.43 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 CA-C-N 119.976 1.027 . . . . 0.01 111.685 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.9 m -140.41 107.54 5.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.02 108.685 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.97 -39.42 85.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.865 -0.522 . . . . 1.8300000000000001 110.553 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttp -66.52 -37.67 85.53 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.967 -1.093 . . . . 1.3400000000000001 109.944 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.39 -39.12 74.73 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.388 -1.445 . . . . 2.1099999999999999 109.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 tt0 -80.29 -47.52 14.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 2.0800000000000001 112.425 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.424 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 66.7 m-85 -111.38 -1.25 16.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.8 . . . . 0.02 112.615 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 61.77 34.29 17.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.71 -1.244 . . . . 0.02 109.742 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.87 135.42 54.22 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.497 -0.752 . . . . 0.02 109.231 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.52 -21.19 23.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 5.3200000000000003 110.768 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.42 164.42 34.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.02 109.968 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 126' ' ' ILE . 51.0 mm -128.61 124.92 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.154 -1.424 . . . . 2.1699999999999999 107.154 178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.1 m-70 -109.27 -13.17 14.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 0.02 112.32 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 t -159.91 152.34 20.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.843 -1.16 . . . . 0.01 109.059 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.7 p -167.42 145.14 4.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.154 -1.054 . . . . 1.22 108.154 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -121.67 104.73 9.82 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.229 1.014 . . . . 1.4099999999999999 109.621 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.62 132.63 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.685 -1.228 . . . . 0.01 107.685 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.04 90.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 106.116 -1.809 . . . . 1.98 106.116 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.516 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 46.4 tt0 -146.71 -69.79 0.25 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.544 -2.021 . . . . 0.01 105.544 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.58 -39.84 1.01 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.751 -1.74 . . . . 0.01 108.751 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.462 ' CG2' ' O ' ' A' ' 86' ' ' HIS . 80.4 p -130.08 101.93 6.03 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.505 -0.997 . . . . 2.2999999999999998 111.919 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 55.3 m95 -129.49 142.26 50.82 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.349 -1.352 . . . . 0.01 107.349 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.2 mt -118.36 133.38 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.41 -1.432 . . . . 1.6899999999999999 109.775 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.72 141.28 44.22 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.378 -1.712 . . . . 2.4900000000000002 106.378 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -122.86 142.73 50.45 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.019 -1.051 . . . . 0.02 109.556 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.18 -30.68 62.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.02 111.718 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.84 154.87 48.23 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 120.749 -1.22 . . . . 1.48 108.896 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.31 167.24 2.74 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.28 1.32 . . . . 0.02 112.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.02 30.91 20.85 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.154 -0.93 . . . . 0.75 111.479 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.79 51.85 8.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.5 -0.75 . . . . 0.02 111.289 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.469 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.73 165.14 19.81 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.513 -0.742 . . . . 0.02 109.703 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.422 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.16 -165.51 34.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.124 -1.19 . . . . 0.02 110.124 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.46 142.02 53.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.981 . . . . 0.02 108.863 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -113.93 148.92 36.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 12.2 m-85 -123.36 133.9 54.06 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.773 -0.825 . . . . 0.01 108.773 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.3 120.47 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.148 . . . . 0.01 109.197 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.7 mp -98.73 138.6 35.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.299 -1.0 . . . . 0.01 108.299 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.752 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 3.1 m-20 -108.08 -173.76 2.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 2.27 109.628 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.67 40.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 1.8400000000000001 109.578 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.493 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.2 mttp -112.13 167.74 10.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.441 -0.787 . . . . 2.2799999999999998 109.358 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -105.06 124.11 48.96 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.752 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 71.4 m-85 -99.54 114.12 26.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.279 -0.888 . . . . 0.01 110.456 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -92.9 -26.22 17.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.01 110.636 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -123.63 154.45 66.66 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.993 -1.114 . . . . 2.54 107.993 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.557 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -61.64 -41.12 41.43 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 CA-C-N 119.245 0.766 . . . . 0.69999999999999996 110.802 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.74 -18.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.727 -1.233 . . . . 0.85999999999999999 109.311 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 50.7 t0 -65.29 -18.39 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.101 . . . . 0.02 111.927 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.75 15.42 29.02 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.8 -1.187 . . . . 0.02 110.164 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.4 76.3 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.163 -0.961 . . . . 0.02 113.113 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -101.15 141.41 34.08 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.836 -1.39 . . . . 0.02 110.227 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.433 ' C ' ' HG ' ' A' ' 166' ' ' SER . . . -84.51 -6.34 59.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.721 -0.612 . . . . 0.58999999999999997 109.641 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.433 ' HG ' ' C ' ' A' ' 165' ' ' ALA . 3.4 m -142.1 150.55 56.12 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.106 -0.996 . . . . 0.87 109.298 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.09 16.49 0.67 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 120.801 1.0 . . . . 0.38 112.018 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 120.79 25.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.17999999999999999 110.78 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.7 mt -149.08 124.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.719 -1.956 . . . . 3.9900000000000002 105.719 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -111.91 -13.72 13.6 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.174 -0.954 . . . . 5.1699999999999999 113.027 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 47.0 t -157.13 159.84 38.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.332 -2.105 . . . . 0.02 109.919 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 20.5 p90 -152.27 153.53 33.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.374 -0.829 . . . . 2.02 110.324 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -143.85 150.03 37.86 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.275 -0.89 . . . . 0.01 110.202 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -87.09 141.29 28.77 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.416 -0.957 . . . . 0.01 108.416 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 mt -94.84 129.61 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 3.04 109.373 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.46 147.67 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.423 -0.798 . . . . 1.8899999999999999 109.561 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 4.8899999999999997 109.431 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.471 -0.566 . . . . 5.2800000000000002 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -82.6 133.58 35.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 5.96 109.753 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.3 p -137.35 -130.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.322 -0.861 . . . . 2.2200000000000002 111.556 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.88 94.63 0.1 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 105.986 -2.846 . . . . 0.81000000000000005 105.986 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.41 147.71 31.68 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.419 -0.896 . . . . 0.01 111.007 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.65 138.66 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.02 108.421 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -130.29 140.83 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.354 0.597 . . . . 0.02 109.693 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -121.8 129.73 52.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.478 -0.764 . . . . 0.39000000000000001 109.778 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 29.1 m-85 -109.14 139.27 44.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.838 -0.801 . . . . 0.02 108.838 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.1 m-85 -122.68 138.56 54.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.297 -0.877 . . . . 0.02 109.742 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -69.14 -27.58 65.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.029999999999999999 111.671 -178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.83 170.33 8.42 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.872 -1.142 . . . . 0.029999999999999999 110.58 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -74.51 157.45 35.5 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.755 0.788 . . . . 0.029999999999999999 110.181 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.9 OUTLIER 65.77 35.33 6.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.891 0.853 . . . . 0.73999999999999999 110.943 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.5 p90 49.82 45.28 24.94 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.679 0.752 . . . . 0.02 111.266 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -112.51 166.78 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.08 -1.081 . . . . 0.02 108.08 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.4 -167.88 36.04 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.737 -1.221 . . . . 0.029999999999999999 110.624 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -69.89 143.76 52.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -1.073 . . . . 2.7599999999999998 109.134 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -120.35 149.07 42.92 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.71 0.767 . . . . 1.8899999999999999 110.582 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -132.24 126.75 34.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.064 -1.087 . . . . 0.02 108.064 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -112.04 136.83 50.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.414 -0.804 . . . . 1.1200000000000001 109.814 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.62 137.78 49.78 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.478 0.656 . . . . 0.02 109.538 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.89 10.59 14.15 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.303 0.573 . . . . 0.20000000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.659 ' HG ' ' H ' ' A' ' 25' ' ' ASP . 43.1 t -158.15 173.86 16.07 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 1.23 108.129 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.659 ' H ' ' HG ' ' A' ' 24' ' ' CYS . 2.9 m-20 -61.77 144.77 54.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.615 -1.303 . . . . 0.02 110.541 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 t -132.2 116.45 16.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.585 -0.895 . . . . 0.02 108.585 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.9 -23.5 55.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.486 -0.758 . . . . 0.23999999999999999 110.634 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -155.61 101.88 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.48 -0.933 . . . . 1.1399999999999999 108.48 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.67 10.22 34.88 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.344 1.069 . . . . 6.3700000000000001 109.816 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -59.88 -23.43 63.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.505 -0.747 . . . . 3.1099999999999999 110.713 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 m -75.35 -16.55 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.688 -1.258 . . . . 0.88 110.373 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -103.15 -21.4 13.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.402 -0.811 . . . . 0.02 109.017 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -149.88 128.58 12.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 3.3199999999999998 108.848 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 p -84.73 -10.12 57.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.71 -0.619 . . . . 0.02 110.376 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -171.61 163.3 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.704 -1.221 . . . . 0.02 107.704 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -141.73 114.77 8.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.853 -1.154 . . . . 0.02 108.663 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.646 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.8 OUTLIER -107.81 -2.18 20.18 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.953 -1.092 . . . . 0.029999999999999999 110.614 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 t -154.36 153.42 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.99 -1.115 . . . . 0.02 107.99 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.0 mt -144.63 146.65 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.89 -1.131 . . . . 0.02 109.9 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' A' ' 42' ' ' GLU . 38.9 ttp180 -123.77 123.76 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.25 -1.389 . . . . 0.02 107.25 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.54 114.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 106.879 -1.526 . . . . 0.02 106.879 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 30.9 mt-10 -83.7 -33.92 25.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.98 -0.688 . . . . 3.8100000000000001 109.721 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.16 150.4 19.64 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 118.475 -1.822 . . . . 0.02 110.369 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 173.57 49.77 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.671 -1.252 . . . . 0.01 110.077 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -119.45 135.86 54.57 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.482 -1.303 . . . . 1.48 107.482 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -124.12 154.45 39.98 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.523 1.154 . . . . 0.02 111.936 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.31 132.93 53.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.032 -2.21 . . . . 0.23999999999999999 105.032 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.9 m -114.99 140.25 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.063 -0.717 . . . . 0.65000000000000002 109.063 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 53.7 m-85 -121.46 144.02 48.92 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 122.22 1.009 . . . . 0.02 109.54 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.452 ' CG ' HH11 ' A' ' 51' ' ' ARG . 1.8 tp10 -66.2 -35.82 81.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.196 -0.911 . . . . 0.02 111.75 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.452 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -122.09 158.6 54.78 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.944 -1.098 . . . . 0.02 109.212 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.66 167.25 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.517 1.478 . . . . 0.02 112.591 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.09 37.26 11.67 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.683 0.754 . . . . 0.02 111.265 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 4.1 m-85 44.87 52.33 8.12 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.935 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -125.8 163.44 22.89 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.846 -0.534 . . . . 2.3300000000000001 109.943 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.21 31.7 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.653 -1.379 . . . . 0.02 109.653 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -65.99 137.15 56.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.324 . . . . 0.02 110.045 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 15.8 ptm -119.37 135.98 54.48 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.447 0.641 . . . . 5.0099999999999998 109.398 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.605 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 47.1 m-85 -133.14 141.01 47.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.566 -0.709 . . . . 0.02 109.267 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.37 132.09 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.571 -0.706 . . . . 1.72 109.431 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.17 109.55 35.18 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.552 -0.718 . . . . 0.02 110.332 -178.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.04 169.39 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.061 1.058 . . . . 1.47 110.229 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -52.82 140.59 23.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.901 -1.124 . . . . 4.25 110.706 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.46 -176.26 32.33 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.432 -1.365 . . . . 0.02 110.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -118.39 129.97 55.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.375 -1.073 . . . . 0.95999999999999996 109.405 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 59.9 m-85 -121.07 97.66 47.79 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.773 -1.195 . . . . 0.02 107.773 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.55 -3.7 13.06 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.648 0.898 . . . . 0.02 113.952 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -155.68 154.07 30.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.454 -1.404 . . . . 2.02 108.044 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -60.59 -38.44 84.64 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.563 -0.711 . . . . 0.02 111.708 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.02 110.152 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.12 -18.75 63.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.009 0.909 . . . . 3.4199999999999999 108.694 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.605 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -107.24 10.86 29.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.251 -1.389 . . . . 0.02 107.251 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 32.9 mtm 61.18 22.47 12.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.02 110.521 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.48 145.06 47.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tp -78.86 -29.97 44.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -1.205 . . . . 0.97999999999999998 107.75 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.419 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 43.9 p30 -156.86 -171.45 3.66 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.57 27.49 4.29 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.731 -1.23 . . . . 0.02 109.987 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -95.92 122.48 38.77 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.032 -1.042 . . . . 3.2000000000000002 110.358 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 mt -144.72 121.66 11.34 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.922 -1.14 . . . . 2.6099999999999999 107.922 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.77 -16.84 9.57 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 121.33 -0.856 . . . . 0.02 112.847 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.7 t -155.15 155.63 34.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 120.023 1.912 . . . . 0.02 111.084 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.0 m -145.5 148.2 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.542 0.687 . . . . 0.02 110.306 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 12.7 mtp180 -134.6 139.25 45.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.01 108.935 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 132.74 37.24 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.623 -0.88 . . . . 0.42999999999999999 108.623 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.72 123.49 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.508 ' HD1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -89.4 135.81 33.38 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.027 -1.101 . . . . 1.77 108.027 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' CD1' ' OE1' ' A' ' 177' ' ' GLU . 1.5 mt -99.2 137.71 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.752 -0.833 . . . . 1.6299999999999999 108.752 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 133' ' ' GLU . 86.6 p -112.64 126.06 54.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.811 -0.811 . . . . 1.0800000000000001 108.811 178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 p -102.96 -155.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.162 -1.792 . . . . 1.26 106.162 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -48.99 0.86 Allowed Glycine 0 N--CA 1.501 2.979 0 O-C-N 120.413 -1.429 . . . . 0.01 112.506 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.69 -100.0 0.14 Allowed Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.632 -1.746 . . . . 0.01 112.019 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -120.18 119.28 32.79 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.111 -1.229 . . . . 4.4299999999999997 110.753 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.84 129.93 36.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.016 -0.674 . . . . 2.9900000000000002 109.406 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -132.12 139.89 48.62 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.495 -0.753 . . . . 6.3600000000000003 109.287 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.89 145.77 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.404 -0.81 . . . . 1.0900000000000001 109.857 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -122.7 132.74 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.25 -1.389 . . . . 2.0499999999999998 107.25 177.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.51 149.24 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.107 . . . . 1.1000000000000001 109.585 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.2 141.45 48.87 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.034 0.921 . . . . 0.72999999999999998 110.998 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.36 -29.27 69.42 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.823 -0.626 . . . . 0.02 111.514 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -116.31 169.46 9.28 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.311 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.3 164.79 50.18 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.801 -0.92 . . . . 0.01 110.801 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.6 m-20 56.74 38.16 29.31 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.875 -0.779 . . . . 0.01 111.3 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.51 ' H ' ' CB ' ' A' ' 128' ' ' SER . 10.7 m-85 53.07 54.69 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.586 -0.696 . . . . 0.01 111.475 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -129.01 165.1 21.81 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.331 -0.989 . . . . 3.1499999999999999 108.331 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.88 -163.9 27.24 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.424 -1.471 . . . . 0.01 109.424 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -75.37 144.07 42.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.108 -1.231 . . . . 0.01 108.577 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.2 tmm? -116.71 142.82 46.41 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.576 0.703 . . . . 0.01 109.836 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.76 135.56 46.9 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.311 -0.996 . . . . 2.48 108.311 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -121.21 135.54 55.12 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.58 -0.7 . . . . 0.01 109.93 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -149.88 152.49 35.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.189 0.995 . . . . 1.6899999999999999 110.799 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -109.41 9.87 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.01 109.97 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -120.77 163.2 18.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.817 . . . . 3.21 111.388 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.8 155.72 37.47 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.083 -1.081 . . . . 0.01 108.083 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 63.1 m -124.66 112.41 27.43 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.423 -0.798 . . . . 0.01 108.94 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.43 ' C ' ' HG ' ' A' ' 171' ' ' SER . 17.8 Cg_endo -76.44 -32.66 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 120.135 1.084 . . . . 0.01 111.551 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.6 t -140.76 107.9 5.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.876 . . . . 0.02 108.989 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -64.15 -39.98 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 1.8300000000000001 110.593 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 118' ' ' MET . 2.0 tmt? -66.17 -37.8 86.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.134 -1.027 . . . . 1.3400000000000001 109.849 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.52 -38.85 74.32 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.448 -1.407 . . . . 2.1099999999999999 109.729 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.31 -47.57 14.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.354 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.46 -0.86 16.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.424 -0.798 . . . . 0.02 112.663 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m170 61.19 33.75 19.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.139 . . . . 0.02 109.662 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.5 mt -114.22 135.93 53.51 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.476 -0.765 . . . . 0.02 109.235 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.66 -22.0 21.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 5.3200000000000003 110.9 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -148.54 163.84 35.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.884 -1.135 . . . . 0.02 110.065 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 126' ' ' ILE . 40.0 mm -128.43 125.28 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.456 -1.313 . . . . 2.1699999999999999 107.456 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -111.56 -14.04 13.73 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.285 -0.885 . . . . 0.02 112.698 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.51 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 18.7 m -160.16 152.06 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.77 -1.206 . . . . 0.01 109.044 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 31.9 p -168.87 150.13 4.59 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.504 -0.924 . . . . 1.22 108.504 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 35.4 mttm -113.28 100.71 8.77 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.327 1.06 . . . . 1.4099999999999999 108.406 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.429 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 1.2 p -108.57 125.97 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.697 -0.853 . . . . 0.01 108.697 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.47 89.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 106.544 -1.65 . . . . 1.98 106.544 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.531 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 11.2 tt0 -151.67 -58.31 0.16 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.534 -1.284 . . . . 0.01 107.534 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.72 -10.8 38.38 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 107.173 -2.371 . . . . 0.01 107.173 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 p -123.39 61.44 1.05 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.833 -0.804 . . . . 2.2999999999999998 111.087 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.531 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 85.6 m95 -132.2 134.3 45.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.671 -1.268 . . . . 0.01 110.192 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.6 mt -120.1 136.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.254 -1.017 . . . . 1.6899999999999999 108.254 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.43 141.43 43.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.109 -1.441 . . . . 2.4900000000000002 107.109 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -122.72 142.77 50.34 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.173 -0.954 . . . . 0.02 109.894 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.03 -30.31 61.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.02 112.319 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.4 154.83 48.99 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.587 -1.321 . . . . 1.48 108.619 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.28 167.06 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.068 1.179 . . . . 0.02 113.04 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.1 m120 58.66 30.75 20.32 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.263 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 57.47 51.21 10.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.665 . . . . 0.02 111.066 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' NH1' ' SD ' ' A' ' 73' ' ' MET . 23.3 mmm180 -125.0 164.8 19.37 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.45 -0.781 . . . . 0.02 109.549 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.34 -165.93 34.47 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.338 -1.105 . . . . 0.02 110.338 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -69.7 142.9 53.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.458 -1.025 . . . . 0.02 109.022 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.483 ' O ' ' CG ' ' A' ' 58' ' ' MET . 6.1 mt-30 -113.41 149.76 33.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.72 -0.613 . . . . 0.02 109.558 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.13 132.51 54.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.904 -1.147 . . . . 0.01 107.904 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 27.8 tp -95.48 121.2 36.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.633 -1.292 . . . . 0.01 109.347 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 24.2 mt -93.49 162.42 13.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.811 -1.181 . . . . 0.01 107.811 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.91 -116.94 0.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.357 -0.839 . . . . 2.27 109.283 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -141.29 26.31 2.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 1.8400000000000001 109.006 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -110.35 -166.81 1.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.849 -0.797 . . . . 2.2799999999999998 108.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.29 131.9 53.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.532 -0.73 . . . . 0.01 109.496 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.06 110.78 23.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.354 -0.841 . . . . 0.01 108.911 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.449 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.0 ptm180 -88.1 -27.79 21.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.01 111.309 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -124.08 154.22 68.13 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.696 -1.224 . . . . 2.54 107.696 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.66 -39.27 44.69 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 CA-C-N 119.382 0.815 . . . . 0.69999999999999996 110.903 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.09 -18.41 17.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.478 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.46 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.039 -1.038 . . . . 0.02 112.272 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.12 15.63 28.07 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.799 -1.188 . . . . 0.02 109.887 178.377 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.22 75.33 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.164 -0.96 . . . . 0.02 112.948 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.416 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.22 140.45 35.49 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.847 -1.384 . . . . 0.02 110.233 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -6.85 59.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.642 -0.661 . . . . 0.58999999999999997 109.711 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.7 p -140.34 150.83 62.51 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.176 -0.952 . . . . 0.87 109.297 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.88 15.23 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.667 0.911 . . . . 0.38 111.865 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.64 24.19 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.33 1.062 . . . . 0.17999999999999999 110.682 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.463 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.01 123.5 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.577 -2.009 . . . . 3.9900000000000002 105.577 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.62 -12.77 12.8 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.21 -0.932 . . . . 5.1699999999999999 113.271 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 9.2 t -157.23 158.93 37.09 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 119.134 -2.229 . . . . 0.02 109.945 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.528 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 18.1 p90 -152.77 154.75 35.82 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.092 -1.005 . . . . 2.02 110.148 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -144.67 150.56 37.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.01 110.395 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -87.89 143.04 27.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.01 108.613 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.65 129.39 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.311 -0.868 . . . . 3.04 109.266 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.08 147.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -0.926 . . . . 1.8899999999999999 109.783 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.473 ' OE1' ' CD1' ' A' ' 87' ' ' LEU . 51.5 tp10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 4.8899999999999997 109.413 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 3' ' ' THR . 70.5 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.377 -0.601 . . . . 5.2800000000000002 109.377 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -50.85 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 5.96 109.223 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 1' ' ' SER . 3.5 m -104.91 -139.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.995 -1.113 . . . . 2.2200000000000002 107.995 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.23 88.4 0.07 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 106.785 -2.526 . . . . 0.81000000000000005 106.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 149.09 33.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.745 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -150.45 136.34 18.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -1.053 . . . . 0.02 109.367 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -128.96 139.25 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.012 -0.736 . . . . 0.02 109.012 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.534 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.3 t -121.77 130.35 53.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.605 -0.684 . . . . 0.39000000000000001 109.438 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -108.67 138.38 45.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.041 -0.726 . . . . 0.02 109.041 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 7.0 m-85 -122.65 138.53 54.57 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.215 -0.928 . . . . 0.02 109.734 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 70.6 mt-10 -71.33 -28.2 63.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.029999999999999999 111.635 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.535 ' C ' HD22 ' A' ' 37' ' ' ASN . 24.0 t0 -113.57 168.04 10.09 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.851 -1.156 . . . . 0.029999999999999999 110.171 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 96.0 mtt180 -73.73 157.19 36.96 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.629 0.728 . . . . 0.029999999999999999 110.051 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.629 ' ND2' ' CE2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER 66.35 35.23 5.9 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.83 0.824 . . . . 0.73999999999999999 110.928 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.629 ' CE2' ' ND2' ' A' ' 14' ' ' ASN . 13.5 p90 50.06 45.49 25.38 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.815 0.817 . . . . 0.02 111.162 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -112.9 166.09 11.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.81 -1.182 . . . . 0.02 107.81 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -166.79 35.86 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.617 -1.278 . . . . 0.029999999999999999 110.825 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -69.42 140.8 54.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.928 . . . . 2.7599999999999998 109.268 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -120.94 149.09 43.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.259 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -132.81 127.09 33.79 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.945 -1.131 . . . . 0.02 107.945 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.81 136.86 50.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.528 -0.732 . . . . 1.1200000000000001 109.706 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.22 138.2 49.26 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.422 0.629 . . . . 0.02 109.449 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -116.81 10.89 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.46 -0.57 . . . . 0.20000000000000001 109.46 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.476 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.2 p -157.88 174.43 15.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.61 144.91 55.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.551 -1.343 . . . . 0.02 110.435 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.2 t -132.48 116.65 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.547 -0.909 . . . . 0.02 108.547 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -24.55 52.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.23999999999999999 110.751 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.76 100.41 2.37 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.445 -0.946 . . . . 1.1399999999999999 108.445 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 20.5 p90 -106.06 9.88 32.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.199 1.0 . . . . 6.3700000000000001 110.058 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -58.89 -22.68 59.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.633 -0.667 . . . . 3.1099999999999999 110.595 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -74.7 -16.61 60.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.676 -1.265 . . . . 0.88 110.324 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.37 -22.0 14.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.376 -0.827 . . . . 0.02 109.053 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -150.3 129.44 12.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.453 -0.944 . . . . 3.3199999999999998 108.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 p -85.26 -9.66 57.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.79 -0.569 . . . . 0.02 110.804 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -169.54 161.43 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 m -141.83 112.68 7.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.796 -1.19 . . . . 0.02 109.125 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.716 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.1 OUTLIER -110.66 -0.6 17.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.054 -1.029 . . . . 0.029999999999999999 110.981 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.31 152.24 30.9 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.736 -1.209 . . . . 0.02 107.736 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -146.4 148.37 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.89 -1.131 . . . . 0.02 110.555 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -125.92 125.88 43.49 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.973 -1.121 . . . . 0.02 107.973 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.8 115.42 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.587 -1.634 . . . . 0.02 106.587 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.68 -33.8 25.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.63 -0.669 . . . . 3.8100000000000001 110.404 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.65 21.22 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.064 -1.541 . . . . 0.02 109.996 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.58 174.76 50.33 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.547 -1.311 . . . . 0.01 109.999 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 14.8 m -109.79 160.65 16.15 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.646 -1.613 . . . . 1.48 106.646 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CD1' ' O ' ' A' ' 45' ' ' THR . 62.5 m95 -147.97 147.81 30.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.285 . . . . 0.02 111.432 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.59 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.157 -2.164 . . . . 0.23999999999999999 105.157 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.3 m -118.9 143.29 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.664 -0.647 . . . . 0.65000000000000002 109.436 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.92 145.46 47.67 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.299 1.047 . . . . 0.02 109.997 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -65.9 -33.56 76.12 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.501 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -124.31 157.4 64.73 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.995 -1.066 . . . . 0.02 109.578 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.11 166.42 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.603 1.535 . . . . 0.02 112.778 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.11 36.39 9.72 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.442 -0.799 . . . . 0.02 111.114 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.03 50.88 9.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.602 0.715 . . . . 3.3900000000000001 110.61 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -125.72 163.58 22.52 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.252 0.548 . . . . 2.3300000000000001 109.914 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.62 -161.93 31.33 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.477 -1.449 . . . . 0.02 109.477 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 16.0 t-80 -66.53 138.29 57.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.948 -1.325 . . . . 0.02 109.897 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.531 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 21.8 ptm -119.1 137.21 53.73 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.557 0.694 . . . . 5.0099999999999998 109.605 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.624 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 13.2 m-85 -132.19 140.31 48.67 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.759 0.79 . . . . 0.02 109.174 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.5 mm -96.5 131.71 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.47 -0.937 . . . . 1.72 108.47 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -122.76 113.58 30.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.373 -0.829 . . . . 0.02 110.741 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.11 169.96 20.54 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 CA-C-N 120.062 1.058 . . . . 1.47 110.238 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 1.8 pm0 -51.9 141.33 17.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 4.25 110.153 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.34 -177.48 32.51 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.341 -1.409 . . . . 0.02 110.707 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -119.08 130.0 55.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.529 -0.983 . . . . 0.95999999999999996 109.62 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 52.3 m-85 -120.71 95.78 48.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 107.765 -1.198 . . . . 0.02 107.765 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -68.37 -3.66 11.35 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 120.699 0.933 . . . . 0.02 113.835 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 82.6 mt-10 -157.6 154.81 29.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.544 -1.348 . . . . 2.02 108.252 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -60.5 -39.36 87.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.492 -0.755 . . . . 0.02 111.937 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -59.49 -23.86 63.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.02 110.132 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.57 62.4 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.443 -0.947 . . . . 3.4199999999999999 108.443 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.592 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.39 9.05 31.9 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.354 -1.35 . . . . 0.02 107.354 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.6 mtm 60.6 21.64 11.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.606 -0.684 . . . . 0.02 110.527 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.87 143.88 44.93 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.195 -1.562 . . . . 0.02 109.195 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.99 -30.14 50.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.084 -1.45 . . . . 0.97999999999999998 107.084 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -156.57 -172.04 3.92 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.27 -1.752 . . . . 0.02 106.27 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -97.78 27.79 4.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.728 -1.232 . . . . 0.02 110.464 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.479 ' HG2' HH11 ' A' ' 78' ' ' ARG . 8.5 mtt-85 -96.4 122.84 39.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.12 -0.988 . . . . 3.2000000000000002 110.752 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.459 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 29.9 mt -144.87 120.15 10.21 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.517 -1.29 . . . . 2.6099999999999999 107.517 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.0 -15.87 11.3 Favored Glycine 0 N--CA 1.507 3.378 0 O-C-N 121.271 -0.893 . . . . 0.02 112.869 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.4 p -155.51 156.14 34.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.217 -1.755 . . . . 0.02 110.276 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.5 p -145.03 148.35 33.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.02 109.484 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -133.71 138.63 45.93 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.751 -0.833 . . . . 0.01 108.751 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.62 131.77 36.84 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.473 -0.936 . . . . 0.42999999999999999 108.473 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.27 123.82 43.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.74 -0.837 . . . . 1.25 108.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.434 ' O ' ' CG2' ' A' ' 135' ' ' THR . 10.5 m-70 -92.18 135.08 34.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.984 -1.073 . . . . 1.77 108.281 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.01 137.84 36.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.471 -0.768 . . . . 1.6299999999999999 109.386 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.8 m -111.03 127.09 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.548 -0.908 . . . . 1.0800000000000001 108.548 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 p -104.02 -154.73 0.51 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 106.464 -1.68 . . . . 1.26 106.464 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.81 -49.02 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.454 -1.403 . . . . 0.01 112.275 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.0 -100.2 0.14 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 118.331 -1.89 . . . . 0.01 112.122 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -119.99 118.58 31.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.27 -1.135 . . . . 4.4299999999999997 110.714 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 130.92 38.22 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.095 -0.705 . . . . 2.9900000000000002 109.095 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -130.48 138.54 50.32 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.834 -0.802 . . . . 6.3600000000000003 108.834 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.15 143.86 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.358 -0.839 . . . . 1.0900000000000001 109.402 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 4.3 pt20 -122.14 133.71 54.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.596 -1.261 . . . . 2.0499999999999998 107.596 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.81 146.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.992 -1.068 . . . . 1.1000000000000001 109.038 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -120.59 141.75 50.02 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 122.127 0.965 . . . . 0.72999999999999998 111.277 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -66.16 -30.01 70.4 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.807 -0.633 . . . . 0.02 111.821 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -116.61 168.05 10.53 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.636 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.75 163.57 43.8 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 111.016 -0.833 . . . . 0.01 111.016 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 57.03 38.86 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 122.011 -0.699 . . . . 0.01 110.979 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.3 m-85 52.23 56.71 7.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.597 -0.69 . . . . 0.01 111.083 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -128.84 165.46 20.96 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.17 -1.048 . . . . 3.1499999999999999 108.17 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.2 -164.43 28.41 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.016 -1.634 . . . . 0.01 109.016 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.22 143.68 45.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.988 -1.301 . . . . 0.01 108.479 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 3.8 tmm? -116.49 142.41 46.91 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.696 0.76 . . . . 0.01 109.683 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -131.58 135.36 46.94 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.978 -1.119 . . . . 2.48 107.978 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.77 135.17 55.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.592 -0.692 . . . . 0.01 109.764 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 111' ' ' THR . 5.1 t -150.26 154.33 37.74 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.486 1.136 . . . . 1.6899999999999999 111.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.523 ' N ' ' HG1' ' A' ' 110' ' ' THR . 10.9 p -111.39 9.86 21.48 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.347 -0.842 . . . . 0.01 109.988 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -122.18 163.52 19.42 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.252 -0.905 . . . . 3.21 111.632 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.94 155.98 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.529 -0.915 . . . . 0.01 108.529 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.34 112.42 27.98 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.965 -0.754 . . . . 0.01 108.965 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.71 -33.44 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.188 1.103 . . . . 0.01 111.548 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.453 ' HG ' ' CB ' ' A' ' 119' ' ' GLU . 4.6 t -140.29 107.53 5.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.02 108.743 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 76.4 mt -64.54 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.819 -0.55 . . . . 1.8300000000000001 111.222 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.1 OUTLIER -66.48 -37.65 85.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.819 -1.152 . . . . 1.3400000000000001 109.578 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.453 ' CB ' ' HG ' ' A' ' 116' ' ' SER . 7.4 tm-20 -70.42 -38.85 74.65 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.464 -1.398 . . . . 2.1099999999999999 109.589 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -80.68 -48.17 12.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 112.485 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.02 -2.13 15.16 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.711 . . . . 0.02 112.705 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.9 33.86 17.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.814 -1.179 . . . . 0.02 109.942 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -114.2 135.49 53.99 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.491 -0.755 . . . . 0.02 109.1 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -90.98 -21.45 21.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 5.3200000000000003 111.273 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.12 163.98 35.28 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.228 . . . . 0.02 110.093 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.38 124.3 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.58 -1.267 . . . . 2.1699999999999999 107.58 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -108.44 -13.94 14.76 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.098 -1.001 . . . . 0.02 112.52 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 129' ' ' CYS . 13.5 t -160.57 152.38 19.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.746 -1.221 . . . . 0.01 108.82 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.528 ' N ' ' HG ' ' A' ' 128' ' ' SER . 10.3 t -167.28 145.09 4.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 1.22 109.164 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -123.65 106.09 10.26 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.398 1.094 . . . . 1.4099999999999999 109.385 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.1 p -110.55 136.74 45.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.334 -1.358 . . . . 0.01 107.334 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.64 92.24 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.515 -1.661 . . . . 1.98 106.515 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.505 ' OE1' ' CD1' ' A' ' 136' ' ' TRP . 26.8 tt0 -147.02 -69.1 0.25 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.491 -2.04 . . . . 0.01 105.491 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.22 -42.78 0.88 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.38 -1.488 . . . . 0.01 109.38 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.434 ' CG2' ' O ' ' A' ' 86' ' ' HIS . 81.9 p -129.82 103.38 6.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.394 -1.062 . . . . 2.2999999999999998 112.222 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.505 ' CD1' ' OE1' ' A' ' 133' ' ' GLU . 15.4 m95 -131.45 145.32 51.73 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.819 -1.178 . . . . 0.01 107.819 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.06 134.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.634 -1.291 . . . . 1.6899999999999999 109.94 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -110.24 141.38 43.28 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.541 -2.022 . . . . 2.4900000000000002 105.541 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.536 ' HH ' ' HE ' ' A' ' 173' ' ' ARG . 39.3 m-85 -123.19 143.24 50.15 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.111 -0.993 . . . . 0.02 110.009 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 35.4 tt0 -72.97 -31.97 64.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.791 -0.568 . . . . 0.02 111.67 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.97 154.76 48.4 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.738 -1.226 . . . . 1.48 108.819 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -56.45 167.44 2.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.069 1.179 . . . . 0.02 112.849 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 59.06 31.63 21.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.159 -0.928 . . . . 0.75 111.51 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.03 51.91 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.765 . . . . 0.02 111.361 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -127.12 165.47 19.47 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.569 -0.707 . . . . 0.02 110.097 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.71 -164.99 34.71 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.211 -1.156 . . . . 0.02 110.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -69.17 141.34 54.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -1.065 . . . . 0.02 108.817 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 5.6 mt-30 -113.69 148.79 35.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.439 -0.578 . . . . 0.02 109.439 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -124.55 134.42 52.99 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.758 -0.83 . . . . 0.01 108.758 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -95.99 121.02 37.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.871 -1.143 . . . . 0.01 109.477 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.38 146.18 26.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.493 -0.929 . . . . 0.01 108.493 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.3 m-20 -110.6 178.46 4.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.599 -0.688 . . . . 2.27 109.532 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -71.65 39.79 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 1.8400000000000001 109.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.6 mttm -110.31 -178.71 3.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.135 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -106.09 120.0 40.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.323 -0.861 . . . . 0.01 108.898 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.07 110.05 22.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.924 . . . . 0.01 108.986 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -28.13 16.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.506 -0.746 . . . . 0.01 111.176 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -123.5 152.27 64.63 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 107.722 -1.214 . . . . 2.54 107.722 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.8 Cg_endo -60.61 -39.65 62.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 CA-C-N 119.866 0.988 . . . . 0.69999999999999996 110.987 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.97 -18.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.779 -1.201 . . . . 0.85999999999999999 109.665 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.95 -18.63 65.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.02 112.38 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.66 16.0 27.17 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.828 -1.17 . . . . 0.02 109.912 178.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.1 11.2 76.69 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.227 -0.921 . . . . 0.02 112.849 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.404 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 140.63 34.95 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.42 . . . . 0.02 110.11 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.64 -7.48 58.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.628 -0.67 . . . . 0.58999999999999997 110.092 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.0 p -139.97 150.72 63.27 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.198 -0.939 . . . . 0.87 109.463 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.93 14.27 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 120.812 1.008 . . . . 0.38 112.094 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.15 27.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.919 -1.113 . . . . 0.17999999999999999 111.15 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 mp -151.65 125.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.513 -1.662 . . . . 3.9900000000000002 106.513 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.0 mp0 -112.2 -12.03 13.68 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.357 -0.84 . . . . 5.1699999999999999 112.533 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.9 t -156.88 158.99 37.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.197 -2.189 . . . . 0.02 110.045 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -152.26 154.15 35.16 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.147 -0.97 . . . . 2.02 110.057 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.536 ' HE ' ' HH ' ' A' ' 139' ' ' TYR . 61.0 mtm180 -143.08 148.39 36.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.01 109.804 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -86.37 141.14 29.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.184 -1.043 . . . . 0.01 108.184 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 25.8 mt -95.1 129.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.212 -0.93 . . . . 3.04 109.516 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.46 147.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 1.8899999999999999 109.618 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 4.8899999999999997 109.718 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.481 -0.563 . . . . 5.2800000000000002 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.06 138.15 16.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 5.96 109.53 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -138.24 -129.04 0.13 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.251 -0.906 . . . . 2.2200000000000002 111.418 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.51 95.12 0.1 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 105.653 -2.979 . . . . 0.81000000000000005 105.653 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 147.6 31.86 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.338 -0.934 . . . . 0.01 111.231 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -152.84 138.05 17.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.586 -0.949 . . . . 0.02 109.184 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.22 140.0 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.259 -0.645 . . . . 0.02 109.259 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -122.56 130.66 53.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.633 -0.667 . . . . 0.39000000000000001 109.877 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 10.9 m-85 -110.6 140.2 45.14 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.85 -0.796 . . . . 0.02 108.85 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.0 m-85 -122.43 139.03 54.32 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.289 -0.882 . . . . 0.02 109.856 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -68.58 -28.47 66.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.063 . . . . 0.029999999999999999 111.88 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.98 170.42 8.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.796 -1.19 . . . . 0.029999999999999999 110.351 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 31.9 mtp180 -74.81 157.58 34.91 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.698 0.761 . . . . 0.029999999999999999 110.354 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t30 66.29 33.85 6.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 111.374 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.23 42.43 28.01 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.287 0.565 . . . . 0.02 111.424 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -113.64 166.35 11.62 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.611 -0.885 . . . . 0.02 108.611 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.4 -167.53 37.44 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.954 -1.117 . . . . 0.029999999999999999 111.094 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.423 HH21 ' H ' ' A' ' 34' ' ' SER . 37.7 ttp180 -69.11 142.13 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.578 -0.954 . . . . 2.7599999999999998 109.265 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -121.51 149.46 43.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.738 0.78 . . . . 1.8899999999999999 110.324 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -131.99 127.39 36.17 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.968 -1.123 . . . . 0.02 107.968 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.26 137.4 50.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.564 -0.71 . . . . 1.1200000000000001 109.564 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.9 t -131.24 138.35 49.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.51 0.671 . . . . 0.02 109.673 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.44 10.52 14.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.608 -0.683 . . . . 0.20000000000000001 109.529 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.1 p -157.37 174.28 15.66 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.216 -1.031 . . . . 1.23 108.216 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.34 144.32 54.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.662 -1.274 . . . . 0.02 110.189 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.13 116.7 17.35 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.468 -0.938 . . . . 0.02 108.468 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.89 -24.29 52.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 110.663 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -153.82 100.72 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 108.509 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -106.7 8.38 30.99 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.182 0.991 . . . . 6.3700000000000001 110.168 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.674 ' NH2' HH12 ' A' ' 78' ' ' ARG . 86.7 mtt180 -59.79 -21.29 60.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 3.1099999999999999 110.495 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.3 m -74.89 -16.48 60.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.905 -1.122 . . . . 0.88 109.871 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -102.37 -21.65 14.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.02 109.086 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tp -150.26 129.66 12.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.913 -0.773 . . . . 3.3199999999999998 108.913 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 29.8 t -86.76 -12.22 48.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.854 -0.529 . . . . 0.02 111.098 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' SER . 10.5 mtm180 -167.1 161.09 14.49 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.153 -1.425 . . . . 0.02 107.153 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.428 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 16.8 p -143.34 115.31 8.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.831 -1.168 . . . . 0.02 108.643 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.5 m-20 -107.3 0.73 23.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.733 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 p -157.08 155.2 30.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.757 -1.201 . . . . 0.02 107.757 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.66 147.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.02 110.27 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -123.25 124.36 42.83 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -106.26 114.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.78 -34.08 27.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 3.8100000000000001 110.265 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.78 151.29 21.02 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.116 -1.516 . . . . 0.02 110.125 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.38 49.64 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.495 -1.336 . . . . 0.01 110.082 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.82 137.41 54.0 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.802 -1.184 . . . . 1.48 107.802 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -125.66 153.62 43.56 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.498 1.142 . . . . 0.02 111.983 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.62 52.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 104.869 -2.271 . . . . 0.23999999999999999 104.869 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.41 142.28 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.526 -0.733 . . . . 0.65000000000000002 109.089 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 13.8 m-85 -119.5 144.04 47.22 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.378 1.085 . . . . 0.02 109.723 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 5.6 tp10 -65.95 -35.02 79.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.669 -0.696 . . . . 0.02 110.882 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -125.17 157.19 68.14 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.093 -1.004 . . . . 0.02 109.702 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 167.43 1.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.806 1.67 . . . . 0.02 113.056 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.06 37.25 9.27 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.144 -0.934 . . . . 0.02 111.017 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 45.21 52.22 8.74 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.598 0.713 . . . . 3.3900000000000001 110.71 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.2 p -127.56 164.32 22.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.297 0.57 . . . . 2.3300000000000001 109.911 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -162.3 31.81 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.922 -1.271 . . . . 0.02 109.922 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.682 ' HD1' ' N ' ' A' ' 58' ' ' MET . 14.9 t-80 -63.29 142.61 58.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.268 . . . . 0.02 110.507 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.682 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 31.4 mtp -116.78 134.56 54.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.266 0.555 . . . . 5.0099999999999998 109.519 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 17.0 m-85 -135.27 134.35 39.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.393 -0.817 . . . . 0.02 109.124 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -96.86 131.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.986 -0.746 . . . . 1.72 108.986 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.0 mt -122.92 111.48 30.89 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.394 -0.816 . . . . 0.02 110.668 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.1 171.29 18.4 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 CA-C-N 119.856 0.984 . . . . 1.47 110.286 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 1.3 tm0? -51.78 140.42 19.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 4.25 109.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 155.95 -178.15 32.65 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.325 -1.417 . . . . 0.02 110.71 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.84 131.24 55.23 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.581 -0.952 . . . . 0.95999999999999996 109.587 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 62.4 m-85 -121.08 99.42 46.53 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.116 -1.068 . . . . 0.02 108.116 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.36 -4.21 13.96 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.64 0.893 . . . . 0.02 113.99 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 37.7 mt-10 -157.44 155.23 30.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.453 -1.405 . . . . 2.02 108.238 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 70' ' ' GLN . 27.7 p90 -60.36 -38.19 83.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.634 -0.666 . . . . 0.02 111.749 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 69' ' ' TYR . 13.3 mm-40 -59.83 -23.89 63.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.915 -1.115 . . . . 0.02 110.211 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.5 -18.6 62.28 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.176 0.989 . . . . 3.4199999999999999 108.588 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.603 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -105.67 9.25 33.25 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.937 -1.505 . . . . 0.02 106.937 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt 59.87 21.56 10.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.606 -0.684 . . . . 0.02 110.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.81 144.09 46.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.02 109.497 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.78 -29.68 51.01 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.324 -1.362 . . . . 0.97999999999999998 107.324 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -156.85 -170.85 3.44 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.405 -1.702 . . . . 0.02 106.405 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -97.82 29.25 3.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.612 -1.305 . . . . 0.02 110.172 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.674 HH12 ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -98.19 122.4 41.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.206 -0.934 . . . . 3.2000000000000002 110.988 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.8 mt -144.59 122.03 11.68 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.362 -1.347 . . . . 2.6099999999999999 107.362 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.19 -16.46 12.31 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 120.448 -0.882 . . . . 0.02 112.405 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.8 p -156.31 157.32 35.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.309 -1.7 . . . . 0.02 110.405 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.3 m -144.85 148.37 33.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.767 -0.583 . . . . 0.02 109.559 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -136.44 140.69 43.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.233 -0.917 . . . . 0.01 109.136 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.48 132.77 36.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.224 -0.922 . . . . 0.42999999999999999 109.323 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.28 123.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.511 -0.922 . . . . 1.25 108.511 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -88.93 135.51 33.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.097 -1.075 . . . . 1.77 108.097 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.29 139.0 37.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.445 -0.576 . . . . 1.6299999999999999 109.445 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 p -111.98 122.39 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.685 -1.228 . . . . 1.0800000000000001 107.685 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.8 p -114.22 133.84 55.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.752 -1.218 . . . . 1.26 107.865 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.5 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.501 3.033 0 C-N-CA 117.459 -2.305 . . . . 0.01 113.652 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.12 -103.03 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 120.308 2.054 . . . . 0.01 111.202 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.45 ' NE2' ' CG2' ' A' ' 111' ' ' THR . 0.3 OUTLIER -119.93 119.2 32.79 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.359 -1.083 . . . . 4.4299999999999997 110.174 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.1 129.98 38.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.191 -0.67 . . . . 2.9900000000000002 109.191 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -132.14 138.19 47.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.717 . . . . 6.3600000000000003 109.319 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -127.36 145.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.478 -0.764 . . . . 1.0900000000000001 109.457 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.445 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 3.3 pt20 -122.02 131.65 54.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.603 -1.258 . . . . 2.0499999999999998 107.603 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.6 m -123.6 146.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 120.811 -1.18 . . . . 1.1000000000000001 109.386 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.25 140.86 49.17 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.022 0.915 . . . . 0.72999999999999998 110.812 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -65.66 -29.96 70.59 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.959 -0.564 . . . . 0.02 111.395 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -116.94 168.36 10.31 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.571 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.61 168.92 30.6 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.959 -0.857 . . . . 0.01 110.959 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 52.21 40.09 28.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.671 0.748 . . . . 0.01 111.168 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 13.7 m-85 51.77 51.92 15.62 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.563 -0.711 . . . . 0.01 110.804 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -124.83 165.33 18.22 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.568 -0.901 . . . . 3.1499999999999999 108.568 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -165.37 26.84 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.34 -1.504 . . . . 0.01 109.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -75.18 145.38 42.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.124 -1.221 . . . . 0.01 108.264 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.464 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.7 tmm? -116.47 142.31 47.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.678 0.752 . . . . 0.01 110.131 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.453 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.6 m-85 -130.85 135.31 47.6 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.844 -1.169 . . . . 2.48 107.844 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.25 135.77 54.8 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.596 -0.69 . . . . 0.01 109.751 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.15 154.46 39.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.039 -1.038 . . . . 1.6899999999999999 110.674 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.45 ' CG2' ' NE2' ' A' ' 92' ' ' GLN . 58.8 p -111.34 8.35 21.32 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.818 -0.628 . . . . 0.01 110.009 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.2 163.5 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.337 -0.852 . . . . 3.21 111.383 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.77 155.92 38.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.124 -1.065 . . . . 0.01 108.124 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.496 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 44.5 t -126.0 112.41 24.33 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.687 -0.857 . . . . 0.01 108.687 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -74.81 -28.69 9.31 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.245 1.123 . . . . 0.01 111.094 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -142.52 108.65 5.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -0.843 . . . . 0.02 108.953 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.62 -38.27 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.879 -0.513 . . . . 1.8300000000000001 110.414 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.78 -37.38 79.27 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.224 -0.99 . . . . 1.3400000000000001 110.451 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.87 -39.25 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.462 -1.399 . . . . 2.1099999999999999 109.963 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.3 tt0 -79.38 -47.27 16.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 2.0800000000000001 112.409 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.71 -0.1 16.11 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.431 -0.793 . . . . 0.02 112.808 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 m80 61.3 34.08 18.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.812 -1.18 . . . . 0.02 109.639 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.25 134.15 54.73 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -21.61 21.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 5.3200000000000003 109.984 -179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -149.83 164.56 35.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.149 -0.97 . . . . 0.02 109.859 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.96 128.52 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.294 -1.373 . . . . 2.1699999999999999 107.294 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -107.23 -12.85 15.28 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.518 -0.739 . . . . 0.02 111.974 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.2 t -161.33 155.14 22.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.01 108.905 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 6.2 t -166.66 144.46 5.11 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.957 -1.127 . . . . 1.22 107.957 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -119.39 101.89 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.176 0.988 . . . . 1.4099999999999999 109.004 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.44 133.36 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.487 -0.931 . . . . 0.01 108.487 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.41 87.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.219 -2.141 . . . . 1.98 105.219 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -146.97 -66.38 0.27 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.967 -1.494 . . . . 0.01 106.967 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.63 44.27 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 107.555 -2.218 . . . . 0.01 107.555 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.0 p -121.73 52.05 1.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.804 -0.821 . . . . 2.2999999999999998 110.515 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.03 139.95 51.83 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 120.689 -1.257 . . . . 0.01 110.384 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -121.14 138.86 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.929 -0.767 . . . . 1.6899999999999999 108.929 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -111.92 142.01 44.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.089 -1.448 . . . . 2.4900000000000002 107.089 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 22.0 m-85 -123.17 144.04 49.62 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.214 -0.929 . . . . 0.02 109.448 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.2 -30.22 60.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.02 111.552 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 155.46 46.76 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.68 -1.262 . . . . 1.48 108.954 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -57.09 167.27 3.38 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.183 1.255 . . . . 0.02 112.721 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.7 t30 59.01 31.63 21.54 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.144 -0.935 . . . . 0.75 111.341 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.52 51.19 10.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.02 111.157 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.34 165.1 18.97 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.614 -0.679 . . . . 0.02 109.914 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.67 -165.38 33.55 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.174 -1.17 . . . . 0.02 110.174 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -69.94 143.02 52.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -1.035 . . . . 0.02 108.915 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -112.03 147.75 35.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.383 0.611 . . . . 0.02 109.816 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.42 133.76 53.29 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.841 -0.8 . . . . 0.01 108.841 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -97.95 122.64 41.31 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.827 -1.17 . . . . 0.01 109.923 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 16.8 mt -91.75 143.46 26.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.01 108.61 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 154' ' ' LYS . 20.1 m-20 -108.23 -179.01 3.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.438 -0.789 . . . . 2.27 109.725 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.522 ' CB ' ' HZ2' ' A' ' 153' ' ' LYS . 0.4 OUTLIER -75.28 36.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 1.8400000000000001 109.526 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 152' ' ' ASP . 89.3 mttt -111.9 177.57 4.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.789 . . . . 2.2799999999999998 109.271 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -106.07 121.87 45.01 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.843 -0.799 . . . . 0.01 108.843 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.97 113.04 25.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.349 -0.844 . . . . 0.01 110.346 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -94.18 -25.58 17.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.127 -0.983 . . . . 0.01 110.934 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -124.75 154.31 70.43 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.922 -1.111 . . . . 2.54 108.119 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.55 -40.69 45.31 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.186 0.745 . . . . 0.69999999999999996 110.555 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.8 -19.72 21.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.991 -1.068 . . . . 0.85999999999999999 109.055 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.14 -18.59 65.44 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.962 -1.086 . . . . 0.02 111.388 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 164' ' ' ALA . 1.8 p90 -102.74 14.27 32.37 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.037 -1.04 . . . . 0.02 109.859 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.15 9.77 69.84 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.393 -0.817 . . . . 0.02 113.734 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.581 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.86 140.89 34.51 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.533 -1.569 . . . . 0.02 110.619 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.14 -7.1 59.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.58999999999999997 109.333 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.8 m -142.53 150.71 55.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.126 -0.984 . . . . 0.87 109.293 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.43 17.7 0.63 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.729 0.953 . . . . 0.38 112.28 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.6 29.07 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.476 1.132 . . . . 0.17999999999999999 111.429 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.5 mt -148.77 127.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.84 -1.541 . . . . 3.9900000000000002 106.84 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -113.34 -16.31 12.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.231 -0.918 . . . . 5.1699999999999999 112.726 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 23.0 t -157.18 159.49 37.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 119.287 -2.133 . . . . 0.02 110.176 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.04 152.85 34.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.868 . . . . 2.02 109.917 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -144.71 151.06 38.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.244 -0.91 . . . . 0.01 110.498 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -87.95 143.52 27.06 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.722 -0.844 . . . . 0.01 108.722 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.2 mt -94.91 128.7 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 3.04 109.119 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.66 146.64 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.19 -0.944 . . . . 1.8899999999999999 109.418 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 4.8899999999999997 109.099 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.375 -0.602 . . . . 5.2800000000000002 109.375 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.43 100.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 5.96 109.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m -106.25 -139.0 0.37 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.265 -1.013 . . . . 2.2200000000000002 108.265 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.88 88.8 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 106.984 -2.447 . . . . 0.81000000000000005 106.984 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 148.15 32.5 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.309 -0.948 . . . . 0.01 110.84 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -152.19 137.05 17.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.944 . . . . 0.02 108.984 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 HD11 HG21 ' A' ' 7' ' ' ILE . 6.5 tt -130.22 140.91 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -121.03 129.21 53.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.774 . . . . 0.39000000000000001 109.833 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 17.1 m-85 -109.42 139.68 44.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.898 -0.778 . . . . 0.02 108.898 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 16.6 m-85 -123.05 138.33 54.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.265 -0.897 . . . . 0.02 109.915 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 34' ' ' SER . 16.6 mm-40 -67.1 -27.68 67.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.029999999999999999 111.258 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 10.2 t70 -114.18 169.78 8.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 110.136 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 16.1 mtp180 -75.61 162.3 28.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 110.276 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.7 m120 62.94 34.49 14.1 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.955 0.883 . . . . 0.73999999999999999 110.397 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.6 42.64 23.38 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.391 -0.822 . . . . 0.02 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.6 166.21 11.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.88 36.07 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 110.522 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -68.32 143.72 55.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -1.02 . . . . 2.7599999999999998 109.153 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -121.33 149.2 43.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.5 -0.75 . . . . 1.8899999999999999 110.179 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -133.36 128.56 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.644 -0.873 . . . . 0.02 108.644 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.72 136.46 50.93 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.457 -0.777 . . . . 1.1200000000000001 109.538 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.39 137.61 49.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.282 -0.636 . . . . 0.02 109.282 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -117.05 11.11 14.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.605 -0.684 . . . . 0.20000000000000001 109.741 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 48.5 t -158.36 174.45 15.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 35.0 t0 -60.58 143.21 54.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.692 -1.255 . . . . 0.02 109.893 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 9.7 t -130.46 116.63 18.49 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.449 -0.945 . . . . 0.02 108.449 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.06 -23.79 51.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.076 -1.015 . . . . 0.23999999999999999 110.678 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -156.0 100.91 2.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.896 -1.127 . . . . 1.1399999999999999 108.576 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -105.32 8.77 33.9 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.177 0.989 . . . . 6.3700000000000001 109.613 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.31 -24.39 63.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.602 -0.686 . . . . 3.1099999999999999 110.94 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.6 p -74.5 -16.62 60.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 109.876 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -105.04 -21.7 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.737 . . . . 0.02 109.259 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 1.7 tp -148.14 125.56 11.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 3.3199999999999998 109.247 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.519 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 4.6 m -85.87 -11.35 53.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.833 . . . . 0.02 111.313 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.51 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 7.2 mtm180 -171.56 161.7 6.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.364 -1.347 . . . . 0.02 107.364 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 39' ' ' ILE . 34.8 t -141.47 113.93 8.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.223 -0.923 . . . . 0.02 109.205 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.456 ' ND2' ' CG ' ' A' ' 77' ' ' ASP . 3.3 m120 -108.13 -0.17 21.23 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.01 -1.056 . . . . 0.029999999999999999 110.589 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' HG ' ' N ' ' A' ' 39' ' ' ILE . 3.3 t -156.21 152.46 27.83 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.524 -1.288 . . . . 0.02 107.524 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.422 ' N ' ' HG ' ' A' ' 38' ' ' SER . 84.2 mt -144.79 147.44 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.35 1.072 . . . . 0.02 110.198 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 22.1 ttp180 -122.5 123.14 40.57 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.412 -1.329 . . . . 0.02 107.412 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.95 113.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 106.723 -1.584 . . . . 0.02 106.723 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 47.8 mm-40 -83.52 -34.09 25.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.968 -0.693 . . . . 3.8100000000000001 109.639 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 150.6 19.94 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 118.7 -1.714 . . . . 0.02 110.463 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.09 173.48 49.7 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.881 -1.152 . . . . 0.01 110.404 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.3 m -119.83 136.73 54.36 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.19 -1.041 . . . . 1.48 108.19 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -125.88 153.83 43.59 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.613 1.197 . . . . 0.02 112.158 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.27 133.8 51.99 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 104.942 -2.244 . . . . 0.23999999999999999 104.942 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.98 142.39 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.65000000000000002 109.329 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 40.8 m-85 -121.63 144.44 48.75 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.058 0.932 . . . . 0.02 109.754 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.33 -35.57 80.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.521 -0.763 . . . . 0.02 111.833 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.401 HH22 ' CZ ' ' A' ' 78' ' ' ARG . 3.6 mmp_? -124.05 153.89 67.96 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.147 -0.97 . . . . 0.02 109.554 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -50.61 166.39 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.306 1.338 . . . . 0.02 113.378 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.81 37.52 9.7 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.123 -0.944 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 44.1 51.82 7.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.779 0.8 . . . . 3.3900000000000001 110.663 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.52 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 42.7 t -124.97 163.17 22.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.572 -0.529 . . . . 2.3300000000000001 109.572 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.73 -161.34 32.07 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.647 -1.381 . . . . 0.02 109.647 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -67.57 139.35 56.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.983 -1.304 . . . . 0.02 110.413 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 22.3 ptm -118.73 137.41 53.37 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.637 -0.664 . . . . 5.0099999999999998 109.719 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.545 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 52.6 m-85 -132.92 138.42 46.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.472 -0.767 . . . . 0.02 109.65 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.5 mp -95.29 132.17 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.737 -0.838 . . . . 1.72 108.737 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -119.85 109.67 37.5 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 121.416 -0.802 . . . . 0.02 110.451 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -76.48 168.67 23.34 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.136 1.084 . . . . 1.47 109.997 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -52.23 140.31 21.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.673 -1.267 . . . . 4.25 110.18 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.88 -177.52 32.11 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.476 -1.345 . . . . 0.02 110.742 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.05 130.94 54.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.43 -1.041 . . . . 0.95999999999999996 109.305 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 27.9 m-85 -121.97 90.6 48.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.43 -4.46 8.16 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 121.006 1.138 . . . . 0.02 113.389 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -154.45 150.62 28.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 2.02 107.527 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 19.6 p90 -60.29 -37.8 81.64 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.02 112.22 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -61.02 -23.51 65.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.02 111.216 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.493 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.7 OUTLIER -72.66 -16.53 61.7 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.116 -1.034 . . . . 3.4199999999999999 109.053 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.545 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.93 10.41 30.52 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.087 -1.449 . . . . 0.02 107.087 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm 61.84 21.75 12.49 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.357 0.599 . . . . 0.02 110.764 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.06 144.66 46.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.02 109.237 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 30.8 tp -79.5 -30.68 42.05 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.837 -1.172 . . . . 0.97999999999999998 107.837 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.67 -172.4 3.94 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.619 -1.622 . . . . 0.02 106.619 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 22.3 m-20 -97.89 27.2 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.687 -1.258 . . . . 0.02 110.382 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.49 122.82 39.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.142 -0.974 . . . . 3.2000000000000002 110.777 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.8 mt -143.63 121.67 12.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.865 -1.161 . . . . 2.6099999999999999 107.865 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.95 -17.75 9.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.345 -0.847 . . . . 0.02 112.54 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 36.5 m -155.28 155.38 33.66 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.757 1.778 . . . . 0.02 110.843 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 12.7 m -145.06 146.98 32.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.567 0.698 . . . . 0.02 110.414 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 71.5 mtm180 -135.64 141.4 45.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.741 -0.837 . . . . 0.01 108.741 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 130.95 37.27 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.136 -0.978 . . . . 0.42999999999999999 108.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -88.82 123.47 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.407 ' O ' ' CG2' ' A' ' 135' ' ' THR . 8.5 m80 -91.02 133.89 34.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 1.77 108.208 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 139.38 35.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.997 -0.742 . . . . 1.6299999999999999 108.997 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 p -112.02 125.71 54.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.671 -0.862 . . . . 1.0800000000000001 108.671 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -102.11 -155.97 0.54 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 106.0 -1.852 . . . . 1.26 106.0 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.4 -47.36 0.97 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 120.561 -1.337 . . . . 0.01 112.279 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.76 -98.61 0.12 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.479 -1.82 . . . . 0.01 112.348 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.53 121.41 36.47 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.218 -1.166 . . . . 4.4299999999999997 111.034 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 132.23 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.166 -0.679 . . . . 2.9900000000000002 109.166 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.424 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.5 ttpm? -132.11 139.46 48.47 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.022 -0.733 . . . . 6.3600000000000003 109.022 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.1 tt -127.48 143.92 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 121.975 0.893 . . . . 1.0900000000000001 109.591 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -124.81 133.54 53.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.743 -1.206 . . . . 2.0499999999999998 107.743 177.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -124.77 147.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.946 -1.096 . . . . 1.1000000000000001 109.546 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -117.57 140.72 49.25 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.987 0.899 . . . . 0.72999999999999998 110.948 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.96 -29.68 70.12 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.987 -0.551 . . . . 0.02 111.444 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' O ' ' OG ' ' A' ' 128' ' ' SER . 54.2 mttm -117.35 171.23 8.11 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.289 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.16 170.16 41.91 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.072 -0.811 . . . . 0.01 111.072 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.3 t0 52.51 39.56 28.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.564 0.697 . . . . 0.01 111.646 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 51.92 49.47 20.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.699 -0.626 . . . . 0.01 110.796 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.76 166.2 15.97 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.369 -0.974 . . . . 3.1499999999999999 108.369 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.78 -165.48 28.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.618 -1.393 . . . . 0.01 109.618 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.419 ' OE1' ' OH ' ' A' ' 108' ' ' TYR . 6.9 tt0 -75.62 144.7 41.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.009 -1.289 . . . . 0.01 108.594 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.6 tmm? -116.9 142.98 46.24 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.684 0.754 . . . . 0.01 110.171 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.423 ' N ' ' SD ' ' A' ' 107' ' ' MET . 42.7 m-85 -130.88 135.68 47.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.891 -1.152 . . . . 2.48 107.891 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.95 135.0 54.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.548 -0.72 . . . . 0.01 110.115 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -149.76 153.15 36.39 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.109 0.957 . . . . 1.6899999999999999 110.572 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.9 p -109.38 10.37 25.47 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.812 -0.631 . . . . 0.01 109.901 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.37 163.53 18.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.409 -0.807 . . . . 3.21 111.379 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.18 154.65 39.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.346 -0.983 . . . . 0.01 108.346 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.21 111.6 30.32 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.47 -0.769 . . . . 0.01 108.928 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -77.33 -33.63 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 119.885 0.994 . . . . 0.01 111.988 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.7 m -140.94 108.44 5.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.21 -0.931 . . . . 0.02 109.188 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 26.8 mt -63.43 -39.66 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.759 -0.588 . . . . 1.8300000000000001 110.791 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttp -66.4 -37.81 86.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.002 -1.079 . . . . 1.3400000000000001 110.033 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.34 -39.19 74.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.678 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 52.6 tt0 -81.19 -47.9 12.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 2.0800000000000001 112.506 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 63.6 m-85 -111.77 -2.53 15.25 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.427 -0.796 . . . . 0.02 112.76 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 61.99 34.02 16.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.719 -1.238 . . . . 0.02 109.323 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 mt -114.7 135.71 53.86 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.333 -0.854 . . . . 0.02 109.291 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -90.0 -20.91 22.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.026 -1.046 . . . . 5.3200000000000003 111.17 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -149.23 164.9 33.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.692 -1.255 . . . . 0.02 110.709 -178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 126' ' ' ILE . 27.8 mm -127.54 124.37 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.553 -1.277 . . . . 2.1699999999999999 107.553 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.1 m80 -110.75 -14.66 13.98 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.107 -0.996 . . . . 0.02 113.113 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.3 p -163.36 155.47 17.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.625 -1.297 . . . . 0.01 109.204 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.5 p -171.0 143.31 1.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.22 108.964 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 24.1 pttt -119.5 99.0 6.4 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.6 1.19 . . . . 1.4099999999999999 109.289 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -105.38 139.96 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.306 -0.998 . . . . 0.01 108.306 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.92 92.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.189 -1.782 . . . . 1.98 106.189 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 21.3 tt0 -146.03 -75.98 0.2 Allowed 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.561 -2.014 . . . . 0.01 105.561 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.77 -41.08 0.88 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.596 -1.402 . . . . 0.01 109.596 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.407 ' CG2' ' O ' ' A' ' 86' ' ' HIS . 60.0 p -129.09 100.66 5.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.2 -1.177 . . . . 2.2999999999999998 112.136 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.554 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 41.3 m95 -129.82 143.71 50.95 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.629 -1.249 . . . . 0.01 107.629 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 43.7 mt -118.7 133.57 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.455 -1.403 . . . . 1.6899999999999999 109.574 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -111.59 141.96 44.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.149 -1.797 . . . . 2.4900000000000002 106.149 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 23.1 m-85 -123.83 144.38 49.76 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.92 -1.113 . . . . 0.02 109.793 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.04 -31.43 62.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.809 -0.557 . . . . 0.02 111.799 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.21 155.14 47.2 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.816 -1.178 . . . . 1.48 108.903 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -56.81 166.75 3.54 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.128 1.219 . . . . 0.02 112.799 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.01 31.1 20.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.206 -0.906 . . . . 0.75 111.375 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 58.26 52.03 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.727 . . . . 0.02 111.285 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -126.94 165.47 19.34 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.599 -0.688 . . . . 0.02 110.021 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.48 -165.53 33.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -69.45 142.56 53.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.578 -0.954 . . . . 0.02 108.843 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -112.89 147.22 37.48 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.294 0.569 . . . . 0.02 109.687 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.57 134.14 53.87 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.676 -0.861 . . . . 0.01 108.676 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.56 120.95 37.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.922 -1.111 . . . . 0.01 109.526 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.47 144.68 27.55 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.315 -0.995 . . . . 0.01 108.315 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.546 ' C ' ' H ' ' A' ' 154' ' ' LYS . 6.2 m-20 -108.64 -175.28 2.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 2.27 109.859 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -73.01 32.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 152' ' ' ASP . 17.6 ttmt -110.4 173.57 6.27 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.694 -0.854 . . . . 2.2799999999999998 108.694 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -105.56 129.35 53.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.01 109.364 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -100.35 111.61 23.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.359 -0.838 . . . . 0.01 109.446 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.442 ' CD ' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -89.71 -26.84 20.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.01 110.816 -177.494 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -123.78 155.26 66.9 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.552 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.3 Cg_endo -63.07 -39.46 39.49 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 CA-C-N 119.349 0.803 . . . . 0.69999999999999996 111.057 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.89 -18.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.773 -1.204 . . . . 0.85999999999999999 109.945 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.48 -18.41 65.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.945 -1.097 . . . . 0.02 112.38 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.552 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.13 15.62 28.11 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 120.737 -1.227 . . . . 0.02 109.917 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.92 76.6 Favored Glycine 0 N--CA 1.5 2.926 0 O-C-N 121.172 -0.955 . . . . 0.02 112.847 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HB2' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 140.74 34.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.726 -1.455 . . . . 0.02 110.278 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -7.11 59.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 109.739 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.0 m -141.96 149.7 53.62 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.186 -0.947 . . . . 0.87 109.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.76 16.89 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.736 0.957 . . . . 0.38 112.06 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.64 120.71 25.42 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.362 1.077 . . . . 0.17999999999999999 110.786 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mp -150.66 124.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 106.194 -1.78 . . . . 3.9900000000000002 106.194 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.33 -12.29 14.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.83 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.9 p -156.97 160.13 38.75 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.231 -2.168 . . . . 0.02 109.925 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.99 153.4 33.98 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.312 -0.867 . . . . 2.02 110.047 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.68 149.26 36.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.01 110.24 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -86.25 142.26 28.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.183 -1.043 . . . . 0.01 108.183 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.35 128.63 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.451 -0.9 . . . . 3.04 109.327 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.73 148.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 1.8899999999999999 109.918 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.712 . . . . 4.8899999999999997 109.562 179.339 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.0 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.486 -0.561 . . . . 5.2800000000000002 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.2 95.41 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -0.944 . . . . 5.96 109.449 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 66.1 p -102.63 -141.64 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.933 -1.136 . . . . 2.2200000000000002 107.933 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.93 87.51 0.07 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 106.987 -2.445 . . . . 0.81000000000000005 106.987 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.29 148.72 33.04 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.607 -0.997 . . . . 0.01 110.607 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -150.77 136.26 17.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -1.005 . . . . 0.02 108.862 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.37 140.52 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.909 -0.774 . . . . 0.02 108.909 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.697 ' HG ' ' HE ' ' A' ' 19' ' ' ARG . 11.0 t -122.25 129.98 52.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.769 . . . . 0.39000000000000001 109.76 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 26.3 m-85 -108.39 138.55 44.49 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.87 -0.789 . . . . 0.02 108.87 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.567 ' HH ' ' CZ ' ' A' ' 19' ' ' ARG . 26.9 m-85 -122.65 138.72 54.51 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.194 -0.941 . . . . 0.02 109.788 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.496 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 91.8 mt-10 -69.55 -27.49 65.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.675 . . . . 0.029999999999999999 112.041 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.33 170.75 8.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.569 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.669 ' NH1' HD21 ' A' ' 37' ' ' ASN . 10.9 mpt_? -73.72 157.15 37.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.757 0.789 . . . . 0.029999999999999999 109.897 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.27 35.41 5.94 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.875 0.845 . . . . 0.73999999999999999 111.117 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 7.6 p90 49.6 45.19 24.44 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.699 0.761 . . . . 0.02 111.01 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -112.0 166.29 11.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.01 -1.108 . . . . 0.02 108.01 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -167.16 35.42 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.029999999999999999 110.71 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -68.97 143.03 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.414 -1.05 . . . . 2.7599999999999998 109.204 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.697 ' HE ' ' HG ' ' A' ' 8' ' ' SER . 56.8 ttt180 -119.04 147.8 43.72 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.544 0.688 . . . . 1.8899999999999999 109.587 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -132.45 126.48 33.15 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.728 -1.212 . . . . 0.02 107.728 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -111.92 136.29 51.43 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.708 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.48 137.56 49.83 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.482 0.658 . . . . 0.02 109.48 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -116.52 10.89 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.703 -0.623 . . . . 0.20000000000000001 109.514 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 49.0 t -157.94 174.35 15.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.151 -1.055 . . . . 1.23 108.151 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 p30 -62.15 144.87 54.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.69 -1.256 . . . . 0.02 110.152 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -132.37 116.56 16.99 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.422 -0.955 . . . . 0.02 108.422 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.13 53.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.877 . . . . 0.23999999999999999 110.732 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.23 100.98 2.35 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -105.2 10.1 33.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.005 0.907 . . . . 6.3700000000000001 110.063 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.664 HH22 ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.49 -22.27 61.34 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.672 -0.642 . . . . 3.1099999999999999 110.701 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -75.54 -16.97 60.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.702 -1.249 . . . . 0.88 110.29 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -102.97 -22.03 13.87 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 0.02 109.221 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.2 tp -150.67 129.49 12.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.822 0.82 . . . . 3.3199999999999998 108.825 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -85.63 -10.12 56.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.656 -0.652 . . . . 0.02 111.142 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -171.65 163.91 6.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 m -141.26 113.69 8.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.823 -1.173 . . . . 0.02 109.133 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.669 HD21 ' NH1' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -107.22 -3.7 19.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.029999999999999999 110.285 -179.002 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.36 152.39 31.03 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.002 -1.11 . . . . 0.02 108.002 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.4 147.76 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.02 109.973 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -125.08 126.11 44.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.876 -1.157 . . . . 0.02 107.876 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.45 114.76 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.883 -1.525 . . . . 0.02 106.883 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.15 -34.07 24.11 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.783 -0.767 . . . . 3.8100000000000001 109.865 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.3 150.11 18.99 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.572 -1.775 . . . . 0.02 110.507 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.638 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 84.11 173.39 49.75 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.623 -1.275 . . . . 0.01 110.062 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.1 m -118.61 136.06 54.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.76 -1.2 . . . . 1.48 107.76 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -126.0 153.52 44.23 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.821 -1.174 . . . . 0.02 112.159 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.11 133.08 52.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.108 -2.182 . . . . 0.23999999999999999 105.108 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.1 m -117.94 142.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.092 -0.707 . . . . 0.65000000000000002 109.092 179.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -121.17 145.78 47.47 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.22 1.01 . . . . 0.02 109.77 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 10.4 tt0 -66.68 -34.09 77.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.752 -0.658 . . . . 0.02 111.663 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' NH1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 mpt_? -122.87 159.04 55.39 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 121.002 -1.061 . . . . 0.02 109.287 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.39 166.2 1.89 Allowed 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.528 1.485 . . . . 0.02 112.31 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.4 36.33 11.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.643 0.735 . . . . 0.02 111.167 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 45.52 52.42 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.462 0.648 . . . . 3.3900000000000001 111.08 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.656 ' HG ' ' N ' ' A' ' 56' ' ' GLY . 6.7 t -125.92 163.47 22.88 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.162 0.506 . . . . 2.3300000000000001 109.752 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.656 ' N ' ' HG ' ' A' ' 55' ' ' SER . . . 87.91 -161.2 31.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.592 -1.403 . . . . 0.02 109.592 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.628 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 2.1 m80 -65.72 137.86 57.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.98 -1.306 . . . . 0.02 109.883 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.478 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.7 ptm -119.69 137.04 54.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.604 -0.685 . . . . 5.0099999999999998 109.392 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 49.8 m-85 -134.08 141.01 47.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.499 -0.751 . . . . 0.02 109.714 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.521 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -95.17 132.1 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.555 -0.906 . . . . 1.72 108.555 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -119.96 109.75 37.23 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.476 -0.765 . . . . 0.02 110.323 -178.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -76.49 168.68 23.32 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.007 1.038 . . . . 1.47 110.327 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 73.9 mt-30 -53.41 140.68 26.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.869 -1.144 . . . . 4.25 110.504 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -176.97 32.36 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.627 -1.273 . . . . 0.02 110.452 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.16 130.16 55.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.489 -1.006 . . . . 0.95999999999999996 109.216 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.49 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 30.5 m-85 -121.48 95.24 48.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.22 -3.71 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.767 0.978 . . . . 0.02 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -157.36 154.89 29.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.352 -1.467 . . . . 2.02 108.311 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -60.85 -39.05 87.63 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.677 . . . . 0.02 111.651 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -60.16 -23.62 64.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.02 110.34 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -18.56 62.95 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.063 0.935 . . . . 3.4199999999999999 108.578 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -107.4 10.49 29.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.337 -1.357 . . . . 0.02 107.337 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 27.6 mtm 61.55 21.98 12.53 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.473 0.654 . . . . 0.02 110.738 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.58 144.36 45.97 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.328 -1.509 . . . . 0.02 109.328 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 tp -78.72 -30.83 46.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.493 -1.299 . . . . 0.97999999999999998 107.493 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -156.37 -171.53 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.255 -1.757 . . . . 0.02 106.255 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -97.73 27.7 4.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.646 -1.284 . . . . 0.02 110.194 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.664 ' NH2' HH22 ' A' ' 30' ' ' ARG . 19.7 mmm180 -96.08 122.06 38.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.893 -1.129 . . . . 3.2000000000000002 110.631 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.1 mt -144.98 119.95 10.01 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.511 -1.292 . . . . 2.6099999999999999 107.511 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.32 -16.07 11.66 Favored Glycine 0 N--CA 1.505 3.267 0 O-C-N 121.264 -0.898 . . . . 0.02 112.879 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.8 p -155.52 155.88 34.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.204 -1.763 . . . . 0.02 110.343 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.2 t -144.94 148.21 33.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.334 0.588 . . . . 0.02 109.71 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -135.55 140.24 44.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.332 -0.855 . . . . 0.01 108.89 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 130.12 36.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.205 -0.935 . . . . 0.42999999999999999 108.72 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.55 122.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 1.25 107.993 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -92.0 133.94 35.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.94 -1.1 . . . . 1.77 108.576 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -98.18 137.96 36.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.242 -1.022 . . . . 1.6299999999999999 108.242 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -110.3 126.9 54.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 1.0800000000000001 108.743 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 p -104.29 -154.86 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.28 -1.748 . . . . 1.26 106.28 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.11 -47.5 0.97 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.509 -1.369 . . . . 0.01 112.237 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.53 -100.18 0.14 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.676 -1.726 . . . . 0.01 111.779 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.31 118.74 31.2 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.293 -1.122 . . . . 4.4299999999999997 110.221 -179.091 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.55 130.38 37.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.102 -0.703 . . . . 2.9900000000000002 109.102 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -131.28 139.19 49.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.464 -0.773 . . . . 6.3600000000000003 109.323 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 tt -129.19 144.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.462 -0.774 . . . . 1.0900000000000001 109.742 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.33 134.01 54.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.424 -1.324 . . . . 2.0499999999999998 107.424 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.44 147.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.902 -1.124 . . . . 1.1000000000000001 109.232 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 95.2 m-85 -118.77 141.34 48.71 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.097 0.951 . . . . 0.72999999999999998 111.088 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.78 -30.01 70.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.791 -0.64 . . . . 0.02 111.57 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -117.03 168.77 9.96 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.947 -1.096 . . . . 3.1800000000000002 110.553 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.07 43.31 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.013 -0.835 . . . . 0.01 111.013 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.2 m-20 56.48 39.09 30.1 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.664 0.745 . . . . 0.01 110.86 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 6.7 m-85 52.29 55.58 8.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.69 -0.631 . . . . 0.01 110.952 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -128.85 166.1 19.73 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.496 -0.927 . . . . 3.1499999999999999 108.496 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 -165.38 27.85 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.523 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.3 tt0 -74.52 145.31 43.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.093 -1.239 . . . . 0.01 108.237 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.3 ttp -117.54 142.75 46.81 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.753 0.787 . . . . 0.01 110.179 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 60.7 m-85 -130.94 135.29 47.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.963 -1.125 . . . . 2.48 107.963 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -119.79 135.56 54.81 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.608 -0.683 . . . . 0.01 109.957 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.524 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.1 t -150.09 152.13 34.29 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.33 1.062 . . . . 1.6899999999999999 111.074 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.7 p -110.28 9.55 23.68 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.622 -0.717 . . . . 0.01 109.808 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -121.08 163.32 18.56 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.311 -0.868 . . . . 3.21 111.398 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -66.51 155.28 38.07 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 27.5 t -124.53 111.6 27.86 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.737 -0.838 . . . . 0.01 108.737 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.86 -32.5 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.128 1.081 . . . . 0.01 111.732 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 m -140.82 107.61 5.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.02 108.855 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.7 mt -63.3 -39.04 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.779 -0.576 . . . . 1.8300000000000001 110.375 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 5.9 tpt -66.1 -37.89 86.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.868 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -70.73 -39.3 73.45 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.374 -1.454 . . . . 2.1099999999999999 109.532 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 42.1 tt0 -80.53 -48.01 13.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 2.0800000000000001 112.458 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 66.0 m-85 -111.23 -1.78 15.98 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.02 112.623 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 61.12 34.33 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.745 -1.222 . . . . 0.02 109.603 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' C ' ' SD ' ' A' ' 118' ' ' MET . 52.5 mt -114.33 136.21 53.23 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.517 -0.74 . . . . 0.02 109.432 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -90.25 -21.96 21.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.323 -0.861 . . . . 5.3200000000000003 110.737 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -148.91 164.3 34.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.966 -1.084 . . . . 0.02 109.939 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 126' ' ' ILE . 34.6 mm -129.49 126.7 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.453 -1.314 . . . . 2.1699999999999999 107.453 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -110.07 -12.93 14.47 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.267 -0.896 . . . . 0.02 112.658 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.5 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.8 t -160.42 153.13 21.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.691 -1.256 . . . . 0.01 109.002 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -167.08 146.32 5.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 1.22 109.349 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -125.22 106.4 9.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.45 1.119 . . . . 1.4099999999999999 109.381 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.36 136.38 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.328 -1.36 . . . . 0.01 107.328 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.35 92.47 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 106.861 -1.533 . . . . 1.98 106.861 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.5 tm-20 -146.92 -70.35 0.24 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 105.399 -2.074 . . . . 0.01 105.399 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.483 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 175.1 -78.94 0.08 OUTLIER Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.42 -1.872 . . . . 0.01 108.42 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.8 p -123.88 127.53 48.15 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 122.344 1.069 . . . . 2.2999999999999998 111.114 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -127.9 151.15 49.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 106.789 -1.56 . . . . 0.01 106.789 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -118.08 134.3 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.446 -1.409 . . . . 1.6899999999999999 109.266 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.51 141.69 44.76 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.344 -1.724 . . . . 2.4900000000000002 106.344 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.643 ' HH ' ' HE ' ' A' ' 173' ' ' ARG . 11.3 m-85 -123.19 143.46 50.0 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.22 -0.925 . . . . 0.02 109.64 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.98 -30.69 62.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.739 -0.601 . . . . 0.02 111.668 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.79 154.31 49.42 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.48 108.874 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.82 169.68 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.156 1.238 . . . . 0.02 113.174 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.51 32.29 21.59 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.99 -1.004 . . . . 0.75 111.462 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 55.57 48.34 18.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.534 -0.729 . . . . 0.02 110.382 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.427 ' CA ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -122.08 163.9 18.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.659 -0.651 . . . . 0.02 109.613 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.13 -165.51 32.95 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.16 -1.176 . . . . 0.02 110.16 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.71 143.18 53.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.499 -1.001 . . . . 0.02 109.15 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.478 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.4 mt-30 -112.95 148.24 35.43 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.281 0.562 . . . . 0.02 109.763 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -123.31 133.28 54.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.435 -0.95 . . . . 0.01 108.435 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.23 120.72 37.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.794 -1.191 . . . . 0.01 109.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.5 mp -97.66 139.71 33.15 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.174 -1.047 . . . . 0.01 108.174 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.514 ' C ' ' H ' ' A' ' 154' ' ' LYS . 0.7 OUTLIER -107.39 -171.82 1.95 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.345 -0.847 . . . . 2.27 109.905 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.01 40.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 1.8400000000000001 109.568 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 152' ' ' ASP . 75.3 tttt -113.57 168.49 9.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.619 -0.675 . . . . 2.2799999999999998 109.28 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -103.48 127.54 50.85 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.18 -1.044 . . . . 0.01 108.18 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.477 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 92.8 m-85 -100.85 110.62 22.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.019 -1.051 . . . . 0.01 110.598 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -93.8 -26.66 16.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.314 -0.867 . . . . 0.01 110.736 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -123.24 154.09 65.23 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 107.897 -1.149 . . . . 2.54 107.897 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -62.14 -42.37 29.82 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.237 0.763 . . . . 0.69999999999999996 111.097 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 -18.68 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 120.68 -1.262 . . . . 0.85999999999999999 109.428 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 60.2 t0 -65.53 -18.18 65.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.841 -1.162 . . . . 0.02 111.964 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.77 15.84 27.7 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 120.737 -1.227 . . . . 0.02 110.037 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.89 74.35 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 121.053 -1.029 . . . . 0.02 112.869 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.415 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.56 140.59 34.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.717 -1.46 . . . . 0.02 110.13 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.83 -6.92 59.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.687 -0.633 . . . . 0.58999999999999997 109.553 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 m -140.84 150.06 58.44 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.223 -0.923 . . . . 0.87 109.088 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.47 16.15 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.672 0.915 . . . . 0.38 111.902 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.48 120.5 25.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.039 . . . . 0.17999999999999999 110.727 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.471 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -150.2 124.92 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.554 -2.017 . . . . 3.9900000000000002 105.554 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -112.41 -13.4 13.4 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.354 0.872 . . . . 5.1699999999999999 113.354 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.5 p -156.73 159.51 38.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.205 -2.184 . . . . 0.02 109.919 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -152.27 154.18 35.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.197 -0.939 . . . . 2.02 110.512 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.643 ' HE ' ' HH ' ' A' ' 139' ' ' TYR . 63.8 mtm180 -142.95 148.99 37.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.307 -0.871 . . . . 0.01 110.142 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -86.43 141.7 28.95 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.103 -1.073 . . . . 0.01 108.103 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.1 mt -94.98 128.95 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.084 -1.01 . . . . 3.04 109.766 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.2 m -137.39 149.31 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.485 -0.759 . . . . 1.8899999999999999 109.69 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 2.7 mp0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 4.8899999999999997 109.638 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' LYS . 5.0 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.26 0.553 . . . . 5.2800000000000002 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . 25.6 mttm 57.13 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 5.96 109.411 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.1 m -112.06 -137.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.8 -0.815 . . . . 2.2200000000000002 108.8 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.67 90.22 0.08 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 106.677 -2.569 . . . . 0.81000000000000005 106.677 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.09 147.53 31.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.632 -0.987 . . . . 0.01 110.632 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -154.14 138.61 16.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.587 -0.949 . . . . 0.02 108.757 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 141.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.266 -0.642 . . . . 0.02 109.266 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.484 ' HG ' HH21 ' A' ' 19' ' ' ARG . 1.4 m -121.79 130.1 53.15 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.507 -0.746 . . . . 0.39000000000000001 109.661 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 16.8 m-85 -110.05 139.19 45.44 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.855 -0.794 . . . . 0.02 108.855 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-85 -123.04 139.39 54.13 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.156 -0.965 . . . . 0.02 110.218 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -69.62 -28.44 65.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.981 -178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.87 170.72 8.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 0.029999999999999999 110.54 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -73.39 156.3 38.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.763 0.792 . . . . 0.029999999999999999 110.371 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.98 34.71 8.72 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.811 0.815 . . . . 0.73999999999999999 111.533 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.58 42.37 29.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.02 111.333 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -112.7 165.38 12.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.202 -1.036 . . . . 0.02 108.202 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.74 -166.76 36.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.752 -1.213 . . . . 0.029999999999999999 110.496 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -69.25 142.38 54.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -1.056 . . . . 2.7599999999999998 109.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.484 HH21 ' HG ' ' A' ' 8' ' ' SER . 58.5 ttt180 -119.18 148.22 43.34 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 1.8899999999999999 109.745 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.99 126.68 32.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.209 -1.034 . . . . 0.02 108.209 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.96 136.44 51.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.429 -0.795 . . . . 1.1200000000000001 109.651 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.0 t -130.59 137.8 49.83 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.465 0.65 . . . . 0.02 109.645 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 13.7 t70 -116.98 11.32 14.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.665 -0.647 . . . . 0.20000000000000001 109.713 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.491 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 48.7 m -158.11 173.97 15.92 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.85 144.77 54.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.661 -1.274 . . . . 0.02 110.214 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.3 p -132.02 116.71 17.44 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.82 -25.68 53.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.23999999999999999 110.657 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.72 100.77 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 108.444 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -104.82 9.36 34.88 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.207 1.004 . . . . 6.3700000000000001 109.755 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.572 ' CZ ' ' NH2' ' A' ' 78' ' ' ARG . 57.8 mtp180 -58.93 -23.28 61.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.678 -0.639 . . . . 3.1099999999999999 110.705 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 69.2 p -75.34 -16.69 60.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.691 -1.256 . . . . 0.88 110.162 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.4 m-85 -103.21 -21.65 13.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.02 109.178 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.62 129.2 12.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 3.3199999999999998 108.816 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -86.1 -10.0 55.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.808 -0.558 . . . . 0.02 110.984 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 25.3 ttt180 -171.1 162.04 6.95 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.4 -1.333 . . . . 0.02 107.4 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 35' ' ' ARG . 3.5 m -141.36 114.33 8.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.111 . . . . 0.02 108.842 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -107.54 -0.15 22.29 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.711 -1.243 . . . . 0.029999999999999999 110.583 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 t -156.72 154.08 29.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.545 -1.28 . . . . 0.02 107.545 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.35 148.39 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.117 -0.989 . . . . 0.02 110.218 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -124.68 125.1 43.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.67 113.61 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.756 -1.572 . . . . 0.02 106.756 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -83.69 -34.14 25.03 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.127 -0.629 . . . . 3.8100000000000001 109.531 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.48 150.23 19.13 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.713 -1.708 . . . . 0.02 110.605 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.07 173.44 49.66 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.472 -1.347 . . . . 0.01 109.782 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 m -119.99 137.38 54.11 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 44.6 m95 -126.6 152.98 45.91 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.524 1.154 . . . . 0.02 111.922 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.42 133.79 51.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 104.841 -2.281 . . . . 0.23999999999999999 104.841 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.3 m -117.73 142.94 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.65000000000000002 109.228 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.6 m-85 -119.81 143.68 47.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.34 1.067 . . . . 0.02 109.703 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.08 -34.31 77.77 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.759 -0.655 . . . . 0.02 110.764 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -125.36 157.43 67.78 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.144 -0.972 . . . . 0.02 109.897 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.01 166.82 1.36 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.706 1.604 . . . . 0.02 113.16 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 64.43 36.37 8.93 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.054 -0.976 . . . . 0.02 111.195 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.77 51.79 10.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.534 0.683 . . . . 3.3900000000000001 110.782 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 p -127.25 164.22 22.19 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.286 0.565 . . . . 2.3300000000000001 109.824 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.47 -162.26 31.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.664 ' HD1' ' N ' ' A' ' 58' ' ' MET . 9.3 t-80 -63.05 142.78 58.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -1.204 . . . . 0.02 110.457 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.664 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 29.6 mtp -117.9 134.69 54.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.346 -0.613 . . . . 5.0099999999999998 109.346 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 31.5 m-85 -135.27 135.22 40.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.34 -0.85 . . . . 0.02 109.2 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -96.52 132.31 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.941 -0.763 . . . . 1.72 108.941 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.2 110.22 31.01 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.376 -0.828 . . . . 0.02 110.657 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -75.83 171.45 18.16 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.83 0.975 . . . . 1.47 109.91 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 1.9 pm0 -52.36 139.71 23.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.118 . . . . 4.25 110.237 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -178.02 33.04 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.435 -1.364 . . . . 0.02 110.446 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -119.11 130.06 55.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -1.084 . . . . 0.95999999999999996 109.423 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -120.87 96.54 48.65 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.75 -5.14 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.603 0.868 . . . . 0.02 114.055 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 67' ' ' PRO . 49.3 mm-40 -151.8 152.53 32.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.628 -1.249 . . . . 2.02 107.628 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -60.77 -37.89 83.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.406 -0.809 . . . . 0.02 111.075 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -59.93 -23.65 63.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.051 -1.031 . . . . 0.02 110.28 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.603 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.56 -18.75 62.23 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.283 1.039 . . . . 3.4199999999999999 108.243 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.596 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -105.66 8.42 33.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.212 -1.403 . . . . 0.02 107.212 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.3 mpt? 59.95 21.75 10.79 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.477 0.656 . . . . 0.02 110.35 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.31 143.98 45.74 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.26 -1.536 . . . . 0.02 109.26 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.4 tp -78.42 -30.78 47.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -156.22 -172.19 4.0 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.245 -1.761 . . . . 0.02 106.245 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 38.6 m-20 -97.57 27.46 4.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.781 -1.199 . . . . 0.02 110.346 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.59 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -96.1 122.09 38.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.071 -1.018 . . . . 3.2000000000000002 110.704 -179.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 mt -144.71 120.39 10.48 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.91 -16.05 12.1 Favored Glycine 0 N--CA 1.506 3.312 0 C-N-CA 120.491 -0.862 . . . . 0.02 112.64 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.3 p -156.3 156.89 34.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.393 -1.651 . . . . 0.02 110.238 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.2 m -144.84 148.66 34.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.698 -0.626 . . . . 0.02 109.415 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -136.38 140.83 43.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.332 -0.855 . . . . 0.01 109.136 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.93 36.47 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.305 -0.872 . . . . 0.42999999999999999 109.001 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.71 124.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.247 -1.02 . . . . 1.25 108.247 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -89.47 134.04 34.28 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.925 -1.139 . . . . 1.77 107.925 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.63 139.31 36.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 1.6299999999999999 109.15 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 p -111.22 122.68 48.49 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.669 -1.234 . . . . 1.0800000000000001 107.669 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 m -114.01 133.19 55.66 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.699 -1.223 . . . . 1.26 107.699 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.4 -46.31 0.02 OUTLIER Glycine 0 N--CA 1.501 3.0 0 C-N-CA 117.59 -2.243 . . . . 0.01 113.573 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.83 -103.13 0.17 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 120.17 1.985 . . . . 0.01 111.006 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -120.4 118.66 30.91 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.249 -1.148 . . . . 4.4299999999999997 110.204 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 131.21 41.34 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.141 -0.624 . . . . 2.9900000000000002 109.369 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.28 136.36 46.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.598 -0.689 . . . . 6.3600000000000003 109.67 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.9 tt -127.93 145.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.472 -0.767 . . . . 1.0900000000000001 109.262 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -121.65 133.12 54.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 m -124.32 147.24 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 120.887 -1.133 . . . . 1.1000000000000001 109.09 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -119.26 141.11 49.24 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.081 0.943 . . . . 0.72999999999999998 111.086 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -66.66 -29.56 69.61 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.758 -0.655 . . . . 0.02 111.465 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' O ' ' OG ' ' A' ' 128' ' ' SER . 27.3 mmtp -115.6 169.02 9.5 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.148 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.83 164.82 51.2 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.056 -0.818 . . . . 0.01 111.056 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 57.14 39.46 28.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.854 -0.792 . . . . 0.01 111.411 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.582 ' H ' ' HG ' ' A' ' 128' ' ' SER . 3.6 m-85 52.04 54.13 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.618 -0.677 . . . . 0.01 111.142 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -129.65 165.49 21.68 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.052 -1.092 . . . . 3.1499999999999999 108.052 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.76 -164.63 27.84 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.171 -1.571 . . . . 0.01 109.171 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.07 144.18 43.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.829 -1.394 . . . . 0.01 108.661 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 13.0 tmm? -116.62 142.56 46.73 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.555 0.693 . . . . 0.01 109.885 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -131.42 136.31 47.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.537 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.7 tm-20 -120.41 135.72 54.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.642 -0.661 . . . . 0.01 109.806 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.537 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 5.0 t -149.37 152.48 35.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.253 1.025 . . . . 1.6899999999999999 110.881 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 p -112.01 8.76 20.3 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.729 -0.669 . . . . 0.01 109.941 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -121.48 163.46 18.76 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.331 -0.856 . . . . 3.21 111.353 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -67.94 156.74 36.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.327 -0.99 . . . . 0.01 108.327 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.08 113.08 26.51 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.511 -0.743 . . . . 0.01 109.016 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.9 -28.06 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 120.234 1.119 . . . . 0.01 111.055 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . 2.6 p -144.82 108.57 4.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 0.02 109.004 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.68 -39.52 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.873 -0.517 . . . . 1.8300000000000001 110.444 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.9 ttt -68.0 -37.25 81.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.114 -1.034 . . . . 1.3400000000000001 110.225 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 116' ' ' SER . 39.6 mt-10 -70.43 -38.78 74.63 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.636 -1.29 . . . . 2.1099999999999999 109.958 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -80.25 -47.9 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.932 . . . . 2.0800000000000001 112.417 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -110.7 -0.72 17.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.389 -0.819 . . . . 0.02 112.677 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 m170 60.39 33.52 20.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.696 -1.252 . . . . 0.02 109.434 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.83 134.52 54.31 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.733 -0.84 . . . . 0.02 108.733 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.7 -22.3 20.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 5.3200000000000003 110.163 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -149.29 163.81 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.238 -0.914 . . . . 0.02 109.843 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mt -133.18 129.37 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.272 -1.381 . . . . 2.1699999999999999 107.272 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -108.68 -12.12 14.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.455 -0.778 . . . . 0.02 112.461 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.582 ' HG ' ' H ' ' A' ' 103' ' ' PHE . 17.8 p -160.15 154.45 23.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.01 108.749 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.8 t -166.0 143.13 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 1.22 108.897 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -120.34 103.93 9.61 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.681 1.229 . . . . 1.4099999999999999 109.153 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.1 p -112.08 133.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.706 -1.22 . . . . 0.01 107.706 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.11 87.45 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.351 -2.092 . . . . 1.98 105.351 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -147.07 -65.7 0.27 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.635 -1.617 . . . . 0.01 106.635 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.93 39.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 107.002 -2.439 . . . . 0.01 107.002 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.8 p -122.06 54.18 1.18 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.978 -0.719 . . . . 2.2999999999999998 110.553 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.8 m95 -130.02 139.11 51.06 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.717 -1.239 . . . . 0.01 110.476 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.72 139.71 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.022 -0.733 . . . . 1.6899999999999999 109.022 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -112.07 141.77 45.33 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 106.799 -1.556 . . . . 2.4900000000000002 106.799 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 23.7 m-85 -122.6 143.15 49.94 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.091 -1.006 . . . . 0.02 109.228 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -74.57 -31.17 61.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.606 -0.684 . . . . 0.02 111.613 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -115.06 155.86 46.06 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.68 -1.262 . . . . 1.48 108.752 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -57.88 166.71 4.99 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.095 1.197 . . . . 0.02 112.735 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 15.8 t30 60.09 31.29 20.52 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.142 -0.935 . . . . 0.75 111.456 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 58.72 51.17 7.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.717 . . . . 0.02 110.863 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -126.09 165.61 18.53 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.611 -0.681 . . . . 0.02 110.02 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.75 -165.35 34.94 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.279 -1.128 . . . . 0.02 110.279 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.18 141.78 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.947 . . . . 0.02 108.848 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 15.2 mt-30 -112.63 147.75 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.517 -0.549 . . . . 0.02 109.517 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.18 133.23 53.61 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.764 -0.828 . . . . 0.01 108.764 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.74 121.83 39.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.941 -1.099 . . . . 0.01 109.341 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 28.0 mt -92.78 146.83 23.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.01 109.123 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 154' ' ' LYS . 24.2 m-20 -108.55 -171.43 1.85 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.576 -0.702 . . . . 2.27 109.442 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -75.46 29.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 1.8400000000000001 109.622 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 152' ' ' ASP . 54.8 mttp -113.21 170.94 7.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.5 -0.75 . . . . 2.2799999999999998 109.549 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.91 135.36 47.5 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -100.28 114.01 27.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.37 -0.831 . . . . 0.01 109.96 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -88.59 -28.18 20.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.01 110.988 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -124.63 155.21 69.81 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 107.4 -1.333 . . . . 2.54 107.4 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.1 Cg_endo -61.99 -39.39 50.82 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.395 0.73 . . . . 0.69999999999999996 111.457 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.79 -18.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.817 -1.177 . . . . 0.85999999999999999 109.829 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.15 -19.24 65.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.891 -1.131 . . . . 0.02 112.569 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.55 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.4 OUTLIER -101.79 16.23 26.5 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 120.696 -1.252 . . . . 0.02 109.881 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.66 10.52 79.19 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.369 -0.919 . . . . 0.02 112.771 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.91 141.03 34.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.898 -1.354 . . . . 0.02 110.069 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.7 59.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.658 -0.651 . . . . 0.58999999999999997 109.848 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -142.17 150.0 53.97 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.033 -1.042 . . . . 0.87 109.119 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -75.33 18.15 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.654 0.902 . . . . 0.38 112.144 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.98 122.76 28.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.545 1.164 . . . . 0.17999999999999999 110.922 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.9 mt -148.02 125.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.433 -1.692 . . . . 3.9900000000000002 106.433 179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -113.67 -16.12 12.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 5.1699999999999999 112.65 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.8 p -157.06 158.98 37.47 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 119.247 -2.158 . . . . 0.02 110.196 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.77 154.57 35.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.053 -1.029 . . . . 2.02 110.114 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.442 HH11 ' HG3' ' A' ' 173' ' ' ARG . 5.4 mtm-85 -144.12 150.54 38.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.153 -0.967 . . . . 0.01 110.612 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -86.93 143.39 27.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.69 127.96 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.171 -0.956 . . . . 3.04 109.418 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.06 147.19 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.243 -0.911 . . . . 1.8899999999999999 109.54 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.401 ' OE1' ' OE1' ' A' ' 63' ' ' GLN . 24.5 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.415 -0.803 . . . . 4.8899999999999997 109.412 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.529 -0.545 . . . . 5.2800000000000002 109.529 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -72.03 94.1 1.46 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.177 -0.952 . . . . 5.96 109.441 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.4 m -102.46 -140.49 0.35 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.689 -1.226 . . . . 2.2200000000000002 107.689 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.18 87.5 0.07 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.957 -2.457 . . . . 0.81000000000000005 106.957 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.95 149.59 33.04 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.117 -1.04 . . . . 0.01 110.725 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -151.49 136.97 17.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.493 -1.004 . . . . 0.02 109.367 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -129.46 140.06 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.881 -0.785 . . . . 0.02 108.881 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -121.39 129.84 53.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.562 -0.711 . . . . 0.39000000000000001 109.242 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -108.94 138.95 44.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.542 -0.91 . . . . 0.02 108.542 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.55 138.82 54.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.265 -0.897 . . . . 0.02 109.416 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.87 -27.75 65.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.767 . . . . 0.029999999999999999 111.705 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.71 169.85 8.76 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.893 -1.129 . . . . 0.029999999999999999 110.656 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 94.2 mtt180 -73.48 157.32 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.702 0.763 . . . . 0.029999999999999999 110.216 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 t-20 65.16 35.7 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.756 0.788 . . . . 0.73999999999999999 111.086 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.1 p90 49.97 45.05 25.52 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.685 0.755 . . . . 0.02 111.122 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -112.63 165.94 11.8 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.41 -167.13 35.28 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 120.761 -1.212 . . . . 0.029999999999999999 110.725 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -69.3 142.48 54.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 2.7599999999999998 109.125 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -121.1 149.51 42.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 1.8899999999999999 110.034 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -132.93 127.42 34.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.1 135.69 50.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 1.1200000000000001 109.22 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -130.13 136.92 49.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 -178.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.84 9.09 11.9 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.534 -0.729 . . . . 0.20000000000000001 110.343 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 44.9 t -157.69 173.69 16.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.018 -1.051 . . . . 1.23 108.469 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 64.4 t0 -60.45 142.23 55.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.074 -1.641 . . . . 0.02 110.834 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.2 m -132.36 116.47 16.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.408 -0.96 . . . . 0.02 108.408 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.1 54.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.795 . . . . 0.23999999999999999 110.873 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -155.67 101.76 2.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 108.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.1 p90 -105.85 9.6 32.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.418 1.104 . . . . 6.3700000000000001 109.908 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -60.21 -22.17 62.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.292 -0.88 . . . . 3.1099999999999999 110.801 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 18.0 p -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.785 -1.197 . . . . 0.88 109.945 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.5 m-85 -102.67 -21.3 14.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.453 -0.779 . . . . 0.02 109.083 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.8 tp -149.81 128.85 12.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.846 -0.798 . . . . 3.3199999999999998 108.846 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t -84.25 -9.67 58.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.02 110.567 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -171.4 163.79 6.94 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.474 -1.306 . . . . 0.02 107.474 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -141.83 113.75 7.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.697 -1.252 . . . . 0.02 108.538 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 1.3 t30 -108.96 -1.58 18.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 111.42 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -153.86 153.53 32.27 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.179 -1.045 . . . . 0.02 108.179 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.77 146.88 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.061 -1.024 . . . . 0.02 110.672 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' NE ' ' HH ' ' A' ' 10' ' ' TYR . 19.8 ttp180 -125.5 125.68 43.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.397 -1.335 . . . . 0.02 107.397 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.56 114.32 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.949 -1.5 . . . . 0.02 106.949 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.8 -34.3 27.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.586 -0.696 . . . . 3.8100000000000001 110.485 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 152.01 21.74 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 118.974 -1.584 . . . . 0.02 110.138 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.83 174.43 49.46 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.255 -1.45 . . . . 0.01 110.026 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.441 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 31.6 m -110.77 161.24 15.98 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' C ' ' A' ' 45' ' ' THR . 70.0 m95 -148.26 148.63 30.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.618 -1.301 . . . . 0.02 111.609 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.81 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 105.452 -2.055 . . . . 0.23999999999999999 105.452 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.1 m -117.11 141.98 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.551 -0.718 . . . . 0.65000000000000002 109.628 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.519 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 -120.34 143.15 48.54 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.062 0.934 . . . . 0.02 109.434 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -64.69 -33.96 77.17 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.589 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -124.59 157.84 64.09 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.131 -0.981 . . . . 0.02 109.575 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.37 166.56 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.663 1.576 . . . . 0.02 112.944 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.4 t30 63.68 37.17 10.27 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.275 -0.875 . . . . 0.02 111.279 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.28 50.92 9.63 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.568 0.699 . . . . 3.3900000000000001 110.56 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.8 m -125.72 163.8 22.03 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.268 0.556 . . . . 2.3300000000000001 109.876 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.59 -162.07 31.47 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.553 -1.419 . . . . 0.02 109.553 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -67.03 138.23 57.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.98 -1.306 . . . . 0.02 110.137 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 17.7 ptm -119.21 137.46 53.62 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.417 0.627 . . . . 5.0099999999999998 109.68 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.0 m-85 -132.92 140.56 47.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.175 -0.676 . . . . 0.02 109.175 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -96.58 132.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.379 -0.971 . . . . 1.72 108.379 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -120.78 113.76 32.97 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.524 -0.735 . . . . 0.02 110.768 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.16 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 CA-C-N 119.915 1.005 . . . . 1.47 110.046 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -53.52 140.82 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.758 -1.214 . . . . 4.25 110.409 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.87 -177.78 32.78 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.512 -1.328 . . . . 0.02 110.55 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.85 130.26 55.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -1.02 . . . . 0.95999999999999996 109.438 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 23.1 m-85 -121.42 92.99 48.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 107.972 -1.121 . . . . 0.02 107.972 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.59 -3.91 8.7 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.877 1.051 . . . . 0.02 113.589 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -156.92 153.37 28.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.535 -1.353 . . . . 2.02 107.969 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -59.89 -38.07 81.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.02 111.888 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -59.9 -24.14 64.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.02 110.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.521 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.03 -18.29 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.088 0.947 . . . . 3.4199999999999999 108.495 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.574 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 0.5 OUTLIER -106.98 10.59 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.184 -1.413 . . . . 0.02 107.184 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.38 22.73 11.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.677 . . . . 0.02 110.417 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 145.53 46.49 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.161 -1.575 . . . . 0.02 109.161 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.43 -30.26 42.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.296 . . . . 0.97999999999999998 107.942 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.523 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 54.2 t30 -157.24 -172.08 3.87 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.477 -1.675 . . . . 0.02 106.477 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.523 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.1 p30 -97.72 27.6 4.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.705 -1.247 . . . . 0.02 110.482 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -95.8 121.78 37.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.922 -1.112 . . . . 3.2000000000000002 110.324 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.449 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 37.1 mt -144.33 119.4 10.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 2.6099999999999999 107.69 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.24 11.15 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 121.381 -0.824 . . . . 0.02 112.938 -177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.532 ' HG ' ' N ' ' A' ' 82' ' ' CYS . 29.6 t -155.6 156.43 35.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.203 -1.763 . . . . 0.02 110.897 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.532 ' N ' ' HG ' ' A' ' 81' ' ' SER . 83.9 m -145.77 148.32 32.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.626 0.727 . . . . 0.02 110.525 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 48.5 mtm180 -134.73 139.42 45.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.677 -0.861 . . . . 0.01 108.677 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.89 130.45 36.62 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.187 -1.042 . . . . 0.42999999999999999 108.187 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.66 124.8 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.395 -0.965 . . . . 1.25 108.395 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -90.74 134.17 34.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.925 -1.109 . . . . 1.77 108.335 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.67 139.35 34.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.938 -0.764 . . . . 1.6299999999999999 108.938 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 p -112.29 125.1 53.8 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.487 -0.931 . . . . 1.0800000000000001 108.487 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -102.28 -156.06 0.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 106.163 -1.791 . . . . 1.26 106.163 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.01 -46.45 1.01 Allowed Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.57 -1.331 . . . . 0.01 112.14 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.36 -97.89 0.11 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 118.352 -1.88 . . . . 0.01 112.382 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -121.51 119.91 33.36 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.336 -1.096 . . . . 4.4299999999999997 110.966 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.81 130.23 38.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.162 -0.681 . . . . 2.9900000000000002 109.162 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -132.1 139.17 48.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.475 -0.766 . . . . 6.3600000000000003 109.319 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -127.46 144.87 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.385 -0.822 . . . . 1.0900000000000001 109.72 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.501 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 0.1 OUTLIER -123.45 132.94 54.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.938 -1.134 . . . . 2.0499999999999998 107.938 177.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.26 147.64 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.881 -1.137 . . . . 1.1000000000000001 109.586 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.9 141.49 48.61 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.019 0.914 . . . . 0.72999999999999998 111.061 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.36 -30.3 70.07 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.898 -0.592 . . . . 0.02 111.83 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 92.0 mttt -116.26 167.63 10.84 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.273 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.77 163.93 43.42 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 57.17 38.44 28.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.828 -0.807 . . . . 0.01 111.088 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 52.46 55.5 9.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.61 -0.682 . . . . 0.01 111.007 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.76 165.34 21.13 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.501 -0.926 . . . . 3.1499999999999999 108.501 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.3 -163.72 27.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.25 -1.54 . . . . 0.01 109.25 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.77 143.5 44.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.006 -1.291 . . . . 0.01 108.653 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.6 142.42 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.465 0.65 . . . . 0.01 109.427 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -131.75 135.51 46.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.239 -1.022 . . . . 2.48 108.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -121.61 135.28 54.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.648 -0.657 . . . . 0.01 110.008 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.544 ' HG1' ' N ' ' A' ' 111' ' ' THR . 3.2 t -149.64 153.4 36.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.222 1.011 . . . . 1.6899999999999999 110.587 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.544 ' N ' ' HG1' ' A' ' 110' ' ' THR . 40.8 p -109.55 10.04 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.844 -0.616 . . . . 0.01 109.712 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 20.6 mp0 -120.53 163.13 18.43 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.315 -0.866 . . . . 3.21 111.175 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.51 154.55 38.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 11.6 t -123.19 110.26 31.01 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.673 -0.862 . . . . 0.01 108.673 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.9 -32.6 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.873 0.99 . . . . 0.01 111.662 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.5 m -140.43 107.79 5.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.322 -0.861 . . . . 0.02 108.819 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.0 mt -63.82 -39.76 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.67 -0.644 . . . . 1.8300000000000001 110.794 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.26 -37.63 83.8 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.053 -1.059 . . . . 1.3400000000000001 110.073 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.24 -39.15 75.2 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.416 -1.427 . . . . 2.1099999999999999 109.763 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.9 tt0 -80.39 -47.24 14.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 2.0800000000000001 112.476 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.5 m-85 -111.27 -1.05 16.21 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.451 -0.781 . . . . 0.02 112.681 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.2 m80 61.77 33.4 17.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.839 -1.163 . . . . 0.02 109.802 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.3 mt -114.18 135.41 54.07 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.563 -0.711 . . . . 0.02 109.248 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -90.25 -22.13 21.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 5.3200000000000003 110.987 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -148.6 164.05 35.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.983 -1.073 . . . . 0.02 109.74 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.411 HG23 HD12 ' A' ' 126' ' ' ILE . 41.8 mm -128.59 125.24 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 107.21 -1.404 . . . . 2.1699999999999999 107.21 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -108.72 -14.1 14.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.305 -0.872 . . . . 0.02 112.573 -177.066 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 13.0 p -160.59 153.71 21.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.661 -1.274 . . . . 0.01 109.069 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 4.1 t -166.39 140.3 4.16 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.115 -1.069 . . . . 1.22 108.115 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.418 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 ptpt -119.53 98.85 6.33 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.4 1.095 . . . . 1.4099999999999999 108.635 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.07 137.69 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -125.76 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 105.485 -2.043 . . . . 1.98 105.485 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.484 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 5.9 mm-40 -148.91 -65.42 0.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.458 -1.682 . . . . 0.01 106.458 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.09 -12.51 26.65 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 108.004 -2.038 . . . . 0.01 108.004 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.8 p -120.42 62.02 0.86 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.827 -0.808 . . . . 2.2999999999999998 110.764 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.484 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 73.7 m95 -132.56 135.34 45.87 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.811 -1.181 . . . . 0.01 110.472 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mt -119.34 137.84 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.058 -1.09 . . . . 1.6899999999999999 108.058 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -111.23 141.29 44.94 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.959 -1.497 . . . . 2.4900000000000002 106.959 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 31.3 m-85 -123.24 143.56 49.97 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.1 -1.0 . . . . 0.02 109.594 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.88 -30.33 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.6 -0.687 . . . . 0.02 111.497 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.4 152.97 47.54 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.788 -1.195 . . . . 1.48 109.003 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.77 167.81 2.02 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.086 1.19 . . . . 0.02 113.05 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.31 30.86 20.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.874 -1.057 . . . . 0.75 111.278 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 58.43 51.88 7.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.528 -0.732 . . . . 0.02 111.065 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -127.16 165.54 19.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.564 -0.71 . . . . 0.02 110.141 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.95 -165.42 34.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.218 -1.153 . . . . 0.02 110.218 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -69.22 141.69 54.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.536 -0.979 . . . . 0.02 108.893 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 58' ' ' MET . 10.0 mt-30 -113.38 148.71 35.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.502 -0.555 . . . . 0.02 109.502 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -123.72 133.51 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.551 -0.907 . . . . 0.01 108.551 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.426 ' H ' ' CE ' ' A' ' 58' ' ' MET . 10.1 tp -95.51 122.28 38.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.884 -1.135 . . . . 0.01 109.266 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.1 mp -91.58 149.82 21.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.724 -0.843 . . . . 0.01 108.724 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.656 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 1.9 m-20 -108.85 -177.15 3.23 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.471 -0.768 . . . . 2.27 109.498 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -74.38 29.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.85 . . . . 1.8400000000000001 109.698 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 152' ' ' ASP . 49.6 mttm -112.94 176.12 5.15 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.476 -0.765 . . . . 2.2799999999999998 109.498 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 2.2 mp0 -105.91 134.8 48.46 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.838 -0.801 . . . . 0.01 108.838 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.656 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 97.1 m-85 -100.0 112.46 24.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.01 110.302 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -88.39 -29.5 20.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.01 111.133 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -122.72 154.35 63.57 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.056 -1.09 . . . . 2.54 108.056 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.3 Cg_endo -61.79 -42.95 28.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 CA-C-N 119.373 0.812 . . . . 0.69999999999999996 110.55 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.61 -18.81 17.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 109.454 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.59 -17.86 64.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.809 -1.182 . . . . 0.02 111.737 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.38 15.52 28.55 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 120.725 -1.234 . . . . 0.02 110.193 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.86 10.55 75.51 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 121.206 -0.934 . . . . 0.02 112.967 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.432 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.68 140.79 34.46 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.855 -1.38 . . . . 0.02 110.009 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.55 -6.83 59.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.669 -0.644 . . . . 0.58999999999999997 109.612 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -140.49 149.94 59.05 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.109 -0.994 . . . . 0.87 109.169 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.81 16.13 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.571 0.847 . . . . 0.38 111.909 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.26 120.76 25.79 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.323 1.059 . . . . 0.17999999999999999 110.841 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.427 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -150.35 123.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.416 -2.068 . . . . 3.9900000000000002 105.416 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -114.79 -11.01 12.32 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 113.365 0.876 . . . . 5.1699999999999999 113.365 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 172' ' ' PHE . 30.9 t -156.64 158.48 37.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.276 -2.14 . . . . 0.02 110.106 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.423 ' N ' ' HG ' ' A' ' 171' ' ' SER . 24.6 p90 -151.7 153.56 34.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.198 -0.939 . . . . 2.02 110.287 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -143.19 149.34 37.87 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.816 0.817 . . . . 0.01 110.206 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.82 143.59 27.05 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.337 -0.986 . . . . 0.01 108.337 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.36 128.5 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.252 -0.905 . . . . 3.04 109.742 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.24 146.61 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.185 -0.947 . . . . 1.8899999999999999 109.839 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.105 -0.702 . . . . 4.8899999999999997 109.105 179.288 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.514 -0.55 . . . . 5.2800000000000002 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -57.97 98.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 5.96 109.46 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.3 m -105.59 -139.44 0.37 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.2 -1.037 . . . . 2.2200000000000002 108.2 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.03 88.6 0.07 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 106.943 -2.463 . . . . 0.81000000000000005 106.943 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.96 149.48 32.89 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.275 -0.964 . . . . 0.01 110.851 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -151.43 137.88 18.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.395 -1.062 . . . . 0.02 109.614 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -130.15 139.84 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.326 -0.62 . . . . 0.02 109.326 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.88 129.74 53.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.39000000000000001 109.836 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -109.59 139.41 44.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -122.89 138.36 54.68 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.266 -0.896 . . . . 0.02 109.576 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.61 -27.7 67.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.029999999999999999 111.904 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -114.97 170.92 7.98 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.613 ' HE ' ' H ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -74.98 157.95 34.09 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.607 0.718 . . . . 0.029999999999999999 110.092 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.5 t-20 66.26 34.97 6.2 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.91 0.862 . . . . 0.73999999999999999 110.873 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.8 p90 50.11 44.94 25.94 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.807 0.813 . . . . 0.02 111.139 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.1 166.49 11.37 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.084 -1.08 . . . . 0.02 108.084 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.22 -167.81 36.3 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.731 -1.231 . . . . 0.029999999999999999 110.788 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -68.24 142.6 55.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 2.7599999999999998 108.939 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -121.18 149.74 42.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.686 0.755 . . . . 1.8899999999999999 110.093 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -133.05 127.62 34.45 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.012 -1.106 . . . . 0.02 108.012 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -110.78 136.15 50.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.609 -0.682 . . . . 1.1200000000000001 109.177 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -130.23 137.02 49.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.02 109.338 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.39 9.19 12.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.628 -0.67 . . . . 0.20000000000000001 110.141 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.5 p -157.8 173.82 16.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 1.23 108.318 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 16.5 t0 -59.65 141.7 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.283 -1.51 . . . . 0.02 110.568 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.5 m -131.68 116.42 17.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.281 -1.007 . . . . 0.02 108.281 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.94 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.048 -1.033 . . . . 0.23999999999999999 110.948 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -153.3 101.04 2.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.99 . . . . 1.1399999999999999 108.806 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -105.59 9.04 33.46 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.637 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.5 mmp_? -57.88 -23.66 54.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.654 -0.654 . . . . 3.1099999999999999 110.565 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -74.05 -16.91 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.154 . . . . 0.88 109.971 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -105.41 -22.06 13.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.481 -0.762 . . . . 0.02 109.498 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.2 tp -148.18 125.34 11.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 3.3199999999999998 109.082 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 58.3 m -87.58 -13.15 43.65 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.74 . . . . 0.02 111.78 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 34' ' ' SER . 51.3 mtm180 -166.27 160.43 15.92 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.2 -1.407 . . . . 0.02 107.2 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' O ' ' SG ' ' A' ' 36' ' ' CYS . 16.3 p -140.76 113.32 8.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.847 -1.158 . . . . 0.02 108.956 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -106.71 -0.49 23.56 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.82 -1.175 . . . . 0.029999999999999999 110.379 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -156.41 154.26 30.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.42 147.71 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.043 -1.036 . . . . 0.02 110.45 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -123.8 125.29 44.44 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.41 -0.959 . . . . 0.02 108.41 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.23 113.7 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.735 -1.58 . . . . 0.02 106.735 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -82.82 -34.19 26.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.366 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 151.77 21.37 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.135 -1.507 . . . . 0.02 110.397 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.42 174.43 50.37 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.696 -1.24 . . . . 0.01 110.175 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 95.4 m -109.49 160.49 16.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.889 -1.523 . . . . 1.48 106.889 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' THR . 50.4 m95 -148.02 146.97 29.12 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.208 -1.557 . . . . 0.02 111.506 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.66 132.37 54.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.519 -2.03 . . . . 0.23999999999999999 105.519 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.42 143.12 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.523 -0.735 . . . . 0.65000000000000002 109.625 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 12.1 m-85 -119.05 142.87 47.47 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.207 1.003 . . . . 0.02 109.803 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.28 -34.68 77.92 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.873 -0.603 . . . . 0.02 111.075 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -124.33 154.21 68.98 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.04 -1.038 . . . . 0.02 109.457 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.71 168.02 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.596 1.531 . . . . 0.02 113.33 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.09 36.45 7.31 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.151 -0.931 . . . . 0.02 111.035 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 45.58 50.54 10.44 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.784 0.802 . . . . 3.3900000000000001 110.527 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -127.21 164.46 21.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.246 0.546 . . . . 2.3300000000000001 109.971 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -162.39 31.68 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.156 -1.178 . . . . 0.02 110.156 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.506 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -62.31 141.23 58.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.089 -1.242 . . . . 0.02 110.568 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 49.4 mtp -117.94 133.12 56.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.529 -0.545 . . . . 5.0099999999999998 109.529 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.55 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.3 m-85 -136.08 137.08 40.71 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.766 0.793 . . . . 0.02 109.703 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.8 mp -97.21 133.28 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.324 -0.991 . . . . 1.72 108.324 178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.9 mt -120.25 113.57 33.84 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.663 -0.648 . . . . 0.02 110.405 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -77.79 169.54 20.55 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 CA-C-N 119.987 1.031 . . . . 1.47 109.951 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -52.62 140.92 21.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 4.25 110.151 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -177.38 32.54 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.331 -1.414 . . . . 0.02 110.748 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.66 131.18 55.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.552 -0.969 . . . . 0.95999999999999996 109.349 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -120.72 97.13 48.63 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.81 -1.181 . . . . 0.02 107.81 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.03 -4.39 12.42 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.738 0.959 . . . . 0.02 113.837 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -157.39 154.68 29.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.419 -1.426 . . . . 2.02 108.254 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -60.7 -37.95 83.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.616 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -23.85 64.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.02 110.213 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.53 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.67 -18.51 62.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.128 0.966 . . . . 3.4199999999999999 108.655 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.55 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -106.73 10.07 30.98 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.17 -1.419 . . . . 0.02 107.17 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.0 mtt 60.49 21.05 10.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.51 0.672 . . . . 0.02 110.231 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 144.59 47.06 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.095 -1.602 . . . . 0.02 109.095 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.1 tp -78.14 -29.38 48.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.597 -1.26 . . . . 0.97999999999999998 107.597 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' C ' HD21 ' A' ' 76' ' ' ASN . 0.1 OUTLIER -156.75 -170.76 3.42 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 97.9 m-20 -98.1 29.05 3.67 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.62 -1.3 . . . . 0.02 110.204 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.1 123.08 41.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.262 -0.899 . . . . 3.2000000000000002 111.329 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.476 ' O ' ' CZ ' ' A' ' 30' ' ' ARG . 28.1 mt -143.18 120.48 11.57 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.733 -1.58 . . . . 2.6099999999999999 106.733 177.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.93 -16.65 13.24 Favored Glycine 0 N--CA 1.503 3.158 0 O-C-N 121.248 -0.908 . . . . 0.02 112.329 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.8 p -156.07 156.0 33.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.465 -1.609 . . . . 0.02 109.656 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.55 147.66 33.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.521 0.677 . . . . 0.02 109.547 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -134.08 139.39 45.93 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.542 -0.911 . . . . 0.01 108.542 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.86 130.12 37.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.11 -1.07 . . . . 0.42999999999999999 108.11 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.05 123.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -90.06 137.92 31.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 1.77 109.165 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.95 136.83 40.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.422 -0.955 . . . . 1.6299999999999999 108.422 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -113.34 126.85 55.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.819 . . . . 1.0800000000000001 108.968 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.9 m -103.25 -155.02 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.197 -1.779 . . . . 1.26 106.197 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.34 -48.89 0.88 Allowed Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.391 -1.443 . . . . 0.01 112.593 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.85 -100.37 0.14 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.495 -1.812 . . . . 0.01 112.136 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.76 119.05 31.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.311 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.77 129.92 36.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.909 -0.716 . . . . 2.9900000000000002 109.24 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.558 ' CB ' ' HZ2' ' A' ' 94' ' ' LYS . 7.8 ttpm? -130.52 139.42 50.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 6.3600000000000003 109.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.58 145.14 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.311 -0.868 . . . . 1.0900000000000001 109.949 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -122.67 133.16 54.52 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.251 -1.388 . . . . 2.0499999999999998 107.251 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.73 148.01 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.041 -1.037 . . . . 1.1000000000000001 109.486 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 45.3 m-85 -119.33 140.99 49.42 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.248 1.023 . . . . 0.72999999999999998 110.824 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -65.86 -29.05 69.44 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.659 -0.7 . . . . 0.02 111.33 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -116.59 169.47 9.32 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.151 -0.968 . . . . 3.1800000000000002 110.443 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.37 52.02 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.938 -0.865 . . . . 0.01 110.938 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 t0 57.36 38.37 28.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 0.01 111.252 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 51.84 54.81 10.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.01 111.296 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -129.61 165.97 20.68 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.07 -164.77 27.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.309 -1.517 . . . . 0.01 109.309 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.05 145.12 40.39 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.023 -1.28 . . . . 0.01 108.473 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 44.3 ttp -116.69 142.45 46.89 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.764 0.792 . . . . 0.01 110.093 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.36 135.0 47.59 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.777 -1.194 . . . . 2.48 107.777 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -120.68 135.54 55.09 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.632 -0.668 . . . . 0.01 110.217 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 1.5 t -149.69 151.32 33.48 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.178 0.989 . . . . 1.6899999999999999 110.84 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.7 p -109.08 9.9 26.17 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 115.641 -0.708 . . . . 0.01 109.756 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.66 163.57 17.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.369 -0.832 . . . . 3.21 111.29 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.32 155.23 37.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.181 -1.044 . . . . 0.01 108.181 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.4 t -122.42 109.25 33.06 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.619 -0.882 . . . . 0.01 108.619 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.81 -34.11 2.55 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 CA-C-N 119.878 0.992 . . . . 0.01 111.44 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 p -139.07 106.79 5.62 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.459 -0.941 . . . . 0.02 108.459 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.51 -40.12 87.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.907 -0.496 . . . . 1.8300000000000001 111.148 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.0 ttp -66.87 -37.6 84.73 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.921 -1.112 . . . . 1.3400000000000001 110.039 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.31 -38.85 75.04 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.867 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.41 ' CD ' ' CE2' ' A' ' 121' ' ' PHE . 65.2 tt0 -80.74 -47.57 13.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.228 -0.92 . . . . 2.0800000000000001 112.471 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.41 ' CE2' ' CD ' ' A' ' 120' ' ' GLN . 75.3 m-85 -111.69 -1.87 15.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.4 -0.812 . . . . 0.02 112.69 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.6 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.35 33.77 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.887 -1.133 . . . . 0.02 109.765 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.02 135.69 53.74 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.478 -0.763 . . . . 0.02 109.099 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -21.77 22.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.908 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -148.45 163.99 35.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.874 -1.141 . . . . 0.02 110.035 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.41 HG23 HD13 ' A' ' 126' ' ' ILE . 35.6 mm -129.57 126.68 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.548 -1.279 . . . . 2.1699999999999999 107.548 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -110.36 -12.99 14.37 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.267 -0.896 . . . . 0.02 112.873 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 p -160.69 153.48 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.658 -1.276 . . . . 0.01 109.255 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.6 p -165.25 143.73 6.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.22 109.26 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -123.87 101.78 7.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.081 -1.012 . . . . 1.4099999999999999 109.631 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.6 p -107.72 138.2 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.984 -1.117 . . . . 0.01 107.984 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.57 92.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 106.598 -1.631 . . . . 1.98 106.598 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.519 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 23.8 tt0 -146.11 -75.9 0.2 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.469 -2.048 . . . . 0.01 105.469 178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.86 -77.49 0.07 OUTLIER Glycine 0 N--CA 1.479 1.566 0 N-CA-C 108.089 -2.005 . . . . 0.01 108.089 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 82.2 p -123.23 126.44 46.95 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.547 1.165 . . . . 2.2999999999999998 111.141 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.519 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 7.0 m95 -126.86 151.17 48.74 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.247 -1.76 . . . . 0.01 106.247 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.51 133.98 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.483 -1.386 . . . . 1.6899999999999999 109.408 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.51 141.4 45.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.56 -1.645 . . . . 2.4900000000000002 106.56 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.457 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 33.4 m-85 -121.52 142.61 49.9 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.258 -0.901 . . . . 0.02 109.091 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 168' ' ' ALA . 9.9 tp10 -73.87 -30.17 62.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.547 -0.72 . . . . 0.02 110.975 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.9 154.81 48.31 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.851 -1.155 . . . . 1.48 108.932 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -57.08 167.96 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.174 1.25 . . . . 0.02 113.024 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 60.09 31.5 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.284 178.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.6 51.48 9.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.74 . . . . 0.02 111.038 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -126.91 164.89 20.44 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.521 -0.737 . . . . 0.02 110.241 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.61 -165.69 32.44 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.251 -1.14 . . . . 0.02 110.251 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.41 142.85 53.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.977 . . . . 0.02 108.712 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.43 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 5.4 mt-30 -112.32 147.77 35.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.657 -0.652 . . . . 0.02 110.074 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -123.83 133.43 53.79 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.731 -0.841 . . . . 0.01 108.731 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.19 121.53 39.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.926 -1.108 . . . . 0.01 109.913 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 9.7 mp -96.48 140.78 30.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.371 -0.974 . . . . 0.01 108.371 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 154' ' ' LYS . 93.5 m-20 -104.29 -174.48 2.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.376 -0.828 . . . . 2.27 109.754 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -70.72 35.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.983 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.528 ' H ' ' C ' ' A' ' 152' ' ' ASP . 50.6 mttp -113.85 173.18 6.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 2.2799999999999998 109.22 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.67 130.67 52.66 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.391 -0.966 . . . . 0.01 108.391 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.05 111.54 23.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.11 -0.994 . . . . 0.01 109.817 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' H ' ' CD ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -92.75 -27.22 17.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.01 111.073 -177.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -123.12 153.71 64.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.813 -1.18 . . . . 2.54 107.813 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.16 -42.72 27.58 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 CA-C-N 119.246 0.766 . . . . 0.69999999999999996 111.102 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -60.6 -18.98 17.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.725 -1.234 . . . . 0.85999999999999999 109.439 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 57.4 t0 -65.72 -18.01 65.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.02 112.087 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.67 15.8 27.78 Favored 'General case' 0 N--CA 1.514 2.735 0 O-C-N 120.66 -1.275 . . . . 0.02 110.086 178.283 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.46 75.28 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.129 -0.982 . . . . 0.02 112.963 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.413 ' HB1' ' HE1' ' A' ' 162' ' ' TRP . . . -100.47 140.43 34.73 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.834 -1.392 . . . . 0.02 110.062 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.48 -7.1 59.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.706 . . . . 0.58999999999999997 109.427 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -140.8 150.37 59.6 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.87 108.992 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -74.36 16.52 0.58 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.632 0.888 . . . . 0.38 111.915 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.36 120.31 25.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.026 -1.046 . . . . 0.17999999999999999 110.759 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.3 mt -149.37 123.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.601 -2.0 . . . . 3.9900000000000002 105.601 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -111.9 -14.05 13.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.233 -0.917 . . . . 5.1699999999999999 113.251 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.1 t -156.24 158.68 37.96 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.257 -2.152 . . . . 0.02 109.965 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -152.9 154.49 35.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.164 -0.96 . . . . 2.02 110.569 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.457 ' NH2' ' OH ' ' A' ' 139' ' ' TYR . 87.1 mtm180 -143.3 148.35 36.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.01 109.946 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -85.96 142.78 28.56 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.388 -0.967 . . . . 0.01 108.388 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.96 126.57 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.967 -1.083 . . . . 3.04 109.764 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 177' ' ' GLU . 31.2 m -137.47 147.08 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 1.8899999999999999 109.199 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' A' ' 176' ' ' VAL . 10.2 tt0 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 108.356 -0.979 . . . . 4.8899999999999997 108.356 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.38 -0.6 . . . . 5.2800000000000002 109.38 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -82.08 136.78 35.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 5.96 109.536 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -138.75 -128.68 0.12 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.159 -0.963 . . . . 2.2200000000000002 111.468 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.48 95.28 0.1 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.981 -2.848 . . . . 0.81000000000000005 105.981 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.81 146.29 30.92 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.312 -0.947 . . . . 0.01 111.196 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -152.86 138.08 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.759 -0.848 . . . . 0.02 108.756 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.05 141.06 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.354 -0.61 . . . . 0.02 109.354 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -122.06 130.26 53.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.499 -0.751 . . . . 0.39000000000000001 109.722 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -109.26 138.93 44.86 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.61 -0.885 . . . . 0.02 108.61 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.6 m-85 -122.36 139.0 54.33 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.353 -0.842 . . . . 0.02 109.802 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 10.1 mm-40 -69.19 -28.6 66.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.029999999999999999 111.79 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -114.34 169.83 8.74 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.471 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 94.7 mtt180 -74.27 157.54 35.63 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.695 0.759 . . . . 0.029999999999999999 110.02 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.5 m-80 65.97 35.56 6.39 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.995 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.8 p90 49.78 45.69 24.53 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.736 0.779 . . . . 0.02 111.414 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -113.01 166.49 11.36 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.132 -1.062 . . . . 0.02 108.132 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.08 -167.58 36.32 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 120.78 -1.2 . . . . 0.029999999999999999 110.8 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' NH2' ' H ' ' A' ' 34' ' ' SER . 30.1 ttp180 -68.94 142.73 54.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.976 . . . . 2.7599999999999998 109.196 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -120.78 148.68 43.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.649 0.737 . . . . 1.8899999999999999 110.29 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -131.73 126.68 35.1 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.915 -1.143 . . . . 0.02 107.915 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -112.09 136.81 51.0 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 1.1200000000000001 109.655 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.49 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.4 t -130.67 138.19 49.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.461 0.648 . . . . 0.02 109.565 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.2 m-20 -117.14 10.16 13.78 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.383 0.611 . . . . 0.20000000000000001 109.398 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.49 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 46.1 m -158.42 174.56 14.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.02 -1.104 . . . . 1.23 108.02 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.3 p-10 -62.11 144.41 55.36 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.581 -1.324 . . . . 0.02 110.49 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -131.59 117.25 18.46 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.99 53.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.23999999999999999 110.567 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 27.8 p-10 -154.11 100.86 2.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 1.1399999999999999 108.682 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.41 9.27 35.77 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.226 1.012 . . . . 6.3700000000000001 109.522 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.604 ' NH2' ' H ' ' A' ' 79' ' ' LEU . 10.7 mmt180 -59.25 -22.93 61.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 3.1099999999999999 110.81 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -74.83 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.699 -1.25 . . . . 0.88 110.257 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -104.06 -21.87 13.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.02 109.387 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 10.7 tp -149.89 128.65 12.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.301 -0.875 . . . . 3.3199999999999998 109.008 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.583 ' H ' ' NH2' ' A' ' 18' ' ' ARG . 82.9 p -85.85 -10.77 54.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.655 -0.653 . . . . 0.02 111.422 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.527 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 5.5 mtp180 -171.57 163.49 6.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.259 -1.385 . . . . 0.02 107.259 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 36' ' ' CYS . 12.5 p -142.23 113.83 7.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.771 -1.205 . . . . 0.02 108.792 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.3 m-20 -105.53 -0.95 25.38 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.537 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.48 ' HG ' ' C ' ' A' ' 67' ' ' PRO . 2.7 m -153.62 154.3 33.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 0.02 107.718 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.27 146.74 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.033 -1.042 . . . . 0.02 110.148 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 38.4 ttm180 -125.18 125.33 43.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.783 -1.192 . . . . 0.02 107.783 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.53 113.86 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.505 -1.665 . . . . 0.02 106.505 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.8 mp0 -83.54 -33.97 25.34 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.088 -0.645 . . . . 3.8100000000000001 109.853 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 150.79 20.15 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.46 -1.829 . . . . 0.02 110.607 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 174.8 50.57 Favored Glycine 0 N--CA 1.486 1.997 0 C-N-CA 119.668 -1.253 . . . . 0.01 110.337 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 23.0 m -109.94 161.98 14.96 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.736 -1.579 . . . . 1.48 106.736 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 72.7 m95 -148.48 147.79 29.51 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.223 -1.548 . . . . 0.02 111.742 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.15 55.33 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.197 -2.149 . . . . 0.23999999999999999 105.197 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.3 m -120.5 144.43 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.679 -0.638 . . . . 0.65000000000000002 109.403 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -121.22 145.75 47.51 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.359 1.076 . . . . 0.02 110.047 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 3.1 tp10 -65.33 -34.35 78.13 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.613 -0.722 . . . . 0.02 110.909 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -123.0 158.52 57.27 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.232 -0.918 . . . . 0.02 109.462 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.6 166.93 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.521 1.481 . . . . 0.02 112.529 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 64.05 36.79 9.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.313 -0.858 . . . . 0.02 111.136 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 44.83 51.68 8.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.587 0.708 . . . . 3.3900000000000001 110.586 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -126.78 164.23 21.81 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.889 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.34 31.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.53 -1.428 . . . . 0.02 109.53 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.418 ' HD1' ' H ' ' A' ' 57' ' ' HIS . 11.1 m80 -66.47 138.7 57.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.312 . . . . 0.02 109.985 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.5 ptm -118.66 137.29 53.4 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.34 0.59 . . . . 5.0099999999999998 109.593 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.535 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.2 m-85 -132.06 138.06 48.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.524 -0.735 . . . . 0.02 109.459 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mm -94.74 131.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.742 -0.836 . . . . 1.72 108.742 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 6.8 mt -120.11 112.6 34.62 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.753 . . . . 0.02 110.857 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -78.31 169.04 20.75 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.006 1.038 . . . . 1.47 109.943 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.53 141.31 25.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.717 -1.239 . . . . 4.25 110.359 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.08 32.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.385 -1.388 . . . . 0.02 110.635 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -119.02 130.7 55.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.431 -1.041 . . . . 0.95999999999999996 109.653 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -120.24 95.64 49.1 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 108.034 -1.098 . . . . 0.02 108.034 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.48 ' C ' ' HG ' ' A' ' 38' ' ' SER . 3.4 Cg_exo -66.24 -4.93 11.38 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.716 0.944 . . . . 0.02 113.416 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -157.31 154.05 28.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.65 -1.281 . . . . 2.02 107.925 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 23.1 p90 -60.46 -37.77 82.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.895 -0.722 . . . . 0.02 111.722 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 14.9 mm100 -60.78 -24.34 65.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.02 110.444 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -69.47 -18.34 63.7 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.444 -0.947 . . . . 3.4199999999999999 108.444 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.561 ' O ' ' CD1' ' A' ' 72' ' ' TRP . 1.0 OUTLIER -107.62 10.83 29.01 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.363 -1.347 . . . . 0.02 107.363 -179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 59.39 21.68 10.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.639 0.733 . . . . 0.02 110.341 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.2 145.69 46.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.909 -1.677 . . . . 0.02 108.909 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.8 -30.98 45.78 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.639 -1.245 . . . . 0.97999999999999998 107.639 178.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -157.38 -171.26 3.53 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.67 -1.604 . . . . 0.02 106.67 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 6.7 p30 -97.99 28.15 4.12 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.769 -1.207 . . . . 0.02 110.311 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.8 mtt-85 -97.86 123.01 41.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.226 -0.921 . . . . 3.2000000000000002 111.122 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.604 ' H ' ' NH2' ' A' ' 30' ' ' ARG . 36.0 mt -144.04 120.83 11.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.918 -1.512 . . . . 2.6099999999999999 106.918 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.42 -16.56 14.24 Favored Glycine 0 N--CA 1.502 3.047 0 O-C-N 121.264 -0.897 . . . . 0.02 112.079 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 44.4 t -156.38 155.64 32.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.402 -1.646 . . . . 0.02 109.978 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.466 ' N ' ' HG ' ' A' ' 81' ' ' SER . 29.3 t -145.04 148.23 33.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.02 109.781 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 44.3 mtm180 -134.17 139.28 45.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.843 . . . . 0.01 109.123 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.51 131.9 38.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.207 -1.034 . . . . 0.42999999999999999 108.207 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.52 124.55 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.917 -0.771 . . . . 1.25 108.917 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.449 ' O ' ' CG2' ' A' ' 135' ' ' THR . 27.0 m80 -91.88 135.68 33.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.167 -0.958 . . . . 1.77 108.967 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -97.63 138.46 34.99 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.17 -0.678 . . . . 1.6299999999999999 109.17 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 133' ' ' GLU . 27.0 p -112.23 126.42 55.21 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.828 -0.804 . . . . 1.0800000000000001 108.828 178.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 p -102.86 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.233 -1.766 . . . . 1.26 106.233 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.21 -49.79 0.83 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.387 -1.445 . . . . 0.01 112.527 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.7 -99.93 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 118.31 -1.9 . . . . 0.01 112.238 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.33 119.98 33.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.802 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.29 130.1 36.74 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.918 -0.713 . . . . 2.9900000000000002 109.104 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 13.7 ttmm -129.75 138.77 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.817 -0.809 . . . . 6.3600000000000003 108.817 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.53 144.47 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.294 -0.879 . . . . 1.0900000000000001 109.891 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' N ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -121.77 133.64 54.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.348 -1.352 . . . . 2.0499999999999998 107.348 176.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -122.85 145.62 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.736 -1.228 . . . . 1.1000000000000001 109.141 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 41.2 m-85 -119.57 141.1 49.56 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.125 0.964 . . . . 0.72999999999999998 111.127 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.77 -29.28 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.697 -0.683 . . . . 0.02 111.485 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.436 ' O ' ' OG ' ' A' ' 128' ' ' SER . 29.3 mmtm -116.36 170.16 8.75 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.125 -0.984 . . . . 3.1800000000000002 110.492 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.0 165.49 53.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.0 t0 57.16 38.27 28.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.01 111.354 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.08 54.26 11.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.62 -0.675 . . . . 0.01 111.282 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -129.51 166.38 19.77 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.165 -1.05 . . . . 3.1499999999999999 108.165 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.31 -164.98 28.6 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.122 -1.591 . . . . 0.01 109.122 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.09 143.94 43.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.999 -1.295 . . . . 0.01 108.373 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.8 tmm? -117.15 142.76 46.61 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.669 0.747 . . . . 0.01 110.147 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.438 ' N ' ' SD ' ' A' ' 107' ' ' MET . 38.7 m-85 -130.63 135.12 47.55 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.56 -1.274 . . . . 2.48 107.56 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 30.7 tt0 -119.67 135.47 54.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.558 -0.714 . . . . 0.01 110.12 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 t -150.51 153.0 35.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.461 1.124 . . . . 1.6899999999999999 111.322 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 p -110.72 9.38 22.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.27 -0.877 . . . . 0.01 109.592 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -121.25 163.74 18.08 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.445 -0.785 . . . . 3.21 111.331 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.86 155.06 39.36 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.01 108.324 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.425 ' O ' ' OG ' ' A' ' 171' ' ' SER . 34.5 t -124.77 111.67 27.4 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.7 -0.852 . . . . 0.01 108.7 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.67 -31.99 3.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.998 1.035 . . . . 0.01 111.876 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -140.29 108.37 5.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.02 109.074 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.04 -40.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.894 -0.504 . . . . 1.8300000000000001 110.57 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.6 tmm? -66.72 -37.81 85.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.001 -1.08 . . . . 1.3400000000000001 110.052 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -69.98 -38.57 76.08 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.479 -1.388 . . . . 2.1099999999999999 109.403 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 52.7 tt0 -80.79 -47.48 13.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.0800000000000001 112.424 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.487 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.0 m-85 -110.83 -1.92 16.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.366 -0.834 . . . . 0.02 112.574 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.33 34.14 18.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.713 -1.242 . . . . 0.02 109.436 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.4 135.92 53.57 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.426 -0.796 . . . . 0.02 109.373 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -88.66 -21.35 24.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.26 -0.9 . . . . 5.3200000000000003 110.589 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.11 165.04 32.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.932 -1.105 . . . . 0.02 110.198 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mm -127.39 123.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.494 -1.299 . . . . 2.1699999999999999 107.494 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -108.34 -13.29 14.91 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.133 -0.979 . . . . 0.02 112.132 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.2 p -160.45 152.5 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.983 -1.073 . . . . 0.01 108.927 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 9.3 t -167.66 144.04 4.16 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.545 -0.909 . . . . 1.22 108.545 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 41.5 tttm -122.45 110.23 15.35 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.38 1.086 . . . . 1.4099999999999999 109.473 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 p -112.98 135.23 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.442 -1.318 . . . . 0.01 107.442 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.1 t -126.99 92.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 106.722 -1.584 . . . . 1.98 106.722 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.522 ' CD ' ' HE1' ' A' ' 136' ' ' TRP . 20.9 tt0 -146.63 -72.7 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.264 -2.124 . . . . 0.01 105.264 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 155.18 -49.79 0.48 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.369 -1.492 . . . . 0.01 109.369 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' HIS . 44.3 p -126.96 105.84 8.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.414 -1.051 . . . . 2.2999999999999998 111.742 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.522 ' HE1' ' CD ' ' A' ' 133' ' ' GLU . 7.5 m95 -130.95 147.33 52.58 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 107.614 -1.254 . . . . 0.01 107.614 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 38.9 mt -119.82 135.75 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.636 -1.29 . . . . 1.6899999999999999 110.089 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -111.06 142.39 43.28 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.819 -1.919 . . . . 2.4900000000000002 105.819 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.532 ' HH ' HH21 ' A' ' 173' ' ' ARG . 18.1 m-85 -123.17 144.17 49.53 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.091 -1.006 . . . . 0.02 109.842 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 25.8 tt0 -74.2 -30.88 62.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.727 -0.608 . . . . 0.02 111.68 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.73 154.54 48.06 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.698 -1.251 . . . . 1.48 108.995 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.04 167.54 2.37 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.257 1.304 . . . . 0.02 112.747 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.8 t30 59.33 31.25 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.457 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.53 51.52 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.02 111.07 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.421 ' CA ' ' HE ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.4 164.72 20.49 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.513 -0.742 . . . . 0.02 109.848 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.67 33.65 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.063 -1.215 . . . . 0.02 110.063 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -69.68 142.31 53.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.595 -0.944 . . . . 0.02 108.892 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.418 ' O ' ' CG ' ' A' ' 58' ' ' MET . 13.1 mt-30 -113.77 149.22 35.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.344 0.593 . . . . 0.02 109.78 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -123.62 133.99 53.85 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.41 123.37 40.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.857 -1.152 . . . . 0.01 109.916 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 10.9 mp -95.35 135.38 37.04 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.971 -1.122 . . . . 0.01 107.971 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -106.19 -167.67 1.33 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.731 -0.606 . . . . 2.27 110.312 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -79.6 34.46 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.576 -0.702 . . . . 1.8400000000000001 109.921 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -111.92 172.17 7.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.445 -0.785 . . . . 2.2799999999999998 109.373 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -104.38 121.28 43.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.273 -1.01 . . . . 0.01 108.273 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.03 113.48 25.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.272 -0.892 . . . . 0.01 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.39 17.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.129 -0.982 . . . . 0.01 110.706 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -123.94 155.66 66.85 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.066 -1.086 . . . . 2.54 108.066 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.5 Cg_endo -61.41 -40.83 45.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.032 0.69 . . . . 0.69999999999999996 110.764 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.76 -18.82 19.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 120.905 -1.122 . . . . 0.85999999999999999 109.295 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 49.1 t0 -65.92 -18.56 65.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.872 -1.143 . . . . 0.02 111.902 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -102.27 15.09 30.18 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 120.886 -1.134 . . . . 0.02 109.979 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.43 10.62 73.5 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.301 -0.874 . . . . 0.02 113.119 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.443 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.25 140.76 35.11 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.744 -1.445 . . . . 0.02 110.18 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.54 -7.1 59.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 0.58999999999999997 110.168 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.3 p -141.41 150.36 57.66 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.87 109.768 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -75.29 14.94 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 120.913 1.075 . . . . 0.38 111.817 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 122.64 27.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.306 1.051 . . . . 0.17999999999999999 111.014 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mp -152.56 123.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.189 -1.782 . . . . 3.9900000000000002 106.189 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 140' ' ' GLU . 3.6 mp0 -111.39 -11.56 14.12 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.524 -0.735 . . . . 5.1699999999999999 112.312 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 22.8 t -156.4 158.74 37.87 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 119.311 -2.118 . . . . 0.02 109.755 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.86 153.38 34.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.274 -0.891 . . . . 2.02 110.219 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.532 HH21 ' HH ' ' A' ' 139' ' ' TYR . 55.7 mtm180 -144.0 149.32 36.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.32 -0.862 . . . . 0.01 109.942 -178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.02 140.56 29.44 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.363 -0.976 . . . . 0.01 108.363 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 45.8 mt -93.89 129.99 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.2 -0.937 . . . . 3.04 109.222 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.46 148.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.475 -0.765 . . . . 1.8899999999999999 109.62 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.564 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.276 0.56 . . . . 5.2800000000000002 109.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.81 98.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 5.96 109.331 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -103.87 -140.21 0.36 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.001 -1.111 . . . . 2.2200000000000002 108.001 177.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.88 88.06 0.07 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 106.982 -2.447 . . . . 0.81000000000000005 106.982 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 148.96 32.71 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.524 -1.03 . . . . 0.01 110.524 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -153.29 138.1 17.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.442 -1.034 . . . . 0.02 108.621 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 8.1 tt -130.59 142.42 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.356 -0.609 . . . . 0.02 109.356 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -122.29 129.81 52.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.424 -0.797 . . . . 0.39000000000000001 109.512 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.29 138.47 44.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.565 -0.902 . . . . 0.02 108.565 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 80.3 m-85 -121.6 138.84 54.15 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.212 -0.93 . . . . 0.02 109.769 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.65 -28.28 66.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.489 -0.757 . . . . 0.029999999999999999 111.61 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -114.66 169.96 8.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.962 -1.086 . . . . 0.029999999999999999 110.394 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.44 158.67 32.32 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.687 0.756 . . . . 0.029999999999999999 109.995 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' ND2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER 66.47 34.61 6.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.845 0.831 . . . . 0.73999999999999999 110.776 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CZ ' ' ND2' ' A' ' 14' ' ' ASN . 16.4 p90 50.07 44.9 25.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.301 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -113.01 165.7 12.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.107 -1.071 . . . . 0.02 108.107 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.57 -168.14 34.42 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.706 -1.235 . . . . 0.029999999999999999 110.927 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.04 143.43 54.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.505 -0.997 . . . . 2.7599999999999998 109.152 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' ' OD1' ' A' ' 21' ' ' ASP . 34.0 ttp180 -119.55 148.7 43.0 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.646 0.736 . . . . 1.8899999999999999 110.392 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -132.09 126.23 33.26 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.887 -1.153 . . . . 0.02 107.887 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' OD1' ' NE ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.7 137.64 51.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.607 -0.683 . . . . 1.1200000000000001 109.751 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.08 139.67 48.59 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.591 0.71 . . . . 0.02 109.47 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 3.4 m-20 -116.09 11.93 15.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.394 -0.595 . . . . 0.20000000000000001 109.394 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 p -158.29 174.47 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.127 -1.064 . . . . 1.23 108.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.99 144.65 54.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.729 -1.232 . . . . 0.02 110.27 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -131.47 116.41 17.44 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.522 -0.918 . . . . 0.02 108.522 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.54 -21.63 55.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.23999999999999999 110.767 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -157.34 101.57 1.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.075 -1.016 . . . . 1.1399999999999999 108.577 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.8 p90 -105.13 9.95 34.05 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.254 1.026 . . . . 6.3700000000000001 110.002 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -59.91 -23.45 63.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.563 -0.711 . . . . 3.1099999999999999 110.954 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.418 ' H ' ' HG ' ' A' ' 31' ' ' SER . 11.4 p -76.05 -16.68 59.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.647 -1.283 . . . . 0.88 110.31 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -102.55 -21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.399 -0.813 . . . . 0.02 108.901 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -150.49 129.23 12.38 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.683 -0.858 . . . . 3.3199999999999998 108.683 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -86.32 -9.81 55.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.847 -0.533 . . . . 0.02 110.846 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -170.49 161.61 7.9 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.16 113.52 8.08 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.643 -1.285 . . . . 0.02 109.094 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -107.45 -3.35 19.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.029999999999999999 110.647 -178.65 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -154.24 153.49 31.81 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.301 -1.0 . . . . 0.02 108.301 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.35 147.71 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.951 -1.093 . . . . 0.02 110.244 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -125.02 125.68 44.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.953 -1.128 . . . . 0.02 107.953 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.16 114.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.948 -1.501 . . . . 0.02 106.948 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -84.16 -34.52 24.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.484 -0.76 . . . . 3.8100000000000001 109.812 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.57 18.22 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.674 -1.727 . . . . 0.02 110.402 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.88 173.74 49.94 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.528 -1.32 . . . . 0.01 109.893 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.4 m -120.66 138.05 54.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.803 -1.184 . . . . 1.48 107.803 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -127.25 154.36 44.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.691 1.234 . . . . 0.02 111.907 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.59 51.58 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.619 -2.363 . . . . 0.23999999999999999 104.619 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 33.1 m -116.54 142.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 18.2 m-85 -119.42 141.35 49.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.021 0.915 . . . . 0.02 109.351 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 10.0 tp10 -64.3 -34.16 77.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.571 -0.74 . . . . 0.02 111.671 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -124.08 156.59 65.94 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.025 -1.047 . . . . 0.02 109.707 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.45 165.7 0.97 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.634 1.556 . . . . 0.02 112.984 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.608 ' ND2' ' N ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 64.97 37.49 6.86 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.72 0.771 . . . . 0.02 111.261 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 45.21 50.89 9.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.457 0.646 . . . . 3.3900000000000001 110.785 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.5 p -126.97 164.55 21.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 110.134 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.25 -162.34 30.8 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.997 -1.241 . . . . 0.02 109.997 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.68 ' HD1' ' N ' ' A' ' 58' ' ' MET . 13.9 t-80 -62.34 143.25 57.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.03 -1.276 . . . . 0.02 110.635 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.68 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 36.5 mtp -116.32 134.58 54.73 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.514 -0.55 . . . . 5.0099999999999998 109.514 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 33.7 m-85 -136.02 134.89 38.98 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.289 -0.882 . . . . 0.02 109.205 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -96.97 131.96 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.527 -0.733 . . . . 1.72 109.114 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -122.8 111.37 31.14 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.414 -0.804 . . . . 0.02 110.784 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.19 171.2 18.55 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 119.924 1.009 . . . . 1.47 110.181 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.04 140.46 20.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 4.25 110.114 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.65 32.83 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.452 -1.356 . . . . 0.02 110.626 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.5 tp10 -119.14 130.32 55.49 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.294 -1.121 . . . . 0.95999999999999996 109.278 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 84.5 m-85 -120.7 97.76 48.34 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.796 -1.187 . . . . 0.02 107.796 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.63 -5.47 17.12 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 120.582 0.855 . . . . 0.02 113.929 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -154.03 154.09 33.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.503 -1.373 . . . . 2.02 107.864 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -60.67 -38.23 84.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.737 . . . . 0.02 111.719 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.74 -23.94 63.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.983 -1.073 . . . . 0.02 109.9 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.82 -18.54 62.73 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.112 0.958 . . . . 3.4199999999999999 108.432 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.618 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.38 9.7 31.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.245 -1.391 . . . . 0.02 107.245 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.4 mpp? 58.93 22.16 10.0 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.568 0.699 . . . . 0.02 110.304 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.26 143.61 45.94 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.258 -1.537 . . . . 0.02 109.258 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -77.75 -29.55 51.12 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.179 -1.415 . . . . 0.97999999999999998 107.179 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.2 p-10 -156.43 -171.33 3.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.118 -1.808 . . . . 0.02 106.118 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -98.47 28.62 4.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.667 -1.271 . . . . 0.02 110.381 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -96.49 122.4 39.36 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.806 -1.184 . . . . 3.2000000000000002 110.709 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 29.6 mt -144.35 120.58 10.85 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.869 -1.16 . . . . 2.6099999999999999 107.869 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.7 10.55 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 121.295 -0.878 . . . . 0.02 112.756 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 66.1 m -154.58 155.82 35.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 119.99 -1.888 . . . . 0.02 111.209 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -144.4 146.76 32.68 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.453 0.644 . . . . 0.02 109.914 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -135.94 140.04 43.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -0.77 . . . . 0.01 108.981 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.03 132.83 36.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 109.286 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.84 123.38 42.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.445 -0.946 . . . . 1.25 108.445 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -89.56 134.73 33.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.832 -1.173 . . . . 1.77 107.832 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.21 139.51 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.739 -0.601 . . . . 1.6299999999999999 109.631 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -111.61 123.35 50.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -115.05 133.88 55.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.749 -1.219 . . . . 1.26 107.971 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.88 -45.86 0.02 OUTLIER Glycine 0 N--CA 1.502 3.079 0 C-N-CA 117.669 -2.205 . . . . 0.01 113.777 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.74 -102.98 0.17 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.432 2.116 . . . . 0.01 111.129 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -119.54 118.23 30.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.284 -1.127 . . . . 4.4299999999999997 110.159 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.07 130.45 39.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.97 -0.692 . . . . 2.9900000000000002 109.258 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -131.31 136.87 48.5 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.055 -0.72 . . . . 6.3600000000000003 109.055 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 tt -128.28 145.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.528 -0.733 . . . . 1.0900000000000001 109.333 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.492 ' O ' ' SG ' ' A' ' 129' ' ' CYS . 16.1 pt20 -121.51 132.88 54.96 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.812 -1.181 . . . . 2.0499999999999998 107.812 177.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.1 m -122.89 145.42 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.785 -1.197 . . . . 1.1000000000000001 109.229 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.95 140.58 49.52 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.059 0.933 . . . . 0.72999999999999998 110.878 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.81 -29.37 69.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.83 -0.623 . . . . 0.02 111.654 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -117.78 168.65 10.27 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.101 -0.999 . . . . 3.1800000000000002 110.453 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.32 169.31 28.68 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.935 -0.866 . . . . 0.01 110.935 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 51.91 39.36 25.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.743 0.782 . . . . 0.01 111.218 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 51.88 51.63 16.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.558 -0.714 . . . . 0.01 110.853 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -124.86 165.98 17.08 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.462 -0.94 . . . . 3.1499999999999999 108.462 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.28 -165.31 27.6 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -74.29 144.65 44.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.081 -1.246 . . . . 0.01 108.239 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 19.0 tmm? -116.01 142.89 46.2 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.642 0.734 . . . . 0.01 109.773 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.422 ' N ' ' SD ' ' A' ' 107' ' ' MET . 63.5 m-85 -131.87 136.13 47.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.068 -1.086 . . . . 2.48 108.068 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -120.13 135.2 55.04 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.589 -0.694 . . . . 0.01 110.052 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.451 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 3.1 t -149.49 151.86 34.65 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.249 1.023 . . . . 1.6899999999999999 111.016 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -111.32 9.21 21.59 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.606 -0.724 . . . . 0.01 110.006 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 5.3 mp0 -120.52 162.87 18.84 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.29 -0.881 . . . . 3.21 111.282 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 173' ' ' ARG . 5.4 p-10 -67.9 156.89 36.2 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.239 -1.023 . . . . 0.01 108.239 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . 0.456 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 43.0 t -125.84 112.08 24.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.745 -0.835 . . . . 0.01 108.745 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.3 -31.42 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.1 1.071 . . . . 0.01 111.197 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 t -140.34 106.97 5.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.583 -0.895 . . . . 0.02 108.583 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.23 -39.47 85.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.765 -0.584 . . . . 1.8300000000000001 110.808 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 ttm -66.53 -37.42 84.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.881 -1.127 . . . . 1.3400000000000001 109.98 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.15 -39.17 75.53 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.525 -1.36 . . . . 2.1099999999999999 109.798 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.456 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 9.4 tt0 -80.62 -47.0 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 2.0800000000000001 112.473 -177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -111.25 -1.24 16.16 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.37 -0.831 . . . . 0.02 112.695 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m170 61.44 34.09 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.747 -1.221 . . . . 0.02 109.775 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -114.09 135.92 53.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.478 -0.764 . . . . 0.02 109.305 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.626 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.33 -22.08 21.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.175 -0.953 . . . . 5.3200000000000003 110.743 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.58 164.52 34.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.94 -1.1 . . . . 0.02 109.932 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 mm -129.12 124.72 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.629 -1.249 . . . . 2.1699999999999999 107.629 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.6 m80 -110.04 -14.43 14.23 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.02 112.633 -177.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.9 m -159.36 151.48 20.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.808 -1.183 . . . . 0.01 108.806 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . 0.492 ' SG ' ' O ' ' A' ' 96' ' ' GLN . 5.7 t -171.42 147.38 2.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.337 -0.852 . . . . 1.22 108.766 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -117.31 108.05 15.13 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.498 1.142 . . . . 1.4099999999999999 108.724 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -111.86 129.62 66.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.396 -1.335 . . . . 0.01 107.396 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -131.35 92.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.569 -1.332 . . . . 1.98 107.436 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -149.79 -61.84 0.21 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.972 -1.862 . . . . 0.01 105.972 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.35 -12.56 26.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.653 -2.579 . . . . 0.01 106.653 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 p -121.4 57.54 1.01 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.039 -0.683 . . . . 2.2999999999999998 110.5 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 74.4 m95 -128.36 134.66 48.9 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.005 -1.059 . . . . 0.01 109.985 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.12 137.7 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.305 -0.998 . . . . 1.6899999999999999 108.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.42 141.45 43.48 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.137 -1.431 . . . . 2.4900000000000002 107.137 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.486 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 25.9 m-85 -121.92 142.43 50.28 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.26 -0.9 . . . . 0.02 109.337 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.85 -30.08 62.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.02 111.551 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -116.17 154.96 48.7 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.801 -1.187 . . . . 1.48 108.858 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.02 166.91 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.146 1.231 . . . . 0.02 113.031 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.09 31.62 20.65 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.096 -0.956 . . . . 0.75 111.36 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.31 51.5 9.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.02 111.045 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.42 165.7 19.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.515 -0.741 . . . . 0.02 109.996 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.17 -165.93 34.74 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.248 -1.141 . . . . 0.02 110.248 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -68.67 141.65 55.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.989 . . . . 0.02 108.917 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.486 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 17.7 mt-30 -113.97 149.41 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.02 109.969 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.19 133.42 53.55 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.707 -0.849 . . . . 0.01 108.707 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.99 121.57 36.75 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.01 109.292 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.2 mt -96.76 139.72 32.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.64 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 21.7 m-20 -108.93 -168.48 1.35 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 2.27 109.514 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -80.33 40.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.8400000000000001 109.403 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -113.56 168.02 10.11 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 2.2799999999999998 109.42 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -102.57 120.59 40.81 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.451 -0.944 . . . . 0.01 108.451 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.64 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 68.6 m-85 -98.01 114.38 26.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.347 -0.846 . . . . 0.01 110.308 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -92.72 -25.66 18.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.01 110.854 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -124.66 153.48 70.02 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 107.953 -1.129 . . . . 2.54 107.953 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.5 Cg_endo -60.55 -39.84 61.56 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.623 0.901 . . . . 0.69999999999999996 110.661 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.39 -19.08 17.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 120.78 -1.2 . . . . 0.85999999999999999 109.39 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.75 -18.32 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.868 -1.145 . . . . 0.02 112.039 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -102.5 15.48 29.12 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.859 -1.151 . . . . 0.02 110.079 178.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.05 10.98 74.02 Favored Glycine 0 N--CA 1.497 2.757 0 O-C-N 121.185 -0.947 . . . . 0.02 113.027 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB1' ' HE1' ' A' ' 162' ' ' TRP . . . -101.24 140.45 35.52 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.727 -1.455 . . . . 0.02 110.276 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.54 -6.98 59.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.546 -0.721 . . . . 0.58999999999999997 110.062 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.0 m -140.25 150.07 60.19 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.061 -1.025 . . . . 0.87 109.747 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.94 14.63 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.815 1.01 . . . . 0.38 111.947 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 121.18 26.22 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.329 1.061 . . . . 0.17999999999999999 110.847 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 mt -149.27 123.92 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.677 -1.972 . . . . 3.9900000000000002 105.677 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.82 -13.62 13.17 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.167 -0.958 . . . . 5.1699999999999999 113.138 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.5 t -157.6 160.76 38.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.153 -2.217 . . . . 0.02 110.192 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.13 152.95 32.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.529 -0.732 . . . . 2.02 109.807 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 144' ' ' TYR . 7.5 mmt180 -144.4 150.4 37.65 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.808 0.813 . . . . 0.01 110.194 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -88.23 143.87 26.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.471 -0.768 . . . . 0.01 109.04 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.89 129.42 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.438 -0.789 . . . . 3.04 109.205 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.5 t -136.01 146.61 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.209 -0.932 . . . . 1.8899999999999999 109.57 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 4.8899999999999997 109.209 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.533 -0.543 . . . . 5.2800000000000002 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -77.05 93.87 3.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 5.96 109.35 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.5 p -101.78 -141.59 0.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.902 -1.148 . . . . 2.2200000000000002 107.902 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.39 87.38 0.07 OUTLIER Glycine 0 N--CA 1.498 2.778 0 N-CA-C 106.926 -2.47 . . . . 0.81000000000000005 106.926 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 149.36 33.55 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.721 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' NZ ' ' OD1' ' A' ' 23' ' ' ASP . 56.0 tttp -149.19 136.36 19.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.994 . . . . 0.02 109.633 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.38 138.92 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.151 -0.685 . . . . 0.02 109.151 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -121.49 130.32 53.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.524 -0.735 . . . . 0.39000000000000001 109.985 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 22.7 m-85 -109.91 139.75 44.65 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.148 -0.686 . . . . 0.02 109.148 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.7 m-85 -122.42 138.44 54.54 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.249 -0.907 . . . . 0.02 109.563 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -70.19 -27.5 64.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.029999999999999999 111.949 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.538 ' C ' HD22 ' A' ' 37' ' ' ASN . 1.3 m-20 -114.16 169.27 9.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.729 -1.232 . . . . 0.029999999999999999 110.14 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.43 157.19 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.639 0.733 . . . . 0.029999999999999999 110.419 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.5 m-20 66.75 34.26 5.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.045 0.926 . . . . 0.73999999999999999 111.441 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.7 m-85 55.53 42.59 29.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.293 0.568 . . . . 0.02 111.323 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -113.56 166.51 11.45 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.467 -0.938 . . . . 0.02 108.467 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.24 -167.72 36.17 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.89 -1.148 . . . . 0.029999999999999999 110.901 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.428 HH21 ' H ' ' A' ' 34' ' ' SER . 39.8 ttp180 -70.33 142.9 52.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.972 . . . . 2.7599999999999998 108.984 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -120.23 148.99 42.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.574 -0.704 . . . . 1.8899999999999999 110.294 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -131.23 126.3 35.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.729 -1.211 . . . . 0.02 107.729 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.43 137.15 51.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.701 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.484 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.43 138.03 48.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.5 0.667 . . . . 0.02 109.621 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD1' ' NZ ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -117.18 10.34 13.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.20000000000000001 109.447 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.9 p -158.19 174.45 15.16 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.41 143.13 56.36 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.682 -1.261 . . . . 0.02 110.456 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.1 t -131.43 117.25 18.59 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.67 -25.68 49.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.23999999999999999 110.857 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -154.5 100.77 2.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.874 -1.141 . . . . 1.1399999999999999 108.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -105.4 9.84 33.57 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.05 0.929 . . . . 6.3700000000000001 109.641 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -57.89 -24.06 55.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.612 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 p -73.93 -16.92 61.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.805 -1.185 . . . . 0.88 109.905 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.51 -22.29 13.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.02 109.5 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 4.0 tp -148.56 125.99 11.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.042 -1.036 . . . . 3.3199999999999998 109.52 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.428 ' H ' HH21 ' A' ' 18' ' ' ARG . 71.0 m -86.26 -10.77 53.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.625 -0.672 . . . . 0.02 111.461 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 30.7 ttt180 -170.5 160.45 7.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.816 -1.179 . . . . 0.02 107.816 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.1 p -141.94 113.09 7.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.86 -1.15 . . . . 0.02 108.728 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 37' ' ' ASN . 0.0 OUTLIER -109.09 2.91 21.45 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.189 -179.398 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -155.52 152.59 29.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.66 -1.237 . . . . 0.02 107.66 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -146.49 147.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.02 110.119 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -124.71 125.5 44.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.78 114.22 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.779 -1.563 . . . . 0.02 106.779 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.75 -34.08 27.24 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.2 -0.6 . . . . 3.8100000000000001 110.408 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.33 151.47 21.07 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 119.081 -1.533 . . . . 0.02 110.33 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 174.46 50.01 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.543 -1.313 . . . . 0.01 110.085 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.435 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m -110.04 161.18 15.78 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.021 -1.474 . . . . 1.48 107.021 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.435 ' CD1' ' C ' ' A' ' 45' ' ' THR . 67.3 m95 -148.0 147.71 29.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.198 -1.564 . . . . 0.02 111.505 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.07 54.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 105.43 -2.063 . . . . 0.23999999999999999 105.43 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 m -117.83 142.29 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.503 -0.748 . . . . 0.65000000000000002 109.406 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 42.4 m-85 -121.56 144.64 48.61 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.952 0.882 . . . . 0.02 109.676 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.66 -34.99 79.07 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.501 -0.772 . . . . 0.02 111.722 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.06 163.59 42.78 Favored Pre-proline 0 N--CA 1.509 2.516 0 O-C-N 120.91 -1.119 . . . . 0.02 109.105 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.14 168.06 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.42 1.414 . . . . 0.02 113.359 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 63.22 36.89 11.6 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.082 -0.963 . . . . 0.02 112.121 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 44.78 52.0 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.675 0.75 . . . . 3.3900000000000001 111.017 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 m -126.58 163.98 22.23 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.239 0.542 . . . . 2.3300000000000001 109.704 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.24 -161.31 32.69 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.538 -1.425 . . . . 0.02 109.538 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.647 ' HD1' ' N ' ' A' ' 58' ' ' MET . 9.1 t-80 -69.72 137.98 52.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.993 -1.298 . . . . 0.02 109.946 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.647 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 19.0 ptm -119.16 136.47 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.333 -0.617 . . . . 5.0099999999999998 109.333 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 93.7 m-85 -128.28 139.51 52.38 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.914 -0.773 . . . . 0.02 108.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.95 131.83 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.2 mt -120.81 112.79 33.47 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.407 -0.808 . . . . 0.02 110.696 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.17 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.047 1.052 . . . . 1.47 110.096 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.542 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.2 pm0 -53.25 140.48 26.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.778 -1.201 . . . . 4.25 110.221 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.19 33.08 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.377 . . . . 0.02 110.438 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -119.25 130.18 55.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.325 -1.103 . . . . 0.95999999999999996 109.635 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -120.82 96.8 48.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.96 -4.1 11.8 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 120.74 0.96 . . . . 0.02 113.756 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -157.68 155.02 29.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.671 -1.268 . . . . 2.02 108.256 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -60.29 -38.95 85.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.02 111.851 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.02 110.544 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.91 -18.6 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.187 0.994 . . . . 3.4199999999999999 108.581 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.543 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.4 t90 -106.87 9.94 30.75 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.386 -1.339 . . . . 0.02 107.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.0 mtt 60.55 21.32 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.475 0.655 . . . . 0.02 110.401 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.05 45.92 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.112 -1.595 . . . . 0.02 109.112 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.13 -29.52 48.86 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.438 -1.319 . . . . 0.97999999999999998 107.438 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -157.17 -171.71 3.73 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.523 -1.658 . . . . 0.02 106.523 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 87.4 m-20 -97.66 27.91 4.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.673 -1.267 . . . . 0.02 110.289 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -98.52 123.49 42.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.882 . . . . 3.2000000000000002 111.655 -178.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.5 mt -143.25 121.05 11.92 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.912 -1.514 . . . . 2.6099999999999999 106.912 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.25 -16.99 13.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.185 -0.947 . . . . 0.02 111.981 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -155.02 154.82 33.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.397 -1.649 . . . . 0.02 110.372 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.32 147.04 32.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.02 109.953 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -134.57 140.03 45.82 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 0.01 108.814 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.07 131.77 38.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.998 -1.112 . . . . 0.42999999999999999 107.998 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.0 t -91.71 123.98 44.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -91.66 136.23 33.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.981 -1.075 . . . . 1.77 108.744 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.64 137.0 38.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.378 -0.971 . . . . 1.6299999999999999 108.378 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -110.8 126.29 54.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.437 -0.949 . . . . 1.0800000000000001 108.437 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -103.71 -154.96 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.348 -1.723 . . . . 1.26 106.348 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.38 -48.1 0.93 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.506 -1.371 . . . . 0.01 112.178 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.78 -99.85 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.484 -1.817 . . . . 0.01 111.936 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -121.54 119.24 31.37 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.342 -1.093 . . . . 4.4299999999999997 110.504 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 129.28 35.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.988 -0.745 . . . . 2.9900000000000002 108.988 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HZ1' ' CB ' ' A' ' 94' ' ' LYS . 7.8 ttpm? -130.08 140.37 50.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.421 -0.799 . . . . 6.3600000000000003 109.15 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 tt -129.97 145.17 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.831 . . . . 1.0900000000000001 109.859 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.67 134.76 54.97 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.431 -1.322 . . . . 2.0499999999999998 107.431 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.91 147.25 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.831 -1.168 . . . . 1.1000000000000001 109.531 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.0 m-85 -119.64 141.66 49.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.123 0.963 . . . . 0.72999999999999998 111.032 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -66.24 -29.2 69.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.694 -0.685 . . . . 0.02 111.369 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -116.41 169.59 9.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.162 -0.961 . . . . 3.1800000000000002 110.459 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.97 165.07 51.28 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.898 -0.881 . . . . 0.01 110.898 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.95 38.03 29.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.833 -0.804 . . . . 0.01 111.349 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 51.83 54.99 9.96 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.632 -0.667 . . . . 0.01 111.494 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -128.77 165.61 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.955 -1.128 . . . . 3.1499999999999999 107.955 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.91 -164.36 28.72 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.214 -1.554 . . . . 0.01 109.214 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 39.8 tt0 -75.35 144.12 42.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.012 -1.287 . . . . 0.01 108.748 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.75 143.17 45.98 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.601 0.715 . . . . 0.01 109.96 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 24.1 m-85 -131.39 135.71 47.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.937 -1.135 . . . . 2.48 107.937 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.2 tm-20 -118.36 134.59 54.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.809 -0.557 . . . . 0.01 109.757 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.598 ' HG1' ' H ' ' A' ' 112' ' ' GLU . 3.7 t -149.48 150.29 32.1 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 1.6899999999999999 110.911 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.465 ' N ' ' HG1' ' A' ' 110' ' ' THR . 46.7 p -109.6 9.95 25.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.51 -0.768 . . . . 0.01 109.863 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.598 ' H ' ' HG1' ' A' ' 110' ' ' THR . 65.1 mm-40 -121.43 163.64 18.41 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.429 -0.794 . . . . 3.21 111.438 -178.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.46 155.37 37.75 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.199 -1.037 . . . . 0.01 108.199 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.8 t -122.17 110.79 32.51 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.462 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.8 Cg_endo -77.28 -32.9 2.8 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.846 0.981 . . . . 0.01 111.584 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.1 t -141.69 107.04 5.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.011 -1.056 . . . . 0.02 108.732 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -64.35 -39.76 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.896 -0.503 . . . . 1.8300000000000001 111.087 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.38 -37.66 85.77 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.936 -1.105 . . . . 1.3400000000000001 109.888 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -70.16 -39.02 75.56 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.549 -1.344 . . . . 2.1099999999999999 109.684 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.31 -48.21 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -0.961 . . . . 2.0800000000000001 112.612 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.99 -1.09 15.52 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.367 -0.833 . . . . 0.02 112.612 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 5.8 m80 62.04 34.36 16.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.816 -1.178 . . . . 0.02 109.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 mt -114.86 135.83 53.76 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.505 -0.747 . . . . 0.02 109.514 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.642 ' N ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.45 -21.28 23.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.123 -0.985 . . . . 5.3200000000000003 110.86 -179.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -148.99 164.3 34.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.943 -1.098 . . . . 0.02 110.015 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 126' ' ' ILE . 38.7 mm -129.44 126.16 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.403 -1.332 . . . . 2.1699999999999999 107.403 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -109.2 -12.72 14.77 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.267 -0.896 . . . . 0.02 112.693 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -159.52 153.13 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.679 -1.263 . . . . 0.01 108.829 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 21.8 p -167.4 142.97 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 1.22 109.399 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -124.44 106.92 10.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.464 1.126 . . . . 1.4099999999999999 109.834 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.95 137.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.575 -1.268 . . . . 0.01 107.575 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.39 92.97 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 106.782 -1.562 . . . . 1.98 106.782 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 3.4 tm-20 -146.59 -67.82 0.27 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.613 -1.995 . . . . 0.01 105.613 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 170.56 -78.44 0.1 OUTLIER Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.556 -1.818 . . . . 0.01 108.556 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 54.6 p -121.71 123.86 42.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.628 -0.925 . . . . 2.2999999999999998 110.587 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -126.6 152.32 46.79 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.574 -1.639 . . . . 0.01 106.574 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.74 134.24 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.577 -1.327 . . . . 1.6899999999999999 109.713 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -111.33 142.45 43.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.307 -1.738 . . . . 2.4900000000000002 106.307 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.475 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 30.9 m-85 -122.37 142.51 50.44 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.133 -0.979 . . . . 0.02 109.431 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 9.9 tp10 -75.04 -30.27 61.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.673 -0.642 . . . . 0.02 111.709 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.9 mt -114.47 152.77 46.44 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 120.66 -1.275 . . . . 1.48 109.054 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.49 165.98 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 120.81 1.007 . . . . 0.02 112.757 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 31.6 20.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.395 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 58.05 51.87 8.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.495 -0.753 . . . . 0.02 111.52 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.427 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.36 166.1 18.49 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.393 -0.817 . . . . 0.02 110.097 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.29 -165.42 34.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.064 -1.214 . . . . 0.02 110.064 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -69.66 142.91 53.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.976 . . . . 0.02 108.927 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 20.9 mt-30 -113.85 148.97 35.74 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.255 0.55 . . . . 0.02 109.727 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -123.69 133.21 53.92 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.14 122.01 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.819 -1.176 . . . . 0.01 109.255 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.8 mp -96.25 146.48 24.68 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.01 108.677 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.666 ' H ' ' HH ' ' A' ' 156' ' ' TYR . 9.0 m-20 -105.58 -169.18 1.55 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.453 -0.78 . . . . 2.27 109.684 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.16 31.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 1.8400000000000001 109.583 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 152' ' ' ASP . 19.5 mtpp -111.7 171.31 7.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.335 -0.853 . . . . 2.2799999999999998 109.153 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.05 133.62 48.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.196 -1.039 . . . . 0.01 108.196 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.666 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 92.6 m-85 -100.22 115.01 28.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.01 110.239 -178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -90.57 -28.38 18.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.736 -0.602 . . . . 0.01 110.958 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -123.38 154.31 65.75 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.739 -1.208 . . . . 2.54 107.739 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -62.01 -41.84 33.97 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 119.207 0.752 . . . . 0.69999999999999996 111.209 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.87 -19.41 19.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.79 -1.193 . . . . 0.85999999999999999 109.707 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 56.2 t0 -65.92 -18.5 65.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.802 -1.187 . . . . 0.02 112.034 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.26 15.9 27.29 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.725 -1.235 . . . . 0.02 110.171 178.396 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.89 10.16 76.2 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.115 -0.99 . . . . 0.02 113.035 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.421 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.53 140.83 34.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.819 -1.401 . . . . 0.02 110.185 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.06 -7.05 59.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.58999999999999997 109.735 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -140.55 151.09 62.72 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.196 -0.94 . . . . 0.87 109.309 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.26 15.46 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.703 0.935 . . . . 0.38 111.952 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.66 120.52 25.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 110.741 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.43 122.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.579 -2.008 . . . . 3.9900000000000002 105.579 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 170' ' ' GLN . 5.2 mp0 -112.17 -13.13 13.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.244 -0.91 . . . . 5.1699999999999999 112.936 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 66.0 m -157.04 158.69 36.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.13 -2.231 . . . . 0.02 110.085 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -153.16 154.81 35.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 2.02 110.188 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -144.19 149.5 36.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.276 -0.89 . . . . 0.01 110.162 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -86.62 143.14 27.78 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.524 -0.917 . . . . 0.01 108.524 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.16 128.38 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.141 -0.975 . . . . 3.04 109.79 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 177' ' ' GLU . 60.6 t -137.06 147.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.229 -0.919 . . . . 1.8899999999999999 109.663 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 176' ' ' VAL . 7.8 tm-20 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 4.8899999999999997 109.297 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.387 0.613 . . . . 5.2800000000000002 109.418 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -65.0 99.19 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 5.96 109.521 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.0 p -104.24 -141.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.349 -0.982 . . . . 2.2200000000000002 108.349 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.57 88.43 0.07 OUTLIER Glycine 0 N--CA 1.496 2.684 0 N-CA-C 107.096 -2.402 . . . . 0.81000000000000005 107.096 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.82 149.82 33.54 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.112 -1.042 . . . . 0.01 110.749 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.05 136.29 18.84 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.981 . . . . 0.02 109.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 7' ' ' ILE . 8.7 tt -130.23 139.44 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.793 -0.567 . . . . 0.02 109.543 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 t -122.16 130.46 53.23 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.553 -0.717 . . . . 0.39000000000000001 109.916 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 m-85 -110.08 139.99 44.62 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.032 -0.729 . . . . 0.02 109.032 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.51 139.14 54.22 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.292 -0.88 . . . . 0.02 109.813 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -68.39 -28.03 66.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.938 -1.101 . . . . 0.029999999999999999 111.804 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -114.14 169.07 9.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.888 -1.132 . . . . 0.029999999999999999 110.201 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -74.96 158.15 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.666 0.746 . . . . 0.029999999999999999 109.895 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.47 34.94 5.84 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.729 0.776 . . . . 0.73999999999999999 110.8 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.1 p90 49.72 44.39 24.73 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.742 0.782 . . . . 0.02 111.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.73 166.72 11.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.87 -1.159 . . . . 0.02 107.87 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.1 -167.75 36.44 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.669 -1.253 . . . . 0.029999999999999999 110.673 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.19 142.73 54.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.977 . . . . 2.7599999999999998 108.943 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' NH1' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tmm_? -121.57 150.67 41.32 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.71 0.766 . . . . 1.8899999999999999 110.42 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -132.82 127.55 34.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 0.02 108.045 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' NH1' ' A' ' 19' ' ' ARG . 3.3 p-10 -111.83 136.46 51.09 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 109.711 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -130.91 137.69 49.43 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.494 0.664 . . . . 0.02 109.467 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -116.83 10.1 14.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.20000000000000001 109.375 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.3 p -158.59 174.3 15.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 13.0 t0 -60.8 142.31 56.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.782 -1.199 . . . . 0.02 110.327 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 43.2 t -131.57 116.58 17.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.316 -0.994 . . . . 0.02 108.316 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.59 -24.33 53.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.23999999999999999 110.995 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -154.65 102.4 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.006 -1.059 . . . . 1.1399999999999999 108.86 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CZ ' ' NH2' ' A' ' 30' ' ' ARG . 17.9 p90 -104.38 8.38 35.8 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.192 0.996 . . . . 6.3700000000000001 109.487 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.428 HH11 ' NH2' ' A' ' 78' ' ' ARG . 3.3 mmp_? -58.3 -24.22 58.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 3.1099999999999999 110.715 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -74.69 -17.1 60.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.768 -1.208 . . . . 0.88 109.933 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -104.13 -22.41 13.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.421 -0.799 . . . . 0.02 109.416 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tp -150.01 128.51 12.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.113 -0.992 . . . . 3.3199999999999998 109.138 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -85.54 -10.03 56.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.723 -0.611 . . . . 0.02 111.288 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -171.86 163.1 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.759 -1.2 . . . . 0.02 107.759 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 p -143.98 115.71 8.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.199 . . . . 0.02 108.736 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -107.06 1.83 24.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.957 -1.089 . . . . 0.029999999999999999 110.548 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.6 p -156.88 154.72 30.25 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.507 -1.294 . . . . 0.02 107.507 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mt -146.17 148.16 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 0.02 109.777 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -125.04 125.43 43.83 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.47 114.94 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.714 -1.587 . . . . 0.02 106.714 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.87 -34.33 26.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.796 -0.565 . . . . 3.8100000000000001 110.42 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.36 151.5 21.1 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.142 -1.504 . . . . 0.02 110.167 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 175.09 50.68 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.582 -1.294 . . . . 0.01 110.264 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.407 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 84.0 m -109.46 161.3 15.45 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.901 -1.518 . . . . 1.48 106.901 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.407 ' CD1' ' C ' ' A' ' 45' ' ' THR . 65.6 m95 -147.38 146.64 29.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.347 -1.47 . . . . 0.02 111.402 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.79 54.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 105.466 -2.05 . . . . 0.23999999999999999 105.466 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.0 m -117.73 141.98 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.607 -0.683 . . . . 0.65000000000000002 109.493 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 8.5 m-85 -122.0 143.36 49.53 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.511 1.148 . . . . 0.02 109.652 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 6.0 tp10 -65.37 -36.25 83.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.729 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.1 153.51 64.56 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.97 -1.081 . . . . 0.02 109.305 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.13 167.74 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.31 1.34 . . . . 0.02 112.772 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 63.26 37.05 11.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.175 -0.921 . . . . 0.02 110.998 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER 45.12 52.83 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.683 0.754 . . . . 3.3900000000000001 110.896 178.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -126.58 163.85 22.52 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.866 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.84 32.27 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.13 -1.188 . . . . 0.02 110.13 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 5.6 m170 -63.93 138.52 58.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.976 -1.308 . . . . 0.02 110.117 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.7 mtm -120.55 134.47 55.27 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.606 0.717 . . . . 5.0099999999999998 109.679 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.503 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.3 m-85 -134.25 139.02 45.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.02 109.561 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.638 ' H ' ' NE2' ' A' ' 148' ' ' GLN . 1.6 mp -97.25 133.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.85 113.68 32.91 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.561 -0.712 . . . . 0.02 110.56 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.4 168.72 22.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.154 1.091 . . . . 1.47 110.155 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.17 141.39 23.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.746 -1.221 . . . . 4.25 110.151 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.03 -176.51 32.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.412 -1.375 . . . . 0.02 110.567 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -119.4 130.6 55.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -1.082 . . . . 0.95999999999999996 109.403 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 49.3 m-85 -121.1 98.71 47.01 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 107.671 -1.233 . . . . 0.02 107.671 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -70.54 -3.39 12.42 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.629 0.886 . . . . 0.02 113.806 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -157.26 155.01 30.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.592 -1.317 . . . . 2.02 108.206 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -60.65 -39.14 87.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.577 -0.702 . . . . 0.02 111.814 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.81 -23.8 63.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.02 110.181 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.73 -18.54 62.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.96 0.886 . . . . 3.4199999999999999 108.626 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -106.82 10.31 30.74 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.171 -1.418 . . . . 0.02 107.171 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.35 22.62 11.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.557 0.694 . . . . 0.02 110.18 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.98 47.36 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.8 tp -78.76 -29.68 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.649 -1.241 . . . . 0.97999999999999998 107.649 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.626 ' ND2' ' N ' ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.67 -171.03 3.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.619 -1.623 . . . . 0.02 106.619 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -98.17 28.29 4.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.633 -1.292 . . . . 0.02 110.238 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 17.7 mmm180 -98.05 123.01 41.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.285 -0.884 . . . . 3.2000000000000002 111.38 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.0 mt -144.65 121.59 11.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.048 -1.464 . . . . 2.6099999999999999 107.048 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 -16.39 14.48 Favored Glycine 0 N--CA 1.5 2.905 0 O-C-N 121.303 -0.873 . . . . 0.02 112.171 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.01 154.65 32.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.247 -1.737 . . . . 0.02 110.401 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.6 p -144.69 147.36 32.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.02 109.688 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -133.86 140.13 46.66 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.664 -0.865 . . . . 0.01 108.664 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.11 129.22 36.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 0.42999999999999999 107.935 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.0 t -91.96 123.69 44.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.893 -0.78 . . . . 1.25 108.893 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -90.66 136.65 32.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.276 -0.89 . . . . 1.77 109.006 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.25 137.48 37.7 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.94 -1.133 . . . . 1.6299999999999999 107.94 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 t -112.25 126.5 55.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -0.876 . . . . 1.0800000000000001 109.14 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -103.61 -154.94 0.51 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.221 -1.77 . . . . 1.26 106.221 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.02 -49.58 0.86 Allowed Glycine 0 N--CA 1.498 2.79 0 O-C-N 120.418 -1.426 . . . . 0.01 112.232 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.04 -100.05 0.14 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 118.397 -1.859 . . . . 0.01 111.889 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.95 118.62 30.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.292 -1.122 . . . . 4.4299999999999997 110.394 -179.068 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.86 129.66 36.53 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 2.9900000000000002 109.287 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -129.97 139.46 51.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.576 -0.703 . . . . 6.3600000000000003 109.436 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tt -129.35 145.78 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.414 -0.804 . . . . 1.0900000000000001 109.71 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -121.18 133.22 55.18 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.29 -1.374 . . . . 2.0499999999999998 107.29 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.4 146.61 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.954 -1.091 . . . . 1.1000000000000001 109.351 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 33.2 m-85 -119.72 141.39 49.46 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.194 0.997 . . . . 0.72999999999999998 110.922 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.31 -29.25 69.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.711 -0.677 . . . . 0.02 111.587 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -116.61 169.8 9.07 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.075 -1.016 . . . . 3.1800000000000002 110.444 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.95 165.33 50.97 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.843 -0.903 . . . . 0.01 110.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' OD1' ' NH1' ' A' ' 157' ' ' ARG . 9.6 t0 56.8 38.37 29.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.956 -0.732 . . . . 0.01 111.307 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 51.65 54.44 10.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.01 111.368 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 166.14 19.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.062 -1.088 . . . . 3.1499999999999999 108.062 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -164.19 28.63 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.014 -1.635 . . . . 0.01 109.014 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.34 143.86 42.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.285 . . . . 0.01 108.518 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.3 ttp -116.79 142.84 46.4 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.59 0.71 . . . . 0.01 109.838 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -131.65 136.38 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.073 -1.084 . . . . 2.48 108.073 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.57 134.8 54.82 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.684 -0.635 . . . . 0.01 110.093 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.514 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -149.14 150.49 32.77 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.237 1.018 . . . . 1.6899999999999999 111.031 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.502 ' N ' ' HG1' ' A' ' 110' ' ' THR . 73.6 p -110.11 10.02 24.01 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.674 -0.694 . . . . 0.01 109.811 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.403 ' H ' ' HG1' ' A' ' 110' ' ' THR . 46.4 mm-40 -120.77 163.23 18.44 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.282 -0.887 . . . . 3.21 111.272 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.1 155.18 37.57 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.021 -1.103 . . . . 0.01 108.021 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.2 t -123.18 109.77 31.3 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.67 -31.91 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 CA-C-N 119.997 1.035 . . . . 0.01 111.696 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -140.96 107.42 5.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.37 -0.832 . . . . 0.02 108.774 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 117' ' ' ILE . 23.6 mt -63.52 -39.44 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.56 . . . . 1.8300000000000001 110.668 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 40.7 ttp -66.32 -37.52 85.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.966 -1.094 . . . . 1.3400000000000001 109.959 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.18 -39.27 71.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.399 -1.438 . . . . 2.1099999999999999 109.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.72 -47.86 13.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 2.0800000000000001 112.447 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.19 -1.96 15.95 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.352 -0.843 . . . . 0.02 112.517 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.0 m80 61.87 33.96 17.29 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.659 -1.276 . . . . 0.02 109.403 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.1 mt -114.63 135.54 54.03 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.487 -0.758 . . . . 0.02 109.264 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.418 ' O ' ' OE2' ' A' ' 125' ' ' GLU . 0.0 OUTLIER -89.13 -21.19 23.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.159 -0.963 . . . . 5.3200000000000003 110.761 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 124' ' ' ARG . 10.9 mp0 -147.32 163.95 34.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.912 -1.117 . . . . 0.02 109.504 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.0 mm -126.97 124.23 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.339 -1.356 . . . . 2.1699999999999999 107.339 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -110.3 -13.48 14.31 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.238 -0.914 . . . . 0.02 112.516 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 t -160.79 151.65 18.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.835 -1.165 . . . . 0.01 109.24 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.2 p -168.78 143.93 3.33 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.674 -0.861 . . . . 1.22 108.674 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.46 109.6 13.48 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.448 1.118 . . . . 1.4099999999999999 109.669 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.5 p -111.04 137.81 41.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.619 -1.252 . . . . 0.01 107.619 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.03 92.81 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 106.693 -1.595 . . . . 1.98 106.693 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 22.8 tt0 -146.82 -73.01 0.22 Allowed 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 105.498 -2.038 . . . . 0.01 105.498 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.67 -75.23 0.09 OUTLIER Glycine 0 N--CA 1.48 1.6 0 N-CA-C 108.362 -1.895 . . . . 0.01 108.362 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.6 p -123.46 124.37 42.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.3 1.048 . . . . 2.2999999999999998 111.311 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 6.4 m95 -127.06 151.36 48.72 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.557 -1.646 . . . . 0.01 106.557 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 12.3 mt -117.18 133.62 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.507 -1.371 . . . . 1.6899999999999999 109.162 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.47 141.14 45.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.29 -1.745 . . . . 2.4900000000000002 106.29 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.8 m-85 -123.05 142.98 50.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.918 . . . . 0.02 109.605 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.66 -30.49 62.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.79 -0.569 . . . . 0.02 111.725 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.9 154.9 48.31 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.655 -1.278 . . . . 1.48 108.975 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.5 167.08 2.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.091 1.194 . . . . 0.02 112.926 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.79 31.38 20.77 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.05 -0.977 . . . . 0.75 111.363 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 57.31 51.89 9.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.42 -0.8 . . . . 0.02 111.361 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -126.57 164.84 20.33 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.504 -0.748 . . . . 0.02 110.114 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.2 33.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.227 -1.149 . . . . 0.02 110.227 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.02 108.61 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 60' ' ' ILE . 2.9 mt-30 -113.4 148.13 36.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.734 -0.604 . . . . 0.02 109.533 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.31 133.99 54.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.912 -0.773 . . . . 0.01 108.912 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 48.0 tp -96.63 121.66 38.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.01 109.378 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.402 ' CD1' ' N ' ' A' ' 151' ' ' LEU . 10.3 mp -95.75 139.08 32.49 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.557 -0.905 . . . . 0.01 108.557 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 3.0 p30 -105.55 -168.32 1.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.498 -0.751 . . . . 2.27 109.499 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -82.57 38.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 1.8400000000000001 110.005 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.28 175.28 5.54 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.379 -0.826 . . . . 2.2799999999999998 109.45 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -105.31 125.51 51.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.723 -0.843 . . . . 0.01 108.723 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 1.5 m-85 -100.35 112.73 25.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.243 -0.911 . . . . 0.01 109.817 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.526 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 12.8 mmm180 -88.35 -28.09 21.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.957 -1.089 . . . . 0.01 110.549 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -126.88 156.04 74.57 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 107.045 -1.465 . . . . 2.54 107.045 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.56 -34.26 96.81 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 CA-C-N 119.721 0.936 . . . . 0.69999999999999996 110.335 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.1 t -62.88 -21.16 27.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.873 -1.142 . . . . 0.85999999999999999 109.564 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.07 -20.51 65.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.672 -1.268 . . . . 0.02 111.439 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.444 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p90 -103.03 13.32 34.53 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.979 -1.075 . . . . 0.02 109.243 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.75 11.98 64.95 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.771 -0.728 . . . . 0.02 113.549 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.444 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.78 138.06 38.33 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 119.627 1.713 . . . . 0.02 110.411 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.79 -7.85 58.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.692 -0.63 . . . . 0.58999999999999997 109.796 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 87.0 p -139.98 150.16 61.3 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.312 -0.868 . . . . 0.87 109.551 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.5 13.5 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.688 0.925 . . . . 0.38 112.031 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.95 120.2 24.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.17999999999999999 110.921 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.15 124.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.79 -1.929 . . . . 3.9900000000000002 105.79 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -112.25 -12.95 13.54 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.311 -0.868 . . . . 5.1699999999999999 113.171 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 33.3 t -156.76 159.0 37.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 119.354 -2.091 . . . . 0.02 110.076 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.01 154.14 34.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.303 -0.873 . . . . 2.02 110.7 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -143.51 149.29 37.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.385 -0.822 . . . . 0.01 110.237 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -86.41 142.83 28.15 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.53 -0.915 . . . . 0.01 108.53 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 mt -94.38 128.45 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.12 -0.987 . . . . 3.04 109.851 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.59 147.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.764 . . . . 1.8899999999999999 109.458 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 4.8899999999999997 109.102 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.431 -0.581 . . . . 5.2800000000000002 109.431 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -72.78 95.81 1.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 5.96 109.541 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.408 ' HG1' ' N ' ' A' ' 4' ' ' GLY . 11.9 p -101.93 -141.45 0.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.978 -1.119 . . . . 2.2200000000000002 107.978 177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' N ' ' HG1' ' A' ' 3' ' ' THR . . . 173.39 87.03 0.06 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 107.088 -2.405 . . . . 0.81000000000000005 107.088 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.37 149.59 34.01 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 120.026 -1.083 . . . . 0.01 110.692 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -150.04 135.98 18.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.978 . . . . 0.02 109.509 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.25 140.83 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.669 ' HG ' ' HE ' ' A' ' 19' ' ' ARG . 4.3 m -121.32 130.06 53.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.625 -0.672 . . . . 0.39000000000000001 109.575 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -109.69 139.24 44.96 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.76 -0.83 . . . . 0.02 108.76 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m-85 -123.18 139.28 54.23 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.266 -0.896 . . . . 0.02 109.765 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 86.2 mt-10 -69.15 -28.1 66.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.989 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.69 170.22 8.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.426 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.495 ' NH2' ' OE1' ' A' ' 70' ' ' GLN . 73.0 mtt180 -74.07 157.71 35.59 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.638 0.732 . . . . 0.029999999999999999 109.929 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.3 t-20 65.76 35.03 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.931 0.872 . . . . 0.73999999999999999 111.037 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.1 p90 50.29 45.61 25.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.839 0.828 . . . . 0.02 111.197 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.39 165.85 11.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.989 -1.115 . . . . 0.02 107.989 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.2 35.91 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.702 -1.237 . . . . 0.029999999999999999 110.853 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' ' OE2' ' A' ' 11' ' ' GLU . 22.3 ttp180 -68.64 142.78 55.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -1.048 . . . . 2.7599999999999998 109.414 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.669 ' HE ' ' HG ' ' A' ' 8' ' ' SER . 54.9 ttt180 -119.79 147.65 44.38 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.593 0.711 . . . . 1.8899999999999999 109.893 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -132.61 126.68 33.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.833 -1.173 . . . . 0.02 107.833 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.39 137.78 50.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.756 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.419 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.7 t -131.08 138.55 49.61 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.648 0.737 . . . . 0.02 109.807 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.28 10.81 14.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.687 -0.633 . . . . 0.20000000000000001 109.542 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 29.8 t -157.08 174.47 15.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 40.3 t0 -60.84 144.46 52.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.733 -1.229 . . . . 0.02 109.969 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 20.9 t -131.95 116.11 16.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.49 -0.93 . . . . 0.02 108.49 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.18 51.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.23999999999999999 110.891 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.6 p-10 -154.4 101.56 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 1.1399999999999999 108.84 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.9 p90 -105.43 10.36 33.34 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.331 1.063 . . . . 6.3700000000000001 110.159 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.418 ' NH2' ' O ' ' A' ' 34' ' ' SER . 21.6 mmm180 -60.22 -23.03 63.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 3.1099999999999999 110.924 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -76.3 -16.94 59.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.619 -1.301 . . . . 0.88 110.222 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.23 -20.97 14.46 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.79 -0.818 . . . . 0.02 108.79 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.6 tp -150.15 129.37 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.78 0.8 . . . . 3.3199999999999998 109.002 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 90.4 p -85.16 -10.78 56.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.762 -0.586 . . . . 0.02 110.717 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.465 ' HE ' HD22 ' A' ' 37' ' ' ASN . 12.5 ptm180 -170.26 162.13 8.51 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.639 -1.245 . . . . 0.02 107.639 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 t -143.6 115.34 8.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.02 108.978 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.657 ' N ' HD21 ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.33 1.2 18.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.739 -1.226 . . . . 0.029999999999999999 111.422 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 t -156.96 154.78 30.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.131 -1.062 . . . . 0.02 108.131 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -146.49 146.88 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 122.185 0.993 . . . . 0.02 111.105 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -122.8 124.11 42.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.616 -1.253 . . . . 0.02 107.616 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.48 114.83 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 106.598 -1.63 . . . . 0.02 106.598 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.7 mp0 -83.83 -33.73 24.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.269 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.32 149.8 18.34 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.104 -1.522 . . . . 0.02 110.133 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.07 173.87 50.03 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.648 -1.263 . . . . 0.01 110.153 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.6 m -119.64 137.28 53.98 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -126.09 153.93 43.8 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.712 1.244 . . . . 0.02 112.361 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.99 133.39 52.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.051 -2.203 . . . . 0.23999999999999999 105.051 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -116.87 142.03 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.658 -0.651 . . . . 0.65000000000000002 109.337 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -120.97 143.01 49.24 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.169 0.985 . . . . 0.02 109.655 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.58 -34.3 77.93 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.376 -0.829 . . . . 0.02 111.778 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -124.82 157.84 64.75 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.942 -1.099 . . . . 0.02 109.549 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.91 166.31 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.739 1.626 . . . . 0.02 112.741 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.77 37.31 9.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.314 -0.857 . . . . 0.02 111.058 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.85 52.23 8.13 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.551 0.691 . . . . 3.3900000000000001 110.598 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -126.21 163.87 22.23 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.181 0.515 . . . . 2.3300000000000001 110.016 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -162.02 31.29 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.871 -1.292 . . . . 0.02 109.871 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.65 136.38 57.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.275 . . . . 0.02 110.035 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 19.1 ptm -118.58 135.66 54.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.62 . . . . 5.0099999999999998 109.435 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.581 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 25.6 m-85 -135.52 141.09 45.21 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.509 -0.744 . . . . 0.02 109.34 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 60' ' ' ILE . 1.6 mp -96.51 133.04 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.59 -0.892 . . . . 1.72 108.59 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.74 111.79 29.27 Favored Pre-proline 0 N--CA 1.502 2.159 0 O-C-N 121.371 -0.831 . . . . 0.02 110.4 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.96 171.37 18.29 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.839 0.978 . . . . 1.47 110.237 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -51.42 140.79 16.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.002 -1.061 . . . . 4.25 109.863 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -178.56 31.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.403 -1.38 . . . . 0.02 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.3 tp10 -120.36 131.21 54.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.44 -1.035 . . . . 0.95999999999999996 109.461 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 93.3 m-85 -122.21 95.29 47.36 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.2 Cg_exo -65.65 -3.45 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.892 1.061 . . . . 0.02 114.179 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 36.1 mt-10 -157.78 154.99 29.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.415 -1.428 . . . . 2.02 108.087 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 7.3 p90 -60.8 -38.57 85.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.523 -0.735 . . . . 0.02 111.995 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 24.7 mt-30 -59.58 -24.21 63.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.02 110.367 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -70.84 -18.18 62.72 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.404 -0.961 . . . . 3.4199999999999999 108.404 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.581 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.89 9.87 30.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.258 -1.386 . . . . 0.02 107.258 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 60.86 21.48 11.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.587 -0.696 . . . . 0.02 110.41 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.05 145.01 46.56 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.392 -1.483 . . . . 0.02 109.392 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 75' ' ' LEU . 8.1 mp -78.6 -29.95 46.31 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.459 -1.682 . . . . 0.02 106.459 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 5.5 p30 -97.21 28.56 3.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.669 -1.27 . . . . 0.02 110.21 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -96.31 121.42 38.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.914 -1.116 . . . . 3.2000000000000002 110.33 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 ' O ' ' CZ ' ' A' ' 29' ' ' PHE . 35.1 mt -144.3 119.72 10.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.794 -1.187 . . . . 2.6099999999999999 107.794 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.22 -15.94 10.12 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.338 -0.851 . . . . 0.02 112.975 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 47.3 t -155.55 155.59 33.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.97 -1.9 . . . . 0.02 110.943 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.43 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 23.9 p -145.86 148.7 33.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.487 -0.758 . . . . 0.02 110.397 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -135.53 140.53 44.8 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.394 -0.816 . . . . 0.01 108.888 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.33 130.97 36.8 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.081 -1.012 . . . . 0.42999999999999999 109.197 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.33 123.31 41.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.334 -0.987 . . . . 1.25 108.334 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 9.6 m-70 -90.65 135.08 33.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.876 -1.14 . . . . 1.77 108.166 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.85 138.49 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.735 -0.839 . . . . 1.6299999999999999 108.735 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -111.56 125.4 53.88 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.495 -0.928 . . . . 1.0800000000000001 108.495 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -102.58 -156.13 0.55 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.93 -45.86 1.05 Allowed Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.339 -1.476 . . . . 0.01 112.068 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.33 -97.85 0.11 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.463 -1.827 . . . . 0.01 112.159 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -121.48 120.42 34.87 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.389 -1.065 . . . . 4.4299999999999997 110.707 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -74.92 131.49 40.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 2.9900000000000002 109.201 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.512 ' NZ ' HE22 ' A' ' 96' ' ' GLN . 0.5 OUTLIER -131.19 137.71 49.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.574 -0.704 . . . . 6.3600000000000003 109.523 -179.266 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 6.6 tt -127.78 142.75 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.861 0.838 . . . . 1.0900000000000001 109.456 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.512 HE22 ' NZ ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -125.21 134.59 52.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.177 -1.045 . . . . 2.0499999999999998 108.177 178.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.72 148.48 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.88 -1.137 . . . . 1.1000000000000001 109.961 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 51.7 m-85 -118.32 141.16 48.81 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.925 0.869 . . . . 0.72999999999999998 110.777 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.9 -29.8 69.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 116.013 -0.54 . . . . 0.02 111.813 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -116.69 167.96 10.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.087 -1.008 . . . . 3.1800000000000002 110.573 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.29 164.03 41.5 Favored Glycine 0 N--CA 1.492 2.398 0 CA-C-O 121.936 0.742 . . . . 0.01 111.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.8 m-20 56.39 39.49 30.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.955 -0.733 . . . . 0.01 110.928 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.504 ' H ' ' CB ' ' A' ' 128' ' ' SER . 4.7 m-85 52.27 55.51 9.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.732 -0.605 . . . . 0.01 110.826 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -128.82 165.84 20.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.399 -0.963 . . . . 3.1499999999999999 108.399 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.85 -164.3 27.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.204 -1.558 . . . . 0.01 109.204 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . 0.527 HE21 ' H ' ' A' ' 107' ' ' MET . 38.9 tp60 -74.51 144.5 44.08 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.263 . . . . 0.01 108.167 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.71 142.28 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.647 0.737 . . . . 0.01 109.454 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.18 136.63 48.45 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.191 -1.04 . . . . 2.48 108.191 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 110' ' ' THR . 8.8 tp10 -119.09 133.67 55.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.714 -0.616 . . . . 0.01 109.741 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.533 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -148.99 149.39 31.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 1.6899999999999999 110.593 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 24.3 p -108.7 10.25 26.88 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.763 -0.653 . . . . 0.01 109.724 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 37.3 mp0 -120.81 163.12 18.65 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.383 -0.823 . . . . 3.21 111.234 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.1 p30 -65.75 154.73 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.052 -1.092 . . . . 0.01 108.052 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.7 t -122.5 110.16 32.33 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 108.512 -0.921 . . . . 0.01 108.512 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.45 ' O ' ' OG ' ' A' ' 171' ' ' SER . 21.0 Cg_endo -76.91 -31.63 3.79 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 119.969 1.025 . . . . 0.01 111.833 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.441 ' HG ' ' H ' ' A' ' 119' ' ' GLU . 26.2 t -142.02 107.92 5.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.088 -1.008 . . . . 0.02 108.792 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.4 mt -63.52 -39.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.913 -0.492 . . . . 1.8300000000000001 110.576 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.49 -37.28 84.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.003 -1.079 . . . . 1.3400000000000001 109.945 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.441 ' H ' ' HG ' ' A' ' 116' ' ' SER . 22.3 tp10 -70.82 -39.12 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.842 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.5 tt0 -80.78 -48.22 12.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 2.0800000000000001 112.564 -176.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.442 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 58.6 m-85 -111.82 -1.49 15.54 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.424 -0.797 . . . . 0.02 112.707 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 61.1 34.4 19.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.095 . . . . 0.02 109.769 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.19 135.49 53.98 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.534 -0.729 . . . . 0.02 109.152 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -90.32 -21.51 22.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 111.006 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -148.42 163.57 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.045 -1.034 . . . . 0.02 110.06 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.404 HG22 HD13 ' A' ' 126' ' ' ILE . 39.4 mm -128.48 125.6 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -109.82 -13.9 14.39 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.145 -0.972 . . . . 0.02 113.118 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 102' ' ' ASP . 8.4 m -161.81 154.16 19.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.573 -1.33 . . . . 0.01 109.627 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.7 p -166.23 142.47 4.92 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.751 -0.833 . . . . 1.22 108.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.504 ' HZ3' ' CB ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -118.72 96.88 5.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 108.221 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.67 137.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.281 -0.872 . . . . 0.01 108.794 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.67 90.23 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 105.336 -2.098 . . . . 1.98 105.336 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.412 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -149.47 -67.71 0.21 Allowed 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.836 -1.542 . . . . 0.01 106.836 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.39 31.39 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 107.168 -2.373 . . . . 0.01 107.168 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.2 p -121.73 58.47 1.01 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.843 -0.798 . . . . 2.2999999999999998 110.535 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.412 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 87.6 m95 -130.69 135.33 47.72 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.809 -1.182 . . . . 0.01 110.658 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.7 mt -119.8 137.71 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.393 -0.966 . . . . 1.6899999999999999 108.393 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.82 141.26 44.41 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.168 -1.419 . . . . 2.4900000000000002 107.168 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -122.5 142.31 50.72 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.234 -0.916 . . . . 0.02 109.646 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -31.2 61.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.714 -0.616 . . . . 0.02 112.187 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.69 155.03 48.0 Favored Pre-proline 0 N--CA 1.506 2.355 0 O-C-N 120.736 -1.228 . . . . 1.48 109.135 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.3 Cg_endo -54.92 166.43 2.09 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.022 1.148 . . . . 0.02 112.913 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 142' ' ' PRO . 5.6 p30 57.05 31.9 20.74 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.056 -0.975 . . . . 0.75 111.822 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.445 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 59.35 51.85 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.02 111.397 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.652 ' HE ' ' H ' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -127.05 166.29 17.88 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.479 -0.763 . . . . 0.02 109.793 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.652 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 87.57 -165.58 35.41 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.307 -1.117 . . . . 0.02 110.307 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.11 141.88 54.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -1.001 . . . . 0.02 108.873 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.475 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.2 mt-30 -114.8 149.15 37.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.267 0.556 . . . . 0.02 109.519 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -123.54 133.77 53.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.507 -0.923 . . . . 0.01 108.507 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.9 tp -94.69 122.3 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.792 -1.193 . . . . 0.01 109.342 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' N ' ' CD1' ' A' ' 151' ' ' LEU . 10.5 mp -93.23 149.0 21.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.01 108.875 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.6 m-20 -108.53 -175.88 2.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.51 -0.743 . . . . 2.27 109.222 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -74.4 27.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 1.8400000000000001 109.501 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 152' ' ' ASP . 55.1 mttm -112.76 174.69 5.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.354 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -106.57 138.02 43.51 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.936 -0.764 . . . . 0.01 108.936 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.465 ' HH ' ' H ' ' A' ' 152' ' ' ASP . 92.2 m-85 -101.82 114.31 28.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.304 -0.872 . . . . 0.01 110.273 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' A' ' 128' ' ' SER . 11.2 mtp180 -86.52 -28.55 23.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.01 111.268 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -123.2 153.68 64.94 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.831 -1.174 . . . . 2.54 107.831 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.6 Cg_endo -61.83 -41.93 34.67 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 CA-C-N 119.323 0.794 . . . . 0.69999999999999996 110.455 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.8 -18.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.808 -1.182 . . . . 0.85999999999999999 109.279 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -65.88 -18.31 65.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.02 111.87 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.76 14.82 30.84 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 120.891 -1.13 . . . . 0.02 110.099 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.36 10.72 73.52 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.219 -0.926 . . . . 0.02 113.047 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.425 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.18 140.54 35.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.79 -1.417 . . . . 0.02 109.994 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.03 -6.81 59.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 109.544 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 97.2 p -140.97 150.2 58.53 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.213 -0.929 . . . . 0.87 109.192 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.33 16.64 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.585 0.857 . . . . 0.38 111.942 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.18 120.19 25.03 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.177 0.989 . . . . 0.17999999999999999 110.904 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.59 124.28 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 105.609 -1.997 . . . . 3.9900000000000002 105.609 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.09 -12.77 13.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.241 -0.912 . . . . 5.1699999999999999 113.246 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 115' ' ' PRO . 16.9 m -157.7 160.76 38.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.146 -2.221 . . . . 0.02 110.388 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -151.59 153.14 33.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.373 -0.83 . . . . 2.02 109.875 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.445 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.2 mtp180 -143.55 150.0 38.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.217 -0.927 . . . . 0.01 110.121 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.519 ' NH2' ' O ' ' A' ' 111' ' ' THR . 3.4 ptp180 -87.4 143.1 27.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.581 -0.896 . . . . 0.01 108.581 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.79 128.51 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.207 -0.933 . . . . 3.04 109.25 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.9 t -137.52 147.81 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.199 -0.938 . . . . 1.8899999999999999 109.653 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.43 -0.794 . . . . 4.8899999999999997 109.412 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.742 0 N-CA-C 107.084 -2.406 . . . . 0.81000000000000005 107.084 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.66 148.9 32.65 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 120.216 -0.992 . . . . 0.01 110.866 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -151.18 136.81 17.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.951 . . . . 0.02 108.839 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -130.25 140.58 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -120.85 129.28 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.455 -0.778 . . . . 0.39000000000000001 109.897 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.6 m-85 -109.42 139.51 44.3 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.839 -0.801 . . . . 0.02 108.839 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -124.18 139.69 53.68 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.184 -0.948 . . . . 0.02 110.126 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.5 mt-10 -68.32 -27.3 66.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.029999999999999999 111.826 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.42 169.97 8.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.838 -1.164 . . . . 0.029999999999999999 110.466 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 59.3 mtt180 -74.93 158.49 33.22 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 109.816 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.2 m120 65.91 34.71 7.01 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.813 0.816 . . . . 0.73999999999999999 110.842 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.2 p90 49.41 44.29 23.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.72 0.771 . . . . 0.02 111.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -111.74 165.95 11.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.43 -167.61 35.73 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.593 -1.289 . . . . 0.029999999999999999 110.487 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -68.6 143.1 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 2.7599999999999998 109.024 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 21' ' ' ASP . 3.0 tmm_? -121.51 149.96 42.32 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.752 0.787 . . . . 1.8899999999999999 110.163 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -133.52 128.17 34.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.444 -0.947 . . . . 0.02 108.444 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' CZ ' ' A' ' 19' ' ' ARG . 45.5 m-20 -111.43 136.9 49.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.494 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.3 t -130.79 137.62 49.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.535 0.684 . . . . 0.02 109.412 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 p-10 -117.0 10.47 14.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.706 -0.621 . . . . 0.20000000000000001 109.535 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -158.32 174.51 15.04 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.158 -1.053 . . . . 1.23 108.158 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.1 p30 -62.08 144.3 55.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.61 -1.306 . . . . 0.02 110.253 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 t -131.33 117.45 18.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.569 -0.9 . . . . 0.02 108.569 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.79 -25.19 53.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.087 -1.008 . . . . 0.23999999999999999 110.613 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.29 101.52 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.966 -1.083 . . . . 1.1399999999999999 108.742 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -104.61 8.35 35.28 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.541 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -59.0 -24.08 62.46 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.556 -0.715 . . . . 3.1099999999999999 110.787 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -74.29 -16.5 60.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.716 -1.24 . . . . 0.88 110.047 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -103.59 -22.16 13.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.02 109.228 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.0 tp -150.27 128.92 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 3.3199999999999998 109.086 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 p -85.64 -9.98 56.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.735 -0.603 . . . . 0.02 111.086 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -170.78 161.66 7.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 t -142.41 114.37 8.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.718 -1.239 . . . . 0.02 108.573 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -108.71 0.82 20.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.895 -1.128 . . . . 0.029999999999999999 110.609 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 3.2 p -156.55 153.39 28.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -145.38 148.47 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.08 -1.013 . . . . 0.02 109.74 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -124.09 124.87 43.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.387 -1.338 . . . . 0.02 107.387 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -105.69 113.29 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.601 -1.629 . . . . 0.02 106.601 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -83.63 -34.14 25.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.049 -0.66 . . . . 3.8100000000000001 109.744 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.75 150.7 19.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.525 -1.798 . . . . 0.02 110.532 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.92 174.18 50.13 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.513 -1.327 . . . . 0.01 110.095 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 53.9 m -109.62 160.73 16.03 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.996 -1.483 . . . . 1.48 106.996 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 74.6 m95 -148.15 146.89 28.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.324 -1.485 . . . . 0.02 111.443 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.05 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.263 -2.125 . . . . 0.23999999999999999 105.263 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.1 m -119.78 143.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.586 -0.696 . . . . 0.65000000000000002 109.65 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.78 144.85 48.08 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.245 1.021 . . . . 0.02 109.903 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.59 -34.74 78.56 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.829 -0.623 . . . . 0.02 111.541 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -124.25 157.5 64.2 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.104 -0.997 . . . . 0.02 109.326 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.28 165.53 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.491 1.461 . . . . 0.02 113.152 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 64.18 37.31 8.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.221 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 45.24 51.32 9.32 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.655 0.741 . . . . 3.3900000000000001 110.483 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -125.81 163.27 23.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 2.3300000000000001 109.714 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.02 -161.42 31.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.642 -1.383 . . . . 0.02 109.642 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -65.15 138.24 58.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.04 -1.271 . . . . 0.02 110.161 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.6 ptm -118.61 135.79 54.24 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.067 -0.716 . . . . 5.0099999999999998 109.067 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.7 m-85 -134.82 139.94 45.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.8 0.809 . . . . 0.02 109.856 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.52 132.49 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.561 -0.903 . . . . 1.72 108.561 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -118.59 111.78 37.63 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.569 -0.707 . . . . 0.02 110.357 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.89 168.1 22.71 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.127 1.081 . . . . 1.47 109.897 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 7.9 tm0? -53.37 140.81 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.796 -1.19 . . . . 4.25 110.36 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.04 -176.9 32.56 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.689 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.1 tp10 -118.13 129.31 55.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -1.146 . . . . 0.95999999999999996 108.929 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.528 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 47.3 m-85 -120.4 96.8 49.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 107.548 -1.278 . . . . 0.02 107.548 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -68.74 -3.9 12.18 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 120.541 0.827 . . . . 0.02 113.818 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -156.91 154.34 29.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.453 -1.405 . . . . 2.02 107.962 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 52.0 p90 -60.51 -37.62 81.72 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.59 -0.694 . . . . 0.02 111.537 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.39 -23.97 64.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.014 -1.053 . . . . 0.02 110.454 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.52 -18.48 62.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.433 -0.951 . . . . 3.4199999999999999 108.433 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.617 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.75 10.98 30.71 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.188 -1.412 . . . . 0.02 107.188 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.4 OUTLIER 59.61 21.76 10.4 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.598 0.713 . . . . 0.02 110.27 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.7 145.1 45.73 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.871 -1.692 . . . . 0.02 108.871 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.3 tt -78.27 -30.48 48.55 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.536 -1.283 . . . . 0.97999999999999998 107.536 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 16.0 t-20 -156.77 -172.36 4.02 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.514 -1.662 . . . . 0.02 106.514 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 32.6 p30 -97.52 27.29 4.38 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.709 -1.245 . . . . 0.02 110.087 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -96.04 122.86 39.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.055 -1.028 . . . . 3.2000000000000002 110.493 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.517 HD22 ' HB ' ' A' ' 48' ' ' VAL . 45.9 mt -144.31 120.55 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.469 -1.308 . . . . 2.6099999999999999 107.469 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 -16.52 13.06 Favored Glycine 0 N--CA 1.504 3.172 0 O-C-N 121.317 -0.864 . . . . 0.02 112.507 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 m -156.06 156.06 33.72 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.372 -1.663 . . . . 0.02 110.239 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.7 p -144.12 146.91 33.09 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.372 0.606 . . . . 0.02 109.447 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -135.03 140.18 45.4 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.01 108.857 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.82 130.57 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.36 -0.978 . . . . 0.42999999999999999 108.36 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.1 125.2 44.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.389 -0.967 . . . . 1.25 108.389 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -90.51 135.8 33.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 1.77 108.94 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.76 138.2 37.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.986 -0.746 . . . . 1.6299999999999999 108.986 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -113.29 126.11 55.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.863 -0.792 . . . . 1.0800000000000001 108.863 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -102.51 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.209 -1.774 . . . . 1.26 106.209 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.56 -48.31 0.9 Allowed Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.376 -1.452 . . . . 0.01 112.529 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.16 -99.63 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 118.259 -1.924 . . . . 0.01 112.388 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -121.58 119.63 32.48 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.285 -1.127 . . . . 4.4299999999999997 110.756 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -77.75 131.08 37.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.105 -0.702 . . . . 2.9900000000000002 109.105 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.3 ttpm? -131.13 140.35 49.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.461 -0.774 . . . . 6.3600000000000003 108.931 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -128.9 143.66 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.386 -0.821 . . . . 1.0900000000000001 110.109 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.23 133.73 54.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.905 -1.146 . . . . 2.0499999999999998 107.905 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.03 147.17 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.876 -1.14 . . . . 1.1000000000000001 109.691 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 29.5 m-85 -118.56 140.87 49.21 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.129 0.966 . . . . 0.72999999999999998 110.835 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -66.26 -29.42 69.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.772 -0.649 . . . . 0.02 111.721 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -116.91 170.25 8.77 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 120.984 -1.072 . . . . 3.1800000000000002 110.573 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 165.32 50.12 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.831 -0.907 . . . . 0.01 110.831 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 56.5 38.41 29.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.834 -0.803 . . . . 0.01 111.461 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE1' ' OG ' ' A' ' 128' ' ' SER . 11.3 m-85 52.57 54.5 10.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.01 111.509 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -129.25 166.31 19.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.196 -1.038 . . . . 3.1499999999999999 108.196 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.46 28.03 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.514 -1.434 . . . . 0.01 109.514 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -75.16 144.54 42.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.1 -1.235 . . . . 0.01 108.493 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 48.2 ttp -116.65 142.11 47.32 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.654 0.74 . . . . 0.01 109.88 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -131.24 135.33 47.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.912 -1.144 . . . . 2.48 107.912 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -120.43 135.09 55.15 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.623 -0.673 . . . . 0.01 110.041 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -149.63 151.62 34.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.295 1.045 . . . . 1.6899999999999999 110.934 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.525 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 5.3 p -110.06 10.3 24.07 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.503 -0.771 . . . . 0.01 109.787 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -121.11 162.92 19.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 3.21 111.156 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -66.78 155.79 37.25 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.151 -1.055 . . . . 0.01 108.151 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.0 t -123.98 110.12 29.47 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.528 -0.916 . . . . 0.01 108.528 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.71 -32.82 3.33 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 120.002 1.036 . . . . 0.01 111.697 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -139.64 106.78 5.47 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.33 -39.91 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.869 -0.519 . . . . 1.8300000000000001 111.065 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 36.1 ttp -66.59 -38.0 86.09 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.996 -1.082 . . . . 1.3400000000000001 109.957 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -70.25 -38.96 75.26 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.522 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 45.7 tt0 -80.16 -48.2 13.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 2.0800000000000001 112.507 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.522 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 81.3 m-85 -111.41 -1.29 15.99 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.353 -0.842 . . . . 0.02 112.611 -175.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 61.79 33.77 17.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.792 -1.193 . . . . 0.02 109.668 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.52 136.05 53.45 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.487 -0.758 . . . . 0.02 109.293 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -90.21 -21.46 22.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.986 . . . . 5.3200000000000003 110.87 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 126' ' ' ILE . 45.3 mt-10 -148.73 164.14 35.24 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.02 110.124 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 125' ' ' GLU . 37.2 mm -129.29 126.57 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.503 -1.295 . . . . 2.1699999999999999 107.503 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.54 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 m80 -109.92 -13.22 14.47 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.251 -0.906 . . . . 0.02 112.618 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.534 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 47.5 t -161.39 154.34 20.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.786 -1.196 . . . . 0.01 109.0 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -170.64 147.28 2.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.22 109.684 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -119.86 109.9 16.11 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.986 -1.071 . . . . 1.4099999999999999 109.237 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 106.273 -1.751 . . . . 0.01 106.273 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 42.9 m95 . . . . . 0 N--CA 1.503 2.198 0 N-CA-C 107.461 -1.311 . . . . 0.01 107.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.47 ' CG1' HD11 ' A' ' 175' ' ' ILE . 36.3 mt -118.51 133.14 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.565 -1.335 . . . . 1.6899999999999999 109.502 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.09 141.62 44.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.334 -1.728 . . . . 2.4900000000000002 106.334 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 21.4 m-85 -123.45 143.07 50.38 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.197 -0.94 . . . . 0.02 109.731 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -74.25 -30.36 62.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.675 -0.641 . . . . 0.02 111.882 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.49 155.12 47.6 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.62 -1.3 . . . . 1.48 108.951 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -56.51 167.27 2.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.098 1.199 . . . . 0.02 112.615 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.25 31.21 21.01 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.413 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.489 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 3.1 m-85 57.48 50.68 10.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 0.02 111.082 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.36 165.13 18.25 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.656 -0.652 . . . . 0.02 109.766 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.7 33.98 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.549 -1.021 . . . . 0.02 110.549 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.57 142.15 53.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.542 -0.975 . . . . 0.02 108.788 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.5 mt-30 -113.14 148.45 35.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.351 0.596 . . . . 0.02 110.083 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -124.3 134.19 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.687 -0.856 . . . . 0.01 108.687 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.0 tp -96.0 120.55 36.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.156 . . . . 0.01 109.654 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -99.95 149.36 23.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.856 -0.794 . . . . 0.01 108.856 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.3 m-20 -109.58 -177.32 3.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 2.27 109.374 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -72.83 35.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.8400000000000001 109.469 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.6 mttp -111.55 176.2 5.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.078 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.92 127.03 52.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.424 -0.797 . . . . 0.01 109.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -98.31 112.26 24.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.01 108.847 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 9.6 ptp180 -88.7 -27.85 20.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.762 -0.586 . . . . 0.01 111.298 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -122.53 153.43 62.59 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 107.907 -1.146 . . . . 2.54 107.907 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.0 Cg_endo -62.24 -41.44 34.61 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.315 0.791 . . . . 0.69999999999999996 110.805 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.57 -18.26 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.862 -1.149 . . . . 0.85999999999999999 109.457 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.5 -18.22 65.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.891 -1.13 . . . . 0.02 111.948 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.31 15.83 27.51 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.737 -1.227 . . . . 0.02 110.207 178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.72 10.14 76.79 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.12 -0.987 . . . . 0.02 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.496 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.06 140.61 34.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.862 -1.375 . . . . 0.02 110.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.27 -7.05 59.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.621 -0.675 . . . . 0.58999999999999997 109.521 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.5 p -140.46 150.38 60.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.239 -0.913 . . . . 0.87 109.06 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.66 16.14 0.64 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 120.566 0.844 . . . . 0.38 111.776 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.19 119.9 24.66 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.307 1.051 . . . . 0.17999999999999999 110.817 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.43 123.64 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.57 -2.011 . . . . 3.9900000000000002 105.57 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -111.9 -13.16 13.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.369 -0.832 . . . . 5.1699999999999999 113.16 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.489 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.1 p -157.03 160.1 38.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 119.276 -2.14 . . . . 0.02 109.965 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.1 153.9 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 2.02 110.202 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -144.18 149.26 36.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.342 -0.849 . . . . 0.01 110.068 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 93' ' ' ALA . 4.6 ptp180 -87.02 141.48 28.64 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.603 -0.888 . . . . 0.01 108.603 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.47 HD11 ' CG1' ' A' ' 137' ' ' ILE . 41.7 mt -93.88 129.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 3.04 109.482 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.78 149.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.407 -0.808 . . . . 1.8899999999999999 109.771 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 4.8899999999999997 109.536 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 105.593 -3.003 . . . . 0.81000000000000005 105.593 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 146.61 31.53 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.383 -0.913 . . . . 0.01 111.179 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.23 137.4 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.76 -0.847 . . . . 0.02 108.82 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 tt -129.89 140.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.937 -0.764 . . . . 0.02 108.937 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -120.9 130.14 53.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.721 . . . . 0.39000000000000001 109.654 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 25.7 m-85 -108.96 138.73 44.84 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.88 -0.785 . . . . 0.02 108.88 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.34 138.28 54.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.302 -0.874 . . . . 0.02 109.398 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -68.21 -27.75 66.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 0.029999999999999999 111.605 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -114.93 170.13 8.57 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.976 -1.077 . . . . 0.029999999999999999 110.422 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -74.73 161.66 29.42 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.708 0.766 . . . . 0.029999999999999999 110.063 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.2 t-20 62.58 34.91 14.74 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.894 0.854 . . . . 0.73999999999999999 110.559 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.0 p90 49.45 42.9 23.23 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.473 -0.785 . . . . 0.02 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -109.35 165.89 11.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.806 -1.183 . . . . 0.02 107.806 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -167.98 35.01 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.681 -1.262 . . . . 0.029999999999999999 110.837 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.9 143.96 54.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.955 . . . . 2.7599999999999998 109.035 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -122.16 150.05 42.76 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.727 0.775 . . . . 1.8899999999999999 110.207 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.24 128.59 36.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.158 -1.053 . . . . 0.02 108.158 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -110.98 135.92 50.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.549 -0.719 . . . . 1.1200000000000001 109.465 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -129.99 137.81 50.49 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.486 0.66 . . . . 0.02 109.682 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 10.89 14.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.248 -0.649 . . . . 0.20000000000000001 109.248 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 t -158.83 174.17 15.4 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.06 -1.089 . . . . 1.23 108.06 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 15.8 p-10 -61.66 144.74 54.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.756 -1.215 . . . . 0.02 110.216 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 t -131.49 117.5 18.88 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.5 -0.926 . . . . 0.02 108.5 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.01 44.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.23999999999999999 111.292 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -153.21 102.49 2.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.149 . . . . 1.1399999999999999 108.946 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' C ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -101.68 8.49 41.62 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.962 0.887 . . . . 6.3700000000000001 109.689 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -59.14 -26.74 65.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.731 -0.606 . . . . 3.1099999999999999 111.657 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.28 -17.32 60.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.591 -1.318 . . . . 0.88 110.36 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.14 -22.22 13.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.02 109.799 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 tp -150.1 128.26 11.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.052 -1.03 . . . . 3.3199999999999998 109.019 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -84.77 -9.21 58.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.781 -0.575 . . . . 0.02 111.016 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -171.03 164.11 7.46 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -142.24 114.15 8.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.726 -1.234 . . . . 0.02 108.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -109.14 -0.93 19.11 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.942 -1.099 . . . . 0.029999999999999999 111.343 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -154.02 153.8 32.59 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.74 146.73 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.136 -0.978 . . . . 0.02 110.552 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' NE ' ' OH ' ' A' ' 10' ' ' TYR . 25.3 ttp180 -124.56 125.22 43.82 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.476 -1.305 . . . . 0.02 107.476 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.589 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 43.8 t -104.07 113.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 106.565 -1.643 . . . . 0.02 106.565 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -83.01 -34.47 26.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 3.8100000000000001 109.389 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.59 18.02 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.726 -1.702 . . . . 0.02 110.302 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.81 173.56 49.82 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.711 -1.233 . . . . 0.01 110.243 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -119.02 135.48 54.61 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.473 -1.306 . . . . 1.48 107.473 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.41 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.2 m95 -123.91 153.65 40.85 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.835 -1.166 . . . . 0.02 112.259 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.29 53.08 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.14 -2.17 . . . . 0.23999999999999999 105.14 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.4 m -118.63 142.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.129 -0.693 . . . . 0.65000000000000002 109.129 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.04 146.33 46.83 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.295 1.045 . . . . 0.02 109.617 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -66.0 -35.66 81.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.55 -0.75 . . . . 0.02 111.121 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -123.46 158.52 58.56 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 121.2 -0.937 . . . . 0.02 109.067 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.83 168.38 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.65 1.567 . . . . 0.02 112.8 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 62.75 37.42 12.57 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.421 -0.809 . . . . 0.02 111.197 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.73 52.11 8.01 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.573 0.701 . . . . 3.3900000000000001 110.793 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -126.61 164.16 21.84 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.193 0.52 . . . . 2.3300000000000001 109.838 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.35 -161.55 32.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.517 -1.433 . . . . 0.02 109.517 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -66.44 137.55 56.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.927 -1.337 . . . . 0.02 109.61 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.49 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.8 ptm -119.24 137.52 53.6 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.305 -0.628 . . . . 5.0099999999999998 109.305 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.1 m-85 -132.3 138.9 47.99 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.02 109.466 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.4 mm -96.23 132.1 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.764 -0.828 . . . . 1.72 108.764 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' A' ' 66' ' ' TYR . 16.4 mt -121.45 110.13 34.23 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.255 -0.903 . . . . 0.02 110.751 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.2 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.793 0.962 . . . . 1.47 109.981 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 28.3 tp60 -50.56 138.71 17.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 4.25 110.254 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.04 -179.17 32.15 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.035 -1.555 . . . . 0.02 110.884 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.0 130.83 55.89 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.547 -0.972 . . . . 0.95999999999999996 109.462 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -120.87 94.33 48.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.664 -1.236 . . . . 0.02 107.664 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.08 -4.47 11.6 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.781 0.988 . . . . 0.02 113.738 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -155.01 154.43 32.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.723 -1.236 . . . . 2.02 108.008 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CE2' ' CD ' ' A' ' 70' ' ' GLN . 33.3 p90 -61.12 -38.74 87.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.514 -0.741 . . . . 0.02 111.396 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.447 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 12.8 mm100 -60.38 -24.39 65.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.102 -0.999 . . . . 0.02 110.058 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.06 -18.09 63.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.293 -1.003 . . . . 3.4199999999999999 108.293 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.7 10.13 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.221 -1.4 . . . . 0.02 107.221 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.1 mpp? 59.2 21.9 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.664 0.745 . . . . 0.02 110.138 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 144.47 46.48 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.321 -1.512 . . . . 0.02 109.321 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 -30.03 48.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.623 -1.251 . . . . 0.97999999999999998 107.623 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.432 ' ND2' ' CG ' ' A' ' 78' ' ' ARG . 53.3 p-10 -157.96 -171.17 3.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.533 -1.654 . . . . 0.02 106.533 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.9 p-10 -98.21 28.3 4.13 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.682 -1.262 . . . . 0.02 110.403 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -97.57 122.83 41.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.814 -1.179 . . . . 3.2000000000000002 111.056 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.7 mt -142.33 122.01 13.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.286 -1.376 . . . . 2.6099999999999999 107.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -18.12 10.6 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.985 -1.072 . . . . 0.02 112.302 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.4 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 28.4 t -156.14 155.86 33.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.463 -1.61 . . . . 0.02 110.277 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 70.4 m -144.33 147.63 33.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.02 109.791 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -135.02 140.22 45.47 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.28 -0.888 . . . . 0.01 109.111 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 134.92 37.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 0.42999999999999999 108.753 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 123.09 45.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.554 -0.906 . . . . 1.25 108.554 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -90.48 136.18 33.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.183 -1.043 . . . . 1.77 108.183 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.51 137.29 38.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 1.6299999999999999 109.6 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.8 m -112.1 126.32 55.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.58 -0.896 . . . . 1.0800000000000001 108.58 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -102.99 -155.47 0.53 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.262 -1.755 . . . . 1.26 106.262 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.16 -48.96 0.86 Allowed Glycine 0 N--CA 1.498 2.83 0 O-C-N 120.438 -1.414 . . . . 0.01 112.384 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.88 -99.58 0.13 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.444 -1.836 . . . . 0.01 112.166 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -120.84 119.6 33.14 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.246 -1.149 . . . . 4.4299999999999997 110.751 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.3 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.187 -0.671 . . . . 2.9900000000000002 109.187 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -130.91 141.16 50.27 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.557 -0.714 . . . . 6.3600000000000003 109.085 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.78 144.84 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.319 -0.863 . . . . 1.0900000000000001 109.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.4 pm0 -121.76 134.37 54.93 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.404 -1.332 . . . . 2.0499999999999998 107.404 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 146.58 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.914 -1.116 . . . . 1.1000000000000001 109.371 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 36.0 m-85 -120.23 141.64 49.75 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.158 0.98 . . . . 0.72999999999999998 111.108 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -66.43 -30.05 70.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.699 -0.682 . . . . 0.02 111.816 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -116.29 168.09 10.44 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.956 -1.09 . . . . 3.1800000000000002 110.54 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.94 164.14 43.77 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 111.153 -0.779 . . . . 0.01 111.153 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 56.54 39.23 29.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.675 0.75 . . . . 0.01 110.941 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 51.45 56.31 8.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.625 -0.672 . . . . 0.01 111.115 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -128.55 165.64 20.36 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.008 -1.108 . . . . 3.1499999999999999 108.008 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.61 -164.08 27.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.151 -1.579 . . . . 0.01 109.151 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -74.66 144.32 43.87 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.983 -1.304 . . . . 0.01 108.411 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.8 ttt -116.5 141.74 47.79 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.619 0.723 . . . . 0.01 109.521 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -131.65 135.72 47.14 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.069 -1.085 . . . . 2.48 108.069 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -118.93 135.12 54.75 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.668 -0.645 . . . . 0.01 109.928 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -149.64 151.55 33.94 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.392 1.091 . . . . 1.6899999999999999 110.95 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.6 p -111.05 9.68 22.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.396 -0.82 . . . . 0.01 109.923 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 30.5 mp0 -121.28 163.85 17.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.324 -0.86 . . . . 3.21 111.556 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -67.73 156.03 37.88 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.443 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 12.3 m -124.83 111.67 27.3 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.753 -0.832 . . . . 0.01 108.753 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -76.21 -31.78 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 CA-C-N 119.958 1.021 . . . . 0.01 111.439 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -141.3 107.03 5.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.573 -0.899 . . . . 0.02 108.573 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.85 -39.28 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.81 -0.557 . . . . 1.8300000000000001 111.139 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.5 tmt? -67.19 -38.2 84.98 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.97 -1.092 . . . . 1.3400000000000001 109.892 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.14 -38.44 78.82 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.484 -1.385 . . . . 2.1099999999999999 109.826 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -79.63 -47.4 15.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 2.0800000000000001 112.38 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.12 -0.48 15.59 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.469 -0.769 . . . . 0.02 112.75 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m80 61.54 33.77 18.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.687 -1.258 . . . . 0.02 109.719 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.8 136.21 53.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.371 -0.831 . . . . 0.02 109.256 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -89.46 -21.73 22.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 5.3200000000000003 110.473 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -150.38 165.67 32.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.958 -1.088 . . . . 0.02 110.256 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.7 mm -129.87 126.57 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.219 -1.4 . . . . 2.1699999999999999 107.219 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -108.97 -12.94 14.81 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.14 -0.975 . . . . 0.02 112.598 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 21.1 m -158.16 152.34 24.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.764 -1.21 . . . . 0.01 108.753 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.8 t -166.51 142.81 4.75 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.099 -1.001 . . . . 1.22 109.152 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.531 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 31.4 ttpt -123.21 105.34 9.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.57 1.176 . . . . 1.4099999999999999 109.504 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 131' ' ' VAL . 11.4 p . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 107.5 -1.296 . . . . 0.01 107.5 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 107.549 -1.278 . . . . 0.01 107.549 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.424 ' CG1' HD11 ' A' ' 175' ' ' ILE . 25.3 mt -118.98 135.75 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.581 -1.324 . . . . 1.6899999999999999 109.566 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.34 142.16 43.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.341 -1.725 . . . . 2.4900000000000002 106.341 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 31.9 m-85 -122.23 143.53 49.53 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.113 -0.992 . . . . 0.02 109.364 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 47.4 tt0 -76.68 -30.03 56.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.747 -0.596 . . . . 0.02 111.833 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.1 mt -114.33 152.57 46.13 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.562 -1.336 . . . . 1.48 109.064 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.72 165.64 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.65 0.9 . . . . 0.02 112.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 59.71 31.67 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.307 -0.86 . . . . 0.75 111.549 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 57.88 52.13 8.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.514 -0.742 . . . . 0.02 111.412 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.0 165.51 19.3 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.473 -0.767 . . . . 0.02 110.059 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.86 -165.54 33.36 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.962 -1.255 . . . . 0.02 109.962 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -69.83 143.59 52.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.02 108.94 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 58' ' ' MET . 16.6 mt-30 -113.08 149.5 33.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.02 110.085 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.87 133.61 53.01 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.92 121.58 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.944 -1.098 . . . . 0.01 109.785 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.7 mp -98.31 142.32 30.1 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.72 -0.845 . . . . 0.01 108.72 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 154' ' ' LYS . 95.1 m-20 -110.26 -172.55 2.06 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.445 -0.784 . . . . 2.27 109.739 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -71.64 37.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.636 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 152' ' ' ASP . 30.6 mmtp -112.31 168.74 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.413 -0.804 . . . . 2.2799999999999998 109.3 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -104.34 127.0 51.92 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.039 -1.097 . . . . 0.01 108.039 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 54.8 m-85 -99.58 112.47 24.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.928 . . . . 0.01 110.258 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.444 ' O ' ' OG ' ' A' ' 128' ' ' SER . 78.7 mtt180 -89.31 -27.39 20.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.632 -0.667 . . . . 0.01 110.845 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -124.43 152.82 68.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 108.134 -1.062 . . . . 2.54 108.134 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 7.8 Cg_endo -60.83 -40.25 55.37 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 CA-C-N 119.437 0.835 . . . . 0.69999999999999996 111.005 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.49 -18.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 120.724 -1.235 . . . . 0.85999999999999999 109.67 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 156' ' ' TYR . 39.2 t70 -65.4 -17.6 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.91 -1.119 . . . . 0.02 112.062 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.17 16.7 24.59 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 120.733 -1.23 . . . . 0.02 110.229 178.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.02 77.68 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.174 -0.954 . . . . 0.02 112.874 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -99.11 139.81 34.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.85 -1.382 . . . . 0.02 110.146 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.67 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.58999999999999997 109.342 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 p -138.92 151.77 68.91 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.87 109.261 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.77 13.58 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.756 0.971 . . . . 0.38 111.892 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.55 119.62 24.0 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.603 1.192 . . . . 0.17999999999999999 111.039 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.508 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 0.9 OUTLIER -150.55 121.93 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.013 -1.847 . . . . 3.9900000000000002 106.013 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.507 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 11.0 mp0 -113.69 -11.57 12.93 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 113.253 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -156.46 159.01 38.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.119 -2.238 . . . . 0.02 110.45 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.443 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 25.3 p90 -152.79 154.34 34.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.029 -1.044 . . . . 2.02 110.3 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -144.21 149.88 37.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 0.01 110.125 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -87.05 141.97 28.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.311 -0.996 . . . . 0.01 108.311 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.424 HD11 ' CG1' ' A' ' 137' ' ' ILE . 24.6 mt -93.71 129.54 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.325 -0.859 . . . . 3.04 109.411 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 m -138.28 149.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.351 -0.843 . . . . 1.8899999999999999 109.756 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 4.8899999999999997 109.56 179.474 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.601 0 N-CA-C 107.16 -2.376 . . . . 0.81000000000000005 107.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 149.31 33.31 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.162 -1.018 . . . . 0.01 110.683 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -150.88 136.84 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.496 -1.002 . . . . 0.02 109.493 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.9 140.42 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 109.2 -0.666 . . . . 0.02 109.2 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -122.03 130.23 53.11 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.571 -0.705 . . . . 0.39000000000000001 109.642 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 24.6 m-85 -110.31 140.13 44.8 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.007 -0.738 . . . . 0.02 109.007 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m-85 -121.98 138.45 54.42 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.339 -0.851 . . . . 0.02 109.546 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 66.2 mt-10 -68.14 -27.82 66.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -0.989 . . . . 0.029999999999999999 111.706 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -114.26 170.03 8.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.867 -1.146 . . . . 0.029999999999999999 110.468 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -75.22 158.26 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.498 0.666 . . . . 0.029999999999999999 110.058 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.2 m120 66.2 34.65 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.826 0.822 . . . . 0.73999999999999999 110.767 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.95 45.22 25.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.668 0.746 . . . . 0.02 111.428 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.24 165.88 11.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.66 -167.71 35.43 Favored Glycine 0 N--CA 1.496 2.674 0 O-C-N 120.793 -1.192 . . . . 0.029999999999999999 110.912 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -68.61 142.74 55.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.45 -1.03 . . . . 2.7599999999999998 109.279 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -120.02 148.65 43.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.597 -0.69 . . . . 1.8899999999999999 110.23 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -132.33 127.06 34.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.257 -1.016 . . . . 0.02 108.257 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -111.81 136.51 50.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.483 -0.761 . . . . 1.1200000000000001 109.762 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -130.91 138.02 49.58 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.573 0.701 . . . . 0.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -116.47 11.29 14.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.623 -0.673 . . . . 0.20000000000000001 109.477 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 19.9 p -157.79 174.15 15.73 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.195 -1.039 . . . . 1.23 108.195 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 19.3 p30 -61.11 144.66 53.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.72 -1.238 . . . . 0.02 109.955 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 t -131.76 116.53 17.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.415 -0.957 . . . . 0.02 108.415 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.59 52.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.23999999999999999 110.733 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -156.58 100.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.676 -0.861 . . . . 1.1399999999999999 108.676 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -104.89 10.46 34.33 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 122.175 0.988 . . . . 6.3700000000000001 109.799 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.4 mmp_? -59.27 -23.44 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.68 -0.638 . . . . 3.1099999999999999 111.018 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 p -75.5 -17.0 60.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.685 -1.259 . . . . 0.88 110.185 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 26.2 m-85 -104.26 -21.74 13.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.495 -0.753 . . . . 0.02 109.132 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.6 tp -148.53 126.42 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 3.3199999999999998 109.41 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 m -86.29 -11.54 51.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.463 -0.773 . . . . 0.02 111.405 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.2 tpp180 -170.65 160.39 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.697 -1.223 . . . . 0.02 107.697 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -140.89 114.61 8.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.897 -1.127 . . . . 0.02 109.455 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 11' ' ' GLU . 2.7 m120 -108.2 -0.96 20.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.535 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.6 m -155.7 153.59 30.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.1 mt -145.14 146.91 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 0.02 110.063 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -123.11 123.92 41.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.78 -1.193 . . . . 0.02 107.78 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 38.3 t -106.52 114.17 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -84.0 -33.74 24.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.234 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.46 18.0 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.109 -1.519 . . . . 0.02 110.048 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 173.41 49.72 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.487 -1.34 . . . . 0.01 110.04 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.2 m -120.39 138.03 53.98 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.107 -1.072 . . . . 1.48 108.107 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -126.99 154.43 44.62 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.559 1.171 . . . . 0.02 112.057 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.54 133.57 51.81 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 104.938 -2.245 . . . . 0.23999999999999999 104.938 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.1 m -116.7 141.42 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.178 -0.675 . . . . 0.65000000000000002 109.178 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.06 144.18 48.68 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.184 0.992 . . . . 0.02 109.706 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.36 -34.51 78.32 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.339 -0.846 . . . . 0.02 111.459 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -124.09 157.81 62.68 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.238 -0.914 . . . . 0.02 109.328 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.67 167.52 0.97 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.762 1.641 . . . . 0.02 112.563 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 2.0 t30 63.27 37.12 11.31 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.457 -0.792 . . . . 0.02 111.211 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 1.8 m-85 45.35 51.26 9.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.613 -0.679 . . . . 3.3900000000000001 110.819 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -125.75 163.91 21.82 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.153 0.501 . . . . 2.3300000000000001 109.994 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -162.01 31.53 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.715 -1.354 . . . . 0.02 109.715 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -65.57 137.25 57.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.332 . . . . 0.02 109.806 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.468 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.4 ptm -117.66 136.35 53.38 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.487 0.66 . . . . 5.0099999999999998 109.692 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -133.62 139.87 46.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.484 -0.76 . . . . 0.02 109.49 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.7 132.03 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.487 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.5 mt -122.25 109.42 33.28 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.57 -0.706 . . . . 0.02 110.206 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -75.49 170.64 19.83 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.893 0.998 . . . . 1.47 110.352 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 11.6 tm0? -51.83 140.26 19.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 4.25 109.862 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 155.53 -177.79 32.49 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.486 -1.34 . . . . 0.02 110.565 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -120.63 131.3 54.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.516 -0.991 . . . . 0.95999999999999996 109.305 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 64.8 m-85 -122.42 93.56 48.4 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.866 -1.161 . . . . 0.02 107.866 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.06 -3.68 7.61 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.034 1.156 . . . . 0.02 113.92 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -156.87 152.95 27.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.379 -1.451 . . . . 2.02 107.91 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -60.07 -38.7 83.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.612 -0.68 . . . . 0.02 111.977 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.5 -24.85 65.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.972 . . . . 0.02 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -17.98 63.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 3.4199999999999999 108.999 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.89 12.06 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.277 -1.379 . . . . 0.02 107.277 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.2 mtp 60.2 21.85 11.2 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.528 0.68 . . . . 0.02 110.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.92 144.65 46.44 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.386 -1.486 . . . . 0.02 109.386 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.24 -30.45 43.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.549 -1.278 . . . . 0.97999999999999998 107.549 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 13.6 t-20 -156.98 -171.92 3.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.397 -1.705 . . . . 0.02 106.397 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 30.6 p-10 -98.58 27.93 4.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.66 -1.275 . . . . 0.02 110.208 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -96.0 122.55 38.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.848 -1.157 . . . . 3.2000000000000002 110.638 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 48' ' ' VAL . 51.3 mt -143.48 121.48 12.08 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.808 -1.182 . . . . 2.6099999999999999 107.808 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.11 -17.71 9.31 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 121.26 -0.9 . . . . 0.02 112.641 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 5.1 t -155.53 155.77 33.99 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.043 -1.857 . . . . 0.02 110.867 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.9 p -145.5 147.72 32.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.02 110.653 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 13.8 mtp180 -136.67 141.83 43.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.01 109.288 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 130.35 36.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.451 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 t -90.18 123.55 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.608 -0.886 . . . . 1.25 108.608 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -90.3 135.41 33.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 1.77 108.703 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -99.65 138.66 36.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.729 -0.841 . . . . 1.6299999999999999 108.729 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 p -113.2 125.67 54.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.942 -0.762 . . . . 1.0800000000000001 108.942 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.0 t -102.79 -155.4 0.52 Allowed 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 105.992 -1.855 . . . . 1.26 105.992 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.74 -47.35 0.95 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 120.356 -1.465 . . . . 0.01 112.345 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.53 -98.86 0.12 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.433 -1.841 . . . . 0.01 112.181 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -119.56 117.97 29.78 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.222 -1.163 . . . . 4.4299999999999997 110.317 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.0 132.1 39.96 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.304 -0.628 . . . . 2.9900000000000002 109.304 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.438 ' HB2' HE22 ' A' ' 92' ' ' GLN . 7.2 ttpm? -131.01 137.42 49.19 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.028 -0.73 . . . . 6.3600000000000003 109.028 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 110' ' ' THR . 5.6 tt -125.22 142.61 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.874 0.845 . . . . 1.0900000000000001 109.139 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' CG ' ' O ' ' A' ' 130' ' ' LYS . 11.0 pt20 -124.77 132.26 53.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.744 -1.206 . . . . 2.0499999999999998 107.744 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.06 148.15 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 120.919 -1.113 . . . . 1.1000000000000001 109.659 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -117.97 140.96 48.99 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.042 0.925 . . . . 0.72999999999999998 110.849 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.59 -30.12 70.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.938 -0.574 . . . . 0.02 111.765 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 128' ' ' SER . 83.3 mttt -116.57 168.4 10.21 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.983 -1.073 . . . . 3.1800000000000002 110.49 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.21 164.59 44.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 56.71 39.18 29.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.635 0.731 . . . . 0.01 111.117 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.53 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.5 m-85 52.53 55.68 8.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.583 -0.698 . . . . 0.01 111.076 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -129.65 166.32 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.515 -0.92 . . . . 3.1499999999999999 108.515 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.79 -164.71 27.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.277 -1.529 . . . . 0.01 109.277 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.26 145.11 42.17 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.009 -1.289 . . . . 0.01 108.619 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.484 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 9.9 tmm? -116.51 141.72 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.633 0.73 . . . . 0.01 109.772 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.484 ' N ' ' SD ' ' A' ' 107' ' ' MET . 59.8 m-85 -130.32 135.17 47.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.888 -1.153 . . . . 2.48 107.888 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -121.32 135.01 55.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.727 -0.608 . . . . 0.01 109.809 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.5 t -149.55 153.63 37.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.242 1.02 . . . . 1.6899999999999999 110.786 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.405 HG22 ' OE1' ' A' ' 92' ' ' GLN . 34.9 p -110.43 9.41 23.38 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.646 -0.706 . . . . 0.01 109.933 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -121.39 163.07 19.3 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.381 -0.824 . . . . 3.21 111.384 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.32 155.0 38.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.193 -1.04 . . . . 0.01 108.193 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 29.4 t -124.15 111.42 28.63 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.77 -31.86 4.97 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 CA-C-N 120.134 1.084 . . . . 0.01 111.554 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -141.6 108.33 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.22 -0.925 . . . . 0.02 108.959 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.8 mt -62.97 -38.75 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.853 -0.529 . . . . 1.8300000000000001 110.408 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 30.9 ttm -66.5 -37.26 84.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.12 -1.032 . . . . 1.3400000000000001 109.831 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -70.91 -39.34 72.78 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.44 -1.412 . . . . 2.1099999999999999 109.69 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.85 -48.2 12.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 2.0800000000000001 112.679 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.95 -1.79 15.33 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.376 -0.828 . . . . 0.02 112.491 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 61.23 33.84 18.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.873 -1.142 . . . . 0.02 109.589 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.6 mt -114.02 135.44 54.0 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.413 -0.804 . . . . 0.02 109.195 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 9.3 ptp180 -90.68 -21.7 21.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.126 -0.984 . . . . 5.3200000000000003 111.276 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 47.9 mt-10 -149.41 164.97 33.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.721 -1.237 . . . . 0.02 110.668 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 11.8 mm -127.66 123.81 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.726 -1.213 . . . . 2.1699999999999999 107.726 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -109.11 -14.78 14.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.11 -0.994 . . . . 0.02 112.642 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.53 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 23.6 p -160.91 153.71 21.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.572 -1.33 . . . . 0.01 108.941 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.8 t -167.0 141.02 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.628 -0.878 . . . . 1.22 108.628 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.538 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -121.26 97.4 5.5 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.133 -1.062 . . . . 1.4099999999999999 108.133 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.9 p . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.396 -0.965 . . . . 0.01 108.396 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.678 ' CD1' HG21 ' A' ' 131' ' ' VAL . 81.9 m95 . . . . . 0 N--CA 1.509 2.508 0 CA-C-O 121.127 0.489 . . . . 0.01 110.318 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.72 136.21 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.304 -0.998 . . . . 1.6899999999999999 108.304 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -112.58 142.36 45.25 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.67 -1.604 . . . . 2.4900000000000002 106.67 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 20.3 m-85 -123.42 145.99 48.36 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.161 -0.962 . . . . 0.02 110.081 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.04 -31.19 61.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.02 111.465 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.7 mt -115.6 155.75 46.99 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.68 -1.263 . . . . 1.48 108.985 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -57.44 167.53 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.101 1.201 . . . . 0.02 112.741 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 59.4 31.44 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.192 -0.913 . . . . 0.75 111.325 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.88 51.77 8.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.5 -0.75 . . . . 0.02 110.952 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.49 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.36 164.82 20.23 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.51 -0.744 . . . . 0.02 109.791 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.425 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.55 -165.62 33.9 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.279 -1.129 . . . . 0.02 110.279 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.58 142.36 53.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.499 -1.001 . . . . 0.02 108.825 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 58' ' ' MET . 14.9 mt-30 -113.06 148.14 35.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.34 0.591 . . . . 0.02 109.826 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -122.86 132.66 54.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.436 -0.95 . . . . 0.01 108.436 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.36 121.56 37.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.933 -1.105 . . . . 0.01 109.702 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.03 161.22 13.92 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.796 -1.187 . . . . 0.01 107.796 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.38 -110.46 0.34 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.413 -0.805 . . . . 2.27 109.801 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -151.16 31.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 1.8400000000000001 109.03 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -109.73 -165.42 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.974 -0.75 . . . . 2.2799999999999998 108.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 2.7 mm-40 -106.26 118.37 36.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.517 -0.739 . . . . 0.01 109.419 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.4 113.13 24.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -90.09 -27.4 19.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.487 -0.758 . . . . 0.01 111.625 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -127.0 156.26 74.52 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.738 -1.226 . . . . 2.54 108.064 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.14 -38.84 53.11 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.51 0.807 . . . . 0.69999999999999996 111.282 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.48 -19.39 18.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.856 -1.152 . . . . 0.85999999999999999 109.914 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.76 -18.32 65.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.823 -1.173 . . . . 0.02 112.111 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.36 16.28 26.1 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.722 -1.236 . . . . 0.02 110.191 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.25 10.69 77.25 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.104 -0.998 . . . . 0.02 112.806 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.52 140.57 34.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.861 -1.376 . . . . 0.02 110.303 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.6 -7.95 58.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.696 -0.628 . . . . 0.58999999999999997 109.715 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 p -140.67 150.85 61.59 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.227 -0.92 . . . . 0.87 109.33 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.59 14.48 1.21 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.903 1.068 . . . . 0.38 112.304 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -81.7 121.28 26.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.891 -1.13 . . . . 0.17999999999999999 111.231 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.5 mp -153.1 124.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.469 -1.678 . . . . 3.9900000000000002 106.469 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -114.15 -8.72 12.97 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.425 -0.797 . . . . 5.1699999999999999 113.143 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 p -157.22 158.69 36.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.359 -2.088 . . . . 0.02 109.448 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -152.82 154.21 34.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -0.886 . . . . 2.02 110.147 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -144.48 150.34 37.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.265 -0.897 . . . . 0.01 110.296 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.4 ptt180 -87.52 142.71 27.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.703 -0.851 . . . . 0.01 108.703 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 175' ' ' ILE . 3.3 mt -94.46 128.61 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.311 -0.868 . . . . 3.04 109.329 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.11 148.47 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.127 -0.983 . . . . 1.8899999999999999 110.009 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.45 -0.781 . . . . 4.8899999999999997 109.435 179.569 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.593 0 N-CA-C 107.095 -2.402 . . . . 0.81000000000000005 107.095 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.06 148.88 33.59 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.174 -1.012 . . . . 0.01 110.625 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -150.72 136.72 18.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.979 . . . . 0.02 109.077 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.71 140.42 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.897 -0.779 . . . . 0.02 108.897 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.88 129.97 52.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.483 -0.76 . . . . 0.39000000000000001 109.644 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 7.7 m-85 -109.68 139.96 44.1 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.572 -0.899 . . . . 0.02 108.572 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.9 m-85 -122.05 138.67 54.35 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.229 -0.92 . . . . 0.02 109.646 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.485 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.23 -27.67 66.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.919 -1.113 . . . . 0.029999999999999999 111.736 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.63 170.4 8.34 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.869 -1.144 . . . . 0.029999999999999999 110.11 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -75.39 161.34 29.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.738 0.78 . . . . 0.029999999999999999 110.217 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 m120 63.04 34.95 13.43 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.933 0.873 . . . . 0.73999999999999999 110.433 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p90 49.51 42.52 22.89 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.39 -0.823 . . . . 0.02 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -109.11 166.07 11.12 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.34 -168.14 34.76 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 120.739 -1.225 . . . . 0.029999999999999999 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -70.05 145.3 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.474 -1.016 . . . . 2.7599999999999998 109.098 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -120.4 149.24 42.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.594 -0.692 . . . . 1.8899999999999999 110.272 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -132.07 126.99 35.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.942 -1.133 . . . . 0.02 107.942 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.33 136.7 51.46 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 110.02 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -131.14 137.96 49.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.56 0.695 . . . . 0.02 109.471 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -116.59 10.7 14.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.672 -0.643 . . . . 0.20000000000000001 109.503 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.8 t -157.71 173.84 16.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.134 -1.061 . . . . 1.23 108.134 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -60.85 144.29 53.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.683 -1.261 . . . . 0.02 110.087 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.52 116.9 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.438 -0.949 . . . . 0.02 108.438 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.89 52.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.192 -0.942 . . . . 0.23999999999999999 110.537 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -153.48 100.61 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 1.1399999999999999 108.701 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -104.21 9.21 36.21 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.285 1.04 . . . . 6.3700000000000001 109.39 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -58.68 -24.03 60.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.741 . . . . 3.1099999999999999 110.571 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 m -74.39 -16.84 60.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.16 . . . . 0.88 110.057 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.66 -22.14 13.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.357 -0.84 . . . . 0.02 109.272 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.06 128.47 12.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 3.3199999999999998 109.014 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.1 p -85.33 -9.87 57.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.689 -0.632 . . . . 0.02 110.964 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.91 163.01 6.17 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -142.7 115.51 8.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.873 -1.142 . . . . 0.02 108.709 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.64 0.91 20.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.854 -1.154 . . . . 0.029999999999999999 110.601 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 t -156.67 153.45 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.6 mt -145.12 148.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.013 -1.054 . . . . 0.02 109.969 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -124.7 124.69 42.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.348 -1.353 . . . . 0.02 107.348 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.46 114.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.099 -1.445 . . . . 0.02 107.099 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.61 -34.47 25.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 3.8100000000000001 109.855 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.28 17.53 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 118.698 -1.715 . . . . 0.02 110.433 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.96 173.26 49.66 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.547 -1.311 . . . . 0.01 110.23 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -120.01 136.13 54.67 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.806 -1.183 . . . . 1.48 107.806 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.5 m95 -125.17 154.5 41.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.518 1.152 . . . . 0.02 112.159 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.12 133.44 52.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 104.964 -2.235 . . . . 0.23999999999999999 104.964 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.23 141.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.58 143.56 48.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.261 1.029 . . . . 0.02 109.224 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.525 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 8.1 tp10 -66.1 -35.23 79.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.359 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 50' ' ' GLU . 10.4 mpt_? -122.75 158.05 58.02 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 121.114 -0.991 . . . . 0.02 109.402 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -54.51 166.7 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.46 1.44 . . . . 0.02 112.567 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 63.12 37.36 11.5 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.382 -0.827 . . . . 0.02 111.173 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 44.67 52.57 7.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.674 0.749 . . . . 3.3900000000000001 110.773 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -126.4 163.75 22.61 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.114 0.483 . . . . 2.3300000000000001 109.705 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.4 -161.62 32.73 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.719 -1.352 . . . . 0.02 109.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -66.22 137.54 57.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.313 . . . . 0.02 110.139 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.2 ptm -121.27 136.53 54.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.664 -0.648 . . . . 5.0099999999999998 109.482 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.4 m-85 -133.32 142.03 48.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.717 . . . . 0.02 109.418 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 mm -96.14 132.56 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.127 -0.694 . . . . 1.72 109.127 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -121.73 109.69 34.04 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.481 -0.762 . . . . 0.02 110.391 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -75.81 169.78 21.51 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.033 1.048 . . . . 1.47 110.403 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -53.06 140.18 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.908 -1.12 . . . . 4.25 110.572 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.18 -177.23 32.52 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.614 -1.279 . . . . 0.02 110.386 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -118.98 129.94 55.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.471 -1.017 . . . . 0.95999999999999996 109.413 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 46.0 m-85 -120.82 95.48 48.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.32 -3.9 10.81 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 120.682 0.921 . . . . 0.02 113.666 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -156.82 154.28 29.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 2.02 108.254 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.37 -38.57 84.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.582 -0.699 . . . . 0.02 111.654 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.63 -24.54 65.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.028 -1.045 . . . . 0.02 110.336 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.68 -18.23 64.23 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.956 0.884 . . . . 3.4199999999999999 108.831 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.657 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.64 11.86 28.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.333 -1.358 . . . . 0.02 107.333 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.5 mpt? 59.49 22.78 11.35 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.504 0.669 . . . . 0.02 110.243 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 146.35 46.62 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.253 -1.539 . . . . 0.02 109.253 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.568 ' HG ' HD21 ' A' ' 76' ' ' ASN . 29.8 tp -79.63 -30.63 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.97999999999999998 108.013 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.568 HD21 ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -157.65 -170.89 3.36 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.64 27.85 4.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.776 -1.203 . . . . 0.02 110.436 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -96.31 122.5 39.25 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.081 -1.012 . . . . 3.2000000000000002 110.0 -178.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD21 ' CH2' ' A' ' 72' ' ' TRP . 62.5 mt -143.5 122.66 12.93 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.957 -1.127 . . . . 2.6099999999999999 107.957 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA3' HH12 ' A' ' 78' ' ' ARG . . . -109.98 -17.82 9.3 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.168 -0.957 . . . . 0.02 112.732 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 t -156.1 156.1 33.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 119.978 -1.896 . . . . 0.02 110.857 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.2 t -145.47 147.54 32.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.02 110.254 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -135.64 140.8 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.921 -0.77 . . . . 0.01 108.921 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.96 132.29 37.8 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.092 -1.005 . . . . 0.42999999999999999 108.679 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.29 124.14 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.438 -0.949 . . . . 1.25 108.438 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.41 134.66 34.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.104 -0.998 . . . . 1.77 108.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.6 137.97 35.72 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.456 -0.942 . . . . 1.6299999999999999 108.456 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -110.9 125.65 53.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.483 -0.932 . . . . 1.0800000000000001 108.483 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -103.28 -155.0 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.59 -48.53 0.92 Allowed Glycine 0 N--CA 1.498 2.809 0 O-C-N 120.458 -1.401 . . . . 0.01 112.055 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.38 -99.33 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.592 -1.766 . . . . 0.01 112.187 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.29 120.12 33.14 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.402 -1.057 . . . . 4.4299999999999997 110.653 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.37 129.83 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.914 -0.714 . . . . 2.9900000000000002 109.142 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -131.48 139.53 49.35 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 6.3600000000000003 109.334 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.83 145.58 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.389 -0.819 . . . . 1.0900000000000001 109.85 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.02 133.63 55.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.284 -1.376 . . . . 2.0499999999999998 107.284 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.68 147.11 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.852 -1.155 . . . . 1.1000000000000001 109.419 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.3 m-85 -119.3 141.61 48.84 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.055 0.931 . . . . 0.72999999999999998 111.07 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -66.27 -29.85 70.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.919 -0.582 . . . . 0.02 111.589 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.54 168.08 10.49 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.933 -1.105 . . . . 3.1800000000000002 110.696 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.07 42.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.989 -0.844 . . . . 0.01 110.989 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t0 56.56 39.47 29.85 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.65 0.738 . . . . 0.01 110.951 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.2 m-85 52.49 55.36 9.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.688 -0.633 . . . . 0.01 111.038 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -128.63 165.81 20.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.468 -0.938 . . . . 3.1499999999999999 108.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.11 -164.94 27.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.23 -1.548 . . . . 0.01 109.23 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.53 144.57 44.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.951 -1.323 . . . . 0.01 108.3 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 24.2 ttp -116.53 142.27 47.1 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.554 0.692 . . . . 0.01 109.804 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -131.56 136.0 47.48 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.05 -1.093 . . . . 2.48 108.05 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.8 tm-20 -120.25 135.35 55.02 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.446 -0.784 . . . . 0.01 110.145 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.534 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -149.2 151.64 34.64 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.277 1.037 . . . . 1.6899999999999999 111.0 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.3 p -110.73 9.39 22.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.606 -0.725 . . . . 0.01 110.009 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -121.1 163.32 18.58 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.291 -0.881 . . . . 3.21 111.366 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.02 155.29 39.02 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 171' ' ' SER . 34.9 t -125.44 113.67 25.56 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.752 -0.832 . . . . 0.01 108.752 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.33 -29.08 8.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.388 1.174 . . . . 0.01 111.278 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.1 t -142.53 109.88 5.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 0.02 109.359 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.0 mt -61.99 -39.62 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 122.003 -0.435 . . . . 1.8300000000000001 110.149 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.44 -37.37 80.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.425 -0.91 . . . . 1.3400000000000001 110.447 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -70.44 -39.37 74.38 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.908 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.458 ' CD ' ' CZ ' ' A' ' 121' ' ' PHE . 63.6 tt0 -79.46 -47.67 15.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.0800000000000001 112.428 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.458 ' CZ ' ' CD ' ' A' ' 120' ' ' GLN . 28.2 m-85 -110.8 0.52 17.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.434 -0.791 . . . . 0.02 112.628 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.1 m80 60.63 33.19 20.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.682 -1.261 . . . . 0.02 109.507 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -113.51 135.23 54.12 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.749 -0.834 . . . . 0.02 108.749 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.62 -21.56 22.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.378 -0.826 . . . . 5.3200000000000003 110.276 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -150.76 165.87 32.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.135 -0.978 . . . . 0.02 109.992 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.73 128.63 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.212 -1.403 . . . . 2.1699999999999999 107.212 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -108.89 -12.44 14.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.539 -0.726 . . . . 0.02 112.256 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.484 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 10.1 t -159.51 152.72 22.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.01 108.555 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.8 p -163.41 145.87 9.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 1.22 109.665 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -116.61 102.93 9.89 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.701 -1.249 . . . . 1.4099999999999999 108.591 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 131' ' ' VAL . 4.3 p . . . . . 0 C--N 1.299 -1.595 0 N-CA-C 107.604 -1.258 . . . . 0.01 107.604 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.511 2.616 0 CA-C-O 121.638 0.732 . . . . 0.01 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -120.13 137.45 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.322 -0.992 . . . . 1.6899999999999999 108.322 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CG ' HD11 ' A' ' 151' ' ' LEU . 3.3 m-30 -111.3 142.03 44.06 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 106.827 -1.546 . . . . 2.4900000000000002 106.827 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.7 m-85 -123.37 143.76 49.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.044 -1.035 . . . . 0.02 109.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.0 -31.24 62.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.796 -0.565 . . . . 0.02 111.854 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.28 155.36 47.01 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.67 -1.269 . . . . 1.48 108.899 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -57.22 166.66 4.11 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.186 1.257 . . . . 0.02 112.832 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.77 31.26 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.2 -0.909 . . . . 0.75 111.386 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.1 m-85 58.11 52.23 7.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.629 -0.669 . . . . 0.02 111.327 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.49 165.15 19.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.529 -0.732 . . . . 0.02 109.954 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.96 -165.34 34.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -69.06 141.55 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.531 -0.982 . . . . 0.02 108.723 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.499 ' O ' ' CG ' ' A' ' 58' ' ' MET . 11.9 mt-30 -113.86 150.12 34.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.543 -0.539 . . . . 0.02 109.543 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.76 132.91 53.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.567 -0.901 . . . . 0.01 108.567 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.93 120.24 34.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.21 . . . . 0.01 108.892 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 138' ' ' PHE . 10.4 mt -102.48 140.22 37.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 154' ' ' LYS . 27.8 m-20 -108.5 -163.27 0.87 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.53 -0.731 . . . . 2.27 109.474 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -75.12 40.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 1.8400000000000001 109.588 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 152' ' ' ASP . 18.6 ttmt -113.55 162.25 16.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.622 -0.674 . . . . 2.2799999999999998 109.413 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 3.3 mp0 -103.32 130.43 50.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.899 -1.148 . . . . 0.01 107.899 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 49.1 m-85 -102.5 112.11 24.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.01 110.515 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -90.06 -27.13 19.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.01 110.432 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -123.77 153.91 66.98 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 107.63 -1.248 . . . . 2.54 107.63 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.05 -41.47 35.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 CA-C-N 119.202 0.751 . . . . 0.69999999999999996 111.047 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.35 -18.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 120.812 -1.18 . . . . 0.85999999999999999 109.389 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.55 -18.87 65.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.808 -1.182 . . . . 0.02 112.029 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.08 15.92 27.12 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 120.705 -1.247 . . . . 0.02 110.311 178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.82 75.82 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.192 -0.942 . . . . 0.02 112.91 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.87 140.35 35.28 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.862 -1.375 . . . . 0.02 110.124 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -6.94 59.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.58999999999999997 109.574 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.2 m -139.43 151.18 66.28 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.19 -0.944 . . . . 0.87 109.548 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.515 ' O ' HD12 ' A' ' 169' ' ' ILE . 35.3 Cg_endo -75.34 14.72 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.934 1.089 . . . . 0.38 112.173 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.9 122.1 28.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.17999999999999999 111.794 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 167' ' ' PRO . 4.1 mp -147.6 127.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.112 -1.81 . . . . 3.9900000000000002 106.112 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -110.68 -14.26 14.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.308 -0.87 . . . . 5.1699999999999999 112.675 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 11.6 t -156.59 158.7 37.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.389 -2.07 . . . . 0.02 110.068 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -150.38 151.9 33.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.192 -0.942 . . . . 2.02 109.889 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.511 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.5 mtp180 -143.87 150.3 38.23 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.173 -0.955 . . . . 0.01 110.543 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.75 143.32 27.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.423 -0.954 . . . . 0.01 108.423 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 175' ' ' ILE . 2.6 mt -96.68 129.97 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.404 -0.81 . . . . 3.04 109.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 177' ' ' GLU . 57.5 t -137.24 148.26 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 1.8899999999999999 109.336 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 176' ' ' VAL . 1.4 pp20? . . . . . 0 N--CA 1.505 2.282 0 CA-C-O 121.244 0.545 . . . . 4.8899999999999997 111.327 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 107.003 -2.439 . . . . 0.81000000000000005 107.003 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.36 148.14 32.25 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.595 -1.002 . . . . 0.01 110.595 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -153.77 138.33 16.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.557 -0.967 . . . . 0.02 108.72 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.18 141.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.163 -0.68 . . . . 0.02 109.163 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -121.9 130.22 53.18 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 0.39000000000000001 109.559 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 13.8 m-85 -109.44 139.08 44.87 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.742 -0.836 . . . . 0.02 108.742 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -122.42 138.79 54.42 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.187 -0.946 . . . . 0.02 109.625 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 33' ' ' LEU . 83.1 mt-10 -68.36 -27.2 66.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.029999999999999999 111.839 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.48 169.47 9.02 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.847 -1.158 . . . . 0.029999999999999999 110.138 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.57 158.67 32.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.611 0.72 . . . . 0.029999999999999999 110.064 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.4 35.04 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.858 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 20.5 p90 50.0 43.88 25.52 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.602 -0.726 . . . . 0.02 111.312 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -112.09 166.39 11.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.031 -1.1 . . . . 0.02 108.031 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -168.06 36.24 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.728 -1.225 . . . . 0.029999999999999999 110.82 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -69.15 143.62 54.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.423 -1.045 . . . . 2.7599999999999998 108.978 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -119.95 149.09 42.7 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.586 0.707 . . . . 1.8899999999999999 110.035 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -132.19 127.16 35.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.991 -1.115 . . . . 0.02 107.991 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 11.4 p30 -111.59 135.84 51.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.603 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.3 t -129.99 137.53 50.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.472 0.653 . . . . 0.02 109.474 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.69 11.47 14.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.722 -0.612 . . . . 0.20000000000000001 109.535 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -157.88 174.07 15.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -61.71 145.4 52.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.709 -1.244 . . . . 0.02 109.984 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.3 t -131.72 116.59 17.5 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.635 -0.876 . . . . 0.02 108.635 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.6 -24.15 53.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.23999999999999999 110.675 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.76 100.84 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.54 -0.911 . . . . 1.1399999999999999 108.54 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -104.32 9.66 35.8 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.165 0.983 . . . . 6.3700000000000001 109.867 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.565 ' NH2' ' CZ ' ' A' ' 51' ' ' ARG . 90.1 mtt180 -59.25 -22.84 61.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.585 -0.697 . . . . 3.1099999999999999 110.857 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -75.9 -16.85 59.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.88 110.227 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.63 -22.12 13.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.445 -0.784 . . . . 0.02 109.307 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 36' ' ' CYS . 6.0 tp -150.55 128.94 12.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.331 -0.856 . . . . 3.3199999999999998 108.813 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.5 p -86.53 -10.86 53.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.796 -0.565 . . . . 0.02 111.286 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -171.14 161.67 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.02 108.021 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.9 m -142.31 115.27 8.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.938 -1.101 . . . . 0.02 109.378 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -106.73 -0.67 23.37 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.224 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -157.05 154.58 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.747 -1.205 . . . . 0.02 107.747 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -144.77 148.54 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -0.999 . . . . 0.02 109.2 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -123.65 123.9 41.58 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.154 -1.424 . . . . 0.02 107.154 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -105.33 114.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.845 -1.539 . . . . 0.02 106.845 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -84.21 -33.96 24.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.462 -0.773 . . . . 3.8100000000000001 109.569 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.79 18.54 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.649 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.4 173.69 49.95 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.726 -1.226 . . . . 0.01 110.407 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.2 m -118.9 136.13 54.22 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.822 -1.177 . . . . 1.48 107.822 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -124.6 152.67 43.27 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.851 -1.156 . . . . 0.02 112.103 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.45 133.6 52.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.007 -2.22 . . . . 0.23999999999999999 105.007 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.5 m -116.46 141.7 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.026 -0.731 . . . . 0.65000000000000002 109.026 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.5 m-85 -119.69 142.85 48.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.223 1.011 . . . . 0.02 109.386 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -64.78 -35.85 82.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.334 -0.848 . . . . 0.02 111.303 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.705 HH12 ' NH2' ' A' ' 78' ' ' ARG . 3.7 mmp_? -121.36 153.83 58.86 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.096 -1.002 . . . . 0.02 109.578 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -52.76 167.45 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.371 1.38 . . . . 0.02 112.457 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 64.68 37.24 7.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.746 0.784 . . . . 0.02 111.26 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 46.37 51.02 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.422 0.629 . . . . 3.3900000000000001 111.156 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -127.47 164.62 21.51 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.289 0.566 . . . . 2.3300000000000001 110.306 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.29 -162.68 30.98 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.216 -1.153 . . . . 0.02 110.216 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.627 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 4.9 t60 -63.37 143.04 58.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.11 -1.229 . . . . 0.02 110.347 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.8 mtp -116.49 135.22 54.02 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.291 0.567 . . . . 5.0099999999999998 109.755 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' HIS . 32.9 m-85 -134.84 133.35 39.66 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.405 -0.809 . . . . 0.02 108.958 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.42 131.84 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.578 -0.897 . . . . 1.72 108.578 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -121.21 109.72 34.97 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.517 -0.739 . . . . 0.02 110.21 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.64 169.54 21.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 119.969 1.025 . . . . 1.47 110.369 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.9 140.71 29.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.76 -1.212 . . . . 4.25 110.667 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.83 -175.11 32.25 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.32 . . . . 0.02 110.255 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -116.17 128.12 55.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -1.054 . . . . 0.95999999999999996 108.804 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 37.7 m-85 -119.28 97.99 50.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.101 -1.074 . . . . 0.02 108.101 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 6.5 Cg_endo -69.88 -6.56 18.96 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 120.553 0.835 . . . . 0.02 114.179 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 76.1 mt-10 -157.53 155.47 30.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.215 -1.553 . . . . 2.02 108.417 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 38.8 p90 -60.24 -36.93 78.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.47 -0.769 . . . . 0.02 112.665 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.63 -21.37 60.37 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.182 -0.949 . . . . 0.02 110.061 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -67.51 -19.96 65.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 3.4199999999999999 110.348 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.45 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.8 p90 -110.04 16.04 22.13 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.305 -0.872 . . . . 0.02 108.828 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.6 OUTLIER 65.32 24.98 12.14 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.234 0.54 . . . . 0.02 110.739 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -62.14 145.56 49.33 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.731 -1.347 . . . . 0.02 109.731 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.1 tt -80.51 -30.27 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.646 -1.242 . . . . 0.97999999999999998 107.646 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -155.82 -171.53 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.702 -1.592 . . . . 0.02 106.702 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' CG ' ' A' ' 69' ' ' TYR . 95.8 m-20 -97.89 27.45 4.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.832 -1.168 . . . . 0.02 110.298 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' NH2' HH12 ' A' ' 51' ' ' ARG . 38.2 mtp180 -95.51 122.42 38.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.962 -1.086 . . . . 3.2000000000000002 110.591 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 48' ' ' VAL . 68.9 mt -142.52 120.53 12.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.536 -1.283 . . . . 2.6099999999999999 107.536 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.37 -17.17 10.21 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 121.358 -0.838 . . . . 0.02 112.485 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 11.3 t -156.23 156.42 34.09 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.331 -1.687 . . . . 0.02 110.648 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.1 p -145.05 147.75 32.93 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.691 0.758 . . . . 0.02 110.247 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 15.9 mtp180 -135.63 140.47 44.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.621 -0.881 . . . . 0.01 108.621 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.11 131.26 38.25 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.204 -0.935 . . . . 0.42999999999999999 108.539 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.92 122.88 40.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.41 -0.959 . . . . 1.25 108.41 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -91.03 134.92 34.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.798 -1.189 . . . . 1.77 108.505 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 136.93 38.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.305 -0.998 . . . . 1.6299999999999999 108.305 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -110.96 126.31 54.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.32 -0.863 . . . . 1.0800000000000001 108.673 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.4 m -103.77 -154.65 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.275 -1.75 . . . . 1.26 106.275 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.16 -48.15 0.93 Allowed Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.567 -1.333 . . . . 0.01 112.103 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.63 -99.57 0.13 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.729 -1.701 . . . . 0.01 111.934 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.74 118.91 31.26 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.096 -1.238 . . . . 4.4299999999999997 110.352 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -74.72 130.55 39.69 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.112 -0.699 . . . . 2.9900000000000002 109.112 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -129.28 136.18 49.73 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.882 -0.784 . . . . 6.3600000000000003 108.882 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -127.64 144.07 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.471 -0.768 . . . . 1.0900000000000001 109.326 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.53 133.06 54.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.922 -1.14 . . . . 2.0499999999999998 107.922 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.06 145.89 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.77 -1.206 . . . . 1.1000000000000001 109.384 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.66 140.91 49.16 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.999 0.904 . . . . 0.72999999999999998 110.816 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.41 ' CD ' HH22 ' A' ' 124' ' ' ARG . 4.1 tm-20 -65.85 -30.38 70.98 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.911 -0.586 . . . . 0.02 111.775 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -117.12 169.77 9.18 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.216 1.007 . . . . 3.1800000000000002 110.663 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.34 36.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.723 -0.951 . . . . 0.01 110.723 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.81 38.12 22.38 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.539 0.685 . . . . 0.01 110.739 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.45 53.73 11.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.705 -0.622 . . . . 0.01 110.974 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -125.91 165.89 17.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.53 28.08 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.27 145.05 42.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.983 -1.304 . . . . 0.01 108.482 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.83 142.53 46.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.558 0.694 . . . . 0.01 109.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.414 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.8 m-85 -130.69 135.87 48.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.947 -1.131 . . . . 2.48 107.947 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -119.34 134.42 55.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.01 109.731 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -149.92 151.17 32.97 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.268 1.033 . . . . 1.6899999999999999 110.798 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.4 p -110.35 10.18 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.536 -0.756 . . . . 0.01 109.676 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -121.36 163.05 19.28 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -0.827 . . . . 3.21 111.393 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.76 154.34 39.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.386 -0.968 . . . . 0.01 108.386 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 14.3 t -123.58 110.25 30.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.527 -0.916 . . . . 0.01 108.527 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -77.85 -32.69 2.53 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 119.932 1.012 . . . . 0.01 112.032 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -140.33 108.43 5.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.108 -0.995 . . . . 0.02 109.189 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 mt -63.49 -40.99 91.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.825 -0.547 . . . . 1.8300000000000001 110.656 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.32 -38.48 87.79 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.134 -1.026 . . . . 1.3400000000000001 110.415 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -70.55 -38.82 74.21 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.145 -1.597 . . . . 2.1099999999999999 109.35 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.482 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 49.6 tt0 -80.54 -48.14 13.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 2.0800000000000001 112.45 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.482 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 70.4 m-85 -111.8 -1.83 15.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.261 -0.899 . . . . 0.02 112.661 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.93 35.01 19.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.851 -1.156 . . . . 0.02 109.506 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 mt -114.57 136.42 53.05 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.53 -0.731 . . . . 0.02 109.381 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.61 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.2 -21.11 23.44 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.217 -0.927 . . . . 5.3200000000000003 110.465 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -149.33 165.48 31.85 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.7 -1.25 . . . . 0.02 110.367 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mm -127.42 123.7 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.206 -1.405 . . . . 2.1699999999999999 107.206 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -109.23 -14.09 14.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.158 -0.964 . . . . 0.02 112.467 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.8 t -159.57 151.49 20.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.01 108.763 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 30.0 p -168.6 146.14 3.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.925 . . . . 1.22 108.906 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -122.17 109.12 14.11 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.353 1.073 . . . . 1.4099999999999999 109.228 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 106.868 -1.53 . . . . 0.01 106.868 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.3 m95 . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 107.062 -1.459 . . . . 0.01 107.062 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG13 HD11 ' A' ' 175' ' ' ILE . 32.0 mt -118.81 132.43 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.335 -1.478 . . . . 1.6899999999999999 109.782 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -111.54 141.99 44.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.221 -1.77 . . . . 2.4900000000000002 106.221 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.5 m-85 -123.06 143.34 50.02 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 0.02 109.755 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.84 -30.86 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.754 -0.591 . . . . 0.02 111.563 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.84 154.93 48.24 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.729 -1.232 . . . . 1.48 108.929 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.49 167.09 2.97 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.349 1.366 . . . . 0.02 113.038 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 44.4 t-20 60.0 31.53 20.69 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.116 -0.947 . . . . 0.75 111.363 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.97 51.48 10.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.498 -0.751 . . . . 0.02 111.01 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -126.65 165.29 19.49 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.601 -0.687 . . . . 0.02 109.937 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.47 -165.3 33.79 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.205 -1.158 . . . . 0.02 110.205 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.39 141.5 54.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.509 -0.995 . . . . 0.02 108.837 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -114.59 148.77 37.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.541 -0.541 . . . . 0.02 109.541 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 4.7 m-85 -123.26 134.25 54.11 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.905 -0.776 . . . . 0.01 108.905 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.2 tp -95.93 120.76 36.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.895 -1.128 . . . . 0.01 109.046 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.5 mp -97.69 140.6 31.85 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.74 -0.837 . . . . 0.01 108.74 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 60.1 m-20 -105.01 -170.39 1.75 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.46 -0.775 . . . . 2.27 109.627 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.53 41.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.8400000000000001 109.881 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -113.34 172.56 6.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.482 -0.761 . . . . 2.2799999999999998 109.43 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.6 126.29 51.55 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.509 -0.923 . . . . 0.01 108.509 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 3.2 m-85 -100.68 111.96 24.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.199 -0.938 . . . . 0.01 110.145 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -92.79 -26.75 17.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.01 110.644 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -123.28 153.62 65.21 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.902 -1.147 . . . . 2.54 107.902 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -60.96 -40.52 51.88 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.33 0.797 . . . . 0.69999999999999996 110.962 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.12 -18.62 18.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.046 -1.033 . . . . 0.85999999999999999 109.332 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 52.9 t0 -65.76 -19.0 65.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.11 . . . . 0.02 112.164 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -101.12 15.69 27.88 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 120.655 -1.278 . . . . 0.02 110.143 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 9.7 76.77 Favored Glycine 0 N--CA 1.5 2.903 0 O-C-N 121.177 -0.952 . . . . 0.02 113.149 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.55 141.18 33.77 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.812 -1.405 . . . . 0.02 110.274 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.11 -7.22 59.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.688 -0.633 . . . . 0.58999999999999997 109.598 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.6 p -142.42 150.77 55.88 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.87 109.107 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -75.81 17.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.698 0.932 . . . . 0.38 112.052 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.429 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -82.1 121.63 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.304 1.05 . . . . 0.17999999999999999 111.154 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.8 mp -151.07 125.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.499 -1.667 . . . . 3.9900000000000002 106.499 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -110.84 -13.34 14.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.746 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.16 158.3 37.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 119.378 -2.076 . . . . 0.02 109.91 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.55 153.06 33.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.28 -0.888 . . . . 2.02 109.905 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -142.92 148.75 37.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.835 0.826 . . . . 0.01 110.081 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -86.01 142.17 28.96 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.868 -1.16 . . . . 0.01 107.868 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.503 HD11 HG13 ' A' ' 137' ' ' ILE . 8.5 mt -95.17 128.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 3.04 109.41 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.57 148.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.36 -0.838 . . . . 1.8899999999999999 109.837 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 4.8899999999999997 109.435 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.679 0 N-CA-C 106.871 -2.492 . . . . 0.81000000000000005 106.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.06 32.24 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.315 -0.945 . . . . 0.01 110.904 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -151.86 137.33 17.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.693 -0.886 . . . . 0.02 108.653 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.19 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.368 -0.604 . . . . 0.02 109.368 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -120.71 128.77 53.26 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.793 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.79 137.94 44.91 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.241 -1.022 . . . . 0.02 108.241 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.6 m-85 -122.13 138.25 54.53 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.125 -0.984 . . . . 0.02 109.96 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' HD11 ' A' ' 33' ' ' LEU . 95.0 mt-10 -68.06 -28.26 67.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 0.029999999999999999 111.292 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.02 170.51 8.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.023 -1.048 . . . . 0.029999999999999999 110.305 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.59 161.85 28.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.795 0.807 . . . . 0.029999999999999999 110.604 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 41.3 t-20 62.59 33.6 15.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.03 0.919 . . . . 0.73999999999999999 110.89 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 65' ' ' GLU . 0.3 OUTLIER 55.31 40.31 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.861 -0.609 . . . . 0.02 110.67 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.12 165.21 11.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.219 -1.03 . . . . 0.02 108.219 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.21 -167.74 36.25 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 120.794 -1.191 . . . . 0.029999999999999999 110.759 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -69.21 143.35 54.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -1.003 . . . . 2.7599999999999998 109.541 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.36 149.74 41.87 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.728 0.775 . . . . 1.8899999999999999 109.713 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -132.97 126.84 32.88 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.598 -1.26 . . . . 0.02 107.598 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -111.78 137.61 49.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.46 -0.775 . . . . 1.1200000000000001 109.666 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 138.17 49.1 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.609 0.718 . . . . 0.02 109.387 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -116.98 10.44 14.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.745 -0.597 . . . . 0.20000000000000001 109.47 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -158.09 174.45 15.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.213 -1.032 . . . . 1.23 108.213 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 29.4 t0 -60.99 143.34 55.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.762 -1.212 . . . . 0.02 110.153 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 58.1 m -131.31 116.94 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.02 108.435 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -26.29 51.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.23999999999999999 110.882 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -152.96 101.14 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 108.641 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -104.86 8.75 34.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.143 0.973 . . . . 6.3700000000000001 109.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -58.29 -23.32 55.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.601 -0.687 . . . . 3.1099999999999999 110.626 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 p -74.56 -17.01 60.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.816 -1.178 . . . . 0.88 110.266 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -103.72 -22.42 13.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.467 -0.771 . . . . 0.02 109.333 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.426 HD11 ' HG3' ' A' ' 11' ' ' GLU . 4.9 tp -149.71 128.0 12.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 3.3199999999999998 108.811 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m -86.47 -9.9 55.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.02 110.96 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 77' ' ' ASP . 40.6 ttt180 -171.04 161.41 6.84 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.681 -1.229 . . . . 0.02 107.681 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.9 t -143.28 115.71 8.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.794 -1.191 . . . . 0.02 108.822 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.588 ' ND2' ' CD1' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -108.16 1.42 22.18 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.318 -178.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -156.43 153.52 29.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.509 -1.293 . . . . 0.02 107.509 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -145.44 148.01 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.095 . . . . 0.02 109.895 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -124.54 125.25 43.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.565 -1.272 . . . . 0.02 107.565 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 t -105.48 114.0 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.98 -1.489 . . . . 0.02 106.98 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.573 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 4.8 tm-20 -83.63 -34.29 25.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 109.689 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.06 148.99 16.89 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.611 -1.757 . . . . 0.02 110.569 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.83 173.89 50.02 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.985 -1.246 . . . . 0.01 109.985 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -119.6 135.89 54.61 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.3 m95 -123.41 153.49 40.34 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.537 1.16 . . . . 0.02 112.155 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.6 132.47 53.25 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.02 -2.215 . . . . 0.23999999999999999 105.02 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.26 142.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.931 -0.766 . . . . 0.65000000000000002 108.931 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.433 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 31.8 m-85 -121.56 145.98 47.42 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.272 1.034 . . . . 0.02 109.801 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.29 -34.85 78.25 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.732 -0.667 . . . . 0.02 111.134 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.64 153.52 66.45 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.113 -0.992 . . . . 0.02 109.309 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -51.54 167.68 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.546 1.497 . . . . 0.02 113.249 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 63.79 37.06 10.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.049 -0.978 . . . . 0.02 111.127 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 45.19 50.77 9.47 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.62 0.724 . . . . 3.3900000000000001 110.379 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -125.2 163.59 22.14 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.746 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 -161.85 32.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.488 -1.445 . . . . 0.02 109.488 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -67.59 137.9 56.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.812 -1.405 . . . . 0.02 109.89 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 21.2 ptm -119.14 137.82 53.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.473 0.654 . . . . 5.0099999999999998 109.541 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -132.9 140.07 47.69 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.476 -0.765 . . . . 0.02 109.666 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.47 132.34 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.355 -0.98 . . . . 1.72 108.355 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.56 108.35 39.6 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.508 -0.745 . . . . 0.02 110.329 -178.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -75.2 168.27 25.06 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.044 1.051 . . . . 1.47 110.267 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 59.1 tt0 -53.43 140.03 28.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.834 -1.166 . . . . 4.25 110.487 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.99 -176.75 32.57 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.508 -1.33 . . . . 0.02 110.301 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 15' ' ' PHE . 62.3 tt0 -118.64 130.06 55.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.389 -1.065 . . . . 0.95999999999999996 109.369 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 25.5 m-85 -120.75 92.83 48.36 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.826 -1.176 . . . . 0.02 107.826 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -65.7 -4.87 10.57 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.035 1.157 . . . . 0.02 113.746 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -157.03 153.57 28.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.579 -1.326 . . . . 2.02 107.889 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 70' ' ' GLN . 8.8 p90 -60.59 -37.62 81.97 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.468 -0.77 . . . . 0.02 112.162 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 69' ' ' TYR . 93.8 mm-40 -60.32 -23.68 64.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.942 -1.099 . . . . 0.02 110.661 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.7 62.39 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.898 0.856 . . . . 3.4199999999999999 108.854 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.74 9.91 28.97 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.393 -1.336 . . . . 0.02 107.393 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.7 mtt 61.34 21.89 12.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.652 . . . . 0.02 110.641 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.27 144.47 45.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.182 -1.567 . . . . 0.02 109.182 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.4 tp -79.06 -30.71 44.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.619 -1.252 . . . . 0.97999999999999998 107.619 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 49.6 t30 -157.69 -173.25 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.476 -1.676 . . . . 0.02 106.476 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -98.16 27.41 4.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.843 -1.161 . . . . 0.02 110.215 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.05 122.24 38.67 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.267 -0.896 . . . . 3.2000000000000002 109.954 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.3 mt -144.5 119.52 10.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.586 -1.264 . . . . 2.6099999999999999 107.586 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.96 -16.02 14.86 Favored Glycine 0 N--CA 1.503 3.136 0 C-N-CA 120.525 -0.845 . . . . 0.02 112.395 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -156.47 155.91 32.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.405 -1.644 . . . . 0.02 110.03 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 30.3 p -144.28 147.59 33.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.02 109.491 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -134.53 140.04 45.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.323 -0.861 . . . . 0.01 108.797 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.03 130.96 37.11 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.205 -0.934 . . . . 0.42999999999999999 108.651 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.62 123.34 42.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.96 133.49 35.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.015 . . . . 1.77 108.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.06 139.67 32.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.766 . . . . 1.6299999999999999 109.049 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 t -111.48 125.59 54.06 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.465 -0.939 . . . . 1.0800000000000001 108.465 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 t -102.75 -155.68 0.53 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.282 -1.747 . . . . 1.26 106.282 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.21 -47.88 0.95 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.545 -1.347 . . . . 0.01 112.051 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.34 -98.6 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 118.587 -1.768 . . . . 0.01 112.267 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -122.48 120.89 35.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.394 -1.062 . . . . 4.4299999999999997 110.762 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 174' ' ' ARG . . . -76.82 132.01 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.171 -0.677 . . . . 2.9900000000000002 109.171 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.32 139.24 49.5 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 6.3600000000000003 109.236 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tt -126.54 143.68 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.743 0.783 . . . . 1.0900000000000001 109.645 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -123.74 131.23 53.56 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.649 -1.241 . . . . 2.0499999999999998 107.649 177.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 m -124.31 148.34 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 120.871 -1.143 . . . . 1.1000000000000001 109.671 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -118.68 141.38 48.66 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.041 0.924 . . . . 0.72999999999999998 111.022 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.52 -29.47 69.57 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.747 -0.66 . . . . 0.02 111.446 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -116.39 169.86 8.99 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.092 -1.005 . . . . 3.1800000000000002 110.353 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.8 165.79 50.13 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.073 -0.811 . . . . 0.01 111.073 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 56.38 39.25 30.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.99 -0.712 . . . . 0.01 111.426 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 51.78 54.57 10.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.599 -0.688 . . . . 0.01 111.2 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -129.62 166.4 19.82 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.154 -1.054 . . . . 3.1499999999999999 108.154 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.97 -164.42 28.68 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -75.55 144.94 41.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.938 -1.331 . . . . 0.01 108.714 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.5 tmm? -116.87 142.3 47.1 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.688 0.756 . . . . 0.01 109.972 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.44 ' N ' ' SD ' ' A' ' 107' ' ' MET . 41.8 m-85 -130.39 134.66 47.31 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.7 -1.222 . . . . 2.48 107.7 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -121.42 135.63 55.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.725 -0.609 . . . . 0.01 109.83 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.499 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 9.5 t -150.34 153.1 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.223 1.011 . . . . 1.6899999999999999 110.738 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 p -109.35 10.0 25.58 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.829 -0.623 . . . . 0.01 109.864 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.5 mp0 -121.0 163.3 18.49 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.426 -0.796 . . . . 3.21 111.046 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 155.16 38.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.283 -1.006 . . . . 0.01 108.283 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.86 111.43 29.17 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.64 -0.874 . . . . 0.01 108.64 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.54 -32.86 3.48 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 CA-C-N 120.032 1.047 . . . . 0.01 111.605 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -141.23 107.81 5.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.285 -0.884 . . . . 0.02 108.855 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.53 -38.77 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.838 -0.539 . . . . 1.8300000000000001 110.361 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.5 ttt -66.4 -37.76 85.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.868 -1.133 . . . . 1.3400000000000001 109.873 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -70.27 -39.06 75.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.408 -1.432 . . . . 2.1099999999999999 109.53 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 61.9 tt0 -80.44 -47.05 14.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -0.975 . . . . 2.0800000000000001 112.316 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.406 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.9 m-85 -110.51 -1.68 16.85 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.375 -0.828 . . . . 0.02 112.752 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m170 61.16 33.48 19.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.677 -1.264 . . . . 0.02 109.343 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 mt -114.34 135.39 54.13 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.517 -0.74 . . . . 0.02 109.161 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -89.41 -21.1 23.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.181 -0.949 . . . . 5.3200000000000003 110.763 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 52.0 mt-10 -148.32 163.69 36.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.949 -1.095 . . . . 0.02 110.105 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.3 mm -129.33 126.05 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.202 -1.407 . . . . 2.1699999999999999 107.202 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -109.55 -13.04 14.62 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.353 -0.842 . . . . 0.02 112.682 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.3 p -160.82 153.5 20.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.269 . . . . 0.01 109.111 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 20.4 p -170.28 144.33 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.925 -1.139 . . . . 1.22 107.925 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.3 pttt -127.92 101.84 6.5 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.903 -1.123 . . . . 1.4099999999999999 109.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 136' ' ' TRP . 14.6 p . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 107.83 -1.174 . . . . 0.01 107.83 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' CD1' HG21 ' A' ' 131' ' ' VAL . 17.6 m95 . . . . . 0 N--CA 1.505 2.319 0 N-CA-C 107.863 -1.162 . . . . 0.01 107.863 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' CG1' HD11 ' A' ' 175' ' ' ILE . 34.3 mt -119.18 134.96 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 120.562 -1.336 . . . . 1.6899999999999999 109.846 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.46 141.7 44.68 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.193 -1.78 . . . . 2.4900000000000002 106.193 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 m-85 -123.51 143.63 50.06 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.206 -0.934 . . . . 0.02 109.88 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.45 -30.96 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.976 -0.452 . . . . 0.02 111.721 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.51 155.14 47.62 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.759 -1.213 . . . . 1.48 108.809 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -56.86 166.79 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.05 1.167 . . . . 0.02 112.927 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 42.8 t-20 59.66 31.89 21.17 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.173 -0.921 . . . . 0.75 111.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.9 m-85 57.45 51.95 9.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.527 -0.733 . . . . 0.02 111.523 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -126.75 165.32 19.5 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.463 -0.773 . . . . 0.02 110.057 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.13 -165.24 34.28 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.286 -1.126 . . . . 0.02 110.286 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -69.39 141.72 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.946 . . . . 0.02 108.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' MET . 18.4 mt-30 -114.12 148.59 36.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.778 -0.576 . . . . 0.02 110.109 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -123.75 133.86 53.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -95.34 121.12 36.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.868 -1.145 . . . . 0.01 109.461 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -98.83 145.49 26.92 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.761 -0.829 . . . . 0.01 108.761 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 13.1 m-20 -110.0 -179.31 3.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.534 -0.729 . . . . 2.27 109.645 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -71.52 38.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.87 . . . . 1.8400000000000001 109.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.1 mttm -112.04 177.18 4.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 109.208 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 26.4 mp0 -105.96 122.31 45.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.505 -0.747 . . . . 0.01 109.018 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.7 113.82 25.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.837 . . . . 0.01 109.242 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.41 -27.59 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.01 111.268 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -124.59 155.57 69.15 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.803 -1.184 . . . . 2.54 107.803 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.3 Cg_endo -61.5 -40.97 43.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.065 0.702 . . . . 0.69999999999999996 111.116 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.11 -18.87 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.8 -1.187 . . . . 0.85999999999999999 109.495 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.89 -18.15 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.02 111.899 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.63 15.42 28.98 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.674 -1.266 . . . . 0.02 110.147 178.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.92 74.3 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 121.088 -1.008 . . . . 0.02 112.939 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.96 140.48 35.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.912 -1.346 . . . . 0.02 109.995 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.04 -6.67 59.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.664 -0.647 . . . . 0.58999999999999997 109.703 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -139.76 150.34 62.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.245 -0.91 . . . . 0.87 109.603 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.08 13.73 0.8 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.746 0.964 . . . . 0.38 111.838 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.04 24.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.312 1.053 . . . . 0.17999999999999999 110.655 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.517 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.1 mt -150.03 123.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.569 -2.011 . . . . 3.9900000000000002 105.569 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -111.84 -12.67 13.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.454 -0.779 . . . . 5.1699999999999999 113.011 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 p -157.08 159.66 38.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.295 -2.128 . . . . 0.02 109.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.13 152.64 33.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.208 -0.932 . . . . 2.02 110.055 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.491 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 15.8 mtp180 -142.42 148.81 38.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.057 -1.027 . . . . 0.01 110.244 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 93' ' ' ALA . 14.7 ptm180 -86.78 140.24 29.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.141 -1.059 . . . . 0.01 108.141 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 137' ' ' ILE . 21.0 mt -94.7 130.59 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.2 -0.937 . . . . 3.04 109.585 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.91 147.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 1.8899999999999999 109.541 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 4.8899999999999997 109.403 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 107.205 -2.358 . . . . 0.81000000000000005 107.205 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.36 150.65 33.67 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 120.184 -1.008 . . . . 0.01 110.779 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -151.48 136.75 17.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.46 -1.023 . . . . 0.02 108.916 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 7.2 tt -130.77 142.16 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.39 -0.596 . . . . 0.02 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.526 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.5 t -122.87 130.48 52.91 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.475 -0.765 . . . . 0.39000000000000001 109.379 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.9 m-85 -109.71 139.94 44.16 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.947 -0.761 . . . . 0.02 108.947 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 12.7 m-85 -122.79 139.1 54.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.433 -0.792 . . . . 0.02 109.64 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.91 -26.66 64.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.029999999999999999 111.985 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.0 m-20 -114.17 170.01 8.6 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.029999999999999999 110.571 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -74.23 157.19 36.31 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.734 0.778 . . . . 0.029999999999999999 110.149 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.27 35.72 5.79 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.821 0.819 . . . . 0.73999999999999999 111.101 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.0 p90 49.66 44.61 24.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.679 0.752 . . . . 0.02 111.105 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -112.3 166.1 11.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.988 -1.115 . . . . 0.02 107.988 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.52 -167.9 34.28 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 120.735 -1.228 . . . . 0.029999999999999999 110.532 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.578 HH21 ' H ' ' A' ' 34' ' ' SER . 36.7 ttp180 -70.01 144.29 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -1.005 . . . . 2.7599999999999998 108.841 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.65 150.22 41.27 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.726 0.774 . . . . 1.8899999999999999 110.412 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -132.7 127.63 35.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.138 -1.06 . . . . 0.02 108.138 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -113.32 137.46 51.47 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 110.119 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.91 139.48 48.76 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.681 0.753 . . . . 0.02 109.351 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 m-20 -117.08 11.28 14.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.271 -0.64 . . . . 0.20000000000000001 109.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -158.57 174.49 14.99 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.119 -1.067 . . . . 1.23 108.119 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.21 144.34 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.601 -1.312 . . . . 0.02 110.249 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.0 m -131.41 116.86 18.08 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.372 -0.973 . . . . 0.02 108.372 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.2 -26.03 52.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.67 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -154.2 100.46 2.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 1.1399999999999999 108.7 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -104.96 9.65 34.47 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.538 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -58.3 -23.76 57.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.618 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -74.38 -16.89 60.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.169 . . . . 0.88 110.002 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -105.11 -21.9 13.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.516 -0.74 . . . . 0.02 109.395 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.1 tp -148.37 125.68 11.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 3.3199999999999998 109.166 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.578 ' H ' HH21 ' A' ' 18' ' ' ARG . 83.2 p -86.3 -11.05 53.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.02 111.263 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.496 ' O ' HD21 ' A' ' 33' ' ' LEU . 11.9 tpp180 -170.68 161.58 7.54 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.746 -1.205 . . . . 0.02 107.746 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.801 ' SG ' HD12 ' A' ' 79' ' ' LEU . 23.6 p -140.51 113.35 8.22 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.848 -1.157 . . . . 0.02 108.752 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 19.2 t-20 -106.35 -2.31 22.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.866 -1.146 . . . . 0.029999999999999999 110.259 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 8.4 m -154.43 154.15 32.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.304 -0.999 . . . . 0.02 108.304 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.418 HD12 ' CZ3' ' A' ' 72' ' ' TRP . 69.2 mt -144.66 146.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.02 109.599 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -124.44 124.8 43.11 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.046 -1.464 . . . . 0.02 107.046 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 24.9 t -105.6 113.65 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.822 -1.547 . . . . 0.02 106.822 177.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.08 -34.61 26.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 110.015 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.09 150.15 19.17 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.48 -1.819 . . . . 0.02 110.468 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.86 175.36 50.91 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.457 -1.354 . . . . 0.01 109.929 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 46' ' ' TRP . 34.3 m -110.29 161.93 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.823 -1.547 . . . . 1.48 106.823 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CZ3' ' SG ' ' A' ' 22' ' ' CYS . 64.5 m95 -147.65 147.01 29.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.286 -1.509 . . . . 0.02 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.31 54.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.158 -2.164 . . . . 0.23999999999999999 105.158 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.8 m -119.02 142.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.679 . . . . 0.65000000000000002 109.466 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 19.7 m-85 -119.72 144.79 47.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.295 1.045 . . . . 0.02 109.46 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.19 -34.88 79.04 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.748 -0.66 . . . . 0.02 111.183 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -125.66 158.36 65.28 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.112 -0.992 . . . . 0.02 109.496 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.41 167.11 1.46 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.739 1.626 . . . . 0.02 113.145 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.97 36.78 9.8 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.097 -0.956 . . . . 0.02 111.208 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.16 51.91 10.74 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.476 0.655 . . . . 3.3900000000000001 110.915 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.9 t -127.37 164.55 21.57 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 2.3300000000000001 110.118 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.16 -162.55 32.4 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.017 -1.233 . . . . 0.02 110.017 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.491 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 85.9 m-70 -62.8 142.03 58.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.02 110.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.2 mtp -115.89 135.09 54.32 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.955 -0.757 . . . . 5.0099999999999998 108.955 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' C ' HD12 ' A' ' 60' ' ' ILE . 53.1 m-85 -136.16 133.31 37.04 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.362 -0.836 . . . . 0.02 109.469 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -96.13 131.78 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.245 -1.02 . . . . 1.72 108.245 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.8 mt -120.48 110.45 35.65 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.673 -0.642 . . . . 0.02 110.344 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.61 169.61 21.49 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 CA-C-N 119.923 1.008 . . . . 1.47 110.079 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 12.7 tm0? -53.13 140.83 24.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.827 -1.171 . . . . 4.25 110.355 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.31 -176.28 32.2 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.02 110.522 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.13 128.75 55.44 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -1.011 . . . . 0.95999999999999996 108.738 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 30.1 m-85 -118.64 98.08 51.04 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' OG ' ' A' ' 38' ' ' SER . 1.8 Cg_endo -67.75 -6.64 17.3 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.645 0.897 . . . . 0.02 114.401 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 31.1 mt-10 -158.64 155.9 29.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.366 -1.459 . . . . 2.02 108.382 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -59.99 -37.39 79.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.02 112.374 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.97 -21.83 61.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.02 109.988 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.38 -20.37 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.703 . . . . 3.4199999999999999 110.294 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.418 ' CZ3' HD12 ' A' ' 39' ' ' ILE . 2.9 p90 -109.49 15.87 22.66 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.232 -0.917 . . . . 0.02 108.669 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt 64.66 23.86 12.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.331 0.586 . . . . 0.02 110.769 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.53 146.54 50.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.35 -1.5 . . . . 0.02 109.35 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 14.2 mt -80.59 -28.69 37.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.97999999999999998 108.261 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.71 -170.66 3.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.012 -1.477 . . . . 0.02 107.012 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 35.2 p30 -98.28 28.28 4.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.753 -1.217 . . . . 0.02 110.274 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -97.08 123.52 40.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.324 -0.86 . . . . 3.2000000000000002 111.246 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.801 HD12 ' SG ' ' A' ' 36' ' ' CYS . 63.0 mt -143.88 120.27 10.95 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.022 -1.473 . . . . 2.6099999999999999 107.022 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.8 -16.4 14.1 Favored Glycine 0 N--CA 1.503 3.101 0 O-C-N 121.312 -0.867 . . . . 0.02 112.166 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.8 t -156.11 155.72 33.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.51 -1.582 . . . . 0.02 109.686 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.0 m -144.91 148.13 33.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.735 . . . . 0.02 109.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.481 ' CZ ' ' OH ' ' A' ' 49' ' ' TYR . 39.5 mtm180 -134.1 139.63 46.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.352 -0.842 . . . . 0.01 108.854 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 131.3 38.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.961 -1.126 . . . . 0.42999999999999999 107.961 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -90.96 124.08 43.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.378 -0.971 . . . . 1.25 108.378 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -91.12 135.12 33.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 1.77 108.457 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.17 137.81 36.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.957 -0.757 . . . . 1.6299999999999999 108.957 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -111.54 125.88 54.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 m -102.74 -155.41 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.222 -1.77 . . . . 1.26 106.222 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.73 -48.64 0.9 Allowed Glycine 0 N--CA 1.498 2.797 0 O-C-N 120.463 -1.398 . . . . 0.01 112.305 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.38 -99.47 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.502 -1.809 . . . . 0.01 112.208 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.25 120.38 33.96 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.231 -1.158 . . . . 4.4299999999999997 110.82 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.643 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -77.74 132.32 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.126 -0.694 . . . . 2.9900000000000002 109.126 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -129.95 140.38 50.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.525 -0.734 . . . . 6.3600000000000003 109.121 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -125.5 141.89 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.867 0.842 . . . . 1.0900000000000001 109.528 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -124.59 131.41 53.48 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.514 -1.291 . . . . 2.0499999999999998 107.514 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -123.84 146.39 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.983 -1.073 . . . . 1.1000000000000001 109.819 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -117.43 140.72 49.22 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.991 0.901 . . . . 0.72999999999999998 110.77 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -66.14 -29.84 70.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.001 -0.545 . . . . 0.02 111.663 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -116.84 167.97 10.64 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.062 -1.024 . . . . 3.1800000000000002 110.586 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.01 43.39 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.08 -0.808 . . . . 0.01 111.08 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 56.55 38.58 29.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.868 -0.783 . . . . 0.01 110.801 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 52.55 55.31 9.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.753 -0.592 . . . . 0.01 110.959 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -128.58 165.96 19.78 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.497 -0.927 . . . . 3.1499999999999999 108.497 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.57 -164.85 26.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.36 -1.496 . . . . 0.01 109.36 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -74.85 144.82 43.25 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.039 -1.271 . . . . 0.01 108.255 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 5.1 tmm? -116.29 142.44 46.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.669 0.747 . . . . 0.01 109.653 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.552 ' N ' ' SD ' ' A' ' 107' ' ' MET . 80.8 m-85 -131.19 135.58 47.53 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.014 -1.106 . . . . 2.48 108.014 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.8 tm-20 -120.37 134.08 55.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.74 -0.6 . . . . 0.01 109.709 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 112' ' ' GLU . 2.8 t -149.63 152.11 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 1.6899999999999999 110.558 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -109.35 10.42 25.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.828 -0.624 . . . . 0.01 109.964 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.2 mp0 -120.58 163.06 18.58 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.41 -0.806 . . . . 3.21 111.317 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.08 155.23 37.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.007 -1.108 . . . . 0.01 108.007 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.2 t -122.54 110.66 31.95 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.938 -0.764 . . . . 0.01 108.938 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.82 -34.35 2.43 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 CA-C-N 119.976 1.027 . . . . 0.01 111.685 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.9 m -140.41 107.54 5.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.02 108.685 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.97 -39.42 85.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.865 -0.522 . . . . 1.8300000000000001 110.553 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttp -66.52 -37.67 85.53 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.967 -1.093 . . . . 1.3400000000000001 109.944 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.39 -39.12 74.73 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.388 -1.445 . . . . 2.1099999999999999 109.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 44.3 tt0 -80.29 -47.52 14.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 2.0800000000000001 112.425 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 66.7 m-85 -111.38 -1.25 16.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.8 . . . . 0.02 112.615 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 m80 61.77 34.29 17.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.71 -1.244 . . . . 0.02 109.742 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.87 135.42 54.22 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.497 -0.752 . . . . 0.02 109.231 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.52 -21.19 23.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 5.3200000000000003 110.768 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.42 164.42 34.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.02 109.968 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.0 mm -128.61 124.92 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.154 -1.424 . . . . 2.1699999999999999 107.154 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -109.27 -13.17 14.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 0.02 112.32 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 t -159.91 152.34 20.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.843 -1.16 . . . . 0.01 109.059 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.7 p -167.42 145.14 4.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.154 -1.054 . . . . 1.22 108.154 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -121.67 104.73 9.82 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.229 1.014 . . . . 1.4099999999999999 109.621 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.685 -1.228 . . . . 0.01 107.685 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 55.3 m95 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 107.349 -1.352 . . . . 0.01 107.349 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' A' ' 175' ' ' ILE . 27.2 mt -118.36 133.38 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.41 -1.432 . . . . 1.6899999999999999 109.775 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.72 141.28 44.22 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.378 -1.712 . . . . 2.4900000000000002 106.378 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -122.86 142.73 50.45 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.019 -1.051 . . . . 0.02 109.556 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.18 -30.68 62.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.02 111.718 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.84 154.87 48.23 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 120.749 -1.22 . . . . 1.48 108.896 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.31 167.24 2.74 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.28 1.32 . . . . 0.02 112.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.02 30.91 20.85 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.154 -0.93 . . . . 0.75 111.479 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.79 51.85 8.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.5 -0.75 . . . . 0.02 111.289 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.73 165.14 19.81 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.513 -0.742 . . . . 0.02 109.703 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.43 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.16 -165.51 34.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.124 -1.19 . . . . 0.02 110.124 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.46 142.02 53.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.981 . . . . 0.02 108.863 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -113.93 148.92 36.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 12.2 m-85 -123.36 133.9 54.06 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.773 -0.825 . . . . 0.01 108.773 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.3 120.47 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.148 . . . . 0.01 109.197 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -98.73 138.6 35.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.299 -1.0 . . . . 0.01 108.299 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.1 m-20 -108.08 -173.76 2.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 2.27 109.628 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.67 40.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 1.8400000000000001 109.578 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.2 mttp -112.13 167.74 10.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.441 -0.787 . . . . 2.2799999999999998 109.358 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -105.06 124.11 48.96 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.54 114.12 26.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.279 -0.888 . . . . 0.01 110.456 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -92.9 -26.22 17.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.01 110.636 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -123.63 154.45 66.66 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.993 -1.114 . . . . 2.54 107.993 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.557 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -61.64 -41.12 41.43 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 CA-C-N 119.245 0.766 . . . . 0.69999999999999996 110.802 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.74 -18.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.727 -1.233 . . . . 0.85999999999999999 109.311 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 50.7 t0 -65.29 -18.39 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.101 . . . . 0.02 111.927 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.75 15.42 29.02 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.8 -1.187 . . . . 0.02 110.164 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.4 76.3 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.163 -0.961 . . . . 0.02 113.113 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.15 141.41 34.08 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.836 -1.39 . . . . 0.02 110.227 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.34 59.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.721 -0.612 . . . . 0.58999999999999997 109.641 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -142.1 150.55 56.12 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.106 -0.996 . . . . 0.87 109.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.09 16.49 0.67 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 120.801 1.0 . . . . 0.38 112.018 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 120.79 25.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.17999999999999999 110.78 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.7 mt -149.08 124.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.719 -1.956 . . . . 3.9900000000000002 105.719 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -111.91 -13.72 13.6 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.174 -0.954 . . . . 5.1699999999999999 113.027 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 t -157.13 159.84 38.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.332 -2.105 . . . . 0.02 109.919 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 20.5 p90 -152.27 153.53 33.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.374 -0.829 . . . . 2.02 110.324 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -143.85 150.03 37.86 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.275 -0.89 . . . . 0.01 110.202 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.643 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 14.2 ptm180 -87.09 141.29 28.77 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.416 -0.957 . . . . 0.01 108.416 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.421 HD11 ' CG1' ' A' ' 137' ' ' ILE . 14.9 mt -94.84 129.61 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 3.04 109.373 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.46 147.67 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.423 -0.798 . . . . 1.8899999999999999 109.561 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 4.8899999999999997 109.431 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.573 0 N-CA-C 105.986 -2.846 . . . . 0.81000000000000005 105.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.41 147.71 31.68 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.419 -0.896 . . . . 0.01 111.007 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.65 138.66 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.02 108.421 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -130.29 140.83 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.354 0.597 . . . . 0.02 109.693 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -121.8 129.73 52.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.478 -0.764 . . . . 0.39000000000000001 109.778 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 29.1 m-85 -109.14 139.27 44.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.838 -0.801 . . . . 0.02 108.838 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.1 m-85 -122.68 138.56 54.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.297 -0.877 . . . . 0.02 109.742 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 33' ' ' LEU . 91.1 mt-10 -69.14 -27.58 65.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.029999999999999999 111.671 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.83 170.33 8.42 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.872 -1.142 . . . . 0.029999999999999999 110.58 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -74.51 157.45 35.5 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.755 0.788 . . . . 0.029999999999999999 110.181 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.9 OUTLIER 65.77 35.33 6.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.891 0.853 . . . . 0.73999999999999999 110.943 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.5 p90 49.82 45.28 24.94 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.679 0.752 . . . . 0.02 111.266 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -112.51 166.78 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.08 -1.081 . . . . 0.02 108.08 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.4 -167.88 36.04 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.737 -1.221 . . . . 0.029999999999999999 110.624 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -69.89 143.76 52.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -1.073 . . . . 2.7599999999999998 109.134 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -120.35 149.07 42.92 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.71 0.767 . . . . 1.8899999999999999 110.582 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -132.24 126.75 34.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.064 -1.087 . . . . 0.02 108.064 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -112.04 136.83 50.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.414 -0.804 . . . . 1.1200000000000001 109.814 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.62 137.78 49.78 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.478 0.656 . . . . 0.02 109.538 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.89 10.59 14.15 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.303 0.573 . . . . 0.20000000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 43.1 t -158.15 173.86 16.07 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 1.23 108.129 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.9 m-20 -61.77 144.77 54.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.615 -1.303 . . . . 0.02 110.541 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 t -132.2 116.45 16.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.585 -0.895 . . . . 0.02 108.585 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.9 -23.5 55.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.486 -0.758 . . . . 0.23999999999999999 110.634 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -155.61 101.88 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.48 -0.933 . . . . 1.1399999999999999 108.48 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.67 10.22 34.88 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.344 1.069 . . . . 6.3700000000000001 109.816 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -59.88 -23.43 63.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.505 -0.747 . . . . 3.1099999999999999 110.713 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 m -75.35 -16.55 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.688 -1.258 . . . . 0.88 110.373 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -103.15 -21.4 13.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.402 -0.811 . . . . 0.02 109.017 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.88 128.58 12.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 3.3199999999999998 108.848 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 p -84.73 -10.12 57.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.71 -0.619 . . . . 0.02 110.376 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -171.61 163.3 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.704 -1.221 . . . . 0.02 107.704 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -141.73 114.77 8.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.853 -1.154 . . . . 0.02 108.663 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -107.81 -2.18 20.18 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.953 -1.092 . . . . 0.029999999999999999 110.614 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 t -154.36 153.42 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.99 -1.115 . . . . 0.02 107.99 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.0 mt -144.63 146.65 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.89 -1.131 . . . . 0.02 109.9 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' A' ' 42' ' ' GLU . 38.9 ttp180 -123.77 123.76 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.25 -1.389 . . . . 0.02 107.25 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.54 114.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 106.879 -1.526 . . . . 0.02 106.879 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 30.9 mt-10 -83.7 -33.92 25.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.98 -0.688 . . . . 3.8100000000000001 109.721 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.16 150.4 19.64 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 118.475 -1.822 . . . . 0.02 110.369 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 173.57 49.77 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.671 -1.252 . . . . 0.01 110.077 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -119.45 135.86 54.57 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.482 -1.303 . . . . 1.48 107.482 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -124.12 154.45 39.98 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.523 1.154 . . . . 0.02 111.936 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.31 132.93 53.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.032 -2.21 . . . . 0.23999999999999999 105.032 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -114.99 140.25 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.063 -0.717 . . . . 0.65000000000000002 109.063 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 53.7 m-85 -121.46 144.02 48.92 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 122.22 1.009 . . . . 0.02 109.54 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.465 ' CG ' HH11 ' A' ' 51' ' ' ARG . 1.8 tp10 -66.2 -35.82 81.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.196 -0.911 . . . . 0.02 111.75 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.465 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -122.09 158.6 54.78 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.944 -1.098 . . . . 0.02 109.212 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.66 167.25 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.517 1.478 . . . . 0.02 112.591 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.09 37.26 11.67 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.683 0.754 . . . . 0.02 111.265 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 4.1 m-85 44.87 52.33 8.12 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.935 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -125.8 163.44 22.89 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.846 -0.534 . . . . 2.3300000000000001 109.943 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.21 31.7 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.653 -1.379 . . . . 0.02 109.653 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -65.99 137.15 56.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.324 . . . . 0.02 110.045 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 15.8 ptm -119.37 135.98 54.48 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.447 0.641 . . . . 5.0099999999999998 109.398 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 47.1 m-85 -133.14 141.01 47.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.566 -0.709 . . . . 0.02 109.267 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.37 132.09 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.571 -0.706 . . . . 1.72 109.431 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.17 109.55 35.18 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.552 -0.718 . . . . 0.02 110.332 -178.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.04 169.39 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.061 1.058 . . . . 1.47 110.229 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -52.82 140.59 23.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.901 -1.124 . . . . 4.25 110.706 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.46 -176.26 32.33 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.432 -1.365 . . . . 0.02 110.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -118.39 129.97 55.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.375 -1.073 . . . . 0.95999999999999996 109.405 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 59.9 m-85 -121.07 97.66 47.79 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.773 -1.195 . . . . 0.02 107.773 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.55 -3.7 13.06 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.648 0.898 . . . . 0.02 113.952 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -155.68 154.07 30.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.454 -1.404 . . . . 2.02 108.044 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -60.59 -38.44 84.64 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.563 -0.711 . . . . 0.02 111.708 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.02 110.152 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.12 -18.75 63.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.009 0.909 . . . . 3.4199999999999999 108.694 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.647 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -107.24 10.86 29.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.251 -1.389 . . . . 0.02 107.251 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 32.9 mtm 61.18 22.47 12.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.02 110.521 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.48 145.06 47.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tp -78.86 -29.97 44.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -1.205 . . . . 0.97999999999999998 107.75 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.419 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 43.9 p30 -156.86 -171.45 3.66 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.57 27.49 4.29 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.731 -1.23 . . . . 0.02 109.987 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -95.92 122.48 38.77 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.032 -1.042 . . . . 3.2000000000000002 110.358 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.4 mt -144.72 121.66 11.34 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.922 -1.14 . . . . 2.6099999999999999 107.922 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.77 -16.84 9.57 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 121.33 -0.856 . . . . 0.02 112.847 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.7 t -155.15 155.63 34.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 120.023 1.912 . . . . 0.02 111.084 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.0 m -145.5 148.2 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.542 0.687 . . . . 0.02 110.306 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 12.7 mtp180 -134.6 139.25 45.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.01 108.935 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 132.74 37.24 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.623 -0.88 . . . . 0.42999999999999999 108.623 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.72 123.49 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -89.4 135.81 33.38 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.027 -1.101 . . . . 1.77 108.027 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' CD1' ' OE1' ' A' ' 177' ' ' GLU . 1.5 mt -99.2 137.71 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.752 -0.833 . . . . 1.6299999999999999 108.752 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.6 p -112.64 126.06 54.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.811 -0.811 . . . . 1.0800000000000001 108.811 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 p -102.96 -155.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.162 -1.792 . . . . 1.26 106.162 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -48.99 0.86 Allowed Glycine 0 N--CA 1.501 2.979 0 O-C-N 120.413 -1.429 . . . . 0.01 112.506 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.69 -100.0 0.14 Allowed Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.632 -1.746 . . . . 0.01 112.019 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -120.18 119.28 32.79 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.111 -1.229 . . . . 4.4299999999999997 110.753 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.84 129.93 36.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.016 -0.674 . . . . 2.9900000000000002 109.406 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -132.12 139.89 48.62 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.495 -0.753 . . . . 6.3600000000000003 109.287 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.89 145.77 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.404 -0.81 . . . . 1.0900000000000001 109.857 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -122.7 132.74 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.25 -1.389 . . . . 2.0499999999999998 107.25 177.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.51 149.24 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.107 . . . . 1.1000000000000001 109.585 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.2 141.45 48.87 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.034 0.921 . . . . 0.72999999999999998 110.998 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.36 -29.27 69.42 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.823 -0.626 . . . . 0.02 111.514 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -116.31 169.46 9.28 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.311 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.3 164.79 50.18 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.801 -0.92 . . . . 0.01 110.801 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.6 m-20 56.74 38.16 29.31 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.875 -0.779 . . . . 0.01 111.3 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' H ' ' CB ' ' A' ' 128' ' ' SER . 10.7 m-85 53.07 54.69 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.586 -0.696 . . . . 0.01 111.475 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -129.01 165.1 21.81 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.331 -0.989 . . . . 3.1499999999999999 108.331 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.88 -163.9 27.24 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.424 -1.471 . . . . 0.01 109.424 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -75.37 144.07 42.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.108 -1.231 . . . . 0.01 108.577 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.2 tmm? -116.71 142.82 46.41 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.576 0.703 . . . . 0.01 109.836 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.76 135.56 46.9 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.311 -0.996 . . . . 2.48 108.311 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -121.21 135.54 55.12 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.58 -0.7 . . . . 0.01 109.93 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -149.88 152.49 35.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.189 0.995 . . . . 1.6899999999999999 110.799 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -109.41 9.87 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.01 109.97 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -120.77 163.2 18.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.817 . . . . 3.21 111.388 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.8 155.72 37.47 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.083 -1.081 . . . . 0.01 108.083 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.599 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 63.1 m -124.66 112.41 27.43 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.423 -0.798 . . . . 0.01 108.94 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.44 -32.66 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 120.135 1.084 . . . . 0.01 111.551 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.6 t -140.76 107.9 5.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.876 . . . . 0.02 108.989 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -64.15 -39.98 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 1.8300000000000001 110.593 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 118' ' ' MET . 2.0 tmt? -66.17 -37.8 86.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.134 -1.027 . . . . 1.3400000000000001 109.849 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.52 -38.85 74.32 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.448 -1.407 . . . . 2.1099999999999999 109.729 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.31 -47.57 14.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.354 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.46 -0.86 16.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.424 -0.798 . . . . 0.02 112.663 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m170 61.19 33.75 19.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.139 . . . . 0.02 109.662 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.5 mt -114.22 135.93 53.51 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.476 -0.765 . . . . 0.02 109.235 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.66 -22.0 21.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 5.3200000000000003 110.9 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' ' 126' ' ' ILE . 76.0 mt-10 -148.54 163.84 35.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.884 -1.135 . . . . 0.02 110.065 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 125' ' ' GLU . 40.0 mm -128.43 125.28 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.456 -1.313 . . . . 2.1699999999999999 107.456 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -111.56 -14.04 13.73 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.285 -0.885 . . . . 0.02 112.698 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.562 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 18.7 m -160.16 152.06 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.77 -1.206 . . . . 0.01 109.044 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 31.9 p -168.87 150.13 4.59 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.504 -0.924 . . . . 1.22 108.504 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.567 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 35.4 mttm -113.28 100.71 8.77 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.327 1.06 . . . . 1.4099999999999999 108.406 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 136' ' ' TRP . 1.2 p . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 108.697 -0.853 . . . . 0.01 108.697 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.447 ' CD1' HG23 ' A' ' 131' ' ' VAL . 85.6 m95 . . . . . 0 N--CA 1.508 2.474 0 CA-C-O 121.193 0.52 . . . . 0.01 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.6 mt -120.1 136.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.254 -1.017 . . . . 1.6899999999999999 108.254 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.43 141.43 43.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.109 -1.441 . . . . 2.4900000000000002 107.109 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -122.72 142.77 50.34 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.173 -0.954 . . . . 0.02 109.894 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.03 -30.31 61.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.02 112.319 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.4 154.83 48.99 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.587 -1.321 . . . . 1.48 108.619 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.28 167.06 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.068 1.179 . . . . 0.02 113.04 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.1 m120 58.66 30.75 20.32 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.263 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 57.47 51.21 10.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.665 . . . . 0.02 111.066 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' NH1' ' SD ' ' A' ' 73' ' ' MET . 23.3 mmm180 -125.0 164.8 19.37 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.45 -0.781 . . . . 0.02 109.549 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.34 -165.93 34.47 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.338 -1.105 . . . . 0.02 110.338 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -69.7 142.9 53.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.458 -1.025 . . . . 0.02 109.022 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.483 ' O ' ' CG ' ' A' ' 58' ' ' MET . 6.1 mt-30 -113.41 149.76 33.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.72 -0.613 . . . . 0.02 109.558 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.13 132.51 54.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.904 -1.147 . . . . 0.01 107.904 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.45 ' H ' ' HE1' ' A' ' 58' ' ' MET . 27.8 tp -95.48 121.2 36.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.633 -1.292 . . . . 0.01 109.347 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.457 HD11 ' CD1' ' A' ' 138' ' ' PHE . 24.2 mt -93.49 162.42 13.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.811 -1.181 . . . . 0.01 107.811 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.91 -116.94 0.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.357 -0.839 . . . . 2.27 109.283 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -141.29 26.31 2.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 1.8400000000000001 109.006 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -110.35 -166.81 1.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.849 -0.797 . . . . 2.2799999999999998 108.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.29 131.9 53.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.532 -0.73 . . . . 0.01 109.496 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.06 110.78 23.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.354 -0.841 . . . . 0.01 108.911 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.449 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.0 ptm180 -88.1 -27.79 21.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.01 111.309 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -124.08 154.22 68.13 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.696 -1.224 . . . . 2.54 107.696 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.66 -39.27 44.69 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 CA-C-N 119.382 0.815 . . . . 0.69999999999999996 110.903 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.09 -18.41 17.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.478 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.46 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.039 -1.038 . . . . 0.02 112.272 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.12 15.63 28.07 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.799 -1.188 . . . . 0.02 109.887 178.377 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.22 75.33 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.164 -0.96 . . . . 0.02 112.948 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.514 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.22 140.45 35.49 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.847 -1.384 . . . . 0.02 110.233 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -6.85 59.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.642 -0.661 . . . . 0.58999999999999997 109.711 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.7 p -140.34 150.83 62.51 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.176 -0.952 . . . . 0.87 109.297 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.88 15.23 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.667 0.911 . . . . 0.38 111.865 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.64 24.19 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.33 1.062 . . . . 0.17999999999999999 110.682 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.463 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.01 123.5 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.577 -2.009 . . . . 3.9900000000000002 105.577 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.62 -12.77 12.8 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.21 -0.932 . . . . 5.1699999999999999 113.271 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 9.2 t -157.23 158.93 37.09 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 119.134 -2.229 . . . . 0.02 109.945 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.599 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 18.1 p90 -152.77 154.75 35.82 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.092 -1.005 . . . . 2.02 110.148 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -144.67 150.56 37.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.01 110.395 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.1 ptt180 -87.89 143.04 27.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.01 108.613 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.65 129.39 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.311 -0.868 . . . . 3.04 109.266 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.08 147.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -0.926 . . . . 1.8899999999999999 109.783 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.473 ' OE1' ' CD1' ' A' ' 87' ' ' LEU . 51.5 tp10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 4.8899999999999997 109.413 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.729 0 N-CA-C 106.785 -2.526 . . . . 0.81000000000000005 106.785 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 149.09 33.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.745 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -150.45 136.34 18.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -1.053 . . . . 0.02 109.367 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -128.96 139.25 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.012 -0.736 . . . . 0.02 109.012 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.411 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.3 t -121.77 130.35 53.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.605 -0.684 . . . . 0.39000000000000001 109.438 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -108.67 138.38 45.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.041 -0.726 . . . . 0.02 109.041 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.0 m-85 -122.65 138.53 54.57 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.215 -0.928 . . . . 0.02 109.734 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 70.6 mt-10 -71.33 -28.2 63.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.029999999999999999 111.635 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.562 ' C ' HD21 ' A' ' 37' ' ' ASN . 24.0 t0 -113.57 168.04 10.09 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.851 -1.156 . . . . 0.029999999999999999 110.171 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 96.0 mtt180 -73.73 157.19 36.96 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.629 0.728 . . . . 0.029999999999999999 110.051 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 21.5 t-20 66.35 35.23 5.9 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.83 0.824 . . . . 0.73999999999999999 110.928 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.5 p90 50.06 45.49 25.38 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.815 0.817 . . . . 0.02 111.162 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -112.9 166.09 11.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.81 -1.182 . . . . 0.02 107.81 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -166.79 35.86 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.617 -1.278 . . . . 0.029999999999999999 110.825 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -69.42 140.8 54.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.928 . . . . 2.7599999999999998 109.268 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -120.94 149.09 43.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.259 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -132.81 127.09 33.79 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.945 -1.131 . . . . 0.02 107.945 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.81 136.86 50.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.528 -0.732 . . . . 1.1200000000000001 109.706 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.22 138.2 49.26 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.422 0.629 . . . . 0.02 109.449 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -116.81 10.89 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.46 -0.57 . . . . 0.20000000000000001 109.46 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.2 p -157.88 174.43 15.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.61 144.91 55.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.551 -1.343 . . . . 0.02 110.435 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.2 t -132.48 116.65 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.547 -0.909 . . . . 0.02 108.547 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -24.55 52.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.23999999999999999 110.751 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.76 100.41 2.37 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.445 -0.946 . . . . 1.1399999999999999 108.445 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 20.5 p90 -106.06 9.88 32.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.199 1.0 . . . . 6.3700000000000001 110.058 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -58.89 -22.68 59.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.633 -0.667 . . . . 3.1099999999999999 110.595 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -74.7 -16.61 60.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.676 -1.265 . . . . 0.88 110.324 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.37 -22.0 14.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.376 -0.827 . . . . 0.02 109.053 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -150.3 129.44 12.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.453 -0.944 . . . . 3.3199999999999998 108.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 p -85.26 -9.66 57.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.79 -0.569 . . . . 0.02 110.804 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -169.54 161.43 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 m -141.83 112.68 7.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.796 -1.19 . . . . 0.02 109.125 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -110.66 -0.6 17.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.054 -1.029 . . . . 0.029999999999999999 110.981 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.31 152.24 30.9 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.736 -1.209 . . . . 0.02 107.736 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -146.4 148.37 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.89 -1.131 . . . . 0.02 110.555 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -125.92 125.88 43.49 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.973 -1.121 . . . . 0.02 107.973 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.8 115.42 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.587 -1.634 . . . . 0.02 106.587 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.68 -33.8 25.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.63 -0.669 . . . . 3.8100000000000001 110.404 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.65 21.22 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.064 -1.541 . . . . 0.02 109.996 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.58 174.76 50.33 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.547 -1.311 . . . . 0.01 109.999 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 46' ' ' TRP . 14.8 m -109.79 160.65 16.15 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.646 -1.613 . . . . 1.48 106.646 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 45' ' ' THR . 62.5 m95 -147.97 147.81 30.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.285 . . . . 0.02 111.432 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.59 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.157 -2.164 . . . . 0.23999999999999999 105.157 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -118.9 143.29 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.664 -0.647 . . . . 0.65000000000000002 109.436 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.92 145.46 47.67 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.299 1.047 . . . . 0.02 109.997 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -65.9 -33.56 76.12 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.501 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -124.31 157.4 64.73 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.995 -1.066 . . . . 0.02 109.578 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.11 166.42 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.603 1.535 . . . . 0.02 112.778 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.11 36.39 9.72 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.442 -0.799 . . . . 0.02 111.114 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.03 50.88 9.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.602 0.715 . . . . 3.3900000000000001 110.61 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -125.72 163.58 22.52 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.252 0.548 . . . . 2.3300000000000001 109.914 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.62 -161.93 31.33 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.477 -1.449 . . . . 0.02 109.477 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 16.0 t-80 -66.53 138.29 57.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.948 -1.325 . . . . 0.02 109.897 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 21.8 ptm -119.1 137.21 53.73 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.557 0.694 . . . . 5.0099999999999998 109.605 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.633 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 13.2 m-85 -132.19 140.31 48.67 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.759 0.79 . . . . 0.02 109.174 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.5 mm -96.5 131.71 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.47 -0.937 . . . . 1.72 108.47 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 61' ' ' LEU . 16.6 mt -122.76 113.58 30.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.373 -0.829 . . . . 0.02 110.741 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.11 169.96 20.54 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 CA-C-N 120.062 1.058 . . . . 1.47 110.238 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.632 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -51.9 141.33 17.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 4.25 110.153 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.34 -177.48 32.51 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.341 -1.409 . . . . 0.02 110.707 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -119.08 130.0 55.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.529 -0.983 . . . . 0.95999999999999996 109.62 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 52.3 m-85 -120.71 95.78 48.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 107.765 -1.198 . . . . 0.02 107.765 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -68.37 -3.66 11.35 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 120.699 0.933 . . . . 0.02 113.835 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 82.6 mt-10 -157.6 154.81 29.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.544 -1.348 . . . . 2.02 108.252 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -60.5 -39.36 87.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.492 -0.755 . . . . 0.02 111.937 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.49 -23.86 63.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.02 110.132 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.57 62.4 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.443 -0.947 . . . . 3.4199999999999999 108.443 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.39 9.05 31.9 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.354 -1.35 . . . . 0.02 107.354 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.6 mtm 60.6 21.64 11.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.606 -0.684 . . . . 0.02 110.527 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.87 143.88 44.93 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.195 -1.562 . . . . 0.02 109.195 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -77.99 -30.14 50.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.084 -1.45 . . . . 0.97999999999999998 107.084 177.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -156.57 -172.04 3.92 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.27 -1.752 . . . . 0.02 106.27 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -97.78 27.79 4.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.728 -1.232 . . . . 0.02 110.464 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 78' ' ' ARG . 8.5 mtt-85 -96.4 122.84 39.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.12 -0.988 . . . . 3.2000000000000002 110.752 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.9 mt -144.87 120.15 10.21 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.517 -1.29 . . . . 2.6099999999999999 107.517 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.0 -15.87 11.3 Favored Glycine 0 N--CA 1.507 3.378 0 O-C-N 121.271 -0.893 . . . . 0.02 112.869 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.4 p -155.51 156.14 34.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.217 -1.755 . . . . 0.02 110.276 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.5 p -145.03 148.35 33.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.02 109.484 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -133.71 138.63 45.93 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.751 -0.833 . . . . 0.01 108.751 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.62 131.77 36.84 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.473 -0.936 . . . . 0.42999999999999999 108.473 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.27 123.82 43.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.74 -0.837 . . . . 1.25 108.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -92.18 135.08 34.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.984 -1.073 . . . . 1.77 108.281 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.01 137.84 36.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.471 -0.768 . . . . 1.6299999999999999 109.386 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.8 m -111.03 127.09 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.548 -0.908 . . . . 1.0800000000000001 108.548 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 p -104.02 -154.73 0.51 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 106.464 -1.68 . . . . 1.26 106.464 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.81 -49.02 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.454 -1.403 . . . . 0.01 112.275 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.0 -100.2 0.14 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 118.331 -1.89 . . . . 0.01 112.122 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -119.99 118.58 31.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.27 -1.135 . . . . 4.4299999999999997 110.714 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -76.9 130.92 38.22 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.095 -0.705 . . . . 2.9900000000000002 109.095 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -130.48 138.54 50.32 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.834 -0.802 . . . . 6.3600000000000003 108.834 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.15 143.86 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.358 -0.839 . . . . 1.0900000000000001 109.402 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.14 133.71 54.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.596 -1.261 . . . . 2.0499999999999998 107.596 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 129' ' ' CYS . 16.7 m -123.81 146.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.992 -1.068 . . . . 1.1000000000000001 109.038 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -120.59 141.75 50.02 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 122.127 0.965 . . . . 0.72999999999999998 111.277 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -66.16 -30.01 70.4 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.807 -0.633 . . . . 0.02 111.821 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -116.61 168.05 10.53 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.636 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.75 163.57 43.8 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 111.016 -0.833 . . . . 0.01 111.016 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 57.03 38.86 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 122.011 -0.699 . . . . 0.01 110.979 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.3 m-85 52.23 56.71 7.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.597 -0.69 . . . . 0.01 111.083 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -128.84 165.46 20.96 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.17 -1.048 . . . . 3.1499999999999999 108.17 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.2 -164.43 28.41 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.016 -1.634 . . . . 0.01 109.016 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.22 143.68 45.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.988 -1.301 . . . . 0.01 108.479 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 3.8 tmm? -116.49 142.41 46.91 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.696 0.76 . . . . 0.01 109.683 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -131.58 135.36 46.94 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.978 -1.119 . . . . 2.48 107.978 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.77 135.17 55.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.592 -0.692 . . . . 0.01 109.764 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -150.26 154.33 37.74 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.486 1.136 . . . . 1.6899999999999999 111.18 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 p -111.39 9.86 21.48 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.347 -0.842 . . . . 0.01 109.988 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -122.18 163.52 19.42 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.252 -0.905 . . . . 3.21 111.632 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.94 155.98 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.529 -0.915 . . . . 0.01 108.529 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.34 112.42 27.98 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.965 -0.754 . . . . 0.01 108.965 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.71 -33.44 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.188 1.103 . . . . 0.01 111.548 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 t -140.29 107.53 5.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.02 108.743 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 126' ' ' ILE . 76.4 mt -64.54 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.819 -0.55 . . . . 1.8300000000000001 111.222 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.1 OUTLIER -66.48 -37.65 85.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.819 -1.152 . . . . 1.3400000000000001 109.578 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.42 -38.85 74.65 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.464 -1.398 . . . . 2.1099999999999999 109.589 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -80.68 -48.17 12.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 112.485 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.02 -2.13 15.16 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.711 . . . . 0.02 112.705 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.9 33.86 17.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.814 -1.179 . . . . 0.02 109.942 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -114.2 135.49 53.99 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.491 -0.755 . . . . 0.02 109.1 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -90.98 -21.45 21.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 5.3200000000000003 111.273 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.12 163.98 35.28 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.228 . . . . 0.02 110.093 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 117' ' ' ILE . 10.0 mm -128.38 124.3 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.58 -1.267 . . . . 2.1699999999999999 107.58 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -108.44 -13.94 14.76 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.098 -1.001 . . . . 0.02 112.52 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 13.5 t -160.57 152.38 19.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.746 -1.221 . . . . 0.01 108.82 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.3 t -167.28 145.09 4.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 1.22 109.164 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -123.65 106.09 10.26 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.398 1.094 . . . . 1.4099999999999999 109.385 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 131' ' ' VAL . 8.1 p . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.334 -1.358 . . . . 0.01 107.334 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.4 m95 . . . . . 0 N--CA 1.505 2.283 0 N-CA-C 107.819 -1.178 . . . . 0.01 107.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.431 ' CG1' HD11 ' A' ' 175' ' ' ILE . 39.5 mt -119.06 134.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.634 -1.291 . . . . 1.6899999999999999 109.94 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -110.24 141.38 43.28 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.541 -2.022 . . . . 2.4900000000000002 105.541 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -123.19 143.24 50.15 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.111 -0.993 . . . . 0.02 110.009 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 35.4 tt0 -72.97 -31.97 64.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.791 -0.568 . . . . 0.02 111.67 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.97 154.76 48.4 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.738 -1.226 . . . . 1.48 108.819 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -56.45 167.44 2.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.069 1.179 . . . . 0.02 112.849 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 59.06 31.63 21.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.159 -0.928 . . . . 0.75 111.51 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.03 51.91 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.765 . . . . 0.02 111.361 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -127.12 165.47 19.47 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.569 -0.707 . . . . 0.02 110.097 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.71 -164.99 34.71 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.211 -1.156 . . . . 0.02 110.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -69.17 141.34 54.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -1.065 . . . . 0.02 108.817 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 5.6 mt-30 -113.69 148.79 35.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.439 -0.578 . . . . 0.02 109.439 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -124.55 134.42 52.99 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.758 -0.83 . . . . 0.01 108.758 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -95.99 121.02 37.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.871 -1.143 . . . . 0.01 109.477 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -99.38 146.18 26.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.493 -0.929 . . . . 0.01 108.493 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.3 m-20 -110.6 178.46 4.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.599 -0.688 . . . . 2.27 109.532 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -71.65 39.79 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 1.8400000000000001 109.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.6 mttm -110.31 -178.71 3.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.135 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -106.09 120.0 40.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.323 -0.861 . . . . 0.01 108.898 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.07 110.05 22.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.924 . . . . 0.01 108.986 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -28.13 16.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.506 -0.746 . . . . 0.01 111.176 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -123.5 152.27 64.63 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 107.722 -1.214 . . . . 2.54 107.722 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.8 Cg_endo -60.61 -39.65 62.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 CA-C-N 119.866 0.988 . . . . 0.69999999999999996 110.987 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.97 -18.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.779 -1.201 . . . . 0.85999999999999999 109.665 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.95 -18.63 65.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.02 112.38 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.66 16.0 27.17 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.828 -1.17 . . . . 0.02 109.912 178.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.1 11.2 76.69 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.227 -0.921 . . . . 0.02 112.849 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 140.63 34.95 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.42 . . . . 0.02 110.11 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.64 -7.48 58.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.628 -0.67 . . . . 0.58999999999999997 110.092 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.0 p -139.97 150.72 63.27 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.198 -0.939 . . . . 0.87 109.463 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.93 14.27 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 120.812 1.008 . . . . 0.38 112.094 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.15 27.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.919 -1.113 . . . . 0.17999999999999999 111.15 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 mp -151.65 125.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.513 -1.662 . . . . 3.9900000000000002 106.513 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.0 mp0 -112.2 -12.03 13.68 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.357 -0.84 . . . . 5.1699999999999999 112.533 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.9 t -156.88 158.99 37.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.197 -2.189 . . . . 0.02 110.045 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -152.26 154.15 35.16 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.147 -0.97 . . . . 2.02 110.057 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -143.08 148.39 36.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.01 109.804 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.467 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 15.7 ptm180 -86.37 141.14 29.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.184 -1.043 . . . . 0.01 108.184 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' A' ' 137' ' ' ILE . 25.8 mt -95.1 129.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.212 -0.93 . . . . 3.04 109.516 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.46 147.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 1.8899999999999999 109.618 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 4.8899999999999997 109.718 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.407 0 N-CA-C 105.653 -2.979 . . . . 0.81000000000000005 105.653 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 147.6 31.86 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.338 -0.934 . . . . 0.01 111.231 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -152.84 138.05 17.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.586 -0.949 . . . . 0.02 109.184 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.22 140.0 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.259 -0.645 . . . . 0.02 109.259 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -122.56 130.66 53.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.633 -0.667 . . . . 0.39000000000000001 109.877 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 10.9 m-85 -110.6 140.2 45.14 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.85 -0.796 . . . . 0.02 108.85 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.0 m-85 -122.43 139.03 54.32 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.289 -0.882 . . . . 0.02 109.856 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.455 ' HG3' HD11 ' A' ' 33' ' ' LEU . 78.4 mt-10 -68.58 -28.47 66.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.063 . . . . 0.029999999999999999 111.88 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.98 170.42 8.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.796 -1.19 . . . . 0.029999999999999999 110.351 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 31.9 mtp180 -74.81 157.58 34.91 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.698 0.761 . . . . 0.029999999999999999 110.354 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t30 66.29 33.85 6.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 111.374 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.23 42.43 28.01 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.287 0.565 . . . . 0.02 111.424 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -113.64 166.35 11.62 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.611 -0.885 . . . . 0.02 108.611 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.4 -167.53 37.44 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.954 -1.117 . . . . 0.029999999999999999 111.094 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.447 HH21 ' H ' ' A' ' 34' ' ' SER . 37.7 ttp180 -69.11 142.13 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.578 -0.954 . . . . 2.7599999999999998 109.265 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -121.51 149.46 43.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.738 0.78 . . . . 1.8899999999999999 110.324 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -131.99 127.39 36.17 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.968 -1.123 . . . . 0.02 107.968 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.26 137.4 50.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.564 -0.71 . . . . 1.1200000000000001 109.564 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.9 t -131.24 138.35 49.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.51 0.671 . . . . 0.02 109.673 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.44 10.52 14.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.608 -0.683 . . . . 0.20000000000000001 109.529 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.1 p -157.37 174.28 15.66 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.216 -1.031 . . . . 1.23 108.216 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.34 144.32 54.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.662 -1.274 . . . . 0.02 110.189 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.13 116.7 17.35 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.468 -0.938 . . . . 0.02 108.468 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.89 -24.29 52.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 110.663 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -153.82 100.72 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 108.509 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -106.7 8.38 30.99 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.182 0.991 . . . . 6.3700000000000001 110.168 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.681 ' NH2' HH12 ' A' ' 78' ' ' ARG . 86.7 mtt180 -59.79 -21.29 60.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 3.1099999999999999 110.495 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.3 m -74.89 -16.48 60.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.905 -1.122 . . . . 0.88 109.871 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -102.37 -21.65 14.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.02 109.086 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.455 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.5 tp -150.26 129.66 12.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.913 -0.773 . . . . 3.3199999999999998 108.913 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.447 ' H ' HH21 ' A' ' 18' ' ' ARG . 29.8 t -86.76 -12.22 48.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.854 -0.529 . . . . 0.02 111.098 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' SER . 10.5 mtm180 -167.1 161.09 14.49 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.153 -1.425 . . . . 0.02 107.153 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.8 p -143.34 115.31 8.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.831 -1.168 . . . . 0.02 108.643 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.5 m-20 -107.3 0.73 23.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.733 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 p -157.08 155.2 30.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.757 -1.201 . . . . 0.02 107.757 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.66 147.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.02 110.27 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -123.25 124.36 42.83 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -106.26 114.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.78 -34.08 27.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 3.8100000000000001 110.265 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.78 151.29 21.02 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.116 -1.516 . . . . 0.02 110.125 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.38 49.64 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.495 -1.336 . . . . 0.01 110.082 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.82 137.41 54.0 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.802 -1.184 . . . . 1.48 107.802 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -125.66 153.62 43.56 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.498 1.142 . . . . 0.02 111.983 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.62 52.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 104.869 -2.271 . . . . 0.23999999999999999 104.869 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.0 m -117.41 142.28 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.526 -0.733 . . . . 0.65000000000000002 109.089 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 13.8 m-85 -119.5 144.04 47.22 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.378 1.085 . . . . 0.02 109.723 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 5.6 tp10 -65.95 -35.02 79.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.669 -0.696 . . . . 0.02 110.882 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -125.17 157.19 68.14 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.093 -1.004 . . . . 0.02 109.702 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 167.43 1.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.806 1.67 . . . . 0.02 113.056 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.06 37.25 9.27 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.144 -0.934 . . . . 0.02 111.017 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 45.21 52.22 8.74 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.598 0.713 . . . . 3.3900000000000001 110.71 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.2 p -127.56 164.32 22.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.297 0.57 . . . . 2.3300000000000001 109.911 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -162.3 31.81 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.922 -1.271 . . . . 0.02 109.922 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 14.9 t-80 -63.29 142.61 58.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.268 . . . . 0.02 110.507 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.511 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 31.4 mtp -116.78 134.56 54.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.266 0.555 . . . . 5.0099999999999998 109.519 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 17.0 m-85 -135.27 134.35 39.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.393 -0.817 . . . . 0.02 109.124 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -96.86 131.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.986 -0.746 . . . . 1.72 108.986 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 61' ' ' LEU . 23.0 mt -122.92 111.48 30.89 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.394 -0.816 . . . . 0.02 110.668 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.1 171.29 18.4 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 CA-C-N 119.856 0.984 . . . . 1.47 110.286 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 1.3 tm0? -51.78 140.42 19.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 4.25 109.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 155.95 -178.15 32.65 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.325 -1.417 . . . . 0.02 110.71 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.84 131.24 55.23 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.581 -0.952 . . . . 0.95999999999999996 109.587 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 62.4 m-85 -121.08 99.42 46.53 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.116 -1.068 . . . . 0.02 108.116 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.36 -4.21 13.96 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.64 0.893 . . . . 0.02 113.99 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 37.7 mt-10 -157.44 155.23 30.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.453 -1.405 . . . . 2.02 108.238 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ASN . 27.7 p90 -60.36 -38.19 83.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.634 -0.666 . . . . 0.02 111.749 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.83 -23.89 63.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.915 -1.115 . . . . 0.02 110.211 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.5 -18.6 62.28 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.176 0.989 . . . . 3.4199999999999999 108.588 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.643 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -105.67 9.25 33.25 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.937 -1.505 . . . . 0.02 106.937 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt 59.87 21.56 10.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.606 -0.684 . . . . 0.02 110.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.81 144.09 46.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.02 109.497 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.78 -29.68 51.01 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.324 -1.362 . . . . 0.97999999999999998 107.324 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -156.85 -170.85 3.44 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.405 -1.702 . . . . 0.02 106.405 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -97.82 29.25 3.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.612 -1.305 . . . . 0.02 110.172 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.681 HH12 ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -98.19 122.4 41.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.206 -0.934 . . . . 3.2000000000000002 110.988 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 79' ' ' LEU . 29.8 mt -144.59 122.03 11.68 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.362 -1.347 . . . . 2.6099999999999999 107.362 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.19 -16.46 12.31 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 120.448 -0.882 . . . . 0.02 112.405 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.8 p -156.31 157.32 35.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.309 -1.7 . . . . 0.02 110.405 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.3 m -144.85 148.37 33.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.767 -0.583 . . . . 0.02 109.559 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -136.44 140.69 43.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.233 -0.917 . . . . 0.01 109.136 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.48 132.77 36.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.224 -0.922 . . . . 0.42999999999999999 109.323 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.28 123.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.511 -0.922 . . . . 1.25 108.511 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -88.93 135.51 33.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.097 -1.075 . . . . 1.77 108.097 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.29 139.0 37.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.445 -0.576 . . . . 1.6299999999999999 109.445 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 p -111.98 122.39 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.685 -1.228 . . . . 1.0800000000000001 107.685 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.8 p -114.22 133.84 55.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.752 -1.218 . . . . 1.26 107.865 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.5 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.501 3.033 0 C-N-CA 117.459 -2.305 . . . . 0.01 113.652 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.12 -103.03 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 120.308 2.054 . . . . 0.01 111.202 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.3 OUTLIER -119.93 119.2 32.79 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.359 -1.083 . . . . 4.4299999999999997 110.174 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.503 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -75.1 129.98 38.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.191 -0.67 . . . . 2.9900000000000002 109.191 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -132.14 138.19 47.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.717 . . . . 6.3600000000000003 109.319 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -127.36 145.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.478 -0.764 . . . . 1.0900000000000001 109.457 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -122.02 131.65 54.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.603 -1.258 . . . . 2.0499999999999998 107.603 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 129' ' ' CYS . 23.6 m -123.6 146.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 120.811 -1.18 . . . . 1.1000000000000001 109.386 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.25 140.86 49.17 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.022 0.915 . . . . 0.72999999999999998 110.812 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -65.66 -29.96 70.59 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.959 -0.564 . . . . 0.02 111.395 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -116.94 168.36 10.31 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.571 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.61 168.92 30.6 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.959 -0.857 . . . . 0.01 110.959 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 52.21 40.09 28.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.671 0.748 . . . . 0.01 111.168 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 13.7 m-85 51.77 51.92 15.62 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.563 -0.711 . . . . 0.01 110.804 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -124.83 165.33 18.22 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.568 -0.901 . . . . 3.1499999999999999 108.568 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -165.37 26.84 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.34 -1.504 . . . . 0.01 109.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -75.18 145.38 42.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.124 -1.221 . . . . 0.01 108.264 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.464 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.7 tmm? -116.47 142.31 47.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.678 0.752 . . . . 0.01 110.131 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.453 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.6 m-85 -130.85 135.31 47.6 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.844 -1.169 . . . . 2.48 107.844 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.25 135.77 54.8 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.596 -0.69 . . . . 0.01 109.751 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.15 154.46 39.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.039 -1.038 . . . . 1.6899999999999999 110.674 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.8 p -111.34 8.35 21.32 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.818 -0.628 . . . . 0.01 110.009 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.2 163.5 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.337 -0.852 . . . . 3.21 111.383 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.77 155.92 38.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.124 -1.065 . . . . 0.01 108.124 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' CYS . . . . . 0.405 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.5 t -126.0 112.41 24.33 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.687 -0.857 . . . . 0.01 108.687 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -74.81 -28.69 9.31 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.245 1.123 . . . . 0.01 111.094 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -142.52 108.65 5.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -0.843 . . . . 0.02 108.953 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.2 mt -62.62 -38.27 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.879 -0.513 . . . . 1.8300000000000001 110.414 -178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.78 -37.38 79.27 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.224 -0.99 . . . . 1.3400000000000001 110.451 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.87 -39.25 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.462 -1.399 . . . . 2.1099999999999999 109.963 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.47 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 55.2 tt0 -79.38 -47.27 16.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 2.0800000000000001 112.409 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.47 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.4 m-85 -111.71 -0.1 16.11 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.431 -0.793 . . . . 0.02 112.808 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 m80 61.3 34.08 18.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.812 -1.18 . . . . 0.02 109.639 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.25 134.15 54.73 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.403 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.94 -21.61 21.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 5.3200000000000003 109.984 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -149.83 164.56 35.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.149 -0.97 . . . . 0.02 109.859 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.96 128.52 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.294 -1.373 . . . . 2.1699999999999999 107.294 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -107.23 -12.85 15.28 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.518 -0.739 . . . . 0.02 111.974 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.2 t -161.33 155.14 22.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.01 108.905 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -166.66 144.46 5.11 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.957 -1.127 . . . . 1.22 107.957 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -119.39 101.89 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.176 0.988 . . . . 1.4099999999999999 109.004 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 131' ' ' VAL . 12.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.487 -0.931 . . . . 0.01 108.487 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.0 m95 . . . . . 0 N--CA 1.51 2.551 0 CA-C-O 121.524 0.678 . . . . 0.01 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -121.14 138.86 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.929 -0.767 . . . . 1.6899999999999999 108.929 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 151' ' ' LEU . 2.8 m-30 -111.92 142.01 44.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.089 -1.448 . . . . 2.4900000000000002 107.089 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 22.0 m-85 -123.17 144.04 49.62 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.214 -0.929 . . . . 0.02 109.448 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.2 -30.22 60.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.02 111.552 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 155.46 46.76 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.68 -1.262 . . . . 1.48 108.954 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -57.09 167.27 3.38 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.183 1.255 . . . . 0.02 112.721 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.7 t30 59.01 31.63 21.54 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.144 -0.935 . . . . 0.75 111.341 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.52 51.19 10.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.02 111.157 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.34 165.1 18.97 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.614 -0.679 . . . . 0.02 109.914 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.67 -165.38 33.55 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.174 -1.17 . . . . 0.02 110.174 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -69.94 143.02 52.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -1.035 . . . . 0.02 108.915 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -112.03 147.75 35.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.383 0.611 . . . . 0.02 109.816 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.42 133.76 53.29 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.841 -0.8 . . . . 0.01 108.841 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -97.95 122.64 41.31 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.827 -1.17 . . . . 0.01 109.923 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 138' ' ' PHE . 16.8 mt -91.75 143.46 26.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.01 108.61 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' LYS . 20.1 m-20 -108.23 -179.01 3.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.438 -0.789 . . . . 2.27 109.725 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.28 36.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 1.8400000000000001 109.526 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 152' ' ' ASP . 89.3 mttt -111.9 177.57 4.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.789 . . . . 2.2799999999999998 109.271 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -106.07 121.87 45.01 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.843 -0.799 . . . . 0.01 108.843 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.97 113.04 25.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.349 -0.844 . . . . 0.01 110.346 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -94.18 -25.58 17.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.127 -0.983 . . . . 0.01 110.934 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -124.75 154.31 70.43 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.922 -1.111 . . . . 2.54 108.119 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.55 -40.69 45.31 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.186 0.745 . . . . 0.69999999999999996 110.555 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.8 -19.72 21.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.991 -1.068 . . . . 0.85999999999999999 109.055 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.14 -18.59 65.44 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.962 -1.086 . . . . 0.02 111.388 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.875 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 1.8 p90 -102.74 14.27 32.37 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.037 -1.04 . . . . 0.02 109.859 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.15 9.77 69.84 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.393 -0.817 . . . . 0.02 113.734 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.619 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.86 140.89 34.51 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.533 -1.569 . . . . 0.02 110.619 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.14 -7.1 59.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.58999999999999997 109.333 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.8 m -142.53 150.71 55.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.126 -0.984 . . . . 0.87 109.293 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.43 17.7 0.63 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.729 0.953 . . . . 0.38 112.28 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.6 29.07 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.476 1.132 . . . . 0.17999999999999999 111.429 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.875 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.5 mt -148.77 127.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.84 -1.541 . . . . 3.9900000000000002 106.84 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -113.34 -16.31 12.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.231 -0.918 . . . . 5.1699999999999999 112.726 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 23.0 t -157.18 159.49 37.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 119.287 -2.133 . . . . 0.02 110.176 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.04 152.85 34.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.868 . . . . 2.02 109.917 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -144.71 151.06 38.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.244 -0.91 . . . . 0.01 110.498 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -87.95 143.52 27.06 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.722 -0.844 . . . . 0.01 108.722 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.2 mt -94.91 128.7 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 3.04 109.119 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.66 146.64 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.19 -0.944 . . . . 1.8899999999999999 109.418 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 4.8899999999999997 109.099 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 106.984 -2.447 . . . . 0.81000000000000005 106.984 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 148.15 32.5 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.309 -0.948 . . . . 0.01 110.84 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -152.19 137.05 17.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.944 . . . . 0.02 108.984 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.5 tt -130.22 140.91 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -121.03 129.21 53.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.774 . . . . 0.39000000000000001 109.833 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 17.1 m-85 -109.42 139.68 44.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.898 -0.778 . . . . 0.02 108.898 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 16.6 m-85 -123.05 138.33 54.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.265 -0.897 . . . . 0.02 109.915 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 34' ' ' SER . 16.6 mm-40 -67.1 -27.68 67.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.029999999999999999 111.258 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 10.2 t70 -114.18 169.78 8.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 110.136 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 16.1 mtp180 -75.61 162.3 28.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 110.276 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.7 m120 62.94 34.49 14.1 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.955 0.883 . . . . 0.73999999999999999 110.397 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.6 42.64 23.38 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.391 -0.822 . . . . 0.02 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.6 166.21 11.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.88 36.07 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 110.522 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -68.32 143.72 55.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -1.02 . . . . 2.7599999999999998 109.153 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -121.33 149.2 43.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.5 -0.75 . . . . 1.8899999999999999 110.179 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -133.36 128.56 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.644 -0.873 . . . . 0.02 108.644 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.72 136.46 50.93 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.457 -0.777 . . . . 1.1200000000000001 109.538 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.39 137.61 49.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.282 -0.636 . . . . 0.02 109.282 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -117.05 11.11 14.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.605 -0.684 . . . . 0.20000000000000001 109.741 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 48.5 t -158.36 174.45 15.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 35.0 t0 -60.58 143.21 54.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.692 -1.255 . . . . 0.02 109.893 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 9.7 t -130.46 116.63 18.49 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.449 -0.945 . . . . 0.02 108.449 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.06 -23.79 51.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.076 -1.015 . . . . 0.23999999999999999 110.678 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -156.0 100.91 2.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.896 -1.127 . . . . 1.1399999999999999 108.576 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -105.32 8.77 33.9 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.177 0.989 . . . . 6.3700000000000001 109.613 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.31 -24.39 63.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.602 -0.686 . . . . 3.1099999999999999 110.94 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.6 p -74.5 -16.62 60.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 109.876 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -105.04 -21.7 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.737 . . . . 0.02 109.259 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 1.7 tp -148.14 125.56 11.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 3.3199999999999998 109.247 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.519 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 4.6 m -85.87 -11.35 53.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.833 . . . . 0.02 111.313 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.51 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 7.2 mtm180 -171.56 161.7 6.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.364 -1.347 . . . . 0.02 107.364 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 39' ' ' ILE . 34.8 t -141.47 113.93 8.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.223 -0.923 . . . . 0.02 109.205 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.456 ' ND2' ' CG ' ' A' ' 77' ' ' ASP . 3.3 m120 -108.13 -0.17 21.23 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.01 -1.056 . . . . 0.029999999999999999 110.589 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 t -156.21 152.46 27.83 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.524 -1.288 . . . . 0.02 107.524 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CG1' ' SG ' ' A' ' 36' ' ' CYS . 84.2 mt -144.79 147.44 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.35 1.072 . . . . 0.02 110.198 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 22.1 ttp180 -122.5 123.14 40.57 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.412 -1.329 . . . . 0.02 107.412 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.95 113.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 106.723 -1.584 . . . . 0.02 106.723 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 47.8 mm-40 -83.52 -34.09 25.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.968 -0.693 . . . . 3.8100000000000001 109.639 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 150.6 19.94 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 118.7 -1.714 . . . . 0.02 110.463 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.09 173.48 49.7 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.881 -1.152 . . . . 0.01 110.404 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.3 m -119.83 136.73 54.36 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.19 -1.041 . . . . 1.48 108.19 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -125.88 153.83 43.59 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.613 1.197 . . . . 0.02 112.158 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.27 133.8 51.99 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 104.942 -2.244 . . . . 0.23999999999999999 104.942 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.98 142.39 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.65000000000000002 109.329 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 40.8 m-85 -121.63 144.44 48.75 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.058 0.932 . . . . 0.02 109.754 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.33 -35.57 80.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.521 -0.763 . . . . 0.02 111.833 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.408 HH22 ' CZ ' ' A' ' 78' ' ' ARG . 3.6 mmp_? -124.05 153.89 67.96 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.147 -0.97 . . . . 0.02 109.554 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -50.61 166.39 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.306 1.338 . . . . 0.02 113.378 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.81 37.52 9.7 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.123 -0.944 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 44.1 51.82 7.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.779 0.8 . . . . 3.3900000000000001 110.663 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -124.97 163.17 22.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.572 -0.529 . . . . 2.3300000000000001 109.572 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.73 -161.34 32.07 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.647 -1.381 . . . . 0.02 109.647 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -67.57 139.35 56.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.983 -1.304 . . . . 0.02 110.413 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 22.3 ptm -118.73 137.41 53.37 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.637 -0.664 . . . . 5.0099999999999998 109.719 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 52.6 m-85 -132.92 138.42 46.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.472 -0.767 . . . . 0.02 109.65 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.29 132.17 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.737 -0.838 . . . . 1.72 108.737 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -119.85 109.67 37.5 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 121.416 -0.802 . . . . 0.02 110.451 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -76.48 168.67 23.34 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.136 1.084 . . . . 1.47 109.997 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -52.23 140.31 21.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.673 -1.267 . . . . 4.25 110.18 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.88 -177.52 32.11 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.476 -1.345 . . . . 0.02 110.742 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.05 130.94 54.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.43 -1.041 . . . . 0.95999999999999996 109.305 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 27.9 m-85 -121.97 90.6 48.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.43 -4.46 8.16 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 121.006 1.138 . . . . 0.02 113.389 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -154.45 150.62 28.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 2.02 107.527 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 19.6 p90 -60.29 -37.8 81.64 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.02 112.22 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -61.02 -23.51 65.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.02 111.216 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.7 OUTLIER -72.66 -16.53 61.7 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.116 -1.034 . . . . 3.4199999999999999 109.053 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.574 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.93 10.41 30.52 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.087 -1.449 . . . . 0.02 107.087 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm 61.84 21.75 12.49 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.357 0.599 . . . . 0.02 110.764 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.06 144.66 46.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.02 109.237 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 30.8 tp -79.5 -30.68 42.05 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.837 -1.172 . . . . 0.97999999999999998 107.837 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.67 -172.4 3.94 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.619 -1.622 . . . . 0.02 106.619 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 22.3 m-20 -97.89 27.2 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.687 -1.258 . . . . 0.02 110.382 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.49 122.82 39.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.142 -0.974 . . . . 3.2000000000000002 110.777 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD22 ' HB ' ' A' ' 48' ' ' VAL . 61.8 mt -143.63 121.67 12.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.865 -1.161 . . . . 2.6099999999999999 107.865 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.95 -17.75 9.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.345 -0.847 . . . . 0.02 112.54 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 36.5 m -155.28 155.38 33.66 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.757 1.778 . . . . 0.02 110.843 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 12.7 m -145.06 146.98 32.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.567 0.698 . . . . 0.02 110.414 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 71.5 mtm180 -135.64 141.4 45.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.741 -0.837 . . . . 0.01 108.741 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 130.95 37.27 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.136 -0.978 . . . . 0.42999999999999999 108.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -88.82 123.47 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -91.02 133.89 34.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 1.77 108.208 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 139.38 35.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.997 -0.742 . . . . 1.6299999999999999 108.997 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 p -112.02 125.71 54.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.671 -0.862 . . . . 1.0800000000000001 108.671 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -102.11 -155.97 0.54 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 106.0 -1.852 . . . . 1.26 106.0 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.4 -47.36 0.97 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 120.561 -1.337 . . . . 0.01 112.279 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.76 -98.61 0.12 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.479 -1.82 . . . . 0.01 112.348 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.53 121.41 36.47 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.218 -1.166 . . . . 4.4299999999999997 111.034 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 132.23 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.166 -0.679 . . . . 2.9900000000000002 109.166 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.424 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.5 ttpm? -132.11 139.46 48.47 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.022 -0.733 . . . . 6.3600000000000003 109.022 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.1 tt -127.48 143.92 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 121.975 0.893 . . . . 1.0900000000000001 109.591 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -124.81 133.54 53.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.743 -1.206 . . . . 2.0499999999999998 107.743 177.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -124.77 147.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.946 -1.096 . . . . 1.1000000000000001 109.546 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -117.57 140.72 49.25 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.987 0.899 . . . . 0.72999999999999998 110.948 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.96 -29.68 70.12 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.987 -0.551 . . . . 0.02 111.444 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 128' ' ' SER . 54.2 mttm -117.35 171.23 8.11 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.289 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.16 170.16 41.91 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.072 -0.811 . . . . 0.01 111.072 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.3 t0 52.51 39.56 28.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.564 0.697 . . . . 0.01 111.646 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 51.92 49.47 20.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.699 -0.626 . . . . 0.01 110.796 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.76 166.2 15.97 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.369 -0.974 . . . . 3.1499999999999999 108.369 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.78 -165.48 28.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.618 -1.393 . . . . 0.01 109.618 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -75.62 144.7 41.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.009 -1.289 . . . . 0.01 108.594 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.6 tmm? -116.9 142.98 46.24 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.684 0.754 . . . . 0.01 110.171 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.423 ' N ' ' SD ' ' A' ' 107' ' ' MET . 42.7 m-85 -130.88 135.68 47.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.891 -1.152 . . . . 2.48 107.891 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.95 135.0 54.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.548 -0.72 . . . . 0.01 110.115 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -149.76 153.15 36.39 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.109 0.957 . . . . 1.6899999999999999 110.572 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.9 p -109.38 10.37 25.47 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.812 -0.631 . . . . 0.01 109.901 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.37 163.53 18.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.409 -0.807 . . . . 3.21 111.379 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.18 154.65 39.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.346 -0.983 . . . . 0.01 108.346 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.21 111.6 30.32 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.47 -0.769 . . . . 0.01 108.928 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -77.33 -33.63 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 119.885 0.994 . . . . 0.01 111.988 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.7 m -140.94 108.44 5.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.21 -0.931 . . . . 0.02 109.188 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 26.8 mt -63.43 -39.66 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.759 -0.588 . . . . 1.8300000000000001 110.791 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttp -66.4 -37.81 86.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.002 -1.079 . . . . 1.3400000000000001 110.033 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.34 -39.19 74.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.678 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.467 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 52.6 tt0 -81.19 -47.9 12.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 2.0800000000000001 112.506 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 63.6 m-85 -111.77 -2.53 15.25 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.427 -0.796 . . . . 0.02 112.76 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 61.99 34.02 16.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.719 -1.238 . . . . 0.02 109.323 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 mt -114.7 135.71 53.86 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.333 -0.854 . . . . 0.02 109.291 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -90.0 -20.91 22.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.026 -1.046 . . . . 5.3200000000000003 111.17 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 35.4 mt-10 -149.23 164.9 33.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.692 -1.255 . . . . 0.02 110.709 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 27.8 mm -127.54 124.37 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.553 -1.277 . . . . 2.1699999999999999 107.553 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.1 m80 -110.75 -14.66 13.98 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.107 -0.996 . . . . 0.02 113.113 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.3 p -163.36 155.47 17.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.625 -1.297 . . . . 0.01 109.204 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.5 p -171.0 143.31 1.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.22 108.964 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 24.1 pttt -119.5 99.0 6.4 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.6 1.19 . . . . 1.4099999999999999 109.289 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.306 -0.998 . . . . 0.01 108.306 179.677 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 41.3 m95 . . . . . 0 N--CA 1.506 2.335 0 N-CA-C 107.629 -1.249 . . . . 0.01 107.629 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 43.7 mt -118.7 133.57 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.455 -1.403 . . . . 1.6899999999999999 109.574 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -111.59 141.96 44.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.149 -1.797 . . . . 2.4900000000000002 106.149 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 23.1 m-85 -123.83 144.38 49.76 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.92 -1.113 . . . . 0.02 109.793 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.04 -31.43 62.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.809 -0.557 . . . . 0.02 111.799 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.21 155.14 47.2 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.816 -1.178 . . . . 1.48 108.903 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -56.81 166.75 3.54 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.128 1.219 . . . . 0.02 112.799 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.01 31.1 20.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.206 -0.906 . . . . 0.75 111.375 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 58.26 52.03 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.727 . . . . 0.02 111.285 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -126.94 165.47 19.34 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.599 -0.688 . . . . 0.02 110.021 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.48 -165.53 33.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -69.45 142.56 53.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.578 -0.954 . . . . 0.02 108.843 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -112.89 147.22 37.48 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.294 0.569 . . . . 0.02 109.687 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.57 134.14 53.87 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.676 -0.861 . . . . 0.01 108.676 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.56 120.95 37.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.922 -1.111 . . . . 0.01 109.526 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -98.47 144.68 27.55 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.315 -0.995 . . . . 0.01 108.315 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 154' ' ' LYS . 6.2 m-20 -108.64 -175.28 2.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 2.27 109.859 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -73.01 32.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 152' ' ' ASP . 17.6 ttmt -110.4 173.57 6.27 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.694 -0.854 . . . . 2.2799999999999998 108.694 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -105.56 129.35 53.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.01 109.364 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -100.35 111.61 23.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.359 -0.838 . . . . 0.01 109.446 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.462 ' H ' ' CD ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -89.71 -26.84 20.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.01 110.816 -177.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -123.78 155.26 66.9 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.552 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.3 Cg_endo -63.07 -39.46 39.49 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 CA-C-N 119.349 0.803 . . . . 0.69999999999999996 111.057 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.89 -18.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.773 -1.204 . . . . 0.85999999999999999 109.945 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.48 -18.41 65.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.945 -1.097 . . . . 0.02 112.38 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.552 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.13 15.62 28.11 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 120.737 -1.227 . . . . 0.02 109.917 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.92 76.6 Favored Glycine 0 N--CA 1.5 2.926 0 O-C-N 121.172 -0.955 . . . . 0.02 112.847 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 140.74 34.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.726 -1.455 . . . . 0.02 110.278 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -7.11 59.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 109.739 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.0 m -141.96 149.7 53.62 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.186 -0.947 . . . . 0.87 109.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.76 16.89 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.736 0.957 . . . . 0.38 112.06 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.64 120.71 25.42 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.362 1.077 . . . . 0.17999999999999999 110.786 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mp -150.66 124.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 106.194 -1.78 . . . . 3.9900000000000002 106.194 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.33 -12.29 14.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.83 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.9 p -156.97 160.13 38.75 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.231 -2.168 . . . . 0.02 109.925 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.99 153.4 33.98 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.312 -0.867 . . . . 2.02 110.047 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.68 149.26 36.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.01 110.24 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -86.25 142.26 28.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.183 -1.043 . . . . 0.01 108.183 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.429 HD11 ' CG1' ' A' ' 137' ' ' ILE . 44.2 mt -93.35 128.63 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.451 -0.9 . . . . 3.04 109.327 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.73 148.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 1.8899999999999999 109.918 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.712 . . . . 4.8899999999999997 109.562 179.339 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 106.987 -2.445 . . . . 0.81000000000000005 106.987 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.29 148.72 33.04 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.607 -0.997 . . . . 0.01 110.607 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -150.77 136.26 17.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -1.005 . . . . 0.02 108.862 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.37 140.52 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.909 -0.774 . . . . 0.02 108.909 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 11.0 t -122.25 129.98 52.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.769 . . . . 0.39000000000000001 109.76 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 26.3 m-85 -108.39 138.55 44.49 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.87 -0.789 . . . . 0.02 108.87 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 26.9 m-85 -122.65 138.72 54.51 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.194 -0.941 . . . . 0.02 109.788 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.496 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 91.8 mt-10 -69.55 -27.49 65.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.675 . . . . 0.029999999999999999 112.041 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.33 170.75 8.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.569 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.688 ' NH1' HD22 ' A' ' 37' ' ' ASN . 10.9 mpt_? -73.72 157.15 37.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.757 0.789 . . . . 0.029999999999999999 109.897 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.27 35.41 5.94 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.875 0.845 . . . . 0.73999999999999999 111.117 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 7.6 p90 49.6 45.19 24.44 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.699 0.761 . . . . 0.02 111.01 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -112.0 166.29 11.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.01 -1.108 . . . . 0.02 108.01 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -167.16 35.42 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.029999999999999999 110.71 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -68.97 143.03 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.414 -1.05 . . . . 2.7599999999999998 109.204 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 56.8 ttt180 -119.04 147.8 43.72 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.544 0.688 . . . . 1.8899999999999999 109.587 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -132.45 126.48 33.15 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.728 -1.212 . . . . 0.02 107.728 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -111.92 136.29 51.43 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.708 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.2 t -130.48 137.56 49.83 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.482 0.658 . . . . 0.02 109.48 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -116.52 10.89 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.703 -0.623 . . . . 0.20000000000000001 109.514 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 49.0 t -157.94 174.35 15.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.151 -1.055 . . . . 1.23 108.151 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 p30 -62.15 144.87 54.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.69 -1.256 . . . . 0.02 110.152 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -132.37 116.56 16.99 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.422 -0.955 . . . . 0.02 108.422 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.13 53.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.877 . . . . 0.23999999999999999 110.732 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.23 100.98 2.35 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -105.2 10.1 33.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.005 0.907 . . . . 6.3700000000000001 110.063 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.681 HH22 ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.49 -22.27 61.34 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.672 -0.642 . . . . 3.1099999999999999 110.701 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -75.54 -16.97 60.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.702 -1.249 . . . . 0.88 110.29 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -102.97 -22.03 13.87 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 0.02 109.221 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.2 tp -150.67 129.49 12.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.822 0.82 . . . . 3.3199999999999998 108.825 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -85.63 -10.12 56.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.656 -0.652 . . . . 0.02 111.142 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -171.65 163.91 6.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.439 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -141.26 113.69 8.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.823 -1.173 . . . . 0.02 109.133 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.688 HD22 ' NH1' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -107.22 -3.7 19.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.029999999999999999 110.285 -179.002 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.36 152.39 31.03 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.002 -1.11 . . . . 0.02 108.002 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.4 147.76 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.02 109.973 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -125.08 126.11 44.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.876 -1.157 . . . . 0.02 107.876 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.45 114.76 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.883 -1.525 . . . . 0.02 106.883 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.15 -34.07 24.11 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.783 -0.767 . . . . 3.8100000000000001 109.865 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.3 150.11 18.99 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.572 -1.775 . . . . 0.02 110.507 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.11 173.39 49.75 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.623 -1.275 . . . . 0.01 110.062 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.1 m -118.61 136.06 54.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.76 -1.2 . . . . 1.48 107.76 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -126.0 153.52 44.23 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.821 -1.174 . . . . 0.02 112.159 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.11 133.08 52.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.108 -2.182 . . . . 0.23999999999999999 105.108 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.1 m -117.94 142.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.092 -0.707 . . . . 0.65000000000000002 109.092 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -121.17 145.78 47.47 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.22 1.01 . . . . 0.02 109.77 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 10.4 tt0 -66.68 -34.09 77.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.752 -0.658 . . . . 0.02 111.663 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' NH1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 mpt_? -122.87 159.04 55.39 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 121.002 -1.061 . . . . 0.02 109.287 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.39 166.2 1.89 Allowed 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.528 1.485 . . . . 0.02 112.31 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.4 36.33 11.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.643 0.735 . . . . 0.02 111.167 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 45.52 52.42 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.462 0.648 . . . . 3.3900000000000001 111.08 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -125.92 163.47 22.88 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.162 0.506 . . . . 2.3300000000000001 109.752 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.91 -161.2 31.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.592 -1.403 . . . . 0.02 109.592 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.494 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 2.1 m80 -65.72 137.86 57.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.98 -1.306 . . . . 0.02 109.883 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.478 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.7 ptm -119.69 137.04 54.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.604 -0.685 . . . . 5.0099999999999998 109.392 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 49.8 m-85 -134.08 141.01 47.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.499 -0.751 . . . . 0.02 109.714 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.669 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.17 132.1 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.555 -0.906 . . . . 1.72 108.555 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -119.96 109.75 37.23 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.476 -0.765 . . . . 0.02 110.323 -178.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -76.49 168.68 23.32 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.007 1.038 . . . . 1.47 110.327 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -53.41 140.68 26.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.869 -1.144 . . . . 4.25 110.504 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -176.97 32.36 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.627 -1.273 . . . . 0.02 110.452 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.16 130.16 55.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.489 -1.006 . . . . 0.95999999999999996 109.216 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.49 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 30.5 m-85 -121.48 95.24 48.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.22 -3.71 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.767 0.978 . . . . 0.02 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -157.36 154.89 29.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.352 -1.467 . . . . 2.02 108.311 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -60.85 -39.05 87.63 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.677 . . . . 0.02 111.651 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -60.16 -23.62 64.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.02 110.34 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -18.56 62.95 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.063 0.935 . . . . 3.4199999999999999 108.578 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -107.4 10.49 29.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.337 -1.357 . . . . 0.02 107.337 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 27.6 mtm 61.55 21.98 12.53 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.473 0.654 . . . . 0.02 110.738 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.58 144.36 45.97 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.328 -1.509 . . . . 0.02 109.328 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 tp -78.72 -30.83 46.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.493 -1.299 . . . . 0.97999999999999998 107.493 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -156.37 -171.53 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.255 -1.757 . . . . 0.02 106.255 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -97.73 27.7 4.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.646 -1.284 . . . . 0.02 110.194 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.681 ' NH2' HH22 ' A' ' 30' ' ' ARG . 19.7 mmm180 -96.08 122.06 38.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.893 -1.129 . . . . 3.2000000000000002 110.631 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.1 mt -144.98 119.95 10.01 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.511 -1.292 . . . . 2.6099999999999999 107.511 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.32 -16.07 11.66 Favored Glycine 0 N--CA 1.505 3.267 0 O-C-N 121.264 -0.898 . . . . 0.02 112.879 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.8 p -155.52 155.88 34.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.204 -1.763 . . . . 0.02 110.343 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.2 t -144.94 148.21 33.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.334 0.588 . . . . 0.02 109.71 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -135.55 140.24 44.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.332 -0.855 . . . . 0.01 108.89 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 130.12 36.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.205 -0.935 . . . . 0.42999999999999999 108.72 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.55 122.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 1.25 107.993 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' C ' HD23 ' A' ' 87' ' ' LEU . 15.1 m80 -92.0 133.94 35.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.94 -1.1 . . . . 1.77 108.576 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -98.18 137.96 36.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.242 -1.022 . . . . 1.6299999999999999 108.242 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -110.3 126.9 54.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 1.0800000000000001 108.743 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 p -104.29 -154.86 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.28 -1.748 . . . . 1.26 106.28 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.11 -47.5 0.97 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.509 -1.369 . . . . 0.01 112.237 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.53 -100.18 0.14 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.676 -1.726 . . . . 0.01 111.779 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.31 118.74 31.2 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.293 -1.122 . . . . 4.4299999999999997 110.221 -179.091 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.55 130.38 37.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.102 -0.703 . . . . 2.9900000000000002 109.102 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -131.28 139.19 49.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.464 -0.773 . . . . 6.3600000000000003 109.323 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 tt -129.19 144.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.462 -0.774 . . . . 1.0900000000000001 109.742 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.33 134.01 54.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.424 -1.324 . . . . 2.0499999999999998 107.424 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.44 147.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.902 -1.124 . . . . 1.1000000000000001 109.232 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 95.2 m-85 -118.77 141.34 48.71 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.097 0.951 . . . . 0.72999999999999998 111.088 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.78 -30.01 70.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.791 -0.64 . . . . 0.02 111.57 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -117.03 168.77 9.96 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.947 -1.096 . . . . 3.1800000000000002 110.553 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.07 43.31 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.013 -0.835 . . . . 0.01 111.013 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.2 m-20 56.48 39.09 30.1 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.664 0.745 . . . . 0.01 110.86 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 6.7 m-85 52.29 55.58 8.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.69 -0.631 . . . . 0.01 110.952 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -128.85 166.1 19.73 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.496 -0.927 . . . . 3.1499999999999999 108.496 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 -165.38 27.85 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -74.52 145.31 43.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.093 -1.239 . . . . 0.01 108.237 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.3 ttp -117.54 142.75 46.81 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.753 0.787 . . . . 0.01 110.179 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.94 135.29 47.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.963 -1.125 . . . . 2.48 107.963 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -119.79 135.56 54.81 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.608 -0.683 . . . . 0.01 109.957 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.524 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.1 t -150.09 152.13 34.29 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.33 1.062 . . . . 1.6899999999999999 111.074 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.7 p -110.28 9.55 23.68 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.622 -0.717 . . . . 0.01 109.808 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -121.08 163.32 18.56 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.311 -0.868 . . . . 3.21 111.398 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -66.51 155.28 38.07 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 27.5 t -124.53 111.6 27.86 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.737 -0.838 . . . . 0.01 108.737 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.86 -32.5 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.128 1.081 . . . . 0.01 111.732 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 m -140.82 107.61 5.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.02 108.855 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.7 mt -63.3 -39.04 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.779 -0.576 . . . . 1.8300000000000001 110.375 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 5.9 tpt -66.1 -37.89 86.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.868 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -70.73 -39.3 73.45 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.374 -1.454 . . . . 2.1099999999999999 109.532 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 42.1 tt0 -80.53 -48.01 13.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 2.0800000000000001 112.458 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 66.0 m-85 -111.23 -1.78 15.98 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.02 112.623 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 61.12 34.33 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.745 -1.222 . . . . 0.02 109.603 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' C ' ' SD ' ' A' ' 118' ' ' MET . 52.5 mt -114.33 136.21 53.23 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.517 -0.74 . . . . 0.02 109.432 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -90.25 -21.96 21.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.323 -0.861 . . . . 5.3200000000000003 110.737 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 37.8 mt-10 -148.91 164.3 34.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.966 -1.084 . . . . 0.02 109.939 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 34.6 mm -129.49 126.7 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.453 -1.314 . . . . 2.1699999999999999 107.453 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -110.07 -12.93 14.47 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.267 -0.896 . . . . 0.02 112.658 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.5 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.8 t -160.42 153.13 21.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.691 -1.256 . . . . 0.01 109.002 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -167.08 146.32 5.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 1.22 109.349 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -125.22 106.4 9.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.45 1.119 . . . . 1.4099999999999999 109.381 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.2 p . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 107.328 -1.36 . . . . 0.01 107.328 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.403 ' CD1' HG21 ' A' ' 131' ' ' VAL . 9.5 m95 . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 106.789 -1.56 . . . . 0.01 106.789 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.439 HG13 HD11 ' A' ' 175' ' ' ILE . 32.6 mt -118.08 134.3 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.446 -1.409 . . . . 1.6899999999999999 109.266 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.51 141.69 44.76 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.344 -1.724 . . . . 2.4900000000000002 106.344 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.3 m-85 -123.19 143.46 50.0 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.22 -0.925 . . . . 0.02 109.64 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.98 -30.69 62.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.739 -0.601 . . . . 0.02 111.668 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.79 154.31 49.42 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.48 108.874 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.82 169.68 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.156 1.238 . . . . 0.02 113.174 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.9 t30 57.51 32.29 21.59 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.99 -1.004 . . . . 0.75 111.462 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 55.57 48.34 18.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.534 -0.729 . . . . 0.02 110.382 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -122.08 163.9 18.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.659 -0.651 . . . . 0.02 109.613 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.13 -165.51 32.95 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.16 -1.176 . . . . 0.02 110.16 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.71 143.18 53.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.499 -1.001 . . . . 0.02 109.15 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.478 ' O ' ' CG ' ' A' ' 58' ' ' MET . 12.0 mt-30 -112.95 148.24 35.43 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.281 0.562 . . . . 0.02 109.763 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -123.31 133.28 54.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.435 -0.95 . . . . 0.01 108.435 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.23 120.72 37.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.794 -1.191 . . . . 0.01 109.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.66 139.71 33.15 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.174 -1.047 . . . . 0.01 108.174 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 154' ' ' LYS . 0.7 OUTLIER -107.39 -171.82 1.95 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.345 -0.847 . . . . 2.27 109.905 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.01 40.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 1.8400000000000001 109.568 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 152' ' ' ASP . 75.3 tttt -113.57 168.49 9.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.619 -0.675 . . . . 2.2799999999999998 109.28 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -103.48 127.54 50.85 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.18 -1.044 . . . . 0.01 108.18 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.85 110.62 22.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.019 -1.051 . . . . 0.01 110.598 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -93.8 -26.66 16.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.314 -0.867 . . . . 0.01 110.736 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -123.24 154.09 65.23 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 107.897 -1.149 . . . . 2.54 107.897 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -62.14 -42.37 29.82 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.237 0.763 . . . . 0.69999999999999996 111.097 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 -18.68 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 120.68 -1.262 . . . . 0.85999999999999999 109.428 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 60.2 t0 -65.53 -18.18 65.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.841 -1.162 . . . . 0.02 111.964 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.77 15.84 27.7 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 120.737 -1.227 . . . . 0.02 110.037 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.89 74.35 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 121.053 -1.029 . . . . 0.02 112.869 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.56 140.59 34.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.717 -1.46 . . . . 0.02 110.13 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.83 -6.92 59.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.687 -0.633 . . . . 0.58999999999999997 109.553 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 m -140.84 150.06 58.44 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.223 -0.923 . . . . 0.87 109.088 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.47 16.15 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.672 0.915 . . . . 0.38 111.902 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.48 120.5 25.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.039 . . . . 0.17999999999999999 110.727 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.471 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -150.2 124.92 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.554 -2.017 . . . . 3.9900000000000002 105.554 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -112.41 -13.4 13.4 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.354 0.872 . . . . 5.1699999999999999 113.354 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.5 p -156.73 159.51 38.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.205 -2.184 . . . . 0.02 109.919 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -152.27 154.18 35.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.197 -0.939 . . . . 2.02 110.512 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -142.95 148.99 37.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.307 -0.871 . . . . 0.01 110.142 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -86.43 141.7 28.95 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.103 -1.073 . . . . 0.01 108.103 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.439 HD11 HG13 ' A' ' 137' ' ' ILE . 13.1 mt -94.98 128.95 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.084 -1.01 . . . . 3.04 109.766 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.2 m -137.39 149.31 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.485 -0.759 . . . . 1.8899999999999999 109.69 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.636 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 2.7 mp0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 4.8899999999999997 109.638 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 N-CA-C 106.677 -2.569 . . . . 0.81000000000000005 106.677 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.09 147.53 31.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.632 -0.987 . . . . 0.01 110.632 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -154.14 138.61 16.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.587 -0.949 . . . . 0.02 108.757 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 141.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.266 -0.642 . . . . 0.02 109.266 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.562 ' HG ' ' CG ' ' A' ' 21' ' ' ASP . 1.4 m -121.79 130.1 53.15 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.507 -0.746 . . . . 0.39000000000000001 109.661 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 16.8 m-85 -110.05 139.19 45.44 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.855 -0.794 . . . . 0.02 108.855 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-85 -123.04 139.39 54.13 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.156 -0.965 . . . . 0.02 110.218 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG2' HD11 ' A' ' 33' ' ' LEU . 19.6 mm-40 -69.62 -28.44 65.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.981 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.87 170.72 8.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 0.029999999999999999 110.54 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -73.39 156.3 38.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.763 0.792 . . . . 0.029999999999999999 110.371 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 64.98 34.71 8.72 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.811 0.815 . . . . 0.73999999999999999 111.533 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.58 42.37 29.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.02 111.333 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -112.7 165.38 12.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.202 -1.036 . . . . 0.02 108.202 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.74 -166.76 36.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.752 -1.213 . . . . 0.029999999999999999 110.496 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -69.25 142.38 54.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -1.056 . . . . 2.7599999999999998 109.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 58.5 ttt180 -119.18 148.22 43.34 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 1.8899999999999999 109.745 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.99 126.68 32.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.209 -1.034 . . . . 0.02 108.209 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' CG ' ' HG ' ' A' ' 8' ' ' SER . 4.2 m-20 -111.96 136.44 51.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.429 -0.795 . . . . 1.1200000000000001 109.651 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.0 t -130.59 137.8 49.83 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.465 0.65 . . . . 0.02 109.645 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 13.7 t70 -116.98 11.32 14.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.665 -0.647 . . . . 0.20000000000000001 109.713 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 48.7 m -158.11 173.97 15.92 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.85 144.77 54.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.661 -1.274 . . . . 0.02 110.214 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.3 p -132.02 116.71 17.44 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.82 -25.68 53.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.23999999999999999 110.657 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.72 100.77 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 108.444 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -104.82 9.36 34.88 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.207 1.004 . . . . 6.3700000000000001 109.755 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.572 ' CZ ' ' NH2' ' A' ' 78' ' ' ARG . 57.8 mtp180 -58.93 -23.28 61.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.678 -0.639 . . . . 3.1099999999999999 110.705 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 69.2 p -75.34 -16.69 60.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.691 -1.256 . . . . 0.88 110.162 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.4 m-85 -103.21 -21.65 13.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.02 109.178 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 11' ' ' GLU . 6.4 tp -150.62 129.2 12.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 3.3199999999999998 108.816 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -86.1 -10.0 55.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.808 -0.558 . . . . 0.02 110.984 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 25.3 ttt180 -171.1 162.04 6.95 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.4 -1.333 . . . . 0.02 107.4 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.5 m -141.36 114.33 8.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.111 . . . . 0.02 108.842 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -107.54 -0.15 22.29 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.711 -1.243 . . . . 0.029999999999999999 110.583 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 t -156.72 154.08 29.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.545 -1.28 . . . . 0.02 107.545 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.35 148.39 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.117 -0.989 . . . . 0.02 110.218 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -124.68 125.1 43.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.67 113.61 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.756 -1.572 . . . . 0.02 106.756 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -83.69 -34.14 25.03 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.127 -0.629 . . . . 3.8100000000000001 109.531 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.48 150.23 19.13 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.713 -1.708 . . . . 0.02 110.605 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.07 173.44 49.66 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.472 -1.347 . . . . 0.01 109.782 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 m -119.99 137.38 54.11 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 44.6 m95 -126.6 152.98 45.91 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.524 1.154 . . . . 0.02 111.922 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.42 133.79 51.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 104.841 -2.281 . . . . 0.23999999999999999 104.841 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.3 m -117.73 142.94 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.65000000000000002 109.228 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.6 m-85 -119.81 143.68 47.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.34 1.067 . . . . 0.02 109.703 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.08 -34.31 77.77 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.759 -0.655 . . . . 0.02 110.764 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -125.36 157.43 67.78 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.144 -0.972 . . . . 0.02 109.897 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.01 166.82 1.36 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.706 1.604 . . . . 0.02 113.16 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.43 36.37 8.93 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.054 -0.976 . . . . 0.02 111.195 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.77 51.79 10.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.534 0.683 . . . . 3.3900000000000001 110.782 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 p -127.25 164.22 22.19 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.286 0.565 . . . . 2.3300000000000001 109.824 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.47 -162.26 31.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.3 t-80 -63.05 142.78 58.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -1.204 . . . . 0.02 110.457 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.434 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 29.6 mtp -117.9 134.69 54.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.346 -0.613 . . . . 5.0099999999999998 109.346 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.636 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 31.5 m-85 -135.27 135.22 40.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.34 -0.85 . . . . 0.02 109.2 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -96.52 132.31 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.941 -0.763 . . . . 1.72 108.941 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.2 110.22 31.01 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.376 -0.828 . . . . 0.02 110.657 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -75.83 171.45 18.16 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.83 0.975 . . . . 1.47 109.91 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 1.9 pm0 -52.36 139.71 23.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.118 . . . . 4.25 110.237 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -178.02 33.04 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.435 -1.364 . . . . 0.02 110.446 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -119.11 130.06 55.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -1.084 . . . . 0.95999999999999996 109.423 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -120.87 96.54 48.65 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.75 -5.14 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.603 0.868 . . . . 0.02 114.055 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 67' ' ' PRO . 49.3 mm-40 -151.8 152.53 32.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.628 -1.249 . . . . 2.02 107.628 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -60.77 -37.89 83.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.406 -0.809 . . . . 0.02 111.075 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -59.93 -23.65 63.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.051 -1.031 . . . . 0.02 110.28 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.56 -18.75 62.23 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.283 1.039 . . . . 3.4199999999999999 108.243 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.636 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -105.66 8.42 33.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.212 -1.403 . . . . 0.02 107.212 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.3 mpt? 59.95 21.75 10.79 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.477 0.656 . . . . 0.02 110.35 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.31 143.98 45.74 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.26 -1.536 . . . . 0.02 109.26 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.4 tp -78.42 -30.78 47.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -156.22 -172.19 4.0 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.245 -1.761 . . . . 0.02 106.245 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 38.6 m-20 -97.57 27.46 4.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.781 -1.199 . . . . 0.02 110.346 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.6 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -96.1 122.09 38.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.071 -1.018 . . . . 3.2000000000000002 110.704 -179.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.8 mt -144.71 120.39 10.48 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.91 -16.05 12.1 Favored Glycine 0 N--CA 1.506 3.312 0 C-N-CA 120.491 -0.862 . . . . 0.02 112.64 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.3 p -156.3 156.89 34.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.393 -1.651 . . . . 0.02 110.238 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.2 m -144.84 148.66 34.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.698 -0.626 . . . . 0.02 109.415 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -136.38 140.83 43.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.332 -0.855 . . . . 0.01 109.136 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.93 36.47 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.305 -0.872 . . . . 0.42999999999999999 109.001 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.71 124.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.247 -1.02 . . . . 1.25 108.247 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -89.47 134.04 34.28 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.925 -1.139 . . . . 1.77 107.925 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.63 139.31 36.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 1.6299999999999999 109.15 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 p -111.22 122.68 48.49 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.669 -1.234 . . . . 1.0800000000000001 107.669 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 m -114.01 133.19 55.66 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.699 -1.223 . . . . 1.26 107.699 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.4 -46.31 0.02 OUTLIER Glycine 0 N--CA 1.501 3.0 0 C-N-CA 117.59 -2.243 . . . . 0.01 113.573 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.83 -103.13 0.17 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 120.17 1.985 . . . . 0.01 111.006 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -120.4 118.66 30.91 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.249 -1.148 . . . . 4.4299999999999997 110.204 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 131.21 41.34 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.141 -0.624 . . . . 2.9900000000000002 109.369 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.28 136.36 46.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.598 -0.689 . . . . 6.3600000000000003 109.67 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ3' ' A' ' 136' ' ' TRP . 10.9 tt -127.93 145.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.472 -0.767 . . . . 1.0900000000000001 109.262 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -121.65 133.12 54.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.427 HG12 ' SG ' ' A' ' 129' ' ' CYS . 22.6 m -124.32 147.24 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 120.887 -1.133 . . . . 1.1000000000000001 109.09 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -119.26 141.11 49.24 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.081 0.943 . . . . 0.72999999999999998 111.086 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -66.66 -29.56 69.61 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.758 -0.655 . . . . 0.02 111.465 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' A' ' 128' ' ' SER . 27.3 mmtp -115.6 169.02 9.5 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.148 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.83 164.82 51.2 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.056 -0.818 . . . . 0.01 111.056 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 57.14 39.46 28.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.854 -0.792 . . . . 0.01 111.411 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 52.04 54.13 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.618 -0.677 . . . . 0.01 111.142 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.65 165.49 21.68 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.052 -1.092 . . . . 3.1499999999999999 108.052 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.76 -164.63 27.84 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.171 -1.571 . . . . 0.01 109.171 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.07 144.18 43.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.829 -1.394 . . . . 0.01 108.661 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 13.0 tmm? -116.62 142.56 46.73 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.555 0.693 . . . . 0.01 109.885 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -131.42 136.31 47.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.537 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.7 tm-20 -120.41 135.72 54.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.642 -0.661 . . . . 0.01 109.806 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.537 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 5.0 t -149.37 152.48 35.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.253 1.025 . . . . 1.6899999999999999 110.881 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 p -112.01 8.76 20.3 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.729 -0.669 . . . . 0.01 109.941 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -121.48 163.46 18.76 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.331 -0.856 . . . . 3.21 111.353 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -67.94 156.74 36.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.327 -0.99 . . . . 0.01 108.327 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.08 113.08 26.51 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.511 -0.743 . . . . 0.01 109.016 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.9 -28.06 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 120.234 1.119 . . . . 0.01 111.055 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . 2.6 p -144.82 108.57 4.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 0.02 109.004 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.68 -39.52 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.873 -0.517 . . . . 1.8300000000000001 110.444 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.9 ttt -68.0 -37.25 81.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.114 -1.034 . . . . 1.3400000000000001 110.225 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 116' ' ' SER . 39.6 mt-10 -70.43 -38.78 74.63 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.636 -1.29 . . . . 2.1099999999999999 109.958 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -80.25 -47.9 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.932 . . . . 2.0800000000000001 112.417 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -110.7 -0.72 17.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.389 -0.819 . . . . 0.02 112.677 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 m170 60.39 33.52 20.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.696 -1.252 . . . . 0.02 109.434 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.83 134.52 54.31 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.733 -0.84 . . . . 0.02 108.733 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.456 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -91.7 -22.3 20.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 5.3200000000000003 110.163 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -149.29 163.81 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.238 -0.914 . . . . 0.02 109.843 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mt -133.18 129.37 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.272 -1.381 . . . . 2.1699999999999999 107.272 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -108.68 -12.12 14.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.455 -0.778 . . . . 0.02 112.461 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.8 p -160.15 154.45 23.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.01 108.749 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.8 t -166.0 143.13 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 1.22 108.897 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -120.34 103.93 9.61 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.681 1.229 . . . . 1.4099999999999999 109.153 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 131' ' ' VAL . 14.1 p . . . . . 0 C--N 1.302 -1.482 0 N-CA-C 107.706 -1.22 . . . . 0.01 107.706 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.409 ' CZ3' HG21 ' A' ' 95' ' ' ILE . 15.8 m95 . . . . . 0 N--CA 1.51 2.55 0 CA-C-O 121.625 0.726 . . . . 0.01 110.476 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.72 139.71 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.022 -0.733 . . . . 1.6899999999999999 109.022 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' HD2' HD13 ' A' ' 169' ' ' ILE . 2.6 m-30 -112.07 141.77 45.33 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 106.799 -1.556 . . . . 2.4900000000000002 106.799 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 23.7 m-85 -122.6 143.15 49.94 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.091 -1.006 . . . . 0.02 109.228 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -74.57 -31.17 61.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.606 -0.684 . . . . 0.02 111.613 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -115.06 155.86 46.06 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.68 -1.262 . . . . 1.48 108.752 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -57.88 166.71 4.99 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.095 1.197 . . . . 0.02 112.735 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 60.09 31.29 20.52 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.142 -0.935 . . . . 0.75 111.456 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 58.72 51.17 7.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.717 . . . . 0.02 110.863 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -126.09 165.61 18.53 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.611 -0.681 . . . . 0.02 110.02 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.75 -165.35 34.94 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.279 -1.128 . . . . 0.02 110.279 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.18 141.78 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.947 . . . . 0.02 108.848 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 15.2 mt-30 -112.63 147.75 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.517 -0.549 . . . . 0.02 109.517 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.18 133.23 53.61 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.764 -0.828 . . . . 0.01 108.764 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.74 121.83 39.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.941 -1.099 . . . . 0.01 109.341 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.41 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.0 mt -92.78 146.83 23.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.01 109.123 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 154' ' ' LYS . 24.2 m-20 -108.55 -171.43 1.85 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.576 -0.702 . . . . 2.27 109.442 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -75.46 29.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 1.8400000000000001 109.622 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 152' ' ' ASP . 54.8 mttp -113.21 170.94 7.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.5 -0.75 . . . . 2.2799999999999998 109.549 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.91 135.36 47.5 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -100.28 114.01 27.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.37 -0.831 . . . . 0.01 109.96 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -88.59 -28.18 20.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.01 110.988 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -124.63 155.21 69.81 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 107.4 -1.333 . . . . 2.54 107.4 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.1 Cg_endo -61.99 -39.39 50.82 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.395 0.73 . . . . 0.69999999999999996 111.457 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.79 -18.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.817 -1.177 . . . . 0.85999999999999999 109.829 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.15 -19.24 65.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.891 -1.131 . . . . 0.02 112.569 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.739 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 0.4 OUTLIER -101.79 16.23 26.5 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 120.696 -1.252 . . . . 0.02 109.881 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.66 10.52 79.19 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.369 -0.919 . . . . 0.02 112.771 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 141.03 34.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.898 -1.354 . . . . 0.02 110.069 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.7 59.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.658 -0.651 . . . . 0.58999999999999997 109.848 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -142.17 150.0 53.97 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.033 -1.042 . . . . 0.87 109.119 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -75.33 18.15 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.654 0.902 . . . . 0.38 112.144 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.98 122.76 28.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.545 1.164 . . . . 0.17999999999999999 110.922 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.739 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.9 mt -148.02 125.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.433 -1.692 . . . . 3.9900000000000002 106.433 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -113.67 -16.12 12.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 5.1699999999999999 112.65 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.8 p -157.06 158.98 37.47 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 119.247 -2.158 . . . . 0.02 110.196 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.77 154.57 35.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.053 -1.029 . . . . 2.02 110.114 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.452 HH11 ' HG3' ' A' ' 173' ' ' ARG . 5.4 mtm-85 -144.12 150.54 38.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.153 -0.967 . . . . 0.01 110.612 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -86.93 143.39 27.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.69 127.96 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.171 -0.956 . . . . 3.04 109.418 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.06 147.19 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.243 -0.911 . . . . 1.8899999999999999 109.54 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.401 ' OE1' ' OE1' ' A' ' 63' ' ' GLN . 24.5 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.415 -0.803 . . . . 4.8899999999999997 109.412 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.664 0 N-CA-C 106.957 -2.457 . . . . 0.81000000000000005 106.957 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.95 149.59 33.04 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.117 -1.04 . . . . 0.01 110.725 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -151.49 136.97 17.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.493 -1.004 . . . . 0.02 109.367 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -129.46 140.06 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.881 -0.785 . . . . 0.02 108.881 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -121.39 129.84 53.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.562 -0.711 . . . . 0.39000000000000001 109.242 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -108.94 138.95 44.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.542 -0.91 . . . . 0.02 108.542 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.55 138.82 54.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.265 -0.897 . . . . 0.02 109.416 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.496 ' HG3' HD11 ' A' ' 33' ' ' LEU . 86.6 mt-10 -69.87 -27.75 65.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.767 . . . . 0.029999999999999999 111.705 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.71 169.85 8.76 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.893 -1.129 . . . . 0.029999999999999999 110.656 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.48 157.32 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.702 0.763 . . . . 0.029999999999999999 110.216 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 t-20 65.16 35.7 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.756 0.788 . . . . 0.73999999999999999 111.086 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.1 p90 49.97 45.05 25.52 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.685 0.755 . . . . 0.02 111.122 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -112.63 165.94 11.8 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.41 -167.13 35.28 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 120.761 -1.212 . . . . 0.029999999999999999 110.725 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -69.3 142.48 54.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 2.7599999999999998 109.125 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -121.1 149.51 42.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 1.8899999999999999 110.034 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -132.93 127.42 34.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.1 135.69 50.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 1.1200000000000001 109.22 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -130.13 136.92 49.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 -178.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.84 9.09 11.9 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.534 -0.729 . . . . 0.20000000000000001 110.343 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 44.9 t -157.69 173.69 16.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.018 -1.051 . . . . 1.23 108.469 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 64.4 t0 -60.45 142.23 55.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.074 -1.641 . . . . 0.02 110.834 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.2 m -132.36 116.47 16.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.408 -0.96 . . . . 0.02 108.408 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.1 54.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.795 . . . . 0.23999999999999999 110.873 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -155.67 101.76 2.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 108.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.1 p90 -105.85 9.6 32.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.418 1.104 . . . . 6.3700000000000001 109.908 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -60.21 -22.17 62.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.292 -0.88 . . . . 3.1099999999999999 110.801 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 18.0 p -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.785 -1.197 . . . . 0.88 109.945 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.5 m-85 -102.67 -21.3 14.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.453 -0.779 . . . . 0.02 109.083 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.81 128.85 12.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.846 -0.798 . . . . 3.3199999999999998 108.846 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t -84.25 -9.67 58.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.02 110.567 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -171.4 163.79 6.94 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.474 -1.306 . . . . 0.02 107.474 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -141.83 113.75 7.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.697 -1.252 . . . . 0.02 108.538 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -108.96 -1.58 18.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 111.42 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -153.86 153.53 32.27 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.179 -1.045 . . . . 0.02 108.179 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.77 146.88 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.061 -1.024 . . . . 0.02 110.672 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -125.5 125.68 43.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.397 -1.335 . . . . 0.02 107.397 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.56 114.32 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.949 -1.5 . . . . 0.02 106.949 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.8 -34.3 27.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.586 -0.696 . . . . 3.8100000000000001 110.485 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 152.01 21.74 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 118.974 -1.584 . . . . 0.02 110.138 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.83 174.43 49.46 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.255 -1.45 . . . . 0.01 110.026 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' TRP . 31.6 m -110.77 161.24 15.98 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' THR . 70.0 m95 -148.26 148.63 30.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.618 -1.301 . . . . 0.02 111.609 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.81 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 105.452 -2.055 . . . . 0.23999999999999999 105.452 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.1 m -117.11 141.98 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.551 -0.718 . . . . 0.65000000000000002 109.628 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.519 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 -120.34 143.15 48.54 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.062 0.934 . . . . 0.02 109.434 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -64.69 -33.96 77.17 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.589 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -124.59 157.84 64.09 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.131 -0.981 . . . . 0.02 109.575 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.37 166.56 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.663 1.576 . . . . 0.02 112.944 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.4 t30 63.68 37.17 10.27 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.275 -0.875 . . . . 0.02 111.279 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.28 50.92 9.63 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.568 0.699 . . . . 3.3900000000000001 110.56 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.8 m -125.72 163.8 22.03 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.268 0.556 . . . . 2.3300000000000001 109.876 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.59 -162.07 31.47 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.553 -1.419 . . . . 0.02 109.553 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -67.03 138.23 57.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.98 -1.306 . . . . 0.02 110.137 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 17.7 ptm -119.21 137.46 53.62 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.417 0.627 . . . . 5.0099999999999998 109.68 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.0 m-85 -132.92 140.56 47.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.175 -0.676 . . . . 0.02 109.175 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.58 132.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.379 -0.971 . . . . 1.72 108.379 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -120.78 113.76 32.97 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.524 -0.735 . . . . 0.02 110.768 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.16 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 CA-C-N 119.915 1.005 . . . . 1.47 110.046 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -53.52 140.82 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.758 -1.214 . . . . 4.25 110.409 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.87 -177.78 32.78 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.512 -1.328 . . . . 0.02 110.55 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.85 130.26 55.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -1.02 . . . . 0.95999999999999996 109.438 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 23.1 m-85 -121.42 92.99 48.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 107.972 -1.121 . . . . 0.02 107.972 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.59 -3.91 8.7 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.877 1.051 . . . . 0.02 113.589 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -156.92 153.37 28.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.535 -1.353 . . . . 2.02 107.969 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -59.89 -38.07 81.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.02 111.888 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -59.9 -24.14 64.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.02 110.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.535 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.03 -18.29 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.088 0.947 . . . . 3.4199999999999999 108.495 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.98 10.59 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.184 -1.413 . . . . 0.02 107.184 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.38 22.73 11.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.677 . . . . 0.02 110.417 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 145.53 46.49 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.161 -1.575 . . . . 0.02 109.161 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.43 -30.26 42.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.296 . . . . 0.97999999999999998 107.942 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 12.4 t-20 -157.24 -172.08 3.87 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.477 -1.675 . . . . 0.02 106.477 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.1 p30 -97.72 27.6 4.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.705 -1.247 . . . . 0.02 110.482 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -95.8 121.78 37.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.922 -1.112 . . . . 3.2000000000000002 110.324 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.1 mt -144.33 119.4 10.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 2.6099999999999999 107.69 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.24 11.15 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 121.381 -0.824 . . . . 0.02 112.938 -177.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -155.6 156.43 35.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.203 -1.763 . . . . 0.02 110.897 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 83.9 m -145.77 148.32 32.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.626 0.727 . . . . 0.02 110.525 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 48.5 mtm180 -134.73 139.42 45.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.677 -0.861 . . . . 0.01 108.677 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.89 130.45 36.62 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.187 -1.042 . . . . 0.42999999999999999 108.187 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.66 124.8 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.395 -0.965 . . . . 1.25 108.395 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -90.74 134.17 34.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.925 -1.109 . . . . 1.77 108.335 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.67 139.35 34.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.938 -0.764 . . . . 1.6299999999999999 108.938 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 p -112.29 125.1 53.8 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.487 -0.931 . . . . 1.0800000000000001 108.487 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -102.28 -156.06 0.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 106.163 -1.791 . . . . 1.26 106.163 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.01 -46.45 1.01 Allowed Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.57 -1.331 . . . . 0.01 112.14 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.36 -97.89 0.11 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 118.352 -1.88 . . . . 0.01 112.382 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -121.51 119.91 33.36 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.336 -1.096 . . . . 4.4299999999999997 110.966 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.81 130.23 38.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.162 -0.681 . . . . 2.9900000000000002 109.162 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -132.1 139.17 48.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.475 -0.766 . . . . 6.3600000000000003 109.319 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -127.46 144.87 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.385 -0.822 . . . . 1.0900000000000001 109.72 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -123.45 132.94 54.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.938 -1.134 . . . . 2.0499999999999998 107.938 177.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.26 147.64 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.881 -1.137 . . . . 1.1000000000000001 109.586 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.9 141.49 48.61 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.019 0.914 . . . . 0.72999999999999998 111.061 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.36 -30.3 70.07 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.898 -0.592 . . . . 0.02 111.83 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 92.0 mttt -116.26 167.63 10.84 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.273 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.77 163.93 43.42 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 57.17 38.44 28.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.828 -0.807 . . . . 0.01 111.088 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 52.46 55.5 9.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.61 -0.682 . . . . 0.01 111.007 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.76 165.34 21.13 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.501 -0.926 . . . . 3.1499999999999999 108.501 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.3 -163.72 27.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.25 -1.54 . . . . 0.01 109.25 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.77 143.5 44.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.006 -1.291 . . . . 0.01 108.653 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.6 142.42 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.465 0.65 . . . . 0.01 109.427 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -131.75 135.51 46.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.239 -1.022 . . . . 2.48 108.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -121.61 135.28 54.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.648 -0.657 . . . . 0.01 110.008 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 t -149.64 153.4 36.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.222 1.011 . . . . 1.6899999999999999 110.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p -109.55 10.04 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.844 -0.616 . . . . 0.01 109.712 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 20.6 mp0 -120.53 163.13 18.43 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.315 -0.866 . . . . 3.21 111.175 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.51 154.55 38.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 11.6 t -123.19 110.26 31.01 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.673 -0.862 . . . . 0.01 108.673 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.9 -32.6 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.873 0.99 . . . . 0.01 111.662 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.5 m -140.43 107.79 5.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.322 -0.861 . . . . 0.02 108.819 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.0 mt -63.82 -39.76 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.67 -0.644 . . . . 1.8300000000000001 110.794 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.26 -37.63 83.8 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.053 -1.059 . . . . 1.3400000000000001 110.073 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.24 -39.15 75.2 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.416 -1.427 . . . . 2.1099999999999999 109.763 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.9 tt0 -80.39 -47.24 14.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 2.0800000000000001 112.476 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.5 m-85 -111.27 -1.05 16.21 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.451 -0.781 . . . . 0.02 112.681 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.2 m80 61.77 33.4 17.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.839 -1.163 . . . . 0.02 109.802 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.3 mt -114.18 135.41 54.07 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.563 -0.711 . . . . 0.02 109.248 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -90.25 -22.13 21.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 5.3200000000000003 110.987 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HD13 ' A' ' 126' ' ' ILE . 81.1 mt-10 -148.6 164.05 35.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.983 -1.073 . . . . 0.02 109.74 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 125' ' ' GLU . 41.8 mm -128.59 125.24 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 107.21 -1.404 . . . . 2.1699999999999999 107.21 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -108.72 -14.1 14.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.305 -0.872 . . . . 0.02 112.573 -177.066 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 13.0 p -160.59 153.71 21.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.661 -1.274 . . . . 0.01 109.069 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.1 t -166.39 140.3 4.16 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.115 -1.069 . . . . 1.22 108.115 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.418 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 ptpt -119.53 98.85 6.33 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.4 1.095 . . . . 1.4099999999999999 108.635 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 131' ' ' VAL . 13.8 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 73.7 m95 . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.38 0.61 . . . . 0.01 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mt -119.34 137.84 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.058 -1.09 . . . . 1.6899999999999999 108.058 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -111.23 141.29 44.94 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.959 -1.497 . . . . 2.4900000000000002 106.959 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 31.3 m-85 -123.24 143.56 49.97 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.1 -1.0 . . . . 0.02 109.594 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.88 -30.33 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.6 -0.687 . . . . 0.02 111.497 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.4 152.97 47.54 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.788 -1.195 . . . . 1.48 109.003 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.77 167.81 2.02 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.086 1.19 . . . . 0.02 113.05 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.31 30.86 20.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.874 -1.057 . . . . 0.75 111.278 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 58.43 51.88 7.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.528 -0.732 . . . . 0.02 111.065 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -127.16 165.54 19.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.564 -0.71 . . . . 0.02 110.141 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.95 -165.42 34.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.218 -1.153 . . . . 0.02 110.218 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -69.22 141.69 54.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.536 -0.979 . . . . 0.02 108.893 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 58' ' ' MET . 10.0 mt-30 -113.38 148.71 35.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.502 -0.555 . . . . 0.02 109.502 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -123.72 133.51 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.551 -0.907 . . . . 0.01 108.551 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.436 ' H ' ' CE ' ' A' ' 58' ' ' MET . 10.1 tp -95.51 122.28 38.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.884 -1.135 . . . . 0.01 109.266 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.1 mp -91.58 149.82 21.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.724 -0.843 . . . . 0.01 108.724 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.9 m-20 -108.85 -177.15 3.23 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.471 -0.768 . . . . 2.27 109.498 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -74.38 29.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.85 . . . . 1.8400000000000001 109.698 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 152' ' ' ASP . 49.6 mttm -112.94 176.12 5.15 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.476 -0.765 . . . . 2.2799999999999998 109.498 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 2.2 mp0 -105.91 134.8 48.46 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.838 -0.801 . . . . 0.01 108.838 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -100.0 112.46 24.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.01 110.302 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -88.39 -29.5 20.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.01 111.133 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -122.72 154.35 63.57 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.056 -1.09 . . . . 2.54 108.056 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.3 Cg_endo -61.79 -42.95 28.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 CA-C-N 119.373 0.812 . . . . 0.69999999999999996 110.55 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.61 -18.81 17.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 109.454 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.59 -17.86 64.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.809 -1.182 . . . . 0.02 111.737 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.38 15.52 28.55 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 120.725 -1.234 . . . . 0.02 110.193 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.86 10.55 75.51 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 121.206 -0.934 . . . . 0.02 112.967 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.525 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.68 140.79 34.46 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.855 -1.38 . . . . 0.02 110.009 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.55 -6.83 59.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.669 -0.644 . . . . 0.58999999999999997 109.612 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -140.49 149.94 59.05 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.109 -0.994 . . . . 0.87 109.169 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.81 16.13 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.571 0.847 . . . . 0.38 111.909 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.26 120.76 25.79 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.323 1.059 . . . . 0.17999999999999999 110.841 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.427 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -150.35 123.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.416 -2.068 . . . . 3.9900000000000002 105.416 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -114.79 -11.01 12.32 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 113.365 0.876 . . . . 5.1699999999999999 113.365 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 t -156.64 158.48 37.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.276 -2.14 . . . . 0.02 110.106 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.7 153.56 34.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.198 -0.939 . . . . 2.02 110.287 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -143.19 149.34 37.87 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.816 0.817 . . . . 0.01 110.206 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.82 143.59 27.05 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.337 -0.986 . . . . 0.01 108.337 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.36 128.5 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.252 -0.905 . . . . 3.04 109.742 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.24 146.61 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.185 -0.947 . . . . 1.8899999999999999 109.839 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.105 -0.702 . . . . 4.8899999999999997 109.105 179.288 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.594 0 N-CA-C 106.943 -2.463 . . . . 0.81000000000000005 106.943 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.96 149.48 32.89 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.275 -0.964 . . . . 0.01 110.851 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -151.43 137.88 18.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.395 -1.062 . . . . 0.02 109.614 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -130.15 139.84 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.326 -0.62 . . . . 0.02 109.326 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.88 129.74 53.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.39000000000000001 109.836 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -109.59 139.41 44.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -122.89 138.36 54.68 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.266 -0.896 . . . . 0.02 109.576 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.61 -27.7 67.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.029999999999999999 111.904 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -114.97 170.92 7.98 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.634 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -74.98 157.95 34.09 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.607 0.718 . . . . 0.029999999999999999 110.092 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.5 t-20 66.26 34.97 6.2 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.91 0.862 . . . . 0.73999999999999999 110.873 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.8 p90 50.11 44.94 25.94 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.807 0.813 . . . . 0.02 111.139 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.1 166.49 11.37 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.084 -1.08 . . . . 0.02 108.084 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.22 -167.81 36.3 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.731 -1.231 . . . . 0.029999999999999999 110.788 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -68.24 142.6 55.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 2.7599999999999998 108.939 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -121.18 149.74 42.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.686 0.755 . . . . 1.8899999999999999 110.093 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -133.05 127.62 34.45 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.012 -1.106 . . . . 0.02 108.012 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -110.78 136.15 50.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.609 -0.682 . . . . 1.1200000000000001 109.177 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -130.23 137.02 49.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.02 109.338 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.39 9.19 12.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.628 -0.67 . . . . 0.20000000000000001 110.141 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.5 p -157.8 173.82 16.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 1.23 108.318 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 16.5 t0 -59.65 141.7 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.283 -1.51 . . . . 0.02 110.568 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.5 m -131.68 116.42 17.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.281 -1.007 . . . . 0.02 108.281 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.94 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.048 -1.033 . . . . 0.23999999999999999 110.948 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -153.3 101.04 2.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.99 . . . . 1.1399999999999999 108.806 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -105.59 9.04 33.46 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.637 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.5 mmp_? -57.88 -23.66 54.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.654 -0.654 . . . . 3.1099999999999999 110.565 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -74.05 -16.91 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.154 . . . . 0.88 109.971 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -105.41 -22.06 13.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.481 -0.762 . . . . 0.02 109.498 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.2 tp -148.18 125.34 11.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 3.3199999999999998 109.082 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 58.3 m -87.58 -13.15 43.65 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.74 . . . . 0.02 111.78 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 34' ' ' SER . 51.3 mtm180 -166.27 160.43 15.92 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.2 -1.407 . . . . 0.02 107.2 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.3 p -140.76 113.32 8.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.847 -1.158 . . . . 0.02 108.956 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -106.71 -0.49 23.56 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.82 -1.175 . . . . 0.029999999999999999 110.379 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -156.41 154.26 30.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.42 147.71 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.043 -1.036 . . . . 0.02 110.45 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -123.8 125.29 44.44 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.41 -0.959 . . . . 0.02 108.41 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.23 113.7 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.735 -1.58 . . . . 0.02 106.735 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -82.82 -34.19 26.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.366 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 151.77 21.37 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.135 -1.507 . . . . 0.02 110.397 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.42 174.43 50.37 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.696 -1.24 . . . . 0.01 110.175 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 95.4 m -109.49 160.49 16.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.889 -1.523 . . . . 1.48 106.889 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' THR . 50.4 m95 -148.02 146.97 29.12 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.208 -1.557 . . . . 0.02 111.506 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.66 132.37 54.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.519 -2.03 . . . . 0.23999999999999999 105.519 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.42 143.12 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.523 -0.735 . . . . 0.65000000000000002 109.625 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 12.1 m-85 -119.05 142.87 47.47 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.207 1.003 . . . . 0.02 109.803 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.28 -34.68 77.92 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.873 -0.603 . . . . 0.02 111.075 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -124.33 154.21 68.98 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.04 -1.038 . . . . 0.02 109.457 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.71 168.02 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.596 1.531 . . . . 0.02 113.33 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 65.09 36.45 7.31 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.151 -0.931 . . . . 0.02 111.035 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 45.58 50.54 10.44 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.784 0.802 . . . . 3.3900000000000001 110.527 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -127.21 164.46 21.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.246 0.546 . . . . 2.3300000000000001 109.971 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -162.39 31.68 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.156 -1.178 . . . . 0.02 110.156 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -62.31 141.23 58.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.089 -1.242 . . . . 0.02 110.568 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 49.4 mtp -117.94 133.12 56.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.529 -0.545 . . . . 5.0099999999999998 109.529 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.3 m-85 -136.08 137.08 40.71 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.766 0.793 . . . . 0.02 109.703 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -97.21 133.28 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.324 -0.991 . . . . 1.72 108.324 178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 61' ' ' LEU . 11.9 mt -120.25 113.57 33.84 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.663 -0.648 . . . . 0.02 110.405 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -77.79 169.54 20.55 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 CA-C-N 119.987 1.031 . . . . 1.47 109.951 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -52.62 140.92 21.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 4.25 110.151 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -177.38 32.54 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.331 -1.414 . . . . 0.02 110.748 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.66 131.18 55.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.552 -0.969 . . . . 0.95999999999999996 109.349 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -120.72 97.13 48.63 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.81 -1.181 . . . . 0.02 107.81 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.03 -4.39 12.42 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.738 0.959 . . . . 0.02 113.837 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -157.39 154.68 29.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.419 -1.426 . . . . 2.02 108.254 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -60.7 -37.95 83.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.616 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -23.85 64.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.02 110.213 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.67 -18.51 62.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.128 0.966 . . . . 3.4199999999999999 108.655 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -106.73 10.07 30.98 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.17 -1.419 . . . . 0.02 107.17 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.0 mtt 60.49 21.05 10.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.51 0.672 . . . . 0.02 110.231 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 144.59 47.06 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.095 -1.602 . . . . 0.02 109.095 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.1 tp -78.14 -29.38 48.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.597 -1.26 . . . . 0.97999999999999998 107.597 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -156.75 -170.76 3.42 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 97.9 m-20 -98.1 29.05 3.67 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.62 -1.3 . . . . 0.02 110.204 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.1 123.08 41.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.262 -0.899 . . . . 3.2000000000000002 111.329 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.516 HD12 ' SG ' ' A' ' 36' ' ' CYS . 28.1 mt -143.18 120.48 11.57 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.733 -1.58 . . . . 2.6099999999999999 106.733 177.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.93 -16.65 13.24 Favored Glycine 0 N--CA 1.503 3.158 0 O-C-N 121.248 -0.908 . . . . 0.02 112.329 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.8 p -156.07 156.0 33.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.465 -1.609 . . . . 0.02 109.656 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.55 147.66 33.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.521 0.677 . . . . 0.02 109.547 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -134.08 139.39 45.93 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.542 -0.911 . . . . 0.01 108.542 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.86 130.12 37.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.11 -1.07 . . . . 0.42999999999999999 108.11 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.05 123.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -90.06 137.92 31.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 1.77 109.165 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -100.95 136.83 40.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.422 -0.955 . . . . 1.6299999999999999 108.422 -179.371 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -113.34 126.85 55.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.819 . . . . 1.0800000000000001 108.968 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.9 m -103.25 -155.02 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.197 -1.779 . . . . 1.26 106.197 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.34 -48.89 0.88 Allowed Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.391 -1.443 . . . . 0.01 112.593 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.85 -100.37 0.14 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.495 -1.812 . . . . 0.01 112.136 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.76 119.05 31.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.311 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.77 129.92 36.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.909 -0.716 . . . . 2.9900000000000002 109.24 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.52 139.42 50.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 6.3600000000000003 109.208 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.58 145.14 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.311 -0.868 . . . . 1.0900000000000001 109.949 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -122.67 133.16 54.52 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.251 -1.388 . . . . 2.0499999999999998 107.251 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.73 148.01 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.041 -1.037 . . . . 1.1000000000000001 109.486 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 45.3 m-85 -119.33 140.99 49.42 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.248 1.023 . . . . 0.72999999999999998 110.824 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -65.86 -29.05 69.44 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.659 -0.7 . . . . 0.02 111.33 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -116.59 169.47 9.32 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.151 -0.968 . . . . 3.1800000000000002 110.443 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.37 52.02 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.938 -0.865 . . . . 0.01 110.938 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 t0 57.36 38.37 28.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 0.01 111.252 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 51.84 54.81 10.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.01 111.296 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -129.61 165.97 20.68 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.07 -164.77 27.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.309 -1.517 . . . . 0.01 109.309 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.05 145.12 40.39 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.023 -1.28 . . . . 0.01 108.473 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 44.3 ttp -116.69 142.45 46.89 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.764 0.792 . . . . 0.01 110.093 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.36 135.0 47.59 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.777 -1.194 . . . . 2.48 107.777 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -120.68 135.54 55.09 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.632 -0.668 . . . . 0.01 110.217 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 1.5 t -149.69 151.32 33.48 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.178 0.989 . . . . 1.6899999999999999 110.84 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.7 p -109.08 9.9 26.17 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 115.641 -0.708 . . . . 0.01 109.756 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.66 163.57 17.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.369 -0.832 . . . . 3.21 111.29 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.32 155.23 37.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.181 -1.044 . . . . 0.01 108.181 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.4 t -122.42 109.25 33.06 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.619 -0.882 . . . . 0.01 108.619 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.81 -34.11 2.55 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 CA-C-N 119.878 0.992 . . . . 0.01 111.44 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 p -139.07 106.79 5.62 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.459 -0.941 . . . . 0.02 108.459 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.51 -40.12 87.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.907 -0.496 . . . . 1.8300000000000001 111.148 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.0 ttp -66.87 -37.6 84.73 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.921 -1.112 . . . . 1.3400000000000001 110.039 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.31 -38.85 75.04 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.867 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.41 ' CD ' ' CE2' ' A' ' 121' ' ' PHE . 65.2 tt0 -80.74 -47.57 13.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.228 -0.92 . . . . 2.0800000000000001 112.471 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.41 ' CE2' ' CD ' ' A' ' 120' ' ' GLN . 75.3 m-85 -111.69 -1.87 15.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.4 -0.812 . . . . 0.02 112.69 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.6 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.35 33.77 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.887 -1.133 . . . . 0.02 109.765 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.02 135.69 53.74 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.478 -0.763 . . . . 0.02 109.099 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -21.77 22.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.908 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 42.5 mt-10 -148.45 163.99 35.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.874 -1.141 . . . . 0.02 110.035 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 35.6 mm -129.57 126.68 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.548 -1.279 . . . . 2.1699999999999999 107.548 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -110.36 -12.99 14.37 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.267 -0.896 . . . . 0.02 112.873 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 p -160.69 153.48 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.658 -1.276 . . . . 0.01 109.255 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.6 p -165.25 143.73 6.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.22 109.26 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -123.87 101.78 7.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.081 -1.012 . . . . 1.4099999999999999 109.631 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.6 p . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 107.984 -1.117 . . . . 0.01 107.984 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' CD1' HG21 ' A' ' 131' ' ' VAL . 7.0 m95 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 106.247 -1.76 . . . . 0.01 106.247 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.51 133.98 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.483 -1.386 . . . . 1.6899999999999999 109.408 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.51 141.4 45.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.56 -1.645 . . . . 2.4900000000000002 106.56 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.457 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 33.4 m-85 -121.52 142.61 49.9 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.258 -0.901 . . . . 0.02 109.091 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 168' ' ' ALA . 9.9 tp10 -73.87 -30.17 62.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.547 -0.72 . . . . 0.02 110.975 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.9 154.81 48.31 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.851 -1.155 . . . . 1.48 108.932 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -57.08 167.96 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.174 1.25 . . . . 0.02 113.024 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 60.09 31.5 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.284 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.6 51.48 9.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.74 . . . . 0.02 111.038 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -126.91 164.89 20.44 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.521 -0.737 . . . . 0.02 110.241 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.61 -165.69 32.44 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.251 -1.14 . . . . 0.02 110.251 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.41 142.85 53.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.977 . . . . 0.02 108.712 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.43 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 23.2 mt-30 -112.32 147.77 35.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.657 -0.652 . . . . 0.02 110.074 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -123.83 133.43 53.79 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.731 -0.841 . . . . 0.01 108.731 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.19 121.53 39.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.926 -1.108 . . . . 0.01 109.913 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -96.48 140.78 30.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.371 -0.974 . . . . 0.01 108.371 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 154' ' ' LYS . 93.5 m-20 -104.29 -174.48 2.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.376 -0.828 . . . . 2.27 109.754 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 15.6 pttp -70.72 35.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.983 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 152' ' ' ASP . 50.6 mttp -113.85 173.18 6.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 2.2799999999999998 109.22 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.67 130.67 52.66 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.391 -0.966 . . . . 0.01 108.391 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.05 111.54 23.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.11 -0.994 . . . . 0.01 109.817 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.514 ' H ' ' CD ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -92.75 -27.22 17.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.01 111.073 -177.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -123.12 153.71 64.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.813 -1.18 . . . . 2.54 107.813 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.16 -42.72 27.58 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 CA-C-N 119.246 0.766 . . . . 0.69999999999999996 111.102 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -60.6 -18.98 17.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.725 -1.234 . . . . 0.85999999999999999 109.439 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 57.4 t0 -65.72 -18.01 65.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.02 112.087 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.67 15.8 27.78 Favored 'General case' 0 N--CA 1.514 2.735 0 O-C-N 120.66 -1.275 . . . . 0.02 110.086 178.283 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.46 75.28 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.129 -0.982 . . . . 0.02 112.963 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.47 140.43 34.73 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.834 -1.392 . . . . 0.02 110.062 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.48 -7.1 59.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.706 . . . . 0.58999999999999997 109.427 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -140.8 150.37 59.6 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.87 108.992 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -74.36 16.52 0.58 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.632 0.888 . . . . 0.38 111.915 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.36 120.31 25.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.026 -1.046 . . . . 0.17999999999999999 110.759 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.3 mt -149.37 123.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.601 -2.0 . . . . 3.9900000000000002 105.601 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -111.9 -14.05 13.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.233 -0.917 . . . . 5.1699999999999999 113.251 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.1 t -156.24 158.68 37.96 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.257 -2.152 . . . . 0.02 109.965 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -152.9 154.49 35.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.164 -0.96 . . . . 2.02 110.569 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.457 ' NH2' ' OH ' ' A' ' 139' ' ' TYR . 87.1 mtm180 -143.3 148.35 36.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.01 109.946 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -85.96 142.78 28.56 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.388 -0.967 . . . . 0.01 108.388 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.96 126.57 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.967 -1.083 . . . . 3.04 109.764 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 177' ' ' GLU . 31.2 m -137.47 147.08 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 1.8899999999999999 109.199 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' A' ' 176' ' ' VAL . 10.2 tt0 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 108.356 -0.979 . . . . 4.8899999999999997 108.356 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 105.981 -2.848 . . . . 0.81000000000000005 105.981 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.81 146.29 30.92 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.312 -0.947 . . . . 0.01 111.196 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -152.86 138.08 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.759 -0.848 . . . . 0.02 108.756 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.05 141.06 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.354 -0.61 . . . . 0.02 109.354 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -122.06 130.26 53.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.499 -0.751 . . . . 0.39000000000000001 109.722 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -109.26 138.93 44.86 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.61 -0.885 . . . . 0.02 108.61 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.6 m-85 -122.36 139.0 54.33 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.353 -0.842 . . . . 0.02 109.802 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 10.1 mm-40 -69.19 -28.6 66.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.029999999999999999 111.79 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -114.34 169.83 8.74 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.471 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -74.27 157.54 35.63 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.695 0.759 . . . . 0.029999999999999999 110.02 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.0 m120 65.97 35.56 6.39 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.995 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.8 p90 49.78 45.69 24.53 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.736 0.779 . . . . 0.02 111.414 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -113.01 166.49 11.36 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.132 -1.062 . . . . 0.02 108.132 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.08 -167.58 36.32 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 120.78 -1.2 . . . . 0.029999999999999999 110.8 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' NH2' ' H ' ' A' ' 34' ' ' SER . 30.1 ttp180 -68.94 142.73 54.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.976 . . . . 2.7599999999999998 109.196 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -120.78 148.68 43.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.649 0.737 . . . . 1.8899999999999999 110.29 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -131.73 126.68 35.1 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.915 -1.143 . . . . 0.02 107.915 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -112.09 136.81 51.0 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 1.1200000000000001 109.655 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.4 t -130.67 138.19 49.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.461 0.648 . . . . 0.02 109.565 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.466 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.2 m-20 -117.14 10.16 13.78 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.383 0.611 . . . . 0.20000000000000001 109.398 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 46.1 m -158.42 174.56 14.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.02 -1.104 . . . . 1.23 108.02 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.3 p-10 -62.11 144.41 55.36 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.581 -1.324 . . . . 0.02 110.49 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -131.59 117.25 18.46 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.99 53.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.23999999999999999 110.567 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 27.8 p-10 -154.11 100.86 2.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 1.1399999999999999 108.682 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.41 9.27 35.77 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.226 1.012 . . . . 6.3700000000000001 109.522 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.596 ' NH2' ' H ' ' A' ' 79' ' ' LEU . 10.7 mmt180 -59.25 -22.93 61.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 3.1099999999999999 110.81 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -74.83 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.699 -1.25 . . . . 0.88 110.257 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -104.06 -21.87 13.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.02 109.387 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.473 HD11 ' HG2' ' A' ' 11' ' ' GLU . 10.7 tp -149.89 128.65 12.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.301 -0.875 . . . . 3.3199999999999998 109.008 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.586 ' H ' ' NH2' ' A' ' 18' ' ' ARG . 82.9 p -85.85 -10.77 54.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.655 -0.653 . . . . 0.02 111.422 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.527 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 5.5 mtp180 -171.57 163.49 6.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.259 -1.385 . . . . 0.02 107.259 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 12.5 p -142.23 113.83 7.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.771 -1.205 . . . . 0.02 108.792 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.3 m-20 -105.53 -0.95 25.38 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.537 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 2.7 m -153.62 154.3 33.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 0.02 107.718 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.27 146.74 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.033 -1.042 . . . . 0.02 110.148 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 38.4 ttm180 -125.18 125.33 43.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.783 -1.192 . . . . 0.02 107.783 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.53 113.86 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.505 -1.665 . . . . 0.02 106.505 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.8 mp0 -83.54 -33.97 25.34 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.088 -0.645 . . . . 3.8100000000000001 109.853 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 150.79 20.15 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.46 -1.829 . . . . 0.02 110.607 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 174.8 50.57 Favored Glycine 0 N--CA 1.486 1.997 0 C-N-CA 119.668 -1.253 . . . . 0.01 110.337 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 23.0 m -109.94 161.98 14.96 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.736 -1.579 . . . . 1.48 106.736 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 72.7 m95 -148.48 147.79 29.51 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.223 -1.548 . . . . 0.02 111.742 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.15 55.33 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.197 -2.149 . . . . 0.23999999999999999 105.197 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' HD22 ' A' ' 79' ' ' LEU . 19.3 m -120.5 144.43 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.679 -0.638 . . . . 0.65000000000000002 109.403 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -121.22 145.75 47.51 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.359 1.076 . . . . 0.02 110.047 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 3.1 tp10 -65.33 -34.35 78.13 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.613 -0.722 . . . . 0.02 110.909 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -123.0 158.52 57.27 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.232 -0.918 . . . . 0.02 109.462 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.6 166.93 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.521 1.481 . . . . 0.02 112.529 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 64.05 36.79 9.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.313 -0.858 . . . . 0.02 111.136 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 44.83 51.68 8.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.587 0.708 . . . . 3.3900000000000001 110.586 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -126.78 164.23 21.81 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.889 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.34 31.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.53 -1.428 . . . . 0.02 109.53 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -66.47 138.7 57.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.312 . . . . 0.02 109.985 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.5 ptm -118.66 137.29 53.4 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.34 0.59 . . . . 5.0099999999999998 109.593 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.2 m-85 -132.06 138.06 48.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.524 -0.735 . . . . 0.02 109.459 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mm -94.74 131.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.742 -0.836 . . . . 1.72 108.742 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.8 mt -120.11 112.6 34.62 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.753 . . . . 0.02 110.857 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -78.31 169.04 20.75 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.006 1.038 . . . . 1.47 109.943 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.53 141.31 25.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.717 -1.239 . . . . 4.25 110.359 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.08 32.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.385 -1.388 . . . . 0.02 110.635 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -119.02 130.7 55.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.431 -1.041 . . . . 0.95999999999999996 109.653 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CE1' HD22 ' A' ' 61' ' ' LEU . 89.7 m-85 -120.24 95.64 49.1 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 108.034 -1.098 . . . . 0.02 108.034 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 38' ' ' SER . 3.4 Cg_exo -66.24 -4.93 11.38 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.716 0.944 . . . . 0.02 113.416 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -157.31 154.05 28.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.65 -1.281 . . . . 2.02 107.925 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 23.1 p90 -60.46 -37.77 82.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.895 -0.722 . . . . 0.02 111.722 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 14.9 mm100 -60.78 -24.34 65.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.02 110.444 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -69.47 -18.34 63.7 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.444 -0.947 . . . . 3.4199999999999999 108.444 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.62 10.83 29.01 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.363 -1.347 . . . . 0.02 107.363 -179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 59.39 21.68 10.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.639 0.733 . . . . 0.02 110.341 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.2 145.69 46.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.909 -1.677 . . . . 0.02 108.909 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -78.8 -30.98 45.78 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.639 -1.245 . . . . 0.97999999999999998 107.639 178.36 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -157.38 -171.26 3.53 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.67 -1.604 . . . . 0.02 106.67 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 6.7 p30 -97.99 28.15 4.12 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.769 -1.207 . . . . 0.02 110.311 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.8 mtt-85 -97.86 123.01 41.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.226 -0.921 . . . . 3.2000000000000002 111.122 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.596 ' H ' ' NH2' ' A' ' 30' ' ' ARG . 36.0 mt -144.04 120.83 11.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.918 -1.512 . . . . 2.6099999999999999 106.918 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.42 -16.56 14.24 Favored Glycine 0 N--CA 1.502 3.047 0 O-C-N 121.264 -0.897 . . . . 0.02 112.079 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 44.4 t -156.38 155.64 32.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.402 -1.646 . . . . 0.02 109.978 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 48' ' ' VAL . 29.3 t -145.04 148.23 33.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.02 109.781 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 44.3 mtm180 -134.17 139.28 45.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.843 . . . . 0.01 109.123 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' ' CH2' ' A' ' 46' ' ' TRP . . . -77.51 131.9 38.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.207 -1.034 . . . . 0.42999999999999999 108.207 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.52 124.55 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.917 -0.771 . . . . 1.25 108.917 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -91.88 135.68 33.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.167 -0.958 . . . . 1.77 108.967 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -97.63 138.46 34.99 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.17 -0.678 . . . . 1.6299999999999999 109.17 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 p -112.23 126.42 55.21 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.828 -0.804 . . . . 1.0800000000000001 108.828 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 p -102.86 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.233 -1.766 . . . . 1.26 106.233 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.21 -49.79 0.83 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.387 -1.445 . . . . 0.01 112.527 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.7 -99.93 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 118.31 -1.9 . . . . 0.01 112.238 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.33 119.98 33.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.802 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.29 130.1 36.74 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.918 -0.713 . . . . 2.9900000000000002 109.104 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -129.75 138.77 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.817 -0.809 . . . . 6.3600000000000003 108.817 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.53 144.47 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.294 -0.879 . . . . 1.0900000000000001 109.891 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.8 pm0 -121.77 133.64 54.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.348 -1.352 . . . . 2.0499999999999998 107.348 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.2 m -122.85 145.62 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.736 -1.228 . . . . 1.1000000000000001 109.141 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 41.2 m-85 -119.57 141.1 49.56 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.125 0.964 . . . . 0.72999999999999998 111.127 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.77 -29.28 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.697 -0.683 . . . . 0.02 111.485 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -116.36 170.16 8.75 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.125 -0.984 . . . . 3.1800000000000002 110.492 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.0 165.49 53.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.0 t0 57.16 38.27 28.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.01 111.354 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.08 54.26 11.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.62 -0.675 . . . . 0.01 111.282 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -129.51 166.38 19.77 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.165 -1.05 . . . . 3.1499999999999999 108.165 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.31 -164.98 28.6 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.122 -1.591 . . . . 0.01 109.122 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -75.09 143.94 43.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.999 -1.295 . . . . 0.01 108.373 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.8 tmm? -117.15 142.76 46.61 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.669 0.747 . . . . 0.01 110.147 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.438 ' N ' ' SD ' ' A' ' 107' ' ' MET . 38.7 m-85 -130.63 135.12 47.55 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.56 -1.274 . . . . 2.48 107.56 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -119.67 135.47 54.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.558 -0.714 . . . . 0.01 110.12 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 t -150.51 153.0 35.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.461 1.124 . . . . 1.6899999999999999 111.322 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 p -110.72 9.38 22.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.27 -0.877 . . . . 0.01 109.592 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -121.25 163.74 18.08 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.445 -0.785 . . . . 3.21 111.331 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.86 155.06 39.36 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.01 108.324 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.77 111.67 27.4 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.7 -0.852 . . . . 0.01 108.7 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.67 -31.99 3.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.998 1.035 . . . . 0.01 111.876 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -140.29 108.37 5.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.02 109.074 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.04 -40.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.894 -0.504 . . . . 1.8300000000000001 110.57 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.6 tmm? -66.72 -37.81 85.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.001 -1.08 . . . . 1.3400000000000001 110.052 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -69.98 -38.57 76.08 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.479 -1.388 . . . . 2.1099999999999999 109.403 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 52.7 tt0 -80.79 -47.48 13.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.0800000000000001 112.424 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.487 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.0 m-85 -110.83 -1.92 16.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.366 -0.834 . . . . 0.02 112.574 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.33 34.14 18.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.713 -1.242 . . . . 0.02 109.436 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.4 135.92 53.57 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.426 -0.796 . . . . 0.02 109.373 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -88.66 -21.35 24.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.26 -0.9 . . . . 5.3200000000000003 110.589 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.11 165.04 32.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.932 -1.105 . . . . 0.02 110.198 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mm -127.39 123.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.494 -1.299 . . . . 2.1699999999999999 107.494 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -108.34 -13.29 14.91 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.133 -0.979 . . . . 0.02 112.132 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 p -160.45 152.5 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.983 -1.073 . . . . 0.01 108.927 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.472 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.3 t -167.66 144.04 4.16 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.545 -0.909 . . . . 1.22 108.545 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.544 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 41.5 tttm -122.45 110.23 15.35 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.38 1.086 . . . . 1.4099999999999999 109.473 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 131' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.442 -1.318 . . . . 0.01 107.442 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.5 m95 . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 107.614 -1.254 . . . . 0.01 107.614 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.471 ' CG1' HD11 ' A' ' 175' ' ' ILE . 38.9 mt -119.82 135.75 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.636 -1.29 . . . . 1.6899999999999999 110.089 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -111.06 142.39 43.28 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.819 -1.919 . . . . 2.4900000000000002 105.819 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.1 m-85 -123.17 144.17 49.53 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.091 -1.006 . . . . 0.02 109.842 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 25.8 tt0 -74.2 -30.88 62.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.727 -0.608 . . . . 0.02 111.68 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.73 154.54 48.06 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.698 -1.251 . . . . 1.48 108.995 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.04 167.54 2.37 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.257 1.304 . . . . 0.02 112.747 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.8 t30 59.33 31.25 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.457 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.53 51.52 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.02 111.07 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.4 164.72 20.49 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.513 -0.742 . . . . 0.02 109.848 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.67 33.65 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.063 -1.215 . . . . 0.02 110.063 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -69.68 142.31 53.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.595 -0.944 . . . . 0.02 108.892 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.418 ' O ' ' CG ' ' A' ' 58' ' ' MET . 13.1 mt-30 -113.77 149.22 35.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.344 0.593 . . . . 0.02 109.78 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -123.62 133.99 53.85 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.41 123.37 40.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.857 -1.152 . . . . 0.01 109.916 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -95.35 135.38 37.04 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.971 -1.122 . . . . 0.01 107.971 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -106.19 -167.67 1.33 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.731 -0.606 . . . . 2.27 110.312 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -79.6 34.46 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.576 -0.702 . . . . 1.8400000000000001 109.921 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -111.92 172.17 7.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.445 -0.785 . . . . 2.2799999999999998 109.373 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -104.38 121.28 43.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.273 -1.01 . . . . 0.01 108.273 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.03 113.48 25.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.272 -0.892 . . . . 0.01 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.39 17.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.129 -0.982 . . . . 0.01 110.706 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -123.94 155.66 66.85 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.066 -1.086 . . . . 2.54 108.066 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.5 Cg_endo -61.41 -40.83 45.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.032 0.69 . . . . 0.69999999999999996 110.764 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.76 -18.82 19.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 120.905 -1.122 . . . . 0.85999999999999999 109.295 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 49.1 t0 -65.92 -18.56 65.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.872 -1.143 . . . . 0.02 111.902 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -102.27 15.09 30.18 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 120.886 -1.134 . . . . 0.02 109.979 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.43 10.62 73.5 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.301 -0.874 . . . . 0.02 113.119 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.25 140.76 35.11 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.744 -1.445 . . . . 0.02 110.18 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.54 -7.1 59.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 0.58999999999999997 110.168 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.3 p -141.41 150.36 57.66 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.87 109.768 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -75.29 14.94 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 120.913 1.075 . . . . 0.38 111.817 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 122.64 27.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.306 1.051 . . . . 0.17999999999999999 111.014 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mp -152.56 123.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.189 -1.782 . . . . 3.9900000000000002 106.189 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 mp0 -111.39 -11.56 14.12 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.524 -0.735 . . . . 5.1699999999999999 112.312 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -156.4 158.74 37.87 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 119.311 -2.118 . . . . 0.02 109.755 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.86 153.38 34.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.274 -0.891 . . . . 2.02 110.219 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -144.0 149.32 36.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.32 -0.862 . . . . 0.01 109.942 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.02 140.56 29.44 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.363 -0.976 . . . . 0.01 108.363 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.471 HD11 ' CG1' ' A' ' 137' ' ' ILE . 45.8 mt -93.89 129.99 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.2 -0.937 . . . . 3.04 109.222 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.46 148.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.475 -0.765 . . . . 1.8899999999999999 109.62 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.564 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 106.982 -2.447 . . . . 0.81000000000000005 106.982 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 148.96 32.71 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.524 -1.03 . . . . 0.01 110.524 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -153.29 138.1 17.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.442 -1.034 . . . . 0.02 108.621 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 8.1 tt -130.59 142.42 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.356 -0.609 . . . . 0.02 109.356 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -122.29 129.81 52.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.424 -0.797 . . . . 0.39000000000000001 109.512 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.29 138.47 44.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.565 -0.902 . . . . 0.02 108.565 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 80.3 m-85 -121.6 138.84 54.15 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.212 -0.93 . . . . 0.02 109.769 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.65 -28.28 66.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.489 -0.757 . . . . 0.029999999999999999 111.61 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -114.66 169.96 8.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.962 -1.086 . . . . 0.029999999999999999 110.394 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.44 158.67 32.32 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.687 0.756 . . . . 0.029999999999999999 109.995 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.5 t-20 66.47 34.61 6.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.845 0.831 . . . . 0.73999999999999999 110.776 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.4 p90 50.07 44.9 25.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.301 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -113.01 165.7 12.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.107 -1.071 . . . . 0.02 108.107 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.57 -168.14 34.42 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.706 -1.235 . . . . 0.029999999999999999 110.927 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.04 143.43 54.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.505 -0.997 . . . . 2.7599999999999998 109.152 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' ' OD1' ' A' ' 21' ' ' ASP . 34.0 ttp180 -119.55 148.7 43.0 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.646 0.736 . . . . 1.8899999999999999 110.392 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -132.09 126.23 33.26 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.887 -1.153 . . . . 0.02 107.887 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' OD1' ' NE ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.7 137.64 51.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.607 -0.683 . . . . 1.1200000000000001 109.751 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.08 139.67 48.59 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.591 0.71 . . . . 0.02 109.47 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 3.4 m-20 -116.09 11.93 15.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.394 -0.595 . . . . 0.20000000000000001 109.394 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 p -158.29 174.47 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.127 -1.064 . . . . 1.23 108.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.99 144.65 54.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.729 -1.232 . . . . 0.02 110.27 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -131.47 116.41 17.44 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.522 -0.918 . . . . 0.02 108.522 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.54 -21.63 55.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.23999999999999999 110.767 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -157.34 101.57 1.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.075 -1.016 . . . . 1.1399999999999999 108.577 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.8 p90 -105.13 9.95 34.05 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.254 1.026 . . . . 6.3700000000000001 110.002 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -59.91 -23.45 63.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.563 -0.711 . . . . 3.1099999999999999 110.954 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p -76.05 -16.68 59.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.647 -1.283 . . . . 0.88 110.31 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -102.55 -21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.399 -0.813 . . . . 0.02 108.901 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -150.49 129.23 12.38 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.683 -0.858 . . . . 3.3199999999999998 108.683 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -86.32 -9.81 55.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.847 -0.533 . . . . 0.02 110.846 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -170.49 161.61 7.9 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.16 113.52 8.08 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.643 -1.285 . . . . 0.02 109.094 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -107.45 -3.35 19.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.029999999999999999 110.647 -178.65 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -154.24 153.49 31.81 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.301 -1.0 . . . . 0.02 108.301 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.35 147.71 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.951 -1.093 . . . . 0.02 110.244 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -125.02 125.68 44.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.953 -1.128 . . . . 0.02 107.953 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.16 114.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.948 -1.501 . . . . 0.02 106.948 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -84.16 -34.52 24.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.484 -0.76 . . . . 3.8100000000000001 109.812 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.57 18.22 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.674 -1.727 . . . . 0.02 110.402 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.88 173.74 49.94 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.528 -1.32 . . . . 0.01 109.893 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.4 m -120.66 138.05 54.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.803 -1.184 . . . . 1.48 107.803 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -127.25 154.36 44.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.691 1.234 . . . . 0.02 111.907 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.59 51.58 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.619 -2.363 . . . . 0.23999999999999999 104.619 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.1 m -116.54 142.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 18.2 m-85 -119.42 141.35 49.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.021 0.915 . . . . 0.02 109.351 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 10.0 tp10 -64.3 -34.16 77.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.571 -0.74 . . . . 0.02 111.671 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -124.08 156.59 65.94 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.025 -1.047 . . . . 0.02 109.707 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.45 165.7 0.97 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.634 1.556 . . . . 0.02 112.984 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 64.97 37.49 6.86 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.72 0.771 . . . . 0.02 111.261 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 45.21 50.89 9.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.457 0.646 . . . . 3.3900000000000001 110.785 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.5 p -126.97 164.55 21.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 110.134 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.25 -162.34 30.8 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.997 -1.241 . . . . 0.02 109.997 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 13.9 t-80 -62.34 143.25 57.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.03 -1.276 . . . . 0.02 110.635 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.498 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 36.5 mtp -116.32 134.58 54.73 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.514 -0.55 . . . . 5.0099999999999998 109.514 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.663 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 33.7 m-85 -136.02 134.89 38.98 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.289 -0.882 . . . . 0.02 109.205 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -96.97 131.96 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.527 -0.733 . . . . 1.72 109.114 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 66' ' ' TYR . 22.9 mt -122.8 111.37 31.14 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.414 -0.804 . . . . 0.02 110.784 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.19 171.2 18.55 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 119.924 1.009 . . . . 1.47 110.181 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.04 140.46 20.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 4.25 110.114 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.65 32.83 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.452 -1.356 . . . . 0.02 110.626 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.5 tp10 -119.14 130.32 55.49 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.294 -1.121 . . . . 0.95999999999999996 109.278 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 84.5 m-85 -120.7 97.76 48.34 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.796 -1.187 . . . . 0.02 107.796 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.63 -5.47 17.12 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 120.582 0.855 . . . . 0.02 113.929 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -154.03 154.09 33.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.503 -1.373 . . . . 2.02 107.864 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -60.67 -38.23 84.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.737 . . . . 0.02 111.719 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.74 -23.94 63.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.983 -1.073 . . . . 0.02 109.9 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.82 -18.54 62.73 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.112 0.958 . . . . 3.4199999999999999 108.432 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.663 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.38 9.7 31.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.245 -1.391 . . . . 0.02 107.245 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.4 mpp? 58.93 22.16 10.0 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.568 0.699 . . . . 0.02 110.304 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.26 143.61 45.94 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.258 -1.537 . . . . 0.02 109.258 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -77.75 -29.55 51.12 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.179 -1.415 . . . . 0.97999999999999998 107.179 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.2 p-10 -156.43 -171.33 3.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.118 -1.808 . . . . 0.02 106.118 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -98.47 28.62 4.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.667 -1.271 . . . . 0.02 110.381 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.557 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -96.49 122.4 39.36 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.806 -1.184 . . . . 3.2000000000000002 110.709 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.6 mt -144.35 120.58 10.85 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.869 -1.16 . . . . 2.6099999999999999 107.869 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.7 10.55 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 121.295 -0.878 . . . . 0.02 112.756 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 66.1 m -154.58 155.82 35.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 119.99 -1.888 . . . . 0.02 111.209 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -144.4 146.76 32.68 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.453 0.644 . . . . 0.02 109.914 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -135.94 140.04 43.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -0.77 . . . . 0.01 108.981 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.03 132.83 36.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 109.286 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.84 123.38 42.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.445 -0.946 . . . . 1.25 108.445 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -89.56 134.73 33.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.832 -1.173 . . . . 1.77 107.832 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.21 139.51 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.739 -0.601 . . . . 1.6299999999999999 109.631 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -111.61 123.35 50.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -115.05 133.88 55.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.749 -1.219 . . . . 1.26 107.971 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.88 -45.86 0.02 OUTLIER Glycine 0 N--CA 1.502 3.079 0 C-N-CA 117.669 -2.205 . . . . 0.01 113.777 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.74 -102.98 0.17 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.432 2.116 . . . . 0.01 111.129 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -119.54 118.23 30.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.284 -1.127 . . . . 4.4299999999999997 110.159 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.07 130.45 39.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.97 -0.692 . . . . 2.9900000000000002 109.258 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -131.31 136.87 48.5 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.055 -0.72 . . . . 6.3600000000000003 109.055 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 tt -128.28 145.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.528 -0.733 . . . . 1.0900000000000001 109.333 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.51 132.88 54.96 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.812 -1.181 . . . . 2.0499999999999998 107.812 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 20.1 m -122.89 145.42 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.785 -1.197 . . . . 1.1000000000000001 109.229 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.95 140.58 49.52 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.059 0.933 . . . . 0.72999999999999998 110.878 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.81 -29.37 69.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.83 -0.623 . . . . 0.02 111.654 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -117.78 168.65 10.27 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.101 -0.999 . . . . 3.1800000000000002 110.453 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.32 169.31 28.68 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.935 -0.866 . . . . 0.01 110.935 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 51.91 39.36 25.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.743 0.782 . . . . 0.01 111.218 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 51.88 51.63 16.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.558 -0.714 . . . . 0.01 110.853 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -124.86 165.98 17.08 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.462 -0.94 . . . . 3.1499999999999999 108.462 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.28 -165.31 27.6 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -74.29 144.65 44.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.081 -1.246 . . . . 0.01 108.239 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 19.0 tmm? -116.01 142.89 46.2 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.642 0.734 . . . . 0.01 109.773 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . 0.422 ' N ' ' SD ' ' A' ' 107' ' ' MET . 63.5 m-85 -131.87 136.13 47.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.068 -1.086 . . . . 2.48 108.068 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -120.13 135.2 55.04 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.589 -0.694 . . . . 0.01 110.052 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -149.49 151.86 34.65 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.249 1.023 . . . . 1.6899999999999999 111.016 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -111.32 9.21 21.59 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.606 -0.724 . . . . 0.01 110.006 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 5.3 mp0 -120.52 162.87 18.84 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.29 -0.881 . . . . 3.21 111.282 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 173' ' ' ARG . 5.4 p-10 -67.9 156.89 36.2 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.239 -1.023 . . . . 0.01 108.239 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.0 t -125.84 112.08 24.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.745 -0.835 . . . . 0.01 108.745 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.3 -31.42 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.1 1.071 . . . . 0.01 111.197 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 t -140.34 106.97 5.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.583 -0.895 . . . . 0.02 108.583 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.23 -39.47 85.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.765 -0.584 . . . . 1.8300000000000001 110.808 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 ttm -66.53 -37.42 84.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.881 -1.127 . . . . 1.3400000000000001 109.98 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.15 -39.17 75.53 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.525 -1.36 . . . . 2.1099999999999999 109.798 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -80.62 -47.0 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 2.0800000000000001 112.473 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -111.25 -1.24 16.16 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.37 -0.831 . . . . 0.02 112.695 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m170 61.44 34.09 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.747 -1.221 . . . . 0.02 109.775 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -114.09 135.92 53.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.478 -0.764 . . . . 0.02 109.305 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.681 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.33 -22.08 21.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.175 -0.953 . . . . 5.3200000000000003 110.743 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.58 164.52 34.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.94 -1.1 . . . . 0.02 109.932 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 mm -129.12 124.72 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.629 -1.249 . . . . 2.1699999999999999 107.629 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.6 m80 -110.04 -14.43 14.23 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.02 112.633 -177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.9 m -159.36 151.48 20.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.808 -1.183 . . . . 0.01 108.806 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -171.42 147.38 2.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.337 -0.852 . . . . 1.22 108.766 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -117.31 108.05 15.13 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.498 1.142 . . . . 1.4099999999999999 108.724 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 11.9 p . . . . . 0 C--N 1.3 -1.572 0 N-CA-C 107.396 -1.335 . . . . 0.01 107.396 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 74.4 m95 . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 121.485 0.66 . . . . 0.01 109.985 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.12 137.7 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.305 -0.998 . . . . 1.6899999999999999 108.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.42 141.45 43.48 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.137 -1.431 . . . . 2.4900000000000002 107.137 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.486 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 25.9 m-85 -121.92 142.43 50.28 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.26 -0.9 . . . . 0.02 109.337 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.85 -30.08 62.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.02 111.551 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -116.17 154.96 48.7 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.801 -1.187 . . . . 1.48 108.858 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.02 166.91 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.146 1.231 . . . . 0.02 113.031 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.09 31.62 20.65 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.096 -0.956 . . . . 0.75 111.36 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.31 51.5 9.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.02 111.045 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.474 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.42 165.7 19.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.515 -0.741 . . . . 0.02 109.996 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.17 -165.93 34.74 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.248 -1.141 . . . . 0.02 110.248 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -68.67 141.65 55.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.989 . . . . 0.02 108.917 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.486 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 17.7 mt-30 -113.97 149.41 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.02 109.969 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.19 133.42 53.55 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.707 -0.849 . . . . 0.01 108.707 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.99 121.57 36.75 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.01 109.292 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 138' ' ' PHE . 18.2 mt -96.76 139.72 32.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -108.93 -168.48 1.35 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 2.27 109.514 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -80.33 40.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.8400000000000001 109.403 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -113.56 168.02 10.11 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 2.2799999999999998 109.42 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -102.57 120.59 40.81 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.451 -0.944 . . . . 0.01 108.451 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -98.01 114.38 26.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.347 -0.846 . . . . 0.01 110.308 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -92.72 -25.66 18.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.01 110.854 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -124.66 153.48 70.02 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 107.953 -1.129 . . . . 2.54 107.953 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.5 Cg_endo -60.55 -39.84 61.56 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.623 0.901 . . . . 0.69999999999999996 110.661 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.39 -19.08 17.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 120.78 -1.2 . . . . 0.85999999999999999 109.39 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.75 -18.32 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.868 -1.145 . . . . 0.02 112.039 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -102.5 15.48 29.12 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.859 -1.151 . . . . 0.02 110.079 178.29 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.05 10.98 74.02 Favored Glycine 0 N--CA 1.497 2.757 0 O-C-N 121.185 -0.947 . . . . 0.02 113.027 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.24 140.45 35.52 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.727 -1.455 . . . . 0.02 110.276 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.54 -6.98 59.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.546 -0.721 . . . . 0.58999999999999997 110.062 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.0 m -140.25 150.07 60.19 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.061 -1.025 . . . . 0.87 109.747 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.94 14.63 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.815 1.01 . . . . 0.38 111.947 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 121.18 26.22 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.329 1.061 . . . . 0.17999999999999999 110.847 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 mt -149.27 123.92 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.677 -1.972 . . . . 3.9900000000000002 105.677 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.82 -13.62 13.17 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.167 -0.958 . . . . 5.1699999999999999 113.138 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.5 t -157.6 160.76 38.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.153 -2.217 . . . . 0.02 110.192 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.13 152.95 32.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.529 -0.732 . . . . 2.02 109.807 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 144' ' ' TYR . 7.5 mmt180 -144.4 150.4 37.65 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.808 0.813 . . . . 0.01 110.194 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -88.23 143.87 26.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.471 -0.768 . . . . 0.01 109.04 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.89 129.42 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.438 -0.789 . . . . 3.04 109.205 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.5 t -136.01 146.61 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.209 -0.932 . . . . 1.8899999999999999 109.57 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 4.8899999999999997 109.209 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.778 0 N-CA-C 106.926 -2.47 . . . . 0.81000000000000005 106.926 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 149.36 33.55 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.721 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.513 ' NZ ' ' OD1' ' A' ' 23' ' ' ASP . 56.0 tttp -149.19 136.36 19.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.994 . . . . 0.02 109.633 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.38 138.92 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.151 -0.685 . . . . 0.02 109.151 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -121.49 130.32 53.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.524 -0.735 . . . . 0.39000000000000001 109.985 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 22.7 m-85 -109.91 139.75 44.65 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.148 -0.686 . . . . 0.02 109.148 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.7 m-85 -122.42 138.44 54.54 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.249 -0.907 . . . . 0.02 109.563 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -70.19 -27.5 64.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.029999999999999999 111.949 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.57 ' C ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-20 -114.16 169.27 9.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.729 -1.232 . . . . 0.029999999999999999 110.14 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.43 157.19 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.639 0.733 . . . . 0.029999999999999999 110.419 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.5 m-20 66.75 34.26 5.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.045 0.926 . . . . 0.73999999999999999 111.441 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.7 m-85 55.53 42.59 29.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.293 0.568 . . . . 0.02 111.323 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -113.56 166.51 11.45 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.467 -0.938 . . . . 0.02 108.467 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.24 -167.72 36.17 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.89 -1.148 . . . . 0.029999999999999999 110.901 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.427 HH21 ' H ' ' A' ' 34' ' ' SER . 39.8 ttp180 -70.33 142.9 52.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.972 . . . . 2.7599999999999998 108.984 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -120.23 148.99 42.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.574 -0.704 . . . . 1.8899999999999999 110.294 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -131.23 126.3 35.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.729 -1.211 . . . . 0.02 107.729 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.43 137.15 51.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.701 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.43 138.03 48.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.5 0.667 . . . . 0.02 109.621 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD1' ' NZ ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -117.18 10.34 13.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.20000000000000001 109.447 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.9 p -158.19 174.45 15.16 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.41 143.13 56.36 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.682 -1.261 . . . . 0.02 110.456 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.1 t -131.43 117.25 18.59 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.67 -25.68 49.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.23999999999999999 110.857 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -154.5 100.77 2.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.874 -1.141 . . . . 1.1399999999999999 108.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -105.4 9.84 33.57 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.05 0.929 . . . . 6.3700000000000001 109.641 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -57.89 -24.06 55.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.612 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 p -73.93 -16.92 61.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.805 -1.185 . . . . 0.88 109.905 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.51 -22.29 13.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.02 109.5 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.0 tp -148.56 125.99 11.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.042 -1.036 . . . . 3.3199999999999998 109.52 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.427 ' H ' HH21 ' A' ' 18' ' ' ARG . 71.0 m -86.26 -10.77 53.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.625 -0.672 . . . . 0.02 111.461 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 30.7 ttt180 -170.5 160.45 7.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.816 -1.179 . . . . 0.02 107.816 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.1 p -141.94 113.09 7.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.86 -1.15 . . . . 0.02 108.728 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.792 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -109.09 2.91 21.45 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.189 -179.398 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -155.52 152.59 29.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.66 -1.237 . . . . 0.02 107.66 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 39' ' ' ILE . 10.4 mt -146.49 147.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.02 110.119 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -124.71 125.5 44.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.78 114.22 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.779 -1.563 . . . . 0.02 106.779 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.75 -34.08 27.24 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.2 -0.6 . . . . 3.8100000000000001 110.408 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.33 151.47 21.07 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 119.081 -1.533 . . . . 0.02 110.33 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 174.46 50.01 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.543 -1.313 . . . . 0.01 110.085 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.435 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m -110.04 161.18 15.78 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.021 -1.474 . . . . 1.48 107.021 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.435 ' CD1' ' C ' ' A' ' 45' ' ' THR . 67.3 m95 -148.0 147.71 29.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.198 -1.564 . . . . 0.02 111.505 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.07 54.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 105.43 -2.063 . . . . 0.23999999999999999 105.43 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.3 m -117.83 142.29 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.503 -0.748 . . . . 0.65000000000000002 109.406 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 42.4 m-85 -121.56 144.64 48.61 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.952 0.882 . . . . 0.02 109.676 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.66 -34.99 79.07 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.501 -0.772 . . . . 0.02 111.722 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.06 163.59 42.78 Favored Pre-proline 0 N--CA 1.509 2.516 0 O-C-N 120.91 -1.119 . . . . 0.02 109.105 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.14 168.06 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.42 1.414 . . . . 0.02 113.359 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 63.22 36.89 11.6 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.082 -0.963 . . . . 0.02 112.121 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 44.78 52.0 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.675 0.75 . . . . 3.3900000000000001 111.017 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 m -126.58 163.98 22.23 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.239 0.542 . . . . 2.3300000000000001 109.704 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.24 -161.31 32.69 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.538 -1.425 . . . . 0.02 109.538 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.638 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.1 t-80 -69.72 137.98 52.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.993 -1.298 . . . . 0.02 109.946 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 19.0 ptm -119.16 136.47 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.333 -0.617 . . . . 5.0099999999999998 109.333 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 93.7 m-85 -128.28 139.51 52.38 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.914 -0.773 . . . . 0.02 108.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.95 131.83 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.2 mt -120.81 112.79 33.47 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.407 -0.808 . . . . 0.02 110.696 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.17 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.047 1.052 . . . . 1.47 110.096 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.2 pm0 -53.25 140.48 26.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.778 -1.201 . . . . 4.25 110.221 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.19 33.08 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.377 . . . . 0.02 110.438 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -119.25 130.18 55.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.325 -1.103 . . . . 0.95999999999999996 109.635 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE1' HD22 ' A' ' 61' ' ' LEU . 84.5 m-85 -120.82 96.8 48.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.96 -4.1 11.8 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 120.74 0.96 . . . . 0.02 113.756 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -157.68 155.02 29.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.671 -1.268 . . . . 2.02 108.256 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -60.29 -38.95 85.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.02 111.851 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.02 110.544 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.91 -18.6 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.187 0.994 . . . . 3.4199999999999999 108.581 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.566 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -106.87 9.94 30.75 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.386 -1.339 . . . . 0.02 107.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.0 mtt 60.55 21.32 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.475 0.655 . . . . 0.02 110.401 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.05 45.92 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.112 -1.595 . . . . 0.02 109.112 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.13 -29.52 48.86 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.438 -1.319 . . . . 0.97999999999999998 107.438 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -157.17 -171.71 3.73 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.523 -1.658 . . . . 0.02 106.523 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 87.4 m-20 -97.66 27.91 4.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.673 -1.267 . . . . 0.02 110.289 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -98.52 123.49 42.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.882 . . . . 3.2000000000000002 111.655 -178.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.5 mt -143.25 121.05 11.92 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.912 -1.514 . . . . 2.6099999999999999 106.912 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.25 -16.99 13.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.185 -0.947 . . . . 0.02 111.981 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -155.02 154.82 33.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.397 -1.649 . . . . 0.02 110.372 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.32 147.04 32.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.02 109.953 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -134.57 140.03 45.82 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 0.01 108.814 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.07 131.77 38.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.998 -1.112 . . . . 0.42999999999999999 107.998 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.0 t -91.71 123.98 44.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -91.66 136.23 33.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.981 -1.075 . . . . 1.77 108.744 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.64 137.0 38.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.378 -0.971 . . . . 1.6299999999999999 108.378 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -110.8 126.29 54.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.437 -0.949 . . . . 1.0800000000000001 108.437 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -103.71 -154.96 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.348 -1.723 . . . . 1.26 106.348 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.38 -48.1 0.93 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.506 -1.371 . . . . 0.01 112.178 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.78 -99.85 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.484 -1.817 . . . . 0.01 111.936 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.54 119.24 31.37 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.342 -1.093 . . . . 4.4299999999999997 110.504 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 129.28 35.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.988 -0.745 . . . . 2.9900000000000002 108.988 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.08 140.37 50.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.421 -0.799 . . . . 6.3600000000000003 109.15 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 tt -129.97 145.17 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.831 . . . . 1.0900000000000001 109.859 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.67 134.76 54.97 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.431 -1.322 . . . . 2.0499999999999998 107.431 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.91 147.25 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.831 -1.168 . . . . 1.1000000000000001 109.531 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.0 m-85 -119.64 141.66 49.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.123 0.963 . . . . 0.72999999999999998 111.032 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -66.24 -29.2 69.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.694 -0.685 . . . . 0.02 111.369 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -116.41 169.59 9.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.162 -0.961 . . . . 3.1800000000000002 110.459 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.97 165.07 51.28 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.898 -0.881 . . . . 0.01 110.898 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.95 38.03 29.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.833 -0.804 . . . . 0.01 111.349 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 51.83 54.99 9.96 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.632 -0.667 . . . . 0.01 111.494 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -128.77 165.61 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.955 -1.128 . . . . 3.1499999999999999 107.955 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.91 -164.36 28.72 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.214 -1.554 . . . . 0.01 109.214 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -75.35 144.12 42.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.012 -1.287 . . . . 0.01 108.748 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.75 143.17 45.98 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.601 0.715 . . . . 0.01 109.96 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -131.39 135.71 47.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.937 -1.135 . . . . 2.48 107.937 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.2 tm-20 -118.36 134.59 54.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.809 -0.557 . . . . 0.01 109.757 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.7 t -149.48 150.29 32.1 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 1.6899999999999999 110.911 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.7 p -109.6 9.95 25.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.51 -0.768 . . . . 0.01 109.863 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -121.43 163.64 18.41 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.429 -0.794 . . . . 3.21 111.438 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.46 155.37 37.75 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.199 -1.037 . . . . 0.01 108.199 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.8 t -122.17 110.79 32.51 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.28 -32.9 2.8 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.846 0.981 . . . . 0.01 111.584 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.1 t -141.69 107.04 5.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.011 -1.056 . . . . 0.02 108.732 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -64.35 -39.76 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.896 -0.503 . . . . 1.8300000000000001 111.087 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.38 -37.66 85.77 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.936 -1.105 . . . . 1.3400000000000001 109.888 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -70.16 -39.02 75.56 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.549 -1.344 . . . . 2.1099999999999999 109.684 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.31 -48.21 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -0.961 . . . . 2.0800000000000001 112.612 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.99 -1.09 15.52 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.367 -0.833 . . . . 0.02 112.612 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 5.8 m80 62.04 34.36 16.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.816 -1.178 . . . . 0.02 109.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 mt -114.86 135.83 53.76 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.505 -0.747 . . . . 0.02 109.514 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.672 ' N ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.45 -21.28 23.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.123 -0.985 . . . . 5.3200000000000003 110.86 -179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.0 mt-10 -148.99 164.3 34.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.943 -1.098 . . . . 0.02 110.015 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.7 mm -129.44 126.16 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.403 -1.332 . . . . 2.1699999999999999 107.403 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -109.2 -12.72 14.77 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.267 -0.896 . . . . 0.02 112.693 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -159.52 153.13 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.679 -1.263 . . . . 0.01 108.829 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 21.8 p -167.4 142.97 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 1.22 109.399 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -124.44 106.92 10.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.464 1.126 . . . . 1.4099999999999999 109.834 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 136' ' ' TRP . 7.2 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 107.575 -1.268 . . . . 0.01 107.575 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 131' ' ' VAL . 6.7 m95 . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 106.574 -1.639 . . . . 0.01 106.574 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.74 134.24 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.577 -1.327 . . . . 1.6899999999999999 109.713 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -111.33 142.45 43.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.307 -1.738 . . . . 2.4900000000000002 106.307 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.475 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 30.9 m-85 -122.37 142.51 50.44 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.133 -0.979 . . . . 0.02 109.431 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.493 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 9.9 tp10 -75.04 -30.27 61.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.673 -0.642 . . . . 0.02 111.709 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.9 mt -114.47 152.77 46.44 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 120.66 -1.275 . . . . 1.48 109.054 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.49 165.98 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 120.81 1.007 . . . . 0.02 112.757 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 60.01 31.6 20.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.395 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 58.05 51.87 8.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.495 -0.753 . . . . 0.02 111.52 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.36 166.1 18.49 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.393 -0.817 . . . . 0.02 110.097 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.29 -165.42 34.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.064 -1.214 . . . . 0.02 110.064 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -69.66 142.91 53.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.976 . . . . 0.02 108.927 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 20.9 mt-30 -113.85 148.97 35.74 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.255 0.55 . . . . 0.02 109.727 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -123.69 133.21 53.92 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.14 122.01 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.819 -1.176 . . . . 0.01 109.255 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -96.25 146.48 24.68 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.01 108.677 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 154' ' ' LYS . 9.0 m-20 -105.58 -169.18 1.55 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.453 -0.78 . . . . 2.27 109.684 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.16 31.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 1.8400000000000001 109.583 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 152' ' ' ASP . 19.5 mtpp -111.7 171.31 7.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.335 -0.853 . . . . 2.2799999999999998 109.153 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.05 133.62 48.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.196 -1.039 . . . . 0.01 108.196 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.22 115.01 28.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.01 110.239 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -90.57 -28.38 18.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.736 -0.602 . . . . 0.01 110.958 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -123.38 154.31 65.75 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.739 -1.208 . . . . 2.54 107.739 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -62.01 -41.84 33.97 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 119.207 0.752 . . . . 0.69999999999999996 111.209 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.87 -19.41 19.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.79 -1.193 . . . . 0.85999999999999999 109.707 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 56.2 t0 -65.92 -18.5 65.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.802 -1.187 . . . . 0.02 112.034 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.26 15.9 27.29 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.725 -1.235 . . . . 0.02 110.171 178.396 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.89 10.16 76.2 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.115 -0.99 . . . . 0.02 113.035 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.53 140.83 34.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.819 -1.401 . . . . 0.02 110.185 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.06 -7.05 59.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.58999999999999997 109.735 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -140.55 151.09 62.72 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.196 -0.94 . . . . 0.87 109.309 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.26 15.46 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.703 0.935 . . . . 0.38 111.952 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.66 120.52 25.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 110.741 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.43 122.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.579 -2.008 . . . . 3.9900000000000002 105.579 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mp0 -112.17 -13.13 13.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.244 -0.91 . . . . 5.1699999999999999 112.936 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.0 m -157.04 158.69 36.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.13 -2.231 . . . . 0.02 110.085 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -153.16 154.81 35.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 2.02 110.188 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -144.19 149.5 36.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.276 -0.89 . . . . 0.01 110.162 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -86.62 143.14 27.78 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.524 -0.917 . . . . 0.01 108.524 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.16 128.38 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.141 -0.975 . . . . 3.04 109.79 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 177' ' ' GLU . 60.6 t -137.06 147.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.229 -0.919 . . . . 1.8899999999999999 109.663 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 176' ' ' VAL . 7.8 tm-20 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 4.8899999999999997 109.297 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.684 0 N-CA-C 107.096 -2.402 . . . . 0.81000000000000005 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.82 149.82 33.54 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.112 -1.042 . . . . 0.01 110.749 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.05 136.29 18.84 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.981 . . . . 0.02 109.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.23 139.44 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.793 -0.567 . . . . 0.02 109.543 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 t -122.16 130.46 53.23 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.553 -0.717 . . . . 0.39000000000000001 109.916 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 m-85 -110.08 139.99 44.62 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.032 -0.729 . . . . 0.02 109.032 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.51 139.14 54.22 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.292 -0.88 . . . . 0.02 109.813 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.451 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.39 -28.03 66.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.938 -1.101 . . . . 0.029999999999999999 111.804 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -114.14 169.07 9.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.888 -1.132 . . . . 0.029999999999999999 110.201 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -74.96 158.15 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.666 0.746 . . . . 0.029999999999999999 109.895 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.47 34.94 5.84 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.729 0.776 . . . . 0.73999999999999999 110.8 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.1 p90 49.72 44.39 24.73 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.742 0.782 . . . . 0.02 111.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.73 166.72 11.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.87 -1.159 . . . . 0.02 107.87 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.1 -167.75 36.44 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.669 -1.253 . . . . 0.029999999999999999 110.673 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.19 142.73 54.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.977 . . . . 2.7599999999999998 108.943 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' NH1' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tmm_? -121.57 150.67 41.32 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.71 0.766 . . . . 1.8899999999999999 110.42 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -132.82 127.55 34.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 0.02 108.045 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' NH1' ' A' ' 19' ' ' ARG . 3.3 p-10 -111.83 136.46 51.09 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 109.711 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -130.91 137.69 49.43 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.494 0.664 . . . . 0.02 109.467 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -116.83 10.1 14.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.20000000000000001 109.375 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.3 p -158.59 174.3 15.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 13.0 t0 -60.8 142.31 56.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.782 -1.199 . . . . 0.02 110.327 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 43.2 t -131.57 116.58 17.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.316 -0.994 . . . . 0.02 108.316 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.59 -24.33 53.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.23999999999999999 110.995 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -154.65 102.4 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.006 -1.059 . . . . 1.1399999999999999 108.86 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CZ ' ' NH2' ' A' ' 30' ' ' ARG . 17.9 p90 -104.38 8.38 35.8 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.192 0.996 . . . . 6.3700000000000001 109.487 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.436 HH11 ' NH2' ' A' ' 78' ' ' ARG . 3.3 mmp_? -58.3 -24.22 58.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 3.1099999999999999 110.715 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -74.69 -17.1 60.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.768 -1.208 . . . . 0.88 109.933 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -104.13 -22.41 13.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.421 -0.799 . . . . 0.02 109.416 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.451 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.01 128.51 12.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.113 -0.992 . . . . 3.3199999999999998 109.138 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -85.54 -10.03 56.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.723 -0.611 . . . . 0.02 111.288 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -171.86 163.1 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.759 -1.2 . . . . 0.02 107.759 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 p -143.98 115.71 8.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.199 . . . . 0.02 108.736 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -107.06 1.83 24.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.957 -1.089 . . . . 0.029999999999999999 110.548 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.6 p -156.88 154.72 30.25 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.507 -1.294 . . . . 0.02 107.507 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mt -146.17 148.16 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 0.02 109.777 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -125.04 125.43 43.83 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.47 114.94 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.714 -1.587 . . . . 0.02 106.714 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.87 -34.33 26.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.796 -0.565 . . . . 3.8100000000000001 110.42 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.36 151.5 21.1 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.142 -1.504 . . . . 0.02 110.167 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 175.09 50.68 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.582 -1.294 . . . . 0.01 110.264 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 46' ' ' TRP . 84.0 m -109.46 161.3 15.45 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.901 -1.518 . . . . 1.48 106.901 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.424 ' N ' HG22 ' A' ' 45' ' ' THR . 65.6 m95 -147.38 146.64 29.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.347 -1.47 . . . . 0.02 111.402 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.79 54.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 105.466 -2.05 . . . . 0.23999999999999999 105.466 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.0 m -117.73 141.98 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.607 -0.683 . . . . 0.65000000000000002 109.493 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 8.5 m-85 -122.0 143.36 49.53 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.511 1.148 . . . . 0.02 109.652 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 6.0 tp10 -65.37 -36.25 83.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.729 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.1 153.51 64.56 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.97 -1.081 . . . . 0.02 109.305 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.13 167.74 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.31 1.34 . . . . 0.02 112.772 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 63.26 37.05 11.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.175 -0.921 . . . . 0.02 110.998 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER 45.12 52.83 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.683 0.754 . . . . 3.3900000000000001 110.896 178.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -126.58 163.85 22.52 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.866 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.84 32.27 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.13 -1.188 . . . . 0.02 110.13 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.93 138.52 58.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.976 -1.308 . . . . 0.02 110.117 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.7 mtm -120.55 134.47 55.27 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.606 0.717 . . . . 5.0099999999999998 109.679 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.3 m-85 -134.25 139.02 45.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.02 109.561 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -97.25 133.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.85 113.68 32.91 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.561 -0.712 . . . . 0.02 110.56 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.4 168.72 22.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.154 1.091 . . . . 1.47 110.155 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.17 141.39 23.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.746 -1.221 . . . . 4.25 110.151 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.03 -176.51 32.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.412 -1.375 . . . . 0.02 110.567 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -119.4 130.6 55.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -1.082 . . . . 0.95999999999999996 109.403 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 49.3 m-85 -121.1 98.71 47.01 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 107.671 -1.233 . . . . 0.02 107.671 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -70.54 -3.39 12.42 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.629 0.886 . . . . 0.02 113.806 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -157.26 155.01 30.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.592 -1.317 . . . . 2.02 108.206 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -60.65 -39.14 87.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.577 -0.702 . . . . 0.02 111.814 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.81 -23.8 63.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.02 110.181 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.549 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.73 -18.54 62.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.96 0.886 . . . . 3.4199999999999999 108.626 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -106.82 10.31 30.74 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.171 -1.418 . . . . 0.02 107.171 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.35 22.62 11.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.557 0.694 . . . . 0.02 110.18 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.98 47.36 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.8 tp -78.76 -29.68 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.649 -1.241 . . . . 0.97999999999999998 107.649 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.6 p30 -157.67 -171.03 3.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.619 -1.623 . . . . 0.02 106.619 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -98.17 28.29 4.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.633 -1.292 . . . . 0.02 110.238 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH2' HH11 ' A' ' 30' ' ' ARG . 17.7 mmm180 -98.05 123.01 41.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.285 -0.884 . . . . 3.2000000000000002 111.38 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.0 mt -144.65 121.59 11.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.048 -1.464 . . . . 2.6099999999999999 107.048 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 -16.39 14.48 Favored Glycine 0 N--CA 1.5 2.905 0 O-C-N 121.303 -0.873 . . . . 0.02 112.171 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.01 154.65 32.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.247 -1.737 . . . . 0.02 110.401 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.6 p -144.69 147.36 32.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.02 109.688 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -133.86 140.13 46.66 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.664 -0.865 . . . . 0.01 108.664 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.11 129.22 36.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 0.42999999999999999 107.935 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.0 t -91.96 123.69 44.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.893 -0.78 . . . . 1.25 108.893 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -90.66 136.65 32.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.276 -0.89 . . . . 1.77 109.006 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -99.25 137.48 37.7 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.94 -1.133 . . . . 1.6299999999999999 107.94 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 t -112.25 126.5 55.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -0.876 . . . . 1.0800000000000001 109.14 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -103.61 -154.94 0.51 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.221 -1.77 . . . . 1.26 106.221 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.02 -49.58 0.86 Allowed Glycine 0 N--CA 1.498 2.79 0 O-C-N 120.418 -1.426 . . . . 0.01 112.232 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.04 -100.05 0.14 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 118.397 -1.859 . . . . 0.01 111.889 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.95 118.62 30.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.292 -1.122 . . . . 4.4299999999999997 110.394 -179.068 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.86 129.66 36.53 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 2.9900000000000002 109.287 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -129.97 139.46 51.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.576 -0.703 . . . . 6.3600000000000003 109.436 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tt -129.35 145.78 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.414 -0.804 . . . . 1.0900000000000001 109.71 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -121.18 133.22 55.18 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.29 -1.374 . . . . 2.0499999999999998 107.29 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.4 146.61 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.954 -1.091 . . . . 1.1000000000000001 109.351 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 33.2 m-85 -119.72 141.39 49.46 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.194 0.997 . . . . 0.72999999999999998 110.922 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.31 -29.25 69.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.711 -0.677 . . . . 0.02 111.587 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -116.61 169.8 9.07 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.075 -1.016 . . . . 3.1800000000000002 110.444 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.95 165.33 50.97 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.843 -0.903 . . . . 0.01 110.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' OD1' ' NH1' ' A' ' 157' ' ' ARG . 9.6 t0 56.8 38.37 29.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.956 -0.732 . . . . 0.01 111.307 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 51.65 54.44 10.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.01 111.368 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 166.14 19.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.062 -1.088 . . . . 3.1499999999999999 108.062 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -164.19 28.63 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.014 -1.635 . . . . 0.01 109.014 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -75.34 143.86 42.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.285 . . . . 0.01 108.518 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.3 ttp -116.79 142.84 46.4 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.59 0.71 . . . . 0.01 109.838 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -131.65 136.38 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.073 -1.084 . . . . 2.48 108.073 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.57 134.8 54.82 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.684 -0.635 . . . . 0.01 110.093 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.514 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -149.14 150.49 32.77 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.237 1.018 . . . . 1.6899999999999999 111.031 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.6 p -110.11 10.02 24.01 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.674 -0.694 . . . . 0.01 109.811 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -120.77 163.23 18.44 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.282 -0.887 . . . . 3.21 111.272 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.1 155.18 37.57 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.021 -1.103 . . . . 0.01 108.021 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.2 t -123.18 109.77 31.3 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.67 -31.91 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 CA-C-N 119.997 1.035 . . . . 0.01 111.696 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -140.96 107.42 5.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.37 -0.832 . . . . 0.02 108.774 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.52 -39.44 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.56 . . . . 1.8300000000000001 110.668 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 40.7 ttp -66.32 -37.52 85.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.966 -1.094 . . . . 1.3400000000000001 109.959 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.18 -39.27 71.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.399 -1.438 . . . . 2.1099999999999999 109.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.72 -47.86 13.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 2.0800000000000001 112.447 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.19 -1.96 15.95 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.352 -0.843 . . . . 0.02 112.517 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.0 m80 61.87 33.96 17.29 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.659 -1.276 . . . . 0.02 109.403 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.1 mt -114.63 135.54 54.03 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.487 -0.758 . . . . 0.02 109.264 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' H ' ' HD2' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.13 -21.19 23.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.159 -0.963 . . . . 5.3200000000000003 110.761 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 124' ' ' ARG . 10.9 mp0 -147.32 163.95 34.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.912 -1.117 . . . . 0.02 109.504 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.0 mm -126.97 124.23 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.339 -1.356 . . . . 2.1699999999999999 107.339 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -110.3 -13.48 14.31 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.238 -0.914 . . . . 0.02 112.516 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 t -160.79 151.65 18.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.835 -1.165 . . . . 0.01 109.24 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.2 p -168.78 143.93 3.33 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.674 -0.861 . . . . 1.22 108.674 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.46 109.6 13.48 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.448 1.118 . . . . 1.4099999999999999 109.669 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 131' ' ' VAL . 11.5 p . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.619 -1.252 . . . . 0.01 107.619 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.4 m95 . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 106.557 -1.646 . . . . 0.01 106.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.463 ' CG1' HD11 ' A' ' 175' ' ' ILE . 12.3 mt -117.18 133.62 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.507 -1.371 . . . . 1.6899999999999999 109.162 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.47 141.14 45.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.29 -1.745 . . . . 2.4900000000000002 106.29 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.8 m-85 -123.05 142.98 50.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.918 . . . . 0.02 109.605 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.66 -30.49 62.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.79 -0.569 . . . . 0.02 111.725 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.9 154.9 48.31 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.655 -1.278 . . . . 1.48 108.975 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.5 167.08 2.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.091 1.194 . . . . 0.02 112.926 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.79 31.38 20.77 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.05 -0.977 . . . . 0.75 111.363 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 57.31 51.89 9.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.42 -0.8 . . . . 0.02 111.361 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -126.57 164.84 20.33 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.504 -0.748 . . . . 0.02 110.114 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.2 33.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.227 -1.149 . . . . 0.02 110.227 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.02 108.61 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -113.4 148.13 36.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.734 -0.604 . . . . 0.02 109.533 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.31 133.99 54.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.912 -0.773 . . . . 0.01 108.912 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 48.0 tp -96.63 121.66 38.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.01 109.378 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -95.75 139.08 32.49 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.557 -0.905 . . . . 0.01 108.557 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 3.0 p30 -105.55 -168.32 1.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.498 -0.751 . . . . 2.27 109.499 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -82.57 38.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 1.8400000000000001 110.005 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.28 175.28 5.54 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.379 -0.826 . . . . 2.2799999999999998 109.45 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -105.31 125.51 51.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.723 -0.843 . . . . 0.01 108.723 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 1.5 m-85 -100.35 112.73 25.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.243 -0.911 . . . . 0.01 109.817 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.526 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 12.8 mmm180 -88.35 -28.09 21.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.957 -1.089 . . . . 0.01 110.549 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -126.88 156.04 74.57 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 107.045 -1.465 . . . . 2.54 107.045 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 162' ' ' TRP . 5.6 Cg_endo -59.56 -34.26 96.81 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 CA-C-N 119.721 0.936 . . . . 0.69999999999999996 110.335 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.1 t -62.88 -21.16 27.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.873 -1.142 . . . . 0.85999999999999999 109.564 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.07 -20.51 65.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.672 -1.268 . . . . 0.02 111.439 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p90 -103.03 13.32 34.53 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.979 -1.075 . . . . 0.02 109.243 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.75 11.98 64.95 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.771 -0.728 . . . . 0.02 113.549 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.78 138.06 38.33 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 119.627 1.713 . . . . 0.02 110.411 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.79 -7.85 58.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.692 -0.63 . . . . 0.58999999999999997 109.796 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 87.0 p -139.98 150.16 61.3 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.312 -0.868 . . . . 0.87 109.551 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.5 13.5 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.688 0.925 . . . . 0.38 112.031 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.95 120.2 24.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.17999999999999999 110.921 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.15 124.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.79 -1.929 . . . . 3.9900000000000002 105.79 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -112.25 -12.95 13.54 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.311 -0.868 . . . . 5.1699999999999999 113.171 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 33.3 t -156.76 159.0 37.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 119.354 -2.091 . . . . 0.02 110.076 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.01 154.14 34.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.303 -0.873 . . . . 2.02 110.7 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -143.51 149.29 37.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.385 -0.822 . . . . 0.01 110.237 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -86.41 142.83 28.15 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.53 -0.915 . . . . 0.01 108.53 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 137' ' ' ILE . 7.3 mt -94.38 128.45 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.12 -0.987 . . . . 3.04 109.851 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.59 147.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.764 . . . . 1.8899999999999999 109.458 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 4.8899999999999997 109.102 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 107.088 -2.405 . . . . 0.81000000000000005 107.088 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.37 149.59 34.01 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 120.026 -1.083 . . . . 0.01 110.692 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -150.04 135.98 18.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.978 . . . . 0.02 109.509 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.25 140.83 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.432 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 4.3 m -121.32 130.06 53.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.625 -0.672 . . . . 0.39000000000000001 109.575 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -109.69 139.24 44.96 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.76 -0.83 . . . . 0.02 108.76 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m-85 -123.18 139.28 54.23 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.266 -0.896 . . . . 0.02 109.765 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 86.2 mt-10 -69.15 -28.1 66.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.989 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.69 170.22 8.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.426 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.495 ' NH2' ' OE1' ' A' ' 70' ' ' GLN . 73.0 mtt180 -74.07 157.71 35.59 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.638 0.732 . . . . 0.029999999999999999 109.929 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 50.9 t30 65.76 35.03 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.931 0.872 . . . . 0.73999999999999999 111.037 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.1 p90 50.29 45.61 25.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.839 0.828 . . . . 0.02 111.197 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.39 165.85 11.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.989 -1.115 . . . . 0.02 107.989 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.2 35.91 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.702 -1.237 . . . . 0.029999999999999999 110.853 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' ' OE2' ' A' ' 11' ' ' GLU . 22.3 ttp180 -68.64 142.78 55.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -1.048 . . . . 2.7599999999999998 109.414 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 54.9 ttt180 -119.79 147.65 44.38 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.593 0.711 . . . . 1.8899999999999999 109.893 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -132.61 126.68 33.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.833 -1.173 . . . . 0.02 107.833 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.39 137.78 50.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.756 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.08 138.55 49.61 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.648 0.737 . . . . 0.02 109.807 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.28 10.81 14.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.687 -0.633 . . . . 0.20000000000000001 109.542 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 t -157.08 174.47 15.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 40.3 t0 -60.84 144.46 52.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.733 -1.229 . . . . 0.02 109.969 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 20.9 t -131.95 116.11 16.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.49 -0.93 . . . . 0.02 108.49 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.18 51.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.23999999999999999 110.891 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.6 p-10 -154.4 101.56 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 1.1399999999999999 108.84 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.9 p90 -105.43 10.36 33.34 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.331 1.063 . . . . 6.3700000000000001 110.159 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.418 ' NH2' ' O ' ' A' ' 34' ' ' SER . 21.6 mmm180 -60.22 -23.03 63.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 3.1099999999999999 110.924 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -76.3 -16.94 59.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.619 -1.301 . . . . 0.88 110.222 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.23 -20.97 14.46 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.79 -0.818 . . . . 0.02 108.79 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.15 129.37 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.78 0.8 . . . . 3.3199999999999998 109.002 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 90.4 p -85.16 -10.78 56.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.762 -0.586 . . . . 0.02 110.717 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.46 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 12.5 ptm180 -170.26 162.13 8.51 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.639 -1.245 . . . . 0.02 107.639 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 t -143.6 115.34 8.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.02 108.978 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.444 HD22 HH21 ' A' ' 35' ' ' ARG . 2.4 m120 -110.33 1.2 18.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.739 -1.226 . . . . 0.029999999999999999 111.422 -178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 t -156.96 154.78 30.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.131 -1.062 . . . . 0.02 108.131 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -146.49 146.88 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 122.185 0.993 . . . . 0.02 111.105 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -122.8 124.11 42.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.616 -1.253 . . . . 0.02 107.616 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.48 114.83 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 106.598 -1.63 . . . . 0.02 106.598 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.7 mp0 -83.83 -33.73 24.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.269 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.32 149.8 18.34 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.104 -1.522 . . . . 0.02 110.133 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.07 173.87 50.03 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.648 -1.263 . . . . 0.01 110.153 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.6 m -119.64 137.28 53.98 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -126.09 153.93 43.8 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.712 1.244 . . . . 0.02 112.361 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.99 133.39 52.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.051 -2.203 . . . . 0.23999999999999999 105.051 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.87 142.03 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.658 -0.651 . . . . 0.65000000000000002 109.337 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -120.97 143.01 49.24 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.169 0.985 . . . . 0.02 109.655 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.58 -34.3 77.93 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.376 -0.829 . . . . 0.02 111.778 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -124.82 157.84 64.75 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.942 -1.099 . . . . 0.02 109.549 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.91 166.31 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.739 1.626 . . . . 0.02 112.741 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.77 37.31 9.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.314 -0.857 . . . . 0.02 111.058 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.85 52.23 8.13 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.551 0.691 . . . . 3.3900000000000001 110.598 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -126.21 163.87 22.23 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.181 0.515 . . . . 2.3300000000000001 110.016 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -162.02 31.29 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.871 -1.292 . . . . 0.02 109.871 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.65 136.38 57.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.275 . . . . 0.02 110.035 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 19.1 ptm -118.58 135.66 54.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.62 . . . . 5.0099999999999998 109.435 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.623 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 25.6 m-85 -135.52 141.09 45.21 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.509 -0.744 . . . . 0.02 109.34 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.51 133.04 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.59 -0.892 . . . . 1.72 108.59 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 66' ' ' TYR . 17.3 mt -123.74 111.79 29.27 Favored Pre-proline 0 N--CA 1.502 2.159 0 O-C-N 121.371 -0.831 . . . . 0.02 110.4 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.96 171.37 18.29 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.839 0.978 . . . . 1.47 110.237 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 11.3 tm0? -51.42 140.79 16.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.002 -1.061 . . . . 4.25 109.863 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.32 -178.56 31.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.403 -1.38 . . . . 0.02 110.883 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.3 tp10 -120.36 131.21 54.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.44 -1.035 . . . . 0.95999999999999996 109.461 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 93.3 m-85 -122.21 95.29 47.36 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.2 Cg_exo -65.65 -3.45 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.892 1.061 . . . . 0.02 114.179 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 36.1 mt-10 -157.78 154.99 29.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.415 -1.428 . . . . 2.02 108.087 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 7.3 p90 -60.8 -38.57 85.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.523 -0.735 . . . . 0.02 111.995 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 24.7 mt-30 -59.58 -24.21 63.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.02 110.367 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -70.84 -18.18 62.72 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.404 -0.961 . . . . 3.4199999999999999 108.404 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.623 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.89 9.87 30.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.258 -1.386 . . . . 0.02 107.258 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 60.86 21.48 11.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.587 -0.696 . . . . 0.02 110.41 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.05 145.01 46.56 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.392 -1.483 . . . . 0.02 109.392 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 75' ' ' LEU . 8.1 mp -78.6 -29.95 46.31 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.459 -1.682 . . . . 0.02 106.459 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 5.5 p30 -97.21 28.56 3.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.669 -1.27 . . . . 0.02 110.21 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -96.31 121.42 38.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.914 -1.116 . . . . 3.2000000000000002 110.33 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.3 119.72 10.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.794 -1.187 . . . . 2.6099999999999999 107.794 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.22 -15.94 10.12 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.338 -0.851 . . . . 0.02 112.975 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 47.3 t -155.55 155.59 33.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.97 -1.9 . . . . 0.02 110.943 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.43 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 23.9 p -145.86 148.7 33.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.487 -0.758 . . . . 0.02 110.397 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -135.53 140.53 44.8 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.394 -0.816 . . . . 0.01 108.888 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.33 130.97 36.8 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.081 -1.012 . . . . 0.42999999999999999 109.197 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.33 123.31 41.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.334 -0.987 . . . . 1.25 108.334 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -90.65 135.08 33.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.876 -1.14 . . . . 1.77 108.166 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.85 138.49 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.735 -0.839 . . . . 1.6299999999999999 108.735 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -111.56 125.4 53.88 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.495 -0.928 . . . . 1.0800000000000001 108.495 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -102.58 -156.13 0.55 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.93 -45.86 1.05 Allowed Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.339 -1.476 . . . . 0.01 112.068 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.33 -97.85 0.11 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.463 -1.827 . . . . 0.01 112.159 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -121.48 120.42 34.87 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.389 -1.065 . . . . 4.4299999999999997 110.707 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -74.92 131.49 40.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 2.9900000000000002 109.201 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.533 ' HZ2' ' HB3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -131.19 137.71 49.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.574 -0.704 . . . . 6.3600000000000003 109.523 -179.266 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 6.6 tt -127.78 142.75 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.861 0.838 . . . . 1.0900000000000001 109.456 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.1 pm0 -125.21 134.59 52.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.177 -1.045 . . . . 2.0499999999999998 108.177 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.72 148.48 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.88 -1.137 . . . . 1.1000000000000001 109.961 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 51.7 m-85 -118.32 141.16 48.81 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.925 0.869 . . . . 0.72999999999999998 110.777 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.9 -29.8 69.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 116.013 -0.54 . . . . 0.02 111.813 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -116.69 167.96 10.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.087 -1.008 . . . . 3.1800000000000002 110.573 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.29 164.03 41.5 Favored Glycine 0 N--CA 1.492 2.398 0 CA-C-O 121.936 0.742 . . . . 0.01 111.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.8 m-20 56.39 39.49 30.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.955 -0.733 . . . . 0.01 110.928 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' H ' ' CB ' ' A' ' 128' ' ' SER . 4.7 m-85 52.27 55.51 9.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.732 -0.605 . . . . 0.01 110.826 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -128.82 165.84 20.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.399 -0.963 . . . . 3.1499999999999999 108.399 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.85 -164.3 27.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.204 -1.558 . . . . 0.01 109.204 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -74.51 144.5 44.08 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.263 . . . . 0.01 108.167 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.71 142.28 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.647 0.737 . . . . 0.01 109.454 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.18 136.63 48.45 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.191 -1.04 . . . . 2.48 108.191 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 110' ' ' THR . 8.8 tp10 -119.09 133.67 55.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.714 -0.616 . . . . 0.01 109.741 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.533 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -148.99 149.39 31.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 1.6899999999999999 110.593 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 24.3 p -108.7 10.25 26.88 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.763 -0.653 . . . . 0.01 109.724 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 37.3 mp0 -120.81 163.12 18.65 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.383 -0.823 . . . . 3.21 111.234 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.1 p30 -65.75 154.73 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.052 -1.092 . . . . 0.01 108.052 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.7 t -122.5 110.16 32.33 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 108.512 -0.921 . . . . 0.01 108.512 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -76.91 -31.63 3.79 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 119.969 1.025 . . . . 0.01 111.833 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.2 t -142.02 107.92 5.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.088 -1.008 . . . . 0.02 108.792 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.4 mt -63.52 -39.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.913 -0.492 . . . . 1.8300000000000001 110.576 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.49 -37.28 84.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.003 -1.079 . . . . 1.3400000000000001 109.945 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -70.82 -39.12 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.842 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.5 tt0 -80.78 -48.22 12.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 2.0800000000000001 112.564 -176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PHE . . . . . 0.442 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 58.6 m-85 -111.82 -1.49 15.54 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.424 -0.797 . . . . 0.02 112.707 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 61.1 34.4 19.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.095 . . . . 0.02 109.769 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.19 135.49 53.98 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.534 -0.729 . . . . 0.02 109.152 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -90.32 -21.51 22.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 111.006 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 126' ' ' ILE . 39.8 mt-10 -148.42 163.57 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.045 -1.034 . . . . 0.02 110.06 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 125' ' ' GLU . 39.4 mm -128.48 125.6 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -109.82 -13.9 14.39 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.145 -0.972 . . . . 0.02 113.118 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.555 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 8.4 m -161.81 154.16 19.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.573 -1.33 . . . . 0.01 109.627 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.7 p -166.23 142.47 4.92 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.751 -0.833 . . . . 1.22 108.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.541 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -118.72 96.88 5.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 108.221 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.493 ' HA ' HE21 ' A' ' 96' ' ' GLN . 11.6 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-N 115.281 -0.872 . . . . 0.01 108.794 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CD1' HG21 ' A' ' 131' ' ' VAL . 87.6 m95 . . . . . 0 N--CA 1.508 2.451 0 CA-C-O 121.347 0.594 . . . . 0.01 110.658 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.7 mt -119.8 137.71 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.393 -0.966 . . . . 1.6899999999999999 108.393 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.82 141.26 44.41 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.168 -1.419 . . . . 2.4900000000000002 107.168 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -122.5 142.31 50.72 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.234 -0.916 . . . . 0.02 109.646 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -31.2 61.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.714 -0.616 . . . . 0.02 112.187 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.69 155.03 48.0 Favored Pre-proline 0 N--CA 1.506 2.355 0 O-C-N 120.736 -1.228 . . . . 1.48 109.135 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.3 Cg_endo -54.92 166.43 2.09 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.022 1.148 . . . . 0.02 112.913 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 142' ' ' PRO . 5.6 p30 57.05 31.9 20.74 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.056 -0.975 . . . . 0.75 111.822 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.445 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 59.35 51.85 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.02 111.397 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HE ' ' H ' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -127.05 166.29 17.88 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.479 -0.763 . . . . 0.02 109.793 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.663 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 87.57 -165.58 35.41 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.307 -1.117 . . . . 0.02 110.307 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.11 141.88 54.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -1.001 . . . . 0.02 108.873 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.475 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.2 mt-30 -114.8 149.15 37.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.267 0.556 . . . . 0.02 109.519 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -123.54 133.77 53.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.507 -0.923 . . . . 0.01 108.507 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.9 tp -94.69 122.3 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.792 -1.193 . . . . 0.01 109.342 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -93.23 149.0 21.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.01 108.875 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.6 m-20 -108.53 -175.88 2.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.51 -0.743 . . . . 2.27 109.222 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -74.4 27.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 1.8400000000000001 109.501 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 152' ' ' ASP . 55.1 mttm -112.76 174.69 5.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.354 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -106.57 138.02 43.51 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.936 -0.764 . . . . 0.01 108.936 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.82 114.31 28.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.304 -0.872 . . . . 0.01 110.273 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' A' ' 128' ' ' SER . 11.2 mtp180 -86.52 -28.55 23.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.01 111.268 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -123.2 153.68 64.94 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.831 -1.174 . . . . 2.54 107.831 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.6 Cg_endo -61.83 -41.93 34.67 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 CA-C-N 119.323 0.794 . . . . 0.69999999999999996 110.455 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.8 -18.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.808 -1.182 . . . . 0.85999999999999999 109.279 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -65.88 -18.31 65.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.02 111.87 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.76 14.82 30.84 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 120.891 -1.13 . . . . 0.02 110.099 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.36 10.72 73.52 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.219 -0.926 . . . . 0.02 113.047 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.18 140.54 35.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.79 -1.417 . . . . 0.02 109.994 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.03 -6.81 59.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 109.544 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 97.2 p -140.97 150.2 58.53 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.213 -0.929 . . . . 0.87 109.192 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.33 16.64 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.585 0.857 . . . . 0.38 111.942 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.18 120.19 25.03 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.177 0.989 . . . . 0.17999999999999999 110.904 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.59 124.28 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 105.609 -1.997 . . . . 3.9900000000000002 105.609 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -112.09 -12.77 13.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.241 -0.912 . . . . 5.1699999999999999 113.246 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.9 m -157.7 160.76 38.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.146 -2.221 . . . . 0.02 110.388 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -151.59 153.14 33.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.373 -0.83 . . . . 2.02 109.875 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.445 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.2 mtp180 -143.55 150.0 38.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.217 -0.927 . . . . 0.01 110.121 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.519 ' NH2' ' O ' ' A' ' 111' ' ' THR . 3.4 ptp180 -87.4 143.1 27.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.581 -0.896 . . . . 0.01 108.581 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.79 128.51 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.207 -0.933 . . . . 3.04 109.25 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.9 t -137.52 147.81 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.199 -0.938 . . . . 1.8899999999999999 109.653 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.43 -0.794 . . . . 4.8899999999999997 109.412 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.469 -0.567 . . . . 5.2800000000000002 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -65.99 98.91 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 5.96 109.3 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 p -104.33 -140.47 0.36 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.208 -1.034 . . . . 2.2200000000000002 108.208 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.65 88.06 0.07 OUTLIER Glycine 0 N--CA 1.497 2.742 0 N-CA-C 107.084 -2.406 . . . . 0.81000000000000005 107.084 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.66 148.9 32.65 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 120.216 -0.992 . . . . 0.01 110.866 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -151.18 136.81 17.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.951 . . . . 0.02 108.839 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -130.25 140.58 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -120.85 129.28 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.455 -0.778 . . . . 0.39000000000000001 109.897 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.6 m-85 -109.42 139.51 44.3 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.839 -0.801 . . . . 0.02 108.839 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -124.18 139.69 53.68 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.184 -0.948 . . . . 0.02 110.126 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.5 mt-10 -68.32 -27.3 66.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.029999999999999999 111.826 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.42 169.97 8.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.838 -1.164 . . . . 0.029999999999999999 110.466 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 59.3 mtt180 -74.93 158.49 33.22 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 109.816 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.2 m120 65.91 34.71 7.01 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.813 0.816 . . . . 0.73999999999999999 110.842 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.2 p90 49.41 44.29 23.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.72 0.771 . . . . 0.02 111.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -111.74 165.95 11.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.43 -167.61 35.73 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.593 -1.289 . . . . 0.029999999999999999 110.487 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -68.6 143.1 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 2.7599999999999998 109.024 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 21' ' ' ASP . 3.0 tmm_? -121.51 149.96 42.32 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.752 0.787 . . . . 1.8899999999999999 110.163 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -133.52 128.17 34.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.444 -0.947 . . . . 0.02 108.444 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' CZ ' ' A' ' 19' ' ' ARG . 45.5 m-20 -111.43 136.9 49.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.494 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.3 t -130.79 137.62 49.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.535 0.684 . . . . 0.02 109.412 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 p-10 -117.0 10.47 14.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.706 -0.621 . . . . 0.20000000000000001 109.535 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -158.32 174.51 15.04 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.158 -1.053 . . . . 1.23 108.158 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.1 p30 -62.08 144.3 55.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.61 -1.306 . . . . 0.02 110.253 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 t -131.33 117.45 18.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.569 -0.9 . . . . 0.02 108.569 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.79 -25.19 53.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.087 -1.008 . . . . 0.23999999999999999 110.613 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.29 101.52 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.966 -1.083 . . . . 1.1399999999999999 108.742 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -104.61 8.35 35.28 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 122.108 0.956 . . . . 6.3700000000000001 109.541 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -59.0 -24.08 62.46 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.556 -0.715 . . . . 3.1099999999999999 110.787 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -74.29 -16.5 60.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.716 -1.24 . . . . 0.88 110.047 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -103.59 -22.16 13.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.02 109.228 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.0 tp -150.27 128.92 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 3.3199999999999998 109.086 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 p -85.64 -9.98 56.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.735 -0.603 . . . . 0.02 111.086 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -170.78 161.66 7.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 t -142.41 114.37 8.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.718 -1.239 . . . . 0.02 108.573 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -108.71 0.82 20.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.895 -1.128 . . . . 0.029999999999999999 110.609 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 3.2 p -156.55 153.39 28.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -145.38 148.47 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.08 -1.013 . . . . 0.02 109.74 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -124.09 124.87 43.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.387 -1.338 . . . . 0.02 107.387 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -105.69 113.29 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.601 -1.629 . . . . 0.02 106.601 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -83.63 -34.14 25.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.049 -0.66 . . . . 3.8100000000000001 109.744 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.75 150.7 19.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.525 -1.798 . . . . 0.02 110.532 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.92 174.18 50.13 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.513 -1.327 . . . . 0.01 110.095 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 53.9 m -109.62 160.73 16.03 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.996 -1.483 . . . . 1.48 106.996 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 74.6 m95 -148.15 146.89 28.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.324 -1.485 . . . . 0.02 111.443 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.05 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.263 -2.125 . . . . 0.23999999999999999 105.263 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.1 m -119.78 143.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.586 -0.696 . . . . 0.65000000000000002 109.65 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.78 144.85 48.08 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.245 1.021 . . . . 0.02 109.903 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.59 -34.74 78.56 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.829 -0.623 . . . . 0.02 111.541 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -124.25 157.5 64.2 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.104 -0.997 . . . . 0.02 109.326 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.28 165.53 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.491 1.461 . . . . 0.02 113.152 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 64.18 37.31 8.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.221 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 45.24 51.32 9.32 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.655 0.741 . . . . 3.3900000000000001 110.483 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -125.81 163.27 23.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 2.3300000000000001 109.714 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.02 -161.42 31.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.642 -1.383 . . . . 0.02 109.642 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -65.15 138.24 58.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.04 -1.271 . . . . 0.02 110.161 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.6 ptm -118.61 135.79 54.24 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.067 -0.716 . . . . 5.0099999999999998 109.067 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.7 m-85 -134.82 139.94 45.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.8 0.809 . . . . 0.02 109.856 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.52 132.49 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.561 -0.903 . . . . 1.72 108.561 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -118.59 111.78 37.63 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.569 -0.707 . . . . 0.02 110.357 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.89 168.1 22.71 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.127 1.081 . . . . 1.47 109.897 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 7.9 tm0? -53.37 140.81 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.796 -1.19 . . . . 4.25 110.36 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.04 -176.9 32.56 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.689 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.1 tp10 -118.13 129.31 55.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -1.146 . . . . 0.95999999999999996 108.929 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.528 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 47.3 m-85 -120.4 96.8 49.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 107.548 -1.278 . . . . 0.02 107.548 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -68.74 -3.9 12.18 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 120.541 0.827 . . . . 0.02 113.818 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -156.91 154.34 29.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.453 -1.405 . . . . 2.02 107.962 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 52.0 p90 -60.51 -37.62 81.72 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.59 -0.694 . . . . 0.02 111.537 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.39 -23.97 64.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.014 -1.053 . . . . 0.02 110.454 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.52 -18.48 62.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.433 -0.951 . . . . 3.4199999999999999 108.433 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.617 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.75 10.98 30.71 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.188 -1.412 . . . . 0.02 107.188 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.4 OUTLIER 59.61 21.76 10.4 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.598 0.713 . . . . 0.02 110.27 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.7 145.1 45.73 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.871 -1.692 . . . . 0.02 108.871 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.3 tt -78.27 -30.48 48.55 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.536 -1.283 . . . . 0.97999999999999998 107.536 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 16.0 t-20 -156.77 -172.36 4.02 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.514 -1.662 . . . . 0.02 106.514 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 32.6 p30 -97.52 27.29 4.38 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.709 -1.245 . . . . 0.02 110.087 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -96.04 122.86 39.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.055 -1.028 . . . . 3.2000000000000002 110.493 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.517 HD22 ' HB ' ' A' ' 48' ' ' VAL . 45.9 mt -144.31 120.55 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.469 -1.308 . . . . 2.6099999999999999 107.469 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 -16.52 13.06 Favored Glycine 0 N--CA 1.504 3.172 0 O-C-N 121.317 -0.864 . . . . 0.02 112.507 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 m -156.06 156.06 33.72 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.372 -1.663 . . . . 0.02 110.239 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.7 p -144.12 146.91 33.09 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.372 0.606 . . . . 0.02 109.447 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -135.03 140.18 45.4 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.01 108.857 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.82 130.57 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.36 -0.978 . . . . 0.42999999999999999 108.36 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.1 125.2 44.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.389 -0.967 . . . . 1.25 108.389 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' O ' ' CG2' ' A' ' 135' ' ' THR . 45.3 m-70 -90.51 135.8 33.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 1.77 108.94 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.76 138.2 37.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.986 -0.746 . . . . 1.6299999999999999 108.986 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -113.29 126.11 55.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.863 -0.792 . . . . 1.0800000000000001 108.863 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -102.51 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.209 -1.774 . . . . 1.26 106.209 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.56 -48.31 0.9 Allowed Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.376 -1.452 . . . . 0.01 112.529 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.16 -99.63 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 118.259 -1.924 . . . . 0.01 112.388 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -121.58 119.63 32.48 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.285 -1.127 . . . . 4.4299999999999997 110.756 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -77.75 131.08 37.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.105 -0.702 . . . . 2.9900000000000002 109.105 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.3 ttpm? -131.13 140.35 49.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.461 -0.774 . . . . 6.3600000000000003 108.931 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -128.9 143.66 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.386 -0.821 . . . . 1.0900000000000001 110.109 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.23 133.73 54.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.905 -1.146 . . . . 2.0499999999999998 107.905 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.03 147.17 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.876 -1.14 . . . . 1.1000000000000001 109.691 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 29.5 m-85 -118.56 140.87 49.21 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.129 0.966 . . . . 0.72999999999999998 110.835 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -66.26 -29.42 69.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.772 -0.649 . . . . 0.02 111.721 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -116.91 170.25 8.77 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 120.984 -1.072 . . . . 3.1800000000000002 110.573 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 165.32 50.12 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.831 -0.907 . . . . 0.01 110.831 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 56.5 38.41 29.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.834 -0.803 . . . . 0.01 111.461 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE1' ' OG ' ' A' ' 128' ' ' SER . 11.3 m-85 52.57 54.5 10.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.01 111.509 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -129.25 166.31 19.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.196 -1.038 . . . . 3.1499999999999999 108.196 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.46 28.03 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.514 -1.434 . . . . 0.01 109.514 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -75.16 144.54 42.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.1 -1.235 . . . . 0.01 108.493 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 48.2 ttp -116.65 142.11 47.32 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.654 0.74 . . . . 0.01 109.88 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -131.24 135.33 47.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.912 -1.144 . . . . 2.48 107.912 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -120.43 135.09 55.15 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.623 -0.673 . . . . 0.01 110.041 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -149.63 151.62 34.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.295 1.045 . . . . 1.6899999999999999 110.934 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.525 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 5.3 p -110.06 10.3 24.07 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.503 -0.771 . . . . 0.01 109.787 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -121.11 162.92 19.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 3.21 111.156 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -66.78 155.79 37.25 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.151 -1.055 . . . . 0.01 108.151 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.0 t -123.98 110.12 29.47 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.528 -0.916 . . . . 0.01 108.528 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.71 -32.82 3.33 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 120.002 1.036 . . . . 0.01 111.697 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -139.64 106.78 5.47 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.33 -39.91 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.869 -0.519 . . . . 1.8300000000000001 111.065 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 36.1 ttp -66.59 -38.0 86.09 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.996 -1.082 . . . . 1.3400000000000001 109.957 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -70.25 -38.96 75.26 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.758 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.522 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 45.7 tt0 -80.16 -48.2 13.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 2.0800000000000001 112.507 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.522 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 81.3 m-85 -111.41 -1.29 15.99 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.353 -0.842 . . . . 0.02 112.611 -175.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 61.79 33.77 17.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.792 -1.193 . . . . 0.02 109.668 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.52 136.05 53.45 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.487 -0.758 . . . . 0.02 109.293 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -90.21 -21.46 22.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.986 . . . . 5.3200000000000003 110.87 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 126' ' ' ILE . 45.3 mt-10 -148.73 164.14 35.24 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.02 110.124 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 125' ' ' GLU . 37.2 mm -129.29 126.57 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.503 -1.295 . . . . 2.1699999999999999 107.503 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.54 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 m80 -109.92 -13.22 14.47 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.251 -0.906 . . . . 0.02 112.618 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.534 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 47.5 t -161.39 154.34 20.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.786 -1.196 . . . . 0.01 109.0 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -170.64 147.28 2.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.22 109.684 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -119.86 109.9 16.11 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.986 -1.071 . . . . 1.4099999999999999 109.237 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.65 131.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.273 -1.751 . . . . 0.01 106.273 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.76 92.06 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 106.793 -1.558 . . . . 1.98 106.793 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.512 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 1.1 tm-20 -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.575 -2.009 . . . . 0.01 105.575 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.74 -43.36 1.04 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.765 -1.734 . . . . 0.01 108.765 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.703 ' HB ' HD12 ' A' ' 175' ' ' ILE . 75.5 p -129.12 104.93 7.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.518 -0.989 . . . . 2.2999999999999998 111.794 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.512 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 42.9 m95 -129.54 144.03 51.09 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.461 -1.311 . . . . 0.01 107.461 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.47 ' CG1' HD11 ' A' ' 175' ' ' ILE . 36.3 mt -118.51 133.14 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.565 -1.335 . . . . 1.6899999999999999 109.502 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.09 141.62 44.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.334 -1.728 . . . . 2.4900000000000002 106.334 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 21.4 m-85 -123.45 143.07 50.38 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.197 -0.94 . . . . 0.02 109.731 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -74.25 -30.36 62.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.675 -0.641 . . . . 0.02 111.882 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.49 155.12 47.6 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.62 -1.3 . . . . 1.48 108.951 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -56.51 167.27 2.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.098 1.199 . . . . 0.02 112.615 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.25 31.21 21.01 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.413 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.489 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 3.1 m-85 57.48 50.68 10.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 0.02 111.082 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.36 165.13 18.25 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.656 -0.652 . . . . 0.02 109.766 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.7 33.98 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.549 -1.021 . . . . 0.02 110.549 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.57 142.15 53.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.542 -0.975 . . . . 0.02 108.788 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.5 mt-30 -113.14 148.45 35.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.351 0.596 . . . . 0.02 110.083 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -124.3 134.19 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.687 -0.856 . . . . 0.01 108.687 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.0 tp -96.0 120.55 36.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.156 . . . . 0.01 109.654 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -99.95 149.36 23.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.856 -0.794 . . . . 0.01 108.856 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.3 m-20 -109.58 -177.32 3.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 2.27 109.374 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -72.83 35.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.8400000000000001 109.469 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.6 mttp -111.55 176.2 5.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.078 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.92 127.03 52.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.424 -0.797 . . . . 0.01 109.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -98.31 112.26 24.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.01 108.847 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 9.6 ptp180 -88.7 -27.85 20.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.762 -0.586 . . . . 0.01 111.298 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -122.53 153.43 62.59 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 107.907 -1.146 . . . . 2.54 107.907 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.0 Cg_endo -62.24 -41.44 34.61 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.315 0.791 . . . . 0.69999999999999996 110.805 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.57 -18.26 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.862 -1.149 . . . . 0.85999999999999999 109.457 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.5 -18.22 65.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.891 -1.13 . . . . 0.02 111.948 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.31 15.83 27.51 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.737 -1.227 . . . . 0.02 110.207 178.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.72 10.14 76.79 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.12 -0.987 . . . . 0.02 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.496 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.06 140.61 34.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.862 -1.375 . . . . 0.02 110.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.27 -7.05 59.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.621 -0.675 . . . . 0.58999999999999997 109.521 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.5 p -140.46 150.38 60.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.239 -0.913 . . . . 0.87 109.06 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.66 16.14 0.64 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 120.566 0.844 . . . . 0.38 111.776 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.19 119.9 24.66 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.307 1.051 . . . . 0.17999999999999999 110.817 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.43 123.64 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.57 -2.011 . . . . 3.9900000000000002 105.57 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -111.9 -13.16 13.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.369 -0.832 . . . . 5.1699999999999999 113.16 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.489 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.1 p -157.03 160.1 38.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 119.276 -2.14 . . . . 0.02 109.965 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.1 153.9 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 2.02 110.202 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -144.18 149.26 36.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.342 -0.849 . . . . 0.01 110.068 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 93' ' ' ALA . 4.6 ptp180 -87.02 141.48 28.64 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.603 -0.888 . . . . 0.01 108.603 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.703 HD12 ' HB ' ' A' ' 135' ' ' THR . 41.7 mt -93.88 129.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 3.04 109.482 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.78 149.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.407 -0.808 . . . . 1.8899999999999999 109.771 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 4.8899999999999997 109.536 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.444 -0.576 . . . . 5.2800000000000002 109.444 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -82.13 135.37 35.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 5.96 109.588 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -138.58 -129.03 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.241 -0.912 . . . . 2.2200000000000002 111.431 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 3' ' ' THR . . . 167.33 94.73 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.593 -3.003 . . . . 0.81000000000000005 105.593 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 146.61 31.53 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.383 -0.913 . . . . 0.01 111.179 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.23 137.4 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.76 -0.847 . . . . 0.02 108.82 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 tt -129.89 140.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.937 -0.764 . . . . 0.02 108.937 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -120.9 130.14 53.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.721 . . . . 0.39000000000000001 109.654 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 25.7 m-85 -108.96 138.73 44.84 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.88 -0.785 . . . . 0.02 108.88 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.34 138.28 54.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.302 -0.874 . . . . 0.02 109.398 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -68.21 -27.75 66.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 0.029999999999999999 111.605 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -114.93 170.13 8.57 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.976 -1.077 . . . . 0.029999999999999999 110.422 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -74.73 161.66 29.42 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.708 0.766 . . . . 0.029999999999999999 110.063 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.2 t-20 62.58 34.91 14.74 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.894 0.854 . . . . 0.73999999999999999 110.559 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.0 p90 49.45 42.9 23.23 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.473 -0.785 . . . . 0.02 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -109.35 165.89 11.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.806 -1.183 . . . . 0.02 107.806 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -167.98 35.01 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.681 -1.262 . . . . 0.029999999999999999 110.837 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.9 143.96 54.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.955 . . . . 2.7599999999999998 109.035 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -122.16 150.05 42.76 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.727 0.775 . . . . 1.8899999999999999 110.207 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.24 128.59 36.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.158 -1.053 . . . . 0.02 108.158 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -110.98 135.92 50.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.549 -0.719 . . . . 1.1200000000000001 109.465 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -129.99 137.81 50.49 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.486 0.66 . . . . 0.02 109.682 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 10.89 14.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.248 -0.649 . . . . 0.20000000000000001 109.248 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 t -158.83 174.17 15.4 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.06 -1.089 . . . . 1.23 108.06 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 15.8 p-10 -61.66 144.74 54.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.756 -1.215 . . . . 0.02 110.216 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 t -131.49 117.5 18.88 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.5 -0.926 . . . . 0.02 108.5 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.01 44.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.23999999999999999 111.292 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -153.21 102.49 2.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.149 . . . . 1.1399999999999999 108.946 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' C ' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -101.68 8.49 41.62 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.962 0.887 . . . . 6.3700000000000001 109.689 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -59.14 -26.74 65.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.731 -0.606 . . . . 3.1099999999999999 111.657 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.28 -17.32 60.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.591 -1.318 . . . . 0.88 110.36 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.14 -22.22 13.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.02 109.799 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 tp -150.1 128.26 11.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.052 -1.03 . . . . 3.3199999999999998 109.019 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -84.77 -9.21 58.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.781 -0.575 . . . . 0.02 111.016 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -171.03 164.11 7.46 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -142.24 114.15 8.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.726 -1.234 . . . . 0.02 108.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -109.14 -0.93 19.11 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.942 -1.099 . . . . 0.029999999999999999 111.343 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -154.02 153.8 32.59 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.74 146.73 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.136 -0.978 . . . . 0.02 110.552 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' NE ' ' OH ' ' A' ' 10' ' ' TYR . 25.3 ttp180 -124.56 125.22 43.82 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.476 -1.305 . . . . 0.02 107.476 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.589 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 43.8 t -104.07 113.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 106.565 -1.643 . . . . 0.02 106.565 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -83.01 -34.47 26.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 3.8100000000000001 109.389 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.59 18.02 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.726 -1.702 . . . . 0.02 110.302 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.81 173.56 49.82 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.711 -1.233 . . . . 0.01 110.243 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -119.02 135.48 54.61 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.473 -1.306 . . . . 1.48 107.473 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.41 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.2 m95 -123.91 153.65 40.85 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.835 -1.166 . . . . 0.02 112.259 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.29 53.08 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.14 -2.17 . . . . 0.23999999999999999 105.14 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.4 m -118.63 142.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.129 -0.693 . . . . 0.65000000000000002 109.129 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.04 146.33 46.83 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.295 1.045 . . . . 0.02 109.617 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.428 ' OE1' ' O ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -66.0 -35.66 81.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.55 -0.75 . . . . 0.02 111.121 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -123.46 158.52 58.56 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 121.2 -0.937 . . . . 0.02 109.067 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.83 168.38 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.65 1.567 . . . . 0.02 112.8 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 62.75 37.42 12.57 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.421 -0.809 . . . . 0.02 111.197 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.73 52.11 8.01 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.573 0.701 . . . . 3.3900000000000001 110.793 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -126.61 164.16 21.84 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.193 0.52 . . . . 2.3300000000000001 109.838 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.35 -161.55 32.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.517 -1.433 . . . . 0.02 109.517 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -66.44 137.55 56.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.927 -1.337 . . . . 0.02 109.61 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.49 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.8 ptm -119.24 137.52 53.6 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.305 -0.628 . . . . 5.0099999999999998 109.305 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.1 m-85 -132.3 138.9 47.99 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.02 109.466 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.4 mm -96.23 132.1 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.764 -0.828 . . . . 1.72 108.764 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' A' ' 66' ' ' TYR . 16.4 mt -121.45 110.13 34.23 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.255 -0.903 . . . . 0.02 110.751 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.2 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.793 0.962 . . . . 1.47 109.981 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 28.3 tp60 -50.56 138.71 17.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 4.25 110.254 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.04 -179.17 32.15 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.035 -1.555 . . . . 0.02 110.884 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.0 130.83 55.89 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.547 -0.972 . . . . 0.95999999999999996 109.462 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -120.87 94.33 48.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.664 -1.236 . . . . 0.02 107.664 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.08 -4.47 11.6 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.781 0.988 . . . . 0.02 113.738 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -155.01 154.43 32.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.723 -1.236 . . . . 2.02 108.008 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CE2' ' CD ' ' A' ' 70' ' ' GLN . 33.3 p90 -61.12 -38.74 87.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.514 -0.741 . . . . 0.02 111.396 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.447 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 12.8 mm100 -60.38 -24.39 65.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.102 -0.999 . . . . 0.02 110.058 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.551 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.06 -18.09 63.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.293 -1.003 . . . . 3.4199999999999999 108.293 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.7 10.13 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.221 -1.4 . . . . 0.02 107.221 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.1 mpp? 59.2 21.9 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.664 0.745 . . . . 0.02 110.138 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 144.47 46.48 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.321 -1.512 . . . . 0.02 109.321 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 -30.03 48.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.623 -1.251 . . . . 0.97999999999999998 107.623 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.432 ' ND2' ' CG ' ' A' ' 78' ' ' ARG . 53.3 p-10 -157.96 -171.17 3.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.533 -1.654 . . . . 0.02 106.533 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.9 p-10 -98.21 28.3 4.13 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.682 -1.262 . . . . 0.02 110.403 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.527 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.4 OUTLIER -97.57 122.83 41.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.814 -1.179 . . . . 3.2000000000000002 111.056 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.7 mt -142.33 122.01 13.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.286 -1.376 . . . . 2.6099999999999999 107.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -18.12 10.6 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.985 -1.072 . . . . 0.02 112.302 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.4 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 28.4 t -156.14 155.86 33.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.463 -1.61 . . . . 0.02 110.277 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 70.4 m -144.33 147.63 33.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.02 109.791 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -135.02 140.22 45.47 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.28 -0.888 . . . . 0.01 109.111 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 134.92 37.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 0.42999999999999999 108.753 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 123.09 45.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.554 -0.906 . . . . 1.25 108.554 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 135' ' ' THR . 50.1 m-70 -90.48 136.18 33.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.183 -1.043 . . . . 1.77 108.183 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.51 137.29 38.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 1.6299999999999999 109.6 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.8 m -112.1 126.32 55.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.58 -0.896 . . . . 1.0800000000000001 108.58 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -102.99 -155.47 0.53 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.262 -1.755 . . . . 1.26 106.262 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.16 -48.96 0.86 Allowed Glycine 0 N--CA 1.498 2.83 0 O-C-N 120.438 -1.414 . . . . 0.01 112.384 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.88 -99.58 0.13 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.444 -1.836 . . . . 0.01 112.166 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -120.84 119.6 33.14 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.246 -1.149 . . . . 4.4299999999999997 110.751 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.3 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.187 -0.671 . . . . 2.9900000000000002 109.187 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -130.91 141.16 50.27 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.557 -0.714 . . . . 6.3600000000000003 109.085 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.78 144.84 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.319 -0.863 . . . . 1.0900000000000001 109.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.4 pm0 -121.76 134.37 54.93 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.404 -1.332 . . . . 2.0499999999999998 107.404 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 146.58 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.914 -1.116 . . . . 1.1000000000000001 109.371 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 36.0 m-85 -120.23 141.64 49.75 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.158 0.98 . . . . 0.72999999999999998 111.108 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -66.43 -30.05 70.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.699 -0.682 . . . . 0.02 111.816 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -116.29 168.09 10.44 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.956 -1.09 . . . . 3.1800000000000002 110.54 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.94 164.14 43.77 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 111.153 -0.779 . . . . 0.01 111.153 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 56.54 39.23 29.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.675 0.75 . . . . 0.01 110.941 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 51.45 56.31 8.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.625 -0.672 . . . . 0.01 111.115 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -128.55 165.64 20.36 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.008 -1.108 . . . . 3.1499999999999999 108.008 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.61 -164.08 27.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.151 -1.579 . . . . 0.01 109.151 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -74.66 144.32 43.87 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.983 -1.304 . . . . 0.01 108.411 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.8 ttt -116.5 141.74 47.79 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.619 0.723 . . . . 0.01 109.521 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -131.65 135.72 47.14 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.069 -1.085 . . . . 2.48 108.069 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -118.93 135.12 54.75 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.668 -0.645 . . . . 0.01 109.928 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -149.64 151.55 33.94 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.392 1.091 . . . . 1.6899999999999999 110.95 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.6 p -111.05 9.68 22.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.396 -0.82 . . . . 0.01 109.923 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 30.5 mp0 -121.28 163.85 17.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.324 -0.86 . . . . 3.21 111.556 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -67.73 156.03 37.88 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.443 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 12.3 m -124.83 111.67 27.3 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.753 -0.832 . . . . 0.01 108.753 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -76.21 -31.78 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 CA-C-N 119.958 1.021 . . . . 0.01 111.439 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -141.3 107.03 5.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.573 -0.899 . . . . 0.02 108.573 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.85 -39.28 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.81 -0.557 . . . . 1.8300000000000001 111.139 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.5 tmt? -67.19 -38.2 84.98 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.97 -1.092 . . . . 1.3400000000000001 109.892 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.14 -38.44 78.82 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.484 -1.385 . . . . 2.1099999999999999 109.826 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -79.63 -47.4 15.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 2.0800000000000001 112.38 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.12 -0.48 15.59 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.469 -0.769 . . . . 0.02 112.75 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m80 61.54 33.77 18.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.687 -1.258 . . . . 0.02 109.719 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.8 136.21 53.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.371 -0.831 . . . . 0.02 109.256 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -89.46 -21.73 22.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 5.3200000000000003 110.473 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -150.38 165.67 32.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.958 -1.088 . . . . 0.02 110.256 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.7 mm -129.87 126.57 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.219 -1.4 . . . . 2.1699999999999999 107.219 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -108.97 -12.94 14.81 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.14 -0.975 . . . . 0.02 112.598 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 21.1 m -158.16 152.34 24.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.764 -1.21 . . . . 0.01 108.753 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.8 t -166.51 142.81 4.75 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.099 -1.001 . . . . 1.22 109.152 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.531 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 31.4 ttpt -123.21 105.34 9.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.57 1.176 . . . . 1.4099999999999999 109.504 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG13 ' O ' ' A' ' 131' ' ' VAL . 11.4 p -109.57 135.7 47.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.5 -1.296 . . . . 0.01 107.5 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -126.15 92.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.347 -1.723 . . . . 1.98 106.347 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.58 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 24.3 tt0 -146.42 -67.39 0.28 Allowed 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 105.355 -2.091 . . . . 0.01 105.355 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 145.55 -44.48 0.87 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.342 -1.503 . . . . 0.01 109.342 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.74 ' HB ' HD12 ' A' ' 175' ' ' ILE . 61.8 p -129.13 106.55 8.93 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.331 -1.099 . . . . 2.2999999999999998 112.205 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 14.3 m95 -132.95 145.54 50.99 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.549 -1.278 . . . . 0.01 107.549 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.424 ' CG1' HD11 ' A' ' 175' ' ' ILE . 25.3 mt -118.98 135.75 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.581 -1.324 . . . . 1.6899999999999999 109.566 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.34 142.16 43.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.341 -1.725 . . . . 2.4900000000000002 106.341 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 31.9 m-85 -122.23 143.53 49.53 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.113 -0.992 . . . . 0.02 109.364 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 47.4 tt0 -76.68 -30.03 56.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.747 -0.596 . . . . 0.02 111.833 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.1 mt -114.33 152.57 46.13 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.562 -1.336 . . . . 1.48 109.064 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.72 165.64 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.65 0.9 . . . . 0.02 112.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 59.71 31.67 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.307 -0.86 . . . . 0.75 111.549 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 57.88 52.13 8.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.514 -0.742 . . . . 0.02 111.412 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.0 165.51 19.3 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.473 -0.767 . . . . 0.02 110.059 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.86 -165.54 33.36 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.962 -1.255 . . . . 0.02 109.962 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -69.83 143.59 52.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.02 108.94 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 58' ' ' MET . 16.6 mt-30 -113.08 149.5 33.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.02 110.085 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.87 133.61 53.01 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.92 121.58 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.944 -1.098 . . . . 0.01 109.785 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.7 mp -98.31 142.32 30.1 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.72 -0.845 . . . . 0.01 108.72 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 154' ' ' LYS . 95.1 m-20 -110.26 -172.55 2.06 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.445 -0.784 . . . . 2.27 109.739 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -71.64 37.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.636 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 152' ' ' ASP . 30.6 mmtp -112.31 168.74 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.413 -0.804 . . . . 2.2799999999999998 109.3 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -104.34 127.0 51.92 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.039 -1.097 . . . . 0.01 108.039 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 54.8 m-85 -99.58 112.47 24.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.928 . . . . 0.01 110.258 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.444 ' O ' ' OG ' ' A' ' 128' ' ' SER . 78.7 mtt180 -89.31 -27.39 20.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.632 -0.667 . . . . 0.01 110.845 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -124.43 152.82 68.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 108.134 -1.062 . . . . 2.54 108.134 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 7.8 Cg_endo -60.83 -40.25 55.37 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 CA-C-N 119.437 0.835 . . . . 0.69999999999999996 111.005 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.49 -18.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 120.724 -1.235 . . . . 0.85999999999999999 109.67 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 156' ' ' TYR . 39.2 t70 -65.4 -17.6 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.91 -1.119 . . . . 0.02 112.062 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.17 16.7 24.59 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 120.733 -1.23 . . . . 0.02 110.229 178.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.02 77.68 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.174 -0.954 . . . . 0.02 112.874 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -99.11 139.81 34.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.85 -1.382 . . . . 0.02 110.146 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.67 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.58999999999999997 109.342 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 p -138.92 151.77 68.91 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.87 109.261 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.77 13.58 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.756 0.971 . . . . 0.38 111.892 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.55 119.62 24.0 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.603 1.192 . . . . 0.17999999999999999 111.039 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.508 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 0.9 OUTLIER -150.55 121.93 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.013 -1.847 . . . . 3.9900000000000002 106.013 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.507 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 11.0 mp0 -113.69 -11.57 12.93 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 113.253 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -156.46 159.01 38.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.119 -2.238 . . . . 0.02 110.45 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.443 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 25.3 p90 -152.79 154.34 34.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.029 -1.044 . . . . 2.02 110.3 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -144.21 149.88 37.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 0.01 110.125 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -87.05 141.97 28.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.311 -0.996 . . . . 0.01 108.311 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.74 HD12 ' HB ' ' A' ' 135' ' ' THR . 24.6 mt -93.71 129.54 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.325 -0.859 . . . . 3.04 109.411 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 m -138.28 149.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.351 -0.843 . . . . 1.8899999999999999 109.756 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 4.8899999999999997 109.56 179.474 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.357 -0.609 . . . . 5.2800000000000002 109.357 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -74.35 93.52 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 5.96 109.437 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -101.3 -141.28 0.34 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.677 -1.231 . . . . 2.2200000000000002 107.677 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' HG22 ' A' ' 3' ' ' THR . . . 174.21 87.36 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 107.16 -2.376 . . . . 0.81000000000000005 107.16 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 149.31 33.31 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.162 -1.018 . . . . 0.01 110.683 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -150.88 136.84 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.496 -1.002 . . . . 0.02 109.493 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.9 140.42 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 109.2 -0.666 . . . . 0.02 109.2 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -122.03 130.23 53.11 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.571 -0.705 . . . . 0.39000000000000001 109.642 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 24.6 m-85 -110.31 140.13 44.8 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.007 -0.738 . . . . 0.02 109.007 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m-85 -121.98 138.45 54.42 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.339 -0.851 . . . . 0.02 109.546 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 66.2 mt-10 -68.14 -27.82 66.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -0.989 . . . . 0.029999999999999999 111.706 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -114.26 170.03 8.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.867 -1.146 . . . . 0.029999999999999999 110.468 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -75.22 158.26 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.498 0.666 . . . . 0.029999999999999999 110.058 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.2 m120 66.2 34.65 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.826 0.822 . . . . 0.73999999999999999 110.767 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.95 45.22 25.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.668 0.746 . . . . 0.02 111.428 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.24 165.88 11.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.66 -167.71 35.43 Favored Glycine 0 N--CA 1.496 2.674 0 O-C-N 120.793 -1.192 . . . . 0.029999999999999999 110.912 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -68.61 142.74 55.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.45 -1.03 . . . . 2.7599999999999998 109.279 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -120.02 148.65 43.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.597 -0.69 . . . . 1.8899999999999999 110.23 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -132.33 127.06 34.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.257 -1.016 . . . . 0.02 108.257 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -111.81 136.51 50.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.483 -0.761 . . . . 1.1200000000000001 109.762 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -130.91 138.02 49.58 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.573 0.701 . . . . 0.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -116.47 11.29 14.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.623 -0.673 . . . . 0.20000000000000001 109.477 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 19.9 p -157.79 174.15 15.73 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.195 -1.039 . . . . 1.23 108.195 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 19.3 p30 -61.11 144.66 53.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.72 -1.238 . . . . 0.02 109.955 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 t -131.76 116.53 17.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.415 -0.957 . . . . 0.02 108.415 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.59 52.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.23999999999999999 110.733 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -156.58 100.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.676 -0.861 . . . . 1.1399999999999999 108.676 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -104.89 10.46 34.33 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 122.175 0.988 . . . . 6.3700000000000001 109.799 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.4 mmp_? -59.27 -23.44 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.68 -0.638 . . . . 3.1099999999999999 111.018 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 p -75.5 -17.0 60.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.685 -1.259 . . . . 0.88 110.185 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 26.2 m-85 -104.26 -21.74 13.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.495 -0.753 . . . . 0.02 109.132 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.6 tp -148.53 126.42 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 3.3199999999999998 109.41 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 m -86.29 -11.54 51.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.463 -0.773 . . . . 0.02 111.405 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.2 tpp180 -170.65 160.39 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.697 -1.223 . . . . 0.02 107.697 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -140.89 114.61 8.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.897 -1.127 . . . . 0.02 109.455 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 11' ' ' GLU . 2.7 m120 -108.2 -0.96 20.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.535 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.6 m -155.7 153.59 30.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.1 mt -145.14 146.91 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 0.02 110.063 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -123.11 123.92 41.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.78 -1.193 . . . . 0.02 107.78 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.569 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 38.3 t -106.52 114.17 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -84.0 -33.74 24.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.234 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.46 18.0 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.109 -1.519 . . . . 0.02 110.048 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 173.41 49.72 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.487 -1.34 . . . . 0.01 110.04 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.2 m -120.39 138.03 53.98 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.107 -1.072 . . . . 1.48 108.107 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -126.99 154.43 44.62 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.559 1.171 . . . . 0.02 112.057 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.54 133.57 51.81 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 104.938 -2.245 . . . . 0.23999999999999999 104.938 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.1 m -116.7 141.42 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.178 -0.675 . . . . 0.65000000000000002 109.178 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.06 144.18 48.68 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.184 0.992 . . . . 0.02 109.706 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.36 -34.51 78.32 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.339 -0.846 . . . . 0.02 111.459 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -124.09 157.81 62.68 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.238 -0.914 . . . . 0.02 109.328 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.67 167.52 0.97 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.762 1.641 . . . . 0.02 112.563 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 2.0 t30 63.27 37.12 11.31 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.457 -0.792 . . . . 0.02 111.211 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 1.8 m-85 45.35 51.26 9.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.613 -0.679 . . . . 3.3900000000000001 110.819 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -125.75 163.91 21.82 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.153 0.501 . . . . 2.3300000000000001 109.994 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -162.01 31.53 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.715 -1.354 . . . . 0.02 109.715 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -65.57 137.25 57.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.332 . . . . 0.02 109.806 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.468 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.4 ptm -117.66 136.35 53.38 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.487 0.66 . . . . 5.0099999999999998 109.692 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -133.62 139.87 46.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.484 -0.76 . . . . 0.02 109.49 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.7 132.03 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.487 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.5 mt -122.25 109.42 33.28 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.57 -0.706 . . . . 0.02 110.206 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -75.49 170.64 19.83 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.893 0.998 . . . . 1.47 110.352 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 11.6 tm0? -51.83 140.26 19.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 4.25 109.862 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 155.53 -177.79 32.49 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.486 -1.34 . . . . 0.02 110.565 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -120.63 131.3 54.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.516 -0.991 . . . . 0.95999999999999996 109.305 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 64.8 m-85 -122.42 93.56 48.4 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.866 -1.161 . . . . 0.02 107.866 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.06 -3.68 7.61 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.034 1.156 . . . . 0.02 113.92 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -156.87 152.95 27.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.379 -1.451 . . . . 2.02 107.91 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -60.07 -38.7 83.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.612 -0.68 . . . . 0.02 111.977 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.5 -24.85 65.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.972 . . . . 0.02 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -17.98 63.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 3.4199999999999999 108.999 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.89 12.06 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.277 -1.379 . . . . 0.02 107.277 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.2 mtp 60.2 21.85 11.2 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.528 0.68 . . . . 0.02 110.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.92 144.65 46.44 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.386 -1.486 . . . . 0.02 109.386 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.24 -30.45 43.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.549 -1.278 . . . . 0.97999999999999998 107.549 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 13.6 t-20 -156.98 -171.92 3.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.397 -1.705 . . . . 0.02 106.397 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 30.6 p-10 -98.58 27.93 4.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.66 -1.275 . . . . 0.02 110.208 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -96.0 122.55 38.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.848 -1.157 . . . . 3.2000000000000002 110.638 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 48' ' ' VAL . 51.3 mt -143.48 121.48 12.08 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.808 -1.182 . . . . 2.6099999999999999 107.808 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.11 -17.71 9.31 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 121.26 -0.9 . . . . 0.02 112.641 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 5.1 t -155.53 155.77 33.99 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.043 -1.857 . . . . 0.02 110.867 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.9 p -145.5 147.72 32.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.02 110.653 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 13.8 mtp180 -136.67 141.83 43.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.01 109.288 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 130.35 36.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.42999999999999999 109.451 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 t -90.18 123.55 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.608 -0.886 . . . . 1.25 108.608 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -90.3 135.41 33.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 1.77 108.703 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -99.65 138.66 36.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.729 -0.841 . . . . 1.6299999999999999 108.729 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 p -113.2 125.67 54.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.942 -0.762 . . . . 1.0800000000000001 108.942 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.0 t -102.79 -155.4 0.52 Allowed 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 105.992 -1.855 . . . . 1.26 105.992 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.74 -47.35 0.95 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 120.356 -1.465 . . . . 0.01 112.345 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.53 -98.86 0.12 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.433 -1.841 . . . . 0.01 112.181 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.5 OUTLIER -119.56 117.97 29.78 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.222 -1.163 . . . . 4.4299999999999997 110.317 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.0 132.1 39.96 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.304 -0.628 . . . . 2.9900000000000002 109.304 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.438 ' HB2' HE22 ' A' ' 92' ' ' GLN . 7.2 ttpm? -131.01 137.42 49.19 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.028 -0.73 . . . . 6.3600000000000003 109.028 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 110' ' ' THR . 5.6 tt -125.22 142.61 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.874 0.845 . . . . 1.0900000000000001 109.139 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.481 ' CG ' ' O ' ' A' ' 130' ' ' LYS . 11.0 pt20 -124.77 132.26 53.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.744 -1.206 . . . . 2.0499999999999998 107.744 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.06 148.15 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 120.919 -1.113 . . . . 1.1000000000000001 109.659 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -117.97 140.96 48.99 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.042 0.925 . . . . 0.72999999999999998 110.849 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.59 -30.12 70.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.938 -0.574 . . . . 0.02 111.765 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 128' ' ' SER . 83.3 mttt -116.57 168.4 10.21 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.983 -1.073 . . . . 3.1800000000000002 110.49 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.21 164.59 44.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 56.71 39.18 29.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.635 0.731 . . . . 0.01 111.117 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.53 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.5 m-85 52.53 55.68 8.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.583 -0.698 . . . . 0.01 111.076 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -129.65 166.32 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.515 -0.92 . . . . 3.1499999999999999 108.515 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.79 -164.71 27.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.277 -1.529 . . . . 0.01 109.277 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.26 145.11 42.17 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.009 -1.289 . . . . 0.01 108.619 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.484 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 9.9 tmm? -116.51 141.72 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.633 0.73 . . . . 0.01 109.772 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.484 ' N ' ' SD ' ' A' ' 107' ' ' MET . 59.8 m-85 -130.32 135.17 47.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.888 -1.153 . . . . 2.48 107.888 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -121.32 135.01 55.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.727 -0.608 . . . . 0.01 109.809 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.5 t -149.55 153.63 37.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.242 1.02 . . . . 1.6899999999999999 110.786 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.405 HG22 ' OE1' ' A' ' 92' ' ' GLN . 34.9 p -110.43 9.41 23.38 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.646 -0.706 . . . . 0.01 109.933 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -121.39 163.07 19.3 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.381 -0.824 . . . . 3.21 111.384 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.32 155.0 38.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.193 -1.04 . . . . 0.01 108.193 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 29.4 t -124.15 111.42 28.63 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.77 -31.86 4.97 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 CA-C-N 120.134 1.084 . . . . 0.01 111.554 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -141.6 108.33 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.22 -0.925 . . . . 0.02 108.959 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.8 mt -62.97 -38.75 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.853 -0.529 . . . . 1.8300000000000001 110.408 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 30.9 ttm -66.5 -37.26 84.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.12 -1.032 . . . . 1.3400000000000001 109.831 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -70.91 -39.34 72.78 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.44 -1.412 . . . . 2.1099999999999999 109.69 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.85 -48.2 12.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 2.0800000000000001 112.679 -176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -111.95 -1.79 15.33 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.376 -0.828 . . . . 0.02 112.491 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 61.23 33.84 18.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.873 -1.142 . . . . 0.02 109.589 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.6 mt -114.02 135.44 54.0 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.413 -0.804 . . . . 0.02 109.195 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 9.3 ptp180 -90.68 -21.7 21.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.126 -0.984 . . . . 5.3200000000000003 111.276 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 47.9 mt-10 -149.41 164.97 33.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.721 -1.237 . . . . 0.02 110.668 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 11.8 mm -127.66 123.81 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.726 -1.213 . . . . 2.1699999999999999 107.726 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -109.11 -14.78 14.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.11 -0.994 . . . . 0.02 112.642 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.53 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 23.6 p -160.91 153.71 21.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.572 -1.33 . . . . 0.01 108.941 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.8 t -167.0 141.02 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.628 -0.878 . . . . 1.22 108.628 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.538 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -121.26 97.4 5.5 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.133 -1.062 . . . . 1.4099999999999999 108.133 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.9 p -109.83 142.59 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.396 -0.965 . . . . 0.01 108.396 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.77 92.29 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.192 -1.781 . . . . 1.98 106.192 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 26.2 tt0 -147.21 -68.24 0.25 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.377 -1.342 . . . . 0.01 107.377 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.14 -14.19 13.78 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.633 -2.187 . . . . 0.01 107.633 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.7 p -122.55 66.93 0.95 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.789 -0.83 . . . . 2.2999999999999998 111.283 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.678 ' CD1' HG21 ' A' ' 131' ' ' VAL . 81.9 m95 -131.18 133.1 45.21 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.86 -1.15 . . . . 0.01 110.318 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.72 136.21 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.304 -0.998 . . . . 1.6899999999999999 108.304 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -112.58 142.36 45.25 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.67 -1.604 . . . . 2.4900000000000002 106.67 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.484 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 20.3 m-85 -123.42 145.99 48.36 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.161 -0.962 . . . . 0.02 110.081 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.04 -31.19 61.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.02 111.465 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.7 mt -115.6 155.75 46.99 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.68 -1.263 . . . . 1.48 108.985 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -57.44 167.53 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.101 1.201 . . . . 0.02 112.741 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 59.4 31.44 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.192 -0.913 . . . . 0.75 111.325 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.88 51.77 8.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.5 -0.75 . . . . 0.02 110.952 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.49 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.36 164.82 20.23 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.51 -0.744 . . . . 0.02 109.791 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.425 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.55 -165.62 33.9 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.279 -1.129 . . . . 0.02 110.279 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.58 142.36 53.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.499 -1.001 . . . . 0.02 108.825 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 58' ' ' MET . 14.9 mt-30 -113.06 148.14 35.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.34 0.591 . . . . 0.02 109.826 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -122.86 132.66 54.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.436 -0.95 . . . . 0.01 108.436 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.36 121.56 37.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.933 -1.105 . . . . 0.01 109.702 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.03 161.22 13.92 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.796 -1.187 . . . . 0.01 107.796 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.38 -110.46 0.34 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.413 -0.805 . . . . 2.27 109.801 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -151.16 31.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 1.8400000000000001 109.03 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -109.73 -165.42 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.974 -0.75 . . . . 2.2799999999999998 108.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 2.7 mm-40 -106.26 118.37 36.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.517 -0.739 . . . . 0.01 109.419 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.4 113.13 24.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -90.09 -27.4 19.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.487 -0.758 . . . . 0.01 111.625 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -127.0 156.26 74.52 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.738 -1.226 . . . . 2.54 108.064 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.14 -38.84 53.11 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.51 0.807 . . . . 0.69999999999999996 111.282 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.48 -19.39 18.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.856 -1.152 . . . . 0.85999999999999999 109.914 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.76 -18.32 65.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.823 -1.173 . . . . 0.02 112.111 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.36 16.28 26.1 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.722 -1.236 . . . . 0.02 110.191 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.25 10.69 77.25 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.104 -0.998 . . . . 0.02 112.806 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.52 140.57 34.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.861 -1.376 . . . . 0.02 110.303 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.6 -7.95 58.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.696 -0.628 . . . . 0.58999999999999997 109.715 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 p -140.67 150.85 61.59 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.227 -0.92 . . . . 0.87 109.33 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.59 14.48 1.21 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.903 1.068 . . . . 0.38 112.304 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -81.7 121.28 26.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.891 -1.13 . . . . 0.17999999999999999 111.231 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.5 mp -153.1 124.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.469 -1.678 . . . . 3.9900000000000002 106.469 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 91.3 mm-40 -114.15 -8.72 12.97 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.425 -0.797 . . . . 5.1699999999999999 113.143 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 p -157.22 158.69 36.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.359 -2.088 . . . . 0.02 109.448 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -152.82 154.21 34.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -0.886 . . . . 2.02 110.147 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -144.48 150.34 37.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.265 -0.897 . . . . 0.01 110.296 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.4 ptt180 -87.52 142.71 27.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.703 -0.851 . . . . 0.01 108.703 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 175' ' ' ILE . 3.3 mt -94.46 128.61 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.311 -0.868 . . . . 3.04 109.329 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.11 148.47 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.127 -0.983 . . . . 1.8899999999999999 110.009 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.45 -0.781 . . . . 4.8899999999999997 109.435 179.569 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.431 -0.581 . . . . 5.2800000000000002 109.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -76.72 92.58 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.396 -0.815 . . . . 5.96 109.538 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.2 p -101.1 -141.69 0.34 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.537 -1.283 . . . . 2.2200000000000002 107.537 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.35 86.51 0.06 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 107.095 -2.402 . . . . 0.81000000000000005 107.095 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.06 148.88 33.59 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.174 -1.012 . . . . 0.01 110.625 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -150.72 136.72 18.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.979 . . . . 0.02 109.077 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.71 140.42 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.897 -0.779 . . . . 0.02 108.897 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.88 129.97 52.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.483 -0.76 . . . . 0.39000000000000001 109.644 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 7.7 m-85 -109.68 139.96 44.1 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.572 -0.899 . . . . 0.02 108.572 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.9 m-85 -122.05 138.67 54.35 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.229 -0.92 . . . . 0.02 109.646 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.485 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.23 -27.67 66.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.919 -1.113 . . . . 0.029999999999999999 111.736 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.63 170.4 8.34 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.869 -1.144 . . . . 0.029999999999999999 110.11 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -75.39 161.34 29.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.738 0.78 . . . . 0.029999999999999999 110.217 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 m120 63.04 34.95 13.43 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.933 0.873 . . . . 0.73999999999999999 110.433 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p90 49.51 42.52 22.89 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.39 -0.823 . . . . 0.02 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -109.11 166.07 11.12 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.34 -168.14 34.76 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 120.739 -1.225 . . . . 0.029999999999999999 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -70.05 145.3 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.474 -1.016 . . . . 2.7599999999999998 109.098 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -120.4 149.24 42.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.594 -0.692 . . . . 1.8899999999999999 110.272 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -132.07 126.99 35.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.942 -1.133 . . . . 0.02 107.942 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.33 136.7 51.46 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.476 -0.765 . . . . 1.1200000000000001 110.02 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -131.14 137.96 49.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.56 0.695 . . . . 0.02 109.471 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -116.59 10.7 14.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.672 -0.643 . . . . 0.20000000000000001 109.503 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.8 t -157.71 173.84 16.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.134 -1.061 . . . . 1.23 108.134 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -60.85 144.29 53.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.683 -1.261 . . . . 0.02 110.087 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.52 116.9 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.438 -0.949 . . . . 0.02 108.438 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.89 52.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.192 -0.942 . . . . 0.23999999999999999 110.537 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -153.48 100.61 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 1.1399999999999999 108.701 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -104.21 9.21 36.21 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.285 1.04 . . . . 6.3700000000000001 109.39 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -58.68 -24.03 60.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.741 . . . . 3.1099999999999999 110.571 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 m -74.39 -16.84 60.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.16 . . . . 0.88 110.057 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.66 -22.14 13.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.357 -0.84 . . . . 0.02 109.272 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.06 128.47 12.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 3.3199999999999998 109.014 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.1 p -85.33 -9.87 57.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.689 -0.632 . . . . 0.02 110.964 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.91 163.01 6.17 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -142.7 115.51 8.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.873 -1.142 . . . . 0.02 108.709 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.64 0.91 20.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.854 -1.154 . . . . 0.029999999999999999 110.601 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 t -156.67 153.45 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.6 mt -145.12 148.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.013 -1.054 . . . . 0.02 109.969 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -124.7 124.69 42.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.348 -1.353 . . . . 0.02 107.348 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.46 114.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.099 -1.445 . . . . 0.02 107.099 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.61 -34.47 25.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 3.8100000000000001 109.855 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.28 17.53 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 118.698 -1.715 . . . . 0.02 110.433 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.96 173.26 49.66 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.547 -1.311 . . . . 0.01 110.23 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -120.01 136.13 54.67 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.806 -1.183 . . . . 1.48 107.806 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.5 m95 -125.17 154.5 41.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.518 1.152 . . . . 0.02 112.159 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.12 133.44 52.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 104.964 -2.235 . . . . 0.23999999999999999 104.964 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.23 141.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.902 -0.777 . . . . 0.65000000000000002 108.902 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.58 143.56 48.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.261 1.029 . . . . 0.02 109.224 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.525 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 8.1 tp10 -66.1 -35.23 79.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.359 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 50' ' ' GLU . 10.4 mpt_? -122.75 158.05 58.02 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 121.114 -0.991 . . . . 0.02 109.402 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -54.51 166.7 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.46 1.44 . . . . 0.02 112.567 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 63.12 37.36 11.5 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.382 -0.827 . . . . 0.02 111.173 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 44.67 52.57 7.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.674 0.749 . . . . 3.3900000000000001 110.773 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -126.4 163.75 22.61 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.114 0.483 . . . . 2.3300000000000001 109.705 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.4 -161.62 32.73 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.719 -1.352 . . . . 0.02 109.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -66.22 137.54 57.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.313 . . . . 0.02 110.139 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.2 ptm -121.27 136.53 54.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.664 -0.648 . . . . 5.0099999999999998 109.482 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.4 m-85 -133.32 142.03 48.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.717 . . . . 0.02 109.418 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 mm -96.14 132.56 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.127 -0.694 . . . . 1.72 109.127 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -121.73 109.69 34.04 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.481 -0.762 . . . . 0.02 110.391 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -75.81 169.78 21.51 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.033 1.048 . . . . 1.47 110.403 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -53.06 140.18 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.908 -1.12 . . . . 4.25 110.572 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.18 -177.23 32.52 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.614 -1.279 . . . . 0.02 110.386 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -118.98 129.94 55.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.471 -1.017 . . . . 0.95999999999999996 109.413 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 46.0 m-85 -120.82 95.48 48.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.32 -3.9 10.81 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 120.682 0.921 . . . . 0.02 113.666 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -156.82 154.28 29.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 2.02 108.254 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.37 -38.57 84.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.582 -0.699 . . . . 0.02 111.654 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.63 -24.54 65.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.028 -1.045 . . . . 0.02 110.336 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.68 -18.23 64.23 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.956 0.884 . . . . 3.4199999999999999 108.831 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.657 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.64 11.86 28.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.333 -1.358 . . . . 0.02 107.333 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.5 mpt? 59.49 22.78 11.35 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.504 0.669 . . . . 0.02 110.243 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 146.35 46.62 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.253 -1.539 . . . . 0.02 109.253 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.568 ' HG ' HD21 ' A' ' 76' ' ' ASN . 29.8 tp -79.63 -30.63 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.97999999999999998 108.013 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.568 HD21 ' HG ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -157.65 -170.89 3.36 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.64 27.85 4.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.776 -1.203 . . . . 0.02 110.436 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' A' ' 50' ' ' GLU . 0.3 OUTLIER -96.31 122.5 39.25 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.081 -1.012 . . . . 3.2000000000000002 110.0 -178.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD21 ' CH2' ' A' ' 72' ' ' TRP . 62.5 mt -143.5 122.66 12.93 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.957 -1.127 . . . . 2.6099999999999999 107.957 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA3' HH12 ' A' ' 78' ' ' ARG . . . -109.98 -17.82 9.3 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.168 -0.957 . . . . 0.02 112.732 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 t -156.1 156.1 33.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 119.978 -1.896 . . . . 0.02 110.857 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.2 t -145.47 147.54 32.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.02 110.254 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -135.64 140.8 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.921 -0.77 . . . . 0.01 108.921 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.96 132.29 37.8 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.092 -1.005 . . . . 0.42999999999999999 108.679 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.29 124.14 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.438 -0.949 . . . . 1.25 108.438 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.41 134.66 34.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.104 -0.998 . . . . 1.77 108.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.6 137.97 35.72 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.456 -0.942 . . . . 1.6299999999999999 108.456 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -110.9 125.65 53.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.483 -0.932 . . . . 1.0800000000000001 108.483 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -103.28 -155.0 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.59 -48.53 0.92 Allowed Glycine 0 N--CA 1.498 2.809 0 O-C-N 120.458 -1.401 . . . . 0.01 112.055 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.38 -99.33 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.592 -1.766 . . . . 0.01 112.187 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.29 120.12 33.14 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.402 -1.057 . . . . 4.4299999999999997 110.653 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.37 129.83 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.914 -0.714 . . . . 2.9900000000000002 109.142 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -131.48 139.53 49.35 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 6.3600000000000003 109.334 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.83 145.58 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.389 -0.819 . . . . 1.0900000000000001 109.85 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.02 133.63 55.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.284 -1.376 . . . . 2.0499999999999998 107.284 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.68 147.11 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.852 -1.155 . . . . 1.1000000000000001 109.419 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.3 m-85 -119.3 141.61 48.84 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.055 0.931 . . . . 0.72999999999999998 111.07 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -66.27 -29.85 70.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.919 -0.582 . . . . 0.02 111.589 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.54 168.08 10.49 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.933 -1.105 . . . . 3.1800000000000002 110.696 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.07 42.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.989 -0.844 . . . . 0.01 110.989 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t0 56.56 39.47 29.85 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.65 0.738 . . . . 0.01 110.951 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.2 m-85 52.49 55.36 9.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.688 -0.633 . . . . 0.01 111.038 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -128.63 165.81 20.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.468 -0.938 . . . . 3.1499999999999999 108.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.11 -164.94 27.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.23 -1.548 . . . . 0.01 109.23 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.53 144.57 44.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.951 -1.323 . . . . 0.01 108.3 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 24.2 ttp -116.53 142.27 47.1 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.554 0.692 . . . . 0.01 109.804 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -131.56 136.0 47.48 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.05 -1.093 . . . . 2.48 108.05 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.8 tm-20 -120.25 135.35 55.02 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.446 -0.784 . . . . 0.01 110.145 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.534 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -149.2 151.64 34.64 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.277 1.037 . . . . 1.6899999999999999 111.0 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.3 p -110.73 9.39 22.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.606 -0.725 . . . . 0.01 110.009 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -121.1 163.32 18.58 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.291 -0.881 . . . . 3.21 111.366 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.02 155.29 39.02 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.424 ' O ' ' OG ' ' A' ' 171' ' ' SER . 34.9 t -125.44 113.67 25.56 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.752 -0.832 . . . . 0.01 108.752 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.33 -29.08 8.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.388 1.174 . . . . 0.01 111.278 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.1 t -142.53 109.88 5.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 0.02 109.359 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.0 mt -61.99 -39.62 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 122.003 -0.435 . . . . 1.8300000000000001 110.149 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.44 -37.37 80.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.425 -0.91 . . . . 1.3400000000000001 110.447 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -70.44 -39.37 74.38 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.908 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.458 ' CD ' ' CZ ' ' A' ' 121' ' ' PHE . 63.6 tt0 -79.46 -47.67 15.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.0800000000000001 112.428 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.458 ' CZ ' ' CD ' ' A' ' 120' ' ' GLN . 28.2 m-85 -110.8 0.52 17.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.434 -0.791 . . . . 0.02 112.628 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.1 m80 60.63 33.19 20.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.682 -1.261 . . . . 0.02 109.507 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -113.51 135.23 54.12 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.749 -0.834 . . . . 0.02 108.749 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.62 -21.56 22.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.378 -0.826 . . . . 5.3200000000000003 110.276 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -150.76 165.87 32.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.135 -0.978 . . . . 0.02 109.992 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.73 128.63 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.212 -1.403 . . . . 2.1699999999999999 107.212 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -108.89 -12.44 14.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.539 -0.726 . . . . 0.02 112.256 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.484 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 10.1 t -159.51 152.72 22.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.01 108.555 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.8 p -163.41 145.87 9.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 1.22 109.665 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -116.61 102.93 9.89 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.701 -1.249 . . . . 1.4099999999999999 108.591 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 131' ' ' VAL . 4.3 p -113.54 128.3 70.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.604 -1.258 . . . . 0.01 107.604 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.02 89.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 106.563 -1.643 . . . . 1.98 106.563 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' OE1' ' OG1' ' A' ' 135' ' ' THR . 1.8 tm-20 -150.82 -64.88 0.19 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 105.88 -1.896 . . . . 0.01 105.88 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.73 -10.08 10.49 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.742 -2.143 . . . . 0.01 107.742 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.402 ' OG1' ' OE1' ' A' ' 133' ' ' GLU . 1.7 p -125.89 70.86 1.22 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.713 -0.874 . . . . 2.2999999999999998 111.911 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -134.87 135.89 42.0 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 120.337 -1.477 . . . . 0.01 110.274 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -120.13 137.45 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.322 -0.992 . . . . 1.6899999999999999 108.322 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CG ' HD11 ' A' ' 151' ' ' LEU . 3.3 m-30 -111.3 142.03 44.06 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 106.827 -1.546 . . . . 2.4900000000000002 106.827 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 24.7 m-85 -123.37 143.76 49.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.044 -1.035 . . . . 0.02 109.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.0 -31.24 62.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.796 -0.565 . . . . 0.02 111.854 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.28 155.36 47.01 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.67 -1.269 . . . . 1.48 108.899 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -57.22 166.66 4.11 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.186 1.257 . . . . 0.02 112.832 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.77 31.26 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.2 -0.909 . . . . 0.75 111.386 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.1 m-85 58.11 52.23 7.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.629 -0.669 . . . . 0.02 111.327 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.49 165.15 19.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.529 -0.732 . . . . 0.02 109.954 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.96 -165.34 34.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -69.06 141.55 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.531 -0.982 . . . . 0.02 108.723 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.499 ' O ' ' CG ' ' A' ' 58' ' ' MET . 11.9 mt-30 -113.86 150.12 34.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.543 -0.539 . . . . 0.02 109.543 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.76 132.91 53.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.567 -0.901 . . . . 0.01 108.567 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.93 120.24 34.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.21 . . . . 0.01 108.892 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 138' ' ' PHE . 10.4 mt -102.48 140.22 37.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 154' ' ' LYS . 27.8 m-20 -108.5 -163.27 0.87 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.53 -0.731 . . . . 2.27 109.474 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -75.12 40.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 1.8400000000000001 109.588 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 152' ' ' ASP . 18.6 ttmt -113.55 162.25 16.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.622 -0.674 . . . . 2.2799999999999998 109.413 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 3.3 mp0 -103.32 130.43 50.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.899 -1.148 . . . . 0.01 107.899 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 49.1 m-85 -102.5 112.11 24.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.01 110.515 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -90.06 -27.13 19.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.01 110.432 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -123.77 153.91 66.98 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 107.63 -1.248 . . . . 2.54 107.63 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.05 -41.47 35.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 CA-C-N 119.202 0.751 . . . . 0.69999999999999996 111.047 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.35 -18.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 120.812 -1.18 . . . . 0.85999999999999999 109.389 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.55 -18.87 65.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.808 -1.182 . . . . 0.02 112.029 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.08 15.92 27.12 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 120.705 -1.247 . . . . 0.02 110.311 178.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.82 75.82 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.192 -0.942 . . . . 0.02 112.91 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.87 140.35 35.28 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.862 -1.375 . . . . 0.02 110.124 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -6.94 59.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.58999999999999997 109.574 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.2 m -139.43 151.18 66.28 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.19 -0.944 . . . . 0.87 109.548 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.515 ' O ' HD12 ' A' ' 169' ' ' ILE . 35.3 Cg_endo -75.34 14.72 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.934 1.089 . . . . 0.38 112.173 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.9 122.1 28.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.17999999999999999 111.794 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 167' ' ' PRO . 4.1 mp -147.6 127.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.112 -1.81 . . . . 3.9900000000000002 106.112 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -110.68 -14.26 14.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.308 -0.87 . . . . 5.1699999999999999 112.675 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 11.6 t -156.59 158.7 37.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.389 -2.07 . . . . 0.02 110.068 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -150.38 151.9 33.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.192 -0.942 . . . . 2.02 109.889 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.511 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.5 mtp180 -143.87 150.3 38.23 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.173 -0.955 . . . . 0.01 110.543 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.75 143.32 27.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.423 -0.954 . . . . 0.01 108.423 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 175' ' ' ILE . 2.6 mt -96.68 129.97 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.404 -0.81 . . . . 3.04 109.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 177' ' ' GLU . 57.5 t -137.24 148.26 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 1.8899999999999999 109.336 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 176' ' ' VAL . 1.4 pp20? . . . . . 0 N--CA 1.505 2.282 0 CA-C-O 121.244 0.545 . . . . 4.8899999999999997 111.327 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.343 0.592 . . . . 5.2800000000000002 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -74.19 100.26 3.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 5.96 109.187 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.3 p -107.04 -140.06 0.37 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.485 -0.932 . . . . 2.2200000000000002 108.485 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.6 88.78 0.07 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 107.003 -2.439 . . . . 0.81000000000000005 107.003 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.36 148.14 32.25 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.595 -1.002 . . . . 0.01 110.595 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -153.77 138.33 16.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.557 -0.967 . . . . 0.02 108.72 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.18 141.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.163 -0.68 . . . . 0.02 109.163 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -121.9 130.22 53.18 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 0.39000000000000001 109.559 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 13.8 m-85 -109.44 139.08 44.87 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.742 -0.836 . . . . 0.02 108.742 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -122.42 138.79 54.42 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.187 -0.946 . . . . 0.02 109.625 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 33' ' ' LEU . 83.1 mt-10 -68.36 -27.2 66.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.029999999999999999 111.839 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.48 169.47 9.02 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.847 -1.158 . . . . 0.029999999999999999 110.138 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.57 158.67 32.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.611 0.72 . . . . 0.029999999999999999 110.064 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.4 35.04 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.858 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 20.5 p90 50.0 43.88 25.52 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.602 -0.726 . . . . 0.02 111.312 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -112.09 166.39 11.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.031 -1.1 . . . . 0.02 108.031 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -168.06 36.24 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.728 -1.225 . . . . 0.029999999999999999 110.82 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -69.15 143.62 54.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.423 -1.045 . . . . 2.7599999999999998 108.978 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -119.95 149.09 42.7 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.586 0.707 . . . . 1.8899999999999999 110.035 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -132.19 127.16 35.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.991 -1.115 . . . . 0.02 107.991 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 11.4 p30 -111.59 135.84 51.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.603 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.3 t -129.99 137.53 50.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.472 0.653 . . . . 0.02 109.474 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.69 11.47 14.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.722 -0.612 . . . . 0.20000000000000001 109.535 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -157.88 174.07 15.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -61.71 145.4 52.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.709 -1.244 . . . . 0.02 109.984 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.3 t -131.72 116.59 17.5 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.635 -0.876 . . . . 0.02 108.635 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.6 -24.15 53.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.23999999999999999 110.675 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.76 100.84 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.54 -0.911 . . . . 1.1399999999999999 108.54 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -104.32 9.66 35.8 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.165 0.983 . . . . 6.3700000000000001 109.867 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' NH2' ' CZ ' ' A' ' 51' ' ' ARG . 90.1 mtt180 -59.25 -22.84 61.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.585 -0.697 . . . . 3.1099999999999999 110.857 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -75.9 -16.85 59.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.88 110.227 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.63 -22.12 13.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.445 -0.784 . . . . 0.02 109.307 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 36' ' ' CYS . 6.0 tp -150.55 128.94 12.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.331 -0.856 . . . . 3.3199999999999998 108.813 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.5 p -86.53 -10.86 53.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.796 -0.565 . . . . 0.02 111.286 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -171.14 161.67 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.02 108.021 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.9 m -142.31 115.27 8.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.938 -1.101 . . . . 0.02 109.378 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -106.73 -0.67 23.37 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.882 -1.136 . . . . 0.029999999999999999 110.224 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -157.05 154.58 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.747 -1.205 . . . . 0.02 107.747 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -144.77 148.54 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -0.999 . . . . 0.02 109.2 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -123.65 123.9 41.58 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.154 -1.424 . . . . 0.02 107.154 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -105.33 114.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.845 -1.539 . . . . 0.02 106.845 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -84.21 -33.96 24.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.462 -0.773 . . . . 3.8100000000000001 109.569 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.79 18.54 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.649 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.4 173.69 49.95 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.726 -1.226 . . . . 0.01 110.407 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.2 m -118.9 136.13 54.22 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.822 -1.177 . . . . 1.48 107.822 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -124.6 152.67 43.27 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.851 -1.156 . . . . 0.02 112.103 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.45 133.6 52.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.007 -2.22 . . . . 0.23999999999999999 105.007 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.5 m -116.46 141.7 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.026 -0.731 . . . . 0.65000000000000002 109.026 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.5 m-85 -119.69 142.85 48.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.223 1.011 . . . . 0.02 109.386 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -64.78 -35.85 82.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.334 -0.848 . . . . 0.02 111.303 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.705 HH12 ' NH2' ' A' ' 78' ' ' ARG . 3.7 mmp_? -121.36 153.83 58.86 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.096 -1.002 . . . . 0.02 109.578 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -52.76 167.45 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.371 1.38 . . . . 0.02 112.457 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 64.68 37.24 7.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.746 0.784 . . . . 0.02 111.26 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 46.37 51.02 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.422 0.629 . . . . 3.3900000000000001 111.156 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -127.47 164.62 21.51 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.289 0.566 . . . . 2.3300000000000001 110.306 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.29 -162.68 30.98 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.216 -1.153 . . . . 0.02 110.216 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.627 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 4.9 t60 -63.37 143.04 58.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.11 -1.229 . . . . 0.02 110.347 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.8 mtp -116.49 135.22 54.02 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.291 0.567 . . . . 5.0099999999999998 109.755 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' HIS . 32.9 m-85 -134.84 133.35 39.66 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.405 -0.809 . . . . 0.02 108.958 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.42 131.84 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.578 -0.897 . . . . 1.72 108.578 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -121.21 109.72 34.97 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.517 -0.739 . . . . 0.02 110.21 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.64 169.54 21.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 119.969 1.025 . . . . 1.47 110.369 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.9 140.71 29.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.76 -1.212 . . . . 4.25 110.667 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.83 -175.11 32.25 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.32 . . . . 0.02 110.255 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -116.17 128.12 55.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -1.054 . . . . 0.95999999999999996 108.804 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 37.7 m-85 -119.28 97.99 50.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.101 -1.074 . . . . 0.02 108.101 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 6.5 Cg_endo -69.88 -6.56 18.96 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 120.553 0.835 . . . . 0.02 114.179 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 76.1 mt-10 -157.53 155.47 30.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.215 -1.553 . . . . 2.02 108.417 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 38.8 p90 -60.24 -36.93 78.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.47 -0.769 . . . . 0.02 112.665 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.63 -21.37 60.37 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.182 -0.949 . . . . 0.02 110.061 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -67.51 -19.96 65.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 3.4199999999999999 110.348 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.45 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.8 p90 -110.04 16.04 22.13 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.305 -0.872 . . . . 0.02 108.828 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.6 OUTLIER 65.32 24.98 12.14 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.234 0.54 . . . . 0.02 110.739 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -62.14 145.56 49.33 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.731 -1.347 . . . . 0.02 109.731 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.1 tt -80.51 -30.27 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.646 -1.242 . . . . 0.97999999999999998 107.646 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -155.82 -171.53 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.702 -1.592 . . . . 0.02 106.702 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' CG ' ' A' ' 69' ' ' TYR . 95.8 m-20 -97.89 27.45 4.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.832 -1.168 . . . . 0.02 110.298 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' NH2' HH12 ' A' ' 51' ' ' ARG . 38.2 mtp180 -95.51 122.42 38.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.962 -1.086 . . . . 3.2000000000000002 110.591 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 48' ' ' VAL . 68.9 mt -142.52 120.53 12.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.536 -1.283 . . . . 2.6099999999999999 107.536 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.37 -17.17 10.21 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 121.358 -0.838 . . . . 0.02 112.485 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 11.3 t -156.23 156.42 34.09 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.331 -1.687 . . . . 0.02 110.648 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.1 p -145.05 147.75 32.93 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.691 0.758 . . . . 0.02 110.247 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 15.9 mtp180 -135.63 140.47 44.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.621 -0.881 . . . . 0.01 108.621 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.11 131.26 38.25 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.204 -0.935 . . . . 0.42999999999999999 108.539 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.92 122.88 40.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.41 -0.959 . . . . 1.25 108.41 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -91.03 134.92 34.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.798 -1.189 . . . . 1.77 108.505 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 136.93 38.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.305 -0.998 . . . . 1.6299999999999999 108.305 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -110.96 126.31 54.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.32 -0.863 . . . . 1.0800000000000001 108.673 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.4 m -103.77 -154.65 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.275 -1.75 . . . . 1.26 106.275 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.16 -48.15 0.93 Allowed Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.567 -1.333 . . . . 0.01 112.103 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.63 -99.57 0.13 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.729 -1.701 . . . . 0.01 111.934 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.56 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.74 118.91 31.26 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.096 -1.238 . . . . 4.4299999999999997 110.352 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -74.72 130.55 39.69 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.112 -0.699 . . . . 2.9900000000000002 109.112 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -129.28 136.18 49.73 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.882 -0.784 . . . . 6.3600000000000003 108.882 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -127.64 144.07 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.471 -0.768 . . . . 1.0900000000000001 109.326 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -122.53 133.06 54.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.922 -1.14 . . . . 2.0499999999999998 107.922 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.06 145.89 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.77 -1.206 . . . . 1.1000000000000001 109.384 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.66 140.91 49.16 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.999 0.904 . . . . 0.72999999999999998 110.816 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' CD ' HH22 ' A' ' 124' ' ' ARG . 4.1 tm-20 -65.85 -30.38 70.98 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.911 -0.586 . . . . 0.02 111.775 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -117.12 169.77 9.18 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.216 1.007 . . . . 3.1800000000000002 110.663 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.34 36.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.723 -0.951 . . . . 0.01 110.723 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.81 38.12 22.38 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.539 0.685 . . . . 0.01 110.739 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.45 53.73 11.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.705 -0.622 . . . . 0.01 110.974 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -125.91 165.89 17.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.53 28.08 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.27 145.05 42.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.983 -1.304 . . . . 0.01 108.482 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.83 142.53 46.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.558 0.694 . . . . 0.01 109.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.414 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.8 m-85 -130.69 135.87 48.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.947 -1.131 . . . . 2.48 107.947 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -119.34 134.42 55.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.01 109.731 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -149.92 151.17 32.97 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.268 1.033 . . . . 1.6899999999999999 110.798 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.4 p -110.35 10.18 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.536 -0.756 . . . . 0.01 109.676 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -121.36 163.05 19.28 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -0.827 . . . . 3.21 111.393 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.76 154.34 39.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.386 -0.968 . . . . 0.01 108.386 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 14.3 t -123.58 110.25 30.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.527 -0.916 . . . . 0.01 108.527 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -77.85 -32.69 2.53 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 119.932 1.012 . . . . 0.01 112.032 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -140.33 108.43 5.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.108 -0.995 . . . . 0.02 109.189 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 mt -63.49 -40.99 91.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.825 -0.547 . . . . 1.8300000000000001 110.656 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.32 -38.48 87.79 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.134 -1.026 . . . . 1.3400000000000001 110.415 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -70.55 -38.82 74.21 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.145 -1.597 . . . . 2.1099999999999999 109.35 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.482 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 49.6 tt0 -80.54 -48.14 13.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 2.0800000000000001 112.45 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.482 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 70.4 m-85 -111.8 -1.83 15.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.261 -0.899 . . . . 0.02 112.661 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.93 35.01 19.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.851 -1.156 . . . . 0.02 109.506 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 mt -114.57 136.42 53.05 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.53 -0.731 . . . . 0.02 109.381 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.61 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.2 -21.11 23.44 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.217 -0.927 . . . . 5.3200000000000003 110.465 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -149.33 165.48 31.85 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.7 -1.25 . . . . 0.02 110.367 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mm -127.42 123.7 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.206 -1.405 . . . . 2.1699999999999999 107.206 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -109.23 -14.09 14.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.158 -0.964 . . . . 0.02 112.467 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.8 t -159.57 151.49 20.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.01 108.763 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 30.0 p -168.6 146.14 3.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.925 . . . . 1.22 108.906 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -122.17 109.12 14.11 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.353 1.073 . . . . 1.4099999999999999 109.228 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.87 132.97 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.868 -1.53 . . . . 0.01 106.868 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.11 93.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.001 -1.481 . . . . 1.98 107.001 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 60.5 tt0 -147.65 -63.0 0.27 Allowed 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 105.383 -2.08 . . . . 0.01 105.383 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 166.42 -73.36 0.16 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.097 -2.001 . . . . 0.01 108.097 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.47 ' CB ' HD12 ' A' ' 175' ' ' ILE . 82.5 p -123.95 125.34 44.43 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.604 -0.939 . . . . 2.2999999999999998 110.483 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.514 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 15.3 m95 -125.9 150.71 47.73 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.062 -1.459 . . . . 0.01 107.062 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG13 HD11 ' A' ' 175' ' ' ILE . 32.0 mt -118.81 132.43 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.335 -1.478 . . . . 1.6899999999999999 109.782 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -111.54 141.99 44.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.221 -1.77 . . . . 2.4900000000000002 106.221 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.5 m-85 -123.06 143.34 50.02 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 0.02 109.755 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.84 -30.86 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.754 -0.591 . . . . 0.02 111.563 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.84 154.93 48.24 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.729 -1.232 . . . . 1.48 108.929 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.49 167.09 2.97 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.349 1.366 . . . . 0.02 113.038 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 44.4 t-20 60.0 31.53 20.69 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.116 -0.947 . . . . 0.75 111.363 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.97 51.48 10.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.498 -0.751 . . . . 0.02 111.01 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -126.65 165.29 19.49 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.601 -0.687 . . . . 0.02 109.937 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.47 -165.3 33.79 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.205 -1.158 . . . . 0.02 110.205 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.39 141.5 54.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.509 -0.995 . . . . 0.02 108.837 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -114.59 148.77 37.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.541 -0.541 . . . . 0.02 109.541 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 4.7 m-85 -123.26 134.25 54.11 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.905 -0.776 . . . . 0.01 108.905 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.2 tp -95.93 120.76 36.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.895 -1.128 . . . . 0.01 109.046 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.5 mp -97.69 140.6 31.85 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.74 -0.837 . . . . 0.01 108.74 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 60.1 m-20 -105.01 -170.39 1.75 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.46 -0.775 . . . . 2.27 109.627 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.53 41.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.8400000000000001 109.881 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -113.34 172.56 6.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.482 -0.761 . . . . 2.2799999999999998 109.43 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.6 126.29 51.55 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.509 -0.923 . . . . 0.01 108.509 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 3.2 m-85 -100.68 111.96 24.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.199 -0.938 . . . . 0.01 110.145 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -92.79 -26.75 17.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.01 110.644 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -123.28 153.62 65.21 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.902 -1.147 . . . . 2.54 107.902 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -60.96 -40.52 51.88 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.33 0.797 . . . . 0.69999999999999996 110.962 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.12 -18.62 18.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.046 -1.033 . . . . 0.85999999999999999 109.332 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 52.9 t0 -65.76 -19.0 65.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.11 . . . . 0.02 112.164 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -101.12 15.69 27.88 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 120.655 -1.278 . . . . 0.02 110.143 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 9.7 76.77 Favored Glycine 0 N--CA 1.5 2.903 0 O-C-N 121.177 -0.952 . . . . 0.02 113.149 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.55 141.18 33.77 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.812 -1.405 . . . . 0.02 110.274 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.11 -7.22 59.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.688 -0.633 . . . . 0.58999999999999997 109.598 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.6 p -142.42 150.77 55.88 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.87 109.107 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -75.81 17.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.698 0.932 . . . . 0.38 112.052 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -82.1 121.63 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.304 1.05 . . . . 0.17999999999999999 111.154 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.8 mp -151.07 125.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.499 -1.667 . . . . 3.9900000000000002 106.499 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -110.84 -13.34 14.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.746 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.16 158.3 37.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 119.378 -2.076 . . . . 0.02 109.91 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.55 153.06 33.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.28 -0.888 . . . . 2.02 109.905 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -142.92 148.75 37.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.835 0.826 . . . . 0.01 110.081 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -86.01 142.17 28.96 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.868 -1.16 . . . . 0.01 107.868 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.503 HD11 HG13 ' A' ' 137' ' ' ILE . 8.5 mt -95.17 128.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 3.04 109.41 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.57 148.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.36 -0.838 . . . . 1.8899999999999999 109.837 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 4.8899999999999997 109.435 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.7 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.315 0.579 . . . . 5.2800000000000002 109.568 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -49.83 101.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 5.96 109.369 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.3 m -106.42 -139.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.294 -1.002 . . . . 2.2200000000000002 108.294 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.55 ' H ' HG22 ' A' ' 3' ' ' THR . . . 172.28 88.83 0.07 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 106.871 -2.492 . . . . 0.81000000000000005 106.871 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.06 32.24 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.315 -0.945 . . . . 0.01 110.904 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -151.86 137.33 17.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.693 -0.886 . . . . 0.02 108.653 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.19 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.368 -0.604 . . . . 0.02 109.368 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -120.71 128.77 53.26 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.4 -0.812 . . . . 0.39000000000000001 109.793 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.79 137.94 44.91 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.241 -1.022 . . . . 0.02 108.241 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.6 m-85 -122.13 138.25 54.53 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.125 -0.984 . . . . 0.02 109.96 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' HD11 ' A' ' 33' ' ' LEU . 95.0 mt-10 -68.06 -28.26 67.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 0.029999999999999999 111.292 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.02 170.51 8.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.023 -1.048 . . . . 0.029999999999999999 110.305 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -75.59 161.85 28.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.795 0.807 . . . . 0.029999999999999999 110.604 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 41.3 t-20 62.59 33.6 15.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.03 0.919 . . . . 0.73999999999999999 110.89 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 65' ' ' GLU . 0.3 OUTLIER 55.31 40.31 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.861 -0.609 . . . . 0.02 110.67 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -110.12 165.21 11.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.219 -1.03 . . . . 0.02 108.219 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.21 -167.74 36.25 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 120.794 -1.191 . . . . 0.029999999999999999 110.759 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -69.21 143.35 54.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -1.003 . . . . 2.7599999999999998 109.541 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.36 149.74 41.87 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.728 0.775 . . . . 1.8899999999999999 109.713 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -132.97 126.84 32.88 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.598 -1.26 . . . . 0.02 107.598 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -111.78 137.61 49.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.46 -0.775 . . . . 1.1200000000000001 109.666 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 138.17 49.1 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.609 0.718 . . . . 0.02 109.387 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -116.98 10.44 14.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.745 -0.597 . . . . 0.20000000000000001 109.47 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -158.09 174.45 15.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.213 -1.032 . . . . 1.23 108.213 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 29.4 t0 -60.99 143.34 55.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.762 -1.212 . . . . 0.02 110.153 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 58.1 m -131.31 116.94 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.02 108.435 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -26.29 51.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.23999999999999999 110.882 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -152.96 101.14 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.025 -1.047 . . . . 1.1399999999999999 108.641 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -104.86 8.75 34.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.143 0.973 . . . . 6.3700000000000001 109.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -58.29 -23.32 55.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.601 -0.687 . . . . 3.1099999999999999 110.626 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 p -74.56 -17.01 60.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.816 -1.178 . . . . 0.88 110.266 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -103.72 -22.42 13.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.467 -0.771 . . . . 0.02 109.333 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.426 HD11 ' HG3' ' A' ' 11' ' ' GLU . 4.9 tp -149.71 128.0 12.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 3.3199999999999998 108.811 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m -86.47 -9.9 55.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.02 110.96 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 77' ' ' ASP . 40.6 ttt180 -171.04 161.41 6.84 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.681 -1.229 . . . . 0.02 107.681 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.9 t -143.28 115.71 8.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.794 -1.191 . . . . 0.02 108.822 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.588 ' ND2' ' CD1' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -108.16 1.42 22.18 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.318 -178.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -156.43 153.52 29.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.509 -1.293 . . . . 0.02 107.509 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -145.44 148.01 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.095 . . . . 0.02 109.895 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -124.54 125.25 43.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.565 -1.272 . . . . 0.02 107.565 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 t -105.48 114.0 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.98 -1.489 . . . . 0.02 106.98 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.573 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 4.8 tm-20 -83.63 -34.29 25.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 109.689 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.06 148.99 16.89 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.611 -1.757 . . . . 0.02 110.569 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.83 173.89 50.02 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.985 -1.246 . . . . 0.01 109.985 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -119.6 135.89 54.61 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.3 m95 -123.41 153.49 40.34 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.537 1.16 . . . . 0.02 112.155 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.6 132.47 53.25 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.02 -2.215 . . . . 0.23999999999999999 105.02 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.26 142.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.931 -0.766 . . . . 0.65000000000000002 108.931 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 31.8 m-85 -121.56 145.98 47.42 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.272 1.034 . . . . 0.02 109.801 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.29 -34.85 78.25 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.732 -0.667 . . . . 0.02 111.134 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.64 153.52 66.45 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.113 -0.992 . . . . 0.02 109.309 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -51.54 167.68 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.546 1.497 . . . . 0.02 113.249 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 63.79 37.06 10.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.049 -0.978 . . . . 0.02 111.127 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 45.19 50.77 9.47 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.62 0.724 . . . . 3.3900000000000001 110.379 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -125.2 163.59 22.14 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.201 0.524 . . . . 2.3300000000000001 109.746 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 -161.85 32.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.488 -1.445 . . . . 0.02 109.488 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -67.59 137.9 56.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.812 -1.405 . . . . 0.02 109.89 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 21.2 ptm -119.14 137.82 53.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.473 0.654 . . . . 5.0099999999999998 109.541 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -132.9 140.07 47.69 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.476 -0.765 . . . . 0.02 109.666 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.47 132.34 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.355 -0.98 . . . . 1.72 108.355 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.56 108.35 39.6 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.508 -0.745 . . . . 0.02 110.329 -178.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -75.2 168.27 25.06 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.044 1.051 . . . . 1.47 110.267 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.573 ' NE2' ' O ' ' A' ' 42' ' ' GLU . 59.1 tt0 -53.43 140.03 28.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.834 -1.166 . . . . 4.25 110.487 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.99 -176.75 32.57 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.508 -1.33 . . . . 0.02 110.301 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 15' ' ' PHE . 62.3 tt0 -118.64 130.06 55.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.389 -1.065 . . . . 0.95999999999999996 109.369 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 25.5 m-85 -120.75 92.83 48.36 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.826 -1.176 . . . . 0.02 107.826 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -65.7 -4.87 10.57 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.035 1.157 . . . . 0.02 113.746 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -157.03 153.57 28.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.579 -1.326 . . . . 2.02 107.889 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.631 ' CE2' ' NE2' ' A' ' 70' ' ' GLN . 8.8 p90 -60.59 -37.62 81.97 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.468 -0.77 . . . . 0.02 112.162 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.631 ' NE2' ' CE2' ' A' ' 69' ' ' TYR . 93.8 mm-40 -60.32 -23.68 64.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.942 -1.099 . . . . 0.02 110.661 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.7 62.39 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.898 0.856 . . . . 3.4199999999999999 108.854 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.74 9.91 28.97 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.393 -1.336 . . . . 0.02 107.393 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.7 mtt 61.34 21.89 12.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.652 . . . . 0.02 110.641 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.27 144.47 45.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.182 -1.567 . . . . 0.02 109.182 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.4 tp -79.06 -30.71 44.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.619 -1.252 . . . . 0.97999999999999998 107.619 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 49.6 t30 -157.69 -173.25 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.476 -1.676 . . . . 0.02 106.476 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -98.16 27.41 4.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.843 -1.161 . . . . 0.02 110.215 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.05 122.24 38.67 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.267 -0.896 . . . . 3.2000000000000002 109.954 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.3 mt -144.5 119.52 10.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.586 -1.264 . . . . 2.6099999999999999 107.586 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.96 -16.02 14.86 Favored Glycine 0 N--CA 1.503 3.136 0 C-N-CA 120.525 -0.845 . . . . 0.02 112.395 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -156.47 155.91 32.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.405 -1.644 . . . . 0.02 110.03 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 30.3 p -144.28 147.59 33.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.02 109.491 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -134.53 140.04 45.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.323 -0.861 . . . . 0.01 108.797 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.03 130.96 37.11 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.205 -0.934 . . . . 0.42999999999999999 108.651 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.62 123.34 42.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' O ' ' CG2' ' A' ' 135' ' ' THR . 14.8 m-70 -91.96 133.49 35.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.015 . . . . 1.77 108.386 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.06 139.67 32.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.766 . . . . 1.6299999999999999 109.049 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 t -111.48 125.59 54.06 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.465 -0.939 . . . . 1.0800000000000001 108.465 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 t -102.75 -155.68 0.53 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.282 -1.747 . . . . 1.26 106.282 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.21 -47.88 0.95 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.545 -1.347 . . . . 0.01 112.051 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.34 -98.6 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 118.587 -1.768 . . . . 0.01 112.267 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -122.48 120.89 35.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.394 -1.062 . . . . 4.4299999999999997 110.762 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 174' ' ' ARG . . . -76.82 132.01 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.171 -0.677 . . . . 2.9900000000000002 109.171 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.32 139.24 49.5 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 6.3600000000000003 109.236 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tt -126.54 143.68 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.743 0.783 . . . . 1.0900000000000001 109.645 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.46 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -123.74 131.23 53.56 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.649 -1.241 . . . . 2.0499999999999998 107.649 177.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 m -124.31 148.34 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 120.871 -1.143 . . . . 1.1000000000000001 109.671 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -118.68 141.38 48.66 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.041 0.924 . . . . 0.72999999999999998 111.022 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.52 -29.47 69.57 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.747 -0.66 . . . . 0.02 111.446 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -116.39 169.86 8.99 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.092 -1.005 . . . . 3.1800000000000002 110.353 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.8 165.79 50.13 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.073 -0.811 . . . . 0.01 111.073 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 56.38 39.25 30.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.99 -0.712 . . . . 0.01 111.426 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 51.78 54.57 10.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.599 -0.688 . . . . 0.01 111.2 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -129.62 166.4 19.82 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.154 -1.054 . . . . 3.1499999999999999 108.154 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.97 -164.42 28.68 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -75.55 144.94 41.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.938 -1.331 . . . . 0.01 108.714 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.459 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.5 tmm? -116.87 142.3 47.1 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.688 0.756 . . . . 0.01 109.972 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.44 ' N ' ' SD ' ' A' ' 107' ' ' MET . 41.8 m-85 -130.39 134.66 47.31 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.7 -1.222 . . . . 2.48 107.7 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -121.42 135.63 55.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.725 -0.609 . . . . 0.01 109.83 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.499 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 9.5 t -150.34 153.1 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.223 1.011 . . . . 1.6899999999999999 110.738 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 p -109.35 10.0 25.58 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.829 -0.623 . . . . 0.01 109.864 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.5 mp0 -121.0 163.3 18.49 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.426 -0.796 . . . . 3.21 111.046 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 155.16 38.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.283 -1.006 . . . . 0.01 108.283 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.86 111.43 29.17 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.64 -0.874 . . . . 0.01 108.64 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.54 -32.86 3.48 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 CA-C-N 120.032 1.047 . . . . 0.01 111.605 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -141.23 107.81 5.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.285 -0.884 . . . . 0.02 108.855 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.53 -38.77 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.838 -0.539 . . . . 1.8300000000000001 110.361 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.5 ttt -66.4 -37.76 85.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.868 -1.133 . . . . 1.3400000000000001 109.873 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -70.27 -39.06 75.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.408 -1.432 . . . . 2.1099999999999999 109.53 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.406 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 61.9 tt0 -80.44 -47.05 14.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -0.975 . . . . 2.0800000000000001 112.316 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.406 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.9 m-85 -110.51 -1.68 16.85 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.375 -0.828 . . . . 0.02 112.752 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m170 61.16 33.48 19.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.677 -1.264 . . . . 0.02 109.343 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 mt -114.34 135.39 54.13 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.517 -0.74 . . . . 0.02 109.161 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -89.41 -21.1 23.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.181 -0.949 . . . . 5.3200000000000003 110.763 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 52.0 mt-10 -148.32 163.69 36.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.949 -1.095 . . . . 0.02 110.105 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.3 mm -129.33 126.05 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.202 -1.407 . . . . 2.1699999999999999 107.202 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -109.55 -13.04 14.62 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.353 -0.842 . . . . 0.02 112.682 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.3 p -160.82 153.5 20.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.269 . . . . 0.01 109.111 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 20.4 p -170.28 144.33 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.925 -1.139 . . . . 1.22 107.925 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.3 pttt -127.92 101.84 6.5 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.903 -1.123 . . . . 1.4099999999999999 109.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 136' ' ' TRP . 14.6 p -101.24 140.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.83 -1.174 . . . . 0.01 107.83 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.69 91.1 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 106.25 -1.759 . . . . 1.98 106.25 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 136' ' ' TRP . 24.7 tt0 -146.83 -70.04 0.24 Allowed 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.455 -2.054 . . . . 0.01 105.455 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.53 -40.63 1.03 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.177 -1.569 . . . . 0.01 109.177 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.678 ' HB ' HD12 ' A' ' 175' ' ' ILE . 70.5 p -129.38 103.07 6.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.407 -1.055 . . . . 2.2999999999999998 112.375 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 133' ' ' GLU . 17.6 m95 -132.88 144.75 50.39 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 107.863 -1.162 . . . . 0.01 107.863 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' CG1' HD11 ' A' ' 175' ' ' ILE . 34.3 mt -119.18 134.96 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 120.562 -1.336 . . . . 1.6899999999999999 109.846 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.46 141.7 44.68 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.193 -1.78 . . . . 2.4900000000000002 106.193 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.509 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 14.7 m-85 -123.51 143.63 50.06 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.206 -0.934 . . . . 0.02 109.88 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.45 -30.96 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.976 -0.452 . . . . 0.02 111.721 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.51 155.14 47.62 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.759 -1.213 . . . . 1.48 108.809 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -56.86 166.79 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.05 1.167 . . . . 0.02 112.927 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 42.8 t-20 59.66 31.89 21.17 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.173 -0.921 . . . . 0.75 111.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.9 m-85 57.45 51.95 9.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.527 -0.733 . . . . 0.02 111.523 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -126.75 165.32 19.5 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.463 -0.773 . . . . 0.02 110.057 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.13 -165.24 34.28 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.286 -1.126 . . . . 0.02 110.286 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -69.39 141.72 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.946 . . . . 0.02 108.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' MET . 18.4 mt-30 -114.12 148.59 36.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.778 -0.576 . . . . 0.02 110.109 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -123.75 133.86 53.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -95.34 121.12 36.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.868 -1.145 . . . . 0.01 109.461 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -98.83 145.49 26.92 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.761 -0.829 . . . . 0.01 108.761 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 13.1 m-20 -110.0 -179.31 3.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.534 -0.729 . . . . 2.27 109.645 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -71.52 38.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.87 . . . . 1.8400000000000001 109.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.1 mttm -112.04 177.18 4.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.514 -0.741 . . . . 2.2799999999999998 109.208 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 26.4 mp0 -105.96 122.31 45.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.505 -0.747 . . . . 0.01 109.018 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.7 113.82 25.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.837 . . . . 0.01 109.242 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.41 -27.59 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.01 111.268 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -124.59 155.57 69.15 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.803 -1.184 . . . . 2.54 107.803 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.3 Cg_endo -61.5 -40.97 43.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.065 0.702 . . . . 0.69999999999999996 111.116 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.11 -18.87 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.8 -1.187 . . . . 0.85999999999999999 109.495 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.89 -18.15 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.02 111.899 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.63 15.42 28.98 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.674 -1.266 . . . . 0.02 110.147 178.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.92 74.3 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 121.088 -1.008 . . . . 0.02 112.939 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.96 140.48 35.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.912 -1.346 . . . . 0.02 109.995 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.04 -6.67 59.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.664 -0.647 . . . . 0.58999999999999997 109.703 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -139.76 150.34 62.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.245 -0.91 . . . . 0.87 109.603 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.08 13.73 0.8 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.746 0.964 . . . . 0.38 111.838 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.04 24.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.312 1.053 . . . . 0.17999999999999999 110.655 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.517 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.1 mt -150.03 123.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.569 -2.011 . . . . 3.9900000000000002 105.569 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -111.84 -12.67 13.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.454 -0.779 . . . . 5.1699999999999999 113.011 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 p -157.08 159.66 38.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.295 -2.128 . . . . 0.02 109.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.13 152.64 33.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.208 -0.932 . . . . 2.02 110.055 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.491 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 15.8 mtp180 -142.42 148.81 38.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.057 -1.027 . . . . 0.01 110.244 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 93' ' ' ALA . 14.7 ptm180 -86.78 140.24 29.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.141 -1.059 . . . . 0.01 108.141 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 135' ' ' THR . 21.0 mt -94.7 130.59 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.2 -0.937 . . . . 3.04 109.585 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.91 147.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 1.8899999999999999 109.541 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 4.8899999999999997 109.403 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.493 -0.558 . . . . 5.2800000000000002 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -73.95 97.64 2.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 5.96 109.313 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.0 p -102.78 -140.7 0.35 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.1 -1.074 . . . . 2.2200000000000002 108.1 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.77 87.89 0.07 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 107.205 -2.358 . . . . 0.81000000000000005 107.205 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.36 150.65 33.67 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 120.184 -1.008 . . . . 0.01 110.779 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -151.48 136.75 17.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.46 -1.023 . . . . 0.02 108.916 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 7.2 tt -130.77 142.16 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.39 -0.596 . . . . 0.02 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.526 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.5 t -122.87 130.48 52.91 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.475 -0.765 . . . . 0.39000000000000001 109.379 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.9 m-85 -109.71 139.94 44.16 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.947 -0.761 . . . . 0.02 108.947 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 12.7 m-85 -122.79 139.1 54.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.433 -0.792 . . . . 0.02 109.64 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.91 -26.66 64.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.029999999999999999 111.985 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.0 m-20 -114.17 170.01 8.6 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.029999999999999999 110.571 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -74.23 157.19 36.31 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.734 0.778 . . . . 0.029999999999999999 110.149 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.27 35.72 5.79 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.821 0.819 . . . . 0.73999999999999999 111.101 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.0 p90 49.66 44.61 24.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.679 0.752 . . . . 0.02 111.105 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -112.3 166.1 11.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.988 -1.115 . . . . 0.02 107.988 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.52 -167.9 34.28 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 120.735 -1.228 . . . . 0.029999999999999999 110.532 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.578 HH21 ' H ' ' A' ' 34' ' ' SER . 36.7 ttp180 -70.01 144.29 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -1.005 . . . . 2.7599999999999998 108.841 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.65 150.22 41.27 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.726 0.774 . . . . 1.8899999999999999 110.412 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -132.7 127.63 35.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.138 -1.06 . . . . 0.02 108.138 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -113.32 137.46 51.47 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 110.119 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.91 139.48 48.76 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.681 0.753 . . . . 0.02 109.351 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 m-20 -117.08 11.28 14.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.271 -0.64 . . . . 0.20000000000000001 109.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -158.57 174.49 14.99 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.119 -1.067 . . . . 1.23 108.119 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.21 144.34 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.601 -1.312 . . . . 0.02 110.249 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.0 m -131.41 116.86 18.08 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.372 -0.973 . . . . 0.02 108.372 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.2 -26.03 52.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.143 -0.973 . . . . 0.23999999999999999 110.67 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -154.2 100.46 2.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 1.1399999999999999 108.7 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -104.96 9.65 34.47 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.103 0.954 . . . . 6.3700000000000001 109.538 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -58.3 -23.76 57.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.618 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -74.38 -16.89 60.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.169 . . . . 0.88 110.002 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -105.11 -21.9 13.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.516 -0.74 . . . . 0.02 109.395 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.1 tp -148.37 125.68 11.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 3.3199999999999998 109.166 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.578 ' H ' HH21 ' A' ' 18' ' ' ARG . 83.2 p -86.3 -11.05 53.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.02 111.263 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' O ' HD21 ' A' ' 33' ' ' LEU . 11.9 tpp180 -170.68 161.58 7.54 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.746 -1.205 . . . . 0.02 107.746 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.801 ' SG ' HD12 ' A' ' 79' ' ' LEU . 23.6 p -140.51 113.35 8.22 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.848 -1.157 . . . . 0.02 108.752 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 19.2 t-20 -106.35 -2.31 22.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.866 -1.146 . . . . 0.029999999999999999 110.259 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 8.4 m -154.43 154.15 32.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.304 -0.999 . . . . 0.02 108.304 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.418 HD12 ' CZ3' ' A' ' 72' ' ' TRP . 69.2 mt -144.66 146.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.02 109.599 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -124.44 124.8 43.11 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.046 -1.464 . . . . 0.02 107.046 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 24.9 t -105.6 113.65 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.822 -1.547 . . . . 0.02 106.822 177.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.08 -34.61 26.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.485 -0.759 . . . . 3.8100000000000001 110.015 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.09 150.15 19.17 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.48 -1.819 . . . . 0.02 110.468 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.86 175.36 50.91 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.457 -1.354 . . . . 0.01 109.929 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 46' ' ' TRP . 34.3 m -110.29 161.93 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.823 -1.547 . . . . 1.48 106.823 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CZ3' ' SG ' ' A' ' 22' ' ' CYS . 64.5 m95 -147.65 147.01 29.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.286 -1.509 . . . . 0.02 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.31 54.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.158 -2.164 . . . . 0.23999999999999999 105.158 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.8 m -119.02 142.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.679 . . . . 0.65000000000000002 109.466 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 19.7 m-85 -119.72 144.79 47.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.295 1.045 . . . . 0.02 109.46 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.19 -34.88 79.04 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.748 -0.66 . . . . 0.02 111.183 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -125.66 158.36 65.28 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.112 -0.992 . . . . 0.02 109.496 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.41 167.11 1.46 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.739 1.626 . . . . 0.02 113.145 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.97 36.78 9.8 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.097 -0.956 . . . . 0.02 111.208 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.16 51.91 10.74 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.476 0.655 . . . . 3.3900000000000001 110.915 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.9 t -127.37 164.55 21.57 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 2.3300000000000001 110.118 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.16 -162.55 32.4 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.017 -1.233 . . . . 0.02 110.017 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.491 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 85.9 m-70 -62.8 142.03 58.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.02 110.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.2 mtp -115.89 135.09 54.32 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.955 -0.757 . . . . 5.0099999999999998 108.955 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' C ' HD12 ' A' ' 60' ' ' ILE . 53.1 m-85 -136.16 133.31 37.04 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.362 -0.836 . . . . 0.02 109.469 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -96.13 131.78 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.245 -1.02 . . . . 1.72 108.245 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.8 mt -120.48 110.45 35.65 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.673 -0.642 . . . . 0.02 110.344 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.61 169.61 21.49 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 CA-C-N 119.923 1.008 . . . . 1.47 110.079 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 12.7 tm0? -53.13 140.83 24.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.827 -1.171 . . . . 4.25 110.355 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.31 -176.28 32.2 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.02 110.522 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.13 128.75 55.44 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -1.011 . . . . 0.95999999999999996 108.738 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 30.1 m-85 -118.64 98.08 51.04 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' OG ' ' A' ' 38' ' ' SER . 1.8 Cg_endo -67.75 -6.64 17.3 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.645 0.897 . . . . 0.02 114.401 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 31.1 mt-10 -158.64 155.9 29.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.366 -1.459 . . . . 2.02 108.382 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -59.99 -37.39 79.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.02 112.374 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.97 -21.83 61.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.02 109.988 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.38 -20.37 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.703 . . . . 3.4199999999999999 110.294 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.418 ' CZ3' HD12 ' A' ' 39' ' ' ILE . 2.9 p90 -109.49 15.87 22.66 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.232 -0.917 . . . . 0.02 108.669 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt 64.66 23.86 12.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.331 0.586 . . . . 0.02 110.769 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.53 146.54 50.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.35 -1.5 . . . . 0.02 109.35 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 14.2 mt -80.59 -28.69 37.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.97999999999999998 108.261 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.71 -170.66 3.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.012 -1.477 . . . . 0.02 107.012 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 35.2 p30 -98.28 28.28 4.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.753 -1.217 . . . . 0.02 110.274 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -97.08 123.52 40.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.324 -0.86 . . . . 3.2000000000000002 111.246 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.801 HD12 ' SG ' ' A' ' 36' ' ' CYS . 63.0 mt -143.88 120.27 10.95 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.022 -1.473 . . . . 2.6099999999999999 107.022 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.8 -16.4 14.1 Favored Glycine 0 N--CA 1.503 3.101 0 O-C-N 121.312 -0.867 . . . . 0.02 112.166 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.8 t -156.11 155.72 33.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.51 -1.582 . . . . 0.02 109.686 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.0 m -144.91 148.13 33.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.735 . . . . 0.02 109.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.481 ' CZ ' ' OH ' ' A' ' 49' ' ' TYR . 39.5 mtm180 -134.1 139.63 46.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.352 -0.842 . . . . 0.01 108.854 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 131.3 38.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.961 -1.126 . . . . 0.42999999999999999 107.961 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -90.96 124.08 43.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.378 -0.971 . . . . 1.25 108.378 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 135' ' ' THR . 9.4 m80 -91.12 135.12 33.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 1.77 108.457 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.17 137.81 36.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.957 -0.757 . . . . 1.6299999999999999 108.957 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -111.54 125.88 54.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.474 -0.936 . . . . 1.0800000000000001 108.474 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 m -102.74 -155.41 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.222 -1.77 . . . . 1.26 106.222 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.73 -48.64 0.9 Allowed Glycine 0 N--CA 1.498 2.797 0 O-C-N 120.463 -1.398 . . . . 0.01 112.305 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.38 -99.47 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.502 -1.809 . . . . 0.01 112.208 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.25 120.38 33.96 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.231 -1.158 . . . . 4.4299999999999997 110.82 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.643 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -77.74 132.32 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.126 -0.694 . . . . 2.9900000000000002 109.126 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -129.95 140.38 50.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.525 -0.734 . . . . 6.3600000000000003 109.121 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -125.5 141.89 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.867 0.842 . . . . 1.0900000000000001 109.528 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -124.59 131.41 53.48 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.514 -1.291 . . . . 2.0499999999999998 107.514 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -123.84 146.39 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.983 -1.073 . . . . 1.1000000000000001 109.819 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -117.43 140.72 49.22 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.991 0.901 . . . . 0.72999999999999998 110.77 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -66.14 -29.84 70.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.001 -0.545 . . . . 0.02 111.663 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -116.84 167.97 10.64 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.062 -1.024 . . . . 3.1800000000000002 110.586 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.01 43.39 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.08 -0.808 . . . . 0.01 111.08 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 56.55 38.58 29.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.868 -0.783 . . . . 0.01 110.801 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 52.55 55.31 9.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.753 -0.592 . . . . 0.01 110.959 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -128.58 165.96 19.78 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.497 -0.927 . . . . 3.1499999999999999 108.497 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.57 -164.85 26.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.36 -1.496 . . . . 0.01 109.36 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -74.85 144.82 43.25 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.039 -1.271 . . . . 0.01 108.255 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 5.1 tmm? -116.29 142.44 46.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.669 0.747 . . . . 0.01 109.653 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.552 ' N ' ' SD ' ' A' ' 107' ' ' MET . 80.8 m-85 -131.19 135.58 47.53 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.014 -1.106 . . . . 2.48 108.014 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.8 tm-20 -120.37 134.08 55.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.74 -0.6 . . . . 0.01 109.709 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 112' ' ' GLU . 2.8 t -149.63 152.11 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 1.6899999999999999 110.558 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -109.35 10.42 25.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.828 -0.624 . . . . 0.01 109.964 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.2 mp0 -120.58 163.06 18.58 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.41 -0.806 . . . . 3.21 111.317 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.08 155.23 37.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.007 -1.108 . . . . 0.01 108.007 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 49.2 t -122.54 110.66 31.95 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.938 -0.764 . . . . 0.01 108.938 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.82 -34.35 2.43 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 CA-C-N 119.976 1.027 . . . . 0.01 111.685 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.9 m -140.41 107.54 5.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.02 108.685 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.97 -39.42 85.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.865 -0.522 . . . . 1.8300000000000001 110.553 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttp -66.52 -37.67 85.53 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.967 -1.093 . . . . 1.3400000000000001 109.944 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.39 -39.12 74.73 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.388 -1.445 . . . . 2.1099999999999999 109.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.571 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 44.3 tt0 -80.29 -47.52 14.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 2.0800000000000001 112.425 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.571 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 66.7 m-85 -111.38 -1.25 16.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.8 . . . . 0.02 112.615 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.9 m80 61.77 34.29 17.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.71 -1.244 . . . . 0.02 109.742 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.87 135.42 54.22 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.497 -0.752 . . . . 0.02 109.231 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.52 -21.19 23.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 5.3200000000000003 110.768 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.42 164.42 34.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.02 109.968 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.0 mm -128.61 124.92 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.154 -1.424 . . . . 2.1699999999999999 107.154 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.3 m80 -109.27 -13.17 14.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 0.02 112.32 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 t -159.91 152.34 20.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.843 -1.16 . . . . 0.01 109.059 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.7 p -167.42 145.14 4.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.154 -1.054 . . . . 1.22 108.154 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -121.67 104.73 9.82 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.229 1.014 . . . . 1.4099999999999999 109.621 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.62 132.63 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.685 -1.228 . . . . 0.01 107.685 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.04 90.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 106.116 -1.809 . . . . 1.98 106.116 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.516 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 46.4 tt0 -146.71 -69.79 0.25 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.544 -2.021 . . . . 0.01 105.544 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.58 -39.84 1.01 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.751 -1.74 . . . . 0.01 108.751 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.748 ' HB ' HD12 ' A' ' 175' ' ' ILE . 80.4 p -130.08 101.93 6.03 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.505 -0.997 . . . . 2.2999999999999998 111.919 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 55.3 m95 -129.49 142.26 50.82 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.349 -1.352 . . . . 0.01 107.349 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' A' ' 175' ' ' ILE . 27.2 mt -118.36 133.38 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.41 -1.432 . . . . 1.6899999999999999 109.775 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.72 141.28 44.22 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.378 -1.712 . . . . 2.4900000000000002 106.378 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -122.86 142.73 50.45 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.019 -1.051 . . . . 0.02 109.556 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.18 -30.68 62.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.02 111.718 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.84 154.87 48.23 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 120.749 -1.22 . . . . 1.48 108.896 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.31 167.24 2.74 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.28 1.32 . . . . 0.02 112.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.02 30.91 20.85 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.154 -0.93 . . . . 0.75 111.479 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.79 51.85 8.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.5 -0.75 . . . . 0.02 111.289 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.73 165.14 19.81 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.513 -0.742 . . . . 0.02 109.703 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.43 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.16 -165.51 34.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.124 -1.19 . . . . 0.02 110.124 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.46 142.02 53.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.981 . . . . 0.02 108.863 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -113.93 148.92 36.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 12.2 m-85 -123.36 133.9 54.06 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.773 -0.825 . . . . 0.01 108.773 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.3 120.47 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.148 . . . . 0.01 109.197 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -98.73 138.6 35.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.299 -1.0 . . . . 0.01 108.299 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.1 m-20 -108.08 -173.76 2.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 2.27 109.628 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.67 40.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 1.8400000000000001 109.578 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.2 mttp -112.13 167.74 10.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.441 -0.787 . . . . 2.2799999999999998 109.358 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -105.06 124.11 48.96 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.54 114.12 26.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.279 -0.888 . . . . 0.01 110.456 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -92.9 -26.22 17.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.01 110.636 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -123.63 154.45 66.66 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.993 -1.114 . . . . 2.54 107.993 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.557 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -61.64 -41.12 41.43 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 CA-C-N 119.245 0.766 . . . . 0.69999999999999996 110.802 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.74 -18.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.727 -1.233 . . . . 0.85999999999999999 109.311 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 50.7 t0 -65.29 -18.39 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.101 . . . . 0.02 111.927 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.75 15.42 29.02 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.8 -1.187 . . . . 0.02 110.164 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.4 76.3 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.163 -0.961 . . . . 0.02 113.113 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.15 141.41 34.08 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.836 -1.39 . . . . 0.02 110.227 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.34 59.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.721 -0.612 . . . . 0.58999999999999997 109.641 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -142.1 150.55 56.12 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.106 -0.996 . . . . 0.87 109.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.09 16.49 0.67 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 120.801 1.0 . . . . 0.38 112.018 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 120.79 25.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.17999999999999999 110.78 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.7 mt -149.08 124.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.719 -1.956 . . . . 3.9900000000000002 105.719 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -111.91 -13.72 13.6 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.174 -0.954 . . . . 5.1699999999999999 113.027 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 t -157.13 159.84 38.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.332 -2.105 . . . . 0.02 109.919 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' C ' ' CD1' ' A' ' 172' ' ' PHE . 20.5 p90 -152.27 153.53 33.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.374 -0.829 . . . . 2.02 110.324 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -143.85 150.03 37.86 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.275 -0.89 . . . . 0.01 110.202 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.643 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 14.2 ptm180 -87.09 141.29 28.77 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.416 -0.957 . . . . 0.01 108.416 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.748 HD12 ' HB ' ' A' ' 135' ' ' THR . 14.9 mt -94.84 129.61 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 3.04 109.373 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.46 147.67 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.423 -0.798 . . . . 1.8899999999999999 109.561 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 4.8899999999999997 109.431 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.471 -0.566 . . . . 5.2800000000000002 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -82.6 133.58 35.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 5.96 109.753 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.3 p -137.35 -130.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.322 -0.861 . . . . 2.2200000000000002 111.556 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.88 94.63 0.1 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 105.986 -2.846 . . . . 0.81000000000000005 105.986 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.41 147.71 31.68 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.419 -0.896 . . . . 0.01 111.007 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.65 138.66 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.02 108.421 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -130.29 140.83 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.354 0.597 . . . . 0.02 109.693 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -121.8 129.73 52.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.478 -0.764 . . . . 0.39000000000000001 109.778 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 29.1 m-85 -109.14 139.27 44.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.838 -0.801 . . . . 0.02 108.838 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.1 m-85 -122.68 138.56 54.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.297 -0.877 . . . . 0.02 109.742 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 33' ' ' LEU . 91.1 mt-10 -69.14 -27.58 65.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.029999999999999999 111.671 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.83 170.33 8.42 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.872 -1.142 . . . . 0.029999999999999999 110.58 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -74.51 157.45 35.5 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.755 0.788 . . . . 0.029999999999999999 110.181 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.9 OUTLIER 65.77 35.33 6.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.891 0.853 . . . . 0.73999999999999999 110.943 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.5 p90 49.82 45.28 24.94 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.679 0.752 . . . . 0.02 111.266 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -112.51 166.78 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.08 -1.081 . . . . 0.02 108.08 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.4 -167.88 36.04 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.737 -1.221 . . . . 0.029999999999999999 110.624 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -69.89 143.76 52.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -1.073 . . . . 2.7599999999999998 109.134 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -120.35 149.07 42.92 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.71 0.767 . . . . 1.8899999999999999 110.582 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -132.24 126.75 34.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.064 -1.087 . . . . 0.02 108.064 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -112.04 136.83 50.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.414 -0.804 . . . . 1.1200000000000001 109.814 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.62 137.78 49.78 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.478 0.656 . . . . 0.02 109.538 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.89 10.59 14.15 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.303 0.573 . . . . 0.20000000000000001 109.626 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 43.1 t -158.15 173.86 16.07 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 1.23 108.129 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.9 m-20 -61.77 144.77 54.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.615 -1.303 . . . . 0.02 110.541 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 t -132.2 116.45 16.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.585 -0.895 . . . . 0.02 108.585 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.9 -23.5 55.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.486 -0.758 . . . . 0.23999999999999999 110.634 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -155.61 101.88 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.48 -0.933 . . . . 1.1399999999999999 108.48 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.67 10.22 34.88 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.344 1.069 . . . . 6.3700000000000001 109.816 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -59.88 -23.43 63.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.505 -0.747 . . . . 3.1099999999999999 110.713 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 m -75.35 -16.55 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.688 -1.258 . . . . 0.88 110.373 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -103.15 -21.4 13.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.402 -0.811 . . . . 0.02 109.017 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.88 128.58 12.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 3.3199999999999998 108.848 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 p -84.73 -10.12 57.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.71 -0.619 . . . . 0.02 110.376 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -171.61 163.3 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.704 -1.221 . . . . 0.02 107.704 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -141.73 114.77 8.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.853 -1.154 . . . . 0.02 108.663 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -107.81 -2.18 20.18 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.953 -1.092 . . . . 0.029999999999999999 110.614 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 t -154.36 153.42 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.99 -1.115 . . . . 0.02 107.99 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.0 mt -144.63 146.65 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.89 -1.131 . . . . 0.02 109.9 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' A' ' 42' ' ' GLU . 38.9 ttp180 -123.77 123.76 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.25 -1.389 . . . . 0.02 107.25 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.54 114.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 106.879 -1.526 . . . . 0.02 106.879 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 30.9 mt-10 -83.7 -33.92 25.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.98 -0.688 . . . . 3.8100000000000001 109.721 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.16 150.4 19.64 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 118.475 -1.822 . . . . 0.02 110.369 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 173.57 49.77 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.671 -1.252 . . . . 0.01 110.077 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -119.45 135.86 54.57 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.482 -1.303 . . . . 1.48 107.482 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -124.12 154.45 39.98 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.523 1.154 . . . . 0.02 111.936 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.31 132.93 53.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.032 -2.21 . . . . 0.23999999999999999 105.032 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -114.99 140.25 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.063 -0.717 . . . . 0.65000000000000002 109.063 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 53.7 m-85 -121.46 144.02 48.92 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 122.22 1.009 . . . . 0.02 109.54 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.465 ' CG ' HH11 ' A' ' 51' ' ' ARG . 1.8 tp10 -66.2 -35.82 81.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.196 -0.911 . . . . 0.02 111.75 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.465 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -122.09 158.6 54.78 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.944 -1.098 . . . . 0.02 109.212 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.66 167.25 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.517 1.478 . . . . 0.02 112.591 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.09 37.26 11.67 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.683 0.754 . . . . 0.02 111.265 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 4.1 m-85 44.87 52.33 8.12 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.692 0.758 . . . . 3.3900000000000001 110.935 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -125.8 163.44 22.89 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.846 -0.534 . . . . 2.3300000000000001 109.943 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.21 31.7 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.653 -1.379 . . . . 0.02 109.653 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -65.99 137.15 56.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.324 . . . . 0.02 110.045 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 15.8 ptm -119.37 135.98 54.48 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.447 0.641 . . . . 5.0099999999999998 109.398 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 47.1 m-85 -133.14 141.01 47.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.566 -0.709 . . . . 0.02 109.267 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.37 132.09 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.571 -0.706 . . . . 1.72 109.431 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.17 109.55 35.18 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.552 -0.718 . . . . 0.02 110.332 -178.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.04 169.39 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.061 1.058 . . . . 1.47 110.229 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -52.82 140.59 23.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.901 -1.124 . . . . 4.25 110.706 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.46 -176.26 32.33 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.432 -1.365 . . . . 0.02 110.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -118.39 129.97 55.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.375 -1.073 . . . . 0.95999999999999996 109.405 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 59.9 m-85 -121.07 97.66 47.79 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.773 -1.195 . . . . 0.02 107.773 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.55 -3.7 13.06 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.648 0.898 . . . . 0.02 113.952 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -155.68 154.07 30.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.454 -1.404 . . . . 2.02 108.044 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -60.59 -38.44 84.64 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.563 -0.711 . . . . 0.02 111.708 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.02 110.152 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.12 -18.75 63.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.009 0.909 . . . . 3.4199999999999999 108.694 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.647 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -107.24 10.86 29.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.251 -1.389 . . . . 0.02 107.251 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 32.9 mtm 61.18 22.47 12.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.02 110.521 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.48 145.06 47.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tp -78.86 -29.97 44.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -1.205 . . . . 0.97999999999999998 107.75 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.419 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 43.9 p30 -156.86 -171.45 3.66 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.57 27.49 4.29 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.731 -1.23 . . . . 0.02 109.987 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' HG2' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -95.92 122.48 38.77 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.032 -1.042 . . . . 3.2000000000000002 110.358 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.4 mt -144.72 121.66 11.34 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.922 -1.14 . . . . 2.6099999999999999 107.922 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.77 -16.84 9.57 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 121.33 -0.856 . . . . 0.02 112.847 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.7 t -155.15 155.63 34.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 120.023 1.912 . . . . 0.02 111.084 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.0 m -145.5 148.2 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.542 0.687 . . . . 0.02 110.306 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 12.7 mtp180 -134.6 139.25 45.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.01 108.935 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 132.74 37.24 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.623 -0.88 . . . . 0.42999999999999999 108.623 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.72 123.49 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -89.4 135.81 33.38 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.027 -1.101 . . . . 1.77 108.027 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' CD1' ' OE1' ' A' ' 177' ' ' GLU . 1.5 mt -99.2 137.71 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.752 -0.833 . . . . 1.6299999999999999 108.752 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.6 p -112.64 126.06 54.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.811 -0.811 . . . . 1.0800000000000001 108.811 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 p -102.96 -155.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.162 -1.792 . . . . 1.26 106.162 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -48.99 0.86 Allowed Glycine 0 N--CA 1.501 2.979 0 O-C-N 120.413 -1.429 . . . . 0.01 112.506 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.69 -100.0 0.14 Allowed Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.632 -1.746 . . . . 0.01 112.019 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -120.18 119.28 32.79 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.111 -1.229 . . . . 4.4299999999999997 110.753 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.84 129.93 36.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.016 -0.674 . . . . 2.9900000000000002 109.406 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -132.12 139.89 48.62 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.495 -0.753 . . . . 6.3600000000000003 109.287 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.89 145.77 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.404 -0.81 . . . . 1.0900000000000001 109.857 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.567 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -122.7 132.74 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.25 -1.389 . . . . 2.0499999999999998 107.25 177.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.51 149.24 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.107 . . . . 1.1000000000000001 109.585 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.2 141.45 48.87 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.034 0.921 . . . . 0.72999999999999998 110.998 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.36 -29.27 69.42 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.823 -0.626 . . . . 0.02 111.514 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -116.31 169.46 9.28 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.023 -1.048 . . . . 3.1800000000000002 110.311 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.3 164.79 50.18 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.801 -0.92 . . . . 0.01 110.801 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.6 m-20 56.74 38.16 29.31 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.875 -0.779 . . . . 0.01 111.3 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' H ' ' CB ' ' A' ' 128' ' ' SER . 10.7 m-85 53.07 54.69 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.586 -0.696 . . . . 0.01 111.475 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -129.01 165.1 21.81 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.331 -0.989 . . . . 3.1499999999999999 108.331 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.88 -163.9 27.24 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.424 -1.471 . . . . 0.01 109.424 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -75.37 144.07 42.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.108 -1.231 . . . . 0.01 108.577 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.452 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.2 tmm? -116.71 142.82 46.41 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.576 0.703 . . . . 0.01 109.836 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.76 135.56 46.9 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.311 -0.996 . . . . 2.48 108.311 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -121.21 135.54 55.12 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.58 -0.7 . . . . 0.01 109.93 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -149.88 152.49 35.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.189 0.995 . . . . 1.6899999999999999 110.799 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -109.41 9.87 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.01 109.97 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -120.77 163.2 18.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.817 . . . . 3.21 111.388 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.8 155.72 37.47 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.083 -1.081 . . . . 0.01 108.083 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.599 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 63.1 m -124.66 112.41 27.43 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.423 -0.798 . . . . 0.01 108.94 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.44 -32.66 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 120.135 1.084 . . . . 0.01 111.551 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.6 t -140.76 107.9 5.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.876 . . . . 0.02 108.989 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -64.15 -39.98 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 1.8300000000000001 110.593 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 118' ' ' MET . 2.0 tmt? -66.17 -37.8 86.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.134 -1.027 . . . . 1.3400000000000001 109.849 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.52 -38.85 74.32 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.448 -1.407 . . . . 2.1099999999999999 109.729 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.31 -47.57 14.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 2.0800000000000001 112.354 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.46 -0.86 16.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.424 -0.798 . . . . 0.02 112.663 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m170 61.19 33.75 19.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.139 . . . . 0.02 109.662 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.5 mt -114.22 135.93 53.51 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.476 -0.765 . . . . 0.02 109.235 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.66 -22.0 21.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 5.3200000000000003 110.9 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' ' 126' ' ' ILE . 76.0 mt-10 -148.54 163.84 35.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.884 -1.135 . . . . 0.02 110.065 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 125' ' ' GLU . 40.0 mm -128.43 125.28 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.456 -1.313 . . . . 2.1699999999999999 107.456 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -111.56 -14.04 13.73 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.285 -0.885 . . . . 0.02 112.698 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.562 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 18.7 m -160.16 152.06 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.77 -1.206 . . . . 0.01 109.044 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 31.9 p -168.87 150.13 4.59 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.504 -0.924 . . . . 1.22 108.504 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.567 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 35.4 mttm -113.28 100.71 8.77 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.327 1.06 . . . . 1.4099999999999999 108.406 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 136' ' ' TRP . 1.2 p -108.57 125.97 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.697 -0.853 . . . . 0.01 108.697 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.47 89.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 106.544 -1.65 . . . . 1.98 106.544 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.531 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 11.2 tt0 -151.67 -58.31 0.16 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.534 -1.284 . . . . 0.01 107.534 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.72 -10.8 38.38 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 107.173 -2.371 . . . . 0.01 107.173 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 p -123.39 61.44 1.05 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.833 -0.804 . . . . 2.2999999999999998 111.087 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.531 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 85.6 m95 -132.2 134.3 45.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.671 -1.268 . . . . 0.01 110.192 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.6 mt -120.1 136.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.254 -1.017 . . . . 1.6899999999999999 108.254 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.43 141.43 43.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.109 -1.441 . . . . 2.4900000000000002 107.109 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -122.72 142.77 50.34 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.173 -0.954 . . . . 0.02 109.894 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.03 -30.31 61.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.02 112.319 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.4 154.83 48.99 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.587 -1.321 . . . . 1.48 108.619 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.28 167.06 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.068 1.179 . . . . 0.02 113.04 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.1 m120 58.66 30.75 20.32 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.263 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 57.47 51.21 10.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.665 . . . . 0.02 111.066 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' NH1' ' SD ' ' A' ' 73' ' ' MET . 23.3 mmm180 -125.0 164.8 19.37 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.45 -0.781 . . . . 0.02 109.549 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.34 -165.93 34.47 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.338 -1.105 . . . . 0.02 110.338 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -69.7 142.9 53.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.458 -1.025 . . . . 0.02 109.022 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.483 ' O ' ' CG ' ' A' ' 58' ' ' MET . 6.1 mt-30 -113.41 149.76 33.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.72 -0.613 . . . . 0.02 109.558 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.13 132.51 54.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.904 -1.147 . . . . 0.01 107.904 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.45 ' H ' ' HE1' ' A' ' 58' ' ' MET . 27.8 tp -95.48 121.2 36.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.633 -1.292 . . . . 0.01 109.347 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.457 HD11 ' CD1' ' A' ' 138' ' ' PHE . 24.2 mt -93.49 162.42 13.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.811 -1.181 . . . . 0.01 107.811 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.91 -116.94 0.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.357 -0.839 . . . . 2.27 109.283 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -141.29 26.31 2.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 1.8400000000000001 109.006 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -110.35 -166.81 1.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.849 -0.797 . . . . 2.2799999999999998 108.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.29 131.9 53.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.532 -0.73 . . . . 0.01 109.496 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.06 110.78 23.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.354 -0.841 . . . . 0.01 108.911 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.449 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.0 ptm180 -88.1 -27.79 21.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.01 111.309 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -124.08 154.22 68.13 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.696 -1.224 . . . . 2.54 107.696 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.66 -39.27 44.69 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 CA-C-N 119.382 0.815 . . . . 0.69999999999999996 110.903 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.09 -18.41 17.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.795 -1.191 . . . . 0.85999999999999999 109.478 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.46 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.039 -1.038 . . . . 0.02 112.272 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.12 15.63 28.07 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.799 -1.188 . . . . 0.02 109.887 178.377 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.22 75.33 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.164 -0.96 . . . . 0.02 112.948 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.514 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.22 140.45 35.49 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.847 -1.384 . . . . 0.02 110.233 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -6.85 59.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.642 -0.661 . . . . 0.58999999999999997 109.711 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.7 p -140.34 150.83 62.51 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.176 -0.952 . . . . 0.87 109.297 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.88 15.23 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.667 0.911 . . . . 0.38 111.865 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.64 24.19 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.33 1.062 . . . . 0.17999999999999999 110.682 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.463 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.01 123.5 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.577 -2.009 . . . . 3.9900000000000002 105.577 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.62 -12.77 12.8 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.21 -0.932 . . . . 5.1699999999999999 113.271 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 9.2 t -157.23 158.93 37.09 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 119.134 -2.229 . . . . 0.02 109.945 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.599 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 18.1 p90 -152.77 154.75 35.82 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.092 -1.005 . . . . 2.02 110.148 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -144.67 150.56 37.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.01 110.395 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.1 ptt180 -87.89 143.04 27.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.01 108.613 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.65 129.39 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.311 -0.868 . . . . 3.04 109.266 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.08 147.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -0.926 . . . . 1.8899999999999999 109.783 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.473 ' OE1' ' CD1' ' A' ' 87' ' ' LEU . 51.5 tp10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 4.8899999999999997 109.413 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 3' ' ' THR . 70.5 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.377 -0.601 . . . . 5.2800000000000002 109.377 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -50.85 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 5.96 109.223 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.5 m -104.91 -139.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.995 -1.113 . . . . 2.2200000000000002 107.995 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.553 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.23 88.4 0.07 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 106.785 -2.526 . . . . 0.81000000000000005 106.785 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 149.09 33.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.745 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -150.45 136.34 18.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -1.053 . . . . 0.02 109.367 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -128.96 139.25 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.012 -0.736 . . . . 0.02 109.012 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.411 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.3 t -121.77 130.35 53.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.605 -0.684 . . . . 0.39000000000000001 109.438 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -108.67 138.38 45.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.041 -0.726 . . . . 0.02 109.041 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.0 m-85 -122.65 138.53 54.57 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.215 -0.928 . . . . 0.02 109.734 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 70.6 mt-10 -71.33 -28.2 63.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.029999999999999999 111.635 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.562 ' C ' HD21 ' A' ' 37' ' ' ASN . 24.0 t0 -113.57 168.04 10.09 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.851 -1.156 . . . . 0.029999999999999999 110.171 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 96.0 mtt180 -73.73 157.19 36.96 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.629 0.728 . . . . 0.029999999999999999 110.051 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.577 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 21.5 t-20 66.35 35.23 5.9 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.83 0.824 . . . . 0.73999999999999999 110.928 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.577 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.5 p90 50.06 45.49 25.38 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.815 0.817 . . . . 0.02 111.162 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -112.9 166.09 11.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.81 -1.182 . . . . 0.02 107.81 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -166.79 35.86 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.617 -1.278 . . . . 0.029999999999999999 110.825 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -69.42 140.8 54.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.928 . . . . 2.7599999999999998 109.268 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -120.94 149.09 43.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.586 0.708 . . . . 1.8899999999999999 110.259 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -132.81 127.09 33.79 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.945 -1.131 . . . . 0.02 107.945 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.81 136.86 50.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.528 -0.732 . . . . 1.1200000000000001 109.706 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.22 138.2 49.26 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.422 0.629 . . . . 0.02 109.449 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -116.81 10.89 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.46 -0.57 . . . . 0.20000000000000001 109.46 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.2 p -157.88 174.43 15.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.61 144.91 55.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.551 -1.343 . . . . 0.02 110.435 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.2 t -132.48 116.65 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.547 -0.909 . . . . 0.02 108.547 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -24.55 52.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.23999999999999999 110.751 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.76 100.41 2.37 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.445 -0.946 . . . . 1.1399999999999999 108.445 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 20.5 p90 -106.06 9.88 32.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.199 1.0 . . . . 6.3700000000000001 110.058 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -58.89 -22.68 59.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.633 -0.667 . . . . 3.1099999999999999 110.595 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -74.7 -16.61 60.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.676 -1.265 . . . . 0.88 110.324 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.37 -22.0 14.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.376 -0.827 . . . . 0.02 109.053 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -150.3 129.44 12.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.453 -0.944 . . . . 3.3199999999999998 108.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 p -85.26 -9.66 57.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.79 -0.569 . . . . 0.02 110.804 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -169.54 161.43 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 m -141.83 112.68 7.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.796 -1.19 . . . . 0.02 109.125 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -110.66 -0.6 17.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.054 -1.029 . . . . 0.029999999999999999 110.981 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.31 152.24 30.9 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.736 -1.209 . . . . 0.02 107.736 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -146.4 148.37 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.89 -1.131 . . . . 0.02 110.555 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -125.92 125.88 43.49 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.973 -1.121 . . . . 0.02 107.973 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.8 115.42 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.587 -1.634 . . . . 0.02 106.587 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.68 -33.8 25.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.63 -0.669 . . . . 3.8100000000000001 110.404 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.65 21.22 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.064 -1.541 . . . . 0.02 109.996 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.58 174.76 50.33 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.547 -1.311 . . . . 0.01 109.999 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 46' ' ' TRP . 14.8 m -109.79 160.65 16.15 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.646 -1.613 . . . . 1.48 106.646 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 45' ' ' THR . 62.5 m95 -147.97 147.81 30.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.285 . . . . 0.02 111.432 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.59 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.157 -2.164 . . . . 0.23999999999999999 105.157 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -118.9 143.29 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.664 -0.647 . . . . 0.65000000000000002 109.436 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.92 145.46 47.67 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.299 1.047 . . . . 0.02 109.997 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -65.9 -33.56 76.12 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.501 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -124.31 157.4 64.73 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.995 -1.066 . . . . 0.02 109.578 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.11 166.42 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.603 1.535 . . . . 0.02 112.778 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.11 36.39 9.72 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.442 -0.799 . . . . 0.02 111.114 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.03 50.88 9.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.602 0.715 . . . . 3.3900000000000001 110.61 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -125.72 163.58 22.52 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.252 0.548 . . . . 2.3300000000000001 109.914 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.62 -161.93 31.33 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.477 -1.449 . . . . 0.02 109.477 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 16.0 t-80 -66.53 138.29 57.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.948 -1.325 . . . . 0.02 109.897 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 21.8 ptm -119.1 137.21 53.73 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.557 0.694 . . . . 5.0099999999999998 109.605 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.633 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 13.2 m-85 -132.19 140.31 48.67 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.759 0.79 . . . . 0.02 109.174 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.5 mm -96.5 131.71 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.47 -0.937 . . . . 1.72 108.47 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 61' ' ' LEU . 16.6 mt -122.76 113.58 30.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.373 -0.829 . . . . 0.02 110.741 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.11 169.96 20.54 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 CA-C-N 120.062 1.058 . . . . 1.47 110.238 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.632 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -51.9 141.33 17.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 4.25 110.153 -179.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.34 -177.48 32.51 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.341 -1.409 . . . . 0.02 110.707 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -119.08 130.0 55.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.529 -0.983 . . . . 0.95999999999999996 109.62 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' N ' ' CD1' ' A' ' 66' ' ' TYR . 52.3 m-85 -120.71 95.78 48.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 107.765 -1.198 . . . . 0.02 107.765 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -68.37 -3.66 11.35 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 120.699 0.933 . . . . 0.02 113.835 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 82.6 mt-10 -157.6 154.81 29.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.544 -1.348 . . . . 2.02 108.252 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -60.5 -39.36 87.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.492 -0.755 . . . . 0.02 111.937 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -59.49 -23.86 63.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.02 110.132 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.57 62.4 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.443 -0.947 . . . . 3.4199999999999999 108.443 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.39 9.05 31.9 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.354 -1.35 . . . . 0.02 107.354 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.6 mtm 60.6 21.64 11.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.606 -0.684 . . . . 0.02 110.527 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.87 143.88 44.93 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.195 -1.562 . . . . 0.02 109.195 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.533 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -77.99 -30.14 50.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.084 -1.45 . . . . 0.97999999999999998 107.084 177.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -156.57 -172.04 3.92 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.27 -1.752 . . . . 0.02 106.27 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -97.78 27.79 4.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.728 -1.232 . . . . 0.02 110.464 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HG2' HH11 ' A' ' 78' ' ' ARG . 8.5 mtt-85 -96.4 122.84 39.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.12 -0.988 . . . . 3.2000000000000002 110.752 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.9 mt -144.87 120.15 10.21 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.517 -1.29 . . . . 2.6099999999999999 107.517 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.0 -15.87 11.3 Favored Glycine 0 N--CA 1.507 3.378 0 O-C-N 121.271 -0.893 . . . . 0.02 112.869 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.4 p -155.51 156.14 34.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.217 -1.755 . . . . 0.02 110.276 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.5 p -145.03 148.35 33.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.02 109.484 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -133.71 138.63 45.93 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.751 -0.833 . . . . 0.01 108.751 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.62 131.77 36.84 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.473 -0.936 . . . . 0.42999999999999999 108.473 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.27 123.82 43.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.74 -0.837 . . . . 1.25 108.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.434 ' O ' ' CG2' ' A' ' 135' ' ' THR . 10.5 m-70 -92.18 135.08 34.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.984 -1.073 . . . . 1.77 108.281 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.01 137.84 36.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.471 -0.768 . . . . 1.6299999999999999 109.386 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.8 m -111.03 127.09 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.548 -0.908 . . . . 1.0800000000000001 108.548 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 p -104.02 -154.73 0.51 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 106.464 -1.68 . . . . 1.26 106.464 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.81 -49.02 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.454 -1.403 . . . . 0.01 112.275 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.0 -100.2 0.14 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 118.331 -1.89 . . . . 0.01 112.122 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -119.99 118.58 31.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.27 -1.135 . . . . 4.4299999999999997 110.714 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -76.9 130.92 38.22 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.095 -0.705 . . . . 2.9900000000000002 109.095 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -130.48 138.54 50.32 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.834 -0.802 . . . . 6.3600000000000003 108.834 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.15 143.86 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.358 -0.839 . . . . 1.0900000000000001 109.402 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.14 133.71 54.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.596 -1.261 . . . . 2.0499999999999998 107.596 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 129' ' ' CYS . 16.7 m -123.81 146.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.992 -1.068 . . . . 1.1000000000000001 109.038 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -120.59 141.75 50.02 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 122.127 0.965 . . . . 0.72999999999999998 111.277 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -66.16 -30.01 70.4 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.807 -0.633 . . . . 0.02 111.821 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -116.61 168.05 10.53 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.636 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.75 163.57 43.8 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 111.016 -0.833 . . . . 0.01 111.016 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 57.03 38.86 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 122.011 -0.699 . . . . 0.01 110.979 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.3 m-85 52.23 56.71 7.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.597 -0.69 . . . . 0.01 111.083 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -128.84 165.46 20.96 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.17 -1.048 . . . . 3.1499999999999999 108.17 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.2 -164.43 28.41 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.016 -1.634 . . . . 0.01 109.016 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.22 143.68 45.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.988 -1.301 . . . . 0.01 108.479 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 3.8 tmm? -116.49 142.41 46.91 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.696 0.76 . . . . 0.01 109.683 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -131.58 135.36 46.94 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.978 -1.119 . . . . 2.48 107.978 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.77 135.17 55.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.592 -0.692 . . . . 0.01 109.764 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -150.26 154.33 37.74 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.486 1.136 . . . . 1.6899999999999999 111.18 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 p -111.39 9.86 21.48 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.347 -0.842 . . . . 0.01 109.988 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -122.18 163.52 19.42 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.252 -0.905 . . . . 3.21 111.632 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.94 155.98 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.529 -0.915 . . . . 0.01 108.529 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.34 112.42 27.98 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.965 -0.754 . . . . 0.01 108.965 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.71 -33.44 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.188 1.103 . . . . 0.01 111.548 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 t -140.29 107.53 5.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.02 108.743 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 126' ' ' ILE . 76.4 mt -64.54 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.819 -0.55 . . . . 1.8300000000000001 111.222 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.1 OUTLIER -66.48 -37.65 85.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.819 -1.152 . . . . 1.3400000000000001 109.578 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.42 -38.85 74.65 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.464 -1.398 . . . . 2.1099999999999999 109.589 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -80.68 -48.17 12.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 2.0800000000000001 112.485 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.02 -2.13 15.16 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.711 . . . . 0.02 112.705 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.9 33.86 17.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.814 -1.179 . . . . 0.02 109.942 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -114.2 135.49 53.99 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.491 -0.755 . . . . 0.02 109.1 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -90.98 -21.45 21.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 5.3200000000000003 111.273 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.12 163.98 35.28 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.228 . . . . 0.02 110.093 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 117' ' ' ILE . 10.0 mm -128.38 124.3 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.58 -1.267 . . . . 2.1699999999999999 107.58 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -108.44 -13.94 14.76 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.098 -1.001 . . . . 0.02 112.52 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 13.5 t -160.57 152.38 19.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.746 -1.221 . . . . 0.01 108.82 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.3 t -167.28 145.09 4.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 1.22 109.164 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -123.65 106.09 10.26 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.398 1.094 . . . . 1.4099999999999999 109.385 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 131' ' ' VAL . 8.1 p -110.55 136.74 45.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.334 -1.358 . . . . 0.01 107.334 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.64 92.24 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.515 -1.661 . . . . 1.98 106.515 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.545 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.8 tt0 -147.02 -69.1 0.25 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.491 -2.04 . . . . 0.01 105.491 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.22 -42.78 0.88 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.38 -1.488 . . . . 0.01 109.38 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.685 ' HB ' HD12 ' A' ' 175' ' ' ILE . 81.9 p -129.82 103.38 6.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.394 -1.062 . . . . 2.2999999999999998 112.222 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.545 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 15.4 m95 -131.45 145.32 51.73 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.819 -1.178 . . . . 0.01 107.819 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.431 ' CG1' HD11 ' A' ' 175' ' ' ILE . 39.5 mt -119.06 134.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.634 -1.291 . . . . 1.6899999999999999 109.94 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -110.24 141.38 43.28 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.541 -2.022 . . . . 2.4900000000000002 105.541 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -123.19 143.24 50.15 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.111 -0.993 . . . . 0.02 110.009 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 35.4 tt0 -72.97 -31.97 64.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.791 -0.568 . . . . 0.02 111.67 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.97 154.76 48.4 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.738 -1.226 . . . . 1.48 108.819 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -56.45 167.44 2.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.069 1.179 . . . . 0.02 112.849 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 59.06 31.63 21.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.159 -0.928 . . . . 0.75 111.51 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.03 51.91 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.765 . . . . 0.02 111.361 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -127.12 165.47 19.47 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.569 -0.707 . . . . 0.02 110.097 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.71 -164.99 34.71 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.211 -1.156 . . . . 0.02 110.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -69.17 141.34 54.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -1.065 . . . . 0.02 108.817 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 5.6 mt-30 -113.69 148.79 35.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.439 -0.578 . . . . 0.02 109.439 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -124.55 134.42 52.99 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.758 -0.83 . . . . 0.01 108.758 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -95.99 121.02 37.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.871 -1.143 . . . . 0.01 109.477 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -99.38 146.18 26.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.493 -0.929 . . . . 0.01 108.493 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.3 m-20 -110.6 178.46 4.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.599 -0.688 . . . . 2.27 109.532 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -71.65 39.79 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 1.8400000000000001 109.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.6 mttm -110.31 -178.71 3.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.452 -0.78 . . . . 2.2799999999999998 109.135 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -106.09 120.0 40.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.323 -0.861 . . . . 0.01 108.898 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.07 110.05 22.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.924 . . . . 0.01 108.986 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -28.13 16.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.506 -0.746 . . . . 0.01 111.176 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -123.5 152.27 64.63 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 107.722 -1.214 . . . . 2.54 107.722 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.8 Cg_endo -60.61 -39.65 62.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 CA-C-N 119.866 0.988 . . . . 0.69999999999999996 110.987 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.97 -18.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.779 -1.201 . . . . 0.85999999999999999 109.665 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.95 -18.63 65.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.02 112.38 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.66 16.0 27.17 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.828 -1.17 . . . . 0.02 109.912 178.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.1 11.2 76.69 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.227 -0.921 . . . . 0.02 112.849 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 140.63 34.95 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.42 . . . . 0.02 110.11 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.64 -7.48 58.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.628 -0.67 . . . . 0.58999999999999997 110.092 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.0 p -139.97 150.72 63.27 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.198 -0.939 . . . . 0.87 109.463 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.93 14.27 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 120.812 1.008 . . . . 0.38 112.094 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.15 27.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.919 -1.113 . . . . 0.17999999999999999 111.15 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 mp -151.65 125.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.513 -1.662 . . . . 3.9900000000000002 106.513 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.451 ' OE1' ' N ' ' A' ' 170' ' ' GLN . 9.0 mp0 -112.2 -12.03 13.68 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.357 -0.84 . . . . 5.1699999999999999 112.533 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.9 t -156.88 158.99 37.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.197 -2.189 . . . . 0.02 110.045 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -152.26 154.15 35.16 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.147 -0.97 . . . . 2.02 110.057 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -143.08 148.39 36.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.01 109.804 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 15.7 ptm180 -86.37 141.14 29.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.184 -1.043 . . . . 0.01 108.184 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.685 HD12 ' HB ' ' A' ' 135' ' ' THR . 25.8 mt -95.1 129.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.212 -0.93 . . . . 3.04 109.516 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.46 147.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 1.8899999999999999 109.618 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 4.8899999999999997 109.718 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.481 -0.563 . . . . 5.2800000000000002 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HB3' ' HZ3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -50.06 138.15 16.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 5.96 109.53 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -138.24 -129.04 0.13 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.251 -0.906 . . . . 2.2200000000000002 111.418 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.51 95.12 0.1 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 105.653 -2.979 . . . . 0.81000000000000005 105.653 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 147.6 31.86 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.338 -0.934 . . . . 0.01 111.231 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -152.84 138.05 17.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.586 -0.949 . . . . 0.02 109.184 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.22 140.0 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.259 -0.645 . . . . 0.02 109.259 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -122.56 130.66 53.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.633 -0.667 . . . . 0.39000000000000001 109.877 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 10.9 m-85 -110.6 140.2 45.14 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.85 -0.796 . . . . 0.02 108.85 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.0 m-85 -122.43 139.03 54.32 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.289 -0.882 . . . . 0.02 109.856 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.455 ' HG3' HD11 ' A' ' 33' ' ' LEU . 78.4 mt-10 -68.58 -28.47 66.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.063 . . . . 0.029999999999999999 111.88 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.98 170.42 8.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.796 -1.19 . . . . 0.029999999999999999 110.351 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 31.9 mtp180 -74.81 157.58 34.91 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.698 0.761 . . . . 0.029999999999999999 110.354 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t30 66.29 33.85 6.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.993 0.901 . . . . 0.73999999999999999 111.374 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.23 42.43 28.01 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.287 0.565 . . . . 0.02 111.424 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -113.64 166.35 11.62 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.611 -0.885 . . . . 0.02 108.611 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.4 -167.53 37.44 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.954 -1.117 . . . . 0.029999999999999999 111.094 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.447 HH21 ' H ' ' A' ' 34' ' ' SER . 37.7 ttp180 -69.11 142.13 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.578 -0.954 . . . . 2.7599999999999998 109.265 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -121.51 149.46 43.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.738 0.78 . . . . 1.8899999999999999 110.324 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -131.99 127.39 36.17 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.968 -1.123 . . . . 0.02 107.968 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.26 137.4 50.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.564 -0.71 . . . . 1.1200000000000001 109.564 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.9 t -131.24 138.35 49.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.51 0.671 . . . . 0.02 109.673 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.44 10.52 14.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.608 -0.683 . . . . 0.20000000000000001 109.529 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.1 p -157.37 174.28 15.66 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.216 -1.031 . . . . 1.23 108.216 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.34 144.32 54.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.662 -1.274 . . . . 0.02 110.189 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.13 116.7 17.35 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.468 -0.938 . . . . 0.02 108.468 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.89 -24.29 52.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.23999999999999999 110.663 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -153.82 100.72 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 1.1399999999999999 108.509 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -106.7 8.38 30.99 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.182 0.991 . . . . 6.3700000000000001 110.168 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.681 ' NH2' HH12 ' A' ' 78' ' ' ARG . 86.7 mtt180 -59.79 -21.29 60.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 3.1099999999999999 110.495 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.3 m -74.89 -16.48 60.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.905 -1.122 . . . . 0.88 109.871 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -102.37 -21.65 14.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.02 109.086 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.455 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.5 tp -150.26 129.66 12.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.913 -0.773 . . . . 3.3199999999999998 108.913 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.447 ' H ' HH21 ' A' ' 18' ' ' ARG . 29.8 t -86.76 -12.22 48.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.854 -0.529 . . . . 0.02 111.098 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' SER . 10.5 mtm180 -167.1 161.09 14.49 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.153 -1.425 . . . . 0.02 107.153 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.8 p -143.34 115.31 8.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.831 -1.168 . . . . 0.02 108.643 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.452 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.5 m-20 -107.3 0.73 23.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.864 -1.147 . . . . 0.029999999999999999 110.733 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 p -157.08 155.2 30.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.757 -1.201 . . . . 0.02 107.757 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.66 147.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.02 110.27 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -123.25 124.36 42.83 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -106.26 114.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.78 -34.08 27.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 3.8100000000000001 110.265 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.78 151.29 21.02 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.116 -1.516 . . . . 0.02 110.125 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.38 49.64 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.495 -1.336 . . . . 0.01 110.082 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.82 137.41 54.0 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.802 -1.184 . . . . 1.48 107.802 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -125.66 153.62 43.56 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.498 1.142 . . . . 0.02 111.983 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.62 52.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 104.869 -2.271 . . . . 0.23999999999999999 104.869 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.0 m -117.41 142.28 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.526 -0.733 . . . . 0.65000000000000002 109.089 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 13.8 m-85 -119.5 144.04 47.22 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.378 1.085 . . . . 0.02 109.723 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 5.6 tp10 -65.95 -35.02 79.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.669 -0.696 . . . . 0.02 110.882 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -125.17 157.19 68.14 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.093 -1.004 . . . . 0.02 109.702 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 167.43 1.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.806 1.67 . . . . 0.02 113.056 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.06 37.25 9.27 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.144 -0.934 . . . . 0.02 111.017 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 45.21 52.22 8.74 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.598 0.713 . . . . 3.3900000000000001 110.71 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.2 p -127.56 164.32 22.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.297 0.57 . . . . 2.3300000000000001 109.911 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -162.3 31.81 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.922 -1.271 . . . . 0.02 109.922 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 14.9 t-80 -63.29 142.61 58.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.268 . . . . 0.02 110.507 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.511 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 31.4 mtp -116.78 134.56 54.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.266 0.555 . . . . 5.0099999999999998 109.519 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 17.0 m-85 -135.27 134.35 39.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.393 -0.817 . . . . 0.02 109.124 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -96.86 131.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.986 -0.746 . . . . 1.72 108.986 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 61' ' ' LEU . 23.0 mt -122.92 111.48 30.89 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.394 -0.816 . . . . 0.02 110.668 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.1 171.29 18.4 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 CA-C-N 119.856 0.984 . . . . 1.47 110.286 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 1.3 tm0? -51.78 140.42 19.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 4.25 109.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 155.95 -178.15 32.65 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.325 -1.417 . . . . 0.02 110.71 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.84 131.24 55.23 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.581 -0.952 . . . . 0.95999999999999996 109.587 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 62.4 m-85 -121.08 99.42 46.53 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.116 -1.068 . . . . 0.02 108.116 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.36 -4.21 13.96 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.64 0.893 . . . . 0.02 113.99 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 37.7 mt-10 -157.44 155.23 30.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.453 -1.405 . . . . 2.02 108.238 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' N ' ' O ' ' A' ' 37' ' ' ASN . 27.7 p90 -60.36 -38.19 83.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.634 -0.666 . . . . 0.02 111.749 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -59.83 -23.89 63.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.915 -1.115 . . . . 0.02 110.211 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.612 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.5 -18.6 62.28 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.176 0.989 . . . . 3.4199999999999999 108.588 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.643 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -105.67 9.25 33.25 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.937 -1.505 . . . . 0.02 106.937 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt 59.87 21.56 10.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.606 -0.684 . . . . 0.02 110.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.81 144.09 46.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.02 109.497 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.78 -29.68 51.01 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.324 -1.362 . . . . 0.97999999999999998 107.324 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -156.85 -170.85 3.44 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.405 -1.702 . . . . 0.02 106.405 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -97.82 29.25 3.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.612 -1.305 . . . . 0.02 110.172 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.681 HH12 ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -98.19 122.4 41.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.206 -0.934 . . . . 3.2000000000000002 110.988 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 79' ' ' LEU . 29.8 mt -144.59 122.03 11.68 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.362 -1.347 . . . . 2.6099999999999999 107.362 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.19 -16.46 12.31 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 120.448 -0.882 . . . . 0.02 112.405 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.8 p -156.31 157.32 35.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.309 -1.7 . . . . 0.02 110.405 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.3 m -144.85 148.37 33.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.767 -0.583 . . . . 0.02 109.559 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -136.44 140.69 43.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.233 -0.917 . . . . 0.01 109.136 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.48 132.77 36.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.224 -0.922 . . . . 0.42999999999999999 109.323 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.28 123.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.511 -0.922 . . . . 1.25 108.511 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -88.93 135.51 33.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.097 -1.075 . . . . 1.77 108.097 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.29 139.0 37.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.445 -0.576 . . . . 1.6299999999999999 109.445 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 p -111.98 122.39 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.685 -1.228 . . . . 1.0800000000000001 107.685 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.8 p -114.22 133.84 55.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.752 -1.218 . . . . 1.26 107.865 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.5 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.501 3.033 0 C-N-CA 117.459 -2.305 . . . . 0.01 113.652 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.12 -103.03 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 120.308 2.054 . . . . 0.01 111.202 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.503 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.3 OUTLIER -119.93 119.2 32.79 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.359 -1.083 . . . . 4.4299999999999997 110.174 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.503 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -75.1 129.98 38.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.191 -0.67 . . . . 2.9900000000000002 109.191 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -132.14 138.19 47.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.717 . . . . 6.3600000000000003 109.319 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -127.36 145.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.478 -0.764 . . . . 1.0900000000000001 109.457 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -122.02 131.65 54.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.603 -1.258 . . . . 2.0499999999999998 107.603 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 129' ' ' CYS . 23.6 m -123.6 146.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 120.811 -1.18 . . . . 1.1000000000000001 109.386 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.25 140.86 49.17 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.022 0.915 . . . . 0.72999999999999998 110.812 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -65.66 -29.96 70.59 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.959 -0.564 . . . . 0.02 111.395 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -116.94 168.36 10.31 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 3.1800000000000002 110.571 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.61 168.92 30.6 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.959 -0.857 . . . . 0.01 110.959 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 52.21 40.09 28.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.671 0.748 . . . . 0.01 111.168 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 13.7 m-85 51.77 51.92 15.62 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.563 -0.711 . . . . 0.01 110.804 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -124.83 165.33 18.22 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.568 -0.901 . . . . 3.1499999999999999 108.568 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -165.37 26.84 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.34 -1.504 . . . . 0.01 109.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -75.18 145.38 42.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.124 -1.221 . . . . 0.01 108.264 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.464 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.7 tmm? -116.47 142.31 47.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.678 0.752 . . . . 0.01 110.131 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.453 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.6 m-85 -130.85 135.31 47.6 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.844 -1.169 . . . . 2.48 107.844 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.25 135.77 54.8 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.596 -0.69 . . . . 0.01 109.751 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.15 154.46 39.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.039 -1.038 . . . . 1.6899999999999999 110.674 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 58.8 p -111.34 8.35 21.32 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.818 -0.628 . . . . 0.01 110.009 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.2 163.5 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.337 -0.852 . . . . 3.21 111.383 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.77 155.92 38.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.124 -1.065 . . . . 0.01 108.124 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' CYS . . . . . 0.405 ' O ' ' OG ' ' A' ' 171' ' ' SER . 44.5 t -126.0 112.41 24.33 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.687 -0.857 . . . . 0.01 108.687 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -74.81 -28.69 9.31 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.245 1.123 . . . . 0.01 111.094 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -142.52 108.65 5.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -0.843 . . . . 0.02 108.953 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.2 mt -62.62 -38.27 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.879 -0.513 . . . . 1.8300000000000001 110.414 -178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.78 -37.38 79.27 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.224 -0.99 . . . . 1.3400000000000001 110.451 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.87 -39.25 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.462 -1.399 . . . . 2.1099999999999999 109.963 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.47 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 55.2 tt0 -79.38 -47.27 16.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 2.0800000000000001 112.409 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.47 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.4 m-85 -111.71 -0.1 16.11 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.431 -0.793 . . . . 0.02 112.808 -176.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 m80 61.3 34.08 18.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.812 -1.18 . . . . 0.02 109.639 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.25 134.15 54.73 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.403 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.94 -21.61 21.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 5.3200000000000003 109.984 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -149.83 164.56 35.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.149 -0.97 . . . . 0.02 109.859 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.96 128.52 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.294 -1.373 . . . . 2.1699999999999999 107.294 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -107.23 -12.85 15.28 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.518 -0.739 . . . . 0.02 111.974 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.2 t -161.33 155.14 22.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.01 108.905 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -166.66 144.46 5.11 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.957 -1.127 . . . . 1.22 107.957 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -119.39 101.89 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.176 0.988 . . . . 1.4099999999999999 109.004 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 131' ' ' VAL . 12.3 p -109.44 133.36 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.487 -0.931 . . . . 0.01 108.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.41 87.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.219 -2.141 . . . . 1.98 105.219 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -146.97 -66.38 0.27 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.967 -1.494 . . . . 0.01 106.967 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.63 44.27 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 107.555 -2.218 . . . . 0.01 107.555 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.0 p -121.73 52.05 1.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.804 -0.821 . . . . 2.2999999999999998 110.515 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.03 139.95 51.83 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 120.689 -1.257 . . . . 0.01 110.384 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -121.14 138.86 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.929 -0.767 . . . . 1.6899999999999999 108.929 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 151' ' ' LEU . 2.8 m-30 -111.92 142.01 44.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.089 -1.448 . . . . 2.4900000000000002 107.089 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 22.0 m-85 -123.17 144.04 49.62 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.214 -0.929 . . . . 0.02 109.448 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.2 -30.22 60.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.02 111.552 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 155.46 46.76 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.68 -1.262 . . . . 1.48 108.954 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -57.09 167.27 3.38 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.183 1.255 . . . . 0.02 112.721 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.7 t30 59.01 31.63 21.54 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.144 -0.935 . . . . 0.75 111.341 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.52 51.19 10.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.02 111.157 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.34 165.1 18.97 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.614 -0.679 . . . . 0.02 109.914 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.67 -165.38 33.55 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.174 -1.17 . . . . 0.02 110.174 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -69.94 143.02 52.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -1.035 . . . . 0.02 108.915 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -112.03 147.75 35.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.383 0.611 . . . . 0.02 109.816 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.42 133.76 53.29 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.841 -0.8 . . . . 0.01 108.841 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -97.95 122.64 41.31 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.827 -1.17 . . . . 0.01 109.923 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 138' ' ' PHE . 16.8 mt -91.75 143.46 26.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.01 108.61 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' LYS . 20.1 m-20 -108.23 -179.01 3.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.438 -0.789 . . . . 2.27 109.725 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.28 36.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 1.8400000000000001 109.526 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 152' ' ' ASP . 89.3 mttt -111.9 177.57 4.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.789 . . . . 2.2799999999999998 109.271 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -106.07 121.87 45.01 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.843 -0.799 . . . . 0.01 108.843 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.97 113.04 25.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.349 -0.844 . . . . 0.01 110.346 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -94.18 -25.58 17.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.127 -0.983 . . . . 0.01 110.934 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -124.75 154.31 70.43 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.922 -1.111 . . . . 2.54 108.119 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.55 -40.69 45.31 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.186 0.745 . . . . 0.69999999999999996 110.555 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.8 -19.72 21.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.991 -1.068 . . . . 0.85999999999999999 109.055 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.14 -18.59 65.44 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.962 -1.086 . . . . 0.02 111.388 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.875 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 1.8 p90 -102.74 14.27 32.37 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.037 -1.04 . . . . 0.02 109.859 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.15 9.77 69.84 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.393 -0.817 . . . . 0.02 113.734 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.619 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.86 140.89 34.51 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.533 -1.569 . . . . 0.02 110.619 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.14 -7.1 59.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.58999999999999997 109.333 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.8 m -142.53 150.71 55.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.126 -0.984 . . . . 0.87 109.293 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.43 17.7 0.63 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.729 0.953 . . . . 0.38 112.28 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.6 29.07 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.476 1.132 . . . . 0.17999999999999999 111.429 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.875 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.5 mt -148.77 127.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.84 -1.541 . . . . 3.9900000000000002 106.84 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -113.34 -16.31 12.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.231 -0.918 . . . . 5.1699999999999999 112.726 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 23.0 t -157.18 159.49 37.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 119.287 -2.133 . . . . 0.02 110.176 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.04 152.85 34.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.868 . . . . 2.02 109.917 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -144.71 151.06 38.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.244 -0.91 . . . . 0.01 110.498 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -87.95 143.52 27.06 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.722 -0.844 . . . . 0.01 108.722 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.2 mt -94.91 128.7 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 3.04 109.119 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.66 146.64 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.19 -0.944 . . . . 1.8899999999999999 109.418 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 4.8899999999999997 109.099 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.375 -0.602 . . . . 5.2800000000000002 109.375 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.43 100.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 5.96 109.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.1 m -106.25 -139.0 0.37 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.265 -1.013 . . . . 2.2200000000000002 108.265 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.535 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.88 88.8 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 106.984 -2.447 . . . . 0.81000000000000005 106.984 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 148.15 32.5 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.309 -0.948 . . . . 0.01 110.84 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -152.19 137.05 17.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.944 . . . . 0.02 108.984 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.5 tt -130.22 140.91 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -121.03 129.21 53.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.774 . . . . 0.39000000000000001 109.833 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 17.1 m-85 -109.42 139.68 44.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.898 -0.778 . . . . 0.02 108.898 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 16.6 m-85 -123.05 138.33 54.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.265 -0.897 . . . . 0.02 109.915 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 34' ' ' SER . 16.6 mm-40 -67.1 -27.68 67.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.029999999999999999 111.258 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 10.2 t70 -114.18 169.78 8.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 110.136 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 16.1 mtp180 -75.61 162.3 28.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.622 0.725 . . . . 0.029999999999999999 110.276 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.7 m120 62.94 34.49 14.1 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.955 0.883 . . . . 0.73999999999999999 110.397 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.6 42.64 23.38 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.391 -0.822 . . . . 0.02 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.6 166.21 11.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.88 36.07 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 120.708 -1.245 . . . . 0.029999999999999999 110.522 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -68.32 143.72 55.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -1.02 . . . . 2.7599999999999998 109.153 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -121.33 149.2 43.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.5 -0.75 . . . . 1.8899999999999999 110.179 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -133.36 128.56 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.644 -0.873 . . . . 0.02 108.644 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.72 136.46 50.93 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.457 -0.777 . . . . 1.1200000000000001 109.538 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.39 137.61 49.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.282 -0.636 . . . . 0.02 109.282 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -117.05 11.11 14.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.605 -0.684 . . . . 0.20000000000000001 109.741 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 48.5 t -158.36 174.45 15.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 35.0 t0 -60.58 143.21 54.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.692 -1.255 . . . . 0.02 109.893 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 9.7 t -130.46 116.63 18.49 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.449 -0.945 . . . . 0.02 108.449 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.06 -23.79 51.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.076 -1.015 . . . . 0.23999999999999999 110.678 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -156.0 100.91 2.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.896 -1.127 . . . . 1.1399999999999999 108.576 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -105.32 8.77 33.9 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.177 0.989 . . . . 6.3700000000000001 109.613 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.31 -24.39 63.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.602 -0.686 . . . . 3.1099999999999999 110.94 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.6 p -74.5 -16.62 60.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 109.876 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -105.04 -21.7 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.737 . . . . 0.02 109.259 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 1.7 tp -148.14 125.56 11.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 3.3199999999999998 109.247 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.519 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 4.6 m -85.87 -11.35 53.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.833 . . . . 0.02 111.313 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.51 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 7.2 mtm180 -171.56 161.7 6.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.364 -1.347 . . . . 0.02 107.364 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 39' ' ' ILE . 34.8 t -141.47 113.93 8.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.223 -0.923 . . . . 0.02 109.205 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.456 ' ND2' ' CG ' ' A' ' 77' ' ' ASP . 3.3 m120 -108.13 -0.17 21.23 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.01 -1.056 . . . . 0.029999999999999999 110.589 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 t -156.21 152.46 27.83 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.524 -1.288 . . . . 0.02 107.524 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CG1' ' SG ' ' A' ' 36' ' ' CYS . 84.2 mt -144.79 147.44 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.35 1.072 . . . . 0.02 110.198 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 22.1 ttp180 -122.5 123.14 40.57 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.412 -1.329 . . . . 0.02 107.412 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.95 113.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 106.723 -1.584 . . . . 0.02 106.723 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 47.8 mm-40 -83.52 -34.09 25.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.968 -0.693 . . . . 3.8100000000000001 109.639 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 150.6 19.94 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 118.7 -1.714 . . . . 0.02 110.463 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.09 173.48 49.7 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.881 -1.152 . . . . 0.01 110.404 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.3 m -119.83 136.73 54.36 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.19 -1.041 . . . . 1.48 108.19 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -125.88 153.83 43.59 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.613 1.197 . . . . 0.02 112.158 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.27 133.8 51.99 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 104.942 -2.244 . . . . 0.23999999999999999 104.942 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.98 142.39 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.65000000000000002 109.329 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 40.8 m-85 -121.63 144.44 48.75 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.058 0.932 . . . . 0.02 109.754 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.33 -35.57 80.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.521 -0.763 . . . . 0.02 111.833 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.408 HH22 ' CZ ' ' A' ' 78' ' ' ARG . 3.6 mmp_? -124.05 153.89 67.96 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.147 -0.97 . . . . 0.02 109.554 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -50.61 166.39 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.306 1.338 . . . . 0.02 113.378 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.81 37.52 9.7 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.123 -0.944 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 44.1 51.82 7.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.779 0.8 . . . . 3.3900000000000001 110.663 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -124.97 163.17 22.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.572 -0.529 . . . . 2.3300000000000001 109.572 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.73 -161.34 32.07 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.647 -1.381 . . . . 0.02 109.647 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -67.57 139.35 56.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.983 -1.304 . . . . 0.02 110.413 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 22.3 ptm -118.73 137.41 53.37 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.637 -0.664 . . . . 5.0099999999999998 109.719 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 52.6 m-85 -132.92 138.42 46.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.472 -0.767 . . . . 0.02 109.65 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.29 132.17 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.737 -0.838 . . . . 1.72 108.737 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -119.85 109.67 37.5 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 121.416 -0.802 . . . . 0.02 110.451 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -76.48 168.67 23.34 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.136 1.084 . . . . 1.47 109.997 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -52.23 140.31 21.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.673 -1.267 . . . . 4.25 110.18 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.88 -177.52 32.11 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.476 -1.345 . . . . 0.02 110.742 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.05 130.94 54.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.43 -1.041 . . . . 0.95999999999999996 109.305 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 27.9 m-85 -121.97 90.6 48.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.43 -4.46 8.16 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 121.006 1.138 . . . . 0.02 113.389 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -154.45 150.62 28.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 2.02 107.527 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 19.6 p90 -60.29 -37.8 81.64 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.02 112.22 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -61.02 -23.51 65.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.02 111.216 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.7 OUTLIER -72.66 -16.53 61.7 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.116 -1.034 . . . . 3.4199999999999999 109.053 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.574 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.93 10.41 30.52 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.087 -1.449 . . . . 0.02 107.087 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm 61.84 21.75 12.49 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.357 0.599 . . . . 0.02 110.764 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.06 144.66 46.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.02 109.237 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 30.8 tp -79.5 -30.68 42.05 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.837 -1.172 . . . . 0.97999999999999998 107.837 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.67 -172.4 3.94 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.619 -1.622 . . . . 0.02 106.619 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 22.3 m-20 -97.89 27.2 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.687 -1.258 . . . . 0.02 110.382 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.49 122.82 39.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.142 -0.974 . . . . 3.2000000000000002 110.777 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD22 ' HB ' ' A' ' 48' ' ' VAL . 61.8 mt -143.63 121.67 12.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.865 -1.161 . . . . 2.6099999999999999 107.865 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.95 -17.75 9.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.345 -0.847 . . . . 0.02 112.54 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 36.5 m -155.28 155.38 33.66 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.757 1.778 . . . . 0.02 110.843 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 12.7 m -145.06 146.98 32.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.567 0.698 . . . . 0.02 110.414 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 71.5 mtm180 -135.64 141.4 45.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.741 -0.837 . . . . 0.01 108.741 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 130.95 37.27 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.136 -0.978 . . . . 0.42999999999999999 108.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -88.82 123.47 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.407 ' O ' ' CG2' ' A' ' 135' ' ' THR . 8.5 m80 -91.02 133.89 34.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 1.77 108.208 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 139.38 35.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.997 -0.742 . . . . 1.6299999999999999 108.997 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 p -112.02 125.71 54.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.671 -0.862 . . . . 1.0800000000000001 108.671 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -102.11 -155.97 0.54 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 106.0 -1.852 . . . . 1.26 106.0 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.4 -47.36 0.97 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 120.561 -1.337 . . . . 0.01 112.279 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.76 -98.61 0.12 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.479 -1.82 . . . . 0.01 112.348 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.53 121.41 36.47 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.218 -1.166 . . . . 4.4299999999999997 111.034 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 132.23 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.166 -0.679 . . . . 2.9900000000000002 109.166 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.424 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 6.5 ttpm? -132.11 139.46 48.47 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.022 -0.733 . . . . 6.3600000000000003 109.022 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.1 tt -127.48 143.92 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 121.975 0.893 . . . . 1.0900000000000001 109.591 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -124.81 133.54 53.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.743 -1.206 . . . . 2.0499999999999998 107.743 177.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -124.77 147.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.946 -1.096 . . . . 1.1000000000000001 109.546 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -117.57 140.72 49.25 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.987 0.899 . . . . 0.72999999999999998 110.948 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.96 -29.68 70.12 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.987 -0.551 . . . . 0.02 111.444 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 128' ' ' SER . 54.2 mttm -117.35 171.23 8.11 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.13 -0.981 . . . . 3.1800000000000002 110.289 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.16 170.16 41.91 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.072 -0.811 . . . . 0.01 111.072 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.3 t0 52.51 39.56 28.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.564 0.697 . . . . 0.01 111.646 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 51.92 49.47 20.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.699 -0.626 . . . . 0.01 110.796 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.76 166.2 15.97 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.369 -0.974 . . . . 3.1499999999999999 108.369 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.78 -165.48 28.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.618 -1.393 . . . . 0.01 109.618 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -75.62 144.7 41.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.009 -1.289 . . . . 0.01 108.594 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 107' ' ' MET . 10.6 tmm? -116.9 142.98 46.24 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.684 0.754 . . . . 0.01 110.171 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.423 ' N ' ' SD ' ' A' ' 107' ' ' MET . 42.7 m-85 -130.88 135.68 47.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.891 -1.152 . . . . 2.48 107.891 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.95 135.0 54.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.548 -0.72 . . . . 0.01 110.115 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -149.76 153.15 36.39 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.109 0.957 . . . . 1.6899999999999999 110.572 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.9 p -109.38 10.37 25.47 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.812 -0.631 . . . . 0.01 109.901 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.37 163.53 18.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.409 -0.807 . . . . 3.21 111.379 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.18 154.65 39.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.346 -0.983 . . . . 0.01 108.346 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.21 111.6 30.32 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.47 -0.769 . . . . 0.01 108.928 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -77.33 -33.63 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 119.885 0.994 . . . . 0.01 111.988 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.7 m -140.94 108.44 5.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.21 -0.931 . . . . 0.02 109.188 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 26.8 mt -63.43 -39.66 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.759 -0.588 . . . . 1.8300000000000001 110.791 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttp -66.4 -37.81 86.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.002 -1.079 . . . . 1.3400000000000001 110.033 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.34 -39.19 74.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.433 -1.417 . . . . 2.1099999999999999 109.678 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 52.6 tt0 -81.19 -47.9 12.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 2.0800000000000001 112.506 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 63.6 m-85 -111.77 -2.53 15.25 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.427 -0.796 . . . . 0.02 112.76 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 61.99 34.02 16.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.719 -1.238 . . . . 0.02 109.323 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 mt -114.7 135.71 53.86 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.333 -0.854 . . . . 0.02 109.291 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -90.0 -20.91 22.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.026 -1.046 . . . . 5.3200000000000003 111.17 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 35.4 mt-10 -149.23 164.9 33.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.692 -1.255 . . . . 0.02 110.709 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 27.8 mm -127.54 124.37 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.553 -1.277 . . . . 2.1699999999999999 107.553 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 1.1 m80 -110.75 -14.66 13.98 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.107 -0.996 . . . . 0.02 113.113 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.3 p -163.36 155.47 17.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.625 -1.297 . . . . 0.01 109.204 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.5 p -171.0 143.31 1.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.22 108.964 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 24.1 pttt -119.5 99.0 6.4 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.6 1.19 . . . . 1.4099999999999999 109.289 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -105.38 139.96 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.306 -0.998 . . . . 0.01 108.306 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.92 92.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.189 -1.782 . . . . 1.98 106.189 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.599 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 21.3 tt0 -146.03 -75.98 0.2 Allowed 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.561 -2.014 . . . . 0.01 105.561 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.77 -41.08 0.88 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.596 -1.402 . . . . 0.01 109.596 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.658 ' HB ' HD12 ' A' ' 175' ' ' ILE . 60.0 p -129.09 100.66 5.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.2 -1.177 . . . . 2.2999999999999998 112.136 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 41.3 m95 -129.82 143.71 50.95 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.629 -1.249 . . . . 0.01 107.629 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 43.7 mt -118.7 133.57 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.455 -1.403 . . . . 1.6899999999999999 109.574 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -111.59 141.96 44.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.149 -1.797 . . . . 2.4900000000000002 106.149 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 23.1 m-85 -123.83 144.38 49.76 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.92 -1.113 . . . . 0.02 109.793 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.04 -31.43 62.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.809 -0.557 . . . . 0.02 111.799 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.21 155.14 47.2 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.816 -1.178 . . . . 1.48 108.903 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -56.81 166.75 3.54 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.128 1.219 . . . . 0.02 112.799 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.01 31.1 20.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.206 -0.906 . . . . 0.75 111.375 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 58.26 52.03 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.727 . . . . 0.02 111.285 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -126.94 165.47 19.34 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.599 -0.688 . . . . 0.02 110.021 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.48 -165.53 33.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -69.45 142.56 53.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.578 -0.954 . . . . 0.02 108.843 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -112.89 147.22 37.48 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.294 0.569 . . . . 0.02 109.687 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.57 134.14 53.87 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.676 -0.861 . . . . 0.01 108.676 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.56 120.95 37.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.922 -1.111 . . . . 0.01 109.526 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -98.47 144.68 27.55 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.315 -0.995 . . . . 0.01 108.315 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 154' ' ' LYS . 6.2 m-20 -108.64 -175.28 2.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 2.27 109.859 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -73.01 32.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.399 -0.813 . . . . 1.8400000000000001 109.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 152' ' ' ASP . 17.6 ttmt -110.4 173.57 6.27 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.694 -0.854 . . . . 2.2799999999999998 108.694 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -105.56 129.35 53.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.01 109.364 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -100.35 111.61 23.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.359 -0.838 . . . . 0.01 109.446 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.462 ' H ' ' CD ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -89.71 -26.84 20.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.01 110.816 -177.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -123.78 155.26 66.9 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.552 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.3 Cg_endo -63.07 -39.46 39.49 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 CA-C-N 119.349 0.803 . . . . 0.69999999999999996 111.057 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.89 -18.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.773 -1.204 . . . . 0.85999999999999999 109.945 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.48 -18.41 65.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.945 -1.097 . . . . 0.02 112.38 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.552 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.13 15.62 28.11 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 120.737 -1.227 . . . . 0.02 109.917 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.92 76.6 Favored Glycine 0 N--CA 1.5 2.926 0 O-C-N 121.172 -0.955 . . . . 0.02 112.847 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 140.74 34.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.726 -1.455 . . . . 0.02 110.278 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -7.11 59.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.63 -0.669 . . . . 0.58999999999999997 109.739 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.0 m -141.96 149.7 53.62 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.186 -0.947 . . . . 0.87 109.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.76 16.89 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.736 0.957 . . . . 0.38 112.06 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.64 120.71 25.42 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.362 1.077 . . . . 0.17999999999999999 110.786 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mp -150.66 124.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 106.194 -1.78 . . . . 3.9900000000000002 106.194 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.33 -12.29 14.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.342 -0.849 . . . . 5.1699999999999999 112.83 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.9 p -156.97 160.13 38.75 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.231 -2.168 . . . . 0.02 109.925 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.99 153.4 33.98 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.312 -0.867 . . . . 2.02 110.047 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.68 149.26 36.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.01 110.24 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -86.25 142.26 28.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.183 -1.043 . . . . 0.01 108.183 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.658 HD12 ' HB ' ' A' ' 135' ' ' THR . 44.2 mt -93.35 128.63 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.451 -0.9 . . . . 3.04 109.327 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.73 148.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 1.8899999999999999 109.918 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.712 . . . . 4.8899999999999997 109.562 179.339 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.0 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.486 -0.561 . . . . 5.2800000000000002 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.2 95.41 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -0.944 . . . . 5.96 109.449 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 66.1 p -102.63 -141.64 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.933 -1.136 . . . . 2.2200000000000002 107.933 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.93 87.51 0.07 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 106.987 -2.445 . . . . 0.81000000000000005 106.987 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.29 148.72 33.04 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.607 -0.997 . . . . 0.01 110.607 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -150.77 136.26 17.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -1.005 . . . . 0.02 108.862 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.37 140.52 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.909 -0.774 . . . . 0.02 108.909 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 11.0 t -122.25 129.98 52.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.769 . . . . 0.39000000000000001 109.76 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 26.3 m-85 -108.39 138.55 44.49 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.87 -0.789 . . . . 0.02 108.87 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 26.9 m-85 -122.65 138.72 54.51 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.194 -0.941 . . . . 0.02 109.788 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.496 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 91.8 mt-10 -69.55 -27.49 65.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.675 . . . . 0.029999999999999999 112.041 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.33 170.75 8.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.569 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.688 ' NH1' HD22 ' A' ' 37' ' ' ASN . 10.9 mpt_? -73.72 157.15 37.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.757 0.789 . . . . 0.029999999999999999 109.897 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.27 35.41 5.94 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.875 0.845 . . . . 0.73999999999999999 111.117 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 7.6 p90 49.6 45.19 24.44 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.699 0.761 . . . . 0.02 111.01 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -112.0 166.29 11.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.01 -1.108 . . . . 0.02 108.01 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -167.16 35.42 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.029999999999999999 110.71 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -68.97 143.03 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.414 -1.05 . . . . 2.7599999999999998 109.204 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 56.8 ttt180 -119.04 147.8 43.72 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.544 0.688 . . . . 1.8899999999999999 109.587 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -132.45 126.48 33.15 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.728 -1.212 . . . . 0.02 107.728 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -111.92 136.29 51.43 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 1.1200000000000001 109.708 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.2 t -130.48 137.56 49.83 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.482 0.658 . . . . 0.02 109.48 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -116.52 10.89 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.703 -0.623 . . . . 0.20000000000000001 109.514 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 49.0 t -157.94 174.35 15.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.151 -1.055 . . . . 1.23 108.151 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 p30 -62.15 144.87 54.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.69 -1.256 . . . . 0.02 110.152 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -132.37 116.56 16.99 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.422 -0.955 . . . . 0.02 108.422 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.13 53.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.877 . . . . 0.23999999999999999 110.732 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.23 100.98 2.35 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.587 -0.894 . . . . 1.1399999999999999 108.587 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -105.2 10.1 33.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.005 0.907 . . . . 6.3700000000000001 110.063 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.681 HH22 ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.49 -22.27 61.34 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.672 -0.642 . . . . 3.1099999999999999 110.701 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -75.54 -16.97 60.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.702 -1.249 . . . . 0.88 110.29 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -102.97 -22.03 13.87 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 0.02 109.221 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.2 tp -150.67 129.49 12.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.822 0.82 . . . . 3.3199999999999998 108.825 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -85.63 -10.12 56.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.656 -0.652 . . . . 0.02 111.142 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -171.65 163.91 6.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.439 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -141.26 113.69 8.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.823 -1.173 . . . . 0.02 109.133 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.688 HD22 ' NH1' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -107.22 -3.7 19.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.029999999999999999 110.285 -179.002 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.36 152.39 31.03 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.002 -1.11 . . . . 0.02 108.002 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.4 147.76 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.02 109.973 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -125.08 126.11 44.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.876 -1.157 . . . . 0.02 107.876 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.45 114.76 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.883 -1.525 . . . . 0.02 106.883 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.15 -34.07 24.11 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.783 -0.767 . . . . 3.8100000000000001 109.865 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.3 150.11 18.99 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.572 -1.775 . . . . 0.02 110.507 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.11 173.39 49.75 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.623 -1.275 . . . . 0.01 110.062 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.1 m -118.61 136.06 54.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.76 -1.2 . . . . 1.48 107.76 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -126.0 153.52 44.23 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.821 -1.174 . . . . 0.02 112.159 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.11 133.08 52.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.108 -2.182 . . . . 0.23999999999999999 105.108 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.1 m -117.94 142.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.092 -0.707 . . . . 0.65000000000000002 109.092 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -121.17 145.78 47.47 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.22 1.01 . . . . 0.02 109.77 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 10.4 tt0 -66.68 -34.09 77.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.752 -0.658 . . . . 0.02 111.663 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' NH1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 mpt_? -122.87 159.04 55.39 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 121.002 -1.061 . . . . 0.02 109.287 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.39 166.2 1.89 Allowed 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.528 1.485 . . . . 0.02 112.31 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.4 36.33 11.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.643 0.735 . . . . 0.02 111.167 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 45.52 52.42 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.462 0.648 . . . . 3.3900000000000001 111.08 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -125.92 163.47 22.88 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.162 0.506 . . . . 2.3300000000000001 109.752 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.91 -161.2 31.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.592 -1.403 . . . . 0.02 109.592 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.494 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 2.1 m80 -65.72 137.86 57.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.98 -1.306 . . . . 0.02 109.883 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.478 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.7 ptm -119.69 137.04 54.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.604 -0.685 . . . . 5.0099999999999998 109.392 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 49.8 m-85 -134.08 141.01 47.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.499 -0.751 . . . . 0.02 109.714 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.669 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.17 132.1 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.555 -0.906 . . . . 1.72 108.555 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -119.96 109.75 37.23 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.476 -0.765 . . . . 0.02 110.323 -178.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -76.49 168.68 23.32 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.007 1.038 . . . . 1.47 110.327 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -53.41 140.68 26.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.869 -1.144 . . . . 4.25 110.504 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -176.97 32.36 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.627 -1.273 . . . . 0.02 110.452 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.16 130.16 55.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.489 -1.006 . . . . 0.95999999999999996 109.216 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.49 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 30.5 m-85 -121.48 95.24 48.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.22 -3.71 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.767 0.978 . . . . 0.02 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -157.36 154.89 29.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.352 -1.467 . . . . 2.02 108.311 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -60.85 -39.05 87.63 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.677 . . . . 0.02 111.651 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -60.16 -23.62 64.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.02 110.34 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -18.56 62.95 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.063 0.935 . . . . 3.4199999999999999 108.578 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -107.4 10.49 29.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.337 -1.357 . . . . 0.02 107.337 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 27.6 mtm 61.55 21.98 12.53 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.473 0.654 . . . . 0.02 110.738 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.58 144.36 45.97 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.328 -1.509 . . . . 0.02 109.328 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 tp -78.72 -30.83 46.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.493 -1.299 . . . . 0.97999999999999998 107.493 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -156.37 -171.53 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.255 -1.757 . . . . 0.02 106.255 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -97.73 27.7 4.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.646 -1.284 . . . . 0.02 110.194 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.681 ' NH2' HH22 ' A' ' 30' ' ' ARG . 19.7 mmm180 -96.08 122.06 38.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.893 -1.129 . . . . 3.2000000000000002 110.631 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.1 mt -144.98 119.95 10.01 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.511 -1.292 . . . . 2.6099999999999999 107.511 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.32 -16.07 11.66 Favored Glycine 0 N--CA 1.505 3.267 0 O-C-N 121.264 -0.898 . . . . 0.02 112.879 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.8 p -155.52 155.88 34.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.204 -1.763 . . . . 0.02 110.343 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.2 t -144.94 148.21 33.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.334 0.588 . . . . 0.02 109.71 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -135.55 140.24 44.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.332 -0.855 . . . . 0.01 108.89 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 130.12 36.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.205 -0.935 . . . . 0.42999999999999999 108.72 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.55 122.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 1.25 107.993 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' C ' HD23 ' A' ' 87' ' ' LEU . 15.1 m80 -92.0 133.94 35.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.94 -1.1 . . . . 1.77 108.576 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -98.18 137.96 36.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.242 -1.022 . . . . 1.6299999999999999 108.242 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -110.3 126.9 54.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 1.0800000000000001 108.743 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 p -104.29 -154.86 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.28 -1.748 . . . . 1.26 106.28 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.11 -47.5 0.97 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.509 -1.369 . . . . 0.01 112.237 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.53 -100.18 0.14 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.676 -1.726 . . . . 0.01 111.779 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.31 118.74 31.2 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.293 -1.122 . . . . 4.4299999999999997 110.221 -179.091 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.55 130.38 37.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.102 -0.703 . . . . 2.9900000000000002 109.102 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -131.28 139.19 49.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.464 -0.773 . . . . 6.3600000000000003 109.323 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 tt -129.19 144.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.462 -0.774 . . . . 1.0900000000000001 109.742 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.33 134.01 54.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.424 -1.324 . . . . 2.0499999999999998 107.424 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.44 147.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.902 -1.124 . . . . 1.1000000000000001 109.232 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 95.2 m-85 -118.77 141.34 48.71 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.097 0.951 . . . . 0.72999999999999998 111.088 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.78 -30.01 70.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.791 -0.64 . . . . 0.02 111.57 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -117.03 168.77 9.96 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.947 -1.096 . . . . 3.1800000000000002 110.553 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.07 43.31 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.013 -0.835 . . . . 0.01 111.013 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.2 m-20 56.48 39.09 30.1 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.664 0.745 . . . . 0.01 110.86 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 6.7 m-85 52.29 55.58 8.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.69 -0.631 . . . . 0.01 110.952 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -128.85 166.1 19.73 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.496 -0.927 . . . . 3.1499999999999999 108.496 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 -165.38 27.85 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -74.52 145.31 43.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.093 -1.239 . . . . 0.01 108.237 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.3 ttp -117.54 142.75 46.81 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.753 0.787 . . . . 0.01 110.179 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -130.94 135.29 47.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.963 -1.125 . . . . 2.48 107.963 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -119.79 135.56 54.81 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.608 -0.683 . . . . 0.01 109.957 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.524 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.1 t -150.09 152.13 34.29 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.33 1.062 . . . . 1.6899999999999999 111.074 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.7 p -110.28 9.55 23.68 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.622 -0.717 . . . . 0.01 109.808 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -121.08 163.32 18.56 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.311 -0.868 . . . . 3.21 111.398 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -66.51 155.28 38.07 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 27.5 t -124.53 111.6 27.86 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.737 -0.838 . . . . 0.01 108.737 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.86 -32.5 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.128 1.081 . . . . 0.01 111.732 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 m -140.82 107.61 5.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.02 108.855 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.7 mt -63.3 -39.04 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.779 -0.576 . . . . 1.8300000000000001 110.375 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 5.9 tpt -66.1 -37.89 86.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.013 -1.075 . . . . 1.3400000000000001 109.868 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -70.73 -39.3 73.45 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.374 -1.454 . . . . 2.1099999999999999 109.532 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 42.1 tt0 -80.53 -48.01 13.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 2.0800000000000001 112.458 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 66.0 m-85 -111.23 -1.78 15.98 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.02 112.623 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 61.12 34.33 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.745 -1.222 . . . . 0.02 109.603 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' C ' ' SD ' ' A' ' 118' ' ' MET . 52.5 mt -114.33 136.21 53.23 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.517 -0.74 . . . . 0.02 109.432 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -90.25 -21.96 21.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.323 -0.861 . . . . 5.3200000000000003 110.737 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 37.8 mt-10 -148.91 164.3 34.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.966 -1.084 . . . . 0.02 109.939 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 34.6 mm -129.49 126.7 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.453 -1.314 . . . . 2.1699999999999999 107.453 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -110.07 -12.93 14.47 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.267 -0.896 . . . . 0.02 112.658 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.5 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.8 t -160.42 153.13 21.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.691 -1.256 . . . . 0.01 109.002 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -167.08 146.32 5.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 1.22 109.349 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -125.22 106.4 9.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.45 1.119 . . . . 1.4099999999999999 109.381 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.2 p -111.36 136.38 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.328 -1.36 . . . . 0.01 107.328 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.35 92.47 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 106.861 -1.533 . . . . 1.98 106.861 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.5 tm-20 -146.92 -70.35 0.24 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 105.399 -2.074 . . . . 0.01 105.399 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.483 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 175.1 -78.94 0.08 OUTLIER Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.42 -1.872 . . . . 0.01 108.42 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 175' ' ' ILE . 70.8 p -123.88 127.53 48.15 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 122.344 1.069 . . . . 2.2999999999999998 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.409 ' HE1' ' HB3' ' A' ' 133' ' ' GLU . 9.5 m95 -127.9 151.15 49.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 106.789 -1.56 . . . . 0.01 106.789 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.439 HG13 HD11 ' A' ' 175' ' ' ILE . 32.6 mt -118.08 134.3 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.446 -1.409 . . . . 1.6899999999999999 109.266 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.51 141.69 44.76 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.344 -1.724 . . . . 2.4900000000000002 106.344 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.506 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 11.3 m-85 -123.19 143.46 50.0 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.22 -0.925 . . . . 0.02 109.64 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.98 -30.69 62.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.739 -0.601 . . . . 0.02 111.668 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.79 154.31 49.42 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.48 108.874 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.82 169.68 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.156 1.238 . . . . 0.02 113.174 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 48.9 t30 57.51 32.29 21.59 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.99 -1.004 . . . . 0.75 111.462 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 55.57 48.34 18.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.534 -0.729 . . . . 0.02 110.382 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -122.08 163.9 18.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.659 -0.651 . . . . 0.02 109.613 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.13 -165.51 32.95 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.16 -1.176 . . . . 0.02 110.16 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.71 143.18 53.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.499 -1.001 . . . . 0.02 109.15 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.478 ' O ' ' CG ' ' A' ' 58' ' ' MET . 12.0 mt-30 -112.95 148.24 35.43 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.281 0.562 . . . . 0.02 109.763 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -123.31 133.28 54.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.435 -0.95 . . . . 0.01 108.435 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.23 120.72 37.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.794 -1.191 . . . . 0.01 109.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.66 139.71 33.15 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.174 -1.047 . . . . 0.01 108.174 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 154' ' ' LYS . 0.7 OUTLIER -107.39 -171.82 1.95 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.345 -0.847 . . . . 2.27 109.905 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.01 40.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 1.8400000000000001 109.568 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 152' ' ' ASP . 75.3 tttt -113.57 168.49 9.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.619 -0.675 . . . . 2.2799999999999998 109.28 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -103.48 127.54 50.85 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.18 -1.044 . . . . 0.01 108.18 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.85 110.62 22.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.019 -1.051 . . . . 0.01 110.598 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -93.8 -26.66 16.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.314 -0.867 . . . . 0.01 110.736 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -123.24 154.09 65.23 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 107.897 -1.149 . . . . 2.54 107.897 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -62.14 -42.37 29.82 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.237 0.763 . . . . 0.69999999999999996 111.097 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 -18.68 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 120.68 -1.262 . . . . 0.85999999999999999 109.428 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 60.2 t0 -65.53 -18.18 65.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.841 -1.162 . . . . 0.02 111.964 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.77 15.84 27.7 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 120.737 -1.227 . . . . 0.02 110.037 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.89 74.35 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 121.053 -1.029 . . . . 0.02 112.869 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.56 140.59 34.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.717 -1.46 . . . . 0.02 110.13 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.83 -6.92 59.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.687 -0.633 . . . . 0.58999999999999997 109.553 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 m -140.84 150.06 58.44 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.223 -0.923 . . . . 0.87 109.088 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.47 16.15 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.672 0.915 . . . . 0.38 111.902 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.48 120.5 25.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.039 . . . . 0.17999999999999999 110.727 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.471 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -150.2 124.92 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.554 -2.017 . . . . 3.9900000000000002 105.554 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -112.41 -13.4 13.4 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.354 0.872 . . . . 5.1699999999999999 113.354 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.5 p -156.73 159.51 38.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.205 -2.184 . . . . 0.02 109.919 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -152.27 154.18 35.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.197 -0.939 . . . . 2.02 110.512 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -142.95 148.99 37.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.307 -0.871 . . . . 0.01 110.142 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -86.43 141.7 28.95 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.103 -1.073 . . . . 0.01 108.103 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.483 HD12 ' HB ' ' A' ' 135' ' ' THR . 13.1 mt -94.98 128.95 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.084 -1.01 . . . . 3.04 109.766 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.2 m -137.39 149.31 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.485 -0.759 . . . . 1.8899999999999999 109.69 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.636 ' H ' ' CD ' ' A' ' 177' ' ' GLU . 2.7 mp0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 4.8899999999999997 109.638 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' LYS . 5.0 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.26 0.553 . . . . 5.2800000000000002 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . 25.6 mttm 57.13 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 5.96 109.411 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.1 m -112.06 -137.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.8 -0.815 . . . . 2.2200000000000002 108.8 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.67 90.22 0.08 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 106.677 -2.569 . . . . 0.81000000000000005 106.677 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.09 147.53 31.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.632 -0.987 . . . . 0.01 110.632 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -154.14 138.61 16.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.587 -0.949 . . . . 0.02 108.757 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 141.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.266 -0.642 . . . . 0.02 109.266 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.562 ' HG ' ' CG ' ' A' ' 21' ' ' ASP . 1.4 m -121.79 130.1 53.15 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.507 -0.746 . . . . 0.39000000000000001 109.661 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 16.8 m-85 -110.05 139.19 45.44 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.855 -0.794 . . . . 0.02 108.855 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-85 -123.04 139.39 54.13 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.156 -0.965 . . . . 0.02 110.218 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG2' HD11 ' A' ' 33' ' ' LEU . 19.6 mm-40 -69.62 -28.44 65.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.069 . . . . 0.029999999999999999 111.981 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.87 170.72 8.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 0.029999999999999999 110.54 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -73.39 156.3 38.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.763 0.792 . . . . 0.029999999999999999 110.371 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 64.98 34.71 8.72 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.811 0.815 . . . . 0.73999999999999999 111.533 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.58 42.37 29.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.02 111.333 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -112.7 165.38 12.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.202 -1.036 . . . . 0.02 108.202 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.74 -166.76 36.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.752 -1.213 . . . . 0.029999999999999999 110.496 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -69.25 142.38 54.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -1.056 . . . . 2.7599999999999998 109.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 58.5 ttt180 -119.18 148.22 43.34 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 1.8899999999999999 109.745 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.99 126.68 32.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.209 -1.034 . . . . 0.02 108.209 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' CG ' ' HG ' ' A' ' 8' ' ' SER . 4.2 m-20 -111.96 136.44 51.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.429 -0.795 . . . . 1.1200000000000001 109.651 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.0 t -130.59 137.8 49.83 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.465 0.65 . . . . 0.02 109.645 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 13.7 t70 -116.98 11.32 14.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.665 -0.647 . . . . 0.20000000000000001 109.713 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 48.7 m -158.11 173.97 15.92 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.85 144.77 54.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.661 -1.274 . . . . 0.02 110.214 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.3 p -132.02 116.71 17.44 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.82 -25.68 53.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.23999999999999999 110.657 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.72 100.77 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 1.1399999999999999 108.444 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -104.82 9.36 34.88 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.207 1.004 . . . . 6.3700000000000001 109.755 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.572 ' CZ ' ' NH2' ' A' ' 78' ' ' ARG . 57.8 mtp180 -58.93 -23.28 61.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.678 -0.639 . . . . 3.1099999999999999 110.705 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 69.2 p -75.34 -16.69 60.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.691 -1.256 . . . . 0.88 110.162 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.4 m-85 -103.21 -21.65 13.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.02 109.178 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 11' ' ' GLU . 6.4 tp -150.62 129.2 12.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 3.3199999999999998 108.816 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -86.1 -10.0 55.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.808 -0.558 . . . . 0.02 110.984 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 25.3 ttt180 -171.1 162.04 6.95 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.4 -1.333 . . . . 0.02 107.4 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.5 m -141.36 114.33 8.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.111 . . . . 0.02 108.842 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -107.54 -0.15 22.29 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.711 -1.243 . . . . 0.029999999999999999 110.583 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 t -156.72 154.08 29.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.545 -1.28 . . . . 0.02 107.545 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.35 148.39 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.117 -0.989 . . . . 0.02 110.218 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -124.68 125.1 43.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.67 113.61 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.756 -1.572 . . . . 0.02 106.756 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -83.69 -34.14 25.03 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.127 -0.629 . . . . 3.8100000000000001 109.531 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.48 150.23 19.13 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.713 -1.708 . . . . 0.02 110.605 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.07 173.44 49.66 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.472 -1.347 . . . . 0.01 109.782 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 m -119.99 137.38 54.11 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 44.6 m95 -126.6 152.98 45.91 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.524 1.154 . . . . 0.02 111.922 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.42 133.79 51.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 104.841 -2.281 . . . . 0.23999999999999999 104.841 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.3 m -117.73 142.94 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.65000000000000002 109.228 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.5 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 17.6 m-85 -119.81 143.68 47.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.34 1.067 . . . . 0.02 109.703 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.08 -34.31 77.77 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.759 -0.655 . . . . 0.02 110.764 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -125.36 157.43 67.78 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.144 -0.972 . . . . 0.02 109.897 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.01 166.82 1.36 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.706 1.604 . . . . 0.02 113.16 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m120 64.43 36.37 8.93 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.054 -0.976 . . . . 0.02 111.195 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.77 51.79 10.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.534 0.683 . . . . 3.3900000000000001 110.782 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 p -127.25 164.22 22.19 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.286 0.565 . . . . 2.3300000000000001 109.824 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.47 -162.26 31.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.3 t-80 -63.05 142.78 58.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -1.204 . . . . 0.02 110.457 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.434 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 29.6 mtp -117.9 134.69 54.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.346 -0.613 . . . . 5.0099999999999998 109.346 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.636 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 31.5 m-85 -135.27 135.22 40.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.34 -0.85 . . . . 0.02 109.2 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -96.52 132.31 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.941 -0.763 . . . . 1.72 108.941 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.2 110.22 31.01 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.376 -0.828 . . . . 0.02 110.657 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -75.83 171.45 18.16 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.83 0.975 . . . . 1.47 109.91 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 1.9 pm0 -52.36 139.71 23.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.118 . . . . 4.25 110.237 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -178.02 33.04 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.435 -1.364 . . . . 0.02 110.446 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -119.11 130.06 55.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -1.084 . . . . 0.95999999999999996 109.423 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -120.87 96.54 48.65 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.75 -5.14 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.603 0.868 . . . . 0.02 114.055 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 67' ' ' PRO . 49.3 mm-40 -151.8 152.53 32.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.628 -1.249 . . . . 2.02 107.628 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -60.77 -37.89 83.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.406 -0.809 . . . . 0.02 111.075 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -59.93 -23.65 63.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.051 -1.031 . . . . 0.02 110.28 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.617 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.56 -18.75 62.23 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.283 1.039 . . . . 3.4199999999999999 108.243 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.636 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -105.66 8.42 33.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.212 -1.403 . . . . 0.02 107.212 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.3 mpt? 59.95 21.75 10.79 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.477 0.656 . . . . 0.02 110.35 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.31 143.98 45.74 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.26 -1.536 . . . . 0.02 109.26 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.4 tp -78.42 -30.78 47.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.34 -1.356 . . . . 0.97999999999999998 107.34 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -156.22 -172.19 4.0 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.245 -1.761 . . . . 0.02 106.245 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 38.6 m-20 -97.57 27.46 4.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.781 -1.199 . . . . 0.02 110.346 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.6 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -96.1 122.09 38.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.071 -1.018 . . . . 3.2000000000000002 110.704 -179.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.8 mt -144.71 120.39 10.48 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.611 -1.255 . . . . 2.6099999999999999 107.611 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.91 -16.05 12.1 Favored Glycine 0 N--CA 1.506 3.312 0 C-N-CA 120.491 -0.862 . . . . 0.02 112.64 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.3 p -156.3 156.89 34.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.393 -1.651 . . . . 0.02 110.238 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.2 m -144.84 148.66 34.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.698 -0.626 . . . . 0.02 109.415 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -136.38 140.83 43.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.332 -0.855 . . . . 0.01 109.136 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.93 36.47 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.305 -0.872 . . . . 0.42999999999999999 109.001 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.71 124.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.247 -1.02 . . . . 1.25 108.247 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -89.47 134.04 34.28 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.925 -1.139 . . . . 1.77 107.925 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.63 139.31 36.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 1.6299999999999999 109.15 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 p -111.22 122.68 48.49 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.669 -1.234 . . . . 1.0800000000000001 107.669 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 m -114.01 133.19 55.66 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.699 -1.223 . . . . 1.26 107.699 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.4 -46.31 0.02 OUTLIER Glycine 0 N--CA 1.501 3.0 0 C-N-CA 117.59 -2.243 . . . . 0.01 113.573 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.83 -103.13 0.17 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 120.17 1.985 . . . . 0.01 111.006 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -120.4 118.66 30.91 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.249 -1.148 . . . . 4.4299999999999997 110.204 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 131.21 41.34 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.141 -0.624 . . . . 2.9900000000000002 109.369 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.28 136.36 46.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.598 -0.689 . . . . 6.3600000000000003 109.67 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ3' ' A' ' 136' ' ' TRP . 10.9 tt -127.93 145.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.472 -0.767 . . . . 1.0900000000000001 109.262 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -121.65 133.12 54.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.437 -1.319 . . . . 2.0499999999999998 107.437 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.427 HG12 ' SG ' ' A' ' 129' ' ' CYS . 22.6 m -124.32 147.24 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 120.887 -1.133 . . . . 1.1000000000000001 109.09 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -119.26 141.11 49.24 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.081 0.943 . . . . 0.72999999999999998 111.086 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -66.66 -29.56 69.61 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.758 -0.655 . . . . 0.02 111.465 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' A' ' 128' ' ' SER . 27.3 mmtp -115.6 169.02 9.5 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.099 -1.001 . . . . 3.1800000000000002 110.148 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.83 164.82 51.2 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.056 -0.818 . . . . 0.01 111.056 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 57.14 39.46 28.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.854 -0.792 . . . . 0.01 111.411 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 52.04 54.13 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.618 -0.677 . . . . 0.01 111.142 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -129.65 165.49 21.68 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.052 -1.092 . . . . 3.1499999999999999 108.052 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.76 -164.63 27.84 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.171 -1.571 . . . . 0.01 109.171 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.07 144.18 43.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.829 -1.394 . . . . 0.01 108.661 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.45 ' C ' ' SD ' ' A' ' 107' ' ' MET . 13.0 tmm? -116.62 142.56 46.73 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.555 0.693 . . . . 0.01 109.885 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -131.42 136.31 47.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.537 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.7 tm-20 -120.41 135.72 54.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.642 -0.661 . . . . 0.01 109.806 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.537 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 5.0 t -149.37 152.48 35.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.253 1.025 . . . . 1.6899999999999999 110.881 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 p -112.01 8.76 20.3 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.729 -0.669 . . . . 0.01 109.941 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -121.48 163.46 18.76 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.331 -0.856 . . . . 3.21 111.353 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -67.94 156.74 36.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.327 -0.99 . . . . 0.01 108.327 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.08 113.08 26.51 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.511 -0.743 . . . . 0.01 109.016 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.9 -28.06 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 120.234 1.119 . . . . 0.01 111.055 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . 2.6 p -144.82 108.57 4.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 0.02 109.004 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.68 -39.52 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.873 -0.517 . . . . 1.8300000000000001 110.444 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.9 ttt -68.0 -37.25 81.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.114 -1.034 . . . . 1.3400000000000001 110.225 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 116' ' ' SER . 39.6 mt-10 -70.43 -38.78 74.63 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.636 -1.29 . . . . 2.1099999999999999 109.958 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -80.25 -47.9 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.932 . . . . 2.0800000000000001 112.417 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -110.7 -0.72 17.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.389 -0.819 . . . . 0.02 112.677 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 m170 60.39 33.52 20.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.696 -1.252 . . . . 0.02 109.434 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.83 134.52 54.31 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.733 -0.84 . . . . 0.02 108.733 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.456 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -91.7 -22.3 20.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 5.3200000000000003 110.163 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -149.29 163.81 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.238 -0.914 . . . . 0.02 109.843 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mt -133.18 129.37 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.272 -1.381 . . . . 2.1699999999999999 107.272 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -108.68 -12.12 14.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.455 -0.778 . . . . 0.02 112.461 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.8 p -160.15 154.45 23.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.01 108.749 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.8 t -166.0 143.13 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 1.22 108.897 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -120.34 103.93 9.61 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.681 1.229 . . . . 1.4099999999999999 109.153 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 131' ' ' VAL . 14.1 p -112.08 133.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.706 -1.22 . . . . 0.01 107.706 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.11 87.45 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.351 -2.092 . . . . 1.98 105.351 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.406 ' HG3' ' HE1' ' A' ' 136' ' ' TRP . 26.2 mm-40 -147.07 -65.7 0.27 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.635 -1.617 . . . . 0.01 106.635 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.93 39.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 107.002 -2.439 . . . . 0.01 107.002 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.8 p -122.06 54.18 1.18 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.978 -0.719 . . . . 2.2999999999999998 110.553 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.409 ' CZ3' HG21 ' A' ' 95' ' ' ILE . 15.8 m95 -130.02 139.11 51.06 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.717 -1.239 . . . . 0.01 110.476 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.72 139.71 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.022 -0.733 . . . . 1.6899999999999999 109.022 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' HD2' HD13 ' A' ' 169' ' ' ILE . 2.6 m-30 -112.07 141.77 45.33 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 106.799 -1.556 . . . . 2.4900000000000002 106.799 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 23.7 m-85 -122.6 143.15 49.94 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.091 -1.006 . . . . 0.02 109.228 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -74.57 -31.17 61.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.606 -0.684 . . . . 0.02 111.613 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -115.06 155.86 46.06 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.68 -1.262 . . . . 1.48 108.752 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -57.88 166.71 4.99 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.095 1.197 . . . . 0.02 112.735 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 60.09 31.29 20.52 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.142 -0.935 . . . . 0.75 111.456 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 58.72 51.17 7.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.717 . . . . 0.02 110.863 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -126.09 165.61 18.53 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.611 -0.681 . . . . 0.02 110.02 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.75 -165.35 34.94 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.279 -1.128 . . . . 0.02 110.279 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.18 141.78 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.947 . . . . 0.02 108.848 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 15.2 mt-30 -112.63 147.75 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.517 -0.549 . . . . 0.02 109.517 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.18 133.23 53.61 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.764 -0.828 . . . . 0.01 108.764 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.74 121.83 39.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.941 -1.099 . . . . 0.01 109.341 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.41 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.0 mt -92.78 146.83 23.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.01 109.123 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 154' ' ' LYS . 24.2 m-20 -108.55 -171.43 1.85 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.576 -0.702 . . . . 2.27 109.442 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -75.46 29.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 1.8400000000000001 109.622 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 152' ' ' ASP . 54.8 mttp -113.21 170.94 7.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.5 -0.75 . . . . 2.2799999999999998 109.549 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.91 135.36 47.5 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -100.28 114.01 27.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.37 -0.831 . . . . 0.01 109.96 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -88.59 -28.18 20.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.01 110.988 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -124.63 155.21 69.81 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 107.4 -1.333 . . . . 2.54 107.4 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.1 Cg_endo -61.99 -39.39 50.82 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.395 0.73 . . . . 0.69999999999999996 111.457 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.79 -18.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.817 -1.177 . . . . 0.85999999999999999 109.829 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.15 -19.24 65.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.891 -1.131 . . . . 0.02 112.569 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.739 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 0.4 OUTLIER -101.79 16.23 26.5 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 120.696 -1.252 . . . . 0.02 109.881 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.66 10.52 79.19 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.369 -0.919 . . . . 0.02 112.771 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 141.03 34.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.898 -1.354 . . . . 0.02 110.069 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.7 59.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.658 -0.651 . . . . 0.58999999999999997 109.848 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -142.17 150.0 53.97 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.033 -1.042 . . . . 0.87 109.119 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -75.33 18.15 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.654 0.902 . . . . 0.38 112.144 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.98 122.76 28.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.545 1.164 . . . . 0.17999999999999999 110.922 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.739 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.9 mt -148.02 125.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.433 -1.692 . . . . 3.9900000000000002 106.433 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -113.67 -16.12 12.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 5.1699999999999999 112.65 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.8 p -157.06 158.98 37.47 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 119.247 -2.158 . . . . 0.02 110.196 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.77 154.57 35.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.053 -1.029 . . . . 2.02 110.114 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.452 HH11 ' HG3' ' A' ' 173' ' ' ARG . 5.4 mtm-85 -144.12 150.54 38.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.153 -0.967 . . . . 0.01 110.612 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -86.93 143.39 27.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.69 127.96 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.171 -0.956 . . . . 3.04 109.418 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.06 147.19 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.243 -0.911 . . . . 1.8899999999999999 109.54 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.401 ' OE1' ' OE1' ' A' ' 63' ' ' GLN . 24.5 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.415 -0.803 . . . . 4.8899999999999997 109.412 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.529 -0.545 . . . . 5.2800000000000002 109.529 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -72.03 94.1 1.46 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.177 -0.952 . . . . 5.96 109.441 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.4 m -102.46 -140.49 0.35 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.689 -1.226 . . . . 2.2200000000000002 107.689 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 3' ' ' THR . . . 174.18 87.5 0.07 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.957 -2.457 . . . . 0.81000000000000005 106.957 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.95 149.59 33.04 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.117 -1.04 . . . . 0.01 110.725 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -151.49 136.97 17.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.493 -1.004 . . . . 0.02 109.367 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -129.46 140.06 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.881 -0.785 . . . . 0.02 108.881 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -121.39 129.84 53.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.562 -0.711 . . . . 0.39000000000000001 109.242 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -108.94 138.95 44.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.542 -0.91 . . . . 0.02 108.542 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.55 138.82 54.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.265 -0.897 . . . . 0.02 109.416 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.496 ' HG3' HD11 ' A' ' 33' ' ' LEU . 86.6 mt-10 -69.87 -27.75 65.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.767 . . . . 0.029999999999999999 111.705 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.71 169.85 8.76 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.893 -1.129 . . . . 0.029999999999999999 110.656 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.48 157.32 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.702 0.763 . . . . 0.029999999999999999 110.216 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 t-20 65.16 35.7 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.756 0.788 . . . . 0.73999999999999999 111.086 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.1 p90 49.97 45.05 25.52 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.685 0.755 . . . . 0.02 111.122 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -112.63 165.94 11.8 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.41 -167.13 35.28 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 120.761 -1.212 . . . . 0.029999999999999999 110.725 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -69.3 142.48 54.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 2.7599999999999998 109.125 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -121.1 149.51 42.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 1.8899999999999999 110.034 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -132.93 127.42 34.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.1 135.69 50.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 1.1200000000000001 109.22 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -130.13 136.92 49.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 -178.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.84 9.09 11.9 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.534 -0.729 . . . . 0.20000000000000001 110.343 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 44.9 t -157.69 173.69 16.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.018 -1.051 . . . . 1.23 108.469 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 64.4 t0 -60.45 142.23 55.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.074 -1.641 . . . . 0.02 110.834 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.2 m -132.36 116.47 16.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.408 -0.96 . . . . 0.02 108.408 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.1 54.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.795 . . . . 0.23999999999999999 110.873 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -155.67 101.76 2.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 1.1399999999999999 108.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.1 p90 -105.85 9.6 32.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.418 1.104 . . . . 6.3700000000000001 109.908 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -60.21 -22.17 62.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.292 -0.88 . . . . 3.1099999999999999 110.801 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 18.0 p -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.785 -1.197 . . . . 0.88 109.945 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.5 m-85 -102.67 -21.3 14.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.453 -0.779 . . . . 0.02 109.083 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.81 128.85 12.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.846 -0.798 . . . . 3.3199999999999998 108.846 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t -84.25 -9.67 58.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.02 110.567 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -171.4 163.79 6.94 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.474 -1.306 . . . . 0.02 107.474 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -141.83 113.75 7.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.697 -1.252 . . . . 0.02 108.538 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -108.96 -1.58 18.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.96 -1.088 . . . . 0.029999999999999999 111.42 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -153.86 153.53 32.27 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.179 -1.045 . . . . 0.02 108.179 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.77 146.88 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.061 -1.024 . . . . 0.02 110.672 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -125.5 125.68 43.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.397 -1.335 . . . . 0.02 107.397 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.56 114.32 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.949 -1.5 . . . . 0.02 106.949 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.8 -34.3 27.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.586 -0.696 . . . . 3.8100000000000001 110.485 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 152.01 21.74 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 118.974 -1.584 . . . . 0.02 110.138 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.83 174.43 49.46 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.255 -1.45 . . . . 0.01 110.026 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' TRP . 31.6 m -110.77 161.24 15.98 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' THR . 70.0 m95 -148.26 148.63 30.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.618 -1.301 . . . . 0.02 111.609 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.81 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 105.452 -2.055 . . . . 0.23999999999999999 105.452 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.1 m -117.11 141.98 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.551 -0.718 . . . . 0.65000000000000002 109.628 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.519 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 -120.34 143.15 48.54 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.062 0.934 . . . . 0.02 109.434 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -64.69 -33.96 77.17 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.589 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -124.59 157.84 64.09 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.131 -0.981 . . . . 0.02 109.575 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.37 166.56 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.663 1.576 . . . . 0.02 112.944 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.4 t30 63.68 37.17 10.27 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.275 -0.875 . . . . 0.02 111.279 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.28 50.92 9.63 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.568 0.699 . . . . 3.3900000000000001 110.56 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.8 m -125.72 163.8 22.03 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.268 0.556 . . . . 2.3300000000000001 109.876 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.59 -162.07 31.47 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.553 -1.419 . . . . 0.02 109.553 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -67.03 138.23 57.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.98 -1.306 . . . . 0.02 110.137 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 17.7 ptm -119.21 137.46 53.62 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.417 0.627 . . . . 5.0099999999999998 109.68 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.0 m-85 -132.92 140.56 47.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.175 -0.676 . . . . 0.02 109.175 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.58 132.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.379 -0.971 . . . . 1.72 108.379 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -120.78 113.76 32.97 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.524 -0.735 . . . . 0.02 110.768 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.16 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 CA-C-N 119.915 1.005 . . . . 1.47 110.046 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -53.52 140.82 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.758 -1.214 . . . . 4.25 110.409 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.87 -177.78 32.78 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.512 -1.328 . . . . 0.02 110.55 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.85 130.26 55.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -1.02 . . . . 0.95999999999999996 109.438 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 23.1 m-85 -121.42 92.99 48.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 107.972 -1.121 . . . . 0.02 107.972 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.59 -3.91 8.7 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.877 1.051 . . . . 0.02 113.589 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -156.92 153.37 28.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.535 -1.353 . . . . 2.02 107.969 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -59.89 -38.07 81.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.02 111.888 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -59.9 -24.14 64.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.02 110.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.535 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.03 -18.29 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.088 0.947 . . . . 3.4199999999999999 108.495 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.98 10.59 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.184 -1.413 . . . . 0.02 107.184 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.38 22.73 11.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.677 . . . . 0.02 110.417 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 145.53 46.49 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.161 -1.575 . . . . 0.02 109.161 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.43 -30.26 42.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.296 . . . . 0.97999999999999998 107.942 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 12.4 t-20 -157.24 -172.08 3.87 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.477 -1.675 . . . . 0.02 106.477 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.1 p30 -97.72 27.6 4.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.705 -1.247 . . . . 0.02 110.482 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -95.8 121.78 37.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.922 -1.112 . . . . 3.2000000000000002 110.324 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.1 mt -144.33 119.4 10.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 2.6099999999999999 107.69 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.24 11.15 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 121.381 -0.824 . . . . 0.02 112.938 -177.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -155.6 156.43 35.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.203 -1.763 . . . . 0.02 110.897 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 83.9 m -145.77 148.32 32.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.626 0.727 . . . . 0.02 110.525 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 48.5 mtm180 -134.73 139.42 45.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.677 -0.861 . . . . 0.01 108.677 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.89 130.45 36.62 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.187 -1.042 . . . . 0.42999999999999999 108.187 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.66 124.8 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.395 -0.965 . . . . 1.25 108.395 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -90.74 134.17 34.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.925 -1.109 . . . . 1.77 108.335 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.67 139.35 34.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.938 -0.764 . . . . 1.6299999999999999 108.938 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 p -112.29 125.1 53.8 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.487 -0.931 . . . . 1.0800000000000001 108.487 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -102.28 -156.06 0.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 106.163 -1.791 . . . . 1.26 106.163 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.01 -46.45 1.01 Allowed Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.57 -1.331 . . . . 0.01 112.14 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.36 -97.89 0.11 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 118.352 -1.88 . . . . 0.01 112.382 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -121.51 119.91 33.36 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.336 -1.096 . . . . 4.4299999999999997 110.966 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.81 130.23 38.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.162 -0.681 . . . . 2.9900000000000002 109.162 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -132.1 139.17 48.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.475 -0.766 . . . . 6.3600000000000003 109.319 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -127.46 144.87 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.385 -0.822 . . . . 1.0900000000000001 109.72 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -123.45 132.94 54.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.938 -1.134 . . . . 2.0499999999999998 107.938 177.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.26 147.64 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.881 -1.137 . . . . 1.1000000000000001 109.586 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.9 141.49 48.61 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.019 0.914 . . . . 0.72999999999999998 111.061 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.36 -30.3 70.07 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.898 -0.592 . . . . 0.02 111.83 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 92.0 mttt -116.26 167.63 10.84 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.913 -1.117 . . . . 3.1800000000000002 110.273 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.77 163.93 43.42 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 57.17 38.44 28.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.828 -0.807 . . . . 0.01 111.088 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 52.46 55.5 9.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.61 -0.682 . . . . 0.01 111.007 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.76 165.34 21.13 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.501 -0.926 . . . . 3.1499999999999999 108.501 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.3 -163.72 27.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.25 -1.54 . . . . 0.01 109.25 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.77 143.5 44.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.006 -1.291 . . . . 0.01 108.653 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.6 142.42 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.465 0.65 . . . . 0.01 109.427 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -131.75 135.51 46.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.239 -1.022 . . . . 2.48 108.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -121.61 135.28 54.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.648 -0.657 . . . . 0.01 110.008 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 t -149.64 153.4 36.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.222 1.011 . . . . 1.6899999999999999 110.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p -109.55 10.04 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.844 -0.616 . . . . 0.01 109.712 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 20.6 mp0 -120.53 163.13 18.43 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.315 -0.866 . . . . 3.21 111.175 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.51 154.55 38.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 11.6 t -123.19 110.26 31.01 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.673 -0.862 . . . . 0.01 108.673 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.9 -32.6 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.873 0.99 . . . . 0.01 111.662 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.5 m -140.43 107.79 5.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.322 -0.861 . . . . 0.02 108.819 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.0 mt -63.82 -39.76 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.67 -0.644 . . . . 1.8300000000000001 110.794 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.26 -37.63 83.8 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.053 -1.059 . . . . 1.3400000000000001 110.073 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.24 -39.15 75.2 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.416 -1.427 . . . . 2.1099999999999999 109.763 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.9 tt0 -80.39 -47.24 14.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 2.0800000000000001 112.476 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.5 m-85 -111.27 -1.05 16.21 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.451 -0.781 . . . . 0.02 112.681 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.2 m80 61.77 33.4 17.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.839 -1.163 . . . . 0.02 109.802 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.3 mt -114.18 135.41 54.07 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.563 -0.711 . . . . 0.02 109.248 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -90.25 -22.13 21.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 5.3200000000000003 110.987 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HD13 ' A' ' 126' ' ' ILE . 81.1 mt-10 -148.6 164.05 35.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.983 -1.073 . . . . 0.02 109.74 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 125' ' ' GLU . 41.8 mm -128.59 125.24 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 107.21 -1.404 . . . . 2.1699999999999999 107.21 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.572 ' N ' ' ND1' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -108.72 -14.1 14.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.305 -0.872 . . . . 0.02 112.573 -177.066 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 13.0 p -160.59 153.71 21.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.661 -1.274 . . . . 0.01 109.069 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.1 t -166.39 140.3 4.16 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.115 -1.069 . . . . 1.22 108.115 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.418 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 ptpt -119.53 98.85 6.33 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.4 1.095 . . . . 1.4099999999999999 108.635 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 131' ' ' VAL . 13.8 p -107.07 137.69 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -125.76 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 105.485 -2.043 . . . . 1.98 105.485 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.524 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 5.9 mm-40 -148.91 -65.42 0.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.458 -1.682 . . . . 0.01 106.458 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.09 -12.51 26.65 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 108.004 -2.038 . . . . 0.01 108.004 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.8 p -120.42 62.02 0.86 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.827 -0.808 . . . . 2.2999999999999998 110.764 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.524 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 73.7 m95 -132.56 135.34 45.87 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.811 -1.181 . . . . 0.01 110.472 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mt -119.34 137.84 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.058 -1.09 . . . . 1.6899999999999999 108.058 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -111.23 141.29 44.94 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.959 -1.497 . . . . 2.4900000000000002 106.959 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 31.3 m-85 -123.24 143.56 49.97 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.1 -1.0 . . . . 0.02 109.594 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.88 -30.33 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.6 -0.687 . . . . 0.02 111.497 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.4 152.97 47.54 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.788 -1.195 . . . . 1.48 109.003 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.77 167.81 2.02 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.086 1.19 . . . . 0.02 113.05 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.31 30.86 20.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.874 -1.057 . . . . 0.75 111.278 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 58.43 51.88 7.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.528 -0.732 . . . . 0.02 111.065 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -127.16 165.54 19.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.564 -0.71 . . . . 0.02 110.141 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.95 -165.42 34.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.218 -1.153 . . . . 0.02 110.218 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -69.22 141.69 54.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.536 -0.979 . . . . 0.02 108.893 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 58' ' ' MET . 10.0 mt-30 -113.38 148.71 35.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.502 -0.555 . . . . 0.02 109.502 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -123.72 133.51 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.551 -0.907 . . . . 0.01 108.551 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.436 ' H ' ' CE ' ' A' ' 58' ' ' MET . 10.1 tp -95.51 122.28 38.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.884 -1.135 . . . . 0.01 109.266 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.1 mp -91.58 149.82 21.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.724 -0.843 . . . . 0.01 108.724 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.9 m-20 -108.85 -177.15 3.23 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.471 -0.768 . . . . 2.27 109.498 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -74.38 29.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.85 . . . . 1.8400000000000001 109.698 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 152' ' ' ASP . 49.6 mttm -112.94 176.12 5.15 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.476 -0.765 . . . . 2.2799999999999998 109.498 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 2.2 mp0 -105.91 134.8 48.46 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.838 -0.801 . . . . 0.01 108.838 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -100.0 112.46 24.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.01 110.302 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -88.39 -29.5 20.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.01 111.133 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -122.72 154.35 63.57 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.056 -1.09 . . . . 2.54 108.056 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.3 Cg_endo -61.79 -42.95 28.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 CA-C-N 119.373 0.812 . . . . 0.69999999999999996 110.55 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.61 -18.81 17.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.751 -1.218 . . . . 0.85999999999999999 109.454 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 58.7 t0 -65.59 -17.86 64.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.809 -1.182 . . . . 0.02 111.737 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.38 15.52 28.55 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 120.725 -1.234 . . . . 0.02 110.193 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.86 10.55 75.51 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 121.206 -0.934 . . . . 0.02 112.967 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.525 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.68 140.79 34.46 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.855 -1.38 . . . . 0.02 110.009 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.55 -6.83 59.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.669 -0.644 . . . . 0.58999999999999997 109.612 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -140.49 149.94 59.05 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.109 -0.994 . . . . 0.87 109.169 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.81 16.13 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.571 0.847 . . . . 0.38 111.909 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.26 120.76 25.79 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.323 1.059 . . . . 0.17999999999999999 110.841 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.427 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -150.35 123.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.416 -2.068 . . . . 3.9900000000000002 105.416 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -114.79 -11.01 12.32 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 113.365 0.876 . . . . 5.1699999999999999 113.365 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 t -156.64 158.48 37.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.276 -2.14 . . . . 0.02 110.106 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.7 153.56 34.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.198 -0.939 . . . . 2.02 110.287 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -143.19 149.34 37.87 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.816 0.817 . . . . 0.01 110.206 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.82 143.59 27.05 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.337 -0.986 . . . . 0.01 108.337 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.36 128.5 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.252 -0.905 . . . . 3.04 109.742 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.24 146.61 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.185 -0.947 . . . . 1.8899999999999999 109.839 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.105 -0.702 . . . . 4.8899999999999997 109.105 179.288 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.514 -0.55 . . . . 5.2800000000000002 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -57.97 98.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 5.96 109.46 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.3 m -105.59 -139.44 0.37 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.2 -1.037 . . . . 2.2200000000000002 108.2 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.03 88.6 0.07 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 106.943 -2.463 . . . . 0.81000000000000005 106.943 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.96 149.48 32.89 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.275 -0.964 . . . . 0.01 110.851 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -151.43 137.88 18.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.395 -1.062 . . . . 0.02 109.614 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -130.15 139.84 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.326 -0.62 . . . . 0.02 109.326 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.88 129.74 53.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.39000000000000001 109.836 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -109.59 139.41 44.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 7.7 m-85 -122.89 138.36 54.68 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.266 -0.896 . . . . 0.02 109.576 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.61 -27.7 67.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.029999999999999999 111.904 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -114.97 170.92 7.98 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.634 ' N ' ' HE ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -74.98 157.95 34.09 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.607 0.718 . . . . 0.029999999999999999 110.092 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.5 t-20 66.26 34.97 6.2 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.91 0.862 . . . . 0.73999999999999999 110.873 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.8 p90 50.11 44.94 25.94 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.807 0.813 . . . . 0.02 111.139 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.1 166.49 11.37 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.084 -1.08 . . . . 0.02 108.084 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.22 -167.81 36.3 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.731 -1.231 . . . . 0.029999999999999999 110.788 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -68.24 142.6 55.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 2.7599999999999998 108.939 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -121.18 149.74 42.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.686 0.755 . . . . 1.8899999999999999 110.093 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -133.05 127.62 34.45 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.012 -1.106 . . . . 0.02 108.012 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -110.78 136.15 50.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.609 -0.682 . . . . 1.1200000000000001 109.177 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -130.23 137.02 49.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.02 109.338 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.39 9.19 12.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.628 -0.67 . . . . 0.20000000000000001 110.141 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.5 p -157.8 173.82 16.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 1.23 108.318 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 16.5 t0 -59.65 141.7 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.283 -1.51 . . . . 0.02 110.568 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.5 m -131.68 116.42 17.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.281 -1.007 . . . . 0.02 108.281 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.94 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.048 -1.033 . . . . 0.23999999999999999 110.948 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -153.3 101.04 2.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.99 . . . . 1.1399999999999999 108.806 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -105.59 9.04 33.46 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.111 0.958 . . . . 6.3700000000000001 109.637 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.5 mmp_? -57.88 -23.66 54.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.654 -0.654 . . . . 3.1099999999999999 110.565 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -74.05 -16.91 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.154 . . . . 0.88 109.971 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -105.41 -22.06 13.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.481 -0.762 . . . . 0.02 109.498 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.2 tp -148.18 125.34 11.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 3.3199999999999998 109.082 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 58.3 m -87.58 -13.15 43.65 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.74 . . . . 0.02 111.78 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 34' ' ' SER . 51.3 mtm180 -166.27 160.43 15.92 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.2 -1.407 . . . . 0.02 107.2 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.3 p -140.76 113.32 8.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.847 -1.158 . . . . 0.02 108.956 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -106.71 -0.49 23.56 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.82 -1.175 . . . . 0.029999999999999999 110.379 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -156.41 154.26 30.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.42 147.71 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.043 -1.036 . . . . 0.02 110.45 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -123.8 125.29 44.44 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.41 -0.959 . . . . 0.02 108.41 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.23 113.7 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.735 -1.58 . . . . 0.02 106.735 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -82.82 -34.19 26.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.366 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 151.77 21.37 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.135 -1.507 . . . . 0.02 110.397 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.42 174.43 50.37 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.696 -1.24 . . . . 0.01 110.175 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 95.4 m -109.49 160.49 16.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.889 -1.523 . . . . 1.48 106.889 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' THR . 50.4 m95 -148.02 146.97 29.12 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.208 -1.557 . . . . 0.02 111.506 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.66 132.37 54.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.519 -2.03 . . . . 0.23999999999999999 105.519 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.42 143.12 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.523 -0.735 . . . . 0.65000000000000002 109.625 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 12.1 m-85 -119.05 142.87 47.47 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.207 1.003 . . . . 0.02 109.803 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.28 -34.68 77.92 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.873 -0.603 . . . . 0.02 111.075 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -124.33 154.21 68.98 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.04 -1.038 . . . . 0.02 109.457 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.71 168.02 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.596 1.531 . . . . 0.02 113.33 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 65.09 36.45 7.31 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.151 -0.931 . . . . 0.02 111.035 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 45.58 50.54 10.44 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.784 0.802 . . . . 3.3900000000000001 110.527 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -127.21 164.46 21.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.246 0.546 . . . . 2.3300000000000001 109.971 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -162.39 31.68 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.156 -1.178 . . . . 0.02 110.156 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -62.31 141.23 58.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.089 -1.242 . . . . 0.02 110.568 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 49.4 mtp -117.94 133.12 56.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.529 -0.545 . . . . 5.0099999999999998 109.529 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.3 m-85 -136.08 137.08 40.71 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.766 0.793 . . . . 0.02 109.703 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -97.21 133.28 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.324 -0.991 . . . . 1.72 108.324 178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 61' ' ' LEU . 11.9 mt -120.25 113.57 33.84 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.663 -0.648 . . . . 0.02 110.405 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -77.79 169.54 20.55 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 CA-C-N 119.987 1.031 . . . . 1.47 109.951 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -52.62 140.92 21.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 4.25 110.151 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -177.38 32.54 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.331 -1.414 . . . . 0.02 110.748 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.66 131.18 55.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.552 -0.969 . . . . 0.95999999999999996 109.349 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -120.72 97.13 48.63 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.81 -1.181 . . . . 0.02 107.81 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.03 -4.39 12.42 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.738 0.959 . . . . 0.02 113.837 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -157.39 154.68 29.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.419 -1.426 . . . . 2.02 108.254 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -60.7 -37.95 83.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.616 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -23.85 64.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.02 110.213 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.54 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.67 -18.51 62.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.128 0.966 . . . . 3.4199999999999999 108.655 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -106.73 10.07 30.98 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.17 -1.419 . . . . 0.02 107.17 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.0 mtt 60.49 21.05 10.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.51 0.672 . . . . 0.02 110.231 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 144.59 47.06 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.095 -1.602 . . . . 0.02 109.095 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.1 tp -78.14 -29.38 48.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.597 -1.26 . . . . 0.97999999999999998 107.597 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -156.75 -170.76 3.42 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 97.9 m-20 -98.1 29.05 3.67 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.62 -1.3 . . . . 0.02 110.204 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.1 123.08 41.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.262 -0.899 . . . . 3.2000000000000002 111.329 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.516 HD12 ' SG ' ' A' ' 36' ' ' CYS . 28.1 mt -143.18 120.48 11.57 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.733 -1.58 . . . . 2.6099999999999999 106.733 177.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.93 -16.65 13.24 Favored Glycine 0 N--CA 1.503 3.158 0 O-C-N 121.248 -0.908 . . . . 0.02 112.329 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.8 p -156.07 156.0 33.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.465 -1.609 . . . . 0.02 109.656 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.55 147.66 33.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.521 0.677 . . . . 0.02 109.547 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -134.08 139.39 45.93 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.542 -0.911 . . . . 0.01 108.542 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.86 130.12 37.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.11 -1.07 . . . . 0.42999999999999999 108.11 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.05 123.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' O ' HG21 ' A' ' 135' ' ' THR . 13.8 m-70 -90.06 137.92 31.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 1.77 109.165 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.418 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -100.95 136.83 40.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.422 -0.955 . . . . 1.6299999999999999 108.422 -179.371 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -113.34 126.85 55.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.819 . . . . 1.0800000000000001 108.968 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.9 m -103.25 -155.02 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.197 -1.779 . . . . 1.26 106.197 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.34 -48.89 0.88 Allowed Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.391 -1.443 . . . . 0.01 112.593 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.85 -100.37 0.14 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.495 -1.812 . . . . 0.01 112.136 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.497 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.76 119.05 31.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.311 -178.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.497 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.77 129.92 36.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.909 -0.716 . . . . 2.9900000000000002 109.24 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.52 139.42 50.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 6.3600000000000003 109.208 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.58 145.14 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.311 -0.868 . . . . 1.0900000000000001 109.949 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -122.67 133.16 54.52 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.251 -1.388 . . . . 2.0499999999999998 107.251 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.73 148.01 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.041 -1.037 . . . . 1.1000000000000001 109.486 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 45.3 m-85 -119.33 140.99 49.42 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.248 1.023 . . . . 0.72999999999999998 110.824 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -65.86 -29.05 69.44 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.659 -0.7 . . . . 0.02 111.33 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -116.59 169.47 9.32 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.151 -0.968 . . . . 3.1800000000000002 110.443 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.37 52.02 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.938 -0.865 . . . . 0.01 110.938 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 t0 57.36 38.37 28.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 0.01 111.252 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 51.84 54.81 10.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.01 111.296 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -129.61 165.97 20.68 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.124 -1.065 . . . . 3.1499999999999999 108.124 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.07 -164.77 27.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.309 -1.517 . . . . 0.01 109.309 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.05 145.12 40.39 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.023 -1.28 . . . . 0.01 108.473 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 44.3 ttp -116.69 142.45 46.89 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.764 0.792 . . . . 0.01 110.093 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.36 135.0 47.59 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.777 -1.194 . . . . 2.48 107.777 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -120.68 135.54 55.09 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.632 -0.668 . . . . 0.01 110.217 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 1.5 t -149.69 151.32 33.48 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.178 0.989 . . . . 1.6899999999999999 110.84 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.7 p -109.08 9.9 26.17 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 115.641 -0.708 . . . . 0.01 109.756 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.66 163.57 17.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.369 -0.832 . . . . 3.21 111.29 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.32 155.23 37.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.181 -1.044 . . . . 0.01 108.181 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.4 t -122.42 109.25 33.06 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.619 -0.882 . . . . 0.01 108.619 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.81 -34.11 2.55 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 CA-C-N 119.878 0.992 . . . . 0.01 111.44 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 p -139.07 106.79 5.62 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.459 -0.941 . . . . 0.02 108.459 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.51 -40.12 87.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.907 -0.496 . . . . 1.8300000000000001 111.148 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.0 ttp -66.87 -37.6 84.73 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.921 -1.112 . . . . 1.3400000000000001 110.039 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.31 -38.85 75.04 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.469 -1.395 . . . . 2.1099999999999999 109.867 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.41 ' CD ' ' CE2' ' A' ' 121' ' ' PHE . 65.2 tt0 -80.74 -47.57 13.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.228 -0.92 . . . . 2.0800000000000001 112.471 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.41 ' CE2' ' CD ' ' A' ' 120' ' ' GLN . 75.3 m-85 -111.69 -1.87 15.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.4 -0.812 . . . . 0.02 112.69 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.6 ' N ' ' ND1' ' A' ' 122' ' ' HIS . 1.1 m-70 61.35 33.77 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.887 -1.133 . . . . 0.02 109.765 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.02 135.69 53.74 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.478 -0.763 . . . . 0.02 109.099 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -21.77 22.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.142 -0.974 . . . . 5.3200000000000003 110.908 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 42.5 mt-10 -148.45 163.99 35.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.874 -1.141 . . . . 0.02 110.035 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 35.6 mm -129.57 126.68 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.548 -1.279 . . . . 2.1699999999999999 107.548 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -110.36 -12.99 14.37 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.267 -0.896 . . . . 0.02 112.873 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 p -160.69 153.48 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.658 -1.276 . . . . 0.01 109.255 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.6 p -165.25 143.73 6.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.22 109.26 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -123.87 101.78 7.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.081 -1.012 . . . . 1.4099999999999999 109.631 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.6 p -107.72 138.2 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.984 -1.117 . . . . 0.01 107.984 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.57 92.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 106.598 -1.631 . . . . 1.98 106.598 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.519 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 23.8 tt0 -146.11 -75.9 0.2 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.469 -2.048 . . . . 0.01 105.469 178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.86 -77.49 0.07 OUTLIER Glycine 0 N--CA 1.479 1.566 0 N-CA-C 108.089 -2.005 . . . . 0.01 108.089 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 86' ' ' HIS . 82.2 p -123.23 126.44 46.95 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.547 1.165 . . . . 2.2999999999999998 111.141 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.519 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 7.0 m95 -126.86 151.17 48.74 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.247 -1.76 . . . . 0.01 106.247 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.51 133.98 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.483 -1.386 . . . . 1.6899999999999999 109.408 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.51 141.4 45.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.56 -1.645 . . . . 2.4900000000000002 106.56 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.457 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 33.4 m-85 -121.52 142.61 49.9 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.258 -0.901 . . . . 0.02 109.091 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 168' ' ' ALA . 9.9 tp10 -73.87 -30.17 62.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.547 -0.72 . . . . 0.02 110.975 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.9 154.81 48.31 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.851 -1.155 . . . . 1.48 108.932 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -57.08 167.96 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.174 1.25 . . . . 0.02 113.024 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 60.09 31.5 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.284 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.6 51.48 9.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.74 . . . . 0.02 111.038 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -126.91 164.89 20.44 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.521 -0.737 . . . . 0.02 110.241 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.61 -165.69 32.44 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.251 -1.14 . . . . 0.02 110.251 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.41 142.85 53.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.977 . . . . 0.02 108.712 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.43 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 23.2 mt-30 -112.32 147.77 35.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.657 -0.652 . . . . 0.02 110.074 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -123.83 133.43 53.79 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.731 -0.841 . . . . 0.01 108.731 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.19 121.53 39.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.926 -1.108 . . . . 0.01 109.913 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -96.48 140.78 30.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.371 -0.974 . . . . 0.01 108.371 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 154' ' ' LYS . 93.5 m-20 -104.29 -174.48 2.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.376 -0.828 . . . . 2.27 109.754 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 15.6 pttp -70.72 35.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 1.8400000000000001 109.983 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 152' ' ' ASP . 50.6 mttp -113.85 173.18 6.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 2.2799999999999998 109.22 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.67 130.67 52.66 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.391 -0.966 . . . . 0.01 108.391 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.05 111.54 23.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.11 -0.994 . . . . 0.01 109.817 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.514 ' H ' ' CD ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -92.75 -27.22 17.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.01 111.073 -177.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -123.12 153.71 64.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.813 -1.18 . . . . 2.54 107.813 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.16 -42.72 27.58 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 CA-C-N 119.246 0.766 . . . . 0.69999999999999996 111.102 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -60.6 -18.98 17.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.725 -1.234 . . . . 0.85999999999999999 109.439 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 57.4 t0 -65.72 -18.01 65.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.02 112.087 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.67 15.8 27.78 Favored 'General case' 0 N--CA 1.514 2.735 0 O-C-N 120.66 -1.275 . . . . 0.02 110.086 178.283 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.46 75.28 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.129 -0.982 . . . . 0.02 112.963 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.47 140.43 34.73 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.834 -1.392 . . . . 0.02 110.062 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.48 -7.1 59.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.706 . . . . 0.58999999999999997 109.427 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -140.8 150.37 59.6 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.87 108.992 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -74.36 16.52 0.58 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.632 0.888 . . . . 0.38 111.915 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.36 120.31 25.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.026 -1.046 . . . . 0.17999999999999999 110.759 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.3 mt -149.37 123.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.601 -2.0 . . . . 3.9900000000000002 105.601 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -111.9 -14.05 13.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.233 -0.917 . . . . 5.1699999999999999 113.251 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.1 t -156.24 158.68 37.96 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.257 -2.152 . . . . 0.02 109.965 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -152.9 154.49 35.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.164 -0.96 . . . . 2.02 110.569 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.457 ' NH2' ' OH ' ' A' ' 139' ' ' TYR . 87.1 mtm180 -143.3 148.35 36.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.01 109.946 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -85.96 142.78 28.56 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.388 -0.967 . . . . 0.01 108.388 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.96 126.57 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.967 -1.083 . . . . 3.04 109.764 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 177' ' ' GLU . 31.2 m -137.47 147.08 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 1.8899999999999999 109.199 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' A' ' 176' ' ' VAL . 10.2 tt0 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 108.356 -0.979 . . . . 4.8899999999999997 108.356 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.38 -0.6 . . . . 5.2800000000000002 109.38 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -82.08 136.78 35.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 5.96 109.536 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -138.75 -128.68 0.12 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.159 -0.963 . . . . 2.2200000000000002 111.468 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 3' ' ' THR . . . 167.48 95.28 0.1 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.981 -2.848 . . . . 0.81000000000000005 105.981 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.81 146.29 30.92 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.312 -0.947 . . . . 0.01 111.196 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -152.86 138.08 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.759 -0.848 . . . . 0.02 108.756 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.05 141.06 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.354 -0.61 . . . . 0.02 109.354 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -122.06 130.26 53.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.499 -0.751 . . . . 0.39000000000000001 109.722 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -109.26 138.93 44.86 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.61 -0.885 . . . . 0.02 108.61 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 8.6 m-85 -122.36 139.0 54.33 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.353 -0.842 . . . . 0.02 109.802 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 10.1 mm-40 -69.19 -28.6 66.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.029999999999999999 111.79 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -114.34 169.83 8.74 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.817 -1.177 . . . . 0.029999999999999999 110.471 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -74.27 157.54 35.63 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.695 0.759 . . . . 0.029999999999999999 110.02 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.0 m120 65.97 35.56 6.39 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.73999999999999999 110.995 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.8 p90 49.78 45.69 24.53 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.736 0.779 . . . . 0.02 111.414 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -113.01 166.49 11.36 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.132 -1.062 . . . . 0.02 108.132 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.08 -167.58 36.32 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 120.78 -1.2 . . . . 0.029999999999999999 110.8 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' NH2' ' H ' ' A' ' 34' ' ' SER . 30.1 ttp180 -68.94 142.73 54.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.976 . . . . 2.7599999999999998 109.196 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -120.78 148.68 43.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.649 0.737 . . . . 1.8899999999999999 110.29 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -131.73 126.68 35.1 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.915 -1.143 . . . . 0.02 107.915 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -112.09 136.81 51.0 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 1.1200000000000001 109.655 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.4 t -130.67 138.19 49.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.461 0.648 . . . . 0.02 109.565 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.2 m-20 -117.14 10.16 13.78 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.383 0.611 . . . . 0.20000000000000001 109.398 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 46.1 m -158.42 174.56 14.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.02 -1.104 . . . . 1.23 108.02 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.3 p-10 -62.11 144.41 55.36 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.581 -1.324 . . . . 0.02 110.49 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -131.59 117.25 18.46 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.99 53.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.23999999999999999 110.567 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 27.8 p-10 -154.11 100.86 2.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 1.1399999999999999 108.682 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.41 9.27 35.77 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.226 1.012 . . . . 6.3700000000000001 109.522 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.596 ' NH2' ' H ' ' A' ' 79' ' ' LEU . 10.7 mmt180 -59.25 -22.93 61.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 3.1099999999999999 110.81 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -74.83 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.699 -1.25 . . . . 0.88 110.257 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -104.06 -21.87 13.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.02 109.387 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.473 HD11 ' HG2' ' A' ' 11' ' ' GLU . 10.7 tp -149.89 128.65 12.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.301 -0.875 . . . . 3.3199999999999998 109.008 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.586 ' H ' ' NH2' ' A' ' 18' ' ' ARG . 82.9 p -85.85 -10.77 54.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.655 -0.653 . . . . 0.02 111.422 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.527 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 5.5 mtp180 -171.57 163.49 6.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.259 -1.385 . . . . 0.02 107.259 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 12.5 p -142.23 113.83 7.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.771 -1.205 . . . . 0.02 108.792 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.3 m-20 -105.53 -0.95 25.38 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.94 -1.1 . . . . 0.029999999999999999 110.537 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 2.7 m -153.62 154.3 33.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 0.02 107.718 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.27 146.74 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.033 -1.042 . . . . 0.02 110.148 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 38.4 ttm180 -125.18 125.33 43.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.783 -1.192 . . . . 0.02 107.783 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.53 113.86 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.505 -1.665 . . . . 0.02 106.505 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.8 mp0 -83.54 -33.97 25.34 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.088 -0.645 . . . . 3.8100000000000001 109.853 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 150.79 20.15 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.46 -1.829 . . . . 0.02 110.607 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 174.8 50.57 Favored Glycine 0 N--CA 1.486 1.997 0 C-N-CA 119.668 -1.253 . . . . 0.01 110.337 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 23.0 m -109.94 161.98 14.96 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.736 -1.579 . . . . 1.48 106.736 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 72.7 m95 -148.48 147.79 29.51 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.223 -1.548 . . . . 0.02 111.742 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.15 55.33 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.197 -2.149 . . . . 0.23999999999999999 105.197 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' HD22 ' A' ' 79' ' ' LEU . 19.3 m -120.5 144.43 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.679 -0.638 . . . . 0.65000000000000002 109.403 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -121.22 145.75 47.51 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.359 1.076 . . . . 0.02 110.047 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 3.1 tp10 -65.33 -34.35 78.13 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.613 -0.722 . . . . 0.02 110.909 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -123.0 158.52 57.27 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.232 -0.918 . . . . 0.02 109.462 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.6 166.93 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.521 1.481 . . . . 0.02 112.529 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.3 m120 64.05 36.79 9.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.313 -0.858 . . . . 0.02 111.136 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 44.83 51.68 8.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.587 0.708 . . . . 3.3900000000000001 110.586 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -126.78 164.23 21.81 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.261 0.553 . . . . 2.3300000000000001 109.889 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.34 31.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.53 -1.428 . . . . 0.02 109.53 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -66.47 138.7 57.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.312 . . . . 0.02 109.985 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.5 ptm -118.66 137.29 53.4 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.34 0.59 . . . . 5.0099999999999998 109.593 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.2 m-85 -132.06 138.06 48.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.524 -0.735 . . . . 0.02 109.459 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mm -94.74 131.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.742 -0.836 . . . . 1.72 108.742 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.8 mt -120.11 112.6 34.62 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.753 . . . . 0.02 110.857 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -78.31 169.04 20.75 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.006 1.038 . . . . 1.47 109.943 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.53 141.31 25.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.717 -1.239 . . . . 4.25 110.359 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.08 32.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.385 -1.388 . . . . 0.02 110.635 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -119.02 130.7 55.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.431 -1.041 . . . . 0.95999999999999996 109.653 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CE1' HD22 ' A' ' 61' ' ' LEU . 89.7 m-85 -120.24 95.64 49.1 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 108.034 -1.098 . . . . 0.02 108.034 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 38' ' ' SER . 3.4 Cg_exo -66.24 -4.93 11.38 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.716 0.944 . . . . 0.02 113.416 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -157.31 154.05 28.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.65 -1.281 . . . . 2.02 107.925 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 23.1 p90 -60.46 -37.77 82.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.895 -0.722 . . . . 0.02 111.722 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 14.9 mm100 -60.78 -24.34 65.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.02 110.444 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.598 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -69.47 -18.34 63.7 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.444 -0.947 . . . . 3.4199999999999999 108.444 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.62 10.83 29.01 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.363 -1.347 . . . . 0.02 107.363 -179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 59.39 21.68 10.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.639 0.733 . . . . 0.02 110.341 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.2 145.69 46.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.909 -1.677 . . . . 0.02 108.909 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 75' ' ' LEU . 1.0 OUTLIER -78.8 -30.98 45.78 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.639 -1.245 . . . . 0.97999999999999998 107.639 178.36 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -157.38 -171.26 3.53 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.67 -1.604 . . . . 0.02 106.67 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 6.7 p30 -97.99 28.15 4.12 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.769 -1.207 . . . . 0.02 110.311 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 78' ' ' ARG . 3.8 mtt-85 -97.86 123.01 41.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.226 -0.921 . . . . 3.2000000000000002 111.122 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.596 ' H ' ' NH2' ' A' ' 30' ' ' ARG . 36.0 mt -144.04 120.83 11.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.918 -1.512 . . . . 2.6099999999999999 106.918 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.42 -16.56 14.24 Favored Glycine 0 N--CA 1.502 3.047 0 O-C-N 121.264 -0.897 . . . . 0.02 112.079 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 44.4 t -156.38 155.64 32.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.402 -1.646 . . . . 0.02 109.978 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 48' ' ' VAL . 29.3 t -145.04 148.23 33.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.02 109.781 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 44.3 mtm180 -134.17 139.28 45.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.843 . . . . 0.01 109.123 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' ' CH2' ' A' ' 46' ' ' TRP . . . -77.51 131.9 38.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.207 -1.034 . . . . 0.42999999999999999 108.207 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.52 124.55 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.917 -0.771 . . . . 1.25 108.917 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.449 ' O ' ' CG2' ' A' ' 135' ' ' THR . 27.0 m80 -91.88 135.68 33.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.167 -0.958 . . . . 1.77 108.967 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -97.63 138.46 34.99 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.17 -0.678 . . . . 1.6299999999999999 109.17 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 p -112.23 126.42 55.21 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.828 -0.804 . . . . 1.0800000000000001 108.828 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 p -102.86 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.233 -1.766 . . . . 1.26 106.233 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.21 -49.79 0.83 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.387 -1.445 . . . . 0.01 112.527 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.7 -99.93 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 118.31 -1.9 . . . . 0.01 112.238 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.33 119.98 33.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.197 -1.178 . . . . 4.4299999999999997 110.802 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.29 130.1 36.74 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.918 -0.713 . . . . 2.9900000000000002 109.104 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -129.75 138.77 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.817 -0.809 . . . . 6.3600000000000003 108.817 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.53 144.47 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.294 -0.879 . . . . 1.0900000000000001 109.891 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.8 pm0 -121.77 133.64 54.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.348 -1.352 . . . . 2.0499999999999998 107.348 176.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.2 m -122.85 145.62 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.736 -1.228 . . . . 1.1000000000000001 109.141 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' N ' ' CD1' ' A' ' 98' ' ' PHE . 41.2 m-85 -119.57 141.1 49.56 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.125 0.964 . . . . 0.72999999999999998 111.127 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.77 -29.28 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.697 -0.683 . . . . 0.02 111.485 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -116.36 170.16 8.75 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.125 -0.984 . . . . 3.1800000000000002 110.492 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.0 165.49 53.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.0 t0 57.16 38.27 28.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.01 111.354 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.08 54.26 11.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.62 -0.675 . . . . 0.01 111.282 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -129.51 166.38 19.77 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.165 -1.05 . . . . 3.1499999999999999 108.165 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.31 -164.98 28.6 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.122 -1.591 . . . . 0.01 109.122 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -75.09 143.94 43.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.999 -1.295 . . . . 0.01 108.373 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 107' ' ' MET . 8.8 tmm? -117.15 142.76 46.61 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.669 0.747 . . . . 0.01 110.147 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.438 ' N ' ' SD ' ' A' ' 107' ' ' MET . 38.7 m-85 -130.63 135.12 47.55 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.56 -1.274 . . . . 2.48 107.56 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -119.67 135.47 54.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.558 -0.714 . . . . 0.01 110.12 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 t -150.51 153.0 35.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.461 1.124 . . . . 1.6899999999999999 111.322 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 p -110.72 9.38 22.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.27 -0.877 . . . . 0.01 109.592 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -121.25 163.74 18.08 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.445 -0.785 . . . . 3.21 111.331 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.86 155.06 39.36 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.01 108.324 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.77 111.67 27.4 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.7 -0.852 . . . . 0.01 108.7 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.67 -31.99 3.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.998 1.035 . . . . 0.01 111.876 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -140.29 108.37 5.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.02 109.074 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.04 -40.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.894 -0.504 . . . . 1.8300000000000001 110.57 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.6 tmm? -66.72 -37.81 85.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.001 -1.08 . . . . 1.3400000000000001 110.052 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -69.98 -38.57 76.08 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.479 -1.388 . . . . 2.1099999999999999 109.403 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 52.7 tt0 -80.79 -47.48 13.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.0800000000000001 112.424 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.487 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.0 m-85 -110.83 -1.92 16.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.366 -0.834 . . . . 0.02 112.574 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.33 34.14 18.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.713 -1.242 . . . . 0.02 109.436 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.4 135.92 53.57 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.426 -0.796 . . . . 0.02 109.373 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -88.66 -21.35 24.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.26 -0.9 . . . . 5.3200000000000003 110.589 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.11 165.04 32.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.932 -1.105 . . . . 0.02 110.198 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mm -127.39 123.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.494 -1.299 . . . . 2.1699999999999999 107.494 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -108.34 -13.29 14.91 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.133 -0.979 . . . . 0.02 112.132 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 p -160.45 152.5 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.983 -1.073 . . . . 0.01 108.927 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.472 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.3 t -167.66 144.04 4.16 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.545 -0.909 . . . . 1.22 108.545 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.544 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 41.5 tttm -122.45 110.23 15.35 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.38 1.086 . . . . 1.4099999999999999 109.473 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 131' ' ' VAL . 14.9 p -112.98 135.23 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.442 -1.318 . . . . 0.01 107.442 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.1 t -126.99 92.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 106.722 -1.584 . . . . 1.98 106.722 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.559 ' CD ' ' HE1' ' A' ' 136' ' ' TRP . 20.9 tt0 -146.63 -72.7 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.264 -2.124 . . . . 0.01 105.264 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 155.18 -49.79 0.48 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.369 -1.492 . . . . 0.01 109.369 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.684 ' HB ' HD12 ' A' ' 175' ' ' ILE . 44.3 p -126.96 105.84 8.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.414 -1.051 . . . . 2.2999999999999998 111.742 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.559 ' HE1' ' CD ' ' A' ' 133' ' ' GLU . 7.5 m95 -130.95 147.33 52.58 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 107.614 -1.254 . . . . 0.01 107.614 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.471 ' CG1' HD11 ' A' ' 175' ' ' ILE . 38.9 mt -119.82 135.75 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.636 -1.29 . . . . 1.6899999999999999 110.089 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -111.06 142.39 43.28 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.819 -1.919 . . . . 2.4900000000000002 105.819 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 139' ' ' TYR . 18.1 m-85 -123.17 144.17 49.53 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.091 -1.006 . . . . 0.02 109.842 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.569 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 25.8 tt0 -74.2 -30.88 62.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.727 -0.608 . . . . 0.02 111.68 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.73 154.54 48.06 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.698 -1.251 . . . . 1.48 108.995 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.04 167.54 2.37 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.257 1.304 . . . . 0.02 112.747 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.8 t30 59.33 31.25 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.457 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.53 51.52 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.02 111.07 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.4 164.72 20.49 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.513 -0.742 . . . . 0.02 109.848 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.67 33.65 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.063 -1.215 . . . . 0.02 110.063 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -69.68 142.31 53.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.595 -0.944 . . . . 0.02 108.892 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.418 ' O ' ' CG ' ' A' ' 58' ' ' MET . 13.1 mt-30 -113.77 149.22 35.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.344 0.593 . . . . 0.02 109.78 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -123.62 133.99 53.85 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.41 123.37 40.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.857 -1.152 . . . . 0.01 109.916 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -95.35 135.38 37.04 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.971 -1.122 . . . . 0.01 107.971 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -106.19 -167.67 1.33 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.731 -0.606 . . . . 2.27 110.312 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -79.6 34.46 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.576 -0.702 . . . . 1.8400000000000001 109.921 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -111.92 172.17 7.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.445 -0.785 . . . . 2.2799999999999998 109.373 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -104.38 121.28 43.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.273 -1.01 . . . . 0.01 108.273 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.03 113.48 25.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.272 -0.892 . . . . 0.01 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.39 17.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.129 -0.982 . . . . 0.01 110.706 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -123.94 155.66 66.85 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.066 -1.086 . . . . 2.54 108.066 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.5 Cg_endo -61.41 -40.83 45.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.032 0.69 . . . . 0.69999999999999996 110.764 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.76 -18.82 19.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 120.905 -1.122 . . . . 0.85999999999999999 109.295 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 49.1 t0 -65.92 -18.56 65.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.872 -1.143 . . . . 0.02 111.902 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -102.27 15.09 30.18 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 120.886 -1.134 . . . . 0.02 109.979 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.43 10.62 73.5 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.301 -0.874 . . . . 0.02 113.119 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.25 140.76 35.11 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.744 -1.445 . . . . 0.02 110.18 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.54 -7.1 59.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 0.58999999999999997 110.168 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.3 p -141.41 150.36 57.66 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.87 109.768 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -75.29 14.94 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 120.913 1.075 . . . . 0.38 111.817 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 122.64 27.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.306 1.051 . . . . 0.17999999999999999 111.014 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mp -152.56 123.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.189 -1.782 . . . . 3.9900000000000002 106.189 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 3.2 mp0 -111.39 -11.56 14.12 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.524 -0.735 . . . . 5.1699999999999999 112.312 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -156.4 158.74 37.87 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 119.311 -2.118 . . . . 0.02 109.755 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.86 153.38 34.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.274 -0.891 . . . . 2.02 110.219 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -144.0 149.32 36.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.32 -0.862 . . . . 0.01 109.942 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.02 140.56 29.44 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.363 -0.976 . . . . 0.01 108.363 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 135' ' ' THR . 45.8 mt -93.89 129.99 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.2 -0.937 . . . . 3.04 109.222 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.46 148.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.475 -0.765 . . . . 1.8899999999999999 109.62 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 4.8899999999999997 109.564 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.276 0.56 . . . . 5.2800000000000002 109.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HZ3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -50.81 98.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 5.96 109.331 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -103.87 -140.21 0.36 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.001 -1.111 . . . . 2.2200000000000002 108.001 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.551 ' H ' HG22 ' A' ' 3' ' ' THR . . . 174.88 88.06 0.07 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 106.982 -2.447 . . . . 0.81000000000000005 106.982 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 148.96 32.71 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.524 -1.03 . . . . 0.01 110.524 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -153.29 138.1 17.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.442 -1.034 . . . . 0.02 108.621 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 8.1 tt -130.59 142.42 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.356 -0.609 . . . . 0.02 109.356 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -122.29 129.81 52.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.424 -0.797 . . . . 0.39000000000000001 109.512 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.29 138.47 44.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.565 -0.902 . . . . 0.02 108.565 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 80.3 m-85 -121.6 138.84 54.15 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.212 -0.93 . . . . 0.02 109.769 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.65 -28.28 66.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.489 -0.757 . . . . 0.029999999999999999 111.61 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -114.66 169.96 8.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.962 -1.086 . . . . 0.029999999999999999 110.394 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.44 158.67 32.32 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.687 0.756 . . . . 0.029999999999999999 109.995 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 10.5 t-20 66.47 34.61 6.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.845 0.831 . . . . 0.73999999999999999 110.776 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.601 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.4 p90 50.07 44.9 25.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.301 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -113.01 165.7 12.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.107 -1.071 . . . . 0.02 108.107 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.57 -168.14 34.42 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.706 -1.235 . . . . 0.029999999999999999 110.927 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.04 143.43 54.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.505 -0.997 . . . . 2.7599999999999998 109.152 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' ' OD1' ' A' ' 21' ' ' ASP . 34.0 ttp180 -119.55 148.7 43.0 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.646 0.736 . . . . 1.8899999999999999 110.392 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -132.09 126.23 33.26 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.887 -1.153 . . . . 0.02 107.887 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' OD1' ' NE ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.7 137.64 51.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.607 -0.683 . . . . 1.1200000000000001 109.751 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.08 139.67 48.59 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.591 0.71 . . . . 0.02 109.47 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 3.4 m-20 -116.09 11.93 15.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.394 -0.595 . . . . 0.20000000000000001 109.394 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 p -158.29 174.47 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.127 -1.064 . . . . 1.23 108.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.99 144.65 54.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.729 -1.232 . . . . 0.02 110.27 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -131.47 116.41 17.44 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.522 -0.918 . . . . 0.02 108.522 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.54 -21.63 55.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.23999999999999999 110.767 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -157.34 101.57 1.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.075 -1.016 . . . . 1.1399999999999999 108.577 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.8 p90 -105.13 9.95 34.05 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.254 1.026 . . . . 6.3700000000000001 110.002 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -59.91 -23.45 63.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.563 -0.711 . . . . 3.1099999999999999 110.954 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p -76.05 -16.68 59.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.647 -1.283 . . . . 0.88 110.31 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -102.55 -21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.399 -0.813 . . . . 0.02 108.901 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -150.49 129.23 12.38 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.683 -0.858 . . . . 3.3199999999999998 108.683 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -86.32 -9.81 55.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.847 -0.533 . . . . 0.02 110.846 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -170.49 161.61 7.9 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.16 113.52 8.08 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.643 -1.285 . . . . 0.02 109.094 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -107.45 -3.35 19.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.029999999999999999 110.647 -178.65 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -154.24 153.49 31.81 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.301 -1.0 . . . . 0.02 108.301 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.35 147.71 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.951 -1.093 . . . . 0.02 110.244 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -125.02 125.68 44.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.953 -1.128 . . . . 0.02 107.953 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.16 114.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.948 -1.501 . . . . 0.02 106.948 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -84.16 -34.52 24.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.484 -0.76 . . . . 3.8100000000000001 109.812 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.57 18.22 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.674 -1.727 . . . . 0.02 110.402 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.88 173.74 49.94 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.528 -1.32 . . . . 0.01 109.893 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.4 m -120.66 138.05 54.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.803 -1.184 . . . . 1.48 107.803 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -127.25 154.36 44.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.691 1.234 . . . . 0.02 111.907 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.59 51.58 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.619 -2.363 . . . . 0.23999999999999999 104.619 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.1 m -116.54 142.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.65000000000000002 109.005 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 18.2 m-85 -119.42 141.35 49.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.021 0.915 . . . . 0.02 109.351 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 10.0 tp10 -64.3 -34.16 77.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.571 -0.74 . . . . 0.02 111.671 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -124.08 156.59 65.94 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.025 -1.047 . . . . 0.02 109.707 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.45 165.7 0.97 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.634 1.556 . . . . 0.02 112.984 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.453 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.0 OUTLIER 64.97 37.49 6.86 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.72 0.771 . . . . 0.02 111.261 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 45.21 50.89 9.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.457 0.646 . . . . 3.3900000000000001 110.785 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.5 p -126.97 164.55 21.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.2 0.524 . . . . 2.3300000000000001 110.134 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.25 -162.34 30.8 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.997 -1.241 . . . . 0.02 109.997 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 13.9 t-80 -62.34 143.25 57.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.03 -1.276 . . . . 0.02 110.635 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.498 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 36.5 mtp -116.32 134.58 54.73 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.514 -0.55 . . . . 5.0099999999999998 109.514 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.663 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 33.7 m-85 -136.02 134.89 38.98 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.289 -0.882 . . . . 0.02 109.205 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -96.97 131.96 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.527 -0.733 . . . . 1.72 109.114 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 66' ' ' TYR . 22.9 mt -122.8 111.37 31.14 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.414 -0.804 . . . . 0.02 110.784 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.19 171.2 18.55 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 119.924 1.009 . . . . 1.47 110.181 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.04 140.46 20.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 4.25 110.114 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.65 32.83 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.452 -1.356 . . . . 0.02 110.626 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.5 tp10 -119.14 130.32 55.49 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.294 -1.121 . . . . 0.95999999999999996 109.278 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 84.5 m-85 -120.7 97.76 48.34 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.796 -1.187 . . . . 0.02 107.796 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.63 -5.47 17.12 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 120.582 0.855 . . . . 0.02 113.929 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -154.03 154.09 33.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.503 -1.373 . . . . 2.02 107.864 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -60.67 -38.23 84.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.737 . . . . 0.02 111.719 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.74 -23.94 63.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.983 -1.073 . . . . 0.02 109.9 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.82 -18.54 62.73 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.112 0.958 . . . . 3.4199999999999999 108.432 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.663 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.38 9.7 31.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.245 -1.391 . . . . 0.02 107.245 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.4 mpp? 58.93 22.16 10.0 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.568 0.699 . . . . 0.02 110.304 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.26 143.61 45.94 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.258 -1.537 . . . . 0.02 109.258 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -77.75 -29.55 51.12 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.179 -1.415 . . . . 0.97999999999999998 107.179 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.2 p-10 -156.43 -171.33 3.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.118 -1.808 . . . . 0.02 106.118 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -98.47 28.62 4.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.667 -1.271 . . . . 0.02 110.381 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.557 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -96.49 122.4 39.36 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.806 -1.184 . . . . 3.2000000000000002 110.709 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.6 mt -144.35 120.58 10.85 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.869 -1.16 . . . . 2.6099999999999999 107.869 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.7 10.55 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 121.295 -0.878 . . . . 0.02 112.756 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 66.1 m -154.58 155.82 35.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 119.99 -1.888 . . . . 0.02 111.209 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -144.4 146.76 32.68 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.453 0.644 . . . . 0.02 109.914 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -135.94 140.04 43.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -0.77 . . . . 0.01 108.981 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.03 132.83 36.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.255 -0.903 . . . . 0.42999999999999999 109.286 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.84 123.38 42.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.445 -0.946 . . . . 1.25 108.445 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -89.56 134.73 33.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.832 -1.173 . . . . 1.77 107.832 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.21 139.51 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.739 -0.601 . . . . 1.6299999999999999 109.631 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -111.61 123.35 50.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.754 -1.202 . . . . 1.0800000000000001 107.754 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -115.05 133.88 55.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.749 -1.219 . . . . 1.26 107.971 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.88 -45.86 0.02 OUTLIER Glycine 0 N--CA 1.502 3.079 0 C-N-CA 117.669 -2.205 . . . . 0.01 113.777 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.74 -102.98 0.17 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.432 2.116 . . . . 0.01 111.129 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -119.54 118.23 30.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.284 -1.127 . . . . 4.4299999999999997 110.159 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.07 130.45 39.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.97 -0.692 . . . . 2.9900000000000002 109.258 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -131.31 136.87 48.5 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.055 -0.72 . . . . 6.3600000000000003 109.055 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 tt -128.28 145.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.528 -0.733 . . . . 1.0900000000000001 109.333 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.51 132.88 54.96 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.812 -1.181 . . . . 2.0499999999999998 107.812 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 20.1 m -122.89 145.42 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.785 -1.197 . . . . 1.1000000000000001 109.229 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.95 140.58 49.52 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.059 0.933 . . . . 0.72999999999999998 110.878 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.81 -29.37 69.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.83 -0.623 . . . . 0.02 111.654 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -117.78 168.65 10.27 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.101 -0.999 . . . . 3.1800000000000002 110.453 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.32 169.31 28.68 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.935 -0.866 . . . . 0.01 110.935 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 51.91 39.36 25.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.743 0.782 . . . . 0.01 111.218 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 51.88 51.63 16.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.558 -0.714 . . . . 0.01 110.853 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -124.86 165.98 17.08 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.462 -0.94 . . . . 3.1499999999999999 108.462 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.28 -165.31 27.6 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -74.29 144.65 44.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.081 -1.246 . . . . 0.01 108.239 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.453 ' C ' ' SD ' ' A' ' 107' ' ' MET . 19.0 tmm? -116.01 142.89 46.2 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.642 0.734 . . . . 0.01 109.773 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.422 ' N ' ' SD ' ' A' ' 107' ' ' MET . 63.5 m-85 -131.87 136.13 47.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.068 -1.086 . . . . 2.48 108.068 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -120.13 135.2 55.04 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.589 -0.694 . . . . 0.01 110.052 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -149.49 151.86 34.65 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.249 1.023 . . . . 1.6899999999999999 111.016 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -111.32 9.21 21.59 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.606 -0.724 . . . . 0.01 110.006 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 5.3 mp0 -120.52 162.87 18.84 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.29 -0.881 . . . . 3.21 111.282 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 173' ' ' ARG . 5.4 p-10 -67.9 156.89 36.2 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.239 -1.023 . . . . 0.01 108.239 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 43.0 t -125.84 112.08 24.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.745 -0.835 . . . . 0.01 108.745 178.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.3 -31.42 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.1 1.071 . . . . 0.01 111.197 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 t -140.34 106.97 5.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.583 -0.895 . . . . 0.02 108.583 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.23 -39.47 85.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.765 -0.584 . . . . 1.8300000000000001 110.808 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 ttm -66.53 -37.42 84.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.881 -1.127 . . . . 1.3400000000000001 109.98 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.15 -39.17 75.53 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.525 -1.36 . . . . 2.1099999999999999 109.798 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -80.62 -47.0 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 2.0800000000000001 112.473 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -111.25 -1.24 16.16 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.37 -0.831 . . . . 0.02 112.695 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m170 61.44 34.09 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.747 -1.221 . . . . 0.02 109.775 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -114.09 135.92 53.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.478 -0.764 . . . . 0.02 109.305 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.681 ' H ' ' CD ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.33 -22.08 21.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.175 -0.953 . . . . 5.3200000000000003 110.743 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.58 164.52 34.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.94 -1.1 . . . . 0.02 109.932 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 mm -129.12 124.72 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.629 -1.249 . . . . 2.1699999999999999 107.629 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.6 m80 -110.04 -14.43 14.23 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.02 112.633 -177.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.9 m -159.36 151.48 20.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.808 -1.183 . . . . 0.01 108.806 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -171.42 147.38 2.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.337 -0.852 . . . . 1.22 108.766 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -117.31 108.05 15.13 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.498 1.142 . . . . 1.4099999999999999 108.724 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -111.86 129.62 66.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.396 -1.335 . . . . 0.01 107.396 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -131.35 92.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.569 -1.332 . . . . 1.98 107.436 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 1.3 tm-20 -149.79 -61.84 0.21 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.972 -1.862 . . . . 0.01 105.972 177.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.35 -12.56 26.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.653 -2.579 . . . . 0.01 106.653 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 p -121.4 57.54 1.01 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.039 -0.683 . . . . 2.2999999999999998 110.5 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 74.4 m95 -128.36 134.66 48.9 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.005 -1.059 . . . . 0.01 109.985 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.12 137.7 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.305 -0.998 . . . . 1.6899999999999999 108.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.42 141.45 43.48 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.137 -1.431 . . . . 2.4900000000000002 107.137 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.486 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 25.9 m-85 -121.92 142.43 50.28 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.26 -0.9 . . . . 0.02 109.337 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.85 -30.08 62.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.02 111.551 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -116.17 154.96 48.7 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.801 -1.187 . . . . 1.48 108.858 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.02 166.91 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.146 1.231 . . . . 0.02 113.031 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.09 31.62 20.65 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.096 -0.956 . . . . 0.75 111.36 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.31 51.5 9.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.02 111.045 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.474 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.42 165.7 19.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.515 -0.741 . . . . 0.02 109.996 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.17 -165.93 34.74 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.248 -1.141 . . . . 0.02 110.248 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -68.67 141.65 55.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.989 . . . . 0.02 108.917 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.486 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 17.7 mt-30 -113.97 149.41 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.02 109.969 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.19 133.42 53.55 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.707 -0.849 . . . . 0.01 108.707 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.99 121.57 36.75 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.01 109.292 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 138' ' ' PHE . 18.2 mt -96.76 139.72 32.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -108.93 -168.48 1.35 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 2.27 109.514 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -80.33 40.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.8400000000000001 109.403 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -113.56 168.02 10.11 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 2.2799999999999998 109.42 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -102.57 120.59 40.81 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.451 -0.944 . . . . 0.01 108.451 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -98.01 114.38 26.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.347 -0.846 . . . . 0.01 110.308 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -92.72 -25.66 18.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.01 110.854 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -124.66 153.48 70.02 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 107.953 -1.129 . . . . 2.54 107.953 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.5 Cg_endo -60.55 -39.84 61.56 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.623 0.901 . . . . 0.69999999999999996 110.661 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.39 -19.08 17.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 120.78 -1.2 . . . . 0.85999999999999999 109.39 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.75 -18.32 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.868 -1.145 . . . . 0.02 112.039 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -102.5 15.48 29.12 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.859 -1.151 . . . . 0.02 110.079 178.29 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.05 10.98 74.02 Favored Glycine 0 N--CA 1.497 2.757 0 O-C-N 121.185 -0.947 . . . . 0.02 113.027 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.24 140.45 35.52 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.727 -1.455 . . . . 0.02 110.276 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.54 -6.98 59.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.546 -0.721 . . . . 0.58999999999999997 110.062 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.0 m -140.25 150.07 60.19 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.061 -1.025 . . . . 0.87 109.747 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.94 14.63 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.815 1.01 . . . . 0.38 111.947 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 121.18 26.22 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.329 1.061 . . . . 0.17999999999999999 110.847 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 mt -149.27 123.92 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.677 -1.972 . . . . 3.9900000000000002 105.677 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.82 -13.62 13.17 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.167 -0.958 . . . . 5.1699999999999999 113.138 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.5 t -157.6 160.76 38.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.153 -2.217 . . . . 0.02 110.192 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.13 152.95 32.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.529 -0.732 . . . . 2.02 109.807 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 144' ' ' TYR . 7.5 mmt180 -144.4 150.4 37.65 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.808 0.813 . . . . 0.01 110.194 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -88.23 143.87 26.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.471 -0.768 . . . . 0.01 109.04 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.89 129.42 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.438 -0.789 . . . . 3.04 109.205 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.5 t -136.01 146.61 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.209 -0.932 . . . . 1.8899999999999999 109.57 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 4.8899999999999997 109.209 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.533 -0.543 . . . . 5.2800000000000002 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -77.05 93.87 3.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 5.96 109.35 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.5 p -101.78 -141.59 0.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.902 -1.148 . . . . 2.2200000000000002 107.902 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.39 87.38 0.07 OUTLIER Glycine 0 N--CA 1.498 2.778 0 N-CA-C 106.926 -2.47 . . . . 0.81000000000000005 106.926 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 149.36 33.55 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.721 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' NZ ' ' OD1' ' A' ' 23' ' ' ASP . 56.0 tttp -149.19 136.36 19.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.994 . . . . 0.02 109.633 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.38 138.92 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.151 -0.685 . . . . 0.02 109.151 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -121.49 130.32 53.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.524 -0.735 . . . . 0.39000000000000001 109.985 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 22.7 m-85 -109.91 139.75 44.65 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.148 -0.686 . . . . 0.02 109.148 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 5.7 m-85 -122.42 138.44 54.54 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.249 -0.907 . . . . 0.02 109.563 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -70.19 -27.5 64.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.029999999999999999 111.949 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.57 ' C ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-20 -114.16 169.27 9.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.729 -1.232 . . . . 0.029999999999999999 110.14 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.43 157.19 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.639 0.733 . . . . 0.029999999999999999 110.419 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.5 m-20 66.75 34.26 5.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.045 0.926 . . . . 0.73999999999999999 111.441 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.7 m-85 55.53 42.59 29.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.293 0.568 . . . . 0.02 111.323 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -113.56 166.51 11.45 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.467 -0.938 . . . . 0.02 108.467 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.24 -167.72 36.17 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.89 -1.148 . . . . 0.029999999999999999 110.901 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.427 HH21 ' H ' ' A' ' 34' ' ' SER . 39.8 ttp180 -70.33 142.9 52.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.972 . . . . 2.7599999999999998 108.984 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -120.23 148.99 42.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.574 -0.704 . . . . 1.8899999999999999 110.294 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -131.23 126.3 35.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.729 -1.211 . . . . 0.02 107.729 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.43 137.15 51.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.456 -0.778 . . . . 1.1200000000000001 109.701 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.43 138.03 48.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.5 0.667 . . . . 0.02 109.621 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD1' ' NZ ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -117.18 10.34 13.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.20000000000000001 109.447 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.9 p -158.19 174.45 15.16 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.41 143.13 56.36 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.682 -1.261 . . . . 0.02 110.456 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.1 t -131.43 117.25 18.59 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.67 -25.68 49.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.23999999999999999 110.857 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -154.5 100.77 2.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.874 -1.141 . . . . 1.1399999999999999 108.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -105.4 9.84 33.57 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.05 0.929 . . . . 6.3700000000000001 109.641 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -57.89 -24.06 55.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.683 -0.636 . . . . 3.1099999999999999 110.612 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 p -73.93 -16.92 61.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.805 -1.185 . . . . 0.88 109.905 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.51 -22.29 13.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.02 109.5 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.0 tp -148.56 125.99 11.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.042 -1.036 . . . . 3.3199999999999998 109.52 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.427 ' H ' HH21 ' A' ' 18' ' ' ARG . 71.0 m -86.26 -10.77 53.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.625 -0.672 . . . . 0.02 111.461 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 30.7 ttt180 -170.5 160.45 7.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.816 -1.179 . . . . 0.02 107.816 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.1 p -141.94 113.09 7.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.86 -1.15 . . . . 0.02 108.728 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.792 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -109.09 2.91 21.45 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.797 -1.189 . . . . 0.029999999999999999 110.189 -179.398 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -155.52 152.59 29.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.66 -1.237 . . . . 0.02 107.66 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 39' ' ' ILE . 10.4 mt -146.49 147.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.02 110.119 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -124.71 125.5 44.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.78 114.22 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.779 -1.563 . . . . 0.02 106.779 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.75 -34.08 27.24 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.2 -0.6 . . . . 3.8100000000000001 110.408 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.33 151.47 21.07 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 119.081 -1.533 . . . . 0.02 110.33 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 174.46 50.01 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.543 -1.313 . . . . 0.01 110.085 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.435 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m -110.04 161.18 15.78 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.021 -1.474 . . . . 1.48 107.021 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.435 ' CD1' ' C ' ' A' ' 45' ' ' THR . 67.3 m95 -148.0 147.71 29.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.198 -1.564 . . . . 0.02 111.505 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.07 54.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 105.43 -2.063 . . . . 0.23999999999999999 105.43 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.3 m -117.83 142.29 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.503 -0.748 . . . . 0.65000000000000002 109.406 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 42.4 m-85 -121.56 144.64 48.61 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.952 0.882 . . . . 0.02 109.676 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.66 -34.99 79.07 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.501 -0.772 . . . . 0.02 111.722 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.06 163.59 42.78 Favored Pre-proline 0 N--CA 1.509 2.516 0 O-C-N 120.91 -1.119 . . . . 0.02 109.105 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.14 168.06 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.42 1.414 . . . . 0.02 113.359 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 63.22 36.89 11.6 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.082 -0.963 . . . . 0.02 112.121 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 44.78 52.0 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.675 0.75 . . . . 3.3900000000000001 111.017 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 m -126.58 163.98 22.23 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.239 0.542 . . . . 2.3300000000000001 109.704 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.24 -161.31 32.69 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.538 -1.425 . . . . 0.02 109.538 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.638 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.1 t-80 -69.72 137.98 52.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.993 -1.298 . . . . 0.02 109.946 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 19.0 ptm -119.16 136.47 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.333 -0.617 . . . . 5.0099999999999998 109.333 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 93.7 m-85 -128.28 139.51 52.38 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.914 -0.773 . . . . 0.02 108.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.95 131.83 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.2 mt -120.81 112.79 33.47 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.407 -0.808 . . . . 0.02 110.696 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.17 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.047 1.052 . . . . 1.47 110.096 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.614 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.2 pm0 -53.25 140.48 26.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.778 -1.201 . . . . 4.25 110.221 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.19 33.08 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.377 . . . . 0.02 110.438 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -119.25 130.18 55.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.325 -1.103 . . . . 0.95999999999999996 109.635 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE1' HD22 ' A' ' 61' ' ' LEU . 84.5 m-85 -120.82 96.8 48.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.96 -4.1 11.8 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 120.74 0.96 . . . . 0.02 113.756 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -157.68 155.02 29.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.671 -1.268 . . . . 2.02 108.256 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -60.29 -38.95 85.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.02 111.851 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.02 110.544 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.614 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.91 -18.6 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.187 0.994 . . . . 3.4199999999999999 108.581 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.566 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -106.87 9.94 30.75 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.386 -1.339 . . . . 0.02 107.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.0 mtt 60.55 21.32 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.475 0.655 . . . . 0.02 110.401 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.05 45.92 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.112 -1.595 . . . . 0.02 109.112 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.13 -29.52 48.86 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.438 -1.319 . . . . 0.97999999999999998 107.438 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -157.17 -171.71 3.73 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.523 -1.658 . . . . 0.02 106.523 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 87.4 m-20 -97.66 27.91 4.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.673 -1.267 . . . . 0.02 110.289 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -98.52 123.49 42.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.882 . . . . 3.2000000000000002 111.655 -178.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.5 mt -143.25 121.05 11.92 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.912 -1.514 . . . . 2.6099999999999999 106.912 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.25 -16.99 13.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.185 -0.947 . . . . 0.02 111.981 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -155.02 154.82 33.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.397 -1.649 . . . . 0.02 110.372 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.32 147.04 32.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.02 109.953 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -134.57 140.03 45.82 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 0.01 108.814 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.07 131.77 38.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.998 -1.112 . . . . 0.42999999999999999 107.998 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.0 t -91.71 123.98 44.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' O ' HG21 ' A' ' 135' ' ' THR . 7.8 m170 -91.66 136.23 33.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.981 -1.075 . . . . 1.77 108.744 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.64 137.0 38.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.378 -0.971 . . . . 1.6299999999999999 108.378 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -110.8 126.29 54.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.437 -0.949 . . . . 1.0800000000000001 108.437 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -103.71 -154.96 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.348 -1.723 . . . . 1.26 106.348 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.38 -48.1 0.93 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.506 -1.371 . . . . 0.01 112.178 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.78 -99.85 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.484 -1.817 . . . . 0.01 111.936 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -121.54 119.24 31.37 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.342 -1.093 . . . . 4.4299999999999997 110.504 -179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 129.28 35.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.988 -0.745 . . . . 2.9900000000000002 108.988 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.08 140.37 50.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.421 -0.799 . . . . 6.3600000000000003 109.15 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 tt -129.97 145.17 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.831 . . . . 1.0900000000000001 109.859 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.67 134.76 54.97 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.431 -1.322 . . . . 2.0499999999999998 107.431 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.91 147.25 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.831 -1.168 . . . . 1.1000000000000001 109.531 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.0 m-85 -119.64 141.66 49.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.123 0.963 . . . . 0.72999999999999998 111.032 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -66.24 -29.2 69.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.694 -0.685 . . . . 0.02 111.369 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -116.41 169.59 9.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.162 -0.961 . . . . 3.1800000000000002 110.459 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.97 165.07 51.28 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.898 -0.881 . . . . 0.01 110.898 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.95 38.03 29.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.833 -0.804 . . . . 0.01 111.349 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 51.83 54.99 9.96 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.632 -0.667 . . . . 0.01 111.494 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -128.77 165.61 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.955 -1.128 . . . . 3.1499999999999999 107.955 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.91 -164.36 28.72 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.214 -1.554 . . . . 0.01 109.214 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -75.35 144.12 42.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.012 -1.287 . . . . 0.01 108.748 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.75 143.17 45.98 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.601 0.715 . . . . 0.01 109.96 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -131.39 135.71 47.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.937 -1.135 . . . . 2.48 107.937 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.2 tm-20 -118.36 134.59 54.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.809 -0.557 . . . . 0.01 109.757 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.7 t -149.48 150.29 32.1 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 1.6899999999999999 110.911 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 46.7 p -109.6 9.95 25.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.51 -0.768 . . . . 0.01 109.863 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -121.43 163.64 18.41 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.429 -0.794 . . . . 3.21 111.438 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.46 155.37 37.75 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.199 -1.037 . . . . 0.01 108.199 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.8 t -122.17 110.79 32.51 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.28 -32.9 2.8 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.846 0.981 . . . . 0.01 111.584 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.1 t -141.69 107.04 5.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.011 -1.056 . . . . 0.02 108.732 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -64.35 -39.76 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.896 -0.503 . . . . 1.8300000000000001 111.087 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.38 -37.66 85.77 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.936 -1.105 . . . . 1.3400000000000001 109.888 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -70.16 -39.02 75.56 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.549 -1.344 . . . . 2.1099999999999999 109.684 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -80.31 -48.21 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -0.961 . . . . 2.0800000000000001 112.612 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.99 -1.09 15.52 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.367 -0.833 . . . . 0.02 112.612 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 5.8 m80 62.04 34.36 16.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.816 -1.178 . . . . 0.02 109.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 mt -114.86 135.83 53.76 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.505 -0.747 . . . . 0.02 109.514 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.672 ' N ' ' HE ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.45 -21.28 23.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.123 -0.985 . . . . 5.3200000000000003 110.86 -179.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.0 mt-10 -148.99 164.3 34.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.943 -1.098 . . . . 0.02 110.015 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.7 mm -129.44 126.16 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.403 -1.332 . . . . 2.1699999999999999 107.403 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -109.2 -12.72 14.77 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.267 -0.896 . . . . 0.02 112.693 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -159.52 153.13 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.679 -1.263 . . . . 0.01 108.829 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 21.8 p -167.4 142.97 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 1.22 109.399 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -124.44 106.92 10.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.464 1.126 . . . . 1.4099999999999999 109.834 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 136' ' ' TRP . 7.2 p -110.95 137.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.575 -1.268 . . . . 0.01 107.575 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.39 92.97 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 106.782 -1.562 . . . . 1.98 106.782 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 3.4 tm-20 -146.59 -67.82 0.27 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.613 -1.995 . . . . 0.01 105.613 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 170.56 -78.44 0.1 OUTLIER Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.556 -1.818 . . . . 0.01 108.556 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 86' ' ' HIS . 54.6 p -121.71 123.86 42.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.628 -0.925 . . . . 2.2999999999999998 110.587 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 131' ' ' VAL . 6.7 m95 -126.6 152.32 46.79 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.574 -1.639 . . . . 0.01 106.574 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.74 134.24 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.577 -1.327 . . . . 1.6899999999999999 109.713 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -111.33 142.45 43.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.307 -1.738 . . . . 2.4900000000000002 106.307 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.475 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 30.9 m-85 -122.37 142.51 50.44 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.133 -0.979 . . . . 0.02 109.431 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.493 ' O ' ' NE2' ' A' ' 170' ' ' GLN . 9.9 tp10 -75.04 -30.27 61.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.673 -0.642 . . . . 0.02 111.709 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.9 mt -114.47 152.77 46.44 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 120.66 -1.275 . . . . 1.48 109.054 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.49 165.98 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 120.81 1.007 . . . . 0.02 112.757 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 60.01 31.6 20.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.395 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 58.05 51.87 8.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.495 -0.753 . . . . 0.02 111.52 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.36 166.1 18.49 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.393 -0.817 . . . . 0.02 110.097 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.29 -165.42 34.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.064 -1.214 . . . . 0.02 110.064 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -69.66 142.91 53.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.976 . . . . 0.02 108.927 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 20.9 mt-30 -113.85 148.97 35.74 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.255 0.55 . . . . 0.02 109.727 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -123.69 133.21 53.92 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.14 122.01 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.819 -1.176 . . . . 0.01 109.255 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -96.25 146.48 24.68 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.01 108.677 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 154' ' ' LYS . 9.0 m-20 -105.58 -169.18 1.55 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.453 -0.78 . . . . 2.27 109.684 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.16 31.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 1.8400000000000001 109.583 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 152' ' ' ASP . 19.5 mtpp -111.7 171.31 7.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.335 -0.853 . . . . 2.2799999999999998 109.153 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.05 133.62 48.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.196 -1.039 . . . . 0.01 108.196 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.22 115.01 28.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.01 110.239 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -90.57 -28.38 18.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.736 -0.602 . . . . 0.01 110.958 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -123.38 154.31 65.75 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.739 -1.208 . . . . 2.54 107.739 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -62.01 -41.84 33.97 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 119.207 0.752 . . . . 0.69999999999999996 111.209 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.87 -19.41 19.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.79 -1.193 . . . . 0.85999999999999999 109.707 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 161' ' ' ASP . 56.2 t0 -65.92 -18.5 65.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.802 -1.187 . . . . 0.02 112.034 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.26 15.9 27.29 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.725 -1.235 . . . . 0.02 110.171 178.396 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.89 10.16 76.2 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.115 -0.99 . . . . 0.02 113.035 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.53 140.83 34.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.819 -1.401 . . . . 0.02 110.185 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.06 -7.05 59.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.58999999999999997 109.735 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -140.55 151.09 62.72 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.196 -0.94 . . . . 0.87 109.309 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.26 15.46 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.703 0.935 . . . . 0.38 111.952 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.66 120.52 25.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.916 -1.115 . . . . 0.17999999999999999 110.741 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.43 122.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.579 -2.008 . . . . 3.9900000000000002 105.579 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mp0 -112.17 -13.13 13.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.244 -0.91 . . . . 5.1699999999999999 112.936 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.0 m -157.04 158.69 36.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.13 -2.231 . . . . 0.02 110.085 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -153.16 154.81 35.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 2.02 110.188 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -144.19 149.5 36.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.276 -0.89 . . . . 0.01 110.162 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -86.62 143.14 27.78 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.524 -0.917 . . . . 0.01 108.524 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.16 128.38 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.141 -0.975 . . . . 3.04 109.79 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 177' ' ' GLU . 60.6 t -137.06 147.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.229 -0.919 . . . . 1.8899999999999999 109.663 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 176' ' ' VAL . 7.8 tm-20 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 4.8899999999999997 109.297 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.387 0.613 . . . . 5.2800000000000002 109.418 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -65.0 99.19 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 5.96 109.521 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.0 p -104.24 -141.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.349 -0.982 . . . . 2.2200000000000002 108.349 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.57 88.43 0.07 OUTLIER Glycine 0 N--CA 1.496 2.684 0 N-CA-C 107.096 -2.402 . . . . 0.81000000000000005 107.096 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.82 149.82 33.54 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.112 -1.042 . . . . 0.01 110.749 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.05 136.29 18.84 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.981 . . . . 0.02 109.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.23 139.44 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.793 -0.567 . . . . 0.02 109.543 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 t -122.16 130.46 53.23 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.553 -0.717 . . . . 0.39000000000000001 109.916 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 m-85 -110.08 139.99 44.62 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.032 -0.729 . . . . 0.02 109.032 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.51 139.14 54.22 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.292 -0.88 . . . . 0.02 109.813 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.451 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.39 -28.03 66.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.938 -1.101 . . . . 0.029999999999999999 111.804 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -114.14 169.07 9.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.888 -1.132 . . . . 0.029999999999999999 110.201 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -74.96 158.15 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.666 0.746 . . . . 0.029999999999999999 109.895 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.47 34.94 5.84 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.729 0.776 . . . . 0.73999999999999999 110.8 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.1 p90 49.72 44.39 24.73 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.742 0.782 . . . . 0.02 111.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.73 166.72 11.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.87 -1.159 . . . . 0.02 107.87 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.1 -167.75 36.44 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.669 -1.253 . . . . 0.029999999999999999 110.673 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.19 142.73 54.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.977 . . . . 2.7599999999999998 108.943 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' NH1' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tmm_? -121.57 150.67 41.32 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.71 0.766 . . . . 1.8899999999999999 110.42 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -132.82 127.55 34.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 0.02 108.045 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' NH1' ' A' ' 19' ' ' ARG . 3.3 p-10 -111.83 136.46 51.09 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.563 -0.711 . . . . 1.1200000000000001 109.711 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -130.91 137.69 49.43 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.494 0.664 . . . . 0.02 109.467 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -116.83 10.1 14.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.20000000000000001 109.375 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.3 p -158.59 174.3 15.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 13.0 t0 -60.8 142.31 56.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.782 -1.199 . . . . 0.02 110.327 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 43.2 t -131.57 116.58 17.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.316 -0.994 . . . . 0.02 108.316 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.59 -24.33 53.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.23999999999999999 110.995 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -154.65 102.4 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.006 -1.059 . . . . 1.1399999999999999 108.86 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CZ ' ' NH2' ' A' ' 30' ' ' ARG . 17.9 p90 -104.38 8.38 35.8 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.192 0.996 . . . . 6.3700000000000001 109.487 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.436 HH11 ' NH2' ' A' ' 78' ' ' ARG . 3.3 mmp_? -58.3 -24.22 58.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 3.1099999999999999 110.715 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -74.69 -17.1 60.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.768 -1.208 . . . . 0.88 109.933 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -104.13 -22.41 13.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.421 -0.799 . . . . 0.02 109.416 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.451 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.01 128.51 12.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.113 -0.992 . . . . 3.3199999999999998 109.138 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -85.54 -10.03 56.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.723 -0.611 . . . . 0.02 111.288 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -171.86 163.1 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.759 -1.2 . . . . 0.02 107.759 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 p -143.98 115.71 8.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.199 . . . . 0.02 108.736 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 1.1 m-20 -107.06 1.83 24.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.957 -1.089 . . . . 0.029999999999999999 110.548 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.6 p -156.88 154.72 30.25 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.507 -1.294 . . . . 0.02 107.507 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mt -146.17 148.16 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 0.02 109.777 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -125.04 125.43 43.83 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.47 114.94 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.714 -1.587 . . . . 0.02 106.714 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.87 -34.33 26.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.796 -0.565 . . . . 3.8100000000000001 110.42 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.36 151.5 21.1 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.142 -1.504 . . . . 0.02 110.167 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 175.09 50.68 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.582 -1.294 . . . . 0.01 110.264 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 46' ' ' TRP . 84.0 m -109.46 161.3 15.45 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.901 -1.518 . . . . 1.48 106.901 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.424 ' N ' HG22 ' A' ' 45' ' ' THR . 65.6 m95 -147.38 146.64 29.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.347 -1.47 . . . . 0.02 111.402 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.79 54.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 105.466 -2.05 . . . . 0.23999999999999999 105.466 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.0 m -117.73 141.98 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.607 -0.683 . . . . 0.65000000000000002 109.493 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' N ' ' CD1' ' A' ' 49' ' ' TYR . 8.5 m-85 -122.0 143.36 49.53 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.511 1.148 . . . . 0.02 109.652 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 6.0 tp10 -65.37 -36.25 83.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.729 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.1 153.51 64.56 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.97 -1.081 . . . . 0.02 109.305 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.13 167.74 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.31 1.34 . . . . 0.02 112.772 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 63.26 37.05 11.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.175 -0.921 . . . . 0.02 110.998 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER 45.12 52.83 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.683 0.754 . . . . 3.3900000000000001 110.896 178.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -126.58 163.85 22.52 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.168 0.509 . . . . 2.3300000000000001 109.866 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.84 32.27 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.13 -1.188 . . . . 0.02 110.13 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.93 138.52 58.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.976 -1.308 . . . . 0.02 110.117 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.7 mtm -120.55 134.47 55.27 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.606 0.717 . . . . 5.0099999999999998 109.679 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.3 m-85 -134.25 139.02 45.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.02 109.561 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -97.25 133.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.85 113.68 32.91 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.561 -0.712 . . . . 0.02 110.56 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.4 168.72 22.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.154 1.091 . . . . 1.47 110.155 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.17 141.39 23.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.746 -1.221 . . . . 4.25 110.151 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.03 -176.51 32.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.412 -1.375 . . . . 0.02 110.567 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -119.4 130.6 55.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -1.082 . . . . 0.95999999999999996 109.403 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 49.3 m-85 -121.1 98.71 47.01 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 107.671 -1.233 . . . . 0.02 107.671 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -70.54 -3.39 12.42 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.629 0.886 . . . . 0.02 113.806 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -157.26 155.01 30.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.592 -1.317 . . . . 2.02 108.206 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -60.65 -39.14 87.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.577 -0.702 . . . . 0.02 111.814 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.81 -23.8 63.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.02 110.181 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.549 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.73 -18.54 62.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.96 0.886 . . . . 3.4199999999999999 108.626 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -106.82 10.31 30.74 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.171 -1.418 . . . . 0.02 107.171 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.35 22.62 11.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.557 0.694 . . . . 0.02 110.18 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.98 47.36 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.8 tp -78.76 -29.68 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.649 -1.241 . . . . 0.97999999999999998 107.649 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.6 p30 -157.67 -171.03 3.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.619 -1.623 . . . . 0.02 106.619 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -98.17 28.29 4.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.633 -1.292 . . . . 0.02 110.238 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH2' HH11 ' A' ' 30' ' ' ARG . 17.7 mmm180 -98.05 123.01 41.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.285 -0.884 . . . . 3.2000000000000002 111.38 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.0 mt -144.65 121.59 11.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.048 -1.464 . . . . 2.6099999999999999 107.048 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 -16.39 14.48 Favored Glycine 0 N--CA 1.5 2.905 0 O-C-N 121.303 -0.873 . . . . 0.02 112.171 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.01 154.65 32.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.247 -1.737 . . . . 0.02 110.401 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.6 p -144.69 147.36 32.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.02 109.688 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -133.86 140.13 46.66 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.664 -0.865 . . . . 0.01 108.664 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.11 129.22 36.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 0.42999999999999999 107.935 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.0 t -91.96 123.69 44.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.893 -0.78 . . . . 1.25 108.893 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . 0.498 ' O ' HG21 ' A' ' 135' ' ' THR . 15.6 m80 -90.66 136.65 32.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.276 -0.89 . . . . 1.77 109.006 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -99.25 137.48 37.7 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.94 -1.133 . . . . 1.6299999999999999 107.94 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 t -112.25 126.5 55.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -0.876 . . . . 1.0800000000000001 109.14 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -103.61 -154.94 0.51 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.221 -1.77 . . . . 1.26 106.221 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.02 -49.58 0.86 Allowed Glycine 0 N--CA 1.498 2.79 0 O-C-N 120.418 -1.426 . . . . 0.01 112.232 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.04 -100.05 0.14 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 118.397 -1.859 . . . . 0.01 111.889 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.95 118.62 30.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.292 -1.122 . . . . 4.4299999999999997 110.394 -179.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.86 129.66 36.53 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 2.9900000000000002 109.287 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -129.97 139.46 51.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.576 -0.703 . . . . 6.3600000000000003 109.436 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tt -129.35 145.78 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.414 -0.804 . . . . 1.0900000000000001 109.71 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -121.18 133.22 55.18 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.29 -1.374 . . . . 2.0499999999999998 107.29 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.4 146.61 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.954 -1.091 . . . . 1.1000000000000001 109.351 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 33.2 m-85 -119.72 141.39 49.46 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.194 0.997 . . . . 0.72999999999999998 110.922 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.31 -29.25 69.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.711 -0.677 . . . . 0.02 111.587 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -116.61 169.8 9.07 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.075 -1.016 . . . . 3.1800000000000002 110.444 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.95 165.33 50.97 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.843 -0.903 . . . . 0.01 110.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' OD1' ' NH1' ' A' ' 157' ' ' ARG . 9.6 t0 56.8 38.37 29.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.956 -0.732 . . . . 0.01 111.307 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 51.65 54.44 10.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.01 111.368 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 166.14 19.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.062 -1.088 . . . . 3.1499999999999999 108.062 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -164.19 28.63 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.014 -1.635 . . . . 0.01 109.014 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 70.2 tp60 -75.34 143.86 42.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.285 . . . . 0.01 108.518 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.3 ttp -116.79 142.84 46.4 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.59 0.71 . . . . 0.01 109.838 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -131.65 136.38 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.073 -1.084 . . . . 2.48 108.073 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.57 134.8 54.82 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.684 -0.635 . . . . 0.01 110.093 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.514 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -149.14 150.49 32.77 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.237 1.018 . . . . 1.6899999999999999 111.031 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.6 p -110.11 10.02 24.01 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.674 -0.694 . . . . 0.01 109.811 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -120.77 163.23 18.44 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.282 -0.887 . . . . 3.21 111.272 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.1 155.18 37.57 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.021 -1.103 . . . . 0.01 108.021 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.2 t -123.18 109.77 31.3 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.67 -31.91 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 CA-C-N 119.997 1.035 . . . . 0.01 111.696 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -140.96 107.42 5.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.37 -0.832 . . . . 0.02 108.774 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.52 -39.44 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.56 . . . . 1.8300000000000001 110.668 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 40.7 ttp -66.32 -37.52 85.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.966 -1.094 . . . . 1.3400000000000001 109.959 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.18 -39.27 71.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.399 -1.438 . . . . 2.1099999999999999 109.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.72 -47.86 13.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 2.0800000000000001 112.447 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.19 -1.96 15.95 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.352 -0.843 . . . . 0.02 112.517 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.0 m80 61.87 33.96 17.29 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.659 -1.276 . . . . 0.02 109.403 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.1 mt -114.63 135.54 54.03 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.487 -0.758 . . . . 0.02 109.264 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' H ' ' HD2' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.13 -21.19 23.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.159 -0.963 . . . . 5.3200000000000003 110.761 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 124' ' ' ARG . 10.9 mp0 -147.32 163.95 34.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.912 -1.117 . . . . 0.02 109.504 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.0 mm -126.97 124.23 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.339 -1.356 . . . . 2.1699999999999999 107.339 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -110.3 -13.48 14.31 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.238 -0.914 . . . . 0.02 112.516 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 t -160.79 151.65 18.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.835 -1.165 . . . . 0.01 109.24 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.2 p -168.78 143.93 3.33 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.674 -0.861 . . . . 1.22 108.674 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.46 109.6 13.48 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.448 1.118 . . . . 1.4099999999999999 109.669 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 131' ' ' VAL . 11.5 p -111.04 137.81 41.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.619 -1.252 . . . . 0.01 107.619 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.03 92.81 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 106.693 -1.595 . . . . 1.98 106.693 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 22.8 tt0 -146.82 -73.01 0.22 Allowed 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 105.498 -2.038 . . . . 0.01 105.498 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.67 -75.23 0.09 OUTLIER Glycine 0 N--CA 1.48 1.6 0 N-CA-C 108.362 -1.895 . . . . 0.01 108.362 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.498 HG21 ' O ' ' A' ' 86' ' ' HIS . 70.6 p -123.46 124.37 42.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.3 1.048 . . . . 2.2999999999999998 111.311 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 6.4 m95 -127.06 151.36 48.72 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.557 -1.646 . . . . 0.01 106.557 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.463 ' CG1' HD11 ' A' ' 175' ' ' ILE . 12.3 mt -117.18 133.62 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.507 -1.371 . . . . 1.6899999999999999 109.162 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.47 141.14 45.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.29 -1.745 . . . . 2.4900000000000002 106.29 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.8 m-85 -123.05 142.98 50.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.918 . . . . 0.02 109.605 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.66 -30.49 62.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.79 -0.569 . . . . 0.02 111.725 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.9 154.9 48.31 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.655 -1.278 . . . . 1.48 108.975 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.5 167.08 2.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.091 1.194 . . . . 0.02 112.926 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.79 31.38 20.77 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.05 -0.977 . . . . 0.75 111.363 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 57.31 51.89 9.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.42 -0.8 . . . . 0.02 111.361 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -126.57 164.84 20.33 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.504 -0.748 . . . . 0.02 110.114 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.2 33.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.227 -1.149 . . . . 0.02 110.227 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.02 108.61 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -113.4 148.13 36.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.734 -0.604 . . . . 0.02 109.533 -178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.31 133.99 54.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.912 -0.773 . . . . 0.01 108.912 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 48.0 tp -96.63 121.66 38.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.01 109.378 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -95.75 139.08 32.49 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.557 -0.905 . . . . 0.01 108.557 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 3.0 p30 -105.55 -168.32 1.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.498 -0.751 . . . . 2.27 109.499 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -82.57 38.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 1.8400000000000001 110.005 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.28 175.28 5.54 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.379 -0.826 . . . . 2.2799999999999998 109.45 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -105.31 125.51 51.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.723 -0.843 . . . . 0.01 108.723 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 1.5 m-85 -100.35 112.73 25.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.243 -0.911 . . . . 0.01 109.817 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.526 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 12.8 mmm180 -88.35 -28.09 21.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.957 -1.089 . . . . 0.01 110.549 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -126.88 156.04 74.57 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 107.045 -1.465 . . . . 2.54 107.045 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 162' ' ' TRP . 5.6 Cg_endo -59.56 -34.26 96.81 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 CA-C-N 119.721 0.936 . . . . 0.69999999999999996 110.335 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.1 t -62.88 -21.16 27.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.873 -1.142 . . . . 0.85999999999999999 109.564 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.07 -20.51 65.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.672 -1.268 . . . . 0.02 111.439 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p90 -103.03 13.32 34.53 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.979 -1.075 . . . . 0.02 109.243 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.75 11.98 64.95 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.771 -0.728 . . . . 0.02 113.549 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.78 138.06 38.33 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 119.627 1.713 . . . . 0.02 110.411 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.79 -7.85 58.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.692 -0.63 . . . . 0.58999999999999997 109.796 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 87.0 p -139.98 150.16 61.3 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.312 -0.868 . . . . 0.87 109.551 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.5 13.5 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.688 0.925 . . . . 0.38 112.031 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.95 120.2 24.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.17999999999999999 110.921 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.15 124.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.79 -1.929 . . . . 3.9900000000000002 105.79 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -112.25 -12.95 13.54 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.311 -0.868 . . . . 5.1699999999999999 113.171 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 33.3 t -156.76 159.0 37.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 119.354 -2.091 . . . . 0.02 110.076 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.01 154.14 34.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.303 -0.873 . . . . 2.02 110.7 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -143.51 149.29 37.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.385 -0.822 . . . . 0.01 110.237 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -86.41 142.83 28.15 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.53 -0.915 . . . . 0.01 108.53 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 137' ' ' ILE . 7.3 mt -94.38 128.45 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.12 -0.987 . . . . 3.04 109.851 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.59 147.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.764 . . . . 1.8899999999999999 109.458 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 4.8899999999999997 109.102 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.431 -0.581 . . . . 5.2800000000000002 109.431 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -72.78 95.81 1.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 5.96 109.541 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 p -101.93 -141.45 0.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.978 -1.119 . . . . 2.2200000000000002 107.978 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.39 87.03 0.06 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 107.088 -2.405 . . . . 0.81000000000000005 107.088 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.37 149.59 34.01 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 120.026 -1.083 . . . . 0.01 110.692 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -150.04 135.98 18.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.978 . . . . 0.02 109.509 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.25 140.83 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.432 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 4.3 m -121.32 130.06 53.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.625 -0.672 . . . . 0.39000000000000001 109.575 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -109.69 139.24 44.96 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.76 -0.83 . . . . 0.02 108.76 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 9.0 m-85 -123.18 139.28 54.23 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.266 -0.896 . . . . 0.02 109.765 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 86.2 mt-10 -69.15 -28.1 66.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.989 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.69 170.22 8.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.932 -1.105 . . . . 0.029999999999999999 110.426 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.495 ' NH2' ' OE1' ' A' ' 70' ' ' GLN . 73.0 mtt180 -74.07 157.71 35.59 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.638 0.732 . . . . 0.029999999999999999 109.929 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 50.9 t30 65.76 35.03 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.931 0.872 . . . . 0.73999999999999999 111.037 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.1 p90 50.29 45.61 25.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.839 0.828 . . . . 0.02 111.197 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.39 165.85 11.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.989 -1.115 . . . . 0.02 107.989 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.2 35.91 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.702 -1.237 . . . . 0.029999999999999999 110.853 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' ' OE2' ' A' ' 11' ' ' GLU . 22.3 ttp180 -68.64 142.78 55.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -1.048 . . . . 2.7599999999999998 109.414 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 54.9 ttt180 -119.79 147.65 44.38 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.593 0.711 . . . . 1.8899999999999999 109.893 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -132.61 126.68 33.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.833 -1.173 . . . . 0.02 107.833 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.39 137.78 50.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.473 -0.767 . . . . 1.1200000000000001 109.756 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.08 138.55 49.61 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.648 0.737 . . . . 0.02 109.807 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.28 10.81 14.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.687 -0.633 . . . . 0.20000000000000001 109.542 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 t -157.08 174.47 15.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 40.3 t0 -60.84 144.46 52.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.733 -1.229 . . . . 0.02 109.969 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 20.9 t -131.95 116.11 16.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.49 -0.93 . . . . 0.02 108.49 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.18 51.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.23999999999999999 110.891 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.6 p-10 -154.4 101.56 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 1.1399999999999999 108.84 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.9 p90 -105.43 10.36 33.34 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.331 1.063 . . . . 6.3700000000000001 110.159 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.418 ' NH2' ' O ' ' A' ' 34' ' ' SER . 21.6 mmm180 -60.22 -23.03 63.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 3.1099999999999999 110.924 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -76.3 -16.94 59.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.619 -1.301 . . . . 0.88 110.222 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.23 -20.97 14.46 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.79 -0.818 . . . . 0.02 108.79 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.15 129.37 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.78 0.8 . . . . 3.3199999999999998 109.002 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 90.4 p -85.16 -10.78 56.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.762 -0.586 . . . . 0.02 110.717 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.46 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 12.5 ptm180 -170.26 162.13 8.51 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.639 -1.245 . . . . 0.02 107.639 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 t -143.6 115.34 8.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.02 108.978 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.444 HD22 HH21 ' A' ' 35' ' ' ARG . 2.4 m120 -110.33 1.2 18.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.739 -1.226 . . . . 0.029999999999999999 111.422 -178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 t -156.96 154.78 30.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.131 -1.062 . . . . 0.02 108.131 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -146.49 146.88 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 122.185 0.993 . . . . 0.02 111.105 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -122.8 124.11 42.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.616 -1.253 . . . . 0.02 107.616 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.48 114.83 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 106.598 -1.63 . . . . 0.02 106.598 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.7 mp0 -83.83 -33.73 24.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 3.8100000000000001 110.269 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.32 149.8 18.34 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.104 -1.522 . . . . 0.02 110.133 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.07 173.87 50.03 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.648 -1.263 . . . . 0.01 110.153 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.6 m -119.64 137.28 53.98 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -126.09 153.93 43.8 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.712 1.244 . . . . 0.02 112.361 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.99 133.39 52.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.051 -2.203 . . . . 0.23999999999999999 105.051 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.87 142.03 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.658 -0.651 . . . . 0.65000000000000002 109.337 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -120.97 143.01 49.24 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.169 0.985 . . . . 0.02 109.655 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.58 -34.3 77.93 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.376 -0.829 . . . . 0.02 111.778 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -124.82 157.84 64.75 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.942 -1.099 . . . . 0.02 109.549 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.91 166.31 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.739 1.626 . . . . 0.02 112.741 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.77 37.31 9.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.314 -0.857 . . . . 0.02 111.058 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.85 52.23 8.13 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.551 0.691 . . . . 3.3900000000000001 110.598 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -126.21 163.87 22.23 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.181 0.515 . . . . 2.3300000000000001 110.016 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -162.02 31.29 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.871 -1.292 . . . . 0.02 109.871 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.65 136.38 57.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.275 . . . . 0.02 110.035 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 19.1 ptm -118.58 135.66 54.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.62 . . . . 5.0099999999999998 109.435 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.623 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 25.6 m-85 -135.52 141.09 45.21 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.509 -0.744 . . . . 0.02 109.34 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.51 133.04 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.59 -0.892 . . . . 1.72 108.59 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 66' ' ' TYR . 17.3 mt -123.74 111.79 29.27 Favored Pre-proline 0 N--CA 1.502 2.159 0 O-C-N 121.371 -0.831 . . . . 0.02 110.4 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.96 171.37 18.29 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.839 0.978 . . . . 1.47 110.237 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 11.3 tm0? -51.42 140.79 16.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.002 -1.061 . . . . 4.25 109.863 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.32 -178.56 31.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.403 -1.38 . . . . 0.02 110.883 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.3 tp10 -120.36 131.21 54.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.44 -1.035 . . . . 0.95999999999999996 109.461 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 93.3 m-85 -122.21 95.29 47.36 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.2 Cg_exo -65.65 -3.45 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.892 1.061 . . . . 0.02 114.179 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 36.1 mt-10 -157.78 154.99 29.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.415 -1.428 . . . . 2.02 108.087 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 7.3 p90 -60.8 -38.57 85.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.523 -0.735 . . . . 0.02 111.995 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 24.7 mt-30 -59.58 -24.21 63.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.02 110.367 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 71' ' ' ARG . 0.1 OUTLIER -70.84 -18.18 62.72 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.404 -0.961 . . . . 3.4199999999999999 108.404 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.623 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.89 9.87 30.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.258 -1.386 . . . . 0.02 107.258 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 60.86 21.48 11.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.587 -0.696 . . . . 0.02 110.41 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.05 145.01 46.56 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.392 -1.483 . . . . 0.02 109.392 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 75' ' ' LEU . 8.1 mp -78.6 -29.95 46.31 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.663 -1.236 . . . . 0.97999999999999998 107.663 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.459 -1.682 . . . . 0.02 106.459 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 5.5 p30 -97.21 28.56 3.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.669 -1.27 . . . . 0.02 110.21 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -96.31 121.42 38.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.914 -1.116 . . . . 3.2000000000000002 110.33 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.3 119.72 10.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.794 -1.187 . . . . 2.6099999999999999 107.794 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.22 -15.94 10.12 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.338 -0.851 . . . . 0.02 112.975 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 47.3 t -155.55 155.59 33.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.97 -1.9 . . . . 0.02 110.943 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.43 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 23.9 p -145.86 148.7 33.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.487 -0.758 . . . . 0.02 110.397 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -135.53 140.53 44.8 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.394 -0.816 . . . . 0.01 108.888 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.33 130.97 36.8 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.081 -1.012 . . . . 0.42999999999999999 109.197 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.33 123.31 41.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.334 -0.987 . . . . 1.25 108.334 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.9 m80 -90.65 135.08 33.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.876 -1.14 . . . . 1.77 108.166 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.85 138.49 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.735 -0.839 . . . . 1.6299999999999999 108.735 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -111.56 125.4 53.88 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.495 -0.928 . . . . 1.0800000000000001 108.495 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -102.58 -156.13 0.55 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.93 -45.86 1.05 Allowed Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.339 -1.476 . . . . 0.01 112.068 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.33 -97.85 0.11 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.463 -1.827 . . . . 0.01 112.159 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -121.48 120.42 34.87 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.389 -1.065 . . . . 4.4299999999999997 110.707 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -74.92 131.49 40.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 2.9900000000000002 109.201 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.533 ' HZ2' ' HB3' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -131.19 137.71 49.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.574 -0.704 . . . . 6.3600000000000003 109.523 -179.266 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 6.6 tt -127.78 142.75 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.861 0.838 . . . . 1.0900000000000001 109.456 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.1 pm0 -125.21 134.59 52.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.177 -1.045 . . . . 2.0499999999999998 108.177 178.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.72 148.48 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.88 -1.137 . . . . 1.1000000000000001 109.961 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 51.7 m-85 -118.32 141.16 48.81 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.925 0.869 . . . . 0.72999999999999998 110.777 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.9 -29.8 69.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 116.013 -0.54 . . . . 0.02 111.813 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -116.69 167.96 10.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.087 -1.008 . . . . 3.1800000000000002 110.573 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.29 164.03 41.5 Favored Glycine 0 N--CA 1.492 2.398 0 CA-C-O 121.936 0.742 . . . . 0.01 111.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.8 m-20 56.39 39.49 30.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.955 -0.733 . . . . 0.01 110.928 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' H ' ' CB ' ' A' ' 128' ' ' SER . 4.7 m-85 52.27 55.51 9.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.732 -0.605 . . . . 0.01 110.826 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -128.82 165.84 20.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.399 -0.963 . . . . 3.1499999999999999 108.399 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.85 -164.3 27.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.204 -1.558 . . . . 0.01 109.204 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -74.51 144.5 44.08 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.263 . . . . 0.01 108.167 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.54 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.6 ttp -116.71 142.28 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.647 0.737 . . . . 0.01 109.454 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.18 136.63 48.45 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.191 -1.04 . . . . 2.48 108.191 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 110' ' ' THR . 8.8 tp10 -119.09 133.67 55.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.714 -0.616 . . . . 0.01 109.741 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.533 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -148.99 149.39 31.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 1.6899999999999999 110.593 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 24.3 p -108.7 10.25 26.88 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.763 -0.653 . . . . 0.01 109.724 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 37.3 mp0 -120.81 163.12 18.65 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.383 -0.823 . . . . 3.21 111.234 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.1 p30 -65.75 154.73 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.052 -1.092 . . . . 0.01 108.052 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.7 t -122.5 110.16 32.33 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 108.512 -0.921 . . . . 0.01 108.512 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -76.91 -31.63 3.79 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 119.969 1.025 . . . . 0.01 111.833 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.2 t -142.02 107.92 5.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.088 -1.008 . . . . 0.02 108.792 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.4 mt -63.52 -39.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.913 -0.492 . . . . 1.8300000000000001 110.576 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.49 -37.28 84.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.003 -1.079 . . . . 1.3400000000000001 109.945 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -70.82 -39.12 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.489 -1.382 . . . . 2.1099999999999999 109.842 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.5 tt0 -80.78 -48.22 12.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 2.0800000000000001 112.564 -176.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.442 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 58.6 m-85 -111.82 -1.49 15.54 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.424 -0.797 . . . . 0.02 112.707 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 61.1 34.4 19.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.095 . . . . 0.02 109.769 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.19 135.49 53.98 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.534 -0.729 . . . . 0.02 109.152 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -90.32 -21.51 22.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.155 -0.966 . . . . 5.3200000000000003 111.006 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 126' ' ' ILE . 39.8 mt-10 -148.42 163.57 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.045 -1.034 . . . . 0.02 110.06 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 125' ' ' GLU . 39.4 mm -128.48 125.6 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.554 -1.276 . . . . 2.1699999999999999 107.554 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -109.82 -13.9 14.39 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.145 -0.972 . . . . 0.02 113.118 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.555 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 8.4 m -161.81 154.16 19.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.573 -1.33 . . . . 0.01 109.627 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.7 p -166.23 142.47 4.92 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.751 -0.833 . . . . 1.22 108.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.541 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -118.72 96.88 5.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.422 1.106 . . . . 1.4099999999999999 108.221 179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.493 ' HA ' HE21 ' A' ' 96' ' ' GLN . 11.6 p -107.67 137.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.281 -0.872 . . . . 0.01 108.794 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.67 90.23 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 105.336 -2.098 . . . . 1.98 105.336 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.449 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -149.47 -67.71 0.21 Allowed 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.836 -1.542 . . . . 0.01 106.836 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.39 31.39 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 107.168 -2.373 . . . . 0.01 107.168 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.2 p -121.73 58.47 1.01 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.843 -0.798 . . . . 2.2999999999999998 110.535 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CD1' HG21 ' A' ' 131' ' ' VAL . 87.6 m95 -130.69 135.33 47.72 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.809 -1.182 . . . . 0.01 110.658 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.7 mt -119.8 137.71 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.393 -0.966 . . . . 1.6899999999999999 108.393 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.82 141.26 44.41 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.168 -1.419 . . . . 2.4900000000000002 107.168 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -122.5 142.31 50.72 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.234 -0.916 . . . . 0.02 109.646 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -31.2 61.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.714 -0.616 . . . . 0.02 112.187 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.69 155.03 48.0 Favored Pre-proline 0 N--CA 1.506 2.355 0 O-C-N 120.736 -1.228 . . . . 1.48 109.135 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.3 Cg_endo -54.92 166.43 2.09 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.022 1.148 . . . . 0.02 112.913 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 142' ' ' PRO . 5.6 p30 57.05 31.9 20.74 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.056 -0.975 . . . . 0.75 111.822 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.445 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 59.35 51.85 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.02 111.397 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HE ' ' H ' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -127.05 166.29 17.88 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.479 -0.763 . . . . 0.02 109.793 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.663 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 87.57 -165.58 35.41 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.307 -1.117 . . . . 0.02 110.307 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.11 141.88 54.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -1.001 . . . . 0.02 108.873 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.475 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.2 mt-30 -114.8 149.15 37.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.267 0.556 . . . . 0.02 109.519 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -123.54 133.77 53.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.507 -0.923 . . . . 0.01 108.507 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.9 tp -94.69 122.3 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.792 -1.193 . . . . 0.01 109.342 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -93.23 149.0 21.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.01 108.875 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.6 m-20 -108.53 -175.88 2.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.51 -0.743 . . . . 2.27 109.222 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -74.4 27.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 1.8400000000000001 109.501 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 152' ' ' ASP . 55.1 mttm -112.76 174.69 5.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.473 -0.767 . . . . 2.2799999999999998 109.354 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -106.57 138.02 43.51 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.936 -0.764 . . . . 0.01 108.936 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.82 114.31 28.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.304 -0.872 . . . . 0.01 110.273 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' A' ' 128' ' ' SER . 11.2 mtp180 -86.52 -28.55 23.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.01 111.268 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -123.2 153.68 64.94 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.831 -1.174 . . . . 2.54 107.831 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.6 Cg_endo -61.83 -41.93 34.67 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 CA-C-N 119.323 0.794 . . . . 0.69999999999999996 110.455 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.8 -18.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.808 -1.182 . . . . 0.85999999999999999 109.279 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -65.88 -18.31 65.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.02 111.87 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.76 14.82 30.84 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 120.891 -1.13 . . . . 0.02 110.099 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.36 10.72 73.52 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.219 -0.926 . . . . 0.02 113.047 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.18 140.54 35.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.79 -1.417 . . . . 0.02 109.994 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.03 -6.81 59.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.708 -0.62 . . . . 0.58999999999999997 109.544 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 97.2 p -140.97 150.2 58.53 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.213 -0.929 . . . . 0.87 109.192 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.33 16.64 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.585 0.857 . . . . 0.38 111.942 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.18 120.19 25.03 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.177 0.989 . . . . 0.17999999999999999 110.904 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.59 124.28 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 105.609 -1.997 . . . . 3.9900000000000002 105.609 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -112.09 -12.77 13.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.241 -0.912 . . . . 5.1699999999999999 113.246 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.9 m -157.7 160.76 38.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.146 -2.221 . . . . 0.02 110.388 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -151.59 153.14 33.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.373 -0.83 . . . . 2.02 109.875 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.445 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.2 mtp180 -143.55 150.0 38.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.217 -0.927 . . . . 0.01 110.121 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.519 ' NH2' ' O ' ' A' ' 111' ' ' THR . 3.4 ptp180 -87.4 143.1 27.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.581 -0.896 . . . . 0.01 108.581 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.79 128.51 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.207 -0.933 . . . . 3.04 109.25 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.9 t -137.52 147.81 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.199 -0.938 . . . . 1.8899999999999999 109.653 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.43 -0.794 . . . . 4.8899999999999997 109.412 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.742 0 N-CA-C 107.084 -2.406 . . . . 0.81 107.084 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.66 148.9 32.65 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 120.216 -0.992 . . . . 0.01 110.866 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -151.18 136.81 17.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.951 . . . . 0.02 108.839 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -130.25 140.58 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -120.85 129.28 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.455 -0.778 . . . . 0.39 109.897 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.6 m-85 -109.42 139.51 44.3 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.839 -0.801 . . . . 0.02 108.839 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.7 m-85 -124.18 139.69 53.68 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.184 -0.948 . . . . 0.02 110.126 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.5 mt-10 -68.32 -27.3 66.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.03 111.826 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.42 169.97 8.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.838 -1.164 . . . . 0.03 110.466 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 59.3 mtt180 -74.93 158.49 33.22 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.622 0.725 . . . . 0.03 109.816 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.4 m-20 65.91 34.71 7.01 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.813 0.816 . . . . 0.74 110.842 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.2 p90 49.41 44.29 23.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.72 0.771 . . . . 0.02 111.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -111.74 165.95 11.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.43 -167.61 35.73 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.593 -1.289 . . . . 0.03 110.487 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -68.6 143.1 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 2.76 109.024 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 21' ' ' ASP . 3.0 tmm_? -121.51 149.96 42.32 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.752 0.787 . . . . 1.89 110.163 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -133.52 128.17 34.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.444 -0.947 . . . . 0.02 108.444 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' CZ ' ' A' ' 19' ' ' ARG . 45.5 m-20 -111.43 136.9 49.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.456 -0.778 . . . . 1.12 109.494 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.3 t -130.79 137.62 49.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.535 0.684 . . . . 0.02 109.412 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 p-10 -117.0 10.47 14.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.706 -0.621 . . . . 0.2 109.535 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -158.32 174.51 15.04 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.158 -1.053 . . . . 1.23 108.158 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.1 p30 -62.08 144.3 55.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.61 -1.306 . . . . 0.02 110.253 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 t -131.33 117.45 18.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.569 -0.9 . . . . 0.02 108.569 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.79 -25.19 53.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.087 -1.008 . . . . 0.24 110.613 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.29 101.52 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.966 -1.083 . . . . 1.14 108.742 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -104.61 8.35 35.28 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 122.108 0.956 . . . . 6.37 109.541 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -59.0 -24.08 62.46 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.556 -0.715 . . . . 3.11 110.787 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -74.29 -16.5 60.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.716 -1.24 . . . . 0.88 110.047 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -103.59 -22.16 13.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.02 109.228 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.462 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.0 tp -150.27 128.92 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 3.32 109.086 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 p -85.64 -9.98 56.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.735 -0.603 . . . . 0.02 111.086 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -170.78 161.66 7.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 t -142.41 114.37 8.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.718 -1.239 . . . . 0.02 108.573 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -108.71 0.82 20.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.895 -1.128 . . . . 0.03 110.609 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 3.2 p -156.55 153.39 28.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -145.38 148.47 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.08 -1.013 . . . . 0.02 109.74 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -124.09 124.87 43.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.387 -1.338 . . . . 0.02 107.387 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -105.69 113.29 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.601 -1.629 . . . . 0.02 106.601 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -83.63 -34.14 25.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.049 -0.66 . . . . 3.81 109.744 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.75 150.7 19.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.525 -1.798 . . . . 0.02 110.532 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.92 174.18 50.13 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.513 -1.327 . . . . 0.01 110.095 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 53.9 m -109.62 160.73 16.03 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.996 -1.483 . . . . 1.48 106.996 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 74.6 m95 -148.15 146.89 28.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.324 -1.485 . . . . 0.02 111.443 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.05 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.263 -2.125 . . . . 0.24 105.263 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.1 m -119.78 143.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.586 -0.696 . . . . 0.65 109.65 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.78 144.85 48.08 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.245 1.021 . . . . 0.02 109.903 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.59 -34.74 78.56 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.829 -0.623 . . . . 0.02 111.541 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -124.25 157.5 64.2 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.104 -0.997 . . . . 0.02 109.326 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.28 165.53 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.491 1.461 . . . . 0.02 113.152 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 64.18 37.31 8.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.221 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 45.24 51.32 9.32 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.655 0.741 . . . . 3.39 110.483 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -125.81 163.27 23.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 2.33 109.714 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.02 -161.42 31.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.642 -1.383 . . . . 0.02 109.642 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -65.15 138.24 58.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.04 -1.271 . . . . 0.02 110.161 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.6 ptm -118.61 135.79 54.24 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.067 -0.716 . . . . 5.01 109.067 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.7 m-85 -134.82 139.94 45.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.8 0.809 . . . . 0.02 109.856 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.52 132.49 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.561 -0.903 . . . . 1.72 108.561 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -118.59 111.78 37.63 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.569 -0.707 . . . . 0.02 110.357 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.89 168.1 22.71 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.127 1.081 . . . . 1.47 109.897 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 7.9 tm0? -53.37 140.81 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.796 -1.19 . . . . 4.25 110.36 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.532 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.04 -176.9 32.56 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.689 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.1 tp10 -118.13 129.31 55.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -1.146 . . . . 0.96 108.929 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.528 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 47.3 m-85 -120.4 96.8 49.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 107.548 -1.278 . . . . 0.02 107.548 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -68.74 -3.9 12.18 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 120.541 0.827 . . . . 0.02 113.818 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -156.91 154.34 29.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.453 -1.405 . . . . 2.02 107.962 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 52.0 p90 -60.51 -37.62 81.72 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.59 -0.694 . . . . 0.02 111.537 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.39 -23.97 64.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.014 -1.053 . . . . 0.02 110.454 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.52 -18.48 62.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.433 -0.951 . . . . 3.42 108.433 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.617 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.75 10.98 30.71 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.188 -1.412 . . . . 0.02 107.188 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.4 OUTLIER 59.61 21.76 10.4 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.598 0.713 . . . . 0.02 110.27 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.7 145.1 45.73 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.871 -1.692 . . . . 0.02 108.871 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.3 tt -78.27 -30.48 48.55 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.536 -1.283 . . . . 0.98 107.536 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 16.0 t-20 -156.77 -172.36 4.02 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.514 -1.662 . . . . 0.02 106.514 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 32.6 p30 -97.52 27.29 4.38 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.709 -1.245 . . . . 0.02 110.087 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -96.04 122.86 39.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.055 -1.028 . . . . 3.2 110.493 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.517 HD22 ' HB ' ' A' ' 48' ' ' VAL . 45.9 mt -144.31 120.55 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.469 -1.308 . . . . 2.61 107.469 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 -16.52 13.06 Favored Glycine 0 N--CA 1.504 3.172 0 O-C-N 121.317 -0.864 . . . . 0.02 112.507 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 m -156.06 156.06 33.72 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.372 -1.663 . . . . 0.02 110.239 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.7 p -144.12 146.91 33.09 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.372 0.606 . . . . 0.02 109.447 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -135.03 140.18 45.4 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.01 108.857 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.82 130.57 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.36 -0.978 . . . . 0.43 108.36 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.1 125.2 44.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.389 -0.967 . . . . 1.25 108.389 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -90.51 135.8 33.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 1.77 108.94 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.76 138.2 37.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.986 -0.746 . . . . 1.63 108.986 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -113.29 126.11 55.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.863 -0.792 . . . . 1.08 108.863 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -102.51 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.209 -1.774 . . . . 1.26 106.209 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.56 -48.31 0.9 Allowed Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.376 -1.452 . . . . 0.01 112.529 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.16 -99.63 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 118.259 -1.924 . . . . 0.01 112.388 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -121.58 119.63 32.48 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.285 -1.127 . . . . 4.43 110.756 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.527 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -77.75 131.08 37.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.105 -0.702 . . . . 2.99 109.105 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.465 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 6.3 ttpm? -131.13 140.35 49.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.461 -0.774 . . . . 6.36 108.931 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -128.9 143.66 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.386 -0.821 . . . . 1.09 110.109 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.23 133.73 54.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.905 -1.146 . . . . 2.05 107.905 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.03 147.17 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.876 -1.14 . . . . 1.1 109.691 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 29.5 m-85 -118.56 140.87 49.21 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.129 0.966 . . . . 0.73 110.835 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -66.26 -29.42 69.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.772 -0.649 . . . . 0.02 111.721 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -116.91 170.25 8.77 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 120.984 -1.072 . . . . 3.18 110.573 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 165.32 50.12 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.831 -0.907 . . . . 0.01 110.831 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 56.5 38.41 29.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.834 -0.803 . . . . 0.01 111.461 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE1' ' OG ' ' A' ' 128' ' ' SER . 11.3 m-85 52.57 54.5 10.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.01 111.509 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.631 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 6.3 t-20 -129.25 166.31 19.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.196 -1.038 . . . . 3.15 108.196 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.631 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 92.52 -164.46 28.03 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.514 -1.434 . . . . 0.01 109.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 65.8 tt0 -75.16 144.54 42.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.1 -1.235 . . . . 0.01 108.493 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 48.2 ttp -116.65 142.11 47.32 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.654 0.74 . . . . 0.01 109.88 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 30.2 m-85 -131.24 135.33 47.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.912 -1.144 . . . . 2.48 107.912 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -120.43 135.09 55.15 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.623 -0.673 . . . . 0.01 110.041 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -149.63 151.62 34.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.295 1.045 . . . . 1.69 110.934 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.525 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 5.3 p -110.06 10.3 24.07 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.503 -0.771 . . . . 0.01 109.787 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -121.11 162.92 19.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 3.21 111.156 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -66.78 155.79 37.25 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.151 -1.055 . . . . 0.01 108.151 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.0 t -123.98 110.12 29.47 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.528 -0.916 . . . . 0.01 108.528 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.71 -32.82 3.33 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 120.002 1.036 . . . . 0.01 111.697 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -139.64 106.78 5.47 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.33 -39.91 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.869 -0.519 . . . . 1.83 111.065 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 36.1 ttp -66.59 -38.0 86.09 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.996 -1.082 . . . . 1.34 109.957 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -70.25 -38.96 75.26 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.469 -1.395 . . . . 2.11 109.758 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.522 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 45.7 tt0 -80.16 -48.2 13.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 2.08 112.507 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.522 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 81.3 m-85 -111.41 -1.29 15.99 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.353 -0.842 . . . . 0.02 112.611 -175.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 61.79 33.77 17.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.792 -1.193 . . . . 0.02 109.668 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.52 136.05 53.45 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.487 -0.758 . . . . 0.02 109.293 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -90.21 -21.46 22.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.986 . . . . 5.32 110.87 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 126' ' ' ILE . 45.3 mt-10 -148.73 164.14 35.24 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.02 110.124 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 125' ' ' GLU . 37.2 mm -129.29 126.57 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.503 -1.295 . . . . 2.17 107.503 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.4 m80 -109.92 -13.22 14.47 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.251 -0.906 . . . . 0.02 112.618 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.534 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 47.5 t -161.39 154.34 20.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.786 -1.196 . . . . 0.01 109.0 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -170.64 147.28 2.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.22 109.684 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -119.86 109.9 16.11 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.986 -1.071 . . . . 1.41 109.237 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 106.273 -1.751 . . . . 0.01 106.273 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 42.9 m95 . . . . . 0 N--CA 1.503 2.198 0 N-CA-C 107.461 -1.311 . . . . 0.01 107.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.47 ' CG1' HD11 ' A' ' 175' ' ' ILE . 36.3 mt -118.51 133.14 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.565 -1.335 . . . . 1.69 109.502 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.09 141.62 44.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.334 -1.728 . . . . 2.49 106.334 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 21.4 m-85 -123.45 143.07 50.38 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.197 -0.94 . . . . 0.02 109.731 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -74.25 -30.36 62.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.675 -0.641 . . . . 0.02 111.882 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.49 155.12 47.6 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.62 -1.3 . . . . 1.48 108.951 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -56.51 167.27 2.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.098 1.199 . . . . 0.02 112.615 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.25 31.21 21.01 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.413 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.489 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 3.1 m-85 57.48 50.68 10.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 0.02 111.082 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.36 165.13 18.25 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.656 -0.652 . . . . 0.02 109.766 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.7 33.98 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.549 -1.021 . . . . 0.02 110.549 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.57 142.15 53.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.542 -0.975 . . . . 0.02 108.788 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.5 mt-30 -113.14 148.45 35.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.351 0.596 . . . . 0.02 110.083 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -124.3 134.19 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.687 -0.856 . . . . 0.01 108.687 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.0 tp -96.0 120.55 36.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.156 . . . . 0.01 109.654 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -99.95 149.36 23.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.856 -0.794 . . . . 0.01 108.856 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.3 m-20 -109.58 -177.32 3.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 2.27 109.374 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -72.83 35.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.84 109.469 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.6 mttp -111.55 176.2 5.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 2.28 109.078 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.92 127.03 52.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.424 -0.797 . . . . 0.01 109.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -98.31 112.26 24.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.01 108.847 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 9.6 ptp180 -88.7 -27.85 20.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.762 -0.586 . . . . 0.01 111.298 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -122.53 153.43 62.59 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 107.907 -1.146 . . . . 2.54 107.907 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.0 Cg_endo -62.24 -41.44 34.61 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.315 0.791 . . . . 0.7 110.805 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.57 -18.26 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.862 -1.149 . . . . 0.86 109.457 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.5 -18.22 65.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.891 -1.13 . . . . 0.02 111.948 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.31 15.83 27.51 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.737 -1.227 . . . . 0.02 110.207 178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.72 10.14 76.79 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.12 -0.987 . . . . 0.02 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.496 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.06 140.61 34.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.862 -1.375 . . . . 0.02 110.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.27 -7.05 59.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.621 -0.675 . . . . 0.59 109.521 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.5 p -140.46 150.38 60.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.239 -0.913 . . . . 0.87 109.06 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.66 16.14 0.64 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 120.566 0.844 . . . . 0.38 111.776 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.19 119.9 24.66 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.307 1.051 . . . . 0.18 110.817 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.43 123.64 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.57 -2.011 . . . . 3.99 105.57 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -111.9 -13.16 13.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.369 -0.832 . . . . 5.17 113.16 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.489 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.1 p -157.03 160.1 38.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 119.276 -2.14 . . . . 0.02 109.965 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.1 153.9 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 2.02 110.202 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -144.18 149.26 36.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.342 -0.849 . . . . 0.01 110.068 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 93' ' ' ALA . 4.6 ptp180 -87.02 141.48 28.64 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.603 -0.888 . . . . 0.01 108.603 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.47 HD11 ' CG1' ' A' ' 137' ' ' ILE . 41.7 mt -93.88 129.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 3.04 109.482 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.78 149.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.407 -0.808 . . . . 1.89 109.771 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 4.89 109.536 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.449 0 N-CA-C 105.593 -3.003 . . . . 0.81 105.593 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 146.61 31.53 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.383 -0.913 . . . . 0.01 111.179 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.23 137.4 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.76 -0.847 . . . . 0.02 108.82 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 tt -129.89 140.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.937 -0.764 . . . . 0.02 108.937 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -120.9 130.14 53.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.721 . . . . 0.39 109.654 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 25.7 m-85 -108.96 138.73 44.84 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.88 -0.785 . . . . 0.02 108.88 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.34 138.28 54.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.302 -0.874 . . . . 0.02 109.398 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -68.21 -27.75 66.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 0.03 111.605 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -114.93 170.13 8.57 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.976 -1.077 . . . . 0.03 110.422 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -74.73 161.66 29.42 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.708 0.766 . . . . 0.03 110.063 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.2 t-20 62.58 34.91 14.74 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.894 0.854 . . . . 0.74 110.559 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.0 p90 49.45 42.9 23.23 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.473 -0.785 . . . . 0.02 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -109.35 165.89 11.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.806 -1.183 . . . . 0.02 107.806 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -167.98 35.01 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.681 -1.262 . . . . 0.03 110.837 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.9 143.96 54.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.955 . . . . 2.76 109.035 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -122.16 150.05 42.76 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.727 0.775 . . . . 1.89 110.207 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.24 128.59 36.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.158 -1.053 . . . . 0.02 108.158 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -110.98 135.92 50.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.549 -0.719 . . . . 1.12 109.465 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -129.99 137.81 50.49 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.486 0.66 . . . . 0.02 109.682 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 10.89 14.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.248 -0.649 . . . . 0.2 109.248 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 t -158.83 174.17 15.4 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.06 -1.089 . . . . 1.23 108.06 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 15.8 p-10 -61.66 144.74 54.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.756 -1.215 . . . . 0.02 110.216 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 t -131.49 117.5 18.88 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.5 -0.926 . . . . 0.02 108.5 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.01 44.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.24 111.292 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -153.21 102.49 2.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.149 . . . . 1.14 108.946 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -101.68 8.49 41.62 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.962 0.887 . . . . 6.37 109.689 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -59.14 -26.74 65.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.731 -0.606 . . . . 3.11 111.657 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.28 -17.32 60.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.591 -1.318 . . . . 0.88 110.36 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.14 -22.22 13.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.02 109.799 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 tp -150.1 128.26 11.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.052 -1.03 . . . . 3.32 109.019 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -84.77 -9.21 58.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.781 -0.575 . . . . 0.02 111.016 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -171.03 164.11 7.46 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -142.24 114.15 8.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.726 -1.234 . . . . 0.02 108.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.557 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.2 m-80 -109.14 -0.93 19.11 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.942 -1.099 . . . . 0.03 111.343 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -154.02 153.8 32.59 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.74 146.73 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.136 -0.978 . . . . 0.02 110.552 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.444 ' NE ' ' OH ' ' A' ' 10' ' ' TYR . 25.3 ttp180 -124.56 125.22 43.82 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.476 -1.305 . . . . 0.02 107.476 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.58 ' C ' HE22 ' A' ' 63' ' ' GLN . 43.8 t -104.07 113.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 106.565 -1.643 . . . . 0.02 106.565 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.543 ' C ' HE22 ' A' ' 63' ' ' GLN . 11.1 tp10 -83.01 -34.47 26.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 3.81 109.389 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.59 18.02 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.726 -1.702 . . . . 0.02 110.302 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.81 173.56 49.82 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.711 -1.233 . . . . 0.01 110.243 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -119.02 135.48 54.61 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.473 -1.306 . . . . 1.48 107.473 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.41 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.2 m95 -123.91 153.65 40.85 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.835 -1.166 . . . . 0.02 112.259 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.29 53.08 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.14 -2.17 . . . . 0.24 105.14 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.4 m -118.63 142.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.129 -0.693 . . . . 0.65 109.129 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.04 146.33 46.83 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.295 1.045 . . . . 0.02 109.617 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' CD ' HD21 ' A' ' 76' ' ' ASN . 0.6 OUTLIER -66.0 -35.66 81.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.55 -0.75 . . . . 0.02 111.121 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -123.46 158.52 58.56 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 121.2 -0.937 . . . . 0.02 109.067 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.83 168.38 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.65 1.567 . . . . 0.02 112.8 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 62.75 37.42 12.57 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.421 -0.809 . . . . 0.02 111.197 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.73 52.11 8.01 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.573 0.701 . . . . 3.39 110.793 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -126.61 164.16 21.84 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.193 0.52 . . . . 2.33 109.838 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.35 -161.55 32.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.517 -1.433 . . . . 0.02 109.517 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -66.44 137.55 56.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.927 -1.337 . . . . 0.02 109.61 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.49 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.8 ptm -119.24 137.52 53.6 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.305 -0.628 . . . . 5.01 109.305 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.1 m-85 -132.3 138.9 47.99 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.02 109.466 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.4 mm -96.23 132.1 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.764 -0.828 . . . . 1.72 108.764 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' A' ' 66' ' ' TYR . 16.4 mt -121.45 110.13 34.23 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.255 -0.903 . . . . 0.02 110.751 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.2 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.793 0.962 . . . . 1.47 109.981 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.58 HE22 ' C ' ' A' ' 41' ' ' VAL . 3.1 tp-100 -50.56 138.71 17.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 4.25 110.254 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.04 -179.17 32.15 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.035 -1.555 . . . . 0.02 110.884 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.0 130.83 55.89 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.547 -0.972 . . . . 0.96 109.462 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -120.87 94.33 48.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.664 -1.236 . . . . 0.02 107.664 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.08 -4.47 11.6 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.781 0.988 . . . . 0.02 113.738 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -155.01 154.43 32.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.723 -1.236 . . . . 2.02 108.008 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CE2' ' CD ' ' A' ' 70' ' ' GLN . 33.3 p90 -61.12 -38.74 87.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.514 -0.741 . . . . 0.02 111.396 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.447 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 12.8 mm100 -60.38 -24.39 65.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.102 -0.999 . . . . 0.02 110.058 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.551 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.06 -18.09 63.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.293 -1.003 . . . . 3.42 108.293 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.7 10.13 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.221 -1.4 . . . . 0.02 107.221 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.1 mpp? 59.2 21.9 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.664 0.745 . . . . 0.02 110.138 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 144.47 46.48 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.321 -1.512 . . . . 0.02 109.321 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 -30.03 48.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.623 -1.251 . . . . 0.98 107.623 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.56 HD21 ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -157.96 -171.17 3.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.533 -1.654 . . . . 0.02 106.533 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.9 p-10 -98.21 28.3 4.13 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.682 -1.262 . . . . 0.02 110.403 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.4 OUTLIER -97.57 122.83 41.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.814 -1.179 . . . . 3.2 111.056 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.7 mt -142.33 122.01 13.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.286 -1.376 . . . . 2.61 107.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -18.12 10.6 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.985 -1.072 . . . . 0.02 112.302 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.4 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 28.4 t -156.14 155.86 33.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.463 -1.61 . . . . 0.02 110.277 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 70.4 m -144.33 147.63 33.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.02 109.791 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -135.02 140.22 45.47 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.28 -0.888 . . . . 0.01 109.111 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 134.92 37.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 0.43 108.753 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 123.09 45.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.554 -0.906 . . . . 1.25 108.554 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -90.48 136.18 33.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.183 -1.043 . . . . 1.77 108.183 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.51 137.29 38.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 1.63 109.6 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.8 m -112.1 126.32 55.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.58 -0.896 . . . . 1.08 108.58 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -102.99 -155.47 0.53 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.262 -1.755 . . . . 1.26 106.262 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.16 -48.96 0.86 Allowed Glycine 0 N--CA 1.498 2.83 0 O-C-N 120.438 -1.414 . . . . 0.01 112.384 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.88 -99.58 0.13 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.444 -1.836 . . . . 0.01 112.166 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -120.84 119.6 33.14 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.246 -1.149 . . . . 4.43 110.751 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.3 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.187 -0.671 . . . . 2.99 109.187 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -130.91 141.16 50.27 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.557 -0.714 . . . . 6.36 109.085 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.78 144.84 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.319 -0.863 . . . . 1.09 109.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.4 pm0 -121.76 134.37 54.93 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.404 -1.332 . . . . 2.05 107.404 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 146.58 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.914 -1.116 . . . . 1.1 109.371 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 36.0 m-85 -120.23 141.64 49.75 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.158 0.98 . . . . 0.73 111.108 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -66.43 -30.05 70.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.699 -0.682 . . . . 0.02 111.816 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -116.29 168.09 10.44 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.956 -1.09 . . . . 3.18 110.54 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.94 164.14 43.77 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 111.153 -0.779 . . . . 0.01 111.153 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 56.54 39.23 29.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.675 0.75 . . . . 0.01 110.941 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 51.45 56.31 8.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.625 -0.672 . . . . 0.01 111.115 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -128.55 165.64 20.36 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.008 -1.108 . . . . 3.15 108.008 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.61 -164.08 27.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.151 -1.579 . . . . 0.01 109.151 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.66 144.32 43.87 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.983 -1.304 . . . . 0.01 108.411 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.8 ttt -116.5 141.74 47.79 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.619 0.723 . . . . 0.01 109.521 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -131.65 135.72 47.14 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.069 -1.085 . . . . 2.48 108.069 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -118.93 135.12 54.75 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.668 -0.645 . . . . 0.01 109.928 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -149.64 151.55 33.94 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.392 1.091 . . . . 1.69 110.95 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.6 p -111.05 9.68 22.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.396 -0.82 . . . . 0.01 109.923 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 30.5 mp0 -121.28 163.85 17.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.324 -0.86 . . . . 3.21 111.556 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -67.73 156.03 37.88 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.443 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 12.3 m -124.83 111.67 27.3 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.753 -0.832 . . . . 0.01 108.753 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -76.21 -31.78 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 CA-C-N 119.958 1.021 . . . . 0.01 111.439 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -141.3 107.03 5.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.573 -0.899 . . . . 0.02 108.573 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.85 -39.28 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.81 -0.557 . . . . 1.83 111.139 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.5 tmt? -67.19 -38.2 84.98 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.97 -1.092 . . . . 1.34 109.892 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.14 -38.44 78.82 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.484 -1.385 . . . . 2.11 109.826 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -79.63 -47.4 15.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 2.08 112.38 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.12 -0.48 15.59 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.469 -0.769 . . . . 0.02 112.75 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m80 61.54 33.77 18.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.687 -1.258 . . . . 0.02 109.719 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.8 136.21 53.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.371 -0.831 . . . . 0.02 109.256 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -89.46 -21.73 22.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 5.32 110.473 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -150.38 165.67 32.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.958 -1.088 . . . . 0.02 110.256 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.7 mm -129.87 126.57 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.219 -1.4 . . . . 2.17 107.219 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -108.97 -12.94 14.81 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.14 -0.975 . . . . 0.02 112.598 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 21.1 m -158.16 152.34 24.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.764 -1.21 . . . . 0.01 108.753 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.8 t -166.51 142.81 4.75 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.099 -1.001 . . . . 1.22 109.152 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.531 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 31.4 ttpt -123.21 105.34 9.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.57 1.176 . . . . 1.41 109.504 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 131' ' ' VAL . 11.4 p . . . . . 0 C--N 1.299 -1.588 0 N-CA-C 107.5 -1.296 . . . . 0.01 107.5 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 N--CA 1.503 2.212 0 N-CA-C 107.549 -1.278 . . . . 0.01 107.549 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.424 ' CG1' HD11 ' A' ' 175' ' ' ILE . 25.3 mt -118.98 135.75 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.581 -1.324 . . . . 1.69 109.566 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.34 142.16 43.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.341 -1.725 . . . . 2.49 106.341 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 31.9 m-85 -122.23 143.53 49.53 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.113 -0.992 . . . . 0.02 109.364 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 47.4 tt0 -76.68 -30.03 56.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.747 -0.596 . . . . 0.02 111.833 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.1 mt -114.33 152.57 46.13 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.562 -1.336 . . . . 1.48 109.064 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.72 165.64 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.65 0.9 . . . . 0.02 112.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 59.71 31.67 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.307 -0.86 . . . . 0.75 111.549 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 57.88 52.13 8.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.514 -0.742 . . . . 0.02 111.412 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.0 165.51 19.3 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.473 -0.767 . . . . 0.02 110.059 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.86 -165.54 33.36 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.962 -1.255 . . . . 0.02 109.962 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -69.83 143.59 52.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.02 108.94 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 58' ' ' MET . 16.6 mt-30 -113.08 149.5 33.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.02 110.085 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.87 133.61 53.01 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.92 121.58 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.944 -1.098 . . . . 0.01 109.785 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.7 mp -98.31 142.32 30.1 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.72 -0.845 . . . . 0.01 108.72 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 154' ' ' LYS . 95.1 m-20 -110.26 -172.55 2.06 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.445 -0.784 . . . . 2.27 109.739 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -71.64 37.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 1.84 109.636 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 152' ' ' ASP . 30.6 mmtp -112.31 168.74 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.413 -0.804 . . . . 2.28 109.3 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -104.34 127.0 51.92 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.039 -1.097 . . . . 0.01 108.039 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 54.8 m-85 -99.58 112.47 24.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.928 . . . . 0.01 110.258 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.444 ' O ' ' OG ' ' A' ' 128' ' ' SER . 78.7 mtt180 -89.31 -27.39 20.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.632 -0.667 . . . . 0.01 110.845 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -124.43 152.82 68.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 108.134 -1.062 . . . . 2.54 108.134 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 7.8 Cg_endo -60.83 -40.25 55.37 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 CA-C-N 119.437 0.835 . . . . 0.7 111.005 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.49 -18.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 120.724 -1.235 . . . . 0.86 109.67 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 156' ' ' TYR . 39.2 t70 -65.4 -17.6 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.91 -1.119 . . . . 0.02 112.062 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.17 16.7 24.59 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 120.733 -1.23 . . . . 0.02 110.229 178.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.02 77.68 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.174 -0.954 . . . . 0.02 112.874 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -99.11 139.81 34.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.85 -1.382 . . . . 0.02 110.146 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.67 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.59 109.342 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 p -138.92 151.77 68.91 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.87 109.261 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.77 13.58 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.756 0.971 . . . . 0.38 111.892 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.55 119.62 24.0 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.603 1.192 . . . . 0.18 111.039 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.508 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 0.9 OUTLIER -150.55 121.93 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.013 -1.847 . . . . 3.99 106.013 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.507 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 11.0 mp0 -113.69 -11.57 12.93 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.342 -0.849 . . . . 5.17 113.253 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -156.46 159.01 38.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.119 -2.238 . . . . 0.02 110.45 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.443 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 25.3 p90 -152.79 154.34 34.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.029 -1.044 . . . . 2.02 110.3 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -144.21 149.88 37.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 0.01 110.125 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -87.05 141.97 28.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.311 -0.996 . . . . 0.01 108.311 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.424 HD11 ' CG1' ' A' ' 137' ' ' ILE . 24.6 mt -93.71 129.54 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.325 -0.859 . . . . 3.04 109.411 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 m -138.28 149.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.351 -0.843 . . . . 1.89 109.756 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 4.89 109.56 179.474 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.601 0 N-CA-C 107.16 -2.376 . . . . 0.81 107.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 149.31 33.31 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.162 -1.018 . . . . 0.01 110.683 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -150.88 136.84 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.496 -1.002 . . . . 0.02 109.493 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.9 140.42 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 109.2 -0.666 . . . . 0.02 109.2 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -122.03 130.23 53.11 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.571 -0.705 . . . . 0.39 109.642 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 24.6 m-85 -110.31 140.13 44.8 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.007 -0.738 . . . . 0.02 109.007 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.0 m-85 -121.98 138.45 54.42 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.339 -0.851 . . . . 0.02 109.546 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 66.2 mt-10 -68.14 -27.82 66.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -0.989 . . . . 0.03 111.706 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -114.26 170.03 8.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.867 -1.146 . . . . 0.03 110.468 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -75.22 158.26 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.498 0.666 . . . . 0.03 110.058 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.9 m-80 66.2 34.65 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.826 0.822 . . . . 0.74 110.767 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.95 45.22 25.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.668 0.746 . . . . 0.02 111.428 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.24 165.88 11.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.66 -167.71 35.43 Favored Glycine 0 N--CA 1.496 2.674 0 O-C-N 120.793 -1.192 . . . . 0.03 110.912 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -68.61 142.74 55.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.45 -1.03 . . . . 2.76 109.279 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -120.02 148.65 43.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.597 -0.69 . . . . 1.89 110.23 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -132.33 127.06 34.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.257 -1.016 . . . . 0.02 108.257 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -111.81 136.51 50.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.483 -0.761 . . . . 1.12 109.762 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -130.91 138.02 49.58 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.573 0.701 . . . . 0.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -116.47 11.29 14.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.623 -0.673 . . . . 0.2 109.477 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 19.9 p -157.79 174.15 15.73 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.195 -1.039 . . . . 1.23 108.195 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 19.3 p30 -61.11 144.66 53.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.72 -1.238 . . . . 0.02 109.955 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 t -131.76 116.53 17.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.415 -0.957 . . . . 0.02 108.415 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.59 52.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.24 110.733 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -156.58 100.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.676 -0.861 . . . . 1.14 108.676 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -104.89 10.46 34.33 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 122.175 0.988 . . . . 6.37 109.799 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.4 mmp_? -59.27 -23.44 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.68 -0.638 . . . . 3.11 111.018 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 p -75.5 -17.0 60.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.685 -1.259 . . . . 0.88 110.185 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 26.2 m-85 -104.26 -21.74 13.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.495 -0.753 . . . . 0.02 109.132 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.6 tp -148.53 126.42 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 3.32 109.41 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 m -86.29 -11.54 51.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.463 -0.773 . . . . 0.02 111.405 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.2 tpp180 -170.65 160.39 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.697 -1.223 . . . . 0.02 107.697 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -140.89 114.61 8.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.897 -1.127 . . . . 0.02 109.455 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 11' ' ' GLU . 2.7 m120 -108.2 -0.96 20.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.94 -1.1 . . . . 0.03 110.535 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.6 m -155.7 153.59 30.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.1 mt -145.14 146.91 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 0.02 110.063 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -123.11 123.92 41.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.78 -1.193 . . . . 0.02 107.78 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 38.3 t -106.52 114.17 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -84.0 -33.74 24.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.567 -0.708 . . . . 3.81 110.234 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.46 18.0 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.109 -1.519 . . . . 0.02 110.048 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 173.41 49.72 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.487 -1.34 . . . . 0.01 110.04 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.2 m -120.39 138.03 53.98 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.107 -1.072 . . . . 1.48 108.107 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -126.99 154.43 44.62 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.559 1.171 . . . . 0.02 112.057 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.54 133.57 51.81 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 104.938 -2.245 . . . . 0.24 104.938 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.1 m -116.7 141.42 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.178 -0.675 . . . . 0.65 109.178 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.06 144.18 48.68 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.184 0.992 . . . . 0.02 109.706 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.36 -34.51 78.32 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.339 -0.846 . . . . 0.02 111.459 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -124.09 157.81 62.68 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.238 -0.914 . . . . 0.02 109.328 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.67 167.52 0.97 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.762 1.641 . . . . 0.02 112.563 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 2.0 t30 63.27 37.12 11.31 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.457 -0.792 . . . . 0.02 111.211 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 1.8 m-85 45.35 51.26 9.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.613 -0.679 . . . . 3.39 110.819 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -125.75 163.91 21.82 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.153 0.501 . . . . 2.33 109.994 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -162.01 31.53 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.715 -1.354 . . . . 0.02 109.715 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -65.57 137.25 57.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.332 . . . . 0.02 109.806 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.468 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.4 ptm -117.66 136.35 53.38 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.487 0.66 . . . . 5.01 109.692 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -133.62 139.87 46.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.484 -0.76 . . . . 0.02 109.49 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.7 132.03 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.487 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.5 mt -122.25 109.42 33.28 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.57 -0.706 . . . . 0.02 110.206 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -75.49 170.64 19.83 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.893 0.998 . . . . 1.47 110.352 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 41' ' ' VAL . 1.1 tm0? -51.83 140.26 19.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 4.25 109.862 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 155.53 -177.79 32.49 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.486 -1.34 . . . . 0.02 110.565 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -120.63 131.3 54.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.516 -0.991 . . . . 0.96 109.305 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 64.8 m-85 -122.42 93.56 48.4 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.866 -1.161 . . . . 0.02 107.866 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.06 -3.68 7.61 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.034 1.156 . . . . 0.02 113.92 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -156.87 152.95 27.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.379 -1.451 . . . . 2.02 107.91 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -60.07 -38.7 83.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.612 -0.68 . . . . 0.02 111.977 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.5 -24.85 65.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.972 . . . . 0.02 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -17.98 63.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 3.42 108.999 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.89 12.06 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.277 -1.379 . . . . 0.02 107.277 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.2 mtp 60.2 21.85 11.2 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.528 0.68 . . . . 0.02 110.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.92 144.65 46.44 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.386 -1.486 . . . . 0.02 109.386 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.24 -30.45 43.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.549 -1.278 . . . . 0.98 107.549 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 51.6 t30 -156.98 -171.92 3.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.397 -1.705 . . . . 0.02 106.397 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 30.6 p-10 -98.58 27.93 4.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.66 -1.275 . . . . 0.02 110.208 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -96.0 122.55 38.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.848 -1.157 . . . . 3.2 110.638 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 48' ' ' VAL . 51.3 mt -143.48 121.48 12.08 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.808 -1.182 . . . . 2.61 107.808 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.11 -17.71 9.31 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 121.26 -0.9 . . . . 0.02 112.641 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 5.1 t -155.53 155.77 33.99 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.043 -1.857 . . . . 0.02 110.867 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.9 p -145.5 147.72 32.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.02 110.653 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 13.8 mtp180 -136.67 141.83 43.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.01 109.288 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 130.35 36.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.43 109.451 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 t -90.18 123.55 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.608 -0.886 . . . . 1.25 108.608 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -90.3 135.41 33.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 1.77 108.703 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -99.65 138.66 36.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.729 -0.841 . . . . 1.63 108.729 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 p -113.2 125.67 54.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.942 -0.762 . . . . 1.08 108.942 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.0 t -102.79 -155.4 0.52 Allowed 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 105.992 -1.855 . . . . 1.26 105.992 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.74 -47.35 0.95 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 120.356 -1.465 . . . . 0.01 112.345 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.53 -98.86 0.12 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.433 -1.841 . . . . 0.01 112.181 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.563 ' NE2' HG22 ' A' ' 111' ' ' THR . 16.7 tm0? -119.56 117.97 29.78 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.222 -1.163 . . . . 4.43 110.317 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.0 132.1 39.96 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.304 -0.628 . . . . 2.99 109.304 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -131.01 137.42 49.19 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.028 -0.73 . . . . 6.36 109.028 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 110' ' ' THR . 5.6 tt -125.22 142.61 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.874 0.845 . . . . 1.09 109.139 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' CG ' ' O ' ' A' ' 130' ' ' LYS . 11.0 pt20 -124.77 132.26 53.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.744 -1.206 . . . . 2.05 107.744 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.06 148.15 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 120.919 -1.113 . . . . 1.1 109.659 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -117.97 140.96 48.99 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.042 0.925 . . . . 0.73 110.849 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.59 -30.12 70.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.938 -0.574 . . . . 0.02 111.765 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 128' ' ' SER . 83.3 mttt -116.57 168.4 10.21 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.983 -1.073 . . . . 3.18 110.49 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.21 164.59 44.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 56.71 39.18 29.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.635 0.731 . . . . 0.01 111.117 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.53 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.5 m-85 52.53 55.68 8.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.583 -0.698 . . . . 0.01 111.076 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -129.65 166.32 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.515 -0.92 . . . . 3.15 108.515 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.79 -164.71 27.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.277 -1.529 . . . . 0.01 109.277 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.26 145.11 42.17 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.009 -1.289 . . . . 0.01 108.619 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.484 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 9.9 tmm? -116.51 141.72 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.633 0.73 . . . . 0.01 109.772 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.484 ' N ' ' SD ' ' A' ' 107' ' ' MET . 59.8 m-85 -130.32 135.17 47.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.888 -1.153 . . . . 2.48 107.888 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -121.32 135.01 55.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.727 -0.608 . . . . 0.01 109.809 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.5 t -149.55 153.63 37.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.242 1.02 . . . . 1.69 110.786 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.563 HG22 ' NE2' ' A' ' 92' ' ' GLN . 34.9 p -110.43 9.41 23.38 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.646 -0.706 . . . . 0.01 109.933 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -121.39 163.07 19.3 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.381 -0.824 . . . . 3.21 111.384 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.32 155.0 38.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.193 -1.04 . . . . 0.01 108.193 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 29.4 t -124.15 111.42 28.63 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.77 -31.86 4.97 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 CA-C-N 120.134 1.084 . . . . 0.01 111.554 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -141.6 108.33 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.22 -0.925 . . . . 0.02 108.959 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.8 mt -62.97 -38.75 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.853 -0.529 . . . . 1.83 110.408 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 30.9 ttm -66.5 -37.26 84.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.12 -1.032 . . . . 1.34 109.831 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -70.91 -39.34 72.78 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.44 -1.412 . . . . 2.11 109.69 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 6.6 tt0 -80.85 -48.2 12.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 2.08 112.679 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.54 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 62.5 m-85 -111.95 -1.79 15.33 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.376 -0.828 . . . . 0.02 112.491 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 61.23 33.84 18.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.873 -1.142 . . . . 0.02 109.589 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.6 mt -114.02 135.44 54.0 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.413 -0.804 . . . . 0.02 109.195 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.409 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 9.3 ptp180 -90.68 -21.7 21.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.126 -0.984 . . . . 5.32 111.276 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 47.9 mt-10 -149.41 164.97 33.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.721 -1.237 . . . . 0.02 110.668 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 11.8 mm -127.66 123.81 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.726 -1.213 . . . . 2.17 107.726 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -109.11 -14.78 14.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.11 -0.994 . . . . 0.02 112.642 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.53 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 23.6 p -160.91 153.71 21.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.572 -1.33 . . . . 0.01 108.941 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.8 t -167.0 141.02 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.628 -0.878 . . . . 1.22 108.628 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.538 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -121.26 97.4 5.5 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.133 -1.062 . . . . 1.41 108.133 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.9 p . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.396 -0.965 . . . . 0.01 108.396 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.678 ' CD1' HG21 ' A' ' 131' ' ' VAL . 81.9 m95 . . . . . 0 N--CA 1.509 2.508 0 CA-C-O 121.127 0.489 . . . . 0.01 110.318 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.72 136.21 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.304 -0.998 . . . . 1.69 108.304 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -112.58 142.36 45.25 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.67 -1.604 . . . . 2.49 106.67 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 20.3 m-85 -123.42 145.99 48.36 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.161 -0.962 . . . . 0.02 110.081 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.04 -31.19 61.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.02 111.465 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.7 mt -115.6 155.75 46.99 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.68 -1.263 . . . . 1.48 108.985 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -57.44 167.53 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.101 1.201 . . . . 0.02 112.741 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 9.9 t30 59.4 31.44 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.192 -0.913 . . . . 0.75 111.325 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.88 51.77 8.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.5 -0.75 . . . . 0.02 110.952 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.49 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.36 164.82 20.23 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.51 -0.744 . . . . 0.02 109.791 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.425 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.55 -165.62 33.9 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.279 -1.129 . . . . 0.02 110.279 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.58 142.36 53.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.499 -1.001 . . . . 0.02 108.825 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.3 mt-30 -113.06 148.14 35.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.34 0.591 . . . . 0.02 109.826 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -122.86 132.66 54.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.436 -0.95 . . . . 0.01 108.436 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.36 121.56 37.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.933 -1.105 . . . . 0.01 109.702 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.03 161.22 13.92 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.796 -1.187 . . . . 0.01 107.796 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.38 -110.46 0.34 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.413 -0.805 . . . . 2.27 109.801 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -151.16 31.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 1.84 109.03 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -109.73 -165.42 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.974 -0.75 . . . . 2.28 108.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 2.7 mm-40 -106.26 118.37 36.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.517 -0.739 . . . . 0.01 109.419 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.4 113.13 24.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -90.09 -27.4 19.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.487 -0.758 . . . . 0.01 111.625 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -127.0 156.26 74.52 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.738 -1.226 . . . . 2.54 108.064 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.14 -38.84 53.11 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.51 0.807 . . . . 0.7 111.282 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.48 -19.39 18.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.856 -1.152 . . . . 0.86 109.914 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.76 -18.32 65.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.823 -1.173 . . . . 0.02 112.111 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.36 16.28 26.1 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.722 -1.236 . . . . 0.02 110.191 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.25 10.69 77.25 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.104 -0.998 . . . . 0.02 112.806 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.52 140.57 34.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.861 -1.376 . . . . 0.02 110.303 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.6 -7.95 58.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.696 -0.628 . . . . 0.59 109.715 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 p -140.67 150.85 61.59 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.227 -0.92 . . . . 0.87 109.33 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.59 14.48 1.21 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.903 1.068 . . . . 0.38 112.304 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -81.7 121.28 26.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.891 -1.13 . . . . 0.18 111.231 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.5 mp -153.1 124.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.469 -1.678 . . . . 3.99 106.469 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -114.15 -8.72 12.97 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.425 -0.797 . . . . 5.17 113.143 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 p -157.22 158.69 36.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.359 -2.088 . . . . 0.02 109.448 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -152.82 154.21 34.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -0.886 . . . . 2.02 110.147 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -144.48 150.34 37.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.265 -0.897 . . . . 0.01 110.296 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.4 ptt180 -87.52 142.71 27.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.703 -0.851 . . . . 0.01 108.703 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 175' ' ' ILE . 3.3 mt -94.46 128.61 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.311 -0.868 . . . . 3.04 109.329 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.11 148.47 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.127 -0.983 . . . . 1.89 110.009 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.45 -0.781 . . . . 4.89 109.435 179.569 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.593 0 N-CA-C 107.095 -2.402 . . . . 0.81 107.095 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.06 148.88 33.59 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.174 -1.012 . . . . 0.01 110.625 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -150.72 136.72 18.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.979 . . . . 0.02 109.077 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.71 140.42 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.897 -0.779 . . . . 0.02 108.897 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.88 129.97 52.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.483 -0.76 . . . . 0.39 109.644 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 7.7 m-85 -109.68 139.96 44.1 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.572 -0.899 . . . . 0.02 108.572 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.9 m-85 -122.05 138.67 54.35 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.229 -0.92 . . . . 0.02 109.646 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.485 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.23 -27.67 66.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.919 -1.113 . . . . 0.03 111.736 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.63 170.4 8.34 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.869 -1.144 . . . . 0.03 110.11 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -75.39 161.34 29.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.738 0.78 . . . . 0.03 110.217 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 m120 63.04 34.95 13.43 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.933 0.873 . . . . 0.74 110.433 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p90 49.51 42.52 22.89 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.39 -0.823 . . . . 0.02 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -109.11 166.07 11.12 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.34 -168.14 34.76 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 120.739 -1.225 . . . . 0.03 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -70.05 145.3 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.474 -1.016 . . . . 2.76 109.098 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -120.4 149.24 42.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.594 -0.692 . . . . 1.89 110.272 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -132.07 126.99 35.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.942 -1.133 . . . . 0.02 107.942 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.33 136.7 51.46 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.476 -0.765 . . . . 1.12 110.02 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -131.14 137.96 49.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.56 0.695 . . . . 0.02 109.471 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -116.59 10.7 14.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.672 -0.643 . . . . 0.2 109.503 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.8 t -157.71 173.84 16.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.134 -1.061 . . . . 1.23 108.134 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.506 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -60.85 144.29 53.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.683 -1.261 . . . . 0.02 110.087 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.52 116.9 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.438 -0.949 . . . . 0.02 108.438 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.89 52.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.192 -0.942 . . . . 0.24 110.537 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -153.48 100.61 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 1.14 108.701 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -104.21 9.21 36.21 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.285 1.04 . . . . 6.37 109.39 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -58.68 -24.03 60.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.741 . . . . 3.11 110.571 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 m -74.39 -16.84 60.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.16 . . . . 0.88 110.057 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.66 -22.14 13.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.357 -0.84 . . . . 0.02 109.272 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.06 128.47 12.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 3.32 109.014 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.1 p -85.33 -9.87 57.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.689 -0.632 . . . . 0.02 110.964 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.91 163.01 6.17 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -142.7 115.51 8.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.873 -1.142 . . . . 0.02 108.709 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.64 0.91 20.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.854 -1.154 . . . . 0.03 110.601 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 t -156.67 153.45 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.6 mt -145.12 148.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.013 -1.054 . . . . 0.02 109.969 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -124.7 124.69 42.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.348 -1.353 . . . . 0.02 107.348 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.46 114.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.099 -1.445 . . . . 0.02 107.099 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.61 -34.47 25.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 3.81 109.855 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.28 17.53 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 118.698 -1.715 . . . . 0.02 110.433 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.96 173.26 49.66 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.547 -1.311 . . . . 0.01 110.23 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -120.01 136.13 54.67 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.806 -1.183 . . . . 1.48 107.806 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.5 m95 -125.17 154.5 41.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.518 1.152 . . . . 0.02 112.159 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.12 133.44 52.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 104.964 -2.235 . . . . 0.24 104.964 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.23 141.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.902 -0.777 . . . . 0.65 108.902 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.58 143.56 48.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.261 1.029 . . . . 0.02 109.224 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 8.1 tp10 -66.1 -35.23 79.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.359 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 50' ' ' GLU . 10.4 mpt_? -122.75 158.05 58.02 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 121.114 -0.991 . . . . 0.02 109.402 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -54.51 166.7 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.46 1.44 . . . . 0.02 112.567 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 63.12 37.36 11.5 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.382 -0.827 . . . . 0.02 111.173 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 44.67 52.57 7.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.674 0.749 . . . . 3.39 110.773 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -126.4 163.75 22.61 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.114 0.483 . . . . 2.33 109.705 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.4 -161.62 32.73 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.719 -1.352 . . . . 0.02 109.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -66.22 137.54 57.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.313 . . . . 0.02 110.139 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.2 ptm -121.27 136.53 54.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.664 -0.648 . . . . 5.01 109.482 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.657 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.4 m-85 -133.32 142.03 48.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.717 . . . . 0.02 109.418 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 mm -96.14 132.56 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.127 -0.694 . . . . 1.72 109.127 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -121.73 109.69 34.04 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.481 -0.762 . . . . 0.02 110.391 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -75.81 169.78 21.51 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.033 1.048 . . . . 1.47 110.403 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -53.06 140.18 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.908 -1.12 . . . . 4.25 110.572 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.18 -177.23 32.52 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.614 -1.279 . . . . 0.02 110.386 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -118.98 129.94 55.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.471 -1.017 . . . . 0.96 109.413 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 46.0 m-85 -120.82 95.48 48.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.32 -3.9 10.81 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 120.682 0.921 . . . . 0.02 113.666 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -156.82 154.28 29.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 2.02 108.254 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.37 -38.57 84.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.582 -0.699 . . . . 0.02 111.654 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.63 -24.54 65.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.028 -1.045 . . . . 0.02 110.336 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.68 -18.23 64.23 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.956 0.884 . . . . 3.42 108.831 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.657 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.64 11.86 28.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.333 -1.358 . . . . 0.02 107.333 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.5 mpt? 59.49 22.78 11.35 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.504 0.669 . . . . 0.02 110.243 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 146.35 46.62 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.253 -1.539 . . . . 0.02 109.253 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.8 tp -79.63 -30.63 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.98 108.013 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.598 HD22 ' H ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -157.65 -170.89 3.36 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.64 27.85 4.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.776 -1.203 . . . . 0.02 110.436 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.598 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -96.31 122.5 39.25 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.081 -1.012 . . . . 3.2 110.0 -178.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD21 ' CH2' ' A' ' 72' ' ' TRP . 62.5 mt -143.5 122.66 12.93 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.957 -1.127 . . . . 2.61 107.957 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA3' HH12 ' A' ' 78' ' ' ARG . . . -109.98 -17.82 9.3 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.168 -0.957 . . . . 0.02 112.732 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 t -156.1 156.1 33.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 119.978 -1.896 . . . . 0.02 110.857 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.2 t -145.47 147.54 32.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.02 110.254 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -135.64 140.8 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.921 -0.77 . . . . 0.01 108.921 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.96 132.29 37.8 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.092 -1.005 . . . . 0.43 108.679 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.29 124.14 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.438 -0.949 . . . . 1.25 108.438 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.41 134.66 34.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.104 -0.998 . . . . 1.77 108.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.6 137.97 35.72 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.456 -0.942 . . . . 1.63 108.456 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -110.9 125.65 53.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.483 -0.932 . . . . 1.08 108.483 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -103.28 -155.0 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.59 -48.53 0.92 Allowed Glycine 0 N--CA 1.498 2.809 0 O-C-N 120.458 -1.401 . . . . 0.01 112.055 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.38 -99.33 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.592 -1.766 . . . . 0.01 112.187 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -122.29 120.12 33.14 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.402 -1.057 . . . . 4.43 110.653 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.37 129.83 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.914 -0.714 . . . . 2.99 109.142 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -131.48 139.53 49.35 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 6.36 109.334 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.83 145.58 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.389 -0.819 . . . . 1.09 109.85 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.02 133.63 55.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.284 -1.376 . . . . 2.05 107.284 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.68 147.11 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.852 -1.155 . . . . 1.1 109.419 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.3 m-85 -119.3 141.61 48.84 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.055 0.931 . . . . 0.73 111.07 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -66.27 -29.85 70.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.919 -0.582 . . . . 0.02 111.589 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.54 168.08 10.49 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.933 -1.105 . . . . 3.18 110.696 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.07 42.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.989 -0.844 . . . . 0.01 110.989 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t0 56.56 39.47 29.85 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.65 0.738 . . . . 0.01 110.951 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.484 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.2 m-85 52.49 55.36 9.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.688 -0.633 . . . . 0.01 111.038 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -128.63 165.81 20.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.468 -0.938 . . . . 3.15 108.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.11 -164.94 27.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.23 -1.548 . . . . 0.01 109.23 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.53 144.57 44.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.951 -1.323 . . . . 0.01 108.3 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 24.2 ttp -116.53 142.27 47.1 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.554 0.692 . . . . 0.01 109.804 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -131.56 136.0 47.48 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.05 -1.093 . . . . 2.48 108.05 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.8 tm-20 -120.25 135.35 55.02 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.446 -0.784 . . . . 0.01 110.145 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.534 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -149.2 151.64 34.64 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.277 1.037 . . . . 1.69 111.0 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.3 p -110.73 9.39 22.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.606 -0.725 . . . . 0.01 110.009 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -121.1 163.32 18.58 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.291 -0.881 . . . . 3.21 111.366 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.02 155.29 39.02 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 34.9 t -125.44 113.67 25.56 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.752 -0.832 . . . . 0.01 108.752 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.33 -29.08 8.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.388 1.174 . . . . 0.01 111.278 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.1 t -142.53 109.88 5.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 0.02 109.359 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.0 mt -61.99 -39.62 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 122.003 -0.435 . . . . 1.83 110.149 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.44 -37.37 80.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.425 -0.91 . . . . 1.34 110.447 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -70.44 -39.37 74.38 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.433 -1.417 . . . . 2.11 109.908 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 8.6 tt0 -79.46 -47.67 15.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.08 112.428 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.458 ' CZ ' ' CD ' ' A' ' 120' ' ' GLN . 28.2 m-85 -110.8 0.52 17.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.434 -0.791 . . . . 0.02 112.628 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.1 m80 60.63 33.19 20.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.682 -1.261 . . . . 0.02 109.507 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -113.51 135.23 54.12 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.749 -0.834 . . . . 0.02 108.749 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.62 -21.56 22.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.378 -0.826 . . . . 5.32 110.276 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -150.76 165.87 32.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.135 -0.978 . . . . 0.02 109.992 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.73 128.63 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.212 -1.403 . . . . 2.17 107.212 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.2 m-70 -108.89 -12.44 14.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.539 -0.726 . . . . 0.02 112.256 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.484 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 10.1 t -159.51 152.72 22.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.01 108.555 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.8 p -163.41 145.87 9.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 1.22 109.665 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -116.61 102.93 9.89 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.701 -1.249 . . . . 1.41 108.591 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 131' ' ' VAL . 4.3 p . . . . . 0 C--N 1.299 -1.595 0 N-CA-C 107.604 -1.258 . . . . 0.01 107.604 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.511 2.616 0 CA-C-O 121.638 0.732 . . . . 0.01 110.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -120.13 137.45 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.322 -0.992 . . . . 1.69 108.322 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CG ' HD11 ' A' ' 151' ' ' LEU . 3.3 m-30 -111.3 142.03 44.06 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 106.827 -1.546 . . . . 2.49 106.827 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 24.7 m-85 -123.37 143.76 49.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.044 -1.035 . . . . 0.02 109.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.0 -31.24 62.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.796 -0.565 . . . . 0.02 111.854 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.28 155.36 47.01 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.67 -1.269 . . . . 1.48 108.899 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -57.22 166.66 4.11 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.186 1.257 . . . . 0.02 112.832 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.77 31.26 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.2 -0.909 . . . . 0.75 111.386 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.1 m-85 58.11 52.23 7.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.629 -0.669 . . . . 0.02 111.327 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.49 165.15 19.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.529 -0.732 . . . . 0.02 109.954 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.96 -165.34 34.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -69.06 141.55 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.531 -0.982 . . . . 0.02 108.723 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.499 ' O ' ' CG ' ' A' ' 58' ' ' MET . 2.2 mt-30 -113.86 150.12 34.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.543 -0.539 . . . . 0.02 109.543 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.76 132.91 53.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.567 -0.901 . . . . 0.01 108.567 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.93 120.24 34.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.21 . . . . 0.01 108.892 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 138' ' ' PHE . 10.4 mt -102.48 140.22 37.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 154' ' ' LYS . 27.8 m-20 -108.5 -163.27 0.87 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.53 -0.731 . . . . 2.27 109.474 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -75.12 40.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 1.84 109.588 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 152' ' ' ASP . 18.6 ttmt -113.55 162.25 16.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.622 -0.674 . . . . 2.28 109.413 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 3.3 mp0 -103.32 130.43 50.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.899 -1.148 . . . . 0.01 107.899 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 49.1 m-85 -102.5 112.11 24.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.01 110.515 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -90.06 -27.13 19.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.01 110.432 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -123.77 153.91 66.98 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 107.63 -1.248 . . . . 2.54 107.63 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.05 -41.47 35.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 CA-C-N 119.202 0.751 . . . . 0.7 111.047 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.35 -18.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 120.812 -1.18 . . . . 0.86 109.389 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 58.7 t0 -65.55 -18.87 65.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.808 -1.182 . . . . 0.02 112.029 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.08 15.92 27.12 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 120.705 -1.247 . . . . 0.02 110.311 178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.82 75.82 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.192 -0.942 . . . . 0.02 112.91 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.87 140.35 35.28 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.862 -1.375 . . . . 0.02 110.124 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -6.94 59.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.59 109.574 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.2 m -139.43 151.18 66.28 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.19 -0.944 . . . . 0.87 109.548 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.515 ' O ' HD12 ' A' ' 169' ' ' ILE . 35.3 Cg_endo -75.34 14.72 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.934 1.089 . . . . 0.38 112.173 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.9 122.1 28.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.18 111.794 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 167' ' ' PRO . 4.1 mp -147.6 127.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.112 -1.81 . . . . 3.99 106.112 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -110.68 -14.26 14.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.308 -0.87 . . . . 5.17 112.675 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 11.6 t -156.59 158.7 37.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.389 -2.07 . . . . 0.02 110.068 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -150.38 151.9 33.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.192 -0.942 . . . . 2.02 109.889 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.511 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.5 mtp180 -143.87 150.3 38.23 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.173 -0.955 . . . . 0.01 110.543 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.75 143.32 27.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.423 -0.954 . . . . 0.01 108.423 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 175' ' ' ILE . 2.6 mt -96.68 129.97 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.404 -0.81 . . . . 3.04 109.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 177' ' ' GLU . 57.5 t -137.24 148.26 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 1.89 109.336 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 176' ' ' VAL . 1.4 pp20? . . . . . 0 N--CA 1.505 2.282 0 CA-C-O 121.244 0.545 . . . . 4.89 111.327 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 107.003 -2.439 . . . . 0.81 107.003 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.36 148.14 32.25 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.595 -1.002 . . . . 0.01 110.595 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -153.77 138.33 16.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.557 -0.967 . . . . 0.02 108.72 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.18 141.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.163 -0.68 . . . . 0.02 109.163 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -121.9 130.22 53.18 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 0.39 109.559 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 13.8 m-85 -109.44 139.08 44.87 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.742 -0.836 . . . . 0.02 108.742 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -122.42 138.79 54.42 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.187 -0.946 . . . . 0.02 109.625 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 33' ' ' LEU . 83.1 mt-10 -68.36 -27.2 66.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.03 111.839 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.48 169.47 9.02 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.847 -1.158 . . . . 0.03 110.138 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.57 158.67 32.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.611 0.72 . . . . 0.03 110.064 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.4 35.04 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.754 0.788 . . . . 0.74 110.858 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 20.5 p90 50.0 43.88 25.52 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.602 -0.726 . . . . 0.02 111.312 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -112.09 166.39 11.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.031 -1.1 . . . . 0.02 108.031 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -168.06 36.24 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.728 -1.225 . . . . 0.03 110.82 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -69.15 143.62 54.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.423 -1.045 . . . . 2.76 108.978 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -119.95 149.09 42.7 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.586 0.707 . . . . 1.89 110.035 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -132.19 127.16 35.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.991 -1.115 . . . . 0.02 107.991 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 11.4 p30 -111.59 135.84 51.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.473 -0.767 . . . . 1.12 109.603 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.3 t -129.99 137.53 50.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.472 0.653 . . . . 0.02 109.474 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.69 11.47 14.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.722 -0.612 . . . . 0.2 109.535 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -157.88 174.07 15.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -61.71 145.4 52.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.709 -1.244 . . . . 0.02 109.984 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.3 t -131.72 116.59 17.5 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.635 -0.876 . . . . 0.02 108.635 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.6 -24.15 53.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.24 110.675 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.76 100.84 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.54 -0.911 . . . . 1.14 108.54 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -104.32 9.66 35.8 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.165 0.983 . . . . 6.37 109.867 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.565 ' NH2' ' CZ ' ' A' ' 51' ' ' ARG . 90.1 mtt180 -59.25 -22.84 61.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.585 -0.697 . . . . 3.11 110.857 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -75.9 -16.85 59.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.88 110.227 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.63 -22.12 13.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.445 -0.784 . . . . 0.02 109.307 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 36' ' ' CYS . 6.0 tp -150.55 128.94 12.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.331 -0.856 . . . . 3.32 108.813 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.5 p -86.53 -10.86 53.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.796 -0.565 . . . . 0.02 111.286 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.672 ' HE ' HD21 ' A' ' 37' ' ' ASN . 54.9 ttt180 -171.14 161.67 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.02 108.021 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.9 m -142.31 115.27 8.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.938 -1.101 . . . . 0.02 109.378 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.672 HD21 ' HE ' ' A' ' 35' ' ' ARG . 3.3 m120 -106.73 -0.67 23.37 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.882 -1.136 . . . . 0.03 110.224 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -157.05 154.58 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.747 -1.205 . . . . 0.02 107.747 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -144.77 148.54 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -0.999 . . . . 0.02 109.2 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -123.65 123.9 41.58 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.154 -1.424 . . . . 0.02 107.154 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -105.33 114.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.845 -1.539 . . . . 0.02 106.845 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -84.21 -33.96 24.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.462 -0.773 . . . . 3.81 109.569 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.79 18.54 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.649 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.4 173.69 49.95 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.726 -1.226 . . . . 0.01 110.407 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.2 m -118.9 136.13 54.22 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.822 -1.177 . . . . 1.48 107.822 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -124.6 152.67 43.27 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.851 -1.156 . . . . 0.02 112.103 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.45 133.6 52.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.007 -2.22 . . . . 0.24 105.007 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.5 m -116.46 141.7 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.026 -0.731 . . . . 0.65 109.026 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 17.5 m-85 -119.69 142.85 48.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.223 1.011 . . . . 0.02 109.386 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -64.78 -35.85 82.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.334 -0.848 . . . . 0.02 111.303 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.705 HH12 ' NH2' ' A' ' 78' ' ' ARG . 3.7 mmp_? -121.36 153.83 58.86 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.096 -1.002 . . . . 0.02 109.578 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -52.76 167.45 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.371 1.38 . . . . 0.02 112.457 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 64.68 37.24 7.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.746 0.784 . . . . 0.02 111.26 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 46.37 51.02 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.422 0.629 . . . . 3.39 111.156 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -127.47 164.62 21.51 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.289 0.566 . . . . 2.33 110.306 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.29 -162.68 30.98 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.216 -1.153 . . . . 0.02 110.216 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.627 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 4.9 t60 -63.37 143.04 58.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.11 -1.229 . . . . 0.02 110.347 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.8 mtp -116.49 135.22 54.02 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.291 0.567 . . . . 5.01 109.755 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' HIS . 32.9 m-85 -134.84 133.35 39.66 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.405 -0.809 . . . . 0.02 108.958 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.42 131.84 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.578 -0.897 . . . . 1.72 108.578 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -121.21 109.72 34.97 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.517 -0.739 . . . . 0.02 110.21 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.64 169.54 21.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 119.969 1.025 . . . . 1.47 110.369 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.9 140.71 29.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.76 -1.212 . . . . 4.25 110.667 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.83 -175.11 32.25 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.32 . . . . 0.02 110.255 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -116.17 128.12 55.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -1.054 . . . . 0.96 108.804 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 37.7 m-85 -119.28 97.99 50.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.101 -1.074 . . . . 0.02 108.101 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 6.5 Cg_endo -69.88 -6.56 18.96 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 120.553 0.835 . . . . 0.02 114.179 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 76.1 mt-10 -157.53 155.47 30.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.215 -1.553 . . . . 2.02 108.417 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 38.8 p90 -60.24 -36.93 78.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.47 -0.769 . . . . 0.02 112.665 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.63 -21.37 60.37 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.182 -0.949 . . . . 0.02 110.061 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -67.51 -19.96 65.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 3.42 110.348 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.45 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.8 p90 -110.04 16.04 22.13 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.305 -0.872 . . . . 0.02 108.828 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.6 OUTLIER 65.32 24.98 12.14 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.234 0.54 . . . . 0.02 110.739 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -62.14 145.56 49.33 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.731 -1.347 . . . . 0.02 109.731 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.528 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.1 tt -80.51 -30.27 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.646 -1.242 . . . . 0.98 107.646 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -155.82 -171.53 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.702 -1.592 . . . . 0.02 106.702 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' CG ' ' A' ' 69' ' ' TYR . 95.8 m-20 -97.89 27.45 4.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.832 -1.168 . . . . 0.02 110.298 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' NH2' HH12 ' A' ' 51' ' ' ARG . 38.2 mtp180 -95.51 122.42 38.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.962 -1.086 . . . . 3.2 110.591 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 48' ' ' VAL . 68.9 mt -142.52 120.53 12.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.536 -1.283 . . . . 2.61 107.536 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.37 -17.17 10.21 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 121.358 -0.838 . . . . 0.02 112.485 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 11.3 t -156.23 156.42 34.09 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.331 -1.687 . . . . 0.02 110.648 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.1 p -145.05 147.75 32.93 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.691 0.758 . . . . 0.02 110.247 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 15.9 mtp180 -135.63 140.47 44.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.621 -0.881 . . . . 0.01 108.621 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.11 131.26 38.25 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.204 -0.935 . . . . 0.43 108.539 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.92 122.88 40.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.41 -0.959 . . . . 1.25 108.41 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -91.03 134.92 34.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.798 -1.189 . . . . 1.77 108.505 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 136.93 38.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.305 -0.998 . . . . 1.63 108.305 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -110.96 126.31 54.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.32 -0.863 . . . . 1.08 108.673 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.4 m -103.77 -154.65 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.275 -1.75 . . . . 1.26 106.275 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.16 -48.15 0.93 Allowed Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.567 -1.333 . . . . 0.01 112.103 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.63 -99.57 0.13 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.729 -1.701 . . . . 0.01 111.934 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -120.74 118.91 31.26 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.096 -1.238 . . . . 4.43 110.352 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' A' ' 92' ' ' GLN . . . -74.72 130.55 39.69 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.112 -0.699 . . . . 2.99 109.112 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -129.28 136.18 49.73 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.882 -0.784 . . . . 6.36 108.882 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -127.64 144.07 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.471 -0.768 . . . . 1.09 109.326 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.53 133.06 54.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.922 -1.14 . . . . 2.05 107.922 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.06 145.89 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.77 -1.206 . . . . 1.1 109.384 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.66 140.91 49.16 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.999 0.904 . . . . 0.73 110.816 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.41 ' CD ' HH22 ' A' ' 124' ' ' ARG . 4.1 tm-20 -65.85 -30.38 70.98 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.911 -0.586 . . . . 0.02 111.775 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -117.12 169.77 9.18 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.216 1.007 . . . . 3.18 110.663 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.34 36.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.723 -0.951 . . . . 0.01 110.723 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.81 38.12 22.38 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.539 0.685 . . . . 0.01 110.739 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.45 53.73 11.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.705 -0.622 . . . . 0.01 110.974 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -125.91 165.89 17.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.124 -1.065 . . . . 3.15 108.124 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.53 28.08 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.27 145.05 42.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.983 -1.304 . . . . 0.01 108.482 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.83 142.53 46.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.558 0.694 . . . . 0.01 109.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.414 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.8 m-85 -130.69 135.87 48.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.947 -1.131 . . . . 2.48 107.947 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -119.34 134.42 55.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.01 109.731 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -149.92 151.17 32.97 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.268 1.033 . . . . 1.69 110.798 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.4 p -110.35 10.18 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.536 -0.756 . . . . 0.01 109.676 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -121.36 163.05 19.28 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -0.827 . . . . 3.21 111.393 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.76 154.34 39.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.386 -0.968 . . . . 0.01 108.386 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 14.3 t -123.58 110.25 30.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.527 -0.916 . . . . 0.01 108.527 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -77.85 -32.69 2.53 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 119.932 1.012 . . . . 0.01 112.032 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -140.33 108.43 5.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.108 -0.995 . . . . 0.02 109.189 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 mt -63.49 -40.99 91.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.825 -0.547 . . . . 1.83 110.656 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.32 -38.48 87.79 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.134 -1.026 . . . . 1.34 110.415 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -70.55 -38.82 74.21 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.145 -1.597 . . . . 2.11 109.35 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.482 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 49.6 tt0 -80.54 -48.14 13.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 2.08 112.45 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.482 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 70.4 m-85 -111.8 -1.83 15.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.261 -0.899 . . . . 0.02 112.661 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.93 35.01 19.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.851 -1.156 . . . . 0.02 109.506 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 mt -114.57 136.42 53.05 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.53 -0.731 . . . . 0.02 109.381 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.61 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.2 -21.11 23.44 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.217 -0.927 . . . . 5.32 110.465 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -149.33 165.48 31.85 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.7 -1.25 . . . . 0.02 110.367 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mm -127.42 123.7 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.206 -1.405 . . . . 2.17 107.206 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.7 m-70 -109.23 -14.09 14.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.158 -0.964 . . . . 0.02 112.467 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.8 t -159.57 151.49 20.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.01 108.763 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 30.0 p -168.6 146.14 3.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.925 . . . . 1.22 108.906 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -122.17 109.12 14.11 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.353 1.073 . . . . 1.41 109.228 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 106.868 -1.53 . . . . 0.01 106.868 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.3 m95 . . . . . 0 N--CA 1.505 2.307 0 N-CA-C 107.062 -1.459 . . . . 0.01 107.062 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.503 HG13 HD11 ' A' ' 175' ' ' ILE . 32.0 mt -118.81 132.43 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.335 -1.478 . . . . 1.69 109.782 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -111.54 141.99 44.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.221 -1.77 . . . . 2.49 106.221 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.5 m-85 -123.06 143.34 50.02 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 0.02 109.755 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.84 -30.86 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.754 -0.591 . . . . 0.02 111.563 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.84 154.93 48.24 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.729 -1.232 . . . . 1.48 108.929 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.49 167.09 2.97 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.349 1.366 . . . . 0.02 113.038 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 44.4 t-20 60.0 31.53 20.69 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.116 -0.947 . . . . 0.75 111.363 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.97 51.48 10.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.498 -0.751 . . . . 0.02 111.01 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -126.65 165.29 19.49 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.601 -0.687 . . . . 0.02 109.937 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.47 -165.3 33.79 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.205 -1.158 . . . . 0.02 110.205 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.39 141.5 54.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.509 -0.995 . . . . 0.02 108.837 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -114.59 148.77 37.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.541 -0.541 . . . . 0.02 109.541 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 4.7 m-85 -123.26 134.25 54.11 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.905 -0.776 . . . . 0.01 108.905 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.2 tp -95.93 120.76 36.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.895 -1.128 . . . . 0.01 109.046 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.5 mp -97.69 140.6 31.85 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.74 -0.837 . . . . 0.01 108.74 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.547 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 60.1 m-20 -105.01 -170.39 1.75 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.46 -0.775 . . . . 2.27 109.627 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.53 41.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.84 109.881 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -113.34 172.56 6.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.482 -0.761 . . . . 2.28 109.43 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.6 126.29 51.55 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.509 -0.923 . . . . 0.01 108.509 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 3.2 m-85 -100.68 111.96 24.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.199 -0.938 . . . . 0.01 110.145 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -92.79 -26.75 17.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.01 110.644 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -123.28 153.62 65.21 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.902 -1.147 . . . . 2.54 107.902 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -60.96 -40.52 51.88 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.33 0.797 . . . . 0.7 110.962 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.12 -18.62 18.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.046 -1.033 . . . . 0.86 109.332 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 52.9 t0 -65.76 -19.0 65.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.11 . . . . 0.02 112.164 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -101.12 15.69 27.88 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 120.655 -1.278 . . . . 0.02 110.143 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 9.7 76.77 Favored Glycine 0 N--CA 1.5 2.903 0 O-C-N 121.177 -0.952 . . . . 0.02 113.149 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.55 141.18 33.77 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.812 -1.405 . . . . 0.02 110.274 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.11 -7.22 59.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.688 -0.633 . . . . 0.59 109.598 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.6 p -142.42 150.77 55.88 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.87 109.107 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -75.81 17.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.698 0.932 . . . . 0.38 112.052 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.429 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -82.1 121.63 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.304 1.05 . . . . 0.18 111.154 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.8 mp -151.07 125.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.499 -1.667 . . . . 3.99 106.499 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -110.84 -13.34 14.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.342 -0.849 . . . . 5.17 112.746 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.16 158.3 37.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 119.378 -2.076 . . . . 0.02 109.91 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.55 153.06 33.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.28 -0.888 . . . . 2.02 109.905 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -142.92 148.75 37.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.835 0.826 . . . . 0.01 110.081 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -86.01 142.17 28.96 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.868 -1.16 . . . . 0.01 107.868 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.503 HD11 HG13 ' A' ' 137' ' ' ILE . 8.5 mt -95.17 128.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 3.04 109.41 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.57 148.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.36 -0.838 . . . . 1.89 109.837 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 4.89 109.435 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.679 0 N-CA-C 106.871 -2.492 . . . . 0.81 106.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.06 32.24 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.315 -0.945 . . . . 0.01 110.904 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -151.86 137.33 17.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.693 -0.886 . . . . 0.02 108.653 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.19 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.368 -0.604 . . . . 0.02 109.368 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -120.71 128.77 53.26 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.4 -0.812 . . . . 0.39 109.793 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.79 137.94 44.91 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.241 -1.022 . . . . 0.02 108.241 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.6 m-85 -122.13 138.25 54.53 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.125 -0.984 . . . . 0.02 109.96 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' HD11 ' A' ' 33' ' ' LEU . 95.0 mt-10 -68.06 -28.26 67.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 0.03 111.292 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.02 170.51 8.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.023 -1.048 . . . . 0.03 110.305 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.6 ' NE ' HD21 ' A' ' 37' ' ' ASN . 96.8 mtt180 -75.59 161.85 28.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.795 0.807 . . . . 0.03 110.604 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 41.3 t-20 62.59 33.6 15.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.03 0.919 . . . . 0.74 110.89 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 65' ' ' GLU . 0.3 OUTLIER 55.31 40.31 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.861 -0.609 . . . . 0.02 110.67 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -110.12 165.21 11.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.219 -1.03 . . . . 0.02 108.219 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.21 -167.74 36.25 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 120.794 -1.191 . . . . 0.03 110.759 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -69.21 143.35 54.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -1.003 . . . . 2.76 109.541 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.36 149.74 41.87 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.728 0.775 . . . . 1.89 109.713 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -132.97 126.84 32.88 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.598 -1.26 . . . . 0.02 107.598 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -111.78 137.61 49.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.46 -0.775 . . . . 1.12 109.666 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 138.17 49.1 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.609 0.718 . . . . 0.02 109.387 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -116.98 10.44 14.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.745 -0.597 . . . . 0.2 109.47 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -158.09 174.45 15.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.213 -1.032 . . . . 1.23 108.213 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 29.4 t0 -60.99 143.34 55.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.762 -1.212 . . . . 0.02 110.153 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 58.1 m -131.31 116.94 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.02 108.435 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -26.29 51.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.24 110.882 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -152.96 101.14 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.025 -1.047 . . . . 1.14 108.641 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -104.86 8.75 34.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.143 0.973 . . . . 6.37 109.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -58.29 -23.32 55.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.601 -0.687 . . . . 3.11 110.626 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 p -74.56 -17.01 60.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.816 -1.178 . . . . 0.88 110.266 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -103.72 -22.42 13.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.467 -0.771 . . . . 0.02 109.333 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.426 HD11 ' HG3' ' A' ' 11' ' ' GLU . 4.9 tp -149.71 128.0 12.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 3.32 108.811 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m -86.47 -9.9 55.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.02 110.96 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 77' ' ' ASP . 40.6 ttt180 -171.04 161.41 6.84 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.681 -1.229 . . . . 0.02 107.681 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.9 t -143.28 115.71 8.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.794 -1.191 . . . . 0.02 108.822 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.6 HD21 ' NE ' ' A' ' 13' ' ' ARG . 33.4 t-20 -108.16 1.42 22.18 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.932 -1.105 . . . . 0.03 110.318 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -156.43 153.52 29.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.509 -1.293 . . . . 0.02 107.509 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -145.44 148.01 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.095 . . . . 0.02 109.895 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -124.54 125.25 43.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.565 -1.272 . . . . 0.02 107.565 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 t -105.48 114.0 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.98 -1.489 . . . . 0.02 106.98 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 4.8 tm-20 -83.63 -34.29 25.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.485 -0.759 . . . . 3.81 109.689 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.06 148.99 16.89 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.611 -1.757 . . . . 0.02 110.569 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.83 173.89 50.02 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.985 -1.246 . . . . 0.01 109.985 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -119.6 135.89 54.61 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.3 m95 -123.41 153.49 40.34 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.537 1.16 . . . . 0.02 112.155 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.6 132.47 53.25 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.02 -2.215 . . . . 0.24 105.02 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.26 142.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.931 -0.766 . . . . 0.65 108.931 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 31.8 m-85 -121.56 145.98 47.42 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.272 1.034 . . . . 0.02 109.801 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.29 -34.85 78.25 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.732 -0.667 . . . . 0.02 111.134 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.64 153.52 66.45 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.113 -0.992 . . . . 0.02 109.309 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -51.54 167.68 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.546 1.497 . . . . 0.02 113.249 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 63.79 37.06 10.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.049 -0.978 . . . . 0.02 111.127 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 45.19 50.77 9.47 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.62 0.724 . . . . 3.39 110.379 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -125.2 163.59 22.14 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.201 0.524 . . . . 2.33 109.746 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 -161.85 32.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.488 -1.445 . . . . 0.02 109.488 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -67.59 137.9 56.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.812 -1.405 . . . . 0.02 109.89 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 21.2 ptm -119.14 137.82 53.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.473 0.654 . . . . 5.01 109.541 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -132.9 140.07 47.69 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.476 -0.765 . . . . 0.02 109.666 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.47 132.34 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.355 -0.98 . . . . 1.72 108.355 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.56 108.35 39.6 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.508 -0.745 . . . . 0.02 110.329 -178.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -75.2 168.27 25.06 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.044 1.051 . . . . 1.47 110.267 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 42' ' ' GLU . 7.9 tt0 -53.43 140.03 28.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.834 -1.166 . . . . 4.25 110.487 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.99 -176.75 32.57 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.508 -1.33 . . . . 0.02 110.301 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 15' ' ' PHE . 62.3 tt0 -118.64 130.06 55.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.389 -1.065 . . . . 0.96 109.369 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 25.5 m-85 -120.75 92.83 48.36 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.826 -1.176 . . . . 0.02 107.826 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -65.7 -4.87 10.57 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.035 1.157 . . . . 0.02 113.746 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -157.03 153.57 28.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.579 -1.326 . . . . 2.02 107.889 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.526 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 8.8 p90 -60.59 -37.62 81.97 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.468 -0.77 . . . . 0.02 112.162 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.526 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 22.1 mm100 -60.32 -23.68 64.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.942 -1.099 . . . . 0.02 110.661 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.7 62.39 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.898 0.856 . . . . 3.42 108.854 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.74 9.91 28.97 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.393 -1.336 . . . . 0.02 107.393 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.7 mtt 61.34 21.89 12.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.652 . . . . 0.02 110.641 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.27 144.47 45.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.182 -1.567 . . . . 0.02 109.182 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.4 tp -79.06 -30.71 44.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.619 -1.252 . . . . 0.98 107.619 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 49.6 t30 -157.69 -173.25 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.476 -1.676 . . . . 0.02 106.476 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.509 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -98.16 27.41 4.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.843 -1.161 . . . . 0.02 110.215 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.05 122.24 38.67 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.267 -0.896 . . . . 3.2 109.954 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.3 mt -144.5 119.52 10.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.586 -1.264 . . . . 2.61 107.586 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.96 -16.02 14.86 Favored Glycine 0 N--CA 1.503 3.136 0 C-N-CA 120.525 -0.845 . . . . 0.02 112.395 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -156.47 155.91 32.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.405 -1.644 . . . . 0.02 110.03 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 30.3 p -144.28 147.59 33.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.02 109.491 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -134.53 140.04 45.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.323 -0.861 . . . . 0.01 108.797 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.03 130.96 37.11 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.205 -0.934 . . . . 0.43 108.651 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.62 123.34 42.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -91.96 133.49 35.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.015 . . . . 1.77 108.386 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.06 139.67 32.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.766 . . . . 1.63 109.049 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 t -111.48 125.59 54.06 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.465 -0.939 . . . . 1.08 108.465 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 t -102.75 -155.68 0.53 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.282 -1.747 . . . . 1.26 106.282 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.21 -47.88 0.95 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.545 -1.347 . . . . 0.01 112.051 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.34 -98.6 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 118.587 -1.768 . . . . 0.01 112.267 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -122.48 120.89 35.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.394 -1.062 . . . . 4.43 110.762 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 174' ' ' ARG . . . -76.82 132.01 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.171 -0.677 . . . . 2.99 109.171 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.32 139.24 49.5 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 6.36 109.236 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tt -126.54 143.68 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.743 0.783 . . . . 1.09 109.645 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -123.74 131.23 53.56 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.649 -1.241 . . . . 2.05 107.649 177.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 m -124.31 148.34 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 120.871 -1.143 . . . . 1.1 109.671 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -118.68 141.38 48.66 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.041 0.924 . . . . 0.73 111.022 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.52 -29.47 69.57 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.747 -0.66 . . . . 0.02 111.446 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -116.39 169.86 8.99 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.092 -1.005 . . . . 3.18 110.353 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.8 165.79 50.13 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.073 -0.811 . . . . 0.01 111.073 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 56.38 39.25 30.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.99 -0.712 . . . . 0.01 111.426 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 51.78 54.57 10.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.599 -0.688 . . . . 0.01 111.2 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -129.62 166.4 19.82 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.154 -1.054 . . . . 3.15 108.154 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.97 -164.42 28.68 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -75.55 144.94 41.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.938 -1.331 . . . . 0.01 108.714 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.459 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.5 tmm? -116.87 142.3 47.1 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.688 0.756 . . . . 0.01 109.972 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.44 ' N ' ' SD ' ' A' ' 107' ' ' MET . 41.8 m-85 -130.39 134.66 47.31 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.7 -1.222 . . . . 2.48 107.7 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -121.42 135.63 55.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.725 -0.609 . . . . 0.01 109.83 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.499 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 9.5 t -150.34 153.1 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.223 1.011 . . . . 1.69 110.738 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 p -109.35 10.0 25.58 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.829 -0.623 . . . . 0.01 109.864 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.5 mp0 -121.0 163.3 18.49 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.426 -0.796 . . . . 3.21 111.046 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 155.16 38.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.283 -1.006 . . . . 0.01 108.283 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.86 111.43 29.17 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.64 -0.874 . . . . 0.01 108.64 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.54 -32.86 3.48 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 CA-C-N 120.032 1.047 . . . . 0.01 111.605 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -141.23 107.81 5.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.285 -0.884 . . . . 0.02 108.855 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.53 -38.77 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.838 -0.539 . . . . 1.83 110.361 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.5 ttt -66.4 -37.76 85.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.868 -1.133 . . . . 1.34 109.873 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -70.27 -39.06 75.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.408 -1.432 . . . . 2.11 109.53 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 8.8 tt0 -80.44 -47.05 14.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -0.975 . . . . 2.08 112.316 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.556 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 m-85 -110.51 -1.68 16.85 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.375 -0.828 . . . . 0.02 112.752 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m170 61.16 33.48 19.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.677 -1.264 . . . . 0.02 109.343 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 mt -114.34 135.39 54.13 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.517 -0.74 . . . . 0.02 109.161 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -89.41 -21.1 23.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.181 -0.949 . . . . 5.32 110.763 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 52.0 mt-10 -148.32 163.69 36.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.949 -1.095 . . . . 0.02 110.105 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.3 mm -129.33 126.05 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.202 -1.407 . . . . 2.17 107.202 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -109.55 -13.04 14.62 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.353 -0.842 . . . . 0.02 112.682 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.3 p -160.82 153.5 20.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.269 . . . . 0.01 109.111 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 20.4 p -170.28 144.33 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.925 -1.139 . . . . 1.22 107.925 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.3 pttt -127.92 101.84 6.5 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.903 -1.123 . . . . 1.41 109.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 136' ' ' TRP . 14.6 p . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 107.83 -1.174 . . . . 0.01 107.83 178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.45 ' CD1' HG21 ' A' ' 131' ' ' VAL . 17.6 m95 . . . . . 0 N--CA 1.505 2.319 0 N-CA-C 107.863 -1.162 . . . . 0.01 107.863 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' CG1' HD11 ' A' ' 175' ' ' ILE . 34.3 mt -119.18 134.96 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 120.562 -1.336 . . . . 1.69 109.846 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.46 141.7 44.68 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.193 -1.78 . . . . 2.49 106.193 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.7 m-85 -123.51 143.63 50.06 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.206 -0.934 . . . . 0.02 109.88 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.45 -30.96 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.976 -0.452 . . . . 0.02 111.721 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.51 155.14 47.62 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.759 -1.213 . . . . 1.48 108.809 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -56.86 166.79 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.05 1.167 . . . . 0.02 112.927 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 42.8 t-20 59.66 31.89 21.17 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.173 -0.921 . . . . 0.75 111.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.9 m-85 57.45 51.95 9.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.527 -0.733 . . . . 0.02 111.523 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -126.75 165.32 19.5 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.463 -0.773 . . . . 0.02 110.057 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.13 -165.24 34.28 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.286 -1.126 . . . . 0.02 110.286 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -69.39 141.72 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.946 . . . . 0.02 108.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' MET . 18.4 mt-30 -114.12 148.59 36.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.778 -0.576 . . . . 0.02 110.109 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -123.75 133.86 53.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -95.34 121.12 36.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.868 -1.145 . . . . 0.01 109.461 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -98.83 145.49 26.92 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.761 -0.829 . . . . 0.01 108.761 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 13.1 m-20 -110.0 -179.31 3.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.534 -0.729 . . . . 2.27 109.645 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -71.52 38.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.87 . . . . 1.84 109.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.1 mttm -112.04 177.18 4.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.514 -0.741 . . . . 2.28 109.208 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 26.4 mp0 -105.96 122.31 45.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.505 -0.747 . . . . 0.01 109.018 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.7 113.82 25.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.837 . . . . 0.01 109.242 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.41 -27.59 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.01 111.268 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -124.59 155.57 69.15 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.803 -1.184 . . . . 2.54 107.803 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.3 Cg_endo -61.5 -40.97 43.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.065 0.702 . . . . 0.7 111.116 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.11 -18.87 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.8 -1.187 . . . . 0.86 109.495 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.89 -18.15 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.02 111.899 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.63 15.42 28.98 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.674 -1.266 . . . . 0.02 110.147 178.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.92 74.3 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 121.088 -1.008 . . . . 0.02 112.939 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.96 140.48 35.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.912 -1.346 . . . . 0.02 109.995 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.04 -6.67 59.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.664 -0.647 . . . . 0.59 109.703 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -139.76 150.34 62.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.245 -0.91 . . . . 0.87 109.603 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.08 13.73 0.8 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.746 0.964 . . . . 0.38 111.838 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.04 24.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.312 1.053 . . . . 0.18 110.655 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.517 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.1 mt -150.03 123.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.569 -2.011 . . . . 3.99 105.569 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -111.84 -12.67 13.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.454 -0.779 . . . . 5.17 113.011 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 p -157.08 159.66 38.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.295 -2.128 . . . . 0.02 109.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.13 152.64 33.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.208 -0.932 . . . . 2.02 110.055 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.491 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 15.8 mtp180 -142.42 148.81 38.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.057 -1.027 . . . . 0.01 110.244 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 93' ' ' ALA . 14.7 ptm180 -86.78 140.24 29.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.141 -1.059 . . . . 0.01 108.141 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.404 HD11 ' CG1' ' A' ' 137' ' ' ILE . 21.0 mt -94.7 130.59 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.2 -0.937 . . . . 3.04 109.585 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.91 147.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 1.89 109.541 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 4.89 109.403 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.721 0 N-CA-C 107.205 -2.358 . . . . 0.81 107.205 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.36 150.65 33.67 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 120.184 -1.008 . . . . 0.01 110.779 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -151.48 136.75 17.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.46 -1.023 . . . . 0.02 108.916 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 7.2 tt -130.77 142.16 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.39 -0.596 . . . . 0.02 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.526 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.5 t -122.87 130.48 52.91 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.475 -0.765 . . . . 0.39 109.379 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.9 m-85 -109.71 139.94 44.16 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.947 -0.761 . . . . 0.02 108.947 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 12.7 m-85 -122.79 139.1 54.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.433 -0.792 . . . . 0.02 109.64 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.91 -26.66 64.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.03 111.985 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.0 m-20 -114.17 170.01 8.6 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.03 110.571 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -74.23 157.19 36.31 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.734 0.778 . . . . 0.03 110.149 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.27 35.72 5.79 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.821 0.819 . . . . 0.74 111.101 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.0 p90 49.66 44.61 24.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.679 0.752 . . . . 0.02 111.105 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -112.3 166.1 11.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.988 -1.115 . . . . 0.02 107.988 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.52 -167.9 34.28 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 120.735 -1.228 . . . . 0.03 110.532 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.578 HH21 ' H ' ' A' ' 34' ' ' SER . 36.7 ttp180 -70.01 144.29 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -1.005 . . . . 2.76 108.841 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.65 150.22 41.27 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.726 0.774 . . . . 1.89 110.412 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -132.7 127.63 35.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.138 -1.06 . . . . 0.02 108.138 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -113.32 137.46 51.47 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.473 -0.767 . . . . 1.12 110.119 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.91 139.48 48.76 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.681 0.753 . . . . 0.02 109.351 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 m-20 -117.08 11.28 14.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.271 -0.64 . . . . 0.2 109.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -158.57 174.49 14.99 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.119 -1.067 . . . . 1.23 108.119 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.21 144.34 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.601 -1.312 . . . . 0.02 110.249 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.0 m -131.41 116.86 18.08 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.372 -0.973 . . . . 0.02 108.372 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.2 -26.03 52.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.143 -0.973 . . . . 0.24 110.67 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -154.2 100.46 2.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 1.14 108.7 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -104.96 9.65 34.47 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.103 0.954 . . . . 6.37 109.538 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -58.3 -23.76 57.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.683 -0.636 . . . . 3.11 110.618 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -74.38 -16.89 60.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.169 . . . . 0.88 110.002 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -105.11 -21.9 13.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.516 -0.74 . . . . 0.02 109.395 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.1 tp -148.37 125.68 11.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 3.32 109.166 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.578 ' H ' HH21 ' A' ' 18' ' ' ARG . 83.2 p -86.3 -11.05 53.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.02 111.263 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.496 ' O ' HD21 ' A' ' 33' ' ' LEU . 11.9 tpp180 -170.68 161.58 7.54 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.746 -1.205 . . . . 0.02 107.746 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.801 ' SG ' HD12 ' A' ' 79' ' ' LEU . 23.6 p -140.51 113.35 8.22 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.848 -1.157 . . . . 0.02 108.752 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 19.2 t-20 -106.35 -2.31 22.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.866 -1.146 . . . . 0.03 110.259 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 8.4 m -154.43 154.15 32.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.304 -0.999 . . . . 0.02 108.304 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.418 HD12 ' CZ3' ' A' ' 72' ' ' TRP . 69.2 mt -144.66 146.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.02 109.599 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -124.44 124.8 43.11 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.046 -1.464 . . . . 0.02 107.046 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 24.9 t -105.6 113.65 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.822 -1.547 . . . . 0.02 106.822 177.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.08 -34.61 26.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.485 -0.759 . . . . 3.81 110.015 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.09 150.15 19.17 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.48 -1.819 . . . . 0.02 110.468 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.86 175.36 50.91 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.457 -1.354 . . . . 0.01 109.929 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 46' ' ' TRP . 34.3 m -110.29 161.93 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.823 -1.547 . . . . 1.48 106.823 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CZ3' ' SG ' ' A' ' 22' ' ' CYS . 64.5 m95 -147.65 147.01 29.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.286 -1.509 . . . . 0.02 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.31 54.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.158 -2.164 . . . . 0.24 105.158 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.8 m -119.02 142.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.679 . . . . 0.65 109.466 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 19.7 m-85 -119.72 144.79 47.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.295 1.045 . . . . 0.02 109.46 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.19 -34.88 79.04 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.748 -0.66 . . . . 0.02 111.183 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -125.66 158.36 65.28 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.112 -0.992 . . . . 0.02 109.496 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.41 167.11 1.46 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.739 1.626 . . . . 0.02 113.145 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.97 36.78 9.8 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.097 -0.956 . . . . 0.02 111.208 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.16 51.91 10.74 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.476 0.655 . . . . 3.39 110.915 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.9 t -127.37 164.55 21.57 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 2.33 110.118 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.16 -162.55 32.4 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.017 -1.233 . . . . 0.02 110.017 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.491 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 85.9 m-70 -62.8 142.03 58.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.02 110.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.2 mtp -115.89 135.09 54.32 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.955 -0.757 . . . . 5.01 108.955 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' C ' HD12 ' A' ' 60' ' ' ILE . 53.1 m-85 -136.16 133.31 37.04 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.362 -0.836 . . . . 0.02 109.469 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -96.13 131.78 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.245 -1.02 . . . . 1.72 108.245 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.8 mt -120.48 110.45 35.65 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.673 -0.642 . . . . 0.02 110.344 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.61 169.61 21.49 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 CA-C-N 119.923 1.008 . . . . 1.47 110.079 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 12.7 tm0? -53.13 140.83 24.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.827 -1.171 . . . . 4.25 110.355 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.31 -176.28 32.2 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.02 110.522 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.13 128.75 55.44 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -1.011 . . . . 0.96 108.738 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 30.1 m-85 -118.64 98.08 51.04 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' OG ' ' A' ' 38' ' ' SER . 1.8 Cg_endo -67.75 -6.64 17.3 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.645 0.897 . . . . 0.02 114.401 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 31.1 mt-10 -158.64 155.9 29.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.366 -1.459 . . . . 2.02 108.382 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -59.99 -37.39 79.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.02 112.374 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.97 -21.83 61.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.02 109.988 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.6 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.38 -20.37 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.703 . . . . 3.42 110.294 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.418 ' CZ3' HD12 ' A' ' 39' ' ' ILE . 2.9 p90 -109.49 15.87 22.66 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.232 -0.917 . . . . 0.02 108.669 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt 64.66 23.86 12.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.331 0.586 . . . . 0.02 110.769 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.53 146.54 50.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.35 -1.5 . . . . 0.02 109.35 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 14.2 mt -80.59 -28.69 37.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.98 108.261 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.71 -170.66 3.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.012 -1.477 . . . . 0.02 107.012 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 35.2 p30 -98.28 28.28 4.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.753 -1.217 . . . . 0.02 110.274 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -97.08 123.52 40.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.324 -0.86 . . . . 3.2 111.246 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.801 HD12 ' SG ' ' A' ' 36' ' ' CYS . 63.0 mt -143.88 120.27 10.95 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.022 -1.473 . . . . 2.61 107.022 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.8 -16.4 14.1 Favored Glycine 0 N--CA 1.503 3.101 0 O-C-N 121.312 -0.867 . . . . 0.02 112.166 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.8 t -156.11 155.72 33.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.51 -1.582 . . . . 0.02 109.686 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.0 m -144.91 148.13 33.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.735 . . . . 0.02 109.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.481 ' CZ ' ' OH ' ' A' ' 49' ' ' TYR . 39.5 mtm180 -134.1 139.63 46.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.352 -0.842 . . . . 0.01 108.854 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 131.3 38.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.961 -1.126 . . . . 0.43 107.961 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -90.96 124.08 43.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.378 -0.971 . . . . 1.25 108.378 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -91.12 135.12 33.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 1.77 108.457 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.17 137.81 36.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.957 -0.757 . . . . 1.63 108.957 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -111.54 125.88 54.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.474 -0.936 . . . . 1.08 108.474 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 m -102.74 -155.41 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.222 -1.77 . . . . 1.26 106.222 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.73 -48.64 0.9 Allowed Glycine 0 N--CA 1.498 2.797 0 O-C-N 120.463 -1.398 . . . . 0.01 112.305 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.38 -99.47 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.502 -1.809 . . . . 0.01 112.208 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.25 120.38 33.96 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.231 -1.158 . . . . 4.43 110.82 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.643 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -77.74 132.32 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.126 -0.694 . . . . 2.99 109.126 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -129.95 140.38 50.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.525 -0.734 . . . . 6.36 109.121 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -125.5 141.89 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.867 0.842 . . . . 1.09 109.528 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -124.59 131.41 53.48 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.514 -1.291 . . . . 2.05 107.514 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -123.84 146.39 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.983 -1.073 . . . . 1.1 109.819 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -117.43 140.72 49.22 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.991 0.901 . . . . 0.73 110.77 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -66.14 -29.84 70.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.001 -0.545 . . . . 0.02 111.663 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -116.84 167.97 10.64 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.062 -1.024 . . . . 3.18 110.586 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.01 43.39 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.08 -0.808 . . . . 0.01 111.08 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 56.55 38.58 29.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.868 -0.783 . . . . 0.01 110.801 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 52.55 55.31 9.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.753 -0.592 . . . . 0.01 110.959 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -128.58 165.96 19.78 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.497 -0.927 . . . . 3.15 108.497 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.57 -164.85 26.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.36 -1.496 . . . . 0.01 109.36 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.548 HE21 ' H ' ' A' ' 107' ' ' MET . 36.7 tp60 -74.85 144.82 43.25 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.039 -1.271 . . . . 0.01 108.255 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 5.1 tmm? -116.29 142.44 46.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.669 0.747 . . . . 0.01 109.653 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.552 ' N ' ' SD ' ' A' ' 107' ' ' MET . 80.8 m-85 -131.19 135.58 47.53 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.014 -1.106 . . . . 2.48 108.014 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.418 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.8 tm-20 -120.37 134.08 55.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.74 -0.6 . . . . 0.01 109.709 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 112' ' ' GLU . 2.8 t -149.63 152.11 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 1.69 110.558 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -109.35 10.42 25.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.828 -0.624 . . . . 0.01 109.964 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.2 mp0 -120.58 163.06 18.58 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.41 -0.806 . . . . 3.21 111.317 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.08 155.23 37.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.007 -1.108 . . . . 0.01 108.007 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 49.2 t -122.54 110.66 31.95 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.938 -0.764 . . . . 0.01 108.938 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.82 -34.35 2.43 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 CA-C-N 119.976 1.027 . . . . 0.01 111.685 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.9 m -140.41 107.54 5.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.02 108.685 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.97 -39.42 85.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.865 -0.522 . . . . 1.83 110.553 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttp -66.52 -37.67 85.53 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.967 -1.093 . . . . 1.34 109.944 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.39 -39.12 74.73 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.388 -1.445 . . . . 2.11 109.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 tt0 -80.29 -47.52 14.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 2.08 112.425 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.424 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 66.7 m-85 -111.38 -1.25 16.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.8 . . . . 0.02 112.615 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 61.77 34.29 17.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.71 -1.244 . . . . 0.02 109.742 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.87 135.42 54.22 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.497 -0.752 . . . . 0.02 109.231 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.52 -21.19 23.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 5.32 110.768 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.42 164.42 34.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.02 109.968 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.0 mm -128.61 124.92 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.154 -1.424 . . . . 2.17 107.154 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.1 m-70 -109.27 -13.17 14.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 0.02 112.32 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 t -159.91 152.34 20.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.843 -1.16 . . . . 0.01 109.059 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.7 p -167.42 145.14 4.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.154 -1.054 . . . . 1.22 108.154 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -121.67 104.73 9.82 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.229 1.014 . . . . 1.41 109.621 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.685 -1.228 . . . . 0.01 107.685 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 55.3 m95 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 107.349 -1.352 . . . . 0.01 107.349 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' A' ' 175' ' ' ILE . 27.2 mt -118.36 133.38 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.41 -1.432 . . . . 1.69 109.775 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.72 141.28 44.22 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.378 -1.712 . . . . 2.49 106.378 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -122.86 142.73 50.45 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.019 -1.051 . . . . 0.02 109.556 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.18 -30.68 62.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.02 111.718 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.84 154.87 48.23 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 120.749 -1.22 . . . . 1.48 108.896 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.31 167.24 2.74 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.28 1.32 . . . . 0.02 112.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.02 30.91 20.85 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.154 -0.93 . . . . 0.75 111.479 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.79 51.85 8.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.5 -0.75 . . . . 0.02 111.289 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.73 165.14 19.81 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.513 -0.742 . . . . 0.02 109.703 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.43 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.16 -165.51 34.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.124 -1.19 . . . . 0.02 110.124 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.46 142.02 53.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.981 . . . . 0.02 108.863 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -113.93 148.92 36.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 12.2 m-85 -123.36 133.9 54.06 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.773 -0.825 . . . . 0.01 108.773 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.3 120.47 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.148 . . . . 0.01 109.197 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -98.73 138.6 35.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.299 -1.0 . . . . 0.01 108.299 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.1 m-20 -108.08 -173.76 2.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 2.27 109.628 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.67 40.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 1.84 109.578 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.2 mttp -112.13 167.74 10.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.441 -0.787 . . . . 2.28 109.358 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -105.06 124.11 48.96 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.54 114.12 26.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.279 -0.888 . . . . 0.01 110.456 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -92.9 -26.22 17.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.01 110.636 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -123.63 154.45 66.66 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.993 -1.114 . . . . 2.54 107.993 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.557 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -61.64 -41.12 41.43 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 CA-C-N 119.245 0.766 . . . . 0.7 110.802 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.74 -18.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.727 -1.233 . . . . 0.86 109.311 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 50.7 t0 -65.29 -18.39 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.101 . . . . 0.02 111.927 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.75 15.42 29.02 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.8 -1.187 . . . . 0.02 110.164 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.4 76.3 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.163 -0.961 . . . . 0.02 113.113 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.15 141.41 34.08 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.836 -1.39 . . . . 0.02 110.227 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.34 59.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.721 -0.612 . . . . 0.59 109.641 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -142.1 150.55 56.12 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.106 -0.996 . . . . 0.87 109.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.09 16.49 0.67 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 120.801 1.0 . . . . 0.38 112.018 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 120.79 25.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.18 110.78 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.7 mt -149.08 124.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.719 -1.956 . . . . 3.99 105.719 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -111.91 -13.72 13.6 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.174 -0.954 . . . . 5.17 113.027 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 t -157.13 159.84 38.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.332 -2.105 . . . . 0.02 109.919 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 20.5 p90 -152.27 153.53 33.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.374 -0.829 . . . . 2.02 110.324 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -143.85 150.03 37.86 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.275 -0.89 . . . . 0.01 110.202 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.643 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 14.2 ptm180 -87.09 141.29 28.77 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.416 -0.957 . . . . 0.01 108.416 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.421 HD11 ' CG1' ' A' ' 137' ' ' ILE . 14.9 mt -94.84 129.61 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 3.04 109.373 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.46 147.67 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.423 -0.798 . . . . 1.89 109.561 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 4.89 109.431 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.573 0 N-CA-C 105.986 -2.846 . . . . 0.81 105.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.41 147.71 31.68 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.419 -0.896 . . . . 0.01 111.007 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.65 138.66 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.02 108.421 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -130.29 140.83 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.354 0.597 . . . . 0.02 109.693 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -121.8 129.73 52.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.478 -0.764 . . . . 0.39 109.778 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 29.1 m-85 -109.14 139.27 44.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.838 -0.801 . . . . 0.02 108.838 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.1 m-85 -122.68 138.56 54.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.297 -0.877 . . . . 0.02 109.742 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 33' ' ' LEU . 91.1 mt-10 -69.14 -27.58 65.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.03 111.671 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.83 170.33 8.42 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.872 -1.142 . . . . 0.03 110.58 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -74.51 157.45 35.5 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.755 0.788 . . . . 0.03 110.181 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.9 OUTLIER 65.77 35.33 6.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.891 0.853 . . . . 0.74 110.943 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.5 p90 49.82 45.28 24.94 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.679 0.752 . . . . 0.02 111.266 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -112.51 166.78 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.08 -1.081 . . . . 0.02 108.08 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.4 -167.88 36.04 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.737 -1.221 . . . . 0.03 110.624 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -69.89 143.76 52.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -1.073 . . . . 2.76 109.134 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -120.35 149.07 42.92 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.71 0.767 . . . . 1.89 110.582 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -132.24 126.75 34.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.064 -1.087 . . . . 0.02 108.064 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -112.04 136.83 50.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.414 -0.804 . . . . 1.12 109.814 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.62 137.78 49.78 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.478 0.656 . . . . 0.02 109.538 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.89 10.59 14.15 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.303 0.573 . . . . 0.2 109.626 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 43.1 t -158.15 173.86 16.07 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 1.23 108.129 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.9 m-20 -61.77 144.77 54.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.615 -1.303 . . . . 0.02 110.541 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 t -132.2 116.45 16.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.585 -0.895 . . . . 0.02 108.585 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.9 -23.5 55.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.486 -0.758 . . . . 0.24 110.634 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -155.61 101.88 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.48 -0.933 . . . . 1.14 108.48 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.67 10.22 34.88 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.344 1.069 . . . . 6.37 109.816 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -59.88 -23.43 63.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.505 -0.747 . . . . 3.11 110.713 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 m -75.35 -16.55 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.688 -1.258 . . . . 0.88 110.373 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -103.15 -21.4 13.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.402 -0.811 . . . . 0.02 109.017 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.88 128.58 12.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 3.32 108.848 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 p -84.73 -10.12 57.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.71 -0.619 . . . . 0.02 110.376 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -171.61 163.3 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.704 -1.221 . . . . 0.02 107.704 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -141.73 114.77 8.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.853 -1.154 . . . . 0.02 108.663 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.671 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -107.81 -2.18 20.18 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.953 -1.092 . . . . 0.03 110.614 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 t -154.36 153.42 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.99 -1.115 . . . . 0.02 107.99 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.0 mt -144.63 146.65 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.89 -1.131 . . . . 0.02 109.9 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' A' ' 42' ' ' GLU . 38.9 ttp180 -123.77 123.76 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.25 -1.389 . . . . 0.02 107.25 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.54 114.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 106.879 -1.526 . . . . 0.02 106.879 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 30.9 mt-10 -83.7 -33.92 25.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.98 -0.688 . . . . 3.81 109.721 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.16 150.4 19.64 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 118.475 -1.822 . . . . 0.02 110.369 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 173.57 49.77 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.671 -1.252 . . . . 0.01 110.077 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -119.45 135.86 54.57 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.482 -1.303 . . . . 1.48 107.482 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -124.12 154.45 39.98 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.523 1.154 . . . . 0.02 111.936 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.31 132.93 53.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.032 -2.21 . . . . 0.24 105.032 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -114.99 140.25 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.063 -0.717 . . . . 0.65 109.063 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 53.7 m-85 -121.46 144.02 48.92 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 122.22 1.009 . . . . 0.02 109.54 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.465 ' CG ' HH11 ' A' ' 51' ' ' ARG . 1.8 tp10 -66.2 -35.82 81.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.196 -0.911 . . . . 0.02 111.75 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.465 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -122.09 158.6 54.78 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.944 -1.098 . . . . 0.02 109.212 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.66 167.25 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.517 1.478 . . . . 0.02 112.591 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.09 37.26 11.67 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.683 0.754 . . . . 0.02 111.265 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 4.1 m-85 44.87 52.33 8.12 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.692 0.758 . . . . 3.39 110.935 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -125.8 163.44 22.89 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.846 -0.534 . . . . 2.33 109.943 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.21 31.7 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.653 -1.379 . . . . 0.02 109.653 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -65.99 137.15 56.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.324 . . . . 0.02 110.045 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 15.8 ptm -119.37 135.98 54.48 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.447 0.641 . . . . 5.01 109.398 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 47.1 m-85 -133.14 141.01 47.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.566 -0.709 . . . . 0.02 109.267 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.37 132.09 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.571 -0.706 . . . . 1.72 109.431 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.17 109.55 35.18 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.552 -0.718 . . . . 0.02 110.332 -178.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.04 169.39 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.061 1.058 . . . . 1.47 110.229 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -52.82 140.59 23.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.901 -1.124 . . . . 4.25 110.706 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.46 -176.26 32.33 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.432 -1.365 . . . . 0.02 110.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -118.39 129.97 55.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.375 -1.073 . . . . 0.96 109.405 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 59.9 m-85 -121.07 97.66 47.79 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.773 -1.195 . . . . 0.02 107.773 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.55 -3.7 13.06 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.648 0.898 . . . . 0.02 113.952 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -155.68 154.07 30.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.454 -1.404 . . . . 2.02 108.044 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -60.59 -38.44 84.64 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.563 -0.711 . . . . 0.02 111.708 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.02 110.152 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.12 -18.75 63.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.009 0.909 . . . . 3.42 108.694 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.647 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -107.24 10.86 29.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.251 -1.389 . . . . 0.02 107.251 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 32.9 mtm 61.18 22.47 12.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.02 110.521 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.48 145.06 47.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tp -78.86 -29.97 44.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -1.205 . . . . 0.98 107.75 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.419 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 43.9 p30 -156.86 -171.45 3.66 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.57 27.49 4.29 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.731 -1.23 . . . . 0.02 109.987 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -95.92 122.48 38.77 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.032 -1.042 . . . . 3.2 110.358 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.4 mt -144.72 121.66 11.34 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.922 -1.14 . . . . 2.61 107.922 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.77 -16.84 9.57 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 121.33 -0.856 . . . . 0.02 112.847 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.7 t -155.15 155.63 34.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 120.023 1.912 . . . . 0.02 111.084 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.0 m -145.5 148.2 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.542 0.687 . . . . 0.02 110.306 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 12.7 mtp180 -134.6 139.25 45.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.01 108.935 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 132.74 37.24 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.623 -0.88 . . . . 0.43 108.623 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.72 123.49 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -89.4 135.81 33.38 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.027 -1.101 . . . . 1.77 108.027 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' CD1' ' OE1' ' A' ' 177' ' ' GLU . 1.5 mt -99.2 137.71 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.752 -0.833 . . . . 1.63 108.752 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.6 p -112.64 126.06 54.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.811 -0.811 . . . . 1.08 108.811 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 p -102.96 -155.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.162 -1.792 . . . . 1.26 106.162 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -48.99 0.86 Allowed Glycine 0 N--CA 1.501 2.979 0 O-C-N 120.413 -1.429 . . . . 0.01 112.506 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.69 -100.0 0.14 Allowed Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.632 -1.746 . . . . 0.01 112.019 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -120.18 119.28 32.79 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.111 -1.229 . . . . 4.43 110.753 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.84 129.93 36.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.016 -0.674 . . . . 2.99 109.406 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -132.12 139.89 48.62 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.495 -0.753 . . . . 6.36 109.287 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.89 145.77 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.404 -0.81 . . . . 1.09 109.857 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -122.7 132.74 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.25 -1.389 . . . . 2.05 107.25 177.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.51 149.24 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.107 . . . . 1.1 109.585 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.2 141.45 48.87 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.034 0.921 . . . . 0.73 110.998 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.36 -29.27 69.42 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.823 -0.626 . . . . 0.02 111.514 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -116.31 169.46 9.28 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.023 -1.048 . . . . 3.18 110.311 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.3 164.79 50.18 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.801 -0.92 . . . . 0.01 110.801 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.6 m-20 56.74 38.16 29.31 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.875 -0.779 . . . . 0.01 111.3 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.562 ' H ' ' CB ' ' A' ' 128' ' ' SER . 10.7 m-85 53.07 54.69 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.586 -0.696 . . . . 0.01 111.475 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -129.01 165.1 21.81 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.331 -0.989 . . . . 3.15 108.331 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.88 -163.9 27.24 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.424 -1.471 . . . . 0.01 109.424 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -75.37 144.07 42.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.108 -1.231 . . . . 0.01 108.577 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.2 tmm? -116.71 142.82 46.41 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.576 0.703 . . . . 0.01 109.836 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.76 135.56 46.9 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.311 -0.996 . . . . 2.48 108.311 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -121.21 135.54 55.12 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.58 -0.7 . . . . 0.01 109.93 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -149.88 152.49 35.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.189 0.995 . . . . 1.69 110.799 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -109.41 9.87 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.01 109.97 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -120.77 163.2 18.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.817 . . . . 3.21 111.388 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.8 155.72 37.47 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.083 -1.081 . . . . 0.01 108.083 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.599 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 63.1 m -124.66 112.41 27.43 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.423 -0.798 . . . . 0.01 108.94 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.44 -32.66 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 120.135 1.084 . . . . 0.01 111.551 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.6 t -140.76 107.9 5.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.876 . . . . 0.02 108.989 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -64.15 -39.98 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 1.83 110.593 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 118' ' ' MET . 2.0 tmt? -66.17 -37.8 86.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.134 -1.027 . . . . 1.34 109.849 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.52 -38.85 74.32 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.448 -1.407 . . . . 2.11 109.729 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.31 -47.57 14.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 2.08 112.354 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.46 -0.86 16.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.424 -0.798 . . . . 0.02 112.663 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m170 61.19 33.75 19.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.139 . . . . 0.02 109.662 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.5 mt -114.22 135.93 53.51 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.476 -0.765 . . . . 0.02 109.235 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.66 -22.0 21.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 5.32 110.9 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' ' 126' ' ' ILE . 76.0 mt-10 -148.54 163.84 35.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.884 -1.135 . . . . 0.02 110.065 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 125' ' ' GLU . 40.0 mm -128.43 125.28 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.456 -1.313 . . . . 2.17 107.456 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -111.56 -14.04 13.73 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.285 -0.885 . . . . 0.02 112.698 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.562 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 18.7 m -160.16 152.06 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.77 -1.206 . . . . 0.01 109.044 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 31.9 p -168.87 150.13 4.59 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.504 -0.924 . . . . 1.22 108.504 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 35.4 mttm -113.28 100.71 8.77 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.327 1.06 . . . . 1.41 108.406 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 136' ' ' TRP . 1.2 p . . . . . 0 C--N 1.301 -1.537 0 N-CA-C 108.697 -0.853 . . . . 0.01 108.697 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.447 ' CD1' HG23 ' A' ' 131' ' ' VAL . 85.6 m95 . . . . . 0 N--CA 1.508 2.474 0 CA-C-O 121.193 0.52 . . . . 0.01 110.192 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.6 mt -120.1 136.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.254 -1.017 . . . . 1.69 108.254 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.43 141.43 43.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.109 -1.441 . . . . 2.49 107.109 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -122.72 142.77 50.34 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.173 -0.954 . . . . 0.02 109.894 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.03 -30.31 61.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.02 112.319 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.4 154.83 48.99 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.587 -1.321 . . . . 1.48 108.619 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.28 167.06 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.068 1.179 . . . . 0.02 113.04 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.1 m120 58.66 30.75 20.32 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.263 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 57.47 51.21 10.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.665 . . . . 0.02 111.066 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.472 ' NH1' ' SD ' ' A' ' 73' ' ' MET . 23.3 mmm180 -125.0 164.8 19.37 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.45 -0.781 . . . . 0.02 109.549 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.34 -165.93 34.47 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.338 -1.105 . . . . 0.02 110.338 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -69.7 142.9 53.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.458 -1.025 . . . . 0.02 109.022 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.483 ' O ' ' CG ' ' A' ' 58' ' ' MET . 6.1 mt-30 -113.41 149.76 33.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.72 -0.613 . . . . 0.02 109.558 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.13 132.51 54.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.904 -1.147 . . . . 0.01 107.904 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.45 ' H ' ' HE1' ' A' ' 58' ' ' MET . 27.8 tp -95.48 121.2 36.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.633 -1.292 . . . . 0.01 109.347 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.457 HD11 ' CD1' ' A' ' 138' ' ' PHE . 24.2 mt -93.49 162.42 13.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.811 -1.181 . . . . 0.01 107.811 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.91 -116.94 0.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.357 -0.839 . . . . 2.27 109.283 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -141.29 26.31 2.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 1.84 109.006 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -110.35 -166.81 1.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.849 -0.797 . . . . 2.28 108.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.29 131.9 53.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.532 -0.73 . . . . 0.01 109.496 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.06 110.78 23.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.354 -0.841 . . . . 0.01 108.911 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.449 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.0 ptm180 -88.1 -27.79 21.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.01 111.309 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -124.08 154.22 68.13 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.696 -1.224 . . . . 2.54 107.696 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.66 -39.27 44.69 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 CA-C-N 119.382 0.815 . . . . 0.7 110.903 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.09 -18.41 17.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.795 -1.191 . . . . 0.86 109.478 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.46 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.039 -1.038 . . . . 0.02 112.272 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.12 15.63 28.07 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.799 -1.188 . . . . 0.02 109.887 178.377 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.22 75.33 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.164 -0.96 . . . . 0.02 112.948 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.514 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.22 140.45 35.49 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.847 -1.384 . . . . 0.02 110.233 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -6.85 59.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.642 -0.661 . . . . 0.59 109.711 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.7 p -140.34 150.83 62.51 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.176 -0.952 . . . . 0.87 109.297 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.88 15.23 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.667 0.911 . . . . 0.38 111.865 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.64 24.19 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.33 1.062 . . . . 0.18 110.682 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.463 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.01 123.5 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.577 -2.009 . . . . 3.99 105.577 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.62 -12.77 12.8 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.21 -0.932 . . . . 5.17 113.271 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 9.2 t -157.23 158.93 37.09 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 119.134 -2.229 . . . . 0.02 109.945 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.599 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 18.1 p90 -152.77 154.75 35.82 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.092 -1.005 . . . . 2.02 110.148 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -144.67 150.56 37.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.01 110.395 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.1 ptt180 -87.89 143.04 27.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.01 108.613 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.65 129.39 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.311 -0.868 . . . . 3.04 109.266 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.08 147.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -0.926 . . . . 1.89 109.783 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.473 ' OE1' ' CD1' ' A' ' 87' ' ' LEU . 51.5 tp10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 4.89 109.413 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.729 0 N-CA-C 106.785 -2.526 . . . . 0.81 106.785 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 149.09 33.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.745 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -150.45 136.34 18.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -1.053 . . . . 0.02 109.367 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -128.96 139.25 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.012 -0.736 . . . . 0.02 109.012 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.411 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.3 t -121.77 130.35 53.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.605 -0.684 . . . . 0.39 109.438 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -108.67 138.38 45.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.041 -0.726 . . . . 0.02 109.041 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.0 m-85 -122.65 138.53 54.57 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.215 -0.928 . . . . 0.02 109.734 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 70.6 mt-10 -71.33 -28.2 63.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.03 111.635 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.562 ' C ' HD21 ' A' ' 37' ' ' ASN . 24.0 t0 -113.57 168.04 10.09 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.851 -1.156 . . . . 0.03 110.171 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 96.0 mtt180 -73.73 157.19 36.96 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.629 0.728 . . . . 0.03 110.051 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.629 ' ND2' ' CE2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER 66.35 35.23 5.9 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.83 0.824 . . . . 0.74 110.928 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.629 ' CE2' ' ND2' ' A' ' 14' ' ' ASN . 13.5 p90 50.06 45.49 25.38 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.815 0.817 . . . . 0.02 111.162 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -112.9 166.09 11.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.81 -1.182 . . . . 0.02 107.81 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -166.79 35.86 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.617 -1.278 . . . . 0.03 110.825 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -69.42 140.8 54.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.928 . . . . 2.76 109.268 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -120.94 149.09 43.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.586 0.708 . . . . 1.89 110.259 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -132.81 127.09 33.79 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.945 -1.131 . . . . 0.02 107.945 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.81 136.86 50.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.528 -0.732 . . . . 1.12 109.706 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.22 138.2 49.26 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.422 0.629 . . . . 0.02 109.449 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -116.81 10.89 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.46 -0.57 . . . . 0.2 109.46 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.2 p -157.88 174.43 15.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.61 144.91 55.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.551 -1.343 . . . . 0.02 110.435 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.2 t -132.48 116.65 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.547 -0.909 . . . . 0.02 108.547 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -24.55 52.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.24 110.751 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.76 100.41 2.37 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.445 -0.946 . . . . 1.14 108.445 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 20.5 p90 -106.06 9.88 32.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.199 1.0 . . . . 6.37 110.058 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -58.89 -22.68 59.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.633 -0.667 . . . . 3.11 110.595 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -74.7 -16.61 60.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.676 -1.265 . . . . 0.88 110.324 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.37 -22.0 14.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.376 -0.827 . . . . 0.02 109.053 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -150.3 129.44 12.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.453 -0.944 . . . . 3.32 108.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 p -85.26 -9.66 57.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.79 -0.569 . . . . 0.02 110.804 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -169.54 161.43 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 m -141.83 112.68 7.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.796 -1.19 . . . . 0.02 109.125 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -110.66 -0.6 17.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.054 -1.029 . . . . 0.03 110.981 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.31 152.24 30.9 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.736 -1.209 . . . . 0.02 107.736 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -146.4 148.37 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.89 -1.131 . . . . 0.02 110.555 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -125.92 125.88 43.49 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.973 -1.121 . . . . 0.02 107.973 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.8 115.42 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.587 -1.634 . . . . 0.02 106.587 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.68 -33.8 25.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.63 -0.669 . . . . 3.81 110.404 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.65 21.22 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.064 -1.541 . . . . 0.02 109.996 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.58 174.76 50.33 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.547 -1.311 . . . . 0.01 109.999 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 46' ' ' TRP . 14.8 m -109.79 160.65 16.15 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.646 -1.613 . . . . 1.48 106.646 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 45' ' ' THR . 62.5 m95 -147.97 147.81 30.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.285 . . . . 0.02 111.432 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.59 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.157 -2.164 . . . . 0.24 105.157 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -118.9 143.29 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.664 -0.647 . . . . 0.65 109.436 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.92 145.46 47.67 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.299 1.047 . . . . 0.02 109.997 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -65.9 -33.56 76.12 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.501 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -124.31 157.4 64.73 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.995 -1.066 . . . . 0.02 109.578 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.11 166.42 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.603 1.535 . . . . 0.02 112.778 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.11 36.39 9.72 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.442 -0.799 . . . . 0.02 111.114 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.03 50.88 9.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.602 0.715 . . . . 3.39 110.61 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -125.72 163.58 22.52 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.252 0.548 . . . . 2.33 109.914 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.62 -161.93 31.33 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.477 -1.449 . . . . 0.02 109.477 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 16.0 t-80 -66.53 138.29 57.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.948 -1.325 . . . . 0.02 109.897 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 21.8 ptm -119.1 137.21 53.73 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.557 0.694 . . . . 5.01 109.605 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.633 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 13.2 m-85 -132.19 140.31 48.67 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.759 0.79 . . . . 0.02 109.174 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.5 mm -96.5 131.71 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.47 -0.937 . . . . 1.72 108.47 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 61' ' ' LEU . 16.6 mt -122.76 113.58 30.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.373 -0.829 . . . . 0.02 110.741 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.11 169.96 20.54 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 CA-C-N 120.062 1.058 . . . . 1.47 110.238 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.632 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.8 pm0 -51.9 141.33 17.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 4.25 110.153 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.34 -177.48 32.51 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.341 -1.409 . . . . 0.02 110.707 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -119.08 130.0 55.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.529 -0.983 . . . . 0.96 109.62 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 52.3 m-85 -120.71 95.78 48.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 107.765 -1.198 . . . . 0.02 107.765 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -68.37 -3.66 11.35 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 120.699 0.933 . . . . 0.02 113.835 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 82.6 mt-10 -157.6 154.81 29.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.544 -1.348 . . . . 2.02 108.252 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -60.5 -39.36 87.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.492 -0.755 . . . . 0.02 111.937 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -59.49 -23.86 63.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.02 110.132 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.57 62.4 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.443 -0.947 . . . . 3.42 108.443 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.39 9.05 31.9 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.354 -1.35 . . . . 0.02 107.354 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.6 mtm 60.6 21.64 11.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.606 -0.684 . . . . 0.02 110.527 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.87 143.88 44.93 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.195 -1.562 . . . . 0.02 109.195 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -77.99 -30.14 50.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.084 -1.45 . . . . 0.98 107.084 177.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -156.57 -172.04 3.92 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.27 -1.752 . . . . 0.02 106.27 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -97.78 27.79 4.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.728 -1.232 . . . . 0.02 110.464 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 78' ' ' ARG . 8.5 mtt-85 -96.4 122.84 39.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.12 -0.988 . . . . 3.2 110.752 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.9 mt -144.87 120.15 10.21 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.517 -1.29 . . . . 2.61 107.517 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.0 -15.87 11.3 Favored Glycine 0 N--CA 1.507 3.378 0 O-C-N 121.271 -0.893 . . . . 0.02 112.869 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.4 p -155.51 156.14 34.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.217 -1.755 . . . . 0.02 110.276 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.5 p -145.03 148.35 33.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.02 109.484 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -133.71 138.63 45.93 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.751 -0.833 . . . . 0.01 108.751 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.62 131.77 36.84 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.473 -0.936 . . . . 0.43 108.473 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.27 123.82 43.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.74 -0.837 . . . . 1.25 108.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -92.18 135.08 34.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.984 -1.073 . . . . 1.77 108.281 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.01 137.84 36.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.471 -0.768 . . . . 1.63 109.386 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.8 m -111.03 127.09 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.548 -0.908 . . . . 1.08 108.548 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 p -104.02 -154.73 0.51 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 106.464 -1.68 . . . . 1.26 106.464 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.81 -49.02 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.454 -1.403 . . . . 0.01 112.275 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.0 -100.2 0.14 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 118.331 -1.89 . . . . 0.01 112.122 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -119.99 118.58 31.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.27 -1.135 . . . . 4.43 110.714 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -76.9 130.92 38.22 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.095 -0.705 . . . . 2.99 109.095 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -130.48 138.54 50.32 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.834 -0.802 . . . . 6.36 108.834 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.15 143.86 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.358 -0.839 . . . . 1.09 109.402 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.14 133.71 54.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.596 -1.261 . . . . 2.05 107.596 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 129' ' ' CYS . 16.7 m -123.81 146.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.992 -1.068 . . . . 1.1 109.038 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -120.59 141.75 50.02 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 122.127 0.965 . . . . 0.73 111.277 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -66.16 -30.01 70.4 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.807 -0.633 . . . . 0.02 111.821 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -116.61 168.05 10.53 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.913 -1.117 . . . . 3.18 110.636 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.75 163.57 43.8 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 111.016 -0.833 . . . . 0.01 111.016 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 57.03 38.86 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 122.011 -0.699 . . . . 0.01 110.979 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.3 m-85 52.23 56.71 7.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.597 -0.69 . . . . 0.01 111.083 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -128.84 165.46 20.96 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.17 -1.048 . . . . 3.15 108.17 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.2 -164.43 28.41 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.016 -1.634 . . . . 0.01 109.016 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.22 143.68 45.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.988 -1.301 . . . . 0.01 108.479 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 3.8 tmm? -116.49 142.41 46.91 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.696 0.76 . . . . 0.01 109.683 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -131.58 135.36 46.94 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.978 -1.119 . . . . 2.48 107.978 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.77 135.17 55.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.592 -0.692 . . . . 0.01 109.764 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -150.26 154.33 37.74 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.486 1.136 . . . . 1.69 111.18 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 p -111.39 9.86 21.48 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.347 -0.842 . . . . 0.01 109.988 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -122.18 163.52 19.42 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.252 -0.905 . . . . 3.21 111.632 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.94 155.98 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.529 -0.915 . . . . 0.01 108.529 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.34 112.42 27.98 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.965 -0.754 . . . . 0.01 108.965 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.71 -33.44 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.188 1.103 . . . . 0.01 111.548 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 t -140.29 107.53 5.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.02 108.743 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 126' ' ' ILE . 76.4 mt -64.54 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.819 -0.55 . . . . 1.83 111.222 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.1 OUTLIER -66.48 -37.65 85.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.819 -1.152 . . . . 1.34 109.578 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.42 -38.85 74.65 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.464 -1.398 . . . . 2.11 109.589 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -80.68 -48.17 12.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 2.08 112.485 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.02 -2.13 15.16 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.711 . . . . 0.02 112.705 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 61.9 33.86 17.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.814 -1.179 . . . . 0.02 109.942 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -114.2 135.49 53.99 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.491 -0.755 . . . . 0.02 109.1 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -90.98 -21.45 21.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 5.32 111.273 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.12 163.98 35.28 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.228 . . . . 0.02 110.093 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 117' ' ' ILE . 10.0 mm -128.38 124.3 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.58 -1.267 . . . . 2.17 107.58 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -108.44 -13.94 14.76 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.098 -1.001 . . . . 0.02 112.52 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 13.5 t -160.57 152.38 19.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.746 -1.221 . . . . 0.01 108.82 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.3 t -167.28 145.09 4.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 1.22 109.164 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -123.65 106.09 10.26 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.398 1.094 . . . . 1.41 109.385 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 131' ' ' VAL . 8.1 p . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.334 -1.358 . . . . 0.01 107.334 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 15.4 m95 . . . . . 0 N--CA 1.505 2.283 0 N-CA-C 107.819 -1.178 . . . . 0.01 107.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.431 ' CG1' HD11 ' A' ' 175' ' ' ILE . 39.5 mt -119.06 134.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.634 -1.291 . . . . 1.69 109.94 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -110.24 141.38 43.28 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.541 -2.022 . . . . 2.49 105.541 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -123.19 143.24 50.15 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.111 -0.993 . . . . 0.02 110.009 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 35.4 tt0 -72.97 -31.97 64.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.791 -0.568 . . . . 0.02 111.67 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.97 154.76 48.4 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.738 -1.226 . . . . 1.48 108.819 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -56.45 167.44 2.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.069 1.179 . . . . 0.02 112.849 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 59.06 31.63 21.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.159 -0.928 . . . . 0.75 111.51 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.03 51.91 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.765 . . . . 0.02 111.361 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -127.12 165.47 19.47 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.569 -0.707 . . . . 0.02 110.097 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.71 -164.99 34.71 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.211 -1.156 . . . . 0.02 110.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -69.17 141.34 54.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -1.065 . . . . 0.02 108.817 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 5.6 mt-30 -113.69 148.79 35.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.439 -0.578 . . . . 0.02 109.439 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -124.55 134.42 52.99 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.758 -0.83 . . . . 0.01 108.758 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -95.99 121.02 37.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.871 -1.143 . . . . 0.01 109.477 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -99.38 146.18 26.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.493 -0.929 . . . . 0.01 108.493 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.3 m-20 -110.6 178.46 4.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.599 -0.688 . . . . 2.27 109.532 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -71.65 39.79 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 1.84 109.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.6 mttm -110.31 -178.71 3.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.452 -0.78 . . . . 2.28 109.135 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -106.09 120.0 40.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.323 -0.861 . . . . 0.01 108.898 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.07 110.05 22.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.924 . . . . 0.01 108.986 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -28.13 16.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.506 -0.746 . . . . 0.01 111.176 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -123.5 152.27 64.63 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 107.722 -1.214 . . . . 2.54 107.722 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.8 Cg_endo -60.61 -39.65 62.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 CA-C-N 119.866 0.988 . . . . 0.7 110.987 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.97 -18.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.779 -1.201 . . . . 0.86 109.665 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.95 -18.63 65.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.02 112.38 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.66 16.0 27.17 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.828 -1.17 . . . . 0.02 109.912 178.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.1 11.2 76.69 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.227 -0.921 . . . . 0.02 112.849 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 140.63 34.95 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.42 . . . . 0.02 110.11 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.64 -7.48 58.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.628 -0.67 . . . . 0.59 110.092 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.0 p -139.97 150.72 63.27 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.198 -0.939 . . . . 0.87 109.463 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.93 14.27 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 120.812 1.008 . . . . 0.38 112.094 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.15 27.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.919 -1.113 . . . . 0.18 111.15 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 mp -151.65 125.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.513 -1.662 . . . . 3.99 106.513 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.451 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 9.0 mp0 -112.2 -12.03 13.68 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.357 -0.84 . . . . 5.17 112.533 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.9 t -156.88 158.99 37.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.197 -2.189 . . . . 0.02 110.045 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -152.26 154.15 35.16 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.147 -0.97 . . . . 2.02 110.057 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -143.08 148.39 36.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.01 109.804 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.467 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 15.7 ptm180 -86.37 141.14 29.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.184 -1.043 . . . . 0.01 108.184 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.431 HD11 ' CG1' ' A' ' 137' ' ' ILE . 25.8 mt -95.1 129.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.212 -0.93 . . . . 3.04 109.516 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.46 147.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 1.89 109.618 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 4.89 109.718 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.407 0 N-CA-C 105.653 -2.979 . . . . 0.81 105.653 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 147.6 31.86 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.338 -0.934 . . . . 0.01 111.231 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -152.84 138.05 17.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.586 -0.949 . . . . 0.02 109.184 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.22 140.0 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.259 -0.645 . . . . 0.02 109.259 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -122.56 130.66 53.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.633 -0.667 . . . . 0.39 109.877 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 10.9 m-85 -110.6 140.2 45.14 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.85 -0.796 . . . . 0.02 108.85 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.0 m-85 -122.43 139.03 54.32 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.289 -0.882 . . . . 0.02 109.856 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.455 ' HG3' HD11 ' A' ' 33' ' ' LEU . 78.4 mt-10 -68.58 -28.47 66.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.063 . . . . 0.03 111.88 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.98 170.42 8.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.796 -1.19 . . . . 0.03 110.351 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 31.9 mtp180 -74.81 157.58 34.91 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.698 0.761 . . . . 0.03 110.354 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t30 66.29 33.85 6.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.993 0.901 . . . . 0.74 111.374 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.23 42.43 28.01 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.287 0.565 . . . . 0.02 111.424 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -113.64 166.35 11.62 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.611 -0.885 . . . . 0.02 108.611 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.4 -167.53 37.44 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.954 -1.117 . . . . 0.03 111.094 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.447 HH21 ' H ' ' A' ' 34' ' ' SER . 37.7 ttp180 -69.11 142.13 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.578 -0.954 . . . . 2.76 109.265 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -121.51 149.46 43.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.738 0.78 . . . . 1.89 110.324 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -131.99 127.39 36.17 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.968 -1.123 . . . . 0.02 107.968 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.26 137.4 50.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.564 -0.71 . . . . 1.12 109.564 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.9 t -131.24 138.35 49.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.51 0.671 . . . . 0.02 109.673 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.44 10.52 14.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.608 -0.683 . . . . 0.2 109.529 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.1 p -157.37 174.28 15.66 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.216 -1.031 . . . . 1.23 108.216 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.34 144.32 54.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.662 -1.274 . . . . 0.02 110.189 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.13 116.7 17.35 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.468 -0.938 . . . . 0.02 108.468 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.89 -24.29 52.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.24 110.663 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -153.82 100.72 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 1.14 108.509 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -106.7 8.38 30.99 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.182 0.991 . . . . 6.37 110.168 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.681 ' NH2' HH12 ' A' ' 78' ' ' ARG . 86.7 mtt180 -59.79 -21.29 60.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 3.11 110.495 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.3 m -74.89 -16.48 60.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.905 -1.122 . . . . 0.88 109.871 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -102.37 -21.65 14.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.02 109.086 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.455 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.5 tp -150.26 129.66 12.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.913 -0.773 . . . . 3.32 108.913 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.447 ' H ' HH21 ' A' ' 18' ' ' ARG . 29.8 t -86.76 -12.22 48.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.854 -0.529 . . . . 0.02 111.098 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' SER . 10.5 mtm180 -167.1 161.09 14.49 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.153 -1.425 . . . . 0.02 107.153 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.8 p -143.34 115.31 8.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.831 -1.168 . . . . 0.02 108.643 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.5 m-20 -107.3 0.73 23.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.864 -1.147 . . . . 0.03 110.733 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 p -157.08 155.2 30.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.757 -1.201 . . . . 0.02 107.757 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.66 147.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.02 110.27 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -123.25 124.36 42.83 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -106.26 114.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.78 -34.08 27.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 3.81 110.265 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.78 151.29 21.02 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.116 -1.516 . . . . 0.02 110.125 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.38 49.64 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.495 -1.336 . . . . 0.01 110.082 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.82 137.41 54.0 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.802 -1.184 . . . . 1.48 107.802 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -125.66 153.62 43.56 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.498 1.142 . . . . 0.02 111.983 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.62 52.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 104.869 -2.271 . . . . 0.24 104.869 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.0 m -117.41 142.28 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.526 -0.733 . . . . 0.65 109.089 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 13.8 m-85 -119.5 144.04 47.22 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.378 1.085 . . . . 0.02 109.723 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.517 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 5.6 tp10 -65.95 -35.02 79.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.669 -0.696 . . . . 0.02 110.882 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -125.17 157.19 68.14 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.093 -1.004 . . . . 0.02 109.702 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 167.43 1.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.806 1.67 . . . . 0.02 113.056 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.06 37.25 9.27 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.144 -0.934 . . . . 0.02 111.017 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 45.21 52.22 8.74 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.598 0.713 . . . . 3.39 110.71 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.2 p -127.56 164.32 22.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.297 0.57 . . . . 2.33 109.911 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -162.3 31.81 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.922 -1.271 . . . . 0.02 109.922 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 14.9 t-80 -63.29 142.61 58.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.268 . . . . 0.02 110.507 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.511 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 31.4 mtp -116.78 134.56 54.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.266 0.555 . . . . 5.01 109.519 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 17.0 m-85 -135.27 134.35 39.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.393 -0.817 . . . . 0.02 109.124 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -96.86 131.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.986 -0.746 . . . . 1.72 108.986 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 61' ' ' LEU . 23.0 mt -122.92 111.48 30.89 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.394 -0.816 . . . . 0.02 110.668 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.1 171.29 18.4 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 CA-C-N 119.856 0.984 . . . . 1.47 110.286 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 1.3 tm0? -51.78 140.42 19.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 4.25 109.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 155.95 -178.15 32.65 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.325 -1.417 . . . . 0.02 110.71 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.84 131.24 55.23 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.581 -0.952 . . . . 0.96 109.587 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 62.4 m-85 -121.08 99.42 46.53 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.116 -1.068 . . . . 0.02 108.116 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.36 -4.21 13.96 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.64 0.893 . . . . 0.02 113.99 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 37.7 mt-10 -157.44 155.23 30.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.453 -1.405 . . . . 2.02 108.238 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 70' ' ' GLN . 27.7 p90 -60.36 -38.19 83.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.634 -0.666 . . . . 0.02 111.749 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 69' ' ' TYR . 13.3 mm-40 -59.83 -23.89 63.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.915 -1.115 . . . . 0.02 110.211 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.5 -18.6 62.28 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.176 0.989 . . . . 3.42 108.588 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.643 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -105.67 9.25 33.25 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.937 -1.505 . . . . 0.02 106.937 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt 59.87 21.56 10.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.606 -0.684 . . . . 0.02 110.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.81 144.09 46.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.02 109.497 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.78 -29.68 51.01 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.324 -1.362 . . . . 0.98 107.324 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -156.85 -170.85 3.44 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.405 -1.702 . . . . 0.02 106.405 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -97.82 29.25 3.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.612 -1.305 . . . . 0.02 110.172 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.681 HH12 ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -98.19 122.4 41.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.206 -0.934 . . . . 3.2 110.988 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 79' ' ' LEU . 29.8 mt -144.59 122.03 11.68 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.362 -1.347 . . . . 2.61 107.362 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.19 -16.46 12.31 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 120.448 -0.882 . . . . 0.02 112.405 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.8 p -156.31 157.32 35.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.309 -1.7 . . . . 0.02 110.405 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.3 m -144.85 148.37 33.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.767 -0.583 . . . . 0.02 109.559 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -136.44 140.69 43.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.233 -0.917 . . . . 0.01 109.136 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.48 132.77 36.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.224 -0.922 . . . . 0.43 109.323 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.28 123.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.511 -0.922 . . . . 1.25 108.511 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -88.93 135.51 33.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.097 -1.075 . . . . 1.77 108.097 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.29 139.0 37.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.445 -0.576 . . . . 1.63 109.445 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 p -111.98 122.39 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.685 -1.228 . . . . 1.08 107.685 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.8 p -114.22 133.84 55.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.752 -1.218 . . . . 1.26 107.865 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.5 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.501 3.033 0 C-N-CA 117.459 -2.305 . . . . 0.01 113.652 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.12 -103.03 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 120.308 2.054 . . . . 0.01 111.202 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.467 HE22 HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -119.93 119.2 32.79 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.359 -1.083 . . . . 4.43 110.174 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.1 129.98 38.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.191 -0.67 . . . . 2.99 109.191 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -132.14 138.19 47.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.717 . . . . 6.36 109.319 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -127.36 145.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.478 -0.764 . . . . 1.09 109.457 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.02 131.65 54.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.603 -1.258 . . . . 2.05 107.603 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 129' ' ' CYS . 23.6 m -123.6 146.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 120.811 -1.18 . . . . 1.1 109.386 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.25 140.86 49.17 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.022 0.915 . . . . 0.73 110.812 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -65.66 -29.96 70.59 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.959 -0.564 . . . . 0.02 111.395 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -116.94 168.36 10.31 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 3.18 110.571 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.61 168.92 30.6 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.959 -0.857 . . . . 0.01 110.959 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 52.21 40.09 28.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.671 0.748 . . . . 0.01 111.168 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 13.7 m-85 51.77 51.92 15.62 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.563 -0.711 . . . . 0.01 110.804 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -124.83 165.33 18.22 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.568 -0.901 . . . . 3.15 108.568 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -165.37 26.84 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.34 -1.504 . . . . 0.01 109.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -75.18 145.38 42.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.124 -1.221 . . . . 0.01 108.264 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.464 ' SD ' ' C ' ' A' ' 107' ' ' MET . 8.7 tmm? -116.47 142.31 47.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.678 0.752 . . . . 0.01 110.131 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.453 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.6 m-85 -130.85 135.31 47.6 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.844 -1.169 . . . . 2.48 107.844 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.25 135.77 54.8 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.596 -0.69 . . . . 0.01 109.751 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.15 154.46 39.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.039 -1.038 . . . . 1.69 110.674 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.467 HG22 HE22 ' A' ' 92' ' ' GLN . 58.8 p -111.34 8.35 21.32 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.818 -0.628 . . . . 0.01 110.009 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.2 163.5 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.337 -0.852 . . . . 3.21 111.383 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.77 155.92 38.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.124 -1.065 . . . . 0.01 108.124 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.496 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 44.5 t -126.0 112.41 24.33 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.687 -0.857 . . . . 0.01 108.687 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -74.81 -28.69 9.31 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.245 1.123 . . . . 0.01 111.094 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -142.52 108.65 5.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -0.843 . . . . 0.02 108.953 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.2 mt -62.62 -38.27 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.879 -0.513 . . . . 1.83 110.414 -178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.78 -37.38 79.27 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.224 -0.99 . . . . 1.34 110.451 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.87 -39.25 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.462 -1.399 . . . . 2.11 109.963 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.3 tt0 -79.38 -47.27 16.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 2.08 112.409 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.71 -0.1 16.11 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.431 -0.793 . . . . 0.02 112.808 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 m80 61.3 34.08 18.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.812 -1.18 . . . . 0.02 109.639 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.25 134.15 54.73 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.403 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.94 -21.61 21.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 5.32 109.984 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -149.83 164.56 35.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.149 -0.97 . . . . 0.02 109.859 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.96 128.52 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.294 -1.373 . . . . 2.17 107.294 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -107.23 -12.85 15.28 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.518 -0.739 . . . . 0.02 111.974 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.2 t -161.33 155.14 22.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.01 108.905 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -166.66 144.46 5.11 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.957 -1.127 . . . . 1.22 107.957 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -119.39 101.89 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.176 0.988 . . . . 1.41 109.004 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.3 p . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.487 -0.931 . . . . 0.01 108.487 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.0 m95 . . . . . 0 N--CA 1.51 2.551 0 CA-C-O 121.524 0.678 . . . . 0.01 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -121.14 138.86 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.929 -0.767 . . . . 1.69 108.929 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 151' ' ' LEU . 2.8 m-30 -111.92 142.01 44.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.089 -1.448 . . . . 2.49 107.089 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 22.0 m-85 -123.17 144.04 49.62 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.214 -0.929 . . . . 0.02 109.448 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.2 -30.22 60.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.02 111.552 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 155.46 46.76 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.68 -1.262 . . . . 1.48 108.954 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -57.09 167.27 3.38 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.183 1.255 . . . . 0.02 112.721 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.7 t30 59.01 31.63 21.54 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.144 -0.935 . . . . 0.75 111.341 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.52 51.19 10.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.02 111.157 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.34 165.1 18.97 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.614 -0.679 . . . . 0.02 109.914 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.67 -165.38 33.55 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.174 -1.17 . . . . 0.02 110.174 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -69.94 143.02 52.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -1.035 . . . . 0.02 108.915 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -112.03 147.75 35.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.383 0.611 . . . . 0.02 109.816 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.42 133.76 53.29 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.841 -0.8 . . . . 0.01 108.841 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -97.95 122.64 41.31 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.827 -1.17 . . . . 0.01 109.923 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 138' ' ' PHE . 16.8 mt -91.75 143.46 26.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.01 108.61 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' LYS . 20.1 m-20 -108.23 -179.01 3.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.438 -0.789 . . . . 2.27 109.725 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.28 36.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 1.84 109.526 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 152' ' ' ASP . 89.3 mttt -111.9 177.57 4.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.789 . . . . 2.28 109.271 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -106.07 121.87 45.01 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.843 -0.799 . . . . 0.01 108.843 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.97 113.04 25.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.349 -0.844 . . . . 0.01 110.346 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -94.18 -25.58 17.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.127 -0.983 . . . . 0.01 110.934 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -124.75 154.31 70.43 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.922 -1.111 . . . . 2.54 108.119 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.55 -40.69 45.31 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.186 0.745 . . . . 0.7 110.555 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.8 -19.72 21.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.991 -1.068 . . . . 0.86 109.055 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.14 -18.59 65.44 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.962 -1.086 . . . . 0.02 111.388 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.875 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 1.8 p90 -102.74 14.27 32.37 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.037 -1.04 . . . . 0.02 109.859 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.15 9.77 69.84 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.393 -0.817 . . . . 0.02 113.734 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.619 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.86 140.89 34.51 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.533 -1.569 . . . . 0.02 110.619 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.14 -7.1 59.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.59 109.333 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.8 m -142.53 150.71 55.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.126 -0.984 . . . . 0.87 109.293 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.43 17.7 0.63 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.729 0.953 . . . . 0.38 112.28 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.6 29.07 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.476 1.132 . . . . 0.18 111.429 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.875 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.5 mt -148.77 127.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.84 -1.541 . . . . 3.99 106.84 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -113.34 -16.31 12.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.231 -0.918 . . . . 5.17 112.726 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 23.0 t -157.18 159.49 37.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 119.287 -2.133 . . . . 0.02 110.176 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.04 152.85 34.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.868 . . . . 2.02 109.917 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -144.71 151.06 38.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.244 -0.91 . . . . 0.01 110.498 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -87.95 143.52 27.06 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.722 -0.844 . . . . 0.01 108.722 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.2 mt -94.91 128.7 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 3.04 109.119 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.66 146.64 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.19 -0.944 . . . . 1.89 109.418 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 4.89 109.099 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 106.984 -2.447 . . . . 0.81 106.984 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 148.15 32.5 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.309 -0.948 . . . . 0.01 110.84 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -152.19 137.05 17.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.944 . . . . 0.02 108.984 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.5 tt -130.22 140.91 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -121.03 129.21 53.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.774 . . . . 0.39 109.833 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 17.1 m-85 -109.42 139.68 44.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.898 -0.778 . . . . 0.02 108.898 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 16.6 m-85 -123.05 138.33 54.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.265 -0.897 . . . . 0.02 109.915 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 34' ' ' SER . 16.6 mm-40 -67.1 -27.68 67.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.03 111.258 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 10.2 t70 -114.18 169.78 8.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.96 -1.088 . . . . 0.03 110.136 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 16.1 mtp180 -75.61 162.3 28.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.622 0.725 . . . . 0.03 110.276 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.7 m120 62.94 34.49 14.1 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.955 0.883 . . . . 0.74 110.397 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.6 42.64 23.38 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.391 -0.822 . . . . 0.02 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.6 166.21 11.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.88 36.07 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 120.708 -1.245 . . . . 0.03 110.522 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -68.32 143.72 55.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -1.02 . . . . 2.76 109.153 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -121.33 149.2 43.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.5 -0.75 . . . . 1.89 110.179 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -133.36 128.56 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.644 -0.873 . . . . 0.02 108.644 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.72 136.46 50.93 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.457 -0.777 . . . . 1.12 109.538 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.39 137.61 49.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.282 -0.636 . . . . 0.02 109.282 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -117.05 11.11 14.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.605 -0.684 . . . . 0.2 109.741 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.452 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 48.5 t -158.36 174.45 15.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 35.0 t0 -60.58 143.21 54.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.692 -1.255 . . . . 0.02 109.893 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.55 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 9.7 t -130.46 116.63 18.49 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.449 -0.945 . . . . 0.02 108.449 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.06 -23.79 51.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.076 -1.015 . . . . 0.24 110.678 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -156.0 100.91 2.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.896 -1.127 . . . . 1.14 108.576 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -105.32 8.77 33.9 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.177 0.989 . . . . 6.37 109.613 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.31 -24.39 63.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.602 -0.686 . . . . 3.11 110.94 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.6 p -74.5 -16.62 60.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 109.876 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -105.04 -21.7 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.737 . . . . 0.02 109.259 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 1.7 tp -148.14 125.56 11.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 3.32 109.247 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.519 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 4.6 m -85.87 -11.35 53.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.833 . . . . 0.02 111.313 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.51 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 7.2 mtm180 -171.56 161.7 6.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.364 -1.347 . . . . 0.02 107.364 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 39' ' ' ILE . 34.8 t -141.47 113.93 8.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.223 -0.923 . . . . 0.02 109.205 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.456 ' ND2' ' CG ' ' A' ' 77' ' ' ASP . 3.3 m120 -108.13 -0.17 21.23 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.01 -1.056 . . . . 0.03 110.589 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 t -156.21 152.46 27.83 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.524 -1.288 . . . . 0.02 107.524 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CG1' ' SG ' ' A' ' 36' ' ' CYS . 84.2 mt -144.79 147.44 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.35 1.072 . . . . 0.02 110.198 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 22.1 ttp180 -122.5 123.14 40.57 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.412 -1.329 . . . . 0.02 107.412 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.95 113.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 106.723 -1.584 . . . . 0.02 106.723 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 47.8 mm-40 -83.52 -34.09 25.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.968 -0.693 . . . . 3.81 109.639 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 150.6 19.94 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 118.7 -1.714 . . . . 0.02 110.463 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.09 173.48 49.7 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.881 -1.152 . . . . 0.01 110.404 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.3 m -119.83 136.73 54.36 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.19 -1.041 . . . . 1.48 108.19 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -125.88 153.83 43.59 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.613 1.197 . . . . 0.02 112.158 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.27 133.8 51.99 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 104.942 -2.244 . . . . 0.24 104.942 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.98 142.39 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.65 109.329 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 40.8 m-85 -121.63 144.44 48.75 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.058 0.932 . . . . 0.02 109.754 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.33 -35.57 80.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.521 -0.763 . . . . 0.02 111.833 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.408 HH22 ' CZ ' ' A' ' 78' ' ' ARG . 3.6 mmp_? -124.05 153.89 67.96 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.147 -0.97 . . . . 0.02 109.554 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -50.61 166.39 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.306 1.338 . . . . 0.02 113.378 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.81 37.52 9.7 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.123 -0.944 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 44.1 51.82 7.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.779 0.8 . . . . 3.39 110.663 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -124.97 163.17 22.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.572 -0.529 . . . . 2.33 109.572 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.73 -161.34 32.07 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.647 -1.381 . . . . 0.02 109.647 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -67.57 139.35 56.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.983 -1.304 . . . . 0.02 110.413 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 22.3 ptm -118.73 137.41 53.37 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.637 -0.664 . . . . 5.01 109.719 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 52.6 m-85 -132.92 138.42 46.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.472 -0.767 . . . . 0.02 109.65 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.29 132.17 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.737 -0.838 . . . . 1.72 108.737 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -119.85 109.67 37.5 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 121.416 -0.802 . . . . 0.02 110.451 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -76.48 168.67 23.34 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.136 1.084 . . . . 1.47 109.997 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -52.23 140.31 21.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.673 -1.267 . . . . 4.25 110.18 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.88 -177.52 32.11 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.476 -1.345 . . . . 0.02 110.742 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.05 130.94 54.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.43 -1.041 . . . . 0.96 109.305 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 27.9 m-85 -121.97 90.6 48.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.43 -4.46 8.16 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 121.006 1.138 . . . . 0.02 113.389 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -154.45 150.62 28.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 2.02 107.527 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 19.6 p90 -60.29 -37.8 81.64 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.02 112.22 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -61.02 -23.51 65.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.02 111.216 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.7 OUTLIER -72.66 -16.53 61.7 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.116 -1.034 . . . . 3.42 109.053 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.574 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.93 10.41 30.52 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.087 -1.449 . . . . 0.02 107.087 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm 61.84 21.75 12.49 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.357 0.599 . . . . 0.02 110.764 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.06 144.66 46.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.02 109.237 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 30.8 tp -79.5 -30.68 42.05 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.837 -1.172 . . . . 0.98 107.837 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.67 -172.4 3.94 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.619 -1.622 . . . . 0.02 106.619 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.456 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 22.3 m-20 -97.89 27.2 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.687 -1.258 . . . . 0.02 110.382 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.49 122.82 39.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.142 -0.974 . . . . 3.2 110.777 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.491 HD22 ' HB ' ' A' ' 48' ' ' VAL . 61.8 mt -143.63 121.67 12.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.865 -1.161 . . . . 2.61 107.865 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.95 -17.75 9.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.345 -0.847 . . . . 0.02 112.54 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 36.5 m -155.28 155.38 33.66 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.757 1.778 . . . . 0.02 110.843 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 12.7 m -145.06 146.98 32.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.567 0.698 . . . . 0.02 110.414 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 71.5 mtm180 -135.64 141.4 45.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.741 -0.837 . . . . 0.01 108.741 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 130.95 37.27 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.136 -0.978 . . . . 0.43 108.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -88.82 123.47 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -91.02 133.89 34.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 1.77 108.208 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 139.38 35.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.997 -0.742 . . . . 1.63 108.997 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 p -112.02 125.71 54.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.671 -0.862 . . . . 1.08 108.671 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -102.11 -155.97 0.54 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 106.0 -1.852 . . . . 1.26 106.0 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.4 -47.36 0.97 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 120.561 -1.337 . . . . 0.01 112.279 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.76 -98.61 0.12 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.479 -1.82 . . . . 0.01 112.348 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.53 121.41 36.47 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.218 -1.166 . . . . 4.43 111.034 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 132.23 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.166 -0.679 . . . . 2.99 109.166 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 6.5 ttpm? -132.11 139.46 48.47 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.022 -0.733 . . . . 6.36 109.022 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.1 tt -127.48 143.92 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 121.975 0.893 . . . . 1.09 109.591 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -124.81 133.54 53.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.743 -1.206 . . . . 2.05 107.743 177.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -124.77 147.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.946 -1.096 . . . . 1.1 109.546 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -117.57 140.72 49.25 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.987 0.899 . . . . 0.73 110.948 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.96 -29.68 70.12 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.987 -0.551 . . . . 0.02 111.444 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 128' ' ' SER . 54.2 mttm -117.35 171.23 8.11 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.13 -0.981 . . . . 3.18 110.289 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.16 170.16 41.91 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.072 -0.811 . . . . 0.01 111.072 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.3 t0 52.51 39.56 28.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.564 0.697 . . . . 0.01 111.646 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 51.92 49.47 20.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.699 -0.626 . . . . 0.01 110.796 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.76 166.2 15.97 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.369 -0.974 . . . . 3.15 108.369 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.78 -165.48 28.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.618 -1.393 . . . . 0.01 109.618 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -75.62 144.7 41.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.009 -1.289 . . . . 0.01 108.594 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.6 tmm? -116.9 142.98 46.24 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.684 0.754 . . . . 0.01 110.171 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.423 ' N ' ' SD ' ' A' ' 107' ' ' MET . 42.7 m-85 -130.88 135.68 47.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.891 -1.152 . . . . 2.48 107.891 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.95 135.0 54.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.548 -0.72 . . . . 0.01 110.115 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -149.76 153.15 36.39 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.109 0.957 . . . . 1.69 110.572 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.9 p -109.38 10.37 25.47 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.812 -0.631 . . . . 0.01 109.901 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.37 163.53 18.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.409 -0.807 . . . . 3.21 111.379 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.18 154.65 39.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.346 -0.983 . . . . 0.01 108.346 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.21 111.6 30.32 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.47 -0.769 . . . . 0.01 108.928 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -77.33 -33.63 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 119.885 0.994 . . . . 0.01 111.988 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.7 m -140.94 108.44 5.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.21 -0.931 . . . . 0.02 109.188 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 26.8 mt -63.43 -39.66 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.759 -0.588 . . . . 1.83 110.791 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttp -66.4 -37.81 86.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.002 -1.079 . . . . 1.34 110.033 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.34 -39.19 74.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.433 -1.417 . . . . 2.11 109.678 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.467 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 52.6 tt0 -81.19 -47.9 12.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 2.08 112.506 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 63.6 m-85 -111.77 -2.53 15.25 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.427 -0.796 . . . . 0.02 112.76 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 61.99 34.02 16.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.719 -1.238 . . . . 0.02 109.323 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 mt -114.7 135.71 53.86 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.333 -0.854 . . . . 0.02 109.291 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -90.0 -20.91 22.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.026 -1.046 . . . . 5.32 111.17 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 35.4 mt-10 -149.23 164.9 33.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.692 -1.255 . . . . 0.02 110.709 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 27.8 mm -127.54 124.37 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.553 -1.277 . . . . 2.17 107.553 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.1 m80 -110.75 -14.66 13.98 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.107 -0.996 . . . . 0.02 113.113 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.3 p -163.36 155.47 17.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.625 -1.297 . . . . 0.01 109.204 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.5 p -171.0 143.31 1.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.22 108.964 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 24.1 pttt -119.5 99.0 6.4 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.6 1.19 . . . . 1.41 109.289 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.306 -0.998 . . . . 0.01 108.306 179.677 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 41.3 m95 . . . . . 0 N--CA 1.506 2.335 0 N-CA-C 107.629 -1.249 . . . . 0.01 107.629 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 43.7 mt -118.7 133.57 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.455 -1.403 . . . . 1.69 109.574 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -111.59 141.96 44.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.149 -1.797 . . . . 2.49 106.149 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 23.1 m-85 -123.83 144.38 49.76 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.92 -1.113 . . . . 0.02 109.793 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.04 -31.43 62.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.809 -0.557 . . . . 0.02 111.799 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.21 155.14 47.2 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.816 -1.178 . . . . 1.48 108.903 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -56.81 166.75 3.54 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.128 1.219 . . . . 0.02 112.799 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.01 31.1 20.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.206 -0.906 . . . . 0.75 111.375 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 58.26 52.03 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.727 . . . . 0.02 111.285 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -126.94 165.47 19.34 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.599 -0.688 . . . . 0.02 110.021 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.48 -165.53 33.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -69.45 142.56 53.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.578 -0.954 . . . . 0.02 108.843 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -112.89 147.22 37.48 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.294 0.569 . . . . 0.02 109.687 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.57 134.14 53.87 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.676 -0.861 . . . . 0.01 108.676 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.56 120.95 37.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.922 -1.111 . . . . 0.01 109.526 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -98.47 144.68 27.55 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.315 -0.995 . . . . 0.01 108.315 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 154' ' ' LYS . 6.2 m-20 -108.64 -175.28 2.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 2.27 109.859 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -73.01 32.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.399 -0.813 . . . . 1.84 109.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 152' ' ' ASP . 17.6 ttmt -110.4 173.57 6.27 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.694 -0.854 . . . . 2.28 108.694 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -105.56 129.35 53.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.01 109.364 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -100.35 111.61 23.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.359 -0.838 . . . . 0.01 109.446 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.462 ' CD ' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -89.71 -26.84 20.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.01 110.816 -177.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -123.78 155.26 66.9 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.552 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.3 Cg_endo -63.07 -39.46 39.49 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 CA-C-N 119.349 0.803 . . . . 0.7 111.057 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.89 -18.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.773 -1.204 . . . . 0.86 109.945 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.48 -18.41 65.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.945 -1.097 . . . . 0.02 112.38 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.552 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.13 15.62 28.11 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 120.737 -1.227 . . . . 0.02 109.917 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.92 76.6 Favored Glycine 0 N--CA 1.5 2.926 0 O-C-N 121.172 -0.955 . . . . 0.02 112.847 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 140.74 34.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.726 -1.455 . . . . 0.02 110.278 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -7.11 59.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.63 -0.669 . . . . 0.59 109.739 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.0 m -141.96 149.7 53.62 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.186 -0.947 . . . . 0.87 109.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.76 16.89 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.736 0.957 . . . . 0.38 112.06 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.64 120.71 25.42 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.362 1.077 . . . . 0.18 110.786 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mp -150.66 124.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 106.194 -1.78 . . . . 3.99 106.194 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.33 -12.29 14.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.342 -0.849 . . . . 5.17 112.83 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.9 p -156.97 160.13 38.75 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.231 -2.168 . . . . 0.02 109.925 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.99 153.4 33.98 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.312 -0.867 . . . . 2.02 110.047 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.68 149.26 36.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.01 110.24 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -86.25 142.26 28.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.183 -1.043 . . . . 0.01 108.183 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.429 HD11 ' CG1' ' A' ' 137' ' ' ILE . 44.2 mt -93.35 128.63 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.451 -0.9 . . . . 3.04 109.327 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.73 148.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 1.89 109.918 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.712 . . . . 4.89 109.562 179.339 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.57 0 N-CA-C 106.987 -2.445 . . . . 0.81 106.987 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.29 148.72 33.04 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.607 -0.997 . . . . 0.01 110.607 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -150.77 136.26 17.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -1.005 . . . . 0.02 108.862 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.37 140.52 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.909 -0.774 . . . . 0.02 108.909 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 11.0 t -122.25 129.98 52.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.769 . . . . 0.39 109.76 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 26.3 m-85 -108.39 138.55 44.49 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.87 -0.789 . . . . 0.02 108.87 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 26.9 m-85 -122.65 138.72 54.51 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.194 -0.941 . . . . 0.02 109.788 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.496 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 91.8 mt-10 -69.55 -27.49 65.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.675 . . . . 0.03 112.041 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.33 170.75 8.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.817 -1.177 . . . . 0.03 110.569 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.688 ' NH1' HD22 ' A' ' 37' ' ' ASN . 10.9 mpt_? -73.72 157.15 37.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.757 0.789 . . . . 0.03 109.897 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.27 35.41 5.94 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.875 0.845 . . . . 0.74 111.117 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 7.6 p90 49.6 45.19 24.44 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.699 0.761 . . . . 0.02 111.01 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -112.0 166.29 11.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.01 -1.108 . . . . 0.02 108.01 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -167.16 35.42 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.03 110.71 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -68.97 143.03 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.414 -1.05 . . . . 2.76 109.204 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 56.8 ttt180 -119.04 147.8 43.72 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.544 0.688 . . . . 1.89 109.587 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -132.45 126.48 33.15 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.728 -1.212 . . . . 0.02 107.728 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -111.92 136.29 51.43 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 1.12 109.708 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.2 t -130.48 137.56 49.83 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.482 0.658 . . . . 0.02 109.48 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -116.52 10.89 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.703 -0.623 . . . . 0.2 109.514 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 49.0 t -157.94 174.35 15.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.151 -1.055 . . . . 1.23 108.151 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 p30 -62.15 144.87 54.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.69 -1.256 . . . . 0.02 110.152 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -132.37 116.56 16.99 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.422 -0.955 . . . . 0.02 108.422 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.13 53.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.877 . . . . 0.24 110.732 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.23 100.98 2.35 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -105.2 10.1 33.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.005 0.907 . . . . 6.37 110.063 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.681 HH22 ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.49 -22.27 61.34 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.672 -0.642 . . . . 3.11 110.701 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -75.54 -16.97 60.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.702 -1.249 . . . . 0.88 110.29 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -102.97 -22.03 13.87 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 0.02 109.221 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.2 tp -150.67 129.49 12.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.822 0.82 . . . . 3.32 108.825 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -85.63 -10.12 56.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.656 -0.652 . . . . 0.02 111.142 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -171.65 163.91 6.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.439 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -141.26 113.69 8.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.823 -1.173 . . . . 0.02 109.133 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.688 HD22 ' NH1' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -107.22 -3.7 19.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.03 110.285 -179.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.36 152.39 31.03 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.002 -1.11 . . . . 0.02 108.002 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.4 147.76 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.02 109.973 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -125.08 126.11 44.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.876 -1.157 . . . . 0.02 107.876 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.45 114.76 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.883 -1.525 . . . . 0.02 106.883 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.15 -34.07 24.11 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.783 -0.767 . . . . 3.81 109.865 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.3 150.11 18.99 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.572 -1.775 . . . . 0.02 110.507 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.704 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 84.11 173.39 49.75 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.623 -1.275 . . . . 0.01 110.062 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.1 m -118.61 136.06 54.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.76 -1.2 . . . . 1.48 107.76 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -126.0 153.52 44.23 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.821 -1.174 . . . . 0.02 112.159 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.11 133.08 52.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.108 -2.182 . . . . 0.24 105.108 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.1 m -117.94 142.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.092 -0.707 . . . . 0.65 109.092 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -121.17 145.78 47.47 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.22 1.01 . . . . 0.02 109.77 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 10.4 tt0 -66.68 -34.09 77.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.752 -0.658 . . . . 0.02 111.663 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' NH1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 mpt_? -122.87 159.04 55.39 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 121.002 -1.061 . . . . 0.02 109.287 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.39 166.2 1.89 Allowed 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.528 1.485 . . . . 0.02 112.31 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.4 36.33 11.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.643 0.735 . . . . 0.02 111.167 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 45.52 52.42 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.462 0.648 . . . . 3.39 111.08 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -125.92 163.47 22.88 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.162 0.506 . . . . 2.33 109.752 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.91 -161.2 31.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.592 -1.403 . . . . 0.02 109.592 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 2.1 m80 -65.72 137.86 57.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.98 -1.306 . . . . 0.02 109.883 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.478 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.7 ptm -119.69 137.04 54.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.604 -0.685 . . . . 5.01 109.392 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 49.8 m-85 -134.08 141.01 47.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.499 -0.751 . . . . 0.02 109.714 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.669 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.17 132.1 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.555 -0.906 . . . . 1.72 108.555 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -119.96 109.75 37.23 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.476 -0.765 . . . . 0.02 110.323 -178.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -76.49 168.68 23.32 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.007 1.038 . . . . 1.47 110.327 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.704 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 73.9 mt-30 -53.41 140.68 26.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.869 -1.144 . . . . 4.25 110.504 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -176.97 32.36 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.627 -1.273 . . . . 0.02 110.452 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.16 130.16 55.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.489 -1.006 . . . . 0.96 109.216 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.49 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 30.5 m-85 -121.48 95.24 48.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.22 -3.71 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.767 0.978 . . . . 0.02 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -157.36 154.89 29.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.352 -1.467 . . . . 2.02 108.311 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -60.85 -39.05 87.63 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.677 . . . . 0.02 111.651 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -60.16 -23.62 64.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.02 110.34 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -18.56 62.95 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.063 0.935 . . . . 3.42 108.578 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -107.4 10.49 29.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.337 -1.357 . . . . 0.02 107.337 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 27.6 mtm 61.55 21.98 12.53 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.473 0.654 . . . . 0.02 110.738 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.58 144.36 45.97 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.328 -1.509 . . . . 0.02 109.328 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 tp -78.72 -30.83 46.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.493 -1.299 . . . . 0.98 107.493 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -156.37 -171.53 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.255 -1.757 . . . . 0.02 106.255 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -97.73 27.7 4.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.646 -1.284 . . . . 0.02 110.194 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.681 ' NH2' HH22 ' A' ' 30' ' ' ARG . 19.7 mmm180 -96.08 122.06 38.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.893 -1.129 . . . . 3.2 110.631 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.1 mt -144.98 119.95 10.01 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.511 -1.292 . . . . 2.61 107.511 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.32 -16.07 11.66 Favored Glycine 0 N--CA 1.505 3.267 0 O-C-N 121.264 -0.898 . . . . 0.02 112.879 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.8 p -155.52 155.88 34.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.204 -1.763 . . . . 0.02 110.343 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.2 t -144.94 148.21 33.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.334 0.588 . . . . 0.02 109.71 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -135.55 140.24 44.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.332 -0.855 . . . . 0.01 108.89 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 130.12 36.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.205 -0.935 . . . . 0.43 108.72 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.55 122.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 1.25 107.993 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.48 ' C ' HD23 ' A' ' 87' ' ' LEU . 15.1 m80 -92.0 133.94 35.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.94 -1.1 . . . . 1.77 108.576 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.59 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -98.18 137.96 36.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.242 -1.022 . . . . 1.63 108.242 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -110.3 126.9 54.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 1.08 108.743 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 p -104.29 -154.86 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.28 -1.748 . . . . 1.26 106.28 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.11 -47.5 0.97 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.509 -1.369 . . . . 0.01 112.237 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.53 -100.18 0.14 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.676 -1.726 . . . . 0.01 111.779 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.31 118.74 31.2 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.293 -1.122 . . . . 4.43 110.221 -179.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.55 130.38 37.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.102 -0.703 . . . . 2.99 109.102 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -131.28 139.19 49.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.464 -0.773 . . . . 6.36 109.323 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 tt -129.19 144.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.462 -0.774 . . . . 1.09 109.742 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.33 134.01 54.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.424 -1.324 . . . . 2.05 107.424 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.44 147.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.902 -1.124 . . . . 1.1 109.232 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 95.2 m-85 -118.77 141.34 48.71 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.097 0.951 . . . . 0.73 111.088 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.78 -30.01 70.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.791 -0.64 . . . . 0.02 111.57 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -117.03 168.77 9.96 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.947 -1.096 . . . . 3.18 110.553 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.07 43.31 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.013 -0.835 . . . . 0.01 111.013 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.2 m-20 56.48 39.09 30.1 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.664 0.745 . . . . 0.01 110.86 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 6.7 m-85 52.29 55.58 8.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.69 -0.631 . . . . 0.01 110.952 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -128.85 166.1 19.73 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.496 -0.927 . . . . 3.15 108.496 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 -165.38 27.85 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.523 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.3 tt0 -74.52 145.31 43.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.093 -1.239 . . . . 0.01 108.237 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.3 ttp -117.54 142.75 46.81 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.753 0.787 . . . . 0.01 110.179 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.523 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 60.7 m-85 -130.94 135.29 47.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.963 -1.125 . . . . 2.48 107.963 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -119.79 135.56 54.81 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.608 -0.683 . . . . 0.01 109.957 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.524 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.1 t -150.09 152.13 34.29 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.33 1.062 . . . . 1.69 111.074 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.7 p -110.28 9.55 23.68 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.622 -0.717 . . . . 0.01 109.808 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -121.08 163.32 18.56 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.311 -0.868 . . . . 3.21 111.398 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -66.51 155.28 38.07 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 27.5 t -124.53 111.6 27.86 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.737 -0.838 . . . . 0.01 108.737 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.86 -32.5 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.128 1.081 . . . . 0.01 111.732 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 m -140.82 107.61 5.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.02 108.855 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.7 mt -63.3 -39.04 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.779 -0.576 . . . . 1.83 110.375 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 5.9 tpt -66.1 -37.89 86.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.013 -1.075 . . . . 1.34 109.868 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -70.73 -39.3 73.45 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.374 -1.454 . . . . 2.11 109.532 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.452 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 42.1 tt0 -80.53 -48.01 13.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 2.08 112.458 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 66.0 m-85 -111.23 -1.78 15.98 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.02 112.623 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 61.12 34.33 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.745 -1.222 . . . . 0.02 109.603 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.403 ' C ' ' SD ' ' A' ' 118' ' ' MET . 52.5 mt -114.33 136.21 53.23 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.517 -0.74 . . . . 0.02 109.432 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -90.25 -21.96 21.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.323 -0.861 . . . . 5.32 110.737 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 37.8 mt-10 -148.91 164.3 34.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.966 -1.084 . . . . 0.02 109.939 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 34.6 mm -129.49 126.7 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.453 -1.314 . . . . 2.17 107.453 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -110.07 -12.93 14.47 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.267 -0.896 . . . . 0.02 112.658 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.5 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.8 t -160.42 153.13 21.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.691 -1.256 . . . . 0.01 109.002 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -167.08 146.32 5.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 1.22 109.349 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -125.22 106.4 9.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.45 1.119 . . . . 1.41 109.381 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.2 p . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 107.328 -1.36 . . . . 0.01 107.328 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.403 ' CD1' HG21 ' A' ' 131' ' ' VAL . 9.5 m95 . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 106.789 -1.56 . . . . 0.01 106.789 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.439 HG13 HD11 ' A' ' 175' ' ' ILE . 32.6 mt -118.08 134.3 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.446 -1.409 . . . . 1.69 109.266 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.51 141.69 44.76 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.344 -1.724 . . . . 2.49 106.344 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.3 m-85 -123.19 143.46 50.0 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.22 -0.925 . . . . 0.02 109.64 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.98 -30.69 62.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.739 -0.601 . . . . 0.02 111.668 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.79 154.31 49.42 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.48 108.874 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.82 169.68 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.156 1.238 . . . . 0.02 113.174 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.51 32.29 21.59 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.99 -1.004 . . . . 0.75 111.462 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 55.57 48.34 18.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.534 -0.729 . . . . 0.02 110.382 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -122.08 163.9 18.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.659 -0.651 . . . . 0.02 109.613 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.13 -165.51 32.95 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.16 -1.176 . . . . 0.02 110.16 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.71 143.18 53.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.499 -1.001 . . . . 0.02 109.15 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.478 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.4 mt-30 -112.95 148.24 35.43 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.281 0.562 . . . . 0.02 109.763 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -123.31 133.28 54.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.435 -0.95 . . . . 0.01 108.435 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.23 120.72 37.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.794 -1.191 . . . . 0.01 109.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.66 139.71 33.15 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.174 -1.047 . . . . 0.01 108.174 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 154' ' ' LYS . 0.7 OUTLIER -107.39 -171.82 1.95 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.345 -0.847 . . . . 2.27 109.905 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.01 40.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 1.84 109.568 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 152' ' ' ASP . 75.3 tttt -113.57 168.49 9.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.619 -0.675 . . . . 2.28 109.28 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -103.48 127.54 50.85 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.18 -1.044 . . . . 0.01 108.18 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.85 110.62 22.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.019 -1.051 . . . . 0.01 110.598 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -93.8 -26.66 16.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.314 -0.867 . . . . 0.01 110.736 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -123.24 154.09 65.23 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 107.897 -1.149 . . . . 2.54 107.897 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -62.14 -42.37 29.82 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.237 0.763 . . . . 0.7 111.097 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 -18.68 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 120.68 -1.262 . . . . 0.86 109.428 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 60.2 t0 -65.53 -18.18 65.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.841 -1.162 . . . . 0.02 111.964 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.77 15.84 27.7 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 120.737 -1.227 . . . . 0.02 110.037 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.89 74.35 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 121.053 -1.029 . . . . 0.02 112.869 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.56 140.59 34.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.717 -1.46 . . . . 0.02 110.13 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.83 -6.92 59.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.687 -0.633 . . . . 0.59 109.553 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 m -140.84 150.06 58.44 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.223 -0.923 . . . . 0.87 109.088 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.47 16.15 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.672 0.915 . . . . 0.38 111.902 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.48 120.5 25.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.039 . . . . 0.18 110.727 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.471 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -150.2 124.92 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.554 -2.017 . . . . 3.99 105.554 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -112.41 -13.4 13.4 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.354 0.872 . . . . 5.17 113.354 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.5 p -156.73 159.51 38.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.205 -2.184 . . . . 0.02 109.919 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -152.27 154.18 35.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.197 -0.939 . . . . 2.02 110.512 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -142.95 148.99 37.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.307 -0.871 . . . . 0.01 110.142 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -86.43 141.7 28.95 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.103 -1.073 . . . . 0.01 108.103 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.439 HD11 HG13 ' A' ' 137' ' ' ILE . 13.1 mt -94.98 128.95 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.084 -1.01 . . . . 3.04 109.766 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.2 m -137.39 149.31 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.485 -0.759 . . . . 1.89 109.69 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 177' ' ' GLU . 2.7 mp0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 4.89 109.638 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.572 0 N-CA-C 106.677 -2.569 . . . . 0.81 106.677 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.09 147.53 31.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.632 -0.987 . . . . 0.01 110.632 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -154.14 138.61 16.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.587 -0.949 . . . . 0.02 108.757 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 141.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.266 -0.642 . . . . 0.02 109.266 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.562 ' HG ' ' CG ' ' A' ' 21' ' ' ASP . 1.4 m -121.79 130.1 53.15 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.507 -0.746 . . . . 0.39 109.661 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 16.8 m-85 -110.05 139.19 45.44 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.855 -0.794 . . . . 0.02 108.855 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-85 -123.04 139.39 54.13 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.156 -0.965 . . . . 0.02 110.218 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG2' HD11 ' A' ' 33' ' ' LEU . 19.6 mm-40 -69.62 -28.44 65.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.069 . . . . 0.03 111.981 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.87 170.72 8.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 0.03 110.54 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -73.39 156.3 38.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.763 0.792 . . . . 0.03 110.371 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.98 34.71 8.72 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.811 0.815 . . . . 0.74 111.533 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.58 42.37 29.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.02 111.333 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -112.7 165.38 12.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.202 -1.036 . . . . 0.02 108.202 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.74 -166.76 36.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.752 -1.213 . . . . 0.03 110.496 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -69.25 142.38 54.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -1.056 . . . . 2.76 109.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 58.5 ttt180 -119.18 148.22 43.34 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 1.89 109.745 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.99 126.68 32.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.209 -1.034 . . . . 0.02 108.209 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.562 ' CG ' ' HG ' ' A' ' 8' ' ' SER . 4.2 m-20 -111.96 136.44 51.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.429 -0.795 . . . . 1.12 109.651 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.0 t -130.59 137.8 49.83 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.465 0.65 . . . . 0.02 109.645 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 13.7 t70 -116.98 11.32 14.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.665 -0.647 . . . . 0.2 109.713 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 48.7 m -158.11 173.97 15.92 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.85 144.77 54.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.661 -1.274 . . . . 0.02 110.214 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.3 p -132.02 116.71 17.44 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.82 -25.68 53.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.24 110.657 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.72 100.77 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 1.14 108.444 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -104.82 9.36 34.88 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.207 1.004 . . . . 6.37 109.755 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.572 ' CZ ' ' NH2' ' A' ' 78' ' ' ARG . 57.8 mtp180 -58.93 -23.28 61.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.678 -0.639 . . . . 3.11 110.705 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 69.2 p -75.34 -16.69 60.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.691 -1.256 . . . . 0.88 110.162 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.4 m-85 -103.21 -21.65 13.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.02 109.178 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 11' ' ' GLU . 6.4 tp -150.62 129.2 12.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 3.32 108.816 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -86.1 -10.0 55.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.808 -0.558 . . . . 0.02 110.984 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 25.3 ttt180 -171.1 162.04 6.95 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.4 -1.333 . . . . 0.02 107.4 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.5 m -141.36 114.33 8.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.111 . . . . 0.02 108.842 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -107.54 -0.15 22.29 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.711 -1.243 . . . . 0.03 110.583 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 t -156.72 154.08 29.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.545 -1.28 . . . . 0.02 107.545 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.35 148.39 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.117 -0.989 . . . . 0.02 110.218 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -124.68 125.1 43.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.67 113.61 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.756 -1.572 . . . . 0.02 106.756 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -83.69 -34.14 25.03 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.127 -0.629 . . . . 3.81 109.531 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.48 150.23 19.13 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.713 -1.708 . . . . 0.02 110.605 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.07 173.44 49.66 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.472 -1.347 . . . . 0.01 109.782 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 m -119.99 137.38 54.11 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 44.6 m95 -126.6 152.98 45.91 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.524 1.154 . . . . 0.02 111.922 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.42 133.79 51.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 104.841 -2.281 . . . . 0.24 104.841 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.3 m -117.73 142.94 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.65 109.228 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 17.6 m-85 -119.81 143.68 47.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.34 1.067 . . . . 0.02 109.703 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.08 -34.31 77.77 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.759 -0.655 . . . . 0.02 110.764 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -125.36 157.43 67.78 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.144 -0.972 . . . . 0.02 109.897 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.01 166.82 1.36 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.706 1.604 . . . . 0.02 113.16 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 64.43 36.37 8.93 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.054 -0.976 . . . . 0.02 111.195 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.77 51.79 10.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.534 0.683 . . . . 3.39 110.782 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 p -127.25 164.22 22.19 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.286 0.565 . . . . 2.33 109.824 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.47 -162.26 31.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.3 t-80 -63.05 142.78 58.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -1.204 . . . . 0.02 110.457 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.434 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 29.6 mtp -117.9 134.69 54.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.346 -0.613 . . . . 5.01 109.346 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.636 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 31.5 m-85 -135.27 135.22 40.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.34 -0.85 . . . . 0.02 109.2 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -96.52 132.31 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.941 -0.763 . . . . 1.72 108.941 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.2 110.22 31.01 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.376 -0.828 . . . . 0.02 110.657 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -75.83 171.45 18.16 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.83 0.975 . . . . 1.47 109.91 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 1.9 pm0 -52.36 139.71 23.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.118 . . . . 4.25 110.237 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -178.02 33.04 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.435 -1.364 . . . . 0.02 110.446 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -119.11 130.06 55.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -1.084 . . . . 0.96 109.423 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -120.87 96.54 48.65 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.75 -5.14 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.603 0.868 . . . . 0.02 114.055 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 67' ' ' PRO . 49.3 mm-40 -151.8 152.53 32.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.628 -1.249 . . . . 2.02 107.628 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -60.77 -37.89 83.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.406 -0.809 . . . . 0.02 111.075 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -59.93 -23.65 63.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.051 -1.031 . . . . 0.02 110.28 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.617 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.56 -18.75 62.23 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.283 1.039 . . . . 3.42 108.243 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.636 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -105.66 8.42 33.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.212 -1.403 . . . . 0.02 107.212 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.3 mpt? 59.95 21.75 10.79 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.477 0.656 . . . . 0.02 110.35 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.31 143.98 45.74 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.26 -1.536 . . . . 0.02 109.26 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.4 tp -78.42 -30.78 47.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.34 -1.356 . . . . 0.98 107.34 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -156.22 -172.19 4.0 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.245 -1.761 . . . . 0.02 106.245 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 38.6 m-20 -97.57 27.46 4.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.781 -1.199 . . . . 0.02 110.346 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -96.1 122.09 38.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.071 -1.018 . . . . 3.2 110.704 -179.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.8 mt -144.71 120.39 10.48 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.611 -1.255 . . . . 2.61 107.611 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.91 -16.05 12.1 Favored Glycine 0 N--CA 1.506 3.312 0 C-N-CA 120.491 -0.862 . . . . 0.02 112.64 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.3 p -156.3 156.89 34.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.393 -1.651 . . . . 0.02 110.238 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.2 m -144.84 148.66 34.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.698 -0.626 . . . . 0.02 109.415 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -136.38 140.83 43.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.332 -0.855 . . . . 0.01 109.136 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.93 36.47 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.305 -0.872 . . . . 0.43 109.001 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.71 124.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.247 -1.02 . . . . 1.25 108.247 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -89.47 134.04 34.28 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.925 -1.139 . . . . 1.77 107.925 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.63 139.31 36.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 1.63 109.15 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 p -111.22 122.68 48.49 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.669 -1.234 . . . . 1.08 107.669 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 m -114.01 133.19 55.66 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.699 -1.223 . . . . 1.26 107.699 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.4 -46.31 0.02 OUTLIER Glycine 0 N--CA 1.501 3.0 0 C-N-CA 117.59 -2.243 . . . . 0.01 113.573 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.83 -103.13 0.17 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 120.17 1.985 . . . . 0.01 111.006 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -120.4 118.66 30.91 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.249 -1.148 . . . . 4.43 110.204 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 131.21 41.34 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.141 -0.624 . . . . 2.99 109.369 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.28 136.36 46.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.598 -0.689 . . . . 6.36 109.67 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ3' ' A' ' 136' ' ' TRP . 10.9 tt -127.93 145.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.472 -0.767 . . . . 1.09 109.262 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -121.65 133.12 54.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.437 -1.319 . . . . 2.05 107.437 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.427 HG12 ' SG ' ' A' ' 129' ' ' CYS . 22.6 m -124.32 147.24 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 120.887 -1.133 . . . . 1.1 109.09 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -119.26 141.11 49.24 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.081 0.943 . . . . 0.73 111.086 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -66.66 -29.56 69.61 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.758 -0.655 . . . . 0.02 111.465 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' A' ' 128' ' ' SER . 27.3 mmtp -115.6 169.02 9.5 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.099 -1.001 . . . . 3.18 110.148 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.83 164.82 51.2 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.056 -0.818 . . . . 0.01 111.056 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 57.14 39.46 28.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.854 -0.792 . . . . 0.01 111.411 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 52.04 54.13 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.618 -0.677 . . . . 0.01 111.142 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -129.65 165.49 21.68 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.052 -1.092 . . . . 3.15 108.052 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.76 -164.63 27.84 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.171 -1.571 . . . . 0.01 109.171 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.07 144.18 43.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.829 -1.394 . . . . 0.01 108.661 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 13.0 tmm? -116.62 142.56 46.73 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.555 0.693 . . . . 0.01 109.885 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -131.42 136.31 47.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.537 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.7 tm-20 -120.41 135.72 54.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.642 -0.661 . . . . 0.01 109.806 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.537 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 5.0 t -149.37 152.48 35.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.253 1.025 . . . . 1.69 110.881 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 p -112.01 8.76 20.3 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.729 -0.669 . . . . 0.01 109.941 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -121.48 163.46 18.76 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.331 -0.856 . . . . 3.21 111.353 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -67.94 156.74 36.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.327 -0.99 . . . . 0.01 108.327 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.08 113.08 26.51 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.511 -0.743 . . . . 0.01 109.016 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.9 -28.06 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 120.234 1.119 . . . . 0.01 111.055 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . 2.6 p -144.82 108.57 4.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 0.02 109.004 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.68 -39.52 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.873 -0.517 . . . . 1.83 110.444 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.9 ttt -68.0 -37.25 81.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.114 -1.034 . . . . 1.34 110.225 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 116' ' ' SER . 39.6 mt-10 -70.43 -38.78 74.63 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.636 -1.29 . . . . 2.11 109.958 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -80.25 -47.9 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.932 . . . . 2.08 112.417 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -110.7 -0.72 17.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.389 -0.819 . . . . 0.02 112.677 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 m170 60.39 33.52 20.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.696 -1.252 . . . . 0.02 109.434 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.83 134.52 54.31 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.733 -0.84 . . . . 0.02 108.733 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.456 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -91.7 -22.3 20.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 5.32 110.163 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -149.29 163.81 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.238 -0.914 . . . . 0.02 109.843 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mt -133.18 129.37 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.272 -1.381 . . . . 2.17 107.272 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -108.68 -12.12 14.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.455 -0.778 . . . . 0.02 112.461 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.8 p -160.15 154.45 23.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.01 108.749 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.8 t -166.0 143.13 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 1.22 108.897 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -120.34 103.93 9.61 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.681 1.229 . . . . 1.41 109.153 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 131' ' ' VAL . 14.1 p . . . . . 0 C--N 1.302 -1.482 0 N-CA-C 107.706 -1.22 . . . . 0.01 107.706 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.409 ' CZ3' HG21 ' A' ' 95' ' ' ILE . 15.8 m95 . . . . . 0 N--CA 1.51 2.55 0 CA-C-O 121.625 0.726 . . . . 0.01 110.476 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.72 139.71 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.022 -0.733 . . . . 1.69 109.022 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' HD2' HD13 ' A' ' 169' ' ' ILE . 2.6 m-30 -112.07 141.77 45.33 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 106.799 -1.556 . . . . 2.49 106.799 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 23.7 m-85 -122.6 143.15 49.94 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.091 -1.006 . . . . 0.02 109.228 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -74.57 -31.17 61.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.606 -0.684 . . . . 0.02 111.613 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -115.06 155.86 46.06 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.68 -1.262 . . . . 1.48 108.752 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -57.88 166.71 4.99 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.095 1.197 . . . . 0.02 112.735 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 15.8 t30 60.09 31.29 20.52 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.142 -0.935 . . . . 0.75 111.456 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 58.72 51.17 7.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.717 . . . . 0.02 110.863 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -126.09 165.61 18.53 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.611 -0.681 . . . . 0.02 110.02 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.75 -165.35 34.94 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.279 -1.128 . . . . 0.02 110.279 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.18 141.78 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.947 . . . . 0.02 108.848 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 15.2 mt-30 -112.63 147.75 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.517 -0.549 . . . . 0.02 109.517 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.18 133.23 53.61 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.764 -0.828 . . . . 0.01 108.764 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.74 121.83 39.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.941 -1.099 . . . . 0.01 109.341 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.41 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.0 mt -92.78 146.83 23.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.01 109.123 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 154' ' ' LYS . 24.2 m-20 -108.55 -171.43 1.85 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.576 -0.702 . . . . 2.27 109.442 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -75.46 29.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 1.84 109.622 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 152' ' ' ASP . 54.8 mttp -113.21 170.94 7.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.5 -0.75 . . . . 2.28 109.549 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.91 135.36 47.5 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -100.28 114.01 27.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.37 -0.831 . . . . 0.01 109.96 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -88.59 -28.18 20.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.01 110.988 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -124.63 155.21 69.81 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 107.4 -1.333 . . . . 2.54 107.4 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.1 Cg_endo -61.99 -39.39 50.82 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.395 0.73 . . . . 0.7 111.457 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.79 -18.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.817 -1.177 . . . . 0.86 109.829 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.15 -19.24 65.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.891 -1.131 . . . . 0.02 112.569 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.739 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 0.4 OUTLIER -101.79 16.23 26.5 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 120.696 -1.252 . . . . 0.02 109.881 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.66 10.52 79.19 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.369 -0.919 . . . . 0.02 112.771 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 141.03 34.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.898 -1.354 . . . . 0.02 110.069 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.7 59.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.658 -0.651 . . . . 0.59 109.848 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -142.17 150.0 53.97 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.033 -1.042 . . . . 0.87 109.119 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -75.33 18.15 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.654 0.902 . . . . 0.38 112.144 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.98 122.76 28.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.545 1.164 . . . . 0.18 110.922 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.739 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.9 mt -148.02 125.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.433 -1.692 . . . . 3.99 106.433 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -113.67 -16.12 12.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 5.17 112.65 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.8 p -157.06 158.98 37.47 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 119.247 -2.158 . . . . 0.02 110.196 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.77 154.57 35.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.053 -1.029 . . . . 2.02 110.114 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.452 HH11 ' HG3' ' A' ' 173' ' ' ARG . 5.4 mtm-85 -144.12 150.54 38.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.153 -0.967 . . . . 0.01 110.612 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -86.93 143.39 27.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.69 127.96 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.171 -0.956 . . . . 3.04 109.418 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.06 147.19 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.243 -0.911 . . . . 1.89 109.54 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.401 ' OE1' ' OE1' ' A' ' 63' ' ' GLN . 24.5 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.415 -0.803 . . . . 4.89 109.412 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.664 0 N-CA-C 106.957 -2.457 . . . . 0.81 106.957 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.95 149.59 33.04 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.117 -1.04 . . . . 0.01 110.725 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -151.49 136.97 17.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.493 -1.004 . . . . 0.02 109.367 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -129.46 140.06 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.881 -0.785 . . . . 0.02 108.881 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -121.39 129.84 53.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.562 -0.711 . . . . 0.39 109.242 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -108.94 138.95 44.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.542 -0.91 . . . . 0.02 108.542 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.55 138.82 54.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.265 -0.897 . . . . 0.02 109.416 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.496 ' HG3' HD11 ' A' ' 33' ' ' LEU . 86.6 mt-10 -69.87 -27.75 65.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.767 . . . . 0.03 111.705 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.71 169.85 8.76 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.893 -1.129 . . . . 0.03 110.656 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.409 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 94.2 mtt180 -73.48 157.32 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.702 0.763 . . . . 0.03 110.216 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 t-20 65.16 35.7 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.756 0.788 . . . . 0.74 111.086 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.1 p90 49.97 45.05 25.52 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.685 0.755 . . . . 0.02 111.122 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -112.63 165.94 11.8 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.41 -167.13 35.28 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 120.761 -1.212 . . . . 0.03 110.725 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -69.3 142.48 54.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 2.76 109.125 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -121.1 149.51 42.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 1.89 110.034 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -132.93 127.42 34.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.1 135.69 50.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 1.12 109.22 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -130.13 136.92 49.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 -178.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.84 9.09 11.9 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.534 -0.729 . . . . 0.2 110.343 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 44.9 t -157.69 173.69 16.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.018 -1.051 . . . . 1.23 108.469 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 64.4 t0 -60.45 142.23 55.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.074 -1.641 . . . . 0.02 110.834 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.2 m -132.36 116.47 16.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.408 -0.96 . . . . 0.02 108.408 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.1 54.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.795 . . . . 0.24 110.873 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -155.67 101.76 2.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 1.14 108.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.1 p90 -105.85 9.6 32.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.418 1.104 . . . . 6.37 109.908 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -60.21 -22.17 62.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.292 -0.88 . . . . 3.11 110.801 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 18.0 p -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.785 -1.197 . . . . 0.88 109.945 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.5 m-85 -102.67 -21.3 14.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.453 -0.779 . . . . 0.02 109.083 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.81 128.85 12.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.846 -0.798 . . . . 3.32 108.846 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t -84.25 -9.67 58.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.02 110.567 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -171.4 163.79 6.94 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.474 -1.306 . . . . 0.02 107.474 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -141.83 113.75 7.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.697 -1.252 . . . . 0.02 108.538 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 1.3 t30 -108.96 -1.58 18.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.96 -1.088 . . . . 0.03 111.42 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -153.86 153.53 32.27 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.179 -1.045 . . . . 0.02 108.179 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.77 146.88 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.061 -1.024 . . . . 0.02 110.672 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -125.5 125.68 43.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.397 -1.335 . . . . 0.02 107.397 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.56 114.32 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.949 -1.5 . . . . 0.02 106.949 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.8 -34.3 27.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.586 -0.696 . . . . 3.81 110.485 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 152.01 21.74 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 118.974 -1.584 . . . . 0.02 110.138 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.83 174.43 49.46 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.255 -1.45 . . . . 0.01 110.026 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' TRP . 31.6 m -110.77 161.24 15.98 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' THR . 70.0 m95 -148.26 148.63 30.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.618 -1.301 . . . . 0.02 111.609 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.81 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 105.452 -2.055 . . . . 0.24 105.452 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.1 m -117.11 141.98 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.551 -0.718 . . . . 0.65 109.628 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.519 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 -120.34 143.15 48.54 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.062 0.934 . . . . 0.02 109.434 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -64.69 -33.96 77.17 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.589 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -124.59 157.84 64.09 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.131 -0.981 . . . . 0.02 109.575 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.37 166.56 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.663 1.576 . . . . 0.02 112.944 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.4 t30 63.68 37.17 10.27 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.275 -0.875 . . . . 0.02 111.279 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.28 50.92 9.63 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.568 0.699 . . . . 3.39 110.56 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.8 m -125.72 163.8 22.03 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.268 0.556 . . . . 2.33 109.876 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.59 -162.07 31.47 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.553 -1.419 . . . . 0.02 109.553 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -67.03 138.23 57.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.98 -1.306 . . . . 0.02 110.137 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 17.7 ptm -119.21 137.46 53.62 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.417 0.627 . . . . 5.01 109.68 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.0 m-85 -132.92 140.56 47.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.175 -0.676 . . . . 0.02 109.175 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.58 132.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.379 -0.971 . . . . 1.72 108.379 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -120.78 113.76 32.97 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.524 -0.735 . . . . 0.02 110.768 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.16 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 CA-C-N 119.915 1.005 . . . . 1.47 110.046 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -53.52 140.82 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.758 -1.214 . . . . 4.25 110.409 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.87 -177.78 32.78 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.512 -1.328 . . . . 0.02 110.55 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.85 130.26 55.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -1.02 . . . . 0.96 109.438 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 23.1 m-85 -121.42 92.99 48.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 107.972 -1.121 . . . . 0.02 107.972 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.59 -3.91 8.7 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.877 1.051 . . . . 0.02 113.589 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -156.92 153.37 28.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.535 -1.353 . . . . 2.02 107.969 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -59.89 -38.07 81.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.02 111.888 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -59.9 -24.14 64.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.02 110.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.03 -18.29 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.088 0.947 . . . . 3.42 108.495 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.98 10.59 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.184 -1.413 . . . . 0.02 107.184 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.38 22.73 11.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.677 . . . . 0.02 110.417 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 145.53 46.49 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.161 -1.575 . . . . 0.02 109.161 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.43 -30.26 42.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.296 . . . . 0.98 107.942 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 54.2 t30 -157.24 -172.08 3.87 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.477 -1.675 . . . . 0.02 106.477 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.1 p30 -97.72 27.6 4.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.705 -1.247 . . . . 0.02 110.482 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -95.8 121.78 37.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.922 -1.112 . . . . 3.2 110.324 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.1 mt -144.33 119.4 10.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 2.61 107.69 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.24 11.15 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 121.381 -0.824 . . . . 0.02 112.938 -177.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -155.6 156.43 35.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.203 -1.763 . . . . 0.02 110.897 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 83.9 m -145.77 148.32 32.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.626 0.727 . . . . 0.02 110.525 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 48.5 mtm180 -134.73 139.42 45.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.677 -0.861 . . . . 0.01 108.677 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.89 130.45 36.62 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.187 -1.042 . . . . 0.43 108.187 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.66 124.8 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.395 -0.965 . . . . 1.25 108.395 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -90.74 134.17 34.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.925 -1.109 . . . . 1.77 108.335 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.67 139.35 34.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.938 -0.764 . . . . 1.63 108.938 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 p -112.29 125.1 53.8 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.487 -0.931 . . . . 1.08 108.487 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -102.28 -156.06 0.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 106.163 -1.791 . . . . 1.26 106.163 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.01 -46.45 1.01 Allowed Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.57 -1.331 . . . . 0.01 112.14 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.36 -97.89 0.11 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 118.352 -1.88 . . . . 0.01 112.382 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -121.51 119.91 33.36 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.336 -1.096 . . . . 4.43 110.966 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.81 130.23 38.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.162 -0.681 . . . . 2.99 109.162 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -132.1 139.17 48.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.475 -0.766 . . . . 6.36 109.319 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -127.46 144.87 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.385 -0.822 . . . . 1.09 109.72 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -123.45 132.94 54.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.938 -1.134 . . . . 2.05 107.938 177.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.26 147.64 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.881 -1.137 . . . . 1.1 109.586 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.9 141.49 48.61 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.019 0.914 . . . . 0.73 111.061 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.36 -30.3 70.07 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.898 -0.592 . . . . 0.02 111.83 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 92.0 mttt -116.26 167.63 10.84 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.913 -1.117 . . . . 3.18 110.273 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.77 163.93 43.42 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 57.17 38.44 28.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.828 -0.807 . . . . 0.01 111.088 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 52.46 55.5 9.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.61 -0.682 . . . . 0.01 111.007 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.76 165.34 21.13 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.501 -0.926 . . . . 3.15 108.501 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.3 -163.72 27.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.25 -1.54 . . . . 0.01 109.25 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.77 143.5 44.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.006 -1.291 . . . . 0.01 108.653 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.6 142.42 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.465 0.65 . . . . 0.01 109.427 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -131.75 135.51 46.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.239 -1.022 . . . . 2.48 108.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -121.61 135.28 54.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.648 -0.657 . . . . 0.01 110.008 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 t -149.64 153.4 36.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.222 1.011 . . . . 1.69 110.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p -109.55 10.04 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.844 -0.616 . . . . 0.01 109.712 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 20.6 mp0 -120.53 163.13 18.43 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.315 -0.866 . . . . 3.21 111.175 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.51 154.55 38.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 11.6 t -123.19 110.26 31.01 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.673 -0.862 . . . . 0.01 108.673 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.9 -32.6 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.873 0.99 . . . . 0.01 111.662 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.5 m -140.43 107.79 5.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.322 -0.861 . . . . 0.02 108.819 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.0 mt -63.82 -39.76 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.67 -0.644 . . . . 1.83 110.794 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.26 -37.63 83.8 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.053 -1.059 . . . . 1.34 110.073 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.24 -39.15 75.2 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.416 -1.427 . . . . 2.11 109.763 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.9 tt0 -80.39 -47.24 14.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 2.08 112.476 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.5 m-85 -111.27 -1.05 16.21 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.451 -0.781 . . . . 0.02 112.681 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.2 m80 61.77 33.4 17.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.839 -1.163 . . . . 0.02 109.802 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.3 mt -114.18 135.41 54.07 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.563 -0.711 . . . . 0.02 109.248 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -90.25 -22.13 21.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 5.32 110.987 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HD13 ' A' ' 126' ' ' ILE . 81.1 mt-10 -148.6 164.05 35.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.983 -1.073 . . . . 0.02 109.74 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 125' ' ' GLU . 41.8 mm -128.59 125.24 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 107.21 -1.404 . . . . 2.17 107.21 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.572 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -108.72 -14.1 14.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.305 -0.872 . . . . 0.02 112.573 -177.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 13.0 p -160.59 153.71 21.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.661 -1.274 . . . . 0.01 109.069 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.1 t -166.39 140.3 4.16 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.115 -1.069 . . . . 1.22 108.115 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.418 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 ptpt -119.53 98.85 6.33 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.4 1.095 . . . . 1.41 108.635 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 131' ' ' VAL . 13.8 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 73.7 m95 . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.38 0.61 . . . . 0.01 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mt -119.34 137.84 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.058 -1.09 . . . . 1.69 108.058 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -111.23 141.29 44.94 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.959 -1.497 . . . . 2.49 106.959 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 31.3 m-85 -123.24 143.56 49.97 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.1 -1.0 . . . . 0.02 109.594 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.88 -30.33 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.6 -0.687 . . . . 0.02 111.497 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.4 152.97 47.54 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.788 -1.195 . . . . 1.48 109.003 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.77 167.81 2.02 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.086 1.19 . . . . 0.02 113.05 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.31 30.86 20.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.874 -1.057 . . . . 0.75 111.278 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 58.43 51.88 7.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.528 -0.732 . . . . 0.02 111.065 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -127.16 165.54 19.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.564 -0.71 . . . . 0.02 110.141 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.95 -165.42 34.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.218 -1.153 . . . . 0.02 110.218 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -69.22 141.69 54.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.536 -0.979 . . . . 0.02 108.893 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 58' ' ' MET . 10.0 mt-30 -113.38 148.71 35.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.502 -0.555 . . . . 0.02 109.502 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -123.72 133.51 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.551 -0.907 . . . . 0.01 108.551 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.436 ' H ' ' CE ' ' A' ' 58' ' ' MET . 10.1 tp -95.51 122.28 38.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.884 -1.135 . . . . 0.01 109.266 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.1 mp -91.58 149.82 21.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.724 -0.843 . . . . 0.01 108.724 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.9 m-20 -108.85 -177.15 3.23 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.471 -0.768 . . . . 2.27 109.498 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -74.38 29.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.85 . . . . 1.84 109.698 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 152' ' ' ASP . 49.6 mttm -112.94 176.12 5.15 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.476 -0.765 . . . . 2.28 109.498 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 2.2 mp0 -105.91 134.8 48.46 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.838 -0.801 . . . . 0.01 108.838 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -100.0 112.46 24.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.01 110.302 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -88.39 -29.5 20.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.01 111.133 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -122.72 154.35 63.57 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.056 -1.09 . . . . 2.54 108.056 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.3 Cg_endo -61.79 -42.95 28.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 CA-C-N 119.373 0.812 . . . . 0.7 110.55 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.61 -18.81 17.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.751 -1.218 . . . . 0.86 109.454 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 58.7 t0 -65.59 -17.86 64.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.809 -1.182 . . . . 0.02 111.737 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.38 15.52 28.55 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 120.725 -1.234 . . . . 0.02 110.193 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.86 10.55 75.51 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 121.206 -0.934 . . . . 0.02 112.967 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.525 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.68 140.79 34.46 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.855 -1.38 . . . . 0.02 110.009 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.55 -6.83 59.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.669 -0.644 . . . . 0.59 109.612 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -140.49 149.94 59.05 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.109 -0.994 . . . . 0.87 109.169 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.81 16.13 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.571 0.847 . . . . 0.38 111.909 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.26 120.76 25.79 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.323 1.059 . . . . 0.18 110.841 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.427 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -150.35 123.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.416 -2.068 . . . . 3.99 105.416 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -114.79 -11.01 12.32 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 113.365 0.876 . . . . 5.17 113.365 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 t -156.64 158.48 37.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.276 -2.14 . . . . 0.02 110.106 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.7 153.56 34.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.198 -0.939 . . . . 2.02 110.287 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -143.19 149.34 37.87 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.816 0.817 . . . . 0.01 110.206 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.82 143.59 27.05 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.337 -0.986 . . . . 0.01 108.337 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.36 128.5 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.252 -0.905 . . . . 3.04 109.742 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.24 146.61 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.185 -0.947 . . . . 1.89 109.839 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.105 -0.702 . . . . 4.89 109.105 179.288 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.594 0 N-CA-C 106.943 -2.463 . . . . 0.81 106.943 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.96 149.48 32.89 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.275 -0.964 . . . . 0.01 110.851 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -151.43 137.88 18.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.395 -1.062 . . . . 0.02 109.614 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -130.15 139.84 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.326 -0.62 . . . . 0.02 109.326 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.88 129.74 53.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.39 109.836 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -109.59 139.41 44.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.7 m-85 -122.89 138.36 54.68 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.266 -0.896 . . . . 0.02 109.576 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.61 -27.7 67.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.03 111.904 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -114.97 170.92 7.98 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.797 -1.189 . . . . 0.03 110.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HE ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -74.98 157.95 34.09 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.607 0.718 . . . . 0.03 110.092 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.5 t-20 66.26 34.97 6.2 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.91 0.862 . . . . 0.74 110.873 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.8 p90 50.11 44.94 25.94 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.807 0.813 . . . . 0.02 111.139 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.1 166.49 11.37 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.084 -1.08 . . . . 0.02 108.084 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.22 -167.81 36.3 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.731 -1.231 . . . . 0.03 110.788 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -68.24 142.6 55.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 2.76 108.939 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -121.18 149.74 42.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.686 0.755 . . . . 1.89 110.093 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -133.05 127.62 34.45 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.012 -1.106 . . . . 0.02 108.012 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -110.78 136.15 50.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.609 -0.682 . . . . 1.12 109.177 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -130.23 137.02 49.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.02 109.338 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.39 9.19 12.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.628 -0.67 . . . . 0.2 110.141 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.5 p -157.8 173.82 16.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 1.23 108.318 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 16.5 t0 -59.65 141.7 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.283 -1.51 . . . . 0.02 110.568 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.5 m -131.68 116.42 17.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.281 -1.007 . . . . 0.02 108.281 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.94 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.048 -1.033 . . . . 0.24 110.948 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -153.3 101.04 2.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.99 . . . . 1.14 108.806 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -105.59 9.04 33.46 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.111 0.958 . . . . 6.37 109.637 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.5 mmp_? -57.88 -23.66 54.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.654 -0.654 . . . . 3.11 110.565 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -74.05 -16.91 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.154 . . . . 0.88 109.971 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -105.41 -22.06 13.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.481 -0.762 . . . . 0.02 109.498 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.2 tp -148.18 125.34 11.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 3.32 109.082 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 58.3 m -87.58 -13.15 43.65 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.74 . . . . 0.02 111.78 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 34' ' ' SER . 51.3 mtm180 -166.27 160.43 15.92 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.2 -1.407 . . . . 0.02 107.2 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.3 p -140.76 113.32 8.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.847 -1.158 . . . . 0.02 108.956 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -106.71 -0.49 23.56 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.82 -1.175 . . . . 0.03 110.379 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -156.41 154.26 30.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.42 147.71 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.043 -1.036 . . . . 0.02 110.45 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -123.8 125.29 44.44 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.41 -0.959 . . . . 0.02 108.41 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.23 113.7 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.735 -1.58 . . . . 0.02 106.735 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -82.82 -34.19 26.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.567 -0.708 . . . . 3.81 110.366 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 151.77 21.37 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.135 -1.507 . . . . 0.02 110.397 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.42 174.43 50.37 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.696 -1.24 . . . . 0.01 110.175 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 95.4 m -109.49 160.49 16.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.889 -1.523 . . . . 1.48 106.889 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' THR . 50.4 m95 -148.02 146.97 29.12 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.208 -1.557 . . . . 0.02 111.506 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.66 132.37 54.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.519 -2.03 . . . . 0.24 105.519 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.42 143.12 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.523 -0.735 . . . . 0.65 109.625 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 12.1 m-85 -119.05 142.87 47.47 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.207 1.003 . . . . 0.02 109.803 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.28 -34.68 77.92 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.873 -0.603 . . . . 0.02 111.075 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -124.33 154.21 68.98 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.04 -1.038 . . . . 0.02 109.457 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.71 168.02 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.596 1.531 . . . . 0.02 113.33 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.09 36.45 7.31 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.151 -0.931 . . . . 0.02 111.035 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 45.58 50.54 10.44 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.784 0.802 . . . . 3.39 110.527 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -127.21 164.46 21.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.246 0.546 . . . . 2.33 109.971 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -162.39 31.68 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.156 -1.178 . . . . 0.02 110.156 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -62.31 141.23 58.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.089 -1.242 . . . . 0.02 110.568 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 49.4 mtp -117.94 133.12 56.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.529 -0.545 . . . . 5.01 109.529 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.3 m-85 -136.08 137.08 40.71 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.766 0.793 . . . . 0.02 109.703 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -97.21 133.28 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.324 -0.991 . . . . 1.72 108.324 178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 61' ' ' LEU . 11.9 mt -120.25 113.57 33.84 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.663 -0.648 . . . . 0.02 110.405 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -77.79 169.54 20.55 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 CA-C-N 119.987 1.031 . . . . 1.47 109.951 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -52.62 140.92 21.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 4.25 110.151 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -177.38 32.54 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.331 -1.414 . . . . 0.02 110.748 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.66 131.18 55.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.552 -0.969 . . . . 0.96 109.349 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -120.72 97.13 48.63 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.81 -1.181 . . . . 0.02 107.81 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.03 -4.39 12.42 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.738 0.959 . . . . 0.02 113.837 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -157.39 154.68 29.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.419 -1.426 . . . . 2.02 108.254 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -60.7 -37.95 83.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.616 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -23.85 64.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.02 110.213 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.67 -18.51 62.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.128 0.966 . . . . 3.42 108.655 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -106.73 10.07 30.98 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.17 -1.419 . . . . 0.02 107.17 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.0 mtt 60.49 21.05 10.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.51 0.672 . . . . 0.02 110.231 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 144.59 47.06 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.095 -1.602 . . . . 0.02 109.095 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.1 tp -78.14 -29.38 48.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.597 -1.26 . . . . 0.98 107.597 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.527 HD22 ' C ' ' A' ' 76' ' ' ASN . 0.1 OUTLIER -156.75 -170.76 3.42 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 97.9 m-20 -98.1 29.05 3.67 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.62 -1.3 . . . . 0.02 110.204 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.1 123.08 41.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.262 -0.899 . . . . 3.2 111.329 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.516 HD12 ' SG ' ' A' ' 36' ' ' CYS . 28.1 mt -143.18 120.48 11.57 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.733 -1.58 . . . . 2.61 106.733 177.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.93 -16.65 13.24 Favored Glycine 0 N--CA 1.503 3.158 0 O-C-N 121.248 -0.908 . . . . 0.02 112.329 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.8 p -156.07 156.0 33.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.465 -1.609 . . . . 0.02 109.656 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.55 147.66 33.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.521 0.677 . . . . 0.02 109.547 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -134.08 139.39 45.93 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.542 -0.911 . . . . 0.01 108.542 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.86 130.12 37.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.11 -1.07 . . . . 0.43 108.11 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.05 123.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -90.06 137.92 31.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 1.77 109.165 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -100.95 136.83 40.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.422 -0.955 . . . . 1.63 108.422 -179.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -113.34 126.85 55.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.819 . . . . 1.08 108.968 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.9 m -103.25 -155.02 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.197 -1.779 . . . . 1.26 106.197 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.34 -48.89 0.88 Allowed Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.391 -1.443 . . . . 0.01 112.593 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.85 -100.37 0.14 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.495 -1.812 . . . . 0.01 112.136 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.76 119.05 31.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.197 -1.178 . . . . 4.43 110.311 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.77 129.92 36.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.909 -0.716 . . . . 2.99 109.24 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.52 139.42 50.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 6.36 109.208 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.58 145.14 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.311 -0.868 . . . . 1.09 109.949 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -122.67 133.16 54.52 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.251 -1.388 . . . . 2.05 107.251 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.73 148.01 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.041 -1.037 . . . . 1.1 109.486 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 45.3 m-85 -119.33 140.99 49.42 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.248 1.023 . . . . 0.73 110.824 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -65.86 -29.05 69.44 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.659 -0.7 . . . . 0.02 111.33 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -116.59 169.47 9.32 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.151 -0.968 . . . . 3.18 110.443 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.37 52.02 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.938 -0.865 . . . . 0.01 110.938 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 t0 57.36 38.37 28.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 0.01 111.252 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 51.84 54.81 10.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.01 111.296 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -129.61 165.97 20.68 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.124 -1.065 . . . . 3.15 108.124 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.07 -164.77 27.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.309 -1.517 . . . . 0.01 109.309 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.05 145.12 40.39 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.023 -1.28 . . . . 0.01 108.473 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 44.3 ttp -116.69 142.45 46.89 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.764 0.792 . . . . 0.01 110.093 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.36 135.0 47.59 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.777 -1.194 . . . . 2.48 107.777 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -120.68 135.54 55.09 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.632 -0.668 . . . . 0.01 110.217 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 1.5 t -149.69 151.32 33.48 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.178 0.989 . . . . 1.69 110.84 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.7 p -109.08 9.9 26.17 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 115.641 -0.708 . . . . 0.01 109.756 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.66 163.57 17.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.369 -0.832 . . . . 3.21 111.29 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.32 155.23 37.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.181 -1.044 . . . . 0.01 108.181 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.4 t -122.42 109.25 33.06 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.619 -0.882 . . . . 0.01 108.619 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.81 -34.11 2.55 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 CA-C-N 119.878 0.992 . . . . 0.01 111.44 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 p -139.07 106.79 5.62 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.459 -0.941 . . . . 0.02 108.459 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.51 -40.12 87.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.907 -0.496 . . . . 1.83 111.148 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.0 ttp -66.87 -37.6 84.73 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.921 -1.112 . . . . 1.34 110.039 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.31 -38.85 75.04 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.469 -1.395 . . . . 2.11 109.867 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.41 ' CD ' ' CE2' ' A' ' 121' ' ' PHE . 65.2 tt0 -80.74 -47.57 13.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.228 -0.92 . . . . 2.08 112.471 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.41 ' CE2' ' CD ' ' A' ' 120' ' ' GLN . 75.3 m-85 -111.69 -1.87 15.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.4 -0.812 . . . . 0.02 112.69 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.6 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 61.35 33.77 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.887 -1.133 . . . . 0.02 109.765 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.02 135.69 53.74 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.478 -0.763 . . . . 0.02 109.099 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -21.77 22.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.142 -0.974 . . . . 5.32 110.908 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 42.5 mt-10 -148.45 163.99 35.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.874 -1.141 . . . . 0.02 110.035 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 35.6 mm -129.57 126.68 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.548 -1.279 . . . . 2.17 107.548 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -110.36 -12.99 14.37 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.267 -0.896 . . . . 0.02 112.873 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 p -160.69 153.48 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.658 -1.276 . . . . 0.01 109.255 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.6 p -165.25 143.73 6.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.22 109.26 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -123.87 101.78 7.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.081 -1.012 . . . . 1.41 109.631 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.6 p . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 107.984 -1.117 . . . . 0.01 107.984 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.428 ' CD1' HG21 ' A' ' 131' ' ' VAL . 7.0 m95 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 106.247 -1.76 . . . . 0.01 106.247 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.51 133.98 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.483 -1.386 . . . . 1.69 109.408 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.51 141.4 45.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.56 -1.645 . . . . 2.49 106.56 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.457 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 33.4 m-85 -121.52 142.61 49.9 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.258 -0.901 . . . . 0.02 109.091 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 168' ' ' ALA . 9.9 tp10 -73.87 -30.17 62.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.547 -0.72 . . . . 0.02 110.975 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.9 154.81 48.31 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.851 -1.155 . . . . 1.48 108.932 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -57.08 167.96 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.174 1.25 . . . . 0.02 113.024 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 60.09 31.5 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.284 178.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.6 51.48 9.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.74 . . . . 0.02 111.038 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -126.91 164.89 20.44 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.521 -0.737 . . . . 0.02 110.241 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.61 -165.69 32.44 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.251 -1.14 . . . . 0.02 110.251 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.41 142.85 53.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.977 . . . . 0.02 108.712 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.43 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 5.4 mt-30 -112.32 147.77 35.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.657 -0.652 . . . . 0.02 110.074 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -123.83 133.43 53.79 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.731 -0.841 . . . . 0.01 108.731 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.19 121.53 39.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.926 -1.108 . . . . 0.01 109.913 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -96.48 140.78 30.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.371 -0.974 . . . . 0.01 108.371 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 154' ' ' LYS . 93.5 m-20 -104.29 -174.48 2.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.376 -0.828 . . . . 2.27 109.754 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 15.6 pttp -70.72 35.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 1.84 109.983 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 152' ' ' ASP . 50.6 mttp -113.85 173.18 6.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 2.28 109.22 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.67 130.67 52.66 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.391 -0.966 . . . . 0.01 108.391 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.05 111.54 23.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.11 -0.994 . . . . 0.01 109.817 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.514 ' CD ' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -92.75 -27.22 17.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.01 111.073 -177.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -123.12 153.71 64.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.813 -1.18 . . . . 2.54 107.813 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.16 -42.72 27.58 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 CA-C-N 119.246 0.766 . . . . 0.7 111.102 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -60.6 -18.98 17.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.725 -1.234 . . . . 0.86 109.439 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 57.4 t0 -65.72 -18.01 65.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.02 112.087 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.67 15.8 27.78 Favored 'General case' 0 N--CA 1.514 2.735 0 O-C-N 120.66 -1.275 . . . . 0.02 110.086 178.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.46 75.28 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.129 -0.982 . . . . 0.02 112.963 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.47 140.43 34.73 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.834 -1.392 . . . . 0.02 110.062 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.48 -7.1 59.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.706 . . . . 0.59 109.427 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -140.8 150.37 59.6 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.87 108.992 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -74.36 16.52 0.58 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.632 0.888 . . . . 0.38 111.915 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.36 120.31 25.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.026 -1.046 . . . . 0.18 110.759 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.3 mt -149.37 123.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.601 -2.0 . . . . 3.99 105.601 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -111.9 -14.05 13.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.233 -0.917 . . . . 5.17 113.251 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.1 t -156.24 158.68 37.96 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.257 -2.152 . . . . 0.02 109.965 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -152.9 154.49 35.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.164 -0.96 . . . . 2.02 110.569 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.457 ' NH2' ' OH ' ' A' ' 139' ' ' TYR . 87.1 mtm180 -143.3 148.35 36.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.01 109.946 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -85.96 142.78 28.56 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.388 -0.967 . . . . 0.01 108.388 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.96 126.57 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.967 -1.083 . . . . 3.04 109.764 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 177' ' ' GLU . 31.2 m -137.47 147.08 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 1.89 109.199 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' A' ' 176' ' ' VAL . 10.2 tt0 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 108.356 -0.979 . . . . 4.89 108.356 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 105.981 -2.848 . . . . 0.81 105.981 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.81 146.29 30.92 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.312 -0.947 . . . . 0.01 111.196 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -152.86 138.08 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.759 -0.848 . . . . 0.02 108.756 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.05 141.06 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.354 -0.61 . . . . 0.02 109.354 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -122.06 130.26 53.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.499 -0.751 . . . . 0.39 109.722 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -109.26 138.93 44.86 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.61 -0.885 . . . . 0.02 108.61 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.6 m-85 -122.36 139.0 54.33 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.353 -0.842 . . . . 0.02 109.802 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 10.1 mm-40 -69.19 -28.6 66.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.03 111.79 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -114.34 169.83 8.74 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.817 -1.177 . . . . 0.03 110.471 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.467 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 94.7 mtt180 -74.27 157.54 35.63 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.695 0.759 . . . . 0.03 110.02 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.5 m-80 65.97 35.56 6.39 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.74 110.995 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.8 p90 49.78 45.69 24.53 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.736 0.779 . . . . 0.02 111.414 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -113.01 166.49 11.36 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.132 -1.062 . . . . 0.02 108.132 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.08 -167.58 36.32 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 120.78 -1.2 . . . . 0.03 110.8 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' NH2' ' H ' ' A' ' 34' ' ' SER . 30.1 ttp180 -68.94 142.73 54.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.976 . . . . 2.76 109.196 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -120.78 148.68 43.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.649 0.737 . . . . 1.89 110.29 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -131.73 126.68 35.1 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.915 -1.143 . . . . 0.02 107.915 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -112.09 136.81 51.0 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 1.12 109.655 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.4 t -130.67 138.19 49.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.461 0.648 . . . . 0.02 109.565 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.466 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.2 m-20 -117.14 10.16 13.78 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.383 0.611 . . . . 0.2 109.398 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 46.1 m -158.42 174.56 14.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.02 -1.104 . . . . 1.23 108.02 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.3 p-10 -62.11 144.41 55.36 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.581 -1.324 . . . . 0.02 110.49 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -131.59 117.25 18.46 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.99 53.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.24 110.567 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 27.8 p-10 -154.11 100.86 2.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 1.14 108.682 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.41 9.27 35.77 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.226 1.012 . . . . 6.37 109.522 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.596 ' NH2' ' H ' ' A' ' 79' ' ' LEU . 10.7 mmt180 -59.25 -22.93 61.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 3.11 110.81 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -74.83 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.699 -1.25 . . . . 0.88 110.257 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -104.06 -21.87 13.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.02 109.387 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.473 HD11 ' HG2' ' A' ' 11' ' ' GLU . 10.7 tp -149.89 128.65 12.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.301 -0.875 . . . . 3.32 109.008 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.586 ' H ' ' NH2' ' A' ' 18' ' ' ARG . 82.9 p -85.85 -10.77 54.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.655 -0.653 . . . . 0.02 111.422 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.527 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 5.5 mtp180 -171.57 163.49 6.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.259 -1.385 . . . . 0.02 107.259 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 12.5 p -142.23 113.83 7.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.771 -1.205 . . . . 0.02 108.792 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 -105.53 -0.95 25.38 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.94 -1.1 . . . . 0.03 110.537 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 2.7 m -153.62 154.3 33.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 0.02 107.718 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.27 146.74 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.033 -1.042 . . . . 0.02 110.148 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 38.4 ttm180 -125.18 125.33 43.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.783 -1.192 . . . . 0.02 107.783 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.53 113.86 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.505 -1.665 . . . . 0.02 106.505 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.8 mp0 -83.54 -33.97 25.34 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.088 -0.645 . . . . 3.81 109.853 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 150.79 20.15 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.46 -1.829 . . . . 0.02 110.607 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 174.8 50.57 Favored Glycine 0 N--CA 1.486 1.997 0 C-N-CA 119.668 -1.253 . . . . 0.01 110.337 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 23.0 m -109.94 161.98 14.96 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.736 -1.579 . . . . 1.48 106.736 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 72.7 m95 -148.48 147.79 29.51 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.223 -1.548 . . . . 0.02 111.742 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.15 55.33 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.197 -2.149 . . . . 0.24 105.197 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' HD22 ' A' ' 79' ' ' LEU . 19.3 m -120.5 144.43 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.679 -0.638 . . . . 0.65 109.403 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -121.22 145.75 47.51 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.359 1.076 . . . . 0.02 110.047 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 3.1 tp10 -65.33 -34.35 78.13 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.613 -0.722 . . . . 0.02 110.909 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -123.0 158.52 57.27 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.232 -0.918 . . . . 0.02 109.462 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.6 166.93 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.521 1.481 . . . . 0.02 112.529 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 64.05 36.79 9.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.313 -0.858 . . . . 0.02 111.136 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 44.83 51.68 8.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.587 0.708 . . . . 3.39 110.586 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -126.78 164.23 21.81 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.261 0.553 . . . . 2.33 109.889 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.34 31.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.53 -1.428 . . . . 0.02 109.53 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -66.47 138.7 57.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.312 . . . . 0.02 109.985 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.5 ptm -118.66 137.29 53.4 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.34 0.59 . . . . 5.01 109.593 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.2 m-85 -132.06 138.06 48.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.524 -0.735 . . . . 0.02 109.459 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mm -94.74 131.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.742 -0.836 . . . . 1.72 108.742 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.8 mt -120.11 112.6 34.62 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.753 . . . . 0.02 110.857 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -78.31 169.04 20.75 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.006 1.038 . . . . 1.47 109.943 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.53 141.31 25.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.717 -1.239 . . . . 4.25 110.359 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.08 32.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.385 -1.388 . . . . 0.02 110.635 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -119.02 130.7 55.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.431 -1.041 . . . . 0.96 109.653 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CE1' HD22 ' A' ' 61' ' ' LEU . 89.7 m-85 -120.24 95.64 49.1 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 108.034 -1.098 . . . . 0.02 108.034 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 38' ' ' SER . 3.4 Cg_exo -66.24 -4.93 11.38 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.716 0.944 . . . . 0.02 113.416 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -157.31 154.05 28.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.65 -1.281 . . . . 2.02 107.925 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 23.1 p90 -60.46 -37.77 82.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.895 -0.722 . . . . 0.02 111.722 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 14.9 mm100 -60.78 -24.34 65.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.02 110.444 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -69.47 -18.34 63.7 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.444 -0.947 . . . . 3.42 108.444 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.62 10.83 29.01 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.363 -1.347 . . . . 0.02 107.363 -179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 59.39 21.68 10.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.639 0.733 . . . . 0.02 110.341 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.2 145.69 46.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.909 -1.677 . . . . 0.02 108.909 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -78.8 -30.98 45.78 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.639 -1.245 . . . . 0.98 107.639 178.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -157.38 -171.26 3.53 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.67 -1.604 . . . . 0.02 106.67 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 6.7 p30 -97.99 28.15 4.12 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.769 -1.207 . . . . 0.02 110.311 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.8 mtt-85 -97.86 123.01 41.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.226 -0.921 . . . . 3.2 111.122 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.596 ' H ' ' NH2' ' A' ' 30' ' ' ARG . 36.0 mt -144.04 120.83 11.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.918 -1.512 . . . . 2.61 106.918 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.42 -16.56 14.24 Favored Glycine 0 N--CA 1.502 3.047 0 O-C-N 121.264 -0.897 . . . . 0.02 112.079 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 44.4 t -156.38 155.64 32.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.402 -1.646 . . . . 0.02 109.978 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 48' ' ' VAL . 29.3 t -145.04 148.23 33.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.02 109.781 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 44.3 mtm180 -134.17 139.28 45.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.843 . . . . 0.01 109.123 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' ' CH2' ' A' ' 46' ' ' TRP . . . -77.51 131.9 38.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.207 -1.034 . . . . 0.43 108.207 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.52 124.55 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.917 -0.771 . . . . 1.25 108.917 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -91.88 135.68 33.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.167 -0.958 . . . . 1.77 108.967 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -97.63 138.46 34.99 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.17 -0.678 . . . . 1.63 109.17 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 p -112.23 126.42 55.21 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.828 -0.804 . . . . 1.08 108.828 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 p -102.86 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.233 -1.766 . . . . 1.26 106.233 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.21 -49.79 0.83 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.387 -1.445 . . . . 0.01 112.527 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.7 -99.93 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 118.31 -1.9 . . . . 0.01 112.238 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.33 119.98 33.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.197 -1.178 . . . . 4.43 110.802 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.29 130.1 36.74 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.918 -0.713 . . . . 2.99 109.104 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -129.75 138.77 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.817 -0.809 . . . . 6.36 108.817 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.53 144.47 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.294 -0.879 . . . . 1.09 109.891 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.618 ' NE2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -121.77 133.64 54.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.348 -1.352 . . . . 2.05 107.348 176.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.2 m -122.85 145.62 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.736 -1.228 . . . . 1.1 109.141 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 41.2 m-85 -119.57 141.1 49.56 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.125 0.964 . . . . 0.73 111.127 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.77 -29.28 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.697 -0.683 . . . . 0.02 111.485 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -116.36 170.16 8.75 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.125 -0.984 . . . . 3.18 110.492 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.0 165.49 53.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 29.0 t0 57.16 38.27 28.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.01 111.354 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.08 54.26 11.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.62 -0.675 . . . . 0.01 111.282 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -129.51 166.38 19.77 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.165 -1.05 . . . . 3.15 108.165 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.31 -164.98 28.6 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.122 -1.591 . . . . 0.01 109.122 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.09 143.94 43.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.999 -1.295 . . . . 0.01 108.373 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 107' ' ' MET . 8.8 tmm? -117.15 142.76 46.61 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.669 0.747 . . . . 0.01 110.147 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.438 ' N ' ' SD ' ' A' ' 107' ' ' MET . 38.7 m-85 -130.63 135.12 47.55 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.56 -1.274 . . . . 2.48 107.56 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -119.67 135.47 54.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.558 -0.714 . . . . 0.01 110.12 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 t -150.51 153.0 35.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.461 1.124 . . . . 1.69 111.322 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 p -110.72 9.38 22.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.27 -0.877 . . . . 0.01 109.592 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -121.25 163.74 18.08 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.445 -0.785 . . . . 3.21 111.331 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.86 155.06 39.36 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.01 108.324 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.77 111.67 27.4 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.7 -0.852 . . . . 0.01 108.7 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.67 -31.99 3.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.998 1.035 . . . . 0.01 111.876 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -140.29 108.37 5.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.02 109.074 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.04 -40.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.894 -0.504 . . . . 1.83 110.57 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.6 tmm? -66.72 -37.81 85.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.001 -1.08 . . . . 1.34 110.052 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -69.98 -38.57 76.08 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.479 -1.388 . . . . 2.11 109.403 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 52.7 tt0 -80.79 -47.48 13.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.08 112.424 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.487 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.0 m-85 -110.83 -1.92 16.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.366 -0.834 . . . . 0.02 112.574 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.33 34.14 18.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.713 -1.242 . . . . 0.02 109.436 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.4 135.92 53.57 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.426 -0.796 . . . . 0.02 109.373 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -88.66 -21.35 24.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.26 -0.9 . . . . 5.32 110.589 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.11 165.04 32.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.932 -1.105 . . . . 0.02 110.198 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mm -127.39 123.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.494 -1.299 . . . . 2.17 107.494 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -108.34 -13.29 14.91 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.133 -0.979 . . . . 0.02 112.132 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 p -160.45 152.5 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.983 -1.073 . . . . 0.01 108.927 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.472 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.3 t -167.66 144.04 4.16 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.545 -0.909 . . . . 1.22 108.545 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 41.5 tttm -122.45 110.23 15.35 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.38 1.086 . . . . 1.41 109.473 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 131' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 107.442 -1.318 . . . . 0.01 107.442 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 7.5 m95 . . . . . 0 N--CA 1.506 2.365 0 N-CA-C 107.614 -1.254 . . . . 0.01 107.614 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.471 ' CG1' HD11 ' A' ' 175' ' ' ILE . 38.9 mt -119.82 135.75 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.636 -1.29 . . . . 1.69 110.089 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -111.06 142.39 43.28 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.819 -1.919 . . . . 2.49 105.819 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 18.1 m-85 -123.17 144.17 49.53 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.091 -1.006 . . . . 0.02 109.842 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 25.8 tt0 -74.2 -30.88 62.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.727 -0.608 . . . . 0.02 111.68 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.73 154.54 48.06 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.698 -1.251 . . . . 1.48 108.995 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.04 167.54 2.37 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.257 1.304 . . . . 0.02 112.747 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.8 t30 59.33 31.25 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.457 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.53 51.52 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.02 111.07 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.4 164.72 20.49 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.513 -0.742 . . . . 0.02 109.848 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.67 33.65 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.063 -1.215 . . . . 0.02 110.063 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -69.68 142.31 53.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.595 -0.944 . . . . 0.02 108.892 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.418 ' O ' ' CG ' ' A' ' 58' ' ' MET . 13.1 mt-30 -113.77 149.22 35.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.344 0.593 . . . . 0.02 109.78 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -123.62 133.99 53.85 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.41 123.37 40.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.857 -1.152 . . . . 0.01 109.916 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -95.35 135.38 37.04 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.971 -1.122 . . . . 0.01 107.971 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -106.19 -167.67 1.33 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.731 -0.606 . . . . 2.27 110.312 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -79.6 34.46 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.576 -0.702 . . . . 1.84 109.921 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -111.92 172.17 7.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.445 -0.785 . . . . 2.28 109.373 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -104.38 121.28 43.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.273 -1.01 . . . . 0.01 108.273 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.03 113.48 25.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.272 -0.892 . . . . 0.01 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.39 17.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.129 -0.982 . . . . 0.01 110.706 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -123.94 155.66 66.85 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.066 -1.086 . . . . 2.54 108.066 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.5 Cg_endo -61.41 -40.83 45.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.032 0.69 . . . . 0.7 110.764 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.76 -18.82 19.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 120.905 -1.122 . . . . 0.86 109.295 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 49.1 t0 -65.92 -18.56 65.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.872 -1.143 . . . . 0.02 111.902 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -102.27 15.09 30.18 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 120.886 -1.134 . . . . 0.02 109.979 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.43 10.62 73.5 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.301 -0.874 . . . . 0.02 113.119 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.25 140.76 35.11 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.744 -1.445 . . . . 0.02 110.18 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.54 -7.1 59.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 0.59 110.168 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.3 p -141.41 150.36 57.66 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.87 109.768 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -75.29 14.94 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 120.913 1.075 . . . . 0.38 111.817 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 122.64 27.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.306 1.051 . . . . 0.18 111.014 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mp -152.56 123.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.189 -1.782 . . . . 3.99 106.189 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 140' ' ' GLU . 3.6 mp0 -111.39 -11.56 14.12 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.524 -0.735 . . . . 5.17 112.312 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -156.4 158.74 37.87 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 119.311 -2.118 . . . . 0.02 109.755 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.86 153.38 34.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.274 -0.891 . . . . 2.02 110.219 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -144.0 149.32 36.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.32 -0.862 . . . . 0.01 109.942 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.02 140.56 29.44 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.363 -0.976 . . . . 0.01 108.363 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.471 HD11 ' CG1' ' A' ' 137' ' ' ILE . 45.8 mt -93.89 129.99 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.2 -0.937 . . . . 3.04 109.222 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.46 148.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.475 -0.765 . . . . 1.89 109.62 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 4.89 109.564 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.64 0 N-CA-C 106.982 -2.447 . . . . 0.81 106.982 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 148.96 32.71 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.524 -1.03 . . . . 0.01 110.524 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -153.29 138.1 17.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.442 -1.034 . . . . 0.02 108.621 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 8.1 tt -130.59 142.42 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.356 -0.609 . . . . 0.02 109.356 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -122.29 129.81 52.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.424 -0.797 . . . . 0.39 109.512 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.29 138.47 44.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.565 -0.902 . . . . 0.02 108.565 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 80.3 m-85 -121.6 138.84 54.15 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.212 -0.93 . . . . 0.02 109.769 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.65 -28.28 66.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.489 -0.757 . . . . 0.03 111.61 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -114.66 169.96 8.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.962 -1.086 . . . . 0.03 110.394 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.44 158.67 32.32 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.687 0.756 . . . . 0.03 109.995 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' ND2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER 66.47 34.61 6.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.845 0.831 . . . . 0.74 110.776 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CZ ' ' ND2' ' A' ' 14' ' ' ASN . 16.4 p90 50.07 44.9 25.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.301 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -113.01 165.7 12.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.107 -1.071 . . . . 0.02 108.107 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.57 -168.14 34.42 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.706 -1.235 . . . . 0.03 110.927 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.04 143.43 54.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.505 -0.997 . . . . 2.76 109.152 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' ' OD1' ' A' ' 21' ' ' ASP . 34.0 ttp180 -119.55 148.7 43.0 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.646 0.736 . . . . 1.89 110.392 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -132.09 126.23 33.26 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.887 -1.153 . . . . 0.02 107.887 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.488 ' OD1' ' NE ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.7 137.64 51.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.607 -0.683 . . . . 1.12 109.751 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.08 139.67 48.59 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.591 0.71 . . . . 0.02 109.47 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 3.4 m-20 -116.09 11.93 15.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.394 -0.595 . . . . 0.2 109.394 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 p -158.29 174.47 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.127 -1.064 . . . . 1.23 108.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.99 144.65 54.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.729 -1.232 . . . . 0.02 110.27 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -131.47 116.41 17.44 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.522 -0.918 . . . . 0.02 108.522 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.54 -21.63 55.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.24 110.767 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -157.34 101.57 1.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.075 -1.016 . . . . 1.14 108.577 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.8 p90 -105.13 9.95 34.05 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.254 1.026 . . . . 6.37 110.002 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -59.91 -23.45 63.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.563 -0.711 . . . . 3.11 110.954 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p -76.05 -16.68 59.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.647 -1.283 . . . . 0.88 110.31 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -102.55 -21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.399 -0.813 . . . . 0.02 108.901 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -150.49 129.23 12.38 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.683 -0.858 . . . . 3.32 108.683 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -86.32 -9.81 55.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.847 -0.533 . . . . 0.02 110.846 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -170.49 161.61 7.9 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.16 113.52 8.08 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.643 -1.285 . . . . 0.02 109.094 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -107.45 -3.35 19.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.03 110.647 -178.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -154.24 153.49 31.81 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.301 -1.0 . . . . 0.02 108.301 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.35 147.71 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.951 -1.093 . . . . 0.02 110.244 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -125.02 125.68 44.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.953 -1.128 . . . . 0.02 107.953 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.16 114.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.948 -1.501 . . . . 0.02 106.948 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -84.16 -34.52 24.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.484 -0.76 . . . . 3.81 109.812 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.57 18.22 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.674 -1.727 . . . . 0.02 110.402 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.88 173.74 49.94 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.528 -1.32 . . . . 0.01 109.893 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.4 m -120.66 138.05 54.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.803 -1.184 . . . . 1.48 107.803 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -127.25 154.36 44.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.691 1.234 . . . . 0.02 111.907 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.59 51.58 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.619 -2.363 . . . . 0.24 104.619 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.1 m -116.54 142.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.65 109.005 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 18.2 m-85 -119.42 141.35 49.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.021 0.915 . . . . 0.02 109.351 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.512 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 10.0 tp10 -64.3 -34.16 77.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.571 -0.74 . . . . 0.02 111.671 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -124.08 156.59 65.94 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.025 -1.047 . . . . 0.02 109.707 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.45 165.7 0.97 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.634 1.556 . . . . 0.02 112.984 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.608 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 64.97 37.49 6.86 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.72 0.771 . . . . 0.02 111.261 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 45.21 50.89 9.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.457 0.646 . . . . 3.39 110.785 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.5 p -126.97 164.55 21.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.2 0.524 . . . . 2.33 110.134 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.25 -162.34 30.8 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.997 -1.241 . . . . 0.02 109.997 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 13.9 t-80 -62.34 143.25 57.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.03 -1.276 . . . . 0.02 110.635 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.498 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 36.5 mtp -116.32 134.58 54.73 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.514 -0.55 . . . . 5.01 109.514 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.663 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 33.7 m-85 -136.02 134.89 38.98 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.289 -0.882 . . . . 0.02 109.205 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -96.97 131.96 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.527 -0.733 . . . . 1.72 109.114 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 66' ' ' TYR . 22.9 mt -122.8 111.37 31.14 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.414 -0.804 . . . . 0.02 110.784 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.19 171.2 18.55 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 119.924 1.009 . . . . 1.47 110.181 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.04 140.46 20.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 4.25 110.114 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.65 32.83 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.452 -1.356 . . . . 0.02 110.626 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.5 tp10 -119.14 130.32 55.49 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.294 -1.121 . . . . 0.96 109.278 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.512 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 84.5 m-85 -120.7 97.76 48.34 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.796 -1.187 . . . . 0.02 107.796 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.63 -5.47 17.12 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 120.582 0.855 . . . . 0.02 113.929 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -154.03 154.09 33.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.503 -1.373 . . . . 2.02 107.864 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -60.67 -38.23 84.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.737 . . . . 0.02 111.719 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.74 -23.94 63.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.983 -1.073 . . . . 0.02 109.9 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.82 -18.54 62.73 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.112 0.958 . . . . 3.42 108.432 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.663 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.38 9.7 31.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.245 -1.391 . . . . 0.02 107.245 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.4 mpp? 58.93 22.16 10.0 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.568 0.699 . . . . 0.02 110.304 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.26 143.61 45.94 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.258 -1.537 . . . . 0.02 109.258 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -77.75 -29.55 51.12 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.179 -1.415 . . . . 0.98 107.179 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.2 p-10 -156.43 -171.33 3.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.118 -1.808 . . . . 0.02 106.118 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -98.47 28.62 4.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.667 -1.271 . . . . 0.02 110.381 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.3 OUTLIER -96.49 122.4 39.36 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.806 -1.184 . . . . 3.2 110.709 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.6 mt -144.35 120.58 10.85 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.869 -1.16 . . . . 2.61 107.869 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.7 10.55 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 121.295 -0.878 . . . . 0.02 112.756 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 66.1 m -154.58 155.82 35.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 119.99 -1.888 . . . . 0.02 111.209 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -144.4 146.76 32.68 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.453 0.644 . . . . 0.02 109.914 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -135.94 140.04 43.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -0.77 . . . . 0.01 108.981 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.03 132.83 36.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.255 -0.903 . . . . 0.43 109.286 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.84 123.38 42.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.445 -0.946 . . . . 1.25 108.445 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -89.56 134.73 33.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.832 -1.173 . . . . 1.77 107.832 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.21 139.51 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.739 -0.601 . . . . 1.63 109.631 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -111.61 123.35 50.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.754 -1.202 . . . . 1.08 107.754 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -115.05 133.88 55.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.749 -1.219 . . . . 1.26 107.971 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.88 -45.86 0.02 OUTLIER Glycine 0 N--CA 1.502 3.079 0 C-N-CA 117.669 -2.205 . . . . 0.01 113.777 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.74 -102.98 0.17 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.432 2.116 . . . . 0.01 111.129 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -119.54 118.23 30.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.284 -1.127 . . . . 4.43 110.159 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.07 130.45 39.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.97 -0.692 . . . . 2.99 109.258 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -131.31 136.87 48.5 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.055 -0.72 . . . . 6.36 109.055 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 tt -128.28 145.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.528 -0.733 . . . . 1.09 109.333 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.51 132.88 54.96 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.812 -1.181 . . . . 2.05 107.812 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 20.1 m -122.89 145.42 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.785 -1.197 . . . . 1.1 109.229 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.95 140.58 49.52 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.059 0.933 . . . . 0.73 110.878 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.81 -29.37 69.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.83 -0.623 . . . . 0.02 111.654 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -117.78 168.65 10.27 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.101 -0.999 . . . . 3.18 110.453 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.32 169.31 28.68 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.935 -0.866 . . . . 0.01 110.935 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 51.91 39.36 25.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.743 0.782 . . . . 0.01 111.218 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 51.88 51.63 16.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.558 -0.714 . . . . 0.01 110.853 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -124.86 165.98 17.08 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.462 -0.94 . . . . 3.15 108.462 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.28 -165.31 27.6 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -74.29 144.65 44.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.081 -1.246 . . . . 0.01 108.239 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 19.0 tmm? -116.01 142.89 46.2 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.642 0.734 . . . . 0.01 109.773 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.422 ' N ' ' SD ' ' A' ' 107' ' ' MET . 63.5 m-85 -131.87 136.13 47.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.068 -1.086 . . . . 2.48 108.068 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -120.13 135.2 55.04 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.589 -0.694 . . . . 0.01 110.052 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -149.49 151.86 34.65 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.249 1.023 . . . . 1.69 111.016 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -111.32 9.21 21.59 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.606 -0.724 . . . . 0.01 110.006 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 5.3 mp0 -120.52 162.87 18.84 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.29 -0.881 . . . . 3.21 111.282 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 173' ' ' ARG . 5.4 p-10 -67.9 156.89 36.2 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.239 -1.023 . . . . 0.01 108.239 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . 0.456 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 43.0 t -125.84 112.08 24.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.745 -0.835 . . . . 0.01 108.745 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.3 -31.42 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.1 1.071 . . . . 0.01 111.197 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 t -140.34 106.97 5.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.583 -0.895 . . . . 0.02 108.583 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.23 -39.47 85.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.765 -0.584 . . . . 1.83 110.808 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 ttm -66.53 -37.42 84.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.881 -1.127 . . . . 1.34 109.98 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.15 -39.17 75.53 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.525 -1.36 . . . . 2.11 109.798 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.456 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 9.4 tt0 -80.62 -47.0 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 2.08 112.473 -177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -111.25 -1.24 16.16 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.37 -0.831 . . . . 0.02 112.695 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m170 61.44 34.09 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.747 -1.221 . . . . 0.02 109.775 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -114.09 135.92 53.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.478 -0.764 . . . . 0.02 109.305 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.681 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.33 -22.08 21.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.175 -0.953 . . . . 5.32 110.743 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.58 164.52 34.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.94 -1.1 . . . . 0.02 109.932 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 mm -129.12 124.72 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.629 -1.249 . . . . 2.17 107.629 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.6 m80 -110.04 -14.43 14.23 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.02 112.633 -177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.9 m -159.36 151.48 20.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.808 -1.183 . . . . 0.01 108.806 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -171.42 147.38 2.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.337 -0.852 . . . . 1.22 108.766 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -117.31 108.05 15.13 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.498 1.142 . . . . 1.41 108.724 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 11.9 p . . . . . 0 C--N 1.3 -1.572 0 N-CA-C 107.396 -1.335 . . . . 0.01 107.396 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 74.4 m95 . . . . . 0 N--CA 1.508 2.426 0 CA-C-O 121.485 0.66 . . . . 0.01 109.985 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.12 137.7 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.305 -0.998 . . . . 1.69 108.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.42 141.45 43.48 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.137 -1.431 . . . . 2.49 107.137 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.486 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 25.9 m-85 -121.92 142.43 50.28 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.26 -0.9 . . . . 0.02 109.337 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.85 -30.08 62.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.02 111.551 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -116.17 154.96 48.7 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.801 -1.187 . . . . 1.48 108.858 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.02 166.91 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.146 1.231 . . . . 0.02 113.031 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.09 31.62 20.65 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.096 -0.956 . . . . 0.75 111.36 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.31 51.5 9.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.02 111.045 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.474 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.42 165.7 19.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.515 -0.741 . . . . 0.02 109.996 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.17 -165.93 34.74 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.248 -1.141 . . . . 0.02 110.248 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -68.67 141.65 55.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.989 . . . . 0.02 108.917 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.486 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 17.7 mt-30 -113.97 149.41 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.02 109.969 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.19 133.42 53.55 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.707 -0.849 . . . . 0.01 108.707 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.99 121.57 36.75 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.01 109.292 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 138' ' ' PHE . 18.2 mt -96.76 139.72 32.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -108.93 -168.48 1.35 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 2.27 109.514 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -80.33 40.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.84 109.403 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -113.56 168.02 10.11 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 2.28 109.42 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -102.57 120.59 40.81 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.451 -0.944 . . . . 0.01 108.451 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -98.01 114.38 26.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.347 -0.846 . . . . 0.01 110.308 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -92.72 -25.66 18.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.01 110.854 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -124.66 153.48 70.02 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 107.953 -1.129 . . . . 2.54 107.953 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.5 Cg_endo -60.55 -39.84 61.56 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.623 0.901 . . . . 0.7 110.661 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.39 -19.08 17.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 120.78 -1.2 . . . . 0.86 109.39 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.75 -18.32 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.868 -1.145 . . . . 0.02 112.039 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -102.5 15.48 29.12 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.859 -1.151 . . . . 0.02 110.079 178.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.05 10.98 74.02 Favored Glycine 0 N--CA 1.497 2.757 0 O-C-N 121.185 -0.947 . . . . 0.02 113.027 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.24 140.45 35.52 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.727 -1.455 . . . . 0.02 110.276 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.54 -6.98 59.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.546 -0.721 . . . . 0.59 110.062 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.0 m -140.25 150.07 60.19 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.061 -1.025 . . . . 0.87 109.747 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.94 14.63 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.815 1.01 . . . . 0.38 111.947 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 121.18 26.22 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.329 1.061 . . . . 0.18 110.847 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 mt -149.27 123.92 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.677 -1.972 . . . . 3.99 105.677 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.82 -13.62 13.17 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.167 -0.958 . . . . 5.17 113.138 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.5 t -157.6 160.76 38.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.153 -2.217 . . . . 0.02 110.192 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.13 152.95 32.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.529 -0.732 . . . . 2.02 109.807 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 144' ' ' TYR . 7.5 mmt180 -144.4 150.4 37.65 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.808 0.813 . . . . 0.01 110.194 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -88.23 143.87 26.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.471 -0.768 . . . . 0.01 109.04 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.89 129.42 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.438 -0.789 . . . . 3.04 109.205 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.5 t -136.01 146.61 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.209 -0.932 . . . . 1.89 109.57 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 4.89 109.209 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.778 0 N-CA-C 106.926 -2.47 . . . . 0.81 106.926 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 149.36 33.55 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.721 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.513 ' NZ ' ' OD1' ' A' ' 23' ' ' ASP . 56.0 tttp -149.19 136.36 19.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.994 . . . . 0.02 109.633 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.38 138.92 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.151 -0.685 . . . . 0.02 109.151 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -121.49 130.32 53.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.524 -0.735 . . . . 0.39 109.985 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 22.7 m-85 -109.91 139.75 44.65 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.148 -0.686 . . . . 0.02 109.148 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.7 m-85 -122.42 138.44 54.54 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.249 -0.907 . . . . 0.02 109.563 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -70.19 -27.5 64.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.03 111.949 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.57 ' C ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-20 -114.16 169.27 9.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.729 -1.232 . . . . 0.03 110.14 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.43 157.19 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.639 0.733 . . . . 0.03 110.419 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.5 m-20 66.75 34.26 5.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.045 0.926 . . . . 0.74 111.441 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.7 m-85 55.53 42.59 29.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.293 0.568 . . . . 0.02 111.323 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -113.56 166.51 11.45 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.467 -0.938 . . . . 0.02 108.467 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.24 -167.72 36.17 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.89 -1.148 . . . . 0.03 110.901 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.427 HH21 ' H ' ' A' ' 34' ' ' SER . 39.8 ttp180 -70.33 142.9 52.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.972 . . . . 2.76 108.984 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -120.23 148.99 42.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.574 -0.704 . . . . 1.89 110.294 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -131.23 126.3 35.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.729 -1.211 . . . . 0.02 107.729 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.43 137.15 51.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.456 -0.778 . . . . 1.12 109.701 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.43 138.03 48.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.5 0.667 . . . . 0.02 109.621 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD1' ' NZ ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -117.18 10.34 13.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.2 109.447 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.9 p -158.19 174.45 15.16 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.41 143.13 56.36 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.682 -1.261 . . . . 0.02 110.456 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.1 t -131.43 117.25 18.59 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.67 -25.68 49.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.24 110.857 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -154.5 100.77 2.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.874 -1.141 . . . . 1.14 108.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -105.4 9.84 33.57 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.05 0.929 . . . . 6.37 109.641 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -57.89 -24.06 55.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.683 -0.636 . . . . 3.11 110.612 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 p -73.93 -16.92 61.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.805 -1.185 . . . . 0.88 109.905 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.51 -22.29 13.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.02 109.5 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.0 tp -148.56 125.99 11.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.042 -1.036 . . . . 3.32 109.52 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.427 ' H ' HH21 ' A' ' 18' ' ' ARG . 71.0 m -86.26 -10.77 53.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.625 -0.672 . . . . 0.02 111.461 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 30.7 ttt180 -170.5 160.45 7.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.816 -1.179 . . . . 0.02 107.816 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.1 p -141.94 113.09 7.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.86 -1.15 . . . . 0.02 108.728 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.792 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -109.09 2.91 21.45 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.797 -1.189 . . . . 0.03 110.189 -179.398 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -155.52 152.59 29.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.66 -1.237 . . . . 0.02 107.66 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 39' ' ' ILE . 10.4 mt -146.49 147.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.02 110.119 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -124.71 125.5 44.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.78 114.22 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.779 -1.563 . . . . 0.02 106.779 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.75 -34.08 27.24 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.2 -0.6 . . . . 3.81 110.408 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.33 151.47 21.07 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 119.081 -1.533 . . . . 0.02 110.33 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 174.46 50.01 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.543 -1.313 . . . . 0.01 110.085 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.435 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m -110.04 161.18 15.78 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.021 -1.474 . . . . 1.48 107.021 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.435 ' CD1' ' C ' ' A' ' 45' ' ' THR . 67.3 m95 -148.0 147.71 29.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.198 -1.564 . . . . 0.02 111.505 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.07 54.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 105.43 -2.063 . . . . 0.24 105.43 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.3 m -117.83 142.29 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.503 -0.748 . . . . 0.65 109.406 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 42.4 m-85 -121.56 144.64 48.61 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.952 0.882 . . . . 0.02 109.676 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.66 -34.99 79.07 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.501 -0.772 . . . . 0.02 111.722 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.06 163.59 42.78 Favored Pre-proline 0 N--CA 1.509 2.516 0 O-C-N 120.91 -1.119 . . . . 0.02 109.105 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.14 168.06 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.42 1.414 . . . . 0.02 113.359 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 63.22 36.89 11.6 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.082 -0.963 . . . . 0.02 112.121 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 44.78 52.0 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.675 0.75 . . . . 3.39 111.017 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 m -126.58 163.98 22.23 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.239 0.542 . . . . 2.33 109.704 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.24 -161.31 32.69 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.538 -1.425 . . . . 0.02 109.538 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.638 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.1 t-80 -69.72 137.98 52.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.993 -1.298 . . . . 0.02 109.946 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 19.0 ptm -119.16 136.47 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.333 -0.617 . . . . 5.01 109.333 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 93.7 m-85 -128.28 139.51 52.38 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.914 -0.773 . . . . 0.02 108.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.95 131.83 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.2 mt -120.81 112.79 33.47 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.407 -0.808 . . . . 0.02 110.696 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.17 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.047 1.052 . . . . 1.47 110.096 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.614 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.2 pm0 -53.25 140.48 26.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.778 -1.201 . . . . 4.25 110.221 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.19 33.08 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.377 . . . . 0.02 110.438 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -119.25 130.18 55.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.325 -1.103 . . . . 0.96 109.635 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE1' HD22 ' A' ' 61' ' ' LEU . 84.5 m-85 -120.82 96.8 48.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.96 -4.1 11.8 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 120.74 0.96 . . . . 0.02 113.756 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -157.68 155.02 29.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.671 -1.268 . . . . 2.02 108.256 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -60.29 -38.95 85.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.02 111.851 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.02 110.544 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.614 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.91 -18.6 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.187 0.994 . . . . 3.42 108.581 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.566 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -106.87 9.94 30.75 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.386 -1.339 . . . . 0.02 107.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.0 mtt 60.55 21.32 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.475 0.655 . . . . 0.02 110.401 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.05 45.92 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.112 -1.595 . . . . 0.02 109.112 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.13 -29.52 48.86 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.438 -1.319 . . . . 0.98 107.438 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -157.17 -171.71 3.73 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.523 -1.658 . . . . 0.02 106.523 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.522 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 87.4 m-20 -97.66 27.91 4.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.673 -1.267 . . . . 0.02 110.289 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.1 OUTLIER -98.52 123.49 42.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.882 . . . . 3.2 111.655 -178.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.5 mt -143.25 121.05 11.92 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.912 -1.514 . . . . 2.61 106.912 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.25 -16.99 13.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.185 -0.947 . . . . 0.02 111.981 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -155.02 154.82 33.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.397 -1.649 . . . . 0.02 110.372 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.32 147.04 32.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.02 109.953 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -134.57 140.03 45.82 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 0.01 108.814 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.07 131.77 38.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.998 -1.112 . . . . 0.43 107.998 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.0 t -91.71 123.98 44.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 7.8 m170 -91.66 136.23 33.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.981 -1.075 . . . . 1.77 108.744 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.64 137.0 38.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.378 -0.971 . . . . 1.63 108.378 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -110.8 126.29 54.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.437 -0.949 . . . . 1.08 108.437 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -103.71 -154.96 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.348 -1.723 . . . . 1.26 106.348 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.38 -48.1 0.93 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.506 -1.371 . . . . 0.01 112.178 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.78 -99.85 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.484 -1.817 . . . . 0.01 111.936 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.48 HE21 HG21 ' A' ' 111' ' ' THR . 46.3 tt0 -121.54 119.24 31.37 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.342 -1.093 . . . . 4.43 110.504 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 129.28 35.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.988 -0.745 . . . . 2.99 108.988 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.08 140.37 50.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.421 -0.799 . . . . 6.36 109.15 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 tt -129.97 145.17 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.831 . . . . 1.09 109.859 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.67 134.76 54.97 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.431 -1.322 . . . . 2.05 107.431 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.91 147.25 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.831 -1.168 . . . . 1.1 109.531 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.0 m-85 -119.64 141.66 49.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.123 0.963 . . . . 0.73 111.032 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -66.24 -29.2 69.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.694 -0.685 . . . . 0.02 111.369 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -116.41 169.59 9.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.162 -0.961 . . . . 3.18 110.459 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.97 165.07 51.28 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.898 -0.881 . . . . 0.01 110.898 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.95 38.03 29.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.833 -0.804 . . . . 0.01 111.349 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 51.83 54.99 9.96 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.632 -0.667 . . . . 0.01 111.494 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -128.77 165.61 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.955 -1.128 . . . . 3.15 107.955 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.91 -164.36 28.72 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.214 -1.554 . . . . 0.01 109.214 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 39.8 tt0 -75.35 144.12 42.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.012 -1.287 . . . . 0.01 108.748 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.75 143.17 45.98 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.601 0.715 . . . . 0.01 109.96 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 24.1 m-85 -131.39 135.71 47.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.937 -1.135 . . . . 2.48 107.937 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.2 tm-20 -118.36 134.59 54.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.809 -0.557 . . . . 0.01 109.757 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.7 t -149.48 150.29 32.1 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 1.69 110.911 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.48 HG21 HE21 ' A' ' 92' ' ' GLN . 46.7 p -109.6 9.95 25.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.51 -0.768 . . . . 0.01 109.863 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -121.43 163.64 18.41 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.429 -0.794 . . . . 3.21 111.438 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.46 155.37 37.75 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.199 -1.037 . . . . 0.01 108.199 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.8 t -122.17 110.79 32.51 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.28 -32.9 2.8 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.846 0.981 . . . . 0.01 111.584 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.1 t -141.69 107.04 5.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.011 -1.056 . . . . 0.02 108.732 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -64.35 -39.76 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.896 -0.503 . . . . 1.83 111.087 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.38 -37.66 85.77 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.936 -1.105 . . . . 1.34 109.888 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -70.16 -39.02 75.56 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.549 -1.344 . . . . 2.11 109.684 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.31 -48.21 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -0.961 . . . . 2.08 112.612 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.99 -1.09 15.52 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.367 -0.833 . . . . 0.02 112.612 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . 0.533 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 5.8 m80 62.04 34.36 16.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.816 -1.178 . . . . 0.02 109.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 mt -114.86 135.83 53.76 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.505 -0.747 . . . . 0.02 109.514 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.672 ' HE ' ' N ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.45 -21.28 23.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.123 -0.985 . . . . 5.32 110.86 -179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.0 mt-10 -148.99 164.3 34.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.943 -1.098 . . . . 0.02 110.015 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.7 mm -129.44 126.16 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.403 -1.332 . . . . 2.17 107.403 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -109.2 -12.72 14.77 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.267 -0.896 . . . . 0.02 112.693 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -159.52 153.13 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.679 -1.263 . . . . 0.01 108.829 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 21.8 p -167.4 142.97 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 1.22 109.399 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -124.44 106.92 10.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.464 1.126 . . . . 1.41 109.834 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 136' ' ' TRP . 7.2 p . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 107.575 -1.268 . . . . 0.01 107.575 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 131' ' ' VAL . 6.7 m95 . . . . . 0 N--CA 1.501 2.087 0 N-CA-C 106.574 -1.639 . . . . 0.01 106.574 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.74 134.24 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.577 -1.327 . . . . 1.69 109.713 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -111.33 142.45 43.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.307 -1.738 . . . . 2.49 106.307 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.475 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 30.9 m-85 -122.37 142.51 50.44 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.133 -0.979 . . . . 0.02 109.431 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 9.9 tp10 -75.04 -30.27 61.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.673 -0.642 . . . . 0.02 111.709 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.9 mt -114.47 152.77 46.44 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 120.66 -1.275 . . . . 1.48 109.054 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.49 165.98 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 120.81 1.007 . . . . 0.02 112.757 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 31.6 20.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.395 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 58.05 51.87 8.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.495 -0.753 . . . . 0.02 111.52 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.36 166.1 18.49 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.393 -0.817 . . . . 0.02 110.097 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.29 -165.42 34.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.064 -1.214 . . . . 0.02 110.064 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -69.66 142.91 53.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.976 . . . . 0.02 108.927 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 20.9 mt-30 -113.85 148.97 35.74 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.255 0.55 . . . . 0.02 109.727 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -123.69 133.21 53.92 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.14 122.01 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.819 -1.176 . . . . 0.01 109.255 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -96.25 146.48 24.68 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.01 108.677 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 154' ' ' LYS . 9.0 m-20 -105.58 -169.18 1.55 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.453 -0.78 . . . . 2.27 109.684 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.16 31.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 1.84 109.583 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 152' ' ' ASP . 19.5 mtpp -111.7 171.31 7.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.335 -0.853 . . . . 2.28 109.153 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.05 133.62 48.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.196 -1.039 . . . . 0.01 108.196 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.22 115.01 28.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.01 110.239 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -90.57 -28.38 18.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.736 -0.602 . . . . 0.01 110.958 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -123.38 154.31 65.75 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.739 -1.208 . . . . 2.54 107.739 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -62.01 -41.84 33.97 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 119.207 0.752 . . . . 0.7 111.209 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.87 -19.41 19.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.79 -1.193 . . . . 0.86 109.707 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 56.2 t0 -65.92 -18.5 65.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.802 -1.187 . . . . 0.02 112.034 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.26 15.9 27.29 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.725 -1.235 . . . . 0.02 110.171 178.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.89 10.16 76.2 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.115 -0.99 . . . . 0.02 113.035 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.53 140.83 34.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.819 -1.401 . . . . 0.02 110.185 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.06 -7.05 59.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.59 109.735 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -140.55 151.09 62.72 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.196 -0.94 . . . . 0.87 109.309 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.26 15.46 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.703 0.935 . . . . 0.38 111.952 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.66 120.52 25.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.916 -1.115 . . . . 0.18 110.741 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.43 122.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.579 -2.008 . . . . 3.99 105.579 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 170' ' ' GLN . 5.2 mp0 -112.17 -13.13 13.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.244 -0.91 . . . . 5.17 112.936 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.0 m -157.04 158.69 36.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.13 -2.231 . . . . 0.02 110.085 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -153.16 154.81 35.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 2.02 110.188 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -144.19 149.5 36.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.276 -0.89 . . . . 0.01 110.162 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -86.62 143.14 27.78 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.524 -0.917 . . . . 0.01 108.524 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.16 128.38 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.141 -0.975 . . . . 3.04 109.79 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 177' ' ' GLU . 60.6 t -137.06 147.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.229 -0.919 . . . . 1.89 109.663 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 176' ' ' VAL . 7.8 tm-20 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 4.89 109.297 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.684 0 N-CA-C 107.096 -2.402 . . . . 0.81 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.82 149.82 33.54 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.112 -1.042 . . . . 0.01 110.749 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.05 136.29 18.84 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.981 . . . . 0.02 109.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.23 139.44 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.793 -0.567 . . . . 0.02 109.543 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 t -122.16 130.46 53.23 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.553 -0.717 . . . . 0.39 109.916 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 m-85 -110.08 139.99 44.62 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.032 -0.729 . . . . 0.02 109.032 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.51 139.14 54.22 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.292 -0.88 . . . . 0.02 109.813 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.451 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.39 -28.03 66.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.938 -1.101 . . . . 0.03 111.804 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -114.14 169.07 9.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.888 -1.132 . . . . 0.03 110.201 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -74.96 158.15 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.666 0.746 . . . . 0.03 109.895 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.47 34.94 5.84 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.729 0.776 . . . . 0.74 110.8 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.1 p90 49.72 44.39 24.73 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.742 0.782 . . . . 0.02 111.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.73 166.72 11.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.87 -1.159 . . . . 0.02 107.87 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.1 -167.75 36.44 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.669 -1.253 . . . . 0.03 110.673 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.19 142.73 54.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.977 . . . . 2.76 108.943 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' NH1' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tmm_? -121.57 150.67 41.32 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.71 0.766 . . . . 1.89 110.42 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -132.82 127.55 34.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 0.02 108.045 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' NH1' ' A' ' 19' ' ' ARG . 3.3 p-10 -111.83 136.46 51.09 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.563 -0.711 . . . . 1.12 109.711 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -130.91 137.69 49.43 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.494 0.664 . . . . 0.02 109.467 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -116.83 10.1 14.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.2 109.375 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.3 p -158.59 174.3 15.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 13.0 t0 -60.8 142.31 56.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.782 -1.199 . . . . 0.02 110.327 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 43.2 t -131.57 116.58 17.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.316 -0.994 . . . . 0.02 108.316 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.59 -24.33 53.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.24 110.995 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -154.65 102.4 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.006 -1.059 . . . . 1.14 108.86 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CZ ' ' NH2' ' A' ' 30' ' ' ARG . 17.9 p90 -104.38 8.38 35.8 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.192 0.996 . . . . 6.37 109.487 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.436 HH11 ' NH2' ' A' ' 78' ' ' ARG . 3.3 mmp_? -58.3 -24.22 58.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 3.11 110.715 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -74.69 -17.1 60.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.768 -1.208 . . . . 0.88 109.933 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -104.13 -22.41 13.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.421 -0.799 . . . . 0.02 109.416 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.451 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.01 128.51 12.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.113 -0.992 . . . . 3.32 109.138 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -85.54 -10.03 56.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.723 -0.611 . . . . 0.02 111.288 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -171.86 163.1 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.759 -1.2 . . . . 0.02 107.759 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 p -143.98 115.71 8.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.199 . . . . 0.02 108.736 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -107.06 1.83 24.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.957 -1.089 . . . . 0.03 110.548 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.6 p -156.88 154.72 30.25 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.507 -1.294 . . . . 0.02 107.507 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mt -146.17 148.16 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 0.02 109.777 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -125.04 125.43 43.83 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.47 114.94 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.714 -1.587 . . . . 0.02 106.714 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.87 -34.33 26.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.796 -0.565 . . . . 3.81 110.42 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.36 151.5 21.1 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.142 -1.504 . . . . 0.02 110.167 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 175.09 50.68 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.582 -1.294 . . . . 0.01 110.264 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 46' ' ' TRP . 84.0 m -109.46 161.3 15.45 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.901 -1.518 . . . . 1.48 106.901 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.424 ' N ' HG22 ' A' ' 45' ' ' THR . 65.6 m95 -147.38 146.64 29.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.347 -1.47 . . . . 0.02 111.402 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.79 54.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 105.466 -2.05 . . . . 0.24 105.466 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.0 m -117.73 141.98 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.607 -0.683 . . . . 0.65 109.493 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 8.5 m-85 -122.0 143.36 49.53 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.511 1.148 . . . . 0.02 109.652 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 6.0 tp10 -65.37 -36.25 83.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.729 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.1 153.51 64.56 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.97 -1.081 . . . . 0.02 109.305 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.13 167.74 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.31 1.34 . . . . 0.02 112.772 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 63.26 37.05 11.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.175 -0.921 . . . . 0.02 110.998 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER 45.12 52.83 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.683 0.754 . . . . 3.39 110.896 178.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -126.58 163.85 22.52 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.168 0.509 . . . . 2.33 109.866 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.84 32.27 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.13 -1.188 . . . . 0.02 110.13 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 5.6 m170 -63.93 138.52 58.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.976 -1.308 . . . . 0.02 110.117 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.7 mtm -120.55 134.47 55.27 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.606 0.717 . . . . 5.01 109.679 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.3 m-85 -134.25 139.02 45.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.02 109.561 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.683 ' H ' ' NE2' ' A' ' 148' ' ' GLN . 1.6 mp -97.25 133.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.85 113.68 32.91 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.561 -0.712 . . . . 0.02 110.56 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.4 168.72 22.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.154 1.091 . . . . 1.47 110.155 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.17 141.39 23.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.746 -1.221 . . . . 4.25 110.151 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.03 -176.51 32.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.412 -1.375 . . . . 0.02 110.567 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -119.4 130.6 55.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -1.082 . . . . 0.96 109.403 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 49.3 m-85 -121.1 98.71 47.01 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 107.671 -1.233 . . . . 0.02 107.671 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -70.54 -3.39 12.42 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.629 0.886 . . . . 0.02 113.806 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -157.26 155.01 30.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.592 -1.317 . . . . 2.02 108.206 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -60.65 -39.14 87.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.577 -0.702 . . . . 0.02 111.814 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.81 -23.8 63.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.02 110.181 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.549 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.73 -18.54 62.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.96 0.886 . . . . 3.42 108.626 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -106.82 10.31 30.74 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.171 -1.418 . . . . 0.02 107.171 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.35 22.62 11.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.557 0.694 . . . . 0.02 110.18 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.98 47.36 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.8 tp -78.76 -29.68 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.649 -1.241 . . . . 0.98 107.649 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.669 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.67 -171.03 3.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.619 -1.623 . . . . 0.02 106.619 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -98.17 28.29 4.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.633 -1.292 . . . . 0.02 110.238 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH2' HH11 ' A' ' 30' ' ' ARG . 17.7 mmm180 -98.05 123.01 41.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.285 -0.884 . . . . 3.2 111.38 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.0 mt -144.65 121.59 11.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.048 -1.464 . . . . 2.61 107.048 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 -16.39 14.48 Favored Glycine 0 N--CA 1.5 2.905 0 O-C-N 121.303 -0.873 . . . . 0.02 112.171 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.01 154.65 32.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.247 -1.737 . . . . 0.02 110.401 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.6 p -144.69 147.36 32.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.02 109.688 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -133.86 140.13 46.66 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.664 -0.865 . . . . 0.01 108.664 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.11 129.22 36.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 0.43 107.935 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.0 t -91.96 123.69 44.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.893 -0.78 . . . . 1.25 108.893 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -90.66 136.65 32.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.276 -0.89 . . . . 1.77 109.006 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -99.25 137.48 37.7 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.94 -1.133 . . . . 1.63 107.94 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 t -112.25 126.5 55.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -0.876 . . . . 1.08 109.14 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -103.61 -154.94 0.51 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.221 -1.77 . . . . 1.26 106.221 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.02 -49.58 0.86 Allowed Glycine 0 N--CA 1.498 2.79 0 O-C-N 120.418 -1.426 . . . . 0.01 112.232 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.04 -100.05 0.14 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 118.397 -1.859 . . . . 0.01 111.889 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.95 118.62 30.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.292 -1.122 . . . . 4.43 110.394 -179.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.86 129.66 36.53 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 2.99 109.287 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -129.97 139.46 51.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.576 -0.703 . . . . 6.36 109.436 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tt -129.35 145.78 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.414 -0.804 . . . . 1.09 109.71 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -121.18 133.22 55.18 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.29 -1.374 . . . . 2.05 107.29 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.4 146.61 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.954 -1.091 . . . . 1.1 109.351 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 33.2 m-85 -119.72 141.39 49.46 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.194 0.997 . . . . 0.73 110.922 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.31 -29.25 69.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.711 -0.677 . . . . 0.02 111.587 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -116.61 169.8 9.07 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.075 -1.016 . . . . 3.18 110.444 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.95 165.33 50.97 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.843 -0.903 . . . . 0.01 110.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.526 ' OD1' ' NH1' ' A' ' 157' ' ' ARG . 9.6 t0 56.8 38.37 29.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.956 -0.732 . . . . 0.01 111.307 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 51.65 54.44 10.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.01 111.368 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 166.14 19.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.062 -1.088 . . . . 3.15 108.062 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -164.19 28.63 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.014 -1.635 . . . . 0.01 109.014 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.34 143.86 42.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.285 . . . . 0.01 108.518 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.3 ttp -116.79 142.84 46.4 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.59 0.71 . . . . 0.01 109.838 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -131.65 136.38 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.073 -1.084 . . . . 2.48 108.073 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.57 134.8 54.82 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.684 -0.635 . . . . 0.01 110.093 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.514 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -149.14 150.49 32.77 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.237 1.018 . . . . 1.69 111.031 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.6 p -110.11 10.02 24.01 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.674 -0.694 . . . . 0.01 109.811 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -120.77 163.23 18.44 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.282 -0.887 . . . . 3.21 111.272 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.1 155.18 37.57 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.021 -1.103 . . . . 0.01 108.021 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.2 t -123.18 109.77 31.3 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.67 -31.91 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 CA-C-N 119.997 1.035 . . . . 0.01 111.696 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -140.96 107.42 5.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.37 -0.832 . . . . 0.02 108.774 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.52 -39.44 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.56 . . . . 1.83 110.668 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 40.7 ttp -66.32 -37.52 85.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.966 -1.094 . . . . 1.34 109.959 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.18 -39.27 71.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.399 -1.438 . . . . 2.11 109.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.72 -47.86 13.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 2.08 112.447 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.19 -1.96 15.95 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.352 -0.843 . . . . 0.02 112.517 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.0 m80 61.87 33.96 17.29 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.659 -1.276 . . . . 0.02 109.403 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.1 mt -114.63 135.54 54.03 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.487 -0.758 . . . . 0.02 109.264 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.459 ' H ' ' HD2' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.13 -21.19 23.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.159 -0.963 . . . . 5.32 110.761 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 124' ' ' ARG . 10.9 mp0 -147.32 163.95 34.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.912 -1.117 . . . . 0.02 109.504 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.0 mm -126.97 124.23 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.339 -1.356 . . . . 2.17 107.339 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -110.3 -13.48 14.31 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.238 -0.914 . . . . 0.02 112.516 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 t -160.79 151.65 18.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.835 -1.165 . . . . 0.01 109.24 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.2 p -168.78 143.93 3.33 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.674 -0.861 . . . . 1.22 108.674 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.46 109.6 13.48 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.448 1.118 . . . . 1.41 109.669 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 131' ' ' VAL . 11.5 p . . . . . 0 C--N 1.297 -1.696 0 N-CA-C 107.619 -1.252 . . . . 0.01 107.619 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 6.4 m95 . . . . . 0 N--CA 1.497 1.876 0 N-CA-C 106.557 -1.646 . . . . 0.01 106.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.463 ' CG1' HD11 ' A' ' 175' ' ' ILE . 12.3 mt -117.18 133.62 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.507 -1.371 . . . . 1.69 109.162 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.47 141.14 45.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.29 -1.745 . . . . 2.49 106.29 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.8 m-85 -123.05 142.98 50.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.918 . . . . 0.02 109.605 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.66 -30.49 62.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.79 -0.569 . . . . 0.02 111.725 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.9 154.9 48.31 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.655 -1.278 . . . . 1.48 108.975 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.5 167.08 2.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.091 1.194 . . . . 0.02 112.926 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.79 31.38 20.77 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.05 -0.977 . . . . 0.75 111.363 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 57.31 51.89 9.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.42 -0.8 . . . . 0.02 111.361 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -126.57 164.84 20.33 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.504 -0.748 . . . . 0.02 110.114 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.2 33.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.227 -1.149 . . . . 0.02 110.227 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.02 108.61 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.683 ' NE2' ' H ' ' A' ' 60' ' ' ILE . 2.9 mt-30 -113.4 148.13 36.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.734 -0.604 . . . . 0.02 109.533 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.31 133.99 54.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.912 -0.773 . . . . 0.01 108.912 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 48.0 tp -96.63 121.66 38.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.01 109.378 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -95.75 139.08 32.49 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.557 -0.905 . . . . 0.01 108.557 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.545 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 3.0 p30 -105.55 -168.32 1.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.498 -0.751 . . . . 2.27 109.499 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -82.57 38.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 1.84 110.005 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.28 175.28 5.54 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.379 -0.826 . . . . 2.28 109.45 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -105.31 125.51 51.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.723 -0.843 . . . . 0.01 108.723 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 1.5 m-85 -100.35 112.73 25.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.243 -0.911 . . . . 0.01 109.817 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.526 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 12.8 mmm180 -88.35 -28.09 21.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.957 -1.089 . . . . 0.01 110.549 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -126.88 156.04 74.57 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 107.045 -1.465 . . . . 2.54 107.045 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 162' ' ' TRP . 5.6 Cg_endo -59.56 -34.26 96.81 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 CA-C-N 119.721 0.936 . . . . 0.7 110.335 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.1 t -62.88 -21.16 27.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.873 -1.142 . . . . 0.86 109.564 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.07 -20.51 65.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.672 -1.268 . . . . 0.02 111.439 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p90 -103.03 13.32 34.53 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.979 -1.075 . . . . 0.02 109.243 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.75 11.98 64.95 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.771 -0.728 . . . . 0.02 113.549 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.78 138.06 38.33 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 119.627 1.713 . . . . 0.02 110.411 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.79 -7.85 58.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.692 -0.63 . . . . 0.59 109.796 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 87.0 p -139.98 150.16 61.3 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.312 -0.868 . . . . 0.87 109.551 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.5 13.5 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.688 0.925 . . . . 0.38 112.031 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.95 120.2 24.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.18 110.921 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.15 124.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.79 -1.929 . . . . 3.99 105.79 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -112.25 -12.95 13.54 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.311 -0.868 . . . . 5.17 113.171 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 33.3 t -156.76 159.0 37.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 119.354 -2.091 . . . . 0.02 110.076 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.01 154.14 34.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.303 -0.873 . . . . 2.02 110.7 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -143.51 149.29 37.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.385 -0.822 . . . . 0.01 110.237 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -86.41 142.83 28.15 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.53 -0.915 . . . . 0.01 108.53 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 137' ' ' ILE . 7.3 mt -94.38 128.45 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.12 -0.987 . . . . 3.04 109.851 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.59 147.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.764 . . . . 1.89 109.458 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 4.89 109.102 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 107.088 -2.405 . . . . 0.81 107.088 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.37 149.59 34.01 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 120.026 -1.083 . . . . 0.01 110.692 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -150.04 135.98 18.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.978 . . . . 0.02 109.509 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.25 140.83 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.432 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 4.3 m -121.32 130.06 53.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.625 -0.672 . . . . 0.39 109.575 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -109.69 139.24 44.96 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.76 -0.83 . . . . 0.02 108.76 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.0 m-85 -123.18 139.28 54.23 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.266 -0.896 . . . . 0.02 109.765 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 86.2 mt-10 -69.15 -28.1 66.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.03 111.989 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.69 170.22 8.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.932 -1.105 . . . . 0.03 110.426 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.495 ' NH2' ' OE1' ' A' ' 70' ' ' GLN . 73.0 mtt180 -74.07 157.71 35.59 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.638 0.732 . . . . 0.03 109.929 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.3 t-20 65.76 35.03 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.931 0.872 . . . . 0.74 111.037 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.1 p90 50.29 45.61 25.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.839 0.828 . . . . 0.02 111.197 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.39 165.85 11.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.989 -1.115 . . . . 0.02 107.989 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.2 35.91 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.702 -1.237 . . . . 0.03 110.853 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' ' OE2' ' A' ' 11' ' ' GLU . 22.3 ttp180 -68.64 142.78 55.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -1.048 . . . . 2.76 109.414 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 54.9 ttt180 -119.79 147.65 44.38 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.593 0.711 . . . . 1.89 109.893 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -132.61 126.68 33.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.833 -1.173 . . . . 0.02 107.833 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.39 137.78 50.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.473 -0.767 . . . . 1.12 109.756 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.08 138.55 49.61 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.648 0.737 . . . . 0.02 109.807 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.28 10.81 14.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.687 -0.633 . . . . 0.2 109.542 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 t -157.08 174.47 15.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 40.3 t0 -60.84 144.46 52.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.733 -1.229 . . . . 0.02 109.969 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 20.9 t -131.95 116.11 16.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.49 -0.93 . . . . 0.02 108.49 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.18 51.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.24 110.891 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.6 p-10 -154.4 101.56 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 1.14 108.84 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.9 p90 -105.43 10.36 33.34 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.331 1.063 . . . . 6.37 110.159 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.418 ' NH2' ' O ' ' A' ' 34' ' ' SER . 21.6 mmm180 -60.22 -23.03 63.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 3.11 110.924 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -76.3 -16.94 59.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.619 -1.301 . . . . 0.88 110.222 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.23 -20.97 14.46 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.79 -0.818 . . . . 0.02 108.79 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.15 129.37 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.78 0.8 . . . . 3.32 109.002 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 90.4 p -85.16 -10.78 56.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.762 -0.586 . . . . 0.02 110.717 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HE ' HD21 ' A' ' 37' ' ' ASN . 12.5 ptm180 -170.26 162.13 8.51 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.639 -1.245 . . . . 0.02 107.639 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 t -143.6 115.34 8.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.02 108.978 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.675 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.33 1.2 18.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.739 -1.226 . . . . 0.03 111.422 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 t -156.96 154.78 30.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.131 -1.062 . . . . 0.02 108.131 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -146.49 146.88 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 122.185 0.993 . . . . 0.02 111.105 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -122.8 124.11 42.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.616 -1.253 . . . . 0.02 107.616 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.48 114.83 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 106.598 -1.63 . . . . 0.02 106.598 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.7 mp0 -83.83 -33.73 24.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 3.81 110.269 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.32 149.8 18.34 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.104 -1.522 . . . . 0.02 110.133 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.07 173.87 50.03 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.648 -1.263 . . . . 0.01 110.153 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.6 m -119.64 137.28 53.98 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -126.09 153.93 43.8 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.712 1.244 . . . . 0.02 112.361 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.99 133.39 52.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.051 -2.203 . . . . 0.24 105.051 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.87 142.03 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.658 -0.651 . . . . 0.65 109.337 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -120.97 143.01 49.24 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.169 0.985 . . . . 0.02 109.655 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.58 -34.3 77.93 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.376 -0.829 . . . . 0.02 111.778 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -124.82 157.84 64.75 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.942 -1.099 . . . . 0.02 109.549 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.91 166.31 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.739 1.626 . . . . 0.02 112.741 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.77 37.31 9.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.314 -0.857 . . . . 0.02 111.058 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.85 52.23 8.13 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.551 0.691 . . . . 3.39 110.598 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -126.21 163.87 22.23 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.181 0.515 . . . . 2.33 110.016 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -162.02 31.29 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.871 -1.292 . . . . 0.02 109.871 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.65 136.38 57.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.275 . . . . 0.02 110.035 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 19.1 ptm -118.58 135.66 54.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.62 . . . . 5.01 109.435 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.623 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 25.6 m-85 -135.52 141.09 45.21 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.509 -0.744 . . . . 0.02 109.34 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.51 133.04 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.59 -0.892 . . . . 1.72 108.59 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 66' ' ' TYR . 17.3 mt -123.74 111.79 29.27 Favored Pre-proline 0 N--CA 1.502 2.159 0 O-C-N 121.371 -0.831 . . . . 0.02 110.4 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.96 171.37 18.29 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.839 0.978 . . . . 1.47 110.237 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -51.42 140.79 16.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.002 -1.061 . . . . 4.25 109.863 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -178.56 31.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.403 -1.38 . . . . 0.02 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.3 tp10 -120.36 131.21 54.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.44 -1.035 . . . . 0.96 109.461 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.52 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 93.3 m-85 -122.21 95.29 47.36 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.2 Cg_exo -65.65 -3.45 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.892 1.061 . . . . 0.02 114.179 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 36.1 mt-10 -157.78 154.99 29.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.415 -1.428 . . . . 2.02 108.087 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 7.3 p90 -60.8 -38.57 85.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.523 -0.735 . . . . 0.02 111.995 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 24.7 mt-30 -59.58 -24.21 63.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.02 110.367 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -70.84 -18.18 62.72 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.404 -0.961 . . . . 3.42 108.404 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.623 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.89 9.87 30.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.258 -1.386 . . . . 0.02 107.258 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 60.86 21.48 11.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.587 -0.696 . . . . 0.02 110.41 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.05 145.01 46.56 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.392 -1.483 . . . . 0.02 109.392 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -78.6 -29.95 46.31 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.663 -1.236 . . . . 0.98 107.663 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.459 -1.682 . . . . 0.02 106.459 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.46 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 5.5 p30 -97.21 28.56 3.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.669 -1.27 . . . . 0.02 110.21 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -96.31 121.42 38.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.914 -1.116 . . . . 3.2 110.33 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.3 119.72 10.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.794 -1.187 . . . . 2.61 107.794 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.22 -15.94 10.12 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.338 -0.851 . . . . 0.02 112.975 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 47.3 t -155.55 155.59 33.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.97 -1.9 . . . . 0.02 110.943 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.43 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 23.9 p -145.86 148.7 33.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.487 -0.758 . . . . 0.02 110.397 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -135.53 140.53 44.8 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.394 -0.816 . . . . 0.01 108.888 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.33 130.97 36.8 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.081 -1.012 . . . . 0.43 109.197 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.33 123.31 41.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.334 -0.987 . . . . 1.25 108.334 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 9.6 m-70 -90.65 135.08 33.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.876 -1.14 . . . . 1.77 108.166 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.85 138.49 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.735 -0.839 . . . . 1.63 108.735 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -111.56 125.4 53.88 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.495 -0.928 . . . . 1.08 108.495 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -102.58 -156.13 0.55 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.93 -45.86 1.05 Allowed Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.339 -1.476 . . . . 0.01 112.068 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.33 -97.85 0.11 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.463 -1.827 . . . . 0.01 112.159 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -121.48 120.42 34.87 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.389 -1.065 . . . . 4.43 110.707 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -74.92 131.49 40.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 2.99 109.201 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.547 ' NZ ' HE22 ' A' ' 96' ' ' GLN . 0.5 OUTLIER -131.19 137.71 49.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.574 -0.704 . . . . 6.36 109.523 -179.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 6.6 tt -127.78 142.75 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.861 0.838 . . . . 1.09 109.456 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.547 HE22 ' NZ ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -125.21 134.59 52.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.177 -1.045 . . . . 2.05 108.177 178.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.72 148.48 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.88 -1.137 . . . . 1.1 109.961 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 51.7 m-85 -118.32 141.16 48.81 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.925 0.869 . . . . 0.73 110.777 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.9 -29.8 69.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 116.013 -0.54 . . . . 0.02 111.813 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -116.69 167.96 10.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.087 -1.008 . . . . 3.18 110.573 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.29 164.03 41.5 Favored Glycine 0 N--CA 1.492 2.398 0 CA-C-O 121.936 0.742 . . . . 0.01 111.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.8 m-20 56.39 39.49 30.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.955 -0.733 . . . . 0.01 110.928 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.555 ' H ' ' CB ' ' A' ' 128' ' ' SER . 4.7 m-85 52.27 55.51 9.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.732 -0.605 . . . . 0.01 110.826 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -128.82 165.84 20.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.399 -0.963 . . . . 3.15 108.399 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.85 -164.3 27.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.204 -1.558 . . . . 0.01 109.204 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.581 HE21 ' H ' ' A' ' 107' ' ' MET . 38.9 tp60 -74.51 144.5 44.08 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.263 . . . . 0.01 108.167 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.581 ' H ' HE21 ' A' ' 106' ' ' GLN . 27.6 ttp -116.71 142.28 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.647 0.737 . . . . 0.01 109.454 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.18 136.63 48.45 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.191 -1.04 . . . . 2.48 108.191 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 110' ' ' THR . 8.8 tp10 -119.09 133.67 55.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.714 -0.616 . . . . 0.01 109.741 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.533 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -148.99 149.39 31.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 1.69 110.593 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 24.3 p -108.7 10.25 26.88 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.763 -0.653 . . . . 0.01 109.724 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 37.3 mp0 -120.81 163.12 18.65 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.383 -0.823 . . . . 3.21 111.234 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.1 p30 -65.75 154.73 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.052 -1.092 . . . . 0.01 108.052 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.7 t -122.5 110.16 32.33 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 108.512 -0.921 . . . . 0.01 108.512 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -76.91 -31.63 3.79 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 119.969 1.025 . . . . 0.01 111.833 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.2 t -142.02 107.92 5.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.088 -1.008 . . . . 0.02 108.792 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.4 mt -63.52 -39.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.913 -0.492 . . . . 1.83 110.576 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.49 -37.28 84.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.003 -1.079 . . . . 1.34 109.945 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -70.82 -39.12 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.489 -1.382 . . . . 2.11 109.842 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.442 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.5 tt0 -80.78 -48.22 12.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 2.08 112.564 -176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PHE . . . . . 0.442 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 58.6 m-85 -111.82 -1.49 15.54 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.424 -0.797 . . . . 0.02 112.707 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 61.1 34.4 19.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.095 . . . . 0.02 109.769 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.19 135.49 53.98 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.534 -0.729 . . . . 0.02 109.152 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -90.32 -21.51 22.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.155 -0.966 . . . . 5.32 111.006 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 126' ' ' ILE . 39.8 mt-10 -148.42 163.57 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.045 -1.034 . . . . 0.02 110.06 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 125' ' ' GLU . 39.4 mm -128.48 125.6 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.554 -1.276 . . . . 2.17 107.554 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -109.82 -13.9 14.39 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.145 -0.972 . . . . 0.02 113.118 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.555 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 8.4 m -161.81 154.16 19.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.573 -1.33 . . . . 0.01 109.627 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.7 p -166.23 142.47 4.92 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.751 -0.833 . . . . 1.22 108.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 96.88 5.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.422 1.106 . . . . 1.41 108.221 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 136' ' ' TRP . 11.6 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-N 115.281 -0.872 . . . . 0.01 108.794 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CD1' HG21 ' A' ' 131' ' ' VAL . 87.6 m95 . . . . . 0 N--CA 1.508 2.451 0 CA-C-O 121.347 0.594 . . . . 0.01 110.658 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.7 mt -119.8 137.71 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.393 -0.966 . . . . 1.69 108.393 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.82 141.26 44.41 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.168 -1.419 . . . . 2.49 107.168 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -122.5 142.31 50.72 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.234 -0.916 . . . . 0.02 109.646 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -31.2 61.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.714 -0.616 . . . . 0.02 112.187 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.69 155.03 48.0 Favored Pre-proline 0 N--CA 1.506 2.355 0 O-C-N 120.736 -1.228 . . . . 1.48 109.135 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.3 Cg_endo -54.92 166.43 2.09 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.022 1.148 . . . . 0.02 112.913 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 142' ' ' PRO . 5.6 p30 57.05 31.9 20.74 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.056 -0.975 . . . . 0.75 111.822 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.445 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 59.35 51.85 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.02 111.397 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HE ' ' H ' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -127.05 166.29 17.88 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.479 -0.763 . . . . 0.02 109.793 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.663 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 87.57 -165.58 35.41 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.307 -1.117 . . . . 0.02 110.307 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.11 141.88 54.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -1.001 . . . . 0.02 108.873 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.475 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.2 mt-30 -114.8 149.15 37.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.267 0.556 . . . . 0.02 109.519 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -123.54 133.77 53.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.507 -0.923 . . . . 0.01 108.507 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.9 tp -94.69 122.3 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.792 -1.193 . . . . 0.01 109.342 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -93.23 149.0 21.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.01 108.875 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.6 m-20 -108.53 -175.88 2.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.51 -0.743 . . . . 2.27 109.222 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -74.4 27.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 1.84 109.501 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 152' ' ' ASP . 55.1 mttm -112.76 174.69 5.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.473 -0.767 . . . . 2.28 109.354 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -106.57 138.02 43.51 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.936 -0.764 . . . . 0.01 108.936 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.82 114.31 28.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.304 -0.872 . . . . 0.01 110.273 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' A' ' 128' ' ' SER . 11.2 mtp180 -86.52 -28.55 23.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.01 111.268 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -123.2 153.68 64.94 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.831 -1.174 . . . . 2.54 107.831 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.6 Cg_endo -61.83 -41.93 34.67 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 CA-C-N 119.323 0.794 . . . . 0.7 110.455 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.8 -18.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.808 -1.182 . . . . 0.86 109.279 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -65.88 -18.31 65.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.02 111.87 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.76 14.82 30.84 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 120.891 -1.13 . . . . 0.02 110.099 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.36 10.72 73.52 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.219 -0.926 . . . . 0.02 113.047 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.18 140.54 35.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.79 -1.417 . . . . 0.02 109.994 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.03 -6.81 59.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.708 -0.62 . . . . 0.59 109.544 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 97.2 p -140.97 150.2 58.53 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.213 -0.929 . . . . 0.87 109.192 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.33 16.64 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.585 0.857 . . . . 0.38 111.942 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.18 120.19 25.03 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.177 0.989 . . . . 0.18 110.904 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.59 124.28 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 105.609 -1.997 . . . . 3.99 105.609 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.09 -12.77 13.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.241 -0.912 . . . . 5.17 113.246 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.9 m -157.7 160.76 38.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.146 -2.221 . . . . 0.02 110.388 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -151.59 153.14 33.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.373 -0.83 . . . . 2.02 109.875 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.445 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.2 mtp180 -143.55 150.0 38.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.217 -0.927 . . . . 0.01 110.121 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.519 ' NH2' ' O ' ' A' ' 111' ' ' THR . 3.4 ptp180 -87.4 143.1 27.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.581 -0.896 . . . . 0.01 108.581 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.79 128.51 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.207 -0.933 . . . . 3.04 109.25 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.9 t -137.52 147.81 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.199 -0.938 . . . . 1.89 109.653 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.43 -0.794 . . . . 4.89 109.412 179.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.469 -0.567 . . . . 5.28 109.469 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -65.99 98.91 0.46 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 5.96 109.3 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.2 p -104.33 -140.47 0.36 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.208 -1.034 . . . . 2.22 108.208 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.65 88.06 0.07 OUTLIER Glycine 0 N--CA 1.497 2.742 0 N-CA-C 107.084 -2.406 . . . . 0.81 107.084 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.66 148.9 32.65 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 120.216 -0.992 . . . . 0.01 110.866 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -151.18 136.81 17.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.583 -0.951 . . . . 0.02 108.839 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tt -130.25 140.58 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 109.205 -0.665 . . . . 0.02 109.205 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -120.85 129.28 53.47 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.455 -0.778 . . . . 0.39 109.897 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.6 m-85 -109.42 139.51 44.3 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 108.839 -0.801 . . . . 0.02 108.839 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.7 m-85 -124.18 139.69 53.68 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.184 -0.948 . . . . 0.02 110.126 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HG3' HD11 ' A' ' 33' ' ' LEU . 94.5 mt-10 -68.32 -27.3 66.16 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.14 -0.975 . . . . 0.03 111.826 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.1 m-20 -114.42 169.97 8.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.838 -1.164 . . . . 0.03 110.466 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 59.3 mtt180 -74.93 158.49 33.22 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.622 0.725 . . . . 0.03 109.816 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.4 m-20 65.91 34.71 7.01 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.813 0.816 . . . . 0.74 110.842 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.2 p90 49.41 44.29 23.76 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.72 0.771 . . . . 0.02 111.104 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -111.74 165.95 11.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.43 -167.61 35.73 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 119.593 -1.289 . . . . 0.03 110.487 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.8 ttp180 -68.6 143.1 54.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -1.009 . . . . 2.76 109.024 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 21' ' ' ASP . 3.0 tmm_? -121.51 149.96 42.32 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.752 0.787 . . . . 1.89 110.163 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -133.52 128.17 34.76 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.444 -0.947 . . . . 0.02 108.444 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' OD2' ' CZ ' ' A' ' 19' ' ' ARG . 45.5 m-20 -111.43 136.9 49.93 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.456 -0.778 . . . . 1.12 109.494 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.3 t -130.79 137.62 49.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.535 0.684 . . . . 0.02 109.412 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 4.7 p-10 -117.0 10.47 14.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.706 -0.621 . . . . 0.2 109.535 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 3.8 p -158.32 174.51 15.04 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.158 -1.053 . . . . 1.23 108.158 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.407 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.1 p30 -62.08 144.3 55.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.61 -1.306 . . . . 0.02 110.253 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.6 t -131.33 117.45 18.95 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.569 -0.9 . . . . 0.02 108.569 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.79 -25.19 53.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.087 -1.008 . . . . 0.24 110.613 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -154.29 101.52 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.966 -1.083 . . . . 1.14 108.742 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -104.61 8.35 35.28 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 122.108 0.956 . . . . 6.37 109.541 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -59.0 -24.08 62.46 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.556 -0.715 . . . . 3.11 110.787 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 t -74.29 -16.5 60.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.716 -1.24 . . . . 0.88 110.047 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -103.59 -22.16 13.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.02 109.228 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.462 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.0 tp -150.27 128.92 12.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.201 -0.937 . . . . 3.32 109.086 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 p -85.64 -9.98 56.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.735 -0.603 . . . . 0.02 111.086 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -170.78 161.66 7.36 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.0 t -142.41 114.37 8.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.718 -1.239 . . . . 0.02 108.573 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -108.71 0.82 20.75 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.895 -1.128 . . . . 0.03 110.609 -178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 3.2 p -156.55 153.39 28.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.487 -1.301 . . . . 0.02 107.487 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.3 mt -145.38 148.47 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.08 -1.013 . . . . 0.02 109.74 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -124.09 124.87 43.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.387 -1.338 . . . . 0.02 107.387 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.3 t -105.69 113.29 42.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.601 -1.629 . . . . 0.02 106.601 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -83.63 -34.14 25.14 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.049 -0.66 . . . . 3.81 109.744 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.75 150.7 19.99 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.525 -1.798 . . . . 0.02 110.532 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.92 174.18 50.13 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.513 -1.327 . . . . 0.01 110.095 178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 53.9 m -109.62 160.73 16.03 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.996 -1.483 . . . . 1.48 106.996 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 74.6 m95 -148.15 146.89 28.94 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.324 -1.485 . . . . 0.02 111.443 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.05 131.85 54.68 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 105.263 -2.125 . . . . 0.24 105.263 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.1 m -119.78 143.83 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.586 -0.696 . . . . 0.65 109.65 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -120.78 144.85 48.08 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.245 1.021 . . . . 0.02 109.903 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.59 -34.74 78.56 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 115.829 -0.623 . . . . 0.02 111.541 -177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -124.25 157.5 64.2 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.104 -0.997 . . . . 0.02 109.326 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -53.28 165.53 1.43 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 121.491 1.461 . . . . 0.02 113.152 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 64.18 37.31 8.94 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.221 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 45.24 51.32 9.32 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.655 0.741 . . . . 3.39 110.483 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.9 p -125.81 163.27 23.26 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.204 0.526 . . . . 2.33 109.714 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.02 -161.42 31.76 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.642 -1.383 . . . . 0.02 109.642 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -65.15 138.24 58.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.04 -1.271 . . . . 0.02 110.161 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.423 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.6 ptm -118.61 135.79 54.24 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 109.067 -0.716 . . . . 5.01 109.067 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.617 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.7 m-85 -134.82 139.94 45.47 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.8 0.809 . . . . 0.02 109.856 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.52 132.49 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.561 -0.903 . . . . 1.72 108.561 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.7 OUTLIER -118.59 111.78 37.63 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 121.569 -0.707 . . . . 0.02 110.357 -178.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -77.89 168.1 22.71 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.127 1.081 . . . . 1.47 109.897 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.532 ' NE2' ' N ' ' A' ' 64' ' ' GLY . 7.9 tm0? -53.37 140.81 26.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.796 -1.19 . . . . 4.25 110.36 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.532 ' N ' ' NE2' ' A' ' 63' ' ' GLN . . . 155.04 -176.9 32.56 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.437 -1.363 . . . . 0.02 110.689 179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.1 tp10 -118.13 129.31 55.45 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -1.146 . . . . 0.96 108.929 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.528 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 47.3 m-85 -120.4 96.8 49.05 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 107.548 -1.278 . . . . 0.02 107.548 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -68.74 -3.9 12.18 Favored 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 120.541 0.827 . . . . 0.02 113.818 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -156.91 154.34 29.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.453 -1.405 . . . . 2.02 107.962 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.542 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 52.0 p90 -60.51 -37.62 81.72 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.59 -0.694 . . . . 0.02 111.537 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -60.39 -23.97 64.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.014 -1.053 . . . . 0.02 110.454 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.52 -18.48 62.95 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.433 -0.951 . . . . 3.42 108.433 179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.617 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.75 10.98 30.71 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.188 -1.412 . . . . 0.02 107.188 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.4 OUTLIER 59.61 21.76 10.4 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.598 0.713 . . . . 0.02 110.27 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.7 145.1 45.73 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.871 -1.692 . . . . 0.02 108.871 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.506 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.3 tt -78.27 -30.48 48.55 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.536 -1.283 . . . . 0.98 107.536 178.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 16.0 t-20 -156.77 -172.36 4.02 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.514 -1.662 . . . . 0.02 106.514 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 32.6 p30 -97.52 27.29 4.38 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.709 -1.245 . . . . 0.02 110.087 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -96.04 122.86 39.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.055 -1.028 . . . . 3.2 110.493 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.517 HD22 ' HB ' ' A' ' 48' ' ' VAL . 45.9 mt -144.31 120.55 10.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.469 -1.308 . . . . 2.61 107.469 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 -16.52 13.06 Favored Glycine 0 N--CA 1.504 3.172 0 O-C-N 121.317 -0.864 . . . . 0.02 112.507 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.3 m -156.06 156.06 33.72 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.372 -1.663 . . . . 0.02 110.239 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.7 p -144.12 146.91 33.09 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.372 0.606 . . . . 0.02 109.447 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 -135.03 140.18 45.4 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.01 108.857 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.82 130.57 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.36 -0.978 . . . . 0.43 108.36 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.9 t -92.1 125.2 44.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.389 -0.967 . . . . 1.25 108.389 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.437 ' O ' ' CG2' ' A' ' 135' ' ' THR . 45.3 m-70 -90.51 135.8 33.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.935 . . . . 1.77 108.94 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -99.76 138.2 37.17 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.986 -0.746 . . . . 1.63 108.986 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.7 t -113.29 126.11 55.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.863 -0.792 . . . . 1.08 108.863 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.0 m -102.51 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 106.209 -1.774 . . . . 1.26 106.209 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.56 -48.31 0.9 Allowed Glycine 0 N--CA 1.498 2.771 0 O-C-N 120.376 -1.452 . . . . 0.01 112.529 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.16 -99.63 0.13 Allowed Glycine 0 N--CA 1.487 2.065 0 C-N-CA 118.259 -1.924 . . . . 0.01 112.388 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -121.58 119.63 32.48 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.285 -1.127 . . . . 4.43 110.756 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.527 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -77.75 131.08 37.48 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.105 -0.702 . . . . 2.99 109.105 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.465 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 6.3 ttpm? -131.13 140.35 49.96 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.461 -0.774 . . . . 6.36 108.931 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -128.9 143.66 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.386 -0.821 . . . . 1.09 110.109 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -122.23 133.73 54.71 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.905 -1.146 . . . . 2.05 107.905 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.03 147.17 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.876 -1.14 . . . . 1.1 109.691 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.602 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 29.5 m-85 -118.56 140.87 49.21 Favored 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 122.129 0.966 . . . . 0.73 110.835 -178.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -66.26 -29.42 69.65 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.772 -0.649 . . . . 0.02 111.721 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -116.91 170.25 8.77 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 120.984 -1.072 . . . . 3.18 110.573 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.54 165.32 50.12 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.831 -0.907 . . . . 0.01 110.831 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 56.5 38.41 29.62 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.834 -0.803 . . . . 0.01 111.461 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.534 ' CE1' ' OG ' ' A' ' 128' ' ' SER . 11.3 m-85 52.57 54.5 10.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.523 -0.736 . . . . 0.01 111.509 178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.631 ' ND2' ' H ' ' A' ' 105' ' ' GLY . 6.3 t-20 -129.25 166.31 19.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.196 -1.038 . . . . 3.15 108.196 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.631 ' H ' ' ND2' ' A' ' 104' ' ' ASN . . . 92.52 -164.46 28.03 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.514 -1.434 . . . . 0.01 109.514 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 65.8 tt0 -75.16 144.54 42.7 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.1 -1.235 . . . . 0.01 108.493 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.602 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 48.2 ttp -116.65 142.11 47.32 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.654 0.74 . . . . 0.01 109.88 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 30.2 m-85 -131.24 135.33 47.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.912 -1.144 . . . . 2.48 107.912 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -120.43 135.09 55.15 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.623 -0.673 . . . . 0.01 110.041 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.1 t -149.63 151.62 34.06 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.295 1.045 . . . . 1.69 110.934 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.525 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 5.3 p -110.06 10.3 24.07 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.503 -0.771 . . . . 0.01 109.787 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -121.11 162.92 19.22 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.462 -0.774 . . . . 3.21 111.156 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -66.78 155.79 37.25 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.151 -1.055 . . . . 0.01 108.151 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 15.0 t -123.98 110.12 29.47 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.528 -0.916 . . . . 0.01 108.528 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.71 -32.82 3.33 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 120.002 1.036 . . . . 0.01 111.697 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.2 m -139.64 106.78 5.47 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.543 -0.91 . . . . 0.02 108.543 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 65.1 mt -64.33 -39.91 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.869 -0.519 . . . . 1.83 111.065 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 36.1 ttp -66.59 -38.0 86.09 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.996 -1.082 . . . . 1.34 109.957 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -70.25 -38.96 75.26 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.469 -1.395 . . . . 2.11 109.758 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.522 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 45.7 tt0 -80.16 -48.2 13.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.298 -0.876 . . . . 2.08 112.507 -177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.522 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 81.3 m-85 -111.41 -1.29 15.99 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.353 -0.842 . . . . 0.02 112.611 -175.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 61.79 33.77 17.59 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.792 -1.193 . . . . 0.02 109.668 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 38.8 mt -114.52 136.05 53.45 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 121.487 -0.758 . . . . 0.02 109.293 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -90.21 -21.46 22.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.123 -0.986 . . . . 5.32 110.87 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.45 ' O ' HD13 ' A' ' 126' ' ' ILE . 45.3 mt-10 -148.73 164.14 35.24 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.893 -1.129 . . . . 0.02 110.124 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.45 HD13 ' O ' ' A' ' 125' ' ' GLU . 37.2 mm -129.29 126.57 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 107.503 -1.295 . . . . 2.17 107.503 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.4 m80 -109.92 -13.22 14.47 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.251 -0.906 . . . . 0.02 112.618 -177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.534 ' OG ' ' CE1' ' A' ' 103' ' ' PHE . 47.5 t -161.39 154.34 20.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.786 -1.196 . . . . 0.01 109.0 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -170.64 147.28 2.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.11 -0.994 . . . . 1.22 109.684 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -119.86 109.9 16.11 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.986 -1.071 . . . . 1.41 109.237 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.65 131.89 61.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.273 -1.751 . . . . 0.01 106.273 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.5 t -126.76 92.06 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 N-CA-C 106.793 -1.558 . . . . 1.98 106.793 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.512 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 1.1 tm-20 -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.575 -2.009 . . . . 0.01 105.575 177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.74 -43.36 1.04 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.765 -1.734 . . . . 0.01 108.765 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.703 ' HB ' HD12 ' A' ' 175' ' ' ILE . 75.5 p -129.12 104.93 7.84 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.518 -0.989 . . . . 2.3 111.794 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.512 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 42.9 m95 -129.54 144.03 51.09 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 107.461 -1.311 . . . . 0.01 107.461 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.47 ' CG1' HD11 ' A' ' 175' ' ' ILE . 36.3 mt -118.51 133.14 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 120.565 -1.335 . . . . 1.69 109.502 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.09 141.62 44.34 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.334 -1.728 . . . . 2.49 106.334 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 21.4 m-85 -123.45 143.07 50.38 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.197 -0.94 . . . . 0.02 109.731 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -74.25 -30.36 62.1 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.675 -0.641 . . . . 0.02 111.882 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.49 155.12 47.6 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.62 -1.3 . . . . 1.48 108.951 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -56.51 167.27 2.88 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.098 1.199 . . . . 0.02 112.615 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 55.8 t30 59.25 31.21 21.01 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.174 -0.921 . . . . 0.75 111.413 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.489 ' HD1' ' HG ' ' A' ' 171' ' ' SER . 3.1 m-85 57.48 50.68 10.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 0.02 111.082 177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -124.36 165.13 18.25 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.656 -0.652 . . . . 0.02 109.766 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.54 -165.7 33.98 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.549 -1.021 . . . . 0.02 110.549 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -69.57 142.15 53.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.542 -0.975 . . . . 0.02 108.788 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.423 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.5 mt-30 -113.14 148.45 35.33 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.351 0.596 . . . . 0.02 110.083 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -124.3 134.19 53.26 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.687 -0.856 . . . . 0.01 108.687 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.0 tp -96.0 120.55 36.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.851 -1.156 . . . . 0.01 109.654 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -99.95 149.36 23.52 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.856 -0.794 . . . . 0.01 108.856 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.3 m-20 -109.58 -177.32 3.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.42 -0.8 . . . . 2.27 109.374 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -72.83 35.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 1.84 109.469 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.6 mttp -111.55 176.2 5.12 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.452 -0.78 . . . . 2.28 109.078 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -105.92 127.03 52.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.424 -0.797 . . . . 0.01 109.088 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -98.31 112.26 24.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.01 108.847 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.413 ' H ' ' HG2' ' A' ' 157' ' ' ARG . 9.6 ptp180 -88.7 -27.85 20.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.762 -0.586 . . . . 0.01 111.298 -177.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -122.53 153.43 62.59 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 107.907 -1.146 . . . . 2.54 107.907 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.0 Cg_endo -62.24 -41.44 34.61 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 CA-C-N 119.315 0.791 . . . . 0.7 110.805 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.6 t -61.57 -18.26 18.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 O-C-N 120.862 -1.149 . . . . 0.86 109.457 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -65.5 -18.22 65.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.891 -1.13 . . . . 0.02 111.948 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.31 15.83 27.51 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.737 -1.227 . . . . 0.02 110.207 178.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.72 10.14 76.79 Favored Glycine 0 N--CA 1.499 2.869 0 O-C-N 121.12 -0.987 . . . . 0.02 112.914 176.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.496 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.06 140.61 34.04 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.862 -1.375 . . . . 0.02 110.206 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.27 -7.05 59.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.621 -0.675 . . . . 0.59 109.521 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.5 p -140.46 150.38 60.61 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.239 -0.913 . . . . 0.87 109.06 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -74.66 16.14 0.64 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 120.566 0.844 . . . . 0.38 111.776 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.19 119.9 24.66 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.307 1.051 . . . . 0.18 110.817 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.422 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.43 123.64 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 105.57 -2.011 . . . . 3.99 105.57 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -111.9 -13.16 13.68 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.369 -0.832 . . . . 5.17 113.16 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.489 ' HG ' ' HD1' ' A' ' 144' ' ' TYR . 3.1 p -157.03 160.1 38.62 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 119.276 -2.14 . . . . 0.02 109.965 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -152.1 153.9 34.84 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.359 -0.838 . . . . 2.02 110.202 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -144.18 149.26 36.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.342 -0.849 . . . . 0.01 110.068 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.527 ' NH2' ' O ' ' A' ' 93' ' ' ALA . 4.6 ptp180 -87.02 141.48 28.64 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.603 -0.888 . . . . 0.01 108.603 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.703 HD12 ' HB ' ' A' ' 135' ' ' THR . 41.7 mt -93.88 129.02 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.2 -0.937 . . . . 3.04 109.482 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 6.1 m -137.78 149.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.407 -0.808 . . . . 1.89 109.771 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 4.89 109.536 179.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.444 -0.576 . . . . 5.28 109.444 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -82.13 135.37 35.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 5.96 109.588 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -138.58 -129.03 0.12 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.241 -0.912 . . . . 2.22 111.431 -178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' HG22 ' A' ' 3' ' ' THR . . . 167.33 94.73 0.1 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 105.593 -3.003 . . . . 0.81 105.593 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.62 146.61 31.53 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.383 -0.913 . . . . 0.01 111.179 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -152.23 137.4 17.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.76 -0.847 . . . . 0.02 108.82 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 tt -129.89 140.34 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 108.937 -0.764 . . . . 0.02 108.937 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -120.9 130.14 53.77 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.546 -0.721 . . . . 0.39 109.654 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 25.7 m-85 -108.96 138.73 44.84 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.88 -0.785 . . . . 0.02 108.88 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.8 m-85 -122.34 138.28 54.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.302 -0.874 . . . . 0.02 109.398 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -68.21 -27.75 66.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.575 -0.703 . . . . 0.03 111.605 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -114.93 170.13 8.57 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.976 -1.077 . . . . 0.03 110.422 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -74.73 161.66 29.42 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.708 0.766 . . . . 0.03 110.063 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 12.2 t-20 62.58 34.91 14.74 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.894 0.854 . . . . 0.74 110.559 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.0 p90 49.45 42.9 23.23 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.473 -0.785 . . . . 0.02 110.878 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 mm100 -109.35 165.89 11.28 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.806 -1.183 . . . . 0.02 107.806 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.06 -167.98 35.01 Favored Glycine 0 N--CA 1.495 2.605 0 O-C-N 120.681 -1.262 . . . . 0.03 110.837 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -68.9 143.96 54.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.576 -0.955 . . . . 2.76 109.035 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -122.16 150.05 42.76 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.727 0.775 . . . . 1.89 110.207 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.24 128.59 36.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.158 -1.053 . . . . 0.02 108.158 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -110.98 135.92 50.77 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.549 -0.719 . . . . 1.12 109.465 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -129.99 137.81 50.49 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.486 0.66 . . . . 0.02 109.682 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -116.83 10.89 14.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.248 -0.649 . . . . 0.2 109.248 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 14.1 t -158.83 174.17 15.4 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.06 -1.089 . . . . 1.23 108.06 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 15.8 p-10 -61.66 144.74 54.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.756 -1.215 . . . . 0.02 110.216 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.7 t -131.49 117.5 18.88 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 108.5 -0.926 . . . . 0.02 108.5 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.65 -25.01 44.89 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.24 111.292 -177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -153.21 102.49 2.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.861 -1.149 . . . . 1.14 108.946 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' CD1' ' C ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -101.68 8.49 41.62 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.962 0.887 . . . . 6.37 109.689 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -59.14 -26.74 65.0 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.731 -0.606 . . . . 3.11 111.657 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -74.28 -17.32 60.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.591 -1.318 . . . . 0.88 110.36 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -105.14 -22.22 13.12 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.391 -0.818 . . . . 0.02 109.799 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 tp -150.1 128.26 11.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.052 -1.03 . . . . 3.32 109.019 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.7 m -84.77 -9.21 58.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.781 -0.575 . . . . 0.02 111.016 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -171.03 164.11 7.46 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.6 t -142.24 114.15 8.07 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.726 -1.234 . . . . 0.02 108.543 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.557 HD22 ' N ' ' A' ' 37' ' ' ASN . 1.2 m-80 -109.14 -0.93 19.11 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 120.942 -1.099 . . . . 0.03 111.343 -178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.3 t -154.02 153.8 32.59 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.278 -1.008 . . . . 0.02 108.278 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.74 146.73 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.136 -0.978 . . . . 0.02 110.552 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' NE ' ' OH ' ' A' ' 10' ' ' TYR . 25.3 ttp180 -124.56 125.22 43.82 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.476 -1.305 . . . . 0.02 107.476 177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.58 ' C ' HE22 ' A' ' 63' ' ' GLN . 43.8 t -104.07 113.23 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 106.565 -1.643 . . . . 0.02 106.565 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' C ' HE22 ' A' ' 63' ' ' GLN . 11.1 tp10 -83.01 -34.47 26.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.71 -0.619 . . . . 3.81 109.389 -178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.18 149.59 18.02 Favored Glycine 0 N--CA 1.489 2.187 0 C-N-CA 118.726 -1.702 . . . . 0.02 110.302 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.81 173.56 49.82 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.711 -1.233 . . . . 0.01 110.243 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 m -119.02 135.48 54.61 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.473 -1.306 . . . . 1.48 107.473 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.41 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 33.2 m95 -123.91 153.65 40.85 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.835 -1.166 . . . . 0.02 112.259 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.84 133.29 53.08 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 105.14 -2.17 . . . . 0.24 105.14 176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.4 m -118.63 142.63 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.129 -0.693 . . . . 0.65 109.129 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -121.04 146.33 46.83 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.295 1.045 . . . . 0.02 109.617 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' CD ' HD21 ' A' ' 76' ' ' ASN . 0.6 OUTLIER -66.0 -35.66 81.17 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.55 -0.75 . . . . 0.02 111.121 -177.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -123.46 158.52 58.56 Favored Pre-proline 0 N--CA 1.504 2.263 0 O-C-N 121.2 -0.937 . . . . 0.02 109.067 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.83 168.38 1.18 Allowed 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.65 1.567 . . . . 0.02 112.8 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.8 t30 62.75 37.42 12.57 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.421 -0.809 . . . . 0.02 111.197 178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.73 52.11 8.01 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-O 121.573 0.701 . . . . 3.39 110.793 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.8 t -126.61 164.16 21.84 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 121.193 0.52 . . . . 2.33 109.838 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.35 -161.55 32.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.517 -1.433 . . . . 0.02 109.517 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -66.44 137.55 56.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.927 -1.337 . . . . 0.02 109.61 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.49 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.8 ptm -119.24 137.52 53.6 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 109.305 -0.628 . . . . 5.01 109.305 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 63.1 m-85 -132.3 138.9 47.99 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.529 -0.732 . . . . 0.02 109.466 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.4 mm -96.23 132.1 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.764 -0.828 . . . . 1.72 108.764 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD22 ' CE1' ' A' ' 66' ' ' TYR . 16.4 mt -121.45 110.13 34.23 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.255 -0.903 . . . . 0.02 110.751 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -75.2 170.73 19.73 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 CA-C-N 119.793 0.962 . . . . 1.47 109.981 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.58 HE22 ' C ' ' A' ' 41' ' ' VAL . 3.1 tp-100 -50.56 138.71 17.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.063 -1.023 . . . . 4.25 110.254 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.04 -179.17 32.15 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.035 -1.555 . . . . 0.02 110.884 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -119.0 130.83 55.89 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.547 -0.972 . . . . 0.96 109.462 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.44 ' CE1' HD22 ' A' ' 61' ' ' LEU . 97.1 m-85 -120.87 94.33 48.91 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 107.664 -1.236 . . . . 0.02 107.664 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.08 -4.47 11.6 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 120.781 0.988 . . . . 0.02 113.738 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -155.01 154.43 32.51 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.723 -1.236 . . . . 2.02 108.008 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.447 ' CE2' ' CD ' ' A' ' 70' ' ' GLN . 33.3 p90 -61.12 -38.74 87.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.514 -0.741 . . . . 0.02 111.396 -177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.447 ' CD ' ' CE2' ' A' ' 69' ' ' TYR . 12.8 mm100 -60.38 -24.39 65.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.102 -0.999 . . . . 0.02 110.058 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.551 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.06 -18.09 63.26 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.293 -1.003 . . . . 3.42 108.293 179.364 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.7 10.13 31.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.221 -1.4 . . . . 0.02 107.221 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.445 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.1 mpp? 59.2 21.9 10.06 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.664 0.745 . . . . 0.02 110.138 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.89 144.47 46.48 Favored Glycine 0 N--CA 1.486 1.987 0 N-CA-C 109.321 -1.512 . . . . 0.02 109.321 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.6 tp -78.32 -30.03 48.04 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.623 -1.251 . . . . 0.98 107.623 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.56 HD21 ' CD ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -157.96 -171.17 3.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.533 -1.654 . . . . 0.02 106.533 178.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 16.9 p-10 -98.21 28.3 4.13 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.682 -1.262 . . . . 0.02 110.403 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.4 OUTLIER -97.57 122.83 41.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.814 -1.179 . . . . 3.2 111.056 -178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD21 ' CH2' ' A' ' 72' ' ' TRP . 80.7 mt -142.33 122.01 13.42 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.286 -1.376 . . . . 2.61 107.286 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.46 -18.12 10.6 Favored Glycine 0 N--CA 1.503 3.136 0 O-C-N 120.985 -1.072 . . . . 0.02 112.302 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.4 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 28.4 t -156.14 155.86 33.24 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.463 -1.61 . . . . 0.02 110.277 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 70.4 m -144.33 147.63 33.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.615 -0.678 . . . . 0.02 109.791 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -135.02 140.22 45.47 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.28 -0.888 . . . . 0.01 109.111 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.71 134.92 37.05 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.262 -0.899 . . . . 0.43 108.753 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 38.7 t -93.26 123.09 45.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.554 -0.906 . . . . 1.25 108.554 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.464 ' O ' ' CG2' ' A' ' 135' ' ' THR . 50.1 m-70 -90.48 136.18 33.22 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.183 -1.043 . . . . 1.77 108.183 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mt -99.51 137.29 38.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.56 -0.712 . . . . 1.63 109.6 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.8 m -112.1 126.32 55.05 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.58 -0.896 . . . . 1.08 108.58 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.7 p -102.99 -155.47 0.53 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 106.262 -1.755 . . . . 1.26 106.262 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.16 -48.96 0.86 Allowed Glycine 0 N--CA 1.498 2.83 0 O-C-N 120.438 -1.414 . . . . 0.01 112.384 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.88 -99.58 0.13 Allowed Glycine 0 N--CA 1.489 2.209 0 C-N-CA 118.444 -1.836 . . . . 0.01 112.166 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -120.84 119.6 33.14 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.246 -1.149 . . . . 4.43 110.751 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.17 129.57 35.3 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.187 -0.671 . . . . 2.99 109.187 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -130.91 141.16 50.27 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.557 -0.714 . . . . 6.36 109.085 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.4 tt -129.78 144.84 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.319 -0.863 . . . . 1.09 109.949 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 1.4 pm0 -121.76 134.37 54.93 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.404 -1.332 . . . . 2.05 107.404 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.04 146.58 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 O-C-N 120.914 -1.116 . . . . 1.1 109.371 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.595 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 36.0 m-85 -120.23 141.64 49.75 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.158 0.98 . . . . 0.73 111.108 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -66.43 -30.05 70.32 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.699 -0.682 . . . . 0.02 111.816 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -116.29 168.09 10.44 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.956 -1.09 . . . . 3.18 110.54 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.94 164.14 43.77 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 111.153 -0.779 . . . . 0.01 111.153 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 56.54 39.23 29.98 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.675 0.75 . . . . 0.01 110.941 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 51.45 56.31 8.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.625 -0.672 . . . . 0.01 111.115 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -128.55 165.64 20.36 Favored 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.008 -1.108 . . . . 3.15 108.008 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.61 -164.08 27.69 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.151 -1.579 . . . . 0.01 109.151 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.66 144.32 43.87 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.983 -1.304 . . . . 0.01 108.411 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.595 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 12.8 ttt -116.5 141.74 47.79 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.619 0.723 . . . . 0.01 109.521 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -131.65 135.72 47.14 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.069 -1.085 . . . . 2.48 108.069 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -118.93 135.12 54.75 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.668 -0.645 . . . . 0.01 109.928 -178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.525 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 0.7 OUTLIER -149.64 151.55 33.94 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.392 1.091 . . . . 1.69 110.95 -179.71 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 18.6 p -111.05 9.68 22.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.396 -0.82 . . . . 0.01 109.923 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.51 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 30.5 mp0 -121.28 163.85 17.94 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.324 -0.86 . . . . 3.21 111.556 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -67.73 156.03 37.88 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.129 -1.063 . . . . 0.01 108.129 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.443 ' SG ' ' CZ ' ' A' ' 172' ' ' PHE . 12.3 m -124.83 111.67 27.3 Favored Pre-proline 0 N--CA 1.499 2.001 0 N-CA-C 108.753 -0.832 . . . . 0.01 108.753 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -76.21 -31.78 4.52 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 CA-C-N 119.958 1.021 . . . . 0.01 111.439 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 8.6 t -141.3 107.03 5.1 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.573 -0.899 . . . . 0.02 108.573 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.85 -39.28 85.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.81 -0.557 . . . . 1.83 111.139 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.441 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.5 tmt? -67.19 -38.2 84.98 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 118.97 -1.092 . . . . 1.34 109.892 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.14 -38.44 78.82 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.484 -1.385 . . . . 2.11 109.826 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -79.63 -47.4 15.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.253 -0.904 . . . . 2.08 112.38 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.12 -0.48 15.59 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.469 -0.769 . . . . 0.02 112.75 -176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m80 61.54 33.77 18.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.687 -1.258 . . . . 0.02 109.719 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.3 mt -113.8 136.21 53.11 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.371 -0.831 . . . . 0.02 109.256 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -89.46 -21.73 22.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.216 -0.928 . . . . 5.32 110.473 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -150.38 165.67 32.39 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.958 -1.088 . . . . 0.02 110.256 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.7 mm -129.87 126.57 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 107.219 -1.4 . . . . 2.17 107.219 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -108.97 -12.94 14.81 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.14 -0.975 . . . . 0.02 112.598 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 157' ' ' ARG . 21.1 m -158.16 152.34 24.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.764 -1.21 . . . . 0.01 108.753 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 8.8 t -166.51 142.81 4.75 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.099 -1.001 . . . . 1.22 109.152 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.531 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 31.4 ttpt -123.21 105.34 9.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 122.57 1.176 . . . . 1.41 109.504 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 131' ' ' VAL . 11.4 p -109.57 135.7 47.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.5 -1.296 . . . . 0.01 107.5 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -126.15 92.06 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 106.347 -1.723 . . . . 1.98 106.347 176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.58 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 24.3 tt0 -146.42 -67.39 0.28 Allowed 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 105.355 -2.091 . . . . 0.01 105.355 177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 145.55 -44.48 0.87 Allowed Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.342 -1.503 . . . . 0.01 109.342 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.74 ' HB ' HD12 ' A' ' 175' ' ' ILE . 61.8 p -129.13 106.55 8.93 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.331 -1.099 . . . . 2.3 112.205 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.58 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 14.3 m95 -132.95 145.54 50.99 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.549 -1.278 . . . . 0.01 107.549 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.424 ' CG1' HD11 ' A' ' 175' ' ' ILE . 25.3 mt -118.98 135.75 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.581 -1.324 . . . . 1.69 109.566 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.34 142.16 43.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 106.341 -1.725 . . . . 2.49 106.341 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.474 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 31.9 m-85 -122.23 143.53 49.53 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.113 -0.992 . . . . 0.02 109.364 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 47.4 tt0 -76.68 -30.03 56.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.747 -0.596 . . . . 0.02 111.833 -177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.1 mt -114.33 152.57 46.13 Favored Pre-proline 0 N--CA 1.505 2.303 0 O-C-N 120.562 -1.336 . . . . 1.48 109.064 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -53.72 165.64 1.7 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 120.65 0.9 . . . . 0.02 112.836 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 59.71 31.67 20.99 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.307 -0.86 . . . . 0.75 111.549 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 57.88 52.13 8.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.514 -0.742 . . . . 0.02 111.412 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.457 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.0 165.51 19.3 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.473 -0.767 . . . . 0.02 110.059 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.86 -165.54 33.36 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.962 -1.255 . . . . 0.02 109.962 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.5 ttt180 -69.83 143.59 52.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 0.02 108.94 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 58' ' ' MET . 16.6 mt-30 -113.08 149.5 33.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.711 -0.618 . . . . 0.02 110.085 -177.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.87 133.61 53.01 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 9.4 tp -95.92 121.58 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.944 -1.098 . . . . 0.01 109.785 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.525 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.7 mp -98.31 142.32 30.1 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.72 -0.845 . . . . 0.01 108.72 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 154' ' ' LYS . 95.1 m-20 -110.26 -172.55 2.06 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.445 -0.784 . . . . 2.27 109.739 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -71.64 37.45 0.06 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.393 -0.817 . . . . 1.84 109.636 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 152' ' ' ASP . 30.6 mmtp -112.31 168.74 9.39 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.413 -0.804 . . . . 2.28 109.3 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -104.34 127.0 51.92 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.039 -1.097 . . . . 0.01 108.039 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.42 ' CD2' ' OD2' ' A' ' 161' ' ' ASP . 54.8 m-85 -99.58 112.47 24.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.928 . . . . 0.01 110.258 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.444 ' O ' ' OG ' ' A' ' 128' ' ' SER . 78.7 mtt180 -89.31 -27.39 20.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.632 -0.667 . . . . 0.01 110.845 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -124.43 152.82 68.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 N-CA-C 108.134 -1.062 . . . . 2.54 108.134 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 7.8 Cg_endo -60.83 -40.25 55.37 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 CA-C-N 119.437 0.835 . . . . 0.7 111.005 178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 90.4 t -61.49 -18.83 19.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 O-C-N 120.724 -1.235 . . . . 0.86 109.67 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.42 ' OD2' ' CD2' ' A' ' 156' ' ' TYR . 39.2 t70 -65.4 -17.6 64.66 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.91 -1.119 . . . . 0.02 112.062 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.17 16.7 24.59 Favored 'General case' 0 N--CA 1.514 2.73 0 O-C-N 120.733 -1.23 . . . . 0.02 110.229 178.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.53 10.02 77.68 Favored Glycine 0 N--CA 1.497 2.76 0 O-C-N 121.174 -0.954 . . . . 0.02 112.874 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -99.11 139.81 34.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.85 -1.382 . . . . 0.02 110.146 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.64 -7.67 59.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.493 -0.754 . . . . 0.59 109.342 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.0 p -138.92 151.77 68.91 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.308 -0.87 . . . . 0.87 109.261 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.77 13.58 0.95 Allowed 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 120.756 0.971 . . . . 0.38 111.892 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.55 119.62 24.0 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.603 1.192 . . . . 0.18 111.039 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.508 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 0.9 OUTLIER -150.55 121.93 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.013 -1.847 . . . . 3.99 106.013 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.507 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 11.0 mp0 -113.69 -11.57 12.93 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.342 -0.849 . . . . 5.17 113.253 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 18.1 m -156.46 159.01 38.26 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.119 -2.238 . . . . 0.02 110.45 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.443 ' CZ ' ' SG ' ' A' ' 114' ' ' CYS . 25.3 p90 -152.79 154.34 34.97 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.029 -1.044 . . . . 2.02 110.3 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -144.21 149.88 37.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.359 -0.838 . . . . 0.01 110.125 -179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -87.05 141.97 28.28 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.311 -0.996 . . . . 0.01 108.311 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.74 HD12 ' HB ' ' A' ' 135' ' ' THR . 24.6 mt -93.71 129.54 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.325 -0.859 . . . . 3.04 109.411 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 m -138.28 149.15 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.351 -0.843 . . . . 1.89 109.756 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.389 -0.819 . . . . 4.89 109.56 179.474 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.357 -0.609 . . . . 5.28 109.357 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -74.35 93.52 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.911 . . . . 5.96 109.437 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.547 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -101.3 -141.28 0.34 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.677 -1.231 . . . . 2.22 107.677 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.547 ' H ' HG22 ' A' ' 3' ' ' THR . . . 174.21 87.36 0.07 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 107.16 -2.376 . . . . 0.81 107.16 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.57 149.31 33.31 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.162 -1.018 . . . . 0.01 110.683 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -150.88 136.84 18.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.496 -1.002 . . . . 0.02 109.493 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -129.9 140.42 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 109.2 -0.666 . . . . 0.02 109.2 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.481 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -122.03 130.23 53.11 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.571 -0.705 . . . . 0.39 109.642 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 24.6 m-85 -110.31 140.13 44.8 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.007 -0.738 . . . . 0.02 109.007 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.0 m-85 -121.98 138.45 54.42 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.339 -0.851 . . . . 0.02 109.546 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.406 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 66.2 mt-10 -68.14 -27.82 66.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -0.989 . . . . 0.03 111.706 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -114.26 170.03 8.59 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.867 -1.146 . . . . 0.03 110.468 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -75.22 158.26 33.24 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.498 0.666 . . . . 0.03 110.058 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.603 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.9 m-80 66.2 34.65 6.52 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.826 0.822 . . . . 0.74 110.767 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.95 45.22 25.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.668 0.746 . . . . 0.02 111.428 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -113.24 165.88 11.99 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.022 -1.103 . . . . 0.02 108.022 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.66 -167.71 35.43 Favored Glycine 0 N--CA 1.496 2.674 0 O-C-N 120.793 -1.192 . . . . 0.03 110.912 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -68.61 142.74 55.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.45 -1.03 . . . . 2.76 109.279 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -120.02 148.65 43.3 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.597 -0.69 . . . . 1.89 110.23 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -132.33 127.06 34.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.257 -1.016 . . . . 0.02 108.257 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -111.81 136.51 50.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.483 -0.761 . . . . 1.12 109.762 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -130.91 138.02 49.58 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.573 0.701 . . . . 0.02 109.512 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -116.47 11.29 14.83 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.623 -0.673 . . . . 0.2 109.477 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 19.9 p -157.79 174.15 15.73 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.195 -1.039 . . . . 1.23 108.195 179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 19.3 p30 -61.11 144.66 53.14 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.72 -1.238 . . . . 0.02 109.955 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.4 t -131.76 116.53 17.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.415 -0.957 . . . . 0.02 108.415 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -23.59 52.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.26 -0.9 . . . . 0.24 110.733 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -156.58 100.71 1.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.676 -0.861 . . . . 1.14 108.676 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -104.89 10.46 34.33 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 122.175 0.988 . . . . 6.37 109.799 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.427 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.4 mmp_? -59.27 -23.44 62.39 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.68 -0.638 . . . . 3.11 111.018 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 p -75.5 -17.0 60.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.685 -1.259 . . . . 0.88 110.185 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 26.2 m-85 -104.26 -21.74 13.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.495 -0.753 . . . . 0.02 109.132 -179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.6 tp -148.53 126.42 11.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 3.32 109.41 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.8 m -86.29 -11.54 51.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.463 -0.773 . . . . 0.02 111.405 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.45 ' O ' ' CD2' ' A' ' 33' ' ' LEU . 11.2 tpp180 -170.65 160.39 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.697 -1.223 . . . . 0.02 107.697 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.9 t -140.89 114.61 8.93 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.897 -1.127 . . . . 0.02 109.455 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 11' ' ' GLU . 2.7 m120 -108.2 -0.96 20.63 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.94 -1.1 . . . . 0.03 110.535 -179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 42.6 m -155.7 153.59 30.2 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.032 -1.099 . . . . 0.02 108.032 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.1 mt -145.14 146.91 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.1 -1.0 . . . . 0.02 110.063 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -123.11 123.92 41.92 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.78 -1.193 . . . . 0.02 107.78 176.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 38.3 t -106.52 114.17 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -84.0 -33.74 24.49 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.567 -0.708 . . . . 3.81 110.234 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.46 18.0 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 119.109 -1.519 . . . . 0.02 110.048 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.79 173.41 49.72 Favored Glycine 0 N--CA 1.488 2.131 0 C-N-CA 119.487 -1.34 . . . . 0.01 110.04 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 42.2 m -120.39 138.03 53.98 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.107 -1.072 . . . . 1.48 108.107 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 48.7 m95 -126.99 154.43 44.62 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.559 1.171 . . . . 0.02 112.057 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.54 133.57 51.81 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 104.938 -2.245 . . . . 0.24 104.938 176.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.1 m -116.7 141.42 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 109.178 -0.675 . . . . 0.65 109.178 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -121.06 144.18 48.68 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.184 0.992 . . . . 0.02 109.706 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.36 -34.51 78.32 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.339 -0.846 . . . . 0.02 111.459 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -124.09 157.81 62.68 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.238 -0.914 . . . . 0.02 109.328 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.67 167.52 0.97 Allowed 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.762 1.641 . . . . 0.02 112.563 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' ND2' ' O ' ' A' ' 53' ' ' ASN . 2.0 t30 63.27 37.12 11.31 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.457 -0.792 . . . . 0.02 111.211 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.507 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 1.8 m-85 45.35 51.26 9.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.613 -0.679 . . . . 3.39 110.819 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 74.5 m -125.75 163.91 21.82 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.153 0.501 . . . . 2.33 109.994 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.52 -162.01 31.53 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.715 -1.354 . . . . 0.02 109.715 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.0 m170 -65.57 137.25 57.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.936 -1.332 . . . . 0.02 109.806 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.468 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 16.4 ptm -117.66 136.35 53.38 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.487 0.66 . . . . 5.01 109.692 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 86.1 m-85 -133.62 139.87 46.76 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.484 -0.76 . . . . 0.02 109.49 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.7 132.03 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 108.715 -0.846 . . . . 1.72 108.715 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.487 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.5 mt -122.25 109.42 33.28 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.57 -0.706 . . . . 0.02 110.206 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -75.49 170.64 19.83 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 CA-C-N 119.893 0.998 . . . . 1.47 110.352 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 41' ' ' VAL . 1.1 tm0? -51.83 140.26 19.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 4.25 109.862 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' N ' ' CD ' ' A' ' 63' ' ' GLN . . . 155.53 -177.79 32.49 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.486 -1.34 . . . . 0.02 110.565 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.525 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -120.63 131.3 54.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.516 -0.991 . . . . 0.96 109.305 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 64.8 m-85 -122.42 93.56 48.4 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 107.866 -1.161 . . . . 0.02 107.866 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.06 -3.68 7.61 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.034 1.156 . . . . 0.02 113.92 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -156.87 152.95 27.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.379 -1.451 . . . . 2.02 107.91 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -60.07 -38.7 83.63 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.612 -0.68 . . . . 0.02 111.977 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -60.5 -24.85 65.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.144 -0.972 . . . . 0.02 110.603 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -17.98 63.65 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.147 -0.97 . . . . 3.42 108.999 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.6 OUTLIER -106.89 12.06 29.28 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.277 -1.379 . . . . 0.02 107.277 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 37.2 mtp 60.2 21.85 11.2 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.528 0.68 . . . . 0.02 110.214 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.92 144.65 46.44 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.386 -1.486 . . . . 0.02 109.386 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.7 tp -79.24 -30.45 43.16 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.549 -1.278 . . . . 0.98 107.549 177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.496 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 51.6 t30 -156.98 -171.92 3.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 106.397 -1.705 . . . . 0.02 106.397 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 30.6 p-10 -98.58 27.93 4.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.66 -1.275 . . . . 0.02 110.208 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -96.0 122.55 38.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.848 -1.157 . . . . 3.2 110.638 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 48' ' ' VAL . 51.3 mt -143.48 121.48 12.08 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.808 -1.182 . . . . 2.61 107.808 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.11 -17.71 9.31 Favored Glycine 0 N--CA 1.502 3.049 0 O-C-N 121.26 -0.9 . . . . 0.02 112.641 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.425 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 5.1 t -155.53 155.77 33.99 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.043 -1.857 . . . . 0.02 110.867 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.9 p -145.5 147.72 32.46 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.497 -0.752 . . . . 0.02 110.653 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 13.8 mtp180 -136.67 141.83 43.15 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.516 -0.74 . . . . 0.01 109.288 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.12 130.35 36.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.43 109.451 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.6 t -90.18 123.55 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.608 -0.886 . . . . 1.25 108.608 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -90.3 135.41 33.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.14 -0.975 . . . . 1.77 108.703 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mt -99.65 138.66 36.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.729 -0.841 . . . . 1.63 108.729 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.6 p -113.2 125.67 54.59 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.942 -0.762 . . . . 1.08 108.942 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.0 t -102.79 -155.4 0.52 Allowed 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 105.992 -1.855 . . . . 1.26 105.992 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.74 -47.35 0.95 Allowed Glycine 0 N--CA 1.498 2.812 0 O-C-N 120.356 -1.465 . . . . 0.01 112.345 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 176.53 -98.86 0.12 Allowed Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.433 -1.841 . . . . 0.01 112.181 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.563 ' NE2' HG22 ' A' ' 111' ' ' THR . 16.7 tm0? -119.56 117.97 29.78 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.222 -1.163 . . . . 4.43 110.317 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.516 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.0 132.1 39.96 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.304 -0.628 . . . . 2.99 109.304 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' CB ' ' NZ ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -131.01 137.42 49.19 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.028 -0.73 . . . . 6.36 109.028 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 110' ' ' THR . 5.6 tt -125.22 142.61 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-O 121.874 0.845 . . . . 1.09 109.139 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.481 ' CG ' ' O ' ' A' ' 130' ' ' LYS . 11.0 pt20 -124.77 132.26 53.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.744 -1.206 . . . . 2.05 107.744 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.06 148.15 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 120.919 -1.113 . . . . 1.1 109.659 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -117.97 140.96 48.99 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.042 0.925 . . . . 0.73 110.849 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -66.59 -30.12 70.34 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.938 -0.574 . . . . 0.02 111.765 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.443 ' O ' ' OG ' ' A' ' 128' ' ' SER . 83.3 mttt -116.57 168.4 10.21 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 120.983 -1.073 . . . . 3.18 110.49 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.21 164.59 44.09 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 111.038 -0.825 . . . . 0.01 111.038 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 56.71 39.18 29.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.635 0.731 . . . . 0.01 111.117 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.53 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.5 m-85 52.53 55.68 8.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.583 -0.698 . . . . 0.01 111.076 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -129.65 166.32 20.02 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.515 -0.92 . . . . 3.15 108.515 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.79 -164.71 27.85 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.277 -1.529 . . . . 0.01 109.277 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -75.26 145.11 42.17 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.009 -1.289 . . . . 0.01 108.619 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.484 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 9.9 tmm? -116.51 141.72 47.81 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.633 0.73 . . . . 0.01 109.772 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.484 ' N ' ' SD ' ' A' ' 107' ' ' MET . 59.8 m-85 -130.32 135.17 47.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.888 -1.153 . . . . 2.48 107.888 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -121.32 135.01 55.15 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.727 -0.608 . . . . 0.01 109.809 -178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.5 t -149.55 153.63 37.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 122.242 1.02 . . . . 1.69 110.786 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.563 HG22 ' NE2' ' A' ' 92' ' ' GLN . 34.9 p -110.43 9.41 23.38 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 115.646 -0.706 . . . . 0.01 109.933 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -121.39 163.07 19.3 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.381 -0.824 . . . . 3.21 111.384 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.32 155.0 38.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.193 -1.04 . . . . 0.01 108.193 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.501 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 29.4 t -124.15 111.42 28.63 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.77 -31.86 4.97 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 CA-C-N 120.134 1.084 . . . . 0.01 111.554 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -141.6 108.33 5.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.22 -0.925 . . . . 0.02 108.959 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 28.8 mt -62.97 -38.75 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.853 -0.529 . . . . 1.83 110.408 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 30.9 ttm -66.5 -37.26 84.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.12 -1.032 . . . . 1.34 109.831 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -70.91 -39.34 72.78 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.44 -1.412 . . . . 2.11 109.69 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.54 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 6.6 tt0 -80.85 -48.2 12.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.132 -0.98 . . . . 2.08 112.679 -176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.54 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 62.5 m-85 -111.95 -1.79 15.33 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.376 -0.828 . . . . 0.02 112.491 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 61.23 33.84 18.99 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.873 -1.142 . . . . 0.02 109.589 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 52.6 mt -114.02 135.44 54.0 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.413 -0.804 . . . . 0.02 109.195 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.409 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 9.3 ptp180 -90.68 -21.7 21.5 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.126 -0.984 . . . . 5.32 111.276 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 47.9 mt-10 -149.41 164.97 33.48 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.721 -1.237 . . . . 0.02 110.668 -178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 11.8 mm -127.66 123.81 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.726 -1.213 . . . . 2.17 107.726 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -109.11 -14.78 14.46 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.11 -0.994 . . . . 0.02 112.642 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.53 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 23.6 p -160.91 153.71 21.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.572 -1.33 . . . . 0.01 108.941 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 1.8 t -167.0 141.02 3.79 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.628 -0.878 . . . . 1.22 108.628 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.538 ' NZ ' ' OE2' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -121.26 97.4 5.5 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.133 -1.062 . . . . 1.41 108.133 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.678 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.9 p -109.83 142.59 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.396 -0.965 . . . . 0.01 108.396 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.1 t -126.77 92.29 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 106.192 -1.781 . . . . 1.98 106.192 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 26.2 tt0 -147.21 -68.24 0.25 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.377 -1.342 . . . . 0.01 107.377 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.14 -14.19 13.78 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 107.633 -2.187 . . . . 0.01 107.633 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.7 p -122.55 66.93 0.95 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.789 -0.83 . . . . 2.3 111.283 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.678 ' CD1' HG21 ' A' ' 131' ' ' VAL . 81.9 m95 -131.18 133.1 45.21 Favored 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.86 -1.15 . . . . 0.01 110.318 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.3 mt -119.72 136.21 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.304 -0.998 . . . . 1.69 108.304 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -112.58 142.36 45.25 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 106.67 -1.604 . . . . 2.49 106.67 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.484 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 20.3 m-85 -123.42 145.99 48.36 Favored 'General case' 0 N--CA 1.508 2.456 0 O-C-N 121.161 -0.962 . . . . 0.02 110.081 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -75.04 -31.19 61.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.02 111.465 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.7 mt -115.6 155.75 46.99 Favored Pre-proline 0 N--CA 1.505 2.276 0 O-C-N 120.68 -1.263 . . . . 1.48 108.985 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -57.44 167.53 3.63 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.101 1.201 . . . . 0.02 112.741 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 9.9 t30 59.4 31.44 21.09 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.192 -0.913 . . . . 0.75 111.325 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 57.88 51.77 8.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.5 -0.75 . . . . 0.02 110.952 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.49 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.36 164.82 20.23 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.51 -0.744 . . . . 0.02 109.791 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.425 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.55 -165.62 33.9 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.279 -1.129 . . . . 0.02 110.279 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.58 142.36 53.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.499 -1.001 . . . . 0.02 108.825 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.468 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.3 mt-30 -113.06 148.14 35.81 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.34 0.591 . . . . 0.02 109.826 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -122.86 132.66 54.29 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.436 -0.95 . . . . 0.01 108.436 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.3 tp -95.36 121.56 37.15 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.933 -1.105 . . . . 0.01 109.702 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.03 161.22 13.92 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.796 -1.187 . . . . 0.01 107.796 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -111.38 -110.46 0.34 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.413 -0.805 . . . . 2.27 109.801 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -151.16 31.08 0.61 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 1.84 109.03 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -109.73 -165.42 1.01 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.974 -0.75 . . . . 2.28 108.974 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.538 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 2.7 mm-40 -106.26 118.37 36.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.517 -0.739 . . . . 0.01 109.419 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -97.4 113.13 24.74 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.565 -0.902 . . . . 0.01 108.565 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -90.09 -27.4 19.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.487 -0.758 . . . . 0.01 111.625 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -127.0 156.26 74.52 Favored Pre-proline 0 N--CA 1.499 2.01 0 O-C-N 120.738 -1.226 . . . . 2.54 108.064 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.14 -38.84 53.11 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.51 0.807 . . . . 0.7 111.282 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.48 -19.39 18.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 120.856 -1.152 . . . . 0.86 109.914 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -65.76 -18.32 65.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.823 -1.173 . . . . 0.02 112.111 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.36 16.28 26.1 Favored 'General case' 0 N--CA 1.515 2.776 0 O-C-N 120.722 -1.236 . . . . 0.02 110.191 178.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.25 10.69 77.25 Favored Glycine 0 N--CA 1.497 2.756 0 O-C-N 121.104 -0.998 . . . . 0.02 112.806 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.52 140.57 34.59 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.861 -1.376 . . . . 0.02 110.303 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.6 -7.95 58.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.696 -0.628 . . . . 0.59 109.715 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 15.1 p -140.67 150.85 61.59 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.227 -0.92 . . . . 0.87 109.33 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -76.59 14.48 1.21 Allowed 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.903 1.068 . . . . 0.38 112.304 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -81.7 121.28 26.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.891 -1.13 . . . . 0.18 111.231 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.5 mp -153.1 124.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 106.469 -1.678 . . . . 3.99 106.469 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -114.15 -8.72 12.97 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.425 -0.797 . . . . 5.17 113.143 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.7 p -157.22 158.69 36.65 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 119.359 -2.088 . . . . 0.02 109.448 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -152.82 154.21 34.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.283 -0.886 . . . . 2.02 110.147 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 81.5 mtm180 -144.48 150.34 37.45 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.265 -0.897 . . . . 0.01 110.296 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.408 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.4 ptt180 -87.52 142.71 27.65 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.703 -0.851 . . . . 0.01 108.703 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.4 HG21 HD13 ' A' ' 175' ' ' ILE . 3.3 mt -94.46 128.61 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.311 -0.868 . . . . 3.04 109.329 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 31.7 m -138.11 148.47 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.127 -0.983 . . . . 1.89 110.009 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.45 -0.781 . . . . 4.89 109.435 179.569 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.431 -0.581 . . . . 5.28 109.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.2 mtpm? -76.72 92.58 3.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.396 -0.815 . . . . 5.96 109.538 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 49.2 p -101.1 -141.69 0.34 Allowed 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.537 -1.283 . . . . 2.22 107.537 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.35 86.51 0.06 OUTLIER Glycine 0 N--CA 1.495 2.593 0 N-CA-C 107.095 -2.402 . . . . 0.81 107.095 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.06 148.88 33.59 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.174 -1.012 . . . . 0.01 110.625 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -150.72 136.72 18.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.536 -0.979 . . . . 0.02 109.077 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.2 tt -129.71 140.42 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.897 -0.779 . . . . 0.02 108.897 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.524 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 1.5 t -121.88 129.97 52.99 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.483 -0.76 . . . . 0.39 109.644 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 7.7 m-85 -109.68 139.96 44.1 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.572 -0.899 . . . . 0.02 108.572 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.537 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.9 m-85 -122.05 138.67 54.35 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.229 -0.92 . . . . 0.02 109.646 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.485 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.23 -27.67 66.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.919 -1.113 . . . . 0.03 111.736 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.63 170.4 8.34 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.869 -1.144 . . . . 0.03 110.11 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -75.39 161.34 29.33 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.738 0.78 . . . . 0.03 110.217 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 m120 63.04 34.95 13.43 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.933 0.873 . . . . 0.74 110.433 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.8 p90 49.51 42.52 22.89 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.39 -0.823 . . . . 0.02 110.907 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -109.11 166.07 11.12 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.34 -168.14 34.76 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 120.739 -1.225 . . . . 0.03 110.669 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -70.05 145.3 51.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.474 -1.016 . . . . 2.76 109.098 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -120.4 149.24 42.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.594 -0.692 . . . . 1.89 110.272 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -132.07 126.99 35.15 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.942 -1.133 . . . . 0.02 107.942 178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.33 136.7 51.46 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.476 -0.765 . . . . 1.12 110.02 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.1 t -131.14 137.96 49.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.56 0.695 . . . . 0.02 109.471 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -116.59 10.7 14.53 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.672 -0.643 . . . . 0.2 109.503 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 52.8 t -157.71 173.84 16.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.134 -1.061 . . . . 1.23 108.134 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.506 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.6 p30 -60.85 144.29 53.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.683 -1.261 . . . . 0.02 110.087 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.4 t -131.52 116.9 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.438 -0.949 . . . . 0.02 108.438 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.23 -25.89 52.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.192 -0.942 . . . . 0.24 110.537 -178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -153.48 100.61 2.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.14 -0.975 . . . . 1.14 108.701 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -104.21 9.21 36.21 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.285 1.04 . . . . 6.37 109.39 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.7 mtm180 -58.68 -24.03 60.53 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.515 -0.741 . . . . 3.11 110.571 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 m -74.39 -16.84 60.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.16 . . . . 0.88 110.057 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -103.66 -22.14 13.62 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.357 -0.84 . . . . 0.02 109.272 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.9 tp -150.06 128.47 12.18 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 3.32 109.014 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.1 p -85.33 -9.87 57.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.689 -0.632 . . . . 0.02 110.964 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.91 163.01 6.17 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.808 -1.182 . . . . 0.02 107.808 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.3 t -142.7 115.51 8.71 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.873 -1.142 . . . . 0.02 108.709 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -108.64 0.91 20.92 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 120.854 -1.154 . . . . 0.03 110.601 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.1 t -156.67 153.45 28.51 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.6 mt -145.12 148.14 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.013 -1.054 . . . . 0.02 109.969 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -124.7 124.69 42.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.348 -1.353 . . . . 0.02 107.348 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 t -105.46 114.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 107.099 -1.445 . . . . 0.02 107.099 177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.61 -34.47 25.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 3.81 109.855 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.28 17.53 Favored Glycine 0 N--CA 1.486 1.99 0 C-N-CA 118.698 -1.715 . . . . 0.02 110.433 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.96 173.26 49.66 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.547 -1.311 . . . . 0.01 110.23 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 26.0 m -120.01 136.13 54.67 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.806 -1.183 . . . . 1.48 107.806 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 38.5 m95 -125.17 154.5 41.44 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 122.518 1.152 . . . . 0.02 112.159 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.12 133.44 52.39 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 104.964 -2.235 . . . . 0.24 104.964 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.23 141.05 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.902 -0.777 . . . . 0.65 108.902 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -120.58 143.56 48.56 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 122.261 1.029 . . . . 0.02 109.224 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 8.1 tp10 -66.1 -35.23 79.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.254 -0.885 . . . . 0.02 111.359 -177.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 50' ' ' GLU . 10.4 mpt_? -122.75 158.05 58.02 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 121.114 -0.991 . . . . 0.02 109.402 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -54.51 166.7 1.7 Allowed 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.46 1.44 . . . . 0.02 112.567 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 t30 63.12 37.36 11.5 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.382 -0.827 . . . . 0.02 111.173 178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 44.67 52.57 7.71 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.674 0.749 . . . . 3.39 110.773 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -126.4 163.75 22.61 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.114 0.483 . . . . 2.33 109.705 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.4 -161.62 32.73 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.719 -1.352 . . . . 0.02 109.719 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -66.22 137.54 57.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.968 -1.313 . . . . 0.02 110.139 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.499 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.2 ptm -121.27 136.53 54.96 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.664 -0.648 . . . . 5.01 109.482 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.657 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 51.4 m-85 -133.32 142.03 48.26 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.553 -0.717 . . . . 0.02 109.418 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.0 mm -96.14 132.56 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.127 -0.694 . . . . 1.72 109.127 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 1.1 mt -121.73 109.69 34.04 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 121.481 -0.762 . . . . 0.02 110.391 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -75.81 169.78 21.51 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.033 1.048 . . . . 1.47 110.403 177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -53.06 140.18 26.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.908 -1.12 . . . . 4.25 110.572 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.18 -177.23 32.52 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.614 -1.279 . . . . 0.02 110.386 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -118.98 129.94 55.42 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.471 -1.017 . . . . 0.96 109.413 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 46.0 m-85 -120.82 95.48 48.93 Favored Pre-proline 0 N--CA 1.493 1.682 0 N-CA-C 107.79 -1.189 . . . . 0.02 107.79 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -67.32 -3.9 10.81 Favored 'Trans proline' 0 N--CA 1.489 1.207 0 C-N-CA 120.682 0.921 . . . . 0.02 113.666 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -156.82 154.28 29.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.433 -1.417 . . . . 2.02 108.254 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -60.37 -38.57 84.31 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.582 -0.699 . . . . 0.02 111.654 -177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -60.63 -24.54 65.61 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.028 -1.045 . . . . 0.02 110.336 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.68 -18.23 64.23 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.956 0.884 . . . . 3.42 108.831 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.657 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.64 11.86 28.12 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.333 -1.358 . . . . 0.02 107.333 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.5 mpt? 59.49 22.78 11.35 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.504 0.669 . . . . 0.02 110.243 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.53 146.35 46.62 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.253 -1.539 . . . . 0.02 109.253 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.8 tp -79.63 -30.63 41.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -1.177 . . . . 0.98 108.013 178.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.598 HD22 ' H ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -157.65 -170.89 3.36 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -98.64 27.85 4.6 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.776 -1.203 . . . . 0.02 110.436 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.3 OUTLIER -96.31 122.5 39.25 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.081 -1.012 . . . . 3.2 110.0 -178.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD21 ' CH2' ' A' ' 72' ' ' TRP . 62.5 mt -143.5 122.66 12.93 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.957 -1.127 . . . . 2.61 107.957 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' HA3' HH12 ' A' ' 78' ' ' ARG . . . -109.98 -17.82 9.3 Favored Glycine 0 N--CA 1.5 2.933 0 O-C-N 121.168 -0.957 . . . . 0.02 112.732 -177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 t -156.1 156.1 33.73 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 119.978 -1.896 . . . . 0.02 110.857 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 39.2 t -145.47 147.54 32.29 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.463 -0.773 . . . . 0.02 110.254 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -135.64 140.8 44.81 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.921 -0.77 . . . . 0.01 108.921 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.96 132.29 37.8 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.092 -1.005 . . . . 0.43 108.679 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.5 t -92.29 124.14 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.438 -0.949 . . . . 1.25 108.438 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -91.41 134.66 34.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.104 -0.998 . . . . 1.77 108.575 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.3 mt -97.6 137.97 35.72 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.456 -0.942 . . . . 1.63 108.456 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -110.9 125.65 53.88 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.483 -0.932 . . . . 1.08 108.483 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.0 m -103.28 -155.0 0.51 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 135.59 -48.53 0.92 Allowed Glycine 0 N--CA 1.498 2.809 0 O-C-N 120.458 -1.401 . . . . 0.01 112.055 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.38 -99.33 0.13 Allowed Glycine 0 N--CA 1.489 2.202 0 C-N-CA 118.592 -1.766 . . . . 0.01 112.187 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.2 OUTLIER -122.29 120.12 33.14 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.402 -1.057 . . . . 4.43 110.653 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.37 129.83 37.17 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.914 -0.714 . . . . 2.99 109.142 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -131.48 139.53 49.35 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.481 -0.762 . . . . 6.36 109.334 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.2 tt -129.83 145.58 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.389 -0.819 . . . . 1.09 109.85 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.02 133.63 55.26 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.284 -1.376 . . . . 2.05 107.284 177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.1 m -123.68 147.11 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.852 -1.155 . . . . 1.1 109.419 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.551 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.3 m-85 -119.3 141.61 48.84 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.055 0.931 . . . . 0.73 111.07 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -66.27 -29.85 70.16 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.919 -0.582 . . . . 0.02 111.589 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.54 168.08 10.49 Favored 'General case' 0 N--CA 1.506 2.331 0 O-C-N 120.933 -1.105 . . . . 3.18 110.696 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.64 164.07 42.75 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.989 -0.844 . . . . 0.01 110.989 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 24.5 t0 56.56 39.47 29.85 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.65 0.738 . . . . 0.01 110.951 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.484 ' H ' ' CB ' ' A' ' 128' ' ' SER . 6.2 m-85 52.49 55.36 9.2 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.688 -0.633 . . . . 0.01 111.038 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -128.63 165.81 20.09 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.468 -0.938 . . . . 3.15 108.468 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.11 -164.94 27.59 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.23 -1.548 . . . . 0.01 109.23 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -74.53 144.57 44.02 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.951 -1.323 . . . . 0.01 108.3 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.551 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 24.2 ttp -116.53 142.27 47.1 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.554 0.692 . . . . 0.01 109.804 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -131.56 136.0 47.48 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.05 -1.093 . . . . 2.48 108.05 178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.8 tm-20 -120.25 135.35 55.02 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.446 -0.784 . . . . 0.01 110.145 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.534 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -149.2 151.64 34.64 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.277 1.037 . . . . 1.69 111.0 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 63.3 p -110.73 9.39 22.75 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.606 -0.725 . . . . 0.01 110.009 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -121.1 163.32 18.58 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.291 -0.881 . . . . 3.21 111.366 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.02 155.29 39.02 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.213 -1.032 . . . . 0.01 108.213 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.55 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 34.9 t -125.44 113.67 25.56 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.752 -0.832 . . . . 0.01 108.752 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.33 -29.08 8.08 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.388 1.174 . . . . 0.01 111.278 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.1 t -142.53 109.88 5.67 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 0.02 109.359 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 169' ' ' ILE . 81.0 mt -61.99 -39.62 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 122.003 -0.435 . . . . 1.83 110.149 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.0 ttt -68.44 -37.37 80.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.425 -0.91 . . . . 1.34 110.447 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -70.44 -39.37 74.38 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.433 -1.417 . . . . 2.11 109.908 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.55 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 8.6 tt0 -79.46 -47.67 15.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.08 112.428 -176.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.458 ' CZ ' ' CD ' ' A' ' 120' ' ' GLN . 28.2 m-85 -110.8 0.52 17.32 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.434 -0.791 . . . . 0.02 112.628 -176.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.1 m80 60.63 33.19 20.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.682 -1.261 . . . . 0.02 109.507 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mt -113.51 135.23 54.12 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 108.749 -0.834 . . . . 0.02 108.749 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.62 -21.56 22.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.378 -0.826 . . . . 5.32 110.276 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -150.76 165.87 32.17 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.135 -0.978 . . . . 0.02 109.992 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.1 mt -131.73 128.63 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 N-CA-C 107.212 -1.403 . . . . 2.17 107.212 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.2 m-70 -108.89 -12.44 14.89 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.539 -0.726 . . . . 0.02 112.256 -177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.484 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 10.1 t -159.51 152.72 22.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.918 -1.114 . . . . 0.01 108.555 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 19.8 p -163.41 145.87 9.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 1.22 109.665 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -116.61 102.93 9.89 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.701 -1.249 . . . . 1.41 108.591 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 131' ' ' VAL . 4.3 p -113.54 128.3 70.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.604 -1.258 . . . . 0.01 107.604 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.9 t -129.02 89.28 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 106.563 -1.643 . . . . 1.98 106.563 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.402 ' OE1' ' OG1' ' A' ' 135' ' ' THR . 1.8 tm-20 -150.82 -64.88 0.19 Allowed 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 105.88 -1.896 . . . . 0.01 105.88 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 120.73 -10.08 10.49 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 107.742 -2.143 . . . . 0.01 107.742 -178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.402 ' OG1' ' OE1' ' A' ' 133' ' ' GLU . 1.7 p -125.89 70.86 1.22 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.713 -0.874 . . . . 2.3 111.911 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -134.87 135.89 42.0 Favored 'General case' 0 N--CA 1.511 2.616 0 O-C-N 120.337 -1.477 . . . . 0.01 110.274 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -120.13 137.45 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.322 -0.992 . . . . 1.69 108.322 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.429 ' CG ' HD11 ' A' ' 151' ' ' LEU . 3.3 m-30 -111.3 142.03 44.06 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 106.827 -1.546 . . . . 2.49 106.827 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 24.7 m-85 -123.37 143.76 49.91 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.044 -1.035 . . . . 0.02 109.712 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.0 -31.24 62.86 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.796 -0.565 . . . . 0.02 111.854 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mt -115.28 155.36 47.01 Favored Pre-proline 0 N--CA 1.504 2.267 0 O-C-N 120.67 -1.269 . . . . 1.48 108.899 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -57.22 166.66 4.11 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.186 1.257 . . . . 0.02 112.832 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 11.3 m120 59.77 31.26 20.72 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.2 -0.909 . . . . 0.75 111.386 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.511 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.1 m-85 58.11 52.23 7.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.629 -0.669 . . . . 0.02 111.327 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -126.49 165.15 19.64 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.529 -0.732 . . . . 0.02 109.954 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.96 -165.34 34.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -69.06 141.55 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.531 -0.982 . . . . 0.02 108.723 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.499 ' O ' ' CG ' ' A' ' 58' ' ' MET . 2.2 mt-30 -113.86 150.12 34.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.543 -0.539 . . . . 0.02 109.543 -177.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -123.76 132.91 53.9 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.567 -0.901 . . . . 0.01 108.567 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 40.8 tp -94.93 120.24 34.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.765 -1.21 . . . . 0.01 108.892 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 138' ' ' PHE . 10.4 mt -102.48 140.22 37.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 154' ' ' LYS . 27.8 m-20 -108.5 -163.27 0.87 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.53 -0.731 . . . . 2.27 109.474 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -75.12 40.99 0.16 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.898 . . . . 1.84 109.588 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 152' ' ' ASP . 18.6 ttmt -113.55 162.25 16.41 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.622 -0.674 . . . . 2.28 109.413 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 3.3 mp0 -103.32 130.43 50.59 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.899 -1.148 . . . . 0.01 107.899 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' TYR . 49.1 m-85 -102.5 112.11 24.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.917 . . . . 0.01 110.515 -178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -90.06 -27.13 19.9 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.01 110.432 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -123.77 153.91 66.98 Favored Pre-proline 0 N--CA 1.496 1.851 0 N-CA-C 107.63 -1.248 . . . . 2.54 107.63 178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.05 -41.47 35.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 CA-C-N 119.202 0.751 . . . . 0.7 111.047 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.35 -18.53 16.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 120.812 -1.18 . . . . 0.86 109.389 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 58.7 t0 -65.55 -18.87 65.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.808 -1.182 . . . . 0.02 112.029 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.08 15.92 27.12 Favored 'General case' 0 N--CA 1.513 2.721 0 O-C-N 120.705 -1.247 . . . . 0.02 110.311 178.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.61 10.82 75.82 Favored Glycine 0 N--CA 1.498 2.829 0 O-C-N 121.192 -0.942 . . . . 0.02 112.91 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.523 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.87 140.35 35.28 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.862 -1.375 . . . . 0.02 110.124 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.43 -6.94 59.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.6 -0.687 . . . . 0.59 109.574 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.2 m -139.43 151.18 66.28 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.19 -0.944 . . . . 0.87 109.548 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.515 ' O ' HD12 ' A' ' 169' ' ' ILE . 35.3 Cg_endo -75.34 14.72 0.89 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.934 1.089 . . . . 0.38 112.173 178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -84.9 122.1 28.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.178 -0.951 . . . . 0.18 111.794 -177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.515 HD12 ' O ' ' A' ' 167' ' ' PRO . 4.1 mp -147.6 127.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 106.112 -1.81 . . . . 3.99 106.112 176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -110.68 -14.26 14.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.308 -0.87 . . . . 5.17 112.675 -177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 11.6 t -156.59 158.7 37.57 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 119.389 -2.07 . . . . 0.02 110.068 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -150.38 151.9 33.55 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.192 -0.942 . . . . 2.02 109.889 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.511 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.5 mtp180 -143.87 150.3 38.23 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.173 -0.955 . . . . 0.01 110.543 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -87.75 143.32 27.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.423 -0.954 . . . . 0.01 108.423 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 175' ' ' ILE . 2.6 mt -96.68 129.97 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.404 -0.81 . . . . 3.04 109.563 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.458 ' O ' ' C ' ' A' ' 177' ' ' GLU . 57.5 t -137.24 148.26 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.268 -0.895 . . . . 1.89 109.336 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 176' ' ' VAL . 1.4 pp20? . . . . . 0 N--CA 1.505 2.282 0 CA-C-O 121.244 0.545 . . . . 4.89 111.327 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.343 0.592 . . . . 5.28 109.579 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -74.19 100.26 3.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 5.96 109.187 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 64.3 p -107.04 -140.06 0.37 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.485 -0.932 . . . . 2.22 108.485 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.6 88.78 0.07 OUTLIER Glycine 0 N--CA 1.495 2.591 0 N-CA-C 107.003 -2.439 . . . . 0.81 107.003 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.36 148.14 32.25 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.595 -1.002 . . . . 0.01 110.595 -179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -153.77 138.33 16.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.557 -0.967 . . . . 0.02 108.72 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.18 141.17 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.163 -0.68 . . . . 0.02 109.163 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -121.9 130.22 53.18 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.533 -0.73 . . . . 0.39 109.559 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 13.8 m-85 -109.44 139.08 44.87 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.742 -0.836 . . . . 0.02 108.742 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -122.42 138.79 54.42 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.187 -0.946 . . . . 0.02 109.625 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.429 ' HG3' HD11 ' A' ' 33' ' ' LEU . 83.1 mt-10 -68.36 -27.2 66.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.159 -0.963 . . . . 0.03 111.839 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.517 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 1.3 m-20 -114.48 169.47 9.02 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.847 -1.158 . . . . 0.03 110.138 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -75.57 158.67 32.18 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.611 0.72 . . . . 0.03 110.064 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.614 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.4 35.04 5.9 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.754 0.788 . . . . 0.74 110.858 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 20.5 p90 50.0 43.88 25.52 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.602 -0.726 . . . . 0.02 111.312 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -112.09 166.39 11.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.031 -1.1 . . . . 0.02 108.031 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -168.06 36.24 Favored Glycine 0 N--CA 1.495 2.618 0 C-N-CA 119.728 -1.225 . . . . 0.03 110.82 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -69.15 143.62 54.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.423 -1.045 . . . . 2.76 108.978 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -119.95 149.09 42.7 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.586 0.707 . . . . 1.89 110.035 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -132.19 127.16 35.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.991 -1.115 . . . . 0.02 107.991 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 11.4 p30 -111.59 135.84 51.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.473 -0.767 . . . . 1.12 109.603 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 12.3 t -129.99 137.53 50.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.472 0.653 . . . . 0.02 109.474 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -116.69 11.47 14.64 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.722 -0.612 . . . . 0.2 109.535 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.468 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.7 p -157.88 174.07 15.82 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.3 p-10 -61.71 145.4 52.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.709 -1.244 . . . . 0.02 109.984 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.3 t -131.72 116.59 17.5 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.635 -0.876 . . . . 0.02 108.635 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.6 -24.15 53.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.166 -0.959 . . . . 0.24 110.675 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -155.76 100.84 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.54 -0.911 . . . . 1.14 108.54 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -104.32 9.66 35.8 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 122.165 0.983 . . . . 6.37 109.867 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.565 ' NH2' ' CZ ' ' A' ' 51' ' ' ARG . 90.1 mtt180 -59.25 -22.84 61.75 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.585 -0.697 . . . . 3.11 110.857 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -75.9 -16.85 59.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.614 -1.304 . . . . 0.88 110.227 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -103.63 -22.12 13.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.445 -0.784 . . . . 0.02 109.307 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.476 HD23 ' SG ' ' A' ' 36' ' ' CYS . 6.0 tp -150.55 128.94 12.1 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.331 -0.856 . . . . 3.32 108.813 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 76.5 p -86.53 -10.86 53.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.796 -0.565 . . . . 0.02 111.286 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.672 ' HE ' HD21 ' A' ' 37' ' ' ASN . 54.9 ttt180 -171.14 161.67 6.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.869 -1.144 . . . . 0.02 108.021 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.9 m -142.31 115.27 8.74 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.938 -1.101 . . . . 0.02 109.378 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.672 HD21 ' HE ' ' A' ' 35' ' ' ARG . 3.3 m120 -106.73 -0.67 23.37 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.882 -1.136 . . . . 0.03 110.224 -179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -157.05 154.58 29.76 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.747 -1.205 . . . . 0.02 107.747 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 69.1 mt -144.77 148.54 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -0.999 . . . . 0.02 109.2 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -123.65 123.9 41.58 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.154 -1.424 . . . . 0.02 107.154 177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.7 t -105.33 114.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.845 -1.539 . . . . 0.02 106.845 177.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -84.21 -33.96 24.02 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.462 -0.773 . . . . 3.81 109.569 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.95 149.79 18.54 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 118.92 -1.609 . . . . 0.02 110.649 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.4 173.69 49.95 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.726 -1.226 . . . . 0.01 110.407 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.2 m -118.9 136.13 54.22 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 107.822 -1.177 . . . . 1.48 107.822 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -124.6 152.67 43.27 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.851 -1.156 . . . . 0.02 112.103 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.45 133.6 52.39 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 105.007 -2.22 . . . . 0.24 105.007 176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.5 m -116.46 141.7 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 109.026 -0.731 . . . . 0.65 109.026 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.476 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 17.5 m-85 -119.69 142.85 48.11 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.223 1.011 . . . . 0.02 109.386 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -64.78 -35.85 82.41 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.334 -0.848 . . . . 0.02 111.303 -178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.705 HH12 ' NH2' ' A' ' 78' ' ' ARG . 3.7 mmp_? -121.36 153.83 58.86 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 121.096 -1.002 . . . . 0.02 109.578 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -52.76 167.45 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 121.371 1.38 . . . . 0.02 112.457 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 64.68 37.24 7.74 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.746 0.784 . . . . 0.02 111.26 177.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CD1' ' OG ' ' A' ' 81' ' ' SER . 5.4 m-85 46.37 51.02 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.422 0.629 . . . . 3.39 111.156 178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 m -127.47 164.62 21.51 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.289 0.566 . . . . 2.33 110.306 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.29 -162.68 30.98 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 110.216 -1.153 . . . . 0.02 110.216 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.627 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 4.9 t60 -63.37 143.04 58.15 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.11 -1.229 . . . . 0.02 110.347 -178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 44.8 mtp -116.49 135.22 54.02 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.291 0.567 . . . . 5.01 109.755 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.627 ' CE2' ' CD2' ' A' ' 57' ' ' HIS . 32.9 m-85 -134.84 133.35 39.66 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.405 -0.809 . . . . 0.02 108.958 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.6 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.42 131.84 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.578 -0.897 . . . . 1.72 108.578 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -121.21 109.72 34.97 Favored Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.517 -0.739 . . . . 0.02 110.21 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.64 169.54 21.61 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 CA-C-N 119.969 1.025 . . . . 1.47 110.369 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -53.9 140.71 29.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.76 -1.212 . . . . 4.25 110.667 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 153.83 -175.11 32.25 Favored Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.527 -1.32 . . . . 0.02 110.255 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' OE2' ' N ' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -116.17 128.12 55.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.408 -1.054 . . . . 0.96 108.804 179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 65' ' ' GLU . 37.7 m-85 -119.28 97.99 50.45 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 108.101 -1.074 . . . . 0.02 108.101 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 6.5 Cg_endo -69.88 -6.56 18.96 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 C-N-CA 120.553 0.835 . . . . 0.02 114.179 -178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 76.1 mt-10 -157.53 155.47 30.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.215 -1.553 . . . . 2.02 108.417 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 38.8 p90 -60.24 -36.93 78.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.47 -0.769 . . . . 0.02 112.665 -176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -59.63 -21.37 60.37 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.182 -0.949 . . . . 0.02 110.061 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -67.51 -19.96 65.38 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.468 -0.77 . . . . 3.42 110.348 -179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.45 ' C ' ' SD ' ' A' ' 73' ' ' MET . 2.8 p90 -110.04 16.04 22.13 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.305 -0.872 . . . . 0.02 108.828 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 0.6 OUTLIER 65.32 24.98 12.14 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.234 0.54 . . . . 0.02 110.739 179.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' HA3' ' HE1' ' A' ' 72' ' ' TRP . . . -62.14 145.56 49.33 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.731 -1.347 . . . . 0.02 109.731 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.528 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.1 tt -80.51 -30.27 37.25 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.646 -1.242 . . . . 0.98 107.646 177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -155.82 -171.53 3.79 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 106.702 -1.592 . . . . 0.02 106.702 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' OD1' ' CG ' ' A' ' 69' ' ' TYR . 95.8 m-20 -97.89 27.45 4.47 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.832 -1.168 . . . . 0.02 110.298 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' NH2' HH12 ' A' ' 51' ' ' ARG . 38.2 mtp180 -95.51 122.42 38.23 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.962 -1.086 . . . . 3.2 110.591 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 48' ' ' VAL . 68.9 mt -142.52 120.53 12.09 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.536 -1.283 . . . . 2.61 107.536 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.37 -17.17 10.21 Favored Glycine 0 N--CA 1.5 2.901 0 O-C-N 121.358 -0.838 . . . . 0.02 112.485 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.442 ' OG ' ' CD1' ' A' ' 54' ' ' PHE . 11.3 t -156.23 156.42 34.09 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.331 -1.687 . . . . 0.02 110.648 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 6.1 p -145.05 147.75 32.93 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.691 0.758 . . . . 0.02 110.247 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 15.9 mtp180 -135.63 140.47 44.58 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.621 -0.881 . . . . 0.01 108.621 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.11 131.26 38.25 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.204 -0.935 . . . . 0.43 108.539 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.8 t -87.92 122.88 40.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.41 -0.959 . . . . 1.25 108.41 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -91.03 134.92 34.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.798 -1.189 . . . . 1.77 108.505 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 136.93 38.96 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.305 -0.998 . . . . 1.63 108.305 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 m -110.96 126.31 54.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.32 -0.863 . . . . 1.08 108.673 178.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.4 m -103.77 -154.65 0.51 Allowed 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.275 -1.75 . . . . 1.26 106.275 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.16 -48.15 0.93 Allowed Glycine 0 N--CA 1.5 2.925 0 O-C-N 120.567 -1.333 . . . . 0.01 112.103 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.63 -99.57 0.13 Allowed Glycine 0 N--CA 1.489 2.211 0 C-N-CA 118.729 -1.701 . . . . 0.01 111.934 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.417 ' OE1' ' O ' ' A' ' 93' ' ' ALA . 0.4 OUTLIER -120.74 118.91 31.26 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.096 -1.238 . . . . 4.43 110.352 -179.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' A' ' 92' ' ' GLN . . . -74.72 130.55 39.69 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 109.112 -0.699 . . . . 2.99 109.112 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -129.28 136.18 49.73 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.882 -0.784 . . . . 6.36 108.882 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.6 tt -127.64 144.07 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.471 -0.768 . . . . 1.09 109.326 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -122.53 133.06 54.58 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.922 -1.14 . . . . 2.05 107.922 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.06 145.89 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.77 -1.206 . . . . 1.1 109.384 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -118.66 140.91 49.16 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 121.999 0.904 . . . . 0.73 110.816 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' CD ' HH22 ' A' ' 124' ' ' ARG . 4.1 tm-20 -65.85 -30.38 70.98 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 115.911 -0.586 . . . . 0.02 111.775 -178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -117.12 169.77 9.18 Favored 'General case' 0 N--CA 1.506 2.326 0 CA-C-O 122.216 1.007 . . . . 3.18 110.663 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 169.34 36.03 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.723 -0.951 . . . . 0.01 110.723 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 36.2 t70 51.81 38.12 22.38 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.539 0.685 . . . . 0.01 110.739 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 52.45 53.73 11.84 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.705 -0.622 . . . . 0.01 110.974 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -125.91 165.89 17.9 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.124 -1.065 . . . . 3.15 108.124 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.52 -164.53 28.08 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.459 -1.457 . . . . 0.01 109.459 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -75.27 145.05 42.2 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.983 -1.304 . . . . 0.01 108.482 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.83 142.53 46.8 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.558 0.694 . . . . 0.01 109.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.414 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.8 m-85 -130.69 135.87 48.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.947 -1.131 . . . . 2.48 107.947 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -119.34 134.42 55.22 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 0.01 109.731 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.9 t -149.92 151.17 32.97 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.268 1.033 . . . . 1.69 110.798 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 66.4 p -110.35 10.18 23.5 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.536 -0.756 . . . . 0.01 109.676 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -121.36 163.05 19.28 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -0.827 . . . . 3.21 111.393 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.76 154.34 39.3 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.386 -0.968 . . . . 0.01 108.386 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 14.3 t -123.58 110.25 30.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.527 -0.916 . . . . 0.01 108.527 178.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -77.85 -32.69 2.53 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 CA-C-N 119.932 1.012 . . . . 0.01 112.032 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -140.33 108.43 5.75 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.108 -0.995 . . . . 0.02 109.189 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 mt -63.49 -40.99 91.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.825 -0.547 . . . . 1.83 110.656 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.32 -38.48 87.79 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.134 -1.026 . . . . 1.34 110.415 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 0.3 OUTLIER -70.55 -38.82 74.21 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 120.145 -1.597 . . . . 2.11 109.35 179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.482 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 49.6 tt0 -80.54 -48.14 13.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -0.909 . . . . 2.08 112.45 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.482 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 70.4 m-85 -111.8 -1.83 15.46 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.261 -0.899 . . . . 0.02 112.661 -176.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.3 m80 60.93 35.01 19.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.851 -1.156 . . . . 0.02 109.506 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 53.1 mt -114.57 136.42 53.05 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.53 -0.731 . . . . 0.02 109.381 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.61 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.2 -21.11 23.44 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.217 -0.927 . . . . 5.32 110.465 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -149.33 165.48 31.85 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.7 -1.25 . . . . 0.02 110.367 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.6 mm -127.42 123.7 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 107.206 -1.405 . . . . 2.17 107.206 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 2.7 m-70 -109.23 -14.09 14.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.158 -0.964 . . . . 0.02 112.467 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.8 t -159.57 151.49 20.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.88 -1.137 . . . . 0.01 108.763 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 30.0 p -168.6 146.14 3.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.221 -0.925 . . . . 1.22 108.906 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -122.17 109.12 14.11 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 122.353 1.073 . . . . 1.41 109.228 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.87 132.97 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.868 -1.53 . . . . 0.01 106.868 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -129.11 93.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 107.001 -1.481 . . . . 1.98 107.001 177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.514 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 60.5 tt0 -147.65 -63.0 0.27 Allowed 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 105.383 -2.08 . . . . 0.01 105.383 177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 166.42 -73.36 0.16 Allowed Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.097 -2.001 . . . . 0.01 108.097 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.47 ' CB ' HD12 ' A' ' 175' ' ' ILE . 82.5 p -123.95 125.34 44.43 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.604 -0.939 . . . . 2.3 110.483 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.514 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 15.3 m95 -125.9 150.71 47.73 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.062 -1.459 . . . . 0.01 107.062 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.503 HG13 HD11 ' A' ' 175' ' ' ILE . 32.0 mt -118.81 132.43 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.335 -1.478 . . . . 1.69 109.782 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -111.54 141.99 44.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 106.221 -1.77 . . . . 2.49 106.221 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.5 m-85 -123.06 143.34 50.02 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.116 -0.99 . . . . 0.02 109.755 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -73.84 -30.86 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.754 -0.591 . . . . 0.02 111.563 -177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -115.84 154.93 48.24 Favored Pre-proline 0 N--CA 1.504 2.241 0 O-C-N 120.729 -1.232 . . . . 1.48 108.929 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.49 167.09 2.97 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.349 1.366 . . . . 0.02 113.038 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 44.4 t-20 60.0 31.53 20.69 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.116 -0.947 . . . . 0.75 111.363 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.97 51.48 10.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.498 -0.751 . . . . 0.02 111.01 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -126.65 165.29 19.49 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.601 -0.687 . . . . 0.02 109.937 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.47 -165.3 33.79 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.205 -1.158 . . . . 0.02 110.205 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -69.39 141.5 54.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.509 -0.995 . . . . 0.02 108.837 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -114.59 148.77 37.58 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.541 -0.541 . . . . 0.02 109.541 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 4.7 m-85 -123.26 134.25 54.11 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.905 -0.776 . . . . 0.01 108.905 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.2 tp -95.93 120.76 36.77 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.895 -1.128 . . . . 0.01 109.046 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.5 mp -97.69 140.6 31.85 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.74 -0.837 . . . . 0.01 108.74 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.547 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 60.1 m-20 -105.01 -170.39 1.75 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.46 -0.775 . . . . 2.27 109.627 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.53 41.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 1.84 109.881 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -113.34 172.56 6.88 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.482 -0.761 . . . . 2.28 109.43 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.6 126.29 51.55 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.509 -0.923 . . . . 0.01 108.509 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.547 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 3.2 m-85 -100.68 111.96 24.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.199 -0.938 . . . . 0.01 110.145 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -92.79 -26.75 17.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.01 110.644 -178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -123.28 153.62 65.21 Favored Pre-proline 0 N--CA 1.497 1.89 0 N-CA-C 107.902 -1.147 . . . . 2.54 107.902 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.53 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -60.96 -40.52 51.88 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.33 0.797 . . . . 0.7 110.962 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 95.2 t -61.12 -18.62 18.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 121.046 -1.033 . . . . 0.86 109.332 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 52.9 t0 -65.76 -19.0 65.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.925 -1.11 . . . . 0.02 112.164 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.534 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -101.12 15.69 27.88 Favored 'General case' 0 N--CA 1.513 2.705 0 O-C-N 120.655 -1.278 . . . . 0.02 110.143 178.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 9.7 76.77 Favored Glycine 0 N--CA 1.5 2.903 0 O-C-N 121.177 -0.952 . . . . 0.02 113.149 176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.55 141.18 33.77 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.812 -1.405 . . . . 0.02 110.274 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.11 -7.22 59.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.688 -0.633 . . . . 0.59 109.598 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.6 p -142.42 150.77 55.88 Favored Pre-proline 0 N--CA 1.499 2.02 0 O-C-N 121.198 -0.939 . . . . 0.87 109.107 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -75.81 17.15 0.71 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 120.698 0.932 . . . . 0.38 112.052 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.429 ' C ' HD12 ' A' ' 169' ' ' ILE . . . -82.1 121.63 26.82 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.304 1.05 . . . . 0.18 111.154 -178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 168' ' ' ALA . 2.8 mp -151.07 125.21 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.499 -1.667 . . . . 3.99 106.499 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -110.84 -13.34 14.16 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.342 -0.849 . . . . 5.17 112.746 -177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.2 t -156.16 158.3 37.41 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 119.378 -2.076 . . . . 0.02 109.91 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -151.55 153.06 33.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.28 -0.888 . . . . 2.02 109.905 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -142.92 148.75 37.43 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.835 0.826 . . . . 0.01 110.081 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -86.01 142.17 28.96 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.868 -1.16 . . . . 0.01 107.868 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.503 HD11 HG13 ' A' ' 137' ' ' ILE . 8.5 mt -95.17 128.03 46.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.159 -0.963 . . . . 3.04 109.41 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.57 148.48 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.36 -0.838 . . . . 1.89 109.837 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 4.89 109.435 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 85.7 p . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.315 0.579 . . . . 5.28 109.568 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -49.83 101.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 5.96 109.369 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.55 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.3 m -106.42 -139.02 0.37 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.294 -1.002 . . . . 2.22 108.294 178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.55 ' H ' HG22 ' A' ' 3' ' ' THR . . . 172.28 88.83 0.07 OUTLIER Glycine 0 N--CA 1.496 2.679 0 N-CA-C 106.871 -2.492 . . . . 0.81 106.871 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.04 149.06 32.24 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 120.315 -0.945 . . . . 0.01 110.904 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -151.86 137.33 17.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.693 -0.886 . . . . 0.02 108.653 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.19 141.71 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 109.368 -0.604 . . . . 0.02 109.368 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -120.71 128.77 53.26 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.4 -0.812 . . . . 0.39 109.793 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.79 137.94 44.91 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.241 -1.022 . . . . 0.02 108.241 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.6 m-85 -122.13 138.25 54.53 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.125 -0.984 . . . . 0.02 109.96 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.426 ' HG3' HD11 ' A' ' 33' ' ' LEU . 95.0 mt-10 -68.06 -28.26 67.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.005 -1.059 . . . . 0.03 111.292 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -115.02 170.51 8.29 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.023 -1.048 . . . . 0.03 110.305 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.6 ' NE ' HD21 ' A' ' 37' ' ' ASN . 96.8 mtt180 -75.59 161.85 28.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.795 0.807 . . . . 0.03 110.604 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 41.3 t-20 62.59 33.6 15.7 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.03 0.919 . . . . 0.74 110.89 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.497 ' CZ ' ' OE2' ' A' ' 65' ' ' GLU . 0.3 OUTLIER 55.31 40.31 31.49 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.861 -0.609 . . . . 0.02 110.67 178.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -110.12 165.21 11.92 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.219 -1.03 . . . . 0.02 108.219 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.21 -167.74 36.25 Favored Glycine 0 N--CA 1.495 2.595 0 O-C-N 120.794 -1.191 . . . . 0.03 110.759 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -69.21 143.35 54.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.495 -1.003 . . . . 2.76 109.541 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.36 149.74 41.87 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 121.728 0.775 . . . . 1.89 109.713 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -132.97 126.84 32.88 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.598 -1.26 . . . . 0.02 107.598 178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -111.78 137.61 49.48 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.46 -0.775 . . . . 1.12 109.666 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.32 138.17 49.1 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.609 0.718 . . . . 0.02 109.387 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -116.98 10.44 14.02 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.745 -0.597 . . . . 0.2 109.47 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.8 p -158.09 174.45 15.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.213 -1.032 . . . . 1.23 108.213 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 29.4 t0 -60.99 143.34 55.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.762 -1.212 . . . . 0.02 110.153 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 58.1 m -131.31 116.94 18.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.02 108.435 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.4 -26.29 51.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 0.24 110.882 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -152.96 101.14 2.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.025 -1.047 . . . . 1.14 108.641 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -104.86 8.75 34.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.143 0.973 . . . . 6.37 109.712 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -58.29 -23.32 55.99 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.601 -0.687 . . . . 3.11 110.626 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.8 p -74.56 -17.01 60.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.816 -1.178 . . . . 0.88 110.266 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -103.72 -22.42 13.56 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.467 -0.771 . . . . 0.02 109.333 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.426 HD11 ' HG3' ' A' ' 11' ' ' GLU . 4.9 tp -149.71 128.0 12.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -0.944 . . . . 3.32 108.811 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.6 m -86.47 -9.9 55.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.736 -0.602 . . . . 0.02 110.96 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' CZ ' ' OD2' ' A' ' 77' ' ' ASP . 40.6 ttt180 -171.04 161.41 6.84 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.681 -1.229 . . . . 0.02 107.681 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.9 t -143.28 115.71 8.55 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.794 -1.191 . . . . 0.02 108.822 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.6 HD21 ' NE ' ' A' ' 13' ' ' ARG . 33.4 t-20 -108.16 1.42 22.18 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.932 -1.105 . . . . 0.03 110.318 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.2 t -156.43 153.52 29.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.509 -1.293 . . . . 0.02 107.509 178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -145.44 148.01 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 120.947 -1.095 . . . . 0.02 109.895 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 25.7 ttp180 -124.54 125.25 43.9 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.565 -1.272 . . . . 0.02 107.565 176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.6 t -105.48 114.0 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 106.98 -1.489 . . . . 0.02 106.98 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' O ' ' OE1' ' A' ' 63' ' ' GLN . 4.8 tm-20 -83.63 -34.29 25.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.485 -0.759 . . . . 3.81 109.689 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.06 148.99 16.89 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.611 -1.757 . . . . 0.02 110.569 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.83 173.89 50.02 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.985 -1.246 . . . . 0.01 109.985 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.0 m -119.6 135.89 54.61 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.403 ' N ' ' CD1' ' A' ' 46' ' ' TRP . 32.3 m95 -123.41 153.49 40.34 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.537 1.16 . . . . 0.02 112.155 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.6 132.47 53.25 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 105.02 -2.215 . . . . 0.24 105.02 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.26 142.26 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.931 -0.766 . . . . 0.65 108.931 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 31.8 m-85 -121.56 145.98 47.42 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-O 122.272 1.034 . . . . 0.02 109.801 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -67.29 -34.85 78.25 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.732 -0.667 . . . . 0.02 111.134 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -123.64 153.52 66.45 Favored Pre-proline 0 N--CA 1.501 2.123 0 O-C-N 121.113 -0.992 . . . . 0.02 109.309 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -51.54 167.68 0.37 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 121.546 1.497 . . . . 0.02 113.249 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.6 t30 63.79 37.06 10.07 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.049 -0.978 . . . . 0.02 111.127 178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 45.19 50.77 9.47 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.62 0.724 . . . . 3.39 110.379 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -125.2 163.59 22.14 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.201 0.524 . . . . 2.33 109.746 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.34 -161.85 32.98 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.488 -1.445 . . . . 0.02 109.488 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -67.59 137.9 56.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.812 -1.405 . . . . 0.02 109.89 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.472 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 21.2 ptm -119.14 137.82 53.34 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.473 0.654 . . . . 5.01 109.541 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.6 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 96.5 m-85 -132.9 140.07 47.69 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.476 -0.765 . . . . 0.02 109.666 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.613 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.47 132.34 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.355 -0.98 . . . . 1.72 108.355 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.504 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -119.56 108.35 39.6 Favored Pre-proline 0 N--CA 1.503 2.186 0 O-C-N 121.508 -0.745 . . . . 0.02 110.329 -178.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -75.2 168.27 25.06 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.044 1.051 . . . . 1.47 110.267 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.43 ' OE1' ' O ' ' A' ' 42' ' ' GLU . 7.9 tt0 -53.43 140.03 28.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.834 -1.166 . . . . 4.25 110.487 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.99 -176.75 32.57 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.508 -1.33 . . . . 0.02 110.301 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.497 ' OE2' ' CZ ' ' A' ' 15' ' ' PHE . 62.3 tt0 -118.64 130.06 55.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.389 -1.065 . . . . 0.96 109.369 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 25.5 m-85 -120.75 92.83 48.36 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 107.826 -1.176 . . . . 0.02 107.826 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -65.7 -4.87 10.57 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.035 1.157 . . . . 0.02 113.746 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -157.03 153.57 28.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.579 -1.326 . . . . 2.02 107.889 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.526 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 8.8 p90 -60.59 -37.62 81.97 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.468 -0.77 . . . . 0.02 112.162 -176.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.526 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 22.1 mm100 -60.32 -23.68 64.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.942 -1.099 . . . . 0.02 110.661 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.7 62.39 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.898 0.856 . . . . 3.42 108.854 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -107.74 9.91 28.97 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.393 -1.336 . . . . 0.02 107.393 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.7 mtt 61.34 21.89 12.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.656 -0.652 . . . . 0.02 110.641 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.27 144.47 45.31 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.182 -1.567 . . . . 0.02 109.182 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.4 tp -79.06 -30.71 44.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.619 -1.252 . . . . 0.98 107.619 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 49.6 t30 -157.69 -173.25 4.29 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.476 -1.676 . . . . 0.02 106.476 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.509 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 0.7 OUTLIER -98.16 27.41 4.63 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.843 -1.161 . . . . 0.02 110.215 -179.455 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -96.05 122.24 38.67 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.267 -0.896 . . . . 3.2 109.954 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.487 HD22 ' HB ' ' A' ' 48' ' ' VAL . 66.3 mt -144.5 119.52 10.03 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.586 -1.264 . . . . 2.61 107.586 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.96 -16.02 14.86 Favored Glycine 0 N--CA 1.503 3.136 0 C-N-CA 120.525 -0.845 . . . . 0.02 112.395 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.0 t -156.47 155.91 32.85 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.405 -1.644 . . . . 0.02 110.03 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.437 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 30.3 p -144.28 147.59 33.73 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.532 -0.73 . . . . 0.02 109.491 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -134.53 140.04 45.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.323 -0.861 . . . . 0.01 108.797 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.03 130.96 37.11 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.205 -0.934 . . . . 0.43 108.651 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 24.9 t -90.62 123.34 42.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.063 -1.088 . . . . 1.25 108.063 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.446 ' O ' ' CG2' ' A' ' 135' ' ' THR . 14.8 m-70 -91.96 133.49 35.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.077 -1.015 . . . . 1.77 108.386 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -97.06 139.67 32.72 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.766 . . . . 1.63 109.049 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 t -111.48 125.59 54.06 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.465 -0.939 . . . . 1.08 108.465 178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 t -102.75 -155.68 0.53 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.282 -1.747 . . . . 1.26 106.282 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.21 -47.88 0.95 Allowed Glycine 0 N--CA 1.498 2.774 0 O-C-N 120.545 -1.347 . . . . 0.01 112.051 178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.34 -98.6 0.12 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 118.587 -1.768 . . . . 0.01 112.267 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -122.48 120.89 35.2 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.394 -1.062 . . . . 4.43 110.762 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 174' ' ' ARG . . . -76.82 132.01 38.97 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.171 -0.677 . . . . 2.99 109.171 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -131.32 139.24 49.5 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.542 -0.724 . . . . 6.36 109.236 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tt -126.54 143.68 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 CA-C-O 121.743 0.783 . . . . 1.09 109.645 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -123.74 131.23 53.56 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.649 -1.241 . . . . 2.05 107.649 177.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.7 m -124.31 148.34 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 120.871 -1.143 . . . . 1.1 109.671 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -118.68 141.38 48.66 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 122.041 0.924 . . . . 0.73 111.022 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -66.52 -29.47 69.57 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.747 -0.66 . . . . 0.02 111.446 -178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -116.39 169.86 8.99 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.092 -1.005 . . . . 3.18 110.353 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.8 165.79 50.13 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 111.073 -0.811 . . . . 0.01 111.073 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 56.38 39.25 30.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.99 -0.712 . . . . 0.01 111.426 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 51.78 54.57 10.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.599 -0.688 . . . . 0.01 111.2 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -129.62 166.4 19.82 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.154 -1.054 . . . . 3.15 108.154 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.97 -164.42 28.68 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.292 -1.523 . . . . 0.01 109.292 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -75.55 144.94 41.63 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.938 -1.331 . . . . 0.01 108.714 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.459 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.5 tmm? -116.87 142.3 47.1 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.688 0.756 . . . . 0.01 109.972 -179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.44 ' N ' ' SD ' ' A' ' 107' ' ' MET . 41.8 m-85 -130.39 134.66 47.31 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.7 -1.222 . . . . 2.48 107.7 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.499 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -121.42 135.63 55.04 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.725 -0.609 . . . . 0.01 109.83 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.499 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 9.5 t -150.34 153.1 35.47 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 122.223 1.011 . . . . 1.69 110.738 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.5 p -109.35 10.0 25.58 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.829 -0.623 . . . . 0.01 109.864 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.5 mp0 -121.0 163.3 18.49 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.426 -0.796 . . . . 3.21 111.046 -178.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.42 155.16 38.25 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.283 -1.006 . . . . 0.01 108.283 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.86 111.43 29.17 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.64 -0.874 . . . . 0.01 108.64 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.54 -32.86 3.48 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 CA-C-N 120.032 1.047 . . . . 0.01 111.605 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 p -141.23 107.81 5.33 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.285 -0.884 . . . . 0.02 108.855 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.53 -38.77 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.838 -0.539 . . . . 1.83 110.361 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 11.5 ttt -66.4 -37.76 85.96 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 118.868 -1.133 . . . . 1.34 109.873 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 tm-20 -70.27 -39.06 75.15 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.408 -1.432 . . . . 2.11 109.53 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.556 ' NE2' ' CE2' ' A' ' 121' ' ' PHE . 8.8 tt0 -80.44 -47.05 14.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -0.975 . . . . 2.08 112.316 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.556 ' CE2' ' NE2' ' A' ' 120' ' ' GLN . 53.9 m-85 -110.51 -1.68 16.85 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.375 -0.828 . . . . 0.02 112.752 -176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.1 m170 61.16 33.48 19.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.677 -1.264 . . . . 0.02 109.343 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 mt -114.34 135.39 54.13 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.517 -0.74 . . . . 0.02 109.161 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -89.41 -21.1 23.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.181 -0.949 . . . . 5.32 110.763 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 52.0 mt-10 -148.32 163.69 36.31 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.949 -1.095 . . . . 0.02 110.105 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.449 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.3 mm -129.33 126.05 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.202 -1.407 . . . . 2.17 107.202 178.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -109.55 -13.04 14.62 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.353 -0.842 . . . . 0.02 112.682 -177.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 21.3 p -160.82 153.5 20.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.669 -1.269 . . . . 0.01 109.111 178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 20.4 p -170.28 144.33 2.53 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.925 -1.139 . . . . 1.22 107.925 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.445 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.3 pttt -127.92 101.84 6.5 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.903 -1.123 . . . . 1.41 109.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.45 HG21 ' CD1' ' A' ' 136' ' ' TRP . 14.6 p -101.24 140.42 20.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 N-CA-C 107.83 -1.174 . . . . 0.01 107.83 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.69 91.1 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 106.25 -1.759 . . . . 1.98 106.25 176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 136' ' ' TRP . 24.7 tt0 -146.83 -70.04 0.24 Allowed 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 105.455 -2.054 . . . . 0.01 105.455 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.53 -40.63 1.03 Allowed Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.177 -1.569 . . . . 0.01 109.177 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.678 ' HB ' HD12 ' A' ' 175' ' ' ILE . 70.5 p -129.38 103.07 6.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.407 -1.055 . . . . 2.3 112.375 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 133' ' ' GLU . 17.6 m95 -132.88 144.75 50.39 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 107.863 -1.162 . . . . 0.01 107.863 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' CG1' HD11 ' A' ' 175' ' ' ILE . 34.3 mt -119.18 134.96 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 120.562 -1.336 . . . . 1.69 109.846 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -111.46 141.7 44.68 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 106.193 -1.78 . . . . 2.49 106.193 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 14.7 m-85 -123.51 143.63 50.06 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.206 -0.934 . . . . 0.02 109.88 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.45 -30.96 62.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.976 -0.452 . . . . 0.02 111.721 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.51 155.14 47.62 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.759 -1.213 . . . . 1.48 108.809 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -56.86 166.79 3.53 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.05 1.167 . . . . 0.02 112.927 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 42.8 t-20 59.66 31.89 21.17 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.173 -0.921 . . . . 0.75 111.313 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 2.9 m-85 57.45 51.95 9.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.527 -0.733 . . . . 0.02 111.523 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -126.75 165.32 19.5 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.463 -0.773 . . . . 0.02 110.057 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.13 -165.24 34.28 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.286 -1.126 . . . . 0.02 110.286 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -69.39 141.72 54.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.592 -0.946 . . . . 0.02 108.836 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.472 ' O ' ' CG ' ' A' ' 58' ' ' MET . 18.4 mt-30 -114.12 148.59 36.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.778 -0.576 . . . . 0.02 110.109 -177.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -123.75 133.86 53.77 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.749 -0.834 . . . . 0.01 108.749 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.6 tp -95.34 121.12 36.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.868 -1.145 . . . . 0.01 109.461 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -98.83 145.49 26.92 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.761 -0.829 . . . . 0.01 108.761 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' LYS . 13.1 m-20 -110.0 -179.31 3.76 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.534 -0.729 . . . . 2.27 109.645 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.9 pttt -71.52 38.95 0.06 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.307 -0.87 . . . . 1.84 109.469 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' ASP . 57.1 mttm -112.04 177.18 4.73 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.514 -0.741 . . . . 2.28 109.208 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 26.4 mp0 -105.96 122.31 45.89 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.505 -0.747 . . . . 0.01 109.018 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.7 113.82 25.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.36 -0.837 . . . . 0.01 109.242 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.41 -27.59 17.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.309 -0.869 . . . . 0.01 111.268 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -124.59 155.57 69.15 Favored Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 107.803 -1.184 . . . . 2.54 107.803 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.3 Cg_endo -61.5 -40.97 43.64 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-N 119.065 0.702 . . . . 0.7 111.116 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.8 t -60.11 -18.87 16.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.8 -1.187 . . . . 0.86 109.495 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.89 -18.15 65.14 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.863 -1.148 . . . . 0.02 111.899 -178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.63 15.42 28.98 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.674 -1.266 . . . . 0.02 110.147 178.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.92 74.3 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 121.088 -1.008 . . . . 0.02 112.939 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.96 140.48 35.2 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 120.912 -1.346 . . . . 0.02 109.995 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.04 -6.67 59.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.664 -0.647 . . . . 0.59 109.703 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -139.76 150.34 62.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.245 -0.91 . . . . 0.87 109.603 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -74.08 13.73 0.8 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 120.746 0.964 . . . . 0.38 111.838 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.11 120.04 24.8 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.312 1.053 . . . . 0.18 110.655 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.517 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.1 mt -150.03 123.89 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.569 -2.011 . . . . 3.99 105.569 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -111.84 -12.67 13.78 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.454 -0.779 . . . . 5.17 113.011 -177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 4.4 p -157.08 159.66 38.13 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.295 -2.128 . . . . 0.02 109.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.13 152.64 33.66 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.208 -0.932 . . . . 2.02 110.055 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.491 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 15.8 mtp180 -142.42 148.81 38.41 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.057 -1.027 . . . . 0.01 110.244 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 93' ' ' ALA . 14.7 ptm180 -86.78 140.24 29.92 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.141 -1.059 . . . . 0.01 108.141 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 135' ' ' THR . 21.0 mt -94.7 130.59 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.2 -0.937 . . . . 3.04 109.585 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.2 m -135.91 147.54 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.54 -0.725 . . . . 1.89 109.541 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 4.89 109.403 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.493 -0.558 . . . . 5.28 109.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -73.95 97.64 2.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 5.96 109.313 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 44.0 p -102.78 -140.7 0.35 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.1 -1.074 . . . . 2.22 108.1 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.77 87.89 0.07 OUTLIER Glycine 0 N--CA 1.497 2.721 0 N-CA-C 107.205 -2.358 . . . . 0.81 107.205 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.36 150.65 33.67 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 120.184 -1.008 . . . . 0.01 110.779 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -151.48 136.75 17.57 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.46 -1.023 . . . . 0.02 108.916 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 7.2 tt -130.77 142.16 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 109.39 -0.596 . . . . 0.02 109.39 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.526 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.5 t -122.87 130.48 52.91 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.475 -0.765 . . . . 0.39 109.379 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 9.9 m-85 -109.71 139.94 44.16 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.947 -0.761 . . . . 0.02 108.947 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.526 ' CZ ' ' OG ' ' A' ' 8' ' ' SER . 12.7 m-85 -122.79 139.1 54.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.433 -0.792 . . . . 0.02 109.64 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.91 -26.66 64.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.508 -0.745 . . . . 0.03 111.985 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 2.0 m-20 -114.17 170.01 8.6 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.03 110.571 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -74.23 157.19 36.31 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.734 0.778 . . . . 0.03 110.149 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.598 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.8 m120 66.27 35.72 5.79 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.821 0.819 . . . . 0.74 111.101 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.598 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 13.0 p90 49.66 44.61 24.62 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.679 0.752 . . . . 0.02 111.105 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -112.3 166.1 11.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.988 -1.115 . . . . 0.02 107.988 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.52 -167.9 34.28 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 120.735 -1.228 . . . . 0.03 110.532 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.578 HH21 ' H ' ' A' ' 34' ' ' SER . 36.7 ttp180 -70.01 144.29 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.491 -1.005 . . . . 2.76 108.841 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -120.65 150.22 41.27 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.726 0.774 . . . . 1.89 110.412 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 37.5 t80 -132.7 127.63 35.21 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.138 -1.06 . . . . 0.02 108.138 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -113.32 137.46 51.47 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.473 -0.767 . . . . 1.12 110.119 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.517 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.91 139.48 48.76 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.681 0.753 . . . . 0.02 109.351 179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 m-20 -117.08 11.28 14.17 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.271 -0.64 . . . . 0.2 109.271 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -158.57 174.49 14.99 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.119 -1.067 . . . . 1.23 108.119 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.21 144.34 55.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.601 -1.312 . . . . 0.02 110.249 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 97.0 m -131.41 116.86 18.08 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.372 -0.973 . . . . 0.02 108.372 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.2 -26.03 52.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.143 -0.973 . . . . 0.24 110.67 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -154.2 100.46 2.31 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.073 -1.017 . . . . 1.14 108.7 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -104.96 9.65 34.47 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.103 0.954 . . . . 6.37 109.538 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mtp180 -58.3 -23.76 57.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.683 -0.636 . . . . 3.11 110.618 -179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 t -74.38 -16.89 60.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.829 -1.169 . . . . 0.88 110.002 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -105.11 -21.9 13.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.516 -0.74 . . . . 0.02 109.395 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.1 tp -148.37 125.68 11.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.156 -0.965 . . . . 3.32 109.166 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.578 ' H ' HH21 ' A' ' 18' ' ' ARG . 83.2 p -86.3 -11.05 53.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.363 -0.836 . . . . 0.02 111.263 -178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.496 ' O ' HD21 ' A' ' 33' ' ' LEU . 11.9 tpp180 -170.68 161.58 7.54 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.746 -1.205 . . . . 0.02 107.746 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.801 ' SG ' HD12 ' A' ' 79' ' ' LEU . 23.6 p -140.51 113.35 8.22 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.848 -1.157 . . . . 0.02 108.752 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.426 ' O ' ' OD1' ' A' ' 37' ' ' ASN . 19.2 t-20 -106.35 -2.31 22.36 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.866 -1.146 . . . . 0.03 110.259 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 8.4 m -154.43 154.15 32.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.304 -0.999 . . . . 0.02 108.304 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.418 HD12 ' CZ3' ' A' ' 72' ' ' TRP . 69.2 mt -144.66 146.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.015 -1.053 . . . . 0.02 109.599 -178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -124.44 124.8 43.11 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.046 -1.464 . . . . 0.02 107.046 176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 24.9 t -105.6 113.65 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.822 -1.547 . . . . 0.02 106.822 177.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -83.08 -34.61 26.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.485 -0.759 . . . . 3.81 110.015 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.09 150.15 19.17 Favored Glycine 0 N--CA 1.488 2.12 0 C-N-CA 118.48 -1.819 . . . . 0.02 110.468 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.86 175.36 50.91 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.457 -1.354 . . . . 0.01 109.929 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.447 HG22 ' N ' ' A' ' 46' ' ' TRP . 34.3 m -110.29 161.93 15.13 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.823 -1.547 . . . . 1.48 106.823 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.511 ' CZ3' ' SG ' ' A' ' 22' ' ' CYS . 64.5 m95 -147.65 147.01 29.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.286 -1.509 . . . . 0.02 111.402 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.62 132.31 54.26 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 105.158 -2.164 . . . . 0.24 105.158 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 79' ' ' LEU . 32.8 m -119.02 142.73 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.679 . . . . 0.65 109.466 178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 83' ' ' ARG . 19.7 m-85 -119.72 144.79 47.05 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 122.295 1.045 . . . . 0.02 109.46 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -66.19 -34.88 79.04 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.748 -0.66 . . . . 0.02 111.183 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -125.66 158.36 65.28 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 121.112 -0.992 . . . . 0.02 109.496 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.41 167.11 1.46 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.739 1.626 . . . . 0.02 113.145 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 63.97 36.78 9.8 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.097 -0.956 . . . . 0.02 111.208 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.16 51.91 10.74 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.476 0.655 . . . . 3.39 110.915 178.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.9 t -127.37 164.55 21.57 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.836 -0.54 . . . . 2.33 110.118 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.16 -162.55 32.4 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 110.017 -1.233 . . . . 0.02 110.017 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.491 ' CE1' ' CD1' ' A' ' 75' ' ' LEU . 85.9 m-70 -62.8 142.03 58.37 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.052 -1.264 . . . . 0.02 110.334 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 29.2 mtp -115.89 135.09 54.32 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.955 -0.757 . . . . 5.01 108.955 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' C ' HD12 ' A' ' 60' ' ' ILE . 53.1 m-85 -136.16 133.31 37.04 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.362 -0.836 . . . . 0.02 109.469 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.586 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -96.13 131.78 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.245 -1.02 . . . . 1.72 108.245 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.8 mt -120.48 110.45 35.65 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.673 -0.642 . . . . 0.02 110.344 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -76.61 169.61 21.49 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 CA-C-N 119.923 1.008 . . . . 1.47 110.079 177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' NE2' ' O ' ' A' ' 41' ' ' VAL . 12.7 tm0? -53.13 140.83 24.69 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.827 -1.171 . . . . 4.25 110.355 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.31 -176.28 32.2 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.595 -1.288 . . . . 0.02 110.522 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.13 128.75 55.44 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -1.011 . . . . 0.96 108.738 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 30.1 m-85 -118.64 98.08 51.04 Favored Pre-proline 0 N--CA 1.493 1.696 0 N-CA-C 108.041 -1.096 . . . . 0.02 108.041 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' O ' ' OG ' ' A' ' 38' ' ' SER . 1.8 Cg_endo -67.75 -6.64 17.3 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 120.645 0.897 . . . . 0.02 114.401 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 31.1 mt-10 -158.64 155.9 29.02 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.366 -1.459 . . . . 2.02 108.382 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -59.99 -37.39 79.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.569 -0.707 . . . . 0.02 112.374 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -59.97 -21.83 61.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.107 -0.996 . . . . 0.02 109.988 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.6 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -68.38 -20.37 64.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.575 -0.703 . . . . 3.42 110.294 -179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.418 ' CZ3' HD12 ' A' ' 39' ' ' ILE . 2.9 p90 -109.49 15.87 22.66 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.232 -0.917 . . . . 0.02 108.669 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.2 mtt 64.66 23.86 12.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.331 0.586 . . . . 0.02 110.769 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.53 146.54 50.43 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.35 -1.5 . . . . 0.02 109.35 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.491 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 14.2 mt -80.59 -28.69 37.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.98 108.261 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -156.71 -170.66 3.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.012 -1.477 . . . . 0.02 107.012 178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 77' ' ' ASP . 35.2 p30 -98.28 28.28 4.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.753 -1.217 . . . . 0.02 110.274 -179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -97.08 123.52 40.85 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.324 -0.86 . . . . 3.2 111.246 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.801 HD12 ' SG ' ' A' ' 36' ' ' CYS . 63.0 mt -143.88 120.27 10.95 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.022 -1.473 . . . . 2.61 107.022 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.8 -16.4 14.1 Favored Glycine 0 N--CA 1.503 3.101 0 O-C-N 121.312 -0.867 . . . . 0.02 112.166 -177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.8 t -156.11 155.72 33.05 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.51 -1.582 . . . . 0.02 109.686 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.0 m -144.91 148.13 33.54 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.525 -0.735 . . . . 0.02 109.878 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.481 ' CZ ' ' OH ' ' A' ' 49' ' ' TYR . 39.5 mtm180 -134.1 139.63 46.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.352 -0.842 . . . . 0.01 108.854 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 131.3 38.12 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.961 -1.126 . . . . 0.43 107.961 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 37.9 t -90.96 124.08 43.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.378 -0.971 . . . . 1.25 108.378 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.462 ' O ' ' CG2' ' A' ' 135' ' ' THR . 13.7 m-70 -91.12 135.12 33.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 1.77 108.457 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.17 137.81 36.38 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.957 -0.757 . . . . 1.63 108.957 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.4 m -111.54 125.88 54.39 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.474 -0.936 . . . . 1.08 108.474 178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.9 m -102.74 -155.41 0.52 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.222 -1.77 . . . . 1.26 106.222 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.73 -48.64 0.9 Allowed Glycine 0 N--CA 1.498 2.797 0 O-C-N 120.463 -1.398 . . . . 0.01 112.305 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.38 -99.47 0.13 Allowed Glycine 0 N--CA 1.488 2.148 0 C-N-CA 118.502 -1.809 . . . . 0.01 112.208 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 36.0 tp60 -122.25 120.38 33.96 Favored 'General case' 0 N--CA 1.507 2.425 0 O-C-N 121.231 -1.158 . . . . 4.43 110.82 -178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.643 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -77.74 132.32 38.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 109.126 -0.694 . . . . 2.99 109.126 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -129.95 140.38 50.93 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.525 -0.734 . . . . 6.36 109.121 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.7 tt -125.5 141.89 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 CA-C-O 121.867 0.842 . . . . 1.09 109.528 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -124.59 131.41 53.48 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.514 -1.291 . . . . 2.05 107.514 177.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -123.84 146.39 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 120.983 -1.073 . . . . 1.1 109.819 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -117.43 140.72 49.22 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.991 0.901 . . . . 0.73 110.77 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -66.14 -29.84 70.21 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.001 -0.545 . . . . 0.02 111.663 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -116.84 167.97 10.64 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.062 -1.024 . . . . 3.18 110.586 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.01 43.39 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 111.08 -0.808 . . . . 0.01 111.08 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 56.55 38.58 29.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.868 -0.783 . . . . 0.01 110.801 179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 52.55 55.31 9.26 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.753 -0.592 . . . . 0.01 110.959 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -128.58 165.96 19.78 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.497 -0.927 . . . . 3.15 108.497 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.57 -164.85 26.96 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.36 -1.496 . . . . 0.01 109.36 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.548 HE21 ' H ' ' A' ' 107' ' ' MET . 36.7 tp60 -74.85 144.82 43.25 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.039 -1.271 . . . . 0.01 108.255 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 108' ' ' TYR . 5.1 tmm? -116.29 142.44 46.84 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.669 0.747 . . . . 0.01 109.653 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.552 ' N ' ' SD ' ' A' ' 107' ' ' MET . 80.8 m-85 -131.19 135.58 47.53 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.014 -1.106 . . . . 2.48 108.014 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.418 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.8 tm-20 -120.37 134.08 55.33 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.74 -0.6 . . . . 0.01 109.709 -178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.431 ' OG1' ' OE1' ' A' ' 112' ' ' GLU . 2.8 t -149.63 152.11 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 1.69 110.558 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.6 p -109.35 10.42 25.51 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 115.828 -0.624 . . . . 0.01 109.964 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.478 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 3.2 mp0 -120.58 163.06 18.58 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.41 -0.806 . . . . 3.21 111.317 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.08 155.23 37.39 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.007 -1.108 . . . . 0.01 108.007 178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 49.2 t -122.54 110.66 31.95 Favored Pre-proline 0 N--CA 1.498 1.947 0 N-CA-C 108.938 -0.764 . . . . 0.01 108.938 178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -76.82 -34.35 2.43 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 CA-C-N 119.976 1.027 . . . . 0.01 111.685 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 57.9 m -140.41 107.54 5.47 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.02 108.685 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 25.0 mt -63.97 -39.42 85.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.865 -0.522 . . . . 1.83 110.553 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.5 ttp -66.52 -37.67 85.53 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 118.967 -1.093 . . . . 1.34 109.944 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -70.39 -39.12 74.73 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.388 -1.445 . . . . 2.11 109.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.1 tt0 -80.29 -47.52 14.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.319 -0.863 . . . . 2.08 112.425 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.424 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 66.7 m-85 -111.38 -1.25 16.04 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.419 -0.8 . . . . 0.02 112.615 -175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 61.77 34.29 17.37 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.71 -1.244 . . . . 0.02 109.742 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 44.0 mt -114.87 135.42 54.22 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.497 -0.752 . . . . 0.02 109.231 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -89.52 -21.19 23.04 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 5.32 110.768 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -148.42 164.42 34.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.02 109.968 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 51.0 mm -128.61 124.92 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 107.154 -1.424 . . . . 2.17 107.154 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' CD2' ' N ' ' A' ' 127' ' ' HIS . 8.1 m-70 -109.27 -13.17 14.68 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.335 -0.853 . . . . 0.02 112.32 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.8 t -159.91 152.34 20.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.843 -1.16 . . . . 0.01 109.059 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.7 p -167.42 145.14 4.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.154 -1.054 . . . . 1.22 108.154 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -121.67 104.73 9.82 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.229 1.014 . . . . 1.41 109.621 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.62 132.63 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.685 -1.228 . . . . 0.01 107.685 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 39.9 t -126.04 90.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 106.116 -1.809 . . . . 1.98 106.116 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.516 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 46.4 tt0 -146.71 -69.79 0.25 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 105.544 -2.021 . . . . 0.01 105.544 178.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.58 -39.84 1.01 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 108.751 -1.74 . . . . 0.01 108.751 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.748 ' HB ' HD12 ' A' ' 175' ' ' ILE . 80.4 p -130.08 101.93 6.03 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.505 -0.997 . . . . 2.3 111.919 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 55.3 m95 -129.49 142.26 50.82 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 107.349 -1.352 . . . . 0.01 107.349 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.421 ' CG1' HD11 ' A' ' 175' ' ' ILE . 27.2 mt -118.36 133.38 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 120.41 -1.432 . . . . 1.69 109.775 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -110.72 141.28 44.22 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 106.378 -1.712 . . . . 2.49 106.378 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -122.86 142.73 50.45 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.019 -1.051 . . . . 0.02 109.556 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -74.18 -30.68 62.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.672 -0.643 . . . . 0.02 111.718 -177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.1 mt -115.84 154.87 48.23 Favored Pre-proline 0 N--CA 1.502 2.163 0 O-C-N 120.749 -1.22 . . . . 1.48 108.896 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.31 167.24 2.74 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.28 1.32 . . . . 0.02 112.97 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 62.3 t30 59.02 30.91 20.85 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.154 -0.93 . . . . 0.75 111.479 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.79 51.85 8.76 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.5 -0.75 . . . . 0.02 111.289 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.491 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.73 165.14 19.81 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.513 -0.742 . . . . 0.02 109.703 179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.43 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 88.16 -165.51 34.43 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 110.124 -1.19 . . . . 0.02 110.124 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -69.46 142.02 53.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.533 -0.981 . . . . 0.02 108.863 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -113.93 148.92 36.0 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.473 -0.566 . . . . 0.02 109.473 -178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 149' ' ' TYR . 12.2 m-85 -123.36 133.9 54.06 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.773 -0.825 . . . . 0.01 108.773 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -95.3 120.47 35.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.862 -1.148 . . . . 0.01 109.197 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -98.73 138.6 35.66 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.299 -1.0 . . . . 0.01 108.299 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.1 m-20 -108.08 -173.76 2.36 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.471 -0.768 . . . . 2.27 109.628 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.2 pttp -71.67 40.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 1.84 109.578 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.46 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.2 mttp -112.13 167.74 10.16 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.441 -0.787 . . . . 2.28 109.358 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -105.06 124.11 48.96 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.54 114.12 26.94 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.279 -0.888 . . . . 0.01 110.456 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -92.9 -26.22 17.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.071 -1.018 . . . . 0.01 110.636 -178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -123.63 154.45 66.66 Favored Pre-proline 0 N--CA 1.497 1.9 0 N-CA-C 107.993 -1.114 . . . . 2.54 107.993 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.557 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -61.64 -41.12 41.43 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 CA-C-N 119.245 0.766 . . . . 0.7 110.802 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.3 t -60.74 -18.96 18.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 O-C-N 120.727 -1.233 . . . . 0.86 109.311 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 50.7 t0 -65.29 -18.39 65.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.101 . . . . 0.02 111.927 -179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.75 15.42 29.02 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 120.8 -1.187 . . . . 0.02 110.164 178.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.71 10.4 76.3 Favored Glycine 0 N--CA 1.498 2.815 0 O-C-N 121.163 -0.961 . . . . 0.02 113.113 176.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.542 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.15 141.41 34.08 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.836 -1.39 . . . . 0.02 110.227 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.51 -6.34 59.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.721 -0.612 . . . . 0.59 109.641 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -142.1 150.55 56.12 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.106 -0.996 . . . . 0.87 109.298 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.09 16.49 0.67 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 120.801 1.0 . . . . 0.38 112.018 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 120.79 25.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.18 110.78 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.403 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.7 mt -149.08 124.1 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.719 -1.956 . . . . 3.99 105.719 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -111.91 -13.72 13.6 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.174 -0.954 . . . . 5.17 113.027 -177.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.0 t -157.13 159.84 38.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 119.332 -2.105 . . . . 0.02 109.919 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.429 ' CD1' ' C ' ' A' ' 172' ' ' PHE . 20.5 p90 -152.27 153.53 33.93 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.374 -0.829 . . . . 2.02 110.324 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.2 mtm180 -143.85 150.03 37.86 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.275 -0.89 . . . . 0.01 110.202 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.643 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 14.2 ptm180 -87.09 141.29 28.77 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.416 -0.957 . . . . 0.01 108.416 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.748 HD12 ' HB ' ' A' ' 135' ' ' THR . 14.9 mt -94.84 129.61 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 3.04 109.373 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 10.9 m -136.46 147.67 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.423 -0.798 . . . . 1.89 109.561 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.915 . . . . 4.89 109.431 179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.471 -0.566 . . . . 5.28 109.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.8 mtmp? -82.6 133.58 35.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.151 -0.968 . . . . 5.96 109.753 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.3 p -137.35 -130.09 0.14 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.322 -0.861 . . . . 2.22 111.556 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.88 94.63 0.1 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 105.986 -2.846 . . . . 0.81 105.986 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.41 147.71 31.68 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.419 -0.896 . . . . 0.01 111.007 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.65 138.66 17.26 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.02 108.421 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.4 tt -130.29 140.83 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.354 0.597 . . . . 0.02 109.693 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.9 t -121.8 129.73 52.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.478 -0.764 . . . . 0.39 109.778 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 29.1 m-85 -109.14 139.27 44.26 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.838 -0.801 . . . . 0.02 108.838 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.1 m-85 -122.68 138.56 54.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.297 -0.877 . . . . 0.02 109.742 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' HG3' HD11 ' A' ' 33' ' ' LEU . 91.1 mt-10 -69.14 -27.58 65.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.229 -0.919 . . . . 0.03 111.671 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 0.6 OUTLIER -114.83 170.33 8.42 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.872 -1.142 . . . . 0.03 110.58 -179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -74.51 157.45 35.5 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.755 0.788 . . . . 0.03 110.181 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 0.9 OUTLIER 65.77 35.33 6.85 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.891 0.853 . . . . 0.74 110.943 179.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.599 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.5 p90 49.82 45.28 24.94 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.679 0.752 . . . . 0.02 111.266 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -112.51 166.78 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.08 -1.081 . . . . 0.02 108.08 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.4 -167.88 36.04 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.737 -1.221 . . . . 0.03 110.624 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -69.89 143.76 52.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.376 -1.073 . . . . 2.76 109.134 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -120.35 149.07 42.92 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.71 0.767 . . . . 1.89 110.582 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -132.24 126.75 34.21 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.064 -1.087 . . . . 0.02 108.064 179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -112.04 136.83 50.89 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.414 -0.804 . . . . 1.12 109.814 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.2 t -130.62 137.78 49.78 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 121.478 0.656 . . . . 0.02 109.538 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.89 10.59 14.15 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.303 0.573 . . . . 0.2 109.626 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 43.1 t -158.15 173.86 16.07 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.129 -1.063 . . . . 1.23 108.129 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 2.9 m-20 -61.77 144.77 54.23 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.615 -1.303 . . . . 0.02 110.541 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.0 t -132.2 116.45 16.98 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.585 -0.895 . . . . 0.02 108.585 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -75.9 -23.5 55.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.486 -0.758 . . . . 0.24 110.634 -178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -155.61 101.88 2.19 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.48 -0.933 . . . . 1.14 108.48 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.67 10.22 34.88 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 122.344 1.069 . . . . 6.37 109.816 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -59.88 -23.43 63.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.505 -0.747 . . . . 3.11 110.713 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 m -75.35 -16.55 60.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.688 -1.258 . . . . 0.88 110.373 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -103.15 -21.4 13.89 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.402 -0.811 . . . . 0.02 109.017 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.88 128.58 12.41 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.848 -0.797 . . . . 3.32 108.848 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.3 p -84.73 -10.12 57.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.71 -0.619 . . . . 0.02 110.376 -178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -171.61 163.3 6.61 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.704 -1.221 . . . . 0.02 107.704 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.2 t -141.73 114.77 8.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.853 -1.154 . . . . 0.02 108.663 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.671 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.8 OUTLIER -107.81 -2.18 20.18 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.953 -1.092 . . . . 0.03 110.614 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.7 t -154.36 153.42 31.58 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.99 -1.115 . . . . 0.02 107.99 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 62.0 mt -144.63 146.65 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 120.89 -1.131 . . . . 0.02 109.9 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' A' ' 42' ' ' GLU . 38.9 ttp180 -123.77 123.76 41.2 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.25 -1.389 . . . . 0.02 107.25 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.54 114.0 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 106.879 -1.526 . . . . 0.02 106.879 177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' A' ' 40' ' ' ARG . 30.9 mt-10 -83.7 -33.92 25.05 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.98 -0.688 . . . . 3.81 109.721 -178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.16 150.4 19.64 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 118.475 -1.822 . . . . 0.02 110.369 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.18 173.57 49.77 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.671 -1.252 . . . . 0.01 110.077 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.3 m -119.45 135.86 54.57 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.482 -1.303 . . . . 1.48 107.482 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 34.1 m95 -124.12 154.45 39.98 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.523 1.154 . . . . 0.02 111.936 -176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.31 132.93 53.2 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 105.032 -2.21 . . . . 0.24 105.032 176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 34.9 m -114.99 140.25 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.063 -0.717 . . . . 0.65 109.063 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 53.7 m-85 -121.46 144.02 48.92 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 122.22 1.009 . . . . 0.02 109.54 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.465 ' CG ' HH11 ' A' ' 51' ' ' ARG . 1.8 tp10 -66.2 -35.82 81.43 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.196 -0.911 . . . . 0.02 111.75 -177.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.465 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -122.09 158.6 54.78 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.944 -1.098 . . . . 0.02 109.212 -178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -54.66 167.25 1.53 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.517 1.478 . . . . 0.02 112.591 -179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 63.09 37.26 11.67 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.683 0.754 . . . . 0.02 111.265 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.444 ' CD1' ' CD ' ' A' ' 83' ' ' ARG . 4.1 m-85 44.87 52.33 8.12 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.692 0.758 . . . . 3.39 110.935 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -125.8 163.44 22.89 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.846 -0.534 . . . . 2.33 109.943 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.94 -161.21 31.7 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.653 -1.379 . . . . 0.02 109.653 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -65.99 137.15 56.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.949 -1.324 . . . . 0.02 110.045 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 15.8 ptm -119.37 135.98 54.48 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.447 0.641 . . . . 5.01 109.398 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.647 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 47.1 m-85 -133.14 141.01 47.91 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.566 -0.709 . . . . 0.02 109.267 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.7 mm -96.37 132.09 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.571 -0.706 . . . . 1.72 109.431 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.8 OUTLIER -121.17 109.55 35.18 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.552 -0.718 . . . . 0.02 110.332 -178.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.04 169.39 22.21 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 CA-C-N 120.061 1.058 . . . . 1.47 110.229 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -52.82 140.59 23.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.901 -1.124 . . . . 4.25 110.706 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.46 -176.26 32.33 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 119.432 -1.365 . . . . 0.02 110.484 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -118.39 129.97 55.72 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.375 -1.073 . . . . 0.96 109.405 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 59.9 m-85 -121.07 97.66 47.79 Favored Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 107.773 -1.195 . . . . 0.02 107.773 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.55 -3.7 13.06 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.648 0.898 . . . . 0.02 113.952 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -155.68 154.07 30.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.454 -1.404 . . . . 2.02 108.044 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -60.59 -38.44 84.64 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.563 -0.711 . . . . 0.02 111.708 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.17 -0.956 . . . . 0.02 110.152 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.12 -18.75 63.25 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.009 0.909 . . . . 3.42 108.694 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.647 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -107.24 10.86 29.78 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.251 -1.389 . . . . 0.02 107.251 179.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.472 ' SD ' ' NH1' ' A' ' 145' ' ' ARG . 32.9 mtm 61.18 22.47 12.79 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.587 -0.696 . . . . 0.02 110.521 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.48 145.06 47.42 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tp -78.86 -29.97 44.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -1.205 . . . . 0.98 107.75 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.419 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 43.9 p30 -156.86 -171.45 3.66 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 106.448 -1.686 . . . . 0.02 106.448 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -97.57 27.49 4.29 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.731 -1.23 . . . . 0.02 109.987 -179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.512 HH11 ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -95.92 122.48 38.77 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.032 -1.042 . . . . 3.2 110.358 -179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 34.4 mt -144.72 121.66 11.34 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.922 -1.14 . . . . 2.61 107.922 178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.77 -16.84 9.57 Favored Glycine 0 N--CA 1.503 3.141 0 O-C-N 121.33 -0.856 . . . . 0.02 112.847 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.7 t -155.15 155.63 34.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 120.023 1.912 . . . . 0.02 111.084 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 25.0 m -145.5 148.2 32.98 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.542 0.687 . . . . 0.02 110.306 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' CD ' ' CD1' ' A' ' 54' ' ' PHE . 12.7 mtp180 -134.6 139.25 45.2 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.01 108.935 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.6 132.74 37.24 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.623 -0.88 . . . . 0.43 108.623 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 43.8 t -92.72 123.49 44.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.851 -0.796 . . . . 1.25 108.851 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.414 ' ND1' ' N ' ' A' ' 86' ' ' HIS . 0.3 OUTLIER -89.4 135.81 33.38 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.027 -1.101 . . . . 1.77 108.027 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' CD1' ' OE1' ' A' ' 177' ' ' GLU . 1.5 mt -99.2 137.71 37.32 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.752 -0.833 . . . . 1.63 108.752 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.6 p -112.64 126.06 54.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.811 -0.811 . . . . 1.08 108.811 178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.2 p -102.96 -155.43 0.53 Allowed 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 106.162 -1.792 . . . . 1.26 106.162 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.82 -48.99 0.86 Allowed Glycine 0 N--CA 1.501 2.979 0 O-C-N 120.413 -1.429 . . . . 0.01 112.506 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.69 -100.0 0.14 Allowed Glycine 0 N--CA 1.49 2.249 0 C-N-CA 118.632 -1.746 . . . . 0.01 112.019 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -120.18 119.28 32.79 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.111 -1.229 . . . . 4.43 110.753 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.84 129.93 36.92 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.016 -0.674 . . . . 2.99 109.406 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -132.12 139.89 48.62 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.495 -0.753 . . . . 6.36 109.287 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.89 145.77 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.404 -0.81 . . . . 1.09 109.857 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -122.7 132.74 54.39 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.25 -1.389 . . . . 2.05 107.25 177.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.4 m -125.51 149.24 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.107 . . . . 1.1 109.585 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -119.2 141.45 48.87 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 122.034 0.921 . . . . 0.73 110.998 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.36 -29.27 69.42 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.823 -0.626 . . . . 0.02 111.514 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -116.31 169.46 9.28 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.023 -1.048 . . . . 3.18 110.311 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.3 164.79 50.18 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.801 -0.92 . . . . 0.01 110.801 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.6 m-20 56.74 38.16 29.31 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.875 -0.779 . . . . 0.01 111.3 178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.562 ' H ' ' CB ' ' A' ' 128' ' ' SER . 10.7 m-85 53.07 54.69 9.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.586 -0.696 . . . . 0.01 111.475 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -129.01 165.1 21.81 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.331 -0.989 . . . . 3.15 108.331 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.88 -163.9 27.24 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.424 -1.471 . . . . 0.01 109.424 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 65.1 tp60 -75.37 144.07 42.49 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.108 -1.231 . . . . 0.01 108.577 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.452 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.2 tmm? -116.71 142.82 46.41 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.576 0.703 . . . . 0.01 109.836 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -131.76 135.56 46.9 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.311 -0.996 . . . . 2.48 108.311 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -121.21 135.54 55.12 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.58 -0.7 . . . . 0.01 109.93 -178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.1 t -149.88 152.49 35.16 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 122.189 0.995 . . . . 1.69 110.799 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 81.1 p -109.41 9.87 25.49 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.739 -0.664 . . . . 0.01 109.97 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -120.77 163.2 18.49 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.392 -0.817 . . . . 3.21 111.388 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.8 155.72 37.47 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.083 -1.081 . . . . 0.01 108.083 178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.599 ' HG ' ' HZ ' ' A' ' 172' ' ' PHE . 63.1 m -124.66 112.41 27.43 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.423 -0.798 . . . . 0.01 108.94 178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.44 -32.66 3.7 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 CA-C-N 120.135 1.084 . . . . 0.01 111.551 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.6 t -140.76 107.9 5.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.298 -0.876 . . . . 0.02 108.989 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -64.15 -39.98 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.735 -0.603 . . . . 1.83 110.593 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.449 ' C ' ' SD ' ' A' ' 118' ' ' MET . 2.0 tmt? -66.17 -37.8 86.53 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.134 -1.027 . . . . 1.34 109.849 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -70.52 -38.85 74.32 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 120.448 -1.407 . . . . 2.11 109.729 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -80.31 -47.57 14.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 2.08 112.354 -177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -111.46 -0.86 16.1 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.424 -0.798 . . . . 0.02 112.663 -175.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.0 m170 61.19 33.75 19.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.878 -1.139 . . . . 0.02 109.662 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.5 mt -114.22 135.93 53.51 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.476 -0.765 . . . . 0.02 109.235 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.4 ptm180 -90.66 -22.0 21.38 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.959 . . . . 5.32 110.9 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' ' 126' ' ' ILE . 76.0 mt-10 -148.54 163.84 35.99 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.884 -1.135 . . . . 0.02 110.065 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 125' ' ' GLU . 40.0 mm -128.43 125.28 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 107.456 -1.313 . . . . 2.17 107.456 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -111.56 -14.04 13.73 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.285 -0.885 . . . . 0.02 112.698 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.562 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 18.7 m -160.16 152.06 20.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.77 -1.206 . . . . 0.01 109.044 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 31.9 p -168.87 150.13 4.59 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.504 -0.924 . . . . 1.22 108.504 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 35.4 mttm -113.28 100.71 8.77 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 122.327 1.06 . . . . 1.41 108.406 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 136' ' ' TRP . 1.2 p -108.57 125.97 65.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.697 -0.853 . . . . 0.01 108.697 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.7 t -130.47 89.88 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 106.544 -1.65 . . . . 1.98 106.544 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.531 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 11.2 tt0 -151.67 -58.31 0.16 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.534 -1.284 . . . . 0.01 107.534 177.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.72 -10.8 38.38 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 107.173 -2.371 . . . . 0.01 107.173 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 p -123.39 61.44 1.05 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.833 -0.804 . . . . 2.3 111.087 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.531 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 85.6 m95 -132.2 134.3 45.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 120.671 -1.268 . . . . 0.01 110.192 178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.6 mt -120.1 136.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.254 -1.017 . . . . 1.69 108.254 178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.43 141.43 43.53 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 107.109 -1.441 . . . . 2.49 107.109 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -122.72 142.77 50.34 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.173 -0.954 . . . . 0.02 109.894 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.03 -30.31 61.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.427 -0.796 . . . . 0.02 112.319 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -116.4 154.83 48.99 Favored Pre-proline 0 N--CA 1.504 2.275 0 O-C-N 120.587 -1.321 . . . . 1.48 108.619 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.28 167.06 2.01 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.068 1.179 . . . . 0.02 113.04 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.1 m120 58.66 30.75 20.32 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.009 -0.996 . . . . 0.75 111.263 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 57.47 51.21 10.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.665 . . . . 0.02 111.066 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.472 ' NH1' ' SD ' ' A' ' 73' ' ' MET . 23.3 mmm180 -125.0 164.8 19.37 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.45 -0.781 . . . . 0.02 109.549 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.34 -165.93 34.47 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.338 -1.105 . . . . 0.02 110.338 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -69.7 142.9 53.27 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.458 -1.025 . . . . 0.02 109.022 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.483 ' O ' ' CG ' ' A' ' 58' ' ' MET . 6.1 mt-30 -113.41 149.76 33.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.72 -0.613 . . . . 0.02 109.558 -178.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -123.13 132.51 54.11 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.904 -1.147 . . . . 0.01 107.904 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.45 ' H ' ' HE1' ' A' ' 58' ' ' MET . 27.8 tp -95.48 121.2 36.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.633 -1.292 . . . . 0.01 109.347 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.457 HD11 ' CD1' ' A' ' 138' ' ' PHE . 24.2 mt -93.49 162.42 13.98 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.811 -1.181 . . . . 0.01 107.811 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -106.91 -116.94 0.26 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.357 -0.839 . . . . 2.27 109.283 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -141.29 26.31 2.0 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.341 -0.849 . . . . 1.84 109.006 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -110.35 -166.81 1.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.849 -0.797 . . . . 2.28 108.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -107.29 131.9 53.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.532 -0.73 . . . . 0.01 109.496 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -100.06 110.78 23.07 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.354 -0.841 . . . . 0.01 108.911 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.449 ' O ' ' OG ' ' A' ' 128' ' ' SER . 13.0 ptm180 -88.1 -27.79 21.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.01 111.309 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -124.08 154.22 68.13 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.696 -1.224 . . . . 2.54 107.696 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.2 Cg_endo -62.66 -39.27 44.69 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 CA-C-N 119.382 0.815 . . . . 0.7 110.903 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.09 -18.41 17.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 O-C-N 120.795 -1.191 . . . . 0.86 109.478 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.46 -18.52 65.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.039 -1.038 . . . . 0.02 112.272 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.12 15.63 28.07 Favored 'General case' 0 N--CA 1.512 2.645 0 O-C-N 120.799 -1.188 . . . . 0.02 109.887 178.377 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.5 11.22 75.33 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 121.164 -0.96 . . . . 0.02 112.948 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.514 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.22 140.45 35.49 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.847 -1.384 . . . . 0.02 110.233 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -6.85 59.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.642 -0.661 . . . . 0.59 109.711 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 18.7 p -140.34 150.83 62.51 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.176 -0.952 . . . . 0.87 109.297 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.88 15.23 0.73 Allowed 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 120.667 0.911 . . . . 0.38 111.865 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.88 119.64 24.19 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 122.33 1.062 . . . . 0.18 110.682 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.463 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.01 123.5 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.577 -2.009 . . . . 3.99 105.577 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -113.62 -12.77 12.8 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.21 -0.932 . . . . 5.17 113.271 -177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 9.2 t -157.23 158.93 37.09 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 119.134 -2.229 . . . . 0.02 109.945 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.599 ' HZ ' ' HG ' ' A' ' 114' ' ' CYS . 18.1 p90 -152.77 154.75 35.82 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.092 -1.005 . . . . 2.02 110.148 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 54.0 mtm180 -144.67 150.56 37.56 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.272 -0.893 . . . . 0.01 110.395 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 174' ' ' ARG . 21.1 ptt180 -87.89 143.04 27.34 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.613 -0.884 . . . . 0.01 108.613 178.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.65 129.39 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 O-C-N 121.311 -0.868 . . . . 3.04 109.266 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -137.08 147.54 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.219 -0.926 . . . . 1.89 109.783 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.473 ' OE1' ' CD1' ' A' ' 87' ' ' LEU . 51.5 tp10 . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 4.89 109.413 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 3' ' ' THR . 70.5 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.377 -0.601 . . . . 5.28 109.377 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -50.85 97.45 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.374 -0.829 . . . . 5.96 109.223 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.553 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.5 m -104.91 -139.31 0.36 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.995 -1.113 . . . . 2.22 107.995 177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.553 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.23 88.4 0.07 OUTLIER Glycine 0 N--CA 1.497 2.729 0 N-CA-C 106.785 -2.526 . . . . 0.81 106.785 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.5 149.09 33.14 Favored Glycine 0 N--CA 1.488 2.123 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.745 -178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -150.45 136.34 18.39 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.41 -1.053 . . . . 0.02 109.367 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -128.96 139.25 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 109.012 -0.736 . . . . 0.02 109.012 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.411 ' OG ' ' CZ ' ' A' ' 10' ' ' TYR . 2.3 t -121.77 130.35 53.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.605 -0.684 . . . . 0.39 109.438 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -108.67 138.38 45.09 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.041 -0.726 . . . . 0.02 109.041 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.512 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.0 m-85 -122.65 138.53 54.57 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.215 -0.928 . . . . 0.02 109.734 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' C ' ' ND2' ' A' ' 37' ' ' ASN . 70.6 mt-10 -71.33 -28.2 63.92 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.03 111.635 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.562 ' C ' HD21 ' A' ' 37' ' ' ASN . 24.0 t0 -113.57 168.04 10.09 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.851 -1.156 . . . . 0.03 110.171 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 96.0 mtt180 -73.73 157.19 36.96 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.629 0.728 . . . . 0.03 110.051 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.629 ' ND2' ' CE2' ' A' ' 15' ' ' PHE . 0.4 OUTLIER 66.35 35.23 5.9 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.83 0.824 . . . . 0.74 110.928 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.629 ' CE2' ' ND2' ' A' ' 14' ' ' ASN . 13.5 p90 50.06 45.49 25.38 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.815 0.817 . . . . 0.02 111.162 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -112.9 166.09 11.71 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.81 -1.182 . . . . 0.02 107.81 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.9 -166.79 35.86 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.617 -1.278 . . . . 0.03 110.825 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.4 ttp180 -69.42 140.8 54.16 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.622 -0.928 . . . . 2.76 109.268 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -120.94 149.09 43.16 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.586 0.708 . . . . 1.89 110.259 -178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -132.81 127.09 33.79 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.945 -1.131 . . . . 0.02 107.945 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -111.81 136.86 50.52 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.528 -0.732 . . . . 1.12 109.706 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 11.4 t -131.22 138.2 49.26 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.422 0.629 . . . . 0.02 109.449 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -116.81 10.89 14.34 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 109.46 -0.57 . . . . 0.2 109.46 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 4.2 p -157.88 174.43 15.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.178 -1.045 . . . . 1.23 108.178 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.61 144.91 55.67 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.551 -1.343 . . . . 0.02 110.435 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.2 t -132.48 116.65 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.547 -0.909 . . . . 0.02 108.547 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.94 -24.55 52.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.209 -0.932 . . . . 0.24 110.751 -178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -153.76 100.41 2.37 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.445 -0.946 . . . . 1.14 108.445 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 20.5 p90 -106.06 9.88 32.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.199 1.0 . . . . 6.37 110.058 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -58.89 -22.68 59.91 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.633 -0.667 . . . . 3.11 110.595 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.2 t -74.7 -16.61 60.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.676 -1.265 . . . . 0.88 110.324 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.37 -22.0 14.18 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.376 -0.827 . . . . 0.02 109.053 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 tp -150.3 129.44 12.72 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.453 -0.944 . . . . 3.32 108.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 p -85.26 -9.66 57.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.79 -0.569 . . . . 0.02 110.804 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -169.54 161.43 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.551 -1.277 . . . . 0.02 107.551 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 m -141.83 112.68 7.31 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.796 -1.19 . . . . 0.02 109.125 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.825 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.1 OUTLIER -110.66 -0.6 17.1 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.054 -1.029 . . . . 0.03 110.981 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.31 152.24 30.9 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.736 -1.209 . . . . 0.02 107.736 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -146.4 148.37 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.89 -1.131 . . . . 0.02 110.555 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -125.92 125.88 43.49 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.973 -1.121 . . . . 0.02 107.973 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.8 115.42 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.587 -1.634 . . . . 0.02 106.587 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -83.68 -33.8 25.11 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.63 -0.669 . . . . 3.81 110.404 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 151.65 21.22 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 119.064 -1.541 . . . . 0.02 109.996 -179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.58 174.76 50.33 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 119.547 -1.311 . . . . 0.01 109.999 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 46' ' ' TRP . 14.8 m -109.79 160.65 16.15 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 106.646 -1.613 . . . . 1.48 106.646 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 45' ' ' THR . 62.5 m95 -147.97 147.81 30.06 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.643 -1.285 . . . . 0.02 111.432 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.42 131.59 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.157 -2.164 . . . . 0.24 105.157 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.3 m -118.9 143.29 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.664 -0.647 . . . . 0.65 109.436 179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -120.92 145.46 47.67 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 122.299 1.047 . . . . 0.02 109.997 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -65.9 -33.56 76.12 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.858 -0.61 . . . . 0.02 111.501 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.9 mtt180 -124.31 157.4 64.73 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.995 -1.066 . . . . 0.02 109.578 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.11 166.42 1.0 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.603 1.535 . . . . 0.02 112.778 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 64.11 36.39 9.72 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.442 -0.799 . . . . 0.02 111.114 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 45.03 50.88 9.08 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.602 0.715 . . . . 3.39 110.61 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -125.72 163.58 22.52 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.252 0.548 . . . . 2.33 109.914 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.62 -161.93 31.33 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.477 -1.449 . . . . 0.02 109.477 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.624 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 16.0 t-80 -66.53 138.29 57.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.948 -1.325 . . . . 0.02 109.897 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.503 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 21.8 ptm -119.1 137.21 53.73 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.557 0.694 . . . . 5.01 109.605 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.633 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 13.2 m-85 -132.19 140.31 48.67 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.759 0.79 . . . . 0.02 109.174 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.5 mm -96.5 131.71 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 108.47 -0.937 . . . . 1.72 108.47 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 61' ' ' LEU . 16.6 mt -122.76 113.58 30.2 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.373 -0.829 . . . . 0.02 110.741 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.11 169.96 20.54 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 CA-C-N 120.062 1.058 . . . . 1.47 110.238 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.632 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.8 pm0 -51.9 141.33 17.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.929 -1.107 . . . . 4.25 110.153 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.34 -177.48 32.51 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.341 -1.409 . . . . 0.02 110.707 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -119.08 130.0 55.38 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.529 -0.983 . . . . 0.96 109.62 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 52.3 m-85 -120.71 95.78 48.91 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 107.765 -1.198 . . . . 0.02 107.765 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 1.3 Cg_endo -68.37 -3.66 11.35 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 120.699 0.933 . . . . 0.02 113.835 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.401 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 82.6 mt-10 -157.6 154.81 29.07 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.544 -1.348 . . . . 2.02 108.252 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -60.5 -39.36 87.46 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.492 -0.755 . . . . 0.02 111.937 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -59.49 -23.86 63.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.02 110.132 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.602 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.31 -18.57 62.4 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.443 -0.947 . . . . 3.42 108.443 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.633 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.39 9.05 31.9 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.354 -1.35 . . . . 0.02 107.354 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 28.6 mtm 60.6 21.64 11.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.606 -0.684 . . . . 0.02 110.527 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.87 143.88 44.93 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.195 -1.562 . . . . 0.02 109.195 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.533 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -77.99 -30.14 50.0 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.084 -1.45 . . . . 0.98 107.084 177.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -156.57 -172.04 3.92 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 106.27 -1.752 . . . . 0.02 106.27 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -97.78 27.79 4.23 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.728 -1.232 . . . . 0.02 110.464 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 78' ' ' ARG . 8.5 mtt-85 -96.4 122.84 39.72 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.12 -0.988 . . . . 3.2 110.752 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.9 mt -144.87 120.15 10.21 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.517 -1.29 . . . . 2.61 107.517 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.0 -15.87 11.3 Favored Glycine 0 N--CA 1.507 3.378 0 O-C-N 121.271 -0.893 . . . . 0.02 112.869 -177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.4 p -155.51 156.14 34.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.217 -1.755 . . . . 0.02 110.276 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.5 p -145.03 148.35 33.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 109.484 -0.561 . . . . 0.02 109.484 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -133.71 138.63 45.93 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.751 -0.833 . . . . 0.01 108.751 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.62 131.77 36.84 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.473 -0.936 . . . . 0.43 108.473 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.27 123.82 43.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.74 -0.837 . . . . 1.25 108.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.434 ' O ' ' CG2' ' A' ' 135' ' ' THR . 10.5 m-70 -92.18 135.08 34.28 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.984 -1.073 . . . . 1.77 108.281 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.6 mt -98.01 137.84 36.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.471 -0.768 . . . . 1.63 109.386 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.8 m -111.03 127.09 55.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.548 -0.908 . . . . 1.08 108.548 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.0 p -104.02 -154.73 0.51 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 106.464 -1.68 . . . . 1.26 106.464 177.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.81 -49.02 0.88 Allowed Glycine 0 N--CA 1.498 2.827 0 O-C-N 120.454 -1.403 . . . . 0.01 112.275 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.0 -100.2 0.14 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 118.331 -1.89 . . . . 0.01 112.122 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -119.99 118.58 31.03 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 121.27 -1.135 . . . . 4.43 110.714 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.467 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . . . -76.9 130.92 38.22 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.095 -0.705 . . . . 2.99 109.095 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -130.48 138.54 50.32 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.834 -0.802 . . . . 6.36 108.834 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.7 tt -128.15 143.86 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.251 0 O-C-N 121.358 -0.839 . . . . 1.09 109.402 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -122.14 133.71 54.75 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.596 -1.261 . . . . 2.05 107.596 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' A' ' 129' ' ' CYS . 16.7 m -123.81 146.55 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 120.992 -1.068 . . . . 1.1 109.038 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -120.59 141.75 50.02 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 122.127 0.965 . . . . 0.73 111.277 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -66.16 -30.01 70.4 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 115.807 -0.633 . . . . 0.02 111.821 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -116.61 168.05 10.53 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.913 -1.117 . . . . 3.18 110.636 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.75 163.57 43.8 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 111.016 -0.833 . . . . 0.01 111.016 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 45.3 t0 57.03 38.86 29.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 122.011 -0.699 . . . . 0.01 110.979 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.519 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 15.3 m-85 52.23 56.71 7.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.597 -0.69 . . . . 0.01 111.083 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -128.84 165.46 20.96 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.17 -1.048 . . . . 3.15 108.17 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.2 -164.43 28.41 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.016 -1.634 . . . . 0.01 109.016 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 47.1 tp60 -74.22 143.68 45.03 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.988 -1.301 . . . . 0.01 108.479 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 3.8 tmm? -116.49 142.41 46.91 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.696 0.76 . . . . 0.01 109.683 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -131.58 135.36 46.94 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.978 -1.119 . . . . 2.48 107.978 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -120.77 135.17 55.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.592 -0.692 . . . . 0.01 109.764 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 5.1 t -150.26 154.33 37.74 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 122.486 1.136 . . . . 1.69 111.18 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 10.9 p -111.39 9.86 21.48 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.347 -0.842 . . . . 0.01 109.988 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -122.18 163.52 19.42 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 121.252 -0.905 . . . . 3.21 111.632 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -67.94 155.98 38.24 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.529 -0.915 . . . . 0.01 108.529 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 40.9 t -124.34 112.42 27.98 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.965 -0.754 . . . . 0.01 108.965 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.71 -33.44 2.99 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.188 1.103 . . . . 0.01 111.548 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 t -140.29 107.53 5.5 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.265 -0.897 . . . . 0.02 108.743 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 126' ' ' ILE . 76.4 mt -64.54 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.819 -0.55 . . . . 1.83 111.222 -178.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 0.1 OUTLIER -66.48 -37.65 85.57 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.819 -1.152 . . . . 1.34 109.578 -178.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -70.42 -38.85 74.65 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 120.464 -1.398 . . . . 2.11 109.589 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -80.68 -48.17 12.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 2.08 112.485 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.02 -2.13 15.16 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.563 -0.711 . . . . 0.02 112.705 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.557 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 61.9 33.86 17.26 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.814 -1.179 . . . . 0.02 109.942 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.8 mt -114.2 135.49 53.99 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.491 -0.755 . . . . 0.02 109.1 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -90.98 -21.45 21.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.086 -1.009 . . . . 5.32 111.273 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -148.12 163.98 35.28 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.736 -1.228 . . . . 0.02 110.093 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 117' ' ' ILE . 10.0 mm -128.38 124.3 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 107.58 -1.267 . . . . 2.17 107.58 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -108.44 -13.94 14.76 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.098 -1.001 . . . . 0.02 112.52 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 13.5 t -160.57 152.38 19.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.746 -1.221 . . . . 0.01 108.82 178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' A' ' 97' ' ' VAL . 10.3 t -167.28 145.09 4.73 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.335 -0.853 . . . . 1.22 109.164 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.7 ttmm -123.65 106.09 10.26 Favored 'General case' 0 N--CA 1.499 1.989 0 CA-C-O 122.398 1.094 . . . . 1.41 109.385 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 131' ' ' VAL . 8.1 p -110.55 136.74 45.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.334 -1.358 . . . . 0.01 107.334 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.9 t -126.64 92.24 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 106.515 -1.661 . . . . 1.98 106.515 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.545 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 26.8 tt0 -147.02 -69.1 0.25 Allowed 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 105.491 -2.04 . . . . 0.01 105.491 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 147.22 -42.78 0.88 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.38 -1.488 . . . . 0.01 109.38 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.685 ' HB ' HD12 ' A' ' 175' ' ' ILE . 81.9 p -129.82 103.38 6.78 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.394 -1.062 . . . . 2.3 112.222 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.545 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 15.4 m95 -131.45 145.32 51.73 Favored 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 107.819 -1.178 . . . . 0.01 107.819 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.431 ' CG1' HD11 ' A' ' 175' ' ' ILE . 39.5 mt -119.06 134.23 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.634 -1.291 . . . . 1.69 109.94 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -110.24 141.38 43.28 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 105.541 -2.022 . . . . 2.49 105.541 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -123.19 143.24 50.15 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.111 -0.993 . . . . 0.02 110.009 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.421 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 35.4 tt0 -72.97 -31.97 64.89 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.791 -0.568 . . . . 0.02 111.67 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.4 mt -115.97 154.76 48.4 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 120.738 -1.226 . . . . 1.48 108.819 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -56.45 167.44 2.73 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.069 1.179 . . . . 0.02 112.849 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 59.06 31.63 21.5 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.159 -0.928 . . . . 0.75 111.51 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 58.03 51.91 8.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.477 -0.765 . . . . 0.02 111.361 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -127.12 165.47 19.47 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.569 -0.707 . . . . 0.02 110.097 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.71 -164.99 34.71 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 110.211 -1.156 . . . . 0.02 110.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -69.17 141.34 54.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -1.065 . . . . 0.02 108.817 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.503 ' O ' ' SD ' ' A' ' 58' ' ' MET . 5.6 mt-30 -113.69 148.79 35.73 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.439 -0.578 . . . . 0.02 109.439 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -124.55 134.42 52.99 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 108.758 -0.83 . . . . 0.01 108.758 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -95.99 121.02 37.29 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.871 -1.143 . . . . 0.01 109.477 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.513 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -99.38 146.18 26.57 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.493 -0.929 . . . . 0.01 108.493 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 154' ' ' LYS . 3.3 m-20 -110.6 178.46 4.36 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.599 -0.688 . . . . 2.27 109.532 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -71.65 39.79 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.275 -0.891 . . . . 1.84 109.344 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' A' ' 152' ' ' ASP . 61.6 mttm -110.31 -178.71 3.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.452 -0.78 . . . . 2.28 109.135 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -106.09 120.0 40.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.323 -0.861 . . . . 0.01 108.898 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.07 110.05 22.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.221 -0.924 . . . . 0.01 108.986 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.93 -28.13 16.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.506 -0.746 . . . . 0.01 111.176 -177.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -123.5 152.27 64.63 Favored Pre-proline 0 N--CA 1.496 1.843 0 N-CA-C 107.722 -1.214 . . . . 2.54 107.722 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.559 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.8 Cg_endo -60.61 -39.65 62.57 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 CA-C-N 119.866 0.988 . . . . 0.7 110.987 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.97 -18.87 18.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 O-C-N 120.779 -1.201 . . . . 0.86 109.665 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -65.95 -18.63 65.47 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.927 -1.108 . . . . 0.02 112.38 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.66 16.0 27.17 Favored 'General case' 0 N--CA 1.512 2.654 0 O-C-N 120.828 -1.17 . . . . 0.02 109.912 178.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.1 11.2 76.69 Favored Glycine 0 N--CA 1.497 2.719 0 O-C-N 121.227 -0.921 . . . . 0.02 112.849 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.93 140.63 34.95 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.786 -1.42 . . . . 0.02 110.11 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.64 -7.48 58.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.628 -0.67 . . . . 0.59 110.092 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 7.0 p -139.97 150.72 63.27 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.198 -0.939 . . . . 0.87 109.463 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -75.93 14.27 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 120.812 1.008 . . . . 0.38 112.094 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.31 122.15 27.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.919 -1.113 . . . . 0.18 111.15 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.2 mp -151.65 125.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 106.513 -1.662 . . . . 3.99 106.513 178.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.451 ' N ' ' OE1' ' A' ' 170' ' ' GLN . 9.0 mp0 -112.2 -12.03 13.68 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.357 -0.84 . . . . 5.17 112.533 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.9 t -156.88 158.99 37.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 119.197 -2.189 . . . . 0.02 110.045 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -152.26 154.15 35.16 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.147 -0.97 . . . . 2.02 110.057 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 -143.08 148.39 36.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.387 -0.821 . . . . 0.01 109.804 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.467 ' NH2' ' HB3' ' A' ' 93' ' ' ALA . 15.7 ptm180 -86.37 141.14 29.4 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.184 -1.043 . . . . 0.01 108.184 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.685 HD12 ' HB ' ' A' ' 135' ' ' THR . 25.8 mt -95.1 129.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.212 -0.93 . . . . 3.04 109.516 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.46 147.96 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.538 -0.726 . . . . 1.89 109.618 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.289 -0.882 . . . . 4.89 109.718 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.481 -0.563 . . . . 5.28 109.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HB3' ' HZ3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER -50.06 138.15 16.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 5.96 109.53 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -138.24 -129.04 0.13 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.251 -0.906 . . . . 2.22 111.418 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 167.51 95.12 0.1 Allowed Glycine 0 N--CA 1.492 2.407 0 N-CA-C 105.653 -2.979 . . . . 0.81 105.653 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 147.6 31.86 Favored Glycine 0 N--CA 1.489 2.198 0 C-N-CA 120.338 -0.934 . . . . 0.01 111.231 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 ttmm -152.84 138.05 17.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.586 -0.949 . . . . 0.02 109.184 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.9 tt -130.22 140.0 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.259 -0.645 . . . . 0.02 109.259 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 m -122.56 130.66 53.26 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.633 -0.667 . . . . 0.39 109.877 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 10.9 m-85 -110.6 140.2 45.14 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 108.85 -0.796 . . . . 0.02 108.85 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.517 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.0 m-85 -122.43 139.03 54.32 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.289 -0.882 . . . . 0.02 109.856 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.455 ' HG3' HD11 ' A' ' 33' ' ' LEU . 78.4 mt-10 -68.58 -28.47 66.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.0 -1.063 . . . . 0.03 111.88 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.98 170.42 8.35 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.796 -1.19 . . . . 0.03 110.351 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' NH2' ' OE2' ' A' ' 68' ' ' GLU . 31.9 mtp180 -74.81 157.58 34.91 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.698 0.761 . . . . 0.03 110.354 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.5 t30 66.29 33.85 6.87 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.993 0.901 . . . . 0.74 111.374 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER 56.23 42.43 28.01 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.287 0.565 . . . . 0.02 111.424 177.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -113.64 166.35 11.62 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.611 -0.885 . . . . 0.02 108.611 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.4 -167.53 37.44 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 119.954 -1.117 . . . . 0.03 111.094 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.447 HH21 ' H ' ' A' ' 34' ' ' SER . 37.7 ttp180 -69.11 142.13 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.578 -0.954 . . . . 2.76 109.265 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -121.51 149.46 43.04 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.738 0.78 . . . . 1.89 110.324 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -131.99 127.39 36.17 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.968 -1.123 . . . . 0.02 107.968 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.26 137.4 50.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.564 -0.71 . . . . 1.12 109.564 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.9 t -131.24 138.35 49.29 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.51 0.671 . . . . 0.02 109.673 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -116.44 10.52 14.65 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.608 -0.683 . . . . 0.2 109.529 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 7.1 p -157.37 174.28 15.66 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.216 -1.031 . . . . 1.23 108.216 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -61.34 144.32 54.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.662 -1.274 . . . . 0.02 110.189 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.13 116.7 17.35 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.468 -0.938 . . . . 0.02 108.468 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.89 -24.29 52.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.24 110.663 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -153.82 100.72 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.169 -0.957 . . . . 1.14 108.509 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -106.7 8.38 30.99 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.182 0.991 . . . . 6.37 110.168 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.681 ' NH2' HH12 ' A' ' 78' ' ' ARG . 86.7 mtt180 -59.79 -21.29 60.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 3.11 110.495 -179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.3 m -74.89 -16.48 60.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.905 -1.122 . . . . 0.88 109.871 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -102.37 -21.65 14.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.02 109.086 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.455 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.5 tp -150.26 129.66 12.95 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.913 -0.773 . . . . 3.32 108.913 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.447 ' H ' HH21 ' A' ' 18' ' ' ARG . 29.8 t -86.76 -12.22 48.78 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.854 -0.529 . . . . 0.02 111.098 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 34' ' ' SER . 10.5 mtm180 -167.1 161.09 14.49 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.153 -1.425 . . . . 0.02 107.153 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.8 p -143.34 115.31 8.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.831 -1.168 . . . . 0.02 108.643 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.452 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.5 m-20 -107.3 0.73 23.33 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.864 -1.147 . . . . 0.03 110.733 -178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.1 p -157.08 155.2 30.71 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.757 -1.201 . . . . 0.02 107.757 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.8 mt -145.66 147.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.02 110.27 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.4 ttp180 -123.25 124.36 42.83 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.083 -1.08 . . . . 0.02 108.083 177.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.8 t -106.26 114.04 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.513 -1.662 . . . . 0.02 106.513 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.78 -34.08 27.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.607 -0.683 . . . . 3.81 110.265 -177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.78 151.29 21.02 Favored Glycine 0 N--CA 1.486 1.973 0 C-N-CA 119.116 -1.516 . . . . 0.02 110.125 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.22 173.38 49.64 Favored Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.495 -1.336 . . . . 0.01 110.082 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.2 m -119.82 137.41 54.0 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.802 -1.184 . . . . 1.48 107.802 177.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -125.66 153.62 43.56 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 122.498 1.142 . . . . 0.02 111.983 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.23 133.62 52.21 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 104.869 -2.271 . . . . 0.24 104.869 176.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.466 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.0 m -117.41 142.28 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.526 -0.733 . . . . 0.65 109.089 178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.53 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 13.8 m-85 -119.5 144.04 47.22 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.378 1.085 . . . . 0.02 109.723 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.517 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 5.6 tp10 -65.95 -35.02 79.46 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.669 -0.696 . . . . 0.02 110.882 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -125.17 157.19 68.14 Favored Pre-proline 0 N--CA 1.503 2.205 0 O-C-N 121.093 -1.004 . . . . 0.02 109.702 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -53.94 167.43 1.12 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 121.806 1.67 . . . . 0.02 113.056 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m120 64.06 37.25 9.27 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.144 -0.934 . . . . 0.02 111.017 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 45.21 52.22 8.74 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.598 0.713 . . . . 3.39 110.71 178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 91.2 p -127.56 164.32 22.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.297 0.57 . . . . 2.33 109.911 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.46 -162.3 31.81 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.922 -1.271 . . . . 0.02 109.922 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 14.9 t-80 -63.29 142.61 58.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.044 -1.268 . . . . 0.02 110.507 -178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.511 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 31.4 mtp -116.78 134.56 54.63 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.266 0.555 . . . . 5.01 109.519 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.643 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 17.0 m-85 -135.27 134.35 39.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.393 -0.817 . . . . 0.02 109.124 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.7 mm -96.86 131.75 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 N-CA-C 108.986 -0.746 . . . . 1.72 108.986 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 61' ' ' LEU . 23.0 mt -122.92 111.48 30.89 Favored Pre-proline 0 N--CA 1.503 2.198 0 O-C-N 121.394 -0.816 . . . . 0.02 110.668 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -76.1 171.29 18.4 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 CA-C-N 119.856 0.984 . . . . 1.47 110.286 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.469 ' OE1' ' N ' ' A' ' 64' ' ' GLY . 1.3 tm0? -51.78 140.42 19.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 4.25 109.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' N ' ' OE1' ' A' ' 63' ' ' GLN . . . 155.95 -178.15 32.65 Favored Glycine 0 N--CA 1.493 2.497 0 C-N-CA 119.325 -1.417 . . . . 0.02 110.71 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -119.84 131.24 55.23 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.581 -0.952 . . . . 0.96 109.587 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 62.4 m-85 -121.08 99.42 46.53 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 108.116 -1.068 . . . . 0.02 108.116 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.36 -4.21 13.96 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.64 0.893 . . . . 0.02 113.99 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' OE2' ' NH2' ' A' ' 13' ' ' ARG . 37.7 mt-10 -157.44 155.23 30.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.453 -1.405 . . . . 2.02 108.238 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 70' ' ' GLN . 27.7 p90 -60.36 -38.19 83.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.634 -0.666 . . . . 0.02 111.749 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 69' ' ' TYR . 13.3 mm-40 -59.83 -23.89 63.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.915 -1.115 . . . . 0.02 110.211 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.612 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.5 -18.6 62.28 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.176 0.989 . . . . 3.42 108.588 179.215 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.643 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.7 OUTLIER -105.67 9.25 33.25 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.937 -1.505 . . . . 0.02 106.937 179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 30.8 mtt 59.87 21.56 10.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.606 -0.684 . . . . 0.02 110.121 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.81 144.09 46.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.497 -1.441 . . . . 0.02 109.497 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.1 tp -77.78 -29.68 51.01 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.324 -1.362 . . . . 0.98 107.324 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.517 ' ND2' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -156.85 -170.85 3.44 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 106.405 -1.702 . . . . 0.02 106.405 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -97.82 29.25 3.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.612 -1.305 . . . . 0.02 110.172 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.681 HH12 ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -98.19 122.4 41.3 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.206 -0.934 . . . . 3.2 110.988 -178.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.48 ' HA ' HD23 ' A' ' 79' ' ' LEU . 29.8 mt -144.59 122.03 11.68 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.362 -1.347 . . . . 2.61 107.362 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.19 -16.46 12.31 Favored Glycine 0 N--CA 1.501 3.032 0 C-N-CA 120.448 -0.882 . . . . 0.02 112.405 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 87.8 p -156.31 157.32 35.51 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.309 -1.7 . . . . 0.02 110.405 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 62.3 m -144.85 148.37 33.89 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.767 -0.583 . . . . 0.02 109.559 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -136.44 140.69 43.31 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.233 -0.917 . . . . 0.01 109.136 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.48 132.77 36.44 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.224 -0.922 . . . . 0.43 109.323 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.1 t -91.28 123.77 43.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.511 -0.922 . . . . 1.25 108.511 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -88.93 135.51 33.5 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.097 -1.075 . . . . 1.77 108.097 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -101.29 139.0 37.56 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.445 -0.576 . . . . 1.63 109.445 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 p -111.98 122.39 47.64 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.685 -1.228 . . . . 1.08 107.685 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 16.8 p -114.22 133.84 55.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.752 -1.218 . . . . 1.26 107.865 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.5 -46.02 0.02 OUTLIER Glycine 0 N--CA 1.501 3.033 0 C-N-CA 117.459 -2.305 . . . . 0.01 113.652 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.12 -103.03 0.17 Allowed Glycine 0 N--CA 1.487 2.082 0 CA-C-N 120.308 2.054 . . . . 0.01 111.202 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.467 HE22 HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -119.93 119.2 32.79 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.359 -1.083 . . . . 4.43 110.174 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.1 129.98 38.48 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.191 -0.67 . . . . 2.99 109.191 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -132.14 138.19 47.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.554 -0.717 . . . . 6.36 109.319 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.7 tt -127.36 145.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 121.478 -0.764 . . . . 1.09 109.457 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -122.02 131.65 54.1 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.603 -1.258 . . . . 2.05 107.603 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.429 HG12 ' SG ' ' A' ' 129' ' ' CYS . 23.6 m -123.6 146.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 120.811 -1.18 . . . . 1.1 109.386 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -118.25 140.86 49.17 Favored 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.022 0.915 . . . . 0.73 110.812 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -65.66 -29.96 70.59 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 115.959 -0.564 . . . . 0.02 111.395 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -116.94 168.36 10.31 Favored 'General case' 0 N--CA 1.506 2.357 0 O-C-N 121.078 -1.014 . . . . 3.18 110.571 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.61 168.92 30.6 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.959 -0.857 . . . . 0.01 110.959 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 52.21 40.09 28.22 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.671 0.748 . . . . 0.01 111.168 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.517 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 13.7 m-85 51.77 51.92 15.62 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.563 -0.711 . . . . 0.01 110.804 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -124.83 165.33 18.22 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.568 -0.901 . . . . 3.15 108.568 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.89 -165.37 26.84 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.34 -1.504 . . . . 0.01 109.34 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -75.18 145.38 42.13 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.124 -1.221 . . . . 0.01 108.264 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.464 ' SD ' ' C ' ' A' ' 107' ' ' MET . 8.7 tmm? -116.47 142.31 47.04 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.678 0.752 . . . . 0.01 110.131 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.453 ' N ' ' SD ' ' A' ' 107' ' ' MET . 55.6 m-85 -130.85 135.31 47.6 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.844 -1.169 . . . . 2.48 107.844 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.25 135.77 54.8 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.596 -0.69 . . . . 0.01 109.751 -178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.15 154.46 39.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.039 -1.038 . . . . 1.69 110.674 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.467 HG22 HE22 ' A' ' 92' ' ' GLN . 58.8 p -111.34 8.35 21.32 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.818 -0.628 . . . . 0.01 110.009 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -121.2 163.5 18.4 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.337 -0.852 . . . . 3.21 111.383 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.77 155.92 38.19 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.124 -1.065 . . . . 0.01 108.124 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.496 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 44.5 t -126.0 112.41 24.33 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 108.687 -0.857 . . . . 0.01 108.687 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -74.81 -28.69 9.31 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 CA-C-N 120.245 1.123 . . . . 0.01 111.094 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.5 p -142.52 108.65 5.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.352 -0.843 . . . . 0.02 108.953 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 169' ' ' ILE . 97.2 mt -62.62 -38.27 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.879 -0.513 . . . . 1.83 110.414 -178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 21.9 ttt -68.78 -37.38 79.27 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.224 -0.99 . . . . 1.34 110.451 -178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -69.87 -39.25 76.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.462 -1.399 . . . . 2.11 109.963 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.496 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 7.3 tt0 -79.38 -47.27 16.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.211 -0.931 . . . . 2.08 112.409 -177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -111.71 -0.1 16.11 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.431 -0.793 . . . . 0.02 112.808 -176.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.1 m80 61.3 34.08 18.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.812 -1.18 . . . . 0.02 109.639 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 8.7 mt -113.25 134.15 54.73 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 108.576 -0.898 . . . . 0.02 108.576 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.403 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.94 -21.61 21.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.272 -0.893 . . . . 5.32 109.984 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -149.83 164.56 35.03 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.149 -0.97 . . . . 0.02 109.859 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.2 mt -131.96 128.52 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.294 -1.373 . . . . 2.17 107.294 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -107.23 -12.85 15.28 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.518 -0.739 . . . . 0.02 111.974 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 2.2 t -161.33 155.14 22.09 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.825 -1.172 . . . . 0.01 108.905 178.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.429 ' SG ' HG12 ' A' ' 97' ' ' VAL . 6.2 t -166.66 144.46 5.11 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.957 -1.127 . . . . 1.22 107.957 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 45.4 tttm -119.39 101.89 8.28 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 122.176 0.988 . . . . 1.41 109.004 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.473 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.3 p -109.44 133.36 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.487 -0.931 . . . . 0.01 108.487 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.41 87.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.219 -2.141 . . . . 1.98 105.219 175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -146.97 -66.38 0.27 Allowed 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 106.967 -1.494 . . . . 0.01 106.967 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.03 -10.63 44.27 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 107.555 -2.218 . . . . 0.01 107.555 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.0 p -121.73 52.05 1.28 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.804 -0.821 . . . . 2.3 110.515 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 17.0 m95 -129.03 139.95 51.83 Favored 'General case' 0 N--CA 1.51 2.551 0 O-C-N 120.689 -1.257 . . . . 0.01 110.384 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 32.6 mt -121.14 138.86 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.929 -0.767 . . . . 1.69 108.929 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.48 ' CE1' HD11 ' A' ' 151' ' ' LEU . 2.8 m-30 -111.92 142.01 44.85 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.089 -1.448 . . . . 2.49 107.089 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 22.0 m-85 -123.17 144.04 49.62 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.214 -0.929 . . . . 0.02 109.448 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.2 -30.22 60.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.543 -0.723 . . . . 0.02 111.552 -176.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 155.46 46.76 Favored Pre-proline 0 N--CA 1.504 2.233 0 O-C-N 120.68 -1.262 . . . . 1.48 108.954 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -57.09 167.27 3.38 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.183 1.255 . . . . 0.02 112.721 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 44.7 t30 59.01 31.63 21.54 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.144 -0.935 . . . . 0.75 111.341 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 57.52 51.19 10.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.486 -0.759 . . . . 0.02 111.157 177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.34 165.1 18.97 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.614 -0.679 . . . . 0.02 109.914 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.67 -165.38 33.55 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.174 -1.17 . . . . 0.02 110.174 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 -69.94 143.02 52.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.44 -1.035 . . . . 0.02 108.915 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -112.03 147.75 35.31 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.383 0.611 . . . . 0.02 109.816 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -124.42 133.76 53.29 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.841 -0.8 . . . . 0.01 108.841 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tp -97.95 122.64 41.31 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.827 -1.17 . . . . 0.01 109.923 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 138' ' ' PHE . 16.8 mt -91.75 143.46 26.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.01 108.61 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 154' ' ' LYS . 20.1 m-20 -108.23 -179.01 3.76 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.438 -0.789 . . . . 2.27 109.725 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.28 36.36 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 1.84 109.526 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 152' ' ' ASP . 89.3 mttt -111.9 177.57 4.6 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.789 . . . . 2.28 109.271 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -106.07 121.87 45.01 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.843 -0.799 . . . . 0.01 108.843 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -98.97 113.04 25.02 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.349 -0.844 . . . . 0.01 110.346 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -94.18 -25.58 17.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.127 -0.983 . . . . 0.01 110.934 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -124.75 154.31 70.43 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 120.922 -1.111 . . . . 2.54 108.119 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.55 -40.69 45.31 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 119.186 0.745 . . . . 0.7 110.555 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 50.1 t -61.8 -19.72 21.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 120.991 -1.068 . . . . 0.86 109.055 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.14 -18.59 65.44 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.962 -1.086 . . . . 0.02 111.388 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.875 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 1.8 p90 -102.74 14.27 32.37 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 121.037 -1.04 . . . . 0.02 109.859 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.15 9.77 69.84 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.393 -0.817 . . . . 0.02 113.734 176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.619 ' CB ' ' HE1' ' A' ' 162' ' ' TRP . . . -100.86 140.89 34.51 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.533 -1.569 . . . . 0.02 110.619 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.14 -7.1 59.46 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.636 -0.665 . . . . 0.59 109.333 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.8 m -142.53 150.71 55.36 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.126 -0.984 . . . . 0.87 109.293 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -75.43 17.7 0.63 Allowed 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 120.729 0.953 . . . . 0.38 112.28 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 123.6 29.07 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.476 1.132 . . . . 0.18 111.429 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.875 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.5 mt -148.77 127.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 106.84 -1.541 . . . . 3.99 106.84 179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -113.34 -16.31 12.51 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.231 -0.918 . . . . 5.17 112.726 -178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 114' ' ' CYS . 23.0 t -157.18 159.49 37.79 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 119.287 -2.133 . . . . 0.02 110.176 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -151.04 152.85 34.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.31 -0.868 . . . . 2.02 109.917 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -144.71 151.06 38.33 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.244 -0.91 . . . . 0.01 110.498 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -87.95 143.52 27.06 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.722 -0.844 . . . . 0.01 108.722 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 10.2 mt -94.91 128.7 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 3.04 109.119 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.3 p -136.66 146.64 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.19 -0.944 . . . . 1.89 109.418 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.36 -0.838 . . . . 4.89 109.099 179.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.375 -0.602 . . . . 5.28 109.375 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -63.43 100.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.221 -0.924 . . . . 5.96 109.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.535 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.1 m -106.25 -139.0 0.37 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.265 -1.013 . . . . 2.22 108.265 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.535 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.88 88.8 0.07 OUTLIER Glycine 0 N--CA 1.493 2.489 0 N-CA-C 106.984 -2.447 . . . . 0.81 106.984 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.2 148.15 32.5 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 120.309 -0.948 . . . . 0.01 110.84 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -152.19 137.05 17.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.595 -0.944 . . . . 0.02 108.984 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.5 tt -130.22 140.91 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.8 t -121.03 129.21 53.27 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.461 -0.774 . . . . 0.39 109.833 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 17.1 m-85 -109.42 139.68 44.09 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.898 -0.778 . . . . 0.02 108.898 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 16.6 m-85 -123.05 138.33 54.71 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.265 -0.897 . . . . 0.02 109.915 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.519 ' OE2' ' N ' ' A' ' 34' ' ' SER . 16.6 mm-40 -67.1 -27.68 67.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.359 -0.838 . . . . 0.03 111.258 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 13' ' ' ARG . 10.2 t70 -114.18 169.78 8.77 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.96 -1.088 . . . . 0.03 110.136 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' A' ' 69' ' ' TYR . 16.1 mtp180 -75.61 162.3 28.39 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.622 0.725 . . . . 0.03 110.276 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.606 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 2.7 m120 62.94 34.49 14.1 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.955 0.883 . . . . 0.74 110.397 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.606 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 15.7 p90 49.6 42.64 23.38 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.391 -0.822 . . . . 0.02 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -109.6 166.21 11.07 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.868 -1.16 . . . . 0.02 107.868 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.39 -167.88 36.07 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 120.708 -1.245 . . . . 0.03 110.522 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -68.32 143.72 55.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.466 -1.02 . . . . 2.76 109.153 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -121.33 149.2 43.29 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.5 -0.75 . . . . 1.89 110.179 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -133.36 128.56 35.91 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 108.644 -0.873 . . . . 0.02 108.644 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -111.72 136.46 50.93 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.457 -0.777 . . . . 1.12 109.538 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 13.2 t -130.39 137.61 49.96 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.282 -0.636 . . . . 0.02 109.282 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -117.05 11.11 14.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.605 -0.684 . . . . 0.2 109.741 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.452 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 48.5 t -158.36 174.45 15.11 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.297 -1.001 . . . . 1.23 108.297 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 35.0 t0 -60.58 143.21 54.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.692 -1.255 . . . . 0.02 109.893 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.55 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 9.7 t -130.46 116.63 18.49 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.449 -0.945 . . . . 0.02 108.449 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.483 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -77.06 -23.79 51.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.076 -1.015 . . . . 0.24 110.678 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -156.0 100.91 2.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.896 -1.127 . . . . 1.14 108.576 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -105.32 8.77 33.9 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 122.177 0.989 . . . . 6.37 109.613 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.31 -24.39 63.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.602 -0.686 . . . . 3.11 110.94 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 64.6 p -74.5 -16.62 60.84 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.806 -1.184 . . . . 0.88 109.876 -179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -105.04 -21.7 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.52 -0.737 . . . . 0.02 109.259 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 1.7 tp -148.14 125.56 11.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 3.32 109.247 -178.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.519 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 4.6 m -85.87 -11.35 53.49 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.368 -0.833 . . . . 0.02 111.313 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.51 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 7.2 mtm180 -171.56 161.7 6.27 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.364 -1.347 . . . . 0.02 107.364 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.402 ' SG ' ' CG1' ' A' ' 39' ' ' ILE . 34.8 t -141.47 113.93 8.23 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.223 -0.923 . . . . 0.02 109.205 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.456 ' ND2' ' CG ' ' A' ' 77' ' ' ASP . 3.3 m120 -108.13 -0.17 21.23 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.01 -1.056 . . . . 0.03 110.589 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 t -156.21 152.46 27.83 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 107.524 -1.288 . . . . 0.02 107.524 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.402 ' CG1' ' SG ' ' A' ' 36' ' ' CYS . 84.2 mt -144.79 147.44 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.35 1.072 . . . . 0.02 110.198 -178.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.453 ' NE ' ' OE2' ' A' ' 42' ' ' GLU . 22.1 ttp180 -122.5 123.14 40.57 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.412 -1.329 . . . . 0.02 107.412 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.0 t -104.95 113.16 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 106.723 -1.584 . . . . 0.02 106.723 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' OE2' ' NE ' ' A' ' 40' ' ' ARG . 47.8 mm-40 -83.52 -34.09 25.36 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.968 -0.693 . . . . 3.81 109.639 -178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.4 150.6 19.94 Favored Glycine 0 N--CA 1.488 2.118 0 C-N-CA 118.7 -1.714 . . . . 0.02 110.463 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.09 173.48 49.7 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.881 -1.152 . . . . 0.01 110.404 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.3 m -119.83 136.73 54.36 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 108.19 -1.041 . . . . 1.48 108.19 177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -125.88 153.83 43.59 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 122.613 1.197 . . . . 0.02 112.158 -176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.27 133.8 51.99 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 104.942 -2.244 . . . . 0.24 104.942 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.491 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.4 m -117.98 142.39 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.678 -0.639 . . . . 0.65 109.329 179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.471 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 40.8 m-85 -121.63 144.44 48.75 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 122.058 0.932 . . . . 0.02 109.754 -179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -66.33 -35.57 80.71 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.521 -0.763 . . . . 0.02 111.833 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.408 HH22 ' CZ ' ' A' ' 78' ' ' ARG . 3.6 mmp_? -124.05 153.89 67.96 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.147 -0.97 . . . . 0.02 109.554 -178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -50.61 166.39 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 121.306 1.338 . . . . 0.02 113.378 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.6 t30 63.81 37.52 9.7 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.123 -0.944 . . . . 0.02 111.21 178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 44.1 51.82 7.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.779 0.8 . . . . 3.39 110.663 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.7 t -124.97 163.17 22.88 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.572 -0.529 . . . . 2.33 109.572 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.73 -161.34 32.07 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.647 -1.381 . . . . 0.02 109.647 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -67.57 139.35 56.91 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.983 -1.304 . . . . 0.02 110.413 -179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 22.3 ptm -118.73 137.41 53.37 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.637 -0.664 . . . . 5.01 109.719 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 52.6 m-85 -132.92 138.42 46.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.472 -0.767 . . . . 0.02 109.65 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.633 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.5 mp -95.29 132.17 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.737 -0.838 . . . . 1.72 108.737 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 1.0 OUTLIER -119.85 109.67 37.5 Favored Pre-proline 0 N--CA 1.503 2.201 0 O-C-N 121.416 -0.802 . . . . 0.02 110.451 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -76.48 168.67 23.34 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 CA-C-N 120.136 1.084 . . . . 1.47 109.997 177.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -52.23 140.31 21.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.673 -1.267 . . . . 4.25 110.18 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.88 -177.52 32.11 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.476 -1.345 . . . . 0.02 110.742 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.05 130.94 54.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.43 -1.041 . . . . 0.96 109.305 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 27.9 m-85 -121.97 90.6 48.72 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 107.627 -1.249 . . . . 0.02 107.627 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -64.43 -4.46 8.16 Favored 'Trans proline' 0 N--CA 1.487 1.13 0 C-N-CA 121.006 1.138 . . . . 0.02 113.389 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -154.45 150.62 28.05 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.426 -1.421 . . . . 2.02 107.527 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.617 ' CE1' ' NH2' ' A' ' 13' ' ' ARG . 19.6 p90 -60.29 -37.8 81.64 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.351 -0.843 . . . . 0.02 112.22 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -61.02 -23.51 65.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.02 111.216 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.534 ' HG2' HH11 ' A' ' 71' ' ' ARG . 0.7 OUTLIER -72.66 -16.53 61.7 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.116 -1.034 . . . . 3.42 109.053 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.574 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.93 10.41 30.52 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.087 -1.449 . . . . 0.02 107.087 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 33.7 mtm 61.84 21.75 12.49 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.357 0.599 . . . . 0.02 110.764 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.06 144.66 46.72 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.237 -1.545 . . . . 0.02 109.237 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 30.8 tp -79.5 -30.68 42.05 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.837 -1.172 . . . . 0.98 107.837 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.67 -172.4 3.94 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 106.619 -1.622 . . . . 0.02 106.619 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.456 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 22.3 m-20 -97.89 27.2 4.61 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.687 -1.258 . . . . 0.02 110.382 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' NH2' ' NH2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.49 122.82 39.81 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.142 -0.974 . . . . 3.2 110.777 -179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.491 HD22 ' HB ' ' A' ' 48' ' ' VAL . 61.8 mt -143.63 121.67 12.12 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.865 -1.161 . . . . 2.61 107.865 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.95 -17.75 9.97 Favored Glycine 0 N--CA 1.501 2.984 0 O-C-N 121.345 -0.847 . . . . 0.02 112.54 -177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 36.5 m -155.28 155.38 33.66 Favored 'General case' 0 N--CA 1.503 2.22 0 CA-C-N 119.757 1.778 . . . . 0.02 110.843 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.438 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 12.7 m -145.06 146.98 32.08 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.567 0.698 . . . . 0.02 110.414 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.471 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 71.5 mtm180 -135.64 141.4 45.03 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.741 -0.837 . . . . 0.01 108.741 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.86 130.95 37.27 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.136 -0.978 . . . . 0.43 108.827 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 t -88.82 123.47 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.071 -1.085 . . . . 1.25 108.071 178.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.407 ' O ' ' CG2' ' A' ' 135' ' ' THR . 8.5 m80 -91.02 133.89 34.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.955 -1.091 . . . . 1.77 108.208 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -99.58 139.38 35.32 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.997 -0.742 . . . . 1.63 108.997 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 10.6 p -112.02 125.71 54.37 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.671 -0.862 . . . . 1.08 108.671 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.4 t -102.11 -155.97 0.54 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 106.0 -1.852 . . . . 1.26 106.0 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.4 -47.36 0.97 Allowed Glycine 0 N--CA 1.498 2.808 0 O-C-N 120.561 -1.337 . . . . 0.01 112.279 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.76 -98.61 0.12 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.479 -1.82 . . . . 0.01 112.348 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -122.53 121.41 36.47 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.218 -1.166 . . . . 4.43 111.034 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 132.23 38.52 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.166 -0.679 . . . . 2.99 109.166 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.424 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 6.5 ttpm? -132.11 139.46 48.47 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.022 -0.733 . . . . 6.36 109.022 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.1 tt -127.48 143.92 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 121.975 0.893 . . . . 1.09 109.591 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -124.81 133.54 53.09 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.743 -1.206 . . . . 2.05 107.743 177.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.0 m -124.77 147.83 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 O-C-N 120.946 -1.096 . . . . 1.1 109.546 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -117.57 140.72 49.25 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-O 121.987 0.899 . . . . 0.73 110.948 -178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.96 -29.68 70.12 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.987 -0.551 . . . . 0.02 111.444 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.435 ' O ' ' OG ' ' A' ' 128' ' ' SER . 54.2 mttm -117.35 171.23 8.11 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.13 -0.981 . . . . 3.18 110.289 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.16 170.16 41.91 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 111.072 -0.811 . . . . 0.01 111.072 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 60.3 t0 52.51 39.56 28.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.564 0.697 . . . . 0.01 111.646 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 51.92 49.47 20.66 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.699 -0.626 . . . . 0.01 110.796 178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -123.76 166.2 15.97 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.369 -0.974 . . . . 3.15 108.369 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.78 -165.48 28.34 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.618 -1.393 . . . . 0.01 109.618 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -75.62 144.7 41.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.009 -1.289 . . . . 0.01 108.594 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.454 ' SD ' ' C ' ' A' ' 107' ' ' MET . 10.6 tmm? -116.9 142.98 46.24 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.684 0.754 . . . . 0.01 110.171 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.423 ' N ' ' SD ' ' A' ' 107' ' ' MET . 42.7 m-85 -130.88 135.68 47.93 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.891 -1.152 . . . . 2.48 107.891 178.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -121.95 135.0 54.84 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.548 -0.72 . . . . 0.01 110.115 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 t -149.76 153.15 36.39 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.109 0.957 . . . . 1.69 110.572 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 44.9 p -109.38 10.37 25.47 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.812 -0.631 . . . . 0.01 109.901 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -121.37 163.53 18.54 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.409 -0.807 . . . . 3.21 111.379 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.18 154.65 39.19 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.346 -0.983 . . . . 0.01 108.346 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 12.6 t -123.21 111.6 30.32 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.47 -0.769 . . . . 0.01 108.928 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -77.33 -33.63 2.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 119.885 0.994 . . . . 0.01 111.988 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.7 m -140.94 108.44 5.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.21 -0.931 . . . . 0.02 109.188 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 26.8 mt -63.43 -39.66 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.759 -0.588 . . . . 1.83 110.791 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.1 ttp -66.4 -37.81 86.07 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.002 -1.079 . . . . 1.34 110.033 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -70.34 -39.19 74.86 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.433 -1.417 . . . . 2.11 109.678 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.467 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 52.6 tt0 -81.19 -47.9 12.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 2.08 112.506 -177.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 63.6 m-85 -111.77 -2.53 15.25 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.427 -0.796 . . . . 0.02 112.76 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 m80 61.99 34.02 16.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.719 -1.238 . . . . 0.02 109.323 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.5 mt -114.7 135.71 53.86 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.333 -0.854 . . . . 0.02 109.291 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -90.0 -20.91 22.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.026 -1.046 . . . . 5.32 111.17 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 35.4 mt-10 -149.23 164.9 33.47 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.692 -1.255 . . . . 0.02 110.709 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 27.8 mm -127.54 124.37 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 107.553 -1.277 . . . . 2.17 107.553 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.1 m80 -110.75 -14.66 13.98 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.107 -0.996 . . . . 0.02 113.113 -177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.3 p -163.36 155.47 17.81 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.625 -1.297 . . . . 0.01 109.204 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 24.5 p -171.0 143.31 1.96 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.466 -0.771 . . . . 1.22 108.964 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' O ' ' NE2' ' A' ' 96' ' ' GLN . 24.1 pttt -119.5 99.0 6.4 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 122.6 1.19 . . . . 1.41 109.289 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.2 p -105.38 139.96 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.306 -0.998 . . . . 0.01 108.306 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 43.4 t -125.92 92.08 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 N-CA-C 106.189 -1.782 . . . . 1.98 106.189 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.599 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 21.3 tt0 -146.03 -75.98 0.2 Allowed 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 105.561 -2.014 . . . . 0.01 105.561 177.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 148.77 -41.08 0.88 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.596 -1.402 . . . . 0.01 109.596 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.658 ' HB ' HD12 ' A' ' 175' ' ' ILE . 60.0 p -129.09 100.66 5.71 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.2 -1.177 . . . . 2.3 112.136 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.599 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 41.3 m95 -129.82 143.71 50.95 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 107.629 -1.249 . . . . 0.01 107.629 178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 139' ' ' TYR . 43.7 mt -118.7 133.57 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 120.455 -1.403 . . . . 1.69 109.574 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -111.59 141.96 44.51 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 106.149 -1.797 . . . . 2.49 106.149 178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 137' ' ' ILE . 23.1 m-85 -123.83 144.38 49.76 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.92 -1.113 . . . . 0.02 109.793 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -74.04 -31.43 62.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.809 -0.557 . . . . 0.02 111.799 -176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.8 mt -115.21 155.14 47.2 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 120.816 -1.178 . . . . 1.48 108.903 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -56.81 166.75 3.54 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.128 1.219 . . . . 0.02 112.799 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 60.01 31.1 20.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.206 -0.906 . . . . 0.75 111.375 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 58.26 52.03 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.536 -0.727 . . . . 0.02 111.285 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -126.94 165.47 19.34 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.599 -0.688 . . . . 0.02 110.021 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.48 -165.53 33.94 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.892 -1.283 . . . . 0.02 109.892 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -69.45 142.56 53.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.578 -0.954 . . . . 0.02 108.843 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -112.89 147.22 37.48 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.294 0.569 . . . . 0.02 109.687 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -123.57 134.14 53.87 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.676 -0.861 . . . . 0.01 108.676 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.3 tp -96.56 120.95 37.8 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.922 -1.111 . . . . 0.01 109.526 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 151' ' ' LEU . 11.1 mp -98.47 144.68 27.55 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.315 -0.995 . . . . 0.01 108.315 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 154' ' ' LYS . 6.2 m-20 -108.64 -175.28 2.73 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.508 -0.745 . . . . 2.27 109.859 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -73.01 32.4 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.399 -0.813 . . . . 1.84 109.404 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 152' ' ' ASP . 17.6 ttmt -110.4 173.57 6.27 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.694 -0.854 . . . . 2.28 108.694 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -105.56 129.35 53.84 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.353 -0.842 . . . . 0.01 109.364 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -100.35 111.61 23.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.359 -0.838 . . . . 0.01 109.446 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.462 ' CD ' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -89.71 -26.84 20.46 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.415 -0.803 . . . . 0.01 110.816 -177.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -123.78 155.26 66.9 Favored Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 107.517 -1.29 . . . . 2.54 107.517 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.552 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.3 Cg_endo -63.07 -39.46 39.49 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 CA-C-N 119.349 0.803 . . . . 0.7 111.057 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.89 -18.58 19.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 O-C-N 120.773 -1.204 . . . . 0.86 109.945 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -66.48 -18.41 65.35 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.945 -1.097 . . . . 0.02 112.38 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.552 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.13 15.62 28.11 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 120.737 -1.227 . . . . 0.02 109.917 178.223 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.32 10.92 76.6 Favored Glycine 0 N--CA 1.5 2.926 0 O-C-N 121.172 -0.955 . . . . 0.02 112.847 176.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 140.74 34.77 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.726 -1.455 . . . . 0.02 110.278 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.56 -7.11 59.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.63 -0.669 . . . . 0.59 109.739 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.0 m -141.96 149.7 53.62 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.186 -0.947 . . . . 0.87 109.112 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -74.76 16.89 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 120.736 0.957 . . . . 0.38 112.06 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.64 120.71 25.42 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 122.362 1.077 . . . . 0.18 110.786 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.9 mp -150.66 124.07 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 106.194 -1.78 . . . . 3.99 106.194 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -111.33 -12.29 14.07 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.342 -0.849 . . . . 5.17 112.83 -177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 10.9 p -156.97 160.13 38.75 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.231 -2.168 . . . . 0.02 109.925 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -151.99 153.4 33.98 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.312 -0.867 . . . . 2.02 110.047 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -143.68 149.26 36.96 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.213 -0.929 . . . . 0.01 110.24 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -86.25 142.26 28.69 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.183 -1.043 . . . . 0.01 108.183 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.658 HD12 ' HB ' ' A' ' 135' ' ' THR . 44.2 mt -93.35 128.63 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.451 -0.9 . . . . 3.04 109.327 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 24.7 m -138.73 148.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 1.89 109.918 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.561 -0.712 . . . . 4.89 109.562 179.339 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.0 p . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.486 -0.561 . . . . 5.28 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -68.2 95.41 0.58 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -0.944 . . . . 5.96 109.449 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 66.1 p -102.63 -141.64 0.35 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.933 -1.136 . . . . 2.22 107.933 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 174.93 87.51 0.07 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 106.987 -2.445 . . . . 0.81 106.987 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.29 148.72 33.04 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.607 -0.997 . . . . 0.01 110.607 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -150.77 136.26 17.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.491 -1.005 . . . . 0.02 108.862 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tt -129.37 140.52 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.909 -0.774 . . . . 0.02 108.909 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 11.0 t -122.25 129.98 52.73 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.47 -0.769 . . . . 0.39 109.76 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 26.3 m-85 -108.39 138.55 44.49 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.87 -0.789 . . . . 0.02 108.87 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.54 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 26.9 m-85 -122.65 138.72 54.51 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.194 -0.941 . . . . 0.02 109.788 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.496 ' O ' ' ND2' ' A' ' 37' ' ' ASN . 91.8 mt-10 -69.55 -27.49 65.19 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.619 -0.675 . . . . 0.03 112.041 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -115.33 170.75 8.16 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.817 -1.177 . . . . 0.03 110.569 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.688 ' NH1' HD22 ' A' ' 37' ' ' ASN . 10.9 mpt_? -73.72 157.15 37.03 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.757 0.789 . . . . 0.03 109.897 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.579 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.27 35.41 5.94 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.875 0.845 . . . . 0.74 111.117 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.579 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 7.6 p90 49.6 45.19 24.44 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.699 0.761 . . . . 0.02 111.01 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -112.0 166.29 11.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.01 -1.108 . . . . 0.02 108.01 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.35 -167.16 35.42 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.687 -1.244 . . . . 0.03 110.71 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -68.97 143.03 54.51 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.414 -1.05 . . . . 2.76 109.204 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NE ' ' OG ' ' A' ' 8' ' ' SER . 56.8 ttt180 -119.04 147.8 43.72 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.544 0.688 . . . . 1.89 109.587 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -132.45 126.48 33.15 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.728 -1.212 . . . . 0.02 107.728 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -111.92 136.29 51.43 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.468 -0.77 . . . . 1.12 109.708 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.2 t -130.48 137.56 49.83 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.482 0.658 . . . . 0.02 109.48 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -116.52 10.89 14.65 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.703 -0.623 . . . . 0.2 109.514 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' N ' ' A' ' 25' ' ' ASP . 49.0 t -157.94 174.35 15.39 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.151 -1.055 . . . . 1.23 108.151 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.537 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 1.8 p30 -62.15 144.87 54.81 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.69 -1.256 . . . . 0.02 110.152 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.3 t -132.37 116.56 16.99 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.422 -0.955 . . . . 0.02 108.422 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.56 -24.13 53.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.877 . . . . 0.24 110.732 -178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.23 100.98 2.35 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.587 -0.894 . . . . 1.14 108.587 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -105.2 10.1 33.87 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-O 122.005 0.907 . . . . 6.37 110.063 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.681 HH22 ' NH2' ' A' ' 78' ' ' ARG . 32.4 mtp180 -59.49 -22.27 61.34 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.672 -0.642 . . . . 3.11 110.701 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.8 m -75.54 -16.97 60.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.702 -1.249 . . . . 0.88 110.29 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -102.97 -22.03 13.87 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.411 -0.805 . . . . 0.02 109.221 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.453 HD11 ' HG3' ' A' ' 11' ' ' GLU . 6.2 tp -150.67 129.49 12.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.822 0.82 . . . . 3.32 108.825 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.0 t -85.63 -10.12 56.26 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.656 -0.652 . . . . 0.02 111.142 -178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -171.65 163.91 6.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.647 -1.242 . . . . 0.02 107.647 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.439 ' SG ' HD23 ' A' ' 33' ' ' LEU . 4.0 m -141.26 113.69 8.15 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.823 -1.173 . . . . 0.02 109.133 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.688 HD22 ' NH1' ' A' ' 13' ' ' ARG . 0.8 OUTLIER -107.22 -3.7 19.53 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.892 -1.13 . . . . 0.03 110.285 -179.002 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.2 t -153.36 152.39 31.03 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.002 -1.11 . . . . 0.02 108.002 177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.4 147.76 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.02 109.973 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -125.08 126.11 44.84 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.876 -1.157 . . . . 0.02 107.876 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.0 t -105.45 114.76 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 106.883 -1.525 . . . . 0.02 106.883 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -84.15 -34.07 24.11 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.783 -0.767 . . . . 3.81 109.865 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.3 150.11 18.99 Favored Glycine 0 N--CA 1.489 2.171 0 C-N-CA 118.572 -1.775 . . . . 0.02 110.507 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.704 ' H ' ' NE2' ' A' ' 63' ' ' GLN . . . 84.11 173.39 49.75 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.623 -1.275 . . . . 0.01 110.062 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.1 m -118.61 136.06 54.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.76 -1.2 . . . . 1.48 107.76 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -126.0 153.52 44.23 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.821 -1.174 . . . . 0.02 112.159 -176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -108.11 133.08 52.89 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.108 -2.182 . . . . 0.24 105.108 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.1 m -117.94 142.39 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.092 -0.707 . . . . 0.65 109.092 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -121.17 145.78 47.47 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 122.22 1.01 . . . . 0.02 109.77 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' OE1' ' NH1' ' A' ' 51' ' ' ARG . 10.4 tt0 -66.68 -34.09 77.1 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.752 -0.658 . . . . 0.02 111.663 -176.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' NH1' ' OE1' ' A' ' 50' ' ' GLU . 10.1 mpt_? -122.87 159.04 55.39 Favored Pre-proline 0 N--CA 1.506 2.353 0 O-C-N 121.002 -1.061 . . . . 0.02 109.287 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -54.39 166.2 1.89 Allowed 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.528 1.485 . . . . 0.02 112.31 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 63.4 36.33 11.54 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.643 0.735 . . . . 0.02 111.167 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 45.52 52.42 9.18 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.462 0.648 . . . . 3.39 111.08 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.7 t -125.92 163.47 22.88 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 121.162 0.506 . . . . 2.33 109.752 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.91 -161.2 31.73 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.592 -1.403 . . . . 0.02 109.592 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.494 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 2.1 m80 -65.72 137.86 57.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.98 -1.306 . . . . 0.02 109.883 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.478 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.7 ptm -119.69 137.04 54.16 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.604 -0.685 . . . . 5.01 109.392 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 49.8 m-85 -134.08 141.01 47.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.499 -0.751 . . . . 0.02 109.714 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.669 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -95.17 132.1 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 108.555 -0.906 . . . . 1.72 108.555 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD2' ' CE1' ' A' ' 66' ' ' TYR . 0.6 OUTLIER -119.96 109.75 37.23 Favored Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.476 -0.765 . . . . 0.02 110.323 -178.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -76.49 168.68 23.32 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 120.007 1.038 . . . . 1.47 110.327 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.704 ' NE2' ' H ' ' A' ' 44' ' ' GLY . 73.9 mt-30 -53.41 140.68 26.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.869 -1.144 . . . . 4.25 110.504 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.81 -176.97 32.36 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 119.627 -1.273 . . . . 0.02 110.452 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.16 130.16 55.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.489 -1.006 . . . . 0.96 109.216 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.49 ' CE1' ' CD2' ' A' ' 61' ' ' LEU . 30.5 m-85 -121.48 95.24 48.35 Favored Pre-proline 0 N--CA 1.493 1.707 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.22 -3.71 10.37 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 120.767 0.978 . . . . 0.02 114.014 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -157.36 154.89 29.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.352 -1.467 . . . . 2.02 108.311 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -60.85 -39.05 87.63 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.616 -0.677 . . . . 0.02 111.651 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -60.16 -23.62 64.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.082 -1.011 . . . . 0.02 110.34 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.52 -18.56 62.95 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.063 0.935 . . . . 3.42 108.578 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.638 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -107.4 10.49 29.54 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.337 -1.357 . . . . 0.02 107.337 -179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 27.6 mtm 61.55 21.98 12.53 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.473 0.654 . . . . 0.02 110.738 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.58 144.36 45.97 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.328 -1.509 . . . . 0.02 109.328 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.9 tp -78.72 -30.83 46.16 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.493 -1.299 . . . . 0.98 107.493 177.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -156.37 -171.53 3.74 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 106.255 -1.757 . . . . 0.02 106.255 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -97.73 27.7 4.25 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.646 -1.284 . . . . 0.02 110.194 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.681 ' NH2' HH22 ' A' ' 30' ' ' ARG . 19.7 mmm180 -96.08 122.06 38.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.893 -1.129 . . . . 3.2 110.631 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.508 HD22 ' HB ' ' A' ' 48' ' ' VAL . 33.1 mt -144.98 119.95 10.01 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.511 -1.292 . . . . 2.61 107.511 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.32 -16.07 11.66 Favored Glycine 0 N--CA 1.505 3.267 0 O-C-N 121.264 -0.898 . . . . 0.02 112.879 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.8 p -155.52 155.88 34.2 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.204 -1.763 . . . . 0.02 110.343 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 32.2 t -144.94 148.21 33.58 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.334 0.588 . . . . 0.02 109.71 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -135.55 140.24 44.54 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.332 -0.855 . . . . 0.01 108.89 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.25 130.12 36.8 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.205 -0.935 . . . . 0.43 108.72 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 28.4 t -88.55 122.97 40.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 107.993 -1.114 . . . . 1.25 107.993 178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.48 ' C ' HD23 ' A' ' 87' ' ' LEU . 15.1 m80 -92.0 133.94 35.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.94 -1.1 . . . . 1.77 108.576 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.59 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -98.18 137.96 36.16 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.242 -1.022 . . . . 1.63 108.242 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 t -110.3 126.9 54.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.339 -0.851 . . . . 1.08 108.743 178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 35.8 p -104.29 -154.86 0.52 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 106.28 -1.748 . . . . 1.26 106.28 177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.11 -47.5 0.97 Allowed Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.509 -1.369 . . . . 0.01 112.237 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.53 -100.18 0.14 Allowed Glycine 0 N--CA 1.487 2.096 0 C-N-CA 118.676 -1.726 . . . . 0.01 111.779 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.7 OUTLIER -120.31 118.74 31.2 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.293 -1.122 . . . . 4.43 110.221 -179.091 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.456 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.55 130.38 37.81 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.102 -0.703 . . . . 2.99 109.102 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -131.28 139.19 49.56 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.464 -0.773 . . . . 6.36 109.323 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.0 tt -129.19 144.98 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.462 -0.774 . . . . 1.09 109.742 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -122.33 134.01 54.65 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 107.424 -1.324 . . . . 2.05 107.424 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.44 147.05 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 120.902 -1.124 . . . . 1.1 109.232 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.587 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 95.2 m-85 -118.77 141.34 48.71 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 122.097 0.951 . . . . 0.73 111.088 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.78 -30.01 70.59 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.791 -0.64 . . . . 0.02 111.57 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -117.03 168.77 9.96 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.947 -1.096 . . . . 3.18 110.553 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -67.16 165.07 43.31 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.013 -0.835 . . . . 0.01 111.013 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.496 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 2.2 m-20 56.48 39.09 30.1 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.664 0.745 . . . . 0.01 110.86 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.5 ' CD1' ' OG ' ' A' ' 128' ' ' SER . 6.7 m-85 52.29 55.58 8.95 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.69 -0.631 . . . . 0.01 110.952 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -128.85 166.1 19.73 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 108.496 -0.927 . . . . 3.15 108.496 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.12 -165.38 27.85 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.427 -1.469 . . . . 0.01 109.427 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.523 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 54.3 tt0 -74.52 145.31 43.59 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.093 -1.239 . . . . 0.01 108.237 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.587 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 27.3 ttp -117.54 142.75 46.81 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.753 0.787 . . . . 0.01 110.179 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.523 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 60.7 m-85 -130.94 135.29 47.53 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.963 -1.125 . . . . 2.48 107.963 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -119.79 135.56 54.81 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.608 -0.683 . . . . 0.01 109.957 -178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.524 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.1 t -150.09 152.13 34.29 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.33 1.062 . . . . 1.69 111.074 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 67.7 p -110.28 9.55 23.68 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.622 -0.717 . . . . 0.01 109.808 -179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -121.08 163.32 18.56 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.311 -0.868 . . . . 3.21 111.398 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -66.51 155.28 38.07 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 27.5 t -124.53 111.6 27.86 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.737 -0.838 . . . . 0.01 108.737 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -76.86 -32.5 3.35 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 CA-C-N 120.128 1.081 . . . . 0.01 111.732 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 m -140.82 107.61 5.38 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.308 -0.87 . . . . 0.02 108.855 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 9.7 mt -63.3 -39.04 83.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.779 -0.576 . . . . 1.83 110.375 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.403 ' SD ' ' C ' ' A' ' 123' ' ' LEU . 5.9 tpt -66.1 -37.89 86.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.013 -1.075 . . . . 1.34 109.868 -178.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -70.73 -39.3 73.45 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.374 -1.454 . . . . 2.11 109.532 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.452 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 42.1 tt0 -80.53 -48.01 13.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.187 -0.946 . . . . 2.08 112.458 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.452 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 66.0 m-85 -111.23 -1.78 15.98 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.38 -0.825 . . . . 0.02 112.623 -175.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 61.12 34.33 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.745 -1.222 . . . . 0.02 109.603 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.403 ' C ' ' SD ' ' A' ' 118' ' ' MET . 52.5 mt -114.33 136.21 53.23 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.517 -0.74 . . . . 0.02 109.432 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -90.25 -21.96 21.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.323 -0.861 . . . . 5.32 110.737 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' O ' HD13 ' A' ' 126' ' ' ILE . 37.8 mt-10 -148.91 164.3 34.93 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.966 -1.084 . . . . 0.02 109.939 -178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 125' ' ' GLU . 34.6 mm -129.49 126.7 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 107.453 -1.314 . . . . 2.17 107.453 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -110.07 -12.93 14.47 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.267 -0.896 . . . . 0.02 112.658 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.5 ' OG ' ' CD1' ' A' ' 103' ' ' PHE . 7.8 t -160.42 153.13 21.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.691 -1.256 . . . . 0.01 109.002 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 32.0 p -167.08 146.32 5.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.367 -0.833 . . . . 1.22 109.349 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -125.22 106.4 9.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.45 1.119 . . . . 1.41 109.381 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 131' ' ' VAL . 12.2 p -111.36 136.38 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.328 -1.36 . . . . 0.01 107.328 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 93.9 t -129.35 92.47 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 106.861 -1.533 . . . . 1.98 106.861 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.483 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 6.5 tm-20 -146.92 -70.35 0.24 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 105.399 -2.074 . . . . 0.01 105.399 177.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.483 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 175.1 -78.94 0.08 OUTLIER Glycine 0 N--CA 1.482 1.757 0 N-CA-C 108.42 -1.872 . . . . 0.01 108.42 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 175' ' ' ILE . 70.8 p -123.88 127.53 48.15 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 122.344 1.069 . . . . 2.3 111.114 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.409 ' HE1' ' HB3' ' A' ' 133' ' ' GLU . 9.5 m95 -127.9 151.15 49.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 106.789 -1.56 . . . . 0.01 106.789 178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.439 HG13 HD11 ' A' ' 175' ' ' ILE . 32.6 mt -118.08 134.3 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 120.446 -1.409 . . . . 1.69 109.266 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.5 m-30 -111.51 141.69 44.76 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.344 -1.724 . . . . 2.49 106.344 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.506 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 11.3 m-85 -123.19 143.46 50.0 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.22 -0.925 . . . . 0.02 109.64 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.98 -30.69 62.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.739 -0.601 . . . . 0.02 111.668 -176.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mt -116.79 154.31 49.42 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 120.774 -1.204 . . . . 1.48 108.874 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.82 169.68 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.156 1.238 . . . . 0.02 113.174 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.448 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER 57.51 32.29 21.59 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 114.99 -1.004 . . . . 0.75 111.462 178.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 55.57 48.34 18.89 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.534 -0.729 . . . . 0.02 110.382 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.454 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -122.08 163.9 18.65 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.659 -0.651 . . . . 0.02 109.613 179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.13 -165.51 32.95 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.16 -1.176 . . . . 0.02 110.16 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -69.71 143.18 53.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.499 -1.001 . . . . 0.02 109.15 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.478 ' O ' ' CG ' ' A' ' 58' ' ' MET . 3.4 mt-30 -112.95 148.24 35.43 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.281 0.562 . . . . 0.02 109.763 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -123.31 133.28 54.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.435 -0.95 . . . . 0.01 108.435 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 19.6 tp -96.23 120.72 37.03 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.794 -1.191 . . . . 0.01 109.558 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.553 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -97.66 139.71 33.15 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.174 -1.047 . . . . 0.01 108.174 178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 154' ' ' LYS . 0.7 OUTLIER -107.39 -171.82 1.95 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.345 -0.847 . . . . 2.27 109.905 -179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.01 40.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.464 -0.773 . . . . 1.84 109.568 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 152' ' ' ASP . 75.3 tttt -113.57 168.49 9.72 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.619 -0.675 . . . . 2.28 109.28 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -103.48 127.54 50.85 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.18 -1.044 . . . . 0.01 108.18 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -100.85 110.62 22.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.019 -1.051 . . . . 0.01 110.598 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -93.8 -26.66 16.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.314 -0.867 . . . . 0.01 110.736 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -123.24 154.09 65.23 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 107.897 -1.149 . . . . 2.54 107.897 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.2 Cg_endo -62.14 -42.37 29.82 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 CA-C-N 119.237 0.763 . . . . 0.7 111.097 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 42.6 t -60.95 -18.68 18.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 O-C-N 120.68 -1.262 . . . . 0.86 109.428 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 60.2 t0 -65.53 -18.18 65.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.841 -1.162 . . . . 0.02 111.964 -178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.77 15.84 27.7 Favored 'General case' 0 N--CA 1.513 2.697 0 O-C-N 120.737 -1.227 . . . . 0.02 110.037 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 10.89 74.35 Favored Glycine 0 N--CA 1.498 2.782 0 O-C-N 121.053 -1.029 . . . . 0.02 112.869 176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.56 140.59 34.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.717 -1.46 . . . . 0.02 110.13 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.83 -6.92 59.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.687 -0.633 . . . . 0.59 109.553 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 m -140.84 150.06 58.44 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.223 -0.923 . . . . 0.87 109.088 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -74.47 16.15 0.62 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 120.672 0.915 . . . . 0.38 111.902 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.48 120.5 25.56 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.037 -1.039 . . . . 0.18 110.727 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.471 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -150.2 124.92 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.554 -2.017 . . . . 3.99 105.554 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -112.41 -13.4 13.4 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 113.354 0.872 . . . . 5.17 113.354 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.5 p -156.73 159.51 38.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 119.205 -2.184 . . . . 0.02 109.919 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -152.27 154.18 35.22 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.197 -0.939 . . . . 2.02 110.512 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -142.95 148.99 37.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.307 -0.871 . . . . 0.01 110.142 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -86.43 141.7 28.95 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.103 -1.073 . . . . 0.01 108.103 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.483 HD12 ' HB ' ' A' ' 135' ' ' THR . 13.1 mt -94.98 128.95 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.084 -1.01 . . . . 3.04 109.766 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.2 m -137.39 149.31 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.485 -0.759 . . . . 1.89 109.69 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.636 ' CD ' ' H ' ' A' ' 177' ' ' GLU . 2.7 mp0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.364 -0.835 . . . . 4.89 109.638 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' LYS . 5.0 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.26 0.553 . . . . 5.28 109.523 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . 25.6 mttm 57.13 108.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 5.96 109.411 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.526 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.1 m -112.06 -137.36 0.37 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.8 -0.815 . . . . 2.22 108.8 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.67 90.22 0.08 OUTLIER Glycine 0 N--CA 1.495 2.572 0 N-CA-C 106.677 -2.569 . . . . 0.81 106.677 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.09 147.53 31.93 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.632 -0.987 . . . . 0.01 110.632 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -154.14 138.61 16.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.587 -0.949 . . . . 0.02 108.757 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.7 tt -130.29 141.19 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.266 -0.642 . . . . 0.02 109.266 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.562 ' HG ' ' CG ' ' A' ' 21' ' ' ASP . 1.4 m -121.79 130.1 53.15 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.507 -0.746 . . . . 0.39 109.661 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 16.8 m-85 -110.05 139.19 45.44 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.855 -0.794 . . . . 0.02 108.855 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-85 -123.04 139.39 54.13 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.156 -0.965 . . . . 0.02 110.218 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' HG2' HD11 ' A' ' 33' ' ' LEU . 19.6 mm-40 -69.62 -28.44 65.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.99 -1.069 . . . . 0.03 111.981 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.87 170.72 8.13 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 0.03 110.54 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -73.39 156.3 38.45 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.763 0.792 . . . . 0.03 110.371 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 64.98 34.71 8.72 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.811 0.815 . . . . 0.74 111.533 178.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 55.58 42.37 29.68 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.321 0.581 . . . . 0.02 111.333 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -112.7 165.38 12.33 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.202 -1.036 . . . . 0.02 108.202 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.74 -166.76 36.11 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.752 -1.213 . . . . 0.03 110.496 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -69.25 142.38 54.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.405 -1.056 . . . . 2.76 109.3 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 58.5 ttt180 -119.18 148.22 43.34 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 1.89 109.745 -178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -132.99 126.68 32.5 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.209 -1.034 . . . . 0.02 108.209 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.562 ' CG ' ' HG ' ' A' ' 8' ' ' SER . 4.2 m-20 -111.96 136.44 51.28 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.429 -0.795 . . . . 1.12 109.651 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 14.0 t -130.59 137.8 49.83 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.465 0.65 . . . . 0.02 109.645 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 13.7 t70 -116.98 11.32 14.28 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.665 -0.647 . . . . 0.2 109.713 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 48.7 m -158.11 173.97 15.92 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.34 -0.985 . . . . 1.23 108.34 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.85 144.77 54.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.661 -1.274 . . . . 0.02 110.214 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.3 p -132.02 116.71 17.44 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.56 -0.904 . . . . 0.02 108.56 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.82 -25.68 53.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.24 110.657 -178.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -152.72 100.77 2.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.123 -0.986 . . . . 1.14 108.444 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -104.82 9.36 34.88 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 122.207 1.004 . . . . 6.37 109.755 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.572 ' CZ ' ' NH2' ' A' ' 78' ' ' ARG . 57.8 mtp180 -58.93 -23.28 61.22 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.678 -0.639 . . . . 3.11 110.705 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 69.2 p -75.34 -16.69 60.38 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.691 -1.256 . . . . 0.88 110.162 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.4 m-85 -103.21 -21.65 13.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.36 -0.838 . . . . 0.02 109.178 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 11' ' ' GLU . 6.4 tp -150.62 129.2 12.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.367 -0.833 . . . . 3.32 108.816 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -86.1 -10.0 55.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.808 -0.558 . . . . 0.02 110.984 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 25.3 ttt180 -171.1 162.04 6.95 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.4 -1.333 . . . . 0.02 107.4 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 33' ' ' LEU . 3.5 m -141.36 114.33 8.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.922 -1.111 . . . . 0.02 108.842 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.6 OUTLIER -107.54 -0.15 22.29 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 120.711 -1.243 . . . . 0.03 110.583 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.6 t -156.72 154.08 29.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.545 -1.28 . . . . 0.02 107.545 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.35 148.39 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.117 -0.989 . . . . 0.02 110.218 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -124.68 125.1 43.55 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.889 -1.152 . . . . 0.02 107.889 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.67 113.61 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 106.756 -1.572 . . . . 0.02 106.756 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -83.69 -34.14 25.03 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 120.127 -0.629 . . . . 3.81 109.531 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.48 150.23 19.13 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 118.713 -1.708 . . . . 0.02 110.605 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.07 173.44 49.66 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.472 -1.347 . . . . 0.01 109.782 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 m -119.99 137.38 54.11 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.404 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 44.6 m95 -126.6 152.98 45.91 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 122.524 1.154 . . . . 0.02 111.922 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.42 133.79 51.41 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 104.841 -2.281 . . . . 0.24 104.841 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.512 ' HB ' HD22 ' A' ' 79' ' ' LEU . 35.3 m -117.73 142.94 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.65 109.228 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.5 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 17.6 m-85 -119.81 143.68 47.73 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.34 1.067 . . . . 0.02 109.703 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -66.08 -34.31 77.77 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.759 -0.655 . . . . 0.02 110.764 -177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -125.36 157.43 67.78 Favored Pre-proline 0 N--CA 1.503 2.194 0 O-C-N 121.144 -0.972 . . . . 0.02 109.897 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.01 166.82 1.36 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 121.706 1.604 . . . . 0.02 113.16 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 64.43 36.37 8.93 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.054 -0.976 . . . . 0.02 111.195 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 45.77 51.79 10.09 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.534 0.683 . . . . 3.39 110.782 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.9 p -127.25 164.22 22.19 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 121.286 0.565 . . . . 2.33 109.824 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.47 -162.26 31.78 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.983 -1.247 . . . . 0.02 109.983 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.3 t-80 -63.05 142.78 58.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.153 -1.204 . . . . 0.02 110.457 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.434 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 29.6 mtp -117.9 134.69 54.7 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 109.346 -0.613 . . . . 5.01 109.346 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.636 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 31.5 m-85 -135.27 135.22 40.69 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.34 -0.85 . . . . 0.02 109.2 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.3 mm -96.52 132.31 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.941 -0.763 . . . . 1.72 108.941 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.2 110.22 31.01 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.376 -0.828 . . . . 0.02 110.657 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -75.83 171.45 18.16 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 CA-C-N 119.83 0.975 . . . . 1.47 109.91 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.507 ' N ' ' CD ' ' A' ' 63' ' ' GLN . 1.9 pm0 -52.36 139.71 23.83 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.118 . . . . 4.25 110.237 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 156.34 -178.02 33.04 Favored Glycine 0 N--CA 1.493 2.491 0 C-N-CA 119.435 -1.364 . . . . 0.02 110.446 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -119.11 130.06 55.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.358 -1.084 . . . . 0.96 109.423 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -120.87 96.54 48.65 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' O ' ' CD ' ' A' ' 68' ' ' GLU . 8.0 Cg_endo -70.75 -5.14 16.15 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 120.603 0.868 . . . . 0.02 114.055 -178.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.41 ' CD ' ' O ' ' A' ' 67' ' ' PRO . 49.3 mm-40 -151.8 152.53 32.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 107.628 -1.249 . . . . 2.02 107.628 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -60.77 -37.89 83.41 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.406 -0.809 . . . . 0.02 111.075 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -59.93 -23.65 63.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.051 -1.031 . . . . 0.02 110.28 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.617 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.56 -18.75 62.23 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.283 1.039 . . . . 3.42 108.243 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.636 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -105.66 8.42 33.09 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.212 -1.403 . . . . 0.02 107.212 -179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.456 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 2.3 mpt? 59.95 21.75 10.79 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.477 0.656 . . . . 0.02 110.35 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.31 143.98 45.74 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.26 -1.536 . . . . 0.02 109.26 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.4 tp -78.42 -30.78 47.83 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.34 -1.356 . . . . 0.98 107.34 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -156.22 -172.19 4.0 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 106.245 -1.761 . . . . 0.02 106.245 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 38.6 m-20 -97.57 27.46 4.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.781 -1.199 . . . . 0.02 110.346 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -96.1 122.09 38.56 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.071 -1.018 . . . . 3.2 110.704 -179.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.8 mt -144.71 120.39 10.48 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 107.611 -1.255 . . . . 2.61 107.611 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.91 -16.05 12.1 Favored Glycine 0 N--CA 1.506 3.312 0 C-N-CA 120.491 -0.862 . . . . 0.02 112.64 -177.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.3 p -156.3 156.89 34.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.393 -1.651 . . . . 0.02 110.238 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 59.2 m -144.84 148.66 34.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.698 -0.626 . . . . 0.02 109.415 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -136.38 140.83 43.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.332 -0.855 . . . . 0.01 109.136 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.0 131.93 36.47 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.305 -0.872 . . . . 0.43 109.001 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.71 124.14 43.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.247 -1.02 . . . . 1.25 108.247 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -89.47 134.04 34.28 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.925 -1.139 . . . . 1.77 107.925 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -100.63 139.31 36.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.566 -0.709 . . . . 1.63 109.15 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.2 p -111.22 122.68 48.49 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.669 -1.234 . . . . 1.08 107.669 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 m -114.01 133.19 55.66 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 107.699 -1.223 . . . . 1.26 107.699 177.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -160.4 -46.31 0.02 OUTLIER Glycine 0 N--CA 1.501 3.0 0 C-N-CA 117.59 -2.243 . . . . 0.01 113.573 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -165.83 -103.13 0.17 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 120.17 1.985 . . . . 0.01 111.006 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -120.4 118.66 30.91 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.249 -1.148 . . . . 4.43 110.204 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.76 131.21 41.34 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.141 -0.624 . . . . 2.99 109.369 -179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.28 136.36 46.89 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.598 -0.689 . . . . 6.36 109.67 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.409 HG21 ' CZ3' ' A' ' 136' ' ' TRP . 10.9 tt -127.93 145.41 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.472 -0.767 . . . . 1.09 109.262 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -121.65 133.12 54.97 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.437 -1.319 . . . . 2.05 107.437 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.427 HG12 ' SG ' ' A' ' 129' ' ' CYS . 22.6 m -124.32 147.24 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 120.887 -1.133 . . . . 1.1 109.09 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -119.26 141.11 49.24 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 122.081 0.943 . . . . 0.73 111.086 -178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -66.66 -29.56 69.61 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.758 -0.655 . . . . 0.02 111.465 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' A' ' 128' ' ' SER . 27.3 mmtp -115.6 169.02 9.5 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.099 -1.001 . . . . 3.18 110.148 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.83 164.82 51.2 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 111.056 -0.818 . . . . 0.01 111.056 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 57.14 39.46 28.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.854 -0.792 . . . . 0.01 111.411 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 52.04 54.13 11.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.618 -0.677 . . . . 0.01 111.142 177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -129.65 165.49 21.68 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.052 -1.092 . . . . 3.15 108.052 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.76 -164.63 27.84 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.171 -1.571 . . . . 0.01 109.171 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 48.6 tp60 -75.07 144.18 43.08 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.829 -1.394 . . . . 0.01 108.661 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.45 ' SD ' ' C ' ' A' ' 107' ' ' MET . 13.0 tmm? -116.62 142.56 46.73 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.555 0.693 . . . . 0.01 109.885 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -131.42 136.31 47.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.192 -1.04 . . . . 2.48 108.192 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.537 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.7 tm-20 -120.41 135.72 54.95 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.642 -0.661 . . . . 0.01 109.806 -178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.537 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 5.0 t -149.37 152.48 35.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.253 1.025 . . . . 1.69 110.881 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.7 p -112.01 8.76 20.3 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 115.729 -0.669 . . . . 0.01 109.941 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -121.48 163.46 18.76 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.331 -0.856 . . . . 3.21 111.353 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -67.94 156.74 36.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.327 -0.99 . . . . 0.01 108.327 178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.8 t -125.08 113.08 26.51 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.511 -0.743 . . . . 0.01 109.016 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.9 -28.06 9.69 Favored 'Trans proline' 0 N--CA 1.49 1.276 0 CA-C-N 120.234 1.119 . . . . 0.01 111.055 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.472 ' CB ' ' OE2' ' A' ' 119' ' ' GLU . 2.6 p -144.82 108.57 4.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 0.02 109.004 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.9 mt -62.68 -39.52 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.873 -0.517 . . . . 1.83 110.444 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 25.9 ttt -68.0 -37.25 81.23 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.114 -1.034 . . . . 1.34 110.225 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.472 ' OE2' ' CB ' ' A' ' 116' ' ' SER . 39.6 mt-10 -70.43 -38.78 74.63 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.636 -1.29 . . . . 2.11 109.958 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -80.25 -47.9 13.88 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.208 -0.932 . . . . 2.08 112.417 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -110.7 -0.72 17.0 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.389 -0.819 . . . . 0.02 112.677 -175.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.6 m170 60.39 33.52 20.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.696 -1.252 . . . . 0.02 109.434 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 43.0 mt -112.83 134.52 54.31 Favored 'General case' 0 N--CA 1.502 2.134 0 N-CA-C 108.733 -0.84 . . . . 0.02 108.733 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.456 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -91.7 -22.3 20.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 5.32 110.163 -179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -149.29 163.81 36.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.238 -0.914 . . . . 0.02 109.843 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.4 mt -133.18 129.37 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.272 -1.381 . . . . 2.17 107.272 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -108.68 -12.12 14.99 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.455 -0.778 . . . . 0.02 112.461 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 17.8 p -160.15 154.45 23.53 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.831 -1.168 . . . . 0.01 108.749 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.8 t -166.0 143.13 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.325 -0.859 . . . . 1.22 108.897 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -120.34 103.93 9.61 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.681 1.229 . . . . 1.41 109.153 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 131' ' ' VAL . 14.1 p -112.08 133.76 56.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.706 -1.22 . . . . 0.01 107.706 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.9 t -125.11 87.45 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 105.351 -2.092 . . . . 1.98 105.351 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.406 ' HG3' ' HE1' ' A' ' 136' ' ' TRP . 26.2 mm-40 -147.07 -65.7 0.27 Allowed 'General case' 0 C--N 1.289 -2.034 0 N-CA-C 106.635 -1.617 . . . . 0.01 106.635 178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.35 -9.93 39.03 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 107.002 -2.439 . . . . 0.01 107.002 -177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.8 p -122.06 54.18 1.18 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.978 -0.719 . . . . 2.3 110.553 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.409 ' CZ3' HG21 ' A' ' 95' ' ' ILE . 15.8 m95 -130.02 139.11 51.06 Favored 'General case' 0 N--CA 1.51 2.55 0 O-C-N 120.717 -1.239 . . . . 0.01 110.476 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 21.5 mt -121.72 139.71 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.022 -0.733 . . . . 1.69 109.022 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' HD2' HD13 ' A' ' 169' ' ' ILE . 2.6 m-30 -112.07 141.77 45.33 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 106.799 -1.556 . . . . 2.49 106.799 178.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.462 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 23.7 m-85 -122.6 143.15 49.94 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.091 -1.006 . . . . 0.02 109.228 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -74.57 -31.17 61.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.606 -0.684 . . . . 0.02 111.613 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mt -115.06 155.86 46.06 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 120.68 -1.262 . . . . 1.48 108.752 -179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -57.88 166.71 4.99 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.095 1.197 . . . . 0.02 112.735 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.402 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 15.8 t30 60.09 31.29 20.52 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.142 -0.935 . . . . 0.75 111.456 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 58.72 51.17 7.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.552 -0.717 . . . . 0.02 110.863 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -126.09 165.61 18.53 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.611 -0.681 . . . . 0.02 110.02 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.75 -165.35 34.94 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 110.279 -1.128 . . . . 0.02 110.279 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -69.18 141.78 54.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.591 -0.947 . . . . 0.02 108.848 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.462 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 15.2 mt-30 -112.63 147.75 36.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.517 -0.549 . . . . 0.02 109.517 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -124.18 133.23 53.61 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.764 -0.828 . . . . 0.01 108.764 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.74 121.83 39.02 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.941 -1.099 . . . . 0.01 109.341 -178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.41 HD11 ' CE1' ' A' ' 138' ' ' PHE . 28.0 mt -92.78 146.83 23.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.41 -0.806 . . . . 0.01 109.123 179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.461 ' C ' ' H ' ' A' ' 154' ' ' LYS . 24.2 m-20 -108.55 -171.43 1.85 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.576 -0.702 . . . . 2.27 109.442 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -75.46 29.65 0.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 1.84 109.622 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 152' ' ' ASP . 54.8 mttp -113.21 170.94 7.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.5 -0.75 . . . . 2.28 109.549 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.91 135.36 47.5 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -100.28 114.01 27.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.37 -0.831 . . . . 0.01 109.96 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -88.59 -28.18 20.87 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.552 -0.718 . . . . 0.01 110.988 -177.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -124.63 155.21 69.81 Favored Pre-proline 0 N--CA 1.498 1.942 0 N-CA-C 107.4 -1.333 . . . . 2.54 107.4 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.55 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 11.1 Cg_endo -61.99 -39.39 50.82 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 120.395 0.73 . . . . 0.7 111.457 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.79 -18.58 19.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 O-C-N 120.817 -1.177 . . . . 0.86 109.829 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.15 -19.24 65.78 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.891 -1.131 . . . . 0.02 112.569 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.739 ' CZ2' HD11 ' A' ' 169' ' ' ILE . 0.4 OUTLIER -101.79 16.23 26.5 Favored 'General case' 0 N--CA 1.514 2.774 0 O-C-N 120.696 -1.252 . . . . 0.02 109.881 178.553 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.66 10.52 79.19 Favored Glycine 0 N--CA 1.496 2.676 0 C-N-CA 120.369 -0.919 . . . . 0.02 112.771 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.91 141.03 34.37 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.898 -1.354 . . . . 0.02 110.069 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.61 -7.7 59.15 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.658 -0.651 . . . . 0.59 109.848 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 22.2 m -142.17 150.0 53.97 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.033 -1.042 . . . . 0.87 109.119 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -75.33 18.15 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 120.654 0.902 . . . . 0.38 112.144 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.98 122.76 28.2 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.545 1.164 . . . . 0.18 110.922 -178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.739 HD11 ' CZ2' ' A' ' 162' ' ' TRP . 3.9 mt -148.02 125.86 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.433 -1.692 . . . . 3.99 106.433 179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.1 mm100 -113.67 -16.12 12.37 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.294 -0.879 . . . . 5.17 112.65 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 24.8 p -157.06 158.98 37.47 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 119.247 -2.158 . . . . 0.02 110.196 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.77 154.57 35.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.053 -1.029 . . . . 2.02 110.114 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.452 HH11 ' HG3' ' A' ' 173' ' ' ARG . 5.4 mtm-85 -144.12 150.54 38.27 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.153 -0.967 . . . . 0.01 110.612 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -86.93 143.39 27.42 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.194 -1.039 . . . . 0.01 108.194 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.3 mt -94.69 127.96 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.171 -0.956 . . . . 3.04 109.418 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.06 147.19 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.243 -0.911 . . . . 1.89 109.54 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.401 ' OE1' ' OE1' ' A' ' 63' ' ' GLN . 24.5 tt0 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.415 -0.803 . . . . 4.89 109.412 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.529 -0.545 . . . . 5.28 109.529 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mttp -72.03 94.1 1.46 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.177 -0.952 . . . . 5.96 109.441 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.4 m -102.46 -140.49 0.35 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.689 -1.226 . . . . 2.22 107.689 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 3' ' ' THR . . . 174.18 87.5 0.07 OUTLIER Glycine 0 N--CA 1.496 2.664 0 N-CA-C 106.957 -2.457 . . . . 0.81 106.957 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.95 149.59 33.04 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 120.117 -1.04 . . . . 0.01 110.725 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -151.49 136.97 17.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.493 -1.004 . . . . 0.02 109.367 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.9 tt -129.46 140.06 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.881 -0.785 . . . . 0.02 108.881 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.8 m -121.39 129.84 53.26 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.562 -0.711 . . . . 0.39 109.242 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -108.94 138.95 44.48 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.542 -0.91 . . . . 0.02 108.542 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.5 m-85 -122.55 138.82 54.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.265 -0.897 . . . . 0.02 109.416 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.496 ' HG3' HD11 ' A' ' 33' ' ' LEU . 86.6 mt-10 -69.87 -27.75 65.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.472 -0.767 . . . . 0.03 111.705 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -114.71 169.85 8.76 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.893 -1.129 . . . . 0.03 110.656 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.409 ' CG ' ' ND2' ' A' ' 37' ' ' ASN . 94.2 mtt180 -73.48 157.32 37.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.702 0.763 . . . . 0.03 110.216 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.605 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.9 t-20 65.16 35.7 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.756 0.788 . . . . 0.74 111.086 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 17.1 p90 49.97 45.05 25.52 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.685 0.755 . . . . 0.02 111.122 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 -112.63 165.94 11.8 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.799 -1.185 . . . . 0.02 107.799 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.41 -167.13 35.28 Favored Glycine 0 N--CA 1.493 2.461 0 O-C-N 120.761 -1.212 . . . . 0.03 110.725 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -69.3 142.48 54.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.539 -0.977 . . . . 2.76 109.125 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -121.1 149.51 42.64 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 1.89 110.034 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -132.93 127.42 34.25 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 21' ' ' ASP . 20.6 p-10 -110.1 135.69 50.52 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.52 -0.738 . . . . 1.12 109.22 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -130.13 136.92 49.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.234 -0.654 . . . . 0.02 109.234 -178.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -118.84 9.09 11.9 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.534 -0.729 . . . . 0.2 110.343 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.55 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 44.9 t -157.69 173.69 16.45 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.018 -1.051 . . . . 1.23 108.469 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 64.4 t0 -60.45 142.23 55.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.074 -1.641 . . . . 0.02 110.834 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.2 m -132.36 116.47 16.89 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.408 -0.96 . . . . 0.02 108.408 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.1 54.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.795 . . . . 0.24 110.873 -177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -155.67 101.76 2.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 1.14 108.61 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.1 p90 -105.85 9.6 32.79 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.418 1.104 . . . . 6.37 109.908 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -60.21 -22.17 62.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.292 -0.88 . . . . 3.11 110.801 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' CE1' ' A' ' 32' ' ' TYR . 18.0 p -74.96 -16.64 60.63 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.785 -1.197 . . . . 0.88 109.945 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CE1' ' OG ' ' A' ' 31' ' ' SER . 51.5 m-85 -102.67 -21.3 14.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.453 -0.779 . . . . 0.02 109.083 -179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.8 tp -149.81 128.85 12.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.846 -0.798 . . . . 3.32 108.846 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.4 t -84.25 -9.67 58.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.602 -0.686 . . . . 0.02 110.567 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -171.4 163.79 6.94 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.474 -1.306 . . . . 0.02 107.474 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 t -141.83 113.75 7.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.697 -1.252 . . . . 0.02 108.538 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 1.3 t30 -108.96 -1.58 18.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.96 -1.088 . . . . 0.03 111.42 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.5 m -153.86 153.53 32.27 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.179 -1.045 . . . . 0.02 108.179 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.3 mt -145.77 146.88 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.061 -1.024 . . . . 0.02 110.672 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -125.5 125.68 43.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.397 -1.335 . . . . 0.02 107.397 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.56 114.32 45.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 106.949 -1.5 . . . . 0.02 106.949 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.8 -34.3 27.01 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.586 -0.696 . . . . 3.81 110.485 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.67 152.01 21.74 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 118.974 -1.584 . . . . 0.02 110.138 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 81.83 174.43 49.46 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 119.255 -1.45 . . . . 0.01 110.026 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.486 HG22 ' N ' ' A' ' 46' ' ' TRP . 31.6 m -110.77 161.24 15.98 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.161 -1.422 . . . . 1.48 107.161 177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.486 ' N ' HG22 ' A' ' 45' ' ' THR . 70.0 m95 -148.26 148.63 30.68 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.618 -1.301 . . . . 0.02 111.609 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.81 132.01 54.54 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 105.452 -2.055 . . . . 0.24 105.452 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.1 m -117.11 141.98 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.551 -0.718 . . . . 0.65 109.628 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.519 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 -120.34 143.15 48.54 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 122.062 0.934 . . . . 0.02 109.434 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -64.69 -33.96 77.17 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.593 -0.73 . . . . 0.02 111.589 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.1 mtm180 -124.59 157.84 64.09 Favored Pre-proline 0 N--CA 1.503 2.209 0 O-C-N 121.131 -0.981 . . . . 0.02 109.575 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.37 166.56 1.1 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.663 1.576 . . . . 0.02 112.944 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.4 t30 63.68 37.17 10.27 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-N 115.275 -0.875 . . . . 0.02 111.279 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 45.28 50.92 9.63 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.568 0.699 . . . . 3.39 110.56 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 41.8 m -125.72 163.8 22.03 Favored 'General case' 0 N--CA 1.501 2.112 0 CA-C-O 121.268 0.556 . . . . 2.33 109.876 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.59 -162.07 31.47 Favored Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.553 -1.419 . . . . 0.02 109.553 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -67.03 138.23 57.04 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.98 -1.306 . . . . 0.02 110.137 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.471 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 17.7 ptm -119.21 137.46 53.62 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.417 0.627 . . . . 5.01 109.68 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 81.0 m-85 -132.92 140.56 47.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.175 -0.676 . . . . 0.02 109.175 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.651 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.58 132.92 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.379 -0.971 . . . . 1.72 108.379 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' A' ' 66' ' ' TYR . 2.1 mt -120.78 113.76 32.97 Favored Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.524 -0.735 . . . . 0.02 110.768 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.16 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 CA-C-N 119.915 1.005 . . . . 1.47 110.046 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -53.52 140.82 27.17 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.758 -1.214 . . . . 4.25 110.409 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.87 -177.78 32.78 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.512 -1.328 . . . . 0.02 110.55 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -118.85 130.26 55.66 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.466 -1.02 . . . . 0.96 109.438 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CZ ' ' CD2' ' A' ' 61' ' ' LEU . 23.1 m-85 -121.42 92.99 48.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 107.972 -1.121 . . . . 0.02 107.972 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -65.59 -3.91 8.7 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.877 1.051 . . . . 0.02 113.589 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -156.92 153.37 28.02 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.535 -1.353 . . . . 2.02 107.969 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -59.89 -38.07 81.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.476 -0.765 . . . . 0.02 111.888 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -59.9 -24.14 64.05 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.105 -0.997 . . . . 0.02 110.716 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -71.03 -18.29 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.088 0.947 . . . . 3.42 108.495 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.607 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -106.98 10.59 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.184 -1.413 . . . . 0.02 107.184 179.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.38 22.73 11.18 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.521 0.677 . . . . 0.02 110.417 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 145.53 46.49 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.161 -1.575 . . . . 0.02 109.161 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.43 -30.26 42.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.998 -1.296 . . . . 0.98 107.942 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 54.2 t30 -157.24 -172.08 3.87 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.477 -1.675 . . . . 0.02 106.477 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' H ' ' CG ' ' A' ' 76' ' ' ASN . 2.1 p30 -97.72 27.6 4.3 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.705 -1.247 . . . . 0.02 110.482 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -95.8 121.78 37.88 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.922 -1.112 . . . . 3.2 110.324 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 48' ' ' VAL . 37.1 mt -144.33 119.4 10.06 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.69 -1.226 . . . . 2.61 107.69 178.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.24 11.15 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 121.381 -0.824 . . . . 0.02 112.938 -177.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.6 t -155.6 156.43 35.04 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.203 -1.763 . . . . 0.02 110.897 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.427 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 83.9 m -145.77 148.32 32.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.626 0.727 . . . . 0.02 110.525 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.519 ' NH2' ' OH ' ' A' ' 49' ' ' TYR . 48.5 mtm180 -134.73 139.42 45.18 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.677 -0.861 . . . . 0.01 108.677 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.89 130.45 36.62 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.187 -1.042 . . . . 0.43 108.187 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.3 t -89.66 124.8 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.395 -0.965 . . . . 1.25 108.395 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -90.74 134.17 34.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.925 -1.109 . . . . 1.77 108.335 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mt -98.67 139.35 34.51 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.938 -0.764 . . . . 1.63 108.938 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 p -112.29 125.1 53.8 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.487 -0.931 . . . . 1.08 108.487 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.5 t -102.28 -156.06 0.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 106.163 -1.791 . . . . 1.26 106.163 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.01 -46.45 1.01 Allowed Glycine 0 N--CA 1.496 2.668 0 O-C-N 120.57 -1.331 . . . . 0.01 112.14 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.36 -97.89 0.11 Allowed Glycine 0 N--CA 1.488 2.114 0 C-N-CA 118.352 -1.88 . . . . 0.01 112.382 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -121.51 119.91 33.36 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.336 -1.096 . . . . 4.43 110.966 -178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.81 130.23 38.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.162 -0.681 . . . . 2.99 109.162 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' NZ ' ' CB ' ' A' ' 94' ' ' LYS . 7.2 ttpm? -132.1 139.17 48.38 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.475 -0.766 . . . . 6.36 109.319 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.2 tt -127.46 144.87 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.385 -0.822 . . . . 1.09 109.72 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 96' ' ' GLN . 0.1 OUTLIER -123.45 132.94 54.09 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.938 -1.134 . . . . 2.05 107.938 177.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.2 m -125.26 147.64 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 120.881 -1.137 . . . . 1.1 109.586 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -118.9 141.49 48.61 Favored 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 122.019 0.914 . . . . 0.73 111.061 -178.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.36 -30.3 70.07 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.898 -0.592 . . . . 0.02 111.83 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' O ' ' OG ' ' A' ' 128' ' ' SER . 92.0 mttt -116.26 167.63 10.84 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.913 -1.117 . . . . 3.18 110.273 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.77 163.93 43.42 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 111.003 -0.839 . . . . 0.01 111.003 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 57.17 38.44 28.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.828 -0.807 . . . . 0.01 111.088 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 52.46 55.5 9.02 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.61 -0.682 . . . . 0.01 111.007 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -128.76 165.34 21.13 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.501 -0.926 . . . . 3.15 108.501 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.3 -163.72 27.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.25 -1.54 . . . . 0.01 109.25 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -74.77 143.5 44.02 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.006 -1.291 . . . . 0.01 108.653 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 12.6 tmm? -116.6 142.42 46.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.465 0.65 . . . . 0.01 109.427 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -131.75 135.51 46.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.239 -1.022 . . . . 2.48 108.239 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -121.61 135.28 54.99 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.648 -0.657 . . . . 0.01 110.008 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.2 t -149.64 153.4 36.98 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 122.222 1.011 . . . . 1.69 110.587 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 40.8 p -109.55 10.04 25.16 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.844 -0.616 . . . . 0.01 109.712 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 20.6 mp0 -120.53 163.13 18.43 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.315 -0.866 . . . . 3.21 111.175 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.51 154.55 38.27 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.278 -1.008 . . . . 0.01 108.278 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 11.6 t -123.19 110.26 31.01 Favored Pre-proline 0 N--CA 1.497 1.907 0 N-CA-C 108.673 -0.862 . . . . 0.01 108.673 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.9 -32.6 3.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 CA-C-N 119.873 0.99 . . . . 0.01 111.662 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.5 m -140.43 107.79 5.54 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.322 -0.861 . . . . 0.02 108.819 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.0 mt -63.82 -39.76 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.67 -0.644 . . . . 1.83 110.794 -178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 118' ' ' MET . 1.8 tmt? -67.26 -37.63 83.8 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.053 -1.059 . . . . 1.34 110.073 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -70.24 -39.15 75.2 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 120.416 -1.427 . . . . 2.11 109.763 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.453 ' NE2' ' CZ ' ' A' ' 121' ' ' PHE . 41.9 tt0 -80.39 -47.24 14.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.234 -0.916 . . . . 2.08 112.476 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.453 ' CZ ' ' NE2' ' A' ' 120' ' ' GLN . 69.5 m-85 -111.27 -1.05 16.21 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.451 -0.781 . . . . 0.02 112.681 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 6.2 m80 61.77 33.4 17.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.839 -1.163 . . . . 0.02 109.802 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.3 mt -114.18 135.41 54.07 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.563 -0.711 . . . . 0.02 109.248 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -90.25 -22.13 21.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 5.32 110.987 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.422 ' O ' HD13 ' A' ' 126' ' ' ILE . 81.1 mt-10 -148.6 164.05 35.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.983 -1.073 . . . . 0.02 109.74 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 125' ' ' GLU . 41.8 mm -128.59 125.24 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 107.21 -1.404 . . . . 2.17 107.21 178.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.572 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 0.7 OUTLIER -108.72 -14.1 14.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.305 -0.872 . . . . 0.02 112.573 -177.066 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 100' ' ' LYS . 13.0 p -160.59 153.71 21.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.661 -1.274 . . . . 0.01 109.069 178.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 4.1 t -166.39 140.3 4.16 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.115 -1.069 . . . . 1.22 108.115 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.418 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 3.7 ptpt -119.53 98.85 6.33 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.4 1.095 . . . . 1.41 108.635 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 131' ' ' VAL . 13.8 p -107.07 137.69 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.343 -0.984 . . . . 0.01 108.343 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.6 t -125.76 88.26 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 105.485 -2.043 . . . . 1.98 105.485 175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.524 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 5.9 mm-40 -148.91 -65.42 0.23 Allowed 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.458 -1.682 . . . . 0.01 106.458 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.09 -12.51 26.65 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 108.004 -2.038 . . . . 0.01 108.004 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.8 p -120.42 62.02 0.86 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.827 -0.808 . . . . 2.3 110.764 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.524 ' HE1' ' CB ' ' A' ' 133' ' ' GLU . 73.7 m95 -132.56 135.34 45.87 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.811 -1.181 . . . . 0.01 110.472 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 22.1 mt -119.34 137.84 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.058 -1.09 . . . . 1.69 108.058 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -111.23 141.29 44.94 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 106.959 -1.497 . . . . 2.49 106.959 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 31.3 m-85 -123.24 143.56 49.97 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.1 -1.0 . . . . 0.02 109.594 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -74.88 -30.33 61.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.6 -0.687 . . . . 0.02 111.497 -177.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 90.3 mt -115.4 152.97 47.54 Favored Pre-proline 0 N--CA 1.503 2.193 0 O-C-N 120.788 -1.195 . . . . 1.48 109.003 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -55.77 167.81 2.02 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.086 1.19 . . . . 0.02 113.05 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 59.31 30.86 20.65 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.874 -1.057 . . . . 0.75 111.278 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 58.43 51.88 7.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.528 -0.732 . . . . 0.02 111.065 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -127.16 165.54 19.38 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.564 -0.71 . . . . 0.02 110.141 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 87.95 -165.42 34.69 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.218 -1.153 . . . . 0.02 110.218 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -69.22 141.69 54.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.536 -0.979 . . . . 0.02 108.893 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.471 ' O ' ' CG ' ' A' ' 58' ' ' MET . 10.0 mt-30 -113.38 148.71 35.26 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 109.502 -0.555 . . . . 0.02 109.502 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -123.72 133.51 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.551 -0.907 . . . . 0.01 108.551 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.436 ' H ' ' CE ' ' A' ' 58' ' ' MET . 10.1 tp -95.51 122.28 38.07 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.884 -1.135 . . . . 0.01 109.266 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.1 mp -91.58 149.82 21.48 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.724 -0.843 . . . . 0.01 108.724 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.9 m-20 -108.85 -177.15 3.23 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.471 -0.768 . . . . 2.27 109.498 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -74.38 29.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.85 . . . . 1.84 109.698 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 152' ' ' ASP . 49.6 mttm -112.94 176.12 5.15 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.476 -0.765 . . . . 2.28 109.498 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.473 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 2.2 mp0 -105.91 134.8 48.46 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.838 -0.801 . . . . 0.01 108.838 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -100.0 112.46 24.75 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.262 -0.899 . . . . 0.01 110.302 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -88.39 -29.5 20.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.01 111.133 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.3 mttp -122.72 154.35 63.57 Favored Pre-proline 0 N--CA 1.499 1.996 0 N-CA-C 108.056 -1.09 . . . . 2.54 108.056 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.3 Cg_endo -61.79 -42.95 28.38 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 CA-C-N 119.373 0.812 . . . . 0.7 110.55 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 21.8 t -60.61 -18.81 17.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 O-C-N 120.751 -1.218 . . . . 0.86 109.454 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 58.7 t0 -65.59 -17.86 64.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.809 -1.182 . . . . 0.02 111.737 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.38 15.52 28.55 Favored 'General case' 0 N--CA 1.512 2.666 0 O-C-N 120.725 -1.234 . . . . 0.02 110.193 178.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.86 10.55 75.51 Favored Glycine 0 N--CA 1.498 2.8 0 O-C-N 121.206 -0.934 . . . . 0.02 112.967 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.525 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.68 140.79 34.46 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.855 -1.38 . . . . 0.02 110.009 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.55 -6.83 59.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.669 -0.644 . . . . 0.59 109.612 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -140.49 149.94 59.05 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.109 -0.994 . . . . 0.87 109.169 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -74.81 16.13 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 120.571 0.847 . . . . 0.38 111.909 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.26 120.76 25.79 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.323 1.059 . . . . 0.18 110.841 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.427 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -150.35 123.91 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 105.416 -2.068 . . . . 3.99 105.416 178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -114.79 -11.01 12.32 Favored 'General case' 0 N--CA 1.501 2.123 0 N-CA-C 113.365 0.876 . . . . 5.17 113.365 -177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.9 t -156.64 158.48 37.1 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 119.276 -2.14 . . . . 0.02 110.106 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.7 153.56 34.62 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.198 -0.939 . . . . 2.02 110.287 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 71.0 mtm180 -143.19 149.34 37.87 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.816 0.817 . . . . 0.01 110.206 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -87.82 143.59 27.05 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.337 -0.986 . . . . 0.01 108.337 178.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 mt -95.36 128.5 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.252 -0.905 . . . . 3.04 109.742 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.24 146.61 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.185 -0.947 . . . . 1.89 109.839 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.105 -0.702 . . . . 4.89 109.105 179.288 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.514 -0.55 . . . . 5.28 109.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -57.97 98.4 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 5.96 109.46 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.3 m -105.59 -139.44 0.37 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.2 -1.037 . . . . 2.22 108.2 177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.552 ' H ' HG22 ' A' ' 3' ' ' THR . . . 173.03 88.6 0.07 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 106.943 -2.463 . . . . 0.81 106.943 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.96 149.48 32.89 Favored Glycine 0 N--CA 1.49 2.268 0 C-N-CA 120.275 -0.964 . . . . 0.01 110.851 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -151.43 137.88 18.61 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.395 -1.062 . . . . 0.02 109.614 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 tt -130.15 139.84 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.326 -0.62 . . . . 0.02 109.326 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -120.88 129.74 53.62 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.529 -0.732 . . . . 0.39 109.836 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -109.59 139.41 44.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.927 -0.768 . . . . 0.02 108.927 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 7.7 m-85 -122.89 138.36 54.68 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.266 -0.896 . . . . 0.02 109.576 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -67.61 -27.7 67.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.146 -0.971 . . . . 0.03 111.904 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -114.97 170.92 7.98 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.797 -1.189 . . . . 0.03 110.503 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HE ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -74.98 157.95 34.09 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.607 0.718 . . . . 0.03 110.092 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 4.5 t-20 66.26 34.97 6.2 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.91 0.862 . . . . 0.74 110.873 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.8 p90 50.11 44.94 25.94 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.807 0.813 . . . . 0.02 111.139 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -113.1 166.49 11.37 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.084 -1.08 . . . . 0.02 108.084 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.22 -167.81 36.3 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 120.731 -1.231 . . . . 0.03 110.788 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -68.24 142.6 55.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 2.76 108.939 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -121.18 149.74 42.36 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.686 0.755 . . . . 1.89 110.093 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -133.05 127.62 34.45 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.012 -1.106 . . . . 0.02 108.012 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -110.78 136.15 50.27 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.609 -0.682 . . . . 1.12 109.177 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -130.23 137.02 49.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.448 0.642 . . . . 0.02 109.338 -178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.39 9.19 12.34 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.628 -0.67 . . . . 0.2 110.141 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 9.5 p -157.8 173.82 16.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.058 -1.026 . . . . 1.23 108.318 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 16.5 t0 -59.65 141.7 54.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.283 -1.51 . . . . 0.02 110.568 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 60.5 m -131.68 116.42 17.31 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.281 -1.007 . . . . 0.02 108.281 178.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.94 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.048 -1.033 . . . . 0.24 110.948 -177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -153.3 101.04 2.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.99 . . . . 1.14 108.806 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -105.59 9.04 33.46 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 122.111 0.958 . . . . 6.37 109.637 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 3.5 mmp_? -57.88 -23.66 54.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.654 -0.654 . . . . 3.11 110.565 -179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.1 m -74.05 -16.91 61.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.154 . . . . 0.88 109.971 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -105.41 -22.06 13.1 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.481 -0.762 . . . . 0.02 109.498 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' CD2' ' O ' ' A' ' 35' ' ' ARG . 2.2 tp -148.18 125.34 11.45 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.121 -0.987 . . . . 3.32 109.082 -178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' ARG . 58.3 m -87.58 -13.15 43.65 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.517 -0.74 . . . . 0.02 111.78 -178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.447 ' CG ' ' O ' ' A' ' 34' ' ' SER . 51.3 mtm180 -166.27 160.43 15.92 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.2 -1.407 . . . . 0.02 107.2 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.516 ' SG ' HD12 ' A' ' 79' ' ' LEU . 16.3 p -140.76 113.32 8.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.847 -1.158 . . . . 0.02 108.956 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.9 OUTLIER -106.71 -0.49 23.56 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.82 -1.175 . . . . 0.03 110.379 -179.039 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.1 t -156.41 154.26 30.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.835 -1.172 . . . . 0.02 107.835 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.42 147.71 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.043 -1.036 . . . . 0.02 110.45 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -123.8 125.29 44.44 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.41 -0.959 . . . . 0.02 108.41 177.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.23 113.7 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.735 -1.58 . . . . 0.02 106.735 177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 -82.82 -34.19 26.99 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.567 -0.708 . . . . 3.81 110.366 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.7 151.77 21.37 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.135 -1.507 . . . . 0.02 110.397 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.42 174.43 50.37 Favored Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.696 -1.24 . . . . 0.01 110.175 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.441 ' O ' ' CD1' ' A' ' 46' ' ' TRP . 95.4 m -109.49 160.49 16.18 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 106.889 -1.523 . . . . 1.48 106.889 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.441 ' CD1' ' O ' ' A' ' 45' ' ' THR . 50.4 m95 -148.02 146.97 29.12 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.208 -1.557 . . . . 0.02 111.506 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.66 132.37 54.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 105.519 -2.03 . . . . 0.24 105.519 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' HD22 ' A' ' 79' ' ' LEU . 30.7 m -118.42 143.12 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.523 -0.735 . . . . 0.65 109.625 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.522 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 12.1 m-85 -119.05 142.87 47.47 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 122.207 1.003 . . . . 0.02 109.803 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 74.0 tt0 -67.28 -34.68 77.92 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.873 -0.603 . . . . 0.02 111.075 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -124.33 154.21 68.98 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 121.04 -1.038 . . . . 0.02 109.457 -178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -52.71 168.02 0.53 Allowed 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.596 1.531 . . . . 0.02 113.33 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 m120 65.09 36.45 7.31 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 115.151 -0.931 . . . . 0.02 111.035 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 45.58 50.54 10.44 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.784 0.802 . . . . 3.39 110.527 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.2 m -127.21 164.46 21.64 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.246 0.546 . . . . 2.33 109.971 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.61 -162.39 31.68 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.156 -1.178 . . . . 0.02 110.156 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.402 ' ND1' ' N ' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -62.31 141.23 58.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.089 -1.242 . . . . 0.02 110.568 -178.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 49.4 mtp -117.94 133.12 56.23 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.529 -0.545 . . . . 5.01 109.529 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 56.3 m-85 -136.08 137.08 40.71 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.766 0.793 . . . . 0.02 109.703 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.8 mp -97.21 133.28 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 108.324 -0.991 . . . . 1.72 108.324 178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 61' ' ' LEU . 11.9 mt -120.25 113.57 33.84 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.663 -0.648 . . . . 0.02 110.405 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -77.79 169.54 20.55 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 CA-C-N 119.987 1.031 . . . . 1.47 109.951 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -52.62 140.92 21.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.743 -1.223 . . . . 4.25 110.151 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -177.38 32.54 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.331 -1.414 . . . . 0.02 110.748 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -119.66 131.18 55.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.552 -0.969 . . . . 0.96 109.349 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -120.72 97.13 48.63 Favored Pre-proline 0 N--CA 1.492 1.655 0 N-CA-C 107.81 -1.181 . . . . 0.02 107.81 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.03 -4.39 12.42 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 120.738 0.959 . . . . 0.02 113.837 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -157.39 154.68 29.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.419 -1.426 . . . . 2.02 108.254 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -60.7 -37.95 83.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.531 -0.731 . . . . 0.02 111.616 -177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -60.2 -23.85 64.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.02 110.213 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.67 -18.51 62.84 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 122.128 0.966 . . . . 3.42 108.655 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.585 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -106.73 10.07 30.98 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.17 -1.419 . . . . 0.02 107.17 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 36.0 mtt 60.49 21.05 10.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.51 0.672 . . . . 0.02 110.231 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.22 144.59 47.06 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.095 -1.602 . . . . 0.02 109.095 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.1 tp -78.14 -29.38 48.75 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.597 -1.26 . . . . 0.98 107.597 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.527 HD22 ' C ' ' A' ' 76' ' ' ASN . 0.1 OUTLIER -156.75 -170.76 3.42 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.575 -1.639 . . . . 0.02 106.575 178.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.508 ' OD2' ' ND2' ' A' ' 37' ' ' ASN . 97.9 m-20 -98.1 29.05 3.67 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.62 -1.3 . . . . 0.02 110.204 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -98.1 123.08 41.96 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.262 -0.899 . . . . 3.2 111.329 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.516 HD12 ' SG ' ' A' ' 36' ' ' CYS . 28.1 mt -143.18 120.48 11.57 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.733 -1.58 . . . . 2.61 106.733 177.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.93 -16.65 13.24 Favored Glycine 0 N--CA 1.503 3.158 0 O-C-N 121.248 -0.908 . . . . 0.02 112.329 -177.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 79.8 p -156.07 156.0 33.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.465 -1.609 . . . . 0.02 109.656 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -144.55 147.66 33.48 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.521 0.677 . . . . 0.02 109.547 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -134.08 139.39 45.93 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.542 -0.911 . . . . 0.01 108.542 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.86 130.12 37.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.11 -1.07 . . . . 0.43 108.11 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.05 123.51 43.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.53 -0.915 . . . . 1.25 108.53 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.491 ' O ' HG21 ' A' ' 135' ' ' THR . 13.8 m-70 -90.06 137.92 31.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.205 -0.934 . . . . 1.77 109.165 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -100.95 136.83 40.18 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.422 -0.955 . . . . 1.63 108.422 -179.371 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 p -113.34 126.85 55.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.389 -0.819 . . . . 1.08 108.968 178.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 57.9 m -103.25 -155.02 0.51 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 106.197 -1.779 . . . . 1.26 106.197 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.34 -48.89 0.88 Allowed Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.391 -1.443 . . . . 0.01 112.593 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.85 -100.37 0.14 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.495 -1.812 . . . . 0.01 112.136 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -120.76 119.05 31.61 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.197 -1.178 . . . . 4.43 110.311 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.426 ' HB2' ' OE2' ' A' ' 133' ' ' GLU . . . -76.77 129.92 36.97 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.909 -0.716 . . . . 2.99 109.24 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.52 139.42 50.5 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 6.36 109.208 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 tt -129.58 145.14 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.152 0 O-C-N 121.311 -0.868 . . . . 1.09 109.949 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -122.67 133.16 54.52 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.251 -1.388 . . . . 2.05 107.251 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.7 m -123.73 148.01 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 121.041 -1.037 . . . . 1.1 109.486 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 45.3 m-85 -119.33 140.99 49.42 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 122.248 1.023 . . . . 0.73 110.824 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -65.86 -29.05 69.44 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.659 -0.7 . . . . 0.02 111.33 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -116.59 169.47 9.32 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.151 -0.968 . . . . 3.18 110.443 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -70.46 165.37 52.02 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.938 -0.865 . . . . 0.01 110.938 -179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 53.8 t0 57.36 38.37 28.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 0.01 111.252 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 51.84 54.81 10.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.514 -0.741 . . . . 0.01 111.296 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -129.61 165.97 20.68 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.124 -1.065 . . . . 3.15 108.124 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.07 -164.77 27.54 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.309 -1.517 . . . . 0.01 109.309 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -76.05 145.12 40.39 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.023 -1.28 . . . . 0.01 108.473 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 44.3 ttp -116.69 142.45 46.89 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.764 0.792 . . . . 0.01 110.093 -179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -130.36 135.0 47.59 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.777 -1.194 . . . . 2.48 107.777 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.0 tm-20 -120.68 135.54 55.09 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.632 -0.668 . . . . 0.01 110.217 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.523 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 1.5 t -149.69 151.32 33.48 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 122.178 0.989 . . . . 1.69 110.84 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 29.7 p -109.08 9.9 26.17 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 115.641 -0.708 . . . . 0.01 109.756 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.66 163.57 17.86 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.369 -0.832 . . . . 3.21 111.29 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.32 155.23 37.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.181 -1.044 . . . . 0.01 108.181 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.4 t -122.42 109.25 33.06 Favored Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 108.619 -0.882 . . . . 0.01 108.619 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.81 -34.11 2.55 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 CA-C-N 119.878 0.992 . . . . 0.01 111.44 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.0 p -139.07 106.79 5.62 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.459 -0.941 . . . . 0.02 108.459 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.51 -40.12 87.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.907 -0.496 . . . . 1.83 111.148 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 38.0 ttp -66.87 -37.6 84.73 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.921 -1.112 . . . . 1.34 110.039 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -70.31 -38.85 75.04 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.469 -1.395 . . . . 2.11 109.867 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.41 ' CD ' ' CE2' ' A' ' 121' ' ' PHE . 65.2 tt0 -80.74 -47.57 13.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.228 -0.92 . . . . 2.08 112.471 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.41 ' CE2' ' CD ' ' A' ' 120' ' ' GLN . 75.3 m-85 -111.69 -1.87 15.54 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.4 -0.812 . . . . 0.02 112.69 -175.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.6 ' ND1' ' N ' ' A' ' 122' ' ' HIS . 1.1 m-70 61.35 33.77 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.887 -1.133 . . . . 0.02 109.765 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.2 mt -114.02 135.69 53.74 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.478 -0.763 . . . . 0.02 109.099 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.15 -21.77 22.06 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.142 -0.974 . . . . 5.32 110.908 -179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 126' ' ' ILE . 42.5 mt-10 -148.45 163.99 35.51 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.874 -1.141 . . . . 0.02 110.035 -178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.453 HD13 ' O ' ' A' ' 125' ' ' GLU . 35.6 mm -129.57 126.68 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 N-CA-C 107.548 -1.279 . . . . 2.17 107.548 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -110.36 -12.99 14.37 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.267 -0.896 . . . . 0.02 112.873 -177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.0 p -160.69 153.48 21.1 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.658 -1.276 . . . . 0.01 109.255 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 28.6 p -165.25 143.73 6.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.22 109.26 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -123.87 101.78 7.44 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.081 -1.012 . . . . 1.41 109.631 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG21 ' CD1' ' A' ' 136' ' ' TRP . 9.6 p -107.72 138.2 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.984 -1.117 . . . . 0.01 107.984 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.57 92.47 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 106.598 -1.631 . . . . 1.98 106.598 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.519 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 23.8 tt0 -146.11 -75.9 0.2 Allowed 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 105.469 -2.048 . . . . 0.01 105.469 178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 177.86 -77.49 0.07 OUTLIER Glycine 0 N--CA 1.479 1.566 0 N-CA-C 108.089 -2.005 . . . . 0.01 108.089 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 86' ' ' HIS . 82.2 p -123.23 126.44 46.95 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.547 1.165 . . . . 2.3 111.141 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.519 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 7.0 m95 -126.86 151.17 48.74 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 106.247 -1.76 . . . . 0.01 106.247 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.51 133.98 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 120.483 -1.386 . . . . 1.69 109.408 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.51 141.4 45.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 106.56 -1.645 . . . . 2.49 106.56 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.457 ' OH ' ' NH2' ' A' ' 173' ' ' ARG . 33.4 m-85 -121.52 142.61 49.9 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.258 -0.901 . . . . 0.02 109.091 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.43 ' OE1' ' O ' ' A' ' 168' ' ' ALA . 9.9 tp10 -73.87 -30.17 62.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.547 -0.72 . . . . 0.02 110.975 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.9 154.81 48.31 Favored Pre-proline 0 N--CA 1.502 2.149 0 O-C-N 120.851 -1.155 . . . . 1.48 108.932 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -57.08 167.96 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.174 1.25 . . . . 0.02 113.024 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 143' ' ' ASN . 0.4 OUTLIER 60.09 31.5 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.119 -0.946 . . . . 0.75 111.284 178.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 57.6 51.48 9.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.74 . . . . 0.02 111.038 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -126.91 164.89 20.44 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.521 -0.737 . . . . 0.02 110.241 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 89.61 -165.69 32.44 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.251 -1.14 . . . . 0.02 110.251 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -69.41 142.85 53.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.539 -0.977 . . . . 0.02 108.712 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.43 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 5.4 mt-30 -112.32 147.77 35.63 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.657 -0.652 . . . . 0.02 110.074 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -123.83 133.43 53.79 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.731 -0.841 . . . . 0.01 108.731 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.8 tp -97.19 121.53 39.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.926 -1.108 . . . . 0.01 109.913 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 151' ' ' LEU . 9.7 mp -96.48 140.78 30.62 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.371 -0.974 . . . . 0.01 108.371 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 154' ' ' LYS . 93.5 m-20 -104.29 -174.48 2.55 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.376 -0.828 . . . . 2.27 109.754 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.407 ' HG2' ' H ' ' A' ' 153' ' ' LYS . 15.6 pttp -70.72 35.88 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 1.84 109.983 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 152' ' ' ASP . 50.6 mttp -113.85 173.18 6.56 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.51 -0.744 . . . . 2.28 109.22 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -104.67 130.67 52.66 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.391 -0.966 . . . . 0.01 108.391 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.05 111.54 23.83 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.11 -0.994 . . . . 0.01 109.817 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.514 ' CD ' ' H ' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -92.75 -27.22 17.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.624 -0.673 . . . . 0.01 111.073 -177.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 39.5 mttm -123.12 153.71 64.68 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.813 -1.18 . . . . 2.54 107.813 179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.553 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 10.1 Cg_endo -62.16 -42.72 27.58 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 CA-C-N 119.246 0.766 . . . . 0.7 111.102 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 38.6 t -60.6 -18.98 17.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 120.725 -1.234 . . . . 0.86 109.439 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 57.4 t0 -65.72 -18.01 65.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.809 -1.182 . . . . 0.02 112.087 -178.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.67 15.8 27.78 Favored 'General case' 0 N--CA 1.514 2.735 0 O-C-N 120.66 -1.275 . . . . 0.02 110.086 178.283 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.46 75.28 Favored Glycine 0 N--CA 1.498 2.784 0 O-C-N 121.129 -0.982 . . . . 0.02 112.963 176.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.47 140.43 34.73 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.834 -1.392 . . . . 0.02 110.062 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.48 -7.1 59.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.706 . . . . 0.59 109.427 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 m -140.8 150.37 59.6 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.242 -0.911 . . . . 0.87 108.992 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -74.36 16.52 0.58 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.632 0.888 . . . . 0.38 111.915 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.43 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.36 120.31 25.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.026 -1.046 . . . . 0.18 110.759 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.462 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.3 mt -149.37 123.67 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.601 -2.0 . . . . 3.99 105.601 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 -111.9 -14.05 13.56 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.233 -0.917 . . . . 5.17 113.251 -177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 30.1 t -156.24 158.68 37.96 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 119.257 -2.152 . . . . 0.02 109.965 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -152.9 154.49 35.17 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.164 -0.96 . . . . 2.02 110.569 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.457 ' NH2' ' OH ' ' A' ' 139' ' ' TYR . 87.1 mtm180 -143.3 148.35 36.19 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.295 -0.878 . . . . 0.01 109.946 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -85.96 142.78 28.56 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.388 -0.967 . . . . 0.01 108.388 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.96 126.57 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.967 -1.083 . . . . 3.04 109.764 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.497 ' O ' ' CB ' ' A' ' 177' ' ' GLU . 31.2 m -137.47 147.08 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.578 -0.701 . . . . 1.89 109.199 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' A' ' 176' ' ' VAL . 10.2 tt0 . . . . . 0 N--CA 1.498 1.973 0 N-CA-C 108.356 -0.979 . . . . 4.89 108.356 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.38 -0.6 . . . . 5.28 109.38 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -82.08 136.78 35.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.334 -0.853 . . . . 5.96 109.536 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -138.75 -128.68 0.12 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.159 -0.963 . . . . 2.22 111.468 -178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 3' ' ' THR . . . 167.48 95.28 0.1 Allowed Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.981 -2.848 . . . . 0.81 105.981 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.81 146.29 30.92 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 120.312 -0.947 . . . . 0.01 111.196 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -152.86 138.08 17.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.759 -0.848 . . . . 0.02 108.756 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tt -130.05 141.06 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 109.354 -0.61 . . . . 0.02 109.354 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 m -122.06 130.26 53.12 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.499 -0.751 . . . . 0.39 109.722 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -109.26 138.93 44.86 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.61 -0.885 . . . . 0.02 108.61 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 8.6 m-85 -122.36 139.0 54.33 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.353 -0.842 . . . . 0.02 109.802 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.527 ' OE2' ' N ' ' A' ' 35' ' ' ARG . 10.1 mm-40 -69.19 -28.6 66.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.03 111.79 -178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -114.34 169.83 8.74 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.817 -1.177 . . . . 0.03 110.471 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.467 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 94.7 mtt180 -74.27 157.54 35.63 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.695 0.759 . . . . 0.03 110.02 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.595 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.5 m-80 65.97 35.56 6.39 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.754 0.788 . . . . 0.74 110.995 179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.595 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 14.8 p90 49.78 45.69 24.53 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.736 0.779 . . . . 0.02 111.414 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -113.01 166.49 11.36 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.132 -1.062 . . . . 0.02 108.132 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.08 -167.58 36.32 Favored Glycine 0 N--CA 1.494 2.561 0 O-C-N 120.78 -1.2 . . . . 0.03 110.8 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' NH2' ' H ' ' A' ' 34' ' ' SER . 30.1 ttp180 -68.94 142.73 54.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.542 -0.976 . . . . 2.76 109.196 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -120.78 148.68 43.66 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.649 0.737 . . . . 1.89 110.29 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -131.73 126.68 35.1 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.915 -1.143 . . . . 0.02 107.915 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -112.09 136.81 51.0 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.459 -0.776 . . . . 1.12 109.655 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.464 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 9.4 t -130.67 138.19 49.94 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.461 0.648 . . . . 0.02 109.565 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 2.2 m-20 -117.14 10.16 13.78 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.383 0.611 . . . . 0.2 109.398 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.466 ' SG ' ' O ' ' A' ' 23' ' ' ASP . 46.1 m -158.42 174.56 14.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.02 -1.104 . . . . 1.23 108.02 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 25' ' ' ASP . 22.3 p-10 -62.11 144.41 55.36 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.581 -1.324 . . . . 0.02 110.49 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 t -131.59 117.25 18.46 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.323 -0.991 . . . . 0.02 108.323 178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.0 -25.99 53.32 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.119 -0.988 . . . . 0.24 110.567 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 27.8 p-10 -154.11 100.86 2.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.083 -1.011 . . . . 1.14 108.682 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -104.41 9.27 35.77 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 122.226 1.012 . . . . 6.37 109.522 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.596 ' NH2' ' H ' ' A' ' 79' ' ' LEU . 10.7 mmt180 -59.25 -22.93 61.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.455 -0.778 . . . . 3.11 110.81 -178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -74.83 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.699 -1.25 . . . . 0.88 110.257 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -104.06 -21.87 13.52 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.321 -0.862 . . . . 0.02 109.387 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.473 HD11 ' HG2' ' A' ' 11' ' ' GLU . 10.7 tp -149.89 128.65 12.45 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.301 -0.875 . . . . 3.32 109.008 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.586 ' H ' ' NH2' ' A' ' 18' ' ' ARG . 82.9 p -85.85 -10.77 54.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.655 -0.653 . . . . 0.02 111.422 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.527 ' N ' ' OE2' ' A' ' 11' ' ' GLU . 5.5 mtp180 -171.57 163.49 6.68 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.259 -1.385 . . . . 0.02 107.259 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 79' ' ' LEU . 12.5 p -142.23 113.83 7.88 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.771 -1.205 . . . . 0.02 108.792 179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.3 m-20 -105.53 -0.95 25.38 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.94 -1.1 . . . . 0.03 110.537 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 67' ' ' PRO . 2.7 m -153.62 154.3 33.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.718 -1.216 . . . . 0.02 107.718 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.7 mt -146.27 146.74 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.033 -1.042 . . . . 0.02 110.148 -178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.424 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 38.4 ttm180 -125.18 125.33 43.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.783 -1.192 . . . . 0.02 107.783 177.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.53 113.86 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 106.505 -1.665 . . . . 0.02 106.505 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.8 mp0 -83.54 -33.97 25.34 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.088 -0.645 . . . . 3.81 109.853 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.84 150.79 20.15 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.46 -1.829 . . . . 0.02 110.607 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.87 174.8 50.57 Favored Glycine 0 N--CA 1.486 1.997 0 C-N-CA 119.668 -1.253 . . . . 0.01 110.337 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 23.0 m -109.94 161.98 14.96 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.736 -1.579 . . . . 1.48 106.736 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CD1' ' C ' ' A' ' 45' ' ' THR . 72.7 m95 -148.48 147.79 29.51 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.223 -1.548 . . . . 0.02 111.742 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.56 131.15 55.33 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 105.197 -2.149 . . . . 0.24 105.197 176.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' HD22 ' A' ' 79' ' ' LEU . 19.3 m -120.5 144.43 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.679 -0.638 . . . . 0.65 109.403 179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -121.22 145.75 47.51 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.359 1.076 . . . . 0.02 110.047 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.442 ' OE2' ' O ' ' A' ' 78' ' ' ARG . 3.1 tp10 -65.33 -34.35 78.13 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.613 -0.722 . . . . 0.02 110.909 -177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 50' ' ' GLU . 10.7 mpt_? -123.0 158.52 57.27 Favored Pre-proline 0 N--CA 1.504 2.231 0 O-C-N 121.232 -0.918 . . . . 0.02 109.462 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -54.6 166.93 1.63 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.521 1.481 . . . . 0.02 112.529 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 64.05 36.79 9.61 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 115.313 -0.858 . . . . 0.02 111.136 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.465 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 5.7 m-85 44.83 51.68 8.35 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.587 0.708 . . . . 3.39 110.586 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 30.6 p -126.78 164.23 21.81 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.261 0.553 . . . . 2.33 109.889 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.88 -161.34 31.88 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.53 -1.428 . . . . 0.02 109.53 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -66.47 138.7 57.72 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.312 . . . . 0.02 109.985 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 18.5 ptm -118.66 137.29 53.4 Favored 'General case' 0 N--CA 1.499 2.01 0 CA-C-O 121.34 0.59 . . . . 5.01 109.593 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.565 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 97.2 m-85 -132.06 138.06 48.02 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.524 -0.735 . . . . 0.02 109.459 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.6 mm -94.74 131.23 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.742 -0.836 . . . . 1.72 108.742 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD22 ' CE1' ' A' ' 66' ' ' TYR . 6.8 mt -120.11 112.6 34.62 Favored Pre-proline 0 N--CA 1.502 2.165 0 O-C-N 121.496 -0.753 . . . . 0.02 110.857 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -78.31 169.04 20.75 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 CA-C-N 120.006 1.038 . . . . 1.47 109.943 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -53.53 141.31 25.76 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.717 -1.239 . . . . 4.25 110.359 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 154.85 -177.08 32.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 119.385 -1.388 . . . . 0.02 110.635 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -119.02 130.7 55.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.431 -1.041 . . . . 0.96 109.653 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.523 ' CE1' HD22 ' A' ' 61' ' ' LEU . 89.7 m-85 -120.24 95.64 49.1 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 108.034 -1.098 . . . . 0.02 108.034 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' OG ' ' A' ' 38' ' ' SER . 3.4 Cg_exo -66.24 -4.93 11.38 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 120.716 0.944 . . . . 0.02 113.416 -178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -157.31 154.05 28.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.65 -1.281 . . . . 2.02 107.925 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.493 ' CE2' ' OE1' ' A' ' 70' ' ' GLN . 23.1 p90 -60.46 -37.77 82.06 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.895 -0.722 . . . . 0.02 111.722 -177.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' OE1' ' CE2' ' A' ' 69' ' ' TYR . 14.9 mm100 -60.78 -24.34 65.71 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.083 -1.011 . . . . 0.02 110.444 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -69.47 -18.34 63.7 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.444 -0.947 . . . . 3.42 108.444 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.565 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -107.62 10.83 29.01 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.363 -1.347 . . . . 0.02 107.363 -179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.444 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.0 mpp? 59.39 21.68 10.05 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.639 0.733 . . . . 0.02 110.341 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.2 145.69 46.32 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.909 -1.677 . . . . 0.02 108.909 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.546 ' O ' HD23 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -78.8 -30.98 45.78 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.639 -1.245 . . . . 0.98 107.639 178.36 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' OD1' ' OE2' ' A' ' 50' ' ' GLU . 16.4 p30 -157.38 -171.26 3.53 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.67 -1.604 . . . . 0.02 106.67 178.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 6.7 p30 -97.99 28.15 4.12 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.769 -1.207 . . . . 0.02 110.311 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.569 ' CG ' HH11 ' A' ' 78' ' ' ARG . 3.8 mtt-85 -97.86 123.01 41.64 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.226 -0.921 . . . . 3.2 111.122 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.596 ' H ' ' NH2' ' A' ' 30' ' ' ARG . 36.0 mt -144.04 120.83 11.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.918 -1.512 . . . . 2.61 106.918 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.42 -16.56 14.24 Favored Glycine 0 N--CA 1.502 3.047 0 O-C-N 121.264 -0.897 . . . . 0.02 112.079 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 44.4 t -156.38 155.64 32.52 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.402 -1.646 . . . . 0.02 109.978 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' A' ' 48' ' ' VAL . 29.3 t -145.04 148.23 33.47 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.544 -0.722 . . . . 0.02 109.781 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' CG ' ' CE1' ' A' ' 54' ' ' PHE . 44.3 mtm180 -134.17 139.28 45.74 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.352 -0.843 . . . . 0.01 109.123 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' ' CH2' ' A' ' 46' ' ' TRP . . . -77.51 131.9 38.13 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.207 -1.034 . . . . 0.43 108.207 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.52 124.55 47.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 108.917 -0.771 . . . . 1.25 108.917 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.449 ' O ' ' CG2' ' A' ' 135' ' ' THR . 27.0 m80 -91.88 135.68 33.74 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.167 -0.958 . . . . 1.77 108.967 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mt -97.63 138.46 34.99 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.17 -0.678 . . . . 1.63 109.17 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 p -112.23 126.42 55.21 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.828 -0.804 . . . . 1.08 108.828 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.9 p -102.86 -155.43 0.52 Allowed 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 106.233 -1.766 . . . . 1.26 106.233 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.21 -49.79 0.83 Allowed Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.387 -1.445 . . . . 0.01 112.527 177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.7 -99.93 0.13 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 118.31 -1.9 . . . . 0.01 112.238 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -121.33 119.98 33.75 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.197 -1.178 . . . . 4.43 110.802 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.29 130.1 36.74 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.918 -0.713 . . . . 2.99 109.104 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -129.75 138.77 51.27 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.817 -0.809 . . . . 6.36 108.817 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.1 tt -129.53 144.47 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.294 -0.879 . . . . 1.09 109.891 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' NE2' ' N ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -121.77 133.64 54.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.348 -1.352 . . . . 2.05 107.348 176.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.472 HG12 ' SG ' ' A' ' 129' ' ' CYS . 17.2 m -122.85 145.62 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 O-C-N 120.736 -1.228 . . . . 1.1 109.141 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 98' ' ' PHE . 41.2 m-85 -119.57 141.1 49.56 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.125 0.964 . . . . 0.73 111.127 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.77 -29.28 69.75 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 115.697 -0.683 . . . . 0.02 111.485 -178.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.3 mmtm -116.36 170.16 8.75 Favored 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.125 -0.984 . . . . 3.18 110.492 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -71.0 165.49 53.07 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.973 -0.851 . . . . 0.01 110.973 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 102' ' ' ASP . 29.0 t0 57.16 38.27 28.86 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.842 -0.799 . . . . 0.01 111.354 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 52.08 54.26 11.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.62 -0.675 . . . . 0.01 111.282 178.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -129.51 166.38 19.77 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.165 -1.05 . . . . 3.15 108.165 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.31 -164.98 28.6 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.122 -1.591 . . . . 0.01 109.122 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.09 143.94 43.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.999 -1.295 . . . . 0.01 108.373 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.451 ' SD ' ' C ' ' A' ' 107' ' ' MET . 8.8 tmm? -117.15 142.76 46.61 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.669 0.747 . . . . 0.01 110.147 -179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.438 ' N ' ' SD ' ' A' ' 107' ' ' MET . 38.7 m-85 -130.63 135.12 47.55 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.56 -1.274 . . . . 2.48 107.56 178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -119.67 135.47 54.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.558 -0.714 . . . . 0.01 110.12 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.3 t -150.51 153.0 35.05 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 122.461 1.124 . . . . 1.69 111.322 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.3 p -110.72 9.38 22.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.27 -0.877 . . . . 0.01 109.592 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -121.25 163.74 18.08 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.445 -0.785 . . . . 3.21 111.331 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.86 155.06 39.36 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.324 -0.991 . . . . 0.01 108.324 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 34.5 t -124.77 111.67 27.4 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 108.7 -0.852 . . . . 0.01 108.7 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -76.67 -31.99 3.86 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 CA-C-N 119.998 1.035 . . . . 0.01 111.876 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 66.8 m -140.29 108.37 5.75 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.02 109.074 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 5.7 mt -64.04 -40.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.894 -0.504 . . . . 1.83 110.57 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.444 ' C ' ' SD ' ' A' ' 118' ' ' MET . 12.6 tmm? -66.72 -37.81 85.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.001 -1.08 . . . . 1.34 110.052 -178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -69.98 -38.57 76.08 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.479 -1.388 . . . . 2.11 109.403 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.487 ' OE1' ' CE2' ' A' ' 121' ' ' PHE . 52.7 tt0 -80.79 -47.48 13.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -0.9 . . . . 2.08 112.424 -177.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.487 ' CE2' ' OE1' ' A' ' 120' ' ' GLN . 53.0 m-85 -110.83 -1.92 16.35 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.366 -0.834 . . . . 0.02 112.574 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.0 m80 61.33 34.14 18.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.713 -1.242 . . . . 0.02 109.436 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -114.4 135.92 53.57 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.426 -0.796 . . . . 0.02 109.373 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -88.66 -21.35 24.0 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.26 -0.9 . . . . 5.32 110.589 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -149.11 165.04 32.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.932 -1.105 . . . . 0.02 110.198 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mm -127.39 123.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.494 -1.299 . . . . 2.17 107.494 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -108.34 -13.29 14.91 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.133 -0.979 . . . . 0.02 112.132 -177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.2 p -160.45 152.5 20.23 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.983 -1.073 . . . . 0.01 108.927 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.472 ' SG ' HG12 ' A' ' 97' ' ' VAL . 9.3 t -167.66 144.04 4.16 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.545 -0.909 . . . . 1.22 108.545 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.409 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 41.5 tttm -122.45 110.23 15.35 Favored 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 122.38 1.086 . . . . 1.41 109.473 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 131' ' ' VAL . 14.9 p -112.98 135.23 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 107.442 -1.318 . . . . 0.01 107.442 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.1 t -126.99 92.31 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 106.722 -1.584 . . . . 1.98 106.722 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.559 ' CD ' ' HE1' ' A' ' 136' ' ' TRP . 20.9 tt0 -146.63 -72.7 0.23 Allowed 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 105.264 -2.124 . . . . 0.01 105.264 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 155.18 -49.79 0.48 Allowed Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.369 -1.492 . . . . 0.01 109.369 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.684 ' HB ' HD12 ' A' ' 175' ' ' ILE . 44.3 p -126.96 105.84 8.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.414 -1.051 . . . . 2.3 111.742 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.559 ' HE1' ' CD ' ' A' ' 133' ' ' GLU . 7.5 m95 -130.95 147.33 52.58 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 107.614 -1.254 . . . . 0.01 107.614 178.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.471 ' CG1' HD11 ' A' ' 175' ' ' ILE . 38.9 mt -119.82 135.75 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 120.636 -1.29 . . . . 1.69 110.089 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -111.06 142.39 43.28 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 105.819 -1.919 . . . . 2.49 105.819 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 18.1 m-85 -123.17 144.17 49.53 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.091 -1.006 . . . . 0.02 109.842 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 25.8 tt0 -74.2 -30.88 62.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.727 -0.608 . . . . 0.02 111.68 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.73 154.54 48.06 Favored Pre-proline 0 N--CA 1.503 2.212 0 O-C-N 120.698 -1.251 . . . . 1.48 108.995 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.04 167.54 2.37 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.257 1.304 . . . . 0.02 112.747 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 46.8 t30 59.33 31.25 20.99 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.118 -0.946 . . . . 0.75 111.457 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.53 51.52 9.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.465 -0.772 . . . . 0.02 111.07 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.449 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -126.4 164.72 20.49 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.513 -0.742 . . . . 0.02 109.848 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.67 33.65 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.063 -1.215 . . . . 0.02 110.063 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -69.68 142.31 53.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.595 -0.944 . . . . 0.02 108.892 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.418 ' O ' ' CG ' ' A' ' 58' ' ' MET . 13.1 mt-30 -113.77 149.22 35.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.344 0.593 . . . . 0.02 109.78 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -123.62 133.99 53.85 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.441 -0.948 . . . . 0.01 108.441 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 11.8 tp -96.41 123.37 40.03 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.857 -1.152 . . . . 0.01 109.916 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.9 mp -95.35 135.38 37.04 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.971 -1.122 . . . . 0.01 107.971 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -106.19 -167.67 1.33 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.731 -0.606 . . . . 2.27 110.312 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -79.6 34.46 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.576 -0.702 . . . . 1.84 109.921 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -111.92 172.17 7.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.445 -0.785 . . . . 2.28 109.373 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -104.38 121.28 43.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.273 -1.01 . . . . 0.01 108.273 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -98.03 113.48 25.36 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.272 -0.892 . . . . 0.01 110.1 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.1 -26.39 17.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.129 -0.982 . . . . 0.01 110.706 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -123.94 155.66 66.85 Favored Pre-proline 0 N--CA 1.497 1.922 0 N-CA-C 108.066 -1.086 . . . . 2.54 108.066 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.5 Cg_endo -61.41 -40.83 45.48 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.032 0.69 . . . . 0.7 110.764 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 59.7 t -61.76 -18.82 19.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 120.905 -1.122 . . . . 0.86 109.295 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 49.1 t0 -65.92 -18.56 65.42 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.872 -1.143 . . . . 0.02 111.902 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -102.27 15.09 30.18 Favored 'General case' 0 N--CA 1.512 2.656 0 O-C-N 120.886 -1.134 . . . . 0.02 109.979 178.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.43 10.62 73.5 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 121.301 -0.874 . . . . 0.02 113.119 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.517 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.25 140.76 35.11 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.744 -1.445 . . . . 0.02 110.18 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.54 -7.1 59.38 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.574 -0.704 . . . . 0.59 110.168 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 11.3 p -141.41 150.36 57.66 Favored Pre-proline 0 N--CA 1.501 2.12 0 O-C-N 120.964 -1.085 . . . . 0.87 109.768 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -75.29 14.94 0.84 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 120.913 1.075 . . . . 0.38 111.817 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.62 122.64 27.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.306 1.051 . . . . 0.18 111.014 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.5 mp -152.56 123.83 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 106.189 -1.782 . . . . 3.99 106.189 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 140' ' ' GLU . 3.6 mp0 -111.39 -11.56 14.12 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.524 -0.735 . . . . 5.17 112.312 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.8 t -156.4 158.74 37.87 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 119.311 -2.118 . . . . 0.02 109.755 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -151.86 153.38 34.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.274 -0.891 . . . . 2.02 110.219 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -144.0 149.32 36.54 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.32 -0.862 . . . . 0.01 109.942 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -87.02 140.56 29.44 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.363 -0.976 . . . . 0.01 108.363 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.684 HD12 ' HB ' ' A' ' 135' ' ' THR . 45.8 mt -93.89 129.99 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.2 -0.937 . . . . 3.04 109.222 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.46 148.3 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.475 -0.765 . . . . 1.89 109.62 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 4.89 109.564 179.996 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.276 0.56 . . . . 5.28 109.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.415 ' HB3' ' HZ3' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -50.81 98.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 5.96 109.331 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 4' ' ' GLY . 3.2 m -103.87 -140.21 0.36 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.001 -1.111 . . . . 2.22 108.001 177.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.551 ' H ' HG22 ' A' ' 3' ' ' THR . . . 174.88 88.06 0.07 OUTLIER Glycine 0 N--CA 1.496 2.64 0 N-CA-C 106.982 -2.447 . . . . 0.81 106.982 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.67 148.96 32.71 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.524 -1.03 . . . . 0.01 110.524 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -153.29 138.1 17.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.442 -1.034 . . . . 0.02 108.621 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 22' ' ' CYS . 8.1 tt -130.59 142.42 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 N-CA-C 109.356 -0.609 . . . . 0.02 109.356 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.506 ' OG ' ' CE1' ' A' ' 10' ' ' TYR . 0.9 OUTLIER -122.29 129.81 52.55 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.424 -0.797 . . . . 0.39 109.512 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -108.29 138.47 44.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.565 -0.902 . . . . 0.02 108.565 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.506 ' CE1' ' OG ' ' A' ' 8' ' ' SER . 80.3 m-85 -121.6 138.84 54.15 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 121.212 -0.93 . . . . 0.02 109.769 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.65 -28.28 66.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.489 -0.757 . . . . 0.03 111.61 -178.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -114.66 169.96 8.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.962 -1.086 . . . . 0.03 110.394 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -75.44 158.67 32.32 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.687 0.756 . . . . 0.03 109.995 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' ND2' ' CZ ' ' A' ' 15' ' ' PHE . 0.1 OUTLIER 66.47 34.61 6.05 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.845 0.831 . . . . 0.74 110.776 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.618 ' CZ ' ' ND2' ' A' ' 14' ' ' ASN . 16.4 p90 50.07 44.9 25.83 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 115.548 -0.751 . . . . 0.02 111.301 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -113.01 165.7 12.11 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.107 -1.071 . . . . 0.02 108.107 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.57 -168.14 34.42 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.706 -1.235 . . . . 0.03 110.927 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -69.04 143.43 54.3 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.505 -0.997 . . . . 2.76 109.152 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' NE ' ' OD1' ' A' ' 21' ' ' ASP . 34.0 ttp180 -119.55 148.7 43.0 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.646 0.736 . . . . 1.89 110.392 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -132.09 126.23 33.26 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.887 -1.153 . . . . 0.02 107.887 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.488 ' OD1' ' NE ' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.7 137.64 51.34 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.607 -0.683 . . . . 1.12 109.751 -179.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.08 139.67 48.59 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.591 0.71 . . . . 0.02 109.47 179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 3.4 m-20 -116.09 11.93 15.43 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.394 -0.595 . . . . 0.2 109.394 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.8 p -158.29 174.47 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.127 -1.064 . . . . 1.23 108.127 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -61.99 144.65 54.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.729 -1.232 . . . . 0.02 110.27 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 66.5 m -131.47 116.41 17.44 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.522 -0.918 . . . . 0.02 108.522 178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.498 ' O ' ' OG ' ' A' ' 81' ' ' SER . . . -76.54 -21.63 55.45 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -0.861 . . . . 0.24 110.767 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -157.34 101.57 1.88 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.075 -1.016 . . . . 1.14 108.577 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.8 p90 -105.13 9.95 34.05 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.254 1.026 . . . . 6.37 110.002 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 -59.91 -23.45 63.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.563 -0.711 . . . . 3.11 110.954 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.4 p -76.05 -16.68 59.89 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.647 -1.283 . . . . 0.88 110.31 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -102.55 -21.09 14.24 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.399 -0.813 . . . . 0.02 108.901 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.4 tp -150.49 129.23 12.38 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.683 -0.858 . . . . 3.32 108.683 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.2 t -86.32 -9.81 55.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.847 -0.533 . . . . 0.02 110.846 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -170.49 161.61 7.9 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.766 -1.198 . . . . 0.02 107.766 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 m -141.16 113.52 8.08 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.643 -1.285 . . . . 0.02 109.094 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.495 ' ND2' ' O ' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -107.45 -3.35 19.58 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.879 -1.138 . . . . 0.03 110.647 -178.65 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.0 t -154.24 153.49 31.81 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.301 -1.0 . . . . 0.02 108.301 178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 mt -146.35 147.71 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.951 -1.093 . . . . 0.02 110.244 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -125.02 125.68 44.23 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.953 -1.128 . . . . 0.02 107.953 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 23.9 t -105.16 114.08 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.948 -1.501 . . . . 0.02 106.948 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -84.16 -34.52 24.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.484 -0.76 . . . . 3.81 109.812 -178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -161.78 149.57 18.22 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 118.674 -1.727 . . . . 0.02 110.402 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.88 173.74 49.94 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.528 -1.32 . . . . 0.01 109.893 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.4 m -120.66 138.05 54.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 107.803 -1.184 . . . . 1.48 107.803 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CD1' ' N ' ' A' ' 46' ' ' TRP . 36.1 m95 -127.25 154.36 44.96 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 122.691 1.234 . . . . 0.02 111.907 -176.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.24 133.59 51.58 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.619 -2.363 . . . . 0.24 104.619 176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 79' ' ' LEU . 33.1 m -116.54 142.04 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.005 -0.739 . . . . 0.65 109.005 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.494 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 18.2 m-85 -119.42 141.35 49.18 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.021 0.915 . . . . 0.02 109.351 -179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.512 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 10.0 tp10 -64.3 -34.16 77.49 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.571 -0.74 . . . . 0.02 111.671 -177.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -124.08 156.59 65.94 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 121.025 -1.047 . . . . 0.02 109.707 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -52.45 165.7 0.97 Allowed 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 121.634 1.556 . . . . 0.02 112.984 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.608 ' N ' ' ND2' ' A' ' 53' ' ' ASN . 0.6 OUTLIER 64.97 37.49 6.86 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.72 0.771 . . . . 0.02 111.261 177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 45.21 50.89 9.47 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.457 0.646 . . . . 3.39 110.785 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.5 p -126.97 164.55 21.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.2 0.524 . . . . 2.33 110.134 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.25 -162.34 30.8 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.997 -1.241 . . . . 0.02 109.997 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 13.9 t-80 -62.34 143.25 57.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.03 -1.276 . . . . 0.02 110.635 -178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.498 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 36.5 mtp -116.32 134.58 54.73 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.514 -0.55 . . . . 5.01 109.514 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.663 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 33.7 m-85 -136.02 134.89 38.98 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.289 -0.882 . . . . 0.02 109.205 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.5 mm -96.97 131.96 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.527 -0.733 . . . . 1.72 109.114 179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 66' ' ' TYR . 22.9 mt -122.8 111.37 31.14 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.414 -0.804 . . . . 0.02 110.784 -179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -76.19 171.2 18.55 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 CA-C-N 119.924 1.009 . . . . 1.47 110.181 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -52.04 140.46 20.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.978 -1.076 . . . . 4.25 110.114 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.65 32.83 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.452 -1.356 . . . . 0.02 110.626 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.5 tp10 -119.14 130.32 55.49 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.294 -1.121 . . . . 0.96 109.278 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.512 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 84.5 m-85 -120.7 97.76 48.34 Favored Pre-proline 0 N--CA 1.494 1.728 0 N-CA-C 107.796 -1.187 . . . . 0.02 107.796 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -71.63 -5.47 17.12 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 120.582 0.855 . . . . 0.02 113.929 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -154.03 154.09 33.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.503 -1.373 . . . . 2.02 107.864 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -60.67 -38.23 84.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.521 -0.737 . . . . 0.02 111.719 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -59.74 -23.94 63.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.983 -1.073 . . . . 0.02 109.9 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.82 -18.54 62.73 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.112 0.958 . . . . 3.42 108.432 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.663 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -106.38 9.7 31.74 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.245 -1.391 . . . . 0.02 107.245 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.447 ' SD ' ' C ' ' A' ' 72' ' ' TRP . 3.4 mpp? 58.93 22.16 10.0 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.568 0.699 . . . . 0.02 110.304 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.26 143.61 45.94 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.258 -1.537 . . . . 0.02 109.258 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.2 tp -77.75 -29.55 51.12 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.179 -1.415 . . . . 0.98 107.179 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 3.2 p-10 -156.43 -171.33 3.66 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.118 -1.808 . . . . 0.02 106.118 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -98.47 28.62 4.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.667 -1.271 . . . . 0.02 110.381 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.3 OUTLIER -96.49 122.4 39.36 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.806 -1.184 . . . . 3.2 110.709 -179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 48' ' ' VAL . 29.6 mt -144.35 120.58 10.85 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.869 -1.16 . . . . 2.61 107.869 178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.64 -16.7 10.55 Favored Glycine 0 N--CA 1.501 2.995 0 O-C-N 121.295 -0.878 . . . . 0.02 112.756 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.498 ' OG ' ' O ' ' A' ' 27' ' ' ALA . 66.1 m -154.58 155.82 35.45 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 119.99 -1.888 . . . . 0.02 111.209 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.6 p -144.4 146.76 32.68 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.453 0.644 . . . . 0.02 109.914 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -135.94 140.04 43.71 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.468 -0.77 . . . . 0.01 108.981 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -79.03 132.83 36.77 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.255 -0.903 . . . . 0.43 109.286 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.84 123.38 42.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.445 -0.946 . . . . 1.25 108.445 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -89.56 134.73 33.98 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.832 -1.173 . . . . 1.77 107.832 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.21 139.51 37.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.739 -0.601 . . . . 1.63 109.631 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.0 m -111.61 123.35 50.05 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.754 -1.202 . . . . 1.08 107.754 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 5.4 t -115.05 133.88 55.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.749 -1.219 . . . . 1.26 107.971 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.88 -45.86 0.02 OUTLIER Glycine 0 N--CA 1.502 3.079 0 C-N-CA 117.669 -2.205 . . . . 0.01 113.777 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.74 -102.98 0.17 Allowed Glycine 0 N--CA 1.488 2.119 0 CA-C-N 120.432 2.116 . . . . 0.01 111.129 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -119.54 118.23 30.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.284 -1.127 . . . . 4.43 110.159 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.07 130.45 39.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.97 -0.692 . . . . 2.99 109.258 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -131.31 136.87 48.5 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.055 -0.72 . . . . 6.36 109.055 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.3 tt -128.28 145.86 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.528 -0.733 . . . . 1.09 109.333 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -121.51 132.88 54.96 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.812 -1.181 . . . . 2.05 107.812 177.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.485 HG12 ' SG ' ' A' ' 129' ' ' CYS . 20.1 m -122.89 145.42 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 120.785 -1.197 . . . . 1.1 109.229 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.95 140.58 49.52 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-O 122.059 0.933 . . . . 0.73 110.878 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -65.81 -29.37 69.85 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.83 -0.623 . . . . 0.02 111.654 -178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.6 mtpt -117.78 168.65 10.27 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.101 -0.999 . . . . 3.18 110.453 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -65.32 169.31 28.68 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.935 -0.866 . . . . 0.01 110.935 -179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 51.91 39.36 25.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.743 0.782 . . . . 0.01 111.218 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 51.88 51.63 16.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.558 -0.714 . . . . 0.01 110.853 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -124.86 165.98 17.08 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.462 -0.94 . . . . 3.15 108.462 178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.28 -165.31 27.6 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.493 -1.443 . . . . 0.01 109.493 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -74.29 144.65 44.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.081 -1.246 . . . . 0.01 108.239 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.453 ' SD ' ' C ' ' A' ' 107' ' ' MET . 19.0 tmm? -116.01 142.89 46.2 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.642 0.734 . . . . 0.01 109.773 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.422 ' N ' ' SD ' ' A' ' 107' ' ' MET . 63.5 m-85 -131.87 136.13 47.21 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.068 -1.086 . . . . 2.48 108.068 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -120.13 135.2 55.04 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.589 -0.694 . . . . 0.01 110.052 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 t -149.49 151.86 34.65 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.249 1.023 . . . . 1.69 111.016 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -111.32 9.21 21.59 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.606 -0.724 . . . . 0.01 110.006 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.479 ' CD ' ' N ' ' A' ' 112' ' ' GLU . 5.3 mp0 -120.52 162.87 18.84 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.29 -0.881 . . . . 3.21 111.282 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 173' ' ' ARG . 5.4 p-10 -67.9 156.89 36.2 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.239 -1.023 . . . . 0.01 108.239 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . 0.456 ' SG ' ' NE2' ' A' ' 120' ' ' GLN . 43.0 t -125.84 112.08 24.76 Favored Pre-proline 0 N--CA 1.497 1.92 0 N-CA-C 108.745 -0.835 . . . . 0.01 108.745 178.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -76.3 -31.42 4.64 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.1 1.071 . . . . 0.01 111.197 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.2 t -140.34 106.97 5.33 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.583 -0.895 . . . . 0.02 108.583 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.23 -39.47 85.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.765 -0.584 . . . . 1.83 110.808 -178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 44.5 ttm -66.53 -37.42 84.97 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.881 -1.127 . . . . 1.34 109.98 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -70.15 -39.17 75.53 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.525 -1.36 . . . . 2.11 109.798 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.456 ' NE2' ' SG ' ' A' ' 114' ' ' CYS . 9.4 tt0 -80.62 -47.0 14.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.213 -0.929 . . . . 2.08 112.473 -177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -111.25 -1.24 16.16 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.37 -0.831 . . . . 0.02 112.695 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 2.7 m170 61.44 34.09 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.747 -1.221 . . . . 0.02 109.775 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 39.5 mt -114.09 135.92 53.5 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.478 -0.764 . . . . 0.02 109.305 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.681 ' CD ' ' H ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -90.33 -22.08 21.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.175 -0.953 . . . . 5.32 110.743 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -148.58 164.52 34.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.94 -1.1 . . . . 0.02 109.932 -178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 mm -129.12 124.72 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 107.629 -1.249 . . . . 2.17 107.629 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 127' ' ' HIS . 1.6 m80 -110.04 -14.43 14.23 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.347 -0.846 . . . . 0.02 112.633 -177.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 10.9 m -159.36 151.48 20.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.808 -1.183 . . . . 0.01 108.806 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 97' ' ' VAL . 5.7 t -171.42 147.38 2.41 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.337 -0.852 . . . . 1.22 108.766 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -117.31 108.05 15.13 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 122.498 1.142 . . . . 1.41 108.724 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' CD1' ' A' ' 136' ' ' TRP . 11.9 p -111.86 129.62 66.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.396 -1.335 . . . . 0.01 107.396 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.4 t -131.35 92.08 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.569 -1.332 . . . . 1.98 107.436 177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 1.3 tm-20 -149.79 -61.84 0.21 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 105.972 -1.862 . . . . 0.01 105.972 177.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.35 -12.56 26.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 106.653 -2.579 . . . . 0.01 106.653 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 10.6 p -121.4 57.54 1.01 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 122.039 -0.683 . . . . 2.3 110.5 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' CD1' ' CG2' ' A' ' 131' ' ' VAL . 74.4 m95 -128.36 134.66 48.9 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.005 -1.059 . . . . 0.01 109.985 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.12 137.7 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 108.305 -0.998 . . . . 1.69 108.305 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.455 ' CD1' HD11 ' A' ' 151' ' ' LEU . 2.7 m-30 -110.42 141.45 43.48 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.137 -1.431 . . . . 2.49 107.137 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.486 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 25.9 m-85 -121.92 142.43 50.28 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.26 -0.9 . . . . 0.02 109.337 179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.85 -30.08 62.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.614 -0.679 . . . . 0.02 111.551 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.0 mt -116.17 154.96 48.7 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 120.801 -1.187 . . . . 1.48 108.858 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.02 166.91 2.71 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.146 1.231 . . . . 0.02 113.031 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 60.09 31.62 20.65 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.096 -0.956 . . . . 0.75 111.36 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.527 ' OH ' ' NE ' ' A' ' 173' ' ' ARG . 2.0 m-85 57.31 51.5 9.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.525 -0.734 . . . . 0.02 111.045 178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.474 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.42 165.7 19.3 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.515 -0.741 . . . . 0.02 109.996 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.17 -165.93 34.74 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.248 -1.141 . . . . 0.02 110.248 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -68.67 141.65 55.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.518 -0.989 . . . . 0.02 108.917 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.486 ' CD ' ' CE2' ' A' ' 139' ' ' TYR . 17.7 mt-30 -113.97 149.41 35.34 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.02 109.969 -177.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -124.19 133.42 53.55 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 108.707 -0.849 . . . . 0.01 108.707 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 38.5 tp -94.99 121.57 36.75 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.748 -1.22 . . . . 0.01 109.292 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.455 HD11 ' CD1' ' A' ' 138' ' ' PHE . 18.2 mt -96.76 139.72 32.39 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.826 -0.805 . . . . 0.01 108.826 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -108.93 -168.48 1.35 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.516 -0.74 . . . . 2.27 109.514 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -80.33 40.98 0.51 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.84 109.403 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -113.56 168.02 10.11 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.454 -0.779 . . . . 2.28 109.42 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -102.57 120.59 40.81 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.451 -0.944 . . . . 0.01 108.451 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -98.01 114.38 26.5 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.347 -0.846 . . . . 0.01 110.308 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -92.72 -25.66 18.11 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.131 -0.981 . . . . 0.01 110.854 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt -124.66 153.48 70.02 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 107.953 -1.129 . . . . 2.54 107.953 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.562 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 6.5 Cg_endo -60.55 -39.84 61.56 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 119.623 0.901 . . . . 0.7 110.661 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 66.6 t -60.39 -19.08 17.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 O-C-N 120.78 -1.2 . . . . 0.86 109.39 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -65.75 -18.32 65.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.868 -1.145 . . . . 0.02 112.039 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -102.5 15.48 29.12 Favored 'General case' 0 N--CA 1.51 2.569 0 O-C-N 120.859 -1.151 . . . . 0.02 110.079 178.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.05 10.98 74.02 Favored Glycine 0 N--CA 1.497 2.757 0 O-C-N 121.185 -0.947 . . . . 0.02 113.027 176.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.24 140.45 35.52 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.727 -1.455 . . . . 0.02 110.276 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.54 -6.98 59.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.546 -0.721 . . . . 0.59 110.062 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.0 m -140.25 150.07 60.19 Favored Pre-proline 0 N--CA 1.502 2.153 0 O-C-N 121.061 -1.025 . . . . 0.87 109.747 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -74.94 14.63 0.82 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.815 1.01 . . . . 0.38 111.947 178.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.04 121.18 26.22 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 122.329 1.061 . . . . 0.18 110.847 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 mt -149.27 123.92 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.677 -1.972 . . . . 3.99 105.677 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 mm100 -112.82 -13.62 13.17 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.167 -0.958 . . . . 5.17 113.138 -177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.5 t -157.6 160.76 38.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 119.153 -2.217 . . . . 0.02 110.192 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -152.13 152.95 32.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.529 -0.732 . . . . 2.02 109.807 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.527 ' NE ' ' OH ' ' A' ' 144' ' ' TYR . 7.5 mmt180 -144.4 150.4 37.65 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.808 0.813 . . . . 0.01 110.194 -177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -88.23 143.87 26.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.471 -0.768 . . . . 0.01 109.04 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.2 mt -96.89 129.42 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.438 -0.789 . . . . 3.04 109.205 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.5 t -136.01 146.61 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.209 -0.932 . . . . 1.89 109.57 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.435 -0.791 . . . . 4.89 109.209 -179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.533 -0.543 . . . . 5.28 109.533 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.5 mtmt -77.05 93.87 3.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.122 -0.986 . . . . 5.96 109.35 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 81.5 p -101.78 -141.59 0.35 Allowed 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.902 -1.148 . . . . 2.22 107.902 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.39 87.38 0.07 OUTLIER Glycine 0 N--CA 1.498 2.778 0 N-CA-C 106.926 -2.47 . . . . 0.81 106.926 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.47 149.36 33.55 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 120.116 -1.04 . . . . 0.01 110.721 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' NZ ' ' OD1' ' A' ' 23' ' ' ASP . 56.0 tttp -149.19 136.36 19.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.994 . . . . 0.02 109.633 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.38 138.92 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 109.151 -0.685 . . . . 0.02 109.151 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -121.49 130.32 53.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.524 -0.735 . . . . 0.39 109.985 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 22.7 m-85 -109.91 139.75 44.65 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.148 -0.686 . . . . 0.02 109.148 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 5.7 m-85 -122.42 138.44 54.54 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.249 -0.907 . . . . 0.02 109.563 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -70.19 -27.5 64.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.878 . . . . 0.03 111.949 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.57 ' C ' HD21 ' A' ' 37' ' ' ASN . 1.3 m-20 -114.16 169.27 9.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.729 -1.232 . . . . 0.03 110.14 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.0 mtm180 -74.43 157.19 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.639 0.733 . . . . 0.03 110.419 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' C ' ' CD2' ' A' ' 15' ' ' PHE . 1.5 m-20 66.75 34.26 5.74 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.045 0.926 . . . . 0.74 111.441 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.4 ' CD2' ' C ' ' A' ' 14' ' ' ASN . 1.7 m-85 55.53 42.59 29.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.293 0.568 . . . . 0.02 111.323 177.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -113.56 166.51 11.45 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.467 -0.938 . . . . 0.02 108.467 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.24 -167.72 36.17 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.89 -1.148 . . . . 0.03 110.901 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.427 HH21 ' H ' ' A' ' 34' ' ' SER . 39.8 ttp180 -70.33 142.9 52.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.548 -0.972 . . . . 2.76 108.984 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -120.23 148.99 42.98 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.574 -0.704 . . . . 1.89 110.294 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -131.23 126.3 35.16 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.729 -1.211 . . . . 0.02 107.729 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.43 137.15 51.03 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.456 -0.778 . . . . 1.12 109.701 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 10.6 t -131.43 138.03 48.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.5 0.667 . . . . 0.02 109.621 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' OD1' ' NZ ' ' A' ' 6' ' ' LYS . 0.9 OUTLIER -117.18 10.34 13.8 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.722 -0.611 . . . . 0.2 109.447 -179.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 28.9 p -158.19 174.45 15.16 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.148 -1.056 . . . . 1.23 108.148 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.41 143.13 56.36 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.682 -1.261 . . . . 0.02 110.456 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.1 t -131.43 117.25 18.59 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.67 -25.68 49.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.097 -1.002 . . . . 0.24 110.857 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -154.5 100.77 2.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.874 -1.141 . . . . 1.14 108.803 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -105.4 9.84 33.57 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 122.05 0.929 . . . . 6.37 109.641 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -57.89 -24.06 55.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.683 -0.636 . . . . 3.11 110.612 -179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.4 p -73.93 -16.92 61.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.805 -1.185 . . . . 0.88 109.905 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -105.51 -22.29 13.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.02 109.5 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 35' ' ' ARG . 4.0 tp -148.56 125.99 11.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.042 -1.036 . . . . 3.32 109.52 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.427 ' H ' HH21 ' A' ' 18' ' ' ARG . 71.0 m -86.26 -10.77 53.95 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.625 -0.672 . . . . 0.02 111.461 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' NH2' ' OD2' ' A' ' 77' ' ' ASP . 30.7 ttt180 -170.5 160.45 7.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.816 -1.179 . . . . 0.02 107.816 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.1 p -141.94 113.09 7.51 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.86 -1.15 . . . . 0.02 108.728 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.792 HD22 ' H ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -109.09 2.91 21.45 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.797 -1.189 . . . . 0.03 110.189 -179.398 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.1 m -155.52 152.59 29.05 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.66 -1.237 . . . . 0.02 107.66 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 39' ' ' ILE . 10.4 mt -146.49 147.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.069 -1.019 . . . . 0.02 110.119 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.7 ttp180 -124.71 125.5 44.18 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.893 -1.151 . . . . 0.02 107.893 177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.78 114.22 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 N-CA-C 106.779 -1.563 . . . . 0.02 106.779 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -82.75 -34.08 27.24 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 120.2 -0.6 . . . . 3.81 110.408 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.33 151.47 21.07 Favored Glycine 0 N--CA 1.485 1.926 0 C-N-CA 119.081 -1.533 . . . . 0.02 110.33 -179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.49 174.46 50.01 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.543 -1.313 . . . . 0.01 110.085 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.435 ' C ' ' CD1' ' A' ' 46' ' ' TRP . 32.5 m -110.04 161.18 15.78 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.021 -1.474 . . . . 1.48 107.021 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.435 ' CD1' ' C ' ' A' ' 45' ' ' THR . 67.3 m95 -148.0 147.71 29.93 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.198 -1.564 . . . . 0.02 111.505 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -110.34 132.07 54.5 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 105.43 -2.063 . . . . 0.24 105.43 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' HD22 ' A' ' 79' ' ' LEU . 21.3 m -117.83 142.29 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.503 -0.748 . . . . 0.65 109.406 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 42.4 m-85 -121.56 144.64 48.61 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.952 0.882 . . . . 0.02 109.676 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.66 -34.99 79.07 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.501 -0.772 . . . . 0.02 111.722 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.06 163.59 42.78 Favored Pre-proline 0 N--CA 1.509 2.516 0 O-C-N 120.91 -1.119 . . . . 0.02 109.105 -179.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.14 168.06 2.15 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.42 1.414 . . . . 0.02 113.359 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 63.22 36.89 11.6 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.082 -0.963 . . . . 0.02 112.121 177.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 44.78 52.0 8.13 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.675 0.75 . . . . 3.39 111.017 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.8 m -126.58 163.98 22.23 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.239 0.542 . . . . 2.33 109.704 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.24 -161.31 32.69 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.538 -1.425 . . . . 0.02 109.538 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.638 ' CE1' ' CZ ' ' A' ' 59' ' ' TYR . 9.1 t-80 -69.72 137.98 52.48 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.993 -1.298 . . . . 0.02 109.946 -179.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 148' ' ' GLN . 19.0 ptm -119.16 136.47 54.17 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.333 -0.617 . . . . 5.01 109.333 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.638 ' CZ ' ' CE1' ' A' ' 57' ' ' HIS . 93.7 m-85 -128.28 139.51 52.38 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.914 -0.773 . . . . 0.02 108.914 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.8 mm -96.95 131.83 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.656 -0.868 . . . . 1.72 108.656 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 66' ' ' TYR . 9.2 mt -120.81 112.79 33.47 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.407 -0.808 . . . . 0.02 110.696 -178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -77.17 168.92 22.36 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 CA-C-N 120.047 1.052 . . . . 1.47 110.096 177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.614 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.2 pm0 -53.25 140.48 26.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.778 -1.201 . . . . 4.25 110.221 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.85 -177.19 33.08 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.407 -1.377 . . . . 0.02 110.438 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -119.25 130.18 55.31 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.325 -1.103 . . . . 0.96 109.635 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE1' HD22 ' A' ' 61' ' ' LEU . 84.5 m-85 -120.82 96.8 48.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 N-CA-C 107.945 -1.132 . . . . 0.02 107.945 179.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.96 -4.1 11.8 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 120.74 0.96 . . . . 0.02 113.756 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -157.68 155.02 29.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.671 -1.268 . . . . 2.02 108.256 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -60.29 -38.95 85.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.564 -0.71 . . . . 0.02 111.851 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -59.79 -24.13 63.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.106 -0.996 . . . . 0.02 110.544 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.614 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.91 -18.6 62.66 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.187 0.994 . . . . 3.42 108.581 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.566 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 1.4 t90 -106.87 9.94 30.75 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.386 -1.339 . . . . 0.02 107.386 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.0 mtt 60.55 21.32 11.11 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.475 0.655 . . . . 0.02 110.401 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.45 144.05 45.92 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.112 -1.595 . . . . 0.02 109.112 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.13 -29.52 48.86 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.438 -1.319 . . . . 0.98 107.438 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -157.17 -171.71 3.73 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.523 -1.658 . . . . 0.02 106.523 178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.522 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 87.4 m-20 -97.66 27.91 4.11 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.673 -1.267 . . . . 0.02 110.289 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.585 ' CG ' HH11 ' A' ' 78' ' ' ARG . 0.1 OUTLIER -98.52 123.49 42.7 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.29 -0.882 . . . . 3.2 111.655 -178.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.477 HD22 ' HB ' ' A' ' 48' ' ' VAL . 32.5 mt -143.25 121.05 11.92 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.912 -1.514 . . . . 2.61 106.912 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.25 -16.99 13.28 Favored Glycine 0 N--CA 1.5 2.945 0 O-C-N 121.185 -0.947 . . . . 0.02 111.981 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.0 t -155.02 154.82 33.09 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.397 -1.649 . . . . 0.02 110.372 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.4 p -144.32 147.04 32.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.516 -0.74 . . . . 0.02 109.953 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 40.4 mtm180 -134.57 140.03 45.82 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.814 -0.81 . . . . 0.01 108.814 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.07 131.77 38.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.998 -1.112 . . . . 0.43 107.998 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.0 t -91.71 123.98 44.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.637 -0.875 . . . . 1.25 108.637 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.452 ' O ' HG21 ' A' ' 135' ' ' THR . 7.8 m170 -91.66 136.23 33.29 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.981 -1.075 . . . . 1.77 108.744 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.64 137.0 38.73 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.378 -0.971 . . . . 1.63 108.378 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.5 m -110.8 126.29 54.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.437 -0.949 . . . . 1.08 108.437 178.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -103.71 -154.96 0.51 Allowed 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.348 -1.723 . . . . 1.26 106.348 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.38 -48.1 0.93 Allowed Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.506 -1.371 . . . . 0.01 112.178 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 177.78 -99.85 0.13 Allowed Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.484 -1.817 . . . . 0.01 111.936 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.48 HE21 HG21 ' A' ' 111' ' ' THR . 46.3 tt0 -121.54 119.24 31.37 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.342 -1.093 . . . . 4.43 110.504 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.31 129.28 35.65 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.988 -0.745 . . . . 2.99 108.988 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -130.08 140.37 50.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.421 -0.799 . . . . 6.36 109.15 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 tt -129.97 145.17 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.371 -0.831 . . . . 1.09 109.859 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -121.67 134.76 54.97 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.431 -1.322 . . . . 2.05 107.431 177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.91 147.25 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 120.831 -1.168 . . . . 1.1 109.531 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.588 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 69.0 m-85 -119.64 141.66 49.14 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.123 0.963 . . . . 0.73 111.032 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -66.24 -29.2 69.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 115.694 -0.685 . . . . 0.02 111.369 -178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -116.41 169.59 9.2 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.162 -0.961 . . . . 3.18 110.459 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.97 165.07 51.28 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.898 -0.881 . . . . 0.01 110.898 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 56.95 38.03 29.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.833 -0.804 . . . . 0.01 111.349 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 51.83 54.99 9.96 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.632 -0.667 . . . . 0.01 111.494 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -128.77 165.61 20.61 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 107.955 -1.128 . . . . 3.15 107.955 178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.91 -164.36 28.72 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.214 -1.554 . . . . 0.01 109.214 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.514 ' NE2' ' OH ' ' A' ' 108' ' ' TYR . 39.8 tt0 -75.35 144.12 42.51 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.012 -1.287 . . . . 0.01 108.748 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.588 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 28.1 ttp -116.75 143.17 45.98 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.601 0.715 . . . . 0.01 109.96 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 106' ' ' GLN . 24.1 m-85 -131.39 135.71 47.43 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.937 -1.135 . . . . 2.48 107.937 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 110' ' ' THR . 1.2 tm-20 -118.36 134.59 54.92 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.809 -0.557 . . . . 0.01 109.757 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.444 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.7 t -149.48 150.29 32.1 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 1.69 110.911 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.48 HG21 HE21 ' A' ' 92' ' ' GLN . 46.7 p -109.6 9.95 25.08 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.51 -0.768 . . . . 0.01 109.863 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -121.43 163.64 18.41 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.429 -0.794 . . . . 3.21 111.438 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -66.46 155.37 37.75 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.199 -1.037 . . . . 0.01 108.199 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.8 t -122.17 110.79 32.51 Favored Pre-proline 0 N--CA 1.5 2.034 0 N-CA-C 108.819 -0.808 . . . . 0.01 108.819 178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -77.28 -32.9 2.8 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 CA-C-N 119.846 0.981 . . . . 0.01 111.584 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.1 t -141.69 107.04 5.01 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.011 -1.056 . . . . 0.02 108.732 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 74.2 mt -64.35 -39.76 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.896 -0.503 . . . . 1.83 111.087 -178.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 39.7 ttm -66.38 -37.66 85.77 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 118.936 -1.105 . . . . 1.34 109.888 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -70.16 -39.02 75.56 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.549 -1.344 . . . . 2.11 109.684 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.31 -48.21 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.163 -0.961 . . . . 2.08 112.612 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -111.99 -1.09 15.52 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.367 -0.833 . . . . 0.02 112.612 -175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.533 ' O ' ' NH2' ' A' ' 124' ' ' ARG . 5.8 m80 62.04 34.36 16.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.816 -1.178 . . . . 0.02 109.936 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 37.5 mt -114.86 135.83 53.76 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.505 -0.747 . . . . 0.02 109.514 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.672 ' HE ' ' N ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.45 -21.28 23.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.123 -0.985 . . . . 5.32 110.86 -179.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.0 mt-10 -148.99 164.3 34.99 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.943 -1.098 . . . . 0.02 110.015 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 125' ' ' GLU . 38.7 mm -129.44 126.16 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 107.403 -1.332 . . . . 2.17 107.403 178.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.6 m80 -109.2 -12.72 14.77 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.267 -0.896 . . . . 0.02 112.693 -177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 11.4 p -159.52 153.13 22.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.679 -1.263 . . . . 0.01 108.829 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 21.8 p -167.4 142.97 4.05 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.161 -0.962 . . . . 1.22 109.399 -179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -124.44 106.92 10.58 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.464 1.126 . . . . 1.41 109.834 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 136' ' ' TRP . 7.2 p -110.95 137.58 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.575 -1.268 . . . . 0.01 107.575 178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.4 t -128.39 92.97 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 106.782 -1.562 . . . . 1.98 106.782 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.469 ' CD ' ' N ' ' A' ' 134' ' ' GLY . 3.4 tm-20 -146.59 -67.82 0.27 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.613 -1.995 . . . . 0.01 105.613 178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' CD ' ' A' ' 133' ' ' GLU . . . 170.56 -78.44 0.1 OUTLIER Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.556 -1.818 . . . . 0.01 108.556 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 86' ' ' HIS . 54.6 p -121.71 123.86 42.87 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.628 -0.925 . . . . 2.3 110.587 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.423 ' CD1' HG21 ' A' ' 131' ' ' VAL . 6.7 m95 -126.6 152.32 46.79 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 106.574 -1.639 . . . . 0.01 106.574 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 19.8 mt -119.74 134.24 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.577 -1.327 . . . . 1.69 109.713 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.6 m-30 -111.33 142.45 43.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 106.307 -1.738 . . . . 2.49 106.307 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.475 ' CE2' ' CD ' ' A' ' 148' ' ' GLN . 30.9 m-85 -122.37 142.51 50.44 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.133 -0.979 . . . . 0.02 109.431 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.44 ' O ' ' OE1' ' A' ' 170' ' ' GLN . 9.9 tp10 -75.04 -30.27 61.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.673 -0.642 . . . . 0.02 111.709 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.9 mt -114.47 152.77 46.44 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 120.66 -1.275 . . . . 1.48 109.054 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -54.49 165.98 2.07 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 120.81 1.007 . . . . 0.02 112.757 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 31.6 20.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.207 -0.906 . . . . 0.75 111.395 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 58.05 51.87 8.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.495 -0.753 . . . . 0.02 111.52 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.447 ' HE ' ' CA ' ' A' ' 145' ' ' ARG . 0.0 OUTLIER -127.36 166.1 18.49 Favored 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.393 -0.817 . . . . 0.02 110.097 179.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.29 -165.42 34.16 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.064 -1.214 . . . . 0.02 110.064 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -69.66 142.91 53.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.54 -0.976 . . . . 0.02 108.927 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 58' ' ' MET . 20.9 mt-30 -113.85 148.97 35.74 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.255 0.55 . . . . 0.02 109.727 -177.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -123.69 133.21 53.92 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.515 -0.92 . . . . 0.01 108.515 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 12.8 tp -96.14 122.01 38.52 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.819 -1.176 . . . . 0.01 109.255 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.8 mp -96.25 146.48 24.68 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.677 -0.86 . . . . 0.01 108.677 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 154' ' ' LYS . 9.0 m-20 -105.58 -169.18 1.55 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.453 -0.78 . . . . 2.27 109.684 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.16 31.76 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.225 -0.922 . . . . 1.84 109.583 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' A' ' 152' ' ' ASP . 19.5 mtpp -111.7 171.31 7.57 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.335 -0.853 . . . . 2.28 109.153 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -104.05 133.62 48.68 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.196 -1.039 . . . . 0.01 108.196 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -100.22 115.01 28.87 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.01 110.239 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -90.57 -28.38 18.5 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.736 -0.602 . . . . 0.01 110.958 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -123.38 154.31 65.75 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 107.739 -1.208 . . . . 2.54 107.739 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.554 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.8 Cg_endo -62.01 -41.84 33.97 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-N 119.207 0.752 . . . . 0.7 111.209 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.87 -19.41 19.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 120.79 -1.193 . . . . 0.86 109.707 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 161' ' ' ASP . 56.2 t0 -65.92 -18.5 65.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.802 -1.187 . . . . 0.02 112.034 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.5 OUTLIER -101.26 15.9 27.29 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.725 -1.235 . . . . 0.02 110.171 178.396 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.89 10.16 76.2 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 121.115 -0.99 . . . . 0.02 113.035 176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.53 140.83 34.23 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.819 -1.401 . . . . 0.02 110.185 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.06 -7.05 59.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.59 109.735 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.8 p -140.55 151.09 62.72 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.196 -0.94 . . . . 0.87 109.309 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -75.26 15.46 0.78 Allowed 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 120.703 0.935 . . . . 0.38 111.952 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.411 ' O ' ' OE1' ' A' ' 140' ' ' GLU . . . -82.66 120.52 25.67 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.916 -1.115 . . . . 0.18 110.741 -178.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.424 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.5 mt -149.43 122.95 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.579 -2.008 . . . . 3.99 105.579 178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.46 ' N ' ' CD ' ' A' ' 170' ' ' GLN . 5.2 mp0 -112.17 -13.13 13.55 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.244 -0.91 . . . . 5.17 112.936 -177.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 66.0 m -157.04 158.69 36.96 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 119.13 -2.231 . . . . 0.02 110.085 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -153.16 154.81 35.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.267 -0.896 . . . . 2.02 110.188 178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 28.4 mtm180 -144.19 149.5 36.51 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.276 -0.89 . . . . 0.01 110.162 -179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -86.62 143.14 27.78 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.524 -0.917 . . . . 0.01 108.524 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 mt -94.16 128.38 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.141 -0.975 . . . . 3.04 109.79 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.412 ' O ' ' O ' ' A' ' 177' ' ' GLU . 60.6 t -137.06 147.47 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.229 -0.919 . . . . 1.89 109.663 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . 0.412 ' O ' ' O ' ' A' ' 176' ' ' VAL . 7.8 tm-20 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.436 -0.79 . . . . 4.89 109.297 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.387 0.613 . . . . 5.28 109.418 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -65.0 99.19 0.33 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.942 . . . . 5.96 109.521 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 67.0 p -104.24 -141.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.349 -0.982 . . . . 2.22 108.349 177.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.57 88.43 0.07 OUTLIER Glycine 0 N--CA 1.496 2.684 0 N-CA-C 107.096 -2.402 . . . . 0.81 107.096 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.82 149.82 33.54 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 120.112 -1.042 . . . . 0.01 110.749 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -150.05 136.29 18.84 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.533 -0.981 . . . . 0.02 109.684 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.7 tt -130.23 139.44 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.793 -0.567 . . . . 0.02 109.543 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.4 t -122.16 130.46 53.23 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.553 -0.717 . . . . 0.39 109.916 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 3.3 m-85 -110.08 139.99 44.62 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.032 -0.729 . . . . 0.02 109.032 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 4.9 m-85 -122.51 139.14 54.22 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.292 -0.88 . . . . 0.02 109.813 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.451 ' HG3' HD11 ' A' ' 33' ' ' LEU . 89.2 mt-10 -68.39 -28.03 66.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.938 -1.101 . . . . 0.03 111.804 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -114.14 169.07 9.29 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.888 -1.132 . . . . 0.03 110.201 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -74.96 158.15 33.76 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.666 0.746 . . . . 0.03 109.895 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.602 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 1.4 m120 66.47 34.94 5.84 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.729 0.776 . . . . 0.74 110.8 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.602 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 16.1 p90 49.72 44.39 24.73 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.742 0.782 . . . . 0.02 111.207 179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -112.73 166.72 11.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.87 -1.159 . . . . 0.02 107.87 178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.1 -167.75 36.44 Favored Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.669 -1.253 . . . . 0.03 110.673 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -69.19 142.73 54.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.538 -0.977 . . . . 2.76 108.943 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' NH1' ' OD1' ' A' ' 21' ' ' ASP . 5.3 tmm_? -121.57 150.67 41.32 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 121.71 0.766 . . . . 1.89 110.42 -179.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -132.82 127.55 34.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.045 -1.095 . . . . 0.02 108.045 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.518 ' OD1' ' NH1' ' A' ' 19' ' ' ARG . 3.3 p-10 -111.83 136.46 51.09 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.563 -0.711 . . . . 1.12 109.711 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 24' ' ' CYS . 8.0 t -130.91 137.69 49.43 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.494 0.664 . . . . 0.02 109.467 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 p30 -116.83 10.1 14.08 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.728 -0.608 . . . . 0.2 109.375 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.416 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 26.3 p -158.59 174.3 15.27 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.184 -1.043 . . . . 1.23 108.184 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 13.0 t0 -60.8 142.31 56.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.782 -1.199 . . . . 0.02 110.327 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 43.2 t -131.57 116.58 17.59 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.316 -0.994 . . . . 0.02 108.316 178.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -76.59 -24.33 53.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.22 -0.925 . . . . 0.24 110.995 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -154.65 102.4 2.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.006 -1.059 . . . . 1.14 108.86 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.424 ' CZ ' ' NH2' ' A' ' 30' ' ' ARG . 17.9 p90 -104.38 8.38 35.8 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.192 0.996 . . . . 6.37 109.487 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.436 HH11 ' NH2' ' A' ' 78' ' ' ARG . 3.3 mmp_? -58.3 -24.22 58.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.655 -0.653 . . . . 3.11 110.715 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.6 m -74.69 -17.1 60.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.768 -1.208 . . . . 0.88 109.933 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -104.13 -22.41 13.42 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.421 -0.799 . . . . 0.02 109.416 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.451 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.7 tp -150.01 128.51 12.25 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.113 -0.992 . . . . 3.32 109.138 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -85.54 -10.03 56.54 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.723 -0.611 . . . . 0.02 111.288 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -171.86 163.1 6.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.759 -1.2 . . . . 0.02 107.759 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.3 p -143.98 115.71 8.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.782 -1.199 . . . . 0.02 108.736 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.51 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 1.1 m-20 -107.06 1.83 24.57 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.957 -1.089 . . . . 0.03 110.548 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.6 p -156.88 154.72 30.25 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.507 -1.294 . . . . 0.02 107.507 178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mt -146.17 148.16 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 0.02 109.777 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -125.04 125.43 43.83 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.063 -1.088 . . . . 0.02 108.063 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.47 114.94 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.714 -1.587 . . . . 0.02 106.714 176.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.87 -34.33 26.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.796 -0.565 . . . . 3.81 110.42 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.36 151.5 21.1 Favored Glycine 0 N--CA 1.486 1.976 0 C-N-CA 119.142 -1.504 . . . . 0.02 110.167 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.72 175.09 50.68 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.582 -1.294 . . . . 0.01 110.264 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.424 HG22 ' N ' ' A' ' 46' ' ' TRP . 84.0 m -109.46 161.3 15.45 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.901 -1.518 . . . . 1.48 106.901 177.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.424 ' N ' HG22 ' A' ' 45' ' ' THR . 65.6 m95 -147.38 146.64 29.7 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.347 -1.47 . . . . 0.02 111.402 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.55 131.79 54.74 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 105.466 -2.05 . . . . 0.24 105.466 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' HB ' HD22 ' A' ' 79' ' ' LEU . 26.0 m -117.73 141.98 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.607 -0.683 . . . . 0.65 109.493 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.58 ' CD1' ' N ' ' A' ' 49' ' ' TYR . 8.5 m-85 -122.0 143.36 49.53 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 122.511 1.148 . . . . 0.02 109.652 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' OE2' ' ND2' ' A' ' 76' ' ' ASN . 6.0 tp10 -65.37 -36.25 83.43 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.16 -0.927 . . . . 0.02 111.729 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -123.1 153.51 64.56 Favored Pre-proline 0 N--CA 1.503 2.206 0 O-C-N 120.97 -1.081 . . . . 0.02 109.305 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -51.13 167.74 0.3 Allowed 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.31 1.34 . . . . 0.02 112.772 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 63.26 37.05 11.39 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.175 -0.921 . . . . 0.02 110.998 178.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 54' ' ' PHE . 0.5 OUTLIER 45.12 52.83 8.26 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.683 0.754 . . . . 3.39 110.896 178.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -126.58 163.85 22.52 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.168 0.509 . . . . 2.33 109.866 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.86 -161.84 32.27 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.13 -1.188 . . . . 0.02 110.13 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' CD2' ' N ' ' A' ' 57' ' ' HIS . 5.6 m170 -63.93 138.52 58.51 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.976 -1.308 . . . . 0.02 110.117 -178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 5.7 mtm -120.55 134.47 55.27 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.606 0.717 . . . . 5.01 109.679 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.534 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 79.3 m-85 -134.25 139.02 45.47 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.471 -0.768 . . . . 0.02 109.561 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.683 ' H ' ' NE2' ' A' ' 148' ' ' GLN . 1.6 mp -97.25 133.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.65 -0.87 . . . . 1.72 108.65 178.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.85 113.68 32.91 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 121.561 -0.712 . . . . 0.02 110.56 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -77.4 168.72 22.4 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.154 1.091 . . . . 1.47 110.155 177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -53.17 141.39 23.39 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.746 -1.221 . . . . 4.25 110.151 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.03 -176.51 32.68 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.412 -1.375 . . . . 0.02 110.567 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -119.4 130.6 55.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.361 -1.082 . . . . 0.96 109.403 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.415 ' CD1' ' N ' ' A' ' 66' ' ' TYR . 49.3 m-85 -121.1 98.71 47.01 Favored Pre-proline 0 N--CA 1.494 1.739 0 N-CA-C 107.671 -1.233 . . . . 0.02 107.671 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -70.54 -3.39 12.42 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 120.629 0.886 . . . . 0.02 113.806 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -157.26 155.01 30.03 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.592 -1.317 . . . . 2.02 108.206 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -60.65 -39.14 87.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.577 -0.702 . . . . 0.02 111.814 -177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -59.81 -23.8 63.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.102 -0.999 . . . . 0.02 110.181 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.549 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -70.73 -18.54 62.79 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.96 0.886 . . . . 3.42 108.626 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.558 ' O ' ' CG ' ' A' ' 72' ' ' TRP . 1.8 t90 -106.82 10.31 30.74 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.171 -1.418 . . . . 0.02 107.171 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 73' ' ' MET . 3.9 mpp? 59.35 22.62 11.03 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.557 0.694 . . . . 0.02 110.18 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.43 144.98 47.36 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.208 -1.557 . . . . 0.02 109.208 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.8 tp -78.76 -29.68 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.649 -1.241 . . . . 0.98 107.649 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.669 ' H ' HD22 ' A' ' 76' ' ' ASN . 0.0 OUTLIER -157.67 -171.03 3.4 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.619 -1.623 . . . . 0.02 106.619 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -98.17 28.29 4.12 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.633 -1.292 . . . . 0.02 110.238 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' NH2' HH11 ' A' ' 30' ' ' ARG . 17.7 mmm180 -98.05 123.01 41.87 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.285 -0.884 . . . . 3.2 111.38 -178.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.498 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.0 mt -144.65 121.59 11.34 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.048 -1.464 . . . . 2.61 107.048 177.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -106.57 -16.39 14.48 Favored Glycine 0 N--CA 1.5 2.905 0 O-C-N 121.303 -0.873 . . . . 0.02 112.171 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 p -155.01 154.65 32.85 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.247 -1.737 . . . . 0.02 110.401 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.434 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 4.6 p -144.69 147.36 32.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.512 -0.742 . . . . 0.02 109.688 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 50.6 mtm180 -133.86 140.13 46.66 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.664 -0.865 . . . . 0.01 108.664 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.11 129.22 36.45 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 0.43 107.935 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.0 t -91.96 123.69 44.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 108.893 -0.78 . . . . 1.25 108.893 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.498 ' O ' HG21 ' A' ' 135' ' ' THR . 15.6 m80 -90.66 136.65 32.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.276 -0.89 . . . . 1.77 109.006 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -99.25 137.48 37.7 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.94 -1.133 . . . . 1.63 107.94 -179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.1 t -112.25 126.5 55.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -0.876 . . . . 1.08 109.14 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -103.61 -154.94 0.51 Allowed 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 106.221 -1.77 . . . . 1.26 106.221 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 137.02 -49.58 0.86 Allowed Glycine 0 N--CA 1.498 2.79 0 O-C-N 120.418 -1.426 . . . . 0.01 112.232 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.04 -100.05 0.14 Allowed Glycine 0 N--CA 1.488 2.122 0 C-N-CA 118.397 -1.859 . . . . 0.01 111.889 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.475 ' NE2' ' O ' ' A' ' 93' ' ' ALA . 0.1 OUTLIER -120.95 118.62 30.35 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.292 -1.122 . . . . 4.43 110.394 -179.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.475 ' O ' ' NE2' ' A' ' 92' ' ' GLN . . . -76.86 129.66 36.53 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.799 -0.76 . . . . 2.99 109.287 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp -129.97 139.46 51.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.576 -0.703 . . . . 6.36 109.436 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tt -129.35 145.78 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.414 -0.804 . . . . 1.09 109.71 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -121.18 133.22 55.18 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 107.29 -1.374 . . . . 2.05 107.29 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.4 146.61 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.954 -1.091 . . . . 1.1 109.351 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.594 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 33.2 m-85 -119.72 141.39 49.46 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 122.194 0.997 . . . . 0.73 110.922 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -66.31 -29.25 69.42 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.711 -0.677 . . . . 0.02 111.587 -178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -116.61 169.8 9.07 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.075 -1.016 . . . . 3.18 110.444 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -69.95 165.33 50.97 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.843 -0.903 . . . . 0.01 110.843 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.526 ' OD1' ' NH1' ' A' ' 157' ' ' ARG . 9.6 t0 56.8 38.37 29.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.956 -0.732 . . . . 0.01 111.307 178.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 51.65 54.44 10.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.01 111.368 178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -129.19 166.14 19.95 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.062 -1.088 . . . . 3.15 108.062 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 -164.19 28.63 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.014 -1.635 . . . . 0.01 109.014 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -75.34 143.86 42.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.016 -1.285 . . . . 0.01 108.518 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.594 ' SD ' ' CZ ' ' A' ' 98' ' ' PHE . 29.3 ttp -116.79 142.84 46.4 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.59 0.71 . . . . 0.01 109.838 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -131.65 136.38 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.073 -1.084 . . . . 2.48 108.073 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' OE2' ' N ' ' A' ' 110' ' ' THR . 2.1 tm-20 -118.57 134.8 54.82 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.684 -0.635 . . . . 0.01 110.093 -178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.514 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -149.14 150.49 32.77 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 122.237 1.018 . . . . 1.69 111.031 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 73.6 p -110.11 10.02 24.01 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 115.674 -0.694 . . . . 0.01 109.811 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -120.77 163.23 18.44 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.282 -0.887 . . . . 3.21 111.272 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -66.1 155.18 37.57 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.021 -1.103 . . . . 0.01 108.021 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 16.2 t -123.18 109.77 31.3 Favored Pre-proline 0 N--CA 1.498 1.956 0 N-CA-C 108.629 -0.878 . . . . 0.01 108.629 178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -76.67 -31.91 3.91 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 CA-C-N 119.997 1.035 . . . . 0.01 111.696 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -140.96 107.42 5.29 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.37 -0.832 . . . . 0.02 108.774 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 23.6 mt -63.52 -39.44 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.56 . . . . 1.83 110.668 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 40.7 ttp -66.32 -37.52 85.57 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.966 -1.094 . . . . 1.34 109.959 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.18 -39.27 71.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.399 -1.438 . . . . 2.11 109.539 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -80.72 -47.86 13.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 2.08 112.447 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -111.19 -1.96 15.95 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.352 -0.843 . . . . 0.02 112.517 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.0 m80 61.87 33.96 17.29 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.659 -1.276 . . . . 0.02 109.403 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 49.1 mt -114.63 135.54 54.03 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.487 -0.758 . . . . 0.02 109.264 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.459 ' H ' ' HD2' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -89.13 -21.19 23.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.159 -0.963 . . . . 5.32 110.761 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 124' ' ' ARG . 10.9 mp0 -147.32 163.95 34.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.912 -1.117 . . . . 0.02 109.504 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.0 mm -126.97 124.23 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 107.339 -1.356 . . . . 2.17 107.339 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -110.3 -13.48 14.31 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.238 -0.914 . . . . 0.02 112.516 -177.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 35.5 t -160.79 151.65 18.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.835 -1.165 . . . . 0.01 109.24 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 27.2 p -168.78 143.93 3.33 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.674 -0.861 . . . . 1.22 108.674 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.46 109.6 13.48 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 122.448 1.118 . . . . 1.41 109.669 -179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 131' ' ' VAL . 11.5 p -111.04 137.81 41.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.619 -1.252 . . . . 0.01 107.619 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 54.3 t -127.03 92.81 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 N-CA-C 106.693 -1.595 . . . . 1.98 106.693 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' OE1' ' NE1' ' A' ' 136' ' ' TRP . 22.8 tt0 -146.82 -73.01 0.22 Allowed 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 105.498 -2.038 . . . . 0.01 105.498 177.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.67 -75.23 0.09 OUTLIER Glycine 0 N--CA 1.48 1.6 0 N-CA-C 108.362 -1.895 . . . . 0.01 108.362 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.498 HG21 ' O ' ' A' ' 86' ' ' HIS . 70.6 p -123.46 124.37 42.73 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.3 1.048 . . . . 2.3 111.311 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.518 ' NE1' ' OE1' ' A' ' 133' ' ' GLU . 6.4 m95 -127.06 151.36 48.72 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.557 -1.646 . . . . 0.01 106.557 178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.463 ' CG1' HD11 ' A' ' 175' ' ' ILE . 12.3 mt -117.18 133.62 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 120.507 -1.371 . . . . 1.69 109.162 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -111.47 141.14 45.42 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 106.29 -1.745 . . . . 2.49 106.29 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 139' ' ' TYR . 26.8 m-85 -123.05 142.98 50.27 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.232 -0.918 . . . . 0.02 109.605 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -73.66 -30.49 62.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.79 -0.569 . . . . 0.02 111.725 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.9 154.9 48.31 Favored Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.655 -1.278 . . . . 1.48 108.975 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.5 167.08 2.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.091 1.194 . . . . 0.02 112.926 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 59.79 31.38 20.77 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.05 -0.977 . . . . 0.75 111.363 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 57.31 51.89 9.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.42 -0.8 . . . . 0.02 111.361 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -126.57 164.84 20.33 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.504 -0.748 . . . . 0.02 110.114 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 88.73 -165.2 33.32 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 110.227 -1.149 . . . . 0.02 110.227 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -68.84 141.69 55.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.502 -0.999 . . . . 0.02 108.61 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.683 ' NE2' ' H ' ' A' ' 60' ' ' ILE . 2.9 mt-30 -113.4 148.13 36.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.734 -0.604 . . . . 0.02 109.533 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.31 133.99 54.1 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.912 -0.773 . . . . 0.01 108.912 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 48.0 tp -96.63 121.66 38.71 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.927 -1.108 . . . . 0.01 109.378 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.3 mp -95.75 139.08 32.49 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.557 -0.905 . . . . 0.01 108.557 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.545 ' N ' ' OH ' ' A' ' 156' ' ' TYR . 3.0 p30 -105.55 -168.32 1.44 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.498 -0.751 . . . . 2.27 109.499 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 ptmm? -82.57 38.93 0.58 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.29 -0.881 . . . . 1.84 110.005 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -114.28 175.28 5.54 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.379 -0.826 . . . . 2.28 109.45 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -105.31 125.51 51.06 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.723 -0.843 . . . . 0.01 108.723 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.545 ' OH ' ' N ' ' A' ' 152' ' ' ASP . 1.5 m-85 -100.35 112.73 25.09 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.243 -0.911 . . . . 0.01 109.817 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.526 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 12.8 mmm180 -88.35 -28.09 21.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.957 -1.089 . . . . 0.01 110.549 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -126.88 156.04 74.57 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 107.045 -1.465 . . . . 2.54 107.045 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 162' ' ' TRP . 5.6 Cg_endo -59.56 -34.26 96.81 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 CA-C-N 119.721 0.936 . . . . 0.7 110.335 179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.1 t -62.88 -21.16 27.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.873 -1.142 . . . . 0.86 109.564 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -67.07 -20.51 65.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.672 -1.268 . . . . 0.02 111.439 -179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 164' ' ' ALA . 1.1 p90 -103.03 13.32 34.53 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.979 -1.075 . . . . 0.02 109.243 178.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.75 11.98 64.95 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.771 -0.728 . . . . 0.02 113.549 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -100.78 138.06 38.33 Favored 'General case' 0 N--CA 1.506 2.357 0 CA-C-N 119.627 1.713 . . . . 0.02 110.411 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -85.79 -7.85 58.49 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.692 -0.63 . . . . 0.59 109.796 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 87.0 p -139.98 150.16 61.3 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.312 -0.868 . . . . 0.87 109.551 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -74.5 13.5 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 120.688 0.925 . . . . 0.38 112.031 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.95 120.2 24.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.847 -1.158 . . . . 0.18 110.921 -178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.15 124.55 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 105.79 -1.929 . . . . 3.99 105.79 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -112.25 -12.95 13.54 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.311 -0.868 . . . . 5.17 113.171 -177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 33.3 t -156.76 159.0 37.88 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 119.354 -2.091 . . . . 0.02 110.076 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -153.01 154.14 34.34 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.303 -0.873 . . . . 2.02 110.7 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 31.6 mtm180 -143.51 149.29 37.28 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.385 -0.822 . . . . 0.01 110.237 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -86.41 142.83 28.15 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.53 -0.915 . . . . 0.01 108.53 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 137' ' ' ILE . 7.3 mt -94.38 128.45 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.12 -0.987 . . . . 3.04 109.851 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.59 147.39 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.477 -0.764 . . . . 1.89 109.458 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 4.89 109.102 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.431 -0.581 . . . . 5.28 109.431 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -72.78 95.81 1.96 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.141 -0.974 . . . . 5.96 109.541 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.9 p -101.93 -141.45 0.35 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.978 -1.119 . . . . 2.22 107.978 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.39 87.03 0.06 OUTLIER Glycine 0 N--CA 1.495 2.606 0 N-CA-C 107.088 -2.405 . . . . 0.81 107.088 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.37 149.59 34.01 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 120.026 -1.083 . . . . 0.01 110.692 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -150.04 135.98 18.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.537 -0.978 . . . . 0.02 109.509 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.2 tt -130.25 140.83 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.113 -0.699 . . . . 0.02 109.113 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.432 ' CB ' ' HE ' ' A' ' 19' ' ' ARG . 4.3 m -121.32 130.06 53.44 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.625 -0.672 . . . . 0.39 109.575 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -109.69 139.24 44.96 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.76 -0.83 . . . . 0.02 108.76 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.0 m-85 -123.18 139.28 54.23 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.266 -0.896 . . . . 0.02 109.765 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' OE2' ' NE ' ' A' ' 18' ' ' ARG . 86.2 mt-10 -69.15 -28.1 66.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.154 -0.966 . . . . 0.03 111.989 -178.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -114.69 170.22 8.49 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.932 -1.105 . . . . 0.03 110.426 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.495 ' NH2' ' OE1' ' A' ' 70' ' ' GLN . 73.0 mtt180 -74.07 157.71 35.59 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.638 0.732 . . . . 0.03 109.929 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 15' ' ' PHE . 5.3 t-20 65.76 35.03 7.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.931 0.872 . . . . 0.74 111.037 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.56 ' CG ' ' O ' ' A' ' 14' ' ' ASN . 2.1 p90 50.29 45.61 25.81 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.839 0.828 . . . . 0.02 111.197 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -112.39 165.85 11.83 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.989 -1.115 . . . . 0.02 107.989 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.09 -167.2 35.91 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.702 -1.237 . . . . 0.03 110.853 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' ' OE2' ' A' ' 11' ' ' GLU . 22.3 ttp180 -68.64 142.78 55.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.418 -1.048 . . . . 2.76 109.414 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HE ' ' CB ' ' A' ' 8' ' ' SER . 54.9 ttt180 -119.79 147.65 44.38 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.593 0.711 . . . . 1.89 109.893 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -132.61 126.68 33.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.833 -1.173 . . . . 0.02 107.833 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -112.39 137.78 50.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.473 -0.767 . . . . 1.12 109.756 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.7 t -131.08 138.55 49.61 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.648 0.737 . . . . 0.02 109.807 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -116.28 10.81 14.9 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.687 -0.633 . . . . 0.2 109.542 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 t -157.08 174.47 15.46 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 26' ' ' CYS . 40.3 t0 -60.84 144.46 52.66 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.733 -1.229 . . . . 0.02 109.969 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.51 ' N ' ' OD1' ' A' ' 25' ' ' ASP . 20.9 t -131.95 116.11 16.73 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.49 -0.93 . . . . 0.02 108.49 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.26 -24.18 51.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.24 110.891 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 20.6 p-10 -154.4 101.56 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.869 . . . . 1.14 108.84 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 79' ' ' LEU . 18.9 p90 -105.43 10.36 33.34 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 122.331 1.063 . . . . 6.37 110.159 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.418 ' NH2' ' O ' ' A' ' 34' ' ' SER . 21.6 mmm180 -60.22 -23.03 63.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 3.11 110.924 -179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.4 m -76.3 -16.94 59.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.619 -1.301 . . . . 0.88 110.222 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -102.23 -20.97 14.46 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.79 -0.818 . . . . 0.02 108.79 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.448 HD11 ' HG3' ' A' ' 11' ' ' GLU . 5.6 tp -150.15 129.37 12.79 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.78 0.8 . . . . 3.32 109.002 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' NH2' ' A' ' 30' ' ' ARG . 90.4 p -85.16 -10.78 56.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.762 -0.586 . . . . 0.02 110.717 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.536 ' HE ' HD21 ' A' ' 37' ' ' ASN . 12.5 ptm180 -170.26 162.13 8.51 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.639 -1.245 . . . . 0.02 107.639 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.7 t -143.6 115.34 8.2 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.856 -1.152 . . . . 0.02 108.978 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.675 HD22 ' N ' ' A' ' 37' ' ' ASN . 0.5 OUTLIER -110.33 1.2 18.35 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.739 -1.226 . . . . 0.03 111.422 -178.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.0 t -156.96 154.78 30.22 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.131 -1.062 . . . . 0.02 108.131 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.2 mt -146.49 146.88 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 122.185 0.993 . . . . 0.02 111.105 -178.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -122.8 124.11 42.57 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 107.616 -1.253 . . . . 0.02 107.616 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.48 114.83 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 106.598 -1.63 . . . . 0.02 106.598 177.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 10.7 mp0 -83.83 -33.73 24.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.567 -0.708 . . . . 3.81 110.269 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.32 149.8 18.34 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 119.104 -1.522 . . . . 0.02 110.133 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.07 173.87 50.03 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.648 -1.263 . . . . 0.01 110.153 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 30.6 m -119.64 137.28 53.98 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.907 -1.146 . . . . 1.48 107.907 177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 49.5 m95 -126.09 153.93 43.8 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.712 1.244 . . . . 0.02 112.361 -176.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -107.99 133.39 52.38 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 105.051 -2.203 . . . . 0.24 105.051 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 79' ' ' LEU . 27.5 m -116.87 142.03 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.658 -0.651 . . . . 0.65 109.337 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -120.97 143.01 49.24 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 122.169 0.985 . . . . 0.02 109.655 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.58 -34.3 77.93 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.376 -0.829 . . . . 0.02 111.778 -177.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.4 mtm180 -124.82 157.84 64.75 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 120.942 -1.099 . . . . 0.02 109.549 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.91 166.31 0.94 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.739 1.626 . . . . 0.02 112.741 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.77 37.31 9.95 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-N 115.314 -0.857 . . . . 0.02 111.058 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.488 ' CE1' ' OG ' ' A' ' 81' ' ' SER . 3.3 m-85 44.85 52.23 8.13 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.551 0.691 . . . . 3.39 110.598 178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 t -126.21 163.87 22.23 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.181 0.515 . . . . 2.33 110.016 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.7 -162.02 31.29 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.871 -1.292 . . . . 0.02 109.871 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -63.65 136.38 57.45 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.033 -1.275 . . . . 0.02 110.035 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 148' ' ' GLN . 19.1 ptm -118.58 135.66 54.3 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.401 0.62 . . . . 5.01 109.435 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.623 ' CB ' ' HE1' ' A' ' 72' ' ' TRP . 25.6 m-85 -135.52 141.09 45.21 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.509 -0.744 . . . . 0.02 109.34 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 60' ' ' ILE . 1.6 mp -96.51 133.04 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.59 -0.892 . . . . 1.72 108.59 178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 HD22 ' CE2' ' A' ' 66' ' ' TYR . 17.3 mt -123.74 111.79 29.27 Favored Pre-proline 0 N--CA 1.502 2.159 0 O-C-N 121.371 -0.831 . . . . 0.02 110.4 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -75.96 171.37 18.29 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 119.839 0.978 . . . . 1.47 110.237 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -51.42 140.79 16.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.002 -1.061 . . . . 4.25 109.863 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 155.32 -178.56 31.89 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.403 -1.38 . . . . 0.02 110.883 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' A' ' 66' ' ' TYR . 7.3 tp10 -120.36 131.21 54.75 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.44 -1.035 . . . . 0.96 109.461 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.52 ' N ' ' OE1' ' A' ' 65' ' ' GLU . 93.3 m-85 -122.21 95.29 47.36 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.696 -1.224 . . . . 0.02 107.696 178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.406 ' O ' ' CG ' ' A' ' 68' ' ' GLU . 3.2 Cg_exo -65.65 -3.45 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.892 1.061 . . . . 0.02 114.179 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 36.1 mt-10 -157.78 154.99 29.01 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.415 -1.428 . . . . 2.02 108.087 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 69' ' ' TYR . 7.3 p90 -60.8 -38.57 85.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.523 -0.735 . . . . 0.02 111.995 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' OE1' ' NH2' ' A' ' 13' ' ' ARG . 24.7 mt-30 -59.58 -24.21 63.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.055 -1.028 . . . . 0.02 110.367 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -70.84 -18.18 62.72 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.404 -0.961 . . . . 3.42 108.404 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.623 ' HE1' ' CB ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -106.89 9.87 30.72 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.258 -1.386 . . . . 0.02 107.258 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 19.1 mtt 60.86 21.48 11.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.587 -0.696 . . . . 0.02 110.41 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.05 145.01 46.56 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.392 -1.483 . . . . 0.02 109.392 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 75' ' ' LEU . 8.1 mp -78.6 -29.95 46.31 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.663 -1.236 . . . . 0.98 107.663 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 75' ' ' LEU . 20.8 m-80 -157.02 -171.55 3.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 106.459 -1.682 . . . . 0.02 106.459 178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.46 ' OD2' ' NH2' ' A' ' 35' ' ' ARG . 5.5 p30 -97.21 28.56 3.57 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.669 -1.27 . . . . 0.02 110.21 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -96.31 121.42 38.08 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.914 -1.116 . . . . 3.2 110.33 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.529 HD22 ' HB ' ' A' ' 48' ' ' VAL . 35.1 mt -144.3 119.72 10.3 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.794 -1.187 . . . . 2.61 107.794 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.22 -15.94 10.12 Favored Glycine 0 N--CA 1.502 3.074 0 O-C-N 121.338 -0.851 . . . . 0.02 112.975 -177.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.488 ' OG ' ' CE1' ' A' ' 54' ' ' PHE . 47.3 t -155.55 155.59 33.65 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 119.97 -1.9 . . . . 0.02 110.943 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.43 ' O ' ' OD1' ' A' ' 25' ' ' ASP . 23.9 p -145.86 148.7 33.15 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.487 -0.758 . . . . 0.02 110.397 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -135.53 140.53 44.8 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.394 -0.816 . . . . 0.01 108.888 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.33 130.97 36.8 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.081 -1.012 . . . . 0.43 109.197 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.33 123.31 41.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 108.334 -0.987 . . . . 1.25 108.334 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.433 ' CD2' ' N ' ' A' ' 86' ' ' HIS . 9.6 m-70 -90.65 135.08 33.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.876 -1.14 . . . . 1.77 108.166 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mt -99.85 138.49 36.86 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.735 -0.839 . . . . 1.63 108.735 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 t -111.56 125.4 53.88 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.495 -0.928 . . . . 1.08 108.495 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -102.58 -156.13 0.55 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.205 -1.776 . . . . 1.26 106.205 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.93 -45.86 1.05 Allowed Glycine 0 N--CA 1.498 2.788 0 O-C-N 120.339 -1.476 . . . . 0.01 112.068 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 178.33 -97.85 0.11 Allowed Glycine 0 N--CA 1.488 2.127 0 C-N-CA 118.463 -1.827 . . . . 0.01 112.159 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -121.48 120.42 34.87 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.389 -1.065 . . . . 4.43 110.707 -179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.489 ' O ' ' NH2' ' A' ' 174' ' ' ARG . . . -74.92 131.49 40.73 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.201 -0.666 . . . . 2.99 109.201 -179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.547 ' NZ ' HE22 ' A' ' 96' ' ' GLN . 0.5 OUTLIER -131.19 137.71 49.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.574 -0.704 . . . . 6.36 109.523 -179.266 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.438 ' O ' ' OE2' ' A' ' 109' ' ' GLU . 6.6 tt -127.78 142.75 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 CA-C-O 121.861 0.838 . . . . 1.09 109.456 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.547 HE22 ' NZ ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -125.21 134.59 52.3 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.177 -1.045 . . . . 2.05 108.177 178.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 m -125.72 148.48 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.88 -1.137 . . . . 1.1 109.961 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CZ ' ' SD ' ' A' ' 107' ' ' MET . 51.7 m-85 -118.32 141.16 48.81 Favored 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.925 0.869 . . . . 0.73 110.777 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -66.9 -29.8 69.78 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 116.013 -0.54 . . . . 0.02 111.813 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -116.69 167.96 10.62 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.087 -1.008 . . . . 3.18 110.573 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -66.29 164.03 41.5 Favored Glycine 0 N--CA 1.492 2.398 0 CA-C-O 121.936 0.742 . . . . 0.01 111.262 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' OG ' ' A' ' 128' ' ' SER . 2.8 m-20 56.39 39.49 30.04 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.955 -0.733 . . . . 0.01 110.928 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.555 ' H ' ' CB ' ' A' ' 128' ' ' SER . 4.7 m-85 52.27 55.51 9.07 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.732 -0.605 . . . . 0.01 110.826 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -128.82 165.84 20.21 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.399 -0.963 . . . . 3.15 108.399 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.85 -164.3 27.53 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.204 -1.558 . . . . 0.01 109.204 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.581 HE21 ' H ' ' A' ' 107' ' ' MET . 38.9 tp60 -74.51 144.5 44.08 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.052 -1.263 . . . . 0.01 108.167 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.581 ' H ' HE21 ' A' ' 106' ' ' GLN . 27.6 ttp -116.71 142.28 47.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.647 0.737 . . . . 0.01 109.454 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -131.18 136.63 48.45 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.191 -1.04 . . . . 2.48 108.191 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.533 ' OE2' ' N ' ' A' ' 110' ' ' THR . 8.8 tp10 -119.09 133.67 55.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.714 -0.616 . . . . 0.01 109.741 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.533 ' N ' ' OE2' ' A' ' 109' ' ' GLU . 3.9 t -148.99 149.39 31.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 1.69 110.593 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.519 ' O ' ' NH2' ' A' ' 174' ' ' ARG . 24.3 p -108.7 10.25 26.88 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.763 -0.653 . . . . 0.01 109.724 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 112' ' ' GLU . 37.3 mp0 -120.81 163.12 18.65 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.383 -0.823 . . . . 3.21 111.234 -178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 113' ' ' ASP . 3.1 p30 -65.75 154.73 38.19 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.052 -1.092 . . . . 0.01 108.052 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' CYS . . . . . . . . . . . . . 10.7 t -122.5 110.16 32.33 Favored Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 108.512 -0.921 . . . . 0.01 108.512 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -76.91 -31.63 3.79 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 CA-C-N 119.969 1.025 . . . . 0.01 111.833 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.2 t -142.02 107.92 5.16 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.088 -1.008 . . . . 0.02 108.792 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.4 mt -63.52 -39.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.913 -0.492 . . . . 1.83 110.576 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 10.5 ttt -66.49 -37.28 84.73 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.003 -1.079 . . . . 1.34 109.945 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -70.82 -39.12 73.23 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.489 -1.382 . . . . 2.11 109.842 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.442 ' OE1' ' CZ ' ' A' ' 121' ' ' PHE . 9.5 tt0 -80.78 -48.22 12.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.222 -0.924 . . . . 2.08 112.564 -176.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.442 ' CZ ' ' OE1' ' A' ' 120' ' ' GLN . 58.6 m-85 -111.82 -1.49 15.54 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.424 -0.797 . . . . 0.02 112.707 -175.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 61.1 34.4 19.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.095 . . . . 0.02 109.769 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.4 mt -114.19 135.49 53.98 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.534 -0.729 . . . . 0.02 109.152 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -90.32 -21.51 22.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.155 -0.966 . . . . 5.32 111.006 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.43 ' O ' HD13 ' A' ' 126' ' ' ILE . 39.8 mt-10 -148.42 163.57 36.73 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.045 -1.034 . . . . 0.02 110.06 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.43 HD13 ' O ' ' A' ' 125' ' ' GLU . 39.4 mm -128.48 125.6 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 107.554 -1.276 . . . . 2.17 107.554 178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -109.82 -13.9 14.39 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.145 -0.972 . . . . 0.02 113.118 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.555 ' CB ' ' H ' ' A' ' 103' ' ' PHE . 8.4 m -161.81 154.16 19.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.573 -1.33 . . . . 0.01 109.627 178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' CYS . . . . . . . . . . . . . 23.7 p -166.23 142.47 4.92 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.751 -0.833 . . . . 1.22 108.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.72 96.88 5.46 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.422 1.106 . . . . 1.41 108.221 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG21 ' CD1' ' A' ' 136' ' ' TRP . 11.6 p -107.67 137.64 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 CA-C-N 115.281 -0.872 . . . . 0.01 108.794 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.67 90.23 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 105.336 -2.098 . . . . 1.98 105.336 175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.449 ' CB ' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -149.47 -67.71 0.21 Allowed 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.836 -1.542 . . . . 0.01 106.836 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.12 -9.39 31.39 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 107.168 -2.373 . . . . 0.01 107.168 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.2 p -121.73 58.47 1.01 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.843 -0.798 . . . . 2.3 110.535 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.466 ' CD1' HG21 ' A' ' 131' ' ' VAL . 87.6 m95 -130.69 135.33 47.72 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 120.809 -1.182 . . . . 0.01 110.658 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 24.7 mt -119.8 137.71 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 N-CA-C 108.393 -0.966 . . . . 1.69 108.393 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -110.82 141.26 44.41 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 107.168 -1.419 . . . . 2.49 107.168 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -122.5 142.31 50.72 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.234 -0.916 . . . . 0.02 109.646 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -74.8 -31.2 61.65 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.714 -0.616 . . . . 0.02 112.187 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 11.3 mt -115.69 155.03 48.0 Favored Pre-proline 0 N--CA 1.506 2.355 0 O-C-N 120.736 -1.228 . . . . 1.48 109.135 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 1.3 Cg_endo -54.92 166.43 2.09 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 121.022 1.148 . . . . 0.02 112.913 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.541 ' ND2' ' O ' ' A' ' 142' ' ' PRO . 5.6 p30 57.05 31.9 20.74 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.056 -0.975 . . . . 0.75 111.822 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.445 ' CD1' ' CD ' ' A' ' 173' ' ' ARG . 1.7 m-85 59.35 51.85 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.02 111.397 177.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HE ' ' H ' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -127.05 166.29 17.88 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.479 -0.763 . . . . 0.02 109.793 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.663 ' H ' ' HE ' ' A' ' 145' ' ' ARG . . . 87.57 -165.58 35.41 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.307 -1.117 . . . . 0.02 110.307 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -69.11 141.88 54.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.499 -1.001 . . . . 0.02 108.873 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.475 ' O ' ' CG ' ' A' ' 58' ' ' MET . 9.2 mt-30 -114.8 149.15 37.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.267 0.556 . . . . 0.02 109.519 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -123.54 133.77 53.94 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.507 -0.923 . . . . 0.01 108.507 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 6.9 tp -94.69 122.3 37.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.792 -1.193 . . . . 0.01 109.342 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.564 ' N ' HD12 ' A' ' 151' ' ' LEU . 10.5 mp -93.23 149.0 21.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.01 108.875 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.495 ' C ' ' H ' ' A' ' 154' ' ' LYS . 1.6 m-20 -108.53 -175.88 2.9 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.51 -0.743 . . . . 2.27 109.222 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -74.4 27.36 0.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 1.84 109.501 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.495 ' H ' ' C ' ' A' ' 152' ' ' ASP . 55.1 mttm -112.76 174.69 5.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.473 -0.767 . . . . 2.28 109.354 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 155' ' ' GLU . 6.6 mp0 -106.57 138.02 43.51 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.936 -0.764 . . . . 0.01 108.936 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.82 114.31 28.27 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.304 -0.872 . . . . 0.01 110.273 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.47 ' O ' ' OG ' ' A' ' 128' ' ' SER . 11.2 mtp180 -86.52 -28.55 23.32 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.01 111.268 -177.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.6 mtmm -123.2 153.68 64.94 Favored Pre-proline 0 N--CA 1.499 1.993 0 N-CA-C 107.831 -1.174 . . . . 2.54 107.831 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.563 ' O ' ' CD1' ' A' ' 162' ' ' TRP . 9.6 Cg_endo -61.83 -41.93 34.67 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 CA-C-N 119.323 0.794 . . . . 0.7 110.455 178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 71.1 t -60.8 -18.56 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.808 -1.182 . . . . 0.86 109.279 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -65.88 -18.31 65.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.887 -1.133 . . . . 0.02 111.87 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TRP . . . . . 0.563 ' CD1' ' O ' ' A' ' 159' ' ' PRO . 0.6 OUTLIER -101.76 14.82 30.84 Favored 'General case' 0 N--CA 1.512 2.635 0 O-C-N 120.891 -1.13 . . . . 0.02 110.099 178.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.36 10.72 73.52 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 121.219 -0.926 . . . . 0.02 113.047 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.51 ' HB3' ' HE1' ' A' ' 162' ' ' TRP . . . -101.18 140.54 35.34 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.79 -1.417 . . . . 0.02 109.994 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -84.03 -6.81 59.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.708 -0.62 . . . . 0.59 109.544 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 97.2 p -140.97 150.2 58.53 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.213 -0.929 . . . . 0.87 109.192 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -74.33 16.64 0.57 Allowed 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.585 0.857 . . . . 0.38 111.942 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.18 120.19 25.03 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 122.177 0.989 . . . . 0.18 110.904 -178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.444 ' CD1' ' CZ2' ' A' ' 162' ' ' TRP . 1.4 mt -149.59 124.28 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 105.609 -1.997 . . . . 3.99 105.609 178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.0 mm100 -112.09 -12.77 13.64 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.241 -0.912 . . . . 5.17 113.246 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.9 m -157.7 160.76 38.28 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 119.146 -2.221 . . . . 0.02 110.388 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -151.59 153.14 33.93 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.373 -0.83 . . . . 2.02 109.875 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.445 ' CD ' ' CD1' ' A' ' 144' ' ' TYR . 16.2 mtp180 -143.55 150.0 38.25 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.217 -0.927 . . . . 0.01 110.121 -178.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.519 ' NH2' ' O ' ' A' ' 111' ' ' THR . 3.4 ptp180 -87.4 143.1 27.41 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.581 -0.896 . . . . 0.01 108.581 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 mt -95.79 128.51 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.207 -0.933 . . . . 3.04 109.25 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.9 t -137.52 147.81 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.199 -0.938 . . . . 1.89 109.653 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.43 -0.794 . . . . 4.89 109.412 179.689 . . . . . . . . 0 0 . 1 stop_ save_